Citrus Sinensis ID: 045256
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 789 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LY50 | 814 | Putative serine/threonine | yes | no | 0.975 | 0.945 | 0.609 | 0.0 | |
| Q9FIJ6 | 751 | Serine/threonine-protein | no | no | 0.797 | 0.837 | 0.368 | 1e-113 | |
| Q9LX29 | 895 | Serine/threonine-protein | no | no | 0.892 | 0.786 | 0.332 | 3e-99 | |
| O80963 | 776 | Serine/threonine-protein | no | no | 0.832 | 0.846 | 0.293 | 1e-69 | |
| O24585 | 901 | Putative receptor protein | N/A | no | 0.358 | 0.314 | 0.493 | 2e-69 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.344 | 0.292 | 0.449 | 3e-58 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.372 | 0.308 | 0.412 | 4e-58 | |
| Q9SR05 | 850 | Receptor-like protein kin | no | no | 0.486 | 0.451 | 0.362 | 2e-56 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.489 | 0.449 | 0.351 | 2e-56 | |
| Q9SCZ4 | 895 | Receptor-like protein kin | no | no | 0.365 | 0.321 | 0.412 | 1e-55 |
| >sp|Q9LY50|ACCR3_ARATH Putative serine/threonine-protein kinase-like protein CCR3 OS=Arabidopsis thaliana GN=CCR3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 874 bits (2258), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/833 (60%), Positives = 597/833 (71%), Gaps = 63/833 (7%)
Query: 1 MTKLPSTTTSFSVAVTVILISLCLPSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRLLC 60
M + ++T +FSV VT+ +I L SP +LGSGST AV YGS TVCA+++ QPTQR+LC
Sbjct: 1 MKRFINSTVTFSVTVTIAVIIFFLLSPVTSLGSGSTYAVVYGSDTVCALISGQPTQRILC 60
Query: 61 YQG--GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDT 118
Y + P +SFSSI+AG +F CGIRSGGYSLLCWD SY+ N KRIY ND
Sbjct: 61 YDTRLNINVTLNPGVSFSSIAAGDNFLCGIRSGGYSLLCWDNIGSYSPN--RKRIYQNDN 118
Query: 119 VLLSSVSVGNNHVCATTVQG--QINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTN 176
VLL ++SVG+ +CAT V G + CWRG V+ ++ P E +F S++SG+ FSCG+
Sbjct: 119 VLLETLSVGDKQICAT-VNGTNSLKCWRGSVS-DQSKPPNE-RFRSISSGVGFSCGVSIR 175
Query: 177 NKTVRCWGINSI-SNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLK-FP 234
N + CWG + + SNQIQT F N M +I+AG +H CG+++ G +IC G+N SGQL
Sbjct: 176 NNRILCWGTDPVKSNQIQTGFGNTPMVTISAGKSHACGLNTTGNLICIGNNDSGQLNVIA 235
Query: 235 LNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNFTCGL 294
+ S+LSLG N +CA+R N SVVCWG E N SFESI SG CGL
Sbjct: 236 PDQPNLYSSSLSLGSNFTCAMRISNNSVVCWGGGAERFNNVTDSISFESISSGPGLICGL 295
Query: 295 TTSNFSVICWGPGWPNVSNDSVSLVPFQQEILPGPC---DNSSCSECGLYPQSDRLCFGN 351
+SN S++CW P +N S +PF E+LPGPC +SS CG+YPQSD+LC G
Sbjct: 296 ISSNLSIMCWNP-----TNFSRIFLPFP-EVLPGPCVESSSSSLCSCGVYPQSDKLCSGT 349
Query: 352 GNICKSCQNVVPTPSAPPPSVEPPRSSSSPS--------RELTRGLLAFAIVGSVGGFAG 403
G+ICKSC P + PP PS + LTRGLLAFAIVGSVG FAG
Sbjct: 350 GSICKSCPIQFPASPPSQFPLPPPPPPPPPSPSTSSPPSKALTRGLLAFAIVGSVGAFAG 409
Query: 404 ICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRL 463
IC+V+YC+WTG C GKKKVHNSVQPTITRGGS + +NS SRS +IRRQGSR+
Sbjct: 410 ICSVVYCLWTGVCLGKKKVHNSVQPTITRGGSNS-------RSNSSNSRSLSIRRQGSRM 462
Query: 464 LTMRRQRSGTSS-KHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVA 522
L+MRRQRSGTSS KHAD+AEEF +ELA+AT NFSLENKIG+GSFGVVY+GKL DG+EVA
Sbjct: 463 LSMRRQRSGTSSMKHADKAEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVA 522
Query: 523 IKRGET-AKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGAL 581
IKRGE AK KKFQEKE+AFDSE+AFLSRLHHKHLVRLVGYCEE++E+LLVYDYMKNGAL
Sbjct: 523 IKRGEVNAKMKKFQEKETAFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGAL 582
Query: 582 YDHLHDRNNVEK----------------NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625
YDHLHD+NNVEK +AARGIEYLHNYAVPPIIHRDIKSSNILLD+
Sbjct: 583 YDHLHDKNNVEKHSSLINSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSN 642
Query: 626 WTARVSDFGLSMMGPESERDF----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVL 681
W ARVSDFGLS+MGP +D RP KAAGTVGYIDPEYY LNVLT KSDVYGLGVVL
Sbjct: 643 WVARVSDFGLSLMGPVLGKDHNPYQRPTKAAGTVGYIDPEYYSLNVLTDKSDVYGLGVVL 702
Query: 682 LELLTGKRAIFK-----DDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAV 736
LELLTGKRAIF+ ++E G PV LVD++VPAI A EL ILD RVG PE+ E +AV
Sbjct: 703 LELLTGKRAIFRNNGDVEEEEGCVPVHLVDYSVPAITADELSTILDPRVGSPELGEGDAV 762
Query: 737 ELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGSISSSGIVSIASD 789
ELVAYTAMHCVN EG+ RPTM DIV NLERALD+C SHGSI SSGI SI SD
Sbjct: 763 ELVAYTAMHCVNAEGRNRPTMTDIVGNLERALDLCGDSHGSI-SSGICSIVSD 814
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FIJ6|ACCR4_ARATH Serine/threonine-protein kinase-like protein CCR4 OS=Arabidopsis thaliana GN=CCR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 410 bits (1054), Expect = e-113, Method: Compositional matrix adjust.
Identities = 270/733 (36%), Positives = 386/733 (52%), Gaps = 104/733 (14%)
Query: 72 NISFSSISAGQSFFCGI----RSGGYSLLCWDTNFSYN-SNFVPKRIYYNDTVLLSSVSV 126
N FS + +G F CG+ S +LLCW FS + +N + KRIY+ L +
Sbjct: 75 NRRFSGVVSGNGFVCGLISRLDSNTSTLLCW--RFSVDGTNMLHKRIYHGPE--LEELEA 130
Query: 127 GNNHVCATT-VQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGI 185
GN +C V ++ CW+ P + + S+ G +F CG+ + C GI
Sbjct: 131 GNFRICGVERVSRRLRCWQ-----PYYLPRPD-NYRSIALGDNFFCGLSQPPGMISCEGI 184
Query: 186 NSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSAL 245
+ + +I AG C I + V C+G +S P ++ AL
Sbjct: 185 AKVP-------SGDHYIAIAAGSRQACAITVDNDVECWGQTQS----LPRE----KFLAL 229
Query: 246 SLGFNHSCAIRRLNGSVVCWGSQGEYSV-NGIRGKSFESIVSGSNFTCGLTTSNFSVICW 304
++G + C +R NG+VVCWG+ +S+ ++ F SI + CG+ T N+++ICW
Sbjct: 230 AVGEDRGCGVRWSNGTVVCWGNNNNFSLPQTLKDIHFTSIYAKGPMFCGVATRNYTLICW 289
Query: 305 GPGWPNVSNDSVSLVPFQ----QEILPGPCDNSSCSECGLYPQS--DRLCFGNGNICKSC 358
G N + S PFQ Q ++PGPC EC P S LC IC
Sbjct: 290 G----NENFKSGVFTPFQGLISQVVMPGPCRR----ECPYRPLSGSQSLCGNELMICDLK 341
Query: 359 QNVVPTPSAPPPSVEPPRSSSSPSRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFG 418
+N P R+ +S ++ +R +AF +VG VG F+ + + + ++ C
Sbjct: 342 RNDGEFPDT--------RAQNSKNKTWSRRNIAFLVVGCVGTFSLLLVISFLIFKSHC-- 391
Query: 419 KKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHA 478
+ +VH+S + TR + I + RL T+ S +
Sbjct: 392 RCRVHDSGRLDDTR--------------------TIDIPKLEKRLCTL------ASLGNP 425
Query: 479 DRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGE--------TAK 530
+ EF + ELA AT+ FS+ +G GSFG VY+G L DG+ VAIKR E T
Sbjct: 426 GQLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKRAELTNPTLSGTTM 485
Query: 531 TKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD--- 587
+ +K+SAF +EL +SRL+HK+LVRL+G+ E+ +ER+LVY+YMKNG+L DHLH+
Sbjct: 486 RHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMKNGSLADHLHNPQF 545
Query: 588 -------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640
R + +AARGI+YLH + VPP+IHRDIKSSNILLDA WTA+VSDFGLS MGP
Sbjct: 546 DPLSWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGLSQMGP 605
Query: 641 ESERDFR--PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG 698
E D + AAGT+GYIDPEYY LT KSDVY GVVLLELL+G +AI +++
Sbjct: 606 TEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSGHKAIHNNEDEN 665
Query: 699 GTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMA 758
P +LV++ VP I+ E +ILD+R+ PP E EAV V Y A C+ ++RP+M
Sbjct: 666 --PRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLAAECLMPCSRKRPSMV 723
Query: 759 DIVANLERALDIC 771
++V+ LE AL C
Sbjct: 724 EVVSKLESALAAC 736
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 363 bits (932), Expect = 3e-99, Method: Compositional matrix adjust.
Identities = 275/826 (33%), Positives = 401/826 (48%), Gaps = 122/826 (14%)
Query: 17 VILISLCLPSP----AHALGSGSTLAVSYGSA-TVCAVVAAQPTQRLLCY--QGGTIRAV 69
++L+ L L + A ALGS S++A+SYG +V + + + ++CY +
Sbjct: 12 ILLVKLVLFTSIWQLASALGSMSSIAISYGEGGSVFCGLKSDGSHLVVCYGSNSAILYGT 71
Query: 70 EPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNN 129
++ F ++ G F CG+ + CW N ++ VP+ + L VS G+
Sbjct: 72 PGHLQFIGLTGGDGFMCGLLMLSHQPYCWG-NSAFIQMGVPQPMTKGAEYL--EVSAGDY 128
Query: 130 HVCA--TTVQGQ-----------INCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTN 176
H+C + G+ ++CW N+++N + Q SL++G +F+C + +
Sbjct: 129 HLCGLRKPIVGRRKNSNIISSSLVDCW--GYNMTRNFVFDK-QLHSLSAGSEFNCALSSK 185
Query: 177 NKTVRCWGINSISNQIQTSFANRSMFSITAGGNHVCGIDS--NGFVICYGDNKSGQLKFP 234
+K+V CWG + S I + I AGG HVCGI V+C+G KS + +
Sbjct: 186 DKSVFCWGDENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLCWG--KSLEFEEE 243
Query: 235 LNSTAFEYSALSL-----------GFNHSCAIRRLNGSVVCWGSQGEYSVNGIRGKSFES 283
+ T+ E L L G ++C I+R + S VCWG S G F
Sbjct: 244 VTGTSTEEKILDLPPKEPLLAVVGGKFYACGIKRYDHSAVCWGFFVNRSTPAPTGIGFYD 303
Query: 284 IVSGSNFTCG-LTTSNFSVICWGPGWPNVSNDSVSLVPFQQEILPGPCDNSSC--SECGL 340
+ +G+ FTCG LT ++ S +CWG G+P +VS PG C ++ C L
Sbjct: 304 LAAGNYFTCGVLTGTSMSPVCWGLGFPASIPLAVS---------PGLCIDTPCPPGTHEL 354
Query: 341 YPQSDRLC-FGNGNICKSCQNVVPTPSAPPPSVEPPRSSS-------------------- 379
Q + C F +IC C P P SV RS
Sbjct: 355 SNQENSPCKFTGSHICLPCSTSCP-PGMYQKSVCTERSDQVCVYNCSSCSSHDCSSNCSS 413
Query: 380 ---SPSRELTRGL-LAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGS 435
S +E + L I + GFA + + T A + + ++ N
Sbjct: 414 SATSGGKEKGKFWSLQLPIATAEIGFALFLVAVVSI-TAALYIRYRLRN----------C 462
Query: 436 RAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNN 495
R N S +S ++ R L RR RA F EL A +
Sbjct: 463 RCSENDTRSSKDSAFTKDNGKIRPDLDELQKRR-----------RARVFTYEELEKAADG 511
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
F E+ +G GSF VYKG L DG VA+KR + K Q+ + F +EL LSRL+H H
Sbjct: 512 FKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDK--QKNSNEFRTELDLLSRLNHAH 569
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-------------NAARGIEYL 602
L+ L+GYCEE ERLLVY++M +G+L++HLH +N K AARGIEYL
Sbjct: 570 LLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYL 629
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H YA PP+IHRDIKSSNIL+D + ARV+DFGLS++GP AGT+GY+DPEY
Sbjct: 630 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSPLAELPAGTLGYLDPEY 689
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
Y L+ LT KSDVY GV+LLE+L+G++AI E G ++V++AVP I AG++ +LD
Sbjct: 690 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEG----NIVEWAVPLIKAGDINALLD 745
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
+ P +E EA++ + A CV + GK+RP+M + LERAL
Sbjct: 746 PVLKHP--SEIEALKRIVSVACKCVRMRGKDRPSMDKVTTALERAL 789
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80963|ACCR2_ARATH Serine/threonine-protein kinase-like protein CCR2 OS=Arabidopsis thaliana GN=CCR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (677), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 242/825 (29%), Positives = 350/825 (42%), Gaps = 168/825 (20%)
Query: 30 ALGSGSTLAVSYGSATVCAVVAAQPTQRLLCY-QGGTIRAVEP---NIS-----FSSISA 80
A GS T+A ++G + A Q ++C+ +G T R++ IS +S+S
Sbjct: 22 AYGSTGTIAAAFGENGFFCAIDASGKQEVICWDRGNTNRSLNRPPGEISGYSPPMTSLSG 81
Query: 81 GQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATT----- 135
G+ F C I S CW+ + N VP+ YN + ++S GNNHVCA +
Sbjct: 82 GEGFLCAITSNTSRAFCWNLE-DPSENLVPRAFQYNSYLQIAS---GNNHVCAISGLYYS 137
Query: 136 --VQGQINCWRGDVNIS-----------KNAPSGELQFESLTSGIDFSCGILTNNKTVRC 182
G ++CW N + N L F + SG FSCG+ T + + C
Sbjct: 138 GPDYGPVHCWEYSDNTNFTSGLLWNSSFHNPYIDSLMFRKIVSGDGFSCGV-TKDGDLVC 196
Query: 183 WGINSISNQIQTSFANRSMFSITAGG-NHVCGIDSN-GFVICYGDNKSGQLKFPLNSTAF 240
WG S N + +F+N F + A G N VCG+ + G + C+GD + +F
Sbjct: 197 WGPKS--NLL--NFSNNEEFEVLASGRNSVCGVSKDSGQLHCFGD----ETEFGSLPNRP 248
Query: 241 EYSALSLGFNHSCAIRRLNGSVVCWGSQ--GEYSVNGIRGKSFESIVSGSNFTCGLTTSN 298
+ ALS G NH C IR + V CWG S + F +I S + TCG+ +
Sbjct: 249 RFIALSAGANHYCGIREDDHGVECWGRNLNSSSSSSAPNTSGFVAISSSDSTTCGVRELD 308
Query: 299 FSVICW----------------------------GPGWPNVS------NDSVSLVPFQQ- 323
+ CW G GW + ++ SL F
Sbjct: 309 LVLDCWRVHDSSKADYSPPLELCSPGMCSPRGNCGDGWFAFNASILKESELTSLCSFHNL 368
Query: 324 --------EILPGPCDNSSCSECGLYPQSDRLCFGNGNICKSCQNVVPTPSAPPPSVEPP 375
L G +S+C+ P +DR+C C CQN + +
Sbjct: 369 NICLRCGISCLEGYFPSSTCN-----PNADRVC----TPCSLCQNSSCYGICKIRATKSK 419
Query: 376 RSSSSPSRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGS 435
RE+ R L I SV GF + + S P +T+G
Sbjct: 420 EHEQKEQREVRR--LVIIIGCSVLGFLVMLIGL----------------SFIPKMTKGSK 461
Query: 436 RAGSNGGAGS------NNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAEL 489
R + NS + + Q L T + + F L+EL
Sbjct: 462 RDDEERSKMTCCFCFDKNSVEADPDPVPHQSVLLPT---------AVSLGETKIFRLSEL 512
Query: 490 AAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLS 549
AT+ F N++G GSFG VYK L DG VA+KR A F+SEL L
Sbjct: 513 KDATHGFKEFNELGRGSFGFVYKAVLSDGIHVAVKRANAATI--IHSNNRGFESELEILC 570
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD---------RNNVEKNAARGIE 600
++ H ++V L+GYC E ERLLVY+YM +G L+DHLH R + AARG++
Sbjct: 571 KIRHNNIVNLLGYCSEMGERLLVYEYMPHGTLHDHLHGDLSQLDWSMRLKIMLQAARGLD 630
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
YLHN PPIIHRD+K+SNILLD + AR++DFGL +ERD G
Sbjct: 631 YLHNEVDPPIIHRDVKTSNILLDGEMCARIADFGLV---SSNERDSSNSDREG------- 680
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
DVY G+VLLE+L+G++AI ++ + P + ++AVP I G+ I
Sbjct: 681 ------------DVYDFGIVLLEILSGRKAIDRESD----PAGIAEWAVPLIRKGKAAAI 724
Query: 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
+DR + P E + +A A V ERP + +I+ L+
Sbjct: 725 IDRNICLPR--NVEPLLKLAELAELAVRENSNERPNIRNILCFLD 767
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 150/304 (49%), Positives = 199/304 (65%), Gaps = 21/304 (6%)
Query: 480 RAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKES 539
RA+EF EL AT FS ++++G GSF V+KG L DG VA+KR A K KE
Sbjct: 489 RAQEFSYEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKE- 547
Query: 540 AFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN-NVEK----- 593
F +EL LSRL+H HL+ L+GYCE+ ERLLVY++M +G+LY HLH ++ N++K
Sbjct: 548 -FHNELDLLSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWA 606
Query: 594 -------NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
AARGIEYLH YA PP+IHRDIKSSNIL+D ARV+DFGLS++GP
Sbjct: 607 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTP 666
Query: 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706
AGT+GY+DPEYY L+ LT KSDVY GVVLLE+L+G++AI E G ++V+
Sbjct: 667 LSELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEG----NIVE 722
Query: 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
+AVP I AG++ ILD + PP ++ EA++ +A A CV + GK+RP+M + LE
Sbjct: 723 WAVPLIKAGDIFAILDPVLSPP--SDLEALKKIASVACKCVRMRGKDRPSMDKVTTALEH 780
Query: 767 ALDI 770
AL +
Sbjct: 781 ALAL 784
|
Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 227 bits (578), Expect = 3e-58, Method: Compositional matrix adjust.
Identities = 134/298 (44%), Positives = 182/298 (61%), Gaps = 26/298 (8%)
Query: 486 LAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSEL 545
L L AT+NFS K+G GSFG VY G++ DG+EVA+K TA ++ F +E+
Sbjct: 598 LPVLEEATDNFS--KKVGRGSFGSVYYGRMKDGKEVAVKI--TADPSSHLNRQ--FVTEV 651
Query: 546 AFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH-----------DRNNVEKN 594
A LSR+HH++LV L+GYCEE D R+LVY+YM NG+L DHLH R + ++
Sbjct: 652 ALLSRIHHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQD 711
Query: 595 AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK--AA 652
AA+G+EYLH P IIHRD+KSSNILLD A+VSDFGLS ++E D + A
Sbjct: 712 AAKGLEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSR---QTEEDLTHVSSVAK 768
Query: 653 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
GTVGY+DPEYY LT KSDVY GVVL ELL+GK+ + +D G +++V +A I
Sbjct: 769 GTVGYLDPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAED--FGPELNIVHWARSLI 826
Query: 713 MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770
G++ I+D + + E+V VA A CV G RP M +++ ++ A+ I
Sbjct: 827 RKGDVCGIIDPCIASNV--KIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRI 882
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 226 bits (577), Expect = 4e-58, Method: Compositional matrix adjust.
Identities = 134/325 (41%), Positives = 191/325 (58%), Gaps = 31/325 (9%)
Query: 467 RRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRG 526
RR+RS +S + + F AELA AT+NF+ +IG G +G VYKG L G VAIKR
Sbjct: 596 RRKRSSKASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGTLGSGTVVAIKRA 655
Query: 527 ETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH 586
+ + E F +E+ LSRLHH++LV L+G+C+E+ E++LVY+YM+NG L D++
Sbjct: 656 QEGSL----QGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMENGTLRDNIS 711
Query: 587 ----------DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636
R + +A+GI YLH A PPI HRDIK+SNILLD+++TA+V+DFGLS
Sbjct: 712 VKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTAKVADFGLS 771
Query: 637 MMGPESERD-FRPMKAA----GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691
+ P + + P + GT GY+DPEY+ + LT KSDVY LGVVLLEL TG + I
Sbjct: 772 RLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLELFTGMQPI 831
Query: 692 FKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP-PEINEAEAVELVAYTAMHCVNLE 750
G V ++ A +G ++ +D+R+ P+ E +E A A+ C E
Sbjct: 832 ----THGKNIVREINIAYE---SGSILSTVDKRMSSVPD----ECLEKFATLALRCCREE 880
Query: 751 GKERPTMADIVANLERALDICDHSH 775
RP+MA++V LE ++ SH
Sbjct: 881 TDARPSMAEVVRELEIIWELMPESH 905
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SR05|ANX1_ARATH Receptor-like protein kinase ANXUR1 OS=Arabidopsis thaliana GN=ANX1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (563), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 154/425 (36%), Positives = 208/425 (48%), Gaps = 41/425 (9%)
Query: 366 SAPPPSVEPPRSSSSPSRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGA-CFGKKKVHN 424
+ P P P ++ +E I+GS GG + V GA CF K
Sbjct: 404 AGPNPEPSPMQAEEEVKKEFKNEKRHAFIIGSAGG-------VLAVLIGALCFTAYK--- 453
Query: 425 SVQPTITRGGSRAGSNGGAGSNNS--PPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAE 482
+ G GG +S P ++T S + S S+ A
Sbjct: 454 ----------KKQGYQGGDSHTSSWLPIYGNSTTSGTKSTISGKSNNGSHLSNLAAGLCR 503
Query: 483 EFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFD 542
F L E+ T NF N IG G FG VYKG + +VA+K+ + E F+
Sbjct: 504 RFSLPEIKHGTQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNE----FE 559
Query: 543 SELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD----------RNNVE 592
+E+ LSRL HKHLV L+GYC+E E LVYDYM G L +HL++ R +
Sbjct: 560 TEIELLSRLRHKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIA 619
Query: 593 KNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA 652
AARG+ YLH A IIHRD+K++NIL+D W A+VSDFGLS GP
Sbjct: 620 IGAARGLHYLHTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVK 679
Query: 653 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
G+ GY+DPEY+ LT KSDVY GVVL E+L + A+ + VSL D+A+
Sbjct: 680 GSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEILCARPAL--NPSLPKEQVSLGDWAMNCK 737
Query: 713 MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772
G L I+D + +IN AE ++ A TA C+N G ERPTM D++ NLE AL + +
Sbjct: 738 RKGNLEDIIDPNL-KGKIN-AECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQLQE 795
Query: 773 HSHGS 777
+ G+
Sbjct: 796 TADGT 800
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 221 bits (562), Expect = 2e-56, Method: Compositional matrix adjust.
Identities = 149/424 (35%), Positives = 218/424 (51%), Gaps = 38/424 (8%)
Query: 366 SAPPPSVEPPRSSSSPSRELT--RGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVH 423
+ P P P +++ ++ + + AF ++GS GG A V++C + +K+
Sbjct: 407 AGPNPKPSPMQANEDVKKDFQGDKRITAF-VIGSAGGVAA---VLFCALCFTMYQRKRKF 462
Query: 424 NSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEE 483
+ + G++ + + ++ +S GS L S+ A
Sbjct: 463 SGSDSHTSSWLPIYGNSHTSATKSTISGKS----NNGSHL----------SNLAAGLCRR 508
Query: 484 FLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS 543
F L+E+ T+NF N IG G FG VYKG + G +VAIK+ + E F++
Sbjct: 509 FSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNE----FET 564
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD----------RNNVEK 593
E+ LSRL HKHLV L+GYC+E E L+YDYM G L +HL++ R +
Sbjct: 565 EIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAI 624
Query: 594 NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAG 653
AARG+ YLH A IIHRD+K++NILLD W A+VSDFGLS GP G
Sbjct: 625 GAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKG 684
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
+ GY+DPEY+ LT KSDVY GVVL E+L + A+ + VSL D+A+
Sbjct: 685 SFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPAL--NPSLSKEQVSLGDWAMNCKR 742
Query: 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773
G L I+D + +IN E ++ A TA C++ G +RPTM D++ NLE AL + +
Sbjct: 743 KGTLEDIIDPNL-KGKIN-PECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQLQET 800
Query: 774 SHGS 777
+ GS
Sbjct: 801 ADGS 804
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1 | Back alignment and function description |
|---|
Score = 218 bits (555), Expect = 1e-55, Method: Compositional matrix adjust.
Identities = 130/315 (41%), Positives = 175/315 (55%), Gaps = 27/315 (8%)
Query: 471 SGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQ-EVAIKRGETA 529
S SS ++ F AE+ AAT NF +G G FG VY+G++ G +VAIKRG
Sbjct: 511 SYASSLPSNLCRHFSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPM 570
Query: 530 KTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN 589
+ E F +E+ LS+L H+HLV L+GYCEE E +LVYDYM +G + +HL+
Sbjct: 571 SEQGVHE----FQTEIEMLSKLRHRHLVSLIGYCEENCEMILVYDYMAHGTMREHLYKTQ 626
Query: 590 N----------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639
N + AARG+ YLH A IIHRD+K++NILLD +W A+VSDFGLS G
Sbjct: 627 NPSLPWKQRLEICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTG 686
Query: 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699
P + G+ GY+DPEY+ LT KSDVY GVVL E L + A+ +
Sbjct: 687 PTLDHTHVSTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEALCARPAL--NPTLAK 744
Query: 700 TPVSLVDFAVPAIMAGELVKILDR----RVGPPEINEAEAVELVAYTAMHCVNLEGKERP 755
VSL ++A G L +I+D ++ P E + A TAM CV +G ERP
Sbjct: 745 EQVSLAEWAPYCYKKGMLDQIVDPYLKGKITP------ECFKKFAETAMKCVLDQGIERP 798
Query: 756 TMADIVANLERALDI 770
+M D++ NLE AL +
Sbjct: 799 SMGDVLWNLEFALQL 813
|
Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 789 | ||||||
| 225448439 | 790 | PREDICTED: putative serine/threonine-pro | 0.946 | 0.945 | 0.688 | 0.0 | |
| 356551446 | 796 | PREDICTED: putative serine/threonine-pro | 0.942 | 0.934 | 0.667 | 0.0 | |
| 449463050 | 821 | PREDICTED: putative serine/threonine-pro | 0.945 | 0.908 | 0.666 | 0.0 | |
| 356501160 | 795 | PREDICTED: putative serine/threonine-pro | 0.964 | 0.957 | 0.652 | 0.0 | |
| 357492697 | 925 | Receptor kinase-like protein [Medicago t | 0.955 | 0.815 | 0.643 | 0.0 | |
| 449510857 | 803 | PREDICTED: putative serine/threonine-pro | 0.931 | 0.915 | 0.667 | 0.0 | |
| 255585374 | 742 | conserved hypothetical protein [Ricinus | 0.851 | 0.905 | 0.688 | 0.0 | |
| 356569298 | 809 | PREDICTED: putative serine/threonine-pro | 0.970 | 0.946 | 0.626 | 0.0 | |
| 356537993 | 805 | PREDICTED: putative serine/threonine-pro | 0.949 | 0.930 | 0.645 | 0.0 | |
| 357461261 | 788 | Serine/threonine protein kinase-like pro | 0.937 | 0.939 | 0.640 | 0.0 |
| >gi|225448439|ref|XP_002272022.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 992 bits (2564), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 542/787 (68%), Positives = 624/787 (79%), Gaps = 40/787 (5%)
Query: 25 PSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTIRAVEPNISFSSISAG-QS 83
P+ H LGSGSTLAVSYGS VC VVA + QR+ CY+GG ++EPNIS S +G +
Sbjct: 22 PALVHGLGSGSTLAVSYGSGAVCGVVAGERYQRIECYRGGETISIEPNISSFSSISGGRD 81
Query: 84 FFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV-QGQINC 142
FFCG+RSGG++L CW N++FV KRIY+N TVLL +++VG++ VCAT G + C
Sbjct: 82 FFCGLRSGGFALFCW------NTSFVAKRIYFNYTVLLENLAVGDDQVCATVNGTGVVKC 135
Query: 143 WRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMF 202
WRG+ + ++ S QF S++SG+ FSCGIL NN+TV+CWG N+I+NQIQ F N M
Sbjct: 136 WRGE---NSSSLSESSQFSSISSGLGFSCGILVNNRTVQCWGSNTIANQIQQEFGNTPML 192
Query: 203 SITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSV 262
SI AGG+HVCG+++ G+++C G N SGQL P + +A+E+S LSLG NHSCAIR+ NGSV
Sbjct: 193 SIMAGGSHVCGLNTTGYLLCEGSNDSGQLNVP-SGSAYEFSNLSLGENHSCAIRQSNGSV 251
Query: 263 VCWGSQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDSVSLVPFQ 322
VCWG GE+S N G SFESIVSG NFTCGL T+N+S+ICWGPGWP+ S + L P
Sbjct: 252 VCWGGGGEFSTNATNGISFESIVSGLNFTCGLITTNYSIICWGPGWPSSSVSGLGLSPLP 311
Query: 323 QEI-LPGPCDNSSCSECGLYPQSDRLCFGNGNICKSCQNVVP--TPSAPPPSVEPPRSSS 379
I LPGPC SS EC +YP S LC+G+ +CK C+ +VP P S S
Sbjct: 312 LSIILPGPCVQSSSCEC-VYPGSQYLCYGSEVVCKPCRVLVPGSPVPLSPVSPPSVSPPS 370
Query: 380 SPSRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGS 439
SPSR L+RGLLAFAIVGSVG F+GICT+IYC+WTG C G KK+HNSVQPTI RG S
Sbjct: 371 SPSRALSRGLLAFAIVGSVGAFSGICTIIYCLWTGVCCGHKKIHNSVQPTIARGNS---- 426
Query: 440 NGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLE 499
NGGA SN+SPPSRS TIRRQ SR MRRQRSGTSSKH DRAEEF L+ELAAAT+NFSLE
Sbjct: 427 NGGANSNSSPPSRSLTIRRQSSR--AMRRQRSGTSSKHTDRAEEFALSELAAATDNFSLE 484
Query: 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETA-KTKKFQEKESAFDSELAFLSRLHHKHLVR 558
NKIGAGSFGVVYKGKLPDG+EVAIKRGET KTKKFQEKESAFDSELAFLSRLHHKHLVR
Sbjct: 485 NKIGAGSFGVVYKGKLPDGREVAIKRGETGLKTKKFQEKESAFDSELAFLSRLHHKHLVR 544
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK----------------NAARGIEYL 602
LVG+C+E DERLLVY+YMKNGALYDHLHD+NN+EK +AARGIEYL
Sbjct: 545 LVGFCQEMDERLLVYEYMKNGALYDHLHDKNNIEKSSNVLNSWKLRIRISLDAARGIEYL 604
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
HNYAVPPIIHRDIKSSNILLDA WTARVSDFGLS+MGP+S FRPMKAAGTVGYIDPEY
Sbjct: 605 HNYAVPPIIHRDIKSSNILLDANWTARVSDFGLSLMGPDSSHSFRPMKAAGTVGYIDPEY 664
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD E+GGTP+S+VDFAVPAI+AGEL+K+LD
Sbjct: 665 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDGENGGTPISVVDFAVPAIIAGELMKVLD 724
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGSISSSG 782
RVGPP+ NEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL +C+ SHGSI SSG
Sbjct: 725 PRVGPPQTNEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALALCEDSHGSI-SSG 783
Query: 783 IVSIASD 789
+SI SD
Sbjct: 784 TISIVSD 790
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356551446|ref|XP_003544086.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 979 bits (2532), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/784 (66%), Positives = 614/784 (78%), Gaps = 40/784 (5%)
Query: 29 HALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTIRAVEPNISFSSISAGQSFFCGI 88
HALGS +TLAV+ S+ VC VVA++PT+R+ CY+ G + AV PN+SFS+IS G+S+FCG+
Sbjct: 30 HALGSAATLAVT--SSAVCGVVASEPTRRIACYRHGEVVAVAPNVSFSTISGGRSYFCGL 87
Query: 89 RSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV-QGQINCWRGDV 147
RSG YSLLCWDT S F KR+Y N TVL ++++G++ VCAT V G+ +CWR
Sbjct: 88 RSGNYSLLCWDTL----SAFQSKRLYNNGTVLFENLALGDSQVCATVVGAGKASCWR--T 141
Query: 148 NISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITAG 207
N + +PSG +F+S++SG FSCG+L + VRCWG+ SI+ ++++ F N SM S+ AG
Sbjct: 142 NAAFESPSGSDRFDSISSGSGFSCGVLKGSDRVRCWGVGSIARKMESEFRNMSMVSLVAG 201
Query: 208 GNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGS 267
+HVCG++S+G+++C G N GQ+ P A E+S L+LG H+CAIRR NGSVVCWG
Sbjct: 202 ESHVCGLNSSGYLVCRGSNNFGQIDVP-EGGALEFSGLALGVEHTCAIRRSNGSVVCWGG 260
Query: 268 QGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDSVSLVPFQQEILP 327
+G + N +G SFE IVSGSNFTCGLTT+NFSVICWGPGW N S + L P
Sbjct: 261 RGLFEDNVTKGVSFEVIVSGSNFTCGLTTNNFSVICWGPGWDNGSGYEIPLPPILPGP-- 318
Query: 328 GPCDNSSCSECGLYPQSDRLCFGNGNICKS--C--QNVVPTPSAPPPSVEPPRSSSSPSR 383
C S CSECG+YPQS LC G GNICK C + +VP P P+ P +S S+
Sbjct: 319 --CVQSPCSECGIYPQSASLCSGYGNICKPKPCLPEMLVPAPPVVMPATPPSPPPASRSK 376
Query: 384 ELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSNGGA 443
LT+GLLAFAIVG VGG AGICT IY +WTG CFGKKKVHNSVQPTITRGGS G G
Sbjct: 377 ALTKGLLAFAIVGCVGGVAGICTAIYSLWTGVCFGKKKVHNSVQPTITRGGSVNGVGGSN 436
Query: 444 GSNNSPPSRSATIRRQGSRLLTMRRQRSGTSS-KHADRAEEFLLAELAAATNNFSLENKI 502
++ SPPSRS+TIRRQGSR+ MRRQRSGTSS KH +RAEEF LAEL AAT+NFSLENKI
Sbjct: 437 -NSISPPSRSSTIRRQGSRI--MRRQRSGTSSTKHPERAEEFTLAELVAATDNFSLENKI 493
Query: 503 GAGSFGVVYKGKLPDGQEVAIKRGETA-KTKKFQEKESAFDSELAFLSRLHHKHLVRLVG 561
GAGS+GVVYKGKL DG+EVAIKRGET+ K KKFQEKE+AF+SELAFLSRLHHKHLVRLVG
Sbjct: 494 GAGSYGVVYKGKLADGREVAIKRGETSTKMKKFQEKETAFESELAFLSRLHHKHLVRLVG 553
Query: 562 YCEEKDERLLVYDYMKNGALYDHLHDRNNVEK----------------NAARGIEYLHNY 605
+CEEKDERLLVY+YMKNGALYDHLHD+NNV+K +A+RGIEYLHNY
Sbjct: 554 FCEEKDERLLVYEYMKNGALYDHLHDKNNVDKSSSVLNSWRMRIKVALDASRGIEYLHNY 613
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
AVP IIHRDIKSSNIL+DA WTARVSDFGLS+M PES+ D++PMKAAGTVGYIDPEYYGL
Sbjct: 614 AVPSIIHRDIKSSNILIDATWTARVSDFGLSLMSPESDHDYQPMKAAGTVGYIDPEYYGL 673
Query: 666 NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725
NVLTAKSDVYGLGVVLLELLTGKRAIFK+DE+GGTPVS+VDFAVP IM GEL KILD RV
Sbjct: 674 NVLTAKSDVYGLGVVLLELLTGKRAIFKNDENGGTPVSVVDFAVPVIMTGELAKILDPRV 733
Query: 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGSISSSGIVS 785
PPE+NE EAVELV YTAMHCVNLEGK+RPTMADIVANLERAL +CD SHGSI SSG +S
Sbjct: 734 KPPEMNETEAVELVGYTAMHCVNLEGKDRPTMADIVANLERALALCDSSHGSI-SSGTIS 792
Query: 786 IASD 789
I SD
Sbjct: 793 IVSD 796
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463050|ref|XP_004149247.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2516), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 520/780 (66%), Positives = 603/780 (77%), Gaps = 34/780 (4%)
Query: 29 HALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTIRAVEPNISFSSISAGQSFFCGI 88
ALGS STLAVSYGS TVC +VA QPTQR+LC++ G +EP ISFS++S G++ FCGI
Sbjct: 28 QALGSASTLAVSYGSRTVCGIVAEQPTQRILCFRDGQTIFIEPGISFSAVSGGRNTFCGI 87
Query: 89 RSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV-QGQINCWRGDV 147
RSGGY++LCW+ N + + F +R+YYN VLL +++VG++ +CAT V G + CWR
Sbjct: 88 RSGGYTILCWNFNLT-TAAFTRRRLYYNPNVLLENLAVGDDQICATVVGAGNVTCWRDGN 146
Query: 148 NISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINS-ISNQIQTSFANRSMFSITA 206
+ S L ++S++SG FSCGIL N+++RCWG NS I+ +I+ F N SM SI A
Sbjct: 147 KVIGGFSS--LLYDSISSGYGFSCGILKGNQSIRCWGRNSSIATEIENGFRNISMLSIVA 204
Query: 207 GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWG 266
GG HVCG++ +G ++C G+N GQL FP N + E+S L+LG HSC I N SV+CWG
Sbjct: 205 GGFHVCGLNISGGLVCKGNNDFGQLDFPSNYSV-EFSELALGERHSCGILVSNRSVICWG 263
Query: 267 SQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDSVSLVPFQQEIL 326
G +SV+ IR SFE I SGS+F CGLTTSNFSV+CWGPGW N S SL +IL
Sbjct: 264 GLG-FSVDLIRETSFELISSGSDFVCGLTTSNFSVLCWGPGWSNNSLSPSSLS--LPKIL 320
Query: 327 PGPCDNSSCSECGLYPQSDRLCFGNGNICKSCQNVVPTPSAPPPSVEPPRSSSSPSR--- 383
PGPC S CG+YP S LC +GN+C C VPTPS+P P P S +
Sbjct: 321 PGPCVLQSSCSCGVYPLSQTLCSNSGNVCNRCFFTVPTPSSPQPLPSSPPRSPPVTTPSP 380
Query: 384 ---ELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSN 440
L RGLLAF IVGSVG FAGICT+IYC+WTG CFG KK+HNSVQPTITR S G
Sbjct: 381 TPAALKRGLLAFGIVGSVGAFAGICTIIYCLWTGVCFGNKKIHNSVQPTITRAASSNGGT 440
Query: 441 GGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLEN 500
+ +NNSPPSRS+TIRRQGSR+ MRRQRSGTSSKHADRAEEF LAELA ATN+FS EN
Sbjct: 441 TTSNTNNSPPSRSSTIRRQGSRI--MRRQRSGTSSKHADRAEEFTLAELAMATNDFSPEN 498
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETA-KTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG GSFGVVY+GKL DG+EVAIKRGET KTKKFQEKESAFDSELAFLSRLHHKHLVRL
Sbjct: 499 KIGEGSFGVVYRGKLYDGREVAIKRGETGQKTKKFQEKESAFDSELAFLSRLHHKHLVRL 558
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK----------------NAARGIEYLH 603
VGYCEEKDERLLVY+YMKNGALY+HLHD+NN EK +AARGIEYLH
Sbjct: 559 VGYCEEKDERLLVYEYMKNGALYNHLHDKNNFEKASSVVNSWKMRIKIALDAARGIEYLH 618
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
NYAVPPIIHRDIKSSNILLDA WTARVSDFGLS+M P S+RD+RP KAAGTVGYIDPEYY
Sbjct: 619 NYAVPPIIHRDIKSSNILLDANWTARVSDFGLSLMSPGSDRDYRPTKAAGTVGYIDPEYY 678
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
GLNVLTAKSDVYGLGVVLLELLTGKRAIFKD+E GGTPVS+VD+AVP IMAGEL KILD+
Sbjct: 679 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDEEQGGTPVSVVDYAVPVIMAGELGKILDQ 738
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGSISSSGI 783
RVGPP+INEAEAVELVAYTAMHCV+LEGK+RPTM DIV+NLERAL++CD SHGSISS+ +
Sbjct: 739 RVGPPQINEAEAVELVAYTAMHCVHLEGKDRPTMTDIVSNLERALNLCDDSHGSISSASL 798
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356501160|ref|XP_003519396.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2515), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/817 (65%), Positives = 626/817 (76%), Gaps = 56/817 (6%)
Query: 3 KLPSTTTSFSV--AVTVILISLCLPSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRLLC 60
K P + +F++ A +IL SL SP HALGS +TLA + S+ VC VVA++PT+R+ C
Sbjct: 5 KSPFSAATFTLFNATLLILSSL---SPTHALGSAATLAAT--SSAVCGVVASEPTRRIAC 59
Query: 61 YQGGTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVL 120
Y+ G + AV PN+SFS+IS G+S+FCG+RSG YSLLCWDT S F KR+Y N TVL
Sbjct: 60 YRHGEVVAVAPNVSFSAISGGRSYFCGLRSGNYSLLCWDTL----SGFQSKRLYNNGTVL 115
Query: 121 LSSVSVGNNHVCATTV-QGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKT 179
L +++G++ VCAT V G +CWR N + +PSG +F+S++SG FSCGIL +
Sbjct: 116 LEKLALGDSQVCATVVGAGTASCWR--TNAAFESPSGSDRFDSISSGSGFSCGILKGSDR 173
Query: 180 VRCWGINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTA 239
VRCWG+ SI+ ++++ F N S+ S+ AG +H+CG++S+G+++C G N GQ+ P A
Sbjct: 174 VRCWGVGSIARKMESEFGNMSLVSLVAGESHICGLNSSGYLVCRGSNDFGQIDVP-EGGA 232
Query: 240 FEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNF 299
E+S L+LG H+CAIRR NGSVVCWG +G + + + SFE IVSGSNFTCGLTT+NF
Sbjct: 233 LEFSGLALGAEHTCAIRRSNGSVVCWGGRGLFEDDVTKTVSFEVIVSGSNFTCGLTTNNF 292
Query: 300 SVICWGPGWPNVSNDSVSLVPFQQEILPGPCDNSSCSECGLYPQSDRLCFGNGNICKSCQ 359
SVICWGPGW N S + L P C SSCSECG+YPQS+ LC G GNICK
Sbjct: 293 SVICWGPGWANGSGYEIPLPPILPGP----CVQSSCSECGIYPQSESLCSGYGNICK--- 345
Query: 360 NVVPTPSAPP---------PSVEPPRSSSSPSRELTRGLLAFAIVGSVGGFAGICTVIYC 410
P P P PP ++S S+ LT+GLLAFAIVG VGG AGICT IYC
Sbjct: 346 ---PKPCWPEMLVPAPPAVVPASPPGPAASRSKALTKGLLAFAIVGCVGGVAGICTAIYC 402
Query: 411 VWTGACFGKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQR 470
+WTG CFGKKKVHNSVQPTITRGGS G G ++ SPPSRS+TIRRQGSR+ MRRQR
Sbjct: 403 LWTGVCFGKKKVHNSVQPTITRGGSVNGVGGSN-NSISPPSRSSTIRRQGSRI--MRRQR 459
Query: 471 SGTSS-KHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETA 529
SGTSS KH +RAEEF LAEL AATNNF+LENKIGAGS+GVVYKGKL DG+EVAIKRG+T+
Sbjct: 460 SGTSSTKHPERAEEFTLAELVAATNNFALENKIGAGSYGVVYKGKLLDGREVAIKRGDTS 519
Query: 530 -KTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR 588
K KKFQEKE+AF+SELAFLSRLHHKHLVRLVG+CEEKDERLLVY+YMKNGALYDHLHD+
Sbjct: 520 TKMKKFQEKETAFESELAFLSRLHHKHLVRLVGFCEEKDERLLVYEYMKNGALYDHLHDK 579
Query: 589 NNVEK----------------NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSD 632
NNV+K +A+RGIEYLHNYAVP IIHRDIKSSNIL+DA WTARVSD
Sbjct: 580 NNVDKSSSVLNSWRMRIKVALDASRGIEYLHNYAVPSIIHRDIKSSNILIDATWTARVSD 639
Query: 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
FGLS+M PES DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIF
Sbjct: 640 FGLSLMSPESNHDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 699
Query: 693 KDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGK 752
K+DE+GGTPVS+VDFAVP IMAGEL KILD RV PPE+NE EAVELV YTAMHCVNLEGK
Sbjct: 700 KNDENGGTPVSVVDFAVPLIMAGELAKILDPRVEPPEMNETEAVELVGYTAMHCVNLEGK 759
Query: 753 ERPTMADIVANLERALDICDHSHGSISSSGIVSIASD 789
+RPTMADIVANLERAL +CD SHGSI SSG +SI SD
Sbjct: 760 DRPTMADIVANLERALALCDSSHGSI-SSGTISIVSD 795
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492697|ref|XP_003616637.1| Receptor kinase-like protein [Medicago truncatula] gi|355517972|gb|AES99595.1| Receptor kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 966 bits (2497), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 519/806 (64%), Positives = 612/806 (75%), Gaps = 52/806 (6%)
Query: 1 MTKLPSTTTSFSVAVTVILISLCLPSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRLLC 60
M K+ ++ FS VILIS LP +ALGSG+TLAV +ATVC ++++Q T +++C
Sbjct: 1 MKKISLSSIIFSTFTFVILIS-SLPV-TNALGSGTTLAVVDSTATVCGIISSQKTHKIIC 58
Query: 61 YQGGTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYND--T 118
Y+ G + P +SFSSIS G+++FCGIRSG YS+LCWDT S N+ F +R+Y N+ T
Sbjct: 59 YRHGHLITAVPEVSFSSISGGRNYFCGIRSGNYSILCWDT-VSSNTTFETRRLYNNNNGT 117
Query: 119 VLLSSVSVGNNHVCATTVQ-GQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNN 177
VL +++VG++HVCAT V G + CWR +N PSG QF S+TSG F+CGIL N
Sbjct: 118 VLYENLAVGDSHVCATMVNVGNVACWR--MNKGFVLPSGFDQFSSITSGFGFTCGILKKN 175
Query: 178 KT--VRCWG---IN--SISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQ 230
+ VRC+G +N SI+ +I+ F N SM S+ AG +HVCG++S GF++C G N GQ
Sbjct: 176 DSGSVRCFGNVNVNESSIAEKIEKEFVNVSMVSLVAGESHVCGLNSKGFLVCKGSNNFGQ 235
Query: 231 LKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNF 290
+ P EYS L+LG HSCAIRR NGSVVCWG G + VN + SFE IVS SNF
Sbjct: 236 INVPNQVEPLEYSDLALGAEHSCAIRRSNGSVVCWGGNGLFDVNVTKNVSFEVIVSASNF 295
Query: 291 TCGLTTSNFSVICWGPGWPNVSNDSVSLVPFQQEILPGPCDNSSCSECGLYPQSDRLCFG 350
TCGLTT+NFSV+CWGP W N S + L P ILPG C SSCSECG+YPQS LC G
Sbjct: 296 TCGLTTNNFSVVCWGPSW-NGSTFQLPLPP----ILPGICVQSSCSECGMYPQSQYLCSG 350
Query: 351 NGNICKS--C--QNVVPTPS--APPPSVEPPRSSSSPSRELTRGLLAFAIVGSVGGFAGI 404
NICK C Q VP PS A PP P S S+ LT+GLL FAIVG +G AG+
Sbjct: 351 FSNICKPKPCWPQMDVPVPSQIATPPQ---PGLPCSRSKTLTKGLLLFAIVGLIGAVAGL 407
Query: 405 CTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLL 464
CTV+YC+W+G CFGKKKVHNSVQPTITRGGS N GA SN SP SRS+TIRRQGSR+
Sbjct: 408 CTVVYCLWSGVCFGKKKVHNSVQPTITRGGSL---NCGAFSNYSPTSRSSTIRRQGSRI- 463
Query: 465 TMRRQRSGTSS-KHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAI 523
MRRQRSGTSS KH DR+EEF LAEL AATNNFSLENK+GAGS+GVVYKGKL DG+EVAI
Sbjct: 464 -MRRQRSGTSSTKHPDRSEEFTLAELVAATNNFSLENKVGAGSYGVVYKGKLADGREVAI 522
Query: 524 KRGETAKTKK-FQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALY 582
KRGET+ K FQEKESAF+SELAFLSRLHHKHLVRLVG+C+EKDERLLVY++MKNGALY
Sbjct: 523 KRGETSTMMKVFQEKESAFESELAFLSRLHHKHLVRLVGFCDEKDERLLVYEFMKNGALY 582
Query: 583 DHLHDRNNVEKN----------------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626
DHLHD+NNV+KN A+RGIEYLHNYAVP IIHRDIKSSNIL+DA W
Sbjct: 583 DHLHDKNNVDKNSSLLNSWKMRIKVALDASRGIEYLHNYAVPSIIHRDIKSSNILIDADW 642
Query: 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
TARVSDFGLSM+ P+S+ D+RP KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT
Sbjct: 643 TARVSDFGLSMLSPDSDHDYRPTKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 702
Query: 687 GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHC 746
GKRAIFK+DE+GGTP+S+VDFAVP IM GEL+KILD+RV PPE+NE EAVELV+YTAMHC
Sbjct: 703 GKRAIFKNDENGGTPISIVDFAVPIIMKGELMKILDQRVEPPEMNETEAVELVSYTAMHC 762
Query: 747 VNLEGKERPTMADIVANLERALDICD 772
V+LEGK+RPT++DIVANLERA +CD
Sbjct: 763 VHLEGKDRPTISDIVANLERAFTLCD 788
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449510857|ref|XP_004163787.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2485), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/769 (66%), Positives = 594/769 (77%), Gaps = 34/769 (4%)
Query: 29 HALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTIRAVEPNISFSSISAGQSFFCGI 88
ALGS STLAVSYGS TVC +VA QPTQR+LC++ G +EP ISFS++S G++ FCGI
Sbjct: 28 QALGSASTLAVSYGSRTVCGIVAEQPTQRILCFRDGQTIFIEPGISFSAVSGGRNTFCGI 87
Query: 89 RSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV-QGQINCWRGDV 147
RSGGY++LCW+ N + + F +R+YYN VLL +++VG++ +CAT V G + CWR
Sbjct: 88 RSGGYTILCWNFNLT-TAAFTRRRLYYNPNVLLENLAVGDDQICATVVGAGNVTCWRDGN 146
Query: 148 NISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINS-ISNQIQTSFANRSMFSITA 206
+ S L ++S++SG FSCGIL N+++RCWG NS I+ +I+ F N SM SI A
Sbjct: 147 KVIGGFSS--LLYDSISSGYGFSCGILKGNQSIRCWGRNSSIATEIENGFRNISMLSIVA 204
Query: 207 GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWG 266
GG HVCG++ +G ++C G+N GQL FP N + E+S L+LG HSC I N SV+CWG
Sbjct: 205 GGFHVCGLNISGGLVCKGNNDFGQLDFPSNYSV-EFSELALGERHSCGILVSNRSVICWG 263
Query: 267 SQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDSVSLVPFQQEIL 326
G +SV+ IR SFE I SGS+F CGLTTSNFSV+CWGPGW N S SL +IL
Sbjct: 264 GLG-FSVDLIRETSFELISSGSDFVCGLTTSNFSVLCWGPGWSNNSLSPSSLS--LPKIL 320
Query: 327 PGPCDNSSCSECGLYPQSDRLCFGNGNICKSCQNVVPTPSAPPPSVEPPRSSSSPSR--- 383
PGPC S CG+YP S LC +GN+C C VPTPS+P P P S +
Sbjct: 321 PGPCVLQSSCSCGVYPLSQTLCSNSGNVCNRCFFTVPTPSSPQPLPSSPPRSPPVTTPSP 380
Query: 384 ---ELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSN 440
L RGLLAF IVGSVG FAGICT+IYC+WTG CFG KK+HNSVQPTITR S G
Sbjct: 381 TPAALKRGLLAFGIVGSVGAFAGICTIIYCLWTGVCFGNKKIHNSVQPTITRAASSNGGT 440
Query: 441 GGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLEN 500
+ +NNSPPSRS+TIRRQGSR+ MRRQRSGTSSKHADRAEEF LAELA ATN+FS EN
Sbjct: 441 TTSNTNNSPPSRSSTIRRQGSRI--MRRQRSGTSSKHADRAEEFTLAELAMATNDFSPEN 498
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETA-KTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG GSFGVVY+GKL DG+EVAIKRGET KTKKFQEKESAFDSELAFLSRLHHKHLVRL
Sbjct: 499 KIGEGSFGVVYRGKLYDGREVAIKRGETGQKTKKFQEKESAFDSELAFLSRLHHKHLVRL 558
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK----------------NAARGIEYLH 603
VGYCEEKDERLLVY+YMKNGALY+HLHD+NN EK +AARGIEYLH
Sbjct: 559 VGYCEEKDERLLVYEYMKNGALYNHLHDKNNFEKASSVVNSWKMRIKIALDAARGIEYLH 618
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
NYAVPPIIHRDIKSSNILLDA WTARVSDFGLS+M P S+RD+RP KAAGTVGYIDPEYY
Sbjct: 619 NYAVPPIIHRDIKSSNILLDANWTARVSDFGLSLMSPGSDRDYRPTKAAGTVGYIDPEYY 678
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
GLNVLTAKSDVYGLGVVLLELLTGKRAIFKD+E GGTPVS+VD+AVP IMAGEL KILD+
Sbjct: 679 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDEEQGGTPVSVVDYAVPVIMAGELGKILDQ 738
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772
RVGPP+INEAEAVELVAYTAMHCV+LEGK+RPTM DIV+NLERAL++CD
Sbjct: 739 RVGPPQINEAEAVELVAYTAMHCVHLEGKDRPTMTDIVSNLERALNLCD 787
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585374|ref|XP_002533383.1| conserved hypothetical protein [Ricinus communis] gi|223526776|gb|EEF29001.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2440), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/716 (68%), Positives = 558/716 (77%), Gaps = 44/716 (6%)
Query: 110 PKRIYYNDTVLLSSVSVGNNHVCA---TTVQ-----GQINCWRGDVNISKNAPSGELQFE 161
PKR+YYN TVLL +++VG N VC TV G + CWRG+ + S +P +F+
Sbjct: 35 PKRVYYNTTVLLQNIAVGGNQVCGLLNNTVSSVDGAGSVQCWRGNGSSSNGSPVDSDKFQ 94
Query: 162 SLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVI 221
S++SG F+CGIL NN + CWG N I I++ F N SM SI AGG+HVCG++S G ++
Sbjct: 95 SISSGFGFNCGILMNNSRIMCWGSNPIGKDIESEFGNMSMMSIVAGGSHVCGVNSTGALV 154
Query: 222 CYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIRGKSF 281
C GDN SGQL PLNSTAFEYS L+LG NHSCA+R GSVVCWG GEYSVNG + F
Sbjct: 155 CKGDNTSGQLDVPLNSTAFEYSQLALGVNHSCALRN-EGSVVCWGGSGEYSVNGTKDLHF 213
Query: 282 ESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDSVSLVPFQQEILPGPCDNSSCSECGLY 341
ESIVSGSNFTCGLTTSN S++CWGPGW NV N + ++P ILPGPC SSC +Y
Sbjct: 214 ESIVSGSNFTCGLTTSNLSIMCWGPGWSNVDNSGIQILPLPDRILPGPCVQSSCEGTRMY 273
Query: 342 PQSDRLCFGNGNIC----------KSCQNVVPTPSAPPPSVEPPRSSSSPSRELTRGLLA 391
P SD LC G+GN+C P PPS S SSPS+ELT GLL
Sbjct: 274 PDSDGLCSGSGNVCYPPGLNISMLFPPSPPQPPFLPFPPSPSVLPSPSSPSKELTTGLLV 333
Query: 392 FAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPP- 450
F I+GSVGGFAGICT+IYC+WTG CFGKKKVHNSVQPTITRGGS NGG SNNS
Sbjct: 334 FCIIGSVGGFAGICTIIYCLWTGVCFGKKKVHNSVQPTITRGGS----NGGTTSNNSGIL 389
Query: 451 SRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVV 510
SRS+TI RQ SR MRRQRSGTSSKHAD+AEEF L ELAAATN+FSL+NKIGAGSFGVV
Sbjct: 390 SRSSTIMRQSSR--AMRRQRSGTSSKHADKAEEFSLGELAAATNDFSLDNKIGAGSFGVV 447
Query: 511 YKGKLPDGQEVAIKRGETA-KTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569
Y+GKL DG+EVAIKRGET KTKKFQEKESAF+SEL+FLSR+HHKHLVRLVGYCE+ DER
Sbjct: 448 YRGKLADGREVAIKRGETGQKTKKFQEKESAFESELSFLSRVHHKHLVRLVGYCEDGDER 507
Query: 570 LLVYDYMKNGALYDHLHDRNNVEKN----------------AARGIEYLHNYAVPPIIHR 613
LLVY+YMKNGALYDHLHD+NN++KN AARGIEYLHNYAVP IIHR
Sbjct: 508 LLVYEYMKNGALYDHLHDKNNIKKNSSVINSWKMRIKIALDAARGIEYLHNYAVPSIIHR 567
Query: 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSD 673
DIKSSNILLDA W ARVSDFGLS+MGPES+RD+RPMKAAGTVGYIDPEYYGLNVLTAKSD
Sbjct: 568 DIKSSNILLDANWIARVSDFGLSLMGPESDRDYRPMKAAGTVGYIDPEYYGLNVLTAKSD 627
Query: 674 VYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEA 733
VYGLGVVLLELLTGKRAIFK D++GGTP S+VDFAVP IM+GEL K+LD RVGPPE+NEA
Sbjct: 628 VYGLGVVLLELLTGKRAIFKGDDNGGTPTSIVDFAVPRIMSGELAKVLDHRVGPPELNEA 687
Query: 734 EAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGSISSSGIVSIASD 789
EAVELVAYTA+HCVNLEGK+RPTMADIVANLERAL +CD SHGSI SSG +S+ S+
Sbjct: 688 EAVELVAYTALHCVNLEGKDRPTMADIVANLERALSLCDGSHGSI-SSGTISVVSE 742
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356569298|ref|XP_003552840.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 942 bits (2434), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/832 (62%), Positives = 614/832 (73%), Gaps = 66/832 (7%)
Query: 1 MTKLPSTTTSF--SVAVTVILISLCLPSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRL 58
M PS++ + +VAV +LI +PS +H GSG+TLA+S S+TVCAVVA++ T+R+
Sbjct: 1 MKTPPSSSVNLCLAVAVAAVLILSLVPS-SHGFGSGATLALSDSSSTVCAVVASESTRRI 59
Query: 59 LCYQGGTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDT 118
CY+ G + + PN+SFSSIS G+++FCGIRS +LLCW+T+ S+F +R+Y + +
Sbjct: 60 ECYRQGQVVPIAPNVSFSSISGGRNYFCGIRSSNSNLLCWNTS----SSFERRRLYNDSS 115
Query: 119 VLLSSVSVGNNHVCATTV-QGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNN 177
V L +++VG+ HVCAT V G + CWR + SG QF S++SG FSCGIL N
Sbjct: 116 VPLENLAVGDTHVCATAVGDGTVRCWR--TGNTFQIVSGSDQFASISSGSGFSCGILKNG 173
Query: 178 KTVRCWGINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNS 237
VRCWG ++S QI+ SF N SM S+ AGG+HVCG++ GF++C G N SGQ P
Sbjct: 174 SRVRCWGDTNVSEQIENSFRNISMLSLVAGGSHVCGLNLTGFLVCRGSNGSGQFDIP-QG 232
Query: 238 TAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGI-RGKSFESIVSGSNFTCGLTT 296
AFEYS L+LG H CAIR NGSVVCWG G++SV+ + G SFE IVSGSNF CGLTT
Sbjct: 233 GAFEYSGLALGAEHGCAIRESNGSVVCWGGNGQFSVSNVTEGVSFEVIVSGSNFVCGLTT 292
Query: 297 SNFSVICWGPGWPNVSNDSVSLVPFQQEILPGPCDNSSCSECGLYPQSDRLCFGNGNICK 356
+N +V+CWGPGW N S + L +LPGPC SSC ECG Y S+ LC G+GNICK
Sbjct: 293 NNLTVVCWGPGWSNGSRFELPL----PRVLPGPCVQSSCGECGSYLNSEFLCSGSGNICK 348
Query: 357 SCQNVVPTPSAPPPSVEPPRSSSSP---------------------SRELTRGLLAFAIV 395
P P +V PP S P S+ LTRGLLAFAI+
Sbjct: 349 ------PMTCRPQTTVPPPLLPSPPPPSPSPPPPPSLTSPSPSPSRSKTLTRGLLAFAII 402
Query: 396 GSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSAT 455
GSVG FAGICT++YC+W+G CFGKKKVHNSVQPTITRG S + SNNS S S+
Sbjct: 403 GSVGAFAGICTIVYCLWSGVCFGKKKVHNSVQPTITRGSSGSNGG--GASNNSNSSISSM 460
Query: 456 IRRQGSRLLTMRRQRSGTSS-KHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGK 514
I RQ S + MRRQRSGTSS KH DRAEEF LAELAAAT+NFS ENKIGAGSFGVVYKGK
Sbjct: 461 IMRQTS--IIMRRQRSGTSSMKHPDRAEEFTLAELAAATDNFSHENKIGAGSFGVVYKGK 518
Query: 515 LPDGQEVAIKRGET-AKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573
L DG+EVAIKRGET +K KKFQEKESAF+SELAFLSRLHHKHLV LVG+CEEKDERLLVY
Sbjct: 519 LTDGREVAIKRGETGSKMKKFQEKESAFESELAFLSRLHHKHLVGLVGFCEEKDERLLVY 578
Query: 574 DYMKNGALYDHLHDRNNVEK----------------NAARGIEYLHNYAVPPIIHRDIKS 617
+YMKNGALYDHLHD+NNVEK +A+RGIEYLHNYAVP IIHRDIKS
Sbjct: 579 EYMKNGALYDHLHDKNNVEKESSVLNNWKMRIKIALDASRGIEYLHNYAVPSIIHRDIKS 638
Query: 618 SNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGL 677
SNILLDA WTARVSDFGLS+M PE +RD RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGL
Sbjct: 639 SNILLDATWTARVSDFGLSLMSPEPDRDHRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGL 698
Query: 678 GVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVE 737
GVVLLELLTGKRAIFK E GGTP+S+VDFAVP+I+AGELVK+LD RV PP + E+EAVE
Sbjct: 699 GVVLLELLTGKRAIFKYGEDGGTPLSVVDFAVPSILAGELVKLLDPRVEPPNVTESEAVE 758
Query: 738 LVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGSISSSGIVSIASD 789
LVAYTA+HCVNLEGK+RPTMADIV+NLERAL IC+ SH SI SSG +S+ S+
Sbjct: 759 LVAYTAIHCVNLEGKDRPTMADIVSNLERALAICESSHDSI-SSGTISVVSE 809
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537993|ref|XP_003537490.1| PREDICTED: putative serine/threonine-protein kinase-like protein CCR3-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 938 bits (2424), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 518/802 (64%), Positives = 609/802 (75%), Gaps = 53/802 (6%)
Query: 22 LCLPSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTIRAVEPNISFSSISAG 81
L L +H GSG+TLA+S SATVCAVVA++ T+R+ CY+ G + + PN++FSSIS G
Sbjct: 23 LSLVPSSHGFGSGTTLALSDASATVCAVVASESTRRIECYRQGQVVPIAPNVNFSSISGG 82
Query: 82 QSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV-QGQI 140
+++FCGI S +LLCW+TN S+F +R+Y +V L +++VG+ HVCAT V G +
Sbjct: 83 RNYFCGIMSSNSNLLCWNTN----SSFEMRRLYNKSSVPLENLAVGDTHVCATAVGDGTV 138
Query: 141 NCWR-GDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANR 199
CWR GD + PSG QF S++SG FSCGIL N VRCWG +++ QI+ SF N
Sbjct: 139 RCWRTGD---TFRNPSGSDQFASISSGSGFSCGILKNGSKVRCWGDTNVAQQIENSFGNM 195
Query: 200 SMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLN 259
SM S+ AGG+++CG++S GF++C SGQL FP AFEYS L+LG H CAIR N
Sbjct: 196 SMLSLVAGGSNICGLNSTGFLVC-----SGQLDFP-RGGAFEYSGLALGAEHGCAIRGSN 249
Query: 260 GSVVCWGSQGEYSVNGI-RGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDSVSL 318
G VVCWG G++SVN + G SFE IVSGSNF CGLTT+N V+CWGPGW N SN S
Sbjct: 250 GWVVCWGGNGQFSVNNVTEGVSFEVIVSGSNFVCGLTTNNLKVVCWGPGWSNYSNSSRFE 309
Query: 319 VPFQQEILPGPCDNSSCSECGLYPQSDRLCFGNGNICK--SCQ-----------NVVPTP 365
+P + +LPGPC + SC+ECG Y S LC G+GNICK +C+ P
Sbjct: 310 LPLPR-VLPGPCVSFSCAECGSYVDSQTLCSGSGNICKPMTCRPQTTAPPPLLPTPPPPS 368
Query: 366 SAPPPSVEPPRSSSSPSRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNS 425
+PPP P SS+ S+ LTRGLLAFAI+GSVG FAGICT+++C+W+G CFGKKKVHNS
Sbjct: 369 QSPPPPPSTPPPSSTRSKTLTRGLLAFAIIGSVGAFAGICTIVHCLWSGVCFGKKKVHNS 428
Query: 426 VQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSS-KHADRAEEF 484
VQPTITRG S + SNNS S S+ I RQ S + MRRQRSGTSS KH DRAEEF
Sbjct: 429 VQPTITRGSSGSSGG--GASNNSNSSISSMIMRQTS--IIMRRQRSGTSSTKHPDRAEEF 484
Query: 485 LLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGET-AKTKKFQEKESAFDS 543
LAEL AATNNFSLENKIG+GSFGVVYKGKL +G+EVAIKRGET +K KKFQEKESAF+S
Sbjct: 485 TLAELVAATNNFSLENKIGSGSFGVVYKGKLAEGREVAIKRGETGSKMKKFQEKESAFES 544
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------- 593
ELAFLSRLHHKHLV LVG+CEEKDERLLVY+YMKNGALYDHLH +NNVEK
Sbjct: 545 ELAFLSRLHHKHLVGLVGFCEEKDERLLVYEYMKNGALYDHLHAKNNVEKESSVLNNWKM 604
Query: 594 ------NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647
+A+RGIEYLHNYAVP IIHRDIKSSNILLDA WTARVSDFGLS+M PE +RD R
Sbjct: 605 RIKIALDASRGIEYLHNYAVPSIIHRDIKSSNILLDATWTARVSDFGLSLMSPEPDRDHR 664
Query: 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF 707
PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK E GGTP+S+VDF
Sbjct: 665 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKYGEDGGTPLSVVDF 724
Query: 708 AVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767
AVPAI+AGELVKILD RVGPP++NEAEAVELVAYTA+HCVNLEGK+RPTMADIVANLERA
Sbjct: 725 AVPAILAGELVKILDPRVGPPDVNEAEAVELVAYTAIHCVNLEGKDRPTMADIVANLERA 784
Query: 768 LDICDHSHGSISSSGIVSIASD 789
L IC+ SH S +SSG +S+ S+
Sbjct: 785 LAICESSHDS-TSSGTISVVSE 805
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461261|ref|XP_003600912.1| Serine/threonine protein kinase-like protein CCR4 [Medicago truncatula] gi|355489960|gb|AES71163.1| Serine/threonine protein kinase-like protein CCR4 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 500/781 (64%), Positives = 592/781 (75%), Gaps = 41/781 (5%)
Query: 13 VAVTVILISLCLPSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTIRAVEPN 72
+ VT I+I PS AH LGSG+TL+V+ ATVC +++ + TQ + CY+ G + + PN
Sbjct: 9 IFVTAIIIFYLSPS-AHTLGSGTTLSVTDSPATVCGIISGETTQHIQCYREGEVFNILPN 67
Query: 73 ISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVC 132
+SFSSIS G+S+FCG+RSG YSL CWD+ S+F KR+Y ND+ LL ++SVG+ VC
Sbjct: 68 VSFSSISGGRSYFCGLRSGNYSLHCWDS-----SSFQTKRLYSNDSFLLENLSVGDFQVC 122
Query: 133 ATTVQ-GQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQ 191
AT V G + CWR PSG F S++SG +FSCGIL VRCWG +++ +
Sbjct: 123 ATVVGVGTVRCWR---TFDGFEPSGLDHFGSISSGSNFSCGILKTGLQVRCWGEKTVAER 179
Query: 192 IQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNH 251
+Q F N SM SI AGG++VCG++S GF++C G N SGQL P AFEY ++LG H
Sbjct: 180 LQNEFRNMSMLSIVAGGSNVCGLNSTGFLVCKGSNSSGQLDVP-QGGAFEYGDIALGDEH 238
Query: 252 SCAIRRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNV 311
CA+RRLNGSVVCWG +GE+S + I G SFE IVSGSNFTCGLTT+NFSV+CWGPGW N
Sbjct: 239 GCAVRRLNGSVVCWGGKGEFSADSIEGVSFELIVSGSNFTCGLTTTNFSVVCWGPGWSNG 298
Query: 312 SNDSVSLVPFQQEILPGPCDNSSCSECGLYPQSDRLCFGNGNICKSCQNVVPTPSAPPPS 371
SN S S++P + ILPGPC SSCSECG+YP S LC G+IC S PPP
Sbjct: 299 SNGSESILPLSR-ILPGPCVQSSCSECGIYPDSQSLCSNFGHICNPNICNTQITSPPPPP 357
Query: 372 VEPPRSSSSPSRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTIT 431
P SS S+ LT GLL FAIVGSVGGF GICT+IYC+WTG CFGKKKVH+SVQPT+T
Sbjct: 358 PAPSPPRSSRSKTLTTGLLVFAIVGSVGGFIGICTIIYCLWTGVCFGKKKVHSSVQPTVT 417
Query: 432 RGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSG-TSSKHADRAEEFLLAELA 490
RG S + SN+S S + I RQGSR+ MRRQRSG +S+KH +RAEEF L+EL
Sbjct: 418 RGSSNS-------SNSSASSIKSVIMRQGSRI--MRRQRSGPSSTKHQERAEEFSLSELM 468
Query: 491 AATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETA-KTKKFQEKESAFDSELAFLS 549
AATNNFS +NKIGAGSFG+VY GKL DG+EVAIKRGE K KK+QEKESAF+SELAFLS
Sbjct: 469 AATNNFSFQNKIGAGSFGIVYFGKLTDGREVAIKRGEPGTKLKKYQEKESAFESELAFLS 528
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------------- 593
RLHHKHLVRLVGYCEEKDERLLVYDYMKNG+L+ HLHD+NNVEK
Sbjct: 529 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGSLHSHLHDKNNVEKGSNLLNSWKMRIKIAL 588
Query: 594 NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAG 653
+A+RGIEYLHNYAVP IIHRDIKSSNILLD+ WTARVSDFGLS+M PES+ D++P K AG
Sbjct: 589 DASRGIEYLHNYAVPSIIHRDIKSSNILLDSTWTARVSDFGLSLMSPESDIDYKPTKTAG 648
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
TVGYIDPEYYGLN+LTAKSDVYGLGVVLLELLTGKRAIF++ E GG P+S+VDFAVPAI+
Sbjct: 649 TVGYIDPEYYGLNLLTAKSDVYGLGVVLLELLTGKRAIFRNGEDGGNPLSIVDFAVPAIL 708
Query: 714 AGELVKILDRRVG--PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771
AGEL+KILD RVG P E NE+EAVEL+AYTA+HCVNLEGK+RPTMADIVANLERAL IC
Sbjct: 709 AGELMKILDSRVGTPPTESNESEAVELMAYTAVHCVNLEGKDRPTMADIVANLERALLIC 768
Query: 772 D 772
+
Sbjct: 769 E 769
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 789 | ||||||
| TAIR|locus:2082033 | 814 | CCR3 "CRINKLY4 related 3" [Ara | 0.775 | 0.751 | 0.560 | 2.2e-244 | |
| UNIPROTKB|O24585 | 901 | CR4 "Putative receptor protein | 0.339 | 0.297 | 0.460 | 2.5e-92 | |
| TAIR|locus:2081227 | 895 | CR4 "crinkly4" [Arabidopsis th | 0.338 | 0.298 | 0.451 | 4.8e-88 | |
| TAIR|locus:2160952 | 751 | CCR4 "CRINKLY4 related 4" [Ara | 0.307 | 0.323 | 0.480 | 1.4e-78 | |
| TAIR|locus:2056033 | 776 | CCR2 "CRINKLY4 related 2" [Ara | 0.187 | 0.190 | 0.475 | 8.2e-62 | |
| TAIR|locus:2075074 | 775 | CCR1 "CRINKLY4 related 1" [Ara | 0.193 | 0.197 | 0.457 | 5.1e-56 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.335 | 0.285 | 0.415 | 5.2e-47 | |
| TAIR|locus:2148830 | 858 | ANX2 "ANXUR2" [Arabidopsis tha | 0.342 | 0.314 | 0.402 | 2.5e-45 | |
| TAIR|locus:2084953 | 850 | ANX1 "ANXUR1" [Arabidopsis tha | 0.342 | 0.317 | 0.406 | 4.6e-44 | |
| TAIR|locus:2199857 | 375 | AT1G24030 [Arabidopsis thalian | 0.339 | 0.714 | 0.379 | 4.3e-43 |
| TAIR|locus:2082033 CCR3 "CRINKLY4 related 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1760 (624.6 bits), Expect = 2.2e-244, Sum P(2) = 2.2e-244
Identities = 373/665 (56%), Positives = 441/665 (66%)
Query: 19 LISLCLPSPAHALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGG-TIRA-VEPNISFS 76
+I L SP +LGSGST AV YGS TVCA+++ QPTQR+LCY I + P +SFS
Sbjct: 19 VIIFFLLSPVTSLGSGSTYAVVYGSDTVCALISGQPTQRILCYDTRLNINVTLNPGVSFS 78
Query: 77 SISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV 136
SI+AG +F CGIRSGGYSLLCWD SY+ N KRIY ND VLL ++SVG+ +CAT V
Sbjct: 79 SIAAGDNFLCGIRSGGYSLLCWDNIGSYSPN--RKRIYQNDNVLLETLSVGDKQICAT-V 135
Query: 137 QG--QINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSI-SNQIQ 193
G + CWRG V+ ++ P E +F S++SG+ FSCG+ N + CWG + + SNQIQ
Sbjct: 136 NGTNSLKCWRGSVS-DQSKPPNE-RFRSISSGVGFSCGVSIRNNRILCWGTDPVKSNQIQ 193
Query: 194 TSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSA-LSLGFNHS 252
T F N M +I+AG +H CG+++ G +IC G+N SGQL YS+ LSLG N +
Sbjct: 194 TGFGNTPMVTISAGKSHACGLNTTGNLICIGNNDSGQLNVIAPDQPNLYSSSLSLGSNFT 253
Query: 253 CAIRRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVS 312
CA+R N SVVCWG E N SFESI SG CGL +SN S++CW P +
Sbjct: 254 CAMRISNNSVVCWGGGAERFNNVTDSISFESISSGPGLICGLISSNLSIMCWNP-----T 308
Query: 313 NDSVSLVPFQQEILPGPCDNSSCSE---CGLYPQSDRLCFGNGNICKSCQNXXXXXXXXX 369
N S +PF E+LPGPC SS S CG+YPQSD+LC G G+ICKSC
Sbjct: 309 NFSRIFLPFP-EVLPGPCVESSSSSLCSCGVYPQSDKLCSGTGSICKSCPIQFPASPPSQ 367
Query: 370 XXXX--------XXXXXXXXXRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKK 421
+ LTRGLLAFAIVGSVG FAGIC+V+YC+WTG C GKKK
Sbjct: 368 FPLPPPPPPPPPSPSTSSPPSKALTRGLLAFAIVGSVGAFAGICSVVYCLWTGVCLGKKK 427
Query: 422 VHNSVQPTITXXXXXXXXXXXXXXXXXXXXXXXTIRRQGSRLLTMRRQRSGTSS-KHADR 480
VHNSVQPTIT +IRRQGSR+L+MRRQRSGTSS KHAD+
Sbjct: 428 VHNSVQPTITRGGSNSRSNSSNSRSL-------SIRRQGSRMLSMRRQRSGTSSMKHADK 480
Query: 481 XXXXXXXXXXXXTNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGET-AKTKKFQEKES 539
T NFSLENKIG+GSFGVVY+GKL DG+EVAIKRGE AK KKFQEKE+
Sbjct: 481 AEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIKRGEVNAKMKKFQEKET 540
Query: 540 AFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN----- 594
AFDSE+AFLSRLHHKHLVRLVGYCEE++E+LLVYDYMKNGALYDHLHD+NNVEK+
Sbjct: 541 AFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGALYDHLHDKNNVEKHSSLIN 600
Query: 595 -----------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643
AARGIEYLHNYAVPPIIHRDIKSSNILLD+ W ARVSDFGLS+MGP
Sbjct: 601 SWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSNWVARVSDFGLSLMGPVLG 660
Query: 644 RDFRP 648
+D P
Sbjct: 661 KDHNP 665
|
|
| UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 601 (216.6 bits), Expect = 2.5e-92, Sum P(2) = 2.5e-92
Identities = 133/289 (46%), Positives = 178/289 (61%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
T FS ++++G GSF V+KG L DG VA+KR A K KE F +EL LSRL+
Sbjct: 502 TGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKE--FHNELDLLSRLN 559
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN-NVEKN------------AARGI 599
H HL+ L+GYCE+ ERLLVY++M +G+LY HLH ++ N++K AARGI
Sbjct: 560 HAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTIAVQAARGI 619
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYID 659
EYLH YA PP+IHRDIKSSNIL+D ARV+DFGLS++GP AGT+GY+D
Sbjct: 620 EYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTPLSELPAGTLGYLD 679
Query: 660 PEYYGLNVLTAKSDXXXXXXXXXXXXXXKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719
PEYY L+ LT KSD ++AI E G ++V++AVP I AG++
Sbjct: 680 PEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEG----NIVEWAVPLIKAGDIFA 735
Query: 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
ILD + PP ++ EA++ +A A CV + GK+RP+M + LE AL
Sbjct: 736 ILDPVLSPP--SDLEALKKIASVACKCVRMRGKDRPSMDKVTTALEHAL 782
|
|
| TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 583 (210.3 bits), Expect = 4.8e-88, Sum P(2) = 4.8e-88
Identities = 130/288 (45%), Positives = 175/288 (60%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ F E+ +G GSF VYKG L DG VA+KR + K Q+ + F +EL LSRL+H
Sbjct: 510 DGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSDK--QKNSNEFRTELDLLSRLNH 567
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN-------------AARGIE 600
HL+ L+GYCEE ERLLVY++M +G+L++HLH +N K AARGIE
Sbjct: 568 AHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIE 627
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
YLH YA PP+IHRDIKSSNIL+D + ARV+DFGLS++GP AGT+GY+DP
Sbjct: 628 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPVDSGSPLAELPAGTLGYLDP 687
Query: 661 EYYGLNVLTAKSDXXXXXXXXXXXXXXKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
EYY L+ LT KSD ++AI E G ++V++AVP I AG++ +
Sbjct: 688 EYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEG----NIVEWAVPLIKAGDINAL 743
Query: 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
LD + P +E EA++ + A CV + GK+RP+M + LERAL
Sbjct: 744 LDPVLKHP--SEIEALKRIVSVACKCVRMRGKDRPSMDKVTTALERAL 789
|
|
| TAIR|locus:2160952 CCR4 "CRINKLY4 related 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 580 (209.2 bits), Expect = 1.4e-78, Sum P(2) = 1.4e-78
Identities = 124/258 (48%), Positives = 167/258 (64%)
Query: 526 GETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL 585
G T + ++ +K+SAF +EL +SRL+HK+LVRL+G+ E+ +ER+LVY+YMKNG+L DHL
Sbjct: 482 GTTMRHRR-ADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMKNGSLADHL 540
Query: 586 HD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635
H+ R + +AARGI+YLH + VPP+IHRDIKSSNILLDA WTA+VSDFGL
Sbjct: 541 HNPQFDPLSWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDATWTAKVSDFGL 600
Query: 636 SMMGPESERDFRPMK--AAGTVGYIDPEYYGLNVLTAKSDXXXXXXXXXXXXXXKRAIFK 693
S MGP E D + AAGT+GYIDPEYY LT KSD +AI
Sbjct: 601 SQMGPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLLELLSGHKAIHN 660
Query: 694 DDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKE 753
+++ P +LV++ VP I+ E +ILD+R+ PP E EAV V Y A C+ ++
Sbjct: 661 NEDEN--PRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLAAECLMPCSRK 718
Query: 754 RPTMADIVANLERALDIC 771
RP+M ++V+ LE AL C
Sbjct: 719 RPSMVEVVSKLESALAAC 736
|
|
| TAIR|locus:2056033 CCR2 "CRINKLY4 related 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 363 (132.8 bits), Expect = 8.2e-62, Sum P(3) = 8.2e-62
Identities = 77/162 (47%), Positives = 99/162 (61%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
T+ F N++G GSFG VYK L DG VA+KR A F+SEL L ++
Sbjct: 516 THGFKEFNELGRGSFGFVYKAVLSDGIHVAVKRANAATI--IHSNNRGFESELEILCKIR 573
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLH 603
H ++V L+GYC E ERLLVY+YM +G L+DHLH R + AARG++YLH
Sbjct: 574 HNNIVNLLGYCSEMGERLLVYEYMPHGTLHDHLHGDLSQLDWSMRLKIMLQAARGLDYLH 633
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645
N PPIIHRD+K+SNILLD + AR++DFGL +ERD
Sbjct: 634 NEVDPPIIHRDVKTSNILLDGEMCARIADFGLVS---SNERD 672
|
|
| TAIR|locus:2075074 CCR1 "CRINKLY4 related 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 362 (132.5 bits), Expect = 5.1e-56, Sum P(4) = 5.1e-56
Identities = 75/164 (45%), Positives = 100/164 (60%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
TN F N++G GS+G VYK L DG++VA+KR A +E F++EL L +
Sbjct: 517 TNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNTRE--FETELEILCNIR 574
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLH 603
H ++V L+GY E ERLLVY+YM +G L+DHLH R + A+G+EYLH
Sbjct: 575 HCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLSWSLRIKIAMQTAKGLEYLH 634
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647
N A P IIH D+KSSN+LLD++W ARV+DFGL E D +
Sbjct: 635 NEAEPRIIHGDVKSSNVLLDSEWVARVADFGLVTSSNEKNLDIK 678
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 506 (183.2 bits), Expect = 5.2e-47, P = 5.2e-47
Identities = 121/291 (41%), Positives = 168/291 (57%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
T+NFS K+G GSFG VY G++ DG+EVA+K TA ++ F +E+A LSR+H
Sbjct: 605 TDNFS--KKVGRGSFGSVYYGRMKDGKEVAVKI--TADPSSHLNRQ--FVTEVALLSRIH 658
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-----------RNNVEKNAARGIEY 601
H++LV L+GYCEE D R+LVY+YM NG+L DHLH R + ++AA+G+EY
Sbjct: 659 HRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEY 718
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK--AAGTVGYID 659
LH P IIHRD+KSSNILLD A+VSDFGLS ++E D + A GTVGY+D
Sbjct: 719 LHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSR---QTEEDLTHVSSVAKGTVGYLD 775
Query: 660 PEYYGLNVLTAKSDXXXXXXXXXXXXXXKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719
PEYY LT KSD K+ + +D G +++V +A I G++
Sbjct: 776 PEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDF--GPELNIVHWARSLIRKGDVCG 833
Query: 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770
I+D + + E+V VA A CV G RP M +++ ++ A+ I
Sbjct: 834 IIDPCIASNV--KIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAIRI 882
|
|
| TAIR|locus:2148830 ANX2 "ANXUR2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 2.5e-45, Sum P(4) = 2.5e-45
Identities = 116/288 (40%), Positives = 155/288 (53%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
T+NF N IG G FG VYKG + G +VAIK+ + E F++E+ LSRL
Sbjct: 518 THNFDESNVIGVGGFGKVYKGVIDGGTKVAIKKSNPNSEQGLNE----FETEIELLSRLR 573
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD----------RNNVEKNAARGIEYL 602
HKHLV L+GYC+E E L+YDYM G L +HL++ R + AARG+ YL
Sbjct: 574 HKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYNTKRPQLTWKRRLEIAIGAARGLHYL 633
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H A IIHRD+K++NILLD W A+VSDFGLS GP G+ GY+DPEY
Sbjct: 634 HTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEY 693
Query: 663 YGLNVLTAKSDXXXXXXXXXXXXXXKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
+ LT KSD + A+ + VSL D+A+ G L I+D
Sbjct: 694 FRRQQLTEKSDVYSFGVVLFEVLCARPAL--NPSLSKEQVSLGDWAMNCKRKGTLEDIID 751
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770
+ +IN E ++ A TA C++ G +RPTM D++ NLE AL +
Sbjct: 752 PNL-KGKINP-ECLKKFADTAEKCLSDSGLDRPTMGDVLWNLEFALQL 797
|
|
| TAIR|locus:2084953 ANX1 "ANXUR1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 478 (173.3 bits), Expect = 4.6e-44, Sum P(3) = 4.6e-44
Identities = 117/288 (40%), Positives = 154/288 (53%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
T NF N IG G FG VYKG + +VA+K+ + E F++E+ LSRL
Sbjct: 514 TQNFDDSNVIGVGGFGKVYKGVIDGTTKVAVKKSNPNSEQGLNE----FETEIELLSRLR 569
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD----------RNNVEKNAARGIEYL 602
HKHLV L+GYC+E E LVYDYM G L +HL++ R + AARG+ YL
Sbjct: 570 HKHLVSLIGYCDEGGEMCLVYDYMAFGTLREHLYNTKKPQLTWKRRLEIAIGAARGLHYL 629
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H A IIHRD+K++NIL+D W A+VSDFGLS GP G+ GY+DPEY
Sbjct: 630 HTGAKYTIIHRDVKTTNILVDENWVAKVSDFGLSKTGPNMNGGHVTTVVKGSFGYLDPEY 689
Query: 663 YGLNVLTAKSDXXXXXXXXXXXXXXKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
+ LT KSD + A+ + VSL D+A+ G L I+D
Sbjct: 690 FRRQQLTEKSDVYSFGVVLFEILCARPAL--NPSLPKEQVSLGDWAMNCKRKGNLEDIID 747
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770
+ +IN AE ++ A TA C+N G ERPTM D++ NLE AL +
Sbjct: 748 PNL-KGKIN-AECLKKFADTAEKCLNDSGLERPTMGDVLWNLEFALQL 793
|
|
| TAIR|locus:2199857 AT1G24030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 4.3e-43, Sum P(2) = 4.3e-43
Identities = 109/287 (37%), Positives = 156/287 (54%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
T++FS EN +G G FG VY+G L G+ VAIK+ + KK + E F E+ LSRL
Sbjct: 73 TSSFSDENLLGKGGFGRVYQGTLKTGEVVAIKKMDLPTFKK-ADGEREFRVEVDILSRLD 131
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD----------RNNVEKNAARGIEYL 602
H +LV L+GYC + R LVY+YM+NG L DHL+ R + AA+G+ YL
Sbjct: 132 HPNLVSLIGYCADGKHRFLVYEYMQNGNLQDHLNGIKEAKISWPIRLRIALGAAKGLAYL 191
Query: 603 HNYAVP--PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
H+ + PI+HRD KS+N+LLD+ + A++SDFGL+ + PE + + GT GY DP
Sbjct: 192 HSSSSVGIPIVHRDFKSTNVLLDSNYNAKISDFGLAKLMPEGKDTCVTARVLGTFGYFDP 251
Query: 661 EYYGLNVLTAKSDXXXXXXXXXXXXXXKRAIFKDDESGGTPVSLVDFAVPAIMAG--ELV 718
EY LT +SD +RA+ D G +LV V I+ +L
Sbjct: 252 EYTSTGKLTLQSDIYAFGVVLLELLTGRRAV--DLTQGPNEQNLV-LQVRNILNDRKKLR 308
Query: 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
K++D + P EA+ + A A C+ +E KERP++ D V L+
Sbjct: 309 KVIDVEL-PRNSYSMEAITMFADLASRCIRIESKERPSVMDCVKELQ 354
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LY50 | ACCR3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6098 | 0.9759 | 0.9459 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00029295001 | SubName- Full=Chromosome chr13 scaffold_48, whole genome shotgun sequence; (792 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 789 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-33 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-17 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-16 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 9e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 9e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-05 | |
| pfam13540 | 30 | pfam13540, RCC1_2, Regulator of chromosome condens | 1e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-04 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 9e-47
Identities = 87/285 (30%), Positives = 133/285 (46%), Gaps = 49/285 (17%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ L K+G+GSFG VYK K G+ VA+K + K +++ + E+ L RL H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR--REIRILRRLSHP 58
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYA 606
++VRL+ E+KD LV +Y + G L+D+L + ++ A+ G+EYLH+
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE----- 661
IIHRD+K NILLD +++DFGL+ +S GT Y+ PE
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF--VGTPWYMAPEVLLGG 173
Query: 662 -YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
Y K DV+ LGV+L ELLTG + F + + +I
Sbjct: 174 NGY-----GPKVDVWSLGVILYELLTG-KPPFSGENILDQLQL-------------IRRI 214
Query: 721 LDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIV 761
L + E EA +L+ C+N + +RPT +I+
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKK----CLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 74/215 (34%), Positives = 110/215 (51%), Gaps = 29/215 (13%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ + K+G GSFG VY + G+ VAIK + K KK +E+ E+ L +L H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER---ILREIKILKKLKHP 57
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYA 606
++VRL E++D+ LV +Y + G L+D L R + ++ AR +EYLH+
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSK- 116
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE----- 661
I+HRD+K NILLD +++DFGL+ E+ GT Y+ PE
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGK 171
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
YG D++ LGV+L ELLTG + F D+
Sbjct: 172 GYG-----KAVDIWSLGVILYELLTG-KPPFPGDD 200
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 5e-43
Identities = 64/195 (32%), Positives = 98/195 (50%), Gaps = 20/195 (10%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G FG VY + G++VAIK K + E+ L +L+H ++V+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKI---IKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNA-------ARGIEYLHNYAVPPII 611
G E+++ LV +Y + G+L D L + E G+EYLH+ II
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 612 HRDIKSSNILLDA-QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY-GLNVLT 669
HRD+K NILLD+ +++DFGLS + + + + GT Y+ PE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYS 172
Query: 670 AKSDVYGLGVVLLEL 684
KSD++ LGV+L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 7e-41
Identities = 78/284 (27%), Positives = 127/284 (44%), Gaps = 49/284 (17%)
Query: 497 SLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+L K+G G+FG VYKG L EVA+K T K +++ F E + +L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK---TLKEDASEQQIEEFLREARIMRKL 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE----------KNAARGIEY 601
H ++V+L+G C E++ ++V +YM G L D+L E ARG+EY
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
L + IHRD+ + N L+ ++SDFGLS + + ++ + ++ PE
Sbjct: 119 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWMAPE 174
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP---VSLVDFAVPAIMAGELV 718
T+KSDV+ GV+L E+ T G P +S + + + G +
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTL----------GEEPYPGMSNAE-VLEYLKKGYRL 223
Query: 719 KILDRRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIV 761
PPE+ Y M C + ++RPT +++V
Sbjct: 224 PKPPN--CPPEL----------YKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 1e-40
Identities = 83/292 (28%), Positives = 131/292 (44%), Gaps = 56/292 (19%)
Query: 500 NKIGAGSFGVVYKGKLPDGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
K+G G+FG VYKGKL EVA+K T K +E+ F E + +L H +
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN-----------------AARG 598
+VRL+G C E++ LV +YM+ G L D+L V + A+G
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
+EYL + +HRD+ + N L+ ++SDFGLS + + + + ++
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM 174
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP---VSLVDFAVPAIMAG 715
PE + T+KSDV+ GV+L E+ T G TP +S + + + G
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTL----------GATPYPGLSNEEV-LEYLRKG 223
Query: 716 ELVKILDR-RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLE 765
L + P E+ Y M C L+ ++RPT +++V LE
Sbjct: 224 ---YRLPKPEYCPDEL----------YELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 79/283 (27%), Positives = 127/283 (44%), Gaps = 48/283 (16%)
Query: 497 SLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+L K+G G+FG VYKGKL EVA+K T K +++ F E + +L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK---TLKEDASEQQIEEFLREARIMRKL 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEK--------NAARGIEYL 602
H ++V+L+G C E++ +V +YM+ G L +L R + ARG+EYL
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
+ IHRD+ + N L+ ++SDFGLS + + R + ++ PE
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-RKRGGKLPIRWMAPES 174
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP---VSLVDFAVPAIMAGELVK 719
T+KSDV+ GV+L E+ T G P +S + + + G +
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTL----------GEQPYPGMSNEE-VLEYLKNGYRLP 223
Query: 720 ILDRRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIV 761
PPE+ Y M C + ++RPT +++V
Sbjct: 224 QPPN--CPPEL----------YDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-38
Identities = 81/301 (26%), Positives = 124/301 (41%), Gaps = 75/301 (24%)
Query: 496 FSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
L K+G G+FG VYKG L +VA+K T K +E+ F E + + +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREEFLEEASIMKK 57
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEY 601
L H ++VRL+G C + + +V +YM G L D L + A+G+EY
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
L + +HRD+ + N L+ ++SDFGLS RD Y D
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLS-------RD----------IYEDDY 157
Query: 662 YY----GL-------------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704
Y G T+KSDV+ GV+L E+ T G P
Sbjct: 158 YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL----------GEQP--- 204
Query: 705 VDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVAN 763
P + E++++L+ E EL Y M C + ++RPT +++V +
Sbjct: 205 ----YPGMSNEEVLELLEDG-YRLPRPENCPDEL--YELMLQCWAYDPEDRPTFSELVED 257
Query: 764 L 764
L
Sbjct: 258 L 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 40/276 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
++ +G GSFG VY D G+ +A+K E + +E+ A + E+ LS L H
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL--SGDSEEELEALEREIRILSSLQH 58
Query: 554 KHLVRLVGYC--EEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
++VR G EEK+ + +Y+ G+L L + + R G+ YLH
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
+ I+HRDIK +NIL+D+ +++DFG + + E GT ++ PE
Sbjct: 119 SNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
+D++ LG ++E+ TGK P S + + A+ KI
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKP-----------PWSELGNPMAALY-----KIG-S 218
Query: 724 RVGPPEINE---AEAVELVAYTAMHCVNLEGKERPT 756
PPEI E EA + + C+ + K+RPT
Sbjct: 219 SGEPPEIPEHLSEEAKDFL----RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 16/203 (7%)
Query: 495 NFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
N+ L + IG G+FGVVYKG L G VAIK+ K K+ K E+ L L H
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS--IMQEIDLLKNLKH 58
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA--------RGIEYLHNY 605
++V+ +G E D ++ +Y +NG+L + ++ +G+ YLH
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
V IHRDIK++NIL +++DFG++ + +D GT ++ PE +
Sbjct: 119 GV---IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEM 173
Query: 666 NVLTAKSDVYGLGVVLLELLTGK 688
+ + SD++ LG ++ELLTG
Sbjct: 174 SGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 72/222 (32%), Positives = 110/222 (49%), Gaps = 39/222 (17%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
F + KIG G FG VYK + G+EVAIK K + ++KE +E+ L + H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKV---IKLESKEKKEKII-NEIQILKKCKHP 57
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNAA-------RGIEYLHNY 605
++V+ G +KDE +V ++ G+L D L N E A +G+EYLH+
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE---- 661
IIHRDIK++NILL + ++ DFGLS +++ + GT ++ PE
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTPYWMAPEVING 171
Query: 662 -YYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
Y K+D++ LG+ +EL GK +A+FK
Sbjct: 172 KPYDY-----KADIWSLGITAIELAEGKPPYSELPPMKALFK 208
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 78/289 (26%), Positives = 125/289 (43%), Gaps = 34/289 (11%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HH 553
++ + K+G GSFG VY + D + VA+K K +E E F E+ L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVER-FLREIQILASLNHP 57
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYL 602
++V+L + +++ LV +Y+ G+L D L + +EYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 603 HNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMM----GPESERDFRPMKAAGTVGY 657
H+ IIHRDIK NILLD ++ DFGL+ + G S P + GT GY
Sbjct: 118 HS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 658 IDPEYYGLNVL---TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714
+ PE L ++ SD++ LG+ L ELLTG + S T +L +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763
PE+ A +L+ + + K R + + +++
Sbjct: 235 ----LASPLSPSNPELISKAASDLL----KKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 76/292 (26%), Positives = 125/292 (42%), Gaps = 66/292 (22%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + +IG GSFG VY + DG+ +K + + + +E+E A +E+ L +L+H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDAL-NEVKILKKLNH 58
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-----EKNA-------ARGIEY 601
++++ EEK + +V +Y G L + + E+ ++Y
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVG---Y 657
LH+ I+HRDIK NI L + ++ DFG+S ++ S D A VG Y
Sbjct: 119 LHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDL----AKTVVGTPYY 169
Query: 658 IDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711
+ PE Y KSD++ LG VL EL T K F+ +
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHP-FEGEN--------------- 207
Query: 712 IMAGELVKILDRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADI 760
+ +KIL + P I +E LV + + +ERP++A I
Sbjct: 208 -LLELALKIL--KGQYPPIPSQYSSELRNLV----SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 72/202 (35%), Positives = 101/202 (50%), Gaps = 27/202 (13%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G GSFG V + D G+ A+K + K K +E E +E LSR++H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 561 GYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPII 611
Y + +E+L LV +Y G L+ HL + AR +EYLH+ II
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---II 115
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY-----YGLN 666
+RD+K NILLDA +++DFGL+ S R GT Y+ PE YG
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 667 VLTAKSDVYGLGVVLLELLTGK 688
V D + LGV+L E+LTGK
Sbjct: 174 V-----DWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 74/287 (25%), Positives = 140/287 (48%), Gaps = 34/287 (11%)
Query: 500 NKIGAGSFGVVYKGK---LPDGQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
++G G FG V + L D +VA+K + ++ S F+ E+ L L H+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK---SLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 555 HLVRLVGYCEEKDER--LLVYDYMKNGALYDHLH---DRNNVEK------NAARGIEYLH 603
++V+ G CE+ R L+ +Y+ +G+L D+L D+ N+++ +G++YL
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT--VGYIDPE 661
+ IHRD+ + NIL++++ ++SDFGL+ + PE +D+ +K G + + PE
Sbjct: 127 SQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPED-KDYYYVKEPGESPIFWYAPE 182
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
+ ++ SDV+ GV L EL T + ++ A ++ L+++L
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGD---PSQSPPAEFLRMIGIAQGQMIVTRLLELL 239
Query: 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
R+ P E +L+ C E ++RP+ AD++ ++R
Sbjct: 240 KEGERLPRPPSCPDEVYDLMK----LCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 72/278 (25%), Positives = 119/278 (42%), Gaps = 47/278 (16%)
Query: 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVG 561
IG G FG V G GQ+VA+K K AF +E + ++ L H +LV+L+G
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVK-----CLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 562 YCEEKDERLLVYDYMKNGALYDHLHDR----NNVEK------NAARGIEYLHNYAVPPII 611
+ + +V +YM G+L D+L R + + + G+EYL +
Sbjct: 68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFV 124
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT--VGYIDPEYYGLNVLT 669
HRD+ + N+L+ A+VSDFGL+ ++ + +G V + PE +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLA-------KEASQGQDSGKLPVKWTAPEALREKKFS 177
Query: 670 AKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729
KSDV+ G++L E+ + R + P + VP + G R+ PE
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPY--------PRIPLKDVVPHVEKG-------YRMEAPE 222
Query: 730 INEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767
E +++ C L+ +RPT + L
Sbjct: 223 GCPPEVYKVM----KDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/204 (29%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+F L IG G+FG V + D +++ A+K K + + + E L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNH 59
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
LV L ++++ LV D + G L HL + + + +EYLH+
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
IIHRDIK NILLD Q ++DF ++ +GT GY+ PE
Sbjct: 120 G---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT---STSGTPGYMAPEVLCR 173
Query: 666 NVLTAKSDVYGLGVVLLELLTGKR 689
+ D + LGV E L GKR
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETA---KTKK----FQEKESAFDSEL 545
++F IG GSF V K +E AIK + K KK EKE
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV------ 54
Query: 546 AFLSRL-HHKHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVEKNAAR----- 597
L+RL H +++L Y +DE L V +Y NG L ++ ++++ R
Sbjct: 55 --LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE 110
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES------------ 642
+EYLH+ IIHRD+K NILLD +++DFG + + +
Sbjct: 111 ILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 643 -ERDFRPMKAA-----GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ + GT Y+ PE SD++ LG ++ ++LTGK
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 46/286 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ L K+GAG FG V++G + VA+K T K K+ F +E + +L H
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVK---TLKPGTMDPKD--FLAEAQIMKKLRH 60
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN--------VEKNA--ARGIEYL- 602
L++L C ++ +V + MK G+L ++L ++ A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
NY IHRD+ + N+L+ +V+DFGL+ + E + R A + + PE
Sbjct: 121 AQNY-----IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE-GAKFPIKWTAPE 174
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
N + KSDV+ G++L E++T R P + E+++ +
Sbjct: 175 AALYNRFSIKSDVWSFGILLTEIVTYGR-----------------MPYPGMTNAEVLQQV 217
Query: 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
D+ R+ P E +++ + C + +RPT + LE
Sbjct: 218 DQGYRMPCPPGCPKELYDIM----LDCWKEDPDDRPTFETLQWKLE 259
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLS 549
+ ++E IG G FG V +G KLP +E VAIK T K ++ F +E + +
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIK---TLKAGSSDKQRLDFLTEASIMG 60
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-----------NAARG 598
+ H +++RL G + +++ +YM+NG+L L R N K A G
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASG 118
Query: 599 IEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG 656
++YL NY +HRD+ + NIL+++ +VSDFGLS +SE + +
Sbjct: 119 MKYLSEMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR 173
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
+ PE T+ SDV+ G+V+ E+++ + + V + A+ G
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMS-----YGERPYWDMSNQDV---IKAVEDG- 224
Query: 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
R+ PP + + + C + ERPT + IV+ L++
Sbjct: 225 ------YRLPPPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 66/205 (32%), Positives = 107/205 (52%), Gaps = 18/205 (8%)
Query: 495 NFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+F + NKIG GSFGVV+K + D + A+K+ + +K + +E+E A D E L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAID-EARVLAKLDS 58
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR-------NNVEK---NAARGIEYLH 603
+++R +K + +V +Y +NG L+ L + + V + G+ +LH
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
+ I+HRDIKS N+ LDA ++ D G++ + ++ + GT Y+ PE
Sbjct: 119 S---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI--VGTPYYLSPELC 173
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGK 688
KSDV+ LGVVL E TGK
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 74/281 (26%), Positives = 131/281 (46%), Gaps = 45/281 (16%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKE------SAFDSELAFLSRLHHK 554
IG G++G VY + G+ +A+K+ E T + A SE+ L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 555 HLVRLVGYCEEKDERLLVY-DYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
++V+ +G E +E L ++ +Y+ G++ L E+ R G+ YLH+
Sbjct: 69 NIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
I+HRD+K+ N+L+DA ++SDFG+S + + + M G+V ++ PE
Sbjct: 128 G---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 666 NV--LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
+AK D++ LG V+LE+ G+R + D+E A+ A+ K+ ++
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGRRP-WSDEE-----------AIAAMF-----KLGNK 227
Query: 724 RVGPPEINEAEAVELVAYTAMH----CVNLEGKERPTMADI 760
R PP I + ++ A+ C + RPT ++
Sbjct: 228 RSAPP-IPP-DVSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 61/227 (26%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD----SELAFLSRLHHK 554
+IG G++G VYK + G+ VA+K K + EKE F E+ L +L H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKE-GFPITAIREIKLLQKLRHP 58
Query: 555 HLVRLVGYCEEKDER--LLVYDYMKNGALYDH----LHDRNNVE----------KNAARG 598
++VRL K + +V++YM DH L D V+ K G
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYM------DHDLTGLLDSPEVKFTESQIKCYMKQLLEG 112
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAG----- 653
++YLH+ I+HRDIK SNIL++ +++DFGL+ R + +A
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLA-------RPYTKRNSADYTNRV 162
Query: 654 -TVGYIDPEY------YGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
T+ Y PE YG V D++ +G +L EL GK IF+
Sbjct: 163 ITLWYRPPELLLGATRYGPEV-----DMWSVGCILAELFLGK-PIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 79/286 (27%), Positives = 125/286 (43%), Gaps = 46/286 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ LE K+GAG FG V+ G +VA+K T K AF E + +L H
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVK---TLKPGTM--SPEAFLQEAQIMKKLRH 60
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN----------AARGIEYLH 603
LV+L C E++ +V +YM G+L D L + A G+ YL
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 604 --NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
NY IHRD+ + NIL+ +++DFGL+ + + E R A + + PE
Sbjct: 121 SRNY-----IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR-EGAKFPIKWTAPE 174
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
T KSDV+ G++L E++T G P P + E+++ +
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVT----------YGRVP-------YPGMTNREVLEQV 217
Query: 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
+R R+ P E +L+ + C + + +ERPT + + LE
Sbjct: 218 ERGYRMPRPPNCPEELYDLM----LQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 47/277 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
L K+GAG FG V+ G +VAIK K+ AF +E + +L H
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIK-----SLKQGSMSPEAFLAEANLMKQLQH 60
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN----------AARGIEYLH 603
LVRL ++ ++ +YM+NG+L D L ++ A G+ ++
Sbjct: 61 PRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 604 --NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
NY IHRD++++NIL+ +++DFGL+ + ++E R A + + PE
Sbjct: 120 RKNY-----IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPE 173
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
T KSDV+ G++L E++T R + P + E+++ L
Sbjct: 174 AINYGTFTIKSDVWSFGILLTEIVTYGRIPY-----------------PGMTNPEVIQNL 216
Query: 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPT 756
+R R+ P+ E EL+ C + +ERPT
Sbjct: 217 ERGYRMPRPDNCPEELYELM----RLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 7e-23
Identities = 72/275 (26%), Positives = 115/275 (41%), Gaps = 52/275 (18%)
Query: 501 KIGAGSFGVVYKGKL-PDGQEVAIKR----GETAKTKKFQEKESAFDSELAFLSRLHHKH 555
+G GS GVVYK + P G+ A+K+ G+ E EL L +
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPY 60
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLHNYA 606
+V+ G ++ E +V +YM G+L D L + + + +G++YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKR 119
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGY-----IDPE 661
IIHRDIK SN+L++++ +++DFG+S + GTV Y I E
Sbjct: 120 --HIIHRDIKPSNLLINSKGEVKIADFGIS--KVLENTLDQCNTFVGTVTYMSPERIQGE 175
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
Y +D++ LG+ LLE GK F L+ AI G +
Sbjct: 176 SYSYA-----ADIWSLGLTLLECALGKFP-FLPPGQPS-FFELMQ----AICDGPPPSL- 223
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT 756
P E E + ++ C+ + K+RP+
Sbjct: 224 -----PAEEFSPEFRDFIS----ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 9e-23
Identities = 76/292 (26%), Positives = 138/292 (47%), Gaps = 45/292 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLS 549
++ + + IGAG FG V++G K+P +E VAIK T K +++ F SE + +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIK---TLKPGYTEKQRQDFLSEASIMG 61
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIE 600
+ H +++RL G + +++ +YM+NGAL +L D + + + A G++
Sbjct: 62 QFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYID 659
YL + +HRD+ + NIL+++ +VSDFGLS ++ + E + + +
Sbjct: 122 YLSDMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVD--FAVPAIMAGE 716
PE T+ SDV+ G+V+ E+++ G+R + D S + ++ F +PA M
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW--DMSNHEVMKAINDGFRLPAPMD-- 234
Query: 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
P + + + C + RP DIV L++ L
Sbjct: 235 ---------CPSAVYQ---------LMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
I G++G V+ K G AIK + A + + + +E LS+ ++V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY 59
Query: 561 GYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPII 611
Y + + L LV +Y+ G L L + +++++ AR +EYLH+ II
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---II 115
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM------KAAGTVGYIDPEYYGL 665
HRD+K NIL+D+ +++DFGLS +G + + GT YI PE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE---- 171
Query: 666 NVLTAKS-----DVYGLGVVLLELLTG 687
V+ + D + LG +L E L G
Sbjct: 172 -VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 4e-22
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 56/229 (24%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS---ELAFLSRL 551
+ K+G G++GVVYK + G+ VA+K K + E+E + E++ L L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN-----NVEKNAA----RGIEYL 602
H ++V+L+ + + LV++Y L +L R N+ K+ RG+ Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAGTVGYID-- 659
H++ I+HRD+K NIL++ +++DFGL+ R F P++ Y
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLA-------RAFGIPLRT-----YTHEV 159
Query: 660 -------PE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
PE +Y V D++ +G + E++TGK +F D
Sbjct: 160 VTLWYRAPEILLGSKHYSTAV-----DIWSVGCIFAEMITGK-PLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 55/288 (19%)
Query: 500 NKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
++G G+FG V KG + G+E VA+K T K + + F E + +++L H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVK---TLKQEHIAAGKKEFLREASVMAQLDHPC 57
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKN-------AARGIEYLHNYAV 607
+VRL+G C+ + +LV + G L +L R + + A G+ YL +
Sbjct: 58 IVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH- 115
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGT--VGYIDPE--Y 662
+HRD+ + N+LL + A++SDFG+S +G S D+ AG + + PE
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWYAPECIN 171
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG-ELVKIL 721
YG ++KSDV+ GV L E + G P M G E++ +L
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFS----------YGAKPY--------GEMKGAEVIAML 211
Query: 722 DR--RVGPPEINEAEAVELVAYTAMH-CVNLEGKERPTMADIVANLER 766
+ R+ PE E Y+ M C ++RPT +++ + R
Sbjct: 212 ESGERLPRPEECPQE-----IYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
F+LE K+G+G FG V++G + VAIK ++ K Q+ F E+ L RL HKH
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD----FQKEVQALKRLRHKH 63
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNY 605
L+ L C + ++ + M+ G+L L ++ A G+ YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE----SERDFRPMKAAGTVGYIDPE 661
IHRD+ + NIL+ +V+DFGL+ + E S P K + PE
Sbjct: 124 N---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLT 686
+ KSDV+ G++L E+ T
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 8e-22
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKE-SAFDSELAFLSRL 551
N+ +G G+FG VY D G+E+A+K+ +KE +A + E+ L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 552 HHKHLVRLVGYCEEKDERLLVY-DYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H+ +V+ G C DE L ++ +YM G++ D L + + R G+EYL
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYL 120
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE 661
H+ I+HRDIK +NIL D+ ++ DFG S MK+ GT ++ PE
Sbjct: 121 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
K+DV+ +G ++E+LT K AIFK
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK 218
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 53/287 (18%)
Query: 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESA---FDSELAFLSRLHH 553
++++K+G G +G VY+G V K T K +E F E A + + H
Sbjct: 9 TMKHKLGGGQYGEVYEG-------VWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------ARGIEYLH 603
+LV+L+G C + ++ ++M G L D+L + N E NA + +EYL
Sbjct: 62 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE 121
Query: 604 --NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
N+ IHRD+ + N L+ +V+DFGLS + + A + + PE
Sbjct: 122 KKNF-----IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPE 175
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
N + KSDV+ GV+L E+ T G +P P I ++ ++L
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSP-------YPGIDLSQVYELL 218
Query: 722 DR--RVGPPEINEAEAVELVAYTAMH-CVNLEGKERPTMADIVANLE 765
++ R+ PE + EL M C +RP+ A+I E
Sbjct: 219 EKGYRMERPEGCPPKVYEL-----MRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 31/210 (14%)
Query: 500 NKIGAGSFGVVYKG-KLPDG-----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
NKIG G+FG VY L G +E+ I+ + K E+ L L H
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIK-------EIADEMKVLELLKH 58
Query: 554 KHLVRLVGYCEEKDERLLVY-DYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
+LV+ G E E++ ++ +Y G L + L ++++ R G+ YLH+
Sbjct: 59 PNLVKYYG-VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKA-AGTVGYIDPEY 662
+ I+HRDIK +NI LD ++ DFG + + + +++ AGT Y+ PE
Sbjct: 118 HG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 663 YGLNVLTAK---SDVYGLGVVLLELLTGKR 689
+D++ LG V+LE+ TGKR
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 32/220 (14%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGET----AKTKKFQEKE-SAFDSELAFLSRLHHKH 555
IG+GSFG VY G G+ +A+K+ E A +K + A E+A L L H++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAV 607
+V+ +G + D + +Y+ G++ L++ E+ R G+ YLHN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG- 126
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSM-----MGPESERDFRPMKAAGTVGYIDPEY 662
IIHRDIK +NIL+D + ++SDFG+S RP G+V ++ PE
Sbjct: 127 --IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARP-SLQGSVFWMAPEV 183
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
T K+D++ LG +++E+LTGK +AIFK
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK 223
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKE-------SAFDSELA 546
+ K+G G++ VVYK + G+ VAIK K K + KE +A E+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK-----KIKLGERKEAKDGINFTAL-REIK 54
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------AR 597
L L H +++ L+ K LV+++M+ L + D++ V A R
Sbjct: 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGY 657
G+EYLH+ I+HRD+K +N+L+ + +++DFGL+ R T Y
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VVTRWY 168
Query: 658 IDPE------YYGLNVLTAKSDVYGLGVVLLELLTGK 688
PE +YG+ V D++ +G + ELL
Sbjct: 169 RAPELLFGARHYGVGV-----DMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 22/198 (11%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG G+ G VYK G+EVAIK+ K Q KE + E+ + H ++V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRK----QNKELIIN-EILIMKDCKHPNIVDY 80
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA----------RGIEYLHNYAVPP 609
DE +V +YM G+L D + +N V N +G+EYLH+
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDII-TQNFVRMNEPQIAYVCREVLQGLEYLHSQ---N 136
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
+IHRDIKS NILL + +++DFG + ++ + GT ++ PE
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 670 AKSDVYGLGVVLLELLTG 687
K D++ LG++ +E+ G
Sbjct: 195 PKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 46/275 (16%)
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
KIG G+FG VYKG L EVA+K T ++ + + F E L + H ++V+L+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------NAARGIEYLHNYAVPPII 611
G C +K +V + + G+L L + N +AA G+EYL + I
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNC---I 115
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT----VGYIDPEYYGLNV 667
HRD+ + N L+ ++SDFG+S E + G + + PE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RV 725
T++SDV+ G++L E + G TP P + + + ++ R+
Sbjct: 172 YTSESDVWSYGILLWETFSL----------GDTP-------YPGMSNQQTRERIESGYRM 214
Query: 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
P++ E L+ + C + + RP+ ++I
Sbjct: 215 PAPQLCPEEIYRLM----LQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-21
Identities = 81/284 (28%), Positives = 131/284 (46%), Gaps = 51/284 (17%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
+L IG G FG V +G+ GQ+VA+K + T + AF E A +++LHHK+
Sbjct: 8 LTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQ------AFLEETAVMTKLHHKN 60
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN----------AARGIEYLHNY 605
LVRL+G +V + M G L + L R + A G+EYL +
Sbjct: 61 LVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES- 118
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAGTVGYIDPEYYG 664
++HRD+ + NIL+ A+VSDFGL+ +G + + P+K + PE
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALK 170
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR- 723
++KSDV+ GV+L E+ + RA + P + E+ + +++
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPY-----------------PKMSLKEVKECVEKG 213
Query: 724 -RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
R+ PPE A+ L+ C E K+RP+ + LE+
Sbjct: 214 YRMEPPEGCPADVYVLMT----SCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 82/302 (27%), Positives = 123/302 (40%), Gaps = 58/302 (19%)
Query: 496 FSLENKIGAGSFGVVYKGKL--PDG--QEVAIKRGETAKTKKFQEKE-SAFDSELAFLSR 550
L +G G FG V +G+L DG +VA+K T K E F SE A +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVK---TMKLDIHTYSEIEEFLSEAACMKD 57
Query: 551 LHHKHLVRLVGYCEEKDER------LLVYDYMKNGALYDHLHDRNNVEKNA--------- 595
H ++++L+G C E +++ +MK+G L+ L + +
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLL 116
Query: 596 ------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
A G+EYL N IHRD+ + N +L T V+DFGLS S +R
Sbjct: 117 KFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKK-IYSGDYYRQG 172
Query: 650 KAAGT-VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708
+ A V +I E V T+KSDV+ GV + E+ T G TP
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGQTP------- 215
Query: 709 VPAIMAGELVKIL--DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
P + E+ L R+ PE + ++ + C + K+RPT + LE
Sbjct: 216 YPGVENHEIYDYLRHGNRLKQPE----DCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271
Query: 767 AL 768
L
Sbjct: 272 IL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 40/227 (17%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGETA-KTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+G+GSFG VY+G L DG A+K A + QE + E+A LS+L H ++V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 560 VGYCEEKDERLLVY-DYMKNGALYDHLHD----RNNVEKNAAR----GIEYLHNYAVPPI 610
+G E +++ L ++ + + G+L L V + R G+EYLH+
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---T 123
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE------YY 663
+HRDIK +NIL+D +++DFG++ E F K+ G+ ++ PE Y
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVE----FSFAKSFKGSPYWMAPEVIAQQGGY 179
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGK---------RAIFKDDESGGTP 701
GL D++ LG +LE+ TGK A+FK S P
Sbjct: 180 GLAA-----DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP 221
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+++ L IG G+ VVY LP+ ++VAIKR + K + ++ E+ +S+ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR---KEVQAMSQCN 57
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-----------VEKNAARGIEY 601
H ++V+ DE LV Y+ G+L D + V K +G+EY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA--AGTVGYID 659
LH+ IHRDIK+ NILL + +++DFG+S + R ++ GT ++
Sbjct: 118 LHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 660 PEYYGLNVL------TAKSDVYGLGVVLLELLTGK 688
PE V+ K+D++ G+ +EL TG
Sbjct: 175 PE-----VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 44/276 (15%)
Query: 502 IGAGSFGVVY--KGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+G G+FG+V+ + K D + V IK+ + K ++ A +E L L H +++
Sbjct: 8 VGRGAFGIVHLCRRK-ADQKLVIIKQIPVEQMTK--DERLAAQNECQVLKLLSHPNII-- 62
Query: 560 VGYCE---EKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEY-------LHNYAVPP 609
Y E E ++V +Y G L +++ R N + + + LH+
Sbjct: 63 -EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL 121
Query: 610 IIHRDIKSSNILLDA-QWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
I+HRD+K+ NILLD + ++ DFG+S ++ +S + GT YI PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS----KAYTVVGTPCYISPELCEGKP 177
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727
KSD++ LG VL EL + KRA E+ P V IM+G I DR
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAF----EAANLPA-----LVLKIMSGTFAPISDRY--S 226
Query: 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763
P++ +L+ + +NL+ +RP ++ I+A
Sbjct: 227 PDLR-----QLI----LSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 502 IGAGSFGVVYKGK-LPDGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
+G+G+FG VYKG +P+G+ VAIK + + + E ++ + H H+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIK---VLREETSPKANKEILDEAYVMASVDHPHV 71
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNA--------ARGIEYLHNYAV 607
VRL+G C + L+ M G L D++ + ++N+ A+G+ YL
Sbjct: 72 VRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
++HRD+ + N+L+ +++DFGL+ + E+++ + ++ E +
Sbjct: 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 668 LTAKSDVYGLGVVLLELLT-GKR 689
T KSDV+ GV + EL+T G +
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 51/284 (17%)
Query: 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
+ ++G+G FGVV+ GK +VAIK + E + F E + +L H +L
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDD--FIEEAKVMMKLSHPNL 61
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIEYL--HNY 605
V+L G C ++ +V +YM NG L ++L +R +EYL + +
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT---VGYIDPEY 662
IHRD+ + N L+ +VSDFGL+ + + + GT V + PE
Sbjct: 122 -----IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVKWAPPEV 172
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
+ + ++KSDV+ GV++ E+ + + ++ + V ++ AG L
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--------VESVSAG---YRLY 221
Query: 723 R-RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANL 764
R ++ P E+ YT M C + + ++RP +++ L
Sbjct: 222 RPKLAPTEV----------YTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 76/299 (25%), Positives = 125/299 (41%), Gaps = 53/299 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKG---KLPDGQ---EVAIKR-GETAKTKKFQEKESAFDSELA 546
+L ++G GSFG+VY+G + G+ VAIK E A ++ E F +E +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE----FLNEAS 61
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------- 595
+ + H+VRL+G L+V + M G L +L R +N
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 596 -------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP 648
A G+ YL +HRD+ + N ++ T ++ DFG++ E++ +R
Sbjct: 122 IQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY-YRK 177
Query: 649 M-KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF 707
K V ++ PE V T KSDV+ GVVL E+ T ++ G + ++ F
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ----GLSNEEVLKF 233
Query: 708 AVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
++ G LD P+ + C K RPT +IV++L+
Sbjct: 234 ----VIDG---GHLDLPENCPDK--------LLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 43/277 (15%)
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
++G G FGVV GK +VAIK K+ E F E + +L H+ LV+L
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHD-RNNVE--------KNAARGIEYLHNYAVPPII 611
G C ++ +V +YM NG L ++L + + K+ G+ YL + I
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FI 122
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
HRD+ + N L+D Q +VSDFGLS + E + + V + PE + ++K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 672 SDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA--VPAIMAGELVKILDRRVGPPE 729
SDV+ GV++ E+ + G P + + V + G R+ P
Sbjct: 182 SDVWAFGVLMWEVYS----------LGKMPYERFNNSETVEKVSQG-------LRLYRPH 224
Query: 730 INEAEAVELVAYTAMH-CVNLEGKERPTMADIVANLE 765
+ A E V Y M+ C + + +ERPT +++++E
Sbjct: 225 L----ASEKV-YAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-19
Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 24/276 (8%)
Query: 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVR 558
EN I G G YKGK +IK G K+ + S SE+A + +L H ++V+
Sbjct: 695 ENVISRGKKGASYKGK-------SIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVK 747
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHD-----RNNVEKNAARGIEYLHNYAVPPIIHR 613
L+G C + L+++Y++ L + L + R + A+ + +LH P ++
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSD 673
++ I++D + + LS+ G + +A Y+ PE +T KSD
Sbjct: 808 NLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISSA----YVAPETRETKDITEKSD 860
Query: 674 VYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV-GPPEINE 732
+YG G++L+ELLTGK D E G S+V++A L +D + G +N+
Sbjct: 861 IYGFGLILIELLTGKSP--ADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 733 AEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
E VE V A+HC + RP D++ LE A
Sbjct: 918 NEIVE-VMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 4e-19
Identities = 72/281 (25%), Positives = 129/281 (45%), Gaps = 45/281 (16%)
Query: 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
+L +IG+G FG+V+ G + ++VAIK T + E++ F E + +L H L
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIK---TIREGAMSEED--FIEEAQVMMKLSHPKL 61
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLH-DRNNVEKNA--------ARGIEYLHNYAV 607
V+L G C E+ LV+++M++G L D+L R + G+ YL + V
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT---VGYIDPEYYG 664
IHRD+ + N L+ +VSDFG++ D + + GT V + PE +
Sbjct: 122 ---IHRDLAARNCLVGENQVVKVSDFGMTRF----VLDDQYTSSTGTKFPVKWSSPEVFS 174
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724
+ ++KSDV+ GV++ E+ + + +++ + V I AG ++ R
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV--------VETINAG--FRLYKPR 224
Query: 725 VGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANL 764
+ + Y M HC ++RP+ + ++ L
Sbjct: 225 LASQSV----------YELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 496 FSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDS------ELAFL 548
F+L IG GSFG VYK Q VAIK + E A D E+ FL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL---------EEAEDEIEDIQQEIQFL 53
Query: 549 SRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAA-------RGIE 600
S+ ++ + G K +L ++ +Y G+ D L E A G+E
Sbjct: 54 SQCRSPYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLE 112
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
YLH IHRDIK++NILL + +++DFG+S G + + GT ++ P
Sbjct: 113 YLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAP 167
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGK 688
E + K+D++ LG+ +EL G+
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 500 NKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVR 558
KIG GS G+V G++VA+K+ +K Q +E F+ E+ + H ++V
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKK---MDLRKQQRRELLFN-EVVIMRDYQHPNIVE 80
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHL-HDRNNVEKNAA------RGIEYLHNYAVPPII 611
+ DE +V ++++ GAL D + H R N E+ A + + +LH V I
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGV---I 137
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY-----YGLN 666
HRDIKS +ILL + ++SDFG S+ R GT ++ PE YG
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 667 VLTAKSDVYGLGVVLLELLTGKRAIFKD 694
V D++ LG++++E++ G+ F +
Sbjct: 196 V-----DIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 76/284 (26%), Positives = 124/284 (43%), Gaps = 36/284 (12%)
Query: 502 IGAGSFGVV----YKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
+G G FG V Y G+ VA+K T K + Q+ S + E+ L L+H+++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVK---TLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 557 VRLVGYCEEKDER--LLVYDYMKNGALYDHLHDRNNVE--------KNAARGIEYLHNYA 606
V+ G C E+ + L+ +Y+ G+L D+L ++ + + G+ YLH+
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT-VGYIDPEYYGL 665
IHRD+ + N+LLD ++ DFGL+ PE +R + + V + E
Sbjct: 128 Y---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 666 NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA---IMAGELVKILD 722
N + SDV+ GV L ELLT D P + P + L+++L+
Sbjct: 185 NKFSYASDVWSFGVTLYELLT------HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238
Query: 723 RRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLE 765
R + P Y M +C E K RPT ++ L+
Sbjct: 239 RGMRLPCPKNC---PQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 69/241 (28%), Positives = 106/241 (43%), Gaps = 62/241 (25%)
Query: 496 FSLENKIGAGSFGVVYKGKL---PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ +E IG G++G VYK K DG+E AIK+ + K + +SA E+A L L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC-REIALLRELK 60
Query: 553 HKHLVRLVGYCEEKDERL--LVYDYMKNGALYD-----HLHDRNNVEKNAAR-------- 597
H+++V LV E ++ L++DY A +D H +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 598 ---GIEYLH-NYAVPPIIHRDIKSSNILL----DAQWTARVSDFGLSMMGPESERDFR-P 648
G+ YLH N+ ++HRD+K +NIL+ + ++ D GL+ R F P
Sbjct: 117 ILNGVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLA-------RLFNAP 165
Query: 649 MK--AAG-----TVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
+K A T+ Y PE +Y T D++ +G + ELLT IFK
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLT-LEPIFKGR 219
Query: 696 E 696
E
Sbjct: 220 E 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 496 FSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
F + K+G GS+G VYK GQ VAIK + QE E++ L +
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIK----EISILKQCDSP 58
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLHNY 605
++V+ G + + +V +Y G++ D + N + +G+EYLH+
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
IHRDIK+ NILL+ + A+++DFG+S G ++ + GT ++ PE
Sbjct: 119 K---KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQE 173
Query: 666 NVLTAKSDVYGLGVVLLELLTGK---------RAIF 692
K+D++ LG+ +E+ GK RAIF
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+IG G+ G+V+K K G+ VA+K+ A + + E+ L H ++V+L
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKK--VALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNN------VEKNAA---RGIEYLHNYAVPPI 610
+ +LV +YM + L + L D V+ +G+ Y+H I
Sbjct: 65 LDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---I 120
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYIDPE-YYGLNVL 668
+HRD+K +N+L+ A +++DFGL+ + E R + T Y PE YG
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH--QVATRWYRAPELLYGARKY 178
Query: 669 TAKSDVYGLGVVLLELLTG 687
D++ +G + ELL G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 502 IGAGSFGVVYKGKL--PDGQEV--AIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
IG G FG VY G L DGQ++ A+K + +E E F E + H +++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVK--SLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59
Query: 558 RLVGYCEEKD-ERLLVYDYMKNGALYDHLHD--RNNVEKN-------AARGIEYLHNYAV 607
L+G C + L+V YMK+G L + + N K+ A+G+EYL A
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---AS 116
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGTVGYIDPEYYGL 665
+HRD+ + N +LD +T +V+DFGL+ + E A V ++ E
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176
Query: 666 NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD-FAVPAIMAGELVKILD-R 723
T KSDV+ GV+L EL+T G P VD F + V +L R
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT----------RGAPPYPDVDSFDI-------TVYLLQGR 219
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
R+ PE E++ + C + + + RPT +++V+ +E
Sbjct: 220 RLLQPEYCPDPLYEVM----LSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G FG V ++ G+ A K+ + + KK + ++ A + E L ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-EKKILEKVSSRFIVSLA 59
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR----------GIEYLHNYAVPPI 610
E KD+ LV M G L H+++ AR G+E+LH I
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---I 116
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTA 670
++RD+K N+LLD R+SD GL++ + + AGT GY+ PE V
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDF 173
Query: 671 KSDVYGLGVVLLELLTGKRAIFKD 694
D + LG L E++ G R+ F+
Sbjct: 174 SVDWFALGCTLYEMIAG-RSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 76/284 (26%), Positives = 120/284 (42%), Gaps = 49/284 (17%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
L IG G FG V G G +VA+K + T + AF +E + +++L H
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ------AFLAEASVMTQLRHS 59
Query: 555 HLVRLVGY-CEEKDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLH 603
+LV+L+G EEK +V +YM G+L D+L R + +EYL
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 119
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAGTVGYIDPEY 662
+HRD+ + N+L+ A+VSDFGL+ ++ + P+K + PE
Sbjct: 120 ANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEA 170
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
+ KSDV+ G++L E+ + R + P + VP + G + D
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY--------PRIPLKDVVPRVEKGYKMDAPD 222
Query: 723 RRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLE 765
G P V Y M C +L+ RP+ + LE
Sbjct: 223 ---GCPP---------VVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 84/308 (27%), Positives = 134/308 (43%), Gaps = 64/308 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-PDG--QEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
N+ ++ IG G+FG V K ++ DG + AIKR K ++ F EL L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCK 63
Query: 551 L-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN--------------- 594
L HH +++ L+G CE + L +Y +G L D L +E +
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 595 ---------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645
ARG++YL IHRD+ + NIL+ + A+++DFGLS ++
Sbjct: 124 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS-----RGQE 175
Query: 646 FRPMKAAG--TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703
K G V ++ E +V T SDV+ GV+L E+++ GGTP
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGTPYC 225
Query: 704 LVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
+ EL + L + R+ P + E +L+ C + ERP+ A I+
Sbjct: 226 -------GMTCAELYEKLPQGYRLEKPLNCDDEVYDLM----RQCWREKPYERPSFAQIL 274
Query: 762 ANLERALD 769
+L R L+
Sbjct: 275 VSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 76/290 (26%), Positives = 134/290 (46%), Gaps = 47/290 (16%)
Query: 498 LENKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+E IGAG FG V +G KLP +E VAIK T K+ +++ F SE + + + H
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIK---TLKSGYTEKQRRDFLSEASIMGQFDH 64
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLH- 603
+++ L G + +++ ++M+NGAL L + + + A G++YL
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 604 -NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAG---TVGYID 659
NY +HRD+ + NIL+++ +VSDFGLS + D + G + +
Sbjct: 125 MNY-----VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718
PE T+ SDV+ G+V+ E+++ G+R + D S ++ ++
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--DMSNQDVINAIE------------ 225
Query: 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
D R+ PP +L+ + C + RP IV+ L++ +
Sbjct: 226 --QDYRLPPPMDCPTALHQLM----LDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 59/220 (26%), Positives = 85/220 (38%), Gaps = 49/220 (22%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKE-SAFDSELAFLSRLHHKHLV 557
IG GSFG V K + DG+ + K EKE SE+ L L H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIV 62
Query: 558 RLVG---------------YCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------- 595
R YCE D L+ K +R +E+
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKK---------ERKYIEEEFIWRILTQ 113
Query: 596 -ARGIEYLHN--YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKA 651
+ HN ++HRD+K +NI LDA ++ DFGL+ ++G +S A
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS------SFA 167
Query: 652 AGTVG---YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
VG Y+ PE KSD++ LG ++ EL
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 86/304 (28%), Positives = 133/304 (43%), Gaps = 73/304 (24%)
Query: 501 KIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKES-------AFDSELAFLSRLH 552
+G GS+G+V K K + GQ VAIK KF E E A E+ L +L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIK--------KFLESEDDKMVKKIAM-REIRMLKQLR 58
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGAL-----YDHLHDRNNVEK---NAARGIEYLHN 604
H++LV L+ K LV++++ + L Y + D + V K RGIE+ H+
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGP-ESERDFRPMKAAGTVGYIDPE 661
+ IIHRDIK NIL+ ++ DFG + + P E D+ T Y PE
Sbjct: 119 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY-----VATRWYRAPE 170
Query: 662 Y------YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA- 714
YG V D++ +G ++ E+LTG+ +F D S +D I
Sbjct: 171 LLVGDTKYGRAV-----DIWAVGCLVTEMLTGE-PLFPGD-------SDIDQLYHIIKCL 217
Query: 715 GELVK----ILDRR-----VGPPEINEAEAVE--------LVAYTAMHCVNLEGKERPTM 757
G L+ I + + PE+ E E +E LV A C+ ++ +RP+
Sbjct: 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS 277
Query: 758 ADIV 761
+ ++
Sbjct: 278 SQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 47/288 (16%)
Query: 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ L K+G G FG V+ G +VA+K T K + +F E + +L
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVK---TLKPGTMSPE--SFLEEAQIMKKL 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD---RN-------NVEKNAARGIEY 601
H LV+L E+ +V +YM G+L D L D R ++ A G+ Y
Sbjct: 59 RHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAY 117
Query: 602 LH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYID 659
+ NY IHRD++S+NIL+ +++DFGL+ + ++E R A + +
Sbjct: 118 IERMNY-----IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTA 171
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719
PE T KSDV+ G++L EL+T R + P + E+++
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPY-----------------PGMNNREVLE 214
Query: 720 ILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
++R R+ P+ EL+ + C + +ERPT + + LE
Sbjct: 215 QVERGYRMPCPQDCPISLHELM----LQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 78/313 (24%), Positives = 120/313 (38%), Gaps = 85/313 (27%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDS------ELA 546
N + + +G G++GVV K + G+ VAIK KF+E E D E+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK--------KFKESEDDEDVKKTALREVK 52
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------G 598
L +L H+++V L K LV++Y++ L + +A R
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQA 112
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
I Y H++ IIHRDIK NIL+ ++ DFG + R ++A
Sbjct: 113 IAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFA----------RALRARPASPLT 159
Query: 659 D---------PEY------YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDES------ 697
D PE YG V DV+ +G ++ ELL G +F D
Sbjct: 160 DYVATRWYRAPELLVGDTNYGKPV-----DVWAIGCIMAELLDG-EPLFPGDSDIDQLYL 213
Query: 698 -----GGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVE-----LVAYTAMH-- 745
G P P+ V PE ++ E++E V+ A+
Sbjct: 214 IQKCLGPLP--------PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFL 265
Query: 746 --CVNLEGKERPT 756
C+ ++ KER T
Sbjct: 266 KACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 32/209 (15%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKE----SAFDSELAFLSRLHHKH 555
KIG G++GVVYK + G+ VAIK K K E E +A E+ L L+H +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIK-----KIKLRFESEGIPKTAL-REIKLLKELNHPN 59
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA---------RGIEYLHNYA 606
+++L+ K + LV+++M LY + DR + +G+ + H++
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPM-KAAGTVGYIDPE-YY 663
I+HRD+K N+L++ + +++DFGL+ G RP T Y PE
Sbjct: 119 ---ILHRDLKPENLLINTEGVLKLADFGLARSFGS----PVRPYTHYVVTRWYRAPELLL 171
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
G + D++ +G + ELL+ R +F
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSR-RPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 75/281 (26%), Positives = 127/281 (45%), Gaps = 44/281 (15%)
Query: 502 IGAGSFGVVYKGK-LPDGQEV----AIK-RGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
+G+G+FG VYKG +P+G+ V AIK ET K E F E ++ + H H
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE----FMDEALIMASMDHPH 70
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKN--------AARGIEYLHNYA 606
LVRL+G C +L V M +G L D++H+ ++N+ A+G+ YL
Sbjct: 71 LVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN 666
++HRD+ + N+L+ + +++DFGL+ + E+++ + ++ E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 667 VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726
T +SDV+ GV + EL+T GG P +P +L++ +R
Sbjct: 187 KFTHQSDVWSYGVTIWELMT----------FGGKPYD----GIPTREIPDLLEKGERLPQ 232
Query: 727 PPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
PP + Y M C ++ RP ++ A R
Sbjct: 233 PP------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 80/312 (25%), Positives = 121/312 (38%), Gaps = 63/312 (20%)
Query: 495 NFSLENKIGAGSFGVVYKGK------LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFL 548
N L +G G FG V K VA+K K + SE L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNLL 57
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE-----KNAARGIEYLH 603
+++H H+++L G C + LL+ +Y K G+L L + V + R YL
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 604 NYAVPPI------------------------IHRDIKSSNILLDAQWTARVSDFGLSMMG 639
N + +HRD+ + N+L+ ++SDFGLS
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699
E + + K V ++ E ++ T +SDV+ GV+L E++T GG
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----------LGG 227
Query: 700 TPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPT 756
P P I L +L R+ PE N +E + Y M C E +RPT
Sbjct: 228 NP-------YPGIAPERLFNLLKTGYRMERPE-NCSEEM----YNLMLTCWKQEPDKRPT 275
Query: 757 MADIVANLERAL 768
ADI LE+ +
Sbjct: 276 FADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 49/234 (20%)
Query: 495 NFSLENKIGAGSFGVVYKGKL----PDGQE--VAIKRGETAKTKKFQEKESAFDSELAFL 548
L+ ++G G+FG V+ G+ P+ + VA+K T K + F+ E L
Sbjct: 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVK---TLKETASNDARKDFEREAELL 62
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRN----------------- 589
+ H+++V+ G C E D ++V++YM++G L L H +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 590 ---NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
+ A G+ YL A +HRD+ + N L+ ++ DFG+S RD
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS-------RDV 172
Query: 647 RP---MKAAGT----VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIF 692
+ G + ++ PE T +SDV+ GVVL E+ T GK+ +
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
++G+G FGVV+ GK +VAIK + E F E + +L H LV+L
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIK-----AINEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPII 611
G C ++ +V ++M+NG L ++L R ++ ++ G+EYL + I
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
HRD+ + N L+ + +VSDFG++ + E A V + PE + + ++K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 672 SDVYGLGVVLLELLTGKRAIFK 693
SDV+ GV++ E+ T + F+
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 83/320 (25%), Positives = 129/320 (40%), Gaps = 90/320 (28%)
Query: 497 SLENKIGAGSFGVVYKG------KLPDGQEVAIKRGETAKTKKFQEKE-SAFDSELAFLS 549
+L +G G+FG V K + VA+K + T EK+ S SE+ +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT----EKDLSDLVSEMEMMK 70
Query: 550 RL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------- 595
+ HK+++ L+G C ++ +V +Y +G L D L R + A
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 596 -----------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644
ARG+E+L A IHRD+ + N+L+ +++DFGL+ R
Sbjct: 131 QKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLA-------R 180
Query: 645 DFR-------------PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691
D P+K ++ PE V T +SDV+ GV+L E+ T
Sbjct: 181 DIHHIDYYRKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLLWEIFT----- 229
Query: 692 FKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVN 748
GG+P P I EL K+L R+ P+ E Y M C +
Sbjct: 230 -----LGGSP-------YPGIPVEELFKLLKEGYRMEKPQNCTQE-----LYHLMRDCWH 272
Query: 749 LEGKERPTMADIVANLERAL 768
+RPT +V +L+R L
Sbjct: 273 EVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 49/292 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLS 549
+ +E IGAG FG V G KLP +E VAIK T K +++ F SE + +
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIK---TLKAGYTEKQRRDFLSEASIMG 60
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRN-------NVEKNAARGIE 600
+ H +++ L G + ++V +YM+NG+L L HD + + A G++
Sbjct: 61 QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMK 120
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM---GPESERDFRPMKAAGTVGY 657
YL + +HRD+ + NIL+++ +VSDFGLS + PE+ R K + +
Sbjct: 121 YLSDMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP--IRW 175
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
PE T+ SDV+ G+V+ E+++ G+R ++ + +
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE------------------MSNQD 217
Query: 717 LVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
++K ++ R+ P A +L+ + C + ERP IV+ L++
Sbjct: 218 VIKAIEEGYRLPAPMDCPAALHQLM----LDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 21/221 (9%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVR 558
++GAG+ GVV K P G+ +A+K + Q+ EL L + + ++V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK---QILRELDILHKCNSPYIVG 63
Query: 559 LVGYCEEKDERLLVYDYMKNGAL---YDHLHDRNNVEKNAA------RGIEYLHNYAVPP 609
G + + +YM G+L + R +G+ YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHK 121
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPES-ERDFRPMKAAGTVGYIDPEYYGLNVL 668
IIHRD+K SNIL++++ ++ DFG+S S + F GT Y+ PE N
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF-----VGTSSYMAPERIQGNDY 176
Query: 669 TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
+ KSD++ LG+ L+EL TG+ +++ L+ + V
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 47/285 (16%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ LE K+G G FG V+ G VAIK K AF E + +L H+
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-----TLKPGTMSPEAFLQEAQVMKKLRHE 61
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLH- 603
LV+L E + +V +YM G+L D L ++ A G+ Y+
Sbjct: 62 KLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 604 -NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
NY +HRD++++NIL+ +V+DFGL+ + ++E R A + + PE
Sbjct: 121 MNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEA 174
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
T KSDV+ G++L EL T R + P ++ E++ ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELTTKGRVPY-----------------PGMVNREVLDQVE 217
Query: 723 R--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
R R+ P +L+ C E +ERPT + A LE
Sbjct: 218 RGYRMPCPPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 66/236 (27%), Positives = 104/236 (44%), Gaps = 56/236 (23%)
Query: 492 ATNNFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKE----SAFDSELA 546
++ + K+G G+FG VYK ++ G+ VA+K K EK+ +A E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITAL-REIK 59
Query: 547 FLSRLHHKHLVRLVGYC-----EEKDERLLVY---DYMKNGALYDH----LHDRNNVEKN 594
L +L H ++V L+ + K +R VY YM DH L + +V+
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM------DHDLSGLLENPSVKLT 113
Query: 595 AAR----------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM------ 638
++ GI YLH I+HRDIK++NIL+D Q +++DFGL+
Sbjct: 114 ESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 639 -----GPESERDFRPMKAAGTVGYIDPEY-YGLNVLTAKSDVYGLGVVLLELLTGK 688
G R + + T Y PE G T D++G+G V E+ T +
Sbjct: 171 NPKGGGGGGTRKYTNLVV--TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 23/201 (11%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
L K+GAG FG V+ G + +VA+K T K + AF E + L H LV
Sbjct: 10 LVKKLGAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSVQ--AFLEEANLMKTLQHDKLV 64
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLH--NY 605
RL +++ ++ +YM G+L D L + A G+ Y+ NY
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
IHRD++++N+L+ +++DFGL+ + ++E R A + + PE
Sbjct: 125 -----IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE-GAKFPIKWTAPEAINF 178
Query: 666 NVLTAKSDVYGLGVVLLELLT 686
T KSDV+ G++L E++T
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 501 KIGAGSFGVVYKG--KLPDGQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
K+G GSFGVV +G G+ VA+K K+ K + F E A + L H++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVK---CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAV--------- 607
+RL G ++V + G+L D L + I L +YAV
Sbjct: 59 IRLYGVVLT-HPLMMVTELAPLGSLLDRLRK----DALGHFLISTLCDYAVQIANGMRYL 113
Query: 608 --PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV--GYIDPEYY 663
IHRD+ + NILL + ++ DFGL P++E + M+ V + PE
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV-MEEHLKVPFAWCAPESL 172
Query: 664 GLNVLTAKSDVYGLGVVLLELLT 686
+ SDV+ GV L E+ T
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 32/217 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGKL------PDGQEVAIK-RGETAKTKKFQEKESAFDSELAF 547
+ +L +G G+FG VY+G +VA+K E+ ++ ES F E
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS----EQDESDFLMEALI 62
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL-HDRNNVEK------------- 593
+S+ +H+++VRL+G E+ R ++ + M G L L +R E+
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 594 -NAARGIEYLHNYAVPPIIHRDIKSSNILLD---AQWTARVSDFGLSMMGPESERDFRPM 649
+ A+G +YL IHRDI + N LL A+++DFG++ + +
Sbjct: 123 RDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
+A + ++ PE + + T+K+DV+ GV+L E+ +
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 45/284 (15%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ LE K+GAG FG V+ +VA+K K AF +E + L H
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVK-----TMKPGSMSVEAFLAEANVMKTLQHD 61
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLH-DRNNVEK---------NAARGIEYLH- 603
LV+L K+ ++ ++M G+L D L D + + A G+ ++
Sbjct: 62 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 604 -NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
NY IHRD++++NIL+ A +++DFGL+ + ++E R A + + PE
Sbjct: 121 RNY-----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE-GAKFPIKWTAPEA 174
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
T KSDV+ G++L+E++T G P P + E+++ L+
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT----------YGRIP-------YPGMSNPEVIRALE 217
Query: 723 RRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLE 765
R P E EL Y M C +ERPT I + L+
Sbjct: 218 RGYRMPR-PENCPEEL--YNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 58/231 (25%)
Query: 502 IGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKF----QEKESAFDSELAFLSRLHHKHL 556
IG G+FG V+ + D +V A+K +K + + + +E L+ +
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKV-----LRKSDMIKRNQIAHVRAERDILADADSPWI 63
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVP 608
V+L ++++ LV +YM G L + L ++ + AR ++ +H
Sbjct: 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG-- 121
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD-------------------FRPM 649
IHRDIK NIL+DA +++DFGL +++ R
Sbjct: 122 -FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 650 K--------AAGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTG 687
K GT YI PE YGL D + LGV+L E+L G
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLEC-----DWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 502 IGAGSFGVVYKGKL--PDGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
+G G+FG VYKG+L P+ + VAIK T K + + F E +S L H +
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIK---TLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN------------------------NV 591
+V L+G C ++ ++++Y+ +G L++ L + ++
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 592 EKNAARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
A G+EYL H++ +HRD+ + N L+ T ++SDFGLS ++
Sbjct: 130 AIQIAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLEL 684
K+ V ++ PE T +SD++ GVVL E+
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 69/289 (23%), Positives = 121/289 (41%), Gaps = 52/289 (17%)
Query: 502 IGAGSFGVVYKGKLPDGQE------VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
+G G FG V+ K +E V +K + K + +S F EL +L HK+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLH-DRNNVEKNA----------------ARG 598
+VRL+G C E + ++ +Y G L L ++ EK A G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
+++L N +HRD+ + N L+ +Q +VS LS + ++ A + ++
Sbjct: 130 MDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLS-KDVYNSEYYKLRNALIPLRWL 185
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD--DESGGTPVSLVDFAVPAIMAGE 716
PE + + KSDV+ GV++ E+ T F DE + + AG+
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE----------VLNRLQAGK 235
Query: 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
L + PE + +L+ C + K+RP+ +++V+ L
Sbjct: 236 L------ELPVPEGCPSRLYKLMT----RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 50/223 (22%)
Query: 495 NFSLENKIGAGSFGVVY---KGKLPDG---------QEVAI-KRGETAKTKKFQEKESAF 541
NF L +G G++G V+ K D Q+ A+ ++ +T + + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 542 DSELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--- 597
+ FL LH Y + + +L L+ DY+ G ++ HL+ R+N ++ R
Sbjct: 61 VRQSPFLVTLH---------YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111
Query: 598 -----GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMK 650
+E+LH I++RDIK NILLD++ ++DFGLS + E ER +
Sbjct: 112 GEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---S 165
Query: 651 AAGTVGYIDPEYYGLNVLTAKS------DVYGLGVVLLELLTG 687
GT+ Y+ PE ++ K D + LG+++ ELLTG
Sbjct: 166 FCGTIEYMAPE-----IIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 72/262 (27%), Positives = 112/262 (42%), Gaps = 51/262 (19%)
Query: 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIK---RGETAKTKKFQEKESAFDSELAFLSR 550
+F + +G GSFG V K G+ AIK + E K K+ Q E + L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH----VAQEKSILME 74
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR----NNVEK----NAARGIEYL 602
L H +V ++ ++++ + +++ G L+ HL N+V K EYL
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H+ II+RD+K N+LLD + +V+DFG + P+ R GT PEY
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCGT-----PEY 181
Query: 663 YGLNVLTAKS-----DVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
V+ +K D + +GV+L E + G F D TP + +
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD-----TPFRIYE----------- 225
Query: 718 VKILDRRVGPPEINEAEAVELV 739
KIL R+ P + A +LV
Sbjct: 226 -KILAGRLKFPNWFDGRARDLV 246
|
Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 501 KIGAGSFGVV-YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG GS G+V + G++VA+K+ + +K Q +E F+ E+ + HH+++V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDL---RKQQRRELLFN-EVVIMRDYHHENVVDM 84
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHL-HDRNNVEKNAA------RGIEYLHNYAVPPIIH 612
DE +V ++++ GAL D + H R N E+ A R + YLHN V IH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGV---IH 141
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKS 672
RDIKS +ILL + ++SDFG S+ + GT ++ PE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 673 DVYGLGVVLLELLTGKRAIFKD 694
D++ LG++++E++ G+ F +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNE 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 56/216 (25%)
Query: 502 IGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKK------------FQEKESAFDSELAFL 548
+G G FG V K+ + A+K KK F EKE L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC-----VKKRHIVETGQQEHIFSEKE--------IL 47
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVY---DYMKNGALYDHLHDRNNVEKNAAR-------- 597
+H +V+L Y KD++ +Y +Y G L+ L DR ++ AR
Sbjct: 48 EECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVL 104
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGY 657
EYLHN II+RD+K N+LLD+ ++ DFG + + + + GT Y
Sbjct: 105 AFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEY 158
Query: 658 IDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGK 688
+ PE Y +V D + LG++L ELLTG+
Sbjct: 159 VAPEIILNKGYDFSV-----DYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 12/203 (5%)
Query: 502 IGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G FG V ++ G+ A K+ E + KK ++ E+ +E L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEY-------LHNYAVPPIIHR 613
E KD LV M G L H+++ N + R I Y L + I++R
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126
Query: 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSD 673
D+K NILLD + R+SD GL++ PE E GTVGY+ PE T D
Sbjct: 127 DLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPD 183
Query: 674 VYGLGVVLLELLTGKRAIFKDDE 696
+GLG ++ E++ G+ K E
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 70/233 (30%), Positives = 101/233 (43%), Gaps = 51/233 (21%)
Query: 495 NFSLENKIGAGSFGVVY----KGKLPDGQEVAIK--RGETAKTK-KFQEKESAFDSEL-- 545
NF L +G G++G V+ G G+ A+K + T K K E L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 546 ----AFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--- 597
FL LH Y + D +L L+ DY+ G L+ HL+ R + ++ R
Sbjct: 61 VRRCPFLVTLH---------YAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111
Query: 598 -----GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMK 650
+++LH II+RDIK NILLD++ ++DFGLS + E ER +
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---S 165
Query: 651 AAGTVGYIDPEYYGLNVLTAKSDVYG-------LGVVLLELLTGKRAIFKDDE 696
GT+ Y+ PE V+ S + LGV+ ELLTG D E
Sbjct: 166 FCGTIEYMAPE-----VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 38/209 (18%)
Query: 502 IGAGSFGVVYKGK---LPD--GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
+G G+FG V + L D G+ VA+K+ + + + ++ F+ E+ L L H ++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD----FEREIEILKSLQHDNI 67
Query: 557 VRLVGYCEEKDER--LLVYDYMKNGALYDHLHDRNNVEKNAAR---------------GI 599
V+ G C R LV +Y+ G+L D+L +K+ R G+
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL------QKHRERLDHRKLLLYASQICKGM 121
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT--VGY 657
EYL +HRD+ + NIL++++ ++ DFGL+ + P+ ++++ ++ G + +
Sbjct: 122 EYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFW 177
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
PE + + SDV+ GVVL EL T
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 25/231 (10%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+++G G+ G V K +L + + A+K T Q++ EL
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ---ILRELEINKSCK 57
Query: 553 HKHLVRLVG-YCEEKDERL-LVYDYMKNG---ALYDHLHDRNN---------VEKNAARG 598
++V+ G + +E + + +Y + G ++Y + R + ++ +G
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
+ YLH+ IIHRDIK SNILL + ++ DFG+S S GT Y+
Sbjct: 118 LSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYM 170
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
PE + SDV+ LG+ LLE+ + + E P+ L+ + V
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 496 FSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
F +G G FG V ++ G+ A K+ E + KK ++ E+ +E L +++ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSR 60
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR----------GIEYLHN 604
+V L E KD LV M G L H+++ N + R G+E LH
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPEYY 663
I++RD+K NILLD R+SD GL++ PE E ++ GTVGY+ PE
Sbjct: 121 ---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVV 173
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGK 688
T D +GLG ++ E++ GK
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 63/198 (31%), Positives = 93/198 (46%), Gaps = 18/198 (9%)
Query: 502 IGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G FG V ++ G+ A KR E + KK ++ ES +E L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLA 66
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR----------GIEYLHNYAVPPI 610
E KD LV M G L H+++ N R G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---T 123
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTA 670
++RD+K NILLD R+SD GL++ PE E GTVGY+ PE T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 671 KSDVYGLGVVLLELLTGK 688
D +GLG ++ E++ G+
Sbjct: 181 SPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKE-SAFDSELAFLSRLH 552
N+ L +G G+FG VY D G+E+A+K+ + KE +A + E+ L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 553 HKHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H+ +V+ G + ER L ++M G++ D L + +N R G+ YL
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE 661
H+ I+HRDIK +NIL D+ ++ DFG S MK+ GT ++ PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGK 688
K+D++ +G ++E+LT K
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 501 KIGAGSFG--VVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVR 558
KIG GSFG ++ K K DG++ IK +K + +ES E+A LS + H ++V+
Sbjct: 7 KIGEGSFGKAILVKSK-EDGKQYVIKEINISKMSPKEREESR--KEVAVLSNMKHPNIVQ 63
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGI------------------E 600
EE +V DY + G LY + NA RG+ +
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGVLFPEDQILDWFVQICLALK 115
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
++H+ I+HRDIKS NI L T ++ DFG++ + + R GT Y+ P
Sbjct: 116 HVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR--TCIGTPYYLSP 170
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGKRA 690
E KSD++ LG VL E+ T K A
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 8e-16
Identities = 76/285 (26%), Positives = 126/285 (44%), Gaps = 47/285 (16%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ L+ K+G G FG V+ G +VAIK T K + AF E + +L H
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIK---TLKPGTMMPE--AFLQEAQIMKKLRHD 61
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLH- 603
LV L E + +V ++M G+L D L + + ++ A G+ Y+
Sbjct: 62 KLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 604 -NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
NY IHRD++++NIL+ +++DFGL+ + ++E R A + + PE
Sbjct: 121 MNY-----IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEA 174
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
T KSDV+ G++L EL+T R + P ++ E+++ ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPY-----------------PGMVNREVLEQVE 217
Query: 723 R--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
R R+ P+ EL+ C + ERPT I + LE
Sbjct: 218 RGYRMPCPQGCPESLHELMK----LCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++F +G GSFG V + + A+K AK K ++ E +E L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVL-NEKRILQSIR 59
Query: 553 HKHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H LV L Y +D+ L V +Y+ G L+ HL + AR +EYL
Sbjct: 60 HPFLVNL--YGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H+ I++RD+K N+LLD+ +++DFG + R GT Y+ PE
Sbjct: 118 HSLD---IVYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEI 169
Query: 663 -----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
YG V D + LG+++ E+L G F DD
Sbjct: 170 ILSKGYGKAV-----DWWALGILIYEMLAG-YPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 68/277 (24%), Positives = 112/277 (40%), Gaps = 44/277 (15%)
Query: 502 IGAGSFG--VVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFD-SELAFLSRLHHKHLVR 558
+G G+FG +Y+ + D V K + EKE +E+ LS L H +++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKE---VNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNN----------VEKNAARGIEYLHNYAVP 608
+ + + L+ +Y G LYD + + + Y+H
Sbjct: 64 YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
I+HRDIK+ NI L ++ DFG+S ++G E GT Y+ PE
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS---MAETVVGTPYYMSPELCQGVK 177
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727
KSD++ LG VL ELLT KR P++LV I+ G ++
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF-----DATNPLNLVV----KIVQGNYTPVVSVY--- 225
Query: 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764
+E + LV + + ++RPT +++
Sbjct: 226 ----SSELISLVH----SLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 37/226 (16%)
Query: 496 FSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKE----SAFDSELAFLSR 550
F + +IG G++G VYK + D G+ VA+K K + EKE +A E+ L +
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALK-----KVRLDNEKEGFPITAI-REIKILRQ 62
Query: 551 LHHKHLVRLVGYCEEKDERL----------LVYDYMKN---GALYDHLHDRN-----NVE 592
L+H+++V L +K + L LV++YM + G L L + +
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 593 KNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP-MKA 651
K G+ Y H +HRDIK SNILL+ + +++DFGL+ + E RP
Sbjct: 123 KQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES--RPYTNK 177
Query: 652 AGTVGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
T+ Y PE G DV+ G +L EL T K+ IF+ ++
Sbjct: 178 VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQ 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ +G G+FG V+ + A+K + + ++++ +E L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV-HNEKRVLKEVSH 60
Query: 554 KHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
++RL + E D+R L + +Y+ G L+ +L + + +EYLH
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
+ I++RD+K NILLD + +++DFG + + RD R GT Y+ PE
Sbjct: 119 SKE---IVYRDLKPENILLDKEGHIKLTDFGFA----KKLRD-RTWTLCGTPEYLAPE-- 168
Query: 664 GLNVLTAKS-----DVYGLGVVLLELLTGKRAIFKDDESG 698
V+ +K D + LG+++ E+L G F D+ G
Sbjct: 169 ---VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 71/263 (26%), Positives = 110/263 (41%), Gaps = 47/263 (17%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFL-SRLHHKHLV 557
I G+FG VY K G AIK + K + + +E A + + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN---QVTNVKAERAIMMIQGESPYVA 60
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPP 609
+L + KD LV +Y+ G + + ++ A+ G+E LH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--- 117
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
IIHRDIK N+L+D +++DFGLS G E+++ GT Y+ PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV------GTPDYLAPETILGVGDD 171
Query: 670 AKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG-PP 728
SD + LG V+ E L G TP ++ D IL RR+ P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPF-----HAETPDAVFD------------NILSRRINWPE 214
Query: 729 EINEA---EAVELVAYTAMHCVN 748
E+ E EAV+L+ + C++
Sbjct: 215 EVKEFCSPEAVDLI--NRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 73/307 (23%)
Query: 498 LENKIGAGSFGVVYKGK----LPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
L+ ++G G+FG V+ + LP+ + VA+K + A Q+ F E L+ L
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD----FQREAELLTVL 64
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------------------- 589
H+H+VR G C E L+V++YM++G L L
Sbjct: 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 590 -NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE----- 643
+ A G+ YL A +HRD+ + N L+ ++ DFG+S ++
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 644 -RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTP 701
R P++ ++ PE T +SD++ GVVL E+ T GK+ ++ +
Sbjct: 182 GRTMLPIR------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--- 232
Query: 702 VSLVDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMH-CVNLEGKERPTMAD 759
A+ I G + L+R R PPE+ Y M C E ++R + D
Sbjct: 233 ------AIECITQG---RELERPRTCPPEV----------YAIMQGCWQREPQQRMVIKD 273
Query: 760 IVANLER 766
I + L+
Sbjct: 274 IHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 51/222 (22%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS---ELAFLSR 550
F N+IG G++G+VY+ + G+ VA+K K + E++ S E+ L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALK-----KVRMDNERDGIPISSLREITLLLN 62
Query: 551 LHHKHLVRL---------------VGYCEEKDERLLVYDYMKN-------GALYDHLHDR 588
L H ++V L + YCE+ LL D M L L
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMPTPFSESQVKCLMLQL--- 117
Query: 589 NNVEKNAARGIEYLH-NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647
RG++YLH N+ IIHRD+K SN+LL + +++DFGL+ +
Sbjct: 118 -------LRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 648 PMKAAGTVGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGK 688
P T+ Y PE G T D++ +G +L ELL K
Sbjct: 167 PKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 47/213 (22%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD-SELAFLSRL-HHKHLV 557
++G G+FG VY + G+ VAIK+ KKF E + E+ L +L H ++V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKK----MKKKFYSWEECMNLREVKSLRKLNEHPNIV 61
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNAAR--------GIEYLH--NY 605
+L E DE V++YM G LY + DR ++ R G+ ++H +
Sbjct: 62 KLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA----AGTVGYIDPE 661
HRD+K N+L+ +++DFGL+ R+ R T Y PE
Sbjct: 121 -----FHRDLKPENLLVSGPEVVKIADFGLA-------REIRSRPPYTDYVSTRWYRAPE 168
Query: 662 ------YYGLNVLTAKSDVYGLGVVLLELLTGK 688
Y ++ D++ LG ++ EL T +
Sbjct: 169 ILLRSTSY-----SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 77/297 (25%), Positives = 120/297 (40%), Gaps = 74/297 (24%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+F + K+G GS+G VYK K L D Q A+K + + +E+E A + E+ L+ ++H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVN-EIRILASVNH 58
Query: 554 KHLVRLVGYCEEK-DERLL--VYDYMKNGALYDHLHDRNNVEK------------NAARG 598
+++ Y E D L V +Y G L + R K RG
Sbjct: 59 PNIIS---YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA------ 652
++ LH I+HRD+KS+NILL A ++ D G+S K
Sbjct: 116 LQALHEQK---ILHRDLKSANILLVANDLVKIGDLGIS-------------KVLKKNMAK 159
Query: 653 ---GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
GT Y+ PE + + KSD++ LG +L E+ T FA
Sbjct: 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT--------------------FAP 199
Query: 710 P--AIMAGEL-VKILDRRVGP-PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762
P A +L K+ + P P I + + + ++ K RP I+A
Sbjct: 200 PFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI----RSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 20/199 (10%)
Query: 502 IGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G FG V ++ G+ A K+ E + KK ++ ES +E L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLA 66
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR----------GIEYLHNYAVPPI 610
E KD LV M G L H++ R G+E LH I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERI 123
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPEYYGLNVLT 669
++RD+K NILLD R+SD GL++ PE + +K GTVGY+ PE T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYT 179
Query: 670 AKSDVYGLGVVLLELLTGK 688
D + LG +L E++ G+
Sbjct: 180 FSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 6e-15
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKE-SAFDSELAFLSRLHHKHLVRL 559
+G G+FG VY D G+E+A K+ + KE SA + E+ L L H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 560 VGYCEEKDERLLV--YDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPP 609
G ++ E+ L +YM G++ D L + ++ R G+ YLH+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--- 126
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPEYYGLNVL 668
I+HRDIK +NIL D+ ++ DFG S +++ GT ++ PE
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 669 TAKSDVYGLGVVLLELLTGK 688
K+DV+ LG ++E+LT K
Sbjct: 187 GRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 6e-15
Identities = 76/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 496 FSLENKIGAGSFGVVYKG--KLPDG--QEVAIKRGETAKTKKFQEKE-SAFDSELAFLSR 550
F+L +G G FG V + K DG Q+VA+K K F + F E A +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVK---MLKADIFSSSDIEEFLREAACMKE 57
Query: 551 LHHKHLVRLVGYCEEKDER------LLVYDYMKNGALYDHLHDRNNVEK----------- 593
H ++++L+G + +++ +MK+G L+ L E+
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 594 ---NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650
+ A G+EYL + IHRD+ + N +L+ T V+DFGLS + +
Sbjct: 118 FMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA-- 708
+ V ++ E NV T SDV+ GV + E++T G TP + V+ +
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT----------RGQTPYAGVENSEI 224
Query: 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMH-CVNLEGKERPTMADIVANLE 765
++ G +K PP+ E Y M C + E K RP+ + LE
Sbjct: 225 YNYLIKGNRLK------QPPDCLED------VYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG G+ G V+ + GQEVAIK+ K Q K+ +E+ + L + ++V
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNF 81
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLHNYAVPPIIH 612
+ DE +V +Y+ G+L D + + E A + +E+LH V IH
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQV---IH 138
Query: 613 RDIKSSNILLDAQWTARVSDFGL-SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
RDIKS N+LL + +++DFG + + PE + GT ++ PE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPK 195
Query: 672 SDVYGLGVVLLELLTGK 688
D++ LG++ +E++ G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 32/220 (14%)
Query: 492 ATNNFSLENKIGAGSFGVVY----KGKLPDGQE--VAIKR-GETAKTKKFQEKESAFDSE 544
A ++ ++G GSFG+VY KG + D E VAIK E A ++ E F +E
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE----FLNE 59
Query: 545 LAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNA-------- 595
+ + + H+VRL+G + L++ + M G L +L R +E N
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 596 ---------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
A G+ YL+ +HRD+ + N ++ +T ++ DFG++ E++
Sbjct: 120 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 176
Query: 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
+ K V ++ PE V T SDV+ GVVL E+ T
Sbjct: 177 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 46/196 (23%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRG-ETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+G+G FG V+KG +P+G + I +T + + ++ + + L H ++VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPI 610
+G C +L V G+L DH+ N A+G+ YL + +
Sbjct: 75 LGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---M 130
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTA 670
+HR++ + NILL + +++DFG++ + ++ + + + ++ E T
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 671 KSDVYGLGVVLLELLT 686
+SDV+ GV + E+++
Sbjct: 191 QSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 60/238 (25%)
Query: 494 NNFSLENKIGAGSFGVVYK----GKLPDGQE--VAIK---RGETAKTKKFQEKESAFDSE 544
NN IG G+FG V++ G LP VA+K +A + F E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA------DFQRE 58
Query: 545 LAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN--------------- 589
A ++ H ++V+L+G C L+++YM G L + L R+
Sbjct: 59 AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 590 ---------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634
+ K A G+ YL + +HRD+ + N L+ +++DFG
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFG 175
Query: 635 LS--MMGPE----SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
LS + + SE D P++ ++ PE N T +SDV+ GVVL E+ +
Sbjct: 176 LSRNIYSADYYKASENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 81/301 (26%), Positives = 127/301 (42%), Gaps = 59/301 (19%)
Query: 497 SLENKIGAGSFGVVYKGKLPDGQ---EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+L +G G FG V +G+L +VA+K + A + + ++ F SE + H
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED--FLSEAVCMKEFDH 59
Query: 554 KHLVRLVGYCEEKDER------LLVYDYMKNG-----ALYDHLHDRN---------NVEK 593
+++RL+G C + E +++ +MK+G LY L D
Sbjct: 60 PNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119
Query: 594 NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKA 651
+ A G+EYL + IHRD+ + N +L+ V+DFGLS + + R R K
Sbjct: 120 DIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176
Query: 652 AGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711
V +I E V T KSDV+ GV + E+ T G TP P
Sbjct: 177 P--VKWIAIESLADRVYTTKSDVWSFGVTMWEIAT----------RGQTP-------YPG 217
Query: 712 IMAGELVKIL---DRRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERA 767
+ E+ L +R PP+ + Y+ M C L K+RP+ + LE+A
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCLDG------LYSLMSSCWLLNPKDRPSFETLRCELEKA 271
Query: 768 L 768
L
Sbjct: 272 L 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 71/206 (34%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
IG GSFG V K DG A+K + K +E+ L L H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 561 GYCEEKDERL-LVYDYMKNGALYDHLH-DRNNVEKNA-------ARGIEYLHNYAVPPII 611
Y + E+L V DY+ G L+ HL +R +E A A I YLH+ II
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---II 118
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
+RD+K NILLD+Q ++DFGL G E E GT Y+ PE
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF--CGTPEYLAPEVLRKEPYDRT 176
Query: 672 SDVYGLGVVLLELLTGKRAIFKDDES 697
D + LG VL E+L G + D S
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVS 202
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFD---SELAFLSRLH 552
F+ +IG GSFG VYKG +EV K +E E + E+ LS+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVV-----AIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLHNY 605
++ R G + + ++ +Y+ G+ D L E A +G++YLH+
Sbjct: 61 SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
IHRDIK++N+LL Q +++DFG++ G ++ + GT ++ PE
Sbjct: 121 RK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 666 NVLTAKSDVYGLGVVLLELLTGK 688
+ K+D++ LG+ +EL G+
Sbjct: 176 SAYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 77/296 (26%), Positives = 121/296 (40%), Gaps = 75/296 (25%)
Query: 505 GSFGVVYKGKLPDG-----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
G+FG ++ G L D +EV +K T K + + + E L L H++++ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVK---TVKDHASEIQVTLLLQESCLLYGLSHQNILPI 73
Query: 560 VGYC-EEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------------ARGIEYL 602
+ C E+ + ++Y YM G L L E N A G+ YL
Sbjct: 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL 133
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-------------RPM 649
H V IH+DI + N ++D + +++D LS RD RP+
Sbjct: 134 HKRGV---IHKDIAARNCVIDEELQVKITDNALS-------RDLFPMDYHCLGDNENRPV 183
Query: 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
K ++ E ++ SDV+ GV+L EL+T G TP +D
Sbjct: 184 K------WMALESLVNKEYSSASDVWSFGVLLWELMT----------LGQTPYVEID--- 224
Query: 710 PAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCV-NLEGKERPTMADIVANL 764
P MA L R+ P IN + EL + M C L+ +ERP+ + +V L
Sbjct: 225 PFEMAAYLKD--GYRLAQP-INCPD--EL--FAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 495 NFSLENKIGAGSFGVVY--KGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ + KIG GSFG +Y K K D + IK E TK +++ A E+ L+++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKS-DSEHCVIK--EIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNA--------ARGIEYL 602
H ++V +E +V +Y G L ++ + V ++ + G++++
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 603 HNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
H+ I+HRDIKS NI L A++ DFG++ +S GT Y+ PE
Sbjct: 118 HDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY--TCVGTPYYLSPE 172
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGK 688
K+D++ LG VL EL T K
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-14
Identities = 68/287 (23%), Positives = 115/287 (40%), Gaps = 70/287 (24%)
Query: 518 GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577
G EVAIK T ++ ++ + F E A +RL+H ++V L+ E L
Sbjct: 3 GHEVAIKLLRTDAPEEEHQR-ARFRRETALCARLYHPNIVALLDSGEAPPGLLF------ 55
Query: 578 NGALYDHLHDRNNVEKNAARGIEYLHNYAVPP---------------------IIHRDIK 616
A+++++ R E AA G A+P I+HRD+K
Sbjct: 56 --AVFEYVPGRTLREVLAADG-------ALPAGETGRLMLQVLDALACAHNQGIVHRDLK 106
Query: 617 SSNILL---DAQWTARVSDFGLSMMGPESE-----RDFRPMKAAGTVGYIDPEYYGLNVL 668
NI++ + A+V DFG+ + P R + GT Y PE +
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 669 TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV-KILDRRVGP 727
T SD+Y G++ LE LTG+R + G V +IL +++ P
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRV----------------------VQGASVAEILYQQLSP 204
Query: 728 PEINEAEAVELVAYTAM--HCVNLEGKERPTMADIVANLERALDICD 772
+++ + + +N + ++R A +A RAL++C
Sbjct: 205 VDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERFRALELCA 251
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFD---SELAFLSRLH 552
F+ +IG GSFG V+KG Q+V K +E E + E+ LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVV-----AIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH----DRNNVE---KNAARGIEYLHNY 605
++ + G + + ++ +Y+ G+ D L D + K +G++YLH+
Sbjct: 61 SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS- 119
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
IHRDIK++N+LL Q +++DFG++ G ++ + GT ++ PE
Sbjct: 120 --EKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
Query: 666 NVLTAKSDVYGLGVVLLELLTGK 688
+ +K+D++ LG+ +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 17/201 (8%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKE--SAFDSELAFLSRLHHKHLVR 558
+G G+F Y+ + + G +A+K+ + +++E A E+ ++RL+H H++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA--------RGIEYLHNYAVPPI 610
++G E L ++M G++ L ++ RG+ YLH I
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---I 124
Query: 611 IHRDIKSSNILLDAQ-WTARVSDFGLS--MMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
IHRD+K +N+L+D+ R++DFG + + + + GT+ ++ PE
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 668 LTAKSDVYGLGVVLLELLTGK 688
DV+ +G V++E+ T K
Sbjct: 185 YGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 49/235 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL----PDGQE--VAIKRGETAKTKKFQEKESAFDSELAF 547
+N L+ ++G G+FG V+ + P+ + VA+K + A ++ F E
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD----FHREAEL 60
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN------------------ 589
L+ L H+H+V+ G C E D ++V++YMK+G L L
Sbjct: 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120
Query: 590 ---NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
++ + A G+ YL A +HRD+ + N L+ ++ DFG+S RD
Sbjct: 121 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS-------RDV 170
Query: 647 RPM---KAAG----TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFK 693
+ G + ++ PE T +SDV+ LGVVL E+ T GK+ ++
Sbjct: 171 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVG 561
+G G+FG V+KG L D VA+K T K QE + F SE L + H ++V+L+G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVK---TCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 562 YCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------NAARGIEYLHNYAVPPIIH 612
C ++ +V + + G L + + K +AA G+ YL + IH
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC---IH 116
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKS 672
RD+ + N L+ ++SDFG+S + +K + + PE +++S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSES 175
Query: 673 DVYGLGVVLLELLT 686
DV+ G++L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 501 KIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG G+ G VY + GQEVAIK+ + Q K+ +E+ + H ++V
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNY 81
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLHNYAVPPIIH 612
+ DE +V +Y+ G+L D + + E A + +E+LH+ V IH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV---IH 138
Query: 613 RDIKSSNILLDAQWTARVSDFGL-SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
RDIKS NILL + +++DFG + + PE + GT ++ PE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPK 195
Query: 672 SDVYGLGVVLLELLTGK 688
D++ LG++ +E++ G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQ--EKESAFD--SELAF 547
NF +E KIG G F VVYK L DG+ VA+K K + F+ + ++ D E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALK-----KVQIFEMMDAKARQDCLKEIDL 55
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDY---------MKNGALYDHLHDRNNVEK---NA 595
L +L H ++++ + E +E +V + +K+ L + K
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF--RPMKAAG 653
+E++H+ I+HRDIK +N+ + A ++ D GL R F + A
Sbjct: 116 CSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLG-------RFFSSKTTAAHS 165
Query: 654 TVG---YIDPEYYGLNVLTAKSDVYGLGVVLLEL 684
VG Y+ PE N KSD++ LG +L E+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 79/308 (25%), Positives = 123/308 (39%), Gaps = 66/308 (21%)
Query: 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESA-----FDSELAFL 548
+ E+ IG G+FG V + + DG ++ A K +E S F EL L
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKM------NAAIKMLKEFASENDHRDFAGELEVL 56
Query: 549 SRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN------------- 594
+L HH +++ L+G CE + + +Y G L D L +E +
Sbjct: 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116
Query: 595 -----------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643
A G++YL IHRD+ + N+L+ ++++DFGLS E
Sbjct: 117 TSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEE 170
Query: 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703
+ V ++ E +V T KSDV+ GV+L E+++ GGTP
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS----------LGGTPYC 220
Query: 704 LVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
+ EL + L + R+ P + E EL+ C ERP A I
Sbjct: 221 -------GMTCAELYEKLPQGYRMEKPRNCDDEVYELMR----QCWRDRPYERPPFAQIS 269
Query: 762 ANLERALD 769
L R L+
Sbjct: 270 VQLSRMLE 277
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 59/244 (24%), Positives = 100/244 (40%), Gaps = 34/244 (13%)
Query: 472 GTSSKHADRAEEFLL-----AELAAATNNFSLENKIGAGSFGVVYKGKLPDGQE--VAIK 524
++S+ D ++ L+ A A+ +++ + GS G V+ GQ V +K
Sbjct: 39 DSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLK 97
Query: 525 RGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH 584
G+ T E L ++H ++R+ +V + + LY +
Sbjct: 98 IGQKGTTL----------IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSD-LYTY 146
Query: 585 LHDRNN---------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635
L R+ +EK G+ YLH IIHRD+K+ NI ++ + D G
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGA 203
Query: 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
+ P F + AGTV PE + +K+D++ G+VL E+L IF+D
Sbjct: 204 AQF-PVVAPAF--LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260
Query: 696 ESGG 699
S
Sbjct: 261 PSTP 264
|
Length = 357 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 24/197 (12%)
Query: 501 KIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+IG G+FG V+ G+L D VA+K + K F E L + H ++VRL
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK---FLQEARILKQYSHPNIVRL 58
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPI 610
+G C +K +V + ++ G L + +NAA G+EYL +
Sbjct: 59 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT----VGYIDPEYYGLN 666
IHRD+ + N L+ + ++SDFG+S E D G V + PE
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 667 VLTAKSDVYGLGVVLLE 683
+++SDV+ G++L E
Sbjct: 172 RYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-14
Identities = 60/248 (24%), Positives = 97/248 (39%), Gaps = 91/248 (36%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS---------EL 545
+ L IG+G++GVV G++VAIK K FD E+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK--------KISN---VFDDLIDAKRILREI 50
Query: 546 AFLSRLHHKHLVRLV-----GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK------- 593
L L H++++ L+ E+ ++ +V + M+ D + V K
Sbjct: 51 KLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME--------TDLHKVIKSPQPLTD 102
Query: 594 --------NAARGIEYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPE 641
RG++YLH N +IHRD+K SNIL+++ ++ DFGL+ + E
Sbjct: 103 DHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 642 SERDF----------RPMKAAGTVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELL 685
E+ F R PE Y + D++ +G + ELL
Sbjct: 158 DEKGFLTEYVVTRWYRA-----------PELLLSSSRYTKAI-----DIWSVGCIFAELL 201
Query: 686 TGKRAIFK 693
T K +F
Sbjct: 202 TRK-PLFP 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 502 IGAGSFGVVYKGKLPDGQ-EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G++G+VY + Q +AIK ++ Q E+A S L H+++V+ +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQ----PLHEEIALHSYLKHRNIVQYL 71
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPP 609
G E + + + G+L L + K G++YLH+
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--- 128
Query: 610 IIHRDIKSSNILLDA-QWTARVSDFG----LSMMGPESERDFRPMKAAGTVGYIDPEY-- 662
I+HRDIK N+L++ ++SDFG L+ + P +E GT+ Y+ PE
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE------TFTGTLQYMAPEVID 182
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGK 688
G A +D++ LG ++E+ TGK
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 51/214 (23%)
Query: 501 KIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKES-------AFDSELAFLSRLH 552
KIG GS+GVV+K + + GQ VAIK KF E E A E+ L +L
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIK--------KFVESEDDPVIKKIAL-REIRMLKQLK 58
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYL 602
H +LV L+ K + LV++Y + L + ++N + + + +
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM--GPESE-RDFRPMKAAGTVGYID 659
H + IHRD+K NIL+ Q ++ DFG + + GP + D+ T Y
Sbjct: 117 HKHNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY-----VATRWYRA 168
Query: 660 PEY------YGLNVLTAKSDVYGLGVVLLELLTG 687
PE YG V DV+ +G V ELLTG
Sbjct: 169 PELLVGDTQYGPPV-----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 78/309 (25%), Positives = 126/309 (40%), Gaps = 75/309 (24%)
Query: 494 NNFSLENKIGAGSFGVVYK------GKLPDGQEVAIKR-GETAKTKKFQEKESAFDSELA 546
NN S +GAG+FG V + K +VA+K TA + E+E A SEL
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SERE-ALMSELK 90
Query: 547 FLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV----------EKNA 595
+S L +H+++V L+G C L++ +Y G L + L +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQV 150
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD---------- 645
A+G+ +L A IHRD+ + N+LL ++ DFGL+ RD
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLA-------RDIMNDSNYVVK 200
Query: 646 ---FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV 702
P+K ++ PE V T +SDV+ G++L E+ + G P
Sbjct: 201 GNARLPVK------WMAPESIFNCVYTFESDVWSYGILLWEIFS----------LGSNP- 243
Query: 703 SLVDFAVPAIMAGELV-KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMAD 759
P + K++ R+ PE AE +++ C + + +RPT
Sbjct: 244 ------YPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIM----KTCWDADPLKRPTFKQ 293
Query: 760 IVANLERAL 768
IV + + L
Sbjct: 294 IVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 26/217 (11%)
Query: 498 LEN--KIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
LEN KIG GS G+V + G++VA+K +K Q +E F+ E+ + H+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVK---MMDLRKQQRRELLFN-EVVIMRDYQHQ 78
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNAA------RGIEYLHNYAV 607
++V + +E ++ ++++ GAL D + R N E+ A + + YLH+ V
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGV 138
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPEYYGLN 666
IHRDIKS +ILL ++SDFG + +D K+ GT ++ PE
Sbjct: 139 ---IHRDIKSDSILLTLDGRVKLSDFGFC---AQISKDVPKRKSLVGTPYWMAPEVISRT 192
Query: 667 VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703
+ D++ LG++++E++ G+ F D +PV
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPPYFSD-----SPVQ 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFD---SELAFLSRLH 552
F+ KIG GSFG V+KG Q+V K +E E + E+ LS+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVV-----AIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH----DRNNVE---KNAARGIEYLHNY 605
++ + G + + ++ +Y+ G+ D L D + + +G++YLH+
Sbjct: 61 SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS- 119
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
IHRDIK++N+LL +++DFG++ G ++ + GT ++ PE
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 666 NVLTAKSDVYGLGVVLLELLTGK 688
+ +K+D++ LG+ +EL G+
Sbjct: 176 SAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 37/221 (16%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKE---SAFDSELAFLSR 550
NF KIG G++GVVYK + G+ VA+K K + E E S E++ L
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALK-----KIRLDTETEGVPSTAIREISLLKE 55
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA----------RGIE 600
L+H ++V+L+ +++ LV++++ + L + +G+
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAG----TV 655
+ H++ V +HRD+K N+L++ + +++DFGL+ R F P++ T+
Sbjct: 115 FCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLA-------RAFGVPVRTYTHEVVTL 164
Query: 656 GYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
Y PE G + D++ LG + E++T +RA+F D
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 21/199 (10%)
Query: 502 IGAGSFGVVY---KGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
+G GSFG V+ K PD GQ A+K + A K + + ++ L+ ++H +V
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDI--LAEVNHPFIV 61
Query: 558 RLVGYCEEKDERL-LVYDYMKNGALYDHL--------HDRNNVEKNAARGIEYLHNYAVP 608
+L Y + + +L L+ D+++ G L+ L D A +++LH+
Sbjct: 62 KL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG-- 118
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL 668
II+RD+K NILLD + +++DFGLS + E+ + GTV Y+ PE
Sbjct: 119 -IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGH 175
Query: 669 TAKSDVYGLGVVLLELLTG 687
T +D + GV++ E+LTG
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKE-SAFDSELAFLSRLH 552
N+ L +G G+FG VY D G+E+A+K+ + KE +A + E+ L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 553 HKHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H +V+ G + +E+ L +YM G++ D L + +N R G+ YL
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE 661
H+ I+HRDIK +NIL D+ ++ DFG S +K+ GT ++ PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGK 688
K+DV+ + ++E+LT K
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 34/203 (16%)
Query: 501 KIGAGSFGVVYKG--KLPDGQEVAIKRGETAKTKKFQEKESAFDSEL----AFLSRLHHK 554
++G+G+FG V KG K+ ++ K K + A EL + +L +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTV-----AVKILKNDNNDPALKDELLREANVMQQLDNP 56
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKN-------AARGIEYL--HN 604
++VR++G CE + +LV + + G L L +V EKN + G++YL N
Sbjct: 57 YIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT----VGYIDP 660
+ +HRD+ + N+LL Q A++SDFGLS E + KA V + P
Sbjct: 116 F-----VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY---KAKTHGKWPVKWYAP 167
Query: 661 EYYGLNVLTAKSDVYGLGVVLLE 683
E ++KSDV+ GV++ E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 501 KIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG GS G+V + G+ VA+K+ + +K Q +E F+ E+ + H+++V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDL---RKQQRRELLFN-EVVIMRDYQHENVVEM 82
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHL-HDRNNVEKNAA------RGIEYLHNYAVPPIIH 612
DE +V ++++ GAL D + H R N E+ AA + + LH V IH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGV---IH 139
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKS 672
RDIKS +ILL ++SDFG S+ R GT ++ PE +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 673 DVYGLGVVLLELLTGKRAIFKD 694
D++ LG++++E++ G+ F +
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEVA-------IKRGETAKTKKFQEKESAFDSELAF 547
NF L +G G++G V+ + G + +K+ + K E +E
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTR---TERQV 57
Query: 548 LSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------G 598
L + + + Y + D +L L+ DY+ G L+ HL R ++ +
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLA 117
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGTVG 656
+E+LH II+RDIK NILLD+ ++DFGLS E ER + GT+
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY---SFCGTIE 171
Query: 657 YIDPEYY--GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
Y+ P+ G D + +GV++ ELLTG D E
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 63/251 (25%), Positives = 98/251 (39%), Gaps = 67/251 (26%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS---ELAFLSRL 551
+ L +IG+G++G VYK + + G+ VAIK K + + F+ E++ L
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIK------VIKLEPGD-DFEIIQQEISMLKEC 57
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYL 602
H ++V G +D+ +V +Y G+L D V + +G+ YL
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM------------------MGPESER 644
H IHRDIK +NILL +++DFG+S M PE
Sbjct: 118 HETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV-- 172
Query: 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFKDD 695
GY K D++ LG+ +EL + RA+F
Sbjct: 173 ----AAVERKGGY-----------DGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217
Query: 696 ESGGTPVSLVD 706
+S P L D
Sbjct: 218 KSNFPPPKLKD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 68/219 (31%), Positives = 92/219 (42%), Gaps = 43/219 (19%)
Query: 502 IGAGSFGVV----YKGKLPDGQEVAIKRGETAKTKKF----QEKESAFDSELAFL--SRL 551
+G G FG V YK G+ AIK A K E ES + F +
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIK----ALKKGDIIARDEVESLMCEKRIFETANSE 59
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA-------ARGIEYLHN 604
H LV L + +D V +Y G L H+H E A G++YLH
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM--MGPESERDFRPMKAAGTVGYIDPEY 662
I++RD+K N+LLD + +++DFGL MG R GT PE+
Sbjct: 120 NK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD----RTSTFCGT-----PEF 167
Query: 663 YGLNVLTAKS-----DVYGLGVVLLELLTGKRAIFKDDE 696
VLT S D +GLGV++ E+L G+ DDE
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 45/230 (19%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE---------------VAIK--RGETAKTKKFQE 536
L+ K+G G FG V+ + E VA+K R + KT +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTAR--- 61
Query: 537 KESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR-------- 588
+ F E+ +SRL + +++RL+G C D ++ +YM+NG L L R
Sbjct: 62 --NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 589 -NNV-----------EKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636
NN+ A G++YL A +HRD+ + N L+ +T +++DFG+S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
+ +A + ++ E L T SDV+ GV L E+ T
Sbjct: 177 RNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 66/200 (33%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
IG GSFG V K DG+ A+K + K +E++ L + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLH-DRNNVEKNA-------ARGIEYLHNYAVPPIIH 612
+ D+ V DY+ G L+ HL +R+ E A A + YLH+ II+
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIY 119
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKS 672
RD+K NILLD+Q ++DFGL G E + GT PEY VL +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF--CGT-----PEYLAPEVLRKQP 172
Query: 673 -----DVYGLGVVLLELLTG 687
D + LG VL E+L G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 501 KIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG G+ G VY + GQEVAI++ + Q K+ +E+ + + ++V
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNY 82
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLHNYAVPPIIH 612
+ DE +V +Y+ G+L D + + E A + +E+LH+ V IH
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV---IH 139
Query: 613 RDIKSSNILLDAQWTARVSDFGL-SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
RDIKS NILL + +++DFG + + PE + GT ++ PE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPK 196
Query: 672 SDVYGLGVVLLELLTGK 688
D++ LG++ +E++ G+
Sbjct: 197 VDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 48/283 (16%)
Query: 502 IGAGSFGVVYKGK-LPDGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
+G+G+FG VYKG +P+G++ VAIK A + K ++ E ++ + + H+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMASVDNPHV 71
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-----------NAARGIEYLHNY 605
RL+G C +L + M G L D++ R + + A+G+ YL
Sbjct: 72 CRLLGICLTSTVQL-ITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEER 128
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
++HRD+ + N+L+ +++DFGL+ + E+++ + ++ E
Sbjct: 129 R---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185
Query: 666 NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR-- 723
+ T +SDV+ GV + EL+T F G P A E+ IL++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT-----FGSKPYDGIP------------ASEISSILEKGE 228
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
R+ P I + V + C ++ RP +++ +
Sbjct: 229 RLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFSK 267
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+IG GSFG VY + + + VAIK+ + K+ EK E+ FL +L H + +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKK-MSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 560 VGYCEEKDERL-LVYDYMKNGA---LYDHLHDRNNVE-----KNAARGIEYLHNYAVPPI 610
G C ++ LV +Y A L H VE A +G+ YLH++
Sbjct: 81 KG-CYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER--- 136
Query: 611 IHRDIKSSNILLDAQWTARVSDFG-LSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
IHRDIK+ NILL T +++DFG S++ P + GT ++ PE V+
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-------FVGTPYWMAPE-----VIL 184
Query: 670 A--------KSDVYGLGVVLLELLTGKRAIF 692
A K DV+ LG+ +EL K +F
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 81/298 (27%), Positives = 127/298 (42%), Gaps = 60/298 (20%)
Query: 502 IGAGSFGVVYKGKLP-DGQEV--AIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLV 557
IG G+FG V K ++ DG + AIK K ++ F EL L +L HH +++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE------------------------K 593
L+G CE + L +Y +G L D L +E
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 594 NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAG 653
+ ARG++YL IHRD+ + NIL+ + A+++DFGLS E +
Sbjct: 120 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 173
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
V ++ E +V T SDV+ GV+L E+++ GGTP +
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS----------LGGTPYC-------GMT 216
Query: 714 AGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769
EL + L + R+ P + E +L+ C + ERP+ A I+ +L R L+
Sbjct: 217 CAELYEKLPQGYRLEKPLNCDDEVYDLM----RQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 68/236 (28%), Positives = 109/236 (46%), Gaps = 30/236 (12%)
Query: 464 LTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQ--EV 521
L + +++ S+K R + +F+ +G GSFG V + V
Sbjct: 7 LQLHKKKDSDSTKEPKRKNKM-------KYEDFNFIRTLGTGSFGRVILATYKNEDFPPV 59
Query: 522 AIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGAL 581
AIKR E +K K ++ + F SE L+ ++H V L G +++ LV +++ G
Sbjct: 60 AIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF 118
Query: 582 YDHLHDRNNVEKN------AARGI---EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSD 632
+ L RN N AA+ + EYL + I++RD+K N+LLD +++D
Sbjct: 119 FTFLR-RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTD 174
Query: 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK-SDVYGLGVVLLELLTG 687
FG + + D R GT YI PE LNV K +D + LG+ + E+L G
Sbjct: 175 FGFAKV-----VDTRTYTLCGTPEYIAPEIL-LNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 51/222 (22%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKE---SAFDSELAFLSRLHHKHL 556
KIG G++GVVYK + G+ VA+K K + E E S E++ L L+H ++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 557 VRL--VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA----------RGIEYLHN 604
VRL V + E K LV++++ + L ++ + +GI Y H+
Sbjct: 61 VRLLDVVHSENK--LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAG----TVGYID 659
+ ++HRD+K N+L+D + +++DFGL+ R F P++ T+ Y
Sbjct: 118 HR---VLHRDLKPQNLLIDREGALKLADFGLA-------RAFGVPVRTYTHEVVTLWYRA 167
Query: 660 PE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
PE Y V D++ +G + E++ +R +F D
Sbjct: 168 PEILLGSRQYSTPV-----DIWSIGCIFAEMVN-RRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 21/202 (10%)
Query: 497 SLENKIGAGSFGVVYKG----KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+L IG G FG VY+G + VA+K T K F E + +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVK---TCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIEYLH 603
H H+V+L+G E + +V + G L +L A + + YL
Sbjct: 66 HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
+ +HRDI + N+L+ + ++ DFGLS E E ++ K + ++ PE
Sbjct: 125 SKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESI 180
Query: 664 GLNVLTAKSDVYGLGVVLLELL 685
T+ SDV+ GV + E+L
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 39/215 (18%)
Query: 502 IGAGSFGVVYKGKLPD-------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+G+G+FG VY+G D VA+K T + +++ F E +S +H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVK---TLRKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK----------------NAARG 598
++V+L+G C + + ++ + M+ G L +L D VE+ + A+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDA-RVERFGPPLLTLKELLDICLDVAKG 118
Query: 599 IEYLHNYAVPPIIHRDIKSSNILL-----DAQWTARVSDFGLSMMGPESERDFRPMKAAG 653
YL IHRD+ + N L+ DA ++ DFGL+ +S D+ + G
Sbjct: 119 CVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS--DYYRKEGEG 173
Query: 654 --TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
V ++ PE T +SDV+ GV++ E+LT
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 501 KIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
KIG G+ G VY + GQEVAIK+ + Q K+ +E+ + + ++V
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNY 81
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLHNYAVPPIIH 612
+ DE +V +Y+ G+L D + + E A + +++LH+ V IH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV---IH 138
Query: 613 RDIKSSNILLDAQWTARVSDFGL-SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
RDIKS NILL + +++DFG + + PE + GT ++ PE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVTRKAYGPK 195
Query: 672 SDVYGLGVVLLELLTGK 688
D++ LG++ +E++ G+
Sbjct: 196 VDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 69/243 (28%), Positives = 97/243 (39%), Gaps = 58/243 (23%)
Query: 492 ATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
T F L IG G++G VYK + GQ VAIK +++E E L +
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-----IMDIIEDEEEEIKEEYNILRK 58
Query: 551 L-HHKHLVRLVGYCEEK------DERLLVYDYMKNGALYD---HLHDRNNVEKN------ 594
+H ++ G +K D+ LV + G++ D L + K
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 595 ---AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM--GPESERDFRPM 649
RG+ YLH V IHRDIK NILL ++ DFG+S R+
Sbjct: 119 LRETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN---- 171
Query: 650 KAAGTVGYIDPE----------YYGLNVLTAKSDVYGLGVVLLELLTGK---------RA 690
GT ++ PE Y A+SDV+ LG+ +EL GK RA
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASY-----DARSDVWSLGITAIELADGKPPLCDMHPMRA 226
Query: 691 IFK 693
+FK
Sbjct: 227 LFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 65/232 (28%), Positives = 96/232 (41%), Gaps = 48/232 (20%)
Query: 486 LAELAAATNNFSLENKIGA--GSFGVVY--KGKLPDGQEVAIKRGETAKTKKFQEKESAF 541
L+EL N + K+ G FG V K K P + K K K F E
Sbjct: 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK-PTQKLFVQK---IIKAKNFNAIEPM- 60
Query: 542 DSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR---- 597
+ L + + + ++L +L+ DY+K+G L+D L + + +
Sbjct: 61 ---VHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIR 116
Query: 598 ----GIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFGLS-MMGPESERDFRPMKA 651
+ LH + IIH DIK N+L D A+ + D+GL ++G S D
Sbjct: 117 QLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------ 167
Query: 652 AGTVGYIDPE------YYGLNVLTAKS-DVYGLGVVLLELLTGKRAIFKDDE 696
GT+ Y PE Y S D + +GV+ ELLTGK FK+DE
Sbjct: 168 -GTLDYFSPEKIKGHNY-------DVSFDWWAVGVLTYELLTGKHP-FKEDE 210
|
Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 74/302 (24%)
Query: 498 LENKIGAGSFGVVYKGK------LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
L+ ++G G+FG V+ + D VA+K K ++ F E L+ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAARKD-FQREAELLTNL 64
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------------------- 589
H+H+V+ G C + D ++V++YMK+G L L
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 590 --NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647
++ A G+ YL A +HRD+ + N L+ A ++ DFG+S RD
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS-------RDVY 174
Query: 648 P---MKAAG----TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGG 699
+ G + ++ PE T +SDV+ GV+L E+ T GK+ F+ +
Sbjct: 175 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-- 232
Query: 700 TPVSLVDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMA 758
+ I G ++L+R RV P E+ + + C E ++R +
Sbjct: 233 -------EVIECITQG---RVLERPRVCPKEVYD---------IMLGCWQREPQQRLNIK 273
Query: 759 DI 760
+I
Sbjct: 274 EI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 64/281 (22%), Positives = 109/281 (38%), Gaps = 61/281 (21%)
Query: 498 LENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----------ELA 546
+G G++G V K G+ VAIK+ + + K+ EL
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 547 FLSRLHHKHLVRLVG-YCEEKDERLLVYDYMKNGALYD--HLHDRN------NVE---KN 594
++ + H++++ LV Y E D LV D M D + DR V+
Sbjct: 73 IMNEIKHENIMGLVDVYVE-GDFINLVMDIMA----SDLKKVVDRKIRLTESQVKCILLQ 127
Query: 595 AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS------MMGPESERDFRP 648
G+ LH + +HRD+ +NI ++++ +++DFGL+ +D
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 649 MKAAG------TVGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP 701
+ T+ Y PE G D++ +G + ELLTGK ++E
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE----- 239
Query: 702 VSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYT 742
+D +L +I + P E N +A +L YT
Sbjct: 240 ---ID---------QLGRIFELLGTPNEDNWPQAKKLPLYT 268
|
Length = 335 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 5e-13
Identities = 68/254 (26%), Positives = 109/254 (42%), Gaps = 46/254 (18%)
Query: 502 IGAGSFGVV-----------YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
+G G+FG V Y K+ +EV I + E A T +E L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILK-KEVIIAKDEVAHTL----------TESRVLKN 51
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H L L + KD V +Y+ G L+ HL ++ R ++YL
Sbjct: 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYL 111
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE 661
H+ I++RD+K N++LD +++DFGL E D MK GT Y+ PE
Sbjct: 112 HS---GKIVYRDLKLENLMLDKDGHIKITDFGLC---KEGITDAATMKTFCGTPEYLAPE 165
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF-KDDESGGTPVSLVDFAVP--------AI 712
N D +GLGVV+ E++ G+ + +D E + + D P ++
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSL 225
Query: 713 MAGELVKILDRRVG 726
++G L+K ++R+G
Sbjct: 226 LSGLLIKDPNKRLG 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQ-EKE-SAFDSELAFLSRLHHKHLV 557
+G G++G VY G GQ +A+K+ E + EKE E+ L L H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPP 609
+ +G C + + + +++ G++ L+ K G+ YLHN V
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV-- 123
Query: 610 IIHRDIKSSNILLDAQWTARVSDFG----LSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
+HRDIK +N++L ++ DFG L+ +G GT ++ PE
Sbjct: 124 -VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 666 NVLTAKSDVYGLGVVLLELLTGK 688
+ KSD++ +G + E+ TGK
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 54/216 (25%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 501 KIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
++G +FG +YKG L Q VAIK T K ++ F E + ++ LHH +
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIK---TLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHL------------HDRNNVEKNA-------- 595
+V L+G ++ ++++Y+ G L++ L D + K++
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 596 -----ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650
A G+EYL ++ +H+D+ + NIL+ Q ++SD GLS ++ K
Sbjct: 129 IAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
+ + ++ PE ++ SD++ GVVL E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSE--LAFLSRLHHKHLVR 558
IG G FG VY + D G+ A+K + + K Q + A + L+ +S +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPI 610
+ D+ + D M G L+ HL + R G+E++HN V
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFV--- 118
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF---RPMKAAGTVGYIDPEYYGL-N 666
++RD+K +NILLD R+SD GL+ DF +P + GT GY+ PE
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLAC-------DFSKKKPHASVGTHGYMAPEVLQKGT 171
Query: 667 VLTAKSDVYGLGVVLLELLTG 687
+ +D + LG +L +LL G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 63/218 (28%), Positives = 107/218 (49%), Gaps = 42/218 (19%)
Query: 501 KIGAGSFGVVYKGKLPDGQE-VAIKRGETAKTKKFQEKE---SAFDSELAFLSRLHHKHL 556
KIG G++GVVYK + E +A+K K + QE E S E++ L + H ++
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALK-----KIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 557 VRL--VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA----------RGIEYLHN 604
VRL V + E++ LV++Y+ + L H+ + KN RGI Y H+
Sbjct: 64 VRLQDVVHSEKR--LYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 605 YAVPPIIHRDIKSSNILLDAQWTA-RVSDFGLSMMGPESERDFR-PMKA----AGTVGYI 658
+ V +HRD+K N+L+D + A +++DFGL+ R F P++ T+ Y
Sbjct: 121 HRV---LHRDLKPQNLLIDRRTNALKLADFGLA-------RAFGIPVRTFTHEVVTLWYR 170
Query: 659 DPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
PE G + D++ +G + E++ ++ +F D
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 35/208 (16%)
Query: 502 IGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G FG V ++ G+ A K+ + KK + E A E L+++H + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAM-VEKRILAKVHSRFIVSLA 59
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLH--DRNNVEKNAAR----------GIEYLHNYAVP 608
+ K + LV M G L H++ D N R G+E+LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMM---GPESERDFRPMKAAGTVGYIDPEY--- 662
II+RD+K N+LLD R+SD GL++ G + + AGT G++ PE
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY-----AGTPGFMAPELLQG 171
Query: 663 --YGLNVLTAKSDVYGLGVVLLELLTGK 688
Y +V D + LGV L E++ +
Sbjct: 172 EEYDFSV-----DYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 71/281 (25%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIK-------RGETAKTKKFQEKESAFDSELAFLSRLHH 553
IG G++G VY+GK +P G+ VA+K + + ++ E+A LS+L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR----------EVALLSQLRQ 58
Query: 554 KHLVRLVGY--CEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLH 603
+ Y K RL ++ +Y + G++ + EK + ++Y+H
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-- 661
+IHRDIK++NIL+ ++ DFG++ + ++ GT ++ PE
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGTPYWMAPEVI 173
Query: 662 ----YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
YY K+D++ LG+ + E+ TG P S VD A A+M
Sbjct: 174 TEGKYY-----DTKADIWSLGITIYEMATGN-----------PPYSDVD-AFRAMM---- 212
Query: 718 VKILDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKER 754
L + PP + + E VA C++ E KER
Sbjct: 213 ---LIPKSKPPRLEDNGYSKLLREFVAA----CLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 8e-13
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 35/244 (14%)
Query: 475 SKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKK 533
S++ AE+ + +L +F + IG G+FG V + ++V A+K +K +
Sbjct: 26 SRYEKAAEK--ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKL--LSKFEM 81
Query: 534 FQEKESAFD-SELAFLSRLHHKHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNN 590
+ +SAF E ++ + + +V+L + +D++ L V +YM G L + + + +
Sbjct: 82 IKRSDSAFFWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI 139
Query: 591 VEKNAA-------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643
EK A ++ +H+ IHRD+K N+LLD +++DFG + M ++
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMDAN 195
Query: 644 RDFRPMKAAGTVGYIDPE---------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694
R A GT YI PE YYG D + +GV L E+L G + D
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC-----DWWSVGVFLYEMLVGDTPFYAD 250
Query: 695 DESG 698
G
Sbjct: 251 SLVG 254
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 77/314 (24%), Positives = 126/314 (40%), Gaps = 66/314 (21%)
Query: 494 NNFSLENKIGAGSFGVVY--------KGKLPDGQEVAIKRGETAKTKKFQEKESAFDSEL 545
+ +L +G G FG V K K + VA+K + T+K S SE+
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK---DLSDLVSEM 71
Query: 546 AFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK----------- 593
+ + HK+++ L+G C + ++ +Y G L ++L R
Sbjct: 72 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 594 -------------NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640
ARG+EYL A IHRD+ + N+L+ +++DFGL+
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR--D 186
Query: 641 ESERDFRPMKAAG--TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG 698
+ D+ G V ++ PE V T +SDV+ GV++ E+ T G
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT----------LG 236
Query: 699 GTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPT 756
G+P P I EL K+L R+ P N + ++ H + RPT
Sbjct: 237 GSP-------YPGIPVEELFKLLKEGHRMDKPA-NCTNELYMMMRDCWHAIP---SHRPT 285
Query: 757 MADIVANLERALDI 770
+V +L+R L +
Sbjct: 286 FKQLVEDLDRILTL 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 59/213 (27%), Positives = 86/213 (40%), Gaps = 35/213 (16%)
Query: 502 IGAGSFGVV-----------YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
+G G+FG V Y K+ +EV I + E A T +E L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTV----------TESRVLQN 51
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H L L + D V +Y G L+ HL + AR +EYL
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 111
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H+ V ++RDIK N++LD +++DFGL G + GT Y+ PE
Sbjct: 112 HSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEV 166
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
N D +GLGVV+ E++ G+ + D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 54/218 (24%), Positives = 105/218 (48%), Gaps = 34/218 (15%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD----SELAFLS 549
+ N+I G++GVVY+ + G+ VA+K+ K ++++ F E+ L
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKK------LKMEKEKEGFPITSLREINILL 59
Query: 550 RLHHKHLVRL----VGYCEEKDERLLVYDYMKNG--ALYDHLHD------RNNVEKNAAR 597
+L H ++V + VG D+ +V +Y+++ +L + + +
Sbjct: 60 KLQHPNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117
Query: 598 GIEYLH-NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG 656
G+ +LH N+ I+HRD+K+SN+LL+ + ++ DFGL+ + + + T+
Sbjct: 118 GVAHLHDNW----ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLW 171
Query: 657 YIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
Y PE G + D++ +G + ELLT K+ +F
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFP 208
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 35/219 (15%)
Query: 490 AAATNNFS-LE--NKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDS 543
+A + S LE N+IG+G+ G VYK P G+ A+K G T + Q
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ-----ICR 121
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGAL----YDHLHDRNNVEKNAARGI 599
E+ L ++H ++V+ + E ++ ++M G+L +V + GI
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQILSGI 181
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-----MMGPESERDFRPMKAAGT 654
YLH I+HRDIK SN+L+++ +++DFG+S M P + + GT
Sbjct: 182 AYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS-------SVGT 231
Query: 655 VGYIDPEYYGLNVLTAK-----SDVYGLGVVLLELLTGK 688
+ Y+ PE ++ D++ LGV +LE G+
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 497 SLENKIGAGSFGVVYKGKLPD---GQ---EVAIKR-GETAKTKKFQEKESAFDSELAFLS 549
+L ++G GSFG+VY+G D G+ VA+K E+A ++ E F +E + +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE----FLNEASVMK 64
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNAAR----------- 597
H+VRL+G + L+V + M +G L +L R E N R
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 598 ------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA 651
G+ YL+ +HRD+ + N ++ +T ++ DFG++ E++ + K
Sbjct: 125 AAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 652 AGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
V ++ PE V T SD++ GVVL E+ +
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAK-TKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+G G FG V ++ + G+ A K+ + + KK EK + + E+ L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEY--------LHNYAVPPII 611
E K LV M G L H+++ R I Y LH +++ I+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD-IV 117
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK 671
+RD+K N+LLD Q R+SD GL++ + + + AGT GY+ PE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYP 174
Query: 672 SDVYGLGVVLLELLTGKRAIFKD 694
D + +G + E++ G R FKD
Sbjct: 175 VDWFAMGCSIYEMVAG-RTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 31/213 (14%)
Query: 502 IGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFD-SELAFLSRLHHKHLVRL 559
IG G+FG VY+ + D + + A+K +K + +KE A E L R +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKV--LSKKEIVAKKEVAHTIGERNILVRTLLDESPFI 58
Query: 560 VG--YCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVP 608
VG + + D L LV DYM G L+ HL ++ A+ +E+LH Y
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY--- 115
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY------ 662
I++RD+K NILLDA + DFGLS + GT Y+ PE
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
Y +V D + LGV++ E+ G + +D
Sbjct: 174 YTKHV-----DFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 60/201 (29%), Positives = 92/201 (45%), Gaps = 25/201 (12%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSE--LAFLSRLHHKHLVR 558
IG G FG VY + D G+ A+K + + K Q + A + L+ +S +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPI 610
+ D+ + D M G L+ HL + R G+E++HN V
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV--- 118
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF---RPMKAAGTVGYIDPEYYGLNV 667
++RD+K +NILLD R+SD GL+ DF +P + GT GY+ PE V
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLAC-------DFSKKKPHASVGTHGYMAPEVLQKGV 171
Query: 668 -LTAKSDVYGLGVVLLELLTG 687
+ +D + LG +L +LL G
Sbjct: 172 AYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 56/239 (23%), Positives = 86/239 (35%), Gaps = 76/239 (31%)
Query: 501 KIGAGSFGVVY--------KGKLPDGQEVAIKRGET---AKTKKFQEKESA---FDSELA 546
K+G G FG V+ E K + ++A F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------- 595
LSRL ++ RL+G C ++ +YM+NG L L
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 596 --------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645
A G+ YL N+ +HRD+ + N L+ +T +++DFG+S
Sbjct: 132 LLYMATQIASGMRYLESLNF-----VHRDLATRNCLVGKNYTIKIADFGMS--------- 177
Query: 646 FRPMKAAGTVGYIDPEYY---GLNVL---------------TAKSDVYGLGVVLLELLT 686
R + ++ +YY G L T KSDV+ GV L E+LT
Sbjct: 178 -RNLYSS--------DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 43/210 (20%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD-SELAFLSRL-HHKHL 556
KIG G+F V K + G+ AIK K F+ E + E+ L RL H ++
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKC----MKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 557 VRL--VGYCEEKDERL-LVYDYMKNGALYDHLHDR------NNVEK---NAARGIEYLHN 604
+RL V + + K RL LV++ M + LY+ + R V+ + ++++H
Sbjct: 61 LRLIEVLF-DRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFG----LSMMGPESE----RDFRPMKAAGTVG 656
I HRDIK NIL+ +++DFG + P +E R +R + T G
Sbjct: 119 NG---IFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
Y P K D++ +G V E+L+
Sbjct: 175 YYGP----------KMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 73/272 (26%), Positives = 115/272 (42%), Gaps = 65/272 (23%)
Query: 502 IGAGSFGVVYKGKLPDGQEV----AIKRG--------ETAKTKKFQEKESAFDSELAFLS 549
+G GSFG V +L E+ +K+ E T+K + A + FL+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEK---RVLALAGKHPFLT 59
Query: 550 RLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIE 600
+LH C + +RL V +Y+ G L H+ ++ AR G++
Sbjct: 60 QLHS---------CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQ 110
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKAAGTVGY 657
+LH II+RD+K N+LLD++ +++DFG+ ++G + F GT Y
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF-----CGTPDY 162
Query: 658 IDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG----------GTPV 702
I PE YG V D + LGV+L E+L G+ DDE P
Sbjct: 163 IAPEILSYQPYGPAV-----DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR 217
Query: 703 SLVDFAVPAIMAGELVKILDRRVGPPEINEAE 734
L A +I+ L K ++R+G E +
Sbjct: 218 WLSKEAK-SILKSFLTKNPEKRLGCLPTGEQD 248
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 32/214 (14%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
F+ +IG GSFG VY + EV + + K+ EK E+ FL R+ H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGA---LYDHLHDRNNVE-----KNAARGIEYLHNYAV 607
+ G + LV +Y A L H VE A +G+ YLH++
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN- 145
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFG-LSMMGPESERDFRPMKAAGTVGYIDPEYYGLN 666
+IHRDIK+ NILL +++DFG S+ P + GT ++ PE
Sbjct: 146 --MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-------FVGTPYWMAPE----- 191
Query: 667 VLTA--------KSDVYGLGVVLLELLTGKRAIF 692
V+ A K DV+ LG+ +EL K +F
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 34/206 (16%)
Query: 501 KIGAGSFGVVYKG--KLPDGQ-EVAIKRGETAKTKKFQEKESAFD---SELAFLSRLHHK 554
++G+G+FG V KG K+ Q +VAIK K + ++S D E + +L +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIK------VLKNENEKSVRDEMMREAEIMHQLDNP 55
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALY-------DHLHDRNNVE--KNAARGIEYLH-- 603
++VR++G CE + +LV + G L D + N VE + G++YL
Sbjct: 56 YIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGT--VGYIDP 660
N+ +HRD+ + N+LL Q A++SDFGLS +G ++ + ++AG + + P
Sbjct: 115 NF-----VHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAP 167
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLT 686
E +++SDV+ G+ + E +
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
FS +IG GSFG VY + EV + + K+ EK E+ FL +L H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGA---LYDHLHDRNNVE-----KNAARGIEYLHNYAV 607
++ G + LV +Y A L H VE A +G+ YLH++
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 135
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFG-LSMMGPESERDFRPMKAAGTVGYIDPEYYGLN 666
+IHRD+K+ NILL ++ DFG S+M P + GT ++ PE
Sbjct: 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-------FVGTPYWMAPE----- 181
Query: 667 VLTA--------KSDVYGLGVVLLELLTGKRAIF 692
V+ A K DV+ LG+ +EL K +F
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 64/211 (30%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
++IG GSFG VY EV + + K+ EK E+ FL +L H + +
Sbjct: 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 560 VGYCEEKDERL-LVYDYMKNGA---LYDHLHDRNNVE-----KNAARGIEYLHNYAVPPI 610
G C K+ LV +Y A L H VE A +G+ YLH++ +
Sbjct: 87 KG-CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 611 IHRDIKSSNILLDAQWTARVSDFG-LSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
IHRDIK+ NILL +++DFG S P + GT ++ PE V+
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-------FVGTPYWMAPE-----VIL 190
Query: 670 A--------KSDVYGLGVVLLELLTGKRAIF 692
A K DV+ LG+ +EL K +F
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 3e-12
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 54/228 (23%)
Query: 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKR--GETAKTKK----FQEKESA---FDSELA 546
+ + K+G G++G+V+K AI R E KK F+ A F E+
Sbjct: 9 YEILQKLGKGAYGIVWK---------AIDRRTKEVVALKKIFDAFRNATDAQRTF-REIM 58
Query: 547 FLSRL-HHKHLVRLVG-YCEEKDERL-LVYDYM--------KNGALYDHLHDRNNVEKNA 595
FL L H ++V+L+ E D+ + LV++YM + L D +H R +
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VHKRY-IMYQL 116
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
+ ++Y+H+ V IHRD+K SNILL++ +++DFGL+ R ++
Sbjct: 117 LKALKYIHSGNV---IHRDLKPSNILLNSDCRVKLADFGLA-------RSLSELEENPEN 166
Query: 656 G----YIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
Y+ +Y G T D++ +G +L E+L GK +F
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 68/295 (23%), Positives = 121/295 (41%), Gaps = 43/295 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
NF +E KIG G F VY+ L DG VA+K+ + + + E+ L +L+H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNH 61
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGAL---YDHLHDRNNV--EKNAAR-------GIEY 601
++++ E +E +V + G L H + + EK + +E+
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
+H+ ++HRDIK +N+ + A ++ D GL S + GT Y+ PE
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPE 176
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
N KSD++ LG +L E+ + + D + L K +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----------------MNLYSLCKKI 220
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHG 776
++ PP ++ + EL M C+N + ++RP ++ D+ H
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNM-CINPDPEKRP-------DITYVYDVAKRMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKE---SAFDSELAFLSRLHHKHL 556
KIG G++GVVYKG+ GQ VA+K K + E+E S E++ L L H ++
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMK-----KIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 557 VRLVGYCEEKDERLLVYDY--MKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYA 606
V L ++ L++++ M D L ++ + GI + H+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKA----AGTVGYIDPE 661
V +HRD+K N+L+D + +++DFGL+ R F P++ T+ Y PE
Sbjct: 122 V---LHRDLKPQNLLIDNKGVIKLADFGLA-------RAFGIPVRVYTHEVVTLWYRAPE 171
Query: 662 -YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
G + D++ +G + E+ T K+ +F D
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFHGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 63/285 (22%)
Query: 502 IGAGSFGVV-----------YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
+G G+FG V Y K+ +EV I + E A T +E L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILK-KEVIIAKDEVAHTL----------TESRVLQN 51
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H L L + D V +Y G L+ HL ++ AR + YL
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYL 111
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE 661
H+ +++RD+K N++LD +++DFGL E D MK GT Y+ PE
Sbjct: 112 HSCD---VVYRDLKLENLMLDKDGHIKITDFGLC---KEGISDGATMKTFCGTPEYLAPE 165
Query: 662 Y-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD----------ESGGTPVSLVD 706
YG V D +GLGVV+ E++ G+ + D E P +L
Sbjct: 166 VLEDNDYGRAV-----DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP 220
Query: 707 FAVPAIMAGELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLE 750
A +++AG L K +R+ G PE +A E++ + +N +
Sbjct: 221 EA-KSLLAGLLKKDPKQRLGGGPE----DAKEIMEHRFFASINWQ 260
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 54/291 (18%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDG-------QEVAIKRGETAKTKKFQEKESAFD---SE 544
+++ +G+G+FG VYK + + +E+ + K K+ E++ + SE
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKR--ERDKSIGDIVSE 58
Query: 545 LAFL-SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL------HDRNNVEK---- 593
+ + +L H ++VR E D +V D ++ L +H R E+
Sbjct: 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNI 118
Query: 594 --NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMK 650
+ YLH I+HRD+ +NI+L ++DFGL+ PES +
Sbjct: 119 FVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES----KLTS 172
Query: 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710
GT+ Y PE K+DV+ G +L ++ T + + +
Sbjct: 173 VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------------- 217
Query: 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
M KI++ P + E E V C+ + + RP DI+
Sbjct: 218 --MLSLATKIVEAVYEP--LPEGMYSEDVTDVITSCLTPDAEARP---DII 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 488 ELAAATNNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDS 543
EL + +E +G G FG + +G KLP +E VAI T + ++ F +
Sbjct: 1 ELDNKS--IKIERILGTGRFGELCRGCLKLPSKRELPVAIH---TLRAGCSDKQRRGFLA 55
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKN 594
E L + H ++VRL G + ++V +YM NGAL L +
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 595 AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE--SERDFRPMKAA 652
A G++YL +H+ + + +L+++ ++S F E SE + M
Sbjct: 116 LASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGK 169
Query: 653 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKR 689
V + PE + ++ SDV+ G+V+ E+++ G+R
Sbjct: 170 SPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 74/308 (24%), Positives = 127/308 (41%), Gaps = 69/308 (22%)
Query: 501 KIGAGSFGVVYKGKLPDGQE-----------------VAIK--RGETAKTKKFQEKESAF 541
K+G G FG V+ ++ + Q+ VA+K R + K + + F
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-----NDF 66
Query: 542 DSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------ 595
E+ LSRL +++RL+G C ++D ++ +YM+NG L L + +K
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126
Query: 596 ---------------------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634
A G++YL + +HRD+ + N L+ T +++DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694
+S + +A + ++ E + T SDV+ GV L E+L + K+
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKE 239
Query: 695 DESGGTPVSLVDFAVPAIMAGELVKILDRRV--GPPEINEAEAVELVAYTAMHCVNLEGK 752
G L D V AGE + R+V P EL+ + C + + +
Sbjct: 240 QPYG----ELTDEQVIE-NAGEFFRDQGRQVYLFRPPPCPQGLYELM----LQCWSRDCR 290
Query: 753 ERPTMADI 760
ERP+ +DI
Sbjct: 291 ERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 31/159 (19%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKES----AFDSELAFLSRL--- 551
+IG G++G VYK + L G+ VA+K+ + E + E+A L +L
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQLESF 58
Query: 552 HHKHLVRLVGYCEEKD-ER----LLVYDYM-KNGALY-DHLHDR-------NNVEKNAAR 597
H ++VRL+ C +R LV++++ ++ A Y ++ + R
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636
G+++LH++ I+HRD+K NIL+ + +++DFGL+
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
NF +E KIG G F VY+ L D + VA+K+ + + + ++ E+ L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-KEIDLLKQLNH 61
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGAL-----YDHLHDRNNVEKNAAR-------GIEY 601
++++ + E +E +V + G L Y R E+ + +E+
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
+H+ V +HRDIK +N+ + A ++ D GL S + GT Y+ PE
Sbjct: 122 MHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPE 176
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694
N KSD++ LG +L E+ + + D
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 36/214 (16%)
Query: 502 IGAGSFGVV-----------YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
+G G+FG V Y K+ +EV + + E A T E +S FL+
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHT--LTENRVLQNSRHPFLTA 59
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
L + + D V +Y G L+ HL ++ AR ++YL
Sbjct: 60 LKYSF--------QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 111
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE 661
H + +++RD+K N++LD +++DFGL E +D MK GT Y+ PE
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLC---KEGIKDGATMKTFCGTPEYLAPE 166
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
N D +GLGVV+ E++ G+ + D
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 77/309 (24%), Positives = 125/309 (40%), Gaps = 64/309 (20%)
Query: 498 LENKIGAGSFGVVY--------KGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLS 549
L +G G FG V K K +VA+K ++ T+K S SE+ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK---DLSDLISEMEMMK 78
Query: 550 RL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR------------NNVEKN-- 594
+ HK+++ L+G C + ++ +Y G L ++L R E+
Sbjct: 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 595 ----------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644
ARG+EYL A IHRD+ + N+L+ +++DFGL+ +
Sbjct: 139 FKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 195
Query: 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704
+ V ++ PE + T +SDV+ GV+L E+ T GG+P
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT----------LGGSP--- 242
Query: 705 VDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMH-CVNLEGKERPTMADIV 761
P + EL K+L R+ P E Y M C + +RPT +V
Sbjct: 243 ----YPGVPVEELFKLLKEGHRMDKPSNCTNE-----LYMMMRDCWHAVPSQRPTFKQLV 293
Query: 762 ANLERALDI 770
+L+R L +
Sbjct: 294 EDLDRILAL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 63/238 (26%), Positives = 99/238 (41%), Gaps = 41/238 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG-QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F I G++G VY + + Q A+K+ + + F E L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAE 59
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
+ +V + E K +V +Y++ G L + + + AR +EYLHN
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 119
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES-------------ERDFRPMKA 651
Y I+HRD+K N+L+ + +++DFGLS +G S R+F +
Sbjct: 120 YG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 652 AGTVGYIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704
GT YI PE YG V D + +G++L E L G F G TP L
Sbjct: 177 CGTPEYIAPEVILRQGYGKPV-----DWWAMGIILYEFLVGCVPFF-----GDTPEEL 224
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 21/198 (10%)
Query: 502 IGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELA---FLSRLHHKHLV 557
IG GSFG V + + D Q + A+K K S LA L++++ +V
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALK----TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPP 609
L + ++ LV ++ G L+ HL + + AR +E LH + V
Sbjct: 57 PLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNV-- 114
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
I+RD+K NILLD Q + DFGL + + D + GT Y+ PE + T
Sbjct: 115 -IYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 670 AKSDVYGLGVVLLELLTG 687
D + LGV+L E+LTG
Sbjct: 172 KAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/199 (26%), Positives = 92/199 (46%), Gaps = 26/199 (13%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G+FG VYK + + G A K + + +E+ F E+ LS H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQI----ESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNN----------VEKNAARGIEYLHNYAVPPI 610
+++ ++ ++ GAL D + V + + +LH++ V
Sbjct: 69 EAYFYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKV--- 124
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY-----YGL 665
IHRD+K+ NILL +++DFG+S +S R GT ++ PE +
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKN-KSTLQKRD-TFIGTPYWMAPEVVACETFKD 182
Query: 666 NVLTAKSDVYGLGVVLLEL 684
N K+D++ LG+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 59/268 (22%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEV-AIK--------RGETAKTKKFQEKESAFDSEL 545
+F+ +G GSFG V + E+ AIK + + + +++ A +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 546 AFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNV-EKNA-------A 596
FL++LH C + +RL V +Y+ G L H+ E +A A
Sbjct: 61 PFLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIA 111
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL---SMMGPESERDFRPMKAAG 653
G+ +LH+ II+RD+K N++LDA+ +++DFG+ ++ G ++ R F G
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTF-----CG 163
Query: 654 TVGYIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE----------SG 698
T YI PE YG +V D + GV+L E+L G+ +DE +
Sbjct: 164 TPDYIAPEIIAYQPYGKSV-----DWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218
Query: 699 GTPVSLVDFAVPAIMAGELVKILDRRVG 726
P SL AV +I G L K +R+G
Sbjct: 219 SYPKSLSKEAV-SICKGLLTKHPAKRLG 245
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 77/310 (24%), Positives = 123/310 (39%), Gaps = 62/310 (20%)
Query: 496 FSLENKIGAGSFGVVY--------KGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAF 547
+L +G G FG V K K VA+K + T K S SE+
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK---DLSDLVSEMEM 70
Query: 548 LSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN----------------- 589
+ + HK+++ L+G C + ++ +Y G L ++L R
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 590 -------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642
+ ARG+EYL A IHRD+ + N+L+ +++DFGL+
Sbjct: 131 LTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV 702
+ + V ++ PE V T +SDV+ GV+L E+ T GG+P
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT----------LGGSP- 236
Query: 703 SLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
P I EL K+L R+ P N + ++ H V +RPT +
Sbjct: 237 ------YPGIPVEELFKLLKEGHRMDKPA-NCTHELYMIMRECWHAVP---SQRPTFKQL 286
Query: 761 VANLERALDI 770
V +L+R L +
Sbjct: 287 VEDLDRVLTV 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 60/198 (30%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
IG GSFG V K DG+ A+K + +E++ L + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLH-DRNNVEKNA-------ARGIEYLHNYAVPPIIH 612
+ ++ V D++ G L+ HL +R+ E A A + YLH+ I++
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVY 119
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMG---PESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
RD+K NILLD+Q ++DFGL G ++ F GT Y+ PE
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF-----CGTPEYLAPEVIRKQPYD 174
Query: 670 AKSDVYGLGVVLLELLTG 687
D + LG VL E+L G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 68/283 (24%), Positives = 122/283 (43%), Gaps = 48/283 (16%)
Query: 502 IGAGSFGVVYKGK-LPDGQE----VAIK--RGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+G+G+FG VYKG +PDG+ VAIK R T+ + + A+ ++ +
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY-----VMAGVGSP 69
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-----------NAARGIEYLH 603
++ RL+G C +L V M G L D++ R N ++ A+G+ YL
Sbjct: 70 YVCRLLGICLTSTVQL-VTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLE 126
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
++HRD+ + N+L+ + +++DFGL+ + E ++ + ++ E
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
T +SDV+ GV + EL+T G P +PA +L++ +R
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT----------FGAKPYD----GIPAREIPDLLEKGER 229
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
PP V + C ++ + RP ++V R
Sbjct: 230 LPQPPICTID-----VYMIMVKCWMIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 41/273 (15%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G GS+G V + DG++ IK+ + +E+++A + E LS+L H ++V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKK-LNLRNASRRERKAA-EQEAQLLSQLKHPNIVAYR 65
Query: 561 GYCEEKDERL-LVYDYMKNGALYDHLHDR-------NNVEK---NAARGIEYLHNYAVPP 609
E +D L +V + + G LY L ++ N V + A ++YLH
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KH 122
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
I+HRD+K+ N+ L +V D G++ + E++ D GT Y+ PE +
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMAST-LIGTPYYMSPELFSNKPYN 180
Query: 670 AKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP-P 728
KSDV+ LG + E+ T K A D M + +I++ ++ P P
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFNAKD-----------------MNSLVYRIIEGKLPPMP 223
Query: 729 EINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
+ E EL+A M E +RP++ I+
Sbjct: 224 KDYSPELGELIA--TMLSKRPE--KRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 59/212 (27%), Positives = 87/212 (41%), Gaps = 30/212 (14%)
Query: 502 IGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSR------LHHK 554
+G GSFG V +L E AIK K E + D E + R H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIK---ALKKDVVLEDD---DVECTMVERRVLALAWEHP 56
Query: 555 HLVRLVGYC--EEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
L L +C + K+ V +Y+ G L H+ ++ AR G+++LH
Sbjct: 57 FLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
II+RD+K N+LLD +++DFG M + + GT YI PE
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFG--MCKENMNGEGKASTFCGTPDYIAPEILK 169
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
D + GV+L E+L G+ +DE
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 40/217 (18%)
Query: 502 IGAGSFGVVYKGKLP-DGQEVAIKR--------GETAKTKKFQEKESAFDSELAFLSRLH 552
+G GSFG V +L G+ A+K + + +++ A E FL+ L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 553 HKHLVRLVGYC--EEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
YC + K+ V +++ G L H+ D+ + A G+++L
Sbjct: 62 ---------YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFL 112
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA---GTVGYID 659
H+ II+RD+K N++LD +++DFG+ E F +A+ GT YI
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMC-----KENVFGDNRASTFCGTPDYIA 164
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
PE T D + GV+L E+L G+ DDE
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 61/237 (25%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESA--FDSELAFLSRLHHKHLVR 558
IG G+FG V + D G A+K+ + + EKE +E L+ + +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKK---LRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 559 LVGYCEEKDER--LLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH--NYA 606
L Y +DE L+ +Y+ G + L ++ + R I+ +H Y
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY- 122
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSM------------------MGPESERDFRP 648
IHRDIK N+LLDA+ ++SDFGL + +P
Sbjct: 123 ----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 649 M---------------KAAGTVG---YIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
M A TVG YI PE + + D + LGV++ E+L G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 61/210 (29%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE-VAIKRGETAKTKKFQEKE-SAFDSELAFLSRL 551
+F + ++G G +G V+ K D E VA+KR K+ F+ E +E L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKR--MKKSLLFKLNEVRHVLTERDILTTT 58
Query: 552 HHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
+ LV+L+ Y + DE L L +Y+ G L++ + ++ AR ++ L
Sbjct: 59 KSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL 117
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H IHRD+K N L+DA +++DFGLS A VG P+Y
Sbjct: 118 HELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--------YANSVVG--SPDY 164
Query: 663 YGLNVLTAKS-----DVYGLGVVLLELLTG 687
VL K D + LG +L E L G
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 59/195 (30%), Positives = 85/195 (43%), Gaps = 14/195 (7%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
IG GSFG V + + + A+K + K +E++ L + H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLH-DRNNVEKNA-------ARGIEYLHNYAVPPIIH 612
+ D+ V DY+ G L+ HL +R +E A A + YLH+ I++
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVY 119
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKS 672
RD+K NILLD+Q ++DFGL E GT Y+ PE
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF--CGTPEYLAPEVLHKQPYDRTV 177
Query: 673 DVYGLGVVLLELLTG 687
D + LG VL E+L G
Sbjct: 178 DWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 502 IGAGSFG-VVYKGKLPDGQEVAIK----RGETAKTKKFQEKESAFDSELAFLSRLH-HKH 555
+G+G+ G V+ ++ DG+ A+K G + K + E F S + H+
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHED 99
Query: 556 LVRLVGYCEEKDERL-----LVYDYMKNGALYDHLHDRNNVEKNAAR---GIEYL----- 602
+ ++ LV DY G L + R + G+ ++
Sbjct: 100 FA----KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
H+ +IHRDIKS+NILL + ++ DFG S M + D GT Y+ PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKR 689
+ + K+D++ LGV+L ELLT KR
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 23/185 (12%)
Query: 519 QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578
+ V IK G+ T +E L ++H +++L G L+ K
Sbjct: 118 EHVVIKAGQRGGTA----------TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT 167
Query: 579 GALYDHLHDRNN--------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630
LY +L + N +E++ R I+YLH IIHRDIK+ NI ++ +
Sbjct: 168 D-LYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCL 223
Query: 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRA 690
DFG + P + AGT+ PE + D++ G+VL E+ T +
Sbjct: 224 GDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282
Query: 691 IFKDD 695
+F+ D
Sbjct: 283 LFEKD 287
|
Length = 391 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 502 IGAGSFGVVYKGKL-PDG----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
+G G FG V + P+G ++VA+K + K + + E+ L L+H+++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVK---SLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 557 VRLVGYCEEKDER--LLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVP------ 608
V+ G C E L+ +++ +G+L ++L RN + N ++ YAV
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKIN----LKQQLKYAVQICKGMD 123
Query: 609 -----PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK--AAGTVGYIDPE 661
+HRD+ + N+L++++ ++ DFGL+ E+++++ +K V + PE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT-KAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLT 686
+ SDV+ GV L ELLT
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 58/226 (25%), Positives = 101/226 (44%), Gaps = 35/226 (15%)
Query: 486 LAELAAATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSE 544
L+ L F L +G G++G VYKG+ + GQ AIK + +++E E
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLE 62
Query: 545 LAFLSRL-HHKHLVRLVGYCEEK------DERLLVYDYMKNGALYDHLHDRNN------- 590
+ L + HH+++ G +K D+ LV ++ G++ D + +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122
Query: 591 ---VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF- 646
+ + RG+ +LH + V IHRDIK N+LL ++ DFG+S + +R
Sbjct: 123 IAYICREILRGLAHLHAHKV---IHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVG 176
Query: 647 RPMKAAGTVGYIDPEYYGLN-----VLTAKSDVYGLGVVLLELLTG 687
R GT ++ PE + +SD++ LG+ +E+ G
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HH 553
F L +G G++G VYKG+ + GQ AIK + ++E E+ L + HH
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHH 62
Query: 554 KHLVRLVGYCEEK------DERLLVYDYMKNGALYDHLHD-RNNVEKNA---------AR 597
+++ G +K D+ LV ++ G++ D + + + N K R
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-RPMKAAGTVG 656
G+ +LH + V IHRDIK N+LL ++ DFG+S + +R R GT
Sbjct: 123 GLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPY 176
Query: 657 YIDPEYYGLN-----VLTAKSDVYGLGVVLLELLTG 687
++ PE + KSD++ LG+ +E+ G
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 69/257 (26%), Positives = 111/257 (43%), Gaps = 51/257 (19%)
Query: 502 IGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKE---SAFDSELAFLSRLHHKHLV 557
+G GSFG V +L EV AIK K Q+ + + + + L+ H L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAA-KHPFLT 59
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPP 609
L + KD V +Y+ G L + ++ +R + +LH + V
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV-- 117
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGL---SMMGPESERDFRPMKAAGTVGYIDPEY---- 662
I+RD+K NILLDA+ +++DFG+ ++ + F GT YI PE
Sbjct: 118 -IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF-----CGTPDYIAPEILQEL 171
Query: 663 -YGLNVLTAKSDVYGLGVVLLELLTGK------------RAIFKDDESGGTPVSLVDFAV 709
YG +V D + LGV++ E++ G+ +I DD PV L AV
Sbjct: 172 EYGPSV-----DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVL--YPVWLSKEAV 224
Query: 710 PAIMAGELVKILDRRVG 726
+I+ + K ++R+G
Sbjct: 225 -SILKAFMTKNPNKRLG 240
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 37/91 (40%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGY 657
G+ YL+N V I+HRDIK SNIL++++ ++ DFG+S S D GT Y
Sbjct: 115 GLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD----TFVGTSTY 168
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ PE T KSDV+ LG+ ++EL GK
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 28/201 (13%)
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
++G G+FG VYK K + + A+ + +TK +E E + E+ L+ +H ++V+L+
Sbjct: 19 ELGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKLL 75
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLH---DRNNVE-------KNAARGIEYLHNYAVPPI 610
G + ++ ++ GA+ D + DR E + ++YLH+ I
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---I 131
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPES--ERDFRPMKAAGTVGYIDPEYYGLNVL 668
IHRD+K+ N+LL +++DFG+S ++ RD GT ++ PE +
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD----SFIGTPYWMAPEVVMCETM 187
Query: 669 TA-----KSDVYGLGVVLLEL 684
K+D++ LG+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 55/226 (24%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS---------E 544
+ + IG G++G+V P G +VAIK K S F+ E
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIK------------KISPFEHQTFCQRTLRE 53
Query: 545 LAFLSRLHHKHLVRL-----VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA--- 596
+ L R H++++ + E ++ +V + M+ LY + ++ +
Sbjct: 54 IKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSNDHIQYFL 112
Query: 597 ----RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKA 651
RG++Y+H+ V +HRD+K SN+LL+ ++ DFGL+ + PE + +
Sbjct: 113 YQILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 652 AGTVGYIDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGKRAIF 692
T Y PE +L +K D++ +G +L E+L+ R +F
Sbjct: 170 VATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSN-RPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 36/236 (15%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+F L +IG+G++G VYK + + G+ AIK + + F + E+ + H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDF----AVVQQEIIMMKDCKH 65
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN--------VEKNAARGIEYLHNY 605
++V G +D+ + ++ G+L D H V + +G+ YLH+
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY-- 663
+HRDIK +NILL +++DFG+S + + GT ++ PE
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF--IGTPYWMAPEVAAV 180
Query: 664 ----GLNVLTAKSDVYGLGVVLLEL---------LTGKRAIFKDDESGGTPVSLVD 706
G N L D++ +G+ +EL L RA+F +S P L D
Sbjct: 181 ERKGGYNQLC---DIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 36/211 (17%)
Query: 496 FSLENKIGAGSFGVVY--KGKLPDGQEV-----AIKRGETAKTKKFQEKESAFDSELAFL 548
+ L+ ++G GSFG VY K K +E I GE + Q + A L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA-----QLL 56
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR----------- 597
S+L H +V+ E+D ++ +Y + L L + + K +
Sbjct: 57 SKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 598 -GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGP-ESERDFRPMKAAG 653
G+ Y+H I+HRD+K+ NI L ++ DFG+S +MG + F G
Sbjct: 117 LGVHYMH---QRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTF-----TG 167
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLEL 684
T Y+ PE +KSD++ LG +L E+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 77/317 (24%), Positives = 127/317 (40%), Gaps = 76/317 (23%)
Query: 494 NNFSLENKIGAGSFGVVYK----GKLPDGQEVAIKRGETAKTKKFQEKESAFDSELA-FL 548
+ L +G G FG V + G + + T K K++A D +LA +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPD----QTVTVAVKML--KDNATDKDLADLI 65
Query: 549 SRLH-------HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN--------NVEK 593
S + HK+++ L+G C ++ ++ +Y G L + L R ++ K
Sbjct: 66 SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125
Query: 594 ----------------NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637
ARG+EYL + IHRD+ + N+L+ +++DFGL+
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 638 MGPESERDFRPMKAAG--TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
+ D+ + G V ++ PE V T +SDV+ G+++ E+ T
Sbjct: 183 --GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT--------- 231
Query: 696 ESGGTPVSLVDFAVPAIMAGELVKIL---DRRVGPPEINEAEAVELVAYTAM-HCVNLEG 751
GG+P P I EL K+L R P EL Y M C +
Sbjct: 232 -LGGSP-------YPGIPVEELFKLLREGHRMDKPSNCTH----EL--YMLMRECWHAVP 277
Query: 752 KERPTMADIVANLERAL 768
+RPT +V L++ L
Sbjct: 278 TQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 30/212 (14%)
Query: 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G GSFG V+ +L Q AIK + + E + H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLH-----DRNNVEKNAAR---GIEYLHNYAVPPIIH 612
+ K+ V +Y+ G L H+ D AA G+++LH+ I++
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVY 119
Query: 613 RDIKSSNILLDAQWTARVSDFGL---SMMGPESERDFRPMKAAGTVGYIDPEY-----YG 664
RD+K NILLD +++DFG+ +M+G D + GT YI PE Y
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLG-----DAKTCTFCGTPDYIAPEILLGQKYN 174
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
+V D + GV+L E+L G+ DE
Sbjct: 175 TSV-----DWWSFGVLLYEMLIGQSPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 39/213 (18%)
Query: 501 KIGAGSFGVVYKGKLPDGQE-VAIKRGETAKTKKFQEKE----SAFDSELAFLSRLHHKH 555
KIG G++G V+K K + E VA+KR + + E SA E+ L L HK+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKR-----VRLDDDDEGVPSSAL-REICLLKELKHKN 60
Query: 556 LVRLVGYCEEKDERLLVYDY----MKNGALYDHLH---DRNNVEK---NAARGIEYLHNY 605
+VRL + LV++Y +K +D + D V+ +G+ + H++
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKK--YFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAG----TVGYIDP 660
V +HRD+K N+L++ +++DFGL+ R F P++ T+ Y P
Sbjct: 119 NV---LHRDLKPQNLLINKNGELKLADFGLA-------RAFGIPVRCYSAEVVTLWYRPP 168
Query: 661 E-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
+ +G + + D++ G + EL R +F
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 64/230 (27%), Positives = 105/230 (45%), Gaps = 33/230 (14%)
Query: 489 LAAATNNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFD-SELA 546
L ++ + IG G+FG V + Q+V A+K +K + + +SAF E
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL--LSKFEMIKRSDSAFFWEERD 95
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVEKNA-------AR 597
++ + +V+L +C +D++ L V +YM G L + + + + EK A
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGY 657
++ +H+ +IHRD+K N+LLD +++DFG M E+ R A GT Y
Sbjct: 154 ALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDY 209
Query: 658 IDPE---------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG 698
I PE YYG + D + +GV L E+L G + D G
Sbjct: 210 ISPEVLKSQGGDGYYG-----RECDWWSVGVFLFEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 25/202 (12%)
Query: 502 IGAGSFGVVYKGKLPDGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
+G G +G V++ + G + A+K + A + Q+ + +E L + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 558 RLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVP 608
L+ Y + +L L+ +Y+ G L+ HL ++ A +E+LH
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG-- 120
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGL---SMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
II+RD+K NILLDAQ +++DFGL S+ F GT+ Y+ PE
Sbjct: 121 -IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF-----CGTIEYMAPEILMR 174
Query: 666 NVLTAKSDVYGLGVVLLELLTG 687
+ D + LG ++ ++LTG
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 68/279 (24%), Positives = 117/279 (41%), Gaps = 64/279 (22%)
Query: 445 SNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATN-NFSLENKIG 503
++ + S +L R + + + D E+ + ++ + N ++ L N IG
Sbjct: 17 NHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDE-EKMIDNDINRSPNKSYKLGNIIG 75
Query: 504 AGSFGVVYKGKLPDGQE-VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGY 562
GSFGVVY+ D E VAIK K Q+ + + EL + L+H +++ L Y
Sbjct: 76 NGSFGVVYEAICIDTSEKVAIK-------KVLQDPQYK-NRELLIMKNLNHINIIFLKDY 127
Query: 563 ----CEEKDERLL------------VYDYMKNGALYDHLHDRNN----------VEKNAA 596
C +K+E+ + V+ YMK+ + RNN
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKH-------YARNNHALPLFLVKLYSYQLC 180
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAAGTV 655
R + Y+H+ I HRD+K N+L+D T ++ DFG S ++ + +V
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG-------SAKNL--LAGQRSV 228
Query: 656 GYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTG 687
YI +Y G T D++ LG ++ E++ G
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 48/196 (24%), Positives = 80/196 (40%), Gaps = 25/196 (12%)
Query: 515 LPDGQE----VAIKRGETAKTK---KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567
L G E V K G+ + K K E+ L + H+ ++ L+ K
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKS 159
Query: 568 ERLLVYDYMKNGALYDH--------LHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619
+V K L+ + L +++ + YLH IIHRD+K+ N
Sbjct: 160 TVCMVMPKYKCD-LFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTEN 215
Query: 620 ILLDAQWTARVSDFGLSM---MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYG 676
I LD A + DFG + P++ + + +GT+ PE L+ AK+D++
Sbjct: 216 IFLDEPENAVLGDFGAACKLDAHPDTPQCY---GWSGTLETNSPELLALDPYCAKTDIWS 272
Query: 677 LGVVLLELLTGKRAIF 692
G+VL E+ +F
Sbjct: 273 AGLVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 58/239 (24%)
Query: 488 ELAAATNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAF 541
E+ +T F E +G FG VYKG L Q VAIK T K K F
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK---TLKDKAEGPLREEF 55
Query: 542 DSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN------------ 589
E SRL H ++V L+G ++ +++ Y + L++ L R+
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 590 ------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637
++ A G+E+L ++ V +H+D+ + N+L+ + ++SD GL
Sbjct: 116 TVKSTLEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGL-- 170
Query: 638 MGPESERDFRPMKAAG----------TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
FR + AA + ++ PE + SD++ GVVL E+ +
Sbjct: 171 --------FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEV-AIK--------RGETAKTKKFQEKESAFDSEL 545
+F+ +G GSFG V + E+ AIK + + + +++ A +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 546 AFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR------- 597
FL++LH C + +RL V +Y+ G L H+ ++ A
Sbjct: 61 PFLTQLHS---------CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEIS 111
Query: 598 -GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL---SMMGPESERDFRPMKAAG 653
G+ +LH II+RD+K N++LD++ +++DFG+ M+ + R F G
Sbjct: 112 VGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF-----CG 163
Query: 654 TVGYIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG---------- 698
T YI PE YG +V D + GV+L E+L G+ +DE
Sbjct: 164 TPDYIAPEIIAYQPYGKSV-----DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 218
Query: 699 GTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKE 753
P SL AV +I G + K +R+G E + E + + LE +E
Sbjct: 219 SYPKSLSKEAV-SICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENRE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLS 549
TN + +G G+FG+V + GQ VAIK+ K F A + EL L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKK----IMKPFSTPVLAKRTYRELKLLK 64
Query: 550 RLHHKHLVRLVG-YCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA--------RGIE 600
L H++++ L + ++ V + + G L +EK RG++
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLK 122
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
Y+H+ V +HRD+K SNIL++ ++ DFGL+ R T GY+
Sbjct: 123 YVHSAGV---VHRDLKPSNILINENCDLKICDFGLA----------RIQDPQMT-GYVST 168
Query: 661 EYYGLN--VLT-----AKSDVYGLGVVLLELLTGK 688
YY +LT + D++ G + E+L GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 43/216 (19%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD----SELAFLSRLHHK 554
KIG G+FG V+K + Q VA+K K EKE F E+ L L H+
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKE-GFPITALREIKILQLLKHE 71
Query: 555 HLVRLVGYCEEKDER--------LLVYDY--------MKNGALYDHLHDRNNVEKNAARG 598
++V L+ C K LV+++ + N + L + V K G
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM--KAAGTVG 656
+ Y+H I+HRD+K++NIL+ +++DFGL+ S+ T+
Sbjct: 132 LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 657 YIDPEY------YGLNVLTAKSDVYGLGVVLLELLT 686
Y PE YG + D++G G ++ E+ T
Sbjct: 189 YRPPELLLGERDYGPPI-----DMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 32/204 (15%)
Query: 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKE-SAFDSELAFLSRLH-HKHLVR 558
+G GSFG V +L G+ A+K K Q+ + +E LS H L +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 559 LVGYCEEKDERLL-VYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPP 609
L C + +RL V +++ G L H+ ++ AR + +LH+
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--- 116
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE-----YY 663
II+RD+K N+LLD + +++DFG M E + + GT YI PE Y
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY 173
Query: 664 GLNVLTAKSDVYGLGVVLLELLTG 687
G +V D + +GV+L E+L G
Sbjct: 174 GPSV-----DWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 33/83 (39%), Positives = 47/83 (56%), Gaps = 7/83 (8%)
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669
+IHRD+K SNILLDA ++ DFG+S +S+ R +AG Y+ PE
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR---SAGCAAYMAPERIDPPDPN 192
Query: 670 AK----SDVYGLGVVLLELLTGK 688
K +DV+ LG+ L+EL TG+
Sbjct: 193 PKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 60/214 (28%), Positives = 91/214 (42%), Gaps = 50/214 (23%)
Query: 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSE---------LAFLSRLH 552
IG GS+ V V +K+ E K +KE D E F +
Sbjct: 3 IGRGSYAKVLL--------VRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 54
Query: 553 HKHLVRLVGYCEEKDERLL-VYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
H LV L C + + RL V +Y+ G L H+ + + + AR + YLH
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 113
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA----GTVGYID 659
II+RD+K N+LLD++ +++D+G+ G RP GT YI
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG------LRPGDTTSTFCGTPNYIA 164
Query: 660 PEY-----YGLNVLTAKSDVYGLGVVLLELLTGK 688
PE YG +V D + LGV++ E++ G+
Sbjct: 165 PEILRGEDYGFSV-----DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 500 NKIGAGSFGVVYKG--KLPDG----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+K+G G++ VYKG KL D +E+ ++ E A +E ++ L L H
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIRE--------VSLLKDLKH 63
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------NAARGIEYLHN 604
++V L + LV++Y+ + L +L D N RG+ Y H
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-YY 663
V +HRD+K N+L++ + +++DFGL+ + + T+ Y P+
Sbjct: 123 RKV---LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS--NEVVTLWYRPPDILL 177
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGK 688
G + + D++G+G + E+ TG+
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV----------AIKRGETAKTKKFQEKESAFDS 543
++F + IG G+FG V K+ + + +KR ETA + +E+ +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNG 58
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNAAR----- 597
+ +++ LH+ ++++ LV DY G L L + + ++ AR
Sbjct: 59 DCQWITTLHYAF--------QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAE 110
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT 654
I +H +HRDIK N+LLD R++DFG S + + + A GT
Sbjct: 111 MVLAIHSIHQLHY---VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166
Query: 655 VGYIDPEYY-----GLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694
YI PE G+ + D + LGV + E+L G+ + +
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 501 KIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKE-SAFDS--ELAFLSRLHHKHL 556
K+G GS+ VYKGK +G+ VA+K + QE+E + F + E + L L H ++
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALK------VIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 557 VRLVGYCEEKDERLLVYDYMKNGA---LYDH---LHDRNNVEK---NAARGIEYLHNYAV 607
V L K+ LV++Y+ + H LH NV+ RG+ Y+H
Sbjct: 66 VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIHQRY- 123
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-YYGLN 666
I+HRD+K N+L+ +++DFGL+ + T+ Y P+ G
Sbjct: 124 --ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS--NEVVTLWYRPPDVLLGST 179
Query: 667 VLTAKSDVYGLGVVLLELLTGKRA 690
+ D++G+G + +E++ G A
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 495 NFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRL 551
+ IG+G++GVV G++VAIK+ A F A + EL L
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA----FDVPTLAKRTLRELKILRHF 61
Query: 552 HHKHLVRLVGYCEEKDERL----LVYDYMKNGALYDHLHDRNNVEKNAA--------RGI 599
H +++ + +V D M++ L+ +H + + RG+
Sbjct: 62 KHDNIIAIRDILRPPGADFKDVYVVMDLMESD-LHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKAAGTVG 656
+Y+H+ V IHRD+K SN+L++ R+ DFG++ P + F A T
Sbjct: 121 KYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRW 176
Query: 657 YIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
Y PE L T D++ +G + E+L G+R +F
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 52/215 (24%)
Query: 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSE-LAFLSRLHHKHLVR-- 558
IG GS+ V V +K+ + K +KE D E + ++ KH+
Sbjct: 3 IGRGSYAKVLL--------VRLKKNDQIYAMKVVKKELVHDDEDIDWVQT--EKHVFEQA 52
Query: 559 -----LVGY--CEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
LVG C + RL LV +Y+ G L H+ + + + AR + +L
Sbjct: 53 SSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFL 112
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA----GTVGYI 658
H II+RD+K N+LLDA +++D+G+ G P GT YI
Sbjct: 113 HERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG------LGPGDTTSTFCGTPNYI 163
Query: 659 DPEY-----YGLNVLTAKSDVYGLGVVLLELLTGK 688
PE YG +V D + LGV++ E++ G+
Sbjct: 164 APEILRGEEYGFSV-----DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 28/233 (12%)
Query: 494 NNFSLENKIGAGSFGVVY--KGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+F +++ +G G FG V + K G A+K + + QE S F+ E LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLA-QETVSFFEEERDILSIS 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGAL------YDHLHDRNNVEKNAARGIEYLHNY 605
+ + +L ++KD LV +Y G L Y+ D + + A + +H+
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
+HRDIK N+L+D +++DFG S + + GT YI PE
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPE---- 173
Query: 666 NVLTAKS-----------DVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF 707
VLT + D + LGV+ E++ G R+ F + S T ++++F
Sbjct: 174 -VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG-RSPFHEGTSAKTYNNIMNF 224
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 40/225 (17%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEV----------AIKRGETAKTKKFQEKESAFDSE 544
+F + IG G+FG V KL + +V +KR ETA + +E++ + +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR--EERDVLVNGD 59
Query: 545 LAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHD-RNNVEKNAAR----- 597
+++ LH Y + + L LV DY G L L + + ++ AR
Sbjct: 60 NQWITTLH---------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAE 110
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT 654
I+ +H +HRDIK NIL+D R++DFG S + + + A GT
Sbjct: 111 MVIAIDSVHQLHY---VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGT 166
Query: 655 VGYIDPEYY-----GLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694
YI PE G + D + LGV + E+L G+ + +
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 53/222 (23%), Positives = 91/222 (40%), Gaps = 49/222 (22%)
Query: 511 YKGKLPDGQEVAIKRGETAKTKKFQEKESAFD---------------------------S 543
+K KL +GQ + E +KF +K+ + D
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRNNVEKNA------ 595
E+ +SRL +++RL+ C D ++ +YM+NG L L H+ + A
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 596 -----------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644
A G++YL + +HRD+ + N L+ +T +++DFG+S +
Sbjct: 129 YSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
+A + ++ E L T SDV+ GV L E+LT
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 66/250 (26%), Positives = 95/250 (38%), Gaps = 57/250 (22%)
Query: 502 IGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESA-FDSELAFLSRLHHKHLVRL 559
IG G+FG V + D + A+K K ++A +E L+ ++ +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLR--KADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPII 611
++KD V DY+ G + L E++ AR IE +H I
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FI 123
Query: 612 HRDIKSSNILLDAQWTARVSDFGL----------------------SMMGPE--SERDFR 647
HRDIK NIL+D +++DFGL SM E SE D
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 648 PMKA-----------------AGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRA 690
+K GT YI PE T D + +GV+L E+L G +
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QP 242
Query: 691 IFKDDESGGT 700
F D T
Sbjct: 243 PFLADTPAET 252
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 56/217 (25%)
Query: 502 IGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKE---------SAFD--SELAFLS 549
IG GS+ V +L + + A+K K + + E F+ S FL
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMK---VIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 550 RLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIE 600
LH C + + RL V +++ G L H+ + + + AR +
Sbjct: 60 GLHS---------CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA----GTVG 656
+LH II+RD+K N+LLDA+ +++D+G+ G RP GT
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG------IRPGDTTSTFCGTPN 161
Query: 657 YIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGK 688
YI PE YG +V D + LGV++ E++ G+
Sbjct: 162 YIAPEILRGEDYGFSV-----DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 45/224 (20%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL----HHKH 555
KIG G++G VYK + G+ VA+K KT+ ++E + L +S L +
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 556 LVRL--VGYCEEKDERL---LVYDYM---------KNGALYDHLHDRNNVEK---NAARG 598
+VRL V + EEK+ + LV++Y+ NG ++ +G
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFGLSMMGPESERDFR-PMKAAG--- 653
+ + H + V +HRD+K N+L+D + +++D GL R F P+K+
Sbjct: 123 VAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLG-------RAFSIPVKSYTHEI 172
Query: 654 -TVGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
T+ Y PE G + D++ +G + E+ K+ +F D
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 32/230 (13%)
Query: 486 LAELAAATNNFSLENKIGAGSFGVVYK-GKLPDGQEVAIKRGETAKTKKFQEKESAFDSE 544
L L T+ + + IG G++G VYK DG A+K + +E E+ ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNI- 71
Query: 545 LAFLSRLHHKHLVRLVGYCEEKDERL-----LVYDYMKNGALYDHLHDR----------- 588
L L +H ++V+ G + D+ + LV + G++ + +
Sbjct: 72 LQSLP--NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 589 -NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647
+ + A G+++LHN IIHRD+K +NILL + ++ DFG+S + R
Sbjct: 130 ISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LR 184
Query: 648 PMKAAGTVGYIDPEYYGLN-----VLTAKSDVYGLGVVLLELLTGKRAIF 692
+ GT ++ PE A+ DV+ LG+ +EL G +F
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF 234
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 501 KIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFD----SELAFLSRLH--- 552
+IG G++G VYK + P G VA+K + + Q E E+A L RL
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 553 HKHLVRLVGYC-----EEKDERLLVYDYMKN------------GALYDHLHDRNNVEKNA 595
H ++VRL+ C + + + LV++++ G + + D + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKD---LMRQF 117
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
RG+++LH I+HRD+K NIL+ + +++DFGL+ + + P+ T+
Sbjct: 118 LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI-YSCQMALTPVVV--TL 171
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDES 697
Y PE + D++ +G + E+ K + E+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 34/85 (40%), Positives = 45/85 (52%), Gaps = 12/85 (14%)
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPES---ERDFRPMKAAGTVGYIDPEYYGLN 666
IIHRD+K SNILLD ++ DFG+S +S RD AG Y+ PE +
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD------AGCRPYMAPERIDPS 182
Query: 667 VLTA---KSDVYGLGVVLLELLTGK 688
+SDV+ LG+ L E+ TGK
Sbjct: 183 ARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 73/288 (25%), Positives = 119/288 (41%), Gaps = 45/288 (15%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEV-AIK--------RGETAKTKKFQEKESAFDSEL 545
+F+ +G GSFG V + E+ AIK + + + +++ A +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 546 AFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEK--------NAA 596
FL++LH C + +RL V +Y+ G L + ++ A
Sbjct: 61 PFLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIA 111
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTV 655
G+ +LH+ II+RD+K N++LD++ +++DFG M E+ D K GT
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTKTFCGTP 165
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG----------GTPVSLV 705
YI PE D + GV+L E+L G+ +DE P S+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS 225
Query: 706 DFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKE 753
AV AI G + K +R+G E + E + + LE KE
Sbjct: 226 KEAV-AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 272
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 69/243 (28%)
Query: 502 IGAGSFGVV---YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHL 556
+G+G++G V Y +L Q+VA+K+ ++ FQ A + EL L + H+++
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKK----LSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 557 VRLVGY------CEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA-------------- 596
+ L+ E +E LV + M GA D NN+ K
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLM--GA------DLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG 656
RG++Y+H+ IIHRD+K SN+ ++ R+ DFGL+ + + T
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY-----VATRW 180
Query: 657 YIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD----------ESGGT 700
Y PE +Y V D++ +G ++ ELL GK A+F + E GT
Sbjct: 181 YRAPEIMLNWMHYNQTV-----DIWSVGCIMAELLKGK-ALFPGNDYIDQLKRIMEVVGT 234
Query: 701 PVS 703
P
Sbjct: 235 PSP 237
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 59/275 (21%), Positives = 110/275 (40%), Gaps = 52/275 (18%)
Query: 510 VYKGKLPDGQEVAIKRGETAKTKKFQEKESA----FDSELAFLSRLHHKHLVRLVGYCEE 565
+YKG + +EV I+ KKF + ++E+ L R+ +++++ G+ +
Sbjct: 36 IYKGIF-NNKEVIIR-----TFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89
Query: 566 KDERL----LVYDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHR 613
+ L L+ +Y G L + L + ++ + +G+ L+ Y P ++
Sbjct: 90 IVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV---LTA 670
++ S + L+ + ++ GL E P K + Y + ++ T
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNFMVYFSYKML-NDIFSEYTI 201
Query: 671 KSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730
K D+Y LGVVL E+ TGK F+ T + D + L LD P EI
Sbjct: 202 KDDIYSLGVVLWEIFTGK-IPFE----NLTTKEIYDLIINKN--NSLKLPLD---CPLEI 251
Query: 731 NEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
C + + +RP + +I+ NL
Sbjct: 252 K---------CIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 42/147 (28%), Positives = 65/147 (44%), Gaps = 13/147 (8%)
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES-ERDFRPMKAAGTV 655
RG+ YL I+HRD+K SNIL++++ ++ DFG+S +S F GT
Sbjct: 110 RGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTR 162
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
Y+ PE T +SD++ LG+ L+E+ G+ I D + F P
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM----FGRPVSEGE 218
Query: 716 ELVKILDRRVGPPEINEAEAV-ELVAY 741
PP+ A+ EL+ Y
Sbjct: 219 AKESHRPVSGHPPDSPRPMAIFELLDY 245
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 55/219 (25%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQE-KESAFDSELAFLSRLHHKHLVRL 559
+G G++GVV K + +P G +A+KR T QE K D +++ S + + V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKR--IRATVNSQEQKRLLMDLDISMRS-VDCPYTVTF 65
Query: 560 VGYCEEKDERLLVYDYMKNG--ALYDHLHDRN-NVEKNA--------ARGIEYLHNYAVP 608
G + + + + M Y ++D+ + ++ + +EYLH +
Sbjct: 66 YGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKL 123
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLS-----------------MMGPESERDFRPMKA 651
+IHRD+K SN+L++ ++ DFG+S M PE
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER--------- 174
Query: 652 AGTVGYIDPE--YYGLNVLTAKSDVYGLGVVLLELLTGK 688
I+PE G +V KSDV+ LG+ ++EL TG+
Sbjct: 175 ------INPELNQKGYDV---KSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 30/211 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
NF K+G G++ VYKG+ G+ VA+K + S E++ + L H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKE---IHLDAEEGTPSTAIREISLMKELKH 57
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNG-ALYDHLH-DRNNVEKNAAR--------GIEYLH 603
+++VRL +++ +LV++YM Y H R ++ N + GI + H
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAG----TVGYI 658
V +HRD+K N+L++ + +++DFGL+ R F P+ T+ Y
Sbjct: 118 ENRV---LHRDLKPQNLLINKRGELKLADFGLA-------RAFGIPVNTFSNEVVTLWYR 167
Query: 659 DPE-YYGLNVLTAKSDVYGLGVVLLELLTGK 688
P+ G + D++ +G ++ E++TG+
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 67/289 (23%), Positives = 109/289 (37%), Gaps = 59/289 (20%)
Query: 502 IGAGSFGVVYKGKL-PDGQEVAIKRGETAKT-----KKFQEKESAFDSELAFLSRLHHKH 555
+G G+F +YKG L + G+ AF + +S+L HKH
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLHNYA 606
LV+L G C +DE ++V +Y+K G L LH N V K A + YL +
Sbjct: 63 LVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 607 VPPIIHRDIKSSNILL-------DAQWTARVSDFGLSM-MGPESERDFRPMKAAGTVGYI 658
++H ++ NIL+ ++SD G+ + + ER R + +I
Sbjct: 122 ---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVER-------IPWI 171
Query: 659 DPEYY--GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
PE G LT +D + G LLE+ + S + +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS----------------SEK 215
Query: 717 LVKILDRRVGP-PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764
D+ P P+ E +A C + +RP+ I+ +L
Sbjct: 216 ERFYQDQHRLPMPDCAE------LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 47/205 (22%), Positives = 93/205 (45%), Gaps = 30/205 (14%)
Query: 500 NKIGAGSFGVVYKG--KLPDG----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
K+G G++ V+KG KL + +E+ ++ E A +E ++ L L H
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE--------VSLLKDLKH 63
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------NAARGIEYLHN 604
++V L LV++Y+ + L ++ D N+ RG+ Y H
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-YY 663
V +HRD+K N+L++ + +++DFGL+ + + T+ Y P+
Sbjct: 123 RKV---LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVLL 177
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGK 688
G + + + D++G+G + E+ +G+
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 31/204 (15%)
Query: 502 IGAGSFG--VVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+G GSFG ++ + D Q+ A+K E K E + E L+++ H ++V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMK--EIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAF 63
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPP 609
E +V +Y G L + + G++++H V
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV-- 121
Query: 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-RPMKAA----GTVGYIDPEYYG 664
+HRDIKS NI L ++ DFG S R P A GT Y+ PE +
Sbjct: 122 -LHRDIKSKNIFLTQNGKVKLGDFG-------SARLLTSPGAYACTYVGTPYYVPPEIWE 173
Query: 665 LNVLTAKSDVYGLGVVLLELLTGK 688
KSD++ LG +L EL T K
Sbjct: 174 NMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 40/239 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+++ L ++G+G++G VYK L G+ A+K + F S E+ +
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF----SLIQQEIFMVKECK 64
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE--------KNAARGIEYLHN 604
H ++V G +++ + +Y G+L D H + + +G+ YLH+
Sbjct: 65 HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGTVGYIDPEY 662
+HRDIK +NILL +++DFG++ + ++R GT ++ PE
Sbjct: 125 KGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK----SFIGTPYWMAPEV 177
Query: 663 Y------GLNVLTAKSDVYGLGVVLLEL---------LTGKRAIFKDDESGGTPVSLVD 706
G N L D++ +G+ +EL L RA+F +S P L D
Sbjct: 178 AAVEKNGGYNQLC---DIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 72/338 (21%), Positives = 128/338 (37%), Gaps = 69/338 (20%)
Query: 474 SSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVV-------YKGKLPDGQEVAIKRG 526
+ +EFL +F + + + AG+FG + + + V
Sbjct: 136 AQAKLKHDDEFL--------AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQ 187
Query: 527 ETAKTKKFQEK--------ESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV------ 572
K ++ K ++E+ L RL+H++++++ + ++
Sbjct: 188 GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247
Query: 573 --YDYMKNGAL----YDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626
Y +M + A L + K +EY+H+ +IHRDIK NI L+
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304
Query: 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELL- 685
+ DFG + M E ER+ GTV PE + +D++ G++LL++L
Sbjct: 305 KIVLGDFG-TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
Query: 686 ---------TGK-----RAIFK-----DDESGGTPVSLVDFAVPAIM--AGELVKILDRR 724
GK I D+E P L D+ A + AG V L R
Sbjct: 364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN 423
Query: 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762
+G P E V+++ + + RP A+++A
Sbjct: 424 LGLPADFEYPLVKMLTF--------DWHLRPGAAELLA 453
|
Length = 501 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 489 LAAATNNFSLENKIGAGSFGVVYKG-KLPDGQEVAIK--RGETAKTKKFQEKESAFDSEL 545
AAT+ +LE K+G GS+ VYKG +GQ VA+K +T + F A
Sbjct: 1 FGAATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREA----- 54
Query: 546 AFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN----------GALYDHLHDRNNVEKNA 595
+ L L H ++V L K+ V++YM G L H ++
Sbjct: 55 SLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGL--HPYNVRLFMFQL 112
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
RG+ Y+H I+HRD+K N+L+ +++DFGL+ + + T+
Sbjct: 113 LRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS--SEVVTL 167
Query: 656 GYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGK 688
Y P+ G ++ D++G G + +E+L G+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 500 NKIGAGSFGVVYKGKLPDGQEVA---IKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
++IG G FG V G+ G A +K + T Q F E+ L+H ++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL---FLQEVQPYRELNHPNV 57
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR-------------GIEYLH 603
++ +G C E LLV ++ G L ++L + A+ G+ +LH
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY- 662
IH D+ N L A + ++ D+GL++ + A + ++ PE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 663 --YGLNVLTAK----SDVYGLGVVLLELLT 686
G ++L S+++ LGV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 486 LAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSE 544
+ +L ++ + IG G+FG V + ++V A+K +K + + +SAF E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWE 92
Query: 545 LAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNA-------A 596
+ + V + Y + D L +V +YM G L + + + + EK A
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV 152
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG 656
++ +H+ IHRD+K N+LLD +++DFG + M E R A GT
Sbjct: 153 LALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG-TCMKMNKEGMVRCDTAVGTPD 208
Query: 657 YIDPE---------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG 698
YI PE YYG + D + +GV L E+L G + D G
Sbjct: 209 YISPEVLKSQGGDGYYG-----RECDWWSVGVFLYEMLVGDTPFYADSLVG 254
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 60/233 (25%), Positives = 86/233 (36%), Gaps = 48/233 (20%)
Query: 496 FSLENKIGAGSFGVVYKGKLPD-GQEVAIK---RGETAKTKKFQEKESAFDSELAFLSRL 551
F +G G G V+ +L G+ A+K + E K K + + E L+ L
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT----EQEILATL 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN--VEKNAAR--------GIEY 601
H L L + + LV DY G L+ L + + + AR +EY
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES------------------- 642
LH I++RD+K NILL +SDF LS
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 643 --------ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
E FR GT YI PE + + D + LG++L E+L G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 56/234 (23%), Positives = 100/234 (42%), Gaps = 43/234 (18%)
Query: 493 TNNFSLENKIGAGSFGVVYK-GKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
++ + + IG G++G V+K +G + A+K + + ++E L L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-----ILDPIHDIDEEIEAEYNILKAL 71
Query: 552 H-HKHLVRLVGYCEEKDER-----LLVYDYMKNGALYDHLH------DRNN------VEK 593
H ++V+ G +KD + LV + G++ D + +R +
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILH 131
Query: 594 NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAG 653
A G+++LH IHRD+K +NILL + ++ DFG+S + R + G
Sbjct: 132 EALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVG 186
Query: 654 TVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
T ++ PE + A+ DV+ LG+ +EL G RA+FK
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
++G G+FG VYK + +E + K +E+ + E+ L+ H ++V+L+
Sbjct: 12 ELGDGAFGKVYKAQ---NKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLHNYAVPPII 611
++ ++ ++ GA+ + + V K + YLH II
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV---- 667
HRD+K+ NIL +++DFG+S + + R GT ++ PE
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 668 -LTAKSDVYGLGVVLLEL 684
K+DV+ LG+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-08
Identities = 57/231 (24%), Positives = 87/231 (37%), Gaps = 58/231 (25%)
Query: 501 KIGAGSFGVVYKGKLPD-GQEVAIKR-----GETAKTKKFQEKESAFDSELAFLSRLHHK 554
IG G G VY P + VA+K+ E KK F E + L H
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK------RFLREAKIAADLIHP 62
Query: 555 HLVRLVGYCEEKDERLLVYDYM------------KN----GALYDHLHDRNNVEK----- 593
+V + C + D VY M K+ +L L ++ +V
Sbjct: 63 GIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 594 -NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR----- 647
IEY+H+ ++HRD+K NILL + D+G ++ + E +
Sbjct: 120 HKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIF-KKLEEEDLLDIDV 175
Query: 648 ------------PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
P K GT Y+ PE + +D+Y LGV+L ++LT
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 53/185 (28%), Positives = 80/185 (43%), Gaps = 39/185 (21%)
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESER--DFR-PM 649
ARG+E+L A IHRD+ + NILL ++ DFGL+ P+ R D R P+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
K ++ PE V T +SDV+ GV+L E+ + G +P V
Sbjct: 240 K------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS----------LGASPYPGVQ--- 280
Query: 710 PAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
+ E + L R+ PE E Y+ M C + ++RPT +++V L
Sbjct: 281 ---IDEEFCRRLKEGTRMRAPEYATPE-----IYSIMLDCWHNNPEDRPTFSELVEILGD 332
Query: 767 ALDIC 771
L
Sbjct: 333 LLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE-VAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
N F + +G G++GVV K + + +E VAIK+ + ++ + + KE+ EL L L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTL-RELKMLRTLK 58
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARG-----IEYLHNYAV 607
+++V L + + LV++Y++ L N V R I+ +H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY----- 662
I+HRDIK N+L+ ++ DFG + E + + T Y PE
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAP 177
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGK 688
YG V D++ +G +L EL G+
Sbjct: 178 YGKAV-----DMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 38/165 (23%)
Query: 502 IGAGSFGVV---YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHL 556
IG+G+ G+V Y GQ VAIK+ ++ FQ A + EL + ++HK++
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKK----LSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 557 VRLVG-YCEEK--DERLLVYDYMKNGALYDH-LHDRNNVEKNAAR----------GIEYL 602
+ L+ + +K +E VY M+ L D L ++ + R GI++L
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVME---LMDANLCQVIQMDLDHERMSYLLYQMLCGIKHL 134
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-------MMGP 640
H+ IIHRD+K SNI++ + T ++ DFGL+ MM P
Sbjct: 135 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 39/139 (28%), Positives = 66/139 (47%), Gaps = 26/139 (18%)
Query: 502 IGAGSFGVVYKGK---LPDGQEVAIKRGETAKTKKFQEK------ESAFDSELAFLSRLH 552
+G G+F ++KG + D E+ +T K +K ES F++ + +S+L
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELH----KTEVLLKVLDKSHRNYSESFFEAA-SMMSQLS 57
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLH 603
HKHLV G C DE ++V +Y+K G+L +L N V K A + +L
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE 117
Query: 604 NYAVPPIIHRDIKSSNILL 622
+ + H ++ + N+LL
Sbjct: 118 DKG---LTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 63/233 (27%), Positives = 101/233 (43%), Gaps = 54/233 (23%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV----------AIKRGETAKTKKFQEKESAFDS 543
++F + IG G+FG V K+ + +V +KR ETA + +E++ +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFR--EERDVLVNG 58
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNG---ALYDHLHDRNNVEKNAAR-- 597
+ +++ LH Y + + L LV DY G L DR + ++ AR
Sbjct: 59 DRRWITNLH---------YAFQDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFY 107
Query: 598 ------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA 651
I+ +H +HRDIK N+LLD R++DFG S + ++ + A
Sbjct: 108 LAEMVLAIDSVHQLGY---VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVA 163
Query: 652 AGTVGYIDPEYYGLNVLTAKSD---VYG-------LGVVLLELLTGKRAIFKD 694
GT YI PE +L A D YG LGV + E+L G+ + +
Sbjct: 164 VGTPDYISPE-----ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 35/264 (13%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G+ G VYK L + +A+K T + Q++ SEL L + +++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQ---IMSELEILYKCDSPYIIGFY 65
Query: 561 GYCEEKDERLLVYDYMKNGAL--YDHL--HDRNNVEKNAARGIEYLHNYAVPPIIHRDIK 616
G ++ + ++M G+L Y + H + +G+ YL + I+HRD+K
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVK 122
Query: 617 SSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYG 676
SN+L++ + ++ DFG+S S GT Y+ PE SDV+
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWS 178
Query: 677 LGVVLLELLTGK---RAIFKDDESGGTPVSLVDFAVPAIMAGELVK-ILDRRVGPPEINE 732
LG+ +EL G+ I K+ S +M +L++ I+D PP +
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGS--------------LMPLQLLQCIVDE--DPPVLPV 222
Query: 733 AEAVELVAYTAMHCVNLEGKERPT 756
+ E + C+ + KERP
Sbjct: 223 GQFSEKFVHFITQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++F +++GAG+ GVV K + P G +A K + + EL L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ---IIRELQVLHECN 61
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN--------AARGIEYLHN 604
++V G E + ++M G+L L + + + RG+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
I+HRD+K SNIL++++ ++ DFG+S +S + GT Y+ PE
Sbjct: 122 KH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQ 175
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAI 691
+ +SD++ +G+ L+EL G+ I
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 500 NKIGAGSFGVVYKG--KLPDG----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+K+G G++ V+KG KL + +E+ ++ E A +E ++ L L H
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE--------VSLLKNLKH 62
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNG--ALYDH---LHDRNNVEK---NAARGIEYLHNY 605
++V L + LV++Y+ + D+ L +NV+ RG+ Y H
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-YYG 664
I+HRD+K N+L++ + +++DFGL+ + + T+ Y P+ G
Sbjct: 123 K---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS--NEVVTLWYRPPDVLLG 177
Query: 665 LNVLTAKSDVYGLGVVLLELLTGK 688
+ D++G+G +L E+ TG+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 59/223 (26%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS---ELAFLSRLHHKH 555
+++G G++G VYK P G +A+K + + ES F+ EL L + +
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKE------IRLELDESKFNQIIMELDILHKAVSPY 60
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGA---LYDHLHDRNNVEKNAARGIEYL---------- 602
+V G + + +YM G+ LY + ++ R I Y
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL----------------SMMGPESERD 645
HN IIHRD+K +N+L++ ++ DFG+ S M PE +
Sbjct: 121 EHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKS 175
Query: 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
P + P Y T +SDV+ LG+ +LE+ G+
Sbjct: 176 GGPNQN--------PTY------TVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 5e-07
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 52/215 (24%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHLVR 558
+G+G++G V G++VAIK+ ++ FQ A + EL L + H++++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKK----LSRPFQSAIHAKRTYRELRLLKHMDHENVIG 78
Query: 559 LVG-YC-----EEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA--------------RG 598
L+ + E+ + LV M GA D NN+ K RG
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLM--GA------DLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG-- 656
++Y+H+ IIHRD+K SNI ++ ++ DFGL+ + + G V
Sbjct: 131 LKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD--------EMTGYVATR 179
Query: 657 -YIDPEYYGLNVL--TAKSDVYGLGVVLLELLTGK 688
Y PE LN + D++ +G ++ ELLTGK
Sbjct: 180 WYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 17/194 (8%)
Query: 513 GKLPDGQEVAIKRGETAKTK---KF----QEKESAF-DSELAFLSRLHHKHLVRLVGYCE 564
G+ P RG K K KF E+++A+ SEL L+ H +V+ +
Sbjct: 76 GRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK 135
Query: 565 EKDERLLVYDYMKNGALYDHLHDRNNVE---KNAARGIEY------LHNYAVPPIIHRDI 615
D+ LL+ +Y G L + R + G+ + L ++HRD+
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195
Query: 616 KSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVY 675
KS+NI L ++ DFG S +S GT Y+ PE + + K+D++
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255
Query: 676 GLGVVLLELLTGKR 689
LGV+L ELLT R
Sbjct: 256 SLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 31/206 (15%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHLVR 558
IG G++G+V K + ++VAIK+ A F + A + E+ L L H++++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA----FDNRIDAKRTLREIKLLRHLDHENVIA 68
Query: 559 LVGYCEEKDER-----LLVYDYM---------KNGALYDHLHDRNNVEKNAARGIEYLHN 604
+ +VY+ M + L D H + + + RG++Y+H+
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDD-HCQYFLYQ-LLRGLKYIHS 126
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
++HRD+K SN+LL+A ++ DFGL+ E DF + T Y PE
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG-DFM-TEYVVTRWYRAPELL- 180
Query: 665 LNV--LTAKSDVYGLGVVLLELLTGK 688
LN T DV+ +G + ELL K
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 501 KIGAGSFGVVYKGKLPDG---QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
K+G G++G VYK K DG +E A+K+ E + E+A L L H +++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR------EIALLRELKHPNVI 61
Query: 558 RLVG-YCEEKDERL-LVYDYMKNGALY-DHLHDRNNVEKNAAR---------------GI 599
L + D ++ L++DY ++ + H + K + GI
Sbjct: 62 ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 600 EYLH-NYAVPPIIHRDIKSSNILLDAQWTAR----VSDFGLSMMGPESER---DFRPMKA 651
YLH N+ ++HRD+K +NIL+ + R ++D G + + + D P+
Sbjct: 122 HYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 652 AGTVGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGK 688
T Y PE G T D++ +G + ELLT +
Sbjct: 178 --TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 501 KIGAGSFGVVYKGKLPDG---QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
K+G G++G VYK K DG ++ A+K+ E + E+A L L H +++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR------EIALLRELKHPNVI 61
Query: 558 RLVG-YCEEKDERL-LVYDYMKNGALY-DHLHDRNNVEKNAAR---------------GI 599
L + D ++ L++DY ++ + H + K + GI
Sbjct: 62 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 600 EYLH-NYAVPPIIHRDIKSSNILLDAQWTAR----VSDFGLSMMGPESER---DFRPMKA 651
YLH N+ ++HRD+K +NIL+ + R ++D G + + + D P+
Sbjct: 122 HYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 652 AGTVGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGK 688
T Y PE G T D++ +G + ELLT +
Sbjct: 178 --TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 18/143 (12%)
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYA 606
++V L Y +D LV + + G L+ H+ N+ + + ++ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFG-LSMMGPESERDFRPMKAAGTVGYIDPEYYGL 665
I+ RD+ +NILLD + +++ F S + + + A Y PE G+
Sbjct: 106 ---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE------AVENMYCAPEVGGI 156
Query: 666 NVLTAKSDVYGLGVVLLELLTGK 688
+ T D + LG +L ELLTGK
Sbjct: 157 SEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 8e-07
Identities = 56/224 (25%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 495 NFSLENKIGAGSFGVVYKGK---LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ L ++G G++G+V + + + VAIK+ +KK K + EL L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL--RELKLLRHF 58
Query: 552 H-HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRNNVEKNAAR----------- 597
HK++ L D ++ LY+ L D + + ++
Sbjct: 59 RGHKNITCLY------DMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY 112
Query: 598 ----GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM---MGPESERDFRPMK 650
G++Y+H+ V +HRD+K N+L++A ++ DFGL+ P F
Sbjct: 113 QILCGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169
Query: 651 AAGTVGYIDPEYYGLNVLTAKS-DVYGLGVVLLELLTGKRAIFK 693
A T Y PE K+ DV+ +G +L ELL G++ +FK
Sbjct: 170 VA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK 211
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 59/239 (24%), Positives = 98/239 (41%), Gaps = 52/239 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++F IG G+FG V + D G A+K A + +E+ + +E L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE-KEQVAHIRAERDILVEAD 59
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
+V++ ++K L+ +++ G + L ++ + + A + I+ +H
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---------------MMGPESERDFRPM 649
IHRDIK N+LLDA+ ++SDFGL P S+ F+ M
Sbjct: 120 LG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 650 KA------------------AGTVGYIDPEYY---GLNVLTAKSDVYGLGVVLLELLTG 687
+ GT YI PE + G N L D + LGV++ E+L G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC---DWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 27/169 (15%)
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
ARG+E+L A IHRD+ + NILL ++ DFGL+ + R A +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
++ PE V T +SDV+ GV+L E+ + G +P P +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS----------LGASP-------YPGVQIN 283
Query: 716 E--LVKILD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
E ++ D R+ PE E ++ + C + KERPT + +V
Sbjct: 284 EEFCQRLKDGTRMRAPENATPEIYRIM----LACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 33/212 (15%)
Query: 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKES---AFDSELAFLSRLHHKHLV 557
IG G+FGVV+ P DG+ VA+K+ FQ S F EL L H +++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNV----FQNLVSCKRVF-RELKMLCFFKHDNVL 62
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA--------------RGIEYLH 603
+ + Y+ + LH + RG++YLH
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQSDLH--KIIVSPQPLSSDHVKVFLYQILRGLKYLH 120
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYIDPE- 661
+ I+HRDIK N+L+++ ++ DFGL+ + E + + M T Y PE
Sbjct: 121 SAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV--EEPDESKHMTQEVVTQYYRAPEI 175
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
G T+ D++ +G + ELL G+R +F+
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELL-GRRILFQ 206
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 43/215 (20%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHLVR 558
IG+G+ G+V G VA+K+ ++ FQ + A + EL L ++HK+++
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKK----LSRPFQNQTHAKRAYRELVLLKCVNHKNIIS 84
Query: 559 LVGY------CEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR------GIEYLHNYA 606
L+ EE + LV + M + L +H + E+ + GI++LH+
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG 143
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLS-------MMGPE-SERDFRPMKAAGTVGYI 658
IIHRD+K SNI++ + T ++ DFGL+ MM P R +R + +GY
Sbjct: 144 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK 200
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
+ NV D++ +G ++ EL+ G IF+
Sbjct: 201 E------NV-----DIWSVGCIMGELVKGS-VIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-06
Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 43/238 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
N + + KIG G FG V+ K QE + + + K +EK S E+ + L H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVMRELKH 71
Query: 554 KHLVRLVG-YCEEKDERL-LVYDYMKNGALYDHL------------HDRNNVEKNAARGI 599
K++VR + + + +++L ++ ++ G L ++ H ++ + +
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 600 EYLHNYAVPP----IIHRDIKSSNILL-----------------DAQWTARVSDFGLSM- 637
Y HN P ++HRD+K NI L + + A++ DFGLS
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 638 MGPESERDFRPMKAAGTVGYIDPEY--YGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
+G ES GT Y PE + KSD++ LG ++ EL +GK K
Sbjct: 192 IGIES----MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
|
Length = 1021 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 494 NNFSLENKIGAGSFGVVYK-GKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++F +++GAG+ GVV+K P G +A K + + EL L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ---IIRELQVLHECN 61
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN--------AARGIEYLHN 604
++V G E + ++M G+L L + + +G+ YL
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
I+HRD+K SNIL++++ ++ DFG+S +S + GT Y+ PE
Sbjct: 122 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQ 175
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAI 691
+ +SD++ +G+ L+E+ G+ I
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 501 KIGAGSFGVVYKGKLPDG---QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
+IG G FG V G++ G +V +K + + + Q K F E L H +L+
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK---FLEEAQPYRSLQHSNLL 58
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA-------------ARGIEYLH- 603
+ +G C E LLV ++ G L +L E A G+ +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 604 -NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
N+ IH D+ N LL A T ++ D+GLS + + P + + +I PE
Sbjct: 119 NNF-----IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 663 ----YGLNVL----TAKSDVYGLGVVLLELL 685
+G N+L T +S+V+ LGV + EL
Sbjct: 174 VDEVHG-NLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 38/230 (16%)
Query: 505 GSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564
+ K K P VA+K+ +E E+ +L H +++ V
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKK--INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69
Query: 565 EKDERLLVYDYMKNGALYDHLHDRNNVE-----------KNAARGIEYLHNYAVPPIIHR 613
E +V M G+ D L + E K+ ++Y+H+ IHR
Sbjct: 70 VDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHR 125
Query: 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------PMKAAGTVGYIDPEYYGLN 666
+K+S+ILL +S GL + R P + + ++ PE N
Sbjct: 126 SVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQN 183
Query: 667 VL--TAKSDVYGLGVVLLELLTGKRAIFKDDES--------GGTPVSLVD 706
+ KSD+Y +G+ EL G FKD + GT L+D
Sbjct: 184 LQGYNEKSDIYSVGITACELANG-HVPFKDMPATQMLLEKVRGTVPCLLD 232
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 25/171 (14%)
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
A+G+E+L A IHRD+ + NILL ++ DFGL+ + R A +
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
++ PE V T +SDV+ GV+L E+ + G +P V +
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----------LGASPYPGVK------IDE 289
Query: 716 ELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764
E + L R+ P+ E + T + C + E +RPT +++V +L
Sbjct: 290 EFCRRLKEGTRMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 55/220 (25%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHLVR 558
+G+G++G V G VA+K+ ++ FQ A + EL L + H++++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKK----LSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80
Query: 559 LVGY------CEEKDERLLVYDYMKNGALYDHLHDRNNVEK--------------NAARG 598
L+ EE ++ LV M GA D NN+ K RG
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLM--GA------DLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
++Y+H+ IIHRD+K SN+ ++ ++ DFGL+ + + T Y
Sbjct: 133 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-----VATRWYR 184
Query: 659 DPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
PE +Y V D++ +G ++ ELLTG R +F
Sbjct: 185 APEIMLNWMHYNQTV-----DIWSVGCIMAELLTG-RTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 46/228 (20%)
Query: 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
IG G+FG V + D G A+K A + +E+ +E L +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMF 67
Query: 561 GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPIIH 612
++K L+ +++ G + L ++ + + + I+ +H IH
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIH 124
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESER-------------DF------------- 646
RDIK N+LLD++ ++SDFGL ++ R DF
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 647 ----RPMKAAGTVG---YIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
R A TVG YI PE + D + LGV++ E+L G
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 59/215 (27%), Positives = 88/215 (40%), Gaps = 47/215 (21%)
Query: 563 CEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL 622
EE E D L D L + V A+G+++L A IHRD+ + N+LL
Sbjct: 199 DEEDTEDSWPLD------LDDLLRFSSQV----AQGMDFL---ASKNCIHRDVAARNVLL 245
Query: 623 DAQWTARVSDFGLSMMGPESERDFR-------PMKAAGTVGYIDPEYYGLNVLTAKSDVY 675
A++ DFGL+ RD A V ++ PE V T +SDV+
Sbjct: 246 TDGRVAKICDFGLA-------RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVW 298
Query: 676 GLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEA 735
G++L E+ + ++ + P LV+ M ++ PPEI
Sbjct: 299 SYGILLWEIFSLGKSPY--------PGILVNSKFYK-MVKRGYQMSRPDFAPPEI----- 344
Query: 736 VELVAYTAMH-CVNLEGKERPTMADIVANLERALD 769
Y+ M C NLE ERPT + I ++R L
Sbjct: 345 -----YSIMKMCWNLEPTERPTFSQISQLIQRQLG 374
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 44/215 (20%)
Query: 502 IGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEK---ESAFDSELAFLSRLHHKHLV 557
+G+G++G V G++VAIK+ ++ FQ + + A+ EL L + H++++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKK----LSRPFQSEIFAKRAY-RELTLLKHMQHENVI 77
Query: 558 RL-------VGYCEEKDERLLVYDYMKN--GALYDHLHDRNNVE---KNAARGIEYLHNY 605
L V E +D LV YM+ + H + V+ G++Y+H+
Sbjct: 78 GLLDVFTSAVSGDEFQD-FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSA 136
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG- 664
IIHRD+K N+ ++ ++ DFGL+ R A T GY+ +Y
Sbjct: 137 G---IIHRDLKPGNLAVNEDCELKILDFGLA----------RHADAEMT-GYVVTRWYRA 182
Query: 665 ----LNVL--TAKSDVYGLGVVLLELLTGKRAIFK 693
LN + D++ +G ++ E+LTGK +FK
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK-TLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 55/226 (24%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD--SELAFLSRLH 552
+ ++ IG GS+GVV G++VAIK+ F+ A E+ L L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV----FEHVSDATRILREIKLLRLLR 57
Query: 553 HKHLVRLVGYCEEKDER-----LLVYDYMKNGALYDHLHD--RNNVEKNAA--------- 596
H +V + R +V++ M++ LH + N +
Sbjct: 58 HPDIVEIKHIMLPPSRREFKDIYVVFELMES-----DLHQVIKANDDLTPEHHQFFLYQL 112
Query: 597 -RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM--KAAG 653
R ++Y+H V HRD+K NIL +A ++ DFGL+ R
Sbjct: 113 LRALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLA----------RVAFNDTPT 159
Query: 654 TVGYID---------PEYYG--LNVLTAKSDVYGLGVVLLELLTGK 688
+ + D PE G + T D++ +G + E+LTGK
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 501 KIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESA-FDS--ELAFLSRLHHKHL 556
K+G GS+ VYKG+ GQ VA+K + + +E A F + E + L L H ++
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 557 VRLVGYCEEKDERLLVYDYM-KNGALYDHLH----DRNNVEK---NAARGIEYLHNYAVP 608
V L K LV++Y+ + Y +NV RG+ Y H
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR-- 123
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-YYGLNV 667
++HRD+K N+L+ + +++DFGL+ + + T+ Y P+ G
Sbjct: 124 -VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS--NEVVTLWYRPPDVLLGSTE 180
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIF 692
+ D++G+G + E+ TG R +F
Sbjct: 181 YSTSLDMWGVGCIFYEMATG-RPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 47/217 (21%)
Query: 502 IGAGSFGVV-YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHLVR 558
+G+G++G V G +VAIK+ + FQ + A + EL L + H++++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKK----LYRPFQSELFAKRAYRELRLLKHMKHENVIG 78
Query: 559 LVGYCEEKDERL-------LVYDYMKN--GALYDHLHDRNNVEK------NAARGIEYLH 603
L+ D L LV +M G L H ++ + ++ +G++Y+H
Sbjct: 79 LLDVFT-PDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH 135
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
IIHRD+K N+ ++ ++ DFGL+ +SE GY+ +Y
Sbjct: 136 AAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT-DSE----------MTGYVVTRWY 181
Query: 664 G-----LNVL--TAKSDVYGLGVVLLELLTGKRAIFK 693
LN + T D++ +G ++ E+LTGK +FK
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFK 217
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 59/223 (26%), Positives = 89/223 (39%), Gaps = 41/223 (18%)
Query: 496 FSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
F++ + GS G V++ PD Q V +K G A + E L RL H
Sbjct: 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVH----------EARLLRRLSHP 220
Query: 555 HL-----VRLVG--YCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARG 598
+ VR+VG C L++ Y + LY +L R V +
Sbjct: 221 AVLALLDVRVVGGLTC------LVLPKYRSD--LYTYLGARLRPLGLAQVTAVARQLLSA 272
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
I+Y+H IIHRDIK+ N+L++ + DFG + S AGTV
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIF---KDDESG 698
PE + T D++ G+V+ E ++F + DE
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR 372
|
Length = 461 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 58/218 (26%)
Query: 502 IGAGSFGVV---YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHL 556
IG+G+ G+V Y L + VAIK+ ++ FQ + A + EL + ++HK++
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKK----LSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 557 VRLVG-YCEEK--DERLLVYDYMKNGALYDHLHDRN-----NVEKNAAR----------G 598
+ L+ + +K +E VY M+ L D N +E + R G
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVME-------LMDANLCQVIQMELDHERMSYLLYQMLCG 138
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-------MMGPE-SERDFRPMK 650
I++LH+ IIHRD+K SNI++ + T ++ DFGL+ MM P R +R +
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 195
Query: 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
+GY + NV D++ +G ++ E++ G
Sbjct: 196 VILGMGYKE------NV-----DIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 58/240 (24%), Positives = 93/240 (38%), Gaps = 56/240 (23%)
Query: 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVG 561
+G G+FG V + D + + + K + + + +E L+ ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 562 YCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPIIHR 613
++KD V DY+ G + L ++ AR +E +H IHR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHR 125
Query: 614 DIKSSNILLDAQWTARVSDFGL----------------------SM------MGPESER- 644
DIK NIL+D +++DFGL SM P + R
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185
Query: 645 --DFRPM--KAA------------GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
+P+ +AA GT YI PE T D + +GV+L E+L G+
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 40/166 (24%), Positives = 62/166 (37%), Gaps = 46/166 (27%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+F L K+G G+FGVVYK L + Q K+ KK E + E+ R+
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQS---KKEGKYVLKKATEYGAV---EIWMNERVRRA 186
Query: 555 HLVRLVGYC---------EEKDERLLVYDYMKNGALYDHLHDRN---NVEK-------NA 595
+ +++DE LV+ Y L D + + NVE +
Sbjct: 187 CPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDL 246
Query: 596 ARGIEY------------------LHNYAVPPIIHRDIKSSNILLD 623
+G+E LH+ I+HRD+K NI+
Sbjct: 247 PKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFS 289
|
Length = 566 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 37/181 (20%)
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------P 648
A+G+ +L A IHRD+ + NILL ++ DFGL+ RD R
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA-------RDIRNDSNYVVK 273
Query: 649 MKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708
A V ++ PE V T +SDV+ G++L E+ + + + G PV +
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP-----GMPVDSKFYK 328
Query: 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMH-CVNLEGKERPTMADIVANLERA 767
M E ++L P E+ Y M C + + +RPT IV +E+
Sbjct: 329 ----MIKEGYRMLSPECAPSEM----------YDIMKSCWDADPLKRPTFKQIVQLIEQQ 374
Query: 768 L 768
L
Sbjct: 375 L 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 48/222 (21%)
Query: 501 KIGAGSFGVVYKGK-LPDGQE-VAIKRGETAKTKKFQEKESAFD----SELAFLSRLH-- 552
+IG G++G V+K + L +G VA+KR + Q E E+A L L
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKR------VRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 553 -HKHLVRLVGYCE----EKDERL-LVYDYMKNGALYDHLHDR----------NNVEKNAA 596
H ++VRL C +++ +L LV++++ L +L ++
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG 656
RG+++LH++ V +HRD+K NIL+ + +++DFGL+ + + A T
Sbjct: 121 RGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARI--------YSFQMALTSV 169
Query: 657 YIDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGKRAIFK 693
+ Y VL S D++ +G + E+ ++ +F+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 36/178 (20%)
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT- 654
ARG+E+L A +HRD+ + N+LL ++ DFGL+ + D + T
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR---DIMHDSNYVSKGSTF 300
Query: 655 --VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDFAV- 709
V ++ PE N+ T SDV+ G++L E+ + GGTP +VD
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS----------LGGTPYPGMIVDSTFY 350
Query: 710 PAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT---MADIVANL 764
I +G R+ P+ E +++ + C N E ++RP+ ++DIV +L
Sbjct: 351 NKIKSG-------YRMAKPDHATQEVYDIM----VKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 24/172 (13%)
Query: 494 NNFSLENKIGAGSFGVVYK------GKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAF 547
+N +GAG+FG V + GK + VA+K K ++ A SEL
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK---MLKASAHTDEREALMSELKI 94
Query: 548 LSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNY- 605
LS L HK++V L+G C L++ +Y G L + L + E N+
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR----------KKAETFLNFV 144
Query: 606 -AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG 656
A+P I NI L+ ++ SD G S G ++ + RP+ ++ +
Sbjct: 145 MALPEISETSSDYKNITLEKKYIR--SDSGFSSQGSDTYVEMRPVSSSSSQS 194
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 494 NNFSLENKIGAGSFGVV-YKGKLPDGQEVAIKRGETAKTKKFQEKESA-FDSELAFLSRL 551
+F IG G+FG V K G+ A+K K++ F++ + A +E L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAES 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
+V L ++ L+ +++ G L L + ++ R IE +H
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637
IHRDIK NIL+D ++SDFGLS
Sbjct: 119 KLG---FIHRDIKPDNILIDRGGHIKLSDFGLST 149
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 17/152 (11%)
Query: 496 FSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAK--TKKFQEKESAFDSELAFLSRLH 552
F + I G+FG VY G K + + A+K + A K + A LA LS+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSK-- 62
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH-----DRNNVEK---NAARGIEYLHN 604
+V L + + LV +Y+ G + LH D K A ++YLH
Sbjct: 63 SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636
+ IIHRD+K N+L+ + +++DFGLS
Sbjct: 123 HG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 28/144 (19%), Positives = 56/144 (38%), Gaps = 10/144 (6%)
Query: 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV-RL 559
+ G VY D + +K + + +E+E A L L+R V ++
Sbjct: 5 LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREVAI---LQLLAR--KGLPVPKV 58
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE--KNAARGIEYLHNYAVPPIIHRDIKS 617
+ E L+ ++++ G D + + + + A + LH + + H D+
Sbjct: 59 LASGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHP 117
Query: 618 SNILLDAQWTARVSDFGLSMMGPE 641
NIL+D + D+ + GP
Sbjct: 118 GNILVDDGKILGIIDWEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 7e-05
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 44/211 (20%)
Query: 502 IGAGSFGVV---YKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLSRLHHKHL 556
IG+G+ G+V Y L + VAIK+ ++ FQ + A + EL + ++HK++
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKK----LSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 557 VRLVGY------CEEKDERLLVYDYMKNGAL----YDHLHDR-NNVEKNAARGIEYLHNY 605
+ L+ EE + LV + M + H+R + + GI++LH+
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLS-------MMGPE-SERDFRPMKAAGTVGY 657
IIHRD+K SNI++ + T ++ DFGL+ MM P R +R + +GY
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ NV D++ +G ++ E++ K
Sbjct: 196 KE------NV-----DIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGLS-MMGPESERDFRPMKAAGT 654
RG++Y+H+ V +HRD+K +N+ ++ ++ DFGL+ ++ P + T
Sbjct: 125 RGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 655 VGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGK 688
Y P N T D++ G + E+LTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|205718 pfam13540, RCC1_2, Regulator of chromosome condensation (RCC1) repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 1e-04
Identities = 14/28 (50%), Positives = 17/28 (60%)
Query: 203 SITAGGNHVCGIDSNGFVICYGDNKSGQ 230
SI AG H + S+G V C+GDN GQ
Sbjct: 3 SIAAGDYHTLALTSDGTVYCWGDNSYGQ 30
|
Length = 30 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 58/222 (26%)
Query: 501 KIGAGSFGVVYKGKL---PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR------L 551
+IG G FG V ++ V +K + + K Q + FL + L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNE---------FLQQGDPYRIL 52
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ARGI 599
H ++++ +G C E LLV++Y + G L +L +N+ A G+
Sbjct: 53 QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP--------ESERD-FRPMK 650
++H + +H D+ N L + T +V D+G+ GP E+E D P++
Sbjct: 113 THMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI---GPSRYKEDYIETEDDKCVPLR 166
Query: 651 AAGTVGYIDPEYYGL---NVLTAK----SDVYGLGVVLLELL 685
++ PE G ++TA+ S+V+ LGV L EL
Sbjct: 167 ------WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 54/183 (29%), Positives = 85/183 (46%), Gaps = 29/183 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGK---LPDGQ---EVAIKRGETAKTKKFQEKESAFDSELAF 547
+N L +G+G+FG V + L Q +VA+K ++ T + EK+ A SEL
Sbjct: 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKS--TARSSEKQ-ALMSELKI 93
Query: 548 LSRLH-HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-------VEKNAARGI 599
+S L H ++V L+G C + ++ +Y + G L D+LH RN ++KN G
Sbjct: 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH-RNKHTFLQYYLDKNRDDGS 152
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYI 658
P+ R S++ L ++ SD G M + D+ PM+ GTV Y
Sbjct: 153 LISGG--STPLSQR---KSHVSLGSE-----SDGGYMDMSKDESADYVPMQDMKGTVKYA 202
Query: 659 DPE 661
D E
Sbjct: 203 DIE 205
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 11/23 (47%), Positives = 15/23 (65%)
Query: 502 IGAGSFGVVYKGKLPDGQEVAIK 524
I A S V++ L DG+EVA+K
Sbjct: 19 IAAASIAQVHRAVLKDGEEVAVK 41
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 42/118 (35%), Positives = 60/118 (50%), Gaps = 23/118 (19%)
Query: 590 NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM------GPESE 643
N+ A RG+ YLH IHR+IK+S+IL+ VS GLS + G +++
Sbjct: 105 NILFGALRGLNYLHQNGY---IHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAK 159
Query: 644 --RDFRPMKAAGTVGYIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694
DF P + + ++ PE YG NV KSD+Y +G+ EL TG R F+D
Sbjct: 160 VVYDF-PQFSTSVLPWLSPELLRQDLYGYNV---KSDIYSVGITACELATG-RVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 40/145 (27%), Positives = 62/145 (42%), Gaps = 17/145 (11%)
Query: 502 IGAGSFG-VVYKGKLPDGQEVAIKRGETAKTKKFQEKESA--FDSELAFLSRLHHKHLVR 558
+G G+FG V K+ A+K T + K + +E L+ ++ +V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMK---TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPI 610
L ++KD V DY+ G + L + AR IE +H
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---F 122
Query: 611 IHRDIKSSNILLDAQWTARVSDFGL 635
IHRDIK NIL+D +++DFGL
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 19/113 (16%), Positives = 38/113 (33%), Gaps = 10/113 (8%)
Query: 535 QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY-MKNGALYDHLHDRNNVEK 593
E+ + ++ L+RLH + RL + + + +
Sbjct: 89 AERGALLEALARLLARLHS-VPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAE 147
Query: 594 NAARGIEYLHNYAVPP---IIHRDIKSSNILLDAQWTARVS---DFGLSMMGP 640
R + L ++H D+ N+L+D RV+ DF + +G
Sbjct: 148 LWERLLAALLALLPALPLVLVHGDLHPGNLLVDPGG--RVTGVIDFEDAGLGD 198
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 31/115 (26%)
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD---------F 646
A G+E+L A +HRD+ + N+L+ ++ DFGL+ + RD F
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR---DIMRDSNYISKGSTF 302
Query: 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP 701
P+K ++ PE N+ T SDV+ G++L E+ T GGTP
Sbjct: 303 LPLK------WMAPESIFNNLYTTLSDVWSFGILLWEIFT----------LGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 21/139 (15%)
Query: 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEK---ESAFDSELAF------LSRLH 552
+G G+ +Y G L + K K K S D LAF + ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLH 603
HKH+V L G C E ++V ++++ G L +H ++ V K A + YL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE 122
Query: 604 NYAVPPIIHRDIKSSNILL 622
+ ++H ++ + NILL
Sbjct: 123 D---KDLVHGNVCTKNILL 138
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 53/243 (21%), Positives = 96/243 (39%), Gaps = 49/243 (20%)
Query: 540 AFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGAL-----YDHLHD----RNN 590
AF + +S++ H HL + G C E ++V +++++G L + +
Sbjct: 62 AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT 121
Query: 591 VEKNAARGIEYLHNYAVPPIIHRDIKSSNILL-------DAQWTARVSDFGLSMMG-PES 642
V + A + YL + ++H ++ + NILL ++SD G+S
Sbjct: 122 VAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE 178
Query: 643 ERDFRPMKAAGTVGYIDPE-YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP 701
ER R + +I PE G N L+ +D + G LLE+ K TP
Sbjct: 179 ERVER-------IPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK----ERTP 227
Query: 702 VSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
E + +++ PE + E L++ C+ E +RP+ I+
Sbjct: 228 -------------SEKERFYEKKHRLPEPSCKELATLIS----QCLTYEPTQRPSFRTIL 270
Query: 762 ANL 764
+L
Sbjct: 271 RDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 789 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.71 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.16 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.7 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 98.56 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 98.56 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.48 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.28 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 98.18 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.86 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.79 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.69 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.48 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.44 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.25 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.25 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.02 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.01 | |
| PLN02236 | 344 | choline kinase | 96.74 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.45 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.22 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.19 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.13 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.71 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=427.45 Aligned_cols=282 Identities=48% Similarity=0.775 Sum_probs=240.7
Q ss_pred hHHHHHHHHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEE
Q 045256 480 RAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559 (789)
Q Consensus 480 ~~~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 559 (789)
....|.+.++..++++|....+||+|+||.||+|.+.+++.||||++....... ..+|.+|++++.+++|||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccE
Confidence 345789999999999999999999999999999999999999999865543321 2349999999999999999999
Q ss_pred EEEEEeCC-eEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcE
Q 045256 560 VGYCEEKD-ERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA 628 (789)
Q Consensus 560 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 628 (789)
+|||.+.+ +.+||||||++|+|.++|+.+ .+|+.++|+||+|||+...|+|+||||||+|||||+++++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999998 499999999999999998753 4899999999999999988899999999999999999999
Q ss_pred EEEeeccCcCCCC-CCCCCccccc-ccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 629 RVSDFGLSMMGPE-SERDFRPMKA-AGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 629 kl~DfGls~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
||+|||+++..+. .... ... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.....+ .....+++
T Consensus 217 KlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~ 291 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVE 291 (361)
T ss_pred EccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHH
Confidence 9999999977554 2211 122 799999999999999999999999999999999999988765432 22334788
Q ss_pred chhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
|..+.+....+.+++|.++........+....+..++.+|++.+|++||+|.||+++|+.+...
T Consensus 292 w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 292 WAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 8888888889999999998743333225566678899999999999999999999999776544
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=389.58 Aligned_cols=394 Identities=22% Similarity=0.351 Sum_probs=257.1
Q ss_pred CCCcccccccCCC---cccCCCCC-CCCCCCCCccCC--CcccccCCccccCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q 045256 312 SNDSVSLVPFQQE---ILPGPCDN-SSCSECGLYPQS--DRLCFGNGNICKSCQNVVPTPSAPPPSVEPPRSSSSPSREL 385 (789)
Q Consensus 312 ~~~~~~~~~~~~~---~~~~~C~~-~~c~~~~~~p~~--~~~C~~~~~~C~~c~~~~p~~~~~~p~~~p~~~~~~~~~~~ 385 (789)
..+.+..++++|| ..+.+|.+ .+|......|.. ..+|||.++.|+......+++.++..+..|.. . ....
T Consensus 76 t~~~~~~v~qGC~~~~~D~~~c~~~~eCv~s~~~~~g~t~~~CcCs~~~CN~n~s~~~~~~~~~t~~~~~~-~---~~~~ 151 (534)
T KOG3653|consen 76 TSGTIEVVKQGCWSHITDDINCEDSSECVVSAEPPPGQTLYFCCCSTDFCNANFSHLPPPGPEGTPSSPDL-A---TNDG 151 (534)
T ss_pred cCCceeEEeecCccccCCccccccccccccCCCCCCCCeEEEEecCCCcccCCccccCCCCCCCCCCCCCc-c---cccC
Confidence 4456889999999 56888974 799887666664 78999999999886655444421110001110 0 1111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhheeeeeeeecccccccCCCCCccccCCCCCCCCCCCCCCCCCCCCcccccccCccchh
Q 045256 386 TRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLT 465 (789)
Q Consensus 386 ~~~~i~~iiv~~v~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (789)
....++++..+.++++++|++.+++.|+.++..|.+......+....+ . +++ +.+..
T Consensus 152 ~~~~~al~~~~~v~~l~~lvi~~~~~~r~~k~~~~~~e~~~~p~~d~~-----------~---~~s---------spl~~ 208 (534)
T KOG3653|consen 152 EVLIYALIPLLLVSLLAALVILAFLGYRQRKNAREEIEPVLIPLEDSG-----------P---APS---------SPLLE 208 (534)
T ss_pred ceehhhHHHHHHHHHHHHHHHHHHHHHHHhhcccccCccCcccCCCCC-----------C---CCC---------ccccc
Confidence 112233333334444444444444444322211211111111111000 0 000 00000
Q ss_pred hhcccCCCCCcchhhHHHHHHHHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHH
Q 045256 466 MRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSEL 545 (789)
Q Consensus 466 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~ 545 (789)
....++.++||+|+||.||||.+ +++.||||++..... +.|.+|-
T Consensus 209 ---------------------------l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~k-------qs~~~Ek 253 (534)
T KOG3653|consen 209 ---------------------------LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEK-------QSFQNEK 253 (534)
T ss_pred ---------------------------CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHHHH-------HHHHhHH
Confidence 12334568899999999999999 459999999765433 2366666
Q ss_pred HHHh--hcCCCcceEEEEEEEeCC----eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcC------
Q 045256 546 AFLS--RLHHKHLVRLVGYCEEKD----ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYA------ 606 (789)
Q Consensus 546 ~~l~--~l~HpnIv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~------ 606 (789)
+|.+ .|+|+||++++++-.... +++||+||.+.|+|.++|... .+++..+++||+|||+..
T Consensus 254 ~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~ 333 (534)
T KOG3653|consen 254 NIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHH 333 (534)
T ss_pred HHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCC
Confidence 6665 458999999999876655 789999999999999999753 489999999999999743
Q ss_pred CCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCC-C-----chhHHHHHHHH
Q 045256 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL-T-----AKSDVYGLGVV 680 (789)
Q Consensus 607 ~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~sDv~SlGvi 680 (789)
+|+|+|||||++||||..|++..|+|||||..+............+||.+|||||++.+... . .+.||||+|+|
T Consensus 334 Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLV 413 (534)
T KOG3653|consen 334 KPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLV 413 (534)
T ss_pred CCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHH
Confidence 47899999999999999999999999999988766555555556899999999999965421 1 36899999999
Q ss_pred HHHHHcCCCCCCCCCCCCCcccccccchhhhh-----hhhhhHHhhcccCCCCCCC----HHHHHHHHHHHHHhhcCcCC
Q 045256 681 LLELLTGKRAIFKDDESGGTPVSLVDFAVPAI-----MAGELVKILDRRVGPPEIN----EAEAVELVAYTAMHCVNLEG 751 (789)
Q Consensus 681 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~d~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp 751 (789)
||||++....++. .+... ++.+.... ..+++.+.+-+....|... .......+.+.+..||+.||
T Consensus 414 LWEi~SRC~~~~~-~~vp~-----Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDa 487 (534)
T KOG3653|consen 414 LWEIASRCTDADP-GPVPE-----YQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDA 487 (534)
T ss_pred HHHHHhhcccccC-CCCCc-----ccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCch
Confidence 9999998766542 11111 11111100 1123333332222111111 12556778888999999999
Q ss_pred CCCCCHHHHHHHHHHHhhhccc
Q 045256 752 KERPTMADIVANLERALDICDH 773 (789)
Q Consensus 752 ~~RPt~~evl~~L~~~~~~~~~ 773 (789)
+.|.|+.=+.+++.++....+.
T Consensus 488 eARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 488 EARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hhhhhhHHHHHHHHHHhccCCc
Confidence 9999999999999998776654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=371.07 Aligned_cols=244 Identities=27% Similarity=0.371 Sum_probs=199.6
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-eEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-ERLLVY 573 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~ 573 (789)
++..+.||+|..|+|||++++ +++.+|+|.+..... .+..+++.+|++++++.+|||||.++|.|+.+. +..++|
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~---~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNID---PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCC---HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 344678999999999999976 688899999743322 345567999999999999999999999999999 599999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||++|+|.+++... .+++.++++||.|||+ .+ ||||||||+|||++..|++||+|||.+..+..+
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999998752 3688999999999996 55 999999999999999999999999999875544
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
...++.||..|||||.+.+..|+.++||||||+.|+|+.+|+.|+....+... + ..+-+..+++..
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~------~------~~~Ll~~Iv~~p 298 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL------D------IFELLCAIVDEP 298 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC------C------HHHHHHHHhcCC
Confidence 33467899999999999999999999999999999999999999865421100 1 112233444432
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+..+ .......++.++..||++||.+||+++|++++
T Consensus 299 pP~lP--~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 299 PPRLP--EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCC--cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22211 22467788899999999999999999999886
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=381.87 Aligned_cols=247 Identities=34% Similarity=0.496 Sum_probs=198.8
Q ss_pred cccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-eEEEEEEe
Q 045256 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-ERLLVYDY 575 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv~e~ 575 (789)
.+.+.||+|+||+||++.++....||||++......... .+.|.+|+.+|.+++|||||+++|+|.++. ...+||||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 345669999999999999955444999998765443332 668999999999999999999999999887 78999999
Q ss_pred cCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCCCCCCC
Q 045256 576 MKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPESER 644 (789)
Q Consensus 576 ~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~~~~~~ 644 (789)
+++|+|.++|+.. .+++.|||+||+|||++.. ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 9999999999762 2689999999999999984 99999999999999997 99999999997644322
Q ss_pred CCcccccccCcCccCccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 645 DFRPMKAAGTVGYIDPEYYG--LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.......||..|||||++. ...|+.|+|||||||+||||+||+.||..... . .....++.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~----------------~~~~~v~~ 260 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V----------------QVASAVVV 260 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H----------------HHHHHHHh
Confidence 1222368999999999999 56999999999999999999999999965432 0 00111111
Q ss_pred --ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 723 --RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 723 --~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+...+.. ....+..++.+||+.||++||++.|++..|+.+...
T Consensus 261 ~~~Rp~~p~~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 261 GGLRPPIPKE----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred cCCCCCCCcc----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 12221222 445566777889999999999999999999998764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=370.13 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=202.8
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHH---HHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQ---EKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
..+.|.+.+.||+|+||.|-+|.. ++|+.||||++.+.+..... .......+|+++|++|+|||||++.++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 346788899999999999999964 57999999998765443321 12233579999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC---CcEEEEeeccC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGLS 636 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGls 636 (789)
..||||||+++|+|++++-.. +.+++|++.|+.|||+++ |+||||||+|||+..+ ..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999998543 358999999999999999 9999999999999665 78999999999
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNV---LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
+...+.. ...+.+||+.|.|||++..+. +..++|+||+||+||-+|+|.+||.......
T Consensus 327 K~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--------------- 388 (475)
T KOG0615|consen 327 KVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--------------- 388 (475)
T ss_pred hccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---------------
Confidence 9865332 334689999999999996543 3458899999999999999999996543210
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.-...+...+....+....+..+...+|+.+||..||++|||+.|++++
T Consensus 389 -sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 389 -SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0112233344444445567778888899999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=381.83 Aligned_cols=244 Identities=24% Similarity=0.398 Sum_probs=201.7
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.+|...+.||+|+|+.+|+++. ..|+.||+|++.+....+ ....+.+.+|++|.++|+|||||+++++|++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k-~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK-PKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC-cchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence 4688899999999999999987 789999999987755444 33455688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
.|+|++++|..+++.++ .+.+||+.||.|||+.+ |+|||||..|+||++++++||+|||||......+.
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999999999998543 58899999999999999 99999999999999999999999999987664432
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
+..+.+|||.|.|||++.....+..+||||+|||||.||.|++||+...- .+....+....
T Consensus 174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v-----------------kety~~Ik~~~ 234 (592)
T KOG0575|consen 174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV-----------------KETYNKIKLNE 234 (592)
T ss_pred --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH-----------------HHHHHHHHhcC
Confidence 23478999999999999999999999999999999999999999965321 11111221111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
...|.....+ -++||.++|+.||.+|||+.+|+.+=
T Consensus 235 Y~~P~~ls~~----A~dLI~~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 YSMPSHLSAE----AKDLIRKLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred cccccccCHH----HHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1122222333 35667789999999999999999763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=360.34 Aligned_cols=194 Identities=33% Similarity=0.533 Sum_probs=171.1
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..+|.+.+.||+|+|++||+|+++ ++..||||.+.+.+.. .+..+.+..|+.+|+.++|||||+|++++++++..||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~--~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN--KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC--HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 367888899999999999999875 5789999998765432 2344568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC------CcEEEEeeccCc
Q 045256 572 VYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ------WTARVSDFGLSM 637 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfGls~ 637 (789)
|||||.+|+|.++|+.+. .++.|+|.||++||+++ ||||||||.||||+.. -.+||+|||+|+
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999999998763 58899999999999999 9999999999999764 568999999998
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
...... ...+.+|++-|||||++...+|+.|+|+||+|+|||||++|+.||...
T Consensus 164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 765432 234679999999999999999999999999999999999999999643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=360.31 Aligned_cols=235 Identities=28% Similarity=0.431 Sum_probs=194.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|+++++||+|+||.||+++.+ +++.||+|++++.+.... ...+...+|..+|.+++||+||++.-.|++.+.+|||
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 67999999999999999999854 588999999887666553 3355688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhch--------HHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRNN--------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~--------i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
+||+.||.|+-+|.+... ++.+|+.||.|||+++ ||||||||+|||||.+|+++|+||||++.......
T Consensus 104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999999999986554 4566888999999999 99999999999999999999999999986443322
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.+.+.+||+.|||||++....|+..+|+||||+++|||++|.+||...+. ......++..+
T Consensus 181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----------------~~~~~~I~~~k 241 (357)
T KOG0598|consen 181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----------------KKMYDKILKGK 241 (357)
T ss_pred --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----------------HHHHHHHhcCc
Confidence 23357999999999999999999999999999999999999999976553 11223333444
Q ss_pred CC-CCCCCHHHHHHHHHHHHHhhcCcCCCCCC
Q 045256 725 VG-PPEINEAEAVELVAYTAMHCVNLEGKERP 755 (789)
Q Consensus 725 ~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 755 (789)
+. .+.....+ .++++.+.+..||++|.
T Consensus 242 ~~~~p~~ls~~----ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLPPGYLSEE----ARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCCCccCCHH----HHHHHHHHhccCHHHhc
Confidence 22 22223333 45566778999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=368.30 Aligned_cols=244 Identities=30% Similarity=0.501 Sum_probs=200.7
Q ss_pred ccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
+.+.+.||+|.||+||.|.++....||+|.++.... ..+.|.+|+++|++|+|+|||+|+++|...+.+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 445788999999999999998777999998765422 234588999999999999999999999998899999999
Q ss_pred cCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 576 MKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 576 ~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|+.|+|.++|++. ..++.|||+|++||++++ +|||||..+||||+++..+||+||||++...++...
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 9999999999862 258899999999999999 999999999999999999999999999954433322
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc-
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR- 723 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 723 (789)
. .....-...|.|||.+....++.|||||||||+||||+| |+.|+... ...++.+.+++
T Consensus 360 ~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m------------------sn~ev~~~le~G 420 (468)
T KOG0197|consen 360 A-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM------------------SNEEVLELLERG 420 (468)
T ss_pred e-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC------------------CHHHHHHHHhcc
Confidence 1 122234678999999999999999999999999999999 66665332 22344455554
Q ss_pred -cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 724 -RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 724 -~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+++.|...+.+ +.+++..||+.+|++|||++.+...|+++...
T Consensus 421 yRlp~P~~CP~~----vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 421 YRLPRPEGCPDE----VYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CcCCCCCCCCHH----HHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 67777766655 45566779999999999999999999887543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=366.77 Aligned_cols=273 Identities=27% Similarity=0.484 Sum_probs=215.3
Q ss_pred HHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 487 AELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 487 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
++++...+++.+.+.||+|+||+||+|++.. .||||.+....... ++.++|++|+.++++-+|.||+-+.|||..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4555566677788999999999999999743 69999987655433 4677899999999999999999999999887
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.. .+|+.+|++.+|+.+||.. ..|++|+++|+.|||.++ |||||||+.||||.+++.|||+||||+.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 66 9999999999999999853 368999999999999999 9999999999999999999999999985
Q ss_pred CCCCCCCCCcccccccCcCccCccccCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGL---NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
....-..........|...|||||+++. .+|++.+||||||+++|||++|..||.....+ + +-|.+ -.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-q-----IifmV---Gr 607 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-Q-----IIFMV---GR 607 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-h-----eEEEe---cc
Confidence 4222222222234567899999999854 47899999999999999999999999632221 1 11110 01
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcccCCCCccccce
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGSISSSGI 783 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~~ 783 (789)
+.+ .+..........+.|++|+..||..++++||.+.+|+..|++++....+.++|.+.+..
T Consensus 608 G~l-------~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~ 669 (678)
T KOG0193|consen 608 GYL-------MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVL 669 (678)
T ss_pred ccc-------CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccch
Confidence 111 01111122345667788888999999999999999999999999888888888877654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=340.74 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=196.2
Q ss_pred CCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEE-EEEeCCe-EE
Q 045256 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVG-YCEEKDE-RL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~-~~~~~~~-~~ 570 (789)
.+|++++.||+|+||+|||+. +.+|..+|.|.+.-. .-.....+++..|+.+|++|+|||||++++ .+.++.+ ++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~--~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG--MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh--hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 357889999999999999996 578999999987632 222345667899999999999999999998 4444444 89
Q ss_pred EEEEecCCCchhHHHhhhc------------hHHHHHHHHHHHHHhcCC-CCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 571 LVYDYMKNGALYDHLHDRN------------NVEKNAARGIEYLHNYAV-PPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~------------~i~~~ia~~l~~LH~~~~-~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
|||||+..|+|...++..+ +++.|+++||.++|+.-. ..|+||||||.||+|+.+|.+||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999986421 578899999999999431 239999999999999999999999999998
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
++..... .....+|||.||+||.+....|+.||||||+||++|||..-++||.+++- . .+
T Consensus 177 ~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------~----------~L 236 (375)
T KOG0591|consen 177 FLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------L----------SL 236 (375)
T ss_pred HhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH--------H----------HH
Confidence 8654432 23357899999999999999999999999999999999999999976521 0 11
Q ss_pred -HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 718 -VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 718 -~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.++-....+ +....-....+..|+..|+..||+.||+...++..+..
T Consensus 237 ~~KI~qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 237 CKKIEQGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HHHHHcCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 111112221 11124455667778888999999999997666666654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.09 Aligned_cols=247 Identities=27% Similarity=0.382 Sum_probs=204.2
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 570 (789)
..+|.+.+.||+|+|++|++|+. +.++.||||++.+....+ +.+...+..|-.+|.+| .||.|++|+-.|++...+|
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 36899999999999999999975 468999999987655444 33445677899999999 8999999999999999999
Q ss_pred EEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+|+||+++|+|.++|++.+ .++.+|+.||+|||+++ ||||||||+|||||.|+++||+|||-++.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999998754 47889999999999999 999999999999999999999999999876543
Q ss_pred CCC---------C--cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 643 ERD---------F--RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 643 ~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
... . ....++||..|.+||++.....+..+|+|+||||||+|+.|++||.+.++ .
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------------y 293 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--------------Y 293 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------------H
Confidence 322 1 11357899999999999999999999999999999999999999977664 1
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.. .+++++.....++..+ +...+|+.+.|..||.+|+|.++|.++.
T Consensus 294 li---FqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 294 LI---FQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH---HHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11 2333443344444444 3445667778999999999999998874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=376.85 Aligned_cols=249 Identities=28% Similarity=0.477 Sum_probs=203.4
Q ss_pred CCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
.+....+.||+|.||.||+|+. ++...||||.++.... .....+|++|++++..|+|||||+|+|+|.+++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~---~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE---NQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc---HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 4455678999999999999974 2356799998765443 334567999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh----------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR----------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~----------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
..+||+|||..|||.+||..+ ..|+.|||.|++||-++. +|||||-.+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 999999999999999999632 258999999999999999 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~ 704 (789)
..|||+||||++.....+.........-..+|||||.+..++++.+||||||||+|||+++ |+.|+++...
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------- 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------- 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence 9999999999987665554433223345689999999999999999999999999999998 8888765432
Q ss_pred ccchhhhhhhhhhHHhhcc-c-CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 705 VDFAVPAIMAGELVKILDR-R-VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~-~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
++..+.+.. + +..++..+ ..+..|+..||+.+|.+||+++||-..|+.....
T Consensus 712 ----------~EVIe~i~~g~lL~~Pe~CP----~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 712 ----------QEVIECIRAGQLLSCPENCP----TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----------HHHHHHHHcCCcccCCCCCC----HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 233333333 2 34444444 4556667789999999999999999999987544
|
|
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=341.42 Aligned_cols=260 Identities=18% Similarity=0.263 Sum_probs=212.5
Q ss_pred eecCCCcEEEeeC---------------CcccccC----CCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCC-----
Q 045256 51 AAQPTQRLLCYQG---------------GTIRAVE----PNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNS----- 106 (789)
Q Consensus 51 ~l~~~g~v~~wG~---------------~~~~~~~----~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~----- 106 (789)
++..-..||+||. ..|...+ ....+++++||+.|+++|+.|| .||+||.|..+..
T Consensus 63 ~~~~~~~v~~~Gsn~~~eLGlg~de~~~~~P~~~~~~~~d~~~i~~~acGg~hsl~ld~Dg-~lyswG~N~~G~Lgr~~~ 141 (476)
T COG5184 63 LLVKMASVYSWGSNGMNELGLGNDETKVDRPQLNPFGRIDKASIIKIACGGNHSLGLDHDG-NLYSWGDNDDGALGRDIH 141 (476)
T ss_pred hhhheeeeEEEecCcceeeccCCchhcccCceecCcccccceeeEEeecCCceEEeecCCC-CEEEeccCcccccccccc
Confidence 5566788999998 2333332 3367999999999999999999 9999999983321
Q ss_pred ------------------CCcceeeee----CCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCC----------
Q 045256 107 ------------------NFVPKRIYY----NDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAP---------- 154 (789)
Q Consensus 107 ------------------~~~p~~v~~----~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~---------- 154 (789)
..+|..|+. ....+|++++||+.++++|++||+||+||.++-+.+...
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~l~cg~e~svil~~~G~V~~~gt~r~~e~~~g~~~~s~k~~~ 221 (476)
T COG5184 142 KDICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVVKLACGWEISVILTADGRVYSWGTFRCGELGQGSYKNSQKTSI 221 (476)
T ss_pred cccccccccccccchhhcccCCceeeccccccCChheEEeecCCceEEEEccCCcEEEecCcccccccccccccccccee
Confidence 346887765 223468899999999999999999999997444332111
Q ss_pred ---C---CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC-------------CceeEEEeeCCceeEEEc
Q 045256 155 ---S---GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA-------------NRSMFSITAGGNHVCGID 215 (789)
Q Consensus 155 ---~---~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~-------------~~~v~~i~~G~~h~~al~ 215 (789)
+ ....|+++++|.+|.++ ++++|+||.||+|..||||..... .+.|+.|+||.+|++||+
T Consensus 222 ~~~p~~v~~~~i~qla~G~dh~i~-lt~~G~vy~~Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al~ 300 (476)
T COG5184 222 QFTPLKVPKKAIVQLAAGADHLIA-LTNEGKVYGWGSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLALD 300 (476)
T ss_pred eeeeeecCchheeeeccCCceEEE-EecCCcEEEecCCcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEEEc
Confidence 0 12369999999999999 688889999999999999986542 233778999999999999
Q ss_pred cCCcEEEEEcCCCCCCCcCCC---------------CCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC---
Q 045256 216 SNGFVICYGDNKSGQLKFPLN---------------STAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR--- 277 (789)
Q Consensus 216 ~dG~v~~wG~n~~Gql~~~~~---------------~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~--- 277 (789)
++|+||+||.|.+|||+.+.. .....|.+|++|+.|+++|+. ||.||+||++.++|++..+
T Consensus 301 ~~G~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~~~~~~~~i~~is~ge~H~l~L~~-~G~l~a~Gr~~~~qlg~~~~~~ 379 (476)
T COG5184 301 EDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQLLSGVTICSISAGESHSLILRK-DGTLYAFGRGDRGQLGIQEEIT 379 (476)
T ss_pred CCCeEEEeccchhcccccCcccccceeeccccccccCCCceEEEEecCcceEEEEec-CceEEEecCCccccccCcccce
Confidence 999999999999999987721 123358999999999999999 9999999999999977654
Q ss_pred -----------CCcEEEEEecCceEEEEeecCCeEEEecCCCCCCCCC
Q 045256 278 -----------GKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSND 314 (789)
Q Consensus 278 -----------~~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~~~~~ 314 (789)
..++..++||..|+.+.+.+| +||+||.|+.+++|+
T Consensus 380 ~~~~~~~~ls~~~~~~~v~~gt~~~~~~t~~g-svy~wG~ge~gnlG~ 426 (476)
T COG5184 380 IDVSTPTKLSVAIKLEQVACGTHHNIARTDDG-SVYSWGWGEHGNLGN 426 (476)
T ss_pred eecCCccccccccceEEEEecCccceeeccCC-ceEEecCchhhhccC
Confidence 246999999999999999998 999999999988764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=324.02 Aligned_cols=231 Identities=26% Similarity=0.412 Sum_probs=195.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.+.+..+. .+.+...+|..+|+.+.||+++++.+.|.+...+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVkl-KQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKL-KQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHH-HHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 57888999999999999999865 578999999887666553 3456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|.|+.+|++.+ -++.+++.||+|||+++ |++|||||+|||||.+|.+||+|||+++....
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 99999999999998754 36788999999999999 99999999999999999999999999986433
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.+.+.+||+.|+|||++..+.++.++|+|||||++|||+.|.+||+.+++ .....+++...
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----------------~~iY~KI~~~~ 257 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----------------IQIYEKILEGK 257 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----------------HHHHHHHHhCc
Confidence 24578999999999999999999999999999999999999999987654 11234555555
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCC
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKER 754 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 754 (789)
+..|.....+ +++|+.+.++.|-.+|
T Consensus 258 v~fP~~fs~~----~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 VKFPSYFSSD----AKDLLKKLLQVDLTKR 283 (355)
T ss_pred ccCCcccCHH----HHHHHHHHHhhhhHhh
Confidence 5555544444 4455666788888888
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.41 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=196.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|+.+.++|+|+||.|||++.+ +|+.||||++...... ....+...+|+++|++|+|||+|.|+++|..+..++||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd--~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD--PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc--HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 35777889999999999999976 5999999998654332 23334567999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
+||++. ++.+.|.. ..++..|+++|+.|+|+++ ++||||||+||||+.++.+||||||+|+.+....
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 999987 66555543 2368999999999999999 9999999999999999999999999999876433
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ..+..+.|..|+|||.+.+ ..|...+||||+||++.||++|.+.|.+..+.++.-. +....-. ...+-.+++.
T Consensus 156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~--I~ktLG~-L~prhq~iF~ 230 (396)
T KOG0593|consen 156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYL--IRKTLGN-LIPRHQSIFS 230 (396)
T ss_pred c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHH--HHHHHcc-cCHHHHHHhc
Confidence 2 2335678999999999976 7899999999999999999999998876554221100 0000000 0011122222
Q ss_pred c-------cCCCCCCCH------HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 R-------RVGPPEINE------AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~-------~~~~~~~~~------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. +++.++..+ ......+.++++.||+.||++|++-+|++.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1 222222111 2334567789999999999999999998854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=325.96 Aligned_cols=270 Identities=24% Similarity=0.390 Sum_probs=197.1
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhh--cCCCcceEEEEEEEeCC---
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR--LHHKHLVRLVGYCEEKD--- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~--- 567 (789)
.++..+.+.||+|.||+||+|++ .|+.||||++....+.. +.+|.+|.+. |+|+||+.+++.-....
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~S-------WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDERS-------WFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccchhh-------hhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 35678899999999999999998 57899999986544333 5566666654 59999999999876543
Q ss_pred -eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHh-----cCCCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 568 -ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHN-----YAVPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 568 -~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
+++||+||.++|||+|+|... .+++..+|.||+|||. +++|.|.|||||+.|||+..++...|+|+|
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 579999999999999999753 4789999999999994 577999999999999999999999999999
Q ss_pred cCcCCCCCCC--CCcccccccCcCccCccccCCCCC------CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 635 LSMMGPESER--DFRPMKAAGTVGYIDPEYYGLNVL------TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 635 ls~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~------~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
||........ +......+||.+|||||++...-. -..+||||||+|+||+.-...-= .-.+.....+.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~g---gi~eey~~Pyyd 438 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESG---GIVEEYQLPYYD 438 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcC---CEehhhcCCccc
Confidence 9976444322 233445789999999999955421 13589999999999997532100 000011112222
Q ss_pred chhhhhhhhhhHHhhc-ccCCCC-C--CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 707 FAVPAIMAGELVKILD-RRVGPP-E--INEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d-~~~~~~-~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
++...-..+++.+++- +++.+. + -...+....|.+|++.||..+|..|.|+--+.+.|.++.+..++
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek 509 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK 509 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence 2222222334444432 222211 1 12346777888999999999999999999999999998765443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=356.96 Aligned_cols=256 Identities=27% Similarity=0.501 Sum_probs=209.0
Q ss_pred hcCCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
......+.++||.|.||+||+|+++ ....||||.++.....+ .+.+|..|..||.+++||||++|.|+.....
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytek---qrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEK---QRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHH---HHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 3355678899999999999999875 24579999988765543 4557999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 ERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..++|+|||+||+|..+|+++. .+.+.||.|+.||-+++ +|||||..+|||++.+...|++||||++.
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceee
Confidence 9999999999999999998653 47889999999999999 99999999999999999999999999997
Q ss_pred CCCCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 639 GPESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 639 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
+.+.... ..+....-..+|.|||.+...+++.+||||||||+|||.++ |.+|+.+..+ .+
T Consensus 781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------------------Qd 842 (996)
T KOG0196|consen 781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------------------QD 842 (996)
T ss_pred cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------------------HH
Confidence 6554421 11111122589999999999999999999999999999887 8899866543 11
Q ss_pred hHHhh--cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcccCC
Q 045256 717 LVKIL--DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSH 775 (789)
Q Consensus 717 ~~~~~--d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~ 775 (789)
..+.+ +.++++|.. ++..|.+|++.||++|..+||++.+|+..|++++...+...
T Consensus 843 VIkaIe~gyRLPpPmD----CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPPMD----CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred HHHHHHhccCCCCCCC----CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 22222 235665544 44567778888999999999999999999999987554433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=331.56 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=197.1
Q ss_pred cCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.++||.|..++||+|+ .+.+..||||++...+ .+...+.+.+|++.|+.++||||++++..|..+..+|+
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk---c~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK---CNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh---hhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 3689999999999999999997 4567999999976543 33446679999999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||.||.+|++.++++... .|.+++++||.|||.++ .||||||+.||||+.+|.+||+|||.+..+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999997542 47889999999999999 89999999999999999999999998754433
Q ss_pred CCC-CCcc-cccccCcCccCccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 642 SER-DFRP-MKAAGTVGYIDPEYYG--LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 642 ~~~-~~~~-~~~~gt~~y~aPE~~~--~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
... .... ....||+.|||||++. ...|+.|+|||||||+..||.+|..||....+..- +
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----------------L 241 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----------------L 241 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----------------H
Confidence 322 1111 4568999999999963 34699999999999999999999999965432110 0
Q ss_pred HHhhcccCC------CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVG------PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..-+....+ .+..........+++++..||++||.+|||+.+++++
T Consensus 242 l~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 242 LLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 000111110 0111122334577888999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=352.15 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=193.9
Q ss_pred hcCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
..++|++.++||+|+||.||++.. .+++.||+|+++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---ASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 346899999999999999999963 2356899998764322 22334688999999999 8999999999887
Q ss_pred eCC-eEEEEEEecCCCchhHHHhhh-------------------------------------------------------
Q 045256 565 EKD-ERLLVYDYMKNGALYDHLHDR------------------------------------------------------- 588 (789)
Q Consensus 565 ~~~-~~~lv~e~~~~gsL~~~l~~~------------------------------------------------------- 588 (789)
..+ ..+++|||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 654 578999999999999988642
Q ss_pred ---------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccccccc
Q 045256 589 ---------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAG 653 (789)
Q Consensus 589 ---------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~g 653 (789)
..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............+
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 238 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence 135779999999999998 99999999999999999999999999976433222222223345
Q ss_pred CcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc-cCCCCCCC
Q 045256 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR-RVGPPEIN 731 (789)
Q Consensus 654 t~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~ 731 (789)
+..|+|||++....++.++||||||++||||++ |+.||....... . ....+.+. ....+.
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~------------~~~~~~~~~~~~~~~-- 300 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----E------------FCQRLKDGTRMRAPE-- 300 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----H------------HHHHHhcCCCCCCCC--
Confidence 688999999988899999999999999999997 999985432100 0 00011111 111111
Q ss_pred HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 732 EAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 732 ~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.....+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 301 --~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 301 --NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred --CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.62 Aligned_cols=234 Identities=20% Similarity=0.342 Sum_probs=196.1
Q ss_pred cceeEEEEecCceeeeeeeecCCCcEEEeeC------------------------------CcccccCC------CCcEE
Q 045256 33 SGSTLAVSYGSATVCAVVAAQPTQRLLCYQG------------------------------GTIRAVEP------NISFS 76 (789)
Q Consensus 33 ~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~------------------------------~~~~~~~~------~~~v~ 76 (789)
...++.+|||++|++ +|+.||.||+||. .+|..++. ..+|+
T Consensus 103 ~~~i~~~acGg~hsl---~ld~Dg~lyswG~N~~G~Lgr~~~~~~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv 179 (476)
T COG5184 103 KASIIKIACGGNHSL---GLDHDGNLYSWGDNDDGALGRDIHKDICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVV 179 (476)
T ss_pred ceeeEEeecCCceEE---eecCCCCEEEeccCcccccccccccccccccccccccchhhcccCCceeeccccccCChheE
Confidence 367999999999999 9999999999998 23444444 34799
Q ss_pred EEEecCceEEEEEeCCceEEEccCCCCC-------C------CCCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEc
Q 045256 77 SISAGQSFFCGIRSGGYSLLCWDTNFSY-------N------SNFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCW 143 (789)
Q Consensus 77 ~i~~G~~~~~~l~~~G~~v~~wG~n~~~-------~------~~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~w 143 (789)
+++||+.++++|++|| +||+||.+..+ + ...+|..++ ...|+++++|.+|.++|+++|+||.|
T Consensus 180 ~l~cg~e~svil~~~G-~V~~~gt~r~~e~~~g~~~~s~k~~~~~~p~~v~---~~~i~qla~G~dh~i~lt~~G~vy~~ 255 (476)
T COG5184 180 KLACGWEISVILTADG-RVYSWGTFRCGELGQGSYKNSQKTSIQFTPLKVP---KKAIVQLAAGADHLIALTNEGKVYGW 255 (476)
T ss_pred EeecCCceEEEEccCC-cEEEecCccccccccccccccccceeeeeeeecC---chheeeeccCCceEEEEecCCcEEEe
Confidence 9999999999999999 99999997611 1 114455554 34578999999999999999999999
Q ss_pred CCCCCCCCCCCCCC--------------ccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC-------------
Q 045256 144 RGDVNISKNAPSGE--------------LQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF------------- 196 (789)
Q Consensus 144 G~~~~~~~~~~~~~--------------~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~------------- 196 (789)
|.+..+|++.+..+ ..|..|+||.+|++| ++.+|+||+||.|.+||++.+..
T Consensus 256 Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~a-l~~~G~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~ 334 (476)
T COG5184 256 GSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLA-LDEDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYK 334 (476)
T ss_pred cCCcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEE-EcCCCeEEEeccchhcccccCcccccceeecccccc
Confidence 99999999765422 236779999999999 56667999999999999998811
Q ss_pred ---CCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCC-----------CCCccceEEeccCcceEEEEEeeCCeE
Q 045256 197 ---ANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPL-----------NSTAFEYSALSLGFNHSCAIRRLNGSV 262 (789)
Q Consensus 197 ---~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~-----------~~~~~~v~~i~~G~~h~~al~~~dG~v 262 (789)
....|.+|++|+.|+++|+.||.||+||+++.|||+.+. ......+.+|+||.+|+.+.++ +|+|
T Consensus 335 ~~~~~~~i~~is~ge~H~l~L~~~G~l~a~Gr~~~~qlg~~~~~~~~~~~~~~ls~~~~~~~v~~gt~~~~~~t~-~gsv 413 (476)
T COG5184 335 QLLSGVTICSISAGESHSLILRKDGTLYAFGRGDRGQLGIQEEITIDVSTPTKLSVAIKLEQVACGTHHNIARTD-DGSV 413 (476)
T ss_pred ccCCCceEEEEecCcceEEEEecCceEEEecCCccccccCcccceeecCCccccccccceEEEEecCccceeecc-CCce
Confidence 222378999999999999999999999999999998776 2234579999999999999999 9999
Q ss_pred EEeeeCCCCcccC
Q 045256 263 VCWGSQGEYSVNG 275 (789)
Q Consensus 263 ~~WG~n~~gq~~~ 275 (789)
|+||+|++||++.
T Consensus 414 y~wG~ge~gnlG~ 426 (476)
T COG5184 414 YSWGWGEHGNLGN 426 (476)
T ss_pred EEecCchhhhccC
Confidence 9999999999763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.77 Aligned_cols=235 Identities=29% Similarity=0.476 Sum_probs=192.1
Q ss_pred ccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
...++-||.|+.|.||+|+++ ++.||||+++.. -..+|+-|++|+||||+.+.|+|....-+++||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 344678999999999999994 589999974322 22578889999999999999999999999999999
Q ss_pred cCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 576 MKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 576 ~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
|..|.|++.|+... .+.++||.|+.|||.+. |||||||+-||||..+..+||+|||-++...+. ..
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---ST 267 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---ST 267 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hh
Confidence 99999999998754 46788999999999999 999999999999999999999999998764433 23
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
.+.++||..|||||+++..+.+.|+|||||||+|||||||..||..-+... +.|-+- ...+ .++-
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwGVG-------sNsL--~Lpv 332 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWGVG-------SNSL--HLPV 332 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEecc-------CCcc--cccC
Confidence 457899999999999999999999999999999999999999985443211 111110 0011 1122
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
+.++++-++-|+++||+..|.+||++++++.+|+-+
T Consensus 333 ----PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 333 ----PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ----cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 234556677788899999999999999999999754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=348.89 Aligned_cols=244 Identities=26% Similarity=0.439 Sum_probs=201.5
Q ss_pred cCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
...|...++||+|..|.||.++ ..+++.||||++..... ...+.+.+|+.+|+..+|+|||++++.|...+++|+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 3577778999999999999996 45788999999765443 234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||||++|+|.|.+... ..|.+++++||+|||..+ |+|||||.+|||++.++.+||+|||++..+.....
T Consensus 348 VMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999999988643 246788999999999999 99999999999999999999999999876554432
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
...+.+||+.|||||+.....|.+|.||||||++++||+-|++||+.++.. .+ ..++...
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl---------------rA---lyLIa~n 484 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---------------RA---LYLIATN 484 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH---------------HH---HHHHhhc
Confidence 334678999999999999999999999999999999999999999764431 00 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
-.+.......+...+++++.+||..|+++||+++|+|++
T Consensus 485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 122222344566778999999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.34 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=193.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC--eEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD--ERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~ 570 (789)
.++...+.||+|+||+||++... +|...|||.+....... .+.+.+|+.+|.+++|||||+++|.....+ .++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~----~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT----SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh----HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 45667889999999999999865 48999999876542211 456889999999999999999999855555 588
Q ss_pred EEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGls~~~~ 640 (789)
+.|||+++|+|.+++.... ++.+|+++||+|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999987543 57889999999999999 999999999999999 7999999999997654
Q ss_pred C-CCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 E-SERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
. ...........||+.|||||++..+ ....++|||||||++.||+||++||....+ ....+.
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~----------------~~~~~~ 233 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE----------------EAEALL 233 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc----------------hHHHHH
Confidence 3 1112223357899999999999853 334599999999999999999999854200 011111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
.+...... | ..+.......++++.+|+..||++|||+.|++++.-..
T Consensus 234 ~ig~~~~~-P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 234 LIGREDSL-P-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHhccCCC-C-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 11111111 1 22233556677889999999999999999999987553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.61 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=193.8
Q ss_pred cCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 569 (789)
.+.|+.+++||+|+||.||+++ ..+|+.||+|+++...... +......+||.||++|+||||++|.+...+. ..+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~--~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE--GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC--cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3567888999999999999997 4679999999987654322 2333467999999999999999999998877 579
Q ss_pred EEEEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|||+|||++ +|.-++.. .+.+++|++.||+|+|..+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999988 88888754 3468999999999999999 9999999999999999999999999999766
Q ss_pred CCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhhhhhh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIMAGEL 717 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~ 717 (789)
...... .+..+-|..|+|||++.+ ..|+..+|+||.||||.||++|++.|.+..+.++....+ ..-+....+. .
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~--~ 346 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP--V 346 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc--c
Confidence 655432 334567999999999865 579999999999999999999999987766543221111 0000000000 0
Q ss_pred HHhhcccC-CCCCCCH-------HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRV-GPPEINE-------AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~-~~~~~~~-------~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.++..... .+..... ........+|+..+|..||++|.|+.++++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 01110000 0000000 0111223356677999999999999998763
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.06 Aligned_cols=262 Identities=22% Similarity=0.321 Sum_probs=198.0
Q ss_pred cCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCC-eE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKD-ER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~-~~ 569 (789)
.++|.+.++||.|+||.||+|+ ..++..||||+++..... +++. .=.+|++.|++|+ ||||++|.+++.+.+ .+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3678899999999999999997 457899999987653322 2222 2458999999998 999999999999988 89
Q ss_pred EEEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|+|||||+. +|++++++|. +|+.||++||+|+|.++ +.||||||+|||+..+..+||+|||+|+...
T Consensus 86 ~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999999977 9999998775 58999999999999999 9999999999999989999999999998754
Q ss_pred CCCCCCcccccccCcCccCcccc-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccchhh-hhhh-h
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYY-GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDFAVP-AIMA-G 715 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~-~~~~-~ 715 (789)
... ..+..+.|..|+|||++ +...|+.+.|||++|||++|+.+=++.|.+.++.++.... +..-+.. .+.. .
T Consensus 162 Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 433 23456789999999987 5678999999999999999999999888776653321100 0000000 0000 1
Q ss_pred hhHHhhcccCCCCCCC-----HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 716 ELVKILDRRVGPPEIN-----EAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 716 ~~~~~~d~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.+...+.-+++.-... -..+.....+|+.+||..||++|||+.|++++-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 2222222222211111 012344556778889999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=342.01 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=203.2
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++...+.++||+|.||+|.++....+..||||.++..... ....+|.+|+++|.+|+||||++|+|+|..++.+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~---~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK---NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch---hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 34567788999999999999999988899999998765433 235679999999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
|+||+++|+|.++|.+. .+|+.||+.||+||.+.. +|||||.++|+|+|.++++||+|||+++-+..
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999999654 268999999999999999 99999999999999999999999999986655
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT--GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt--G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
.+.........-..+|||||.+..++++.++|||+||+++||+++ ...||....++ ...+...+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e--------------~vven~~~ 755 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE--------------QVVENAGE 755 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH--------------HHHHhhhh
Confidence 554433344556789999999999999999999999999999977 45566332210 01112222
Q ss_pred hhcc-----cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 720 ILDR-----RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 720 ~~d~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
+++. .+..|.. ++..+.+++..||..|-++||+++++...|++.
T Consensus 756 ~~~~~~~~~~l~~P~~----cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 756 FFRDQGRQVVLSRPPA----CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hcCCCCcceeccCCCc----CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3322 1222333 344555778899999999999999999999764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.08 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=197.7
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHH-HHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCe
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQ-EKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDE 568 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~ 568 (789)
..++|.+.+.||+|+||.|+++.. .+++.||+|++......... ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346899999999999999999975 46899999976654222111 23445778999999998 9999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGls~~~ 639 (789)
.|+||||+.+|+|++++.++. .++.|++.|++|+|+.+ |+||||||+|||+|.+ +++||+|||++...
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999997632 58999999999999999 9999999999999999 99999999999876
Q ss_pred CCCCCCCcccccccCcCccCccccCCCC-CC-chhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNV-LT-AKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
. .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+. + .-.
T Consensus 172 ~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------------~----~l~ 232 (370)
T KOG0583|consen 172 P--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------------P----NLY 232 (370)
T ss_pred C--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------------H----HHH
Confidence 4 1223344679999999999998877 75 789999999999999999999965321 0 011
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 761 (789)
..+.......+.... ......|+.+||..||.+|+++.|++
T Consensus 233 ~ki~~~~~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RKIRKGEFKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHhcCCccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 123333333333321 34456778889999999999999999
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.43 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=195.2
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|...++||+|.||.||+|++ ++|+.||||+++..+... .......+|++.|+.++||||+.|+++|...+.+-||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc--CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence 4688889999999999999974 579999999987764332 1223467899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
+||++. +|...++.+ +.++.++++||+|||++. |+||||||+|+|+++++.+||+|||+++.+....
T Consensus 80 fEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 80 FEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred EEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 999987 999998764 357888999999999999 9999999999999999999999999999877665
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--------ccchhhhhhh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--------VDFAVPAIMA 714 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--------~~~~~~~~~~ 714 (789)
.... ..+-|..|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.++.+.++....+ .+|+.-....
T Consensus 156 ~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 4432 3367999999998855 578999999999999999999887666554432211111 1122111111
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+. .++..-..++....-..+.....+|+.+++..||.+|+++.|++++
T Consensus 234 dY-~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DY-VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cH-HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1111000011110111222333567778999999999999999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=348.84 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=193.9
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 570 (789)
.++|.++++||+|.||.|+++..+ +++.+|||.+++...... +..+....|.+|+... +||.+++|+.+|+.++++|
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 478999999999999999999875 578999999988766543 3355677888888887 5999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
+||||+.+|++..+.+.. .-++..++.||.|||+++ |||||||.+|||||.+|++||+||||++.....
T Consensus 446 fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~- 521 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ- 521 (694)
T ss_pred EEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC-
Confidence 999999999976665522 246788999999999999 999999999999999999999999999864322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
...+.+++||+.|||||++.+..|+..+|+|||||+|||||.|+.||.+++++ +++|.
T Consensus 522 -g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------------------e~Fds 579 (694)
T KOG0694|consen 522 -GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------------------EVFDS 579 (694)
T ss_pred -CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------------HHHHH
Confidence 23556889999999999999999999999999999999999999999876651 22333
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTM 757 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 757 (789)
.+.....++.-+......++.++|.++|++|.-+
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 3322222333333344456667899999999866
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=337.53 Aligned_cols=201 Identities=27% Similarity=0.414 Sum_probs=170.9
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|+++++||+|+||.||+++.+ +|..+|+|++++..... ..+.+.++.|-.+|...++|+||+|+-.|++.+.+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 4579999999999999999999854 68999999988765544 344667889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC-
Q 045256 571 LVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE- 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~- 641 (789)
|||||++||++..+|.... .++.+++.|++-||+.+ ||||||||+|+|||..|++||+||||+.-+..
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999999986543 45667788999999999 99999999999999999999999999842111
Q ss_pred -------------------CCCCCc-------------------------ccccccCcCccCccccCCCCCCchhHHHHH
Q 045256 642 -------------------SERDFR-------------------------PMKAAGTVGYIDPEYYGLNVLTAKSDVYGL 677 (789)
Q Consensus 642 -------------------~~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~sDv~Sl 677 (789)
...... ....+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000000 012369999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCC
Q 045256 678 GVVLLELLTGKRAIFKDDE 696 (789)
Q Consensus 678 Gvil~elltG~~pf~~~~~ 696 (789)
|||+||||.|.+||..+..
T Consensus 375 G~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred HHHHHHHHhCCCCCCCCCH
Confidence 9999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.45 Aligned_cols=242 Identities=25% Similarity=0.382 Sum_probs=199.9
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+..... .....+.+|++|+++|+||||+.++++|+...++++|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~--k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE--KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch--HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 47888899999999999999754 67899999976654332 3345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
+||+.+ +|+.+|... ..++.++..||.|||+.. |.|||+||.|||++..+.+|++|||+++......
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t- 154 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT- 154 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence 999987 999999753 358889999999999999 9999999999999999999999999998754432
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.......||+.|||||.+.+.+|+..+|+||+|||+|||++|++||+... +.+++...
T Consensus 155 -~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---------------------i~~Lv~~I 212 (808)
T KOG0597|consen 155 -SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---------------------ITQLVKSI 212 (808)
T ss_pred -eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---------------------HHHHHHHH
Confidence 23335679999999999999999999999999999999999999996532 12222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+..+...+..+...+..++...|.+||.+|.+-.+++.+=
T Consensus 213 ~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 213 LKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred hcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 2222222335666777888889999999999999988763
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=363.23 Aligned_cols=251 Identities=27% Similarity=0.483 Sum_probs=203.1
Q ss_pred cCCccccceEeecccEEEEEEEeCC--Cc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD--GQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~--g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
.+..++.+.||+|.||.||+|...+ +. .||||.++.... .+...+|.+|..+|++++|||||+++|+|.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~---~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS---EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 4566778999999999999998643 33 488888665432 34456799999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
...++++|||++|+|..+|++. ..++.|+|+|+.||++++ +|||||..+|+||+....+||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 9999999999999999999864 258899999999999999 9999999999999999999999
Q ss_pred eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhh
Q 045256 632 DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 632 DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
|||||+.+...+.........-..+|||||.+....++.|+|||||||+|||++| |..||...++
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------------- 910 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------------- 910 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------------
Confidence 9999985544443332222334579999999999999999999999999999999 6667644332
Q ss_pred hhhhhhhHH--hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 711 AIMAGELVK--ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 711 ~~~~~~~~~--~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
.++.. +-..++.+|...+. .+.+++.+||+.+|++||++..+++.++.++...
T Consensus 911 ----~~v~~~~~~ggRL~~P~~CP~----~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 911 ----FEVLLDVLEGGRLDPPSYCPE----KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ----HHHHHHHHhCCccCCCCCCCh----HHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11111 12236777766654 4456677899999999999999999999987653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.04 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=190.6
Q ss_pred CCccccceEeecccEEEEEEEeCC-----------------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-----------------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 556 (789)
++|++.++||+|+||.||++.+++ +..||+|.+..... ......|.+|++++.+++||||
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN---KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC---HHHHHHHHHHHHHHhhcCCCCe
Confidence 578899999999999999997532 33699998765322 2234568899999999999999
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhHHHhhh---------------------------chHHHHHHHHHHHHHhcCCCC
Q 045256 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDR---------------------------NNVEKNAARGIEYLHNYAVPP 609 (789)
Q Consensus 557 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---------------------------~~i~~~ia~~l~~LH~~~~~~ 609 (789)
+++++++.+.+..++||||+++++|.+++... .+++.|+++||+|||+.+
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--- 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--- 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999999999999999988542 258899999999999998
Q ss_pred eEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc--C
Q 045256 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT--G 687 (789)
Q Consensus 610 ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt--G 687 (789)
|+||||||+|||++.++.+||+|||++................++..|+|||.+....++.++||||||+++|||++ +
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 99999999999999999999999999875433322112223345788999999988889999999999999999987 4
Q ss_pred CCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCC-CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 688 KRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 688 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
..||..... ..... ...+.+..... .........+..+.+++.+||+.||++|||+.||.+.|++
T Consensus 239 ~~p~~~~~~-----~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGELTD-----EQVIE---------NAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCcCCH-----HHHHH---------HHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 456643221 00000 01111111000 0000011223456788899999999999999999988863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.40 Aligned_cols=253 Identities=30% Similarity=0.407 Sum_probs=198.4
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHH----------HHHHHHHHHHHHHhhcCCCcceEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQ----------EKESAFDSELAFLSRLHHKHLVRLV 560 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~l~ 560 (789)
..++|++.+.||+|.||.|-+++.. +++.||||++.+....... ...+...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999999854 6899999998764432211 1134688999999999999999999
Q ss_pred EEEEeC--CeEEEEEEecCCCchhHH------H--hhhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEE
Q 045256 561 GYCEEK--DERLLVYDYMKNGALYDH------L--HDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630 (789)
Q Consensus 561 ~~~~~~--~~~~lv~e~~~~gsL~~~------l--~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 630 (789)
.+..+. +.+|||+|||..|.+... | .+.+++++++..||+|||.++ |+||||||+|+||++++++||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEe
Confidence 998765 468999999998876443 1 234578999999999999999 999999999999999999999
Q ss_pred EeeccCcCCCCCCC---CCcccccccCcCccCccccCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 045256 631 SDFGLSMMGPESER---DFRPMKAAGTVGYIDPEYYGLN----VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703 (789)
Q Consensus 631 ~DfGls~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~ 703 (789)
+|||.+........ +.......||+.|+|||...++ ..+.+.||||+||+||.|+.|+.||+.+.+
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------- 324 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------- 324 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-------
Confidence 99999976533211 1112236899999999988653 235688999999999999999999976543
Q ss_pred cccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 704 LVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.+-..+++...+..+.. .+..+.+++|++++|.+||++|.+..+|..+.=-
T Consensus 325 ----------~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 ----------LELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ----------HHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 11223444555544442 2556678889999999999999999999887743
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=341.23 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=199.4
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.-|++.+.||+|+.|.|.+|++ .+|+.+|||++.+..... ......+.+|+-+|+.+.|||+++++++++++.++|||
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 3578889999999999999985 579999999987653222 23344588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
.||+++|.|+++|..++ ++++||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|.+....
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g-- 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG-- 165 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence 99999999999986543 68999999999999999 999999999999999999999999999763322
Q ss_pred CCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
..-.+.+|++.|.+||++.+.+| ..++||||+|||||.||||+.||.+++- ..-+.++...
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----------------r~LLlKV~~G 227 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----------------RVLLLKVQRG 227 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----------------HHHHHHHHcC
Confidence 12236799999999999999887 5789999999999999999999974331 1122333333
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
...-|.....+ .++|+.+|+..||++|.|++||+++-
T Consensus 228 ~f~MPs~Is~e----aQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 228 VFEMPSNISSE----AQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cccCCCcCCHH----HHHHHHHHhccCccccccHHHHhhCc
Confidence 44444444444 45666779999999999999999986
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=345.43 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=192.4
Q ss_pred cCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 565 (789)
.++|++.+.||+|+||.||++.. .++..||||+++..... ...+.+.+|+++++.+ +||||+++++++.+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc---HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 35788899999999999999963 24568999997643321 2234688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh---------------------------------------------------------
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR--------------------------------------------------------- 588 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------- 588 (789)
.+..++||||+++|+|.++++++
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999999999988642
Q ss_pred --------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 589 --------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 589 --------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 136679999999999998 999999999999999999999999998764333
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
..........++..|+|||.+....++.++||||||+++|||++ |..||...... ....+.+
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-----------------~~~~~~~ 330 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-----------------SKFYKMI 330 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-----------------HHHHHHH
Confidence 22111112334678999999999899999999999999999998 78887543210 0111111
Q ss_pred ccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 722 DRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 722 d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
... ...+.. ....+.+++.+||+.||++||++.|+++.|++.
T Consensus 331 ~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGYRMLSPEC----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCccCCCCCC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111 111111 234567888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=302.95 Aligned_cols=241 Identities=25% Similarity=0.397 Sum_probs=200.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|-||.||.++.+ ++-.||+|++.+..... .....++.+|++|.+.|+||||++++++|.+....||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 67899999999999999999864 56789999987665433 23355799999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+||.+.|+|+..|.+.. .+..|+|.||.|+|... |+||||||+|+|++.++.+||+|||.+...+.+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999998432 58899999999999999 999999999999999999999999998764422
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
...+.+||..|.+||...+...+..+|+|++|++.||++.|.+||..... .+-..++..
T Consensus 178 ----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-----------------~etYkrI~k 236 (281)
T KOG0580|consen 178 ----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-----------------SETYKRIRK 236 (281)
T ss_pred ----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-----------------HHHHHHHHH
Confidence 23467999999999999999999999999999999999999999965432 112223333
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
-++..+.. .....++++++|+..+|.+|.+..|++++
T Consensus 237 ~~~~~p~~----is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 VDLKFPST----ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccccCCcc----cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 33333332 23345677888999999999999999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=343.80 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=193.8
Q ss_pred cCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 565 (789)
.++|++.+.||+|+||.||++.. .+++.||+|+++..... .....+.+|+++++.+ +||||++++++|.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 35788999999999999999873 23457999997653322 2344688999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh---------------------------------------------------------
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR--------------------------------------------------------- 588 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------------------------- 588 (789)
.+..++||||+++|+|.++++..
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999988532
Q ss_pred ---------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 589 ---------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 589 ---------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
.+++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++...........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 246789999999999998 99999999999999999999999999875433222111
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc--
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR-- 724 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-- 724 (789)
.....++..|+|||++....++.++||||||+++|||++ |+.||...... ....+.+...
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-----------------~~~~~~~~~~~~ 333 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-----------------SKFYKMVKRGYQ 333 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc-----------------HHHHHHHHcccC
Confidence 112335678999999988899999999999999999997 99998543210 0011111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
...+.. ....+.+++.+||+.||++||++.++++.|++++
T Consensus 334 ~~~~~~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 334 MSRPDF----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111111 1345677888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.94 Aligned_cols=238 Identities=19% Similarity=0.308 Sum_probs=189.0
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----CCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----KDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~e~ 575 (789)
..|++|+++.||+|.+ +|+.||||+++...... ....+.|.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGH-KVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEecccccccc-HHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999998 78999999986543222 2234568899999999999999999999977 3467899999
Q ss_pred cCCCchhHHHhhh--------chHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 576 MKNGALYDHLHDR--------NNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 576 ~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
+++|+|.+++.+. .+++.+++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999998653 35788999999999985 6 7899999999999999999999999987543221
Q ss_pred cccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc-
Q 045256 647 RPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR- 723 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~- 723 (789)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||..... . +....++..
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~------------~~~~~i~~~~ 238 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----K------------EIYDLIINKN 238 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----H------------HHHHHHHhcC
Confidence 13467899999999976 6789999999999999999999999964321 0 001111111
Q ss_pred -cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 724 -RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 724 -~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+...+ ......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 239 ~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NSLKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111 123456788899999999999999999999998864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=329.16 Aligned_cols=244 Identities=28% Similarity=0.362 Sum_probs=191.0
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|+..+.||+|+||.||++.. .+++.||+|.+....... ......+.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 377889999999999999985 478999999876543322 122345788999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998877432 247789999999999998 9999999999999999999999999987643222
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH-hhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK-ILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d 722 (789)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||....+... ...+.. +..
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--------------~~~~~~~~~~ 219 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--------------REEVDRRVKE 219 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--------------HHHHHHHhhc
Confidence 1 1234689999999999999999999999999999999999999965432100 001111 111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
.... ........+..|+.+||+.||++||+ ++|++++
T Consensus 220 ~~~~----~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQEE----YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred cccc----CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1111 11223445677888999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.04 Aligned_cols=240 Identities=22% Similarity=0.337 Sum_probs=192.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||+|++....... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR-LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-hHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 46889999999999999999865 68899999876433221 22344688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 9999999999998653 257889999999999998 9999999999999999999999999987643221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
....|++.|+|||++.+..++.++||||||+++|||++|+.||..... .+....+....
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----------------~~~~~~i~~~~ 214 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----------------FGIYEKILAGK 214 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhCC
Confidence 234689999999999988899999999999999999999999864321 00111222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
+..+.. ....+.+++.+||+.||.+||+ +.|++++
T Consensus 215 ~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 LEFPRH----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred cCCCcc----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 222221 1335677888999999999995 8888776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.60 Aligned_cols=242 Identities=26% Similarity=0.423 Sum_probs=199.5
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.+|++.+.||+|+||.|-++.. ..|+.||||.+++.+....+ ..-.+++|++||+.|+||||+.++.+|+.++...+|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeq-DlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQ-DLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHH-HHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4688889999999999999974 67999999998887766543 345689999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||..+|.|+|++.++. ++++||..|+.|+|.+. ++|||||.+|||||+++++||+||||+.++.....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 99999999999997654 68999999999999999 99999999999999999999999999987654432
Q ss_pred CCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
..+++|++-|.+||+..+.+| .+.+|-|||||+||.|+.|.-||.+.+- ..+.+.+..
T Consensus 209 ---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh------------------k~lvrQIs~ 267 (668)
T KOG0611|consen 209 ---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH------------------KRLVRQISR 267 (668)
T ss_pred ---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH------------------HHHHHHhhc
Confidence 236799999999999998887 5789999999999999999999966432 111222222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
..-..+..+.+ -.-||.+||..||++|.|+.+|..+.
T Consensus 268 GaYrEP~~PSd----A~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 268 GAYREPETPSD----ASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccccCCCCCch----HHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11111111222 23467889999999999999999886
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=302.69 Aligned_cols=254 Identities=24% Similarity=0.383 Sum_probs=200.1
Q ss_pred cCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+|+-||+++ ..+++.||+|++.-.. .+..+...+|++..++++|||+++++++...+
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~----~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS----QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc----hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 4689999999999999999997 5678999999976544 23445678999999999999999999887543
Q ss_pred CeEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 567 DERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
.+.||+++|...|+|.+.+..+ ..++.++.+||++||+.. ||+.||||||.|||+.+++.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 3489999999999999998643 268899999999999987 789999999999999999999999999
Q ss_pred cCcCCCCCCCCCc-------ccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 045256 635 LSMMGPESERDFR-------PMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 635 ls~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~ 704 (789)
.+...+..-.... ......|..|+|||.+. +...+.++|||||||+||+|+.|..||....+.++...-
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL- 253 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL- 253 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE-
Confidence 8865332221111 11235689999999983 456789999999999999999999999766554432211
Q ss_pred ccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 705 VDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
.+....+..|.... ..+.+.+++++|++.||.+||+..|++.+++.++
T Consensus 254 --------------Av~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 --------------AVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------------eeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11122222222221 5567788899999999999999999999998875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=316.01 Aligned_cols=247 Identities=25% Similarity=0.316 Sum_probs=201.1
Q ss_pred CCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++++.||.|.-|+||++++++ +..+|+|++.+..... ..+......|-+||+.++||.+..|+..++.++..+|+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 457778999999999999999865 5899999987765544 34455677899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC-
Q 045256 573 YDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE- 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~- 641 (789)
||||+||+|..+++++. -++.+++-||+|||.++ ||+|||||+||||.++|++.|+||.|+.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999987653 36777888999999999 99999999999999999999999999742100
Q ss_pred --------------------------------CCC---------------------CCcccccccCcCccCccccCCCCC
Q 045256 642 --------------------------------SER---------------------DFRPMKAAGTVGYIDPEYYGLNVL 668 (789)
Q Consensus 642 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 668 (789)
... ..+....+||-.|+|||++++...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011224579999999999999999
Q ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcC
Q 045256 669 TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVN 748 (789)
Q Consensus 669 ~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~ 748 (789)
+.++|+|+|||+|||||.|+.||.+.+. .+.+..++.+.+..+... +.....++||++.|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~-----------------~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN-----------------KETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLV 373 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc-----------------hhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhc
Confidence 9999999999999999999999977654 223455555555544432 455667888999999
Q ss_pred cCCCCCCC----HHHHHHH
Q 045256 749 LEGKERPT----MADIVAN 763 (789)
Q Consensus 749 ~dp~~RPt----~~evl~~ 763 (789)
+||.+|.. +.||-++
T Consensus 374 KdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cChhhhhccccchHHhhcC
Confidence 99999998 7776654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=339.45 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=200.8
Q ss_pred HHHhcCCccccceEeecccEEEEEEEeCC--C--cE-EEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEE
Q 045256 489 LAAATNNFSLENKIGAGSFGVVYKGKLPD--G--QE-VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYC 563 (789)
Q Consensus 489 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~--g--~~-vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 563 (789)
++...++..+.++||+|.||.||+|+++. + .. ||||..+... ....+...+|.+|.++|++++|||||+++|++
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 33444566777999999999999998642 2 23 8999865422 12245567899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
....++|+|||++.+|+|.++|++. .++..++|+||+|||++. ++||||-.+|+|++.+..+||+|||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccc
Confidence 9999999999999999999999753 357889999999999999 9999999999999999999999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhh
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
|++.... .........-..+|+|||.+....++.++|||||||++||+++ |..||.....
T Consensus 308 Ls~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~----------------- 368 (474)
T KOG0194|consen 308 LSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN----------------- 368 (474)
T ss_pred cccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-----------------
Confidence 9876431 1111111134689999999999999999999999999999999 7777754332
Q ss_pred hhhhHHhh---cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 714 AGELVKIL---DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 714 ~~~~~~~~---d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
..+..-+ ..++..+. ..+..+..++.+||..||++||+|.++.+.|+.+....+.
T Consensus 369 -~~v~~kI~~~~~r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 369 -YEVKAKIVKNGYRMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -HHHHHHHHhcCccCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1111111 22333333 3344566667789999999999999999999998766553
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.72 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=186.3
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|+..+.||+|+||.||++... +++.||||++..... ......+.+|++++++++|+||+++++++.+.+..++||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc---HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 4556789999999999999864 689999998754322 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHh----hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 574 DYMKNGALYDHLH----DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 574 e~~~~gsL~~~l~----~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
||+++++|.+... ....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 152 e~~~~~~L~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 226 (353)
T PLN00034 152 EFMDGGSLEGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCN 226 (353)
T ss_pred ecCCCCcccccccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--ccc
Confidence 9999999876532 12368899999999999998 99999999999999999999999999876433221 112
Q ss_pred ccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 650 KAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
...||..|+|||.+.. ...+.++|||||||++|||++|+.||...... ++.. .........
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--------~~~~------~~~~~~~~~ 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--------DWAS------LMCAICMSQ 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--------cHHH------HHHHHhccC
Confidence 3568999999998743 23456899999999999999999999632210 1100 000110000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...........+.+|+.+||+.||++||++.|++++
T Consensus 293 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011112234456788889999999999999999986
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=325.61 Aligned_cols=247 Identities=27% Similarity=0.458 Sum_probs=195.7
Q ss_pred CCccccceEeecccEEEEEEEeCC------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++|++.+.||+|+||.||++.... .+.|++|.+..... ......|.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE---PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC---HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 468889999999999999997533 25799998764322 233456889999999999999999999999988
Q ss_pred eEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD 623 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~ 623 (789)
..+++|||+++++|.+++... ..++.|++.||+|||+.+ ++|+||||+|||++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEc
Confidence 999999999999999998643 258899999999999998 99999999999999
Q ss_pred CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 045256 624 AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPV 702 (789)
Q Consensus 624 ~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~ 702 (789)
+++.+||+|||++................+++.|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------ 232 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999876443332222223456788999999988889999999999999999998 9999865322
Q ss_pred ccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 703 SLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.++.+.+......+ .....+..+.+|+.+||+.||++||+++||+++|+.
T Consensus 233 ------------~~~~~~i~~~~~~~--~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 ------------QEVIEMIRSRQLLP--CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHHHHcCCcCC--CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111221111111 122344667788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=338.86 Aligned_cols=253 Identities=24% Similarity=0.353 Sum_probs=196.0
Q ss_pred hcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 564 (789)
..++|.+.++||+|+||.||+|... .+..||||+++..... ...+.+.+|+++++++. ||||+++++++.
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS---SEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3568999999999999999999752 2346999998653322 22346889999999996 999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh--------------------------------------------------------
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR-------------------------------------------------------- 588 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 588 (789)
+.+..||||||+++|+|.++|+..
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999987642
Q ss_pred ------------------------------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 045256 589 ------------------------------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNI 620 (789)
Q Consensus 589 ------------------------------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NI 620 (789)
..++.|+++||+|||+.+ |+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 136778999999999998 99999999999
Q ss_pred EECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 045256 621 LLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGG 699 (789)
Q Consensus 621 ll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~ 699 (789)
|++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 999999999999999876433322222223456788999999988889999999999999999997 88887543210
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
......+......+ ........+.+++.+||+.||++||++.++.+.|++++.
T Consensus 347 ---------------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 ---------------STFYNKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---------------HHHHHHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 00001111111100 112334567788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=334.60 Aligned_cols=237 Identities=23% Similarity=0.337 Sum_probs=187.0
Q ss_pred ceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCC
Q 045256 500 NKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 578 (789)
+.||+|+||.||+++. .+++.||+|+++...... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIA-KDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999986 468899999976533222 22344577899999999999999999999999999999999999
Q ss_pred CchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 579 GALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 579 gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~ 154 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cccc
Confidence 9999988643 247789999999999999 99999999999999999999999999875322211 1224
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 730 (789)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .....+.......+.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----------------~~~~~~~~~~~~~p~- 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELILMEEIRFPR- 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCC-
Confidence 57899999999999989999999999999999999999999643210 001111111222222
Q ss_pred CHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 731 NEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 731 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.....+.+++.+||+.||++|| ++.+++++
T Consensus 217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 ---TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2334566788899999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.21 Aligned_cols=240 Identities=25% Similarity=0.392 Sum_probs=193.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.||+|++....... ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 57899999999999999999875 58899999976533222 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++.... .++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 99999999999986532 46789999999999998 9999999999999999999999999987643322
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
....||+.|+|||++....++.++||||||+++|||++|+.||..... ......+....
T Consensus 173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------------~~~~~~i~~~~ 231 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----------------FRIYEKILAGR 231 (329)
T ss_pred ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHhcCC
Confidence 235789999999999998899999999999999999999999964321 00111222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
+..+.. ....+.+|+.+||+.||++||+ ++|++++
T Consensus 232 ~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 LKFPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred cCCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 222222 2234667888999999999996 6888765
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=344.94 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=198.8
Q ss_pred cCCccccceEeecccEEEEEEEeCCC-cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEE-EEe----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDG-QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGY-CEE---- 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~-~~~---- 565 (789)
..++++.+.|.+|+|+.||++.+..+ ..||+|++.... ....+.+.+|+++|++|+ |||||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~d----e~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVND----EEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCC----HHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 35678899999999999999997766 999999965542 344567899999999996 9999999993 221
Q ss_pred --CCeEEEEEEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 566 --KDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 566 --~~~~~lv~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
.-+++|+||||.+|.|.|++.+|. +|+.++++|+++||.+. |||||||||-+||||+.+++.|||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence 236789999999999999998653 69999999999999997 88999999999999999999999999
Q ss_pred ccCcCCCCCCCCCc-------ccccccCcCccCcccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 045256 634 GLSMMGPESERDFR-------PMKAAGTVGYIDPEYY---GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703 (789)
Q Consensus 634 Gls~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~ 703 (789)
|.+.-......... .....-|+.|+|||++ ++..++.|+|||+|||+||-|+....||+....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------- 263 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------- 263 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence 98853211111100 1123468999999976 778899999999999999999999999965432
Q ss_pred cccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 704 LVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
..+++.....|.. ......|.+||..||+.||++||++-+++..+.++..
T Consensus 264 --------------laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 --------------LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred --------------eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1123333222221 3456678888999999999999999999999998865
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=332.97 Aligned_cols=248 Identities=22% Similarity=0.289 Sum_probs=193.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||+|+++...... ......+.+|++++.+++||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK-LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 46899999999999999999875 58899999976543222 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999998643 247789999999999999 99999999999999999999999999875433
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ...+. .....+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~----~~~i~--~~~~~~~~~ 220 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-----T----WENLK--YWKETLQRP 220 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-----H----HHHHH--hccccccCC
Confidence 1224578999999999998899999999999999999999999986432200 0 00000 000111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. ...........+.+++.+||..+|++||+++|++++
T Consensus 221 ~--~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 V--YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred C--CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 000011234456678889999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=375.43 Aligned_cols=258 Identities=25% Similarity=0.418 Sum_probs=199.3
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
..|...++||+|+||.||+|.. .+++.||||++...... ..+|++++++++||||++++++|.+.+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI--------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 3566778999999999999986 57899999987543221 23468889999999999999999999999999
Q ss_pred EEecCCCchhHHHhh-----hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 573 YDYMKNGALYDHLHD-----RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~-----~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
|||+++|+|.++++. +.+++.++++||+|||....++|+||||||+||+++.++.+++. |+........
T Consensus 762 ~Ey~~~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----- 835 (968)
T PLN00113 762 HEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----- 835 (968)
T ss_pred EeCCCCCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----
Confidence 999999999999863 45789999999999996655669999999999999999988876 6655432111
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
....+++.|+|||++....++.++|||||||++|||+||+.||...... ......|.............++..+..
T Consensus 836 -~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 -TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred -CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---CCcHHHHHHHhcCccchhheeCccccC
Confidence 1235789999999999999999999999999999999999998543221 122333433322223334445554433
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
......+....+.+++.+||+.||++||+|+|+++.|+++.+
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 222233445566788999999999999999999999998755
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=319.59 Aligned_cols=246 Identities=23% Similarity=0.429 Sum_probs=192.7
Q ss_pred CCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||.||++.++ .+..||+|.++..... .....|.+|+.++++++||||+++++++...+..
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD---KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 56889999999999999999753 3568999987654322 2234688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999988642 257889999999999998 9999999999999999999999999875432
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
... ........++..|+|||.+....++.++||||||+++|||++ |+.||...... +.+..
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-----------------~~~~~ 220 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-----------------DVIKA 220 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----------------HHHHH
Confidence 211 111112345678999999998999999999999999999875 99998543220 00111
Q ss_pred hhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 720 ILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 720 ~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
+.+. ..+.+ ...+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 221 ~~~~~~~~~~----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 221 VEDGFRLPAP----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHCCCCCCCC----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111 11111 22345577788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=303.20 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=202.2
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhh----HHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKK----FQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 567 (789)
+.|...+.||+|..+.|.++.. ++++.+|+|++....... ..+..++-.+|+.||+++ .||||+.+.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677788999999999998865 468899999876433222 234456678899999999 6999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 568 ERLLVYDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.+++|+|.|+.|.|+|+|.+ .++|++|+++|++|||... ||||||||+|||+|++.++||+|||+++.+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999964 3579999999999999999 999999999999999999999999999887
Q ss_pred CCCCCCCcccccccCcCccCccccCC------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGL------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
+..++. ...+||++|+|||.+.- ..|+..+|+|++|+|+|.||.|.+||+.... +.
T Consensus 174 ~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---------------ml 235 (411)
T KOG0599|consen 174 EPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---------------ML 235 (411)
T ss_pred CCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---------------HH
Confidence 666543 35799999999998832 3578899999999999999999999965322 00
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.++.+.............+.....++|+.+||+.||.+|.|++|++++=
T Consensus 236 --MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 236 --MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred --HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 1122223333333334567778888999999999999999999999863
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.62 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=194.9
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... ++..||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999865 578899998764322 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999999998653 257889999999999853 29999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC--------------ccccccc---
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG--------------TPVSLVD--- 706 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~--------------~~~~~~~--- 706 (789)
.....+++.|+|||++.+..++.++||||||+++|||++|+.||...+...- .+.....
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 1234689999999999988999999999999999999999999954321000 0000000
Q ss_pred --------c---hhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 707 --------F---AVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 707 --------~---~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
. ..+......+.+.+.... .+..........+.+|+.+||+.||++|||++|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEP-PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCC-CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 000000000011111100 01111112345577889999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=308.58 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=191.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--CCeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--KDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~ 570 (789)
++|+.++.|++|+||.||+|+++ +++.||+|+++..+... ..--...+|+.+|.+++|||||.+..+... -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~--GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE--GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC--CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 46778899999999999999864 68899999988755322 112235689999999999999999988764 45699
Q ss_pred EEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
|||||++. +|..++... +-+..|+++|++|||.+. |+|||||++|+|++..|.+||+|||+|+.+..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99999988 898888653 357889999999999999 99999999999999999999999999998766
Q ss_pred CCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhhhhh--
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIMAGE-- 716 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~-- 716 (789)
..... +..+-|..|+|||++.+ ..|+...|+||+|||+.||+++++.|.+..+..+....+ ...+...+..+.
T Consensus 230 p~k~~--T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 PLKPY--TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CcccC--cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 54322 34567999999999865 568999999999999999999999887765543221111 111111111110
Q ss_pred --hH----------HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 --LV----------KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 --~~----------~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ..+.+.+.... ..+.=.+|+...|..||++|.|+.|.+++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~-----lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALS-----LSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccc-----cchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 00111111000 12333456677899999999999998875
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=303.02 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=194.2
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..+.|++.+.||+|.|+.||++.. .+|+.+|+|++...+... ..-+.+.+|+.|.+.|+||||++|.+.+.+....|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 346788889999999999999964 578999999876544332 23456899999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEeeccCcCC
Q 045256 571 LVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDFGLSMMG 639 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGls~~~ 639 (789)
||+|++++++|..-+-.|. ..++||+++|.|.|.++ |||||+||.|+||-. .--+||+|||++...
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999999987665442 57889999999999999 999999999999943 346899999999876
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
... .......|||.|||||+++..+|+..+|||+.|||||-||.|.+||.+++.. .+. ..
T Consensus 164 ~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------------rly----e~ 223 (355)
T KOG0033|consen 164 NDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------------RLY----EQ 223 (355)
T ss_pred CCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------------HHH----HH
Confidence 522 2334578999999999999999999999999999999999999999774431 000 11
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+......-+........+.-++|+.+||..||.+|.|+.|.+++
T Consensus 224 I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 224 IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11111111111122233445667788999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=323.28 Aligned_cols=242 Identities=23% Similarity=0.381 Sum_probs=198.7
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
..|+..+.||+|.||.||+|.+ +.++.||+|++..... ....+++.+|+.+|.+++++||.++++.|.....++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~---~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA---EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhc---chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 4577789999999999999975 4688999999765433 33455788999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+.+|++.+.|+... -+.++++.||.|||..+ .+|||||+.|||+..++.+||+|||++........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999999986432 36889999999999999 89999999999999999999999999876544332
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
...+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+ +.+. -++-+.
T Consensus 167 --rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----mrvl-------------flIpk~ 226 (467)
T KOG0201|consen 167 --RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----MRVL-------------FLIPKS 226 (467)
T ss_pred --ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----ceEE-------------EeccCC
Confidence 22578999999999999988999999999999999999999999855432 1110 011111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.|+..+......+++++..||.+||+.||++.+++++
T Consensus 227 --~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 227 --APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred --CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1222233566778899999999999999999999875
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.41 Aligned_cols=248 Identities=25% Similarity=0.331 Sum_probs=190.8
Q ss_pred CccccceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
+|++.+.||+|+||.||+++. .+++.||+|++............+.+.+|+++++++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999875 357899999976544333333445678899999999 599999999999999999
Q ss_pred EEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
++||||+++++|.+++..+. .++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 99999999999999886532 47789999999999998 99999999999999999999999999875433
Q ss_pred CCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......... . .....+
T Consensus 158 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---------~----~~~~~~ 223 (332)
T cd05614 158 EEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---------S----EVSRRI 223 (332)
T ss_pred cCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---------H----HHHHHH
Confidence 2221 22245789999999998765 4788999999999999999999999643321100 0 001111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.......+. .....+.+++.+||+.||++|| ++++++++
T Consensus 224 ~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 224 LKCDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred hcCCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111111 2334567788899999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.22 Aligned_cols=238 Identities=24% Similarity=0.355 Sum_probs=188.3
Q ss_pred ceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
+.||+|+||.||+++. .+++.||+|+++.............+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 357899999987544333333345578899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 576 MKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 576 ~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
+++++|.+++.... .++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--V 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--c
Confidence 99999999886432 46789999999999998 99999999999999999999999999864322221 1
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
.....|++.|+|||++....++.++||||||+++|||++|+.||...+. ...+..+.......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----------------~~~~~~~~~~~~~~ 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----------------KKTIDKILKGKLNL 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCCCCC
Confidence 2235689999999999888899999999999999999999999964331 01112222222222
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
+.. ....+.+++.+||+.||++|| ++.+++++
T Consensus 220 ~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 222 233466788899999999999 78888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.58 Aligned_cols=248 Identities=25% Similarity=0.452 Sum_probs=192.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
.+|++.+.||+|+||.||+|.+. +++ .||+|.++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 56899999999999999999753 333 389998754322 22344688999999999999999999999764 5
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++++||+++|+|.+++.+. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 78999999999999998753 257889999999999998 999999999999999999999999999865
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..............+..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------------------~~~~ 221 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEIS 221 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------------------HHHH
Confidence 44333222222334678999999998899999999999999999998 8888743211 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.++.. .++.+.. ....+..++.+||..||++||++.+++..|.++.+.
T Consensus 222 ~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 222 SILEKGERLPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred HHHhCCCCCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11111 1122222 123456788899999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.31 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=191.8
Q ss_pred CCccccceEeecccEEEEEEEeCC--CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD--GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||++..++ +..||+|++....... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK-QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 578999999999999999997543 3689999876543222 2334568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999999999998653 257889999999999999 999999999999999999999999998764322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. .....+...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----------------~~~~~i~~~ 243 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----------------LIYQKILEG 243 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----------------HHHHHHhcC
Confidence 12457899999999998888999999999999999999999999653320 011122222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
....+... ...+.+++.+|++.||++|+ +++|++++
T Consensus 244 ~~~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 IIYFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 22222222 23456778899999999995 89988876
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.02 Aligned_cols=237 Identities=24% Similarity=0.340 Sum_probs=186.4
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 578 (789)
+.||+|+||.||+++.. +++.||+|+++...... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 46999999999999864 68999999976533221 22344577899999999999999999999999999999999999
Q ss_pred CchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 579 GALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 579 gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~ 154 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKT 154 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cccc
Confidence 9999887643 257889999999999998 99999999999999999999999999865322211 1123
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 730 (789)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. .....+.......+.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----------------~~~~~~~~~~~~~p~- 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------RLFELILMEEIRFPR- 216 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHhcCCCCCCC-
Confidence 56899999999999889999999999999999999999998643320 001111112222222
Q ss_pred CHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 731 NEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 731 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.....+.+++.+||+.||++|| ++.+++++
T Consensus 217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 ---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2234566788899999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=329.41 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=193.2
Q ss_pred hcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
..++|++.+.||+|+||.||++... +++.||+|+++.... ......+.+|++++.++ +||||++++++|.
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT---ASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC---HHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 3457999999999999999999632 347899998764322 12234577899999999 8999999999887
Q ss_pred eC-CeEEEEEEecCCCchhHHHhhh-------------------------------------------------------
Q 045256 565 EK-DERLLVYDYMKNGALYDHLHDR------------------------------------------------------- 588 (789)
Q Consensus 565 ~~-~~~~lv~e~~~~gsL~~~l~~~------------------------------------------------------- 588 (789)
.. ...+++|||+++++|.+++...
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 54 4578999999999999987531
Q ss_pred --------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccC
Q 045256 589 --------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT 654 (789)
Q Consensus 589 --------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt 654 (789)
..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++................++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~ 238 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCC
Confidence 246789999999999998 999999999999999999999999999765433222222234556
Q ss_pred cCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHH
Q 045256 655 VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEA 733 (789)
Q Consensus 655 ~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 733 (789)
..|+|||++....++.++|||||||+||||++ |+.||....... .+.+.+....... .+.
T Consensus 239 ~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~--~~~ 299 (337)
T cd05054 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----------------EFCRRLKEGTRMR--APE 299 (337)
T ss_pred ccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-----------------HHHHHHhccCCCC--CCc
Confidence 78999999999999999999999999999998 998885422100 0111111111000 011
Q ss_pred HHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 734 EAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 734 ~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.....+.+++.+||+.+|++||++.|++++|+++++
T Consensus 300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 223456778889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.10 Aligned_cols=235 Identities=25% Similarity=0.338 Sum_probs=184.6
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|+||.||++... +++.||+|++....... ......+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVS-RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 689999999999865 57899999876433221 2234567889999999999999999999999999999999999999
Q ss_pred hhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccc
Q 045256 581 LYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA 652 (789)
Q Consensus 581 L~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~ 652 (789)
|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 154 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFC 154 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccccc
Confidence 99998643 247889999999999998 99999999999999999999999999875322221 222457
Q ss_pred cCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCH
Q 045256 653 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINE 732 (789)
Q Consensus 653 gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 732 (789)
||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......++......+.
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----------------~~~~~~~~~~~~~~~~--- 214 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------NEMYRKILQEPLRFPD--- 214 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----------------HHHHHHHHcCCCCCCC---
Confidence 89999999999998999999999999999999999999964321 0111122222222222
Q ss_pred HHHHHHHHHHHHhhcCcCCCCCCC---HHHHHHH
Q 045256 733 AEAVELVAYTAMHCVNLEGKERPT---MADIVAN 763 (789)
Q Consensus 733 ~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~ 763 (789)
.....+.+++.+||+.||++||+ +.|++.+
T Consensus 215 -~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 215 -GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred -cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 23345677888999999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=310.66 Aligned_cols=266 Identities=24% Similarity=0.325 Sum_probs=194.8
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-----C
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-----K 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~ 566 (789)
...|...+.||+|+||.|+.+.. .+|+.||||++...-... -..+...+|+++|++++|+||+.+++.+.. -
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~--~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ--IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch--HHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 35666679999999999999975 478999999876433222 223457799999999999999999999865 3
Q ss_pred CeEEEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 DERLLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...|+|+|+|+. +|...++... -+..|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+.
T Consensus 99 ~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 99 NDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred ceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 468999999965 9999987654 47789999999999999 99999999999999999999999999997
Q ss_pred CCCCCCCCcccccccCcCccCcccc-CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccch----hhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYY-GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDFA----VPA 711 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~----~~~ 711 (789)
..........+..+-|..|+|||++ ....|+...||||.||||.||++|++-|.+.+...+.... +..-+ ...
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 6544222233456789999999987 4568999999999999999999999998766543322111 11111 111
Q ss_pred hhhhhhHHhhcccCCCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+..+.....+......+...- ..+.....+|+.+||..||.+|+|++|++++-
T Consensus 255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 122223333322211111110 01122234566779999999999999999874
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=320.04 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=191.9
Q ss_pred hcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE 565 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 565 (789)
..++|++.+.||+|+||.||++... ++..||+|.+...... .....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM---RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4567999999999999999998753 3467999986543221 223458899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT 627 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 627 (789)
....++||||+++++|.+++... ..++.++++||+|||+.+ ++|+||||+|||+++++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCC
Confidence 99999999999999999998642 246779999999999988 999999999999999999
Q ss_pred EEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccccc
Q 045256 628 ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 628 ~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 706 (789)
++|+|||++................++..|+|||.+....++.++||||||+++|||++ |+.||..... .
T Consensus 158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~---- 228 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----E---- 228 (277)
T ss_pred EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H----
Confidence 99999999875433222111122345778999999988889999999999999999999 6777743221 0
Q ss_pred chhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.....+........ .......+.+++.+||+.||++||++.|+++.|++
T Consensus 229 --------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 229 --------QVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --------HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00011111111111 11233457788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.77 Aligned_cols=237 Identities=24% Similarity=0.332 Sum_probs=186.4
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 578 (789)
++||+|+||.||++... +++.||+|++....... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999864 68999999976533222 22345678899999999999999999999999999999999999
Q ss_pred CchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 579 GALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 579 gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~ 154 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKT 154 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cccc
Confidence 9999887543 257889999999999998 99999999999999999999999999875322211 1224
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 730 (789)
..||+.|+|||++....++.++||||||+++|||++|+.||...+.. .....+.......+.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----------------~~~~~~~~~~~~~p~- 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELILMEDIKFPR- 216 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----------------HHHHHhccCCccCCC-
Confidence 56899999999999889999999999999999999999999643210 001111111111122
Q ss_pred CHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 731 NEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 731 ~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.....+.+++.+||+.||++|| ++.|++++
T Consensus 217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 ---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2234456778899999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=329.95 Aligned_cols=197 Identities=25% Similarity=0.387 Sum_probs=166.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.||+|++....... ......+.+|+.++.+++||||+++++.+.+....|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence 47899999999999999999764 58899999976533222 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 9999999999998653 257889999999999998 99999999999999999999999999865332110
Q ss_pred C---------------------------------CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 045256 645 D---------------------------------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 645 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf 691 (789)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0012347999999999999889999999999999999999999999
Q ss_pred CCC
Q 045256 692 FKD 694 (789)
Q Consensus 692 ~~~ 694 (789)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=334.29 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=186.9
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|++.+.||+|+||+||+++. .+++.||+|++....... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN-RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 588899999999999999975 467899999976533222 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC-
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER- 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~- 644 (789)
||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999998643 246789999999999998 99999999999999999999999999753211000
Q ss_pred --------------------------------------------CCcccccccCcCccCccccCCCCCCchhHHHHHHHH
Q 045256 645 --------------------------------------------DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVV 680 (789)
Q Consensus 645 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvi 680 (789)
........||+.|+|||++....++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000113469999999999988889999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc--c--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC
Q 045256 681 LLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD--R--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPT 756 (789)
Q Consensus 681 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt 756 (789)
+|||++|+.||...... .....+++ . ..+.......++.+.+.++ .|+..+|..||+
T Consensus 238 l~elltG~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~l--l~~~~~~~~R~~ 298 (381)
T cd05626 238 LFEMLVGQPPFLAPTPT-----------------ETQLKVINWENTLHIPPQVKLSPEAVDLITKL--CCSAEERLGRNG 298 (381)
T ss_pred HHHHHhCCCCCcCCCHH-----------------HHHHHHHccccccCCCCCCCCCHHHHHHHHHH--ccCcccccCCCC
Confidence 99999999999654320 00111111 1 1111112234444444332 156677777999
Q ss_pred HHHHHHH
Q 045256 757 MADIVAN 763 (789)
Q Consensus 757 ~~evl~~ 763 (789)
+.|++++
T Consensus 299 ~~~~l~h 305 (381)
T cd05626 299 ADDIKAH 305 (381)
T ss_pred HHHHhcC
Confidence 9999886
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=318.22 Aligned_cols=245 Identities=25% Similarity=0.440 Sum_probs=192.3
Q ss_pred CCccccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||.||+|.. .+++.|++|.+..... ......+.+|++++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN---PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 4688899999999999999974 3467899998764322 2234468899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh-------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC
Q 045256 569 RLLVYDYMKNGALYDHLHDR-------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD 623 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~-------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~ 623 (789)
.+++|||+++++|.+++..+ ..++.+++.||+|||+.+ |+|+||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEc
Confidence 99999999999999988422 247889999999999998 99999999999999
Q ss_pred CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 045256 624 AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPV 702 (789)
Q Consensus 624 ~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~ 702 (789)
+++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------ 232 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------ 232 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------
Confidence 999999999999976433322222223345678999999988889999999999999999998 8888854321
Q ss_pred ccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 703 SLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
..+.+.+... +..+. .....+..++.+||+.||++||++.+++++|..
T Consensus 233 ------------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 ------------QEVIEMVRKRQLLPCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ------------HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111122111 11111 223456778889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.80 Aligned_cols=261 Identities=19% Similarity=0.268 Sum_probs=187.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +++.||+|+++...... ....+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57999999999999999999865 67899999876433211 223477899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 999975 898887532 247889999999999998 9999999999999999999999999987543222
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhh-----hh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIM-----AG 715 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~-----~~ 715 (789)
. ......+++.|+|||.+.+ ..++.++||||||+++|||++|++||............. ...+..... ..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1 1123467899999998865 568999999999999999999999996543211000000 000000000 00
Q ss_pred hhHHhhcccCCCCC--CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 716 ELVKILDRRVGPPE--INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 716 ~~~~~~d~~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+....+........ ...........+|+.+||+.||.+|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00111100000000 0000112345678889999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=324.92 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=206.9
Q ss_pred hcCCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 569 (789)
....|++.+.||+|.||.||++..+. |+.+|+|.+.+....... ..+.+.+|+++|+++. |||||.+.+.|++...+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34678999999999999999998765 999999998776554322 3456899999999998 99999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC----CcEEEEeeccCcC
Q 045256 570 LLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ----WTARVSDFGLSMM 638 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGls~~ 638 (789)
++|||++.+|.|++.+..+ ..++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++..
T Consensus 112 ~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 9999999999999998764 257889999999999999 9999999999999543 5799999999987
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.... ......+||+.|+|||++....|+..+||||+|+++|.|+.|.+||....+.. ...
T Consensus 189 ~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-----------------~~~ 248 (382)
T KOG0032|consen 189 IKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-----------------IFL 248 (382)
T ss_pred ccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-----------------HHH
Confidence 6552 23346789999999999999999999999999999999999999998765421 112
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
++................+...+++..++..||.+|+|+.+++++
T Consensus 249 ~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 333443333334445566777888999999999999999999996
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=314.19 Aligned_cols=248 Identities=27% Similarity=0.521 Sum_probs=195.2
Q ss_pred CCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||.||+|.++. ...|++|.++.... ......|.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS---DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC---hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 578899999999999999998642 45799998764332 22344688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+++|||+++++|.+++... ..++.+++.||+|||+.+ |+|+||||+|||+++++.++|+|||++....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999998542 357889999999999988 9999999999999999999999999998764
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
............++..|+|||.+....++.++||||||+++|||++ |..||..... . .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------------~----~~~~~ 220 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------------Q----DVIKA 220 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------------H----HHHHH
Confidence 3222222223345678999999998899999999999999999998 9888743221 0 00111
Q ss_pred hhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 720 ILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 720 ~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+.+. ..+.+. .....+.+++.+||+.+|++||++.|++++|++++
T Consensus 221 ~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 221 VEDGYRLPPPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred HHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1111 111111 22345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=339.83 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=190.1
Q ss_pred CccccceEeecccEEEEEEEeC-C-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-D-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.|.+.+.||+|+||.||++... + ++.|++|.+.... ......+.+|+.++++++||||+++++++...+..|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND----ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4889999999999999999743 3 5778888754322 22234578899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 573 YDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|||+++|+|.++|+++ ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 9999999999887542 247789999999999998 9999999999999999999999999998654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
............||+.|+|||++....++.++||||||+++|||++|+.||..... .+.+..+
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----------------~~~~~~~ 283 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----------------REIMQQV 283 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHH
Confidence 43322223345799999999999989999999999999999999999999854321 0111111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.....+. +......+.+++.+||+.||++||++.+++.+
T Consensus 284 ~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 284 LYGKYDPF---PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HhCCCCCC---CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11111110 11223456778889999999999999998753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.49 Aligned_cols=247 Identities=24% Similarity=0.432 Sum_probs=193.6
Q ss_pred CCccccceEeecccEEEEEEEeCC------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++|.+.+.||+|+||.||++...+ ++.|++|.++.... .+....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC---HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 467888999999999999997633 47899998765332 223456899999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh----------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR----------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~----------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
..++||||+++++|.+++... ..++.+++.+|+|||+.+ ++||||||+|||++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCC
Confidence 999999999999999998642 246889999999999998 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~ 704 (789)
+.+||+|||++................++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------- 231 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------- 231 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------
Confidence 9999999999875433221111223345788999999999999999999999999999998 99998643320
Q ss_pred ccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 705 VDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.....+........ .......+.+++.+||+.||++||++.|+++.|++
T Consensus 232 ----------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 ----------EVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----------HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 00111111111111 11233456788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=320.79 Aligned_cols=193 Identities=25% Similarity=0.399 Sum_probs=160.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||+++.. +++.||+|++...... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE---GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc---ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence 368999999999999999999875 6889999987643321 122346789999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 999996 5888777532 357889999999999999 999999999999999999999999998653222
Q ss_pred CCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
.. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1223567899999998865 46889999999999999999999999653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=314.38 Aligned_cols=245 Identities=27% Similarity=0.454 Sum_probs=193.7
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.++||+|+||.||++...+++.|++|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 367899999999999999999988888999998654322 234688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++++|.++++.. ..++.++++||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999998642 247789999999999988 999999999999999999999999999764432
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......++..|+|||.+....++.++||||||+++|||+| |+.||...... .....+
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------------------~~~~~~ 217 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------------------DVMSAL 217 (261)
T ss_pred cee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------------------HHHHHH
Confidence 211 1112345678999999988889999999999999999998 88888543210 000111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
......+. .......+.+++.+||..+|++||+++++.+.|++
T Consensus 218 ~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 218 QRGYRMPR--MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HcCCCCCC--CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111111 11223456778899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=330.73 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=189.4
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..+|++.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 46899999999999999999986 468899999632 1236789999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|+|++. ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 999996 5888887543 367899999999999998 9999999999999999999999999986532221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc---cccc-------h--hhh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS---LVDF-------A--VPA 711 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~---~~~~-------~--~~~ 711 (789)
. .......||+.|+|||++....++.++||||||+++|||++|+.||+........... +... + .+.
T Consensus 237 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 A-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred c-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 1 1222457999999999999889999999999999999999999988754322111000 0000 0 000
Q ss_pred hhhhhhHHh----hcccCCCCCC-----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKI----LDRRVGPPEI-----NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~----~d~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+.+. .......+.. ...+....+.+|+.+||+.||++|||++|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000001111 1110000000 012334567889999999999999999999864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=328.00 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=186.6
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-----e
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-----E 568 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~ 568 (789)
+|++.+.||+|+||.||++... +++.||||++...... ......+.+|++++++++||||+++++++.... .
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH--VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc--chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 5888999999999999999854 6899999987643211 122345789999999999999999999886432 4
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.|+||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 799999996 5898887543 357889999999999998 9999999999999999999999999987532
Q ss_pred CCCC-CCcccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc--cccccch----hhh
Q 045256 641 ESER-DFRPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP--VSLVDFA----VPA 711 (789)
Q Consensus 641 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~----~~~ 711 (789)
.... ........+|+.|+|||++.. ..++.++||||||+++|||++|++||...+...... ......+ ...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 111124568999999999865 678999999999999999999999986543210000 0000000 000
Q ss_pred hhhhhhHHhhcccCCCCCCC-H---HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEIN-E---AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~-~---~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+......+.+.......... . ......+.+++.+||+.||++||+++|++++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 01111111111100000000 0 0123445678899999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.67 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=197.9
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.|+||.+....... ......+.+|++++++++||||+++++++.+.+..+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC-HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 57899999999999999999854 78999999865432222 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 573 YDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+||+++++|.+++.. ...++.++++||+|||+.+ ++|+||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988742 1257889999999999998 9999999999999999999999999987643
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...... . ..+.+.
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~-------------~~~~~~ 219 (267)
T cd08228 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---L-------------FSLCQK 219 (267)
T ss_pred chhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---H-------------HHHHHH
Confidence 3221 112345788999999998888999999999999999999999998643210 0 011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
+.... .+..........+.+++.+||..+|++||++.|+++.|+++
T Consensus 220 ~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 220 IEQCD-YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HhcCC-CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11111 11111233446678889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=332.28 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=193.8
Q ss_pred HHHHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe
Q 045256 487 AELAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE 565 (789)
Q Consensus 487 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 565 (789)
.++....++|++.+.||+|+||.||+++.. +++.||+|++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 344445678999999999999999999865 57899999876432222 2223457889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
.+..|+||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 99999999999999999998642 257889999999999998 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLN----VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
...... .......||+.|+|||++... .++.++||||||++||||++|+.||..... .
T Consensus 192 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----------------~ 253 (370)
T cd05621 192 MDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----------------V 253 (370)
T ss_pred cccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----------------H
Confidence 433221 122345799999999998653 378899999999999999999999965432 0
Q ss_pred hhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCC--CCCHHHHHHH
Q 045256 715 GELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKE--RPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 763 (789)
+...++.+.. +..+. ..+....+.+++..|+..++.+ ||++.|++++
T Consensus 254 ~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 254 GTYSKIMDHKNSLNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHHHHhCCcccCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1112222211 11111 1223445666777788755543 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=332.73 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=189.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.||||++....... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE-KEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence 47899999999999999999865 68899999976533221 23345678899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999998653 257889999999999999 99999999999999999999999999864322110
Q ss_pred C------------------------------------CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCC
Q 045256 645 D------------------------------------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688 (789)
Q Consensus 645 ~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~ 688 (789)
. .......||+.|+|||++....++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 0011246899999999999889999999999999999999999
Q ss_pred CCCCCCCCCCCcccccccchhhhhhhhhhHHhhc--ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC---HHHHHHH
Q 045256 689 RAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT---MADIVAN 763 (789)
Q Consensus 689 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~ 763 (789)
.||...... .....++. ..+..+.. ......+.+++.+|+. +|.+|++ ++|++++
T Consensus 237 ~Pf~~~~~~-----------------~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQ-----------------ETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHH-----------------HHHHHHHcCCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999643320 00111111 11111111 1122345566777886 9999998 9888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=333.05 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=192.9
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
...++|++.+.||+|+||.||+++.. +++.||+|++....... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIK-RSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34568999999999999999999864 68899999976432221 12234577899999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
++||||+++|+|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999998653 246789999999999998 999999999999999999999999998754332
Q ss_pred CCCCcccccccCcCccCccccCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLN----VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.. .......||+.|+|||++... .++.++|||||||++|||++|+.||...... ....
T Consensus 196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----------------~~~~ 257 (370)
T cd05596 196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----------------GTYS 257 (370)
T ss_pred Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----------------HHHH
Confidence 21 122345789999999998643 4788999999999999999999999654320 1112
Q ss_pred Hhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCC--CCCHHHHHHH
Q 045256 719 KILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKE--RPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 763 (789)
++.+.. +..+. .......+.+++.+||..+|++ ||++.|++++
T Consensus 258 ~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 258 KIMDHKNSLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHcCCCcCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 222211 11111 1123345667788899999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=323.40 Aligned_cols=192 Identities=27% Similarity=0.377 Sum_probs=164.3
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.+++|++..... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 368999999999999999999875 578899998654322 2234468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.+++... ..++.+++++|+|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999998653 25778999999999975 5 999999999999999999999999998654322
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred cc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 11 2346889999999999888999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.20 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=194.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.||+|++....... ......+.+|++++..++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 47899999999999999999865 68999999976543221 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC-
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE- 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~- 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 9999999999998654 257889999999999988 9999999999999999999999999987644332
Q ss_pred --------------------------CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 045256 644 --------------------------RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDES 697 (789)
Q Consensus 644 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~ 697 (789)
.........||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001122356899999999999999999999999999999999999999654320
Q ss_pred CCcccccccchhhhhhhhhhHHhhc--ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-HHHHHHH
Q 045256 698 GGTPVSLVDFAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-MADIVAN 763 (789)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~~ 763 (789)
.....+.. ..+..+... .....+.+++.+|+. ||++||+ +.|++++
T Consensus 237 -----------------~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -----------------ETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----------------HHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 01111111 111111111 123456677788997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.71 Aligned_cols=262 Identities=20% Similarity=0.254 Sum_probs=191.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.+ +++.||+|++...... ......+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence 47899999999999999999875 5788999987654322 22344578899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||++++.+..+... ...++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999998766554321 2358899999999999998 99999999999999999999999999976533221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh---
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL--- 721 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 721 (789)
. ......+++.|+|||++.+..++.++|||||||++|||++|++||......... ........ ...........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~ 232 (287)
T cd07848 156 A-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL-FTIQKVLG-PLPAEQMKLFYSNP 232 (287)
T ss_pred c-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhhC-CCCHHHHHhhhccc
Confidence 1 122346899999999998888999999999999999999999999654321100 00000000 00000000000
Q ss_pred ---cccCCCC---CC----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 ---DRRVGPP---EI----NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 ---d~~~~~~---~~----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+.. .. ........+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 00 001234567889999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=313.08 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=194.1
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.+.||+|+||.||++...+++.|++|.++.... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467899999999999999999987788999998764322 13358899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+|||+++++|.+++... ..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 99999999999998643 257889999999999998 99999999999999999999999999876542
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .......+..|+|||.+....++.++||||||+++|||++ |+.||..... ..+...
T Consensus 156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------------~~~~~~ 216 (261)
T cd05068 156 DIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN------------------AEVLQQ 216 (261)
T ss_pred Cccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH------------------HHHHHH
Confidence 2111 1111223457999999988899999999999999999999 8888843221 011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
++.....+. .......+.+++.+|++.+|++||++.++++.|+++
T Consensus 217 ~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 217 VDQGYRMPC--PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HHcCCCCCC--CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111111110 112335567788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=317.07 Aligned_cols=249 Identities=27% Similarity=0.420 Sum_probs=193.1
Q ss_pred CccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
+|++.+.||+|+||.||+|... ....+++|.+..... ......+.+|+.++++++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS---SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence 4778899999999999999752 235688888654332 1223468899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh--------------------------------chHHHHHHHHHHHHHhcCCCCeEeccCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIK 616 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlk 616 (789)
.++++||+++++|.+++... ..++.|++.+|+|||+.+ |+|||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dik 154 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLA 154 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhh
Confidence 99999999999999987532 257889999999999998 9999999
Q ss_pred CCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 045256 617 SSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDD 695 (789)
Q Consensus 617 p~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~ 695 (789)
|+|||+++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||....
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999875433322111223345678999999988889999999999999999998 888884322
Q ss_pred CCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 696 ESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
. .++.+.+......+. .......+..++.+||+.||++||++.|+++.|++++.
T Consensus 235 ~------------------~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 235 P------------------ERLFNLLKTGYRMER--PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H------------------HHHHHHHhCCCCCCC--CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 111122222111110 11223456778889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=340.51 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=192.5
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC---
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD--- 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--- 567 (789)
..++|++.+.||+|+||+||+++. .+++.||||++...... ......+.+|+.++..++|+||+++...+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~--~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS--EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 346899999999999999999975 47899999997654322 223445789999999999999999988775432
Q ss_pred -----eEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEE
Q 045256 568 -----ERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630 (789)
Q Consensus 568 -----~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 630 (789)
..++||||+++|+|.++++.+ ..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 267999999999999988643 247889999999999998 999999999999999999999
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
+|||+++...............||+.|+|||++....++.++||||||++||||++|+.||.....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------------- 250 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------------- 250 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------------
Confidence 999999765433222223346799999999999999999999999999999999999999854321
Q ss_pred hhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+...+.....+ .+......+.+++.+||+.||++||++.+++++
T Consensus 251 ---~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 ---EEVMHKTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---HHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00111111111111 011223456778889999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=331.67 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=193.3
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEK 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 566 (789)
++|.+.+.||+|+||.||++++. .++.||+|+++..... ...+.+.+|+++|.++. ||||+++++++...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS---SEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh---hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 46778899999999999999853 3468999998653222 22345889999999997 99999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh----------------------------------------------------------
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------------------------------------------------------- 588 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------------------------------------------------------- 588 (789)
+..++||||+++|+|.++++..
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999998642
Q ss_pred ------------------------------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 045256 589 ------------------------------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNI 620 (789)
Q Consensus 589 ------------------------------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NI 620 (789)
..++.|++.||+|||+.+ |+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 125679999999999988 99999999999
Q ss_pred EECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 045256 621 LLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGG 699 (789)
Q Consensus 621 ll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~ 699 (789)
|+++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---
Confidence 999999999999999875432221111223356788999999988889999999999999999998 8888743221
Q ss_pred cccccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
.+...+.+... +..+. .....+.+++.+||..+|++||+++|+++.|++++
T Consensus 348 --------------~~~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 --------------NEQFYNAIKRGYRMAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --------------hHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00111111111 11111 22345778888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=332.93 Aligned_cols=196 Identities=26% Similarity=0.357 Sum_probs=164.0
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.++||+|+||+||+++.. +++.||+|++...... .......+.+|++++++++||||+++++.+.+.+..|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 6889999999999999999864 6789999987653321 2233456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC-
Q 045256 574 DYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER- 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~- 644 (789)
||+++|+|.+++.+.. .++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 9999999999986532 46789999999999998 99999999999999999999999999743210000
Q ss_pred --------------------------------------------CCcccccccCcCccCccccCCCCCCchhHHHHHHHH
Q 045256 645 --------------------------------------------DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVV 680 (789)
Q Consensus 645 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvi 680 (789)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112468999999999998899999999999999
Q ss_pred HHHHHcCCCCCCCC
Q 045256 681 LLELLTGKRAIFKD 694 (789)
Q Consensus 681 l~elltG~~pf~~~ 694 (789)
||||++|+.||...
T Consensus 238 l~elltG~~Pf~~~ 251 (382)
T cd05625 238 LYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=324.36 Aligned_cols=244 Identities=22% Similarity=0.333 Sum_probs=200.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe-EEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE-RLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-~~l 571 (789)
++|..++++|+|+||.++..+.+ +.+.|++|.+...+.... .++...+|+.++++++|||||.+.+.|.+++. .++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~--~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP--ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch--hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57888999999999999999764 578899998776543332 22257789999999999999999999999988 899
Q ss_pred EEEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||+|++||+|.+.+.+.+ +++.|++.|+.|||++. |+|||||+.|||++.+..+||.|||+|+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999999987543 57889999999999888 99999999999999999999999999998665
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......||+.||.||++.+.+|..|+|||||||++|||++-+++|...+- .+-+.+++
T Consensus 159 ~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----------------~~Li~ki~ 219 (426)
T KOG0589|consen 159 EDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----------------SELILKIN 219 (426)
T ss_pred chh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------------HHHHHHHh
Confidence 541 23367899999999999999999999999999999999999999966542 12223333
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.....+. +......++.++..|+..+|+.||++.+++.+-
T Consensus 220 ~~~~~Pl---p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 220 RGLYSPL---PSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred hccCCCC---CccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 3332221 223345567788899999999999999999874
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=332.68 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=187.0
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++.. .+++.||||++....... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK-KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence 4789999999999999999975 468899999876533221 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 9999999999988643 247889999999999999 99999999999999999999999999863211100
Q ss_pred C---------------------------------------------CcccccccCcCccCccccCCCCCCchhHHHHHHH
Q 045256 645 D---------------------------------------------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGV 679 (789)
Q Consensus 645 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGv 679 (789)
. .......||+.|+|||++....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0001246899999999999889999999999999
Q ss_pred HHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc--ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCC---
Q 045256 680 VLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAMHCVNLEGKER--- 754 (789)
Q Consensus 680 il~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R--- 754 (789)
+||||++|+.||...... +....+.. ..+..+.. ......+.+++.+|+. +|.+|
T Consensus 237 il~elltG~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 237 IMFECLIGWPPFCSENSH-----------------ETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred hhhhhhcCCCCCCCCCHH-----------------HHHHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCC
Confidence 999999999999543320 00011111 11111111 1122345667778887 66665
Q ss_pred CCHHHHHHH
Q 045256 755 PTMADIVAN 763 (789)
Q Consensus 755 Pt~~evl~~ 763 (789)
|++.|++++
T Consensus 297 ~~~~~~l~h 305 (377)
T cd05629 297 GGAHEIKSH 305 (377)
T ss_pred CCHHHHhcC
Confidence 699998886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.55 Aligned_cols=241 Identities=29% Similarity=0.479 Sum_probs=189.8
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.+.||+|+||.||++..+++..+++|.+..... ....+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 46888999999999999999988888999998654322 1235888999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++++|.++++.. ..++.+++.||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999999998642 257789999999999998 99999999999999999999999999875432221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||...... +.+..+...
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-----------------~~~~~i~~~ 217 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-----------------EVVEMISRG 217 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-----------------HHHHHHHCC
Confidence 1 1112234568999999988889999999999999999999 88888543210 001111111
Q ss_pred -cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 -RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 -~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+...+.. ....+.+++.+||+.||++||++.|+++.|
T Consensus 218 ~~~~~~~~----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 218 FRLYRPKL----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCC----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111111 223567888999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.21 Aligned_cols=232 Identities=29% Similarity=0.371 Sum_probs=179.0
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHH-HHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSEL-AFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||+||++... +++.||+|++.........+. ..+..|. .+++.++||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQ-KHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHH-HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46999999999999864 689999999765433222222 2344444 45678999999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTS 154 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccc
Confidence 99999888643 247889999999999998 99999999999999999999999999865322211 222
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+. .+....++......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----------------~~~~~~i~~~~~~~~~ 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----------------AEMYDNILNKPLRLKP 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----------------HHHHHHHHcCCCCCCC
Confidence 45689999999999988999999999999999999999999964321 0111122222222222
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMA 758 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 758 (789)
. ....+.+++.+||+.||++||+++
T Consensus 218 ~----~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 N----ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 234566788899999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.07 Aligned_cols=249 Identities=27% Similarity=0.442 Sum_probs=194.3
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++|.+.+.||+|+||.||++... ++..+++|.+.... ......+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 57888999999999999999742 34568999875432 223446889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh---------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR---------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~---------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 626 (789)
..++||||+++++|.+++... ..++.|++.+|+|||+.+ ++||||||+|||+++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 999999999999999988532 247889999999999998 99999999999999999
Q ss_pred cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccc
Q 045256 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 627 ~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 705 (789)
.+||+|||++................++..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------- 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------- 229 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence 999999999875433222111223345778999999988889999999999999999998 88887543210
Q ss_pred cchhhhhhhhhhHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 706 DFAVPAIMAGELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+..+..... ..+.. ....+.+++.+||+.||.+|||+.|+++.|+++...
T Consensus 230 ---------~~~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 ---------EVIECITQGRVLQRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ---------HHHHHHHcCCcCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 00111111111 11111 223467889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=311.30 Aligned_cols=258 Identities=26% Similarity=0.358 Sum_probs=186.8
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe---E-
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE---R- 569 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---~- 569 (789)
.|...+++|.|+||.||+|... +++.||||+.-..+..+ .+|+++|++++|||||+|+-+|....+ .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 4666789999999999999864 56899999876544322 269999999999999999998875432 2
Q ss_pred -EEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEeecc
Q 045256 570 -LLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGL 635 (789)
Q Consensus 570 -~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGl 635 (789)
.|||||||. +|.+.++.. +-+..|+++||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCc
Confidence 489999998 999998741 247889999999999988 9999999999999987 9999999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
|+.+...+... ...-|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+++...+.....--+-.|. .
T Consensus 173 AK~L~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt--~ 247 (364)
T KOG0658|consen 173 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT--R 247 (364)
T ss_pred ceeeccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC--H
Confidence 99876665542 4567899999998855 5799999999999999999999999877554222110000000000 0
Q ss_pred hhhHHhh-------cccCCCCC---CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHHhh
Q 045256 715 GELVKIL-------DRRVGPPE---INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN--LERALD 769 (789)
Q Consensus 715 ~~~~~~~-------d~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~ 769 (789)
+++..+- ...+.... ...........+|+.+++..+|.+|.++.|++.+ ++++++
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 1111111 11111110 0111222334567888999999999999999875 344433
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.12 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=194.9
Q ss_pred CCccccceEeecccEEEEEEEeC--------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
++|.+.+.||+|+||.||++... +...+|+|.+..... ......+.+|+++++++ +||||+++++++.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC---hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 57899999999999999999742 235699998765322 12234588899999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNI 620 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NI 620 (789)
..+..++||||+++++|.+++..+ ..++.|++.||+|||+.+ ++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHhe
Confidence 999999999999999999998642 146889999999999998 99999999999
Q ss_pred EECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 045256 621 LLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGG 699 (789)
Q Consensus 621 ll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~ 699 (789)
|++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--- 248 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 248 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence 999999999999999875433221111112234568999999988889999999999999999998 7777743211
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
..+.+.+....... ........+.+++.+||..+|++||++.|+++.|++++....
T Consensus 249 ---------------~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 ---------------EELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ---------------HHHHHHHHcCCCCC--CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 01111111111100 111234566778899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=318.28 Aligned_cols=260 Identities=21% Similarity=0.337 Sum_probs=183.1
Q ss_pred CCccccceEeecccEEEEEEEeC--CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc---CCCcceEEEEEEEe---
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP--DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL---HHKHLVRLVGYCEE--- 565 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~--- 565 (789)
++|++.+.||+|+||.||++... +++.||+|+++...... .....+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~ 78 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 78 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC--CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence 47899999999999999999863 46789999876433221 1122355677766665 69999999999853
Q ss_pred --CCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 566 --KDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 566 --~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
....++||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 79 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 345899999997 5898887532 358899999999999998 999999999999999999999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc---hhh
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF---AVP 710 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~---~~~ 710 (789)
|++....... ......+++.|+|||.+....++.++||||||+++|||++|++||.......... .+.+. +.+
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~-~i~~~~~~~~~ 230 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG-KILDVIGLPGE 230 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH-HHHHHhCCCCh
Confidence 9987543321 2224568999999999988889999999999999999999999996543211000 00000 000
Q ss_pred hhhhhhh---HHhhcccCCCC-CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 AIMAGEL---VKILDRRVGPP-EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 ~~~~~~~---~~~~d~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....... ...+......+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000 00000000000 00001234556788999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=333.71 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=186.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.||+|++....... ......+.+|+++|++++||||+++++.+.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM-RNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh-hhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 36899999999999999999864 58899999876533221 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++.... .++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 99999999999986532 46789999999999998 99999999999999999999999999742210000
Q ss_pred -----------------------------------------CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHH
Q 045256 645 -----------------------------------------DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLE 683 (789)
Q Consensus 645 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~e 683 (789)
........||+.|+|||++....++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112468999999999999899999999999999999
Q ss_pred HHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc--ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC---CHH
Q 045256 684 LLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAMHCVNLEGKERP---TMA 758 (789)
Q Consensus 684 lltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP---t~~ 758 (789)
|++|+.||....... ....+.. ..+..+. .......+.+++.+|+ .+|++|+ ++.
T Consensus 237 ll~G~~Pf~~~~~~~-----------------~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 237 MLVGQPPFLADTPAE-----------------TQLKVINWETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred hhhCCCCCCCCCHHH-----------------HHHHHhccCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 999999996543210 0001111 0111111 0112223444555655 5999999 899
Q ss_pred HHHHH
Q 045256 759 DIVAN 763 (789)
Q Consensus 759 evl~~ 763 (789)
|++++
T Consensus 297 ell~h 301 (376)
T cd05598 297 EIKAH 301 (376)
T ss_pred HHhCC
Confidence 99877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.14 Aligned_cols=249 Identities=26% Similarity=0.418 Sum_probs=195.3
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
.+|.+.+.||+|+||.||++... +...+++|.+..... .....+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL----AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH----HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 46888899999999999999742 345689998654332 22345889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD 623 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~ 623 (789)
..++||||+++++|.+++... ..++.+++.+|+|||+.+ |+||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEc
Confidence 999999999999999998532 357889999999999998 99999999999999
Q ss_pred CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 045256 624 AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPV 702 (789)
Q Consensus 624 ~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~ 702 (789)
.++.+||+|||++................++..|+|||.+....++.++||||||+++|||+| |+.||......
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 232 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----- 232 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 999999999999875443322222223456788999999998899999999999999999999 99998553320
Q ss_pred ccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 703 SLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
. .+..+........ ....+..+.+++.+||+.||++||+++++++.|+++..
T Consensus 233 ~------------~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 E------------VIECITQGRVLER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred H------------HHHHHhCCCCCCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0 0011111111111 11223457788999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.96 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=196.6
Q ss_pred cCCccccceEeecccEEEEEEEe--------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL--------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~--------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 563 (789)
.++|.+.+.||+|+||.||+++. .++..|++|.+..... ......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc---hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 45788899999999999999963 1245799998654321 22344688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
......+++|||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccce
Confidence 9999999999999999999998653 246789999999999998 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESG 698 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~ 698 (789)
||++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-- 245 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 245 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 9999999999999999876543332222223345678999999988889999999999999999998 6777643211
Q ss_pred CcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
.++.+.+....... ........+..++.+||+.+|++||++.|+++.|++++....+
T Consensus 246 ----------------~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 246 ----------------EELFKLLKEGHRMD--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred ----------------HHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 01111111111000 0112345567788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.29 Aligned_cols=241 Identities=25% Similarity=0.375 Sum_probs=185.2
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHH---hhcCCCcceEEEEEEEeCCeEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFL---SRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
|++.+.||+|+||.||++... +++.||||+++...... ....+.+.+|++++ ++++||||+++++++.+.+..|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence 677899999999999999864 68899999976543221 12233466666554 56789999999999999999999
Q ss_pred EEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||||+++++|..+++.. ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 v~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 80 VMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred EEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 99999999998887542 358889999999999998 99999999999999999999999999864322211
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||...+.. .....+....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----------------~~~~~i~~~~ 217 (324)
T cd05589 157 --RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----------------EVFDSIVNDE 217 (324)
T ss_pred --cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHhCC
Confidence 122457899999999999889999999999999999999999998643220 0111122222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
...+.. ....+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 VRYPRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCCCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 222222 234456788899999999999 56676664
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.99 Aligned_cols=245 Identities=23% Similarity=0.305 Sum_probs=190.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||+|+++..... ..+....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 47899999999999999999864 6889999997654321 223455688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999998653 247789999999999998 9999999999999999999999999997644332
Q ss_pred CCCcccccccCcCccCccccC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG------LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
.. ......+|+.|+|||++. ...++.++||||||+++|||++|+.||...... ...
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----------------~~~ 218 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----------------KTY 218 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----------------HHH
Confidence 21 222346899999999986 456788999999999999999999999643320 011
Q ss_pred HHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..++.. .+..+. .......+.+|+..|+. +|++||++.+++++
T Consensus 219 ~~i~~~~~~~~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 219 NNIMNFQRFLKFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred HHHHcCCCccCCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111111 111111 11123345667778997 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=318.20 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=195.7
Q ss_pred HHhcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEE
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGY 562 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 562 (789)
....++|++.+.||+|+||.||++... +...+++|++..... ......+.+|+++++++ +||||++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 334567899999999999999999753 236799998764322 12234588999999999 79999999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSS 618 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 618 (789)
+...+..+++|||+++++|.++++.+ ..++.|++.||+|||+.+ |+||||||+
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~ 161 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAAR 161 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---cccccccee
Confidence 99999999999999999999998642 247889999999999998 999999999
Q ss_pred CEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 045256 619 NILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDES 697 (789)
Q Consensus 619 NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~ 697 (789)
|||++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 240 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 240 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-
Confidence 99999999999999999976544322222222335678999999988889999999999999999998 8888743221
Q ss_pred CCcccccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 698 GGTPVSLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
.++.+.+... ...+. .....+.+|+.+||..||++|||+.|+++.|++++
T Consensus 241 -----------------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -----------------EELFKLLKEGYRMEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -----------------HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 0111111111 11111 22345667889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.06 Aligned_cols=245 Identities=28% Similarity=0.353 Sum_probs=191.1
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|++.++||+|+||+||++... +++.||+|++....... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence 4788899999999999999864 68899999876543322 222345778999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999999887432 247889999999999998 9999999999999999999999999987643222
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. .....|++.|+|||++....++.++||||||+++|||++|+.||....... ....+...+..
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--------------~~~~~~~~~~~ 219 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--------------KREEVERRVKE 219 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--------------HHHHHHHHhhh
Confidence 1 123468899999999988889999999999999999999999996432210 00111111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.. ..........+.+++.+||+.||++|| ++.+++++
T Consensus 220 ~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 DQ---EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cc---cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11 111123445677889999999999999 78888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.40 Aligned_cols=240 Identities=32% Similarity=0.519 Sum_probs=180.2
Q ss_pred ccceEeecccEEEEEEEeC-----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 498 LENKIGAGSFGVVYKGKLP-----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.+.||.|.||.||+|.+. .+..|+||.+..... .+..+.|.+|++.+++++||||+++++++...+..++|
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS---EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS---HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc---cccceeeeeccccccccccccccccccccccccccccc
Confidence 4678999999999999875 356899999854222 22355689999999999999999999999988889999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++|+|.++|+.. ..++.|+++||+|||+.+ ++|+||+++|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 9999999999999765 258899999999999998 999999999999999999999999998765222
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
..............|+|||.+....++.++||||||+++|||++ |+.||..... ......+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----------------~~~~~~~~ 219 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----------------EEIIEKLK 219 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----------------HHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----------------cccccccc
Confidence 22222223456789999999988889999999999999999999 6777633211 00111111
Q ss_pred cc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 722 DR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 722 d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+. ++..+.. ....+..++.+||+.||++||+++++++.|
T Consensus 220 ~~~~~~~~~~----~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 220 QGQRLPIPDN----CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTEETTSBTT----SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccceeccc----hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11 1222222 234466788899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=326.30 Aligned_cols=236 Identities=25% Similarity=0.343 Sum_probs=180.1
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 578 (789)
+.||+|+||.||+++.. +++.||+|++..............+.++..+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999865 57789999976543322222222233344457888999999999999999999999999999
Q ss_pred CchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 579 GALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 579 gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
++|.+++.... .++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cccc
Confidence 99999886432 47889999999999999 99999999999999999999999999865322211 1224
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 730 (789)
..||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. +....+.........
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~~~~i~~~~~~~~~- 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----------------EMYDNILNKPLQLKP- 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHhCCcCCCC-
Confidence 56899999999999989999999999999999999999999643320 011112222222111
Q ss_pred CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHH
Q 045256 731 NEAEAVELVAYTAMHCVNLEGKERPTMADIV 761 (789)
Q Consensus 731 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 761 (789)
.....+.+++.+||+.||.+||++.+.+
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 ---NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 2234566778899999999999877443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=313.32 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=195.2
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
...+|++.++||+|+||.||++...+++.+++|.+..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 3456888999999999999999988889999998765432 123458899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||+++++|.++++.. ..++.+++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~ 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKE 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCC
Confidence 99999999999998642 357889999999999998 99999999999999999999999999876533
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... .+....+
T Consensus 157 ~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----------------~~~~~~~ 217 (261)
T cd05148 157 DVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----------------HEVYDQI 217 (261)
T ss_pred ccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----------------HHHHHHH
Confidence 221 1113345678999999988889999999999999999998 7888844321 0001111
Q ss_pred hcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 721 LDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 721 ~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
... +...+ ......+.+++.+||..||++|||++++++.|+.+
T Consensus 218 ~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 TAGYRMPCP----AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HhCCcCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111 11111 12234566788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.70 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=192.7
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc-ceEEEEEEEeCC-----
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH-LVRLVGYCEEKD----- 567 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~----- 567 (789)
.|...++||+|+||+||+|+. .+|+.||+|+++...... -.-....+|+.+|++|+|+| |++|.+++...+
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E--G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE--GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc--CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 466678899999999999985 478999999977654321 11223568999999999999 999999999877
Q ss_pred -eEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 568 -ERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 568 -~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
.++|||||++. +|..++... +.++.|+++||+|||+++ |+||||||.||||++++.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999976 998888642 358899999999999999 9999999999999999999999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--------ccc
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--------SLV 705 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--------~~~ 705 (789)
+|+......+. ......|..|+|||++.+. .|+...||||+|||++||+++++.|.+..+..+... ...
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 99865544332 2356789999999998765 799999999999999999999988876654221100 001
Q ss_pred cchhhhhhhhhhHHhhcccCCCCCCCHHHHH---HHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHH
Q 045256 706 DFAVPAIMAGELVKILDRRVGPPEINEAEAV---ELVAYTAMHCVNLEGKERPTMADIVAN--LERA 767 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~---~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 767 (789)
+|+......+.-. .+.. ...+........ ....+++.+|++.+|.+|.|++.++++ +..+
T Consensus 244 ~Wp~v~~~~~~k~-~f~~-~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 244 DWPGVSSLPDYKA-PFPK-WPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCCccccccccc-cCcC-CCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1221111000000 0000 000111111111 245567889999999999999999987 5443
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.13 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=189.4
Q ss_pred CCccccceEeecccEEEEEEEeCC---------------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD---------------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVR 558 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~ 558 (789)
++|++.+.||+|+||.||++...+ ...||+|.+..... ....+.|.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 579999999999999999987532 23589998764322 223456899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCchhHHHhhh--------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 045256 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDR--------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSS 618 (789)
Q Consensus 559 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 618 (789)
+++++...+..++||||+++++|.+++... ..++.++++||+|||+.+ ++|+||||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~ 158 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR 158 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChh
Confidence 999999999999999999999999988532 247889999999999998 999999999
Q ss_pred CEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc--CCCCCCCCCC
Q 045256 619 NILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT--GKRAIFKDDE 696 (789)
Q Consensus 619 NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt--G~~pf~~~~~ 696 (789)
|||++.++.+||+|||++................++..|+|||.+....++.++||||||+++|||++ +..||.....
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~ 238 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence 99999999999999999875433322111122345678999999988889999999999999999998 4556543221
Q ss_pred CCCcccccccchhhhhhhhhhHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 697 SGGTPVSLVDFAVPAIMAGELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
. ... ....+..+... ..........+..+.+++.+||+.||++||++.+|++.|++
T Consensus 239 ~-----~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 E-----QVI---------ENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred H-----HHH---------HHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 0 000 00011111000 00000011123467788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.81 Aligned_cols=241 Identities=25% Similarity=0.430 Sum_probs=185.1
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 578 (789)
+.||+|+||.||++... +++.|++|.+..... .+....+.+|++++++++||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 46899999999999864 688999998653321 22345688999999999999999999999999999999999999
Q ss_pred CchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 579 GALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 579 gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
++|.+++... ..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.............
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999998542 247889999999999998 9999999999999999999999999987543221111111
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPP 728 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 728 (789)
....+..|+|||.+....++.++||||||+++|||++ |..||..... ......+......+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~------------------~~~~~~~~~~~~~~ 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN------------------QQTREAIEQGVRLP 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH------------------HHHHHHHHcCCCCC
Confidence 1123457999999988889999999999999999998 7777743211 01111111111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 729 EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 729 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
........+.+++.+|++.||++||++.|+++.|++
T Consensus 217 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 217 --CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred --CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 111223456778899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=316.18 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=191.2
Q ss_pred CccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
+|++.+.||+|+||.||++... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 4777889999999999999753 357899999764332 2234568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC
Q 045256 569 RLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA 624 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 624 (789)
.++++||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecC
Confidence 99999999999999997421 247789999999999998 999999999999999
Q ss_pred CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccc
Q 045256 625 QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVS 703 (789)
Q Consensus 625 ~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~ 703 (789)
++.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------- 232 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 232 (283)
T ss_pred CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999876433322222223345789999999988889999999999999999998 7777743221
Q ss_pred cccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 704 LVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.+....+.+....+. .......+..++.+||+.+|++||+++||++.|+.
T Consensus 233 ----------~~~~~~i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 ----------QDVIEMIRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----------HHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 011111112211111 12334556778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=310.81 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=186.2
Q ss_pred ccccceEeecccEEEEEEEeCCC-c--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC------
Q 045256 496 FSLENKIGAGSFGVVYKGKLPDG-Q--EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK------ 566 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~g-~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 566 (789)
|.+.+.||+|+||.||+|...+. + .+|+|.++..... ....+.+.+|++++++++||||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICT--RSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 35678999999999999986543 2 5899987653221 23345688999999999999999999987532
Q ss_pred CeEEEEEEecCCCchhHHHhh--------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEe
Q 045256 567 DERLLVYDYMKNGALYDHLHD--------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSD 632 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~--------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 632 (789)
...+++|||+++++|.+++.. ...++.|++.||+|||+.+ |+||||||+|||+++++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~D 155 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVAD 155 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECC
Confidence 246899999999999887631 1257789999999999988 99999999999999999999999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhh
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
||++.................++.|+|||.+....++.++||||||+++|||++ |+.||..... .
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~--------- 221 (272)
T cd05075 156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----S--------- 221 (272)
T ss_pred CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-----H---------
Confidence 999876543322111122345678999999998899999999999999999999 7788743221 0
Q ss_pred hhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 712 IMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 712 ~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
.+.+.+.. ....+. .....+.+++.+||+.||++|||+.|+++.|++++
T Consensus 222 ----~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 222 ----EIYDYLRQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred ----HHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01111111 111111 23345678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.62 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=193.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE 565 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 565 (789)
..++|++.+.||+|+||.||+|..+ .+..||+|.+...... .....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL---RERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 4578999999999999999999643 2457999986543221 223357889999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT 627 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 627 (789)
.+..++||||+++|+|.+++... ..++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCc
Confidence 99999999999999999998642 247789999999999998 999999999999999999
Q ss_pred EEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccccc
Q 045256 628 ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 628 ~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 706 (789)
+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---------- 227 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---------- 227 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----------
Confidence 99999999875433322222222345678999999988889999999999999999998 6777743221
Q ss_pred chhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
.+....+.+...... .......+.+++.+||+.||++||++.|+++.|++.+
T Consensus 228 -------~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 228 -------EQVLKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -------HHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 001111111111110 1122346778899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.31 Aligned_cols=239 Identities=24% Similarity=0.316 Sum_probs=184.2
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|+||+||++... +++.||+|.+....... ....+.+..|++++++++||||+++.+++......++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK-RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh-hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 689999999999864 68899999876543222 2223457789999999999999999999999999999999999999
Q ss_pred hhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcc
Q 045256 581 LYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP 648 (789)
Q Consensus 581 L~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~ 648 (789)
|.+++.. ...++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~ 154 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence 9887632 1247889999999999998 99999999999999999999999999875433222 12
Q ss_pred cccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCC
Q 045256 649 MKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPP 728 (789)
Q Consensus 649 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 728 (789)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ........+.....
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-------------~~~~~~~~~~~~~~-- 219 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------------NKELKQRILNDSVT-- 219 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-------------HHHHHHhhcccCCC--
Confidence 234689999999999999999999999999999999999999965332100 00001111111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 729 EINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 729 ~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
........+.+++.+||+.||++|| +++|++++
T Consensus 220 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 --YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1122344567788899999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=312.21 Aligned_cols=247 Identities=24% Similarity=0.405 Sum_probs=189.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||+||++... +++ .+++|.+..... .....++..|+..+++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG---RQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc---hHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 46888899999999999999863 444 477777543211 2223457788889999999999999998754 55
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++++||+++|+|.+++... ..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 78999999999999998642 257889999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------------~~~~ 221 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP------------------HEVP 221 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH------------------HHHH
Confidence 44333222233456788999999988889999999999999999998 9988854321 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
+.+.. ....+... ...+..++.+||..||++||++.|+++.|+.+.+
T Consensus 222 ~~~~~~~~~~~~~~~----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 222 DLLEKGERLAQPQIC----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HHHHCCCcCCCCCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111 11111211 2334567889999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=313.31 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=194.1
Q ss_pred Cc-cccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--
Q 045256 495 NF-SLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK-- 566 (789)
Q Consensus 495 ~~-~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 566 (789)
+| ++.+.||+|+||+||++.. .+++.||+|.++.... ......+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 44 8889999999999988652 3577899998764322 12334588999999999999999999988764
Q ss_pred CeEEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 567 DERLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
...+++|||+++++|.+++.. ...++.++++||+|||+.+ |+|+||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 357899999999999998764 2368889999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCc-ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFR-PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
........ .....++..|+|||.+....++.++||||||+++|||++|+.|+......- ...............+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGPKQGQMTVVRLI 234 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcccccccchhhhh
Confidence 43322111 112345667999999988889999999999999999999999975432210 01111111111111222
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+.++.....+. +......+.+++.+||+.||++|||++++++.|+++.
T Consensus 235 ~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPC--PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222221111 1223456778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=325.95 Aligned_cols=237 Identities=24% Similarity=0.338 Sum_probs=185.3
Q ss_pred ceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCC
Q 045256 500 NKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~ 578 (789)
+.||+|+||.||++.. .+++.||+|+++...... ......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 468899999976543222 22334577899999999999999999999999999999999999
Q ss_pred CchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 579 GALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 579 gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
++|.+++... ..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK 154 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence 9999887543 2578899999999997 67 99999999999999999999999999864322211 112
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. .....+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----------------~~~~~i~~~~~~~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----------------KLFELILMEEIRFPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----------------HHHHHHhcCCCCCCC
Confidence 356899999999999889999999999999999999999999543210 001111111222222
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
. ....+.+++.+||+.||++|+ ++.+++++
T Consensus 218 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 T----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2 223456778899999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.98 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=193.6
Q ss_pred HHHHHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE
Q 045256 486 LAELAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564 (789)
Q Consensus 486 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 564 (789)
+.++....++|++.+.||+|+||.||+++.+ +++.||+|++....... ......+.+|+.+++.++||||+++++.+.
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3445555689999999999999999999865 57899999875432221 222345788999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
+....++||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999999998653 247789999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLN----VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
....... .......||+.|+|||++... .++.++|||||||++|||++|+.||...+..
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---------------- 253 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------------- 253 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH----------------
Confidence 6433221 122345799999999998653 3788999999999999999999999653320
Q ss_pred hhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCC--CCCHHHHHHHH
Q 045256 714 AGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKE--RPTMADIVANL 764 (789)
Q Consensus 714 ~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~L 764 (789)
....++.... +..+. .......+..++.+|+..++.+ ||++.|++++.
T Consensus 254 -~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 254 -GTYSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -HHHHHHHcCCCcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0111122111 11111 1123445667778899744433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=342.41 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=196.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.++||+|+||.||++... +++.||+|++...... .....+.+.+|++++++++||||+++++++.+.+..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 57999999999999999999864 5889999997643221 123345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 573 YDYMKNGALYDHLHDR-------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
|||+++++|.+++... .+++.|+++||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence 9999999999988531 246789999999999998 999999999999999999999999
Q ss_pred ccCcCCCCCCC----------------CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 045256 634 GLSMMGPESER----------------DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDES 697 (789)
Q Consensus 634 Gls~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~ 697 (789)
|+++....... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 99976421110 00112346899999999999999999999999999999999999999653221
Q ss_pred CCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-CHHHHHHHHHHHhhh
Q 045256 698 GGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-TMADIVANLERALDI 770 (789)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~ 770 (789)
.. .. . ..+.+.. . .....+.+..+.+++.+|++.||++|| +++++++.|+..++.
T Consensus 238 ki--------~~----~---~~i~~P~-~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KI--------SY----R---DVILSPI-E--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh--------hh----h---hhccChh-h--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 00 0 0000000 0 000123345567788999999999995 678888888887653
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.77 Aligned_cols=236 Identities=25% Similarity=0.353 Sum_probs=179.9
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++... +++.||+|+++...... ....+.+..|..++..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999864 57889999976543222 12233455566666654 89999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~ 154 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence 99999988643 247889999999999998 9999999999999999999999999987533222 1222
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. .....+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----------------~~~~~i~~~~~~~~~ 217 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----------------ELFDSILNDRPHFPR 217 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHcCCCCCCC
Confidence 457899999999999888999999999999999999999999643210 001111111111112
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHH-HHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMA-DIVA 762 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~ 762 (789)
. ....+.+++.+||+.||++||++. ++++
T Consensus 218 ~----~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 218 W----ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C----CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 233456778899999999999875 4544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.81 Aligned_cols=242 Identities=24% Similarity=0.319 Sum_probs=186.6
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-CcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-KHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv 572 (789)
+|++.+.||+|+||.||++..+ +++.||+|++....... ....+.+..|.+++..++| ++|+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 5888999999999999999865 56789999976543222 2234457789999999976 5688899999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 9999999999988643 247889999999999998 99999999999999999999999999864221111
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......||+.|+|||++.+..++.++||||||+++|||+||+.||..... ......+....
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----------------~~~~~~i~~~~ 217 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----------------DELFQSIMEHN 217 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence 12245689999999999998999999999999999999999999954321 00111122222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH-----HHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTM-----ADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~ 763 (789)
...+.. ....+.+++.+||..||++||+. ++++++
T Consensus 218 ~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 218 VSYPKS----LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 222222 23345677889999999999976 566554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.12 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=193.7
Q ss_pred CCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEK 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 566 (789)
++|.+.+.||+|+||.||++.. ..+..||+|+++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 5688999999999999999964 1345799998764322 22344688999999999 799999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
+..+++|||+++++|.++++.. ..++.+++.||+|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999998642 247789999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
................++..|+|||.+....++.++||||||+++|||++ |+.||...... .
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-----------------~ 251 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-----------------S 251 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-----------------H
Confidence 75443322111122345678999999988889999999999999999998 89888543210 0
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 716 ELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 716 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
...+.+........ .......+.+++.+||+.+|++||++.|+++.|++++
T Consensus 252 ~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 252 KFYKLIKEGYRMAQ--PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred HHHHHHHcCCcCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 11111111111100 1112345778899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.17 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=188.8
Q ss_pred ccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe---
Q 045256 496 FSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE--- 568 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 568 (789)
|++.+.||+|+||.||++.... +..||+|+++..... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT--YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 5678999999999999998642 367999987653222 2234568899999999999999999998876554
Q ss_pred ---EEEEEEecCCCchhHHHhhh--------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 569 ---RLLVYDYMKNGALYDHLHDR--------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 569 ---~~lv~e~~~~gsL~~~l~~~--------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
.+++|||+++++|..++... ..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEEC
Confidence 78999999999999887432 247889999999999998 9999999999999999999999
Q ss_pred eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhh
Q 045256 632 DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 632 DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
|||+++................+..|+|||.+....++.++||||||+++|||++ |..||..... .
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-----~-------- 222 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-----H-------- 222 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-----H--------
Confidence 9999876543332221222334678999999988889999999999999999999 7788743321 0
Q ss_pred hhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 711 AIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 711 ~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
.....+.+. ....+ ......+.+++.+||+.||++||++.|+++.|+++
T Consensus 223 ----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 223 ----EIYDYLRHGNRLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHHHHHHcCCCCCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001111111 11111 12334567788899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.44 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=191.0
Q ss_pred cCCccccceEeecccEEEEEEEeCC-----------------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD-----------------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn 555 (789)
.++|++.+.||+|+||.||++...+ +..|++|++...... ...+.+.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD---NAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH---HHHHHHHHHHHHHHhcCCCC
Confidence 3678999999999999999987542 245899987644322 33456889999999999999
Q ss_pred ceEEEEEEEeCCeEEEEEEecCCCchhHHHhhhc-------------------hHHHHHHHHHHHHHhcCCCCeEeccCC
Q 045256 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN-------------------NVEKNAARGIEYLHNYAVPPIIHRDIK 616 (789)
Q Consensus 556 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------~i~~~ia~~l~~LH~~~~~~ivH~Dlk 616 (789)
|+++++++...+..+++|||+++++|.+++.... .++.|+++||+|||+.+ |+|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccc
Confidence 9999999999999999999999999999885432 47789999999999998 9999999
Q ss_pred CCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc--CCCCCCCC
Q 045256 617 SSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT--GKRAIFKD 694 (789)
Q Consensus 617 p~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt--G~~pf~~~ 694 (789)
|+|||++.++.++|+|||++................++..|+|||.+....++.++||||||+++|||++ +..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999876443322222223456788999999988889999999999999999998 56666432
Q ss_pred CCCCCcccccccchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 695 DESGGTPVSLVDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.. .... ....+.... ............+..+.+++.+||+.||++||++.|+++.|++
T Consensus 238 ~~-----~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 TD-----QQVI---------ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred Ch-----HHHH---------HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 21 0000 000011000 0000000011123456788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.64 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=191.5
Q ss_pred cCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 565 (789)
.++|++.+.||+|+||.||+|.. .+++.||||+++.... ......+.+|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC---hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 46799999999999999999963 3578899999764322 22234588899999999 68999999998866
Q ss_pred CC-eEEEEEEecCCCchhHHHhhh--------------------------------------------------------
Q 045256 566 KD-ERLLVYDYMKNGALYDHLHDR-------------------------------------------------------- 588 (789)
Q Consensus 566 ~~-~~~lv~e~~~~gsL~~~l~~~-------------------------------------------------------- 588 (789)
.+ ..+++|||+++|+|.++++..
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 44 578999999999999987532
Q ss_pred -------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 589 -------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 589 -------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 135779999999999998 9999999999999999999999999987643322222222
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc--cCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVG 726 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~--~~~ 726 (789)
...++..|+|||.+....++.++||||||+++|||++ |..||...... ....+.+.. ...
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~ 302 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----------------EEFCRRLKEGTRMR 302 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----------------HHHHHHHhccCCCC
Confidence 2345678999999988889999999999999999997 88887432210 000111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+.. ....+.+++.+||+.||++||++.|++++|+++++.
T Consensus 303 ~~~~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 303 APDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1111 123466778899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.26 Aligned_cols=248 Identities=27% Similarity=0.454 Sum_probs=191.4
Q ss_pred CCccccceEeecccEEEEEEEeCC-Cc--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-GQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.++||+|+||.||++..++ +. .+++|.++..... ...+.+.+|++++.++ +||||+++++++.+....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE---NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH---HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 578999999999999999998653 33 4788876532221 2234588999999999 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 570 LLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
+++|||+++++|.+++++. ..++.|++.||+|||+.+ |+||||||+|||++++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGEN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCC
Confidence 9999999999999998642 357889999999999988 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~ 704 (789)
+.+||+|||++....... .......+..|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 156 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------- 225 (297)
T cd05089 156 LASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------- 225 (297)
T ss_pred CeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 999999999986422111 1111223567999999988889999999999999999997 99998543210
Q ss_pred ccchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 705 VDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
......... ....+. .....+.+|+.+||+.+|.+||++.++++.|+++++..
T Consensus 226 ----------~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 226 ----------ELYEKLPQGYRMEKPR----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----------HHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 001111111 111111 23345678899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.58 Aligned_cols=254 Identities=24% Similarity=0.367 Sum_probs=190.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-----------------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-----------------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn 555 (789)
.++|++.+.||+|+||.||++... +...||+|++..... ......+.+|++++++++|||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN---KNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCC
Confidence 357999999999999999998532 234689998764322 223456889999999999999
Q ss_pred ceEEEEEEEeCCeEEEEEEecCCCchhHHHhh-------------------hchHHHHHHHHHHHHHhcCCCCeEeccCC
Q 045256 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-------------------RNNVEKNAARGIEYLHNYAVPPIIHRDIK 616 (789)
Q Consensus 556 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-------------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk 616 (789)
|+++++++...+..+++|||+++++|.+++.. ...++.|++.||+|||+.+ |+|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCC
Confidence 99999999999999999999999999999864 2357889999999999998 9999999
Q ss_pred CCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc--CCCCCCCC
Q 045256 617 SSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT--GKRAIFKD 694 (789)
Q Consensus 617 p~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt--G~~pf~~~ 694 (789)
|+|||++.++.++|+|||++.................+..|++||......++.++||||||+++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999875433221111112334678999999888889999999999999999998 66777433
Q ss_pred CCCCCcccccccchhhhhhhhhhHHhh-cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 695 DESGGTPVSLVDFAVPAIMAGELVKIL-DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
... .... . ......... ...++.+. .....+.+++.+||+.||++||++.||++.|++
T Consensus 238 ~~~-----~~~~----~-~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDE-----QVIE----N-TGEFFRDQGRQVYLPKPA----LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChH-----HHHH----H-HHHHHhhccccccCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 220 0000 0 000000000 00111111 123557788999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.15 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=189.7
Q ss_pred cCCccccceEeecccEEEEEEEeCC------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
.++|.+.+.||+|+||.||++.+.+ +..|++|.+...... .....|.+|+.++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE---QDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 3568899999999999999998643 567899986543222 2234588899999999999999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC---cE
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW---TA 628 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~ 628 (789)
+..++||||+++++|.+++... ..++.|++.+|+|||+.+ ++|+||||+|||++.++ .+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcce
Confidence 9999999999999999988643 247889999999999998 99999999999998654 69
Q ss_pred EEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccc
Q 045256 629 RVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDF 707 (789)
Q Consensus 629 kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~ 707 (789)
||+|||+++................+..|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----------- 227 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----------- 227 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----------
Confidence 9999999976532221111112233568999999988889999999999999999997 8888854321
Q ss_pred hhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 708 AVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 708 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
+.+.+.+....... ........+.+++.+|++.+|++||++.+++++|++
T Consensus 228 -------~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 228 -------QEVMEFVTGGGRLD--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -------HHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 01111111111000 011223456778899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.52 Aligned_cols=237 Identities=24% Similarity=0.314 Sum_probs=184.5
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
++||+|+||.||++... +++.||+|++....... ....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQ-DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 46999999999999865 57899999976533222 22344577888888876 79999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT 154 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence 99999888543 247889999999999998 99999999999999999999999999865322221 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++....++.++||||||+++|||++|+.||...++. .....+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----------------~~~~~i~~~~~~~p~ 217 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----------------DLFESILHDDVLYPV 217 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----------------HHHHHHHcCCCCCCC
Confidence 456899999999999889999999999999999999999999644320 111112222222222
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCC-------CHHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERP-------TMADIVAN 763 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RP-------t~~evl~~ 763 (789)
. ....+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 W----LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 223456778889999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.84 Aligned_cols=245 Identities=25% Similarity=0.416 Sum_probs=191.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.+|++.+.||+|+||.||++..+ +++.|++|++.... .....+.+|++++++++||||+++++++...+..+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 45888899999999999999864 57899999875432 1234588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++++|.+++... ..++.|++++|+|||+.+ ++||||||+|||+++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999988542 246889999999999998 999999999999999999999999998764432
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... .......+..|+|||.+.+..++.++||||||+++|||++ |..||..... .+..+.+
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------------~~~~~~~ 218 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------------SQVYELL 218 (263)
T ss_pred eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------------HHHHHHH
Confidence 211 1112234568999999988899999999999999999998 8888753221 0011111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
....... ........+.+++.+||..||++||++.|+++.|+.+
T Consensus 219 ~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 EKGYRME--RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HCCCCCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111100 0112234567788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=306.73 Aligned_cols=242 Identities=30% Similarity=0.489 Sum_probs=190.3
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 46888999999999999999887777899998764322 1235889999999999999999999999988899999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++++|.+++... ..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999988642 358899999999999998 99999999999999999999999999875433221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.......++..|+|||.+....++.++||||||+++|||++ |+.||..... + .....+...
T Consensus 156 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------------~----~~~~~~~~~ 217 (256)
T cd05113 156 -TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------------S----ETVEKVSQG 217 (256)
T ss_pred -eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------------H----HHHHHHhcC
Confidence 11112235678999999988889999999999999999999 8888753321 0 001111111
Q ss_pred -cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 724 -RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 724 -~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
+...+.. ....+.+++.+||+.||++||++.++++.|+
T Consensus 218 ~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 218 LRLYRPHL----ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111111 2355677888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.29 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=197.3
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++.. .+++.++||.+....... ......+.+|+++++.++||||+++++++.+.+..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhh-HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 4688889999999999999985 578999999876433222 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 573 YDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|||+++++|.+++.. ...++.+++++|+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999998752 1246789999999999998 9999999999999999999999999987643
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
..... .....++..|+|||.+....++.++||||||+++|||++|+.||....... ....+.
T Consensus 158 ~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------------~~~~~~ 219 (267)
T cd08229 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----------------YSLCKK 219 (267)
T ss_pred cCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----------------HHHhhh
Confidence 32211 123467889999999988889999999999999999999999986432200 000001
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+... ..+..........+.+++.+||..||++||||.+|++.++++.
T Consensus 220 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 220 IEQC-DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhcC-CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1110 0111112234456778889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=322.29 Aligned_cols=232 Identities=30% Similarity=0.394 Sum_probs=177.9
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHH-HHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSEL-AFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
++||+|+||.||+++.. +++.||+|++.......... ...+..|. .+++.++||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH-HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999864 67899999976543322222 22344444 46788999999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+.+... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTS 154 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccc
Confidence 99998887543 247889999999999998 99999999999999999999999999865322211 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||.+....++.++||||||+++|||++|+.||...+. ......+....+..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~~~~~~i~~~~~~~~~ 217 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----------------SQMYDNILHKPLQLPG 217 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----------------HHHHHHHhcCCCCCCC
Confidence 45689999999999988899999999999999999999999965321 0011122222222222
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMA 758 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 758 (789)
.. ...+.+++.+||+.||++||+..
T Consensus 218 ~~----~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GK----TVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CC----CHHHHHHHHHHccCCHhhcCCCC
Confidence 22 23456778899999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.79 Aligned_cols=231 Identities=24% Similarity=0.337 Sum_probs=180.5
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++..+ +++.||+|++....... ....+.+..|..++..+ +||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999865 57899999876543221 22334567788888877 69999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTS 154 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--ccc
Confidence 99999888643 247889999999999998 99999999999999999999999999865322211 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----------------~~~~~~i~~~~~~~~~ 217 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----------------DDLFEAILNDEVVYPT 217 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----------------HHHHHHHhcCCCCCCC
Confidence 45689999999999988999999999999999999999999964331 0011112222222222
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTM 757 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 757 (789)
. ....+.+++.+||+.||++||++
T Consensus 218 ~----~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 W----LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C----CCHHHHHHHHHHcccCHHHCCCC
Confidence 1 23345678889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=310.54 Aligned_cols=263 Identities=23% Similarity=0.397 Sum_probs=191.3
Q ss_pred CCccccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK-- 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 566 (789)
++|++.+.||+|+||.||++.. .+++.|++|++..... .....+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 5788899999999999999974 3578999998764332 2234688999999999999999999987543
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
...++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 4578999999999999998642 257889999999999998 9999999999999999999999999998
Q ss_pred CCCCCCCCCc-ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 638 MGPESERDFR-PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 638 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
.......... .....++..|+|||.+.+..++.++||||||+++|||++|..++......-. ..+............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM--RMMGNDKQGQMIVYH 234 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh--hhcccccccccchHH
Confidence 6543322111 1112234569999999888899999999999999999998876533221000 000000000000111
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
+.+.+......+. .......+.+++.+||+.+|++|||++|+++.|+.+
T Consensus 235 ~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLPA--PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 2222222111111 112234577888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.67 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=191.4
Q ss_pred CCccccceEeecccEEEEEEEe-CCCc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||+||+|.. .+++ .||+|.++.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS---PKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC---HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 5788899999999999999974 3444 489998754322 2234468899999999999999999999875 45
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++++||+++|+|.+++++. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 78999999999999998653 257889999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............++..|+|||.+....++.++||||||+++|||++ |..||..... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------------~~~~ 221 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA------------------REIP 221 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------------HHHH
Confidence 43322222222334678999999988889999999999999999998 8888743221 0111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+......+. .......+.+++.+||..||++||++.|+++.|+++...
T Consensus 222 ~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 222 DLLEKGERLPQ--PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHHCCCcCCC--CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11111111110 112234567788999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=323.91 Aligned_cols=232 Identities=26% Similarity=0.392 Sum_probs=182.5
Q ss_pred ceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
+.||+|+||.||+++. .+++.||+|++...... ......+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 6799999999999874 36789999997654322 12233567899999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 576 MKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 576 ~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~ 154 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--K 154 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--c
Confidence 9999999988643 357889999999999998 99999999999999999999999999875433221 1
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
.....|++.|+|||.+....++.++||||||+++|||++|+.||...+. ......+.......
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----------------~~~~~~i~~~~~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----------------KETMTMILKAKLGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----------------HHHHHHHHcCCCCC
Confidence 2245789999999999888899999999999999999999999854321 01111122222222
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHH
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMAD 759 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e 759 (789)
+.. ....+.+++.+||+.||++||++.+
T Consensus 218 p~~----~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQF----LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC----CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 222 2344667888999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=303.84 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=198.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.|++|.++...... ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 57999999999999999999876 78999999876433222 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 573 YDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|||+++++|.+++.. ...++.+++++|+|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999988753 1257889999999999998 9999999999999999999999999987543
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. .+.+.
T Consensus 158 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~----------~~~~~ 219 (267)
T cd08224 158 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LY----------SLCKK 219 (267)
T ss_pred CCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HH----------HHHhh
Confidence 3221 112346788999999998888999999999999999999999998543210 00 01111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+......+ .........+.+++.+||..+|++||++.++++.|+++.
T Consensus 220 ~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 220 IEKCDYPP-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhcCCCCC-CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11111111 111234456778899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.87 Aligned_cols=240 Identities=24% Similarity=0.303 Sum_probs=183.5
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|+||.||++..+ +++.||+|++....... ......+..|++++++++||||+++++++.+....++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 689999999999864 58999999876433222 1223345679999999999999999999999999999999999999
Q ss_pred hhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 581 LYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 581 L~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++....... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 98887532 246789999999999998 9999999999999999999999999987543322 1123
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 730 (789)
..++..|+|||++....++.++||||||+++|||++|+.||....+... ........+...+...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-------------~~~~~~~~~~~~~~~~-- 218 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-------------KEELKRRTLEDEVKFE-- 218 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-------------HHHHHHHhhccccccc--
Confidence 4688999999999888899999999999999999999999864332100 0001111111111111
Q ss_pred CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 731 NEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 731 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.......+.+++.+||+.||++||+++|+++.+
T Consensus 219 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 219 -HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred -cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 112334567888999999999999997766544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=305.73 Aligned_cols=242 Identities=27% Similarity=0.455 Sum_probs=188.3
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.+|++.+.||+|+||.||++..+++..+++|.+..... ....+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 35788899999999999999987778899998654322 1234778999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++++|.+++... ..++.|++.+|+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999998642 357889999999999998 99999999999999999999999999875432211
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.......++..|+|||.+....++.++||||||+++|||++ |+.||...... . ....+....
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------------~-~~~~~~~~~-- 218 (256)
T cd05059 156 -TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------------E-VVESVSAGY-- 218 (256)
T ss_pred -cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------------H-HHHHHHcCC--
Confidence 11111223467999999988899999999999999999999 78887543210 0 000111100
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
....+. .....+.+++.+||..+|++|||+.|+++.|
T Consensus 219 ~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 219 RLYRPK----LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred cCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111111 1334577888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.40 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=187.4
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 572 (789)
+|++.+.||+|+||.||++... +++.||+|++....... ......+..|..++..+ +||+|+++++++.+.+..++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 5888999999999999999865 57899999976543222 22234466788888777 589999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence 9999999999888543 357889999999999998 9999999999999999999999999986432221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.......||+.|+|||++....++.++|||||||++|||++|+.||...+. ......+....
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----------------~~~~~~i~~~~ 217 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------------DELFQSIMEHN 217 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhCC
Confidence 112245789999999999999999999999999999999999999964321 00111222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH-----HHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTM-----ADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~ 763 (789)
...+.. ....+.+++.+|++.||++|++. .++.++
T Consensus 218 ~~~p~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 VAYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCCCCc----CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 222222 23445678889999999999984 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=304.42 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=192.9
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhh-HHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKK-FQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
++|.+.+.||+|+||.||++.. .+++.|++|.+....... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688999999999999999985 468999999876443221 12234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
++||+++++|.+++... ..++.+++.||+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999988642 357889999999999998 9999999999999999999999999986543221
Q ss_pred CCCc-ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFR-PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...+.. ........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------------~~~~~~~~ 221 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----------------AAIFKIAT 221 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----------------HHHHHHhc
Confidence 1111 12345778999999999888999999999999999999999998543210 00011111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... ...+......+.+++.+||..+|++||++.|++++
T Consensus 222 ~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QPTN--PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCCC--CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1110 01112234456778889999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=310.47 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=195.5
Q ss_pred hcCCccccceEeecccEEEEEEEeCC-----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD-----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE- 565 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~- 565 (789)
..++|++.++||+|+||.||+|...+ +..|++|++..... ......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS---EIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 34689999999999999999998755 68899998754322 2334568899999999999999999998876
Q ss_pred CCeEEEEEEecCCCchhHHHhhh----------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEE
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR----------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR 629 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~----------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 629 (789)
....++++||+++++|.+++... ..++.+++.||+|||+.+ ++|+||||+|||++.++.+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEE
Confidence 46789999999999999988542 247889999999999998 99999999999999999999
Q ss_pred EEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccch
Q 045256 630 VSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 630 l~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 708 (789)
|+|||+++.+.............++..|+|||.+....++.++||||||+++|||++ |+.||...+. .
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~------ 226 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----F------ 226 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----H------
Confidence 999999976433322111122345678999999988889999999999999999999 9999854321 0
Q ss_pred hhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.+...+........ .......+.+++.+||..||++|||+.|+++.|+.+..
T Consensus 227 -------~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 227 -------EMAAYLKDGYRLAQ--PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -------HHHHHHHcCCCCCC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01111111111111 11123456788899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.09 Aligned_cols=242 Identities=24% Similarity=0.419 Sum_probs=191.0
Q ss_pred cccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe--EEEEE
Q 045256 497 SLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE--RLLVY 573 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--~~lv~ 573 (789)
+..++||+|.|-+||||.+. +|..||--.++.....+..+..+.|..|+++|+.|+||||++++.+|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45688999999999999864 5778886655555555555666789999999999999999999999988766 77999
Q ss_pred EecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGls~~~~~~~~ 644 (789)
|.+..|+|..|+++.+ ++.+||++||.|||++. |||+|||||-+||||+.+ |.+||+|+|||.+...+..
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 9999999999987643 58999999999999987 889999999999999764 8999999999987554432
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
....|||.|||||++. ..|+..+||||||++++||+|+..|+..-.. +..++.-+..-+....+.++-
T Consensus 202 ----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----~AQIYKKV~SGiKP~sl~kV~--- 269 (632)
T KOG0584|consen 202 ----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----PAQIYKKVTSGIKPAALSKVK--- 269 (632)
T ss_pred ----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----HHHHHHHHHcCCCHHHhhccC---
Confidence 2468999999999998 6799999999999999999999999843322 211111111111111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
-..+++||.+|+.. .++|||+.|++++
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 12367789999999 9999999999875
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=305.42 Aligned_cols=246 Identities=29% Similarity=0.443 Sum_probs=191.9
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++..++...|++|+++.... ..+.+.+|++++++++||||+++++++. .+..++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence 357999999999999999999887777899998764322 1235889999999999999999999875 4568999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++++|.+++.+. ..++.+++++|+|||+.+ |+|+||||+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999998642 357889999999999998 999999999999999999999999998754433
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......++..|+|||.+....++.++||||||+++|||+| |+.||..... ..+.+.+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~------------------~~~~~~~ 216 (262)
T cd05071 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------------REVLDQV 216 (262)
T ss_pred ccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh------------------HHHHHHH
Confidence 221 1112345678999999988889999999999999999999 7777743221 0001111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
......+ ...+....+.+++.+|++.||++||++.++++.|++..
T Consensus 217 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 217 ERGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred hcCCCCC--CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1111111 12234556778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.00 Aligned_cols=197 Identities=26% Similarity=0.389 Sum_probs=166.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +++.||+|++...... ..+....+.+|+.++.+++||||+++++.+.+.+..++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 46889999999999999999865 5889999987643222 123345688899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++.+.. .++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999986532 47889999999999999 99999999999999999999999999864322110
Q ss_pred C---------------------------------CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 045256 645 D---------------------------------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 645 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf 691 (789)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011346899999999999999999999999999999999999999
Q ss_pred CCC
Q 045256 692 FKD 694 (789)
Q Consensus 692 ~~~ 694 (789)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=320.35 Aligned_cols=263 Identities=20% Similarity=0.249 Sum_probs=189.0
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|++.+.||+|+||.||++... +++.||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN--QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc--hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 478999999999999999999864 5889999987643221 223345778999999999999999999986543
Q ss_pred --eEEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 568 --ERLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 568 --~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
..|+||||+++ +|.+.++. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999976 66665532 2357889999999999998 999999999999999999999999998753
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhh---h
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIM---A 714 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~---~ 714 (789)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||...+......... ...+..... .
T Consensus 174 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 174 CTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 3221 1223568999999999999899999999999999999999999996543211000000 000000000 0
Q ss_pred hhhHHhhcccCCCCC----------------CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 715 GELVKILDRRVGPPE----------------INEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~----------------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.............+. .........+.+|+.+||..||++|||+.|++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 001111111100000 00111234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.43 Aligned_cols=234 Identities=26% Similarity=0.326 Sum_probs=178.5
Q ss_pred ceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHH-HHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELA-FLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||+||++.. .+++.||+|++........ .....+..|.. +++.++||||+++++++...+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 4699999999999985 4689999999765432221 22233445544 5677899999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|..++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTT 154 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Ccc
Confidence 99999887643 257889999999999998 99999999999999999999999999865322211 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......++...+....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----------------~~~~~~~~~~~~~~~~ 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----------------AEMYDNILHKPLVLRP 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----------------HHHHHHHHcCCccCCC
Confidence 45689999999999999999999999999999999999999965321 0011122222222122
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMADI 760 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev 760 (789)
.. ...+.+++.+|++.||++||++++.
T Consensus 218 ~~----~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 218 GA----SLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred CC----CHHHHHHHHHHhccCHHhcCCCCCC
Confidence 12 2334567788999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=303.13 Aligned_cols=242 Identities=29% Similarity=0.405 Sum_probs=192.7
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++..+ +++.|++|.+...... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN--RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC--HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence 4788899999999999999864 6889999987543222 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.++++.. ..++.+++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 999999999998653 257889999999999988 9999999999999999999999999987544332
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.. .....+++.|+|||++....++.++|+||||+++|||++|+.||..... ......+...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~~~~~ 216 (256)
T cd08529 156 NF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----------------GALILKIIRG 216 (256)
T ss_pred ch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHcC
Confidence 21 1234678899999999988899999999999999999999999854321 0011111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... .......+.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPV---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCC---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111 11334557788899999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.95 Aligned_cols=235 Identities=26% Similarity=0.347 Sum_probs=180.6
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++... +++.||+|+++...... ......+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 46999999999999865 57899999876543211 12233456677777764 89999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence 99999988643 357889999999999998 99999999999999999999999999864222111 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc-ccCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD-RRVGPP 728 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~ 728 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+. . .+.+.+. .....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~-------------~~~~~i~~~~~~~~ 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----E-------------ELFQSIRMDNPCYP 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----H-------------HHHHHHHhCCCCCC
Confidence 45689999999999988999999999999999999999999864321 0 0001111 111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCcCCCCCCCHH-HHHH
Q 045256 729 EINEAEAVELVAYTAMHCVNLEGKERPTMA-DIVA 762 (789)
Q Consensus 729 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~ 762 (789)
. .....+.+++.+||+.||++||++. ++.+
T Consensus 217 ~----~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 R----WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred c----cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 1233456788899999999999997 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.59 Aligned_cols=245 Identities=22% Similarity=0.363 Sum_probs=189.3
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++.. .+++.|++|++..... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc----chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 5789999999999999999986 4688999998754322 1223578899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.++++.. ..++.|++.+|+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999999988643 357889999999999998 99999999999999999999999999875432211
Q ss_pred CCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 645 DFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
......++..|+|||.+. ...++.++||||||+++|||++|+.||......... .. +.
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----~~-------------~~ 222 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FL-------------MS 222 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh----ee-------------ee
Confidence 112346788999999874 345788999999999999999999998543321100 00 00
Q ss_pred cccCCCCC-CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 722 DRRVGPPE-INEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 722 d~~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
...+..+. .........+.+++.+||..||++||++++++++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 223 KSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00111000 01112335677889999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=318.20 Aligned_cols=235 Identities=24% Similarity=0.329 Sum_probs=180.3
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
++||+|+||.||++..+ +++.||+|+++...... ......+..|..++..+ +||||+++++++.+.+..|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-DDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-cchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 46999999999999865 57899999976543211 12233466777777765 89999999999999999999999999
Q ss_pred CCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++.... .++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~ 154 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS 154 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence 999998886532 46789999999999998 9999999999999999999999999986422111 1223
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. . ....+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-------------~----~~~~~~~~~~~~~~ 217 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-------------E----LFESIRVDTPHYPR 217 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-------------H----HHHHHHhCCCCCCC
Confidence 457899999999999989999999999999999999999999643320 0 00111111111111
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHH-HHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMA-DIV 761 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl 761 (789)
. ....+.+++.+||+.||++||++. +++
T Consensus 218 ~----~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 W----ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 233456788899999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=305.70 Aligned_cols=249 Identities=28% Similarity=0.505 Sum_probs=192.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CC---cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DG---QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|+..+.||+|+||.||++... ++ ..+++|.++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT---EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 46788899999999999999864 33 3699998754322 12244688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999998642 357889999999999998 9999999999999999999999999987543
Q ss_pred CCCCCCc-ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDFR-PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
....... ......+..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------------------~~~~ 220 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------------------HEVM 220 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------------------HHHH
Confidence 3222111 111223457999999988889999999999999999997 9999854321 0111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
..+......+. .......+.+++.+||+.+|++||++.++++.|++++
T Consensus 221 ~~i~~~~~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 221 KAINDGFRLPA--PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred HHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11111111111 1123455678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=310.19 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=189.9
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++|+..++||+|+||.||++... ++..+++|.+..... .....+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE----SARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH----HHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 46788899999999999999632 356789998654322 23446899999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh-----------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-----------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA 624 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-----------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 624 (789)
..+++|||+++++|.+++... ..++.|++.||+|||+.+ |+|+||||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcC
Confidence 999999999999999988542 246789999999999998 999999999999999
Q ss_pred CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccc
Q 045256 625 QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVS 703 (789)
Q Consensus 625 ~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~ 703 (789)
++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |++||......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 231 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------ 231 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------
Confidence 99999999999865433222111122345678999999988889999999999999999998 88887543210
Q ss_pred cccchhhhhhhhhhHHhhccc-CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 704 LVDFAVPAIMAGELVKILDRR-VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.......... ...+. .....+.+++.+||+.||++||++.|+++.|++
T Consensus 232 -----------~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 232 -----------EAIECITQGRELERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -----------HHHHHHHcCccCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0011111111 11111 223456788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=317.66 Aligned_cols=237 Identities=26% Similarity=0.368 Sum_probs=184.8
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++... +++.||+|+++...... ......+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999865 57899999976543222 22334567888888888 69999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS 154 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence 99999887643 257889999999999998 99999999999999999999999999864222211 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...+.. .....+.......+.
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----------------~~~~~i~~~~~~~~~ 217 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----------------ELFQSILEDEVRYPR 217 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----------------HHHHHHHcCCCCCCC
Confidence 346899999999999999999999999999999999999999543210 001111122221111
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCH-----HHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTM-----ADIVAN 763 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~ 763 (789)
.....+.+++.+||+.||++||++ .+++++
T Consensus 218 ----~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 ----WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred ----cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 223456778889999999999999 777764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=314.18 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=193.9
Q ss_pred cCCccccceEeecccEEEEEEEeC--------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 563 (789)
.++|.+.+.||+|+||.||+++.. ....+++|.++.... ......+.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT---DKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC---hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 357888999999999999999742 245799998764322 22344588899999999 699999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
.+.+..+++|||+++++|.+++..+ ..++.|++.||.|||+.+ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecccccee
Confidence 9989999999999999999998642 246789999999999998 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESG 698 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~ 698 (789)
||++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-- 242 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-- 242 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999976543222111112234567999999988889999999999999999999 7888743221
Q ss_pred CcccccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
..+.+.+... ...+. .....+.+++.+||..||++||++.|+++.|+++.....
T Consensus 243 ----------------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 243 ----------------EELFKLLREGHRMDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred ----------------HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 0011111111 11111 223356678899999999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=316.27 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=184.9
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++... +++.||+|+++...... ......+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 47999999999999864 57899999976543222 22344577888888877 79999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~ 154 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS 154 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence 99998887543 357889999999999998 99999999999999999999999999865322211 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh-HHhhcccCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL-VKILDRRVGPP 728 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~ 728 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||............ ....+ ..+.......+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~---------~~~~~~~~i~~~~~~~p 225 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---------TEDYLFQVILEKQIRIP 225 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc---------cHHHHHHHHhcCCCCCC
Confidence 457899999999999999999999999999999999999999532211110000 00111 11222222222
Q ss_pred CCCHHHHHHHHHHHHHhhcCcCCCCCCC------HHHHHHH
Q 045256 729 EINEAEAVELVAYTAMHCVNLEGKERPT------MADIVAN 763 (789)
Q Consensus 729 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt------~~evl~~ 763 (789)
.. ....+.+++.+||+.||++||+ +.+++++
T Consensus 226 ~~----~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 226 RS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CC----CCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 22 2334567888999999999998 5676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=316.87 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=192.6
Q ss_pred cCCccccceEeecccEEEEEEEeC--------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 563 (789)
..+|++.+.||+|+||.||++... ....|++|.++.... ......+.+|+++++++ +||||+++++++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT---DKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC---HHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 357889999999999999999642 123689998664322 22345688999999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
.+.+..+++|||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 9999999999999999999998642 136789999999999998 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESG 698 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~ 698 (789)
||++.++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999875433222111222334568999999998899999999999999999998 7777743221
Q ss_pred CcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.++.+.+........ .......+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 243 ----------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 ----------------EELFKLLKEGHRMDK--PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ----------------HHHHHHHHcCCCCCC--CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 011111111111000 11223456778899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=309.05 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=192.5
Q ss_pred cCCccccceEeecccEEEEEEEeCC------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
.++|++.+.||+|+||.||++...+ +..|++|.+..... ......+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS---MRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4578899999999999999997642 36899998754322 12234588999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcE
Q 045256 567 DERLLVYDYMKNGALYDHLHDR------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA 628 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 628 (789)
...++||||+++++|.+++... ..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCE
Confidence 9999999999999999998532 247789999999999988 9999999999999999999
Q ss_pred EEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccc
Q 045256 629 RVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDF 707 (789)
Q Consensus 629 kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~ 707 (789)
||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||..... ..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~---- 229 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EE---- 229 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----HH----
Confidence 9999999875443332222223456789999999988889999999999999999998 8888743221 00
Q ss_pred hhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 708 AVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 708 ~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
......+. ....+.. ....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 230 --------~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 230 --------VLKFVIDGGHLDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred --------HHHHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 00111111 1111121 24556788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=304.69 Aligned_cols=244 Identities=27% Similarity=0.450 Sum_probs=190.7
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++..+++..+++|.+...... .+.+.+|+.++++++||||+++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC-----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 3578889999999999999999888889999987653321 235889999999999999999999875 4568999
Q ss_pred EEecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++++|.++++. ...++.+++.+|+|||+.+ |+|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999998854 2367889999999999998 999999999999999999999999998764332
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... .+..+.+
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------------------~~~~~~~ 216 (260)
T cd05070 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------------------REVLEQV 216 (260)
T ss_pred ccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------------------HHHHHHH
Confidence 211 1112234568999999988889999999999999999999 8888854321 0111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
......+. +......+.+++.+|+..||++|||+.++.+.|++
T Consensus 217 ~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ERGYRMPC--PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HcCCCCCC--CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111111 12234457788999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.24 Aligned_cols=249 Identities=27% Similarity=0.502 Sum_probs=191.5
Q ss_pred CCccccceEeecccEEEEEEEeCC-C---cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-G---QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
.+|++.+.||+|+||.||+|.... + ..|++|.+..... ......|..|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 457889999999999999998643 3 3699998764322 22345689999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999988642 357789999999999998 9999999999999999999999999987544
Q ss_pred CCCCCCccccc---ccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 641 ESERDFRPMKA---AGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 641 ~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........... ..+..|+|||.+....++.++||||||+++|||++ |+.||...+.. .. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-----~~---------~~~ 223 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-----DV---------INA 223 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-----HH---------HHH
Confidence 32221111111 12457999999998899999999999999999986 99998543210 00 000
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+.. +..++.+. +.+..+.+++.+||+.+|++||++.+++..|++++
T Consensus 224 i~~--~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 224 IEQ--DYRLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred HHc--CCcCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 100 11112211 23345677888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=326.66 Aligned_cols=255 Identities=21% Similarity=0.278 Sum_probs=179.6
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC----
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 566 (789)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+|+.+|++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ--------YKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 4468999999999999999999864 678999998643211 234799999999999999999987532
Q ss_pred ----CeEEEEEEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEE
Q 045256 567 ----DERLLVYDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TAR 629 (789)
Q Consensus 567 ----~~~~lv~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~k 629 (789)
..+++||||+++ +|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCcee
Confidence 235689999985 77776642 1246789999999999999 99999999999998664 799
Q ss_pred EEeeccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch
Q 045256 630 VSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 630 l~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 708 (789)
|+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||+||||++|++||.................
T Consensus 212 L~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 212 LCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred eeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999976543222 123467999999998865 4689999999999999999999999965432110000000000
Q ss_pred hhhhhhhhhHHh----hcccCCCCC--C----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 VPAIMAGELVKI----LDRRVGPPE--I----NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 ~~~~~~~~~~~~----~d~~~~~~~--~----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+ ..+.+..+ .+..++... . .+......+.+|+.+||..||++|||+.|++++
T Consensus 289 ~p--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TP--TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CC--CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 00000000 000000000 0 000122456678899999999999999999865
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.63 Aligned_cols=246 Identities=23% Similarity=0.308 Sum_probs=185.9
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
++||+|+||.||++... +++.||+|+++...... .+....+..|..++.++ +||||+++++++.+.+..|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 46999999999999864 68899999986543222 23344578899999998 79999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~ 154 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS 154 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence 99999887543 257889999999999998 9999999999999999999999999986422211 1222
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||+++|||++|+.||..............+ .....+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~p~ 226 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTED--------YLFQVILEKQIRIPR 226 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchH--------HHHHHHHcCCCCCCC
Confidence 457899999999999989999999999999999999999999533211100000000 001112222222222
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCC------HHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPT------MADIVAN 763 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt------~~evl~~ 763 (789)
. ....+.+++.+||+.||++||+ +++++++
T Consensus 227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 2 2234567788999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.22 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=191.0
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.++||+|+||.||++.. .+++.||+|++..... ......+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT---VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC---hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence 3678889999999999999975 4688999998754321 22344688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHh----hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcc
Q 045256 573 YDYMKNGALYDHLH----DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP 648 (789)
Q Consensus 573 ~e~~~~gsL~~~l~----~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~ 648 (789)
|||+++++|..+.. ....++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~---- 150 (279)
T cd06619 78 TEFMDGGSLDVYRKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---- 150 (279)
T ss_pred EecCCCCChHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccc----
Confidence 99999999876532 23468899999999999998 99999999999999999999999999875433221
Q ss_pred cccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCC
Q 045256 649 MKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPP 728 (789)
Q Consensus 649 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 728 (789)
....++..|+|||.+....++.++||||||+++|||++|+.||........... + ......+.+.....
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~---~~~~~~~~~~~~~~- 219 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------P---LQLLQCIVDEDPPV- 219 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------h---HHHHHHHhccCCCC-
Confidence 234688999999999988899999999999999999999999865332111110 0 00011111111110
Q ss_pred CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 729 EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 729 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.........+.+++.+|++.||++||+++|++++-
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 -LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred -CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 00111223467788899999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.15 Aligned_cols=238 Identities=25% Similarity=0.422 Sum_probs=184.7
Q ss_pred eEeecccEEEEEEEe---CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 501 KIGAGSFGVVYKGKL---PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
.||+|+||.||+|.+ .+++.+|+|+++.... .....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC--cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 589999999999964 3578899998764322 1234456889999999999999999999885 456789999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC-cc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-RP 648 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~-~~ 648 (789)
+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999998642 357889999999999998 9999999999999999999999999987654332211 11
Q ss_pred cccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc--C
Q 045256 649 MKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR--V 725 (789)
Q Consensus 649 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--~ 725 (789)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.+.++.. .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------------~~~~~~i~~~~~~ 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------------------NEVTQMIESGERM 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHHHCCCCC
Confidence 12234578999999988889999999999999999998 8989854321 0111112221 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
..+. .....+.+++.+||+.||++||++.+|.+.|++
T Consensus 218 ~~~~----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ECPQ----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCC----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 1112 233456788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=313.03 Aligned_cols=249 Identities=30% Similarity=0.500 Sum_probs=191.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCc--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||.||++.++ ++. .+++|++..... ......+.+|++++.++ +||||+++++++.+.+..
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCC---HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 57888999999999999999864 444 457776543221 22345688999999999 899999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 570 LLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
|+||||+++++|.++++.. ..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCC
Confidence 9999999999999998632 257889999999999998 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~ 704 (789)
+.+||+|||++....... .......+..|+|||.+....++.++||||||+++|||+| |..||...... .
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~- 231 (303)
T cd05088 161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E- 231 (303)
T ss_pred CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----H-
Confidence 999999999986321111 1112234567999999988889999999999999999998 99998543210 0
Q ss_pred ccchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 705 VDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
....+... ....+. .....+.+++.+||+.+|++||++.+++++|++++....
T Consensus 232 -----------~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 -----------LYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -----------HHHHHhcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00011111 111111 123346778899999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.43 Aligned_cols=244 Identities=23% Similarity=0.411 Sum_probs=192.7
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..+|++.+.||+|+||.||++.. .+++.|++|.+...... ..+.+.+|+.+++.++||||+++++.+......++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 36899999999999999999985 46889999987653322 23458899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||||+++++|.+++.+. ..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999999998642 357889999999999998 99999999999999999999999999875433221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
. .....+++.|+|||.+....++.++||||||+++|||++|+.||........ +.......
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----------------~~~~~~~~ 232 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----------------LYLIATNG 232 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----------------HHHHhcCC
Confidence 1 1234678899999999888889999999999999999999999965432100 00000000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. ............+.+++.+||..||++||++.|++++
T Consensus 233 ~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 T-PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred C-CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0 0001122344557788899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=309.38 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=192.3
Q ss_pred cCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
.++|++.+.||+|+||.||++... ++..|++|++..... ......+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC---HHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 467899999999999999999853 467899998764322 22334688999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh------------------------------chHHHHHHHHHHHHHhcCCCCeEeccCC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR------------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIK 616 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~------------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlk 616 (789)
+..+++|||+++++|.+++... ..++.+++.||+|||+.+ ++|||||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eeccccc
Confidence 9999999999999999998632 358899999999999998 9999999
Q ss_pred CCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 045256 617 SSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDD 695 (789)
Q Consensus 617 p~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~ 695 (789)
|+|||++.++.++|+|||++.................+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999865332211111112234667999999988899999999999999999997 777875322
Q ss_pred CCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 696 ESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
. .+....+.+...... .......+.+++.+||+.||++||++.|+++.|++
T Consensus 238 ~-----------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 H-----------------EEVIYYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-----------------HHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 001111111211110 11223456778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.72 Aligned_cols=188 Identities=27% Similarity=0.378 Sum_probs=159.9
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
...|.+.+.||+|+||.||++... .++.||||.... ..+.+|+++|++|+||||+++++++...+..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 457999999999999999999865 478899995321 125689999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||++. ++|.+++..+ ..++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 999995 6888887542 368899999999999998 999999999999999999999999999765433
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
..........||..|+|||++.+..++.++|||||||+||||++|..+++..
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 2222222456999999999999999999999999999999999998877644
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.75 Aligned_cols=247 Identities=29% Similarity=0.444 Sum_probs=189.8
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|++.+.||+|+||+||+++.. +++.||+|++......... .....+|+.++++++||||+++++++.+....++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE--REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH--HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc--cchhhhhhhcccccccccccccccccccccccccccc
Confidence 678899999999999999875 4668999998765443322 2234569999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 575 YMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 575 ~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
|+++++|.+++... ..++.|++++|+|||+.+ |+|+||||+|||++.++.++|+|||++..... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccc
Confidence 99999999998732 368899999999999998 99999999999999999999999999865311 112
Q ss_pred cccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 647 RPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
......++..|+|||.+. ...++.++||||||+++|+|++|+.||..... . .............+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~-----~~~~~~~~~~~~~~~~~~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----D-----DQLEIIEKILKRPLPSSS 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----H-----HHHHHHHHHHHTHHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----h-----hhhhhhhhcccccccccc
Confidence 223456889999999998 88899999999999999999999999865410 0 000001111111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. .......+.+++.+||+.||++||++.+++++
T Consensus 224 ~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQ----SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TS----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cc----cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 11112567788899999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.09 Aligned_cols=236 Identities=22% Similarity=0.306 Sum_probs=183.4
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv 572 (789)
+|+..+.||+|+||+||++... +++.||+|++....... ....+.+..|..++..+. |++|+++.+++.+.+..|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence 4778899999999999999864 68899999876533222 223345778888888885 57888899999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 9999999999988642 357889999999999998 99999999999999999999999999875322211
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-----------------~~~~~~i~~~~ 217 (323)
T cd05615 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-----------------DELFQSIMEHN 217 (323)
T ss_pred --cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhCC
Confidence 12235689999999999988899999999999999999999999864321 00111222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTM 757 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 757 (789)
...+.. ....+.+++.+||+.||++|++.
T Consensus 218 ~~~p~~----~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKS----LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCcc----CCHHHHHHHHHHcccCHhhCCCC
Confidence 222222 23345677889999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.84 Aligned_cols=244 Identities=28% Similarity=0.365 Sum_probs=188.3
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|+..+.||+|+||+||++.. .+++.||+|.+....... ......+.+|++++++++|+||+++.+++...+..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKK-RKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhh-hhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEE
Confidence 367788999999999999976 468899999876543222 222345778999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999998887532 357889999999999998 9999999999999999999999999986543221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH-Hhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV-KILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~d 722 (789)
. .....|+..|+|||.+.+..++.++|+||||+++|||++|+.||....+.. ....+. .+..
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--------------~~~~~~~~~~~ 219 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--------------KREEVDRRVLE 219 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--------------HHHHHHHhhhc
Confidence 1 123468999999999988889999999999999999999999986432200 000111 1111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
.... ........+.+|+..||+.||++||+ +.+++.+
T Consensus 220 ~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 220 TEEV----YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccc----cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1111 11223345667888999999999999 6666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.98 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=190.6
Q ss_pred CccccceEeecccEEEEEEEeCCCcEEEEEEcccchhh--hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK--KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+|++.+.||+|+||+||++...+++.+|+|.+...... ........+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999998888999999987643221 1223345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++.+. ..++.|++.+|+|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999998653 247789999999999998 99999999999999999999999999865322111
Q ss_pred ----CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 645 ----DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 645 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
........++..|+|||.+....++.++||||||+++|||++|+.||...+.... . ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------------~--~~~~~~ 223 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA------------M--FYIGAH 223 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH------------H--HHhhhc
Confidence 1111234578999999999888899999999999999999999999854322100 0 000000
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
....+. ........+..++.+||+.+|++||++.|+++
T Consensus 224 -~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 -RGLMPR---LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -cCCCCC---CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000110 01123345667888999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=315.65 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=185.1
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++... +++.||+|+++...... .+..+.+.+|+.++.++ +||||+++++++.+.+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 46999999999999864 57899999986543222 23345688899999888 69999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 154 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTS 154 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--cee
Confidence 99999887542 358899999999999998 99999999999999999999999999864222111 122
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...||+.|+|||++.+..++.++||||||++||||++|+.||.......... .. ......+.......+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~--------~~~~~~~~~~~~~~p~ 224 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TE--------DYLFQVILEKPIRIPR 224 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cH--------HHHHHHHHhCCCCCCC
Confidence 4578999999999999999999999999999999999999996433211100 00 0001111222222222
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCH------HHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTM------ADIVAN 763 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~ 763 (789)
. ....+.+++.+||+.||++||++ .+++++
T Consensus 225 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 F----LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 2 23345677889999999999984 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.53 Aligned_cols=243 Identities=28% Similarity=0.434 Sum_probs=189.6
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.+.||+|+||.||++..+++..+++|++..... ..+.+.+|++++++++|||++++++++. .+..+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 56888999999999999999987777899998654322 1235888999999999999999999875 45688999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.++++.. ..++.+++.||+|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999998642 257889999999999998 9999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. ......++..|+|||.+....++.++||||||+++|||+| |+.||..... .+..+.+.
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------------------~~~~~~~~ 217 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN------------------REVLEQVE 217 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHHH
Confidence 11 1112245678999999988889999999999999999999 8888754321 00111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.....+ ........+.+++.+||..||++||+++++++.|++
T Consensus 218 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGYRMP--CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCCCC--CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111111 112334567788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.36 Aligned_cols=189 Identities=28% Similarity=0.407 Sum_probs=161.4
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-C-----CcceEEEEEEEeC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-H-----KHLVRLVGYCEEK 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H-----pnIv~l~~~~~~~ 566 (789)
-+|.++++||+|+||.|.+|.+ ++++.||||+++..+... .+-..|+.+|.+|+ | -|+|+++++|...
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~-----~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL-----RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH-----HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3899999999999999999975 568999999987654332 23557999999996 4 5899999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC--CCcEEEEeec
Q 045256 567 DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA--QWTARVSDFG 634 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG 634 (789)
++.+||+|.++. +|+++|+.. +.++.|++.+|.+||+.+ |||+||||+||||.+ ...+||+|||
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 999999999976 999999764 368999999999999999 999999999999954 3489999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~ 696 (789)
.|+.....- ....-+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.++++
T Consensus 337 SSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 998633221 145678899999999999999999999999999999999887766654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.98 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=194.7
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv 572 (789)
..|+++++||+|+.+.||++...+.+.||+|++... ........-|.+|+..|.+|+ |.+|++|++|-..++.+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 568899999999999999999888889999875432 223344567999999999994 99999999999999999999
Q ss_pred EEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||=+. +|..+|+++. .+.+|++.++.++|+.+ |||.||||.|+|+-. |.+||+|||+|.......
T Consensus 439 mE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 439 MECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred eecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 998755 9999987643 47789999999999999 999999999999854 699999999998887777
Q ss_pred CCCcccccccCcCccCccccCCC-----------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLN-----------VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 712 (789)
........+||+.||+||.+... ..++++||||||||||+|+.|++||..-..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------------- 577 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------------- 577 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------------
Confidence 66666778999999999988332 256789999999999999999999943221
Q ss_pred hhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+..+.+. .+..+...+.. .+.++++.||..||++||+..|++++
T Consensus 578 ~~aKl~aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 QIAKLHAITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHhhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11233334443 22222222222 15567888999999999999999875
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.67 Aligned_cols=238 Identities=31% Similarity=0.523 Sum_probs=183.3
Q ss_pred ceEeecccEEEEEEEeCC-Cc--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKLPD-GQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
+.||+|+||.||++.+.+ +. .+++|.++.... ....+.+.+|+++++++ +||||+++++++......+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 77 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC---HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence 468999999999998753 43 468887653221 12334588999999999 799999999999999999999999
Q ss_pred cCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 576 MKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 576 ~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
+++++|.++++.. ..++.+++.||+|||+.+ ++||||||+|||+++++.+||+
T Consensus 78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEEC
Confidence 9999999998632 357789999999999988 9999999999999999999999
Q ss_pred eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhh
Q 045256 632 DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 632 DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
|||++...... ........+..|+|||++....++.++||||||+++|||++ |+.||......
T Consensus 155 dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------------- 218 (270)
T cd05047 155 DFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------------- 218 (270)
T ss_pred CCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-------------
Confidence 99998532111 11112233567999999988889999999999999999997 99998543210
Q ss_pred hhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 711 AIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 711 ~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
...+.+.. .+..+. .....+.+++.+||..||.+||++.|+++.|++++
T Consensus 219 -----~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 219 -----ELYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -----HHHHHHhCCCCCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00011111 111111 22345678889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=299.37 Aligned_cols=240 Identities=26% Similarity=0.432 Sum_probs=186.8
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCC
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNG 579 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 579 (789)
++||+|+||.||++.+.+++.|++|++...... .....+.+|++++++++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999877999999987654332 23456889999999999999999999999999999999999999
Q ss_pred chhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 580 ALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 580 sL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
+|.+++... ..++.+++.+|+|||+.+ ++||||||+|||++.++.+||+|||++..............
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999988542 246778999999999998 99999999999999999999999999875432211111112
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...+..|+|||.+.+..++.++||||||+++|||+| |..||..... ....+.+......+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------------------~~~~~~~~~~~~~~- 215 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------------------QQTRERIESGYRMP- 215 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------------------HHHHHHHhcCCCCC-
Confidence 234567999999988889999999999999999999 7777744321 01111111111100
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
........+.+++.+||..+|++||++.|+++.|+
T Consensus 216 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 -APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11223446778899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.65 Aligned_cols=261 Identities=18% Similarity=0.288 Sum_probs=187.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||+++.+ +++.||+|+++...... ....+.+|++++++++||||+++++++..++..++|
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC---cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 57999999999999999999865 57889999876443221 123467899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 999986 888877532 247789999999999998 9999999999999999999999999986533222
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhhhh--hhH
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIMAG--ELV 718 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~--~~~ 718 (789)
.. .....+++.|+|||.+.+ ..++.++||||||+++|||+||++||............. ...+....... ...
T Consensus 159 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 KT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11 123467899999998854 568899999999999999999999996543211000000 00000000000 000
Q ss_pred HhhcccCCCC--C---CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPP--E---INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~--~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+..+...... . .........+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000 0 0001223445678899999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.61 Aligned_cols=243 Identities=28% Similarity=0.464 Sum_probs=191.4
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.++||+|+||.||++..++++.|++|.+...... ...+.+|+.++++++||||+++++++. .+..++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc-----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 34678999999999999999999888999999987643321 235889999999999999999999874 467899
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+|||+++++|.+++... ..++.+++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999987532 257889999999999988 99999999999999999999999999876442
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.+.
T Consensus 155 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------------~~~~~~ 215 (260)
T cd05067 155 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------------------PEVIQN 215 (260)
T ss_pred CCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------------------HHHHHH
Confidence 2211 1112345678999999988889999999999999999999 9999854321 001111
Q ss_pred hccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 721 LDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 721 ~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
+... ...+. .....+.+++.+||..+|++||+++++++.|+.
T Consensus 216 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 216 LERGYRMPRPD----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHcCCCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111 11111 123457788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=326.52 Aligned_cols=193 Identities=20% Similarity=0.317 Sum_probs=153.6
Q ss_pred HHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC------CCcceEEEE
Q 045256 489 LAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH------HKHLVRLVG 561 (789)
Q Consensus 489 l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~ 561 (789)
+....++|++.++||+|+||+||++.+. +++.||||+++.... ....+..|++++++++ |++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-----YTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-----hHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 3445689999999999999999999864 578899999754221 1223455666666664 456899999
Q ss_pred EEEeC-CeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCC-----
Q 045256 562 YCEEK-DERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQW----- 626 (789)
Q Consensus 562 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~----- 626 (789)
++... ...++|||++ +++|.+++.+. ..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 98765 4678999988 66888887643 3688999999999997 47 99999999999998765
Q ss_pred -----------cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 627 -----------TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 627 -----------~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998754221 1224578999999999999999999999999999999999999996543
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=319.96 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=189.7
Q ss_pred cCCccccceEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
..+|.+.+.||+|+||.||++... .++.|++|.+.... .+.+|++++++++||||+++++++......
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 457999999999999999999753 35789999865321 245799999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+++||++. ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99999996 5888887432 368899999999999998 99999999999999999999999999976544
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch---------hhhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA---------VPAI 712 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~---------~~~~ 712 (789)
...........||+.|+|||++....++.++|||||||+||||++|+.||+........ ..+.... .+..
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS-SQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH-HHHHHHHHHhccCccccCCc
Confidence 33332333457899999999999889999999999999999999999999765432110 0000000 0000
Q ss_pred hhhhhHHhh---cccCCC----CCC-CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGELVKIL---DRRVGP----PEI-NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~~~~~~---d~~~~~----~~~-~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+.+.+ .....+ +.. ........+.+++.+||..||++||++.|++.+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 000000 000 001123456678889999999999999999886
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.99 Aligned_cols=248 Identities=27% Similarity=0.486 Sum_probs=192.3
Q ss_pred CCccccceEeecccEEEEEEEeC-C---CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-D---GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
.+|++.+.||+|+||.||++... + +..+++|.++.... ......+.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46888999999999999999753 2 33799998764332 22345688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999998643 357789999999999998 9999999999999999999999999987654
Q ss_pred CCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... ......++..|+|||.+....++.++|+||||+++||+++ |+.||...... +...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----------------~~~~ 220 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----------------DVIK 220 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----------------HHHH
Confidence 332111 1112233568999999988889999999999999999887 99998543220 0001
Q ss_pred Hhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 719 KILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 719 ~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
.+.+. +.+.+ ......+.+++.+|++.+|++||+|.++++.|++++
T Consensus 221 ~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 221 AIEEGYRLPAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred HHhCCCcCCCC----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 11111 11111 122345677888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.10 Aligned_cols=242 Identities=24% Similarity=0.381 Sum_probs=192.3
Q ss_pred cCCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|.||.||++...+ ++.+++|.+..... .+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l 75 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI 75 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence 3678999999999999999998764 78999998754321 4568999999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
++||+++++|.+++... ..++.+++++|.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred EEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999999998532 257889999999999998 999999999999999999999999998765433
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. ......++..|+|||++.+..++.++||||||+++|||++|+.||........ . ..+.
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----------------~-~~~~ 212 (256)
T cd06612 153 MA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----------------I-FMIP 212 (256)
T ss_pred cc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----------------h-hhhc
Confidence 21 11234578899999999888999999999999999999999999864322100 0 0000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
................+.+++.+||+.||++||++.|++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 213 NKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11111111122234557788899999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.27 Aligned_cols=238 Identities=24% Similarity=0.443 Sum_probs=183.0
Q ss_pred eEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 501 KIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
.||+|+||.||+|.+. ++..||+|++..... ....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC---hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 3899999999999753 355799998765432 223456889999999999999999999885 457899999999
Q ss_pred CCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc-
Q 045256 578 NGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR- 647 (789)
Q Consensus 578 ~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~- 647 (789)
+++|.+++..+ .+++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999998532 367889999999999998 99999999999999999999999999875433322111
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc--c
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--R 724 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~--~ 724 (789)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+...+.. +
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------------~~~~~~~~~~~~ 216 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------------------PEVMSFIEQGKR 216 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------------------HHHHHHHHCCCC
Confidence 111223578999999988889999999999999999996 9999854321 011111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
...+. .....+.+++.+||..||++||++.+|.+.|+++
T Consensus 217 ~~~~~----~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 LDCPA----ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11111 2234566788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.25 Aligned_cols=242 Identities=23% Similarity=0.360 Sum_probs=175.8
Q ss_pred eEeecccEEEEEEEeCC---CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 501 KIGAGSFGVVYKGKLPD---GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
.||+|+||.||+|...+ ...+++|.+..... ......+.+|+++++.++||||+++++.+.+....++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT---PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC---hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999997543 34688887653322 2233458889999999999999999999999999999999999
Q ss_pred CCchhHHHhhh-------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 578 NGALYDHLHDR-------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 578 ~gsL~~~l~~~-------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99999998542 257789999999999998 99999999999999999999999999865332221
Q ss_pred CCcccccccCcCccCccccC-------CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 645 DFRPMKAAGTVGYIDPEYYG-------LNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........++..|+|||++. ...++.++||||||+++|||++ |+.||....+. ......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------------~~~~~~ 222 (269)
T cd05042 156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------------QVLKQV 222 (269)
T ss_pred eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------------HHHHHH
Confidence 11112234567899999874 2356889999999999999999 66776433210 000000
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+ ...+..+..+. ........+..++..|+ .||++||+++||++.|
T Consensus 223 ~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 223 V-REQDIKLPKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred h-hccCccCCCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0 00111111111 11223344556667788 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=305.18 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=193.1
Q ss_pred CCccccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK-- 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 566 (789)
..|++.+.||+|+||.||+++. .+++.|++|.++.... ......+.+|++++++++||||+++++++.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 3467889999999999999974 3578899999764432 22344689999999999999999999999875
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
...++||||+++++|.+++.+. ..++.+++.+|+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 5688999999999999988542 357889999999999998 9999999999999999999999999987
Q ss_pred CCCCCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 638 MGPESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 638 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........ .......++..|+|||.+.+..++.++||||||+++|||++++.|+....... ...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF---LKMIGPTHGQMTVTR 234 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh---hhhcccccccccHHH
Confidence 65433221 11123456778999999988889999999999999999999887653221100 000000000000001
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
..+.+......+. .......+.+|+.+||+.||++||++.++++.|++++
T Consensus 235 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 235 LVRVLEEGKRLPR--PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HHHHHHcCccCCC--CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1111111111111 1123456778899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.88 Aligned_cols=240 Identities=28% Similarity=0.446 Sum_probs=191.4
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.+.||+|+||.||++.. .++.|++|.+..... ....+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 5788899999999999999987 478999998765432 3445889999999999999999999999989999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999998643 257889999999999998 9999999999999999999999999987653221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ....+..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.+.+.
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------------~~~~~~~~ 213 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------------KDVVPHVE 213 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH------------------HHHHHHHh
Confidence 1 2234578999999988889999999999999999997 8888743221 01111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
..... .........+.+++.+||..+|++||++.|+++.|+.+
T Consensus 214 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 214 KGYRM--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred cCCCC--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11110 00112235567788999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.72 Aligned_cols=257 Identities=24% Similarity=0.322 Sum_probs=192.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.+++|.+..... .+....+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK---PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence 46899999999999999999864 578899998654321 22344588899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.++++.. ..++.|+++||+|||+ .+ ++|+||||+|||++.++.+||+|||++.......
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999998643 3678899999999997 46 9999999999999999999999999986543221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch---------------
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA--------------- 708 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~--------------- 708 (789)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...+..... ......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE--AMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH--HhhcCccccccccCCcccccC
Confidence 12346789999999998888999999999999999999999998543321100 000000
Q ss_pred ------hhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 709 ------VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 709 ------~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.+..........+.... +..........+.+++.+||..||++||+++|++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPP--PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCC--ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000001111111110 1111111344577889999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.93 Aligned_cols=263 Identities=25% Similarity=0.443 Sum_probs=196.6
Q ss_pred CCccccceEeecccEEEEEEEeC-----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--C
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--K 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 566 (789)
++|++.+.||+|+||.||++... +++.+|+|.+...... .....|.+|++++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 46778899999999999999853 3678999997654332 334569999999999999999999999887 5
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
...+++|||+++++|.+++... ..++.+++.||+|||+.+ |+|+||||+|||++.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 5789999999999999998642 357889999999999998 9999999999999999999999999997
Q ss_pred CCCCCCCCCc-ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 638 MGPESERDFR-PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 638 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
.......... .....++..|+|||.+....++.++||||||+++|||++|+.|+....... ..+............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~ 234 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF---LRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh---ccccccccccccHHH
Confidence 6543322111 112234567999999988889999999999999999999999875432211 000000000011112
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
+.+.+......+. .......+.+++.+||+.+|++||++.|++++|+++
T Consensus 235 ~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222222211111 112235577889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.33 Aligned_cols=241 Identities=22% Similarity=0.318 Sum_probs=190.0
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +++.+++|.++..... ...+.+.+|+.++++++||||+++++.+.+.+..+++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS---SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch---HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence 5788999999999999999864 6889999987543322 22345788999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.++++||.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999999987532 257889999999999998 9999999999999999999999999986543322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......++..|+|||.+....++.++|+||||+++|+|++|+.||...+. ......+...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----------------~~~~~~~~~~ 215 (255)
T cd08219 155 A--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----------------KNLILKVCQG 215 (255)
T ss_pred c--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----------------HHHHHHHhcC
Confidence 1 11234678899999999888899999999999999999999999854321 0001111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+. +......+.+++.+||+.||++||++.|++..
T Consensus 216 ~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYKPL---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCC---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11111 11233456788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.67 Aligned_cols=244 Identities=27% Similarity=0.343 Sum_probs=188.8
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|+..+.||+|+||+||++... +++.||+|.+....... ......+.+|+.++++++|+||+++++.+.+.+..++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 3677899999999999999864 68899999876533222 222345778999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999887532 247889999999999988 9999999999999999999999999986543222
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. .....|+..|+|||.+....++.++||||||+++|||++|+.||........ .......++.
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--------------~~~~~~~~~~ 219 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--------------REEVERLVKE 219 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--------------HHHHHhhhhh
Confidence 1 1234689999999999988999999999999999999999999965322100 0001111111
Q ss_pred cC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 724 RV-GPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 724 ~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
.. ..+ ......+.+|+.+||+.||++||| ++|++++
T Consensus 220 ~~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 VQEEYS----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhhcC----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00 001 112334667888999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.26 Aligned_cols=239 Identities=27% Similarity=0.445 Sum_probs=186.9
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE-eCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE-EKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~~lv 572 (789)
++|++.+.||+|+||.||++.. .++.|++|.++... ..+.+.+|+.++++++|+|++++++++. +....+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 4788899999999999999986 47889999865322 2335889999999999999999999765 44568999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++++|.++++++ ..++.+++.+|+|||+.+ |+||||||+||++++++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999998653 257789999999999998 999999999999999999999999998753322
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
. .....+..|+|||++....++.++||||||+++|||++ |+.||..... ..+...+
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------------------~~~~~~~ 212 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------------------KDVVPRV 212 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHH
Confidence 1 12234568999999988889999999999999999997 8888743211 0011111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
...... .........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 213 EKGYKM--DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred hcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111110 01112345567888999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=303.51 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=192.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
.+|++.+.||+|+||.||++..+ +++ .+++|.+..... ......+.+|+.++++++||||+++++++.. ..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 56888999999999999999854 233 589998654432 2334568899999999999999999999987 78
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 89999999999999998652 357889999999999988 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............++..|+|||.+....++.++|+||||+++|||++ |+.||..... .++.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------------~~~~ 221 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------------------VEIP 221 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------------------HHHH
Confidence 43332222112234578999999988889999999999999999998 9999854321 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+.+.. ....+.... ..+..++.+||..||++||++.++++.|+++.+.
T Consensus 222 ~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 222 DLLEKGERLPQPPICT----IDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHHhCCCCCCCCCCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11111 112222222 3456778899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=303.54 Aligned_cols=242 Identities=22% Similarity=0.389 Sum_probs=199.7
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..-|.+.+.||+|-|..|-++++ -+|..||||++.+.+.... ....+.+|++-|+.++|||||+||.+......+||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~--st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL--STGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh--hhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 35688899999999999999974 3799999999887665432 23457889999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE-CCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL-DAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGls~~~~~ 641 (789)
|+|+=++|+|+||+.+. .+++.||..|+.|+|+.+ +|||||||+||.+ ..-|-+||+|||++..+..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999998643 368899999999999999 9999999999876 5668999999999976555
Q ss_pred CCCCCcccccccCcCccCccccCCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLT-AKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
... ..+.+|+..|.|||++.+..|+ +++||||||||||.|+.|++||...++. +.+..+
T Consensus 172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmI 231 (864)
T KOG4717|consen 172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMI 231 (864)
T ss_pred cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhh
Confidence 433 2367999999999999988876 5789999999999999999999766542 234455
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+|-...-|. -.....++||..||..||.+|.+.+||+..
T Consensus 232 mDCKYtvPs----hvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 MDCKYTVPS----HVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hcccccCch----hhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 555443333 344556777888999999999999998764
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.88 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=189.0
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC----
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 566 (789)
..++|++.+.||+|+||.||++... .++.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC--hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 3468999999999999999999754 5889999987643221 22334577899999999999999999988643
Q ss_pred --CeEEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 --DERLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 --~~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...++||||+++ +|.+.+.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccccc
Confidence 346999999976 67666543 2357889999999999998 99999999999999999999999999975
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc--chhhhh---h
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD--FAVPAI---M 713 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~--~~~~~~---~ 713 (789)
..... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...+........... ...+.. .
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 43321 122356899999999999889999999999999999999999999654321000000000 000000 0
Q ss_pred hhhhHHhhccc----------------CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRR----------------VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......++.. .+............+.+++.+||..||++|||+.|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00011111100 000001111223456788999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.89 Aligned_cols=235 Identities=24% Similarity=0.387 Sum_probs=190.3
Q ss_pred eEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCC
Q 045256 501 KIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNG 579 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 579 (789)
+||+|+||+||-|++.+ ...+|||.+..... ...+-+.+|+.+.++|+|.|||+++|.+.+++.+-+.||.+++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds----r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS----REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc----hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 69999999999998765 45689997654332 33445889999999999999999999999999889999999999
Q ss_pred chhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEEEEeeccCcCCCCCCCCCc
Q 045256 580 ALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 580 sL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
+|.++|+.. .-+.+||++||.|||++. |||||||-+|||++ -.|.+||+|||-++.+..-. ..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PC 732 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--cc
Confidence 999999753 246899999999999999 99999999999995 57899999999987644332 33
Q ss_pred ccccccCcCccCccccCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc-
Q 045256 648 PMKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR- 724 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~- 724 (789)
+.++.||..|||||++..+ .|..++|||||||++.||.||++||..-.+ +. ..++.-.
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-----------pq--------AAMFkVGm 793 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-----------PQ--------AAMFKVGM 793 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-----------hh--------Hhhhhhcc
Confidence 4467899999999999654 588999999999999999999999965432 00 1112111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+..+.++....+.++++|+.+||.+||+++++++.
T Consensus 794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 122233456777788889999999999999999999874
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.34 Aligned_cols=244 Identities=23% Similarity=0.390 Sum_probs=192.8
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..+|++.+.||+|+||.||++.. .+++.|++|.+...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 36899999999999999999985 47899999987543322 23457899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||||+++++|.+++.+. ..++.+++.+|.|||+.+ |+|+||||+|||++.++.++|+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999999988542 367889999999999998 99999999999999999999999999865433221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...... ......
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----------------~~~~~~ 231 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----------------LIATNG 231 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----------------eeccCC
Confidence 1 123467889999999998889999999999999999999999996543211100 000000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+...........+.+++.+||..||++||+++|++++
T Consensus 232 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 -TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001122334556778899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.73 Aligned_cols=245 Identities=29% Similarity=0.473 Sum_probs=193.8
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.+.||+|+||.||++..++++.|++|.+..... ....+.+|+.++++++||||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 4578999999999999999999988888999998764332 12358899999999999999999999998889999
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+|||+++++|.+++.+. ..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999998642 357889999999999998 99999999999999999999999999876443
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .......+..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...+..+
T Consensus 156 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----------------~~~~~~~ 217 (261)
T cd05034 156 DEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----------------REVLEQV 217 (261)
T ss_pred hhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHHH
Confidence 2111 1112234568999999988889999999999999999998 8888843221 0011111
Q ss_pred hcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 721 LDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 721 ~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
... ....+. +....+.+++.+|+..+|++||+++++++.|+.
T Consensus 218 ~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 ERGYRMPRPP----NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcCCCCCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111 111111 123456788899999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.68 Aligned_cols=196 Identities=27% Similarity=0.400 Sum_probs=163.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.||+|++.+..... ....+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 47899999999999999999864 58899999976432221 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++.+. ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999998642 247889999999999999 9999999999999999999999999986543322
Q ss_pred CCCcccccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 1 11123468999999999863 45788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.59 Aligned_cols=244 Identities=28% Similarity=0.452 Sum_probs=181.7
Q ss_pred ceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-CCeEEEEEE
Q 045256 500 NKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-KDERLLVYD 574 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~lv~e 574 (789)
+.||+|+||.||+|... +...+|+|++..... ....+.+.+|+.+++.++||||+++++++.. +...+++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD---LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC---HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence 46899999999999753 235799998653221 2234468889999999999999999998764 455789999
Q ss_pred ecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 575 YMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 575 ~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|+++++|.+++... ..++.+++.||+|||+.+ |+||||||+|||+++++.+||+|||++.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 78 YMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999998642 246779999999999998 999999999999999999999999998754322110
Q ss_pred --CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 646 --FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 646 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.......++..|+|||.+....++.++||||||+++|||++|+.|++.... ... ....+...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~~------------~~~~~~~~ 218 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SFD------------ITVYLLQG 218 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HHH------------HHHHHhcC
Confidence 011123456789999999888899999999999999999996554332211 000 01111111
Q ss_pred -cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 724 -RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 724 -~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
....+. ..+..+.+++.+||+.+|++||++.|+++.|++++.
T Consensus 219 ~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 219 RRLLQPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111111 123456778899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.59 Aligned_cols=247 Identities=24% Similarity=0.318 Sum_probs=185.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.++||+|+||.||+++.+ +++.||+|++.+..... ......+.+|+.++..++|+||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH-hhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 47899999999999999999865 46789999875432222 22344588899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++|+|.+++.+. ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999999652 247789999999999998 9999999999999999999999999986543222
Q ss_pred CCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
. .......||+.|+|||++. ...++.++||||||+++|||++|+.||...+.. ....
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-----------------~~~~ 218 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----------------ETYG 218 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-----------------HHHH
Confidence 1 1122356899999999985 346788999999999999999999999643210 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcC--CCCCCCHHHHHHH
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLE--GKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~d--p~~RPt~~evl~~ 763 (789)
.+... +...+.. .......+.+++.+|+..+ +..||++.|++++
T Consensus 219 ~i~~~~~~~~~p~~-~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 KIMNHKERFQFPAQ-VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HHhCCCccccCCCc-cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11111 1111110 1122334555666666544 4447899999888
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=298.61 Aligned_cols=239 Identities=27% Similarity=0.481 Sum_probs=184.9
Q ss_pred ceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
++||+|+||.||+|.... +..+++|.+...... .....+.+|++++++++||||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 469999999999997432 268999987654432 23456889999999999999999999876 4568999999
Q ss_pred cCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 576 MKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 576 ~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
+++++|.+++... ..++.|++++|+|||+.+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999999998643 367889999999999998 99999999999999999999999999876543322111
Q ss_pred -ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc--
Q 045256 648 -PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR-- 723 (789)
Q Consensus 648 -~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 723 (789)
.....++..|+|||.+....++.++||||||+++|||++ |+.||..... . .+.+.+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~-------------~~~~~~~~~~ 215 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----A-------------EVIAMLESGE 215 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----H-------------HHHHHHHcCC
Confidence 111223568999999988889999999999999999998 8988854321 0 01111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
.+..+ ......+.+++.+||..+|++||++.++++.|+++
T Consensus 216 ~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 216 RLPRP----EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11111 12234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=316.18 Aligned_cols=262 Identities=19% Similarity=0.240 Sum_probs=188.1
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||.||++... .++.||||++...... ......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC--chhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 468999999999999999999854 5789999987643221 22334577899999999999999999987543
Q ss_pred -CeEEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 567 -DERLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
...|+||||+++ +|.+.+.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 357999999976 77776642 2357899999999999998 999999999999999999999999999764
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc--cchhhhhh---h
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV--DFAVPAIM---A 714 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~---~ 714 (789)
.... ......+|..|+|||++.+..++.++||||||+++|||++|+.||...+........+. ..+.+... .
T Consensus 177 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 177 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred CCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 3321 12235689999999999999999999999999999999999999965432110000000 00000000 0
Q ss_pred hhhHHhhcccCC----------------CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVG----------------PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~----------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+...+..+.. ............+.+|+.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000011111000 0000011122456788999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.99 Aligned_cols=246 Identities=27% Similarity=0.426 Sum_probs=190.6
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhh-----HHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKK-----FQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
+|.+.+.||+|+||.||+|... +++.|++|.+....... ..+..+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677899999999999999764 57899999876432211 12234568899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.+++|||+++++|.+++... ..++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999998643 257889999999999998 9999999999999999999999999987654
Q ss_pred CCCCCC----cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 641 ESERDF----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 641 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
...... ......++..|+|||.+....++.++||||||+++|||++|+.||...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------------~~ 220 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----------------QA 220 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----------------HH
Confidence 221111 111245788999999998888999999999999999999999998643210 00
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.+......+ .........+..++.+||+.||++||++.|++++
T Consensus 221 ~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 221 IFKIGENASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHhccCCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111111110 0111233556778889999999999999998863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=296.86 Aligned_cols=239 Identities=25% Similarity=0.423 Sum_probs=185.5
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCC
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNG 579 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~g 579 (789)
++||+|+||.||++..++++.+++|.+..... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999988889999998764332 222345889999999999999999999999999999999999999
Q ss_pred chhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 580 ALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 580 sL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
+|.+++... ..+..+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... ....
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 153 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL 153 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence 999987532 257789999999999998 999999999999999999999999998653322111 1112
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
..++..|+|||++....++.++||||||+++|||++ |..||...... . ....+.... +...+.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------------~-~~~~~~~~~--~~~~~~ 217 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------------Q-AREQVEKGY--RMSCPQ 217 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------------H-HHHHHHcCC--CCCCCC
Confidence 234567999999988889999999999999999998 88888533210 0 000111100 111111
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
.....+.+++++|+..+|++||++.|+++.|.
T Consensus 218 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 ----KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 22345778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.79 Aligned_cols=244 Identities=23% Similarity=0.380 Sum_probs=187.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.|++|.++..... ....+.+|+.+++.++||||+++++++...+..++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE----DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 46788899999999999999754 6889999987543221 223477899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.+|+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 9999999999988643 357889999999999998 99999999999999999999999999865432211
Q ss_pred CCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 645 DFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
......|+..|+|||.+. ...++.++||||||+++|||++|+.||....+... +....
T Consensus 162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-----------------~~~~~ 222 (267)
T cd06645 162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----------------LFLMT 222 (267)
T ss_pred --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----------------HHhhh
Confidence 112346889999999874 45688899999999999999999999865432100 00000
Q ss_pred cccCCCCC-CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPE-INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....++. .........+.+++.+||..||++||++.+++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 223 KSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01110000 0001123446778899999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.29 Aligned_cols=239 Identities=31% Similarity=0.508 Sum_probs=190.3
Q ss_pred ceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
+.||+|+||.||++.... +..|++|.+....... ....+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence 468999999999998653 7889999976543322 345688999999999999999999999998999999999
Q ss_pred cCCCchhHHHhhh-----------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 576 MKNGALYDHLHDR-----------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 576 ~~~gsL~~~l~~~-----------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+++++|.+++... ..++.++++||+|||+.+ |+|+||||+||+++.++.+||+|||.+..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccc
Confidence 9999999998764 257889999999999988 99999999999999999999999999987
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
..............++..|+|||.+....++.++||||||+++|||++ |+.||..... . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~------------~~~ 217 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----E------------EVL 217 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----H------------HHH
Confidence 554432222234567889999999988889999999999999999999 5888854321 0 001
Q ss_pred HHhhc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 718 VKILD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 718 ~~~~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
..+.+ ..+..+ ......+.+++.+||..||++||++.|++++|+
T Consensus 218 ~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 218 EYLRKGYRLPKP----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHHcCCCCCCC----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111 111111 222455677888999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=319.24 Aligned_cols=262 Identities=22% Similarity=0.302 Sum_probs=187.3
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-----e
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-----E 568 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~ 568 (789)
+|++.+.||+|+||.||++.. .+++.||+|++...... ......+.+|+++++.++||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN--LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc--hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence 478899999999999999986 47899999987543211 122345789999999999999999999998876 7
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.|+||||+.+ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 79 IYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEEEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 8999999974 787776432 357889999999999998 9999999999999999999999999987543
Q ss_pred CCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccchhhhhh---h
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDFAVPAIM---A 714 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~~~---~ 714 (789)
..... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||............ ....+..... .
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 155 PDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred cCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 32211 11234578999999998764 5789999999999999999999999654321100000 0000000000 0
Q ss_pred hhhHHhhcccC-CCCC-----CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRV-GPPE-----INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~-~~~~-----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+.... ..+. ....+....+.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 01111111111 1110 0001123456778999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=297.64 Aligned_cols=243 Identities=24% Similarity=0.330 Sum_probs=192.5
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|+..+.||+|+||.||.++. ++++.+++|.+....... .....+.+|++++++++|+||+++++++.+.+..+++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE--KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch--hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 588899999999999999975 468899999875433222 23445889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.+++++|+|||+.+ ++|+||||+||++++++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999998654 257789999999999998 9999999999999999999999999987643332
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+...++...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------------~~~~~~~~~~ 216 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----------------LNLVVKIVQG 216 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHHcC
Confidence 1 12234688999999999888889999999999999999999999854221 0111111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
..... .......+.+++.+||+.+|++||++.|+++++
T Consensus 217 ~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 217 NYTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11111 123344567788899999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=309.44 Aligned_cols=258 Identities=22% Similarity=0.363 Sum_probs=181.5
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc---CCCcceEEEEEEEeC----
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL---HHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~---- 566 (789)
+|++.+.||+|+||+||++... +++.||+|.++...... .....+.+|+++++++ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED--GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC--CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 5888999999999999999865 68899999876532211 1112345667666655 799999999998652
Q ss_pred -CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeecc
Q 045256 567 -DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 635 (789)
...+++|||+++ +|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 357899999985 888887542 357889999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc---hhhhh
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF---AVPAI 712 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~---~~~~~ 712 (789)
+........ .....++..|+|||.+.+..++.++||||||+++|||++|++||.......... ..... .....
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~-~~~~~~~~~~~~~ 230 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG-KIFDLIGLPPEDD 230 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH-HHHHHhCCCChhh
Confidence 876533221 123467899999999988889999999999999999999999985443211000 00000 00000
Q ss_pred hhhhhHHhhcccCCCC-----CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGELVKILDRRVGPP-----EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... ........... .....+..+.+.+++.+||+.||++|||+.|++.+
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 231 WPRD-VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred Cccc-ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000 00000000000 00011234556788999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.85 Aligned_cols=242 Identities=21% Similarity=0.327 Sum_probs=173.3
Q ss_pred eEeecccEEEEEEEeCCCc---EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 501 KIGAGSFGVVYKGKLPDGQ---EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~~g~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
.||+|+||.||++...++. .+++|.+..... ....+.+.+|+.+++.++||||+++++.+.+....++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS---SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC---hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 5899999999999754433 455665443322 2234568899999999999999999999999999999999999
Q ss_pred CCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 578 NGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 578 ~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
+++|.+++++. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 99999998642 246789999999999998 999999999999999999999999997643222111
Q ss_pred CcccccccCcCccCccccCC-------CCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 646 FRPMKAAGTVGYIDPEYYGL-------NVLTAKSDVYGLGVVLLELLTG-KRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
.......++..|+|||++.. ..++.++||||||+++|||+++ ..||....+ .. .......+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~----~~~~~~~~~~ 226 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----RE----VLNHVIKDQQ 226 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HH----HHHHHHhhcc
Confidence 11223467889999998743 2457899999999999999975 556633221 00 0000001111
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
....+..+.. .....+.+++..|| .+|++||+++|+++.|
T Consensus 227 ~~~~~~~~~~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 227 VKLFKPQLEL------PYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cccCCCccCC------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1111111111 12234555677798 6899999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.77 Aligned_cols=244 Identities=24% Similarity=0.356 Sum_probs=178.9
Q ss_pred ceEeecccEEEEEEEeCC---CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 500 NKIGAGSFGVVYKGKLPD---GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
+.||+|+||.||+|...+ +..+++|.++..... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV---QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 368999999999997543 457999987654322 22335888999999999999999999999999999999999
Q ss_pred CCCchhHHHhhh-------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 577 KNGALYDHLHDR-------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 577 ~~gsL~~~l~~~-------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
++++|.++++.. ..++.|+++||+|||+.+ ++|+||||+||+++.++++||+|||++.......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 999999998632 246789999999999998 9999999999999999999999999986543322
Q ss_pred CCCcccccccCcCccCccccCCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLN-------VLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
.........++..|+|||++... .++.++||||||+++|||++ |+.||....+. .. ...
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-----~~--------~~~ 221 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-----QV--------LTY 221 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-----HH--------HHH
Confidence 21122234567889999988532 35789999999999999996 99998543220 00 000
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 716 ELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 716 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
.... ....+..+.. .....+.+.+++..|+ .+|++|||++||++.|+
T Consensus 222 ~~~~-~~~~~~~~~~-~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 222 TVRE-QQLKLPKPRL-KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred Hhhc-ccCCCCCCcc-CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000 0111111110 1112234556777898 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.46 Aligned_cols=248 Identities=27% Similarity=0.473 Sum_probs=190.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|+..+.||+|+||.||++... +++ .|++|.+...... .....+.+|+.++++++||||+++++++... .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP---KANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 56788899999999999999753 444 4788886543221 2233588999999999999999999998764 4
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++++||+++|+|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 67999999999999998643 357789999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~------------------~~~~ 221 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT------------------REIP 221 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHH
Confidence 43332222223345678999999988889999999999999999997 8888743211 0011
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+.+.. .+..+.. ....+..++.+||..+|++||+++|+++.|+++...
T Consensus 222 ~~~~~~~~~~~~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 222 DLLEKGERLPQPPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHCCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111 1111111 223456788899999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=308.04 Aligned_cols=187 Identities=25% Similarity=0.391 Sum_probs=150.7
Q ss_pred cceEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--CCeEEEEE
Q 045256 499 ENKIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--KDERLLVY 573 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~ 573 (789)
.++||+|+||+||++... +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....+++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999864 467899998754321 1236789999999999999999999864 34578999
Q ss_pred EecCCCchhHHHhh-----------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----CCCCcEEEEe
Q 045256 574 DYMKNGALYDHLHD-----------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSD 632 (789)
Q Consensus 574 e~~~~gsL~~~l~~-----------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~D 632 (789)
||+.+ +|.+++.. ...++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEee
Confidence 99965 88777642 1257899999999999998 9999999999999 4567999999
Q ss_pred eccCcCCCCCCCCC-cccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 633 FGLSMMGPESERDF-RPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 633 fGls~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
||+++......... ......+|+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 99997654332211 1224568999999999876 468999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=299.89 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=191.2
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhh------hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTK------KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
+|.+.+.||+|+||.||+|.. .+++.||+|.++..... ......+.+.+|+.++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999975 46889999987542221 11223456889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
..++||||+++++|.++++.. ..++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999988653 246789999999999998 999999999999999999999999998754
Q ss_pred CCCCCCCcccccccCcCccCccccCCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNV--LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
.............++..|+|||.+.... ++.++|+||||+++|||++|+.||...+.. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----------------~~~ 221 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-----------------AAM 221 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-----------------HHH
Confidence 3322222223456789999999987654 789999999999999999999998532210 001
Q ss_pred HHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.... ....+.....+....+.+++.+||..||++||++.+++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 222 FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred HHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111 1111111122345667788999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=299.09 Aligned_cols=245 Identities=27% Similarity=0.466 Sum_probs=191.6
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.+.||+|+||.||++...++..+++|.+..... ..+.+.+|++++++++|+||+++.+++.+ ...++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh-----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 4578999999999999999999987788899998654321 23458899999999999999999999887 77899
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+|||+++++|.+++... ..++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999998642 247789999999999988 99999999999999999999999999875433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......++..|+|||.+....++.++|+||||+++|||++ |+.||..... ..+.+.
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------------------~~~~~~ 215 (260)
T cd05073 155 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------------------PEVIRA 215 (260)
T ss_pred CCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH------------------HHHHHH
Confidence 2211 1112345678999999988889999999999999999999 8888854321 000111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
+......+ ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 216 ~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 216 LERGYRMP--RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HhCCCCCC--CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111100 011233456778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=304.43 Aligned_cols=244 Identities=24% Similarity=0.418 Sum_probs=191.7
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..+|++.+.||.|+||.||++.. .+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 93 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFV 93 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEE
Confidence 35799999999999999999975 5789999998754322 223457899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|+||+++++|.+++... ..++.+++++|+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 94 VMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred EEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999999987643 357889999999999998 99999999999999999999999999875433221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
. .....++..|+|||.+....++.++||||||+++|||++|+.||...+... ....+....
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----------------~~~~~~~~~ 231 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----------------ALYLIATNG 231 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHHHHHhcC
Confidence 1 123467889999999988889999999999999999999999986543210 000111000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. ............+.+++.+||..||++||++.+++.+
T Consensus 232 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 232 T-PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred C-cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 0001112233456778889999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.30 Aligned_cols=186 Identities=27% Similarity=0.414 Sum_probs=156.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
...+|++.+.||+|+||.||++... +++.||+|..... ....|+.++++++||||+++++++.+....+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3457999999999999999999865 4678999974321 1346899999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+||||+. ++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9999995 5888887532 368899999999999998 99999999999999999999999999875322
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
.. ......||..|+|||++.+..++.++|||||||++|||+++..+++..
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 21 112356899999999999889999999999999999999977776544
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=335.80 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=186.4
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--Ce
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DE 568 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~ 568 (789)
..++|.+.+.||+|+||+||++... +++.|++|.+...... ......|..|+.++++|+||||++++++|.+. ..
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~--e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK--EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC--HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4468999999999999999999865 5678999987643322 22345688999999999999999999988654 46
Q ss_pred EEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCC----CCeEeccCCCCCEEECC--------
Q 045256 569 RLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAV----PPIIHRDIKSSNILLDA-------- 624 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~----~~ivH~Dlkp~NIll~~-------- 624 (789)
+||||||+++++|.++|... ..++.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999999999988642 2578899999999998542 34999999999999964
Q ss_pred ---------CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 045256 625 ---------QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAIFK 693 (789)
Q Consensus 625 ---------~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf~~ 693 (789)
...+||+|||++........ .....||+.|+|||++.. ..++.++||||||||||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999976432221 123468999999999853 4588999999999999999999999954
Q ss_pred CCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 694 DDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... ..+...+......+. ......+.+|+..||..+|++||++.|++.+
T Consensus 246 ~~~~-----------------~qli~~lk~~p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANNF-----------------SQLISELKRGPDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCcH-----------------HHHHHHHhcCCCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 3220 011111111111111 1123456778889999999999999999853
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.00 Aligned_cols=245 Identities=26% Similarity=0.419 Sum_probs=192.4
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.+++|.+...... ....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 77 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI 77 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence 468999999999999999999864 5788999987644322 34568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+|||+++++|.+++... ..++.|++.+|+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999999988654 257889999999999998 999999999999999999999999998754332
Q ss_pred CCCCcccccccCcCccCccccCCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLN---VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
.. ......++..|+|||.+... .++.++||||||+++|||++|+.||...... .....
T Consensus 155 ~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-----------------~~~~~ 215 (262)
T cd06613 155 IA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-----------------RALFL 215 (262)
T ss_pred hh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHH
Confidence 21 11234678899999999776 7889999999999999999999998643210 00000
Q ss_pred hhcccCCCC-CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPP-EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+... ..........+.+++.+||..||++||++.+++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 216 ISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred HHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111111 11123344567888999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.28 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=185.3
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeC---
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEK--- 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~--- 566 (789)
+.+.|++.+.||+|+||.||++... +++.||+|++..... ....+..|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 4567888999999999999999864 578899998754321 223578899999998 799999999998753
Q ss_pred ---CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 567 ---DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 567 ---~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
...|++|||+++++|.+++... ..++.|++.||+|||+.+ |+|+||||+||++++++.+||+||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 4578999999999999988642 147889999999999998 999999999999999999999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 708 (789)
|++........ ......|+..|+|||++. ...++.++||||||+++|||++|+.||.......
T Consensus 156 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~---------- 223 (272)
T cd06637 156 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR---------- 223 (272)
T ss_pred CCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----------
Confidence 99875433221 122456889999999985 3457889999999999999999999985332100
Q ss_pred hhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. ...........+. .......+.+++.+||..||++|||+.|++++
T Consensus 224 -~---~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 224 -A---LFLIPRNPAPRLK-----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -H---HHHHhcCCCCCCC-----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 0 0000000011111 11223456788889999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=296.21 Aligned_cols=240 Identities=23% Similarity=0.374 Sum_probs=196.4
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
-|.++++||+|+||.||++.++ .|+.+|||.+.... ..+++..|+.+|++.+.|++|+++|.|.....+++||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 3667899999999999999764 69999999865432 3446889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||--|+..|.++-|. .+.++.++||+|||... -+|||||..||||+.+|.+||+|||.+-.+.....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999999997654 35677889999999988 69999999999999999999999999865433222
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
...+..||+.|||||++..-.|+.++||||||++..||..|++|+..-.+ +. ..-++...
T Consensus 185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----MR-------------AIFMIPT~ 244 (502)
T KOG0574|consen 185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----MR-------------AIFMIPTK 244 (502)
T ss_pred --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----cc-------------eeEeccCC
Confidence 22357899999999999998999999999999999999999999854322 10 01112222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.++...-+++....+.+++++||.++|++|-|+.+++++
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 233333456778889999999999999999999988875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=302.30 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=187.3
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.+.|++.+.||+|+||.||++... +++.|++|.+.... ....+.+.+|++++++++||||+++++++......++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 367889999999999999999875 47899999875432 2234568889999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|..++.+. ..++.|++++|+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999998876432 357889999999999998 999999999999999999999999988653222
Q ss_pred CCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
. .......++..|+|||.+. ...++.++||||||+++|||++|+.||...+.. ...
T Consensus 164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----------------~~~ 224 (292)
T cd06644 164 L--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----------------RVL 224 (292)
T ss_pred c--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----------------HHH
Confidence 1 1112346788999999884 345688999999999999999999998543210 001
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.++..... +...........+.+++.+||+.||++||++.|++++
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 225 LKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred HHHhcCCC-ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111110 0001111223446678889999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.46 Aligned_cols=253 Identities=25% Similarity=0.298 Sum_probs=194.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.|++|++..... ......+.+|+++++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK---SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc---chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 56888999999999999999864 688999998654322 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.+++++|.|||+ .+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999999888653 3678899999999997 45 9999999999999999999999999986532221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ....++..|+|||.+....++.++||||||+++|||++|+.||........... .+....+....+...
T Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 228 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD------DPMGILDLLQQIVQE 228 (284)
T ss_pred c----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh------hhhHHHHHHHHHhhc
Confidence 1 234689999999999888899999999999999999999999965433211000 000001111222221
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
... .....+....+.+++.+||+.||++||++.|++++.
T Consensus 229 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 PPP--RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred cCC--CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111 111123445677889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=300.87 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=185.5
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|++.+.||+|+||.||++... ++..+++|.+..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH----HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567889999999999999865 467889988654322 234458889999999999999999999999999999999
Q ss_pred ecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 575 YMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 575 ~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|+++++|..++.. ...++.|++++|+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 9999999887753 1357889999999999998 99999999999999999999999999865432211
Q ss_pred CcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 646 FRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
......++..|+|||.+. ...++.++||||||+++|||++|++||...... +.....
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----------------~~~~~~ 220 (282)
T cd06643 159 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-----------------RVLLKI 220 (282)
T ss_pred -ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-----------------HHHHHH
Confidence 122346889999999883 445778999999999999999999998543210 000111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
...... ....+......+.+++.+||+.||++||++.+++++-
T Consensus 221 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 221 AKSEPP-TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred hhcCCC-CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111000 0001112334567888999999999999999988653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.64 Aligned_cols=247 Identities=23% Similarity=0.316 Sum_probs=186.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.||+|++....... ......+.+|..++..++|+||+++++++.+.+..|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK-RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999865 57889999876432222 22344588899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++|+|.+++.+. ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999998652 246789999999999998 9999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
. .......||+.|+|||++.. ..++.++||||||++||||++|+.||...+.. +...
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----------------~~~~ 218 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-----------------ETYG 218 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-----------------HHHH
Confidence 1 11223568999999999865 46788999999999999999999999643210 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCC--CCCHHHHHHH
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKE--RPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 763 (789)
.+... ++..+.. .....+.+.+++.+|+..++++ |+++++++++
T Consensus 219 ~i~~~~~~~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 219 KIMNHEERFQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred HHHcCCCcccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 1111111 1122344566677777765544 5688888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=297.52 Aligned_cols=240 Identities=28% Similarity=0.437 Sum_probs=186.1
Q ss_pred ceEeecccEEEEEEEeCC--C--cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKLPD--G--QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
++||+|++|.||++.+.+ + ..|++|.+...... ...+.+.+|+.++++++||||+++++++.+ ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999998643 3 36999987665442 345568899999999999999999999988 889999999
Q ss_pred cCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 576 MKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 576 ~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
+++++|.+++.+.. .++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999986532 46789999999999998 999999999999999999999999999765442221
Q ss_pred C-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 646 F-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 646 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||...... + . ...+.. ...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~-----~-~~~~~~-~~~ 218 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------Q-----I-LKKIDK-EGE 218 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------H-----H-HHHHHh-cCC
Confidence 1 1123456788999999988889999999999999999998 99998533210 0 0 000000 001
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
....+ ...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERP----EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCC----ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11111 123456778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=308.16 Aligned_cols=191 Identities=21% Similarity=0.343 Sum_probs=155.5
Q ss_pred ccceEeec--ccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 498 LENKIGAG--SFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 498 ~~~~LG~G--~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
+.++||+| +|++||++.. .+++.||+|++...... ......+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 46789999 7899999975 47899999997653321 2234467889999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 575 YMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 575 ~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.++++||+..........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999988532 257889999999999998 99999999999999999999999986533211111
Q ss_pred CC-----cccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 045256 645 DF-----RPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAIFK 693 (789)
Q Consensus 645 ~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf~~ 693 (789)
.. ......++..|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 00 1112346778999999865 4588999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=298.69 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=190.4
Q ss_pred CCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|.+.+.||+|+||.||+|...+ ...|++|....... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 568889999999999999998643 24689998654332 2234468899999999999999999999875 557
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.+++.||+|||+.+ ++|+||||+|||++.++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 8999999999999998642 247789999999999998 9999999999999999999999999987544
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
..... ......++..|+|||.+....++.++||||||+++|||++ |+.||...... +....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----------------~~~~~ 220 (270)
T cd05056 159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----------------DVIGR 220 (270)
T ss_pred cccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHH
Confidence 33211 1112234568999999988889999999999999999996 99998543321 00000
Q ss_pred hhc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 720 ILD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 720 ~~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
+.. ..+..+. .....+.+++.+|+..+|++|||+.|+++.|+++++
T Consensus 221 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 221 IENGERLPMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred HHcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 100 1111122 223456778889999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.03 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=192.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||.|+||+||++... ++..+++|++....... ....+.+|+++++.++|+||+++++.+...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT---SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch---HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence 47899999999999999999854 67889999875433222 345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
|||+++++|.++++.. ..++.|++.+|+|||+.+ |+|+||||+||++++++.++|+|||++.....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999998642 247889999999999998 99999999999999999999999999865544
Q ss_pred CCCCC--cccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 642 SERDF--RPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 642 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... ......++..|+|||.+... .++.++|+||||+++|||++|+.||....... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-----------------~~~ 217 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-----------------VLM 217 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-----------------hHH
Confidence 33221 12234688999999998766 78999999999999999999999986443210 011
Q ss_pred HhhcccCCCCCC--CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEI--NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.+......... ........+.+++.+||..||++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 218 LTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred HHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111100000 012334566788899999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.31 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=187.2
Q ss_pred HHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
+.+++.+.....||+|+||.||++.+. +++.|++|.+..... ...+.+.+|++++++++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH----HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 344566666789999999999999854 577899998654322 223468899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEeeccC
Q 045256 569 RLLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGLS 636 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGls 636 (789)
.++++||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+||+++. ++.++|+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 99999999999999988642 136779999999999998 999999999999976 679999999998
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
........ ......++..|+|||.+... .++.++||||||+++|||++|+.||........ ....
T Consensus 157 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-----------~~~~ 223 (268)
T cd06624 157 KRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-----------AMFK 223 (268)
T ss_pred eecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-----------hHhh
Confidence 65432221 11223578999999998654 378899999999999999999999854321000 0000
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........ ..+......+..++.+||+.+|++|||+.|++++
T Consensus 224 ---~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 ---VGMFKIHP----EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---hhhhccCC----CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00000100 1112233456778899999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.08 Aligned_cols=230 Identities=22% Similarity=0.387 Sum_probs=175.1
Q ss_pred ceEeecccEEEEEEEeCC-------------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 500 NKIGAGSFGVVYKGKLPD-------------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
+.||+|+||.||+|...+ ...|++|.+.... ......|.+|+.++++++||||+++++++.++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 468999999999997432 2258888765432 22344688899999999999999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc-------EEE
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT-------ARV 630 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl 630 (789)
...+++|||+++++|..+++.. ..++.|+++||+|||+.+ |+||||||+|||++.++. +++
T Consensus 77 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999998887642 258899999999999998 999999999999987654 899
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHH-cCCCCCCCCCCCCCcccccccch
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELL-TGKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~ell-tG~~pf~~~~~~~~~~~~~~~~~ 708 (789)
+|||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.||......
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----------- 216 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----------- 216 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----------
Confidence 999998653222 1235678899999886 567899999999999999998 577776432110
Q ss_pred hhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+.............. ....+.+++.+||+.||++||++.++++.|
T Consensus 217 -------~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 217 -------EKERFYEGQCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------HHHHHHhcCccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000111111111111 123567788999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.10 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=190.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... .++.|++|.+...... .......+.+|+++++.++||||+++++.+...+..++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence 46889999999999999999865 5788999987654321 123345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.++++||+|||+.+ ++||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 9999999999998643 256789999999999998 99999999999999999999999999864211100
Q ss_pred -------------CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 645 -------------DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 645 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
........++..|+|||.+....++.++|+||||+++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~-------------- 222 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------------- 222 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------
Confidence 00111235788999999998888999999999999999999999998643210
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
+............+.. .......+..++.+||+.||++||++.++.+.|+.
T Consensus 223 ---~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 223 ---ELFGQVISDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---HHHHHHHhcccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0011111111111111 11234456788999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=296.05 Aligned_cols=242 Identities=27% Similarity=0.481 Sum_probs=188.6
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.+|++.+.||+|+||.||++...+++.+++|.+...... ...|.+|++++++++||||+++++++......+++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 468889999999999999998877889999987643221 235889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++++|.+++... ..++.+++.+|+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999999988642 246778999999999998 99999999999999999999999999865432211
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||...... . ....+.+. .
T Consensus 156 ~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~---------~~~~~~~~--~ 218 (256)
T cd05112 156 T-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----E---------VVETINAG--F 218 (256)
T ss_pred c-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----H---------HHHHHhCC--C
Confidence 1 1112234578999999988889999999999999999998 88888543210 0 00011100 0
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+...+.. ....+.+++.+||+.+|++||++.|+++.|
T Consensus 219 ~~~~~~~----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 219 RLYKPRL----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCC----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111111 224567789999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=299.30 Aligned_cols=243 Identities=26% Similarity=0.401 Sum_probs=191.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||.|+||.||++... +++.|++|.+..... ......+.+|++++++++||||+++++++.+....++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc---chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence 46888899999999999999865 688999998754321 22334588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
+||+++++|.+++... ..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999999998753 367889999999999998 99999999999999999999999999876543321
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
......++..|+|||.+.+..++.++||||||+++|||+||+.||...+.. . ....+....
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~-------------~~~~~~~~~ 214 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----R-------------VLFLIPKNN 214 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----H-------------HHHHhhhcC
Confidence 122346788999999998888999999999999999999999998543310 0 000011111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+ ..........+.+++.+||..||++||++++++++
T Consensus 215 ~~-~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 215 PP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CC-CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 10 00011133456778889999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=302.10 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=189.6
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.+++|++..... ...+.+.+|++++++++||||+++++++.+....++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE----EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI 79 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH----HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence 357889999999999999999864 688999998754322 233468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.+++... ..++.|++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 80 LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 99999999999988642 258899999999999999 999999999999999999999999988654322
Q ss_pred CCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
.. ......++..|+|||.+. ...++.++||||||+++|||++|+.||...+.. ..+
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-----------------~~~ 217 (280)
T cd06611 157 LQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-----------------RVL 217 (280)
T ss_pred cc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-----------------HHH
Confidence 11 112346889999999874 345778999999999999999999998543210 001
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+..... +....+......+.+++.+||+.||++||++.+++++
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 LKILKSEP-PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhcCCC-CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11111110 0000111233456678889999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=303.87 Aligned_cols=257 Identities=20% Similarity=0.304 Sum_probs=186.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +++.||+|.++...... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC---chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 57999999999999999999865 57899999876433221 123467899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||++ ++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 99997 4898887542 247789999999999998 9999999999999999999999999986543222
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--ccccchhhhhhhhhhHHh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--SLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 720 (789)
.. .....+++.|+|||.+.+ ..++.++||||||+++|||++|++||...+....... .....+.. ..+..+
T Consensus 159 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 232 (301)
T cd07873 159 KT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE----ETWPGI 232 (301)
T ss_pred Cc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh----hhchhh
Confidence 11 123356889999998865 4578899999999999999999999965432100000 00000000 000000
Q ss_pred hcc------cCCCC-----CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDR------RVGPP-----EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~------~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.. ..+.. ..........+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 00000 00001223456788999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.63 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=187.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhh-hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTK-KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 569 (789)
.+|+..+.||+|+||.||++... +++.|++|++...... ........+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46888999999999999999864 5889999987543221 1122345688999999999999999999998763 567
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
++++||+++++|.+++... ..++.|++++|+|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 8999999999999988643 257889999999999988 99999999999999999999999999875432
Q ss_pred CCC-CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SER-DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..... ...+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-----------------~~~~~~~ 221 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-----------------MAAIFKI 221 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-----------------HHHHHHH
Confidence 211 1111234578899999999888899999999999999999999999854321 0011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... ....+....+.+..++ +||..+|++||+++|++++
T Consensus 222 ~~~~~--~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 222 ATQPT--NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred hcCCC--CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 11110 1111223344555655 6888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.83 Aligned_cols=260 Identities=20% Similarity=0.260 Sum_probs=185.3
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +++.|++|++...... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE--EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc--CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence 4788999999999999999864 6889999987543221 122345788999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 574 DYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 574 e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||++ ++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 9997 5888877531 247899999999999998 999999999999999999999999998654322
Q ss_pred CCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--------cccchhhhhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--------LVDFAVPAIM 713 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--------~~~~~~~~~~ 713 (789)
.. ......+++.|+|||.+.+ ..++.++||||||+++|||+||++||....+....... ...|......
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 155 VR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 21 1123356889999998865 45788999999999999999999998654321000000 0000000000
Q ss_pred hhhhHHhhcccCCCC-CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRRVGPP-EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+....... ..........+.+++.+||+.||++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 -PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred -HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000000 00001123445678889999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=299.60 Aligned_cols=239 Identities=27% Similarity=0.452 Sum_probs=184.3
Q ss_pred ceEeecccEEEEEEEeCC-------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 500 NKIGAGSFGVVYKGKLPD-------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.||+|+||.||+++..+ ++.+++|.+..... ......+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc---hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence 368999999999998642 25789997654321 12344688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-----cEEEEe
Q 045256 573 YDYMKNGALYDHLHDR---------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-----TARVSD 632 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~D 632 (789)
|||+++++|.+++... ..++.+++.+|+|||+.+ ++|+||||+|||++.+. .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECC
Confidence 9999999999998642 247789999999999988 99999999999999877 899999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhh
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
||++.................+..|+|||.+....++.++||||||+++|||++ |+.||..... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~--------- 220 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----Q--------- 220 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----H---------
Confidence 999875433222111122345688999999998899999999999999999998 9988853321 0
Q ss_pred hhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 712 IMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 712 ~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.....+.. .+..+ ...+..+.+++.+||..+|++||++.++++.|++
T Consensus 221 ----~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 221 ----EVLQHVTAGGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ----HHHHHHhcCCccCCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00111111 11111 2234566788999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.32 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=191.3
Q ss_pred HHHHHHHHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEE
Q 045256 484 FLLAELAAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVG 561 (789)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 561 (789)
+.+.++..+.++|++.+.||+|+||.||++.. .+++.+++|++.... .....+.+|+.+++++ +|||++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~~h~ni~~~~~ 86 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEYNILQSLPNHPNVVKFYG 86 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-----cHHHHHHHHHHHHHHhcCCCCeEEEEE
Confidence 34455666788999999999999999999986 468899999875432 1223577899999999 8999999999
Q ss_pred EEEeCC-----eEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC
Q 045256 562 YCEEKD-----ERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA 624 (789)
Q Consensus 562 ~~~~~~-----~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 624 (789)
++...+ ..++||||+++++|.++++.. ..++.|++.+|+|||+.+ |+|+||||+||+++.
T Consensus 87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~ 163 (291)
T cd06639 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTT 163 (291)
T ss_pred EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcC
Confidence 987643 579999999999999987521 247889999999999998 999999999999999
Q ss_pred CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 625 QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-----VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 625 ~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
++.+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||......
T Consensus 164 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-- 239 (291)
T cd06639 164 EGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-- 239 (291)
T ss_pred CCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--
Confidence 99999999999875433221 11234678899999988543 3678999999999999999999998643220
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.++..... .......+....+.+++.+||+.||++||++.|++++
T Consensus 240 ---------------~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 ---------------KTLFKIPRNPP-PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---------------HHHHHHhcCCC-CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00111111100 0001112233457788999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.24 Aligned_cols=236 Identities=25% Similarity=0.321 Sum_probs=176.8
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc---CCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL---HHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
||+|+||+||+++.. +++.||+|++........ .....+..|..++.++ +||||+++++++.+.+..|+||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh-hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 689999999999864 589999999765332221 1223345566666655 69999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ ...
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~ 154 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN 154 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence 99999888643 247889999999999998 99999999999999999999999999865322221 122
Q ss_pred ccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCC
Q 045256 650 KAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPP 728 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 728 (789)
...||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. +....+.......+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~-----------------~~~~~i~~~~~~~~ 217 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ-----------------QMYRNIAFGKVRFP 217 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH-----------------HHHHHHHcCCCCCC
Confidence 45689999999998654 4789999999999999999999999653210 00111111111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCcCCCCCC----CHHHHHHH
Q 045256 729 EINEAEAVELVAYTAMHCVNLEGKERP----TMADIVAN 763 (789)
Q Consensus 729 ~~~~~~~~~~l~~l~~~cl~~dp~~RP----t~~evl~~ 763 (789)
. ......+.+++.+||+.||++|| ++.|++++
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 1 11234456788899999999998 56666553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=301.44 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=187.1
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE-
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE- 564 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~- 564 (789)
.+..+.++|++.+.||+|+||.||++... +++.+++|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-----IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-----hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 34456789999999999999999999764 578999998654221 123577899999999 6999999999884
Q ss_pred ----eCCeEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcE
Q 045256 565 ----EKDERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA 628 (789)
Q Consensus 565 ----~~~~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 628 (789)
..+..++||||+++++|.++++.. ..++.|+++||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 335689999999999999887521 137789999999999998 9999999999999999999
Q ss_pred EEEeeccCcCCCCCCCCCcccccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 045256 629 RVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703 (789)
Q Consensus 629 kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~ 703 (789)
||+|||++....... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~---- 237 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA---- 237 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH----
Confidence 999999987543321 12223468899999998853 4578899999999999999999999864322100
Q ss_pred cccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 704 LVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+. .........+..+. .....+..++.+||+.||++||++.|+++++
T Consensus 238 ~~----------~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LF----------KIPRNPPPTLHQPE----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hh----------hccccCCCcccCCC----CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00000000111111 1123467788899999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.42 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=192.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.|++|.+....... ......+.+|++++++++||||+++++.+.+....++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence 46889999999999999999865 48999999876543322 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++++|.+++... ..++.|++++|+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999998642 246789999999999998 999999999999999999999999998653222
Q ss_pred CCC---------------------------CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 643 ERD---------------------------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 643 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01112357889999999988889999999999999999999999986443
Q ss_pred CCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC----HHHHHH
Q 045256 696 ESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT----MADIVA 762 (789)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt----~~evl~ 762 (789)
.. ....++.+.....+.. ......+.+++.+||+.||++||+ +.|+++
T Consensus 237 ~~-----------------~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD-----------------ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH-----------------HHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 20 1112222222222211 114566788899999999999999 555555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.74 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=192.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
..|+..+.||+|+||.||++... +++.||+|.+..... ......+.+|++++++++||||+++++++.+....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 35777889999999999999864 578999998764322 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|||+++++|.+++... ..++.+++++|+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 9999999999988642 257889999999999998 99999999999999999999999999865433221
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
......++..|+|||.+....++.++|+||||+++|||++|+.||...... .....+....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~------------------~~~~~~~~~~ 217 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM------------------RVLFLIPKNN 217 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH------------------hHhhhhhcCC
Confidence 112345788999999998888999999999999999999999998543221 0001111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+..........+.+++.+||+.+|++||++.|++++
T Consensus 218 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 --PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111223455667788999999999999999999887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.05 Aligned_cols=242 Identities=24% Similarity=0.385 Sum_probs=188.7
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-eEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-ERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~~~lv 572 (789)
+|++.+.||+|++|.||++..+ +++.|++|++...... ....+.+.+|++++++++|||++++++.+...+ ..+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS--RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 4888999999999999999864 5788999987543221 223445888999999999999999999876544 57899
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++++|.+++... ..++.+++.+|+|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999988642 367889999999999998 999999999999999999999999998764332
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||...+. ......+..
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----------------~~~~~~~~~ 216 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----------------NSLVYRIIE 216 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHHh
Confidence 21 12234678999999999988999999999999999999999999853221 000111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.. ........+.+++.+|++.||++||++.|++++
T Consensus 217 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 GKLPP---MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cCCCC---CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11211 112344567788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.77 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=186.6
Q ss_pred HhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC---
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--- 566 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--- 566 (789)
...++|++.+.||+|+||.||++.. .+++.||||++...... ......+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS--LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh--hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3457899999999999999999975 46789999987643221 12234577899999999999999999987543
Q ss_pred ---CeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 567 ---DERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 567 ---~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
...|+++|++ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccc
Confidence 3468999988 66888877532 368899999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccchhh---
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDFAVP--- 710 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~--- 710 (789)
....... ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...+........ ......+
T Consensus 166 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07878 166 RQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVL 240 (343)
T ss_pred eecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 7643321 23468999999999876 56889999999999999999999998543211000000 0000000
Q ss_pred -hhhhhhhHHhhcccCCCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 -AIMAGELVKILDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 -~~~~~~~~~~~d~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+........+......+.... ......+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 241 KKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000001111111000000000 0112345678999999999999999999976
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.47 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=189.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC--eEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD--ERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~~ 570 (789)
++|+..+.||.|.+|.||++.+. +++.+++|.+...... .....+.+|++++++++||||+++++++.+.. .++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP---DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch---HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence 46888999999999999999874 5788999987643221 23456889999999999999999999986543 689
Q ss_pred EEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 571 LVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+||||+++++|.+++... ..++.+++++|+|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccc
Confidence 999999999998886531 258889999999999998 99999999999999999999999999865
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... ....++..|+|||.+....++.++||||||+++|||++|+.||.........+..+ ...+.
T Consensus 155 ~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------~~~~~ 221 (287)
T cd06621 155 LVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL---------LSYIV 221 (287)
T ss_pred cccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH---------HHHHh
Confidence 432221 13356789999999988899999999999999999999999986543210000000 00000
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..-...+.............+.+++.+||+.||++|||+.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000001111111111234567889999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=301.19 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=188.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||+|.+..... ......+.+|++++++++||||+++++++...+..++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence 46888999999999999999875 689999998754321 22234688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 573 YDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|||+++++|..++... ..++.+++.+|.|||+. + |+|+||||+||+++.++.+||+|||++....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999999887652 35788999999999974 6 9999999999999999999999999986543
Q ss_pred CCCCCCcccccccCcCccCccccCCC------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLN------VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
.... ....++..|+|||.+... .++.++||||||+++|||++|+.||...... ...
T Consensus 155 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--------------~~~ 216 (286)
T cd06622 155 ASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA--------------NIF 216 (286)
T ss_pred CCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh--------------hHH
Confidence 2221 234578899999998543 3478999999999999999999998543210 000
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+..+.+.... ....+....+..++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 217 AQLSAIVDGDPP---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHhhcCCC---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111222222111 1122345567788899999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.80 Aligned_cols=242 Identities=26% Similarity=0.383 Sum_probs=191.5
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.+|++... +++.|++|++....... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP--KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh--HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 5888999999999999999754 68899999876432221 22346889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.|++.+|+|||+.+ ++|+||+|+|||++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999988642 257889999999999998 9999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||...+. .+...+++..
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----------------~~~~~~~~~~ 216 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----------------KNLVLKIIRG 216 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----------------HHHHHHHhcC
Confidence 1 11234578899999999888899999999999999999999999854321 0111112222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... ........+.+++.+||+.+|++||++.|++++
T Consensus 217 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 217 SYPP---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCC---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 112334557788899999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=298.54 Aligned_cols=240 Identities=26% Similarity=0.403 Sum_probs=191.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.|++|.+....... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 46889999999999999999864 68899999876433221 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++.... .++.|++++|+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 99999999999986433 47789999999999988 999999999999999999999999998765433
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....+++.|+|||.+....++.++||||||+++|||++|+.||...+. ......+....
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~~~~~~ 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----------------IQIYEKILEGK 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHhcCC
Confidence 2234688999999999888889999999999999999999999854321 00111122222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
...+.. ....+.+++.+||..||++|| +++|++++
T Consensus 215 ~~~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 VRFPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 222222 234566788899999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.31 Aligned_cols=246 Identities=23% Similarity=0.386 Sum_probs=189.2
Q ss_pred CccccceEeecccEEEEEEEeCC--CcEEEEEEcccchhh------hHHHHHHHHHHHHHHHhh-cCCCcceEEEEEEEe
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPD--GQEVAIKRGETAKTK------KFQEKESAFDSELAFLSR-LHHKHLVRLVGYCEE 565 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~------~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~ 565 (789)
+|++.+.||+|+||.||++..+. ++.+++|.+...... ........+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999998754 678999986543211 112233457788888875 799999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhh------------hchHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEe
Q 045256 566 KDERLLVYDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSD 632 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~D 632 (789)
.+..+++|||+++++|.+++.. ...++.|++.+|.|||+ .+ ++|+||||+|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999988742 12577899999999996 55 99999999999999999999999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 712 (789)
||++....... ......++..|+|||.+....++.++||||||+++|||++|+.||...+..
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------------- 219 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------------- 219 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---------------
Confidence 99987644332 122346788999999998888999999999999999999999998543210
Q ss_pred hhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 713 MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
.....+.+....+.. .......+.+++.+||+.||++||++.|+.++++
T Consensus 220 --~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 --SLATKIVEAVYEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --HHHHHHhhccCCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 001111111111111 1122345677888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=295.60 Aligned_cols=237 Identities=31% Similarity=0.490 Sum_probs=185.5
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.+.||+|+||.||++.. +++.|++|.+.... ..+.+.+|+.++++++||||+++++++... ..+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 4688899999999999999975 67889999865422 123588999999999999999999998764 579999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+++++|.+++... ..++.|+++||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 999999999998642 247889999999999988 9999999999999999999999999986533221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ....+..|+|||.+....++.++|+||||+++|||++ |+.||..... .+..+.+.
T Consensus 155 ~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------------------~~~~~~~~ 211 (254)
T cd05083 155 D-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------------------KEVKECVE 211 (254)
T ss_pred C-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------------------HHHHHHHh
Confidence 1 1233568999999988889999999999999999998 8888754321 01111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
....... .......+.+++.+||+.+|++||+++++++.|++
T Consensus 212 ~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 212 KGYRMEP--PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCC--CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111110 11234556788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.93 Aligned_cols=244 Identities=27% Similarity=0.484 Sum_probs=198.9
Q ss_pred cccceEeecccEEEEEEEe-CCCc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 497 SLENKIGAGSFGVVYKGKL-PDGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
+..++||.|+||+||+|.+ ++|+ +||||++...... +...++.+|+-+|.+|+|||+++|+++|.... +.|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~---~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP---KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc---hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3468999999999999964 4444 5788876554332 23446899999999999999999999998866 789
Q ss_pred EEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|++|++.|+|.|+++..+ .+..|||+||.|||++. ++||||-.+|||+..-.++||+|||+++.....
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999997543 57889999999999999 999999999999999999999999999988777
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
+.........-.+.|||-|.+....++.++|||||||++||++| |..|++.-. .+++.+++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------------------~~eI~dll 913 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------------------AEEIPDLL 913 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------------------HHHhhHHH
Confidence 76665555555788999999999999999999999999999998 777764432 22333333
Q ss_pred cc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 722 d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.. ++..|+....+.. .++.+||..|++.||+++++...+.+..+
T Consensus 914 e~geRLsqPpiCtiDVy----~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVY----MVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hccccCCCCCCccHHHH----HHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 32 4666766665544 45567999999999999999999987754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.16 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=187.1
Q ss_pred ccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 496 FSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
|.+.+.||+|+||.||++... +++.||||++...... ....+.+.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 567889999999999999753 3688999987653322 223456889999999999999999999886542
Q ss_pred --eEEEEEEecCCCchhHHHhh--------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 568 --ERLLVYDYMKNGALYDHLHD--------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 568 --~~~lv~e~~~~gsL~~~l~~--------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
..++++||+++++|.+++.. ...++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEEC
Confidence 24788999999999887632 1357889999999999998 9999999999999999999999
Q ss_pred eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhh
Q 045256 632 DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 632 DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
|||+++...............++..|++||.+....++.++||||||+++|||++ |++||...+. ...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~~~------ 224 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----SEI------ 224 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----HHH------
Confidence 9999876543322222223345678999999988889999999999999999999 7888753321 000
Q ss_pred hhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 711 AIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 711 ~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
...+... .+..+ ......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 225 ------~~~~~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 ------YNYLIKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------HHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0001111 11111 12234677888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=297.61 Aligned_cols=232 Identities=24% Similarity=0.390 Sum_probs=175.5
Q ss_pred ceEeecccEEEEEEEeCC--------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 500 NKIGAGSFGVVYKGKLPD--------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
+.||+|+||.||++.... ...+++|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence 469999999999997532 2347777754322 2234468889999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc--------EEEEeec
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT--------ARVSDFG 634 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG 634 (789)
||||+++++|.++++.. ..++.|++.||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 77 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999998643 247889999999999998 999999999999987765 6999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
++...... ....++..|+|||.+.. ..++.++||||||+++|||++|..+++...+ +
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~----~------------ 211 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD----S------------ 211 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc----H------------
Confidence 88653321 12457889999999976 4578999999999999999999644322211 0
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
.............+... ...+.+++.+||+.||++|||++++++.|+
T Consensus 212 -~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 -QKKLQFYEDRHQLPAPK----WTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -HHHHHHHHccccCCCCC----cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00011111111111111 234678888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=293.09 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=191.3
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +++.|++|.++..... ......+.+|++++++++|+||+++++++...+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence 5888899999999999999864 6889999997654432 334567899999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
||+++++|.+++... ..++.++++||+|||+.+ |+|+||||+||++++++.+||+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 999999999998653 257889999999999998 999999999999999999999999998765433322
Q ss_pred Cc--ccccccCcCccCccccCCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 646 FR--PMKAAGTVGYIDPEYYGLNV---LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 646 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. .....++..|+|||.+.... ++.++||||||+++|||++|+.||...+.. +.... .+..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---------~~~~~----~~~~- 221 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---------FQIMF----HVGA- 221 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---------HHHHH----HHhc-
Confidence 11 11245788999999997766 889999999999999999999998543210 00000 0000
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
......+. .......+.+++.+||+.+|++||++.|++.
T Consensus 222 -~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 -GHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111 1122344567888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.40 Aligned_cols=187 Identities=26% Similarity=0.391 Sum_probs=149.9
Q ss_pred cceEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--CCeEEEEE
Q 045256 499 ENKIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--KDERLLVY 573 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~lv~ 573 (789)
..+||+|+||.||++... +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 368999999999999864 357899998754321 1246789999999999999999999854 45678999
Q ss_pred EecCCCchhHHHhh-----------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----CCCCcEEEEe
Q 045256 574 DYMKNGALYDHLHD-----------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSD 632 (789)
Q Consensus 574 e~~~~gsL~~~l~~-----------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~D 632 (789)
||+++ +|.+++.. ...++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 99875 77776631 1257889999999999998 9999999999999 5667999999
Q ss_pred eccCcCCCCCCCCC-cccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 633 FGLSMMGPESERDF-RPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 633 fGls~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
||+++......... ......+|+.|+|||.+.+ ..++.++||||||+++|||+||++||....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 99997654332211 1123467899999999866 457999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.93 Aligned_cols=247 Identities=27% Similarity=0.447 Sum_probs=198.6
Q ss_pred hcCCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
.+.+..+..+||-|.||.||.|.++. .-.||||.++... ...++|..|..+|+.++|||+|+|+|+|..+..+|
T Consensus 265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 34456677899999999999998754 5679999865432 23557999999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+|+|||.+|+|.++|++.. .++.||+.|++||...+ +|||||..+|+|+.++..+|++||||++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999998643 47889999999999999 9999999999999999999999999999865
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
...... .....-.+.|.|||.+....++.|+|||+|||+|||+.| |-.|+.+-+ ...+.+
T Consensus 417 gDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------------------lSqVY~ 477 (1157)
T KOG4278|consen 417 GDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------------------LSQVYG 477 (1157)
T ss_pred CCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------------------HHHHHH
Confidence 543322 112234678999999999999999999999999999998 445542211 112223
Q ss_pred hhc--ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 720 ILD--RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 720 ~~d--~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
++. .++..++.++. .+.+|+++||+.+|.+||+++|+-+.+|.+..
T Consensus 478 LLEkgyRM~~PeGCPp----kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPP----KVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HHhccccccCCCCCCH----HHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 333 25555555544 45566778999999999999999999998864
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=297.31 Aligned_cols=246 Identities=25% Similarity=0.386 Sum_probs=193.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|+..+.||+|+||.||++..+ +++.+++|++...... .....+.+|++++++++||||+++++.+......+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE---AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh---HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence 36778899999999999999875 6889999987654322 3345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+||+++++|.+++... ..++.+++.+|+|||+ .+ ++|+||||+||+++.++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999998753 2578899999999999 77 999999999999999999999999998654322
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ....+.....
T Consensus 155 ~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------------~~~~~~~~~~ 218 (265)
T cd06605 155 LAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG------------IFELLQYIVN 218 (265)
T ss_pred Hhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc------------HHHHHHHHhc
Confidence 111 256788999999998889999999999999999999999998654321000 0011112222
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
... +..........+.+++.+||..||++|||+.|++.+
T Consensus 219 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 EPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCC--CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 111111244557788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=292.75 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=187.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhh-hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTK-KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 569 (789)
.+|++.+.||+|+||.||++... +++.|++|.+...... ........+.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999999864 5889999987532211 1122345688999999999999999999998764 457
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+++|||+++++|.+++... .+++.+++.+|+|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 8999999999999988543 357889999999999998 99999999999999999999999999875432
Q ss_pred CCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----------------~~~~~~ 221 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----------------AAIFKI 221 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----------------HHHHHH
Confidence 21111 112345888999999998888999999999999999999999998543210 011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... ....+......+..++.+|+ .+|++||+++|++++
T Consensus 222 ~~~~~--~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 222 ATQPT--NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred hcCCC--CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 11100 01112233445666777888 499999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=295.52 Aligned_cols=229 Identities=24% Similarity=0.413 Sum_probs=174.2
Q ss_pred eEeecccEEEEEEEeCC-------------------------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc
Q 045256 501 KIGAGSFGVVYKGKLPD-------------------------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn 555 (789)
.||+|+||.||+|.+.. ...|++|++.... ......|.+|+.++++++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence 58999999999997421 1358888865432 223346888999999999999
Q ss_pred ceEEEEEEEeCCeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC
Q 045256 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626 (789)
Q Consensus 556 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 626 (789)
|+++++++.+....++||||+++++|..++... ..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG 154 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence 999999999999999999999999999888542 258899999999999988 99999999999997643
Q ss_pred -------cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHH-cCCCCCCCCCCC
Q 045256 627 -------TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELL-TGKRAIFKDDES 697 (789)
Q Consensus 627 -------~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~ell-tG~~pf~~~~~~ 697 (789)
.+|++|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 4899999987543221 12346788999998865 56899999999999999994 788888543210
Q ss_pred CCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 698 GGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.....+......+... ...+.+++.+||+.+|++||++.++++.|
T Consensus 229 ------------------~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 229 ------------------EKERFYEKKHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ------------------HHHHHHHhccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0011111111111111 12466788899999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.40 Aligned_cols=241 Identities=24% Similarity=0.390 Sum_probs=189.4
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+.+|++++++++||||+++++++......++||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 4667788999999999999754 578899998654322 123456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 574 e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
||+++++|.+++... ..++.+++++|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 999999999987542 257889999999999988 99999999999999999999999999875433221
Q ss_pred cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCC
Q 045256 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 726 (789)
......++..|+|||++....++.++||||||+++|||++|+.||....... ....+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------------------~~~~~~~~~~ 218 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------------------VLFLIPKNSP 218 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------------------HHhhhhcCCC
Confidence 1123457889999999998889999999999999999999999985432110 0000111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..........+.+++.+||+.+|++||++.|++++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 --PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01112234456788999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=307.70 Aligned_cols=239 Identities=28% Similarity=0.416 Sum_probs=192.1
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|.-++.||.|+||.||.+++ .+.+.||||++.-... ...++-+++..|+.+|++++|||++.+.|+|......||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 355578899999999999985 4678999998754332 22445567899999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||-| +-.|+|.-.+ .|..+.+.||+|||+.+ .||||||..||||++.+.+||+|||.+.+.....
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn- 180 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN- 180 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence 99965 8777775322 36678899999999999 8999999999999999999999999987643332
Q ss_pred CCcccccccCcCccCcccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 645 DFRPMKAAGTVGYIDPEYY---GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.++|||.|||||++ ..+.|+-|+|||||||+..||.-.++|.|..+... .+.-+.
T Consensus 181 -----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-----------------ALYHIA 238 (948)
T KOG0577|consen 181 -----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----------------ALYHIA 238 (948)
T ss_pred -----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-----------------HHHHHH
Confidence 56899999999987 46789999999999999999999999987654310 011111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. -.+|.....+....+..++..||++-|.+|||..+++++
T Consensus 239 Q--NesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 239 Q--NESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred h--cCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1 112333356777888899999999999999999988765
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=300.81 Aligned_cols=260 Identities=19% Similarity=0.267 Sum_probs=186.0
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +|+.|++|++...... ......+.+|++++++++||||+++++++.+....++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc--ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 4788899999999999999864 6889999987643221 122335778999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++ +|.+++... ..++.|+++||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 99975 888776532 367889999999999998 99999999999999999999999999875433222
Q ss_pred CCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc---cchhhhhhhhhhHHh
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV---DFAVPAIMAGELVKI 720 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 720 (789)
. .....++..|+|||.+.+. .++.++||||||+++|||+||+.|++...+......... ....... ...+.+.
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES-WPGVSKL 231 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHH-hHHhhhc
Confidence 1 1234568899999988654 478999999999999999999999754332110000000 0000000 0000000
Q ss_pred hccc-CCCC-CC-----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRR-VGPP-EI-----NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~-~~~~-~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.. .... .. ........+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0100 0000 00 001234566788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=302.95 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=186.8
Q ss_pred cccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 497 SLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
.....||+|+||.||++... +++.|+||.+.... ....+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 33467999999999999864 68899999865432 22344588999999999999999999999999999999999
Q ss_pred cCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcc
Q 045256 576 MKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP 648 (789)
Q Consensus 576 ~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~ 648 (789)
+++++|.+++.. ...++.+++.+|+|||+.+ |+||||||+||+++.++.++|+|||++........ ..
T Consensus 101 ~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 101 LEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 999999988743 2367889999999999998 99999999999999999999999999865432221 11
Q ss_pred cccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCC
Q 045256 649 MKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPP 728 (789)
Q Consensus 649 ~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 728 (789)
....++..|+|||.+....++.++||||||+++|||++|+.||...... . . ...+...+...+..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~-------~--~~~~~~~~~~~~~~- 240 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----Q-------A--MRRIRDNLPPRVKD- 240 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H-------H--HHHHHhcCCCcccc-
Confidence 2346789999999998888999999999999999999999998643210 0 0 00111111111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 729 EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 729 ~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+..++.+||..||++|||++|++++
T Consensus 241 ---~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 ---SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ---ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233456778889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.17 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=189.7
Q ss_pred HHHHHHHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEE
Q 045256 485 LLAELAAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGY 562 (789)
Q Consensus 485 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 562 (789)
.+.++....+.|++.+.||+|+||.||++.. .+++.+++|++.... .....+..|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-----DEEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-----HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 3445555667899999999999999999986 467899999865432 1233577899999998 79999999999
Q ss_pred EEe------CCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC
Q 045256 563 CEE------KDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626 (789)
Q Consensus 563 ~~~------~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 626 (789)
+.. .+..+++|||+++++|.+++... ..++.|++.+|+|||+.+ |+|+||||+||++++++
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~ 158 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENA 158 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCC
Confidence 853 45689999999999999988542 246789999999999998 99999999999999999
Q ss_pred cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc
Q 045256 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP 701 (789)
Q Consensus 627 ~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~ 701 (789)
.++|+|||++........ ......++..|+|||.+. ...++.++||||||+++|||++|+.||.......
T Consensus 159 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~--- 233 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR--- 233 (282)
T ss_pred CEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh---
Confidence 999999999865432211 122356889999999885 3467889999999999999999999985432100
Q ss_pred cccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 702 VSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+...... ..+..........+.+++.+||+.||.+||++.|++++
T Consensus 234 --------------~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 234 --------------ALFLIPRN--PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --------------hhhhHhhC--CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00001111 01111112334567788899999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.98 Aligned_cols=248 Identities=26% Similarity=0.425 Sum_probs=198.8
Q ss_pred CCccccceEeecccEEEEEEEeC---CCc--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP---DGQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~---~g~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
+...+.+.||+|.||.||+|.+. .|+ .||||..+..... +..+.|..|..+|++++||||++|+|+|.+ ..
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~---d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP---DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh---hhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34456688999999999999753 233 5888986654333 335569999999999999999999999986 57
Q ss_pred EEEEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++|||.++.|.|..+|+.+. .+..|+..+|+|||+.. +|||||..+|||+...-.+||+|||+++..
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 899999999999999998654 46789999999999999 999999999999999999999999999987
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
........ ....-...|||||.+...+++.+||||-|||.+||+++ |..||+.-.+.+ ++. .+.
T Consensus 542 ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-----VI~---------~iE 606 (974)
T KOG4257|consen 542 EDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-----VIG---------HIE 606 (974)
T ss_pred cccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-----eEE---------Eec
Confidence 66554332 23445689999999999999999999999999999986 899997654421 000 000
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
-..+++.|+..+. .+..|+.+||..||.+||++.|+...|.++++
T Consensus 607 --nGeRlP~P~nCPp----~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 --NGERLPCPPNCPP----ALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --CCCCCCCCCCCCh----HHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1235555665554 34456778999999999999999999988876
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.28 Aligned_cols=243 Identities=27% Similarity=0.425 Sum_probs=189.5
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhh-hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTK-KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+|+..+.||+|+||.||++... +++.|++|.+...... ...+..+.+.+|++++++++||||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999875 7899999987543321 1123345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
+||+++++|.+++.... .++.+++++|+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 99999999999986432 47889999999999998 9999999999999999999999999987543322
Q ss_pred CCcccccccCcCccCccccCCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc-
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNV-LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD- 722 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d- 722 (789)
......++..|++||.+.... ++.++|+||||+++|||++|+.||...... ........
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~~~~~ 217 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-----------------AAVFKIGRS 217 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-----------------HHHHHHHhc
Confidence 112346788999999987666 899999999999999999999998543210 00000001
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... ........+.+++.+||+.+|++||++.+++++
T Consensus 218 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 218 KELPP---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ccCCC---cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 00110 111223456678889999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.66 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=189.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +++.|++|++....... ...+.+.+|++++++++||||+++++++......++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc--cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence 46888999999999999999875 58899999876432211 2233578999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||++++.|..++.. ...++.|++.+|+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999888777642 2368899999999999988 99999999999999999999999999976544332
Q ss_pred CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ......... .. ....+..+.
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~-~~~~~~~~~-~~-~~~~~~~~~ 230 (286)
T cd07847 156 D--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL-YLIRKTLGD-LI-PRHQQIFST 230 (286)
T ss_pred c--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCC-CC-hHHhhhccc
Confidence 1 123456789999999865 56789999999999999999999998654321100 000000000 00 000000000
Q ss_pred -------cCCCCCC-C-----HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 -------RVGPPEI-N-----EAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 -------~~~~~~~-~-----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.+.. . .......+.+++.+||+.||++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000 0 01224556788999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.26 Aligned_cols=229 Identities=27% Similarity=0.428 Sum_probs=175.5
Q ss_pred ceEeecccEEEEEEEeCCCc-----------EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 500 NKIGAGSFGVVYKGKLPDGQ-----------EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
+.||+|+||.||++.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-----SLAFFETASLMSQLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-----HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence 46899999999999875433 4777765433211 4568899999999999999999999988 77
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-------cEEEEe
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-------TARVSD 632 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~D 632 (789)
.++||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCC
Confidence 89999999999999998642 247789999999999988 99999999999999887 799999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCC--CCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCCCcccccccchh
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTG-KRAIFKDDESGGTPVSLVDFAV 709 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~ 709 (789)
||++...... ....++..|+|||++... .++.++||||||+++|||++| ..||....... .
T Consensus 152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--------~-- 215 (259)
T cd05037 152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------K-- 215 (259)
T ss_pred CCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--------H--
Confidence 9998754331 123456789999999776 789999999999999999995 56654322100 0
Q ss_pred hhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 710 PAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 710 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
. .... .......+. . ..+.+++.+||..+|++||++.|+++.|+
T Consensus 216 ----~-~~~~-~~~~~~~~~--~----~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 216 ----E-RFYQ-DQHRLPMPD--C----AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----H-HHHh-cCCCCCCCC--c----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0000 001111111 1 45677889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=274.87 Aligned_cols=243 Identities=22% Similarity=0.350 Sum_probs=184.1
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.+.+..||.|+.|.|++++.+ .|...|||.+...... +....+...+.++.+- .+|+||+.+|||..+...++.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk---ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic 169 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC 169 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH---HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence 3445678999999999999875 5889999987654332 2333466667666555 489999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||.|.. .+..+|+.. .++...+..||.||.+++ +|+|||+||+|||+|+.|++||+|||++-.+.++.
T Consensus 170 MelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 170 MELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 998853 444444321 256667889999999876 49999999999999999999999999997654443
Q ss_pred CCCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
. .....|-+.|||||.+. ...|+-++||||||+.|+||.||+.||..-+. ..+-+.++
T Consensus 247 A---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----------------dFe~ltkv 307 (391)
T KOG0983|consen 247 A---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----------------DFEVLTKV 307 (391)
T ss_pred c---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----------------cHHHHHHH
Confidence 2 23567899999999984 34688899999999999999999999965433 12234455
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
++...+. -.........+.+++..||.+|+.+||...+++++
T Consensus 308 ln~ePP~-L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 308 LNEEPPL-LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred HhcCCCC-CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 5533221 11122256677888899999999999999998875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=325.97 Aligned_cols=245 Identities=28% Similarity=0.389 Sum_probs=182.2
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC----
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 566 (789)
...+|+.+++||+|+||.|||++.+ ||+.||||++.... .......+.+|+..|.+|+|||||+++..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3457888899999999999999865 89999999987654 123344588999999999999999998742000
Q ss_pred --------------------------------------------------------------------------------
Q 045256 567 -------------------------------------------------------------------------------- 566 (789)
Q Consensus 567 -------------------------------------------------------------------------------- 566 (789)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHH
Q 045256 567 -----------------------------------DERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYL 602 (789)
Q Consensus 567 -----------------------------------~~~~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~L 602 (789)
..+|+-||||+.-.|.++++... +++++|++||+|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 12477899999877777765422 5889999999999
Q ss_pred HhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC----------------CCCCCCcccccccCcCccCccccCCC
Q 045256 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP----------------ESERDFRPMKAAGTVGYIDPEYYGLN 666 (789)
Q Consensus 603 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 666 (789)
|+++ ||||||||.|||||++..+||+|||++.... ........+...||.-|+|||++...
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999997511 00111122356899999999999654
Q ss_pred ---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCC-CHHHHHHHHHHH
Q 045256 667 ---VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI-NEAEAVELVAYT 742 (789)
Q Consensus 667 ---~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~-~~~~~~~~l~~l 742 (789)
.|+.|+|+|||||||+||+. ||....+ +...+..+-+..++.+.. ...++... +.+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----------------Ra~iL~~LR~g~iP~~~~f~~~~~~~e-~sl 850 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----------------RASILTNLRKGSIPEPADFFDPEHPEE-ASL 850 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHH----------------HHHHHHhcccCCCCCCcccccccchHH-HHH
Confidence 59999999999999999996 4532221 222233333333433311 22333333 457
Q ss_pred HHhhcCcCCCCCCCHHHHHH
Q 045256 743 AMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 743 ~~~cl~~dp~~RPt~~evl~ 762 (789)
+.++++.||++|||+.|++.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 88999999999999999886
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=293.11 Aligned_cols=250 Identities=23% Similarity=0.409 Sum_probs=191.9
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhh--HHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKK--FQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
+|+..+.||+|+||.||++.. .+++.|++|.+....... .......+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999975 568899999876433221 12234578899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.+++.+. ..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999988642 357889999999999998 99999999999998775 6999999998765433
Q ss_pred CCCC--cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 643 ERDF--RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 643 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......++..|+|||.+....++.++||||||+++|||++|+.||........ ...+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--------------~~~~~~~ 223 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--------------LALIFKI 223 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--------------HHHHHHH
Confidence 2111 11234578899999999888899999999999999999999999854322100 0001111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... .....+......+.+++.+|+..+|++||++.|++++
T Consensus 224 ~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 224 ASAT--TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred hccC--CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111 1111223344567788899999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.61 Aligned_cols=241 Identities=23% Similarity=0.378 Sum_probs=186.7
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|+....||+|+||.||++... +++.|++|++..... ...+.+.+|+.+++.++||||+++++++...+..+++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 334457999999999999864 688999998754322 123457889999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 575 YMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 575 ~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
|+++++|.+++... ..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++........ .
T Consensus 99 ~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 99 FLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred cCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 99999999887542 357889999999999998 99999999999999999999999999865433221 1
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
.....++..|+|||.+....++.++||||||+++|||++|+.||....... .+. .+......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----------------~~~-~~~~~~~~ 235 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----------------AMK-RLRDSPPP 235 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------------HHH-HHhccCCC
Confidence 123468899999999988889999999999999999999999986433200 000 01110000
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...........+.+++.+||+.+|++||++.|++++
T Consensus 236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 236 KLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000111223446678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.42 Aligned_cols=245 Identities=28% Similarity=0.419 Sum_probs=188.4
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCC-
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKD- 567 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~- 567 (789)
...++|++.+.||+|+||.||++..+ +++.+++|++..... ..+.+.+|+.+++++ +||||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 34578999999999999999999874 578899998654332 234588999999999 7999999999997654
Q ss_pred -----eEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEE
Q 045256 568 -----ERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630 (789)
Q Consensus 568 -----~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 630 (789)
..++||||+++++|.+++... ..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEE
Confidence 389999999999999887542 147889999999999998 999999999999999999999
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~ 705 (789)
+|||++........ ......++..|+|||.+.. ..++.++||||||++||||++|+.||......
T Consensus 155 ~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------- 224 (275)
T cd06608 155 VDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------- 224 (275)
T ss_pred CCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------
Confidence 99999865432221 1223467889999998743 34678899999999999999999998533210
Q ss_pred cchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 706 DFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.++.... .............+.+++.+||..||++|||+.|++++
T Consensus 225 ---------~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 225 ---------RALFKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ---------HHHHHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0111111111 11111122345567888999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.00 Aligned_cols=246 Identities=26% Similarity=0.434 Sum_probs=188.9
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++|++.+.||+|+||.||+++.+ +.+.|++|.+..... ......+.+|++++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD---ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc---hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 57888999999999999999853 346799998654322 223456889999999999999999999999988
Q ss_pred eEEEEEEecCCCchhHHHhhhc-----------------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEE
Q 045256 568 ERLLVYDYMKNGALYDHLHDRN-----------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~~-----------------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 630 (789)
..++||||+++++|.+++.... .++.|++++|+|||+.+ |+||||||+|||++.++.++|
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEE
Confidence 9999999999999999986422 47789999999999998 999999999999999999999
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchh
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAV 709 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~ 709 (789)
+|||++........ .......++..|+|||.+....++.++||||||+++|||++ |..||...... .
T Consensus 159 ~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----~------ 226 (275)
T cd05046 159 SLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----E------ 226 (275)
T ss_pred cccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----H------
Confidence 99999864322211 11123355778999999988888999999999999999999 77787432210 0
Q ss_pred hhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 710 PAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 710 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
.........+..+. .......+.+++.+||+.||++||++.|+++.|.
T Consensus 227 ------~~~~~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 227 ------VLNRLQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------HHHHHHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00111111111100 1123346778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=297.48 Aligned_cols=241 Identities=27% Similarity=0.412 Sum_probs=187.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.+.|++.+.||+|+||.||++... +++.|++|.+....... .+....+.+|++++++++||||+++.+++.+.+..++
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 356888999999999999999864 68899999875432222 2334468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||++ ++|.+++.. ...++.|++.+|.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 999997 477776642 1257889999999999998 999999999999999999999999998654322
Q ss_pred CCCCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
. ...++..|+|||.+. ...++.++||||||+++|||++|+.||...+.. .....
T Consensus 169 ~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----------------~~~~~ 225 (307)
T cd06607 169 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------------SALYH 225 (307)
T ss_pred C------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----------------HHHHH
Confidence 1 345788999999873 456888999999999999999999998543210 00000
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... .+..........+.+++.+||+.||++||++.+++.+
T Consensus 226 ~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 226 IAQND--SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HhcCC--CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11110 1111122344567888999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=297.19 Aligned_cols=255 Identities=17% Similarity=0.242 Sum_probs=177.5
Q ss_pred cCCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHH-------HHHHHHHHHHHhhcCCCcceEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEK-------ESAFDSELAFLSRLHHKHLVRLVG 561 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l~~ 561 (789)
.++|++.++||+|+||.||++...+ +..+++|...........+. ......++..+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998654 34567765332211110010 111233445566778999999999
Q ss_pred EEEeCC----eEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEE
Q 045256 562 YCEEKD----ERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR 629 (789)
Q Consensus 562 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 629 (789)
++.... ..++++|++.. ++.+.+... ..++.|+++||+|||+.+ |+||||||+|||++.++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEE
Confidence 876544 34678887754 565555432 258899999999999998 99999999999999999999
Q ss_pred EEeeccCcCCCCCCCC-----CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 045256 630 VSDFGLSMMGPESERD-----FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 630 l~DfGls~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~ 704 (789)
|+|||+++........ .......||+.|+|||++.+..++.++||||||++||||++|+.||........ +
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~----~ 242 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN----L 242 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH----H
Confidence 9999999764332211 111224689999999999999999999999999999999999999965432111 0
Q ss_pred ccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 705 VDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.. ....+.+..+....+.. ..+...+.+++..|+..+|++||++.++++.|
T Consensus 243 ~~----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IH----AAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HH----HhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00 00011111111111111 12235567788899999999999999999876
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=289.44 Aligned_cols=246 Identities=27% Similarity=0.400 Sum_probs=195.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|++|.||++... +++.|++|++...... .....+.+|+..+.+++||||+++++++...+..++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence 36888999999999999999876 4899999987654322 3345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|++++|+|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999998642 3688999999999999 88 9999999999999999999999999987643332
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.. .....++..|+|||.+....++.++|+||||+++|||++|+.||...... .+ ......+...
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--------~~------~~~~~~~~~~ 218 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--------SF------FELMQAICDG 218 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--------CH------HHHHHHHhcC
Confidence 21 12345788999999999889999999999999999999999998554320 00 0111111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... ........+.+++.+||..+|++||++.|++++
T Consensus 219 ~~~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 219 PPPSL--PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCC--CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 111144567788889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=288.58 Aligned_cols=241 Identities=26% Similarity=0.401 Sum_probs=188.5
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++.. .+++.+++|++...... ......+.+|++++++++||||+++++.+...+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT--KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc--cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 588899999999999999976 46788999987653322 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEeeccCcCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPES 642 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGls~~~~~~ 642 (789)
||+++++|.+++..+ ..++.+++++|+|||+++ |+|+||||+||+++++ ..+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999998653 246789999999999998 9999999999999865 46899999998765433
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
... ....++..|+|||.+....++.++||||||+++|+|++|+.||...+.. ....+...
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----------------~~~~~~~~ 215 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----------------ALVLKIMS 215 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----------------HHHHHHHh
Confidence 211 2346788999999998888899999999999999999999998543210 00111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...... .......+..++.+||+.||++|||+.|++++
T Consensus 216 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 216 GTFAPI---SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred cCCCCC---CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111110 11133456778889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=288.55 Aligned_cols=241 Identities=30% Similarity=0.502 Sum_probs=187.2
Q ss_pred ccccceEeecccEEEEEEEeCC-----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLPD-----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
|++.+.||.|+||.||++...+ +..|++|.+...... +....+.+|++++++++||||+++++++.+.+..+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence 3567899999999999998653 378999997554322 13456889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++|||+++++|.+++... ..++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++....
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999999988642 247889999999999998 9999999999999999999999999987654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
....... ....++..|+|||.+....++.++||||||+++|||++ |++||..... ......
T Consensus 155 ~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----------------~~~~~~ 216 (258)
T smart00219 155 DDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----------------EEVLEY 216 (258)
T ss_pred ccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----------------HHHHHH
Confidence 4322111 12336789999999988889999999999999999998 6777643211 000011
Q ss_pred hhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 720 ILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 720 ~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+... ....+. .....+.+++.+|+..||++|||+.|+++.|
T Consensus 217 ~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 LKKGYRLPKPE----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HhcCCCCCCCC----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111 111111 1344567788999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=319.00 Aligned_cols=266 Identities=20% Similarity=0.296 Sum_probs=181.3
Q ss_pred hcCCccccceEeecccEEEEEEEeCC--CcEEEEEEcc-------------cchhhhHHHHHHHHHHHHHHHhhcCCCcc
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD--GQEVAIKRGE-------------TAKTKKFQEKESAFDSELAFLSRLHHKHL 556 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~-------------~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 556 (789)
..++|++.+.||+|+||+||++..+. +...++|.+. .............+.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 34689999999999999999987532 2222222110 00011111234468899999999999999
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhHHHhh-------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC
Q 045256 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHD-------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD 623 (789)
Q Consensus 557 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~ 623 (789)
+++++++.+.+..|+++|++.. +|.+++.. ...++.|++.||+|||+.+ |+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 9999999999999999999854 77776532 2358889999999999998 99999999999999
Q ss_pred CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 045256 624 AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703 (789)
Q Consensus 624 ~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~ 703 (789)
.++.+||+|||++......... ......||..|+|||++.+..++.++|||||||+||||++|+.++......... ..
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~-~~ 379 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG-KQ 379 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH-HH
Confidence 9999999999999765433221 122357899999999999999999999999999999999998655432211100 00
Q ss_pred cccch------hhhh--hhhhhHHhhccc-CCC-CCCCH-----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 704 LVDFA------VPAI--MAGELVKILDRR-VGP-PEINE-----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 704 ~~~~~------~~~~--~~~~~~~~~d~~-~~~-~~~~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.... .... ....+.+.++.. +.. +.... ......+.+++.+||+.||++|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 0000 000111111110 000 00000 0112345667889999999999999999875
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=296.77 Aligned_cols=243 Identities=24% Similarity=0.404 Sum_probs=191.8
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||++.. .+++.|++|.+..... ...+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ----PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc----hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 5788899999999999999975 4678999998653322 1234588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
+||+++++|.+++.+. ..++.+++++|+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 9999999999988642 357889999999999998 999999999999999999999999988654333221
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
.....+++.|+|||.+....++.++||||||+++|||++|+.||...+...... .+....
T Consensus 172 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----------------~~~~~~- 231 (293)
T cd06647 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----------------LIATNG- 231 (293)
T ss_pred --cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----------------ehhcCC-
Confidence 123457889999999988889999999999999999999999996543211100 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+...........+.+++.+||..+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011122234557788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=294.40 Aligned_cols=242 Identities=22% Similarity=0.364 Sum_probs=181.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHH-HhhcCCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAF-LSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||++... +++.||+|+++...... ....+..|+.+ ++.++||||+++++++......++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l 77 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI 77 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH---HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence 47889999999999999999865 68999999876543221 12234455554 566789999999999999999999
Q ss_pred EEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 572 VYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+|||++ ++|.+++... ..++.|++.||+|||+. + ++||||||+|||++.++.+||+|||++..
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~ 153 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGY 153 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999997 5887776531 25788999999999986 6 99999999999999999999999999876
Q ss_pred CCCCCCCCcccccccCcCccCccccCC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGL----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
...... .....++..|+|||.+.. ..++.++|+||||+++|||++|+.||...... .
T Consensus 154 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~ 214 (283)
T cd06617 154 LVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----------------F 214 (283)
T ss_pred cccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----------------H
Confidence 432211 122457889999998854 45688999999999999999999998532210 0
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.+......... ..........+.+++.+||..+|++||++.+++++
T Consensus 215 ~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 215 QQLKQVVEEPSP--QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred HHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111111 01111234557788899999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.85 Aligned_cols=193 Identities=25% Similarity=0.373 Sum_probs=158.4
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|.+.+.||+|+||.||++... +++.|++|++....... ....+.+|++++++++|+||+++.+++.+.+..++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG---VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC---CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 468999999999999999999754 68899999875432211 12246789999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||++ ++|.+++.. ...++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 999996 577766542 2357889999999999998 999999999999999999999999998753322
Q ss_pred CCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 211 123356889999999865 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.51 Aligned_cols=192 Identities=25% Similarity=0.410 Sum_probs=158.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +++.|++|.+....... ....+.+|++++++++||||+++++++.+.+..++|
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG---APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC---CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 67899999999999999999865 67899999876433211 122366899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++ +|.+++... ..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 999985 898887542 256789999999999998 9999999999999999999999999986532221
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 158 KT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 112346789999998865 45789999999999999999999998543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.50 Aligned_cols=243 Identities=26% Similarity=0.422 Sum_probs=194.1
Q ss_pred CccccceEeecccEEEEEEEeC--CCc--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP--DGQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
+.++.|+||+|.||.|++|.+. +|+ .||||+++...... ....|.+|+.+|.+|+|||+++|+|+..+ ....
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 4455789999999999999864 344 58999987765543 45579999999999999999999999987 6788
Q ss_pred EEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
||||+++.|+|.+.|++. ..++.|||.||.||.+++ +|||||..+|+||-..-.+||+||||.+-+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence 999999999999999872 258899999999999999 9999999999999988899999999998766
Q ss_pred CCCCCCcc-cccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDFRP-MKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..+..+.. ....-...|.|||.+....++.++|||+|||+||||+| |+.||-+-.. ..+.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------------------~qIL 325 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------------------IQIL 325 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------------------HHHH
Confidence 65543321 12233578999999999999999999999999999999 4556533221 2233
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
+.+|. ++..++.+ .+.|.++++.||..+|++|||+..|.+++-.
T Consensus 326 ~~iD~~erLpRPk~c----sedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 326 KNIDAGERLPRPKYC----SEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HhccccccCCCCCCC----hHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 33343 45555444 4556777888999999999999999866533
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=288.99 Aligned_cols=242 Identities=21% Similarity=0.323 Sum_probs=188.3
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--CCeEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--KDERLL 571 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~l 571 (789)
+|++.+.||.|+||.||++.. .+++.|++|++...... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT--EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC--HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence 478889999999999999975 46789999987543322 2334568899999999999999999998864 345789
Q ss_pred EEEecCCCchhHHHhhh------------chHHHHHHHHHHHHH-----hcCCCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 572 VYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLH-----NYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
+|||+++++|.+++... ..++.+++.+|+||| +.+ |+|+||||+||+++.++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccc
Confidence 99999999999998642 257889999999999 666 9999999999999999999999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
++......... .....++..|+|||.+....++.++|+||||+++|+|++|+.||...+.
T Consensus 156 ~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------------ 215 (265)
T cd08217 156 LAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------------------ 215 (265)
T ss_pred ccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------------------
Confidence 98765433321 1234688999999999888899999999999999999999999854321
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.+.+...... .........+.+++.+|++.+|++||++++|+++
T Consensus 216 ~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 216 LQLASKIKEGKFR--RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHHhcCCCC--CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0011111111110 1112334556788889999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=292.88 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=188.7
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +++.|++|++....... .....+.+|+.++++++||||+++++++......++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 5888999999999999999864 68899999876543211 22346889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+ +++|.+++... ..++.|++++|+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999 99999987532 357889999999999998 99999999999999999999999999876543322
Q ss_pred CCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccc----hhhhhhh-hh
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDF----AVPAIMA-GE 716 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~----~~~~~~~-~~ 716 (789)
.......++..|+|||.+.+. .++.++||||||+++|||++|++||....+........ ... ..+.... ..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 112235688999999998654 46899999999999999999977774432210000000 000 0000000 00
Q ss_pred hHHhhcccCCC-C-CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGP-P-EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~-~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+....... + .....+....+.+++.+||..||++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0 00001223667788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.94 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=188.6
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhH-HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKF-QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+|++.+.||+|+||.||+|... +++.|++|++........ ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999864 688999999865443211 12234577899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+ +++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 88999998643 257889999999999999 9999999999999999999999999987654432
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhh--hhhhH
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIM--AGELV 718 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~--~~~~~ 718 (789)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|.+||....+........ ...+..... .....
T Consensus 157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 RK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred cc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 21 122346788999998854 567899999999999999999977775433211000000 000000000 00000
Q ss_pred HhhcccCCCCC---CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPE---INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........... .........+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 0011224566788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=297.03 Aligned_cols=264 Identities=22% Similarity=0.279 Sum_probs=189.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +++.|++|+++..... ......+.+|++++++++||||+++++++...+..+++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc--ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence 36889999999999999999865 5789999987543221 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||++++.+..++... ..++.+++++|+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999986666554321 357889999999999998 99999999999999999999999999876544432
Q ss_pred CCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc---cccchhhhhhhhhhHHh
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS---LVDFAVPAIMAGELVKI 720 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 720 (789)
.......++..|+|||++... .++.++||||||+++|||++|++||............ +................
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 111234678899999999877 8899999999999999999999988643221000000 00000000000000000
Q ss_pred hcc-cCCCCCC-------CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDR-RVGPPEI-------NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~-~~~~~~~-------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
... .+..... ........+.+++.+||..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0000000 011124567888999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.98 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=184.8
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +++.|+||++...... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc--cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence 4788999999999999999864 6889999987643321 122345889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+. ++|.+++.. ...++.++++||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 79 e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 79 EFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred eccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 9996 588887753 1257889999999999998 9999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc-------hhhhhhh-
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF-------AVPAIMA- 714 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~-------~~~~~~~- 714 (789)
.. .....++..|+|||.+.+. .++.++||||||+++|||+||+.||...++..... ..... ..+....
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHHHhCCCChhhhhhhhHH
Confidence 11 1233567899999988654 46889999999999999999999986543211000 00000 0000000
Q ss_pred hhhHHhhcccCC-CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+..... ............+.+++.+||+.||++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0000001123445678999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=294.25 Aligned_cols=241 Identities=28% Similarity=0.391 Sum_probs=193.2
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
-.+.|+.-++||+|+||.||-++.+ +|+.||.|++.+.+.++ ...+....+|-.+|.+++.+.||.+--.|+.++.++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKk-r~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKK-RKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHH-hhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3467888899999999999999754 69999999887655544 333455778999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
||+..|.+|+|.-+|.+.. -++.+|+.||++||... ||+|||||+|||||+.|+++|+|+|||..++
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999988876433 36889999999999999 9999999999999999999999999998766
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
....- ...+||.+|||||++.+..|+...|+|||||+||||+.|+.||....+. ...+ -
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK--------------vk~e----E 397 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK--------------VKRE----E 397 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh--------------hhHH----H
Confidence 55432 2348999999999999999999999999999999999999999654431 1111 1
Q ss_pred hccc-CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH
Q 045256 721 LDRR-VGPPEINEAEAVELVAYTAMHCVNLEGKERPTM 757 (789)
Q Consensus 721 ~d~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 757 (789)
+|++ +..+...+....+..+.|....|.+||++|.-.
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2222 122223333444555666677899999999743
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=296.09 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=188.9
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence 46888999999999999999875 58899999875433222 2344578899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.++... ...++.|++++|+|||+.+ |+|+||+|+||++++++.++|+|||++........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999999888876542 2357889999999999998 99999999999999999999999999876443332
Q ss_pred CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc-
Q 045256 645 DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD- 722 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d- 722 (789)
. .....++..|+|||++.+ ..++.++||||||+++|||++|++||......... ........ . ......+..+
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~-~~~~~~~~-~-~~~~~~~~~~~ 230 (286)
T cd07846 156 V--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL-YHIIKCLG-N-LIPRHQEIFQK 230 (286)
T ss_pred c--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHH-HHHHHHhC-C-CchhhHHHhcc
Confidence 2 123457889999998865 45788999999999999999999888543321000 00000000 0 0000000000
Q ss_pred -----cc-CCCCCC------CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 -----RR-VGPPEI------NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 -----~~-~~~~~~------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. .+.... ........+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 000000 001234567788999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.96 Aligned_cols=241 Identities=31% Similarity=0.459 Sum_probs=191.3
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++||||+++++++......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 4778899999999999999875 688999999765433 23446889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++++|.+++... ..++.+++++|+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 77 EFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred ecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999988654 257889999999999988 99999999999999999999999999876544331
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....++..|+|||.+....++.++||||||+++|||++|+.||...+.. ..+.... ..
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------------~~~~~~~-~~ 212 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----------------KALFKIA-TN 212 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----------------HHHHHHH-hc
Confidence 22456789999999998888999999999999999999999998543210 0000000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..............+.+++.+||+.||++|||+.|++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 213 GPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000111124557788899999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.51 Aligned_cols=241 Identities=24% Similarity=0.402 Sum_probs=189.3
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
-|++.+.||+|+||.||++.. .+++.||+|.+..... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 467788999999999999975 4678999998654322 223446889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 574 e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
||+++++|.+++... ..++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999999988642 357889999999999988 99999999999999999999999999865433221
Q ss_pred cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCC
Q 045256 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 726 (789)
......++..|+|||.+....++.++|+||||+++|||++|+.||...... .....+....
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------------------~~~~~~~~~~- 217 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------------------KVLFLIPKNN- 217 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------------------HHHHHHhcCC-
Confidence 112345788999999998888899999999999999999999998532210 0000111100
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...........+.+++.+||+.+|++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 -PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 001112233456778889999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.28 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=187.5
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|...+.||+|++|.||++.. .+++.+++|++..... ...+.+.+|+.++++++||||+++++++...+..++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 344467999999999999985 4688999998643221 22345789999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 574 e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
||+++++|.+++... ..++.+++.+|+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 999999999988642 258899999999999998 99999999999999999999999998765432221
Q ss_pred cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCC
Q 045256 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 726 (789)
......++..|+|||.+....++.++||||||+++|||++|+.||...+.. .....+.......+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------------QAMKRIRDNLPPKLK 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------------HHHHHHHhcCCCCCc
Confidence 112345789999999998888999999999999999999999998643210 000011111001111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+.+++.+||+.+|++||++.+++++
T Consensus 237 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 ----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ----ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111233457788999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.59 Aligned_cols=241 Identities=27% Similarity=0.318 Sum_probs=190.8
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||.|+||.||++... +++.|++|.+....... ....+.+.+|++++++++||||+++++++.+.+..++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 4888999999999999999875 58899999876433221 123456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
||+++++|.+++... ..++.+++++|.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 999999999998654 257889999999999998 9999999999999999999999999987644332
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc-cc
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD-RR 724 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-~~ 724 (789)
......++..|+|||.+....++.++|+||||+++|+|++|+.||....... ...+..... ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------------~~~~~~~~~~~~ 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI---------------RDQIRAKQETAD 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH---------------HHHHHHHhcccc
Confidence 1123467889999999988889999999999999999999999986543210 011111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH--HHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTM--ADIV 761 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~--~evl 761 (789)
...+ ......+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYP----ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCc----ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111 2233566778889999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.20 Aligned_cols=236 Identities=26% Similarity=0.312 Sum_probs=177.1
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHH-HhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAF-LSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++... +++.||+|.+........ .....+..|..+ ....+||||+++++++...+..|+|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK-NQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHH-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 56899999999999864 588999998764432221 122234445444 445589999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
+++|.+++... ..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..... ..
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~ 151 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK 151 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence 99999998642 367889999999999998 99999999999999999999999999865332 11
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
...++..|+|||.+.+..++.++||||||+++|||++|+.||...+. . .....+.......+.
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~------------~~~~~~~~~~~~~~~ 214 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----D------------AVFDNILSRRINWPE 214 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----H------------HHHHHHHhcccCCCC
Confidence 34578899999999888889999999999999999999999854321 0 000111111111111
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
.........+.+++.+||+.||++||++.++.+
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 111233456778899999999999997754444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=280.32 Aligned_cols=242 Identities=25% Similarity=0.359 Sum_probs=191.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|+.+++||+|.||.|.+++-+ .++.||+|++++...... +....-..|-++|+..+||.+..|.-.|+..+++++|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-dEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-DEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-HHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 57888999999999999999854 689999999877554332 2334466788999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||..+|.|+-+|.... -+-..|..||.|||+.+ ||.||||.+|.|||.||++||+||||++..-...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g- 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG- 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccccc-
Confidence 99999999998886432 24567899999999998 9999999999999999999999999997532222
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH-hhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK-ILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~ 723 (789)
....+++||+.|+|||++....|...+|+|.+||++|||+.|+.||+..+.. .+-+ ++-.
T Consensus 323 -~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~------------------kLFeLIl~e 383 (516)
T KOG0690|consen 323 -DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE------------------KLFELILME 383 (516)
T ss_pred -ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh------------------HHHHHHHhh
Confidence 2334689999999999999999999999999999999999999999765431 1111 1222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.+..|.....++..+| ...|.+||.+|. .++||.++
T Consensus 384 d~kFPr~ls~eAktLL----sGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 DLKFPRTLSPEAKTLL----SGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hccCCccCCHHHHHHH----HHHhhcChHhhcCCCchhHHHHHhh
Confidence 3333444455555444 457889999995 45555443
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.70 Aligned_cols=242 Identities=23% Similarity=0.446 Sum_probs=187.5
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC---CCcceEEEEEEEeCCeEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH---HKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~ 570 (789)
.|++.+.||+|+||.||++.. .+++.|++|.+..... ......+.+|++++++++ |||++++++++.+....+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~ 78 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP---DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW 78 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC---chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence 477789999999999999985 5688999998754322 122345788999999996 999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
+||||+++++|.+++... ..++.+++++|.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 79 IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999999988543 257789999999999998 9999999999999999999999999987654433
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ......++..|+|||.+.. ..++.++|+||||+++|||++|+.||........ . ..+.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----------------~-~~~~ 215 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----------------M-MLIP 215 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----------------h-hccc
Confidence 2 1223468889999998864 4568899999999999999999999854322100 0 0000
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ..+..........+.+++.+||+.||++||++.|++++
T Consensus 216 ~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 KS-KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred cC-CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00 00111111133456778889999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=284.49 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=194.5
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DERLL 571 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 571 (789)
+|++.+.||+|++|.||++... +++.|++|++...... ....+.+.+|++++++++||||+++++.+.+. ...++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence 4778899999999999999876 6889999987654432 23455688999999999999999999999988 88999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
++||+++++|.+++... ..++.+++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 99999999999998654 358889999999999988 9999999999999999999999999987654443
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.........++..|+|||.+.....+.++||||||+++|+|++|+.||...+.. .....+....
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------------~~~~~~~~~~ 219 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP----------------MAALYKIGSS 219 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----------------HHHHHhcccc
Confidence 211122456789999999998888999999999999999999999998654310 0000111110
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ....+......+.+++.+|++.||++||++.|++++
T Consensus 220 ~~--~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 GE--PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CC--CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 00 011112224567788999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.56 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=193.8
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
...+.|+..+.||+|.||.||++..+ +++.|++|++..... ....+.+|++++++++|+||+++++++...+..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 34567888899999999999999876 688999998765432 234588999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++++||+++++|.+++.... .++.+++.+|+|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 99999999999999987652 47889999999999988 9999999999999999999999999876533
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......++..|++||.+....++.++|+||||+++|||++|+.||...+.. ......
T Consensus 168 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-----------------~~~~~~ 228 (286)
T cd06614 168 KEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-----------------RALFLI 228 (286)
T ss_pred cchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHH
Confidence 2221 112335778999999998888999999999999999999999998543220 000111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
....... ..........+.+++.+||+.+|.+||++.+++++-
T Consensus 229 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 229 TTKGIPP-LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HhcCCCC-CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 1111111 111122345677889999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.28 Aligned_cols=247 Identities=28% Similarity=0.366 Sum_probs=187.6
Q ss_pred CccccceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
+|++.+.||+|+||.||++.. .+|+.||+|++............+.+.+|+++++++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999975 368899999976543333233345678899999999 599999999999998899
Q ss_pred EEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
++||||+++++|.+++.... .++.|++++|.|||+.+ ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 99999999999999986432 35668999999999998 99999999999999999999999999876433
Q ss_pred CCCCCcccccccCcCccCccccCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
... .......++..|+|||.+... .++.++||||||+++|||++|+.||........ ...+.+
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--------------~~~~~~ 222 (290)
T cd05613 158 DEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--------------QAEISR 222 (290)
T ss_pred ccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--------------HHHHHH
Confidence 221 112234688999999998653 467899999999999999999999853221100 001111
Q ss_pred -hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 720 -ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 720 -~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
+....... +......+..++.+||+.||++|| +..+++.+
T Consensus 223 ~~~~~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 RILKSEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HhhccCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 11111111 122344567788899999999997 67777664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=293.82 Aligned_cols=252 Identities=26% Similarity=0.314 Sum_probs=191.5
Q ss_pred CccccceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
+|++.+.||+|+||.||++.. .+++.|+||.++.............+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478889999999999999874 356889999876543333333445688999999999 599999999999999999
Q ss_pred EEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
++||||+++++|.+++.... .++.|++++|+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999999999876432 46779999999999988 99999999999999999999999999876433
Q ss_pred CCCCCcccccccCcCccCccccCCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNV--LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
... .......++..|+|||.+.+.. .+.++||||||+++|||++|+.||........ . ......
T Consensus 158 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----------~---~~~~~~ 223 (288)
T cd05583 158 EEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----------Q---SEISRR 223 (288)
T ss_pred ccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----------H---HHHHHH
Confidence 321 1122345789999999986654 78899999999999999999999854322100 0 001111
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
+.......+. .....+.+++.+||+.||++|||++++.+.|+..
T Consensus 224 ~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 224 ILKSKPPFPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHccCCCCCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 2222222122 1234567788899999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.99 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=186.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~ 570 (789)
++|++.+.||+|.||.||++..+ +++.+++|.++..... ......+.+|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46888899999999999999875 5789999987654322 22233467899999999999999999999887 7899
Q ss_pred EEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+||||+++ +|.+++... ..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99999975 888887542 258899999999999998 99999999999999999999999999876544
Q ss_pred CCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cc------cchhh--
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LV------DFAVP-- 710 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~------~~~~~-- 710 (789)
.... .....++..|+|||.+.+. .++.++|+||||+++|||++|++||............ .. .|...
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3211 1234568899999988654 4688999999999999999999998644321000000 00 00000
Q ss_pred --hhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 --AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 --~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+.....+.. ........+.+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000000000 00000124556788999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=293.84 Aligned_cols=197 Identities=27% Similarity=0.425 Sum_probs=159.3
Q ss_pred CccccceEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DER 569 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 569 (789)
+|++.+.||+|+||.||++... +++.||+|.+..... ........+.+|+.++++++||||+++++++.+. +..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence 4788899999999999999864 478999999775331 1122234577899999999999999999999988 789
Q ss_pred EEEEEecCCCchhHHHhh-------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC----CCcEEEEe
Q 045256 570 LLVYDYMKNGALYDHLHD-------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA----QWTARVSD 632 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~-------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~D 632 (789)
++||||+++ +|.+++.. ...++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~D 155 (316)
T cd07842 80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGD 155 (316)
T ss_pred EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECC
Confidence 999999976 67666532 1257889999999999998 999999999999999 99999999
Q ss_pred eccCcCCCCCCCC-CcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 045256 633 FGLSMMGPESERD-FRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696 (789)
Q Consensus 633 fGls~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~ 696 (789)
||++......... .......++..|+|||.+.+ ..++.++||||||+++|||++|++||.....
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 9998765433221 11223467889999998765 4578999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.18 Aligned_cols=237 Identities=24% Similarity=0.305 Sum_probs=176.3
Q ss_pred eEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHH---hhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 501 KIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFL---SRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l---~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
+||+|+||.||++... +++.+|+|.+........ .....+.+|..++ ...+||||+.+++++...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 4899999999999864 588999998765432211 1122233444333 3447999999999999999999999999
Q ss_pred CCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcc
Q 045256 577 KNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP 648 (789)
Q Consensus 577 ~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~ 648 (789)
++++|.+++... ..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++....... .
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~ 152 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence 999999888643 257889999999999999 9999999999999999999999999986543221 1
Q ss_pred cccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 649 MKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 649 ~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
....++..|+|||.+. +..++.++||||||+++|||++|+.||........ ..+.+.... .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~---~ 214 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------------HEIDRMTLT---V 214 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH---------------HHHHHHhhc---C
Confidence 2346899999999886 45688999999999999999999999864432100 011111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
...........+.+++.+||..||++|| +++|++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 0111122345567788899999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=286.56 Aligned_cols=235 Identities=27% Similarity=0.369 Sum_probs=185.3
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|+||.||++... +++.|++|++....... ....+.+.+|++++++++||||+++++++.+....+++|||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 689999999999875 48899999876543222 2234568899999999999999999999999999999999999999
Q ss_pred hhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccc
Q 045256 581 LYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA 652 (789)
Q Consensus 581 L~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~ 652 (789)
|.+++.... .++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||++....... ......
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~ 153 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC 153 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence 999986532 47789999999999988 9999999999999999999999999987654432 112346
Q ss_pred cCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc--ccCCCCCC
Q 045256 653 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD--RRVGPPEI 730 (789)
Q Consensus 653 gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~ 730 (789)
++..|++||.+....++.++|+||||+++|||++|+.||....+. + .....++.+ .....+.
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~------------~~~~~~~~~~~~~~~~~~- 217 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---P------------MEIYNDILKGNGKLEFPN- 217 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---H------------HHHHHHHhccCCCCCCCc-
Confidence 788999999998888999999999999999999999999654420 0 011122221 1111111
Q ss_pred CHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHH
Q 045256 731 NEAEAVELVAYTAMHCVNLEGKERPT-----MADIVA 762 (789)
Q Consensus 731 ~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 762 (789)
.....+..++.+||+.||++||+ ++|+++
T Consensus 218 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 ---YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 12456778889999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=299.69 Aligned_cols=243 Identities=24% Similarity=0.358 Sum_probs=195.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
...|.+.+.||+|.|+.|.++++. ++..||||.+.+..... ...+.+.+|+++|+.|+|||||+++.+...+..+|+
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~--~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP--SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh--HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 467899999999999999999854 68999999887654433 333448899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||..+|.++++|.... .++.|+.++++|||++. |+|||||.+||||+.+.++||+|||++..+....
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccc
Confidence 999999999999997533 57889999999999999 9999999999999999999999999997755333
Q ss_pred CCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ..+.+|++.|.|||++.+..| .+++|+||+|++||.|+.|..||....-.+-. .+.+.
T Consensus 210 ~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rvl~ 269 (596)
T KOG0586|consen 210 M---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRVLR 269 (596)
T ss_pred c---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chhee
Confidence 2 235789999999999987765 67999999999999999999999654321111 11222
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
..+..+..-. ...++++.+++..+|.+|++++++.++-
T Consensus 270 gk~rIp~~ms----~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 270 GKYRIPFYMS----CDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eeecccceee----chhHHHHHHhhccCccccCCHHHhhhhc
Confidence 2222222222 3345566778999999999999988753
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=286.82 Aligned_cols=242 Identities=25% Similarity=0.411 Sum_probs=188.2
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++..+ +++.+++|.+....... ...+.+.+|++++++++||||+++++.+.+....++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV--KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc--hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence 5788999999999999999865 57899999875532211 22345789999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPES 642 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~~~~ 642 (789)
||+++++|.+++... ..++.+++++|+|||+.+ ++|+||||+||++++++ .+||+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999988542 257789999999999998 99999999999998885 5699999998765432
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. ......++..|+|||.+....++.++|+||||+++|||++|+.||...+. .....+...
T Consensus 156 ~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~~~~ 216 (257)
T cd08225 156 ME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----------------HQLVLKICQ 216 (257)
T ss_pred cc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------------HHHHHHHhc
Confidence 21 11234578899999999888899999999999999999999999853221 001111122
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...... .......+.+++.+||..+|++|||+.|++++
T Consensus 217 ~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 GYFAPI---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ccCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 211111 11223456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=279.63 Aligned_cols=258 Identities=26% Similarity=0.306 Sum_probs=202.8
Q ss_pred HHHHHHHHhcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcce
Q 045256 484 FLLAELAAATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557 (789)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv 557 (789)
-...++.....++++..++-+|.||.||+|.++ +.+.|.+|.++.. ..+-+...+..|--.+..+.|||+.
T Consensus 274 ~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll 350 (563)
T KOG1024|consen 274 RRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLL 350 (563)
T ss_pred hhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCcc
Confidence 346778888889999999999999999999543 3456777754432 2233455688899999999999999
Q ss_pred EEEEEEEeC-CeEEEEEEecCCCchhHHHhhh----------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 045256 558 RLVGYCEEK-DERLLVYDYMKNGALYDHLHDR----------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNI 620 (789)
Q Consensus 558 ~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~----------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NI 620 (789)
.+.+++.+. +..+.+|.++.-|+|..+|... -.++.|++.|++|||+.+ |||.||..+|+
T Consensus 351 ~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNC 427 (563)
T KOG1024|consen 351 SVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNC 427 (563)
T ss_pred ceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcc
Confidence 999998664 4578899999999999999721 147889999999999999 99999999999
Q ss_pred EECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 045256 621 LLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGG 699 (789)
Q Consensus 621 ll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~ 699 (789)
+||+..++||+|-.+++.+-..+.............||+||.+....|+..+||||||++||||+| |+.|+..-++
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--- 504 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--- 504 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---
Confidence 999999999999999987655554433344456789999999999999999999999999999998 7777643221
Q ss_pred cccccccchhhhhhhhhhHHhhc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 700 TPVSLVDFAVPAIMAGELVKILD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
..+... +.| .++..|.+.+.|....| .-||..+|++||++++++.-|.+.-
T Consensus 505 -----------fEm~~y---lkdGyRlaQP~NCPDeLf~vM----acCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 505 -----------FEMEHY---LKDGYRLAQPFNCPDELFTVM----ACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -----------HHHHHH---HhccceecCCCCCcHHHHHHH----HHHHhcCcccCCCHHHHHHHHHHHH
Confidence 111111 222 35677777777655544 4599999999999999999987753
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=292.37 Aligned_cols=242 Identities=26% Similarity=0.399 Sum_probs=187.3
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|+..+.||+|+||.||++... +++.|++|++....... .+....+.+|++++++++|||++++++++.+.+..++||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-NEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCc-hHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4667889999999999999854 68899999876433222 233456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++ +|.+++... ..++.+++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99975 787776432 247889999999999998 999999999999999999999999988653322
Q ss_pred CCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 645 DFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...+.. ..+..+.
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----------------~~~~~~~ 237 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------------SALYHIA 237 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----------------HHHHHHH
Confidence 1345788999999873 456889999999999999999999998643210 0011111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
...... .........+.+++.+||+.+|.+||++.++++++..
T Consensus 238 ~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 238 QNESPT--LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred hccCCC--CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 111111 1112334557788999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=299.55 Aligned_cols=263 Identities=20% Similarity=0.255 Sum_probs=189.0
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC----
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 566 (789)
..++|++.+.||+|+||.||++... +++.||+|++...... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN--VTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccC--hhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3478999999999999999999864 6899999987543211 12234577899999999999999999998644
Q ss_pred --CeEEEEEEecCCCchhHHHhhh------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 --DERLLVYDYMKNGALYDHLHDR------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 --~~~~lv~e~~~~gsL~~~l~~~------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...|+||||+++ +|.+.+... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 346999999965 888876532 357889999999999998 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccchhhhh---h
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDFAVPAI---M 713 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~~~~---~ 713 (789)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+........ ....+.+.. .
T Consensus 168 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 168 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred CCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 433221 22345788999999999989999999999999999999999998654321000000 000000000 0
Q ss_pred hhhhHHhhc---------------ccCCCCC--CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILD---------------RRVGPPE--INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d---------------~~~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+ ..+.+.. .........+.+++.+||+.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000111 0000000 0011234556788999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.06 Aligned_cols=243 Identities=24% Similarity=0.345 Sum_probs=182.4
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv 572 (789)
+|...+.||+|+||.||++... +++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4566788999999999999864 5789999987643322 23446889999999996 99999999999999999999
Q ss_pred EEecCCCchhHHH---hh----------hchHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 573 YDYMKNGALYDHL---HD----------RNNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 573 ~e~~~~gsL~~~l---~~----------~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
|||++. ++.++. .. ...++.+++.||+|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 999865 554432 11 135788999999999975 6 99999999999999999999999999865
Q ss_pred CCCCCCCCcccccccCcCccCccccCCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLN---VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
...... .....++..|+|||.+... .++.++||||||+++|||++|+.||..... ..+
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------------~~~ 218 (288)
T cd06616 158 LVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------------VFD 218 (288)
T ss_pred hccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------------HHH
Confidence 433221 1234578899999998765 688999999999999999999999854321 001
Q ss_pred hhHHhhcccCC-CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 716 ELVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 716 ~~~~~~d~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.+......+ ............+.+|+.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 219 QLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred HHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111100 0111112344567788999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=290.96 Aligned_cols=262 Identities=21% Similarity=0.295 Sum_probs=184.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|.+|.||++... +++.|++|.+...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc--ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 57899999999999999999865 6889999987543221 12234578899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGls~~~~~ 641 (789)
|||+++ +|.+++... ..++.|++.||+|||+.+ ++|+||||+||+++. +..+||+|||++.....
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 999964 887776432 146789999999999998 999999999999985 56799999999875433
Q ss_pred CCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchh--hhhhh--hh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV--PAIMA--GE 716 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~--~~~~~--~~ 716 (789)
.... .....+++.|+|||.+.+ ..++.++||||||+++|||+||+.||....+.+.....+..... ..... ..
T Consensus 156 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 2111 123456889999998865 45789999999999999999999998654321100000000000 00000 00
Q ss_pred hHHhhcccCCCCCCC----HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEIN----EAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.+............ .......+.+++.+|++.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000 01123446778889999999999999999874
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.21 Aligned_cols=236 Identities=26% Similarity=0.352 Sum_probs=180.6
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|+||+||++... +++.|++|.+....... ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKK-RKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhh-hhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999754 68899999876533222 2234456789999999999999999999999999999999999999
Q ss_pred hhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 581 LYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 581 L~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
|.+++.... .++.|++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++....... ....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999886432 46789999999999998 9999999999999999999999999987543311 1123
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh-hcccCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI-LDRRVGPPE 729 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d~~~~~~~ 729 (789)
..++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.+. .......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~~~-- 217 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--------------KEELKRRTLEMAVEY-- 217 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--------------HHHHHhccccccccC--
Confidence 4577899999999888899999999999999999999999854432100 0011111 1111111
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERP-----TMADIVA 762 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~ 762 (789)
.......+.+++.+||+.||++|| ++.++++
T Consensus 218 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 218 --PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 112244567788899999999999 5655654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.14 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=184.5
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|++.+.||+|.+|.||++... +++.|++|++...... ......+.+|++++++++||||+++++++.+.+..+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED--EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc--ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 567889999999999999864 7899999987643221 1222357789999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 575 YMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 575 ~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|++ ++|.+++.... .++.|++++|+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 995 58998875432 57889999999999988 99999999999999999999999999875432221
Q ss_pred CCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc---------chhhhhhh
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD---------FAVPAIMA 714 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~---------~~~~~~~~ 714 (789)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..... ....+ |.......
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL-FRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHHhhhhhhch
Confidence 1 1223568899999987654 5788999999999999999999998654321000 00000 00000000
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.......................+.+++.+||+.||++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000000000011122456678999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=290.96 Aligned_cols=238 Identities=22% Similarity=0.340 Sum_probs=184.8
Q ss_pred cceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 499 ENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
..+||+|+||.||++.. .+++.|++|.+..... .....+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch----hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 36799999999999986 4688999998643221 234458899999999999999999999999999999999999
Q ss_pred CCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 578 NGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 578 ~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
+++|.+++... ..++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++......... ...
T Consensus 101 ~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred CCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 99999887432 257889999999999998 999999999999999999999999988654332211 123
Q ss_pred cccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCC
Q 045256 651 AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 730 (789)
..++..|+|||.+....++.++|+||||+++|||++|+.||...... .. ...+.+.+...+...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----~~---------~~~~~~~~~~~~~~~-- 239 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KA---------MKMIRDNLPPKLKNL-- 239 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HH---------HHHHHhhCCcccCCc--
Confidence 45788999999998888899999999999999999999998543210 00 000111111111111
Q ss_pred CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 731 NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 731 ~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+.+++.+||+.||.+||++.+++++
T Consensus 240 --~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 --HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1223346677889999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=277.44 Aligned_cols=197 Identities=26% Similarity=0.382 Sum_probs=161.1
Q ss_pred CCccccceEeecccEEEEEEEeC---C--CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-CC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP---D--GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-KD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 567 (789)
..|+....||+|+||.||++.-. + .+.+|||.++..+... .......+|+.+++.++||||+.|..++.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 35788899999999999999532 2 3479999877543321 112236689999999999999999999987 66
Q ss_pred eEEEEEEecCCCchhHHHhhh-------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC----CcEEE
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ----WTARV 630 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl 630 (789)
..+|++||.+. +|.+.++-. +.|..||+.|+.|||++. |+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 78999999988 999988632 258889999999999999 9999999999999777 89999
Q ss_pred EeeccCcCCCCCCCCC-cccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 045256 631 SDFGLSMMGPESERDF-RPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~ 696 (789)
+|||+++++...-... .....+-|..|+|||.+.+ ..|+.+.|||+.|||+.||+|-++.|...++
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 9999999876654433 2234567999999999865 5789999999999999999999988876543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=298.87 Aligned_cols=266 Identities=22% Similarity=0.310 Sum_probs=188.3
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCC--
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKD-- 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~-- 567 (789)
..++|++.+.||+|+||.||++... +++.+++|++....... .....+.+|+.+++++ +||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc--hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3467888999999999999999865 57899999875422111 2233577899999999 9999999999986543
Q ss_pred eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
..++||||+++ +|.+++... ..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred eEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 57999999974 998887542 247899999999999998 9999999999999999999999999987654
Q ss_pred CCCCC---CcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccc----hhh
Q 045256 641 ESERD---FRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDF----AVP 710 (789)
Q Consensus 641 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~----~~~ 710 (789)
..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||............ .... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 12223468899999998754 56788999999999999999999998543221000000 0000 000
Q ss_pred hhhhhhhHHhhcccC----CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 AIMAGELVKILDRRV----GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~----~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+......++++... .............+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000001111111100 00000011134567788999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=272.67 Aligned_cols=251 Identities=21% Similarity=0.360 Sum_probs=194.2
Q ss_pred cceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEEec
Q 045256 499 ENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
.+.||+|+|+.|--+. +.++++||||++.+... ..+..+.+|++++.+. .|+||+.|+++|+++..+|||||.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g----HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG----HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc----hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 3789999999999885 67899999999876533 2344578999999999 4999999999999999999999999
Q ss_pred CCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC---cEEEEeeccCcCCCCCC--
Q 045256 577 KNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMMGPESE-- 643 (789)
Q Consensus 577 ~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGls~~~~~~~-- 643 (789)
.+|+|..+++++. ++.++|+.||.|||..+ |.||||||+|||..... -+||+||.|..-.....
T Consensus 159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999999998654 68889999999999999 99999999999996543 58999998864321111
Q ss_pred ---CCCcccccccCcCccCcccc-----CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh---hh
Q 045256 644 ---RDFRPMKAAGTVGYIDPEYY-----GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP---AI 712 (789)
Q Consensus 644 ---~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~---~~ 712 (789)
......+.+|+..|||||+. ....|+.+.|.||||||||-||.|.+||.+.-... -.|..- ..
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d------CGWdrGe~Cr~ 309 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD------CGWDRGEVCRV 309 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc------CCccCCCccHH
Confidence 11122356899999999976 33468999999999999999999999997653311 112211 11
Q ss_pred hhhhh-HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 713 MAGEL-VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 713 ~~~~~-~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
....+ ..+.+.....|+........+-++++...+..|+.+|.++.+++.
T Consensus 310 CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 310 CQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22223 233334455555556667777788888889999999999999887
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=282.80 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=188.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchh-hhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKT-KKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 569 (789)
.+|++.+.||+|+||.||++... +++.|++|.+..... .........+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57899999999999999999864 688999998643211 11223345788999999999999999999998764 457
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
++++||+++++|.+++... ..++.+++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 8999999999999988643 257889999999999998 99999999999999999999999999875432
Q ss_pred CCC-CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SER-DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
... ........++..|+|||.+.+..++.++|+||||+++|||++|+.||..... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~~ 221 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----------------MAAIFKI 221 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----------------HHHHHHH
Confidence 111 1111234578999999999888889999999999999999999999853221 0011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... .....+....+.+.+++.+||. +|.+||+..+++.+
T Consensus 222 ~~~~--~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 222 ATQP--TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HcCC--CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111 1111223344567788889998 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=289.60 Aligned_cols=261 Identities=18% Similarity=0.277 Sum_probs=183.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCe---
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDE--- 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~--- 568 (789)
++|++.+.||+|+||.||++... +++.|++|.+...... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 78 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE--EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK 78 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc--cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence 46889999999999999999864 6889999986543221 122345788999999995 6999999999987665
Q ss_pred --EEEEEEecCCCchhHHHhhh-------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEe
Q 045256 569 --RLLVYDYMKNGALYDHLHDR-------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSD 632 (789)
Q Consensus 569 --~~lv~e~~~~gsL~~~l~~~-------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~D 632 (789)
.|+||||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|
T Consensus 79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~d 154 (295)
T cd07837 79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIAD 154 (295)
T ss_pred ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEee
Confidence 8999999986 888876431 247889999999999998 999999999999998 89999999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch-hh
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA-VP 710 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~~ 710 (789)
||++......... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||....+..... .+.... .+
T Consensus 155 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~ 231 (295)
T cd07837 155 LGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTP 231 (295)
T ss_pred cccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCC
Confidence 9998754322211 112356788999998854 457899999999999999999999986543210000 000000 00
Q ss_pred h-hhhhhhHHhhcc-cCC--CC---CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 A-IMAGELVKILDR-RVG--PP---EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 ~-~~~~~~~~~~d~-~~~--~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. .......+..+. ... .+ ..........+.+++.+||..||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000000000 000 00 00001234556788999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=287.61 Aligned_cols=260 Identities=20% Similarity=0.308 Sum_probs=185.9
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|++|.||+++.. +++.|+||++...... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE---GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc---cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence 5888999999999999999875 6889999987654321 12334678999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 574 DYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 574 e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||+++ +|.+++... ..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 99985 888877532 257889999999999998 999999999999999999999999998654332
Q ss_pred CCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh-hhhhhhHHh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA-IMAGELVKI 720 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 720 (789)
... .....++..|++||.+.+ ..++.++||||||+++|||++|+.||...+........+..+..+. .....+...
T Consensus 154 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 154 VNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred ccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC
Confidence 211 123456889999998855 4578899999999999999999999865432110000000000000 000000000
Q ss_pred --hcccCCCCCC-----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 --LDRRVGPPEI-----NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 --~d~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+....+.... ........+.+++.+|++.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000 001223556788999999999999999998853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=274.58 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=194.7
Q ss_pred hcCCcccc-ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe---
Q 045256 492 ATNNFSLE-NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE--- 565 (789)
Q Consensus 492 ~~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~--- 565 (789)
.+++|++. ++||-|-.|.|-.+..+ +++.+|+|++.... ..++|+++.-.. .|||||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~---------KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP---------KARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH---------HHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 44667655 58999999999999764 68899999864322 245777766555 59999999999864
Q ss_pred -CCeEEEEEEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEE
Q 045256 566 -KDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVS 631 (789)
Q Consensus 566 -~~~~~lv~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 631 (789)
...+++|||.|++|.|+..+.++. .|++||..|+.|||+.. |.||||||+|+|... |..+||+
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEec
Confidence 345789999999999999998765 58899999999999999 999999999999954 5679999
Q ss_pred eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 632 DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 632 DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
|||+++..... ....+.+-|+.|.|||++...+|+...|+||+||++|-||.|.+||+......
T Consensus 207 DfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------------- 270 (400)
T KOG0604|consen 207 DFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------------- 270 (400)
T ss_pred ccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------------
Confidence 99999864432 22346788999999999999999999999999999999999999997654311
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+..+-..++-......+.....+.++..+++++.+|..+|.+|.|+.|++++
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1222233343444555666677888888999999999999999999998865
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.18 Aligned_cols=269 Identities=21% Similarity=0.306 Sum_probs=189.1
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|++.+.||+|+||.||++.. .+++.||+|++..... ......+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 46899999999999999999975 4689999998754221 122345778999999999999999999876543
Q ss_pred -eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 568 -ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 568 -~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
..++++||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 57999999975 888776542 257889999999999998 999999999999999999999999998764
Q ss_pred CCCCCCC-cccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc---chhhh---
Q 045256 640 PESERDF-RPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD---FAVPA--- 711 (789)
Q Consensus 640 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~---~~~~~--- 711 (789)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... ...+.+ .+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ-LNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCCHHHHH
Confidence 3322111 1123467899999998654 5688999999999999999999999854321000 000000 00000
Q ss_pred -hhhhhhHHhhcccCCCCCCC----HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHHhh
Q 045256 712 -IMAGELVKILDRRVGPPEIN----EAEAVELVAYTAMHCVNLEGKERPTMADIVAN--LERALD 769 (789)
Q Consensus 712 -~~~~~~~~~~d~~~~~~~~~----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~ 769 (789)
+......+.+......+... .......+.+++.+||+.||++|||+.|++++ ++...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000000000000000000 01123456788999999999999999999998 665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=285.33 Aligned_cols=241 Identities=26% Similarity=0.338 Sum_probs=185.7
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|+||.||++... +++.+++|++....... ....+.+.+|++++++++||||+++++.+......+++|||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 588999999999876 48999999876543221 3445568899999999999999999999999999999999999999
Q ss_pred hhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC------CC
Q 045256 581 LYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER------DF 646 (789)
Q Consensus 581 L~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~------~~ 646 (789)
|.+++... ..++.|++++|+|||+.+ ++|+||+|+||++++++.++|+|||++........ ..
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99988653 258899999999999998 99999999999999999999999999865433211 11
Q ss_pred cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCC
Q 045256 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 726 (789)
......++..|+|||.+.....+.++||||||+++|||++|+.||..... .+....+......
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----------------~~~~~~~~~~~~~ 219 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----------------EEIFQNILNGKIE 219 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHhcCCcC
Confidence 12234578899999999888889999999999999999999999854321 0011111111222
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
.+... .....+..++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 22111 12455677888999999999999955555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=280.57 Aligned_cols=242 Identities=26% Similarity=0.397 Sum_probs=191.9
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +++.|++|++...... ......+.+|++++++++|||++++++.+...+..++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS--EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC--hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence 5788899999999999999864 5889999987654322 233445889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 574 DYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 574 e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||+++++|.+++... ..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 999999999988653 257889999999999998 99999999999999999999999999876433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. .......+++.|+|||.+....++.++|+||||+++|+|++|+.||...+. . .......
T Consensus 156 ~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------------~----~~~~~~~ 216 (258)
T cd08215 156 TV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------------L----ELALKIL 216 (258)
T ss_pred Cc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------------H----HHHHHHh
Confidence 32 112234678899999999888899999999999999999999999854321 0 0111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........ ......+.+++.+||..+|++||++.|++++
T Consensus 217 ~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 217 KGQYPPIP---SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred cCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11111111 1233456778889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=287.45 Aligned_cols=259 Identities=23% Similarity=0.289 Sum_probs=185.5
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DERLLV 572 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~lv 572 (789)
|++.+.||+|+||.||++... +++.+++|++.... ........+.+|++++++++|||++++++++.+. +..++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence 567899999999999999865 57899999977543 1122234578899999999999999999999988 789999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++ +|.+++... ..++.++++||+|||+.+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 79 FEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred eccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 999985 888887543 368889999999999998 9999999999999999999999999987654432
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--------ccccchhhhhhh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--------SLVDFAVPAIMA 714 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--------~~~~~~~~~~~~ 714 (789)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ....|... ..
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 231 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV--SK 231 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc--cc
Confidence 11 1123356788999997754 4678999999999999999999999865432100000 00000000 00
Q ss_pred hhhHHhhcccCCCCCCC---HHH-HHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEIN---EAE-AVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~---~~~-~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
-............+... ... ....+.+++.+||..||++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000000000000000 001 14456788999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-32 Score=280.19 Aligned_cols=241 Identities=29% Similarity=0.486 Sum_probs=190.9
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|.+|.||++... +++.|++|.+...... ......+.+|++++++++|||++++++++.+....+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence 4788899999999999999765 5789999997665432 233456899999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
||+++++|.+++... ..++.+++.+|.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 79 EYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred ecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 999999999988643 357889999999999998 999999999999999999999999998765443321
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
.....++..|+|||.+....++.++||||||+++|||++|+.||...... . ..........
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------------~-----~~~~~~~~~~ 216 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM------------A-----ALFRIVQDDH 216 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH------------H-----HHHHHhccCC
Confidence 12346788999999998878899999999999999999999998543210 0 0001111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
.. .+......+..++.+||..+|++||++.|++.
T Consensus 217 ~~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PP---LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CC---CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 10 01122345677888999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=281.85 Aligned_cols=239 Identities=26% Similarity=0.355 Sum_probs=190.9
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|++.+.||+|+||.||++... +++.+++|.+...... ......+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence 5788999999999999999754 6789999987653322 223445778999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 574 DYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 574 e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||+++++|.+++..+ ..++.++++||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 999999999988551 257789999999999998 99999999999999999999999999876544
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. .....++..|++||.+.+..++.++|+||||+++|||++|+.||...+. .++...+
T Consensus 156 ~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------------------~~~~~~~ 213 (256)
T cd08530 156 NM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------------------QDLRYKV 213 (256)
T ss_pred CC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------------HHHHHHH
Confidence 31 1134578899999999988899999999999999999999999854321 0011111
Q ss_pred c-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 D-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. ..... ........+..++.+|++.+|++||++.|++++
T Consensus 214 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 214 QRGKYPP---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hcCCCCC---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 11111 112344567888999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=327.01 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=193.8
Q ss_pred HHHhcCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 489 LAAATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 489 l~~~~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
+...+-++.....||.|.||.||-+. .++|...|+|-++..... ......+.+|+.++..|+|||+|+++|+-.+.+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe 1307 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE 1307 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHH
Confidence 33445567777899999999999996 567888999976544332 222345789999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
..+|.||||++|+|.+++..- +.+..|++.|++|||+.+ ||||||||+||||+.+|.+|+.|||.|...
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 999999999999999998642 246789999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCc--ccccccCcCccCccccCCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 640 PESERDFR--PMKAAGTVGYIDPEYYGLN---VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 640 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
.....+.. -....||+.|||||++.+. ....+.||||+|||++||+||++||...+. .|+.-+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy--- 1452 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMY--- 1452 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHh---
Confidence 55532221 1135799999999999654 345689999999999999999999965443 121111
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+--... |+ .+..+..+=.+++.+||+.||++|.++.|++++
T Consensus 1453 ----~V~~gh~--Pq-~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 ----HVAAGHK--PQ-IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----HHhccCC--CC-CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111111 11 122355666788999999999999888876654
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=290.49 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=184.5
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~ 569 (789)
.++|++.+.||+|+||.||++... +++.||+|.++...... .....+.+|+.++++++|+||+++++++.+. +..
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD--GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC--CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 367999999999999999999864 58999999875432211 1122356799999999999999999998765 468
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++ +|.+++... ..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999999975 787776532 358899999999999999 9999999999999999999999999987654
Q ss_pred CCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhhhhhh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIMAGEL 717 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~ 717 (789)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|++||...+......... ...+..... ...
T Consensus 160 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (309)
T cd07845 160 LPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW-PGF 236 (309)
T ss_pred CccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc-hhh
Confidence 332111 12345788999999865 567899999999999999999999986443211000000 000000000 000
Q ss_pred HHhhc-c--cCCCC--CCCH---HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILD-R--RVGPP--EINE---AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d-~--~~~~~--~~~~---~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... . .+... .... ......+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000 0 00000 0000 1124456678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=296.93 Aligned_cols=270 Identities=22% Similarity=0.286 Sum_probs=191.4
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|.+.+.||+|+||.||++.. .+++.|+||.+....... .....+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR--IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc--chhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45799999999999999999985 468899999876432211 22335678999999999999999999886542
Q ss_pred -eEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 -ERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 -~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..+++|||+. ++|.+++... ..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 4799999996 5888887542 357889999999999998 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc--cccccchh----hh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP--VSLVDFAV----PA 711 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~----~~ 711 (789)
...... ......++..|+|||.+.. ..++.++||||||+++|||++|++||...+...... ........ ..
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 543321 1123457889999998864 468899999999999999999999985432100000 00000000 00
Q ss_pred hhhhhhHHhhcccCCCCC----CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHHhhh
Q 045256 712 IMAGELVKILDRRVGPPE----INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN--LERALDI 770 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~----~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~~ 770 (789)
.......+.++.....+. .........+.+++.+||+.||++|||++|++++ ++.+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 001111111111000000 0011234556788999999999999999999998 6665443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=288.24 Aligned_cols=244 Identities=25% Similarity=0.391 Sum_probs=182.1
Q ss_pred CCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||++..++ ++.||||+++..... .....+..|+.++.++. ||||+++++++.+....++
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK---EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh---HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 578889999999999999998764 889999997643221 12334566777676664 9999999999999999999
Q ss_pred EEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+|||+++ +|.+++.. ...++.+++++|+|||+ .+ |+||||||+||+++.++.+||+|||++.....
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999864 66665533 23688999999999997 46 99999999999999999999999999875433
Q ss_pred CCCCCcccccccCcCccCccccCCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNV----LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
.... ....++..|+|||.+.... ++.++||||||+++|||++|+.||...... .+.+
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----------------~~~~ 228 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE----------------FEVL 228 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH----------------HHHH
Confidence 2211 1235678999999986553 788999999999999999999998532110 0111
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
...+......... .......+.+++.+||+.||++||++.+++++-
T Consensus 229 ~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 229 TKILQEEPPSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred HHHhcCCCCCCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 1222221111110 011234567788999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=290.76 Aligned_cols=195 Identities=27% Similarity=0.409 Sum_probs=156.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe----
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE---- 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 568 (789)
++|++.+.||+|+||.||++... +++.||||++....... .....+.+|++++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC--CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 57999999999999999999864 68899999875432211 112235689999999999999999999876543
Q ss_pred ----EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeecc
Q 045256 569 ----RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635 (789)
Q Consensus 569 ----~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 635 (789)
.++||||+.+ +|.+++... ..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 4999999975 888776543 357889999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCCC--cccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 636 SMMGPESERDF--RPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 636 s~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
+.......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 87654332211 11234567899999988654 4688999999999999999999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=290.59 Aligned_cols=258 Identities=19% Similarity=0.293 Sum_probs=181.8
Q ss_pred ceEeec--ccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 500 NKIGAG--SFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 500 ~~LG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
+.||+| +|++||++.+. +++.||+|++...... .+..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 456666 99999999864 7899999987643322 233457889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 577 KNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 577 ~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999988642 157889999999999998 9999999999999999999999998653221111100
Q ss_pred -----cccccccCcCccCccccCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc----------ccchh
Q 045256 647 -----RPMKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL----------VDFAV 709 (789)
Q Consensus 647 -----~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~----------~~~~~ 709 (789)
......++..|+|||++.+. .++.++||||||+++|||++|+.||............+ ..+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 01112345679999999663 47889999999999999999999986432210000000 00000
Q ss_pred h--hh----------------hhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 710 P--AI----------------MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 710 ~--~~----------------~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
. .. .......+.+..+. ..........+.+|+.+||+.||++|||+.|++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred hhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence 0 00 00000000001111 111234456778899999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=284.62 Aligned_cols=252 Identities=22% Similarity=0.262 Sum_probs=181.4
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeC--CeEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEK--DERLL 571 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~~l 571 (789)
|++.+.||+|+||.||++... +++.||+|+++...... . .....+|+.++.++. ||||+++++++.+. +..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 567889999999999999854 68899999876432211 1 122457888898885 99999999999987 88999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||++ ++|.+++..+ ..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||++......
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 999997 4888877642 257889999999999998 999999999999999 99999999998764332
Q ss_pred CCCCcccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh--hhhhhHH
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI--MAGELVK 719 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 719 (789)
... ....++..|+|||.+. ...++.++||||||+++|||++|+.||...+..+ .+....... ....+..
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-----QIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-----HHHHHHHHcCCCCHHHHH
Confidence 211 1245788999999764 4567889999999999999999999996543211 000000000 0000000
Q ss_pred hhccc----CCCCCC-------CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRR----VGPPEI-------NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~----~~~~~~-------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+... ...+.. ........+.+++.+||+.||++||++.|++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred hhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000 000000 011335677889999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=286.27 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=183.8
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc---CCCcceEEEEEEEeCCe---
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL---HHKHLVRLVGYCEEKDE--- 568 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~~~~--- 568 (789)
|++.+.||+|+||.||++..+ +++.|++|++...... ......+.+|+.+++++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE--EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc--chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 567899999999999999976 4899999997643321 12223466777777666 59999999999998877
Q ss_pred --EEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 569 --RLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 569 --~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
.+++|||+++ +|.+++... ..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 888877542 247889999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch---hhh-h
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA---VPA-I 712 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~---~~~-~ 712 (789)
......... ....++..|+|||.+.+..++.++||||||+++|||++|++||....+..... ...+.. ... .
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD-KIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH-HHHHHcCCCChHhc
Confidence 764333211 12346889999999998889999999999999999999998886543211000 000000 000 0
Q ss_pred hhhh--hHHhhcccCC-CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGE--LVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~--~~~~~d~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... ....+..... .......+....+.+++.+||+.||++||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0000 0000000000 0011112334566788999999999999999998853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-33 Score=297.55 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=188.0
Q ss_pred CCccccceEeecccEEEEEEEeCCCcE-EEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQE-VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~-vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|.++..||.|+||.||++..++... .|-|.+.... .+..++|.-||+||....||+||+|++.|+-.+.++++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks----eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS----EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc----hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 456677889999999999998765443 4556554322 34456788999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
.|||.||-....+-+.. -+..+++.||.|||++. |||||||..|||++.+|.++|+|||.+......
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t- 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST- 183 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-
Confidence 99999999888765432 46789999999999999 999999999999999999999999998542111
Q ss_pred CCCcccccccCcCccCcccc-----CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 644 RDFRPMKAAGTVGYIDPEYY-----GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
......+.||++|||||+. ...+|+.++||||||++|.||..+.+|-..-+. +. -+.
T Consensus 184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----MR------------Vll 245 (1187)
T KOG0579|consen 184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MR------------VLL 245 (1187)
T ss_pred -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----HH------------HHH
Confidence 1122357899999999976 567899999999999999999999988533221 10 011
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
++. +.-++.-..+......+.+++.+||.+||+.||++.+++++
T Consensus 246 Kia-KSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 246 KIA-KSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHh-hcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 111 11122222344556778889999999999999999998864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=290.74 Aligned_cols=260 Identities=18% Similarity=0.208 Sum_probs=183.1
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.+.+|.|+++.||++.. +++.||+|++..... ..+....+.+|++++++++||||+++++++.+.+..+++|||++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 345556666666666655 689999999765321 12344568999999999999999999999999999999999999
Q ss_pred CCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC--
Q 045256 578 NGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD-- 645 (789)
Q Consensus 578 ~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~-- 645 (789)
+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999998642 257889999999999998 999999999999999999999999988643322111
Q ss_pred ---CcccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc-------cc-cchhhhh
Q 045256 646 ---FRPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS-------LV-DFAVPAI 712 (789)
Q Consensus 646 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~-------~~-~~~~~~~ 712 (789)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||............ .. ....+..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence 11123456788999999865 35788999999999999999999999653321000000 00 0000000
Q ss_pred hhhhhHH----hhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 713 MAGELVK----ILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 713 ~~~~~~~----~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
...... ..+. ...............+.+++.+||..||++|||++|++++-
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p 296 (314)
T cd08216 240 -EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296 (314)
T ss_pred -cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence 000000 0000 00011111223345677889999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=285.29 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=189.2
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|++.+.||+|++|.||++... +++.+++|++....... .....+.+|++++++++||||+++++++.+.+..++++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence 566789999999999999864 68899999876543221 233457889999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 575 YMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 575 ~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|+++ +|.+++... ..++.+++++|.|||+.+ |+|+||||+||+++.++.+||+|||.+.........
T Consensus 79 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~ 154 (283)
T cd05118 79 FMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154 (283)
T ss_pred ccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc
Confidence 9976 888877653 257889999999999998 999999999999999999999999998765443311
Q ss_pred CcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc--cchhhhhhh-------h
Q 045256 646 FRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV--DFAVPAIMA-------G 715 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~-------~ 715 (789)
.....++..|+|||.+... .++.++|+||||+++|+|++|+.||...+.......... ....+.... .
T Consensus 155 --~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 155 --YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred --ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 1224577899999998766 789999999999999999999999855432110000000 000000000 0
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 716 ELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 716 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+...........+....+.+++.+||+.||.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000000000011123456678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=280.02 Aligned_cols=236 Identities=23% Similarity=0.308 Sum_probs=178.0
Q ss_pred hcCCccccceE--eecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCC
Q 045256 492 ATNNFSLENKI--GAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKD 567 (789)
Q Consensus 492 ~~~~~~~~~~L--G~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 567 (789)
..++|++.+.+ |+|+||.||++.. .+++.+++|.+....... .|+.....+ +||||+++++++...+
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 34566666665 9999999999985 467889999865432111 122222222 7999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMM 638 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~ 638 (789)
..++||||+++++|.+++... ..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++..
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 999999999999999998754 258899999999999998 99999999999999998 999999999865
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... ...++..|+|||.+....++.++||||||+++|||++|+.||....+.. .+ ...+.
T Consensus 160 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~------~~-------~~~~~ 220 (267)
T PHA03390 160 IGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE------LD-------LESLL 220 (267)
T ss_pred cCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch------hh-------HHHHH
Confidence 43221 2357899999999988889999999999999999999999996433211 00 01111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-HHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-MADIVA 762 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~ 762 (789)
......... .......+.+++.+||+.||.+||+ ++|+++
T Consensus 221 ~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 221 KRQQKKLPF----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HhhcccCCc----ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111111111 1134455677888999999999995 688875
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=283.04 Aligned_cols=236 Identities=24% Similarity=0.340 Sum_probs=175.7
Q ss_pred eEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHH---HHHhhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 501 KIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSEL---AFLSRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~---~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
+||+|+||.||++... +++.||+|.+........ .....+..|. +.++..+||||+++++++.+.+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 4899999999999864 588999998765332211 1111233333 3445568999999999999999999999999
Q ss_pred CCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcc
Q 045256 577 KNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP 648 (789)
Q Consensus 577 ~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~ 648 (789)
++++|.+++... ..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~ 152 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P 152 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence 999999887542 358889999999999988 9999999999999999999999999986543222 1
Q ss_pred cccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh-cccCC
Q 045256 649 MKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL-DRRVG 726 (789)
Q Consensus 649 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-d~~~~ 726 (789)
....|+..|+|||.+... .++.++||||||+++|||++|+.||........ ....+.. .....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~ 217 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---------------HEIDRMTLTMAVE 217 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch---------------HHHHHHhhccCCC
Confidence 234689999999998644 688999999999999999999999865422100 0000000 00111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.+. .....+.+++.+|+..+|++|| ++.|++++
T Consensus 218 ~~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 218 LPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 111 1234566778899999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=285.44 Aligned_cols=244 Identities=27% Similarity=0.383 Sum_probs=191.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 571 (789)
++|.+.+.||+|+||.||++... +++.|++|++....... ......+.+|++++++++ ||||+++++++.+.+..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 47889999999999999999865 68999999876533222 223356888999999998 9999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++.+. ..++.|++.+|+|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999998654 368889999999999998 9999999999999999999999999987543322
Q ss_pred CC------------------CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 045256 644 RD------------------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 644 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~ 705 (789)
.. .......++..|+|||.+....++.++||||||+++|||++|+.||....+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------- 228 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-------- 228 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--------
Confidence 11 1122345788999999998888999999999999999999999998643310
Q ss_pred cchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH----HHHHH
Q 045256 706 DFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTM----ADIVA 762 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~----~evl~ 762 (789)
.......+.....+. .....+.+++.+||+.||++||++ +++++
T Consensus 229 ---------~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 ---------LTFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---------HHHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 011111122111111 123456778889999999999999 77665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=287.85 Aligned_cols=265 Identities=24% Similarity=0.333 Sum_probs=185.2
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC--
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-- 567 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-- 567 (789)
...++|++.+.||+|+||.||++..+ +++.|++|+++...... .....+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~--~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE--GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc--CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 34568999999999999999999875 58899999876543221 22235778999999999999999999987655
Q ss_pred --------eEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEE
Q 045256 568 --------ERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630 (789)
Q Consensus 568 --------~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 630 (789)
..++|+||+++ +|.+++... ..++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999986 777766532 357889999999999998 999999999999999999999
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc--
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF-- 707 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~-- 707 (789)
+|||++......... ......++..|+|||.+.. ..++.++||||||+++|||++|++||...+..... ..+...
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~ 235 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCG 235 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhC
Confidence 999998765433321 1112345778999998854 45788999999999999999999998643321000 000000
Q ss_pred -hhh----hhhhhhhHHhhcccCCC-CC--CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 708 -AVP----AIMAGELVKILDRRVGP-PE--INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 708 -~~~----~~~~~~~~~~~d~~~~~-~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.+ ...........+..... .. .........+.+++.+||+.||++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00000000000000000 00 0000123456788889999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-31 Score=285.16 Aligned_cols=238 Identities=28% Similarity=0.419 Sum_probs=183.2
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|...+.||+|+||.||++... +++.|++|++....... ......+.+|++++++++|||++++++++.+.+..|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT-NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 566788999999999999864 68899999876433222 2233457889999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 575 YMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 575 ~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|+. ++|.+++... ..++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--- 174 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--- 174 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC---
Confidence 996 4787776432 247889999999999998 999999999999999999999999988642211
Q ss_pred CcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 646 FRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...+... .......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-----------------~~~~~~~ 234 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----------------ALYHIAQ 234 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-----------------HHHHHHh
Confidence 2346788999999984 4568889999999999999999999986543200 0001111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
... +..........+.+++.+||+.+|++||++.+++.+
T Consensus 235 ~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 NDS--PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 111111223456778899999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=287.54 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=184.9
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|+..+.||+|+||.||++... +++.+++|.+....... ......+.+|+++++.++|||++++++++......++|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34667788999999999999864 57889999875432221 22334577899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+. ++|.+++... ..++.+++.+|.|||+.+ ++|+||||+|||++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99997 5887766421 256789999999999998 999999999999999999999999998654322
Q ss_pred CCCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
....++..|+|||.+. ...++.++||||||+++|||++|+.||...+.. ......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------------~~~~~~ 226 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----------------SALYHI 226 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----------------HHHHHH
Confidence 1345788999999874 356788999999999999999999998543210 000111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
...... ..........+.+++.+||..+|++||++.+++++..
T Consensus 227 ~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 227 AQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred hhcCCC--CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 111111 1111223455678899999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=295.91 Aligned_cols=265 Identities=20% Similarity=0.285 Sum_probs=188.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----CCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----KDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~ 568 (789)
++|++.+.||+|+||.||++... +++.|++|++...... ......+.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc--ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 68999999999999999999854 6899999987643221 1223457789999999999999999998763 345
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.++||||+. ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 799999996 5888887532 357889999999999998 9999999999999999999999999986543
Q ss_pred CCCCC--CcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc--cccccchhh----h
Q 045256 641 ESERD--FRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP--VSLVDFAVP----A 711 (789)
Q Consensus 641 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~----~ 711 (789)
..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...+...... ......+.+ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 11123468899999998855 468899999999999999999999996543210000 000000000 0
Q ss_pred hhhhhhHHhhcccCCCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.....+.+..+.......... ......+.+++.+||+.||++||++.+++.+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 011112222211111111100 12345678889999999999999999988853
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=291.13 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=188.0
Q ss_pred HHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-CC
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-KD 567 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 567 (789)
....++|++.+.||+|+||.||++... +++.|++|++...... ......+.+|++++++++||||+++++++.. ..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 446789999999999999999999754 7899999987543221 1223457789999999999999999999876 45
Q ss_pred eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
..++++||+. ++|.++++.. ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred cEEEEeehhc-cCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 6889999984 5888887542 257889999999999998 9999999999999999999999999987532
Q ss_pred CCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc--cccccchhh----hhh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP--VSLVDFAVP----AIM 713 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~----~~~ 713 (789)
... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||.......... ......+.. ...
T Consensus 160 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 160 PQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 211 13356789999998765 578999999999999999999999985432100000 000000000 000
Q ss_pred hhhhHHhhccc-CCCCCCCH---HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRR-VGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~-~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+.+... ...+.... ......+.+++.+||+.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00111111110 00000000 1123567788999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=290.51 Aligned_cols=271 Identities=20% Similarity=0.267 Sum_probs=191.3
Q ss_pred HHHHHHHHHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEE
Q 045256 483 EFLLAELAAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVG 561 (789)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 561 (789)
.....++....++|++.+.||+|+||.||++.. .+++.||+|++...... ....+.+.+|++++++++||||+++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh--hHHHHHHHHHHHHHHHcCCCcccceee
Confidence 344566777889999999999999999999975 47889999987653221 122345778999999999999999999
Q ss_pred EEEeC------CeEEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcE
Q 045256 562 YCEEK------DERLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA 628 (789)
Q Consensus 562 ~~~~~------~~~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 628 (789)
++... ...++++|++ +++|.+++.. ...++.|+++||+|||+.+ |+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 88643 3367888876 6788887653 2357889999999999998 9999999999999999999
Q ss_pred EEEeeccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--ccc
Q 045256 629 RVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--SLV 705 (789)
Q Consensus 629 kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--~~~ 705 (789)
||+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+....... ...
T Consensus 160 kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999987533221 23467889999998865 5688899999999999999999999854332100000 000
Q ss_pred cchhhhh----hhhhhHHhhcc--cCCCCCCC--HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 706 DFAVPAI----MAGELVKILDR--RVGPPEIN--EAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 706 ~~~~~~~----~~~~~~~~~d~--~~~~~~~~--~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
....+.. ........+.. ..+..... .......+.+++.+|++.||++||++.+++++=
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000 00000011100 00000000 001234567888999999999999999998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=312.19 Aligned_cols=140 Identities=27% Similarity=0.419 Sum_probs=123.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||++.+. +++.||||+++...... ......+.+|+.++..++||||+++++++...+..|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMIN-KNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccC-HHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 67999999999999999999875 68899999976543222 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 573 YDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
|||+++++|.+++.. ...++.|++.||+|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999864 2368889999999999998 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-33 Score=281.51 Aligned_cols=235 Identities=25% Similarity=0.337 Sum_probs=185.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 571 (789)
.+|..+.+||+|+||.|-++..+ +.+.||||++++.......+ .+--..|-++|... +-|.++.+..+|+..+.+|+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDD-vectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDD-VECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCc-ccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 46888999999999999999754 35679999988755433222 22334566777666 57899999999999999999
Q ss_pred EEEecCCCchhHHHhhhch--------HHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDRNN--------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~~--------i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+.+|+|.-++++..+ ++..||-||-|||+.+ |++||||.+|||||.+|++||+|||+++..-...
T Consensus 428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCC
Confidence 9999999999988876553 5778999999999999 9999999999999999999999999997533222
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
..+.+.+||+.|+|||++...+|+..+|+|||||+|||||.|++||.++++. +-...+.+.
T Consensus 505 --~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-----------------elF~aI~eh 565 (683)
T KOG0696|consen 505 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----------------ELFQAIMEH 565 (683)
T ss_pred --cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-----------------HHHHHHHHc
Confidence 2344689999999999999999999999999999999999999999877651 112333344
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERP 755 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP 755 (789)
...-|.....|+. .+.+..+.+.|.+|.
T Consensus 566 nvsyPKslSkEAv----~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 NVSYPKSLSKEAV----AICKGLLTKHPGKRL 593 (683)
T ss_pred cCcCcccccHHHH----HHHHHHhhcCCcccc
Confidence 4444444444444 345557778888885
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=298.04 Aligned_cols=265 Identities=22% Similarity=0.346 Sum_probs=193.1
Q ss_pred ccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC------e
Q 045256 496 FSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD------E 568 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------~ 568 (789)
+...+.||+|+||.||++++ +.|+.||||.+......+ ..+...+|+++|++|+|||||++++.-++.. .
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r---~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR---PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccc---hHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34568899999999999994 579999999877644322 2345789999999999999999999865543 5
Q ss_pred EEEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC----CCCcEEEEee
Q 045256 569 RLLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD----AQWTARVSDF 633 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~----~~~~~kl~Df 633 (789)
..+|||||.+|||...|.+- ..+..++..||.|||+++ |+||||||.||++- ..--.||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecc
Confidence 68999999999999999642 257788999999999999 99999999999982 2335799999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC-cccccccc---h
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG-TPVSLVDF---A 708 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~-~~~~~~~~---~ 708 (789)
|.|+...+.. ......||..|.+||.+.. +.|+..+|.|||||++||..||..||........ ....+... +
T Consensus 169 G~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp 245 (732)
T KOG4250|consen 169 GAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP 245 (732)
T ss_pred cccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence 9999766554 3346789999999999984 8899999999999999999999999964432110 00000000 0
Q ss_pred hhhhh--hhhhHHhh--cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC--CHHHHHHHHHHHhh
Q 045256 709 VPAIM--AGELVKIL--DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP--TMADIVANLERALD 769 (789)
Q Consensus 709 ~~~~~--~~~~~~~~--d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP--t~~evl~~L~~~~~ 769 (789)
..... ..+...-+ ...++.+..........+..++..+|..+|++|- ...+....+..++.
T Consensus 246 ~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 246 SGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred CceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 00000 00000000 1123333333444455566677778899999998 77788777777764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-33 Score=314.17 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=194.3
Q ss_pred HHHHHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE
Q 045256 486 LAELAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564 (789)
Q Consensus 486 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 564 (789)
..++....++|.++++||+|+||.|..++.+ +++.||+|++.+-...+ ......|..|-.+|..-+.+-|+.|.-.|+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 4556666789999999999999999999875 57899999976633322 222346899999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhhch--------HHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDRNN--------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
+++++|||||||+||+|..+|.+..+ +...+..||.-||+.+ +|||||||+|||||..|++||+|||.+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999999987654 3445667999999999 999999999999999999999999988
Q ss_pred cCCCCCCCCCcccccccCcCccCccccC----C-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYG----L-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
..+.... .......+|||.|.+||++. + +.|...+|+||+||++||||.|..||+.+.-.
T Consensus 223 lkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv-------------- 287 (1317)
T KOG0612|consen 223 LKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV-------------- 287 (1317)
T ss_pred HhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH--------------
Confidence 6554333 23344678999999999983 3 57899999999999999999999999865421
Q ss_pred hhhhhhHHhhcc--cCCCC--CCCHHHHHHHHHHHHHhhcCcCCCCCCC---HHHHHHHH
Q 045256 712 IMAGELVKILDR--RVGPP--EINEAEAVELVAYTAMHCVNLEGKERPT---MADIVANL 764 (789)
Q Consensus 712 ~~~~~~~~~~d~--~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt---~~evl~~L 764 (789)
+...++++. .+..| .....++..+|..|+ -+|+.|.. +.++..+-
T Consensus 288 ---eTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-----~~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 288 ---ETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-----CDREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ---HHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-----cChhhhcccccHHHHHhCc
Confidence 111222222 33333 222344444444332 57888887 88877654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=288.33 Aligned_cols=265 Identities=20% Similarity=0.233 Sum_probs=183.8
Q ss_pred CCcc-ccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHH----------HHHHHHHHHHHHHhhcCCCcceEEEE
Q 045256 494 NNFS-LENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQ----------EKESAFDSELAFLSRLHHKHLVRLVG 561 (789)
Q Consensus 494 ~~~~-~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~----------~~~~~~~~E~~~l~~l~HpnIv~l~~ 561 (789)
++|. +.+.||+|+||.||++... +++.||+|.+......... .....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4577999999999999864 6889999987543222110 00124678999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 562 YCEEKDERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 562 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
++...+..++||||++ ++|.+++..+ ..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCc
Confidence 9999999999999997 5899888543 258889999999999998 999999999999999999999999
Q ss_pred ccCcCCCCCC------------CCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 045256 634 GLSMMGPESE------------RDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700 (789)
Q Consensus 634 Gls~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~ 700 (789)
|++....... .........++..|+|||.+.+. .++.++||||||+++|||++|++||...++....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987543111 00111123467889999998654 4689999999999999999999998654421100
Q ss_pred ccccc--cchhhhhhhhhhHHhh--cccCC-CCCCC---HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 701 PVSLV--DFAVPAIMAGELVKIL--DRRVG-PPEIN---EAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 701 ~~~~~--~~~~~~~~~~~~~~~~--d~~~~-~~~~~---~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... .-+...... ...... ..... .+... .......+.+++.+||+.||++||++.|++.+
T Consensus 244 ~~i~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 244 GRIFELLGTPNEDNWP-QAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHhCCCchhhCc-chhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 00000 000000000 000000 00000 00000 01123456788999999999999999999874
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=290.79 Aligned_cols=267 Identities=23% Similarity=0.284 Sum_probs=192.1
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-----e
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-----E 568 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~ 568 (789)
+|++.+.||+|+||.||++... +++.|++|++..... .....+.+.+|+.++++++||||+++++++...+ .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 5888999999999999999865 488999998765322 1223346889999999999999999999998775 7
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.|++|||+++ +|.+++... ..++.++++||+|||+.+ |+|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 8999999985 888887653 358889999999999998 9999999999999999999999999987644
Q ss_pred CCCCC-CcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhh----h
Q 045256 641 ESERD-FRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPA----I 712 (789)
Q Consensus 641 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~----~ 712 (789)
..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......... ...+.+. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 43210 111234578899999999877 88999999999999999999999986543210000000 0000000 0
Q ss_pred hhhhhHHhhcccCCCCCC----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHH
Q 045256 713 MAGELVKILDRRVGPPEI----NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN--LERA 767 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 767 (789)
......+.+......... ........+.+++.+||+.||++||++.+++++ ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000011111100000000 011134556788999999999999999999986 5554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=290.70 Aligned_cols=267 Identities=20% Similarity=0.284 Sum_probs=188.0
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|.+.+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS--EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc--ccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 478999999999999999999854 6899999987643211 122335788999999999999999999987543
Q ss_pred --eEEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 568 --ERLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 568 --~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
..++|+||+.. +|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred CceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 46899999975 77765432 2357889999999999998 999999999999999999999999998754
Q ss_pred CCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhh---
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIM--- 713 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~--- 713 (789)
.... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||...+......... .....+...
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 168 DAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 3221 13456889999999865 468899999999999999999999996543110000000 000000000
Q ss_pred -hhhhHHhhcccCCCCCCC-H---HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHHhhh
Q 045256 714 -AGELVKILDRRVGPPEIN-E---AEAVELVAYTAMHCVNLEGKERPTMADIVAN--LERALDI 770 (789)
Q Consensus 714 -~~~~~~~~d~~~~~~~~~-~---~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~~~ 770 (789)
.......++.....+... . ......+.+++.+||+.||++||++.|++.+ ++...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000000000000000 0 0123446678899999999999999999976 7776543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=288.77 Aligned_cols=262 Identities=20% Similarity=0.280 Sum_probs=186.1
Q ss_pred HHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD- 567 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 567 (789)
....++|++.+.||+|+||.||++.. .+++.||||++..... .......+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34568899999999999999999975 4688999998754221 1222345779999999999999999999987643
Q ss_pred -----eEEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeecc
Q 045256 568 -----ERLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635 (789)
Q Consensus 568 -----~~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 635 (789)
..++||||+ +++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999999 6688887753 2357899999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch------
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA------ 708 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~------ 708 (789)
+....... ....+++.|+|||.+.. ..++.++|+||||+++|+|++|+.||...+..... .......
T Consensus 165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL-MEIMKVTGTPSKE 238 (343)
T ss_pred ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHH
Confidence 87543221 13456889999998865 45889999999999999999999998643321000 0000000
Q ss_pred -hhhhhhhhhHHhhccc--CCCCC--CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 -VPAIMAGELVKILDRR--VGPPE--INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 -~~~~~~~~~~~~~d~~--~~~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+............ ..... .........+.+++.+|++.||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 00000 0001123346688999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=270.58 Aligned_cols=242 Identities=24% Similarity=0.308 Sum_probs=178.6
Q ss_pred cccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEEE
Q 045256 497 SLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
+-+..||.|.||+|+|-.++ .|+..|||+++.....+ ...++..|.+...+- +.||||+++|.+..++.-|+.||
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~k---eq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEK---EQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchH---HHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 33567999999999999764 69999999987765533 234577777665554 79999999999999999999999
Q ss_pred ecCCCchhHHHh---h--hchHHHH--------HHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 575 YMKNGALYDHLH---D--RNNVEKN--------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 575 ~~~~gsL~~~l~---~--~~~i~~~--------ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
.|+- +|..+-+ . ..++.++ ..+||.||.+... |+|||+||+|||||..|.+||+|||++-.+..
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9965 6654432 1 1223333 4679999987654 99999999999999999999999999865443
Q ss_pred CCCCCcccccccCcCccCccccC--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYG--LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
+- ......|-..|||||.+. ...|+-+|||||||++|||+.||+.|+..++. ..+.+..
T Consensus 221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----------------vfeql~~ 281 (361)
T KOG1006|consen 221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----------------VFEQLCQ 281 (361)
T ss_pred HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----------------HHHHHHH
Confidence 32 223457889999999994 33589999999999999999999999865543 1122333
Q ss_pred hhcccCCC--CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGP--PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
++....+. ......+....+.+++.-|+.+|.+.||...++.+.
T Consensus 282 Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 282 VVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 33222111 111112345567788889999999999999988764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=285.30 Aligned_cols=265 Identities=24% Similarity=0.304 Sum_probs=182.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|++.+.||+|+||.||++... +++.+++|++....... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD--GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC--CcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 468999999999999999999864 68899999875433211 11224678999999999999999999875533
Q ss_pred ----eEEEEEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 568 ----ERLLVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 568 ----~~~lv~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
..++|+||++. +|.+.+.. ...++.|++++|+|||+.+ |+|+||||+|||+++++.+||+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 67666543 2358889999999999998 9999999999999999999999999
Q ss_pred cCcCCCCCCCCC---------cccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 045256 635 LSMMGPESERDF---------RPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 635 ls~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~ 704 (789)
++.......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|++||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 987543322111 1122356788999998754 457899999999999999999999986433210000000
Q ss_pred --ccchhhhhh--hhhhHHhhc-ccC-CCCCCCH---HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 705 --VDFAVPAIM--AGELVKILD-RRV-GPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 705 --~~~~~~~~~--~~~~~~~~d-~~~-~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+... ...+....+ ... ..+.... ......+.+++.+||+.||++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000000 000000000 000 0000000 1122456788999999999999999998763
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=286.22 Aligned_cols=237 Identities=23% Similarity=0.365 Sum_probs=186.8
Q ss_pred cceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 499 ENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
.++||+|.||+||-|++ ++|+.||||++.+.+....+ ++.+++|+.||++++||.||.|.-.|+.++..++|||.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCch--HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 48999999999999986 47999999998876655433 3579999999999999999999999999999999999995
Q ss_pred CCchhHHHh-h-h--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC---CcEEEEeeccCcCCCCCCC
Q 045256 578 NGALYDHLH-D-R--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGLSMMGPESER 644 (789)
Q Consensus 578 ~gsL~~~l~-~-~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGls~~~~~~~~ 644 (789)
+ ++.+.+- . . +-+..||+.||.|||.++ |+|+||||+||||... -++||+|||+++.+.+...
T Consensus 647 G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 647 G-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred c-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 5 7666552 1 1 236789999999999999 9999999999999543 5899999999998766543
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
. ...+||+.|+|||+++++.|+..-|+||.|||+|--|+|..||..+++..+ .+.+..
T Consensus 723 R---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd-------------------QIQNAa 780 (888)
T KOG4236|consen 723 R---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND-------------------QIQNAA 780 (888)
T ss_pred h---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH-------------------Hhhccc
Confidence 2 257899999999999999999999999999999999999999976554111 111112
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..-+.....|....-.+||...|+..-++|-+....+.+
T Consensus 781 FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 781 FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 222233344444444556666778888888888765543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=279.31 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=183.6
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~ 573 (789)
|++.+.||+|+||+||+|... +++.|+||++...... .......+|+..+++++ ||||+++++++.+.+..++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence 567899999999999999875 4788999987543221 11223457899999998 999999999999999999999
Q ss_pred EecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 574 DYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||+ +++|.+++... ..++.|++++|.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 78 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 78 EYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred ecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 999 77999887643 247789999999999998 9999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--ccccchhhhhh--hhhhH
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--SLVDFAVPAIM--AGELV 718 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--~~~~~~~~~~~--~~~~~ 718 (789)
. .....++..|+|||.+. ...++.++|+||||+++|||++|++||........... ...+.+..... ...+.
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 P---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred C---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 1 12345788999999874 45678999999999999999999999854432110000 00000000000 00000
Q ss_pred HhhcccCCCCCC-CHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEI-NEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~-~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+..+..... ... .....+.+++.+||+.||++||+++|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 011111110000 000 113457788999999999999999998764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=277.45 Aligned_cols=243 Identities=24% Similarity=0.331 Sum_probs=183.1
Q ss_pred CccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhH-HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKF-QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+|.+.+.||+|+||.||++.... +..+++|.++....... ......+..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58889999999999999997643 44566665443222111 12233466799999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 573 YDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|||+++++|.+++.+. ..++.|+++||+|||+.+ ++|+||||+||+++. +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887531 257789999999999998 999999999999975 569999999987643
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......++..|+|||.+....++.++|+||||+++|+|++|..||..... .......
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----------------~~~~~~~ 217 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----------------LSVVLRI 217 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------------HHHHHHH
Confidence 3222 12234578899999999888889999999999999999999999843211 0011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...... ..+......+.+++.+||..||++||++.|++++
T Consensus 218 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 VEGPTP---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred HcCCCC---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111111 1122344566778899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=280.41 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=186.8
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|++.+.||+|.||.||++... +++.|++|.+...... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc--ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence 566788999999999999865 5899999987654311 1223457789999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 575 YMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 575 ~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|+++ +|.+++... ..++.+++++|+|||+.+ |+|+||+|+||++++++.+||+|||++.........
T Consensus 79 ~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 79 YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred CcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 9984 999988654 357889999999999998 999999999999999999999999998765433221
Q ss_pred CcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhhhhhhHHh--
Q 045256 646 FRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIMAGELVKI-- 720 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-- 720 (789)
......+..|+|||.+... .++.++||||||+++|||++|++||............. .....+... .....+
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 231 (282)
T cd07829 155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW-PGVTKLPD 231 (282)
T ss_pred --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHH-Hhhccccc
Confidence 1223457789999998766 78999999999999999999998885543210000000 000000000 000000
Q ss_pred hcccCCCCCCC-----HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEIN-----EAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~-----~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+...+..... .......+.+++.+||..||++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000000 01123457788999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=285.84 Aligned_cols=263 Identities=21% Similarity=0.260 Sum_probs=181.5
Q ss_pred CccccceEeecccEEEEEEEeC-C--CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeC----
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-D--GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~--g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~---- 566 (789)
+|++.+.||+|+||.||++... . ++.||+|++...... ......+.+|+++++++ +||||+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 78 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF 78 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence 4788899999999999999864 3 678999987543221 12234577899999999 599999999875432
Q ss_pred CeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...++++||+. ++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 79 NELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred CcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 45788899986 5888887532 357899999999999998 99999999999999999999999999975
Q ss_pred CCCCCCC--CcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccch----h
Q 045256 639 GPESERD--FRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFA----V 709 (789)
Q Consensus 639 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~----~ 709 (789)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||...+......... ...+ .
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 4332211 11123468899999998755 568999999999999999999999986533210000000 0000 0
Q ss_pred hhhhhhhhHHhhcccCCCCCC----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 710 PAIMAGELVKILDRRVGPPEI----NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 710 ~~~~~~~~~~~~d~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..................+.. ........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000000000000 000123456788999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=303.40 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=195.4
Q ss_pred hcCCccccceEeecccEEEEEEEeC----C----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP----D----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGY 562 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~----~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 562 (789)
..++..+.+.||+|.||.|++|... . ...||||.++..... ...+.+..|+++|+.+ +||||+.++|+
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3344556679999999999999742 1 457999987654433 3455799999999999 69999999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhhc------------------------hHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDRN------------------------NVEKNAARGIEYLHNYAVPPIIHRDIKSS 618 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 618 (789)
|......++|+||++.|+|.++|++.+ .++.|||+|++||++.. ++||||-.+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997655 47889999999999998 999999999
Q ss_pred CEEECCCCcEEEEeeccCcCCCCCCCCCcccccc--cCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 045256 619 NILLDAQWTARVSDFGLSMMGPESERDFRPMKAA--GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDD 695 (789)
Q Consensus 619 NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~ 695 (789)
|||+.++..+||+|||+++........... ... -...|||||.+....++.|+|||||||+||||+| |..|+....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999999865444332211 112 2456999999999999999999999999999999 566653211
Q ss_pred CCCCcccccccchhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 696 ESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
. ..++.+.+.. ++..|.....+ +..+++.||+.+|++||++.|+++.|+..+.
T Consensus 527 ~-----------------~~~l~~~l~~G~r~~~P~~c~~e----iY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 P-----------------TEELLEFLKEGNRMEQPEHCSDE----IYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred c-----------------HHHHHHHHhcCCCCCCCCCCCHH----HHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 0 1111222222 44555555444 4566778999999999999999999999654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=272.91 Aligned_cols=231 Identities=29% Similarity=0.386 Sum_probs=182.1
Q ss_pred EeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|+||.||++... +++.+++|++....... ......+.+|++++++++||||+++++.+...+..+++|||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 689999999999865 58899999876543322 2234568899999999999999999999999999999999999999
Q ss_pred hhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccc
Q 045256 581 LYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA 652 (789)
Q Consensus 581 L~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~ 652 (789)
|.+++... ..++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||++........ ......
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFC 154 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCc
Confidence 99998643 257889999999999988 99999999999999999999999999876433221 122346
Q ss_pred cCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCH
Q 045256 653 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINE 732 (789)
Q Consensus 653 gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 732 (789)
++..|++||.+.....+.++|+||||+++|||++|+.||...+. ......+....+..+...
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~- 216 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----------------KEIYEKILKDPLRFPEFL- 216 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHhcCCCCCCCCC-
Confidence 78899999999888889999999999999999999999854321 001111122222222221
Q ss_pred HHHHHHHHHHHHhhcCcCCCCCCCHHH
Q 045256 733 AEAVELVAYTAMHCVNLEGKERPTMAD 759 (789)
Q Consensus 733 ~~~~~~l~~l~~~cl~~dp~~RPt~~e 759 (789)
...+.+++.+||..||++||++.+
T Consensus 217 ---~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 ---SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CHHHHHHHHHHhcCCHhhCCCccc
Confidence 345567888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.66 Aligned_cols=234 Identities=24% Similarity=0.351 Sum_probs=187.8
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
.++.|.+...+|.|+|+.|-++.. .+++..++|++..... +..+|+.++.+. +||||+++.+.+.+..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~--------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD--------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc--------ccccccchhhhhcCCCcceeecceecCCcee
Confidence 356788888899999999999975 4678999999765421 134577666666 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE-CCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL-DAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfGls~~~~~ 641 (789)
|+|||++.++-|.+.+.. ...++.+|+.++.|||+++ +|||||||+|||+ +..++++|+|||.++....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999999988877643 2248889999999999999 9999999999999 5889999999999986544
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
. ..+.+-|..|.|||++....|+.++||||||++|||||+|+.||...... .++.
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----------------~ei~--- 523 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----------------IEIH--- 523 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----------------HHHH---
Confidence 4 23456789999999999999999999999999999999999999654431 0111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.++..+.. ........++|+.+||+.||.+||+|.++..+
T Consensus 524 -~~i~~~~~-s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 524 -TRIQMPKF-SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -HhhcCCcc-ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11222211 13445556778888999999999999998875
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=290.68 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=182.5
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
..+|++.+.||.|+||.||++... +++.|++|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 368999999999999999999864 688999998755432 2234578899999999999999999876553
Q ss_pred ---------CeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEE
Q 045256 567 ---------DERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTAR 629 (789)
Q Consensus 567 ---------~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 629 (789)
...++||||+++ +|.+++.+. ..++.|+++||+|||+.+ |+||||||+|||++ ++..+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 357899999974 888877532 357889999999999998 99999999999997 456789
Q ss_pred EEeeccCcCCCCCCCCC-cccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 045256 630 VSDFGLSMMGPESERDF-RPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF 707 (789)
Q Consensus 630 l~DfGls~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 707 (789)
|+|||++.......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||....+.......+...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 235 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV 235 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999987543221111 1112357889999998644 567889999999999999999999996543211000000000
Q ss_pred hh--hhhhh---hhhHHhhcccCCCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 708 AV--PAIMA---GELVKILDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 708 ~~--~~~~~---~~~~~~~d~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+. +.... ..+............... ......+.+++.+||..||++||++.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 00000 000000000000000000 1123456678999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=275.52 Aligned_cols=254 Identities=23% Similarity=0.390 Sum_probs=189.3
Q ss_pred CCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHH---HHHHHHHHHHHHHhhcCCCcceEEEEEEE-eCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQ---EKESAFDSELAFLSRLHHKHLVRLVGYCE-EKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 568 (789)
++|-++.+||+|+|+.||++. +...+.||+|+-...+..+.+ .......+|.+|.+.|.||.||+++++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 578889999999999999997 456789999985443332222 22345678999999999999999999996 5566
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC---CCCcEEEEeeccCc
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD---AQWTARVSDFGLSM 637 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGls~ 637 (789)
++-|+|||++.+|.-+|+.. +.|+.||..||.||.+.. |||+|-||||.||||- .-|.+||+||||++
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 88999999999998888643 368899999999999987 8899999999999994 45789999999999
Q ss_pred CCCCCCCCC-----cccccccCcCccCccccCC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch
Q 045256 638 MGPESERDF-----RPMKAAGTVGYIDPEYYGL----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 638 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 708 (789)
.+....... .+....||..|++||.+.- ..++.|+||||.|||+|..+.|+.||....... .+
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----dI---- 693 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----DI---- 693 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----HH----
Confidence 876554432 2334679999999999843 357889999999999999999999995443210 00
Q ss_pred hhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+....+.+.-.-.+++.+ ........+|++||++.-++|....++..+
T Consensus 694 ---LqeNTIlkAtEVqFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 694 ---LQENTILKATEVQFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred ---HhhhchhcceeccCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 001111111111222222 222334567889999999999988877653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.53 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=186.9
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe--
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE-- 568 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~-- 568 (789)
..++|++.+.||+|+||.||+++.. +++.|++|++...... ......+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch--hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4578999999999999999999875 5789999987643211 2233457789999999999999999998876654
Q ss_pred ----EEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 569 ----RLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 569 ----~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.++|+||+ +++|.+++.. ...++.|++++|+|||+.+ |+|+||||+||+++.++.+||+|||++.
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999998 5699888754 2357889999999999998 9999999999999999999999999987
Q ss_pred CCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--ccccchhhhh--
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--SLVDFAVPAI-- 712 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--~~~~~~~~~~-- 712 (789)
...... ....++..|+|||.+.. ..++.++||||||+++|||++|+.||........... .....+.+..
T Consensus 167 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 167 HTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred cccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 543321 23457889999998854 4678999999999999999999999864432110000 0000000000
Q ss_pred --hhhhhHHhhcccCCCCC-CCH---HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 --MAGELVKILDRRVGPPE-INE---AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 --~~~~~~~~~d~~~~~~~-~~~---~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+........ ... ......+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 242 KISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00001111111000000 000 0124567788999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=273.77 Aligned_cols=200 Identities=28% Similarity=0.395 Sum_probs=164.5
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.-|..++.||-|+||+|.+++. ++...||+|.+++..... .........|-.||...+.+-||+|+-.|++++.+|+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4577788999999999999964 456679999877654433 33455678899999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc-------
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM------- 637 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~------- 637 (789)
|||+++|++..+|-+.. -++.++..|+++.|.++ +|||||||+|||||.+|++||+||||+.
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceeccc
Confidence 99999999999886543 34566778999999999 9999999999999999999999999963
Q ss_pred --CCCCCCCC-------------------------------CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHH
Q 045256 638 --MGPESERD-------------------------------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLEL 684 (789)
Q Consensus 638 --~~~~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~el 684 (789)
.+...+.. ......+||+.|+|||++....|+..+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 11111000 000123699999999999999999999999999999999
Q ss_pred HcCCCCCCCCCCC
Q 045256 685 LTGKRAIFKDDES 697 (789)
Q Consensus 685 ltG~~pf~~~~~~ 697 (789)
+.|++||..+...
T Consensus 865 ~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 865 LVGQPPFLADTPG 877 (1034)
T ss_pred hhCCCCccCCCCC
Confidence 9999999876653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=279.81 Aligned_cols=245 Identities=22% Similarity=0.282 Sum_probs=194.2
Q ss_pred cCCccccceEeecccEEEEEEEeCCCc-EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQ-EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~-~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++..+..||-|+||.|=+++.+... .+|+|++++....+. ...+.+..|-++|...+.|.||+++..|.+....|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt-kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT-KQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccch-hHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 345666788999999999999875433 489998877655443 345568889999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhhch--------HHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDRNN--------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~~--------i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
+||-|-+|.|+..|+++.. +..-+.+|++|||.++ ||+|||||+|.+||.+|-+||.|||+++.+....
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999999998764 4566889999999999 9999999999999999999999999998876654
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
+ +.+++||+.|.|||++.++..+.++|.||||+++||||+|++||...++. . .-..+.+-+|.
T Consensus 575 K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----k---------tYn~ILkGid~ 637 (732)
T KOG0614|consen 575 K---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----K---------TYNLILKGIDK 637 (732)
T ss_pred c---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----H---------HHHHHHhhhhh
Confidence 4 45789999999999999999999999999999999999999999765531 1 11111122222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
.- .| ....+.-.+|+++.+..+|.+|.- +.||.++
T Consensus 638 i~-~P----r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 638 IE-FP----RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hh-cc----cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11 11 112233345677788999999975 5555554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=264.93 Aligned_cols=212 Identities=22% Similarity=0.236 Sum_probs=164.1
Q ss_pred cccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCchhH
Q 045256 505 GSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYD 583 (789)
Q Consensus 505 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~ 583 (789)
|.|+.||++... +++.||+|++.... .+.+|...+....||||+++++++.+.+..+++|||+++++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 889999999864 68899999875432 13344555556679999999999999999999999999999999
Q ss_pred HHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCc
Q 045256 584 HLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655 (789)
Q Consensus 584 ~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~ 655 (789)
++.+. ..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||++....... ....++.
T Consensus 75 ~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~ 146 (237)
T cd05576 75 HISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVEN 146 (237)
T ss_pred HHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCc
Confidence 88643 357889999999999998 9999999999999999999999999875433221 1234567
Q ss_pred CccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHH
Q 045256 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEA 735 (789)
Q Consensus 656 ~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 735 (789)
.|+|||.+....++.++||||+|+++|||++|+.|+...... . ... ..+..+. ..
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~-------------~~~--~~~~~~~----~~ 201 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------I-------------NTH--TTLNIPE----WV 201 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------c-------------ccc--cccCCcc----cC
Confidence 899999998888899999999999999999999886432110 0 000 0001111 12
Q ss_pred HHHHHHHHHhhcCcCCCCCCCHH
Q 045256 736 VELVAYTAMHCVNLEGKERPTMA 758 (789)
Q Consensus 736 ~~~l~~l~~~cl~~dp~~RPt~~ 758 (789)
...+.+++.+|++.||++||++.
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCC
Confidence 34466788899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=268.97 Aligned_cols=259 Identities=19% Similarity=0.275 Sum_probs=189.2
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--C----cceEEEEEE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--K----HLVRLVGYC 563 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--p----nIv~l~~~~ 563 (789)
....+|.+...||+|.||.|-++.+. .+..||||+++... ...++..-|+++|+++.+ | -++.+.++|
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 34789999999999999999999754 46889999865432 334456679999999942 3 368888899
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC----------
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD---------- 623 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~---------- 623 (789)
.-.++.++|+|.+ +-|++++|.+. +.++.|++++++|||+.+ ++|.||||+|||+-
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEecc
Confidence 9999999999988 55999999763 368899999999999999 99999999999982
Q ss_pred ----------CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 045256 624 ----------AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693 (789)
Q Consensus 624 ----------~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~ 693 (789)
.+..+||+|||.+....... ...+.|..|+|||++.+-.++.++||||+||||+||.||...|+.
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 13468999999987633222 356789999999999999999999999999999999999999976
Q ss_pred CCCCCCcc---cccccchhhhhhhhhhHHhhcc-cCCC---------------CC------CCHHHHHHHHHHHHHhhcC
Q 045256 694 DDESGGTP---VSLVDFAVPAIMAGELVKILDR-RVGP---------------PE------INEAEAVELVAYTAMHCVN 748 (789)
Q Consensus 694 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~d~-~~~~---------------~~------~~~~~~~~~l~~l~~~cl~ 748 (789)
.++.+... ..+..++...+......+.+.+ ++.. +. ....+....|.+|+.+||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 65432110 0111111111111101111111 0100 00 0112233446688999999
Q ss_pred cCCCCCCCHHHHHHH
Q 045256 749 LEGKERPTMADIVAN 763 (789)
Q Consensus 749 ~dp~~RPt~~evl~~ 763 (789)
.||.+|+|++|++.+
T Consensus 392 fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 392 FDPARRITLREALSH 406 (415)
T ss_pred cCccccccHHHHhcC
Confidence 999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=255.99 Aligned_cols=195 Identities=25% Similarity=0.387 Sum_probs=165.4
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
..++|+++++||+|+|..|.+++++ +.+.||+|++++.-... .+...-...|-.+..+. +||.+|-|..+|+.+..+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nd-dedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCC-cccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 3478999999999999999999865 57889999877643332 23344456777777776 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhhhch--------HHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDRNN--------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~~--------i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
++|.||+++|+|.-+++++++ +...|..||.|||+.+ |+.||||.+|||+|.++++||+|||+.+..-.
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999999877765544 3456788999999999 99999999999999999999999999976433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~ 692 (789)
.. ..+.+++||+.|.|||++++..|...+|+|+||++++||+.|+.||.
T Consensus 404 ~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 PG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 32 23457899999999999999999999999999999999999999995
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=295.21 Aligned_cols=254 Identities=20% Similarity=0.286 Sum_probs=160.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC-C----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEE----
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-D----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGY---- 562 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~---- 562 (789)
..++|++.+.||+|+||.||+|.+. + +..||+|++....... .+..| .+.+..+.++..++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e------~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE------IWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH------HHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 3478999999999999999999875 4 6899999865322111 01111 1122222222222111
Q ss_pred --EEeCCeEEEEEEecCCCchhHHHhhh----------------------------chHHHHHHHHHHHHHhcCCCCeEe
Q 045256 563 --CEEKDERLLVYDYMKNGALYDHLHDR----------------------------NNVEKNAARGIEYLHNYAVPPIIH 612 (789)
Q Consensus 563 --~~~~~~~~lv~e~~~~gsL~~~l~~~----------------------------~~i~~~ia~~l~~LH~~~~~~ivH 612 (789)
.....+.++||||+++++|.++++.. ..++.|+++||+|||+.+ |+|
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiH 278 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVH 278 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 24566789999999999999988642 147889999999999998 999
Q ss_pred ccCCCCCEEECC-CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC----------------------CCC
Q 045256 613 RDIKSSNILLDA-QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN----------------------VLT 669 (789)
Q Consensus 613 ~Dlkp~NIll~~-~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~ 669 (789)
|||||+|||++. ++.+||+|||+++....... .......+++.|+|||.+... .++
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999999986 57999999999975433221 223346789999999966322 234
Q ss_pred chhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc-chhhhhhhhhhHHhhcccCCCCCCC----HHHHHHHHHHHHH
Q 045256 670 AKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD-FAVPAIMAGELVKILDRRVGPPEIN----EAEAVELVAYTAM 744 (789)
Q Consensus 670 ~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~~~~~~~~----~~~~~~~l~~l~~ 744 (789)
.++|||||||+||||+++..++.... ..+.. +.........+...+.......... .........+|+.
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~ 431 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNL------IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLK 431 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHH------HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHH
Confidence 56799999999999998765532110 00000 0000000001111111110000000 0000112346888
Q ss_pred hhcCcCCCCCCCHHHHHHH
Q 045256 745 HCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 745 ~cl~~dp~~RPt~~evl~~ 763 (789)
+||+.||++|||++|++++
T Consensus 432 ~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 432 SMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHccCCcccCCCHHHHhCC
Confidence 9999999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=281.56 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=195.4
Q ss_pred HHHHHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 487 AELAAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 487 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
..+...++.|++.+.||+|.+|.||+++. ++++..|+|+....... .++++.|.++|+.+ +|||++.++++|.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-----deEiE~eynil~~~~~hpnv~~fyg~~~ 86 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-----EEEIELEYNMLKKYSHHPNVATFYGAFI 86 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-----cHHHHHHHHHHHhccCCCCcceEEEEEE
Confidence 34445567899999999999999999974 57889999986654432 33477889999988 6999999999986
Q ss_pred e-----CCeEEEEEEecCCCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEE
Q 045256 565 E-----KDERLLVYDYMKNGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR 629 (789)
Q Consensus 565 ~-----~~~~~lv~e~~~~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 629 (789)
. .+.+|||||||.+|+.-|+++..+ -|...+++||.+||... ++|||||-.|||++.++.+|
T Consensus 87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 4 467999999999999999987532 36678899999999999 99999999999999999999
Q ss_pred EEeeccCcCCCCCCCCCcccccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 045256 630 VSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 630 l~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~ 704 (789)
|.|||++......- ....+..||+.|||||++.. ..|+.++|+||||++..||--|.+|+....+
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------- 233 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------
Confidence 99999987543221 23346789999999999843 3467899999999999999999999865432
Q ss_pred ccchhhhhhhhhhHHhhcc-cCCCCC-CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 705 VDFAVPAIMAGELVKILDR-RVGPPE-INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~-~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.++.- +-+++. ..+....+.+.++|..||.+|-++||++.+++++
T Consensus 234 ------------mraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 ------------MRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------------hhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111111 222222 2345667888999999999999999999988764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=238.31 Aligned_cols=193 Identities=24% Similarity=0.408 Sum_probs=157.6
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|...++||+|.||+||+++.+ +++.||+|+++...... ..-....+|+-+|+.++|.|||++++....+...-||+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde--gvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC--CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 4666789999999999999865 57889999976543221 11234678999999999999999999999999999999
Q ss_pred EecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+. +|..+... .+.++.|+++||.|.|+.. +.||||||.|.||+.++++|++|||+++.+...-+
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 99976 77777643 2468899999999999999 89999999999999999999999999986554433
Q ss_pred CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 645 DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
-+ ....-|..|++|.++.+ +.|+...|+||-|||+.|+....+|.+...
T Consensus 157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 22 23456899999999865 468999999999999999998666655433
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=257.20 Aligned_cols=231 Identities=32% Similarity=0.424 Sum_probs=181.5
Q ss_pred ccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCchhHH
Q 045256 506 SFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH 584 (789)
Q Consensus 506 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 584 (789)
+||.||++... +++.+++|++........ ...+.+|++.+++++|+||+++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK---RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 58999999876 489999999765433221 45688999999999999999999999999999999999999999998
Q ss_pred Hhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcC
Q 045256 585 LHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVG 656 (789)
Q Consensus 585 l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~ 656 (789)
+.... .++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 86432 67889999999999998 9999999999999999999999999987654432 1223467889
Q ss_pred ccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHH
Q 045256 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAV 736 (789)
Q Consensus 657 y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 736 (789)
|++||.+....++.++||||||+++|||++|+.||..... ...+.+.+...............
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~ 214 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----------------LLELFKKIGKPKPPFPPPEWKIS 214 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------------HHHHHHHHhccCCCCccccccCC
Confidence 9999999888889999999999999999999999854221 01111111111111111111134
Q ss_pred HHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 737 ELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 737 ~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
..+..++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 56777899999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-31 Score=254.74 Aligned_cols=196 Identities=28% Similarity=0.441 Sum_probs=156.0
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-------
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK------- 566 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------- 566 (789)
.|....+||+|.||+||+++.+ .++.||+|++.....+. ..-....+|+++|..|+|+|++.+++.|...
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe--GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc--CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4555678999999999999864 57788988643321111 1122356899999999999999999888542
Q ss_pred -CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 567 -DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
..+||||++|+. +|.-+|..+ .++++++..||.|+|... |+|||+|+.|+||+.++.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 347999999987 888888654 368889999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCC--CcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 045256 637 MMGPESERD--FRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696 (789)
Q Consensus 637 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~ 696 (789)
+.+...... ......+-|..|++||.+.+ ..|+++.|||.-|||+.||.|+.+-+....+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 765444332 22334566999999998854 5789999999999999999999887765543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=276.14 Aligned_cols=259 Identities=19% Similarity=0.291 Sum_probs=170.4
Q ss_pred cCCccccceEeecccEEEEEEEe-----------------CCCcEEEEEEcccchhhhHHH----------HHHHHHHHH
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-----------------PDGQEVAIKRGETAKTKKFQE----------KESAFDSEL 545 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~----------~~~~~~~E~ 545 (789)
.++|++.++||+|+||.||+|.+ .+++.||||++.........+ ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 46899999999999999999963 245689999976432211111 112344577
Q ss_pred HHHhhcCCCcc-----eEEEEEEEe--------CCeEEEEEEecCCCchhHHHhhh------------------------
Q 045256 546 AFLSRLHHKHL-----VRLVGYCEE--------KDERLLVYDYMKNGALYDHLHDR------------------------ 588 (789)
Q Consensus 546 ~~l~~l~HpnI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------ 588 (789)
.++.+++|.++ ++++++|.. ++..+|||||+++++|.++|+..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876554 677787753 35689999999999999988631
Q ss_pred --------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCc
Q 045256 589 --------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660 (789)
Q Consensus 589 --------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aP 660 (789)
..++.+++++|+|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 136778999999999998 99999999999999999999999999865433211 112223457899999
Q ss_pred cccCCCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 661 EYYGLNVL----------------------TAKSDVYGLGVVLLELLTGKR-AIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 661 E~~~~~~~----------------------~~~sDv~SlGvil~elltG~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
|.+..... ..+.||||+||++|||+++.. ||.......... ...+.. ...+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~-~~~~~~-----~~~~ 453 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL-RQYDND-----LNRW 453 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH-hhccch-----HHHH
Confidence 98854321 124799999999999999885 553211100000 000000 0001
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCC---CCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEG---KERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp---~~RPt~~evl~~ 763 (789)
+.........+ ..........+|+.+++..+| .+|+|++|+++|
T Consensus 454 r~~~~~~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 454 RMYKGQKYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HhhcccCCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11111111111 111223445667777888765 789999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=239.54 Aligned_cols=193 Identities=23% Similarity=0.365 Sum_probs=154.8
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 571 (789)
++....+.||+|++|.|-+-++ .+|+..|+|++......+ ....+..|+.+..+- .+|.+|.++|.+.+....++
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q---~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ---EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH---HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3344467899999999988875 479999999987544322 233466788776665 69999999999999999999
Q ss_pred EEEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 572 VYDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.||.|+. ||..+-++ ..+|+..+.+||.|||++-. ++|||+||+|||++.+|++|+||||++-.+
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999965 77766443 13688899999999998764 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccC----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYG----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
.++-.. ....|-..|||||.+. ...|+-|+||||||+.+.||.+++.|+..+.
T Consensus 200 ~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 200 VDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred hhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 444322 1246788999999883 3478999999999999999999999986543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=279.05 Aligned_cols=236 Identities=26% Similarity=0.386 Sum_probs=178.8
Q ss_pred ccccceEeecccE-EEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEEE
Q 045256 496 FSLENKIGAGSFG-VVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 496 ~~~~~~LG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
|.-.+++|.|+.| .||+|.. +++.||||++-.. ......+|+..|+.- +|||||++++.-.+....|+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH-------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4455789999887 4799998 6789999985432 122356899999888 6999999999988888999999
Q ss_pred EecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-----CCcEEEEeeccC
Q 045256 574 DYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-----QWTARVSDFGLS 636 (789)
Q Consensus 574 e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGls 636 (789)
|.|.. +|.+++... ..+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||++
T Consensus 583 ELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred hHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 99976 999998762 246789999999999999 999999999999965 358999999999
Q ss_pred cCCCCCCCCCc-ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCCCcccccccchhhhhhh
Q 045256 637 MMGPESERDFR-PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG-KRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 637 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
+........+. .....||-+|+|||++.....+..+|||||||++|+.++| .+||...-+.... +.. ..
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N---Il~------~~ 729 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN---ILT------GN 729 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh---hhc------Cc
Confidence 87655544333 3456799999999999988888899999999999999997 7888543221100 000 00
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+ . .+.+.. +. +-.+||.+|+++||..||++.+|+.+
T Consensus 730 ~~L----~-~L~~~~--d~----eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 730 YTL----V-HLEPLP--DC----EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred cce----e-eeccCc--hH----HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 000 0 011111 11 34567888999999999999999854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=233.37 Aligned_cols=254 Identities=19% Similarity=0.340 Sum_probs=186.2
Q ss_pred cCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCe--
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDE-- 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~-- 568 (789)
.++|++.+++|+|.|++||.|. ..+.+.++||++++.+..+ +.+|+.||..|. ||||++|++...++..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkK-------IkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKK-------IKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHH-------HHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4789999999999999999997 4578899999988765543 889999999996 9999999999887654
Q ss_pred EEEEEEecCCCchhHHHhh-----hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEeeccCcCCCCC
Q 045256 569 RLLVYDYMKNGALYDHLHD-----RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPES 642 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~-----~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGls~~~~~~ 642 (789)
+.|++||+.+.+...+... -.-.+.+++.||.|+|+++ |.|||+||.|+++|.. -.++|+|+|++.+....
T Consensus 110 paLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 5799999999776665432 2357889999999999999 9999999999999865 57999999999876554
Q ss_pred CCCCcccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh--------
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM-------- 713 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 713 (789)
.... ....+..|.-||.+- ...|+..-|+|||||+|.+|+..+.||+...+..++ ++..+...-.
T Consensus 187 ~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ---LVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 187 KEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ---LVKIAKVLGTDELYAYLN 260 (338)
T ss_pred ceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH---HHHHHHHhChHHHHHHHH
Confidence 4322 235677889999884 456788899999999999999999999876553322 2221111000
Q ss_pred ------hhhhHHhhcccCC-------CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 ------AGELVKILDRRVG-------PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ------~~~~~~~~d~~~~-------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+...++.+... .++... -......+++.+.|..|-.+|||++|.+.+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~h-l~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQH-LVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccc-cCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0111111111000 001100 111223356667889999999999998875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=245.81 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=185.3
Q ss_pred ccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-----eE
Q 045256 496 FSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-----ER 569 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-----~~ 569 (789)
.+..+.||.|.||.||.+++ ++|+.|++|++......- .....+.+|+++|..++|.|++..++..+-.. +.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L--~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNL--ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHH--HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34467899999999999975 589999999875533222 22345889999999999999999998876543 46
Q ss_pred EEEEEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
|+++|.|.. +|..++-. .+-+..||++||.|||+.+ |.||||||.|.|++.+..+||+|||+++.-..
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 788888855 77766532 2347789999999999999 99999999999999999999999999986433
Q ss_pred CCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc--cccccchhh----hhhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP--VSLVDFAVP----AIMA 714 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~----~~~~ 714 (789)
.+.. ......-|..|+|||++.+ ..|+...||||.|||+.||+-.+..|...++..+.. ..+...+.. ...+
T Consensus 209 d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 3322 2233456889999999966 578999999999999999998888887655432221 111111111 1122
Q ss_pred hhhHHhhcccCCCCCC-----------CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 715 GELVKILDRRVGPPEI-----------NEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
+....++......+.. .+.+.+ .+.++++..||++|.+..+.+.++.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav----~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAV----DLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHH----HHHHHHhCCCCcccccHhhhccccc
Confidence 3334444443333221 112222 3456789999999999999888763
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=230.10 Aligned_cols=233 Identities=18% Similarity=0.238 Sum_probs=192.0
Q ss_pred CcEEEEEec--CceEEEEEeCCceEEEccCCCCCCCC-------CcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEc
Q 045256 73 ISFSSISAG--QSFFCGIRSGGYSLLCWDTNFSYNSN-------FVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCW 143 (789)
Q Consensus 73 ~~v~~i~~G--~~~~~~l~~~G~~v~~wG~n~~~~~~-------~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~w 143 (789)
.++.-|+.| ..|+++|+-+| +.|+||.|..+|.. ..|.-|+.+...+|++.+||++|+++|+++|+||.+
T Consensus 56 v~iR~VasG~~aaH~vli~meg-k~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~ltdtG~v~af 134 (443)
T KOG1427|consen 56 VNIRFVASGCAAAHCVLIDMEG-KCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVLTDTGQVLAF 134 (443)
T ss_pred ceEEEEecccchhhEEEEeccc-ceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEEecCCcEEEe
Confidence 345556655 67999999999 99999999976643 468889988888899999999999999999999999
Q ss_pred CCCCCCCCCCCCC-------------CccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC-------------
Q 045256 144 RGDVNISKNAPSG-------------ELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA------------- 197 (789)
Q Consensus 144 G~~~~~~~~~~~~-------------~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~------------- 197 (789)
|.|..+|++.... ...|..|+||.+|+.. ++..+++.+.|.-.|||||+++..
T Consensus 135 GeNK~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~-l~~~~si~t~glp~ygqlgh~td~~~~~~~~~~~~~~ 213 (443)
T KOG1427|consen 135 GENKYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVW-LSSTESILTAGLPQYGQLGHGTDNEFNMKDSSVRLAY 213 (443)
T ss_pred cccccccccccccccccccCCCccccCccceeeccccceEEE-eecccceeecCCccccccccCcchhhccccccceeee
Confidence 9999999966432 1348999999999988 566669999999999999987651
Q ss_pred -------------CceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCC-------------CccceEEeccCcce
Q 045256 198 -------------NRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNS-------------TAFEYSALSLGFNH 251 (789)
Q Consensus 198 -------------~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~-------------~~~~v~~i~~G~~h 251 (789)
...|++++||.+|++|++++++||+||-+.||.|+..... ....-.++-||+..
T Consensus 214 e~~pr~~~i~~~dgvqiv~~acg~nhtvavd~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~~~~~g~t~ 293 (443)
T KOG1427|consen 214 EAQPRPKAIASLDGVQIVKVACGTNHTVAVDKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPPNAILGYTG 293 (443)
T ss_pred ecCCCccccccccceeeEEEeccCcceeeecCCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCcceeeeccc
Confidence 1238899999999999999999999999999999766532 12345678899999
Q ss_pred EEEEEeeCCeEEEeeeCCCCc--------ccCCCCCcEEEEEecCceEEEEeecCCeEEEecCCCCC
Q 045256 252 SCAIRRLNGSVVCWGSQGEYS--------VNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPN 310 (789)
Q Consensus 252 ~~al~~~dG~v~~WG~n~~gq--------~~~~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~ 310 (789)
++.+.+ -|.+|.||.+.... +..+.+-++..+.+|..|-+.-. |. +...||-..++
T Consensus 294 Sl~v~e-~G~Lf~~g~~k~~ge~~mypkP~~dlsgwnl~~~~~~~~h~~v~a-d~-s~i~wg~~~~g 357 (443)
T KOG1427|consen 294 SLNVAE-GGQLFMWGKIKNNGEDWMYPKPMMDLSGWNLRWMDSGSMHHFVGA-DS-SCISWGHAQYG 357 (443)
T ss_pred ceeecc-cceeEEeeccccCcccccCCCchhhcCCccCCCcCccceeeeecc-cc-ccccccccccc
Confidence 999998 99999999886544 23344677889999998876654 66 89999987443
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-28 Score=254.73 Aligned_cols=192 Identities=24% Similarity=0.394 Sum_probs=161.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHH----HHHHHHHHHHhhcC---CCcceEEEEEEEe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKE----SAFDSELAFLSRLH---HKHLVRLVGYCEE 565 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~----~~~~~E~~~l~~l~---HpnIv~l~~~~~~ 565 (789)
.+|...+.||+|+||.|+++.++ +...|+||.+.+.+.......+ -.+-.|++||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46899999999999999999875 4678999987765543322211 23557999999997 9999999999999
Q ss_pred CCeEEEEEEec-CCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 566 KDERLLVYDYM-KNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 566 ~~~~~lv~e~~-~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
++.+||+||-. ++-+|++++.-+ .-|++|++.|+++||+++ |||||||-+||.++.+|.+||+|||.+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 99999999965 346899998533 358999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCC
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIF 692 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~ 692 (789)
........ ..+.||..|.|||++.+..| ...-|||++|++||.++....||+
T Consensus 718 a~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 76444332 25789999999999988876 456899999999999999888875
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=252.40 Aligned_cols=260 Identities=21% Similarity=0.253 Sum_probs=193.1
Q ss_pred HHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC------CCcceEEEEE
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH------HKHLVRLVGY 562 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~------HpnIv~l~~~ 562 (789)
+....+|.+....|+|-|++|.+|.+. -|+.||||++....... ..=..|++||++|+ -.++++|+..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-----KTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-----hhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 445578999999999999999999864 47899999987654432 22457999999996 3588999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhhc-----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEE
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDRN-----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARV 630 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl 630 (789)
|....+++||||-+.- +|.+.|++.+ .++.|++-||..|..++ |+|.||||+|||+++. ..+||
T Consensus 503 F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence 9999999999998854 9999987643 58899999999999999 9999999999999875 57899
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC----------Cc
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG----------GT 700 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~----------~~ 700 (789)
||||.|......+.. ...-+..|.|||++.+-+|+...|+||.||+||||+||+..|.+..... ..
T Consensus 579 CDfGSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~ 654 (752)
T KOG0670|consen 579 CDFGSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF 654 (752)
T ss_pred ccCcccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence 999999775554432 2344678999999999999999999999999999999998886432211 00
Q ss_pred c-----------------cccccchhhhhhhh-------------hhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcC
Q 045256 701 P-----------------VSLVDFAVPAIMAG-------------ELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLE 750 (789)
Q Consensus 701 ~-----------------~~~~~~~~~~~~~~-------------~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~d 750 (789)
| .+++......+... .+...+... ...+..+......+.+|+.+||..|
T Consensus 655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~-q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV-QRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc-CCCCchhHHHHHHHHHHHHHHhccC
Confidence 0 00110001111110 011111110 0012234456777889999999999
Q ss_pred CCCCCCHHHHHHH
Q 045256 751 GKERPTMADIVAN 763 (789)
Q Consensus 751 p~~RPt~~evl~~ 763 (789)
|++|.|..++|++
T Consensus 734 P~KRit~nqAL~H 746 (752)
T KOG0670|consen 734 PEKRITVNQALKH 746 (752)
T ss_pred hhhcCCHHHHhcC
Confidence 9999999998875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-26 Score=227.14 Aligned_cols=203 Identities=32% Similarity=0.532 Sum_probs=171.8
Q ss_pred EeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
||+|.+|.||++...+ ++.+++|++....... ....+.+|++.++.++|++|+++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999998754 8999999976544321 23468899999999999999999999999999999999999899
Q ss_pred hhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEeeccCcCCCCCCCCCcccc
Q 045256 581 LYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGLSMMGPESERDFRPMK 650 (789)
Q Consensus 581 L~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGls~~~~~~~~~~~~~~ 650 (789)
|.+++... ..++.+++++|.|||+.+ ++|+||+|.||+++. +..++|+|||.+........ ....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99998653 257889999999999998 999999999999999 89999999999876444321 1123
Q ss_pred cccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCC
Q 045256 651 AAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPE 729 (789)
Q Consensus 651 ~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 729 (789)
..+...|++||.+... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4567899999999776 788999999999999999
Q ss_pred CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 730 INEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 730 ~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
..+.+++.+|++.||++||++.++++.+
T Consensus 188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3456678889999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-26 Score=220.78 Aligned_cols=255 Identities=13% Similarity=0.144 Sum_probs=195.9
Q ss_pred ceeEEEEec--CceeeeeeeecCCCcEEEeeC----------------CcccccCCCCcEEEEEecCceEEEEEeCCceE
Q 045256 34 GSTLAVSYG--SATVCAVVAAQPTQRLLCYQG----------------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSL 95 (789)
Q Consensus 34 ~~~~~i~~G--~~h~~~~~~l~~~g~v~~wG~----------------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v 95 (789)
-++.-|+.| ..|++ +|+-+|+.|+||+ |+.++-....++++.+||++||++|+++| +|
T Consensus 56 v~iR~VasG~~aaH~v---li~megk~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~ltdtG-~v 131 (443)
T KOG1427|consen 56 VNIRFVASGCAAAHCV---LIDMEGKCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVLTDTG-QV 131 (443)
T ss_pred ceEEEEecccchhhEE---EEecccceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEEecCC-cE
Confidence 345666655 48999 9999999999999 33344445667999999999999999999 99
Q ss_pred EEccCCCCCCCCC---------cceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCC-----------
Q 045256 96 LCWDTNFSYNSNF---------VPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPS----------- 155 (789)
Q Consensus 96 ~~wG~n~~~~~~~---------~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~----------- 155 (789)
|++|.|..+|... +|......+ .|+.|+||..+++-|+..+++.+.|--.++|++...
T Consensus 132 ~afGeNK~GQlGlgn~~~~v~s~~~~~~~~~--~v~~v~cga~ftv~l~~~~si~t~glp~ygqlgh~td~~~~~~~~~~ 209 (443)
T KOG1427|consen 132 LAFGENKYGQLGLGNAKNEVESTPLPCVVSD--EVTNVACGADFTVWLSSTESILTAGLPQYGQLGHGTDNEFNMKDSSV 209 (443)
T ss_pred EEecccccccccccccccccccCCCccccCc--cceeeccccceEEEeecccceeecCCccccccccCcchhhccccccc
Confidence 9999999777442 221111112 367999999999999999999999988888874321
Q ss_pred ----------------CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCC--------------ceeEEEe
Q 045256 156 ----------------GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFAN--------------RSMFSIT 205 (789)
Q Consensus 156 ----------------~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~--------------~~v~~i~ 205 (789)
..++|+++|||.+|+.|+ +++++||.||.+.||.||+..+.+ +.-.++-
T Consensus 210 ~~~~e~~pr~~~i~~~dgvqiv~~acg~nhtvav-d~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~~~~ 288 (443)
T KOG1427|consen 210 RLAYEAQPRPKAIASLDGVQIVKVACGTNHTVAV-DKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPPNAI 288 (443)
T ss_pred eeeeecCCCccccccccceeeEEEeccCcceeee-cCCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCccee
Confidence 235699999999999995 666699999999999999876532 2344889
Q ss_pred eCCceeEEEccCCcEEEEEcCCCC-CC--CcCC--CCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcc-------
Q 045256 206 AGGNHVCGIDSNGFVICYGDNKSG-QL--KFPL--NSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSV------- 273 (789)
Q Consensus 206 ~G~~h~~al~~dG~v~~wG~n~~G-ql--~~~~--~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~------- 273 (789)
||+..++.+.+-|.+|-||.+..- .- -+.+ ....-++..+.+|..|.+.- . |-+..+||...+|.+
T Consensus 289 ~g~t~Sl~v~e~G~Lf~~g~~k~~ge~~mypkP~~dlsgwnl~~~~~~~~h~~v~-a-d~s~i~wg~~~~g~~lggp~~Q 366 (443)
T KOG1427|consen 289 LGYTGSLNVAEGGQLFMWGKIKNNGEDWMYPKPMMDLSGWNLRWMDSGSMHHFVG-A-DSSCISWGHAQYGELLGGPNGQ 366 (443)
T ss_pred eecccceeecccceeEEeeccccCcccccCCCchhhcCCccCCCcCccceeeeec-c-cccccccccccccccccCcccc
Confidence 999999999999999999976543 22 1222 23344678899999887655 3 678999998877762
Q ss_pred ---------cCCCCCcEEEEEecCceEEEEeec
Q 045256 274 ---------NGIRGKSFESIVSGSNFTCGLTTS 297 (789)
Q Consensus 274 ---------~~~~~~~v~~i~~G~~h~~al~~~ 297 (789)
+.+....+..|++|..|++.|.++
T Consensus 367 kss~~Pk~v~~l~~i~v~~VamGysHs~vivd~ 399 (443)
T KOG1427|consen 367 KSSAAPKKVDMLEGIHVMGVAMGYSHSMVIVDR 399 (443)
T ss_pred ccccCccccchhcceeccceeeccceEEEEEcc
Confidence 223355688999999999999754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=234.86 Aligned_cols=260 Identities=21% Similarity=0.255 Sum_probs=182.0
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK------ 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 566 (789)
.+|.-++.++.|.- .|.-+.+ -.++.|++|++...... ........+|+..+..++|+||++++.+|.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n--~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN--QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc--CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 45666778888887 5555543 25789999986544221 12223466899999999999999999998533
Q ss_pred CeEEEEEEecCCCchhHHHhhh------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.+.|+|||||.. +|.+.++.+ ..+..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++...
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILMELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 357999999965 898887532 368899999999999999 9999999999999999999999999997533
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhh-----
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIM----- 713 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~----- 713 (789)
.. +.......|..|.|||++.+..+...+||||+||++.||++|+.-|.+.+...+..... ...+.+...
T Consensus 170 ~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 170 TD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 22 34445678999999999988889999999999999999999998886443211100000 000000000
Q ss_pred ---------hh----hhHHhhccc-CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 ---------AG----ELVKILDRR-VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ---------~~----~~~~~~d~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ...+.+... .....+.+.--....++++.+||..||++|-++++++++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 001111110 010011111223456778889999999999999999986
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=230.28 Aligned_cols=121 Identities=25% Similarity=0.427 Sum_probs=100.1
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-----C---CcceEEEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-----H---KHLVRLVGYCE 564 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----H---pnIv~l~~~~~ 564 (789)
.+|.+.++||.|-|++||++.+ .+.+.||+|+.+.. +...+....||++|++++ | ..||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 6899999999999999999964 46789999986543 334456778999999984 3 46999999997
Q ss_pred eC----CeEEEEEEecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 045256 565 EK----DERLLVYDYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL 622 (789)
Q Consensus 565 ~~----~~~~lv~e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll 622 (789)
.. .+++||+|++ +.+|..+|.. .+.|.+|++.||.|||... +|||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 64 4689999999 5588888754 2478999999999999765 39999999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=223.43 Aligned_cols=191 Identities=32% Similarity=0.536 Sum_probs=161.7
Q ss_pred ccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|++.+.||+|+++.||++...+ ++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence 5667899999999999998765 889999997654332 234568899999999999999999999999899999999
Q ss_pred ecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 575 YMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 575 ~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|+++++|.+++.... .++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999986532 47788999999999998 999999999999999999999999998765443211
Q ss_pred CcccccccCcCccCcccc-CCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 045256 646 FRPMKAAGTVGYIDPEYY-GLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvil~elltG~~pf~~ 693 (789)
......++..|++||.+ ....++.++|||+||+++|||++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11234577889999998 677788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=235.88 Aligned_cols=202 Identities=29% Similarity=0.424 Sum_probs=163.3
Q ss_pred HHHHHhcCCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEE
Q 045256 487 AELAAATNNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVG 561 (789)
Q Consensus 487 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~ 561 (789)
..+....+.|...++||+|.|++||++.+. ..+.||+|.+....... .+.+|+++|..+ .+.||+++.+
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~------ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS------RILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch------HHHHHHHHHHHhccchhhhcchh
Confidence 345556678999999999999999999753 36789999876544332 478999999999 5999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhHHHhh-----hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEeecc
Q 045256 562 YCEEKDERLLVYDYMKNGALYDHLHD-----RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGL 635 (789)
Q Consensus 562 ~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGl 635 (789)
++..++...+|+||++.-+..+++.. ...+...++.||+++|.++ ||||||||+|+|.+. .+.-.|.|||+
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999999888887653 4467889999999999999 999999999999975 46789999999
Q ss_pred CcCCC-----------------C-CCCC------------------------CcccccccCcCccCccccC-CCCCCchh
Q 045256 636 SMMGP-----------------E-SERD------------------------FRPMKAAGTVGYIDPEYYG-LNVLTAKS 672 (789)
Q Consensus 636 s~~~~-----------------~-~~~~------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~s 672 (789)
+.... . .... .......||++|+|||++. ....++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 86110 0 0000 0001246999999999984 45678899
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCC
Q 045256 673 DVYGLGVVLLELLTGKRAIFKDDES 697 (789)
Q Consensus 673 Dv~SlGvil~elltG~~pf~~~~~~ 697 (789)
||||.|+|++-+++++.||+.....
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred ceeeccceeehhhccccccccCccc
Confidence 9999999999999999999876543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-26 Score=249.22 Aligned_cols=243 Identities=24% Similarity=0.418 Sum_probs=187.0
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|.++..+|.|+||.|||+++ ..++..|+|.++....... .-+.+|+-+++..+||||+.+++.|...+..++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~----~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF----SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc----cccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 46899999999999999999985 4688999998776544332 236789999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
+|||+.+|+|.+.-+-.. .+.+..++||+|||+++ =+|||||-.|||+++.+.+|+.|||.+-.+...-
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999999998754221 34567889999999999 5999999999999999999999999986543322
Q ss_pred CCCcccccccCcCccCcccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 644 RDFRPMKAAGTVGYIDPEYY---GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
. ....+.||+.|||||+. +.+.|..++|||++|+...|+---++|.+.-.+ + .. ..+
T Consensus 167 ~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----m-----r~--------l~L 226 (829)
T KOG0576|consen 167 A--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----M-----RA--------LFL 226 (829)
T ss_pred h--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----H-----HH--------HHH
Confidence 1 22356899999999987 456789999999999999999877777543221 0 00 011
Q ss_pred hcc-cCCCC-CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 721 LDR-RVGPP-EINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 721 ~d~-~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
.-+ ...++ -.......+.+.++++.|+.++|++||+++.++.
T Consensus 227 mTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 227 MTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111 11111 1122344566788899999999999999987765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=218.79 Aligned_cols=189 Identities=22% Similarity=0.428 Sum_probs=149.3
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEE-EEeCCeE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGY-CEEKDER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~-~~~~~~~ 569 (789)
.+.|.+.+.||+|.||.+-+++++ ..+.+++|-+.... ....+|.+|..---.| .|.||+..++. |+..+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 467899999999999999999976 45679999765432 3345688898766666 48999988764 5667778
Q ss_pred EEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE-CC-CCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL-DA-QWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll-~~-~~~~kl~DfGls~~~~ 640 (789)
++++||++.|+|..-+.. .++++.|++.||.|||+.. +||||||.+|||| +. ..++||+|||+++...
T Consensus 98 vF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred EEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 899999999999887643 3479999999999999999 9999999999999 33 3589999999986532
Q ss_pred CCCCCCcccccccCcCccCccccCCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLN-----VLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
..-. ...-+..|.+||..... ...+.+|||.||+++|..|||+.|+...
T Consensus 175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka 228 (378)
T KOG1345|consen 175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA 228 (378)
T ss_pred ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh
Confidence 2211 12335679999976332 2467899999999999999999999743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=261.33 Aligned_cols=189 Identities=19% Similarity=0.239 Sum_probs=127.9
Q ss_pred hhcCC-CcceEEEEEE-------EeCCeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeE
Q 045256 549 SRLHH-KHLVRLVGYC-------EEKDERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPII 611 (789)
Q Consensus 549 ~~l~H-pnIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~iv 611 (789)
+.++| +||++++++| .+.+.+++++||++ ++|.++|... ..++.||++||+|||+++ |+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 34555 5888888877 23345778899884 5999999532 258899999999999999 99
Q ss_pred eccCCCCCEEECCCC-------------------cEEEEeeccCcCCCCCCCC--------------CcccccccCcCcc
Q 045256 612 HRDIKSSNILLDAQW-------------------TARVSDFGLSMMGPESERD--------------FRPMKAAGTVGYI 658 (789)
Q Consensus 612 H~Dlkp~NIll~~~~-------------------~~kl~DfGls~~~~~~~~~--------------~~~~~~~gt~~y~ 658 (789)
||||||+||||+..+ .+||+|||+++........ .......||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 4555566655432110000 0001235788999
Q ss_pred CccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHH
Q 045256 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVEL 738 (789)
Q Consensus 659 aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 738 (789)
|||++.+..++.++|||||||+||||++|.+|+..... .+..+....++ +.. ... ...
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-------------------~~~~~~~~~~~-~~~-~~~-~~~ 240 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-------------------TMSSLRHRVLP-PQI-LLN-WPK 240 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-------------------HHHHHHHhhcC-hhh-hhc-CHH
Confidence 99999988999999999999999999998877532110 00000000111 100 011 112
Q ss_pred HHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 739 VAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 739 l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...++.+||++||.+||+|.|++++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 3456778999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=200.89 Aligned_cols=157 Identities=22% Similarity=0.188 Sum_probs=116.5
Q ss_pred CchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 579 GALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 579 gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
|+|.++++.+ ..++.|+++||+|||+.+ ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-------
Confidence 5788887642 268899999999999875 999999999999999 9998764332
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc---cCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR---RVG 726 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---~~~ 726 (789)
...|++.|||||++.+..++.++||||||+++|||+||+.||....... ..+..++.. ...
T Consensus 63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~----------------~~~~~~~~~~~~~~~ 126 (176)
T smart00750 63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS----------------AILEILLNGMPADDP 126 (176)
T ss_pred cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc----------------HHHHHHHHHhccCCc
Confidence 1257899999999999999999999999999999999999985432210 001111111 100
Q ss_pred CCCCCHHHHHH--HHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 727 PPEINEAEAVE--LVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 727 ~~~~~~~~~~~--~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
........... .+.+++.+||..||++||++.|+++++..+..
T Consensus 127 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 127 RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 00111222333 57889999999999999999999999977643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-24 Score=205.03 Aligned_cols=241 Identities=21% Similarity=0.375 Sum_probs=177.2
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecC
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+..+|.+...|+.|+|+++ |..++.|++...... .....+|.+|...|+-+.||||+++++.|..+.++.++..||+
T Consensus 194 l~tkl~e~hsgelwrgrwq-gndivakil~vr~~t--~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT--ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhccCCCccccccccc-Ccchhhhhhhhhhcc--hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 4567888889999999985 456677776543221 1223468999999999999999999999999999999999999
Q ss_pred CCchhHHHhhhc----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 578 NGALYDHLHDRN----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 578 ~gsL~~~l~~~~----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
.|+|+..|++.. +++.++|+|++|||+.. |-|..--|.+..|++|++.+++|+--. .++ .+.
T Consensus 271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad-~kf------sfq 342 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMAD-TKF------SFQ 342 (448)
T ss_pred chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccc-cee------eee
Confidence 999999998643 68999999999999987 335555799999999999998886211 111 112
Q ss_pred ccccccCcCccCccccCCCCC---CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 648 PMKAAGTVGYIDPEYYGLNVL---TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~---~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....-.+.||+||.+..++- -..+|+|||+++||||.|...||....+.+ ... ....+-+...
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme------cgm-------kialeglrv~ 409 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME------CGM-------KIALEGLRVH 409 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh------hhh-------hhhhcccccc
Confidence 222344689999999976653 347899999999999999999996544311 000 0001111222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+ ++ .....+.+|+.-|+..||.+||.+..|+-.||+++
T Consensus 410 i--pp----gis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 I--PP----GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred C--CC----CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2 22 22344566777799999999999999999999874
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=219.13 Aligned_cols=168 Identities=18% Similarity=0.138 Sum_probs=128.3
Q ss_pred hcCCccccceEeecccEEEEEEEeC--CCcEEEEEEcccchhh-hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP--DGQEVAIKRGETAKTK-KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
..++|++.+.||+|+||+||+|.++ +++.||||++...... ......+.|.+|+++|++++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3468999999999999999999764 5777899986432110 112234568999999999999999853322 246
Q ss_pred EEEEEEecCCCchhHHHh-hhchHHHHHHHHHHHHHhcCCCCeEeccC-CCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 569 RLLVYDYMKNGALYDHLH-DRNNVEKNAARGIEYLHNYAVPPIIHRDI-KSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~-~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
.||||||+++++|..... ....++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|||+++.........
T Consensus 93 ~~LVmE~~~G~~L~~~~~~~~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~ 169 (365)
T PRK09188 93 DGLVRGWTEGVPLHLARPHGDPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALY 169 (365)
T ss_pred cEEEEEccCCCCHHHhCccchHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchh
Confidence 799999999999974321 12468889999999999998 999999 9999999999999999999998654432111
Q ss_pred c------ccccccCcCccCccccCC
Q 045256 647 R------PMKAAGTVGYIDPEYYGL 665 (789)
Q Consensus 647 ~------~~~~~gt~~y~aPE~~~~ 665 (789)
. -....+++.|+|||.+..
T Consensus 170 ~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 170 RIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhhhhccCccCCcccCCh
Confidence 1 124568889999998843
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-20 Score=198.38 Aligned_cols=253 Identities=23% Similarity=0.219 Sum_probs=181.2
Q ss_pred CccccceEeecccEEEEEEEeCCC--cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC----CcceEEEEEE-EeCC
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPDG--QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH----KHLVRLVGYC-EEKD 567 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H----pnIv~l~~~~-~~~~ 567 (789)
+|.+.+.||+|+||.||++...+. ..+|+|.......... ..+..|..++..+.. +++..+++.. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 799999999999999999986553 4788887544322211 136778888888863 6899999988 4777
Q ss_pred eEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-----CcEEEEe
Q 045256 568 ERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-----WTARVSD 632 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~D 632 (789)
..|+||+.+ +.+|.++.... .+++.|++.+|++||+.+ ++||||||+|+++... ..+.|.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 889999987 67999977432 268889999999999999 9999999999999754 4699999
Q ss_pred eccCc--CCCCCCCC----Cc--ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 045256 633 FGLSM--MGPESERD----FR--PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 633 fGls~--~~~~~~~~----~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~ 704 (789)
||+++ ........ .. .....||.+|.+++...+...+++.|+||++.++.||+.|..|+........
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----- 245 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----- 245 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----
Confidence 99998 32222211 11 1234599999999999999999999999999999999999999844332100
Q ss_pred ccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 705 VDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
.....+......... ........+..+...+-..+...+|....+...|+++....
T Consensus 246 ---------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 ---------KSKFEKDPRKLLTDR--FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ---------HHHHHHHhhhhcccc--ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 001111111111110 00111223334444455589999999999999998876654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.7e-20 Score=195.89 Aligned_cols=248 Identities=28% Similarity=0.418 Sum_probs=186.8
Q ss_pred ccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCC-cceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK-HLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~~~~~~~lv~e 574 (789)
|.+.+.||.|.|+.||++... ..+++|.+........ .....+.+|+.++..+.|+ +|+++.+.+......++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 667889999999999999876 7899998766544332 2355688999999999988 79999999977777899999
Q ss_pred ecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCCCCC
Q 045256 575 YMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPES 642 (789)
Q Consensus 575 ~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~~~~ 642 (789)
|+.++++.+++... ..+..+++.++.|+|+.+ ++|||+||+||+++... .++++|||++......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 99999999777643 257888999999999999 99999999999999988 7999999998754433
Q ss_pred CCCC----cccccccCcCccCccccCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 643 ERDF----RPMKAAGTVGYIDPEYYGL---NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 643 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
.... ......++..|++||.+.. ..++...|+||+|++++++++|..||...... ....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--------------~~~~ 221 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--------------SATS 221 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--------------ccHH
Confidence 3221 2345689999999999987 57889999999999999999999996443321 0000
Q ss_pred hhHHhhcccC----CCCCCC--HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 716 ELVKILDRRV----GPPEIN--EAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 716 ~~~~~~d~~~----~~~~~~--~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+.+.... ...... .......+..++..++..+|..|.++.+....
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 222 QTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111111111 000000 01122456677888999999999999987775
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.3e-22 Score=226.40 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=180.7
Q ss_pred cccceEeecccEEEEEEEe-CCCcEEEEEEcccc--hhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 497 SLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETA--KTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
....++|.|.+|.|+.... ...+.+..|.+... ...........+..|+.+-..|+|||++..+..+++....+-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999997777653 23444444433210 11111111122677888889999999998888888877777779
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
||++. +|+.++... ..+++|+.+|+.|||+.+ |.|||||++|++++.++.+||+|||.+..+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~ 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence 99999 999998763 258899999999999999 999999999999999999999999998765444333
Q ss_pred --CcccccccCcCccCccccCCCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc--cccccchhhhhhhhhhHHh
Q 045256 646 --FRPMKAAGTVGYIDPEYYGLNVLTA-KSDVYGLGVVLLELLTGKRAIFKDDESGGTP--VSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 646 --~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~SlGvil~elltG~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 720 (789)
.......|+..|+|||.+....|.+ ..||||.|+++..|++|+.||.......... .....+
T Consensus 477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~------------- 543 (601)
T KOG0590|consen 477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ------------- 543 (601)
T ss_pred hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc-------------
Confidence 3445678999999999999888876 4899999999999999999986544322110 000000
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+.....+.....+.++.++|+.||.+|-|+++|++.
T Consensus 544 -~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 544 -RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 001111122234455566778889999999999999999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-21 Score=191.11 Aligned_cols=175 Identities=14% Similarity=0.106 Sum_probs=136.5
Q ss_pred HhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHH------HHHHHHHHHHhhcCCCcceEEEEEEE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKE------SAFDSELAFLSRLHHKHLVRLVGYCE 564 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~------~~~~~E~~~l~~l~HpnIv~l~~~~~ 564 (789)
...++|+..++||.|+||.||+... ++..+|||.+....... +... ..+.+|++.+.+++||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~-~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRT-ERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCch-HHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3468999999999999999999766 57789999986543322 2221 22689999999999999999999876
Q ss_pred eCC--------eEEEEEEecCCCchhHHHhhhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 565 EKD--------ERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 565 ~~~--------~~~lv~e~~~~gsL~~~l~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
... ..+|+|||+++.+|.++.........+++.+|..||+.+ ++|||+||+||++++++ ++|+|||..
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~ 181 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPEISEDVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGK 181 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhhccHHHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEECCCc
Confidence 542 478999999999998876444456779999999999999 99999999999999988 999999987
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHH
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELL 685 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ell 685 (789)
......... ..+.....+..++|+|+||+.+.-+.
T Consensus 182 ~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 182 RCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 643211110 01333445667899999999877654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.4e-20 Score=180.88 Aligned_cols=193 Identities=18% Similarity=0.191 Sum_probs=145.1
Q ss_pred cccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEEEEe
Q 045256 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
.+...|++|.||+||.+.. .+..++.+.+.....-...-....+.+|+++|++|+ |+++.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999998876 677888776654433221122235889999999995 5889999886 456999999
Q ss_pred cCCCchhHHHh-hhchHHHHHHHHHHHHHhcCCCCeEeccC-CCCCEEECCCCcEEEEeeccCcCCCCCCCCC---c---
Q 045256 576 MKNGALYDHLH-DRNNVEKNAARGIEYLHNYAVPPIIHRDI-KSSNILLDAQWTARVSDFGLSMMGPESERDF---R--- 647 (789)
Q Consensus 576 ~~~gsL~~~l~-~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfGls~~~~~~~~~~---~--- 647 (789)
+++.+|.+.+. ....+..+++++|.++|+.+ |+|||| ||+|||++.++.++|+|||++.......... .
T Consensus 80 I~G~~L~~~~~~~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rD 156 (218)
T PRK12274 80 LAGAAMYQRPPRGDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARED 156 (218)
T ss_pred ecCccHHhhhhhhhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHH
Confidence 99999977653 23357889999999999999 999999 7999999999999999999997544332100 0
Q ss_pred -----ccccccCcCccCccccCCC-CCC-chhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 045256 648 -----PMKAAGTVGYIDPEYYGLN-VLT-AKSDVYGLGVVLLELLTGKRAIFKDDES 697 (789)
Q Consensus 648 -----~~~~~gt~~y~aPE~~~~~-~~~-~~sDv~SlGvil~elltG~~pf~~~~~~ 697 (789)
......++.|++|+....- ..+ .+.++++.|.-+|.++|++.+...+.+.
T Consensus 157 l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 157 LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 0112357888888754321 223 5679999999999999999998776653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-20 Score=177.83 Aligned_cols=192 Identities=27% Similarity=0.319 Sum_probs=155.8
Q ss_pred cCCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-CcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-KHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~ 570 (789)
...|.++++||.|+||.+|.+. ..+|..||||.-..... ..++..|.++.+.|++ ..|..+.-+..+.+...
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~------hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK------HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV 87 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC------CcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence 4679999999999999999996 56899999997433221 2247788899999974 67777888888888889
Q ss_pred EEEEecCCCchhHHHh---------hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC---CcEEEEeeccCcC
Q 045256 571 LVYDYMKNGALYDHLH---------DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGLSMM 638 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~---------~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGls~~ 638 (789)
||||.+ +.+|.+++. +..-++.|++.-++|+|..+ ++||||||+|+|+.-+ ..+.|+|||+|+.
T Consensus 88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 999988 779988864 23357889999999999999 9999999999999543 4789999999987
Q ss_pred CCCCCCCC-----cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 045256 639 GPESERDF-----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694 (789)
Q Consensus 639 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~ 694 (789)
+.+..... ......||.+|.+-....+...+.+.|+-|+|.+|..+.-|..||.+-
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 54443221 122457999999999888888899999999999999999999998654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=181.36 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=183.6
Q ss_pred CCccccceEeecccEEEEEEE-eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 571 (789)
-.|++.++||+|+||..+.|+ +-+++.||||.-.... ..-+++.|.+..+.|. .++|...+-+-.+..+..|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS------~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS------EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC------CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 368999999999999999996 5588999999632211 1224788999998885 7999998888888888899
Q ss_pred EEEecCCCchhHHHh---------hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-----CCcEEEEeeccCc
Q 045256 572 VYDYMKNGALYDHLH---------DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-----QWTARVSDFGLSM 637 (789)
Q Consensus 572 v~e~~~~gsL~~~l~---------~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGls~ 637 (789)
|+|.+ +.+|.|++. ....++.|++.-++|+|+.. +|.|||||+|+||.. ...+.|+|||+++
T Consensus 102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 99988 779888864 33468899999999999999 999999999999954 3468999999998
Q ss_pred CCCCCCCCC-----cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh
Q 045256 638 MGPESERDF-----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712 (789)
Q Consensus 638 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 712 (789)
.+.+..... ......||.+||+-....+.+.+.+.|+-|||=++..+|-|..||.+-....
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t-------------- 243 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT-------------- 243 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc--------------
Confidence 766554321 1224579999999999999999999999999999999999999996543210
Q ss_pred hhhhhHHhhcccCCCC-----CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 713 MAGELVKILDRRVGPP-----EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
..+...++-+..-..+ ...+.|+..-|. -.-..+-++-|..+-+...+..+++..
T Consensus 244 nK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~----yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 244 NKEKYEKIGETKRSTPIEVLCEGFPEEFATYLR----YVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred hHHHHHHhccccccCCHHHHHhcCHHHHHHHHH----HHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 0111112211111111 112334333333 234467778899988888777776643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.6e-21 Score=215.38 Aligned_cols=243 Identities=20% Similarity=0.251 Sum_probs=170.3
Q ss_pred CccccceEeecccEEEEEEEeCCCcEEEEEEcccch-hhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAK-TKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|...+.||.+.|=.|.++++++|. |+||++.+.. ........+.+ +|++ ...++|||.+++...-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL-~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRL-EEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHH-HHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6777899999999999999998887 8899875543 22222222222 3444 55668999999988877777788999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC--CCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG--PESE 643 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~--~~~~ 643 (789)
+|..+ +|+|.|..| +-|+.|++.||.-.|..+ |.|+|||.+||||+.-.-+.|+||..-+.. ++.+
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 99976 999998754 468899999999999999 999999999999999999999999765432 1111
Q ss_pred C---CCcccccccCcCccCccccCC----------CC-CCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccch
Q 045256 644 R---DFRPMKAAGTVGYIDPEYYGL----------NV-LTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 644 ~---~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~ 708 (789)
. .+...+...-..|.|||.+-. .. .+++.||||+||++.||++ |+++|.-.+- +.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----------~a 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----------LA 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----------Hh
Confidence 1 111112234467999998732 12 5778999999999999998 5666632110 00
Q ss_pred hhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
+.... ....+.+-+.+.. ..++.|+..|++.||++|.++++.++.-
T Consensus 247 Yr~~~-~~~~e~~Le~Ied---------~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 247 YRSGN-ADDPEQLLEKIED---------VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HhccC-ccCHHHHHHhCcC---------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 00000 0001111111111 1356788899999999999999999983
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-19 Score=193.13 Aligned_cols=246 Identities=18% Similarity=0.224 Sum_probs=187.8
Q ss_pred eecCCCcEEEeeC--------------Ccc--cccCC--CCcEEEEEecCceEEEEEeCCceEEEccCCC-------CCC
Q 045256 51 AAQPTQRLLCYQG--------------GTI--RAVEP--NISFSSISAGQSFFCGIRSGGYSLLCWDTNF-------SYN 105 (789)
Q Consensus 51 ~l~~~g~v~~wG~--------------~~~--~~~~~--~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~-------~~~ 105 (789)
+++.-..||.||. ..| +.++. +.-+.||..+.+|++++++.| .||++|.+. +.|
T Consensus 137 ~~d~pndvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl~~kg-qvY~cGhG~GGRlG~gdeq 215 (1267)
T KOG0783|consen 137 VLDLPNDVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFLTEKG-QVYVCGHGAGGRLGFGDEQ 215 (1267)
T ss_pred ccCCccceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEecCCC-cEEEeccCCCCccCcCccc
Confidence 5677788999999 222 33332 334788999999999999999 999999887 334
Q ss_pred CCCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCCC-----------------ccEEEEeeeCc
Q 045256 106 SNFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSGE-----------------LQFESLTSGID 168 (789)
Q Consensus 106 ~~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~-----------------~~v~~va~G~~ 168 (789)
....|.+|+.+.+-++.+|++-..|+++||++|.||+||-|...|++..+.. ..|+.|++|..
T Consensus 216 ~~~iPkrV~gL~gh~~~qisvs~~HslvLT~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIgvaAg~~ 295 (1267)
T KOG0783|consen 216 YNFIPKRVPGLIGHKVIQISVSHTHSLVLTKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIGVAAGKS 295 (1267)
T ss_pred ccccccccccccccceEEEEeecceeEEEeecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhhhhcccc
Confidence 4568988998888889999999999999999999999999999999765432 24789999999
Q ss_pred eeEEEEeCCCeEEEeecCCCCCcccCCC------------CCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCC
Q 045256 169 FSCGILTNNKTVRCWGINSISNQIQTSF------------ANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLN 236 (789)
Q Consensus 169 hs~al~~~~g~v~~wG~n~~gqlg~~~~------------~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~ 236 (789)
|++| -++. .||.||.| .||+|..+. ....+.-|+|...-|+.++++|.+|++-+ |-|...+.+
T Consensus 296 hsVa-wt~~-~VY~wGlN-~GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~~~~~i~~~ad--y~~~k~~~n 370 (1267)
T KOG0783|consen 296 HSVA-WTDT-DVYSWGLN-NGQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLLQNNSIIAFAD--YNQVKLPFN 370 (1267)
T ss_pred eeee-eecc-eEEEeccc-CceecCCCCCceeecchhhcccccceEEEEecCccEEEEecCCcEEEEec--ccceecCcc
Confidence 9999 5776 89999986 699996543 12236788899999999999999999975 334433332
Q ss_pred CC---------------ccceEEeccCcceEEEEEeeCCeEEEeeeCCCCc----ccCCCCCcEEEEEecCceEEEEeec
Q 045256 237 ST---------------AFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYS----VNGIRGKSFESIVSGSNFTCGLTTS 297 (789)
Q Consensus 237 ~~---------------~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq----~~~~~~~~v~~i~~G~~h~~al~~~ 297 (789)
.. ..++....+-..--+++++ -|.||+|=.+..-. ...+....+.+|+--.+..+.+++|
T Consensus 371 ~~~lks~~V~gg~l~~~~~~~~k~~a~~~kll~lte-~g~Vy~w~s~ns~~~~c~ftp~r~~~isdIa~~~N~~~~~t~d 449 (1267)
T KOG0783|consen 371 VDFLKSLKVTGGPLSLTRFNVRKLLASENKLLVLTE-LGEVYEWDSKNSTRTSCKFTPLRIFEISDIAWTANSLILCTRD 449 (1267)
T ss_pred hhccceeEEecCccchhhhhhhhcchhhhheeeecc-CCeEEEEecCCCceeeeecccceeeehhhhhhccceEEEEecC
Confidence 11 1234455555667789998 99999999765432 2223345567788777889999999
Q ss_pred CCeEEEecCC
Q 045256 298 NFSVICWGPG 307 (789)
Q Consensus 298 g~~v~~WG~n 307 (789)
| ||=++
T Consensus 450 G----c~~Rg 455 (1267)
T KOG0783|consen 450 G----CWKRG 455 (1267)
T ss_pred c----ceehh
Confidence 9 88777
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-20 Score=205.46 Aligned_cols=219 Identities=25% Similarity=0.320 Sum_probs=169.3
Q ss_pred eEeecccEEEEEEE----eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEEEEe
Q 045256 501 KIGAGSFGVVYKGK----LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
.+|+|.||.|++++ .+.+..+++|.+++......... ....|..++...+ ||.++++.-.++.+...+++++|
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~ 78 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF 78 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence 37899999999874 34577899998766443322211 4566888888886 99999999999999999999999
Q ss_pred cCCCchhHHHhhhch--------HHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 576 MKNGALYDHLHDRNN--------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 576 ~~~gsL~~~l~~~~~--------i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
..+|+|...+.+... ....++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++..-+...
T Consensus 79 ~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 79 LRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred cccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 999999988865442 3445778999999999 99999999999999999999999999986544332
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
.+||..|||||++. .....+|.||||++++||+||-.||.. +....++...+..
T Consensus 153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---------------------~~~~~Il~~~~~~ 206 (612)
T KOG0603|consen 153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---------------------DTMKRILKAELEM 206 (612)
T ss_pred ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---------------------HHHHHHhhhccCC
Confidence 28999999999997 567789999999999999999999854 1222333333333
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCCCH
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERPTM 757 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~ 757 (789)
+ .++....+.++..++..+|.+|.-.
T Consensus 207 p----~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 P----RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred c----hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 3 3444455566666777888888644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.7e-19 Score=192.75 Aligned_cols=210 Identities=23% Similarity=0.370 Sum_probs=152.7
Q ss_pred HhhcCCCcceEEEEEEEeCCeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 045256 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSS 618 (789)
Q Consensus 548 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 618 (789)
|+.+.|.|+.+++|.+.+....+.|.+|+..|+|.|.+... ..+.++++.||+|||.-.. ..|+.|++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeeccc
Confidence 46789999999999999999999999999999999999753 2578899999999998662 399999999
Q ss_pred CEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCC-------CCchhHHHHHHHHHHHHHcCCCCC
Q 045256 619 NILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV-------LTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 619 NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~sDv~SlGvil~elltG~~pf 691 (789)
|+++|..+.+||+|||+.................-..-|.|||.++... .+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999999999987654311111111222456799999986631 466799999999999999999999
Q ss_pred CCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCC-HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 692 FKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEIN-EAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
......... ..+ ...+.+ .......|... ..+....+..++.+||..+|++||+++.+...++.+...
T Consensus 159 ~~~~~~~~~-~ei---------i~~~~~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDP-DEI---------ILRVKK-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCCh-HHH---------HHHHHh-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 654332111 000 001111 00111111111 114444566778899999999999999999998876543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=172.42 Aligned_cols=134 Identities=19% Similarity=0.205 Sum_probs=100.5
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHH----------------------HHHHHHHHHHHHhhcCCCcc
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQE----------------------KESAFDSELAFLSRLHHKHL 556 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~----------------------~~~~~~~E~~~l~~l~HpnI 556 (789)
...||+|+||.||+|...+|+.||||+++......... .......|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999998889999999987543211000 01123459999999988776
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhHH-Hhh-------hchHHHHHHHHHHHH-HhcCCCCeEeccCCCCCEEECCCCc
Q 045256 557 VRLVGYCEEKDERLLVYDYMKNGALYDH-LHD-------RNNVEKNAARGIEYL-HNYAVPPIIHRDIKSSNILLDAQWT 627 (789)
Q Consensus 557 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~-------~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlkp~NIll~~~~~ 627 (789)
.....+.. ...+|||||++++++... +.. ...++.|++.+|.|| |+.+ |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 44333322 234899999998776544 222 235788999999999 6888 99999999999998 478
Q ss_pred EEEEeeccCcC
Q 045256 628 ARVSDFGLSMM 638 (789)
Q Consensus 628 ~kl~DfGls~~ 638 (789)
++|+|||++..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.3e-18 Score=169.74 Aligned_cols=136 Identities=18% Similarity=0.189 Sum_probs=104.5
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhh---------------------H-HHHHHHHHHHHHHHhhcCCCcc
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKK---------------------F-QEKESAFDSELAFLSRLHHKHL 556 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---------------------~-~~~~~~~~~E~~~l~~l~HpnI 556 (789)
...||+|+||.||+|.+.+|+.||||+++...... . ......+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 57899999999999998789999999977542110 0 0112234689999999999988
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhHH-Hh-------hhchHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCc
Q 045256 557 VRLVGYCEEKDERLLVYDYMKNGALYDH-LH-------DRNNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWT 627 (789)
Q Consensus 557 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~-------~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~ 627 (789)
.....+... ..+|||||++++++... +. +...++.+++.+|.+||+ .+ |+||||||+|||++ ++.
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 555444333 34899999998754332 32 234688999999999999 88 99999999999999 789
Q ss_pred EEEEeeccCcCCC
Q 045256 628 ARVSDFGLSMMGP 640 (789)
Q Consensus 628 ~kl~DfGls~~~~ 640 (789)
++|+|||++....
T Consensus 156 ~~liDFG~a~~~~ 168 (190)
T cd05145 156 PYIIDVSQAVELD 168 (190)
T ss_pred EEEEEcccceecC
Confidence 9999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.5e-18 Score=173.38 Aligned_cols=224 Identities=20% Similarity=0.256 Sum_probs=140.5
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC----------CCcceEEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH----------HKHLVRLVGYCE 564 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----------HpnIv~l~~~~~ 564 (789)
+...+.||.|+++.||.+++. +++.+++|.+..... ......+.+++|.-....+. |-.++-.++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~-~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPAD-ASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESST-THTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccc-cchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 445689999999999999875 589999998765542 22333455666664444432 212222222211
Q ss_pred ---------eCC--------eEEEEEEecCCCchhHHHhh---------------hchHHHHHHHHHHHHHhcCCCCeEe
Q 045256 565 ---------EKD--------ERLLVYDYMKNGALYDHLHD---------------RNNVEKNAARGIEYLHNYAVPPIIH 612 (789)
Q Consensus 565 ---------~~~--------~~~lv~e~~~~gsL~~~l~~---------------~~~i~~~ia~~l~~LH~~~~~~ivH 612 (789)
... ..+++|+-+. ++|.+++.. +..+..|+.+.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 111 2367888774 488887542 2345678899999999999 999
Q ss_pred ccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCC--------CCCCchhHHHHHHHHHHHH
Q 045256 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL--------NVLTAKSDVYGLGVVLLEL 684 (789)
Q Consensus 613 ~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlGvil~el 684 (789)
+||||+|+|++++|.++|+||+.......... ....+..|.+||.... -.++.+.|.|+||++||.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999987654222111 1234578999997633 2578899999999999999
Q ss_pred HcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCC
Q 045256 685 LTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKER 754 (789)
Q Consensus 685 ltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 754 (789)
..++.||........... .+ ..+. ++++.++.|+..+|+.||++|
T Consensus 244 WC~~lPf~~~~~~~~~~~-----------------~f-------~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW-----------------DF-------SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG-----------------GG-------TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc-----------------cc-------hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999965432111110 01 1223 566778888999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6e-19 Score=200.67 Aligned_cols=167 Identities=28% Similarity=0.476 Sum_probs=128.6
Q ss_pred CCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.+|..++.|-.|+||.||..+++. .+.+|+|+ .+... .+++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn---ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN---ILTFAGNPFVV--------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc---cccccCCccee---------------
Confidence 578889999999999999998764 56788854 11110 0111 33333444444
Q ss_pred EEecCCCchhHHHhhhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC----------
Q 045256 573 YDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES---------- 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~---------- 642 (789)
|+-...++.-.....+++.+++|||+.+ |+|||+||+|.||+.-|++|++|||+++.....
T Consensus 136 ------gDc~tllk~~g~lPvdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred ------chhhhhcccCCCCcchhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 5666666666666667789999999999 999999999999999999999999998653221
Q ss_pred ---CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 045256 643 ---ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696 (789)
Q Consensus 643 ---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~ 696 (789)
...+.....+||+.|+|||++....|...+|+|++|+|+||.+-|+.||+++..
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 112233356899999999999999999999999999999999999999987643
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.1e-17 Score=184.32 Aligned_cols=234 Identities=17% Similarity=0.190 Sum_probs=167.2
Q ss_pred ceeEEEEecCceeeeeeeecCCCcEEEeeCCcc----------cccCCCCcEEEEEecCceEEEE--EeCCceEEEccCC
Q 045256 34 GSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTI----------RAVEPNISFSSISAGQSFFCGI--RSGGYSLLCWDTN 101 (789)
Q Consensus 34 ~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~~~~----------~~~~~~~~v~~i~~G~~~~~~l--~~~G~~v~~wG~n 101 (789)
+..+.+-+|....+ .-..+|+||--|+.+. ..+.-..+|++|+.|-+-..++ ..+| .++.-|+.
T Consensus 479 ~qtv~L~~~RE~A~---iqa~sGKvYYaGn~t~~Gl~e~G~nWmEL~l~~~IVq~SVG~D~~~~~~~A~~G-~I~~v~D~ 554 (3738)
T KOG1428|consen 479 PQTVDLHFTREMAF---IQARSGKVYYAGNGTRFGLFETGNNWMELCLPEPIVQISVGIDTIMFRSGAGHG-WIASVDDK 554 (3738)
T ss_pred chheecccchhhhh---hhhcCccEEEecCccEEeEEccCCceEEecCCCceEEEEeccchhheeeccCcc-eEEeccCc
Confidence 34445555555555 5578899999888222 2222234899999998765555 5677 67776655
Q ss_pred CCCCCCCcceeeeeCCcceEEEEEecCCeEEE-EeeCCeEEEcCC-----CCCCCCCCCCCCccEEEEeeeCceeEEEEe
Q 045256 102 FSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCA-TTVQGQINCWRG-----DVNISKNAPSGELQFESLTSGIDFSCGILT 175 (789)
Q Consensus 102 ~~~~~~~~p~~v~~~~~~~i~~v~~G~~h~~a-l~~~G~v~~wG~-----~~~~~~~~~~~~~~v~~va~G~~hs~al~~ 175 (789)
..... .-+.++ ...-+|+.+ ||..|... +.+||++|..|- |...|......+.-|.++|-|..|+|+ ++
T Consensus 555 k~~~~--~Rr~~P-~n~rKIv~v-~~s~~VY~~vSenGkifM~G~~tm~~n~SSqmln~L~~~~isslAlGKsH~~a-v~ 629 (3738)
T KOG1428|consen 555 KRNGR--LRRLVP-SNRRKIVHV-CASGHVYGYVSENGKIFMGGLHTMRVNVSSQMLNGLDNVMISSLALGKSHGVA-VT 629 (3738)
T ss_pred ccccc--hhhcCC-CCcceeEEE-eeeeEEEEEEccCCeEEeecceeEEecchHHHhhccccceeehhhccccceeE-EE
Confidence 42221 111121 122245555 56667765 789999999994 333444444444568899999999999 56
Q ss_pred CCCeEEEeecCCCCCcccCCC-----------------------------------------------------------
Q 045256 176 NNKTVRCWGINSISNQIQTSF----------------------------------------------------------- 196 (789)
Q Consensus 176 ~~g~v~~wG~n~~gqlg~~~~----------------------------------------------------------- 196 (789)
.+|.||+||.|+.+|.|....
T Consensus 630 rNG~l~T~GlNN~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~HtW~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~C 709 (3738)
T KOG1428|consen 630 RNGHLFTWGLNNMNQCGRVESTSTTSSPRHSGRQEYQICPIGEHTWLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHC 709 (3738)
T ss_pred eCCeEEEEecCCcccccccccccccCCcccccceeecccCCccceeecCCcchhhhcccccccccccccCCCCCCccccc
Confidence 677999999999999865221
Q ss_pred -------------------------------------------------------CCceeEEEeeCCceeEEEccCCcEE
Q 045256 197 -------------------------------------------------------ANRSMFSITAGGNHVCGIDSNGFVI 221 (789)
Q Consensus 197 -------------------------------------------------------~~~~v~~i~~G~~h~~al~~dG~v~ 221 (789)
.+-++++|+||..|++.|.+||+||
T Consensus 710 G~GES~C~~CG~Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~~HPs~V~~sq~~Hdvkv~sVSCG~~HtVlL~sd~~Vf 789 (3738)
T KOG1428|consen 710 GVGESTCLRCGLCRPCGEVTEPAQPGRAQHVQFSSTAAPQRSTLHPSRVILSQGPHDVKVSSVSCGNFHTVLLASDRRVF 789 (3738)
T ss_pred CCCcccceeccccccccCcCCcCCCCHHHhheecccccccccccCchheeeccCCcceeEEEEeccCceEEEEecCCcEE
Confidence 0001779999999999999999999
Q ss_pred EEEcCCCCCCCcCCC-----------CCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC
Q 045256 222 CYGDNKSGQLKFPLN-----------STAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR 277 (789)
Q Consensus 222 ~wG~n~~Gql~~~~~-----------~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~ 277 (789)
++|.|.+||||.+.. +....++||++|++||..+.. ||+||++|.-..||+.-|.
T Consensus 790 TFG~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~l~~~-DGsVFTFGaF~KGQL~RP~ 855 (3738)
T KOG1428|consen 790 TFGSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTILRAN-DGSVFTFGAFGKGQLARPA 855 (3738)
T ss_pred EecCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceEEEec-CCcEEEeccccCccccCcc
Confidence 999999999977653 234579999999999999999 9999999999999976553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.5e-18 Score=198.01 Aligned_cols=193 Identities=25% Similarity=0.300 Sum_probs=149.9
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC---CCcceEEEEEEE
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH---HKHLVRLVGYCE 564 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~ 564 (789)
+.+...+.|.+.+.||+|+||+||+|...+++.||+|+-+....-. |.--.+++.||+ -+-|+.+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-------fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-------FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-------eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 4445567899999999999999999998889999999855543322 222233445554 234455555556
Q ss_pred eCCeEEEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-------CCCcEE
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-------AQWTAR 629 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-------~~~~~k 629 (789)
-.+.-+||+||.+.|+|.+++.... .+..|+++.+++||..+ |||+||||+|.||. ...-++
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 6677899999999999999997433 47889999999999999 99999999999993 234689
Q ss_pred EEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCC
Q 045256 630 VSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRA 690 (789)
Q Consensus 630 l~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~p 690 (789)
|+|||-+..+.-..........++|-.+--+|+..++.++.+.|.|.|+-+++-||.|+..
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999988543222222333456788999999999999999999999999999999999854
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.5e-17 Score=161.83 Aligned_cols=129 Identities=18% Similarity=0.229 Sum_probs=99.1
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-----CCCcceEEEEEEEeCC---eE
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-----HHKHLVRLVGYCEEKD---ER 569 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~~~~---~~ 569 (789)
-.++||+|+|+.||. +++....+||++...... ..+.+.+|+.+++++ .||||++++++++++. ..
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCeEEEEEeccccc----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999996 433333468886543221 234589999999999 5799999999999874 33
Q ss_pred E-EEEEe--cCCCchhHHHhhhc-----hHHHHHHHHH-HHHHhcCCCCeEeccCCCCCEEECC----CCcEEEEeecc
Q 045256 570 L-LVYDY--MKNGALYDHLHDRN-----NVEKNAARGI-EYLHNYAVPPIIHRDIKSSNILLDA----QWTARVSDFGL 635 (789)
Q Consensus 570 ~-lv~e~--~~~gsL~~~l~~~~-----~i~~~ia~~l-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DfGl 635 (789)
+ +|+|| +++++|.+++.+.. .++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEEDVAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHhHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 3 78999 55799999996421 2456777777 9999999 999999999999974 34899999543
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-17 Score=179.41 Aligned_cols=215 Identities=17% Similarity=0.159 Sum_probs=161.4
Q ss_pred EEEeCCceEEEccCCC-------CCCCCCcceeeeeC--CcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCC--
Q 045256 87 GIRSGGYSLLCWDTNF-------SYNSNFVPKRIYYN--DTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPS-- 155 (789)
Q Consensus 87 ~l~~~G~~v~~wG~n~-------~~~~~~~p~~v~~~--~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~-- 155 (789)
+++.-. .||+||.|. +++....|++|..+ .++-+++|..|..|++.+++.|.||++|-+..|.++...
T Consensus 137 ~~d~pn-dvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl~~kgqvY~cGhG~GGRlG~gdeq 215 (1267)
T KOG0783|consen 137 VLDLPN-DVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFLTEKGQVYVCGHGAGGRLGFGDEQ 215 (1267)
T ss_pred ccCCcc-ceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEecCCCcEEEeccCCCCccCcCccc
Confidence 445555 799999998 45566789888654 455577999999999999999999999977776664332
Q ss_pred -----------CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCC----------------ceeEEEeeCC
Q 045256 156 -----------GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFAN----------------RSMFSITAGG 208 (789)
Q Consensus 156 -----------~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~----------------~~v~~i~~G~ 208 (789)
...++.+|++...|+++ +|..|.||+||.|..+|||..++.. ..++.|+||.
T Consensus 216 ~~~iPkrV~gL~gh~~~qisvs~~Hslv-LT~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIgvaAg~ 294 (1267)
T KOG0783|consen 216 YNFIPKRVPGLIGHKVIQISVSHTHSLV-LTKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIGVAAGK 294 (1267)
T ss_pred ccccccccccccccceEEEEeecceeEE-EeecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhhhhccc
Confidence 12358999999999999 5777799999999999999866521 2377899999
Q ss_pred ceeEEEccCCcEEEEEcCCCCCCCcCCCC-----------CccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC
Q 045256 209 NHVCGIDSNGFVICYGDNKSGQLKFPLNS-----------TAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR 277 (789)
Q Consensus 209 ~h~~al~~dG~v~~wG~n~~Gql~~~~~~-----------~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~ 277 (789)
.|++|-+. -.||.||.|. ||||..++. ....+.-|.|...-|+.++. +|.+|++-+-..-.++...
T Consensus 295 ~hsVawt~-~~VY~wGlN~-GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~~-~~~i~~~ady~~~k~~~n~ 371 (1267)
T KOG0783|consen 295 SHSVAWTD-TDVYSWGLNN-GQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLLQ-NNSIIAFADYNQVKLPFNV 371 (1267)
T ss_pred ceeeeeec-ceEEEecccC-ceecCCCCCceeecchhhcccccceEEEEecCccEEEEec-CCcEEEEecccceecCcch
Confidence 99999864 5699999886 999765441 23467788899999999998 9999999864333322110
Q ss_pred ----------------CCcEEEEEecCceEEEEeecCCeEEEecCC
Q 045256 278 ----------------GKSFESIVSGSNFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 278 ----------------~~~v~~i~~G~~h~~al~~~g~~v~~WG~n 307 (789)
-.++....+-..--+++++-| .||+|=.+
T Consensus 372 ~~lks~~V~gg~l~~~~~~~~k~~a~~~kll~lte~g-~Vy~w~s~ 416 (1267)
T KOG0783|consen 372 DFLKSLKVTGGPLSLTRFNVRKLLASENKLLVLTELG-EVYEWDSK 416 (1267)
T ss_pred hccceeEEecCccchhhhhhhhcchhhhheeeeccCC-eEEEEecC
Confidence 012333444445567888777 99999866
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.1e-16 Score=175.66 Aligned_cols=233 Identities=15% Similarity=0.141 Sum_probs=170.2
Q ss_pred EEEEEecCceEEEEEeCCceEEEccCCCCC---CCCCcceeeeeCCcceEEEEEecCCeEEEE--eeCCeEEEcCCCC-C
Q 045256 75 FSSISAGQSFFCGIRSGGYSLLCWDTNFSY---NSNFVPKRIYYNDTVLLSSVSVGNNHVCAT--TVQGQINCWRGDV-N 148 (789)
Q Consensus 75 v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~---~~~~~p~~v~~~~~~~i~~v~~G~~h~~al--~~~G~v~~wG~~~-~ 148 (789)
-+.+..|..+.+.-+.+| +||--|....- +.+..-..+... ..|++|+.|-+-..++ ..+|.++.-|... .
T Consensus 481 tv~L~~~RE~A~iqa~sG-KvYYaGn~t~~Gl~e~G~nWmEL~l~--~~IVq~SVG~D~~~~~~~A~~G~I~~v~D~k~~ 557 (3738)
T KOG1428|consen 481 TVDLHFTREMAFIQARSG-KVYYAGNGTRFGLFETGNNWMELCLP--EPIVQISVGIDTIMFRSGAGHGWIASVDDKKRN 557 (3738)
T ss_pred heecccchhhhhhhhcCc-cEEEecCccEEeEEccCCceEEecCC--CceEEEEeccchhheeeccCcceEEeccCcccc
Confidence 455677777888888999 99999887611 111122222222 3577999998876665 4567777776422 2
Q ss_pred CCC--CCCCCCccEEEEeeeCceeEEEEeCCCeEEEeecC-----CCCCcccCCCCCceeEEEeeCCceeEEEccCCcEE
Q 045256 149 ISK--NAPSGELQFESLTSGIDFSCGILTNNKTVRCWGIN-----SISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVI 221 (789)
Q Consensus 149 ~~~--~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n-----~~gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~ 221 (789)
+.+ ..|....+|+.+ ||..|.......+|++|..|.. ...|+-.+ ..+.-|.+++-|..|.+|++.+|.||
T Consensus 558 ~~~Rr~~P~n~rKIv~v-~~s~~VY~~vSenGkifM~G~~tm~~n~SSqmln~-L~~~~isslAlGKsH~~av~rNG~l~ 635 (3738)
T KOG1428|consen 558 GRLRRLVPSNRRKIVHV-CASGHVYGYVSENGKIFMGGLHTMRVNVSSQMLNG-LDNVMISSLALGKSHGVAVTRNGHLF 635 (3738)
T ss_pred cchhhcCCCCcceeEEE-eeeeEEEEEEccCCeEEeecceeEEecchHHHhhc-cccceeehhhccccceeEEEeCCeEE
Confidence 222 233334467766 6778888888899999999953 33444332 23445889999999999999999999
Q ss_pred EEEcCCCCCCCcCCC-----------------------------------------------------------------
Q 045256 222 CYGDNKSGQLKFPLN----------------------------------------------------------------- 236 (789)
Q Consensus 222 ~wG~n~~Gql~~~~~----------------------------------------------------------------- 236 (789)
+||-|..||.|....
T Consensus 636 T~GlNN~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~HtW~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~CG~GES~ 715 (3738)
T KOG1428|consen 636 TWGLNNMNQCGRVESTSTTSSPRHSGRQEYQICPIGEHTWLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHCGVGEST 715 (3738)
T ss_pred EEecCCcccccccccccccCCcccccceeecccCCccceeecCCcchhhhcccccccccccccCCCCCCcccccCCCccc
Confidence 999999999821100
Q ss_pred ------------------------------------------------CCccceEEeccCcceEEEEEeeCCeEEEeeeC
Q 045256 237 ------------------------------------------------STAFEYSALSLGFNHSCAIRRLNGSVVCWGSQ 268 (789)
Q Consensus 237 ------------------------------------------------~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n 268 (789)
+-..++++|+||..|++.|.+ ||.||++|.|
T Consensus 716 C~~CG~Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~~HPs~V~~sq~~Hdvkv~sVSCG~~HtVlL~s-d~~VfTFG~~ 794 (3738)
T KOG1428|consen 716 CLRCGLCRPCGEVTEPAQPGRAQHVQFSSTAAPQRSTLHPSRVILSQGPHDVKVSSVSCGNFHTVLLAS-DRRVFTFGSN 794 (3738)
T ss_pred ceeccccccccCcCCcCCCCHHHhheecccccccccccCchheeeccCCcceeEEEEeccCceEEEEec-CCcEEEecCC
Confidence 001268899999999999999 9999999999
Q ss_pred CCCcccCCC--------------CCcEEEEEecCceEEEEeecCCeEEEecCCCCCCCCC
Q 045256 269 GEYSVNGIR--------------GKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSND 314 (789)
Q Consensus 269 ~~gq~~~~~--------------~~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~~~~~ 314 (789)
.+||++..+ +..+++|+||++||..+..|| +||++|.=-.||++.
T Consensus 795 ~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~l~~~DG-sVFTFGaF~KGQL~R 853 (3738)
T KOG1428|consen 795 CHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTILRANDG-SVFTFGAFGKGQLAR 853 (3738)
T ss_pred cccccCcCccccCCCcceEEcCCCCceEEEecCCCceEEEecCC-cEEEeccccCccccC
Confidence 999976543 567999999999999999999 999999866677643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-16 Score=159.00 Aligned_cols=133 Identities=24% Similarity=0.374 Sum_probs=109.2
Q ss_pred eEeecccEEEEEEEeCCCcEEEEEEcccchhh----hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 501 KIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK----KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
.||+|+||.||++.. +++.+++|........ ........+.+|++++..++|+++....-++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 6788999985432211 11122356789999999999887665555666677789999999
Q ss_pred CCCchhHHHhhhc-hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 577 KNGALYDHLHDRN-NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 577 ~~gsL~~~l~~~~-~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
++++|.+++.... .++.+++++|.+||+.+ ++|+|+||.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGNDELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999887655 78999999999999998 99999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.5e-17 Score=165.18 Aligned_cols=191 Identities=19% Similarity=0.248 Sum_probs=131.5
Q ss_pred CCCcceEEEEEEEe---------------------------CCeEEEEEEecCCCchhHHHhhh-------chHHHHHHH
Q 045256 552 HHKHLVRLVGYCEE---------------------------KDERLLVYDYMKNGALYDHLHDR-------NNVEKNAAR 597 (789)
Q Consensus 552 ~HpnIv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~ 597 (789)
+|||||++.++|.+ +..+|+||..++. +|.++|-.+ .-+..|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999987743 2346899998876 999998543 247889999
Q ss_pred HHHHHHhcCCCCeEeccCCCCCEEE--CCCC--cEEEEeeccCcCCCCCCCC----CcccccccCcCccCccccCCCC--
Q 045256 598 GIEYLHNYAVPPIIHRDIKSSNILL--DAQW--TARVSDFGLSMMGPESERD----FRPMKAAGTVGYIDPEYYGLNV-- 667 (789)
Q Consensus 598 ~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfGls~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-- 667 (789)
|+.|||.++ |.|||||++|||+ |+|. .+.|+|||.+.--....-+ ......-|...-||||+....+
T Consensus 353 av~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 353 AVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 999999999 9999999999999 4443 5788999976421111111 1112345778899999984432
Q ss_pred ----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHH
Q 045256 668 ----LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTA 743 (789)
Q Consensus 668 ----~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~ 743 (789)
.-.|+|.|+.|.+.||++....||+...+.- .+. .......++.- +...+..+++++
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~------L~~----------r~Yqe~qLPal---p~~vpp~~rqlV 490 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML------LDT----------RTYQESQLPAL---PSRVPPVARQLV 490 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccchhe------ech----------hhhhhhhCCCC---cccCChHHHHHH
Confidence 2358999999999999999999998744310 110 00111112111 122334566777
Q ss_pred HhhcCcCCCCCCCHHHHHHHHH
Q 045256 744 MHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 744 ~~cl~~dp~~RPt~~evl~~L~ 765 (789)
...|+.||.+||+..=....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 7899999999998866655553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=157.74 Aligned_cols=146 Identities=25% Similarity=0.258 Sum_probs=112.7
Q ss_pred HHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhh------------------HHHHHHHHHHHHHHH
Q 045256 487 AELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKK------------------FQEKESAFDSELAFL 548 (789)
Q Consensus 487 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------------~~~~~~~~~~E~~~l 548 (789)
.++......|.+.+.||+|+||.||++..++|+.||||++....... .......+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 34444445588889999999999999998889999999865432100 001122367899999
Q ss_pred hhcCCCc--ceEEEEEEEeCCeEEEEEEecCCCchhHHHh--hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC
Q 045256 549 SRLHHKH--LVRLVGYCEEKDERLLVYDYMKNGALYDHLH--DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA 624 (789)
Q Consensus 549 ~~l~Hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 624 (789)
.++.|++ +.+.++ ....++||||+++++|.+... ....++.++++++.++|+.+ |+|+||||+||++++
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~ 160 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVLEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDD 160 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccccccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcC
Confidence 9998874 444443 245689999999999877653 23467889999999999988 999999999999999
Q ss_pred CCcEEEEeeccCcCC
Q 045256 625 QWTARVSDFGLSMMG 639 (789)
Q Consensus 625 ~~~~kl~DfGls~~~ 639 (789)
++.++|+|||++...
T Consensus 161 ~~~~~liDfg~~~~~ 175 (198)
T cd05144 161 DEKIYIIDWPQMVST 175 (198)
T ss_pred CCcEEEEECCccccC
Confidence 999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.5e-16 Score=183.19 Aligned_cols=140 Identities=21% Similarity=0.279 Sum_probs=114.0
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEE-cccchhh---hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKR-GETAKTK---KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
..|...++||+|+||+||++.+.+. .+++|+ ..+.... ......+.+.+|++++++++|++++....++.+.+..
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445678999999999999987544 444443 2221111 1112235688999999999999999888888887888
Q ss_pred EEEEEecCCCchhHHHhhhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 570 LLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
++||||+++++|.+++.....++.+++++|.|||+.+ |+||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLEGNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHHHHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999999888889999999999999998 9999999999999 577999999999865
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.1e-16 Score=158.60 Aligned_cols=134 Identities=22% Similarity=0.332 Sum_probs=111.4
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhh----hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK----KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
+.||+|++|.||++.. ++..+++|+....... ........+.+|++++..++|++|.....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999975432211 1111234578899999999999998887787788888999999
Q ss_pred cCCCchhHHHhhh----chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 576 MKNGALYDHLHDR----NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 576 ~~~gsL~~~l~~~----~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+++++|.+++... ..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNGMEELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhccHHHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988653 378889999999999998 99999999999999 78999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=9.9e-16 Score=156.67 Aligned_cols=143 Identities=17% Similarity=0.164 Sum_probs=108.1
Q ss_pred HHHhcCCccccceEeecccEEEEEEE--eCCCcEEEEEEcccchhhh--------------------HHHHHHHHHHHHH
Q 045256 489 LAAATNNFSLENKIGAGSFGVVYKGK--LPDGQEVAIKRGETAKTKK--------------------FQEKESAFDSELA 546 (789)
Q Consensus 489 l~~~~~~~~~~~~LG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~~--------------------~~~~~~~~~~E~~ 546 (789)
+..-...|++.+.||+|+||.||+|. ..+|+.||+|+++...... .......+.+|++
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444468899999999999999998 5689999999876532110 0111234678999
Q ss_pred HHhhcCCCc--ceEEEEEEEeCCeEEEEEEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCC
Q 045256 547 FLSRLHHKH--LVRLVGYCEEKDERLLVYDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIK 616 (789)
Q Consensus 547 ~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk 616 (789)
+++++.+.. +.+++++ ...++||||+++.+|...+.. ...++.+++.+|.+||+.+. |+|+|||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 999997633 3444443 235899999999887665421 23688999999999999873 8999999
Q ss_pred CCCEEECCCCcEEEEeeccCcC
Q 045256 617 SSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 617 p~NIll~~~~~~kl~DfGls~~ 638 (789)
|+||+++ ++.++|+|||++..
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhc
Confidence 9999999 88999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-16 Score=168.82 Aligned_cols=113 Identities=31% Similarity=0.487 Sum_probs=96.1
Q ss_pred eEEEEEEecCCCchhHHHhhhc-----------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 568 ERLLVYDYMKNGALYDHLHDRN-----------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~~-----------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
.+|+.|++++..+|.++|..+. .+++|++.+++| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 4789999999999999996432 578899999999 66 799999999999999999999999997
Q ss_pred cCCCCCC----CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc
Q 045256 637 MMGPESE----RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686 (789)
Q Consensus 637 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt 686 (789)
....... .........||..||+||.+.+..|+.|+||||||+||+||++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 5543333 1122345679999999999999999999999999999999997
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=143.34 Aligned_cols=132 Identities=23% Similarity=0.266 Sum_probs=97.5
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHH--------------------HHHHHHHHHHhhcCCCc--c
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKE--------------------SAFDSELAFLSRLHHKH--L 556 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~--------------------~~~~~E~~~l~~l~Hpn--I 556 (789)
.+.||+|+||+||++...+++.||||++............ .....|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987653221111000 01245777777775443 4
Q ss_pred eEEEEEEEeCCeEEEEEEecCCC-----chhHHHh--hhchHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcE
Q 045256 557 VRLVGYCEEKDERLLVYDYMKNG-----ALYDHLH--DRNNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTA 628 (789)
Q Consensus 557 v~l~~~~~~~~~~~lv~e~~~~g-----sL~~~l~--~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~ 628 (789)
.+++++ ...++||||++++ .|.+... +...++.+++.++.++|. .+ |+|+||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcE
Confidence 555543 2458999999984 4444432 345688999999999999 77 99999999999999 8999
Q ss_pred EEEeeccCcC
Q 045256 629 RVSDFGLSMM 638 (789)
Q Consensus 629 kl~DfGls~~ 638 (789)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.9e-14 Score=144.50 Aligned_cols=135 Identities=18% Similarity=0.225 Sum_probs=104.1
Q ss_pred ceEe-ecccEEEEEEEeCCCcEEEEEEcccchh----hh-----HHHHHHHHHHHHHHHhhcCCCcc--eEEEEEEEeCC
Q 045256 500 NKIG-AGSFGVVYKGKLPDGQEVAIKRGETAKT----KK-----FQEKESAFDSELAFLSRLHHKHL--VRLVGYCEEKD 567 (789)
Q Consensus 500 ~~LG-~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~-----~~~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~~~ 567 (789)
..|| .|+.|+||++... +..++||++..... .. .......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5687 8899999999874 67899998753211 00 01223457889999999998875 67777654432
Q ss_pred e----EEEEEEecCC-CchhHHHhhh---chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 E----RLLVYDYMKN-GALYDHLHDR---NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 ~----~~lv~e~~~~-gsL~~~l~~~---~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
. .++||||+++ .+|.+++.+. .....+++++|.+||+.+ |+||||||.|||++.++.++|+|||.+..
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAPLSEEQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 2 2599999997 6888887642 245778999999999999 99999999999999999999999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-14 Score=133.75 Aligned_cols=134 Identities=16% Similarity=0.236 Sum_probs=110.5
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--CcceEEEEEEEeCCeEEEEEEe
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--KHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~e~ 575 (789)
+.+.|++|.++.||++...+ +.+++|....... ...+.+|+.+++.++| +++.+++.+....+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35789999999999999754 7899998654332 2358889999999976 5899999988887889999999
Q ss_pred cCCCchhHH-HhhhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 576 MKNGALYDH-LHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 576 ~~~gsL~~~-l~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+++..+..+ ......+..+++++|++||....++++|+||||+||++++++.++++||+.+..
T Consensus 75 ~~g~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccCCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877643 123346788999999999987545699999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.9e-16 Score=177.52 Aligned_cols=246 Identities=22% Similarity=0.316 Sum_probs=179.1
Q ss_pred CccccceEeecccEEEEEEEeC--CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP--DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 571 (789)
.|.+.+.||+|.|+.|-..... ....+++|.+.... +..........|..+.+.+. |+|++.+++...+.+..++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4666778999999999888653 33456666654433 22222334556888888887 9999999999999999999
Q ss_pred EEEecCCCchhHHH-hh---------hchHHHHHHHHHHHHH-hcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCC
Q 045256 572 VYDYMKNGALYDHL-HD---------RNNVEKNAARGIEYLH-NYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMG 639 (789)
Q Consensus 572 v~e~~~~gsL~~~l-~~---------~~~i~~~ia~~l~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~ 639 (789)
.+||.+++++++.+ +. ......|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||++..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999999888 42 2357889999999999 877 99999999999999999 9999999999776
Q ss_pred CC-CCCCCccccccc-CcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 640 PE-SERDFRPMKAAG-TVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 640 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
.. ..........+| ++.|+|||.+.+. ...+..|+||.|+++.-+++|..|+.........- ..|.. ..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---~~~~~-----~~ 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---SSWKS-----NK 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc---eeecc-----cc
Confidence 55 444444445678 9999999999774 55678999999999999999999986544322111 11110 00
Q ss_pred hHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 717 LVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 717 ~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
+. .... .........++..+++..+|+.|.+.+++..
T Consensus 248 -----~~~~~~~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 -----GRFTQLP----WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -----cccccCc----cccCChhhhhcccccccCCchhccccccccc
Confidence 00 0111 1112222334566788899999998887654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-12 Score=144.33 Aligned_cols=141 Identities=25% Similarity=0.299 Sum_probs=101.3
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHH------------------------------------H
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQE------------------------------------K 537 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~------------------------------------~ 537 (789)
..|+ .+.||.|++|.||+|++++|+.||||+.++........ .
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 36899999999999999999999999976542211110 0
Q ss_pred HHHHHHHHHHHhhcC----CCcceEEEEEE-EeCCeEEEEEEecCCCchhHHHhh------hchHHHHHHH-HHHHHHhc
Q 045256 538 ESAFDSELAFLSRLH----HKHLVRLVGYC-EEKDERLLVYDYMKNGALYDHLHD------RNNVEKNAAR-GIEYLHNY 605 (789)
Q Consensus 538 ~~~~~~E~~~l~~l~----HpnIv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~-~l~~LH~~ 605 (789)
+-.|.+|.+.+.+++ |.+-+.+-..+ ......+|||||+++.+|.++... +..++..+++ .+..+|..
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLDRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCCHHHHHHHHHHHHHHHHHhC
Confidence 113556666666663 33333333333 234557999999999999887642 2356666666 46788988
Q ss_pred CCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 606 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+ ++|+|+||.||+++.+++++|+|||++..
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 8 99999999999999999999999999864
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.8e-14 Score=140.68 Aligned_cols=196 Identities=20% Similarity=0.334 Sum_probs=133.9
Q ss_pred HHHHhhcCCCcceEEEEEEEeC-----CeEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCC
Q 045256 545 LAFLSRLHHKHLVRLVGYCEEK-----DERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAV 607 (789)
Q Consensus 545 ~~~l~~l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~ 607 (789)
+.-|-++.|.|||++..|+.+. .+..++.|||..|+|..+|++. .++..||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445567899999999998654 3468999999999999999753 367889999999999998
Q ss_pred CCeEeccCCCCCEEECCCCcEEEEeeccCcCCC--CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHH
Q 045256 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP--ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELL 685 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ell 685 (789)
|+|+|+++..+-|++..++-+|+.----..... ............+-++|.+||.=.....+..+|||+||+..+||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999888874211111100 001111112234678999999887777888999999999999998
Q ss_pred cCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 686 TGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 686 tG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.+......... . ....+.+...+. ..... +-+.++.+|++..|..||+|++++.+.
T Consensus 277 ilEiq~tnseS-----~--------~~~ee~ia~~i~---~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 277 ILEIQSTNSES-----K--------VEVEENIANVII---GLENG-------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HheeccCCCcc-----e--------eehhhhhhhhee---eccCc-------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 87643211110 0 000111111110 00010 113457789999999999999998764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.9e-11 Score=133.72 Aligned_cols=143 Identities=19% Similarity=0.209 Sum_probs=97.8
Q ss_pred hcCCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhH------------------------------HHHHH-
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKF------------------------------QEKES- 539 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~------------------------------~~~~~- 539 (789)
...+|+. +.||+|++|+||+|++++ |+.||||+.++...... .+..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999987 99999999875421110 01111
Q ss_pred -----HHHHHHHHHhhcC----CCcceEEEEEEEe-CCeEEEEEEecCCCchhHH--Hhhhc----hHHHHHHHH-HHHH
Q 045256 540 -----AFDSELAFLSRLH----HKHLVRLVGYCEE-KDERLLVYDYMKNGALYDH--LHDRN----NVEKNAARG-IEYL 602 (789)
Q Consensus 540 -----~~~~E~~~l~~l~----HpnIv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~----~i~~~ia~~-l~~L 602 (789)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++++.+.++ +.... .++...++. +.-+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 2445555555553 4444554444433 4567899999999999774 33322 344444432 2334
Q ss_pred HhcCCCCeEeccCCCCCEEECCCC----cEEEEeeccCcC
Q 045256 603 HNYAVPPIIHRDIKSSNILLDAQW----TARVSDFGLSMM 638 (789)
Q Consensus 603 H~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGls~~ 638 (789)
...+ ++|+|+||.||+++.++ ++++.|||+...
T Consensus 277 f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 277 FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 5566 99999999999999888 999999999764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8.4e-12 Score=121.36 Aligned_cols=130 Identities=12% Similarity=0.140 Sum_probs=97.8
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcce-EEEEEEEeCCeEEEEEEecC
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV-RLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~e~~~ 577 (789)
.+.|+.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecC
Confidence 467889999999999874 77899998644321 112367899999988765554 444432 334589999999
Q ss_pred CCchhHHHhhhchHHHHHHHHHHHHHhcCC--CCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 578 NGALYDHLHDRNNVEKNAARGIEYLHNYAV--PPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 578 ~gsL~~~l~~~~~i~~~ia~~l~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
+.++.+..........+++++|+.||.... ..++|+|++|.||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTEDFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccccccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 988875422334577899999999999872 3369999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.4e-11 Score=130.57 Aligned_cols=242 Identities=21% Similarity=0.273 Sum_probs=164.4
Q ss_pred CCccccceEee--cccEEEEEEEe---CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGA--GSFGVVYKGKL---PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~--G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~ 567 (789)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+.......... .=.+|+.-..++ .|+|.++....+...+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~--~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSK--RKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccc--cccchhhcccccCccccccccCcccccCC
Confidence 35666788999 99999999975 4678899997332211110000 112455555556 4999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhhc---------hHHHHHHH----HHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEee
Q 045256 568 ERLLVYDYMKNGALYDHLHDRN---------NVEKNAAR----GIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDF 633 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~----~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 633 (789)
..++-+|++. .+|..+.+... ....+..+ ||.++|+.. ++|-|+||.||++..+ ...+++||
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9999999986 58888876543 34455556 999999998 9999999999999999 88999999
Q ss_pred ccCcCCCCCCCCCc---ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh
Q 045256 634 GLSMMGPESERDFR---PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 634 Gls~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
|+...+........ .....+...|++||...+ .++...|+|++|.++.|..++..++...... .|..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~- 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQ- 337 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccc-
Confidence 99876555442211 123367889999998754 5788999999999999999987665322110 1110
Q ss_pred hhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
++....+.+... .....+...++.+++.+|..|++.+++..
T Consensus 338 ----------~r~~~ip~e~~~-~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ----------LRQGYIPLEFCE-GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----------cccccCchhhhc-CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 001000111110 11122333577799999999998877654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.7e-10 Score=105.84 Aligned_cols=134 Identities=22% Similarity=0.325 Sum_probs=102.7
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEE-cccchhhhHH-H--HHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKR-GETAKTKKFQ-E--KESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~~~~-~--~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
..+.+|+-+.+|.+.+.+ ..+++|. +++......- + ......+|..++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357789999999997643 4466664 3332222211 1 133567899999999766666556667788888999999
Q ss_pred cCCCchhHHHhhh-chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 576 MKNGALYDHLHDR-NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 576 ~~~gsL~~~l~~~-~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+++..|.+.+... ..+.+.+=+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcchHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 578888888899999999 99999999999998764 99999999864
|
|
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.2e-11 Score=78.93 Aligned_cols=30 Identities=47% Similarity=0.980 Sum_probs=26.2
Q ss_pred eEEEeeCCceeEEEccCCcEEEEEcCCCCC
Q 045256 201 MFSITAGGNHVCGIDSNGFVICYGDNKSGQ 230 (789)
Q Consensus 201 v~~i~~G~~h~~al~~dG~v~~wG~n~~Gq 230 (789)
|++|+||..|+++|++||+||+||+|.+||
T Consensus 1 V~~ia~G~~ht~al~~~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALTSDGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE-TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEEEcCCCEEEEcCCcCCC
Confidence 689999999999999999999999999998
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.5e-09 Score=120.27 Aligned_cols=162 Identities=16% Similarity=0.221 Sum_probs=119.2
Q ss_pred eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCchhHHHhhhch----
Q 045256 515 LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---- 590 (789)
Q Consensus 515 ~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---- 590 (789)
..++.+|.|...+.... +..+...+-++.|+.++||||+++++.++..+..|||+|.+. .|..++.+...
T Consensus 34 k~~~~~vsVF~~~~~~~----~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG----EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCc----hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHHHHHH
Confidence 44677777776544333 223346778889999999999999999999999999999985 56667765543
Q ss_pred -HHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCC
Q 045256 591 -VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLT 669 (789)
Q Consensus 591 -i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 669 (789)
-+.||+.||.|||+.+. ++|++|.-+.|++++.|+-||.+|-+............ ...---.|..|+.+....
T Consensus 108 ~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~--~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAK--SLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccc--cchhhhcccChhhcCccc--
Confidence 46789999999996654 99999999999999999999999987654222221000 111123466676553322
Q ss_pred chhHHHHHHHHHHHHHcCC
Q 045256 670 AKSDVYGLGVVLLELLTGK 688 (789)
Q Consensus 670 ~~sDv~SlGvil~elltG~ 688 (789)
-..|.|-||++++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 2469999999999999993
|
|
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-10 Score=76.66 Aligned_cols=30 Identities=30% Similarity=0.696 Sum_probs=23.8
Q ss_pred eEEeccCcceEEEEEeeCCeEEEeeeCCCCc
Q 045256 242 YSALSLGFNHSCAIRRLNGSVVCWGSQGEYS 272 (789)
Q Consensus 242 v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq 272 (789)
|++|+||..|+++|++ ||+||+||+|.+||
T Consensus 1 V~~ia~G~~ht~al~~-~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALTS-DGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE--TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEEEc-CCCEEEEcCCcCCC
Confidence 6788999999999998 99999999998887
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.4e-11 Score=128.72 Aligned_cols=248 Identities=17% Similarity=0.119 Sum_probs=170.9
Q ss_pred HHhcCCccccceEeecccEEEEEEEe--CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeC
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKL--PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEK 566 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~ 566 (789)
.....+|.++..|+.+.|+.|++... .++..|++|.+.........+ + .-..|+.+...+ .|.+++++...|...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i-~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-I-FSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-h-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence 34456889999999999999999853 467889999765543333222 1 123455555555 599999998888888
Q ss_pred CeEEEEEEecCCCchhHHHh--------hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEeeccCc
Q 045256 567 DERLLVYDYMKNGALYDHLH--------DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSM 637 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~--------~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGls~ 637 (789)
+..|+=.||++++++...+. .+.++..+++.++.++|+.. ++|+|+||+||++..+ +..++.||+...
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 88899999999988766542 23467889999999999988 9999999999999876 788999999875
Q ss_pred CCCCCCCCCcccccccCcCcc--CccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYI--DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
.+.... .......+++ +|+......+..+.|+||||.-+.|.+++..--.... .|.
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------~~~------- 473 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------QSL------- 473 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------cce-------
Confidence 311111 1122334444 5556667778899999999999999999875422111 110
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 716 ELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 716 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
.+............ ..+..+.+.+...++..||.+.++..+.+...+.+
T Consensus 474 ---~i~~~~~p~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~~ 522 (524)
T KOG0601|consen 474 ---TIRSGDTPNLPGLK----LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDSR 522 (524)
T ss_pred ---eeecccccCCCchH----HhhhhhhhhhcCCccccchhhhhhcccchhhhhcc
Confidence 11111111111111 33444566688899999999999888777654433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.6e-09 Score=106.21 Aligned_cols=131 Identities=20% Similarity=0.222 Sum_probs=92.7
Q ss_pred ceEeecccEEEEEEEeCC-------CcEEEEEEcccchh-----hh-------H------HHHHHHHH----HHHHHHhh
Q 045256 500 NKIGAGSFGVVYKGKLPD-------GQEVAIKRGETAKT-----KK-------F------QEKESAFD----SELAFLSR 550 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~-----~~-------~------~~~~~~~~----~E~~~l~~ 550 (789)
..||.|--+.||.|...+ +..+|||+.+.... .. . ......+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 47999997553211 00 0 01122333 89999999
Q ss_pred cCC--CcceEEEEEEEeCCeEEEEEEecCCCch-----hHHHh---hhchHHHHHHHHHHHH-HhcCCCCeEeccCCCCC
Q 045256 551 LHH--KHLVRLVGYCEEKDERLLVYDYMKNGAL-----YDHLH---DRNNVEKNAARGIEYL-HNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 551 l~H--pnIv~l~~~~~~~~~~~lv~e~~~~gsL-----~~~l~---~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlkp~N 619 (789)
+.. -++.+++++ ...+|||||+.+..+ .+... +...+..+++.+|..| |..+ |+|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 953 456666654 456899999976433 22211 1235678899999988 8888 9999999999
Q ss_pred EEECCCCcEEEEeeccCcC
Q 045256 620 ILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~ 638 (789)
||+++ +.+.|+|||.+..
T Consensus 156 IL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred EEEEC-CcEEEEECCCcee
Confidence 99974 6899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=2.2e-09 Score=109.08 Aligned_cols=137 Identities=18% Similarity=0.336 Sum_probs=102.2
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--CcceEEEEEEEeCC---eEEEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--KHLVRLVGYCEEKD---ERLLVY 573 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~---~~~lv~ 573 (789)
.+.|+.|.++.+|++...+|+.+++|+....... .....+..|.++++.+++ .++.+++.+..... ..++||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3678999999999998877789999986543321 122357889999999975 44567777766542 568999
Q ss_pred EecCCCchhHHHh-------hhchHHHHHHHHHHHHHhcC----------------------------------------
Q 045256 574 DYMKNGALYDHLH-------DRNNVEKNAARGIEYLHNYA---------------------------------------- 606 (789)
Q Consensus 574 e~~~~gsL~~~l~-------~~~~i~~~ia~~l~~LH~~~---------------------------------------- 606 (789)
||+++.++.+.+. ....++.++++.|.+||+..
T Consensus 80 e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 80 ERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999988877552 23456778888888887421
Q ss_pred -------------CCCeEeccCCCCCEEECC--CCcEEEEeeccCcC
Q 045256 607 -------------VPPIIHRDIKSSNILLDA--QWTARVSDFGLSMM 638 (789)
Q Consensus 607 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGls~~ 638 (789)
...++|+|++|.||+++. +..+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.1e-08 Score=96.12 Aligned_cols=137 Identities=20% Similarity=0.242 Sum_probs=101.7
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEE-cccchhhhH---HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKR-GETAKTKKF---QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~-~~~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.+.+|-+|+-+.|+++.. .|+...||. +.+...... +-......+|++.|.++.--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999988 567777774 333222221 112345778999999987656655555666777778999
Q ss_pred EecCC-CchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC---cEEEEeeccCcC
Q 045256 574 DYMKN-GALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMM 638 (789)
Q Consensus 574 e~~~~-gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGls~~ 638 (789)
||+++ .++.+++... ..+++.+-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4777776532 256777888999999999 99999999999996554 468999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.4e-10 Score=131.55 Aligned_cols=243 Identities=21% Similarity=0.229 Sum_probs=154.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|.+.+-+-++.++.++...-. .|...++|..........+ ..+....+-.++-..+||.+++..--+......+|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~-~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTN-DYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccc-cccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45566667778888888876532 2333333332211111000 011122233333333457666655555556778999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc-CCC---
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM-MGP--- 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~-~~~--- 640 (789)
++|+.+++|...|+... .....+...++|||... +.|+|++|.|+|...+++.+++||+... ...
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999987643 34556778899999987 8999999999999999999999998432 100
Q ss_pred ---C--------------CCCC--------CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 641 ---E--------------SERD--------FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 641 ---~--------------~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
. .... .......+|+.|.+||.+.+......+|+|++|++++|.++|.+||....
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcc
Confidence 0 0000 01123468999999999999999999999999999999999999996654
Q ss_pred CCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHH
Q 045256 696 ESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMA 758 (789)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 758 (789)
... ....++...++ ......+.....+.++...+..+|.+|-.+.
T Consensus 1040 pq~-----------------~f~ni~~~~~~-~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1040 PQQ-----------------IFENILNRDIP-WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhh-----------------hhhccccCCCC-CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 311 01122222222 2222333444455666667778888887665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=3.3e-08 Score=96.65 Aligned_cols=122 Identities=26% Similarity=0.306 Sum_probs=79.5
Q ss_pred EEEEEEeCCCcEEEEEEcccchh----------------------hhHHHHHHHHHHHHHHHhhcCCC--cceEEEEEEE
Q 045256 509 VVYKGKLPDGQEVAIKRGETAKT----------------------KKFQEKESAFDSELAFLSRLHHK--HLVRLVGYCE 564 (789)
Q Consensus 509 ~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~ 564 (789)
.||.|...++..+|+|+.+.... ...........+|.+.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988999999997543211 00111233567899999999765 456666442
Q ss_pred eCCeEEEEEEecC--CCchhHHHhh------hchHHHHHHHHHHH-HHhcCCCCeEeccCCCCCEEECCCCcEEEEeecc
Q 045256 565 EKDERLLVYDYMK--NGALYDHLHD------RNNVEKNAARGIEY-LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635 (789)
Q Consensus 565 ~~~~~~lv~e~~~--~gsL~~~l~~------~~~i~~~ia~~l~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 635 (789)
...|||||++ +..+..+... ...+..++++.+.. +|..+ |+|+||.+.|||++++ .+.|+|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEecCc
Confidence 4479999999 5444443322 23577778775555 57888 9999999999999988 999999998
Q ss_pred CcC
Q 045256 636 SMM 638 (789)
Q Consensus 636 s~~ 638 (789)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.6e-07 Score=97.43 Aligned_cols=134 Identities=19% Similarity=0.174 Sum_probs=93.5
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhhh-HH------HHHHHHHHHHHHHhhcCCCcc--eEEEEEEEe-----
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKK-FQ------EKESAFDSELAFLSRLHHKHL--VRLVGYCEE----- 565 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~~------~~~~~~~~E~~~l~~l~HpnI--v~l~~~~~~----- 565 (789)
+.+-+-....|++... +|+.|.||+........ .. .....+.+|...+.+|...+| .+++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4454444455777766 67899999764322111 00 001136788888888854333 344555543
Q ss_pred CCeEEEEEEecCCC-chhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-------CCc
Q 045256 566 KDERLLVYDYMKNG-ALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-------QWT 627 (789)
Q Consensus 566 ~~~~~lv~e~~~~g-sL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~ 627 (789)
...-+||||++++- +|.+++.+ ...++.++++.+.-||..+ |+|+||++.|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23468999999985 78888742 2367888999999999999 999999999999975 478
Q ss_pred EEEEeeccCc
Q 045256 628 ARVSDFGLSM 637 (789)
Q Consensus 628 ~kl~DfGls~ 637 (789)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 9999999775
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2e-07 Score=97.79 Aligned_cols=256 Identities=17% Similarity=0.120 Sum_probs=146.4
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEE----E--e-CCeE
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYC----E--E-KDER 569 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~----~--~-~~~~ 569 (789)
..+.||+|+-+.+|-.-- -...+-|+........... . ++.|... .||-+-.-+.+= . + ....
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq----k---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ----K---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHH----H---HHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 456799999999996531 1223445544332221111 1 1122222 455433211111 1 1 1124
Q ss_pred EEEEEecCCCc-hhHHHh---hh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 570 LLVYDYMKNGA-LYDHLH---DR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 570 ~lv~e~~~~gs-L~~~l~---~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
-++|..+++.. +.+++. .| .+.++.++.+.+-||+.+ .+-+|++++|+|+.+++.+.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccc
Confidence 46777776532 222221 11 257888999999999999 8999999999999999999999754
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcC-CCCCCCCCCCCCcccccccch
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTG-KRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG-~~pf~~~~~~~~~~~~~~~~~ 708 (789)
.-.. ... .....-.+|...|.+||... +-.-+...|-|.||+++++||.| ++||.+-......+-.+.
T Consensus 163 sfqi-~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--- 236 (637)
T COG4248 163 SFQI-NAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--- 236 (637)
T ss_pred ceee-ccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---
Confidence 3221 111 22223457889999999764 23345678999999999999997 889865433222221110
Q ss_pred hhhhhhhhhHHhhcc---cCCCCCCCH-HHHHHHHHHHHHhhcCc--CCCCCCCHHHHHHHHHHHhhhcc
Q 045256 709 VPAIMAGELVKILDR---RVGPPEINE-AEAVELVAYTAMHCVNL--EGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~---~~~~~~~~~-~~~~~~l~~l~~~cl~~--dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
..+..+.....-+. ..+.+...+ .-....++.|..+|+.. ++.-|||.+.++..|.++.+...
T Consensus 237 -~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 237 -TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred -hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 01111111111111 122222222 22334555666678864 35689999999999988866544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.5e-07 Score=96.10 Aligned_cols=158 Identities=22% Similarity=0.275 Sum_probs=116.5
Q ss_pred ccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----CCeEEEEEEecCC-C
Q 045256 506 SFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----KDERLLVYDYMKN-G 579 (789)
Q Consensus 506 ~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~lv~e~~~~-g 579 (789)
.-.+.||+.. .||..|++||+...+...... ...-++.++++.|+|||++.+++.. ...++|||+|+++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk----~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK----DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCccc----chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3467899974 489999999984333222111 2345678999999999999998873 3457899999997 5
Q ss_pred chhHHHhh----h-------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 580 ALYDHLHD----R-------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 580 sL~~~l~~----~-------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
+|.++--. . -.++.|+..||.++|+.+ +.-+-|.|.+||++.+.+++|+-.|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccce
Confidence 77775311 0 036789999999999999 888999999999999999999988876
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCC
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKR 689 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~ 689 (789)
.+...... |-+. --.+-|.=.||.+++.|.||..
T Consensus 441 Dvl~~d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 441 DVLQEDPT----------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred eeecCCCC----------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 55333220 1111 1235799999999999999963
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.5e-07 Score=91.81 Aligned_cols=135 Identities=21% Similarity=0.301 Sum_probs=99.3
Q ss_pred CccccceEeecccEEEEEEEeCCCcEEEEEEcccchh-------hhH-----------HHHHHHHHHHHHHHhhcCCC--
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKT-------KKF-----------QEKESAFDSELAFLSRLHHK-- 554 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-------~~~-----------~~~~~~~~~E~~~l~~l~Hp-- 554 (789)
-..+.+.||-|--+.||.|..++|..++||.=+.... ... ...+....+|+++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4456789999999999999999999999995222111 000 01123456899999999654
Q ss_pred cceEEEEEEEeCCeEEEEEEecCCCchhHHH--h-hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHL--H-DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 555 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--~-~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
.+.+.+++ +...+||||+++-.|...- . +-..+...|++-+.-+-..+ |||+|+.+-|||+++|+.+.++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vI 244 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVI 244 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEE
Confidence 67777765 4557999999987766543 1 22345666777666666777 9999999999999999999999
Q ss_pred eeccC
Q 045256 632 DFGLS 636 (789)
Q Consensus 632 DfGls 636 (789)
||--+
T Consensus 245 DwPQ~ 249 (304)
T COG0478 245 DWPQA 249 (304)
T ss_pred eCccc
Confidence 99654
|
|
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.2e-09 Score=120.45 Aligned_cols=152 Identities=18% Similarity=0.215 Sum_probs=119.6
Q ss_pred CCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCc-------ceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcC
Q 045256 72 NISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFV-------PKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWR 144 (789)
Q Consensus 72 ~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~-------p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG 144 (789)
..++.|++||.+|++++...| ++++||.|.+++.... |.+++.+.++...+|++|.+|++++..
T Consensus 13 ~k~~lq~~cGn~hclal~~~g-~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~lS~-------- 83 (850)
T KOG0941|consen 13 YKHILQVGCGNNHCLALSCAG-ELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFALSS-------- 83 (850)
T ss_pred hhhhhhhccccHHHHhhhccC-CeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhhhh--------
Confidence 447899999999999999999 9999999997764433 999999999999999999999999976
Q ss_pred CCCCCCCCCCCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC------------CceeEEEeeCCceeE
Q 045256 145 GDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA------------NRSMFSITAGGNHVC 212 (789)
Q Consensus 145 ~~~~~~~~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~------------~~~v~~i~~G~~h~~ 212 (789)
|++. +++.|.++..|....||+|+.... ...+.+|+||..|++
T Consensus 84 ------------------------~~~~-lt~e~~~fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t~ia~~~~ht~ 138 (850)
T KOG0941|consen 84 ------------------------HTVL-LTDEGKVFSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVTRIACVRGHTL 138 (850)
T ss_pred ------------------------chhh-cchhccccccCCcccccccccccccccccHHHHHHHhhhhHHHHHHHHHHH
Confidence 8877 688889999999999999984332 233779999999999
Q ss_pred EEccC-CcEEEEEcCCCC--CCCcCCCC---------CccceEEeccCcceEEEEEe
Q 045256 213 GIDSN-GFVICYGDNKSG--QLKFPLNS---------TAFEYSALSLGFNHSCAIRR 257 (789)
Q Consensus 213 al~~d-G~v~~wG~n~~G--ql~~~~~~---------~~~~v~~i~~G~~h~~al~~ 257 (789)
+.... |++|..|.+..| ++-..... ....+.++.+|...+..+..
T Consensus 139 a~v~~l~qsf~~~~~~sGk~~i~s~s~~~~l~~~d~~~~~~~~~~~~g~dq~~~l~~ 195 (850)
T KOG0941|consen 139 AIVPRLGQSFSFGKGASGKGVIVSLSGEDLLRDHDSEKDHRCSLAFAGGDQTFSLSS 195 (850)
T ss_pred hhhhhhcceeecccCCCCCceeeccchhhhcccccHHHHHHHHHHhcCCCceEEEEe
Confidence 98655 999999999988 33111110 11234456777776666654
|
|
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=98.56 E-value=7.7e-08 Score=72.86 Aligned_cols=39 Identities=28% Similarity=0.380 Sum_probs=29.6
Q ss_pred CCcEEEEEcCCCCCCC-cCCC-----------CCccceEEeccCcceEEEE
Q 045256 217 NGFVICYGDNKSGQLK-FPLN-----------STAFEYSALSLGFNHSCAI 255 (789)
Q Consensus 217 dG~v~~wG~n~~Gql~-~~~~-----------~~~~~v~~i~~G~~h~~al 255 (789)
||+||+||+|.+|||+ .... ....+|++|+||+.||++|
T Consensus 1 dG~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DGRVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TSEEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CCcEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 7999999999999998 3222 1234688888888888876
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.5e-06 Score=94.77 Aligned_cols=136 Identities=23% Similarity=0.320 Sum_probs=94.8
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHH------------------------------H------HHHHHHH
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQ------------------------------E------KESAFDS 543 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------------~------~~~~~~~ 543 (789)
+.|+.++-|.||+|++++|+.||||+.++.-..... + .+-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 689999999999999999999999987654322211 0 0112445
Q ss_pred HHHHHhhcC-----CCcceEEEEEEEeCCeEEEEEEecCCCchhHH--Hhh----hchHHHHHHHH-HHHHHhcCCCCeE
Q 045256 544 ELAFLSRLH-----HKHLVRLVGYCEEKDERLLVYDYMKNGALYDH--LHD----RNNVEKNAARG-IEYLHNYAVPPII 611 (789)
Q Consensus 544 E~~~l~~l~-----HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~--l~~----~~~i~~~ia~~-l~~LH~~~~~~iv 611 (789)
|...+.+++ .|++.-..=|++-.....|+|||++|-.+.+. +++ +..++..++++ +.-+-..+ ++
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~~dg---ff 287 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLLRDG---FF 287 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHHhcC---cc
Confidence 666565552 34443333334445677899999999888877 333 23556655554 23333455 99
Q ss_pred eccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 612 HRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 612 H~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
|.|..|.||+++.++++.+.|||+...
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceec
Confidence 999999999999999999999998754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.3e-06 Score=84.40 Aligned_cols=142 Identities=15% Similarity=0.181 Sum_probs=95.4
Q ss_pred HhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHH-----HHHHHHHHHHhhcCCC---cceEEEEE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKE-----SAFDSELAFLSRLHHK---HLVRLVGY 562 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~-----~~~~~E~~~l~~l~Hp---nIv~l~~~ 562 (789)
....+|...+++-......|.+-.. +|+.+++|..+.......+... ....+++..+.+++.. ....++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3457888888888888777877776 6789999986653322211111 1233455555555332 22222222
Q ss_pred EE-----eCCeEEEEEEecCCCchhHHHhhhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 563 CE-----EKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 563 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.. -....+|+|||++|..|.++..-...+...+.+.+.-||+.+ ++|+|..|.|++++.+ .++++||+..+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~e~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIEDIDEDLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchhcCHHHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECcccc
Confidence 22 223456899999998887764333346677888999999999 9999999999999865 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.5e-07 Score=71.25 Aligned_cols=43 Identities=23% Similarity=0.405 Sum_probs=38.1
Q ss_pred CCceEEEccCCCCCCCC--------CcceeeeeCCcceEEEEEecCCeEEEE
Q 045256 91 GGYSLLCWDTNFSYNSN--------FVPKRIYYNDTVLLSSVSVGNNHVCAT 134 (789)
Q Consensus 91 ~G~~v~~wG~n~~~~~~--------~~p~~v~~~~~~~i~~v~~G~~h~~al 134 (789)
|| +||+||.|.++|.. ..|++|..+.+.+|++|+||..|++||
T Consensus 1 dG-~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DG-RVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TS-EEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CC-cEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 78 99999999977655 469999988889999999999999987
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.6e-08 Score=109.17 Aligned_cols=149 Identities=20% Similarity=0.349 Sum_probs=95.5
Q ss_pred HHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC-c------ccccccCcCccCccccCCCC
Q 045256 595 AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-R------PMKAAGTVGYIDPEYYGLNV 667 (789)
Q Consensus 595 ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~-~------~~~~~gt~~y~aPE~~~~~~ 667 (789)
++.||.|+|... .+||++|.|++|.++.++..||+.|+.+.......... . +.-......|.|||++....
T Consensus 108 v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 448999999765 39999999999999999999999998875433321111 0 01123567899999999888
Q ss_pred CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhh
Q 045256 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHC 746 (789)
Q Consensus 668 ~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~c 746 (789)
.+.++|+||+|+++|.+..|..+......... ... .. ....+. ........+.| +++=+.+.
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~------~~---~~~~~~~~~~~s~~~p~e----l~~~l~k~ 248 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYS------FS---RNLLNAGAFGYSNNLPSE----LRESLKKL 248 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcc----hhh------hh---hcccccccccccccCcHH----HHHHHHHH
Confidence 89999999999999999955544332221000 000 00 000000 01111222333 33445568
Q ss_pred cCcCCCCCCCHHHHHH
Q 045256 747 VNLEGKERPTMADIVA 762 (789)
Q Consensus 747 l~~dp~~RPt~~evl~ 762 (789)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 8999999998877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.4e-06 Score=87.48 Aligned_cols=119 Identities=26% Similarity=0.292 Sum_probs=85.4
Q ss_pred CCcEEEEEEcccchhhh---HHHHHHHHHHHHHHHhhcCCC--cceEEEEEEEeCC----eEEEEEEecCCC-chhHHHh
Q 045256 517 DGQEVAIKRGETAKTKK---FQEKESAFDSELAFLSRLHHK--HLVRLVGYCEEKD----ERLLVYDYMKNG-ALYDHLH 586 (789)
Q Consensus 517 ~g~~vavK~~~~~~~~~---~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~ 586 (789)
.++.+.+|......... ..-......+|...+.+|..- ...+.+++..... ..+||+|++++- +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45667777533211111 011233477888888888533 3456666665532 348999999984 7888887
Q ss_pred h--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC---cEEEEeeccCcC
Q 045256 587 D--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMM 638 (789)
Q Consensus 587 ~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGls~~ 638 (789)
. ...+..++++.++-||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 5 3468889999999999999 99999999999998887 899999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=5.5e-06 Score=81.55 Aligned_cols=131 Identities=18% Similarity=0.148 Sum_probs=93.9
Q ss_pred EeecccEEEEEEEeCCCcEEEEEEcccchhhhH--HHHHHHHHHHHHHHhhcCC--CcceEEEEEEE-eC----CeEEEE
Q 045256 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKF--QEKESAFDSELAFLSRLHH--KHLVRLVGYCE-EK----DERLLV 572 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~-~~----~~~~lv 572 (789)
-++|+.+-|++..+ +|+.+-+|+-........ .-....|.+|+..+.+|.. -.+.+++ ++. .. ..-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35689999999887 445799998542111110 1234569999999999953 2244554 332 21 135799
Q ss_pred EEecCC-CchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc--EEEEeeccCc
Q 045256 573 YDYMKN-GALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT--ARVSDFGLSM 637 (789)
Q Consensus 573 ~e~~~~-gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGls~ 637 (789)
+|-+++ -+|.+++.+ +..+..++++.++-||..+ +.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998874 588887743 2368889999999999999 999999999999986666 9999997554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.1e-06 Score=83.03 Aligned_cols=128 Identities=13% Similarity=0.152 Sum_probs=83.7
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc--ceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH--LVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.|++|..+.||+. .+..+++|....... .....+|.++++.+..-. +.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD------KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCC------HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 67899999999984 245678888654221 123578999999886433 4667777777777889999999
Q ss_pred CCc-hhHHHh----hhchHHHHHHHHH---------------------------------------HHHHhcC-CCCeEe
Q 045256 578 NGA-LYDHLH----DRNNVEKNAARGI---------------------------------------EYLHNYA-VPPIIH 612 (789)
Q Consensus 578 ~gs-L~~~l~----~~~~i~~~ia~~l---------------------------------------~~LH~~~-~~~ivH 612 (789)
|.+ +...+. +...+...+++.+ ++|.... .+.++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 222211 1111222222222 2232211 134789
Q ss_pred ccCCCCCEEECCCCcEEEEeeccCc
Q 045256 613 RDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 613 ~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.18 E-value=9.4e-08 Score=107.66 Aligned_cols=112 Identities=19% Similarity=0.307 Sum_probs=89.1
Q ss_pred cEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC------------CCceeEEEeeCCceeEEEcc-------CCc
Q 045256 159 QFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF------------ANRSMFSITAGGNHVCGIDS-------NGF 219 (789)
Q Consensus 159 ~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~------------~~~~v~~i~~G~~h~~al~~-------dG~ 219 (789)
++.+++||..|..| ++.+|+++.||.|.+||++.+.. ......+|++|..|+++++. +|.
T Consensus 15 ~~lq~~cGn~hcla-l~~~g~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~lS~~~~~lt~e~~ 93 (850)
T KOG0941|consen 15 HILQVGCGNNHCLA-LSCAGELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFALSSHTVLLTDEGK 93 (850)
T ss_pred hhhhhccccHHHHh-hhccCCeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhhhhchhhcchhcc
Confidence 46788888888888 56667888888888888876511 11225589999999988877 999
Q ss_pred EEEEEcCCCCCCCcCCCC-----------CccceEEeccCcceEEEEEeeCCeEEEeeeCCCC
Q 045256 220 VICYGDNKSGQLKFPLNS-----------TAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEY 271 (789)
Q Consensus 220 v~~wG~n~~Gql~~~~~~-----------~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~g 271 (789)
++..|....||++..... -...+++|+||..|+.+...+-|++|..|.+..|
T Consensus 94 ~fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t~ia~~~~ht~a~v~~l~qsf~~~~~~sG 156 (850)
T KOG0941|consen 94 VFSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVTRIACVRGHTLAIVPRLGQSFSFGKGASG 156 (850)
T ss_pred ccccCCcccccccccccccccccHHHHHHHhhhhHHHHHHHHHHHhhhhhhcceeecccCCCC
Confidence 999999999999773221 1347999999999999988767999999999998
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2e-05 Score=81.44 Aligned_cols=129 Identities=15% Similarity=0.162 Sum_probs=84.2
Q ss_pred eEeeccc-EEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEEEEecCC
Q 045256 501 KIGAGSF-GVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLVYDYMKN 578 (789)
Q Consensus 501 ~LG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~~ 578 (789)
.|-.|.+ ..||+...+ +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||++++
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 4445555 789999764 4788889854432 123667888888884 44456777777666678999999999
Q ss_pred CchhHHHh--hhchHHHHHHHHHHHHHhc---------------------------------------------------
Q 045256 579 GALYDHLH--DRNNVEKNAARGIEYLHNY--------------------------------------------------- 605 (789)
Q Consensus 579 gsL~~~l~--~~~~i~~~ia~~l~~LH~~--------------------------------------------------- 605 (789)
.+|.+... .+..+..++++.|.-||+.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 77764421 1112222222222222211
Q ss_pred ----CCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 606 ----AVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 606 ----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
..+.++|+|+.|.|||++++....|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 12448999999999999998778899998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=2.2e-05 Score=88.10 Aligned_cols=141 Identities=23% Similarity=0.298 Sum_probs=89.7
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHH---------------------------HHHH------HHHHHH
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQ---------------------------EKES------AFDSEL 545 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~---------------------------~~~~------~~~~E~ 545 (789)
.+.|+.-+.+.||++++++|+.||||+-++.-..... +..+ +|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 3689999999999999999999999986553222110 1111 244454
Q ss_pred HHHhhc----CCCcc---eEEEEEEE-eCCeEEEEEEecCCCchhHH--Hhhh----chHHHHHHHHHHHHHhcCCCCeE
Q 045256 546 AFLSRL----HHKHL---VRLVGYCE-EKDERLLVYDYMKNGALYDH--LHDR----NNVEKNAARGIEYLHNYAVPPII 611 (789)
Q Consensus 546 ~~l~~l----~HpnI---v~l~~~~~-~~~~~~lv~e~~~~gsL~~~--l~~~----~~i~~~ia~~l~~LH~~~~~~iv 611 (789)
+...+. .|-+. |.+-.++. -.....|+|||++|..+.|. |.++ ..+...+.++ |++..-..+++
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~--~~~qIf~~Gff 323 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEA--YLEQIFKTGFF 323 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHH--HHHHHHhcCCc
Confidence 443333 35551 22223332 23467899999999877665 3332 2455555444 33322223499
Q ss_pred eccCCCCCEEECC----CCcEEEEeeccCcCCCC
Q 045256 612 HRDIKSSNILLDA----QWTARVSDFGLSMMGPE 641 (789)
Q Consensus 612 H~Dlkp~NIll~~----~~~~kl~DfGls~~~~~ 641 (789)
|.|-.|.||+++. ++++.+-|||+......
T Consensus 324 HaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 324 HADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999984 67899999999765433
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00016 Score=72.41 Aligned_cols=148 Identities=18% Similarity=0.216 Sum_probs=98.0
Q ss_pred HHHHHHHHHhcCCccccceEe---ecccEEEEEEEeCCCcEEEEEEcccchhhhHH-------------------HH-HH
Q 045256 483 EFLLAELAAATNNFSLENKIG---AGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQ-------------------EK-ES 539 (789)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~LG---~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-------------------~~-~~ 539 (789)
..++..+....++..+.+..| .|.-+.||+|...++..+|+|+.+........ .. ..
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 345555666666666666554 56777899998888999999987653221111 00 01
Q ss_pred HHHHHHHHHhhcC--CCcceEEEEEEEeCCeEEEEEEecCCC-----chhHHH---hhhchHHHHHHHHHHHHHh-cCCC
Q 045256 540 AFDSELAFLSRLH--HKHLVRLVGYCEEKDERLLVYDYMKNG-----ALYDHL---HDRNNVEKNAARGIEYLHN-YAVP 608 (789)
Q Consensus 540 ~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~lv~e~~~~g-----sL~~~l---~~~~~i~~~ia~~l~~LH~-~~~~ 608 (789)
-...|+..|+++. +-.+.+.+.+. +..|||||+... .|.+.- .+-..+..++++.+.-|-. .+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~-- 187 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG-- 187 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC--
Confidence 1346888888884 44455555553 347999998653 222221 1123456667777777665 56
Q ss_pred CeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 609 ~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+||+||..-|||+. ++.+.|+||+-+..
T Consensus 188 -LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 188 -LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred -cccccchhhheEEE-CCeEEEEECccccc
Confidence 99999999999999 78999999998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=74.93 Aligned_cols=74 Identities=15% Similarity=0.158 Sum_probs=47.6
Q ss_pred cceEeecccEEEEEEEeCC--CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeEEEEEEe
Q 045256 499 ENKIGAGSFGVVYKGKLPD--GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e~ 575 (789)
.+.|..|-...+|+....+ ++.|++|+........ ....+|+.+++.+...++ .+++..+. ..++|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-----~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-----IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-----ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEe
Confidence 3567778888999998764 6789999754322111 123468888888854333 44443322 2479999
Q ss_pred cCCCch
Q 045256 576 MKNGAL 581 (789)
Q Consensus 576 ~~~gsL 581 (789)
+++.++
T Consensus 74 i~G~~l 79 (235)
T cd05157 74 IPGRTL 79 (235)
T ss_pred eCCCcC
Confidence 998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00014 Score=88.52 Aligned_cols=80 Identities=14% Similarity=0.348 Sum_probs=57.3
Q ss_pred cceEeecccEEEEEEEeCCC---cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcc--eEEEEEEEeC---CeE
Q 045256 499 ENKIGAGSFGVVYKGKLPDG---QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHL--VRLVGYCEEK---DER 569 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnI--v~l~~~~~~~---~~~ 569 (789)
.+.|+.|.+..+|+....++ ..+++|+........ ....+.+|+++|+.+. |+++ .+++.+|.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~---~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ---SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc---cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 57789999999999887554 467888754332111 1235789999999995 6665 7778877664 357
Q ss_pred EEEEEecCCCch
Q 045256 570 LLVYDYMKNGAL 581 (789)
Q Consensus 570 ~lv~e~~~~gsL 581 (789)
|+||||+++..+
T Consensus 120 flVME~v~G~~~ 131 (822)
T PLN02876 120 FYIMEYLEGRIF 131 (822)
T ss_pred eEEEEecCCccc
Confidence 899999988643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00019 Score=73.20 Aligned_cols=132 Identities=20% Similarity=0.276 Sum_probs=80.6
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCC--cceEEEEEEEe---CCeEEEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK--HLVRLVGYCEE---KDERLLVY 573 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~~~~---~~~~~lv~ 573 (789)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... -+.+++.+... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999999877 69999985443 1233467888888888533 34566654432 33468999
Q ss_pred EecCCCchhH---------H-------H---hhh----c----------h-------H------------HHHHHH-HHH
Q 045256 574 DYMKNGALYD---------H-------L---HDR----N----------N-------V------------EKNAAR-GIE 600 (789)
Q Consensus 574 e~~~~gsL~~---------~-------l---~~~----~----------~-------i------------~~~ia~-~l~ 600 (789)
+++++..+.. . + +.. . . . ...+.+ .++
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 0 0 100 0 0 0 011222 334
Q ss_pred HHHhc----CCCCeEeccCCCCCEEEC-CCCcEEEEeeccCc
Q 045256 601 YLHNY----AVPPIIHRDIKSSNILLD-AQWTARVSDFGLSM 637 (789)
Q Consensus 601 ~LH~~----~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGls~ 637 (789)
.+++. ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 44432 224499999999999999 66667899998653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00015 Score=68.53 Aligned_cols=127 Identities=19% Similarity=0.243 Sum_probs=86.5
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceE-EEEEEEeCCeEEEEEEec
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVR-LVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~-l~~~~~~~~~~~lv~e~~ 576 (789)
..+.|++|.+|.||++.+. |..+|+|+-+.... ...+..|.++|..++-.++.+ ++.|- +-++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~------r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP------RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcc------hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhh
Confidence 3577999999999999984 45888887444322 234888999999998777654 33332 224559999
Q ss_pred CCCchhHHHhh-hchHHHHHHHHHHHHHhcCCCCeEeccCC-CCCEEECCCCcEEEEeeccCcC
Q 045256 577 KNGALYDHLHD-RNNVEKNAARGIEYLHNYAVPPIIHRDIK-SSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 577 ~~gsL~~~l~~-~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DfGls~~ 638 (789)
++..|.+.-.. ..+-...+++.-.-|-..+ |-|..|. |...+|-.+..+.|+||.-+..
T Consensus 95 ~G~~L~~~~~~~~rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGGDRKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcccHHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99888776542 2333444555544455666 8888885 4444444445999999987753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00026 Score=69.36 Aligned_cols=129 Identities=25% Similarity=0.365 Sum_probs=92.5
Q ss_pred CCccccceEeeccc-EEEEEEEeCCCcEEEEEEccc---chh-------hh-H------HHHHHHHHHHHHHHhhcC---
Q 045256 494 NNFSLENKIGAGSF-GVVYKGKLPDGQEVAIKRGET---AKT-------KK-F------QEKESAFDSELAFLSRLH--- 552 (789)
Q Consensus 494 ~~~~~~~~LG~G~~-g~Vy~~~~~~g~~vavK~~~~---~~~-------~~-~------~~~~~~~~~E~~~l~~l~--- 552 (789)
.+++.++.||.|.- |.||++++ +|+.||+|.++. ... .. . .....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 678999998322 000 00 0 012235778888888774
Q ss_pred CCcc--eEEEEEEEeCC------------------eEEEEEEecCCCchhHHHhhhchHHHHHHHHHHHHHhcCCCCeEe
Q 045256 553 HKHL--VRLVGYCEEKD------------------ERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIH 612 (789)
Q Consensus 553 HpnI--v~l~~~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~i~~~ia~~l~~LH~~~~~~ivH 612 (789)
+.++ |+.+||..-.. ...+|.||.+... .-...-+.++.+-|..+|..+ |+-
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----~~~~~~~~~~~~dl~~~~k~g---I~~ 187 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----PLQIRDIPQMLRDLKILHKLG---IVP 187 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----ccchhHHHHHHHHHHHHHHCC---eee
Confidence 4566 89999874321 1358999987744 112334567788888999999 999
Q ss_pred ccCCCCCEEECCCCcEEEEeeccC
Q 045256 613 RDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 613 ~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
+|+|+.|.. .-||+|||.+
T Consensus 188 ~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 188 RDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccCcccccc-----CCEEEecccC
Confidence 999999975 3489999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00016 Score=74.32 Aligned_cols=128 Identities=17% Similarity=0.252 Sum_probs=74.7
Q ss_pred ceEeecccE-EEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCC---cceEEEEEEEeCC---eEEEE
Q 045256 500 NKIGAGSFG-VVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK---HLVRLVGYCEEKD---ERLLV 572 (789)
Q Consensus 500 ~~LG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~~~~---~~~lv 572 (789)
+.|+.|+.. .||+.. ..+++|...... ....+.+|.+++..+... -+.++++.....+ ..+++
T Consensus 3 ~~~~~gG~~n~vy~~~----~~~VlR~~~~~~------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG----DDMSVRLPSAAG------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC----CceEEEcCCccc------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 567766665 588762 357778644311 122477899999887532 2334444333222 34789
Q ss_pred EEecCCCchhHHHh-hhchHHHHHHHHHHHHHhc----------------------------------------------
Q 045256 573 YDYMKNGALYDHLH-DRNNVEKNAARGIEYLHNY---------------------------------------------- 605 (789)
Q Consensus 573 ~e~~~~gsL~~~l~-~~~~i~~~ia~~l~~LH~~---------------------------------------------- 605 (789)
||++++.++.+... ....+..++++.|.-||+.
T Consensus 73 ~~~i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 152 (235)
T cd05155 73 YRWLEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALW 152 (235)
T ss_pred EEeecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHH
Confidence 99999977643311 1112222222222222210
Q ss_pred ---------CCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 606 ---------AVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 606 ---------~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
..+.++|+|+.+.|||++.+...-|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 153 EAALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred HHHhcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 12338999999999999877556799999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.0007 Score=66.90 Aligned_cols=131 Identities=21% Similarity=0.332 Sum_probs=90.3
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhh------------HHHHHHHHHHHHHHHhhcC------CCcceEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKK------------FQEKESAFDSELAFLSRLH------HKHLVRLV 560 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~------------~~~~~~~~~~E~~~l~~l~------HpnIv~l~ 560 (789)
...||+|+.=.||. +++.....||+........ ......++.+|+.-..++. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999998886 4556678888876654000 0011234556666555555 88999999
Q ss_pred EEEEeCCeEEEEEEecCC------CchhHHHhhhc---hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC---C-c
Q 045256 561 GYCEEKDERLLVYDYMKN------GALYDHLHDRN---NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ---W-T 627 (789)
Q Consensus 561 ~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~---~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~-~ 627 (789)
|+.+++...-+|+|.+.+ .+|.+++.+.. .+...+-+-..||-+.. |+.+||+|.||++..+ . .
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~~~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~ 160 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTEELRQALDEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFR 160 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccHHHHHHHHHHHHHHHHcC---CeecCCCcccEEEEecCCCceE
Confidence 999999999999998765 25777775322 23333444557888888 9999999999999432 2 5
Q ss_pred EEEEe-ec
Q 045256 628 ARVSD-FG 634 (789)
Q Consensus 628 ~kl~D-fG 634 (789)
+.|+| ||
T Consensus 161 lvlIDG~G 168 (199)
T PF10707_consen 161 LVLIDGLG 168 (199)
T ss_pred EEEEeCCC
Confidence 77887 44
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00018 Score=74.88 Aligned_cols=127 Identities=11% Similarity=0.095 Sum_probs=72.8
Q ss_pred EeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeEEEEEEecCCCc
Q 045256 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDERLLVYDYMKNGA 580 (789)
Q Consensus 502 LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e~~~~gs 580 (789)
+..|-...+|+... +++.+++|+........ .....+|.++++.+....+ .+++... . .++||||+++..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKAL----GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccc----cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 44577788998874 56788888744321111 0124578888888854333 3333332 2 368999999866
Q ss_pred hhHHHhhhchHHHHHH---------------------------------------HHHHHHHhcC-----CCCeEeccCC
Q 045256 581 LYDHLHDRNNVEKNAA---------------------------------------RGIEYLHNYA-----VPPIIHRDIK 616 (789)
Q Consensus 581 L~~~l~~~~~i~~~ia---------------------------------------~~l~~LH~~~-----~~~ivH~Dlk 616 (789)
+............+++ +.+..+-... .+.++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5321000000111111 1112221111 1348999999
Q ss_pred CCCEEECCCCcEEEEeeccCcC
Q 045256 617 SSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 617 p~NIll~~~~~~kl~DfGls~~ 638 (789)
|.||++++++ +.|+||..+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999876 78999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00063 Score=72.36 Aligned_cols=77 Identities=10% Similarity=0.094 Sum_probs=55.4
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC---CcceEEEEEEEeC---CeEEE
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH---KHLVRLVGYCEEK---DERLL 571 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H---pnIv~l~~~~~~~---~~~~l 571 (789)
-.+.|+.|..+.||+....++ .+++|..+... ....+..|.+.|+.|.. -.+.++++++... +..+|
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~------~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS------TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-CEEEEEecccc------cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 356899999999999987665 46667632210 11248889999998853 3577888877543 56899
Q ss_pred EEEecCCCch
Q 045256 572 VYDYMKNGAL 581 (789)
Q Consensus 572 v~e~~~~gsL 581 (789)
|||++++.++
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=7.1e-06 Score=90.84 Aligned_cols=173 Identities=17% Similarity=0.170 Sum_probs=124.9
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc-ceEEEEEEEeCCeEEEEEEecC
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH-LVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lv~e~~~ 577 (789)
..-+++++++.++|.+....+....+.+... ....-++++|.+++||| .++.++-++.++..+++++++.
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~---------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT---------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc---------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 3456789999999987544444445553322 12456888999999999 7777777777778889999998
Q ss_pred CC-chhHHH-------h--hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 578 NG-ALYDHL-------H--DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 578 ~g-sL~~~l-------~--~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
.+ +-.... . +...+.+..+++|+|||+.. =+|+| |||..+ ...|..||+....+.... .
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~ 386 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---K 386 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---c
Confidence 77 221111 0 11234455678999999875 38998 777766 588999999876543332 3
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf 691 (789)
.....+++.++|||......+..+.|+|+++.--.+|--|-+|-
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 34567899999999999999999999999998777777776664
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00081 Score=71.65 Aligned_cols=131 Identities=19% Similarity=0.189 Sum_probs=80.3
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCC--cceEEEEE------EEeCCeEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK--HLVRLVGY------CEEKDERL 570 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~------~~~~~~~~ 570 (789)
.+.|..|....+|+....+ ..+++|+.... . ...+..|++++..|.+. .+.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~-~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV-S------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC-C------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 4567778778999987644 47888986531 1 12355677777777432 24444432 12344568
Q ss_pred EEEEecCCCchhH----H----------Hhhhc-------------h----------------HHHHHHHHHHHHHhc--
Q 045256 571 LVYDYMKNGALYD----H----------LHDRN-------------N----------------VEKNAARGIEYLHNY-- 605 (789)
Q Consensus 571 lv~e~~~~gsL~~----~----------l~~~~-------------~----------------i~~~ia~~l~~LH~~-- 605 (789)
+|+||+++..+.. . ||... . ....+.+.+.++...
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999866532 1 11000 0 001122344454431
Q ss_pred --CCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 606 --AVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 606 --~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
....++|+|+.|.|||++++....|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 12348999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00039 Score=68.36 Aligned_cols=93 Identities=19% Similarity=0.328 Sum_probs=75.7
Q ss_pred HHHHHHHhhcCC-CcceEEEEEEEeCCeEEEEEEecCCCchh-------HHH----hhhchHHHHHHHHHHHHHhcCCCC
Q 045256 542 DSELAFLSRLHH-KHLVRLVGYCEEKDERLLVYDYMKNGALY-------DHL----HDRNNVEKNAARGIEYLHNYAVPP 609 (789)
Q Consensus 542 ~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~lv~e~~~~gsL~-------~~l----~~~~~i~~~ia~~l~~LH~~~~~~ 609 (789)
.+|.-+++.+.+ +++.+++|+|-+ +++.||...+++. +++ ..|.+++.++++.+++|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888876 699999999943 6789999876543 333 346689999999999999865555
Q ss_pred eEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 610 IIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 610 ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+...|++++|+-+++++++|++|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 89999999999999999999999986643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00063 Score=72.72 Aligned_cols=74 Identities=24% Similarity=0.341 Sum_probs=46.2
Q ss_pred ceEeecccEEEEEEEeCC-------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeEEE
Q 045256 500 NKIGAGSFGVVYKGKLPD-------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDERLL 571 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~l 571 (789)
+.|..|-.-.+|+....+ ++.+++|+....... .....+|.+++..+....+ .+++.++. -.+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~-----~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~ 74 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL-----LIDRERELVVFARLSERNLGPKLYGIFP----NGR 74 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc-----eechHHHHHHHHHHHhCCCCCceEEEeC----CCc
Confidence 456667777899998655 578999985443211 1124578888888853333 34454443 136
Q ss_pred EEEecCCCchh
Q 045256 572 VYDYMKNGALY 582 (789)
Q Consensus 572 v~e~~~~gsL~ 582 (789)
|+||+++..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0023 Score=70.20 Aligned_cols=80 Identities=14% Similarity=0.228 Sum_probs=53.6
Q ss_pred cceEeecccEEEEEEEeCCC-cEEEEEEcccchh---hhHHHHHHHHHHHHHHHhhcC---CCcceEEEEEEEeCCeEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDG-QEVAIKRGETAKT---KKFQEKESAFDSELAFLSRLH---HKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~---~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~l 571 (789)
.+.||.|.+..||++...+| +.++||.-..... ..+....+.+..|.+.|+.+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998777 5899997432111 111112334666777777763 2456667666 4456789
Q ss_pred EEEecCCCc
Q 045256 572 VYDYMKNGA 580 (789)
Q Consensus 572 v~e~~~~gs 580 (789)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0023 Score=68.52 Aligned_cols=132 Identities=17% Similarity=0.190 Sum_probs=77.7
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCC--cceEEEEE------EEeCCeEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK--HLVRLVGY------CEEKDERL 570 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp--nIv~l~~~------~~~~~~~~ 570 (789)
.+.++.|....+|+....++ .+++|+...... .+.+..|++++..|... .+.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~------~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK------AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC------HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 45677787789999876555 577887543211 11244566667666321 23344332 12245678
Q ss_pred EEEEecCCCchh----HH----------Hhhh--------------ch---H---------------HHHHHHHHHHHHh
Q 045256 571 LVYDYMKNGALY----DH----------LHDR--------------NN---V---------------EKNAARGIEYLHN 604 (789)
Q Consensus 571 lv~e~~~~gsL~----~~----------l~~~--------------~~---i---------------~~~ia~~l~~LH~ 604 (789)
+++||++|..+. +. +|.. .. . ...+.+.++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885432 10 1100 00 0 0112234555543
Q ss_pred ----cCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 605 ----YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 605 ----~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.....++|+|+.+.||+++.+....|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 122459999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.003 Score=68.04 Aligned_cols=131 Identities=15% Similarity=0.159 Sum_probs=72.9
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc--ceEEEE------EEEeCCeEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH--LVRLVG------YCEEKDERL 570 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~------~~~~~~~~~ 570 (789)
.+.|..|....+|+....+| .+++|+... ... +.+..|+.++..|...+ +.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~-~~~------~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFER-LTA------EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEecc-CCh------HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35567777789999987655 688887641 111 12334555555553111 223332 122345678
Q ss_pred EEEEecCCCchhH-----H---------Hhhhc-----------------hHHHH----------------HHHHHHHHH
Q 045256 571 LVYDYMKNGALYD-----H---------LHDRN-----------------NVEKN----------------AARGIEYLH 603 (789)
Q Consensus 571 lv~e~~~~gsL~~-----~---------l~~~~-----------------~i~~~----------------ia~~l~~LH 603 (789)
+++||+++..+.. . ||... ..... +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 9999999864311 1 11000 00000 111122222
Q ss_pred hc----CCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 604 NY----AVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 604 ~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.. -..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 22459999999999999976556899999764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.004 Score=65.49 Aligned_cols=75 Identities=17% Similarity=0.358 Sum_probs=47.3
Q ss_pred cccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC---CCcceEEEEEEEeCCeEEEEE
Q 045256 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH---HKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+..+.|+-|....+|+.. .+++.+.||.-... ....|..|.+-|+.|. --.+.+.+++....+..+|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~-------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES-------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG-------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecChh-------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 335678889999999988 57789999974311 1224778888888883 345778888888777889999
Q ss_pred EecCCC
Q 045256 574 DYMKNG 579 (789)
Q Consensus 574 e~~~~g 579 (789)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.00074 Score=69.77 Aligned_cols=135 Identities=21% Similarity=0.232 Sum_probs=94.5
Q ss_pred CccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhh--HHH----------------HHHHHHHHHHHHhhcC-C-C
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKK--FQE----------------KESAFDSELAFLSRLH-H-K 554 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~----------------~~~~~~~E~~~l~~l~-H-p 554 (789)
-+.+.+.||-|--+.+|.+...+|++.++|.-+..+... ... .+-...+|+..|+.|. | -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456789999999999999999999999999522211100 000 0112457889999884 3 2
Q ss_pred cceEEEEEEEeCCeEEEEEEecCCCchhHHHh--hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEe
Q 045256 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLH--DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSD 632 (789)
Q Consensus 555 nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 632 (789)
-+.+.+++ ...++|||++.+-.|...-+ .-..+...+..-+--|-..+ +||+|..-=||+++++..++++|
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vID 245 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVID 245 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCChHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEee
Confidence 24444444 45589999999877766432 23345555555566676777 99999999999999999999999
Q ss_pred eccC
Q 045256 633 FGLS 636 (789)
Q Consensus 633 fGls 636 (789)
|--.
T Consensus 246 FPQm 249 (465)
T KOG2268|consen 246 FPQM 249 (465)
T ss_pred chHh
Confidence 9654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.02 E-value=0.0063 Score=63.92 Aligned_cols=31 Identities=19% Similarity=0.401 Sum_probs=25.3
Q ss_pred CCeEeccCCCCCEEECCCCc-EEEEeeccCcC
Q 045256 608 PPIIHRDIKSSNILLDAQWT-ARVSDFGLSMM 638 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~~-~kl~DfGls~~ 638 (789)
+.++|+|++|.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997555 46999997754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0021 Score=76.66 Aligned_cols=189 Identities=22% Similarity=0.268 Sum_probs=124.9
Q ss_pred HHHHHHHHHhhcCCCcceEEEEEEEeCCeE----EEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCC
Q 045256 540 AFDSELAFLSRLHHKHLVRLVGYCEEKDER----LLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAV 607 (789)
Q Consensus 540 ~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~ 607 (789)
...-|+..+.++.|+|++.++.|-.+.... .+..|++..-++...+.... .+..++.+||+|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~- 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS- 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc-
Confidence 345677788888999999999987654332 24457777777777776433 35566788999999986
Q ss_pred CCeEeccCCCC---CEEECCCCcEEEE--eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCch--hHHHHHHHH
Q 045256 608 PPIIHRDIKSS---NILLDAQWTARVS--DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAK--SDVYGLGVV 680 (789)
Q Consensus 608 ~~ivH~Dlkp~---NIll~~~~~~kl~--DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDv~SlGvi 680 (789)
..|.-|..+ +--.+.++...++ ||+.+.......... ...-+..|.+||.+.......+ .|+|.+|..
T Consensus 307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 455544444 4445666777777 998887655544332 2234567888888876655544 799999999
Q ss_pred HHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHH
Q 045256 681 LLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760 (789)
Q Consensus 681 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev 760 (789)
+..+..+..+-..... ...+++.. . .. .+..+..+|+..++++|++..++
T Consensus 382 ~~~~~~~~~i~~~~~~--------------------~~~~l~~~----~--~~----~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV--------------------PVSLLDVL----S--TS----ELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HhhhhhcCcccccccc--------------------hhhhhccc----c--ch----hhhhhhhhhcchhhhhccchhhh
Confidence 9999987654211100 00111110 0 00 23445667999999999999999
Q ss_pred HHHH
Q 045256 761 VANL 764 (789)
Q Consensus 761 l~~L 764 (789)
+.+.
T Consensus 432 l~~~ 435 (1351)
T KOG1035|consen 432 LTHP 435 (1351)
T ss_pred hhch
Confidence 8876
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.013 Score=63.79 Aligned_cols=129 Identities=17% Similarity=0.220 Sum_probs=74.0
Q ss_pred ceEeecccEEEEEEEeCC-----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcce-EEEEEEEeCCeEEEEE
Q 045256 500 NKIGAGSFGVVYKGKLPD-----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV-RLVGYCEEKDERLLVY 573 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~~~~~~~~~~~lv~ 573 (789)
+.|-.|-.-.+|+....+ ++.|++|+...... .. . .-.+|..+++.+..-++. ++++.+.. . .|+
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~---i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LF---F-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-ee---e-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 455557778899987532 36789998654321 11 1 124688888888644443 45555432 2 589
Q ss_pred EecCCCchhHH-----------------Hhhh-------chHHHH------------------------HHHHHHHHH--
Q 045256 574 DYMKNGALYDH-----------------LHDR-------NNVEKN------------------------AARGIEYLH-- 603 (789)
Q Consensus 574 e~~~~gsL~~~-----------------l~~~-------~~i~~~------------------------ia~~l~~LH-- 603 (789)
||+++.+|... +|+. ..+..+ +..-+..|.
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665321 1100 000010 111112221
Q ss_pred --h-cCCCCeEeccCCCCCEEECC-CCcEEEEeeccCc
Q 045256 604 --N-YAVPPIIHRDIKSSNILLDA-QWTARVSDFGLSM 637 (789)
Q Consensus 604 --~-~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGls~ 637 (789)
. .....++|+|+++.|||+++ +..+.|+||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 11124899999999999976 4689999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.026 Score=59.84 Aligned_cols=139 Identities=19% Similarity=0.318 Sum_probs=80.6
Q ss_pred cccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--CcceEEEEEEEeCC--eEEEE
Q 045256 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--KHLVRLVGYCEEKD--ERLLV 572 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~--~~~lv 572 (789)
.+.+.+..|..-.+|..... ++.+++++ .. ............+|+++++.+.- -=+...+++|.+.. ..|.|
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR~-P~--~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT-GQKYVLRK-PP--RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred ceeeeccCCcccceEEEecC-CceEEEec-CC--ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 33444544444445555443 77888872 21 11112233346678888888743 22334456665554 56999
Q ss_pred EEecCCCchhHHHhh---hchHHH-H--------------------------------------------------HHHH
Q 045256 573 YDYMKNGALYDHLHD---RNNVEK-N--------------------------------------------------AARG 598 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~---~~~i~~-~--------------------------------------------------ia~~ 598 (789)
|+|+++..+.+.+.. ...++. . ..+-
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 999988332221100 000111 1 2223
Q ss_pred HHHHHhcCC-----CCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 599 IEYLHNYAV-----PPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 599 l~~LH~~~~-----~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
..||++... +.++|+|+.+.||+++.+..+=|.||+++.+.
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 455554432 45999999999999999888999999998763
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.057 Score=57.86 Aligned_cols=29 Identities=31% Similarity=0.345 Sum_probs=24.8
Q ss_pred CCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 578999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.037 Score=59.88 Aligned_cols=73 Identities=14% Similarity=0.230 Sum_probs=44.1
Q ss_pred ceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeEEEEEE
Q 045256 500 NKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e 574 (789)
+.|..|-.-.+|+....+ +..|++|+........ -.-.+|..+++.+..-++ .++++++. . . +|.+
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-----IdR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~ 90 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-----IDRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQS 90 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-----echHHHHHHHHHHHhcCCCCceeEEeC-C-c--Eeeh
Confidence 455557777889887543 2478899754432211 113468888888865455 34555542 2 2 5899
Q ss_pred ecCCCch
Q 045256 575 YMKNGAL 581 (789)
Q Consensus 575 ~~~~gsL 581 (789)
|+++..|
T Consensus 91 fi~g~~l 97 (330)
T PLN02421 91 FINARTL 97 (330)
T ss_pred hhcCCCC
Confidence 9977655
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.034 Score=59.75 Aligned_cols=77 Identities=14% Similarity=0.194 Sum_probs=47.6
Q ss_pred eEeecccEEEEEEEeCCC-cEEEEEEcccchhh---hHHHHHHHHHHHHHHHhhcC--CCc-ceEEEEEEEeCCeEEEEE
Q 045256 501 KIGAGSFGVVYKGKLPDG-QEVAIKRGETAKTK---KFQEKESAFDSELAFLSRLH--HKH-LVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~---~~~~~~~~~~~E~~~l~~l~--Hpn-Iv~l~~~~~~~~~~~lv~ 573 (789)
.||-|..-.||++..+++ +.|+||.-...... .+.-..+...-|.+.|+... -|. +.+++. .+++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 478899999999998655 68999974322111 11222233445667776653 353 444443 3555667999
Q ss_pred EecCCC
Q 045256 574 DYMKNG 579 (789)
Q Consensus 574 e~~~~g 579 (789)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.11 Score=64.59 Aligned_cols=31 Identities=35% Similarity=0.514 Sum_probs=25.6
Q ss_pred CCeEeccCCCCCEEECCCC--cEE-EEeeccCcC
Q 045256 608 PPIIHRDIKSSNILLDAQW--TAR-VSDFGLSMM 638 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~--~~k-l~DfGls~~ 638 (789)
..+||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3499999999999999875 555 999997653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 789 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-33 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-25 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 9e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-08 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-08 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-08 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-08 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-08 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-08 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-08 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 6e-08 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-08 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-08 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 9e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-05 | ||
| 1jtd_B | 273 | Crystal Structure Of Beta-Lactamase Inhibitor Prote | 9e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-05 | ||
| 3qhy_B | 282 | Structural, Thermodynamic And Kinetic Analysis Of T | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-04 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-04 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-04 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-04 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1JTD|B Chain B, Crystal Structure Of Beta-Lactamase Inhibitor Protein-Ii In Complex With Tem-1 Beta-Lactamase Length = 273 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QHY|B Chain B, Structural, Thermodynamic And Kinetic Analysis Of The Picomolar Binding Affinity Interaction Of The Beta-Lactamase Inhibitor Protein- Ii (Blip-Ii) With Class A Beta-Lactamases Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 363 bits (934), Expect = e-120
Identities = 125/340 (36%), Positives = 180/340 (52%), Gaps = 38/340 (11%)
Query: 444 GSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIG 503
GS S + S S L+ R L +L ATNNF + IG
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYR-------------VPLVDLEEATNNFDHKFLIG 48
Query: 504 AGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQ-EKESAFDSELAFLSRLHHKHLVRLVGY 562
G FG VYKG L DG +VA+KR + Q +E F++E+ LS H HLV L+G+
Sbjct: 49 HGVFGKVYKGVLRDGAKVALKR---RTPESSQGIEE--FETEIETLSFCRHPHLVSLIGF 103
Query: 563 CEEKDERLLVYDYMKNGALYDHLHDRNNVEKN------------AARGIEYLHNYAVPPI 610
C+E++E +L+Y YM+NG L HL+ + + AARG+ YLH I
Sbjct: 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAI 160
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTA 670
IHRD+KS NILLD + +++DFG+S G E ++ GT+GYIDPEY+ LT
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE 220
Query: 671 KSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730
KSDVY GVVL E+L + AI + V+L ++AV + G+L +I+D + +I
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNGQLEQIVDPNLA-DKI 277
Query: 731 NEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770
E++ TA+ C+ L ++RP+M D++ LE AL +
Sbjct: 278 RP-ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-108
Identities = 109/299 (36%), Positives = 163/299 (54%), Gaps = 28/299 (9%)
Query: 484 FLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS 543
F L EL A++NFS +N +G G FG VYKG+L DG VA+KR K ++ Q E F +
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR---LKEERTQGGELQFQT 76
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN--------- 594
E+ +S H++L+RL G+C ERLLVY YM NG++ L +R +
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 595 ---AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE-----SERDF 646
+ARG+ YLH++ P IIHRD+K++NILLD ++ A V DFGL+ + +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA-- 194
Query: 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706
GT+G+I PEY + K+DV+G GV+LLEL+TG+RA + V L+D
Sbjct: 195 ----VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
+ + +L ++D + + E +L+ A+ C ERP M+++V LE
Sbjct: 251 WVKGLLKEKKLEALVDVDLQ-GNYKDEEVEQLIQ-VALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 314 bits (808), Expect = e-101
Identities = 97/301 (32%), Positives = 148/301 (49%), Gaps = 32/301 (10%)
Query: 484 FLLAELAAATNNFSLE------NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEK 537
F EL TNNF NK+G G FGVVYKG + + VA+K+ +E
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 538 ESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---- 593
+ FD E+ +++ H++LV L+G+ + D+ LVY YM NG+L D L +
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 594 -------NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
AA GI +LH IHRDIKS+NILLD +TA++SDFGL+ + +
Sbjct: 134 MRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 647 RPMKAAGTVGYIDPEYY-GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV 705
+ GT Y+ PE G +T KSD+Y GVVLLE++TG A+ DE P L+
Sbjct: 191 MTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAV---DEHRE-PQLLL 244
Query: 706 DFAVPAIM-AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764
D + +D+++ + + + + A C++ + +RP + + L
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYS-VASQCLHEKKNKRPDIKKVQQLL 301
Query: 765 E 765
+
Sbjct: 302 Q 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-71
Identities = 63/310 (20%), Positives = 124/310 (40%), Gaps = 35/310 (11%)
Query: 483 EFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFD 542
+ L + L G FG V+K + + VA+K + +Q +
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-----NE 66
Query: 543 SELAFLSRLHHKHLVRLVGYCEEKD----ERLLVYDYMKNGALYDHLH-------DRNNV 591
E+ L + H+++++ +G + + L+ + + G+L D L + ++
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI 126
Query: 592 EKNAARGIEYLHNYAV-------PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644
+ ARG+ YLH P I HRDIKS N+LL TA ++DFGL++ +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 645 DFRPMKAAGTVGYIDPEY--YGLNV---LTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699
GT Y+ PE +N + D+Y +G+VL EL + A +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEA----EAVELVAYTAMHCVNLEGKERP 755
P P++ ++ +++ + P + + + ++ T C + + + R
Sbjct: 247 LPFEEEIGQHPSLE--DMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 756 TMADIVANLE 765
+ + +
Sbjct: 305 SAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (540), Expect = 2e-62
Identities = 78/336 (23%), Positives = 130/336 (38%), Gaps = 44/336 (13%)
Query: 483 EFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKF-QEKESAF 541
E +E + +N L IG G +G VYKG L D + VA+K A + F EK
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN--- 57
Query: 542 DSELAFLSRLHHKHLVRLVGYCEE-----KDERLLVYDYMKNGALYDHLHDRNNVEKN-- 594
+ + + H ++ R + E + E LLV +Y NG+L +L + +
Sbjct: 58 ---IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC 114
Query: 595 -----AARGIEYLHN------YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM----- 638
RG+ YLH + P I HRD+ S N+L+ T +SDFGLSM
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 639 -GPESERDFRPMKAAGTVGYIDPEY-------YGLNVLTAKSDVYGLGVVLLELLTGKRA 690
E D + GT+ Y+ PE + D+Y LG++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 691 IFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEA-----EAVELVAYTAMH 745
+F + ++ ++ ++ R P+ EA AV + T
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 746 CVNLEGKERPTMADIVANLERALDICDHSHGSISSS 781
C + + + R T + + I + + ++
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTA 330
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-57
Identities = 83/284 (29%), Positives = 134/284 (47%), Gaps = 36/284 (12%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ +++ KIGAGSFG V++ + G +VA+K + E F E+A + RL H
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE--FLREVAIMKRLRH 93
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-----------NAARGIEYL 602
++V +G + +V +Y+ G+LY LH E+ + A+G+ YL
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
HN PPI+HR++KS N+L+D ++T +V DFGLS + ++ AAGT ++ PE
Sbjct: 154 HNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEV 210
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
KSDVY GV+L EL T + P ++ A ++A V
Sbjct: 211 LRDEPSNEKSDVYSFGVILWELATLQ-----------QPWGNLNPA--QVVAA--VGFKC 255
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
+R+ P + ++ C E +RP+ A I+ L
Sbjct: 256 KRLEIPRNLNPQVAAIIE----GCWTNEPWKRPSFATIMDLLRP 295
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 39/283 (13%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
LE IG G FG VY+ G EVA+K + + E + L H +++
Sbjct: 11 LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRN-------NVEKNAARGIEYLHNYAVPPI 610
L G C ++ LV ++ + G L L + N ARG+ YLH+ A+ PI
Sbjct: 70 ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 611 IHRDIKSSNILLD--------AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
IHRD+KSSNIL+ + +++DFGL+ + + M AAG ++ PE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEV 185
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
++ + SDV+ GV+L ELLTG+ P +D A+ G V +
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGE-----------VPFRGIDGL--AVAYG--VAMNK 230
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
+ P +L+ C N + RP+ +I+ L
Sbjct: 231 LALPIPSTCPEPFAKLM----EDCWNPDPHSRPSFTNILDQLT 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-55
Identities = 72/285 (25%), Positives = 126/285 (44%), Gaps = 44/285 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+E +G G+FGVV K K ++VAIK+ E+ + + AF EL LSR++H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES------ESERKAFIVELRQLSRVNH 60
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-----------NAARGIEYL 602
++V+L G C + LV +Y + G+LY+ LH + ++G+ YL
Sbjct: 61 PNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWT-ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
H+ +IHRD+K N+LL A T ++ DFG + + G+ ++ PE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPE 173
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
+ + + K DV+ G++L E++T ++ F + PA V
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKP-FD------------EIGGPAFRIMWAVHNG 220
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
R + + + C + + +RP+M +IV +
Sbjct: 221 TRPPLIKNLPKP-----IESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-54
Identities = 58/289 (20%), Positives = 111/289 (38%), Gaps = 47/289 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESA-FDSELAFLSRLH 552
+ K+ G ++KG+ G ++ +K K + + ++S F+ E L
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKV---LKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 553 HKHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVE----------KNAARGIE 600
H +++ ++G C+ + +M G+LY+ LH+ N + ARG+
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
+LH P I + S ++++D TAR+S + F+ ++ P
Sbjct: 126 FLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAP 177
Query: 661 E---YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
E + +D++ V+L EL+T + F D + + G
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVP-FAD--------------LSNMEIGMK 222
Query: 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
V + R P +L+ C+N + +RP IV LE+
Sbjct: 223 VALEGLRPTIPPGISPHVSKLM----KICMNEDPAKRPKFDMIVPILEK 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-54
Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 45/293 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKR---GETAKTKKFQEKESAFDSELAFLS 549
N E +IG G FG+V+KG+ + D VAIK G++ + EK F E+ +S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIE 600
L+H ++V+L G + +V +++ G LY L D+ + + + A GIE
Sbjct: 79 NLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQW-----TARVSDFGLSMMGPESERDFRPMKAAGTV 655
Y+ N PPI+HRD++S NI L + A+V+DFGLS S G
Sbjct: 137 YMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNF 190
Query: 656 GYIDPE-YYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
++ PE T K+D Y ++L +LTG+ P + +
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG-----------PFDEYSYGKIKFI 239
Query: 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
++ R PE ++ C + + K+RP + IV L
Sbjct: 240 NM--IREEGLRPTIPEDCPPRLRNVI----ELCWSGDPKKRPHFSYIVKELSE 286
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 5e-52
Identities = 74/286 (25%), Positives = 122/286 (42%), Gaps = 37/286 (12%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEK-ESAFDSELAFLSRLH 552
++ +IG+GSFG VYKGK +VA+K + AF +E+ L +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW--HGDVAVK---MLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLH 603
H +++ +GY + +V + + +LY HLH + + ARG++YLH
Sbjct: 79 HVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-- 661
IIHRD+KS+NI L T ++ DFGL+ + + +G++ ++ PE
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 662 -YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
N + +SDVY G+VL EL+TG+ S + V G
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMV-----GRGSLS 244
Query: 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
D + + C+ + ERP+ I+A +E
Sbjct: 245 PDLSKVRSNCPKR-----MKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-50
Identities = 63/290 (21%), Positives = 112/290 (38%), Gaps = 48/290 (16%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
+ IG G FG VY G+ EVAI+ + + + Q K F E+ + H+++V
Sbjct: 37 IGELIGKGRFGQVYHGRW--HGEVAIRLIDIERDNEDQLKA--FKREVMAYRQTRHENVV 92
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVP 608
+G C ++ K LY + D + + +G+ YLH
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMM---GPESERDFRPMKAAGTVGYIDPE---- 661
I+H+D+KS N+ D ++DFGL + R+ + G + ++ PE
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 662 -----YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
+ SDV+ LG + EL + FK P + + + G
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-FK-----TQPAEAIIWQM---GTGM 259
Query: 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
P +++ + ++ + C E +ERPT ++ LE+
Sbjct: 260 K----------PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 7e-50
Identities = 65/296 (21%), Positives = 110/296 (37%), Gaps = 35/296 (11%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQEVAIKR-GETAKTKKFQEKESAFDSELAFLSRLHHKHL 556
L +G G +G V++G G+ VA+K + F+E E L L H+++
Sbjct: 12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETE------LYNTVMLRHENI 64
Query: 557 VRLVGYC----EEKDERLLVYDYMKNGALYDHLHDRN-------NVEKNAARGIEYLHNY 605
+ + + L+ Y + G+LYD+L + + A G+ +LH
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 606 AV-----PPIIHRDIKSSNILLDAQWTARVSDFGLSMM--GPESERDFRPMKAAGTVGYI 658
P I HRD+KS NIL+ ++D GL++M ++ D GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 659 DPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
PE + D++ G+VL E+ + E P V P+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS-NGIVEDYKPPFYDVVPNDPSF 243
Query: 713 MA-GELVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
++V + +R P + +A C R T I L +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-49
Identities = 68/300 (22%), Positives = 118/300 (39%), Gaps = 43/300 (14%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
+ +IG G +G V+ GK G++VA+K +E ++E+ + H++++
Sbjct: 41 MVKQIGKGRYGEVWMGKW-RGEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHENIL 94
Query: 558 RLVGYCEEKDER----LLVYDYMKNGALYDHLHDRN-------NVEKNAARGIEYLHNYA 606
+ + L+ DY +NG+LYD+L + ++ G+ +LH
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 607 V-----PPIIHRDIKSSNILLDAQWTARVSDFGLSMM--GPESERDFRPMKAAGTVGYID 659
P I HRD+KS NIL+ T ++D GL++ +E D P GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 660 PEYYGLNVL-----------TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708
PE VL +D+Y G++L E+ + E P + +
Sbjct: 215 PE-----VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS-GGIVEEYQLPYHDLVPS 268
Query: 709 VPAIMA-GELVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
P+ E+V I R P + E + + C R T + L +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 6e-49
Identities = 61/291 (20%), Positives = 112/291 (38%), Gaps = 49/291 (16%)
Query: 498 LENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEK-ESAFDSELAFLSRLHHKH 555
+G G FG K G+ + +K + +F E+ + F E+ + L H +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMK-----ELIRFDEETQRTFLKEVKVMRCLEHPN 68
Query: 556 LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLHNYA 606
+++ +G + + +Y+K G L + ++ K+ A G+ YLH+
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM- 127
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLS------------MMGPESERDFRPMKAAGT 654
IIHRD+ S N L+ V+DFGL+ + + + G
Sbjct: 128 --NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185
Query: 655 VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714
++ PE K DV+ G+VL E++ A + P + +DF +
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPDYLPRT-MDFGL----- 234
Query: 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
V+ R PP + + C +L+ ++RP+ + LE
Sbjct: 235 --NVRGFLDRYCPPNCPPS-----FFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-48
Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 41/299 (13%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
L+ IG G FG V++GK G+EVA+K +E+ ++E+ L H++++
Sbjct: 46 LQESIGKGRFGEVWRGKW-RGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENIL 99
Query: 558 RLVGYCEEKD----ERLLVYDYMKNGALYDHLHDRN-------NVEKNAARGIEYLHNYA 606
+ + + + LV DY ++G+L+D+L+ + + A G+ +LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 607 V-----PPIIHRDIKSSNILLDAQWTARVSDFGLSMM--GPESERDFRPMKAAGTVGYID 659
V P I HRD+KS NIL+ T ++D GL++ D P GT Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 660 PEYYGLNVL-----------TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708
PE VL ++D+Y +G+V E+ ++ LV
Sbjct: 220 PE-----VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274
Query: 709 VPAIMAGELVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
++V R P EA+ ++A C G R T I L +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-38
Identities = 59/236 (25%), Positives = 99/236 (41%), Gaps = 54/236 (22%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
++F +G G+FG V K + D + AIK K + +EK S SE+ L+ L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIK-----KIRHTEEKLSTILSEVMLLASL 59
Query: 552 HHKHLVRLVG-YCEEKDERL------------LVYDYMKNGALYDHLHDRN-NVEKNAAR 597
+H+++VR + E ++ + +Y +NG LYD +H N N +++
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 598 --------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
+ Y+H+ IIHRD+K NI +D ++ DFGL+ S +
Sbjct: 120 RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 650 KAA------------GTVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTG 687
GT Y+ E +Y K D+Y LG++ E++
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 66/279 (23%), Positives = 107/279 (38%), Gaps = 58/279 (20%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
+IG GSF VYKG EVA E K + + F E L L H ++VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWC--ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 560 VGYCE---EKDERLLVY-DYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAV 607
E + + +++ + M +G L +L ++ R G+++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT- 149
Query: 608 PPIIHRDIKSSNILLDA-QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN 666
PPIIHRD+K NI + + ++ D GL+ + S + + GT ++ PE Y
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVI--GTPEFMAPEMYEEK 205
Query: 667 VLTAKSDVYGLGVVLLELLTGK---------RAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
DVY G+ +LE+ T + I++ SG P S
Sbjct: 206 Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF------------- 251
Query: 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT 756
++ E E++ C+ ER +
Sbjct: 252 ----------DKVAIPEVKEII----EGCIRQNKDERYS 276
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 66/292 (22%), Positives = 121/292 (41%), Gaps = 53/292 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ L +IG G+FG V+ G+L D VA+K + + + ++ F E L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK---SCRETLPPDLKAKFLQEARILKQYS 170
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------NAARGIEYLH 603
H ++VRL+G C +K +V + ++ G L + +AA G+EYL
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 604 --NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI--- 658
IHRD+ + N L+ + ++SDFG+S + A+G + +
Sbjct: 231 SKCC-----IHRDLAARNCLVTEKNVLKISDFGMSREEADGV-----YAASGGLRQVPVK 280
Query: 659 --DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
PE +++SDV+ G++L E + G +P P + +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSL----------GASP-------YPNLSNQQ 323
Query: 717 LVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
+ +++ R+ PE+ L+ C E +RP+ + I L+
Sbjct: 324 TREFVEKGGRLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQS 371
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 49/231 (21%), Positives = 93/231 (40%), Gaps = 48/231 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS---------- 543
N++ + + G F + + D + A+K+ E + +K ++ + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 544 ---ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--- 597
EL ++ + +++ + G DE ++Y+YM+N ++ ++KN
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 598 -------------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644
Y+HN I HRD+K SNIL+D ++SDFG S + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 645 DFRPMKAAGTVGYIDPE-------YYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ GT ++ PE Y G AK D++ LG+ L +
Sbjct: 208 K----GSRGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNV 249
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 63/330 (19%), Positives = 119/330 (36%), Gaps = 56/330 (16%)
Query: 466 MRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK 524
M F + ++ K+G G F V + L DG A+K
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALK 60
Query: 525 RGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER----LLVYDYMKNGA 580
R ++ Q++E A E +H +++RLV YC + L+ + K G
Sbjct: 61 R--ILCHEQ-QDREEAQ-READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGT 116
Query: 581 LYDHLHDRNNV-----EKNA-------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA 628
L++ + + E RG+E +H HRD+K +NILL +
Sbjct: 117 LWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQP 173
Query: 629 RVSDFGLS---MMGPESERDFRPMKAA----GTVGYIDPE---YYGLNVLTAKSDVYGLG 678
+ D G + E R ++ T+ Y PE V+ ++DV+ LG
Sbjct: 174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG 233
Query: 679 VVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINE--AEAV 736
VL ++ G+ P + + + + ++ P+ +
Sbjct: 234 CVLYAMMFGE-----------GP-----YDMVFQKGDSVALAVQNQLSIPQSPRHSSALW 277
Query: 737 ELVAYTAMHCVNLEGKERPTMADIVANLER 766
+L+ + ++ +RP + +++ LE
Sbjct: 278 QLLNS----MMTVDPHQRPHIPLLLSQLEA 303
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 68/261 (26%), Positives = 110/261 (42%), Gaps = 38/261 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F + +G G FG VY + +A+K A+ +K + E+ S L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR-------GIEYLHN 604
H +++RL GY + L+ +Y G +Y L + E+ A + Y H+
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE--- 661
V IHRDIK N+LL + +++DFG S+ P S R GT+ Y+ PE
Sbjct: 128 KRV---IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----DLCGTLDYLPPEMIE 180
Query: 662 --YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT--PVSLVDFAVPAIMAGE- 716
+ K D++ LGV+ E L GK F+ + T +S V+F P +
Sbjct: 181 GRMHD-----EKVDLWSLGVLCYEFLVGK-PPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 717 ---LVKILDR----RVGPPEI 730
+ ++L R E+
Sbjct: 235 RDLISRLLKHNPSQRPMLREV 255
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 54/286 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ KIG GSFG K DG++ IK ++ +E+E + E+A L+ +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESR-REVAVLANMK 81
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV---EKNAAR-------GIEYL 602
H ++V+ EE +V DY + G L+ ++ + V E ++++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYIDPE 661
H+ I+HRDIKS NI L T ++ DFG++ ++ S + GT Y+ PE
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELA-RACIGTPYYLSPE 195
Query: 662 ------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
Y KSD++ LG VL EL T K A F+ G+ +LV
Sbjct: 196 ICENKPY------NNKSDIWALGCVLYELCTLKHA-FE----AGSMKNLV---------- 234
Query: 716 ELVKILDRRVGP-PEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+KI+ P + LV ++RP++ I
Sbjct: 235 --LKIISGSFPPVSLHYSYDLRSLV----SQLFKRNPRDRPSVNSI 274
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 59/291 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
L IG G FG V G G +VA+K K AF +E + +++L H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVK------CIKNDATAQAFLAEASVMTQLRH 245
Query: 554 KHLVRLVGYC-EEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------ARGIEYL 602
+LV+L+G EEK +V +YM G+L D+L R +EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 603 --HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMK-AAGTVGYI 658
+N+ +HRD+ + N+L+ A+VSDFGL+ ++ + P+K A
Sbjct: 306 EGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA------ 354
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718
PE + KSDV+ G++L E+ + G P P I ++V
Sbjct: 355 -PEALREKKFSTKSDVWSFGILLWEIYSF----------GRVP-------YPRIPLKDVV 396
Query: 719 KILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
+++ ++ P+ AV Y M +C +L+ RPT + LE
Sbjct: 397 PRVEKGYKMDAPD-GCPPAV----YDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 62/262 (23%), Positives = 108/262 (41%), Gaps = 40/262 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++F + +G G FG VY + + +A+K ++ +K + E+ S L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLR 72
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRNNVEKNAAR-------GIEYLH 603
H +++R+ Y ++ L+ ++ G LY L H R + E+ +A + Y H
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFMEELADALHYCH 131
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-- 661
V IHRDIK N+L+ + +++DFG S+ P R GT+ Y+ PE
Sbjct: 132 ERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----TMCGTLDYLPPEMI 184
Query: 662 ---YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT--PVSLVDFAVPAIMAGE 716
+ K D++ GV+ E L G F T + VD P ++
Sbjct: 185 EGKTHD-----EKVDLWCAGVLCYEFLVGM-PPFDSPSHTETHRRIVNVDLKFPPFLSDG 238
Query: 717 ----LVKILDR----RVGPPEI 730
+ K+L R+ +
Sbjct: 239 SKDLISKLLRYHPPQRLPLKGV 260
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 60/297 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-PDGQE----VAIKRGETAKTKKFQEKESAFDSELAFL 548
F +G+G+FG VYKG P+G++ VAIK + + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEILDEAYVM 71
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNA--------ARGI 599
+ + + H+ RL+G C L+ M G L D++ + ++N+ A+G+
Sbjct: 72 ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 600 EYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGT- 654
YL +HRD+ + N+L+ +++DFGL+ + E E A G
Sbjct: 131 NYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----HAEGGK 180
Query: 655 --VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
+ ++ E + T +SDV+ GV + EL+T G P I
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF----------GSKP-------YDGI 223
Query: 713 MAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
A E+ IL++ R+ P I + Y M C ++ RP +++ +
Sbjct: 224 PASEISSILEKGERLPQPPICTID-----VYMIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 61/284 (21%), Positives = 113/284 (39%), Gaps = 44/284 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
NF +E KIG G F VY+ L DG VA+K+ + + + E+ L +L+
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLN 90
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN------------AARGIE 600
H ++++ E +E +V + G L + ++ +E
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVG--- 656
++H+ ++HRDIK +N+ + A ++ D GL ++ A VG
Sbjct: 151 HMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT------AAHSLVGTPY 201
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
Y+ PE N KSD++ LG +L E+ + + D + + I +
Sbjct: 202 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-------LYSLCKKIEQCD 254
Query: 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+ P + E +LV C+N + ++RP + +
Sbjct: 255 YPPL------PSDHYSEELRQLV----NMCINPDPEKRPDVTYV 288
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-34
Identities = 62/341 (18%), Positives = 129/341 (37%), Gaps = 53/341 (15%)
Query: 445 SNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATN-NFSLENKIG 503
++ R + ++ + + S D E + +S+ +IG
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 504 AGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK--HLVRLVG 561
+G V++ Q AIK + + ++ +E+A+L++L ++RL
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKY--VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 562 YCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPIIHR 613
Y +V + N L L + +++ + + +H + I+H
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179
Query: 614 DIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYIDPE----------- 661
D+K +N L+ ++ DFG++ M P++ + G V Y+ PE
Sbjct: 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK-DSQVGAVNYMPPEAIKDMSSSREN 237
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
+ ++ KSDV+ LG +L + GK TP F +L I+
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGK-----------TP-----FQQIINQISKLHAII 281
Query: 722 DRRVGP--PEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
D P+I E + +++ C+ + K+R ++ ++
Sbjct: 282 DPNHEIEFPDIPEKDLQDVL----KCCLKRDPKQRISIPEL 318
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 64/300 (21%), Positives = 113/300 (37%), Gaps = 78/300 (26%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F IG+G FG V+K K DG+ IK + K E A E+ L++L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK-----RVKY--NNEKAE-REVKALAKLD 62
Query: 553 HKHLVRLVGYCEEKDERL----------------LVYDYMKNGALYDHLHDRNNV---EK 593
H ++V G + D + ++ G L + R +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 594 NAAR-------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERD 645
A G++Y+H+ +I+RD+K SNI L ++ DFGL + + +R
Sbjct: 123 LALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR- 178
Query: 646 FRPMKAAGTVGYIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700
++ GT+ Y+ PE YG + D+Y LG++L ELL
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGK-----EVDLYALGLILAELLHVCD----------- 219
Query: 701 PVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
A + L + ++ + L+ ++ + ++RP ++I
Sbjct: 220 ---------TAFETSKFFTDLRDGIISDIFDK-KEKTLLQ----KLLSKKPEDRPNTSEI 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 57/290 (19%), Positives = 113/290 (38%), Gaps = 50/290 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+S+ +IG+G V++ Q AIK + + ++ +E+A+L++L
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY--VNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 554 K--HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
++RL Y +V + N L L + +++ + + +H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-- 661
+ I+H D+K +N L+ ++ DFG++ GTV Y+ PE
Sbjct: 145 QHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 662 ---------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
+ ++ KSDV+ LG +L + GK TP F
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-----------TP-----FQQIIN 244
Query: 713 MAGELVKILDRRVGP--PEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+L I+D P+I E + +++ C+ + K+R ++ ++
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVL----KCCLKRDPKQRISIPEL 290
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-34
Identities = 60/291 (20%), Positives = 119/291 (40%), Gaps = 52/291 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-- 551
+S+ +IG+G V++ Q AIK + + ++ +E+A+L++L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKY--VNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
H ++RL Y +V + N L L + +++ + + +H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYIDPE- 661
+ I+H D+K +N L+ ++ DFG++ M P++ + GTV Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK-DSQVGTVNYMPPEA 180
Query: 662 ----------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711
+ ++ KSDV+ LG +L + GK TP F
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-----------TP-----FQQII 224
Query: 712 IMAGELVKILDRRVGP--PEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+L I+D P+I E + +++ C+ + K+R ++ ++
Sbjct: 225 NQISKLHAIIDPNHEIEFPDIPEKDLQDVL----KCCLKRDPKQRISIPEL 271
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 64/292 (21%), Positives = 114/292 (39%), Gaps = 57/292 (19%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++ + IG GS+G K + DG+ + K + + EK+ SE+ L L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLV-SEVNLLRELK 63
Query: 553 HKHLVRLVG-YCEEKDERL-LVYDYMKNGALYDHL--HDRNNV---EKNAAR-------G 598
H ++VR + + L +V +Y + G L + + E+ R
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 599 IEYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTV 655
++ H + ++HRD+K +N+ LD + ++ DFGL+ ++ + F GT
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFA-KTFVGTP 180
Query: 656 GYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
Y+ PE Y KSD++ LG +L EL F + L
Sbjct: 181 YYMSPEQMNRMSY------NEKSDIWSLGCLLYELCALMPP-FT----AFSQKELAG--- 226
Query: 710 PAIMAGELVKILDRRVGP-PEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
KI + + P E E++ +NL+ RP++ +I
Sbjct: 227 ---------KIREGKFRRIPYRYSDELNEIIT----RMLNLKDYHRPSVEEI 265
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 37/222 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ + L + +G G+ V++G+ G AIK F E L +L+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65
Query: 553 HKHLVRLVGYCEEKDERL--LVYDYMKNGALYDHLHDRNNV----EKNAAR-------GI 599
HK++V+L EE R L+ ++ G+LY L + +N E G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 600 EYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSDFGLSMMGPESERDFRPMK-AAGT 654
+L I+HR+IK NI+ D Q +++DFG + + E GT
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGT 178
Query: 655 VGYIDPEYYGLNVL--------TAKSDVYGLGVVLLELLTGK 688
Y+ P+ Y VL A D++ +GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 77/291 (26%), Positives = 124/291 (42%), Gaps = 59/291 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
L IG G FG V G G +VA+K K AF +E + +++L H
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVK------CIKNDATAQAFLAEASVMTQLRH 73
Query: 554 KHLVRLVGYC-EEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------ARGIEYL 602
+LV+L+G EEK +V +YM G+L D+L R +EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 603 --HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMK-AAGTVGYI 658
+N+ +HRD+ + N+L+ A+VSDFGL+ ++ + P+K A
Sbjct: 134 EGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTA------ 182
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718
PE + KSDV+ G++L E+ + G P P I ++V
Sbjct: 183 -PEALREKKFSTKSDVWSFGILLWEIYSF----------GRVP-------YPRIPLKDVV 224
Query: 719 KILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
+++ ++ P+ AV Y M +C +L+ RP+ + LE
Sbjct: 225 PRVEKGYKMDAPD-GCPPAV----YEVMKNCWHLDAAMRPSFLQLREQLEH 270
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEK-ESAFDSELAFLSRL 551
+F + N +G GSF VY+ + + G EVAIK K ++ +E+ +L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIK--MIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNAAR-------GIEYL 602
H ++ L Y E+ + LV + NG + +L +R E A G+ YL
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE- 661
H++ + +HRD+ SN+LL +++DFGL+ + + GT YI PE
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQ-LKMPHEKH-YTLCGTPNYISPEI 183
Query: 662 ----YYGLNVLTAKSDVYGLGVVLLELLTGK 688
+G +SDV+ LG + LL G+
Sbjct: 184 ATRSAHG-----LESDVWSLGCMFYTLLIGR 209
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 79/293 (26%), Positives = 123/293 (41%), Gaps = 59/293 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ LE K+G G FG V+ G VAIK K AF E + +L H
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-----TLKPGTMSPEAFLQEAQVMKKLRH 238
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRNNVEKN--------AARGIEYL- 602
+ LV+L ++ +V +YM G+L D L + A G+ Y+
Sbjct: 239 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-----PMKAAGTVG 656
NY +HRD++++NIL+ +V+DFGL+ + ++E R P+K
Sbjct: 298 RMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------ 346
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
+ PE T KSDV+ G++L EL T G P P ++ E
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTK----------GRVP-------YPGMVNRE 389
Query: 717 LVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
++ ++R R+ P E++ + M C E +ERPT + A LE
Sbjct: 390 VLDQVERGYRMPCPP-ECPESL----HDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-33
Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 49/289 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ ++++K+G G +G VY+G VA+K T K + +E F E A + +
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEE--FLKEAAVMKEIK 274
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN----------AARGIEYL 602
H +LV+L+G C + ++ ++M G L D+L + N E + + +EYL
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 603 --HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
N+ IHR++ + N L+ +V+DFGLS + A + + P
Sbjct: 335 EKKNF-----IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAP 388
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
E N + KSDV+ GV+L E+ T G +P P I ++ ++
Sbjct: 389 ESLAYNKFSIKSDVWAFGVLLWEIAT----------YGMSP-------YPGIDLSQVYEL 431
Query: 721 LDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
L++ R+ PE E V Y M C +RP+ A+I E
Sbjct: 432 LEKDYRMERPE----GCPEKV-YELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-33
Identities = 56/286 (19%), Positives = 110/286 (38%), Gaps = 49/286 (17%)
Query: 495 NFSLENKIGAGSFG-VVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-H 552
+F ++ +G G+ G +VY+G D ++VA+KR E S D E+ L
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKR-------ILPECFSFADREVQLLRESDE 76
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNAAR-------GIEYLH 603
H +++R +++ + + + L +++ ++ G+ +LH
Sbjct: 77 HPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 604 NYAVPPIIHRDIKSSNILL-----DAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGY 657
+ I+HRD+K NIL+ + A +SDFGL F GT G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 658 IDPEYYGLNV---LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714
I PE + T D++ G V +++ F + L ++ +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH- 251
Query: 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
P + + A EL+ + ++ ++RP+ +
Sbjct: 252 ------------PEKHEDVIARELI----EKMIAMDPQKRPSAKHV 281
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 37/222 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ + L + +G G+ V++G+ G AIK F E L +L+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIK---VFNNISFLRPVDVQMREFEVLKKLN 65
Query: 553 HKHLVRLVGYCEEKDERL--LVYDYMKNGALYDHLHDRNNV----EKNAAR-------GI 599
HK++V+L EE R L+ ++ G+LY L + +N E G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 600 EYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSDFGLSMMGPESERDFRPMK-AAGT 654
+L I+HR+IK NI+ D Q +++DFG + + E GT
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE----QFVSLYGT 178
Query: 655 VGYIDPEYYGLNVL--------TAKSDVYGLGVVLLELLTGK 688
Y+ P+ Y VL A D++ +GV TG
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 60/299 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE-----VAIKRGETAKTKKFQEKESAFDSELAFL 548
+G+G FG V+KG E V IK + K ++ A + +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK---VIEDKSGRQSFQAVTDHMLAI 69
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNA--------ARGI 599
L H H+VRL+G C LV Y+ G+L DH+ R + A+G+
Sbjct: 70 GSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 600 EYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGT- 654
YL H +HR++ + N+LL + +V+DFG++ + + + +
Sbjct: 129 YYLEEHGM-----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL-----LYSEAK 178
Query: 655 --VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
+ ++ E T +SDV+ GV + EL+T G P +
Sbjct: 179 TPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF----------GAEP-------YAGL 221
Query: 713 MAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERAL 768
E+ +L++ R+ P+I + Y M C ++ RPT ++ R
Sbjct: 222 RLAEVPDLLEKGERLAQPQICTID-----VYMVMVKCWMIDENIRPTFKELANEFTRMA 275
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 76/312 (24%), Positives = 117/312 (37%), Gaps = 68/312 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFL 548
+G G FG V G+ VA+K K + S + E+ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK---ALKADAGPQHRSGWKQEIDIL 87
Query: 549 SRLHHKHLVRLVGYCEEKDER--LLVYDYMKNGALYDHLHDRNNVEKN-------AARGI 599
L+H+H+++ G CE+ LV +Y+ G+L D+L + G+
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGM 147
Query: 600 EYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------PMK 650
YLH +Y IHRD+ + N+LLD ++ DFGL+ PE +R P+
Sbjct: 148 AYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 651 --AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDF 707
A PE SDV+ GV L ELLT + L+
Sbjct: 203 WYA--------PECLKEYKFYYASDVWSFGVTLYELLTHCD----SSQSPPTKFLELIGI 250
Query: 708 AVPAIMAGELVKILDRRVG---------PPEINEAEAVELVAYTAM-HCVNLEGKERPTM 757
A + L ++L+R G P E+ Y M +C E RPT
Sbjct: 251 AQGQMTVLRLTELLER--GERLPRPDKCPAEV----------YHLMKNCWETEASFRPTF 298
Query: 758 ADIVANLERALD 769
+++ L+ +
Sbjct: 299 ENLIPILKTVHE 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 68/305 (22%), Positives = 109/305 (35%), Gaps = 64/305 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F +G G FGVV++ K D AIKR + +EK E+ L++L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK---VMREVKALAKLE 61
Query: 553 HKHLVRLVGYCEEKDE---------RLLVY---DYMKNGALYDHLHDRNNV----EKNA- 595
H +VR EK+ ++ +Y + L D ++ R +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 596 ------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS----------MMG 639
A +E+LH+ ++HRD+K SNI +V DFGL +
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699
R GT Y+ PE N + K D++ LG++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-------------- 224
Query: 700 TPVSLVDFAVPAIMAGELVKILDRRVGP-PEINEAEAVELVAYTAMHCVNLEGKERPTMA 758
P F+ L + + + P +V ++ ERP
Sbjct: 225 YP-----FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ----DMLSPSPMERPEAI 275
Query: 759 DIVAN 763
+I+ N
Sbjct: 276 NIIEN 280
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRL 551
+ +G G F ++ + A K +EK E++ L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK---MSMEISIHRSL 72
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
H+H+V G+ E+ D +V + + +L + R + + AR G +YLH
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
V IHRD+K N+ L+ ++ DFGL+ E + + + GT YI PE
Sbjct: 133 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERK-KVLCGTPNYIAPE-- 185
Query: 664 GLNVLTAK-----SDVYGLGVVLLELLTGK 688
VL+ K DV+ +G ++ LL GK
Sbjct: 186 ---VLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 69/293 (23%), Positives = 120/293 (40%), Gaps = 59/293 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + +IG+G FG+V+ G + +VAIK ++ E F E + +L H
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIK-----TIREGAMSEEDFIEEAEVMMKLSH 62
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIEYL-- 602
LV+L G C E+ LV ++M++G L D+L + + G+ YL
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-----PMK-AAGTVG 656
IHRD+ + N L+ +VSDFG++ + + P+K A+
Sbjct: 123 ACV-----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS---- 173
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
PE + + ++KSDV+ GV++ E+ + G P E
Sbjct: 174 ---PEVFSFSRYSSKSDVWSFGVLMWEVFSE----------GKIP-------YENRSNSE 213
Query: 717 LVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
+V+ + R+ P + V Y M HC ++RP + ++ L
Sbjct: 214 VVEDISTGFRLYKPR-LASTHV----YQIMNHCWRERPEDRPAFSRLLRQLAE 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-32
Identities = 66/256 (25%), Positives = 105/256 (41%), Gaps = 29/256 (11%)
Query: 459 QGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGK-LPD 517
+ R+ F+ ++ + + K+G+G++G V +
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 518 GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577
E AIK KT S E+A L L H ++++L + E+K LV + K
Sbjct: 62 HVERAIKI--IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119
Query: 578 NGALYDHLHDRNN-VEKNAAR-------GIEYLHNYAVPPIIHRDIKSSNILL---DAQW 626
G L+D + R E +AA G+ YLH + I+HRD+K N+LL +
Sbjct: 120 GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDA 176
Query: 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL----TAKSDVYGLGVVLL 682
++ DFGLS + ++ + GT YI PE VL K DV+ +GV+L
Sbjct: 177 LIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPE-----VLRKKYDEKCDVWSIGVILF 228
Query: 683 ELLTGKRAIFKDDESG 698
LL G +
Sbjct: 229 ILLAGYPPFGGQTDQE 244
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 75/306 (24%), Positives = 117/306 (38%), Gaps = 65/306 (21%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ IG G FGVVY G+ D + AIK + ++ AF E + L+H
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 554 KHLVRLVGYCEEKDERLL-VYDYMKNGALYDHLHDRNNVEKNA---------ARGIEYL- 602
+++ L+G + + YM +G L + ARG+EYL
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD------FRPMKAAGT- 654
+ +HRD+ + N +LD +T +V+DFGL+ RD + +
Sbjct: 142 EQKF-----VHRDLAARNCMLDESFTVKVADFGLA-------RDILDREYYSVQQHRHAR 189
Query: 655 --VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
V + E T KSDV+ GV+L ELLT G P I
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTR----------GAPP-------YRHI 232
Query: 713 MAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERALD 769
+L L + R+ PE +++ Y M C + RPT +V +E+ +
Sbjct: 233 DPFDLTHFLAQGRRLPQPE-YCPDSL----YQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287
Query: 770 ICDHSH 775
H
Sbjct: 288 ALLGDH 293
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 68/297 (22%), Positives = 117/297 (39%), Gaps = 60/297 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE-----VAIKRGETAKTKKFQEKESAFDSELAFL 548
F +G+G+FG VYKG E VAIK + + E +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEILDEAYVM 71
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHD-RNNVEKNA--------ARGI 599
+ + + H+ RL+G C L+ M G L D++ + ++N+ A+G+
Sbjct: 72 ASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 600 EYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGT- 654
YL +HRD+ + N+L+ +++DFGL+ + E E A G
Sbjct: 131 NYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----HAEGGK 180
Query: 655 --VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
+ ++ E + T +SDV+ GV + EL+T G P I
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF----------GSKP-------YDGI 223
Query: 713 MAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
A E+ IL++ R+ P I + Y M C ++ RP +++ +
Sbjct: 224 PASEISSILEKGERLPQPPICTID-----VYMIMVKCWMIDADSRPKFRELIIEFSK 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 62/306 (20%), Positives = 113/306 (36%), Gaps = 60/306 (19%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLP-----DGQEVAIKRGETAKTKKFQEKESAFDSELAFL 548
+G G FG V + G++VA+K + K + + E+ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK---SLKPESGGNHIADLKKEIEIL 77
Query: 549 SRLHHKHLVRLVGYCEEKDER--LLVYDYMKNGALYDHLHDRNNVEK-----------NA 595
L+H+++V+ G C E L+ +++ +G+L ++L N K
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQI 135
Query: 596 ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR------ 647
+G++YL Y +HRD+ + N+L++++ ++ DFGL+ + +
Sbjct: 136 CKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190
Query: 648 -PMK--AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVS 703
P+ A PE + SDV+ GV L ELLT +
Sbjct: 191 SPVFWYA--------PECLMQSKFYIASDVWSFGVTLHELLTYCDSD----SSPMALFLK 238
Query: 704 LVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADI 760
++ + LV L R+ P E Y M C + R + ++
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDE-----VYQLMRKCWEFQPSNRTSFQNL 293
Query: 761 VANLER 766
+ E
Sbjct: 294 IEGFEA 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-32
Identities = 69/306 (22%), Positives = 123/306 (40%), Gaps = 54/306 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLP-----DGQEVAIKRGETAKTKKFQEKESAFDSELAFL 548
+ ++G G+FG V + G+ VA+K + + F+ E+ L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLR-DFEREIEIL 65
Query: 549 SRLHHKHLVRLVGYCEEKDER--LLVYDYMKNGALYDHLHD-RNNVEKNA--------AR 597
L H ++V+ G C R L+ +Y+ G+L D+L + ++ +
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 598 GIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------P 648
G+EYL Y IHRD+ + NIL++ + ++ DFGL+ + P+ + F+ P
Sbjct: 126 GMEYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 649 MK--AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706
+ A PE + + SDV+ GVVL EL T +
Sbjct: 181 IFWYA--------PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 707 FAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVAN 763
++ L+++L R+ P+ E Y M C N +RP+ D+
Sbjct: 233 Q--GQMIVFHLIELLKNNGRLPRPDGCPDE-----IYMIMTECWNNNVNQRPSFRDLALR 285
Query: 764 LERALD 769
+++ D
Sbjct: 286 VDQIRD 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 55/280 (19%), Positives = 105/280 (37%), Gaps = 37/280 (13%)
Query: 438 GSNG-GAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNF 496
GS +G +S S + T ++L + + + + E +
Sbjct: 1 GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60
Query: 497 SLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH 555
+ + ++G GSFG V++ K G + A+K+ E EL + L
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKK---------VRLEVFRVEELVACAGLSSPR 111
Query: 556 LVRLVGYCEEKDERLLVY-DYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNYA 606
+V L G + + ++ + ++ G+L + + ++ A G+EYLH
Sbjct: 112 IVPLYG-AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 607 VPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAA---GTVGYIDPEY 662
I+H D+K+ N+LL + A + DFG ++ + GT ++ PE
Sbjct: 171 ---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
AK D++ ++L +L G K
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 78/292 (26%), Positives = 128/292 (43%), Gaps = 55/292 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG-QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ ++++K+G G +G VY+G VA+K T K + +E F E A + +
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEE--FLKEAAVMKEIK 67
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------ARGIEYL 602
H +LV+L+G C + ++ ++M G L D+L + N E +A + +EYL
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 603 --HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGT---VGY 657
N+ IHRD+ + N L+ +V+DFGLS + AG + +
Sbjct: 128 EKKNF-----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY----TAHAGAKFPIKW 178
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
PE N + KSDV+ GV+L E+ T G +P P I ++
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATY----------GMSP-------YPGIDLSQV 221
Query: 718 VKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
++L++ R+ PE E V Y M C +RP+ A+I E
Sbjct: 222 YELLEKDYRMERPE-GCPEKV----YELMRACWQWNPSDRPSFAEIHQAFET 268
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 65/307 (21%)
Query: 497 SLENKIGAGSFGVVYKGKLPDG----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
IG G FG VY G L D A+K + + S F +E +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 553 HKHLVRLVGYCEEKDE-RLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIEYL 602
H +++ L+G C + L+V YMK+G L + + + + A+G++YL
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 603 --HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD------FRPMKAAGT 654
+ +HRD+ + N +LD ++T +V+DFGL+ RD + G
Sbjct: 145 ASKKF-----VHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEYYSVHNKTGA 192
Query: 655 ---VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711
V ++ E T KSDV+ GV+L EL+T G P P
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR----------GAPP-------YPD 235
Query: 712 IMAGELVKILD--RRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERAL 768
+ ++ L RR+ PE + + Y M C + + + RP+ +++V+ +
Sbjct: 236 VNTFDITVYLLQGRRLLQPE-YCPDPL----YEVMLKCWHPKAEMRPSFSELVSRISAIF 290
Query: 769 DICDHSH 775
H
Sbjct: 291 STFIGEH 297
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 77/294 (26%), Positives = 131/294 (44%), Gaps = 61/294 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
L ++GAG FG V+ G +VA+K K+ AF +E + +L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-----SLKQGSMSPDAFLAEANLMKQLQH 67
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------ARGIEYL- 602
+ LVRL ++ ++ +YM+NG+L D L + ++ A G+ ++
Sbjct: 68 QRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-----PMK-AAGTV 655
NY IHRD++++NIL+ + +++DFGL+ + ++E R P+K A
Sbjct: 127 ERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA--- 178
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
PE T KSDV+ G++L E++T G P P +
Sbjct: 179 ----PEAINYGTFTIKSDVWSFGILLTEIVTH----------GRIP-------YPGMTNP 217
Query: 716 ELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
E+++ L+R R+ P+ N E + Y M C ++RPT + + LE
Sbjct: 218 EVIQNLERGYRMVRPD-NCPEEL----YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 54/306 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLP-----DGQEVAIKRGETAKTKKFQEKESAFDSELAFL 548
+ ++G G+FG V + G+ VA+K + + F+ E+ L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK---KLQHSTEEHLR-DFEREIEIL 96
Query: 549 SRLHHKHLVRLVGYCEEKDER--LLVYDYMKNGALYDHLHD-RNNVEKNA--------AR 597
L H ++V+ G C R L+ +Y+ G+L D+L + ++ +
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 598 GIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------P 648
G+EYL Y IHRD+ + NIL++ + ++ DFGL+ + P+ + ++ P
Sbjct: 157 GMEYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 649 MK--AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706
+ A PE + + SDV+ GVVL EL T +
Sbjct: 212 IFWYA--------PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263
Query: 707 FAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVAN 763
++ L+++L R+ P+ E Y M C N +RP+ D+
Sbjct: 264 Q--GQMIVFHLIELLKNNGRLPRPDGCPDE-----IYMIMTECWNNNVNQRPSFRDLALR 316
Query: 764 LERALD 769
+++ D
Sbjct: 317 VDQIRD 322
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 72/296 (24%), Positives = 124/296 (41%), Gaps = 59/296 (19%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + ++G G FGVV GK +VAIK K+ E F E + L H
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIK-----MIKEGSMSEDEFIEEAKVMMNLSH 78
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIEYL-- 602
+ LV+L G C ++ ++ +YM NG L ++L + + + +EYL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-----PMK-AAGTVG 656
+ +HRD+ + N L++ Q +VSDFGLS + E P++ +
Sbjct: 139 KQF-----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP---- 189
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
PE + ++KSD++ GV++ E+ + G P E
Sbjct: 190 ---PEVLMYSKFSSKSDIWAFGVLMWEIYSL----------GKMP-------YERFTNSE 229
Query: 717 LVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERALD 769
+ + + R+ P +E V YT M C + + ERPT +++N+ +D
Sbjct: 230 TAEHIAQGLRLYRPH-LASEKV----YTIMYSCWHEKADERPTFKILLSNILDVMD 280
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 39/238 (16%), Positives = 76/238 (31%), Gaps = 47/238 (19%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK------LPDGQEVAIKRGETAKTKKFQEKESAFDSELA 546
+ + + +G G+F VY+ + Q+ +K + A +F +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ----LME 119
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE-------------K 593
L ++ ++ +LV + G L + ++ N
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 594 NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA-----------RVSDFGLSMMGPES 642
IE +H+ IIH DIK N +L + + D G S+
Sbjct: 180 RMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGKRAIFKDD 695
+ T G+ E +L+ K D +G+ + +L G K++
Sbjct: 237 PKGTIFTAKCETSGFQCVE-----MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 80/293 (27%), Positives = 123/293 (41%), Gaps = 59/293 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ LE K+G G FG V+ G VAIK K AF E + +L H
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-----TLKPGTMSPEAFLQEAQVMKKLRH 321
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRNNVEKN--------AARGIEYL- 602
+ LV+L E + +V +YM G+L D L + A G+ Y+
Sbjct: 322 EKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-----PMKAAGTVG 656
NY +HRD++++NIL+ +V+DFGL+ + ++E R P+K
Sbjct: 381 RMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------ 429
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716
+ PE T KSDV+ G++L EL T G P P ++ E
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTK----------GRVP-------YPGMVNRE 472
Query: 717 LVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
++ ++R R+ P E++ + M C E +ERPT + A LE
Sbjct: 473 VLDQVERGYRMPCPP-ECPESL----HDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 29/210 (13%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRL 551
+ +G G F ++ + A K +EK E++ L
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK---MSMEISIHRSL 98
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
H+H+V G+ E+ D +V + + +L + R + + AR G +YLH
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-- 661
V IHRD+K N+ L+ ++ DFGL+ E + + + GT YI PE
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGERK-KVLCGTPNYIAPEVL 213
Query: 662 ---YYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ + DV+ +G ++ LL GK
Sbjct: 214 SKKGHSF-----EVDVWSIGCIMYTLLVGK 238
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-31
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 38/220 (17%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ ++ ++G G FG V + G++VAIK+ + K +E+ + E+ + +L+H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER---WCLEIQIMKKLNH 71
Query: 554 KHLVRLVGYCEEK------DERLLVYDYMKNGALYDHLHDRNNV----EKNAAR------ 597
++V + D LL +Y + G L +L+ N E
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 598 -GIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDFGLSMMGPESERDFRP----M 649
+ YLH IIHRD+K NI+L + ++ D G + ++
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYA-------KELDQGELCT 181
Query: 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKR 689
+ GT+ Y+ PE T D + G + E +TG R
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-31
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 61/294 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ LE K+GAG FG V+ +VA+K K AF +E + L H
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVK-----TMKPGSMSVEAFLAEANVMKTLQH 242
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHL--HDRNNVEKN--------AARGIEYL- 602
LV+L K+ ++ ++M G+L D L + + A G+ ++
Sbjct: 243 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-----PMK-AAGTV 655
NY IHRD++++NIL+ A +++DFGL+ + ++E R P+K A
Sbjct: 302 QRNY-----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA--- 353
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
PE T KSDV+ G++L+E++T G P P +
Sbjct: 354 ----PEAINFGSFTIKSDVWSFGILLMEIVTY----------GRIP-------YPGMSNP 392
Query: 716 ELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
E+++ L+R R+ PE N E + Y M C +ERPT I + L+
Sbjct: 393 EVIRALERGYRMPRPE-NCPEEL----YNIMMRCWKNRPEERPTFEYIQSVLDD 441
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 76/313 (24%), Positives = 115/313 (36%), Gaps = 74/313 (23%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG----QEVAIKRGETAKTKKFQEKE-SAFDSELAFL 548
F+L +G G FG V + +L +VA+K K + F E A +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVK---MLKADIIASSDIEEFLREAACM 79
Query: 549 SRLHHKHLVRLVGYCEEKDER------LLVYDYMKNGALYDHLHDRNNVEKNA------- 595
H H+ +LVG + +++ +MK+G L+ L E
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139
Query: 596 -------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
A G+EYL N+ IHRD+ + N +L T V+DFGLS R
Sbjct: 140 VRFMVDIACGMEYLSSRNF-----IHRDLAARNCMLAEDMTVCVADFGLS-------RKI 187
Query: 647 RPM----KAAGT---VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699
+ + V ++ E N+ T SDV+ GV + E++T G
Sbjct: 188 YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR----------GQ 237
Query: 700 TPVSLVDFAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPT 756
TP I E+ L R+ P E V Y M C + + K+RP+
Sbjct: 238 TP-------YAGIENAEIYNYLIGGNRLKQPP-ECMEEV----YDLMYQCWSADPKQRPS 285
Query: 757 MADIVANLERALD 769
+ LE L
Sbjct: 286 FTCLRMELENILG 298
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 82/326 (25%), Positives = 126/326 (38%), Gaps = 100/326 (30%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE---VAIKRGETAKTKKFQEKESAFDSELAFLSR 550
N+ ++ IG G+FG V K ++ AIK K ++ F EL L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDDHRDFAGELEVLCK 81
Query: 551 L-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA-------------- 595
L HH +++ L+G CE + L +Y +G L D L +E +
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 596 ----------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM------ 637
ARG++YL + IHRD+ + NIL+ + A+++DFGLS
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF-----IHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 638 -----------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT 686
M ES +V T SDV+ GV+L E+++
Sbjct: 197 KKTMGRLPVRWMAIESLNY--------------------SVYTTNSDVWSYGVLLWEIVS 236
Query: 687 GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM 744
GGTP + EL + L + R+ P N + V Y M
Sbjct: 237 ----------LGGTP-------YCGMTCAELYEKLPQGYRLEKPL-NCDDEV----YDLM 274
Query: 745 -HCVNLEGKERPTMADIVANLERALD 769
C + ERP+ A I+ +L R L+
Sbjct: 275 RQCWREKPYERPSFAQILVSLNRMLE 300
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-31
Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 36/255 (14%)
Query: 469 QRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--- 524
+ + A ++ + ++ K+G+G++G V K E AIK
Sbjct: 11 RENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIK 70
Query: 525 ------RGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKN 578
+ K ++ +E++ L L H ++++L E+K LV ++ +
Sbjct: 71 KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130
Query: 579 GALYDHLHDRNN-VEKNAAR-------GIEYLHNYAVPPIIHRDIKSSNILL---DAQWT 627
G L++ + +R+ E +AA GI YLH + I+HRDIK NILL ++
Sbjct: 131 GELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187
Query: 628 ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL----TAKSDVYGLGVVLLE 683
++ DFGLS + + GT YI PE VL K DV+ GV++
Sbjct: 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYI 239
Query: 684 LLTGKRAIFKDDESG 698
LL G ++
Sbjct: 240 LLCGYPPFGGQNDQD 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-31
Identities = 66/304 (21%), Positives = 124/304 (40%), Gaps = 57/304 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLP-----DGQEVAIKRGETAKTKKFQEKESAFDSELAFL 548
+ +++G G+FG V + G VA+K + +++ F E+ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVK---QLQHSG-PDQQRDFQREIQIL 78
Query: 549 SRLHHKHLVRLVGYCEEKDER--LLVYDYMKNGALYDHLHD-RNNVEKNA--------AR 597
LH +V+ G + LV +Y+ +G L D L R ++ + +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 598 GIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------P 648
G+EYL +HRD+ + NIL++++ +++DFGL+ + P + + P
Sbjct: 139 GMEYLGSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 649 MK--AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLV 705
+ A PE N+ + +SDV+ GVVL EL T ++ E ++
Sbjct: 194 IFWYA--------PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR----MM 241
Query: 706 DFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVA 762
L+++L+ R+ P AE + M C ++RP+ + +
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAE-----VHELMKLCWAPSPQDRPSFSALGP 296
Query: 763 NLER 766
L+
Sbjct: 297 QLDM 300
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 68/295 (23%), Positives = 120/295 (40%), Gaps = 65/295 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKT-KKFQEKESAFDSELAFLSRLH 552
+L ++G+G FGVV GK +VA+K K+ E F E + +L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVK------MIKEGSMSEDEFFQEAQTMMKLS 61
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIEYL- 602
H LV+ G C ++ +V +Y+ NG L ++L + + G+ +L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-----PMK-AAGTV 655
H + IHRD+ + N L+D +VSDFG++ + + P+K +A
Sbjct: 122 SHQF-----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA--- 173
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP---VSLVDFAVPAI 712
PE + ++KSDV+ G+++ E+ + G P + + V +
Sbjct: 174 ----PEVFHYFKYSSKSDVWAFGILMWEVFSL----------GKMPYDLYTNSE-VVLKV 218
Query: 713 MAGELVKILDRRVG-PPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLE 765
G L R I Y M C + ++RPT +++++E
Sbjct: 219 SQGH---RLYRPHLASDTI----------YQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 63/325 (19%), Positives = 118/325 (36%), Gaps = 99/325 (30%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE------VAIKRGETAKTKKFQEKESAFDSELAF 547
++ ++G GSFG+VY+G + VAIK T + F +E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRERIEFLNEASV 81
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
+ + H+VRL+G + L++ + M G L +L N
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 596 ------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM---------- 637
A G+ YL + + +HRD+ + N ++ +T ++ DFG++
Sbjct: 142 QMAGEIADGMAYLNANKF-----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 638 ----------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
M PES +D V T SDV+ GVVL E+ T
Sbjct: 197 GGKGLLPVRWMSPESLKD--------------------GVFTTYSDVWSFGVVLWEIAT- 235
Query: 688 KRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM- 744
P + ++++ + + P+ N + + + M
Sbjct: 236 ---------LAEQP-------YQGLSNEQVLRFVMEGGLLDKPD-NCPDML----FELMR 274
Query: 745 HCVNLEGKERPTMADIVANLERALD 769
C K RP+ +I+++++ ++
Sbjct: 275 MCWQYNPKMRPSFLEIISSIKEEME 299
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 81/372 (21%), Positives = 141/372 (37%), Gaps = 68/372 (18%)
Query: 435 SRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLA---ELAA 491
GS G G + ++ ++ GS L + + A E +
Sbjct: 27 VPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP 86
Query: 492 ATNNFSLENKIGAGSFGVVYKGKLPDG----QEVAIKRGETAKTKKFQEKESAFDSELAF 547
++ IG G FG VY G L D A+K + + S F +E
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGEVSQFLTEGII 143
Query: 548 LSRLHHKHLVRLVGYCEEKDE-RLLVYDYMKNGALYDHLHDRNNVEKNA---------AR 597
+ H +++ L+G C + L+V YMK+G L + + + + A+
Sbjct: 144 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 598 GIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD------FRPM 649
G+++L + +HRD+ + N +LD ++T +V+DFGL+ RD
Sbjct: 204 GMKFLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLA-------RDMYDKEFDSVH 251
Query: 650 KAAGT---VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706
G V ++ E T KSDV+ GV+L EL+T G P
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR----------GAPP----- 296
Query: 707 FAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVAN 763
P + ++ L RR+ PE + + Y M C + + + RP+ +++V+
Sbjct: 297 --YPDVNTFDITVYLLQGRRLLQPE-YCPDPL----YEVMLKCWHPKAEMRPSFSELVSR 349
Query: 764 LERALDICDHSH 775
+ H
Sbjct: 350 ISAIFSTFIGEH 361
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+++ +G GSFG V K K QE A+K K + S E+ L +L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTILREVELLKKL 78
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLH 603
H ++++L E+ +V + G L+D + R E +AAR GI Y+H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 604 NYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYID 659
+ I+HRD+K NILL + ++ DFGLS ++ + MK GT YI
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTAYYIA 191
Query: 660 PEYYGLNVL----TAKSDVYGLGVVLLELLTG 687
PE VL K DV+ GV+L LL+G
Sbjct: 192 PE-----VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 79/312 (25%), Positives = 122/312 (39%), Gaps = 73/312 (23%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE----VAIKRGETAKTKKFQEKE-SAFDSELAFL 548
N L +G G FG V +G L VA+K T K ++E F SE A +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK---TMKLDNSSQREIEEFLSEAACM 90
Query: 549 SRLHHKHLVRLVGYCEEKD-----ERLLVYDYMKNGALYDHLHDRNNVEKNA-------- 595
H +++RL+G C E + +++ +MK G L+ +L
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150
Query: 596 ------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647
A G+EYL N+ +HRD+ + N +L T V+DFGLS +
Sbjct: 151 KFMVDIALGMEYLSNRNF-----LHRDLAARNCMLRDDMTVCVADFGLS-------KKIY 198
Query: 648 PM----KAAGT---VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700
+ V +I E V T+KSDV+ GV + E+ T G T
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGMT 248
Query: 701 PVSLVDFAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTM 757
P P + E+ L R+ PE + + + Y M C + +RPT
Sbjct: 249 P-------YPGVQNHEMYDYLLHGHRLKQPE-DCLDEL----YEIMYSCWRTDPLDRPTF 296
Query: 758 ADIVANLERALD 769
+ + LE+ L+
Sbjct: 297 SVLRLQLEKLLE 308
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 70/222 (31%), Positives = 102/222 (45%), Gaps = 28/222 (12%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
++ + + +G GSFG V K GQE A+K + K+ +KES E+ L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQL 83
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLH 603
H ++++L + E+K LV + G L+D + R E +AAR GI Y+H
Sbjct: 84 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 604 NYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
I+HRD+K N+LL R+ DFGLS S++ GT YI P
Sbjct: 144 KNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAP 197
Query: 661 EYYGLNVL----TAKSDVYGLGVVLLELLTGKRAIFKDDESG 698
E VL K DV+ GV+L LL+G +E
Sbjct: 198 E-----VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 55/288 (19%), Positives = 99/288 (34%), Gaps = 59/288 (20%)
Query: 495 NFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+F +++G GS+G V+K DG+ A+KR + +++ + H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQH 116
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNA-------ARGIEYLHN 604
VRL EE L + +L H E + +LH+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGTVGYIDPEY 662
++H D+K +NI L + ++ DFGL + + G Y+ PE
Sbjct: 176 QG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ-----EGDPRYMAPE- 226
Query: 663 YGLNVL----TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718
+L +DV+ LG+ +LE+ + + G L
Sbjct: 227 ----LLQGSYGTAADVFSLGLTILEVACNMELPHGGEG------------WQQLRQGYL- 269
Query: 719 KILDRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763
PPE +E ++ + + + K R T ++A
Sbjct: 270 --------PPEFTAGLSSELRSVL----VMMLEPDPKLRATAEALLAL 305
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 61/320 (19%), Positives = 112/320 (35%), Gaps = 96/320 (30%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL--------PDGQEVAIKRGETAKTKKFQEKESAFDSEL 545
+ +G G+F ++KG EV +K K + +F
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK---VLD-KAHRNYSESFFEAA 63
Query: 546 AFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAA 596
+ +S+L HKHLV G C DE +LV +++K G+L +L N V K A
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 597 RGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTAR--------VSDFGLSM--------- 637
+ +L + IH ++ + NILL + + +SD G+S+
Sbjct: 124 AAMHFLEENTL-----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ 178
Query: 638 -----MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
+ PE + + L +D + G L E+ +G
Sbjct: 179 ERIPWVPPECIENPK-------------------NLNLATDKWSFGTTLWEICSG----- 214
Query: 693 KDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNL 749
G P + A+ + ++ + ++ P+ E + +C++
Sbjct: 215 -----GDKP-------LSALDSQRKLQFYEDRHQLPAPKAAE-------LANLINNCMDY 255
Query: 750 EGKERPTMADIVANLERALD 769
E RP+ I+ +L
Sbjct: 256 EPDHRPSFRAIIRDLNSLFT 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 60/305 (19%), Positives = 102/305 (33%), Gaps = 64/305 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-H 552
N E +G GS G V G+ VA+KR + E+ L+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR-------MLIDFCDIALMEIKLLTESDD 67
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------------- 597
H +++R + + N L D + +N ++N
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQ-------------WTARVSDFGLS-MMGPESE 643
G+ +LH+ IIHRD+K NIL+ +SDFGL +
Sbjct: 127 GVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 644 RDFRPMK-AAGTVGYIDPE-------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
+ +GT G+ PE LT D++ +G V +L+ + F D
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 696 ESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP 755
S I+ G + + + EA +L+ ++ + +RP
Sbjct: 244 YS----------RESNIIRGIFSLDEMKCLHDRSLIA-EATDLI----SQMIDHDPLKRP 288
Query: 756 TMADI 760
T +
Sbjct: 289 TAMKV 293
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 74/331 (22%), Positives = 121/331 (36%), Gaps = 105/331 (31%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE------VAIKRGETAKTKKFQEKESAFDSELAF 547
NN +GAG+FG V + + VA+K K+ +++ A SEL
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKI 102
Query: 548 LSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------- 595
+S L H+++V L+G C L++ +Y G L + L ++ V +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 596 -----------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM----- 637
A+G+ +L N IHRD+ + N+LL A++ DFGL+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 638 ---------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLL 682
M PES D V T +SDV+ G++L
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFD--------------------CVYTVQSDVWSYGILLW 257
Query: 683 ELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG-ELVKILDR--RVGPPEINEAEAVELV 739
E+ + G P P I+ + K++ ++ P + +
Sbjct: 258 EIFSL----------GLNP-------YPGILVNSKFYKLVKDGYQMAQPA-FAPKNI--- 296
Query: 740 AYTAM-HCVNLEGKERPTMADIVANLERALD 769
Y+ M C LE RPT I + L+
Sbjct: 297 -YSIMQACWALEPTHRPTFQQICSFLQEQAQ 326
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 69/294 (23%), Positives = 123/294 (41%), Gaps = 53/294 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL--PDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLS 549
+ +E IG+G G V G+L P ++ VAIK K + + F SE + +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFLSEASIMG 105
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIE 600
+ H +++RL G ++V +YM+NG+L L + G+
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 601 YL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGY 657
YL Y +HRD+ + N+L+D+ +VSDFGLS ++ + + + + +
Sbjct: 166 YLSDLGY-----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP---VSLVDFAVPAIMA 714
PE ++ SDV+ GVV+ E+L G P ++ D + ++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAY----------GERPYWNMTNRD-VISSVEE 269
Query: 715 GELVKILDRRVG-PPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
G L +G P + + M C + + +RP + IV+ L+
Sbjct: 270 GY---RLPAPMGCPHAL----------HQLMLDCWHKDRAQRPRFSQIVSVLDA 310
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 72/312 (23%), Positives = 124/312 (39%), Gaps = 73/312 (23%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAF 547
N +L +G G+FG VY+G++ P +VA+K T ++ E F E
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALI 86
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
+S+ +H+++VR +G + R ++ + M G L L +
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 596 ---ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMMGPESERDFR 647
A G +YL +++ IHRDI + N LL A++ DFG++ RD
Sbjct: 147 RDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMA-------RDIY 194
Query: 648 PMK--AAGTVGYI-----DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700
G + PE + + T+K+D + GV+L E+ + G
Sbjct: 195 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------LGYM 244
Query: 701 PVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTM 757
P P+ E+++ + R+ PP+ N V Y M C + ++RP
Sbjct: 245 P-------YPSKSNQEVLEFVTSGGRMDPPK-NCPGPV----YRIMTQCWQHQPEDRPNF 292
Query: 758 ADIVANLERALD 769
A I+ +E
Sbjct: 293 AIILERIEYCTQ 304
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 78/338 (23%), Positives = 118/338 (34%), Gaps = 113/338 (33%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG------QEVAIKRGETAKTKKFQEKESAFDSELAF 547
N L +G G FG V K VA+K K + SE
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNV 79
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
L +++H H+++L G C + LL+ +Y K G+L L + V
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 596 --------------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633
++G++YL +HRD+ + NIL+ ++SDF
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKL-----VHRDLAARNILVAEGRKMKISDF 194
Query: 634 GLSM--------------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSD 673
GLS M ES D ++ T +SD
Sbjct: 195 GLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------------------HIYTTQSD 234
Query: 674 VYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEIN 731
V+ GV+L E++T GG P P I L +L R+ P+ N
Sbjct: 235 VWSFGVLLWEIVTL----------GGNP-------YPGIPPERLFNLLKTGHRMERPD-N 276
Query: 732 EAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERAL 768
+E + Y M C E +RP ADI +LE+ +
Sbjct: 277 CSEEM----YRLMLQCWKQEPDKRPVFADISKDLEKMM 310
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 5e-30
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
F +G+G+F V+ K G+ A+K K+ ++S+ ++E+A L ++
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKC--IKKSPA--FRDSSLENEIAVLKKI 63
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLH 603
H+++V L E LV + G L+D + +R EK+A+ ++YLH
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH 123
Query: 604 NYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYID 659
I+HRD+K N+L + ++DFGLS M M A GT GY+
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-----IMSTACGTPGYVA 175
Query: 660 PEYYGLNVLTAKS-----DVYGLGVVLLELLTG 687
PE VL K D + +GV+ LL G
Sbjct: 176 PE-----VLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 74/286 (25%), Positives = 116/286 (40%), Gaps = 42/286 (14%)
Query: 431 TRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELA 490
+R S PS+SA + + +L + + + + E+ L A
Sbjct: 29 LPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAA 88
Query: 491 AA--TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK----RGETAKTKKFQEKESAFDS 543
A + ++ IG G VV + G E A+K E ++ +E A
Sbjct: 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 544 ELAFLSRLH-HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR---- 597
E L ++ H H++ L+ E LV+D M+ G L+D+L ++ + EK
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMK-AA 652
+ +LH I+HRD+K NILLD R+SDFG S + P ++
Sbjct: 209 LLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-----KLRELC 260
Query: 653 GTVGYIDPE-----------YYGLNVLTAKSDVYGLGVVLLELLTG 687
GT GY+ PE YG V D++ GV+L LL G
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEV-----DLWACGVILFTLLAG 301
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 53/294 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLS 549
N S++ +GAG FG V G KLP +E VAIK T K +++ F E + +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFLGEASIMG 101
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIE 600
+ H +++RL G + ++V +YM+NG+L L + A G++
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMK 161
Query: 601 YL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGY 657
YL Y +HRD+ + NIL+++ +VSDFGL ++ + E + + +
Sbjct: 162 YLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP---VSLVDFAVPAIMA 714
PE T+ SDV+ G+VL E+++ G P +S D + A+
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSY----------GERPYWEMSNQD-VIKAVDE 265
Query: 715 GELVKILDRRVG-PPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
G L + P + Y M C + RP IV+ L++
Sbjct: 266 GYR---LPPPMDCPAAL----------YQLMLDCWQKDRNNRPKFEQIVSILDK 306
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-30
Identities = 76/382 (19%), Positives = 126/382 (32%), Gaps = 74/382 (19%)
Query: 409 YCVWTGACFGKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRR 468
YC ++P G S +N RS T+ +
Sbjct: 317 YCR----LVNGATQSFIIRPQ-KEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEII 371
Query: 469 QRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIK 524
T + + R E + L IG G FG V++G P+ VAIK
Sbjct: 372 DEEDTYTMPSTRDYEIQRERI-------ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIK 424
Query: 525 RGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH 584
T K F E + + H H+V+L+G ++ ++ + G L
Sbjct: 425 ---TCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF 480
Query: 585 LHDRNNVEKNA---------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633
L R A + + YL + +HRDI + N+L+ + ++ DF
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDF 535
Query: 634 GLSMMGPESERDFRP---MKAAGT---VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
GLS R KA+ + ++ PE T+ SDV+ GV + E+L
Sbjct: 536 GLS-------RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH 588
Query: 688 KRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM- 744
G P + +++ ++ R+ P Y+ M
Sbjct: 589 ----------GVKP-------FQGVKNNDVIGRIENGERLPMPPNCPPT-----LYSLMT 626
Query: 745 HCVNLEGKERPTMADIVANLER 766
C + RP ++ A L
Sbjct: 627 KCWAYDPSRRPRFTELKAQLST 648
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 69/304 (22%), Positives = 113/304 (37%), Gaps = 69/304 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIK---RGETAKTKKFQEKESAFDSELA 546
+ L K+G GSFGVV +G P G+ VA+K ++ + + F E+
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD----FIREVN 73
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------AR 597
+ L H++L+RL G +V + G+L D L A
Sbjct: 74 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 132
Query: 598 GIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------P 648
G+ YL + IHRD+ + N+LL + ++ DFGL P+++ + P
Sbjct: 133 GMGYLESKRF-----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187
Query: 649 MK-AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF 707
A PE + SD + GV L E+ T G P
Sbjct: 188 FAWCA-------PESLKTRTFSHASDTWMFGVTLWEMFTY----------GQEP------ 224
Query: 708 AVPAIMAGELVKILDR---RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVAN 763
+ +++ +D+ R+ PE + Y M C + ++RPT +
Sbjct: 225 -WIGLNGSQILHKIDKEGERLPRPEDCPQD-----IYNVMVQCWAHKPEDRPTFVALRDF 278
Query: 764 LERA 767
L A
Sbjct: 279 LLEA 282
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + + +G GS+G V + A+K + K ++ E+ E+ L RL H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 554 KHLVRL--VGYCEEKDERLLVYDYMKNGA--LYDHLHDRNNVEKNAAR-------GIEYL 602
K++++L V Y EEK + +V +Y G + D + ++ A G+EYL
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYIDPE 661
H+ I+H+DIK N+LL T ++S G++ + + G+ + PE
Sbjct: 126 HSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA-LHPFAADDTCRTSQGSPAFQPPE 181
Query: 662 -------YYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ G K D++ GV L + TG
Sbjct: 182 IANGLDTFSG-----FKVDIWSAGVTLYNITTGL 210
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 65/297 (21%), Positives = 108/297 (36%), Gaps = 62/297 (20%)
Query: 494 NNFSLENKIGAGSFGVVYKG--KLPDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLS 549
L IG G FG V++G P+ VAIK T K F E +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIK---TCKNCTSDSVREKFLQEALTMR 71
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA---------ARGIE 600
+ H H+V+L+G ++ ++ + G L L R A + +
Sbjct: 72 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 601 YL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP---MKAAGT- 654
YL + +HRDI + N+L+ + ++ DFGLS R KA+
Sbjct: 131 YLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKGK 178
Query: 655 --VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712
+ ++ PE T+ SDV+ GV + E+L G P +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMH----------GVKP-------FQGV 221
Query: 713 MAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
+++ ++ R+ P N + Y+ M C + RP ++ A L
Sbjct: 222 KNNDVIGRIENGERLPMPP-NCPPTL----YSLMTKCWAYDPSRRPRFTELKAQLST 273
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 74/334 (22%), Positives = 119/334 (35%), Gaps = 108/334 (32%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD--------GQEVAIKRGETAKTKKFQEKESAFDSEL 545
+ +L +G G+FG V + VA+K K ++ S SE+
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEM 91
Query: 546 AFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA--------- 595
+ + HK+++ L+G C + ++ +Y G L ++L R
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 596 ---------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM- 637
ARG+EYL IHRD+ + N+L+ +++DFGL+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 638 -------------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLG 678
M PE+ D V T +SDV+ G
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFD--------------------RVYTHQSDVWSFG 246
Query: 679 VVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAV 736
V++ E+ T GG+P P I EL K+L R+ P N +
Sbjct: 247 VLMWEIFTL----------GGSP-------YPGIPVEELFKLLKEGHRMDKPA-NCTNEL 288
Query: 737 ELVAYTAM-HCVNLEGKERPTMADIVANLERALD 769
Y M C + +RPT +V +L+R L
Sbjct: 289 ----YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 66/212 (31%), Positives = 97/212 (45%), Gaps = 31/212 (14%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+++ +G GSFG V K K QE A+K K + S E+ L +L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKV--INKASAKNKDTSTILREVELLKKL 78
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLH 603
H ++++L E+ +V + G L+D + R E +AAR GI Y+H
Sbjct: 79 DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMH 138
Query: 604 NYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYID 659
+ I+HRD+K NILL + ++ DFGLS ++ + MK GT YI
Sbjct: 139 KHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK----MKDRIGTAYYIA 191
Query: 660 PEYYGLNVL----TAKSDVYGLGVVLLELLTG 687
PE VL K DV+ GV+L LL+G
Sbjct: 192 PE-----VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 70/308 (22%), Positives = 113/308 (36%), Gaps = 84/308 (27%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL--PDGQE--VAIKRGETAKTKKFQEKESAFDSELAFLS 549
+ L +G G FG VY+G G++ VA+K T K + + F SE +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMSEAVIMK 68
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-----------NAARG 598
L H H+V+L+G E ++ ++ + G L +L N +
Sbjct: 69 NLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKA 125
Query: 599 IEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR--------- 647
+ YL N +HRDI NIL+ + ++ DFGLS R
Sbjct: 126 MAYLESINC-----VHRDIAVRNILVASPECVKLGDFGLS-------RYIEDEDYYKASV 173
Query: 648 ---PMK-AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP-- 701
P+K + PE T SDV+ V + E+L+ G P
Sbjct: 174 TRLPIKWMS-------PESINFRRFTTASDVWMFAVCMWEILSF----------GKQPFF 216
Query: 702 -VSLVDFAVPAIMAGELVKILDRRVG-PPEINEAEAVELVAYTAM-HCVNLEGKERPTMA 758
+ D + + G+ L + PP + YT M C + + +RP
Sbjct: 217 WLENKD-VIGVLEKGDR---LPKPDLCPPVL----------YTLMTRCWDYDPSDRPRFT 262
Query: 759 DIVANLER 766
++V +L
Sbjct: 263 ELVCSLSD 270
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/222 (27%), Positives = 97/222 (43%), Gaps = 39/222 (17%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK-----RGETAKTKKFQEKESAFDSELA 546
N+ + +G G VV + P +E A+K G + ++ QE A E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 547 FLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR------- 597
L ++ H ++++L E LV+D MK G L+D+L ++ + EK +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVG 656
I LH I+HRD+K NILLD +++DFG S E+ ++ GT
Sbjct: 136 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK----LREVCGTPS 188
Query: 657 YIDPE-----------YYGLNVLTAKSDVYGLGVVLLELLTG 687
Y+ PE YG V D++ GV++ LL G
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEV-----DMWSTGVIMYTLLAG 225
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 74/334 (22%), Positives = 119/334 (35%), Gaps = 108/334 (32%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL--------PDGQEVAIKRGETAKTKKFQEKESAFDSEL 545
+ +L +G G FG V + + VA+K K ++ S SE+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEM 137
Query: 546 AFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA--------- 595
+ + HK+++ L+G C + ++ +Y G L ++L R
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 596 ---------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM- 637
ARG+EYL IHRD+ + N+L+ +++DFGL+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 638 -------------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLG 678
M PE+ D V T +SDV+ G
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFD--------------------RVYTHQSDVWSFG 292
Query: 679 VVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAV 736
V++ E+ T GG+P P I EL K+L R+ P N +
Sbjct: 293 VLMWEIFTL----------GGSP-------YPGIPVEELFKLLKEGHRMDKPA-NCTNEL 334
Query: 737 ELVAYTAM-HCVNLEGKERPTMADIVANLERALD 769
Y M C + +RPT +V +L+R L
Sbjct: 335 ----YMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 81/295 (27%), Positives = 133/295 (45%), Gaps = 54/295 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKG--KLPDGQE---VAIKRGETAKTKKFQEKESAFDSELAFL 548
+ + + IGAG FG VYKG K G++ VAIK T K +++ F E +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIK---TLKAGYTEKQRVDFLGEAGIM 100
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGI 599
+ H +++RL G + +++ +YM+NGAL L +++ + + A G+
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 600 EYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVG 656
+YL NY +HRD+ + NIL+++ +VSDFGLS ++ + E + +
Sbjct: 161 KYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP---VSLVDFAVPAIM 713
+ PE T+ SDV+ G+V+ E++T G P +S + + AI
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTY----------GERPYWELSNHE-VMKAIN 264
Query: 714 AGELVKILDRRVG-PPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
G L + P I Y M C E RP ADIV+ L++
Sbjct: 265 DGF---RLPTPMDCPSAI----------YQLMMQCWQQERARRPKFADIVSILDK 306
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
++ L +G G++G V + VA+K + + E E+ L+H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN---IKKEICINKMLNH 64
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
+++V+ G+ E + + L +Y G L+D + + + A+ G+ YLH
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE---- 661
I HRDIK N+LLD + ++SDFGL+ + + R+ K GT+ Y+ PE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 662 --YYGLNVLTAKSDVYGLGVVLLELLTG 687
++ DV+ G+VL +L G
Sbjct: 182 REFHA-----EPVDVWSCGIVLTAMLAG 204
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 67/296 (22%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQE---VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ ++G G+FG V +G ++ VAIK K + E + +L +
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK-----------NAARGIEYL- 602
++VRL+G C+ + +LV + G L+ L E+ + G++YL
Sbjct: 71 YIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLE 127
Query: 603 -HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------PMK-AAG 653
N+ +HRD+ + N+LL + A++SDFGLS + + P+K A
Sbjct: 128 EKNF-----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA- 181
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
PE +++SDV+ GV + E L+ G P +
Sbjct: 182 ------PECINFRKFSSRSDVWSYGVTMWEALSY----------GQKP-------YKKMK 218
Query: 714 AGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
E++ +++ R+ P + Y M C + ++RP + +
Sbjct: 219 GPEVMAFIEQGKRMECPP-ECPPEL----YALMSDCWIYKWEDRPDFLTVEQRMRA 269
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 73/312 (23%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG------QEVAIKRGETAKTKKFQEKESAFDSELAF 547
N +L +G G+FG VY+G++ +VA+K T ++ E F E
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALI 127
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
+S+ +H+++VR +G + R ++ + M G L L +
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 596 ---ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMMGPESERDFR 647
A G +YL +++ IHRDI + N LL A++ DFG++ RD
Sbjct: 188 RDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMA-------RDIY 235
Query: 648 PMK--AAGTVGYI-----DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700
G + PE + + T+K+D + GV+L E+ + G
Sbjct: 236 RAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS----------LGYM 285
Query: 701 PVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTM 757
P P+ E+++ + R+ PP+ N V Y M C + ++RP
Sbjct: 286 P-------YPSKSNQEVLEFVTSGGRMDPPK-NCPGPV----YRIMTQCWQHQPEDRPNF 333
Query: 758 ADIVANLERALD 769
A I+ +E
Sbjct: 334 AIILERIEYCTQ 345
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 36/216 (16%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ F + K+G+G+FG V+ + G E IK T + Q ++E+ L L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK---TINKDRSQVPMEQIEAEIEVLKSL 77
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-----EKNAAR-------GI 599
H +++++ E+ +V + + G L + + E A +
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 600 EYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMK-AAGTV 655
Y H+ ++H+D+K NIL ++ DFGL+ + E AAGT
Sbjct: 138 AYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH----STNAAGTA 190
Query: 656 GYIDPE----YYGLNVLTAKSDVYGLGVVLLELLTG 687
Y+ PE K D++ GVV+ LLTG
Sbjct: 191 LYMAPEVFKRDVTF-----KCDIWSAGVVMYFLLTG 221
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 72/301 (23%), Positives = 123/301 (40%), Gaps = 68/301 (22%)
Query: 494 NNFSLENK-IGAGSFGVVYKGKLPDG---QEVAIK---RGETAKTKKFQEKESAFDSELA 546
+LE+K +G+G+FG V KG + VA+K K +E
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK-----DELLAEAN 70
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA--------ARG 598
+ +L + ++VR++G CE + +LV + + G L +L +V+ + G
Sbjct: 71 VMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 599 IEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------PM 649
++YL N+ +HRD+ + N+LL Q A++SDFGLS E ++ P+
Sbjct: 130 MKYLEESNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 650 K-AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708
K A PE ++KSDV+ GV++ E + G P
Sbjct: 185 KWYA-------PECINYYKFSSKSDVWSFGVLMWEAFSY----------GQKP------- 220
Query: 709 VPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLE 765
+ E+ +L++ R+G P + Y M C + + RP A + L
Sbjct: 221 YRGMKGSEVTAMLEKGERMGCPA-GCPREM----YDLMNLCWTYDVENRPGFAAVELRLR 275
Query: 766 R 766
Sbjct: 276 N 276
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 64/238 (26%), Positives = 106/238 (44%), Gaps = 32/238 (13%)
Query: 468 RQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRG 526
S T + R EF++ ++N+ ++ ++G G+F VV + G E A K
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 527 ETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH 586
T K + E +L H ++VRL +E+ LV+D + G L++ +
Sbjct: 63 NTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 587 DRNN-VEKNAAR-------GIEYLHNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGL 635
R E +A+ I Y H+ I+HR++K N+LL ++ +++DFGL
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177
Query: 636 SMMGPESERDFRPMK-AAGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTG 687
++ +SE AGT GY+ PE Y V D++ GV+L LL G
Sbjct: 178 AIEVNDSE----AWHGFAGTPGYLSPEVLKKDPYSKPV-----DIWACGVILYILLVG 226
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
++ L +G G++G V + VA+K + + E E+ L+H
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN---IKKEICINKMLNH 64
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
+++V+ G+ E + + L +Y G L+D + + + A+ G+ YLH
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE---- 661
I HRDIK N+LLD + ++SDFGL+ + + R+ K GT+ Y+ PE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 662 --YYGLNVLTAKSDVYGLGVVLLELLTG 687
++ DV+ G+VL +L G
Sbjct: 182 REFHA-----EPVDVWSCGIVLTAMLAG 204
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 74/335 (22%), Positives = 118/335 (35%), Gaps = 109/335 (32%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE------VAIKRGETAKTKKFQEKESAFDSELAF 547
N S +GAG+FG V + + VA+K K + A SEL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKV 79
Query: 548 LSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------- 595
LS L +H ++V L+G C L++ +Y G L + L + + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 596 ---------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM- 637
A+G+ +L N IHRD+ + NILL ++ DFGL+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARD 194
Query: 638 -------------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLG 678
M PES + V T +SDV+ G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN--------------------CVYTFESDVWSYG 234
Query: 679 VVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG-ELVKILDR--RVGPPEINEAEA 735
+ L EL + G +P P + + K++ R+ PE +
Sbjct: 235 IFLWELFSL----------GSSP-------YPGMPVDSKFYKMIKEGFRMLSPE-HAPAE 276
Query: 736 VELVAYTAM-HCVNLEGKERPTMADIVANLERALD 769
+ Y M C + + +RPT IV +E+ +
Sbjct: 277 M----YDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 60/257 (23%), Positives = 88/257 (34%), Gaps = 69/257 (26%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKF-QEKESAFDSELAFLSR 550
+ L+ IG GS+GVV AIK K ++ + +E+ + +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV------------------- 591
LHH ++ RL E++ LV + G L D L+ +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144
Query: 592 ----------------------EKNAAR-------GIEYLHNYAVPPIIHRDIKSSNILL 622
EK + + YLHN I HRDIK N L
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLF 201
Query: 623 DAQWTARV--SDFGLS-MMGPESERDFRPMK-AAGTVGYIDPE-------YYGLNVLTAK 671
+ + DFGLS + ++ M AGT ++ PE YG K
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG-----PK 256
Query: 672 SDVYGLGVVLLELLTGK 688
D + GV+L LL G
Sbjct: 257 CDAWSAGVLLHLLLMGA 273
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 72/346 (20%), Positives = 122/346 (35%), Gaps = 108/346 (31%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD--------GQEVAIKRGETAKTKKFQEKESAFDSEL 545
+ L +G G+FG V + +VA+K K+ ++ S SE+
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEM 125
Query: 546 AFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA--------- 595
+ + HK+++ L+G C + ++ +Y G L ++L R
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 596 ---------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM- 637
ARG+EYL IHRD+ + N+L+ +++DFGL+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 638 -------------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLG 678
M PE+ D + T +SDV+ G
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFD--------------------RIYTHQSDVWSFG 280
Query: 679 VVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAV 736
V+L E+ T GG+P P + EL K+L R+ P N +
Sbjct: 281 VLLWEIFTL----------GGSP-------YPGVPVEELFKLLKEGHRMDKPS-NCTNEL 322
Query: 737 ELVAYTAM-HCVNLEGKERPTMADIVANLERALDICDHSHGSISSS 781
Y M C + +RPT +V +L+R + + +
Sbjct: 323 ----YMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHH 364
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 62/290 (21%), Positives = 118/290 (40%), Gaps = 36/290 (12%)
Query: 418 GKKKVHNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKH 477
G ++ + S G S + R + +
Sbjct: 11 GVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPP 70
Query: 478 ADRAEEFLLAELAAATNNFSLENK--IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKF 534
A + A+ A + +++ +G G FG V+K + G ++A K KT+
Sbjct: 71 APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK---IIKTRGM 127
Query: 535 QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--E 592
++KE +E++ +++L H +L++L E K++ +LV +Y+ G L+D + D + E
Sbjct: 128 KDKEE-VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 593 KNAAR-------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSMMGPESE 643
+ GI ++H I+H D+K NIL + ++ DFGL+ E
Sbjct: 187 LDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243
Query: 644 RDFRPMK-AAGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTG 687
+K GT ++ PE + +D++ +GV+ LL+G
Sbjct: 244 ----KLKVNFGTPEFLAPEVVNYDFVSF-----PTDMWSVGVIAYMLLSG 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 75/320 (23%), Positives = 123/320 (38%), Gaps = 85/320 (26%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE------VAIKRGETAKTKKFQEKESAFDSELAF 547
+ L+ ++G G+FG V+ + + VA+K K ++ F E
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVK---ALKEASESARQD-FQREAEL 96
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
L+ L H+H+VR G C E L+V++YM++G L L K
Sbjct: 97 LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156
Query: 596 -----------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642
A G+ YL ++ +HRD+ + N L+ ++ DFG+S +
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 643 E------RDFRPMK--AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKD 694
+ R P++ PE T +SDV+ GVVL E+ T
Sbjct: 212 DYYRVGGRTMLPIRWMP--------PESILYRKFTTESDVWSFGVVLWEIFT-------- 255
Query: 695 DESGGTP---VSLVDFAVPAIMAGELVKILDRRVG-PPEINEAEAVELVAYTAM-HCVNL 749
G P +S + A+ I G + L+R PPE+ Y M C
Sbjct: 256 --YGKQPWYQLSNTE-AIDCITQG---RELERPRACPPEV----------YAIMRGCWQR 299
Query: 750 EGKERPTMADIVANLERALD 769
E ++R ++ D+ A L+
Sbjct: 300 EPQQRHSIKDVHARLQALAQ 319
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 70/328 (21%), Positives = 118/328 (35%), Gaps = 106/328 (32%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG------QEVAIKRGETAKTKKFQEKESAFDSELAF 547
+ L+ ++G G+FG V+ + + VA+K K ++ F E
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLAARKD-FQREAEL 70
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
L+ L H+H+V+ G C + D ++V++YMK+G L L
Sbjct: 71 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 596 ------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641
A G+ YL ++ +HRD+ + N L+ A ++ DFG+S
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMS----- 180
Query: 642 SERDFRPMKAAGTVGYIDPEYY-----GL-------------NVLTAKSDVYGLGVVLLE 683
RD +YY + T +SDV+ GV+L E
Sbjct: 181 --RDV-----------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 227
Query: 684 LLTGKRAIFKDDESGGTP---VSLVDFAVPAIMAGELVKILDRRVG-PPEINEAEAVELV 739
+ T G P +S + + I G ++L+R P E+
Sbjct: 228 IFT----------YGKQPWFQLSNTE-VIECITQG---RVLERPRVCPKEV--------- 264
Query: 740 AYTAM-HCVNLEGKERPTMADIVANLER 766
Y M C E ++R + +I L
Sbjct: 265 -YDVMLGCWQREPQQRLNIKEIYKILHA 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 32/213 (15%)
Query: 493 TNNFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
++N+ ++ ++G G+F VV + G E A K K + E +L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI--INTKKLSARDFQKLEREARICRKL 62
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLH 603
H ++VRL +E+ LV+D + G L++ + R E +A+ I Y H
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 122
Query: 604 NYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMMGPESERDFRPMK-AAGTVGYID 659
+ I+HR++K N+LL ++ +++DFGL++ +SE AGT GY+
Sbjct: 123 SNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE----AWHGFAGTPGYLS 175
Query: 660 PE-----YYGLNVLTAKSDVYGLGVVLLELLTG 687
PE Y V D++ GV+L LL G
Sbjct: 176 PEVLKKDPYSKPV-----DIWACGVILYILLVG 203
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 52/257 (20%), Positives = 110/257 (42%), Gaps = 27/257 (10%)
Query: 444 GSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIG 503
++ + G ++ + K+ + E + + + + ++G
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSV---YDYYDILEELG 60
Query: 504 AGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGY 562
+G+FGVV++ G+ K T +K + +E++ +++LHH L+ L
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAK---FINTPYPLDKYT-VKNEISIMNQLHHPKLINLHDA 116
Query: 563 CEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNAAR-------GIEYLHNYAVPPIIHR 613
E+K E +L+ +++ G L+D + + E G++++H ++ I+H
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHL 173
Query: 614 DIKSSNILLDAQWTARV--SDFGLSMMGPESERDFRPMK-AAGTVGYIDPEYYGLNVLTA 670
DIK NI+ + + + V DFGL+ E +K T + PE +
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGF 229
Query: 671 KSDVYGLGVVLLELLTG 687
+D++ +GV+ LL+G
Sbjct: 230 YTDMWAIGVLGYVLLSG 246
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 50/235 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK-------------------RGETAKTKK 533
N ++L+++IG GS+GVV D A+K RG
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 534 FQEKESAFDS---ELAFLSRLHHKHLVRL--VGYCEEKDERLLVYDYMKNGALYDHLHDR 588
+ + E+A L +L H ++V+L V +D +V++ + G + + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 589 NNVEKNAAR-------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641
E A GIEYLH IIHRDIK SN+L+ +++DFG+S
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 642 SERDFRPMKAAGTVGYIDPE--------YYGLNVLTAKSDVYGLGVVLLELLTGK 688
S+ GT ++ PE + G DV+ +GV L + G+
Sbjct: 190 SDALLS--NTVGTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQ 237
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 65/339 (19%), Positives = 115/339 (33%), Gaps = 114/339 (33%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE------VAIKRGETAKTKKFQEKESAFDSELAF 547
N +G+G+FG V + VA+K K K + A SEL
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKM 101
Query: 548 LSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------- 595
+++L H+++V L+G C L+++Y G L ++L +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 596 --------------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633
A+G+E+L + +HRD+ + N+L+ ++ DF
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC-----VHRDLAARNVLVTHGKVVKICDF 216
Query: 634 GLSM--------------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSD 673
GL+ M PES + + T KSD
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------------------GIYTIKSD 256
Query: 674 VYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG-ELVKILDR--RVGPPEI 730
V+ G++L E+ + G P P I K++ ++ P
Sbjct: 257 VWSYGILLWEIFSL----------GVNP-------YPGIPVDANFYKLIQNGFKMDQPF- 298
Query: 731 NEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERAL 768
E + Y M C + ++RP+ ++ + L L
Sbjct: 299 YATEEI----YIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 72/334 (21%), Positives = 118/334 (35%), Gaps = 108/334 (32%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAF 547
+ L +G G+FG V + + VA+K K + A SEL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKI 83
Query: 548 LSRL-HHKHLVRLVGYCEEKDE-RLLVYDYMKNGALYDHLHDRNNVEKNA---------- 595
L + HH ++V L+G C + +++ ++ K G L +L + N
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 596 --------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM-- 637
A+G+E+L IHRD+ + NILL + ++ DFGL+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 638 ------------------MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGV 679
M PE+ D V T +SDV+ GV
Sbjct: 199 YKDPDYVRKGDARLPLKWMAPETIFD--------------------RVYTIQSDVWSFGV 238
Query: 680 VLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG-ELVKILDR--RVGPPEINEAEAV 736
+L E+ + G +P P + E + L R+ P+ +
Sbjct: 239 LLWEIFS----------LGASP-------YPGVKIDEEFCRRLKEGTRMRAPD-YTTPEM 280
Query: 737 ELVAYTAM-HCVNLEGKERPTMADIVANLERALD 769
Y M C + E +RPT +++V +L L
Sbjct: 281 ----YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 68/325 (20%), Positives = 110/325 (33%), Gaps = 101/325 (31%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG------QEVAIKRGETAKTKKFQEKESAFDSELAF 547
+ ++G FG VYKG L Q VAIK T K K F E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREEFRHEAML 65
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
+RL H ++V L+G + +++ Y +G L++ L R+
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 596 ------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641
A G+EYL H+ +H+D+ + N+L+ + ++SD GL
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLF----- 175
Query: 642 SERDFRPMKAAGTVGYIDPEYY-----GL-------------NVLTAKSDVYGLGVVLLE 683
R+ +YY L + SD++ GVVL E
Sbjct: 176 --REV-----------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 684 LLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAY 741
+ + G P ++V+++ + P+ + V Y
Sbjct: 223 VFS----------YGLQP-------YCGYSNQDVVEMIRNRQVLPCPD-DCPAWV----Y 260
Query: 742 TAM-HCVNLEGKERPTMADIVANLE 765
M C N RP DI + L
Sbjct: 261 ALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 50/274 (18%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
+G G++G+VY G+ L + +AIK ++ E+A L HK++V+ +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIP----ERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 561 GYCEEKDERLLVY-DYMKNGALYDHLHDR----NNVEKNAA-------RGIEYLHNYAVP 608
G ++ + ++ + + G+L L + + E+ G++YLH+
Sbjct: 86 G-SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142
Query: 609 PIIHRDIKSSNILLDA-QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE--YYGL 665
I+HRDIK N+L++ ++SDFG S GT+ Y+ PE G
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIIDKGP 199
Query: 666 NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725
+D++ LG ++E+ TGK P + A+ K+ +
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKP-----------PFYELGEPQAAMF-----KVGMFK- 242
Query: 726 GPPEINE---AEAVELVAYTAMHCVNLEGKERPT 756
PEI E AEA + + C + +R
Sbjct: 243 VHPEIPESMSAEAKAFI----LKCFEPDPDKRAC 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-28
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
T + L ++G G+F VV + + GQE A K + E L
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMI--INTKKLSARDHQKLEREARICRLL 67
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLH 603
H ++VRL E+ L++D + G L++ + R E +A+ + + H
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 604 NYAVPPIIHRDIKSSNILL-----DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
++HR++K N+LL A +++DFGL++ ++ + AGT GY+
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAA--VKLADFGLAIEVEGEQQAWF--GFAGTPGYL 180
Query: 659 DPE-----YYGLNVLTAKSDVYGLGVVLLELLTG 687
PE YG V D++ GV+L LL G
Sbjct: 181 SPEVLRKDPYGKPV-----DLWACGVILYILLVG 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
N+ L IG G+F V + + G+EVAIK + KT+ E+ + L+H
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIID--KTQLNPTSLQKLFREVRIMKILNH 73
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
++V+L E + L+ +Y G ++D+L +++ AR ++Y H
Sbjct: 74 PNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA-GTVGYIDPE--- 661
I+HRD+K+ N+LLDA +++DFG S + A G Y PE
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNE----FTVGGKLDAFCGAPPYAAPELFQ 186
Query: 662 ---YYGLNVLTAKSDVYGLGVVLLELLTGK 688
Y G + DV+ LGV+L L++G
Sbjct: 187 GKKYDG-----PEVDVWSLGVILYTLVSGS 211
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 40/221 (18%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK----RGETAKTKKFQEKESAFDSELAF 547
+ + + +G+G+ G V ++VAIK R + + + ++E+
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR-------GI 599
L +L+H ++++ + + +D +V + M+ G L+D + + E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGLS-MMGPESERDFRPMK-AAGT 654
+YLH IIHRD+K N+LL +Q +++DFG S ++G S M+ GT
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-----LMRTLCGT 179
Query: 655 VGYIDPEYYGLNVLTAKS--------DVYGLGVVLLELLTG 687
Y+ PE VL + D + LGV+L L+G
Sbjct: 180 PTYLAPE-----VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 51/212 (24%), Positives = 84/212 (39%), Gaps = 33/212 (15%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
++LEN IG GS+G V A K ++ + F E+ + L
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK---KIPKYFVEDVDR-FKQEIEIMKSL 63
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLH 603
H +++RL E+ + LV + G L++ + + E +AAR + Y H
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCH 123
Query: 604 NYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYID 659
+ HRD+K N L ++ DFGL+ + M+ GT Y+
Sbjct: 124 KLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM----MRTKVGTPYYVS 176
Query: 660 PE----YYGLNVLTAKSDVYGLGVVLLELLTG 687
P+ YG + D + GV++ LL G
Sbjct: 177 PQVLEGLYGP-----ECDEWSAGVMMYVLLCG 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 73/339 (21%), Positives = 137/339 (40%), Gaps = 71/339 (20%)
Query: 444 GSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIG 503
GS++ S+ + +GS + + + ++ + + + +G
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLE---------SQYQVGPLLG 52
Query: 504 AGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAF--DSELAFLSRLHHK--HLVR 558
+G FG VY G + D VAIK E + + E + E+ L ++ ++R
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 559 LVGYCEEKDERLLVYDYMKN-GALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPP 609
L+ + E D +L+ + + L+D + +R +++ AR + + HN V
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV-- 170
Query: 610 IIHRDIKSSNILLDA-QWTARVSDFGLSMMGPESE-RDFRPMKAAGTVGYIDPE------ 661
+HRDIK NIL+D + ++ DFG + ++ DF GT Y PE
Sbjct: 171 -LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-----DGTRVYSPPEWIRYHR 224
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
Y+G + V+ LG++L +++ G F+ DE +I+
Sbjct: 225 YHG-----RSAAVWSLGILLYDMVCG-DIPFEHDE----------------------EII 256
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+V + +E L+ C+ L +RPT +I
Sbjct: 257 RGQVFFRQRVSSECQHLIR----WCLALRPSDRPTFEEI 291
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 53/221 (23%), Positives = 99/221 (44%), Gaps = 40/221 (18%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK----RGETAKTKKFQEKESAFDSELAF 547
+ + + +G+G+ G V ++VAI+ R + + + ++E+
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR-------GI 599
L +L+H ++++ + + +D +V + M+ G L+D + + E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGLS-MMGPESERDFRPMK-AAGT 654
+YLH IIHRD+K N+LL +Q +++DFG S ++G S M+ GT
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-----LMRTLCGT 304
Query: 655 VGYIDPEYYGLNVLTAKS--------DVYGLGVVLLELLTG 687
Y+ PE VL + D + LGV+L L+G
Sbjct: 305 PTYLAPE-----VLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 50/214 (23%), Positives = 90/214 (42%), Gaps = 33/214 (15%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAFLS 549
+S + +G+G+FG V+ +EV +K + K + E E+A LS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGA-LYDHLHDRNNVEKNAAR--------GIE 600
R+ H ++++++ E + LV + +G L+ + +++ A +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYID 659
YL IIHRDIK NI++ +T ++ DFG + + GT+ Y
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL----ERGKLFYTFCGTIEYCA 197
Query: 660 PE------YYGLNVLTAKSDVYGLGVVLLELLTG 687
PE Y G + +++ LGV L L+
Sbjct: 198 PEVLMGNPYRG-----PELEMWSLGVTLYTLVFE 226
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 49/214 (22%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD-----SELA 546
+ + + ++G+G F +V K + G E A K K ++ + E++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVCREEIEREVS 67
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR-------G 598
L ++ H +++ L E + + +L+ + + G L+D L + ++ E+ A G
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 599 IEYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSDFGLSMMGPESERDFRPMK-AAG 653
+ YLH I H D+K NI+L ++ DFGL+ + K G
Sbjct: 128 VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFG 180
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
T ++ PE L ++D++ +GV+ LL+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 49/214 (22%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD-----SELA 546
+ + + ++G+G F +V K + G E A K K ++ + E++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAK---FIKKRQSRASRRGVSREEIEREVS 67
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR-------G 598
L ++ H +++ L E + + +L+ + + G L+D L + ++ E+ A G
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 599 IEYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSDFGLSMMGPESERDFRPMK-AAG 653
+ YLH I H D+K NI+L ++ DFGL+ + K G
Sbjct: 128 VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EFKNIFG 180
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
T ++ PE L ++D++ +GV+ LL+G
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 35/208 (16%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ + +G G FG+V++ + K K K + E++ L+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK---FVKVKG--TDQVLVKKEISILNIA 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNAAR-------GIEYL 602
H++++ L E +E +++++++ +++ ++ E+ +++L
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSMMGPESERDFRPMK-AAGTVGYID 659
H++ I H DI+ NI+ + ++ + +FG + + + Y
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN----FRLLFTAPEYYA 171
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLTG 687
PE + +V++ +D++ LG ++ LL+G
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 64/290 (22%), Positives = 120/290 (41%), Gaps = 64/290 (22%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD--SELAFLSRL 551
+ L +G G FG V+ G L D +VAIK + + + E+A L ++
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 552 H----HKHLVRLVGYCEEKDERLLVYDYMKNGA-LYDHLHDRNNVEKNAAR--------G 598
H ++RL+ + E ++ +LV + L+D++ ++ + + +R
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPESE-RDFRPMKAAGTVG 656
I++ H+ V +HRDIK NIL+D + A++ DFG + + DF GT
Sbjct: 152 IQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-----DGTRV 203
Query: 657 YIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710
Y PE Y+ + V+ LG++L +++ G F+ D+
Sbjct: 204 YSPPEWISRHQYHA-----LPATVWSLGILLYDMVCG-DIPFERDQ-------------- 243
Query: 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+IL+ + P + L+ C+ + RP++ +I
Sbjct: 244 --------EILEAELHFPAHVSPDCCALIR----RCLAPKPSSRPSLEEI 281
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 70/335 (20%), Positives = 120/335 (35%), Gaps = 105/335 (31%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG------QEVAIKRGETAKTKKFQEKESAFDSELAF 547
NN IG G+FG V++ + P VA+K K + + ++ F E A
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAAL 103
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------------ 595
++ + ++V+L+G C L+++YM G L + L + +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 596 --------------------ARGIEYL--HNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633
A G+ YL + +HRD+ + N L+ +++DF
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIADF 218
Query: 634 GLSMMGPESERD------FRPMKAAGTVGYI-----DPEYYGLNVLTAKSDVYGLGVVLL 682
GLS R+ ++ A I PE N T +SDV+ GVVL
Sbjct: 219 GLS-------RNIYSADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 683 ELLTGKRAIFKDDESGGTP---VS---LVDFAVPAIMAGELVKILDRRVG-PPEINEAEA 735
E+ + G P ++ ++ + + G IL P E+
Sbjct: 268 EIFS----------YGLQPYYGMAHEEVIYY----VRDG---NILACPENCPLEL----- 305
Query: 736 VELVAYTAMH-CVNLEGKERPTMADIVANLERALD 769
Y M C + +RP+ I L+R +
Sbjct: 306 -----YNLMRLCWSKLPADRPSFCSIHRILQRMCE 335
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 49/214 (22%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD-----SELA 546
+++ + ++G+G F +V K + G+E A K K ++ E+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAK---FIKKRRLSSSRRGVSREEIEREVN 60
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR-------G 598
L + H +++ L E K + +L+ + + G L+D L ++ ++ E A + G
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTA----RVSDFGLSMMGPESERDFRPMK-AAG 653
+ YLH+ I H D+K NI+L + ++ DFG++ K G
Sbjct: 121 VHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EFKNIFG 173
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
T ++ PE L ++D++ +GV+ LL+G
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
++ L + +G G+FG V G+ G +VA+K K + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRH 70
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
H+++L + +V +Y+ G L+D++ VE+ AR ++Y H +
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA-GTVGYIDPE--- 661
++HRD+K N+LLDA A+++DFGLS M D ++ + G+ Y PE
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRTSCGSPNYAAPEVIS 183
Query: 662 ---YYGLNVLTAKSDVYGLGVVLLELLTGK 688
Y G + D++ GV+L LL G
Sbjct: 184 GRLYAG-----PEVDIWSCGVILYALLCGT 208
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 55/210 (26%), Positives = 82/210 (39%), Gaps = 33/210 (15%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ IG+G+FGV + + VA+K E + E E+ L H
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE--RGAAIDEN---VQREIINHRSLRH 75
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
++VR ++ +Y G LY+ + + ++ AR G+ Y H+
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM 135
Query: 606 AVPPIIHRDIKSSNILLDAQWTAR--VSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-- 661
+ HRD+K N LLD R + DFG S S +P GT YI PE
Sbjct: 136 QI---CHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVL 189
Query: 662 ----YYGLNVLTAKSDVYGLGVVLLELLTG 687
Y G +DV+ GV L +L G
Sbjct: 190 LRQEYDG-----KIADVWSCGVTLYVMLVG 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-27
Identities = 62/294 (21%), Positives = 116/294 (39%), Gaps = 63/294 (21%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQE---VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ ++G G+FG V +G ++ VAIK K + E + +L +
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYL--H 603
++VRL+G C+ + +LV + G L+ L + + + G++YL
Sbjct: 397 YIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-------PMK-AAGTV 655
N+ +HR++ + N+LL + A++SDFGLS + + P+K A
Sbjct: 456 NF-----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA--- 507
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
PE +++SDV+ GV + E L+ G P +
Sbjct: 508 ----PECINFRKFSSRSDVWSYGVTMWEALSY----------GQKP-------YKKMKGP 546
Query: 716 ELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLER 766
E++ +++ R+ P E Y M C + ++RP + +
Sbjct: 547 EVMAFIEQGKRMECPPECPPE-----LYALMSDCWIYKWEDRPDFLTVEQRMRA 595
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 29/210 (13%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
++ L + +G G+FG V GK G +VA+K K + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRH 75
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
H+++L + +V +Y+ G L+D++ +++ +R G++Y H +
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA-GTVGYIDPE--- 661
V +HRD+K N+LLDA A+++DFGLS M D ++ + G+ Y PE
Sbjct: 136 MV---VHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRTSCGSPNYAAPEVIS 188
Query: 662 ---YYGLNVLTAKSDVYGLGVVLLELLTGK 688
Y G + D++ GV+L LL G
Sbjct: 189 GRLYAG-----PEVDIWSSGVILYALLCGT 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 54/214 (25%), Positives = 87/214 (40%), Gaps = 37/214 (17%)
Query: 493 TNNFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
T+ + ++ IG GS+ V + E A+K K E E+ L R
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPTE-----EIEILLRY 72
Query: 552 -HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYL 602
H +++ L ++ +V + MK G L D + + E+ A+ +EYL
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 603 HNYAVPPIIHRDIKSSNILL----DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
H ++HRD+K SNIL + R+ DFG + M T ++
Sbjct: 133 HAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYTANFV 187
Query: 659 DPEYYGLNVLTAKS-----DVYGLGVVLLELLTG 687
PE VL + D++ LGV+L +LTG
Sbjct: 188 APE-----VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/240 (25%), Positives = 109/240 (45%), Gaps = 42/240 (17%)
Query: 482 EEFLLAELAAATNN------FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKF 534
+E +L +L + + ++ KIG G+ G VY + GQEVAI++ +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---- 57
Query: 535 QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN 594
Q K+ +E+ + + ++V + DE +V +Y+ G+L D + + E
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 117
Query: 595 AA-------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647
A + +E+LH+ +IHRDIKS NILL + +++DFG + +
Sbjct: 118 IAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSK 172
Query: 648 PMKAAGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
GT ++ PE YG K D++ LG++ +E++ G+ RA++
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYG-----PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 61/307 (19%), Positives = 108/307 (35%), Gaps = 72/307 (23%)
Query: 493 TNNFSLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
T F KIG+G FG V+K K DG AIKR + ++++A A
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLG 68
Query: 552 HHKHLVRLVGYCEEKDERLLVY-DYMKNGALYDHLHDRNNVEKN------------AARG 598
H H+VR +D+ +L+ +Y G+L D + + + RG
Sbjct: 69 QHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER------DF------ 646
+ Y+H+ + ++H DIK SNI + + S + D
Sbjct: 128 LRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 647 -RPMKAAGTVGYIDPEYYGLNVL------TAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699
P G ++ E VL K+D++ L + ++ +
Sbjct: 185 SSPQVEEGDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAE----------- 228
Query: 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPT 756
P G+ + R+ P I + E EL+ ++ + + RP+
Sbjct: 229 ----------PLPRNGDQWHEI-RQGRLPRIPQVLSQEFTELLK----VMIHPDPERRPS 273
Query: 757 MADIVAN 763
+V +
Sbjct: 274 AMALVKH 280
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 55/214 (25%), Positives = 85/214 (39%), Gaps = 32/214 (14%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAK-TKKFQEKESAFDSELAFLSRLHH 553
+ L IG G F VV + GQ+ A+K + AK T E + L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-----EKNAAR-------GIEY 601
H+V L+ +V+++M L + R + E A+ + Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 602 LHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
H+ IIHRD+K +LL + ++ FG+++ ES GT ++
Sbjct: 146 CHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG--GRVGTPHFM 200
Query: 659 DPE-----YYGLNVLTAKSDVYGLGVVLLELLTG 687
PE YG DV+G GV+L LL+G
Sbjct: 201 APEVVKREPYGK-----PVDVWGCGVILFILLSG 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD-----SELA 546
+ + ++G+G F VV K + G + A K K ++ + E++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAK---FIKKRRTKSSRRGVSREDIEREVS 66
Query: 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAAR-------G 598
L + H +++ L E K + +L+ + + G L+D L ++ ++ E+ A G
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTA----RVSDFGLSMMGPESERDFRPMK-AAG 653
+ YLH+ I H D+K NI+L + ++ DFGL+ K G
Sbjct: 127 VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFG 179
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
T ++ PE L ++D++ +GV+ LL+G
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/227 (22%), Positives = 87/227 (38%), Gaps = 38/227 (16%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-H 552
+ + G F VY+ + + G+E A+KR ++ EK A E+ F+ +L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKR--LLSNEE--EKNRAIIQEVCFMKKLSG 84
Query: 553 HKHLVRLVGYCEEKDER-------LLVYDYMKNGALYDHLHDRNNVEK-----------N 594
H ++V+ E L+ + G L + L +
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 595 AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
R ++++H PPIIHRD+K N+LL Q T ++ DFG + P+ +
Sbjct: 145 TCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 652 A-------GTVGYIDPE---YYGLNVLTAKSDVYGLGVVLLELLTGK 688
T Y PE Y + K D++ LG +L L +
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 58/219 (26%), Positives = 105/219 (47%), Gaps = 33/219 (15%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
F+ KIG GSFG V+KG + VAIK ++ +++ E+ LS+
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI---IDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 555 HLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLHNYA 606
++ + G KD +L ++ +Y+ G+ D L E A +G++YLH+
Sbjct: 81 YVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERD-FRPMKAAGTVGYIDPEYY 663
IHRDIK++N+LL +++DFG++ + + +R+ F GT ++ PE
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-----VGTPFWMAPEVI 191
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
+ +K+D++ LG+ +EL G+ + +F
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 48/239 (20%), Positives = 94/239 (39%), Gaps = 37/239 (15%)
Query: 497 SLENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHK 554
+ +G GSF + K Q A+K +K+ E+ E+ L H
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVK----IISKR---MEANTQKEITALKLCEGHP 66
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLHNYA 606
++V+L ++ LV + + G L++ + + + E A+ + ++H+
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 607 VPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
++HRD+K N+L + ++ DFG + + P + T+ Y PE
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAPE-- 179
Query: 664 GLNVLTAKS-----DVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
+L D++ LGV+L +L+G+ D S ++ I G+
Sbjct: 180 ---LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK--KIKKGDF 233
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 57/260 (21%), Positives = 106/260 (40%), Gaps = 36/260 (13%)
Query: 446 NNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAG 505
++ + ++ + + + A ++ F +E+++G G
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64
Query: 506 SFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564
+ +VY+ K + A+K KT + +E+ L RL H ++++L E
Sbjct: 65 ATSIVYRCKQKGTQKPYALKV--LKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 565 EKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLHNYAVPPIIHRDIK 616
E LV + + G L+D + ++ E++AA + YLH I+HRD+K
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLK 175
Query: 617 SSNILL---DAQWTARVSDFGLSMMGPESERDFRPMK-AAGTVGYIDPEYYGLNVLTAKS 672
N+L +++DFGLS + MK GT GY PE +L +
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVL----MKTVCGTPGYCAPE-----ILRGCA 226
Query: 673 -----DVYGLGVVLLELLTG 687
D++ +G++ LL G
Sbjct: 227 YGPEVDMWSVGIITYILLCG 246
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 52/220 (23%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
KIG GS G+V + G++VA+K + K Q++ +E+ + H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHF 102
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA-------RGIEYLHNYAV 607
++V + +E ++ ++++ GAL D + E+ A + + YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-----Y 662
+IHRDIKS +ILL ++SDFG S+ + GT ++ PE
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
Y + D++ LG++++E++ G+ +A+ +
Sbjct: 218 YA-----TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 45/228 (19%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ + ++G G+FG VYK K G A K ET +E+ + E+ L+ H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS----EEELEDYIVEIEILATCDHP 76
Query: 555 HLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLHN 604
++V+L+G D +L ++ ++ GA+ + + + V + + +LH+
Sbjct: 77 YIVKLLG-AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERD-FRPMKAAGT------- 654
+ IHRD+K+ N+L+ + R++DFG+S + +RD F GT
Sbjct: 136 KRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF-----IGTPYWMAPE 187
Query: 655 VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
V + E K+D++ LG+ L+E+ + R + K
Sbjct: 188 V--VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 53/239 (22%), Positives = 90/239 (37%), Gaps = 31/239 (12%)
Query: 76 SSISAGQSFFCGIRSGGYSLLCWDTNFSY---NSNFVPKRIYYNDTVLLSSVSVGNNHVC 132
+I+ G ++ G +L W N + + +++ GN H
Sbjct: 27 DAIAGGYFHGLALKGG--KVLGWGANLNGQLTMPAATQSGV--------DAIAAGNYHSL 76
Query: 133 ATTVQGQINCW----RGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSI 188
A G++ W G + A SG +++ +G S + + V WG +S
Sbjct: 77 ALK-DGEVIAWGGNEDGQTTVPAEARSG---VDAIAAGAWASYAL--KDGKVIAWGDDS- 129
Query: 189 SNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLG 248
Q +S + GG + NG VI +GDN GQ P + + ++ G
Sbjct: 130 DGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQS-GVDDVAGG 188
Query: 249 FNHSCAIRRLNGSVVCWG--SQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWG 305
HS A++ +G V+ WG + +V +I SG ++ L VI WG
Sbjct: 189 IFHSLALK--DGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWYSLALKNG--KVIAWG 243
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 49/222 (22%), Positives = 84/222 (37%), Gaps = 17/222 (7%)
Query: 77 SISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV 136
+I+AG ++ G ++ W N VP V +++ G A
Sbjct: 67 AIAAGNYHSLALKDG--EVIAWGGN-EDGQTTVPAEA--RSGV--DAIAAGAWASYALK- 118
Query: 137 QGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF 196
G++ W D + P+ + G ++ + N V WG N Q
Sbjct: 119 DGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVKNG-GVIAWGDNY-FGQTTVPA 176
Query: 197 ANRSMF-SITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAI 255
+S + G H + +G VI +GDN+ Q P + + SA++ G +S A+
Sbjct: 177 EAQSGVDDVAGGIFHSLALK-DGKVIAWGDNRYKQTTVPTEALS-GVSAIASGEWYSLAL 234
Query: 256 RRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNFTCGLTTS 297
+ NG V+ WGS + + + SI +G N L
Sbjct: 235 K--NGKVIAWGS-SRTAPSSV-QSGVSSIEAGPNAAYALKGG 272
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 35/130 (26%), Positives = 58/130 (44%), Gaps = 9/130 (6%)
Query: 179 TVRCWGINSISNQIQTSFANRSMF-SITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNS 237
+V WG N+ + +S +I G H + G V+ +G N +GQL P +
Sbjct: 3 SVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALK-GGKVLGWGANLNGQLTMP-AA 60
Query: 238 TAFEYSALSLGFNHSCAIRRLNGSVVCWG--SQGEYSVNGIRGKSFESIVSGSNFTCGLT 295
T A++ G HS A++ +G V+ WG G+ +V ++I +G+ + L
Sbjct: 61 TQSGVDAIAAGNYHSLALK--DGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALK 118
Query: 296 TSNFSVICWG 305
VI WG
Sbjct: 119 DG--KVIAWG 126
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 38/189 (20%), Positives = 70/189 (37%), Gaps = 23/189 (12%)
Query: 77 SISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV 136
+I+AG ++ G ++ W + S VP V +++ G A
Sbjct: 106 AIAAGAWASYALKDG--KVIAWGDD-SDGQTTVPAEA--QSGV--TALDGGVYTALAVK- 157
Query: 137 QGQINCW----RGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQI 192
G + W G + A SG + + GI S L + V WG N
Sbjct: 158 NGGVIAWGDNYFGQTTVPAEAQSG---VDDVAGGIFHSL-ALKDG-KVIAWGDNRYKQTT 212
Query: 193 QTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHS 252
+ A + +I +G + + NG VI +G +++ + ++ G N +
Sbjct: 213 VPTEALSGVSAIASGEWYSLALK-NGKVIAWGSSRTAPSSVQSGVS-----SIEAGPNAA 266
Query: 253 CAIRRLNGS 261
A++ +GS
Sbjct: 267 YALKGGSGS 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-26
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSE---LAFLS 549
N+FS+ IG G FG VY + D ++ A+K + + K Q + A +E L+ +S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-NERIMLSLVS 247
Query: 550 RLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIE 600
+V + Y ++L + D M G L+ HL + R G+E
Sbjct: 248 TGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
++HN +++RD+K +NILLD R+SD GL+ + +P + GT GY+ P
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAP 359
Query: 661 EYYGLNVLTAKS------DVYGLGVVLLELLTGK 688
E VL D + LG +L +LL G
Sbjct: 360 E-----VLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 54/225 (24%), Positives = 90/225 (40%), Gaps = 26/225 (11%)
Query: 480 RAEEFLLAELAAATNNFSLENK-IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEK 537
E + N + L +K +G G F VV + GQE A K K ++ Q+
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKF--LKKRRRGQDC 71
Query: 538 ESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV---EK 593
+ E+A L ++ L E E +L+ +Y G ++ E
Sbjct: 72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN 131
Query: 594 NAAR-------GIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESE 643
+ R G+ YLH I+H D+K NILL ++ DFG+S +
Sbjct: 132 DVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 644 RDFRPMK-AAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
++ GT Y+ PE + +T +D++ +G++ LLT
Sbjct: 189 E----LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 64/268 (23%), Positives = 114/268 (42%), Gaps = 53/268 (19%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + +G GSFG V Q+VA+K KK E+++L L H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRH 68
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHNY 605
H+++L + ++V +Y G L+D++ ++ + ++ R IEY H +
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA-GTVGYIDPE--- 661
I+HRD+K N+LLD +++DFGLS + D +K + G+ Y PE
Sbjct: 128 K---IVHRDLKPENLLLDDNLNVKIADFGLSNI----MTDGNFLKTSCGSPNYAAPEVIN 180
Query: 662 ---YYGLNVLTAKSDVYGLGVVLLELLTGK--------RAIFKDDESGGTPVSLVDFAVP 710
Y G + DV+ G+VL +L G+ +FK S + +P
Sbjct: 181 GKLYAG-----PEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-------VYVMP 228
Query: 711 AIMAGE----LVKILD----RRVGPPEI 730
++ + +++ +R+ EI
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQRITIQEI 256
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 43/391 (10%), Positives = 101/391 (25%), Gaps = 91/391 (23%)
Query: 423 HNSVQPTITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAE 482
H+S + + G G R S + ++S
Sbjct: 7 HSSGRENLYFQGP-----GDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 61
Query: 483 EFLLAELAAATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK----------------R 525
+ +EL +G + G+ + +
Sbjct: 62 FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 526 GETAKTKKFQEKESA--------FDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMK 577
E + + + ++ F + K ++R+ + + Y +
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPR 181
Query: 578 N--------GALYDHLHDRNNVEKNAAR--------GIEYLHNYAVPPIIHRDIKSSNIL 621
L H ++ +A + LH+Y ++H ++ +I+
Sbjct: 182 MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIV 238
Query: 622 LDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY-----------YGLNVLTA 670
LD + ++ F + RD + ++ + G+ PE ++T
Sbjct: 239 LDQRGGVFLTGFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTF 292
Query: 671 KSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEI 730
D + LG+V+ + D + G I P+
Sbjct: 293 SFDAWALGLVIYWIWCADLP-ITKDAALGG----------------SEWIFRSCKNIPQ- 334
Query: 731 NEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
L+ + ++R +
Sbjct: 335 ---PVRALL----EGFLRYPKEDRLLPLQAM 358
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 35/224 (15%)
Query: 498 LENKIGAGSFGVVYKGKLPD---GQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRLH 552
+ +K+G G VY + D +VAIK + ++ ++ F+ E+ S+L
Sbjct: 15 IVDKLGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKR---FEREVHNSSQLS 69
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA--------RGIEYLHN 604
H+++V ++ EE D LV +Y++ L +++ + + A GI++ H+
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA----GTVGYIDP 660
I+HRDIK NIL+D+ T ++ DFG++ E+ + GTV Y P
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-----SLTQTNHVLGTVQYFSP 181
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704
E +D+Y +G+VL E+L G+ F +G T VS+
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPP-F----NGETAVSI 220
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 36/356 (10%), Positives = 79/356 (22%), Gaps = 66/356 (18%)
Query: 452 RSATIRRQGSRLL--TMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGV 509
I L + T++ AE + + L+ L + G V
Sbjct: 18 EEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSV 77
Query: 510 VYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYC----- 563
V+ + + ++ A+K E E +RL +
Sbjct: 78 VFLVRDVERLEDFALKVFTMGAENSRSELE-RLHEATFAAARLLGESPEEARDRRRLLLP 136
Query: 564 ---------------------EEKDERLLVYDYMK-----NGALYDHLHDRNNVEKNAAR 597
LL+ + D ++ E A
Sbjct: 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILAL 196
Query: 598 ---------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRP 648
L + ++H N+ + + D
Sbjct: 197 HILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS-- 251
Query: 649 MKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706
+ V Y E+ + T + + LG+ + + F G +
Sbjct: 252 ---SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL-FLPFGLVTPG------IK 301
Query: 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762
+ + + L+ +N + + R + +
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPD-FVKTLI----GRFLNFDRRRRLLPLEAME 352
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-25
Identities = 56/260 (21%), Positives = 107/260 (41%), Gaps = 28/260 (10%)
Query: 445 SNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFS----LEN 500
+ R + QG + S + D +++ + ++ +
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559
++G G+FGVV++ G A K T +KE+ E+ +S L H LV L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAK---FVMTPHESDKET-VRKEIQTMSVLRHPTLVNL 219
Query: 560 VGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNAAR-------GIEYLHNYAVPPI 610
E+ +E +++Y++M G L++ + D +N E A G+ ++H
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 276
Query: 611 IHRDIKSSNILLDAQWTARV--SDFGLSMMGPESERDFRPMK-AAGTVGYIDPEYYGLNV 667
+H D+K NI+ + + + DFGL+ + +K GT + PE
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS----VKVTTGTAEFAAPEVAEGKP 332
Query: 668 LTAKSDVYGLGVVLLELLTG 687
+ +D++ +GV+ LL+G
Sbjct: 333 VGYYTDMWSVGVLSYILLSG 352
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 48/229 (20%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
F + K+G GS+G VYK GQ VAIK+ + E++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ------VPVESDLQEIIKEISIMQQC 81
Query: 552 HHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNN---------VEKNAARGIEY 601
H+V+ G K+ L +V +Y G++ D + RN + ++ +G+EY
Sbjct: 82 DSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEY 140
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERD-FRPMKAAGTVGYI 658
LH IHRDIK+ NILL+ + A+++DFG++ + ++R+ GT ++
Sbjct: 141 LHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV-----IGTPFWM 192
Query: 659 DPE-----YYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
PE Y +D++ LG+ +E+ GK RAIF
Sbjct: 193 APEVIQEIGYN-----CVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 44/242 (18%), Positives = 84/242 (34%), Gaps = 39/242 (16%)
Query: 474 SSKHADRAEEFLLAELAAATNNFSLENKIGAG--SFGVVYKGK-LPDGQEVAIKRG--ET 528
H + ++ + L IG G V + P G+ V ++R E
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA 64
Query: 529 AKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDR 588
+ + EL +H ++V +E +V +M G+ D +
Sbjct: 65 CSNEMVTFLQG----ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH 120
Query: 589 NN----------VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-- 636
+ + + ++Y+H+ +HR +K+S+IL+ +S +
Sbjct: 121 FMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 637 MMGPESERDFRPMKAAGTVG---YIDPEYYGLNVLT-------AKSDVYGLGVVLLELLT 686
M+ + +V ++ PE VL AKSD+Y +G+ EL
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPE-----VLQQNLQGYDAKSDIYSVGITACELAN 232
Query: 687 GK 688
G
Sbjct: 233 GH 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 67/286 (23%), Positives = 106/286 (37%), Gaps = 60/286 (20%)
Query: 445 SNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATN---NFSLENK 501
S L + A ++ +AEL + FS +
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLRE 61
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLV 560
IG GSFG VY + + + + VAIK+ + + EK E+ FL +L H + ++
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 561 GYCEEKDERL-LVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYLHNYAVPPI 610
G C ++ LV +Y G+ D L V A +G+ YLH++ +
Sbjct: 121 G-CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---M 175
Query: 611 IHRDIKSSNILLDAQWTARVSDFGLSM--------------MGPESERDFRPMKAAGTVG 656
IHRD+K+ NILL ++ DFG + M PE +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPE------------VIL 223
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
+D Y K DV+ LG+ +EL K A++
Sbjct: 224 AMDEGQYD-----GKVDVWSLGITCIELAERKPPLFNMNAMSALYH 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 34/214 (15%)
Query: 499 ENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHL 556
E+ +G G+ V L QE A+K + + + F E+ L + H+++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVK---IIEKQPGHIRSRVF-REVEMLYQCQGHRNV 73
Query: 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-VEKNAAR-------GIEYLHNYAVP 608
+ L+ + EE+D LV++ M+ G++ H+H R + E A+ +++LHN
Sbjct: 74 LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG-- 131
Query: 609 PIIHRDIKSSNILL---DAQWTARVSDFGLSMM----GPESERDFRPMK-AAGTVGYIDP 660
I HRD+K NIL + ++ DF L G S + G+ Y+ P
Sbjct: 132 -IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 661 EYYGLNVLTAKSDVYG-------LGVVLLELLTG 687
E + + ++ +Y LGV+L LL+G
Sbjct: 191 EV--VEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 474 SSKHADRAEEFLLAELAAAT-NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKT 531
S + R ++ E + F +G G FG V+ ++ ++ A K+ +
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 532 KKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNN 590
KK + + A E L+++H + +V L Y E L LV M G + H+++ +
Sbjct: 224 KKRKGYQGAM-VEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDE 281
Query: 591 VEK----NAAR--------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638
A G+E+LH II+RD+K N+LLD R+SD GL++
Sbjct: 282 DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVE 338
Query: 639 GPESERDFRPMKAAGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ + AGT G++ PE Y +V D + LGV L E++ +
Sbjct: 339 LKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSV-----DYFALGVTLYEMIAAR 386
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+++ L+ IG+G+ VV P ++VAIKR +K Q E+ +S+ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKR---INLEKCQTSMDELLKEIQAMSQCH 71
Query: 553 HKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNN----------------VEKNA 595
H ++V + L LV + G++ D + + +
Sbjct: 72 HPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
G+EYLH IHRD+K+ NILL + +++DFG+S R V
Sbjct: 131 LEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 656 G---YIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGK 688
G ++ PE Y K+D++ G+ +EL TG
Sbjct: 188 GTPCWMAPEVMEQVRGYD-----FKADIWSFGITAIELATGA 224
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-24
Identities = 47/297 (15%), Positives = 93/297 (31%), Gaps = 66/297 (22%)
Query: 71 PNISFSSISAGQSFFCGIRSGGYSLLCWDTNF-------SYNSNFVPKRIYYNDTVLLSS 123
S++ G G + W + + F P I + +
Sbjct: 66 DGHQIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQ 125
Query: 124 VSVGNNHVCATTVQGQINCW-RGD-------VNISKNAP-----SGELQFESLTSGIDFS 170
++ G++H A T++G++ W R P ++ + + +G + +
Sbjct: 126 IACGDSHCLAVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGAEHT 185
Query: 171 CGILTNNKTVRCWGIN--------SISNQIQ----TSFANRSMFSITAGGNHVCGIDSNG 218
+T + + WG ++++ TS M + G H + +G
Sbjct: 186 A-AVTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSYSG 244
Query: 219 FVICYGDNKSGQLKFPLNSTAFEYS-------------ALSLGFNHSCAIRRLNGSVVCW 265
+ YG +K GQL +S G+ H+ A+ +G + W
Sbjct: 245 ALYTYGWSKYGQL--GHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTS-DGKLYGW 301
Query: 266 GSQGEY---------------SVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPG 307
G ++ V + + G T +T N +V WG G
Sbjct: 302 GW-NKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVTERN-NVFAWGRG 356
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-21
Identities = 47/301 (15%), Positives = 90/301 (29%), Gaps = 70/301 (23%)
Query: 67 RAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNF-------SYNSNFVPKRIYYNDTV 119
P ISAG S + SG + W P ++ D
Sbjct: 10 EVTAPPRKVLIISAGASHSVALLSGD-IVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGH 68
Query: 120 LLSSVSVGNNHVCATTVQG-QINCW---------RGDVNISKNAPS-----GELQFESLT 164
+ SV+ G +H A + G ++ W G+ + P ++ + +
Sbjct: 69 QIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGN-SSDLFTPLPIKALHGIRIKQIA 127
Query: 165 SGIDFSCGILTNNKTVRCWGINS--------ISNQIQ----TSFANRSMFSITAGGNHVC 212
G +T V+ WG N + + +F + + AG H
Sbjct: 128 CGDSHCL-AVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGAEHTA 186
Query: 213 GIDSNGFVICYGDNKSGQLKFPLNSTAFEYS-------------ALSLGFNHSCAIRRLN 259
+ +G + +G + G L L ++ G+ H+ ++ +
Sbjct: 187 AVTEDGDLYGWGWGRYGNLG--LGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSY-S 243
Query: 260 GSVVCWGSQGEY---------------SVNGIRGKSFESIVSGSNFTCGLTTSNFSVICW 304
G++ +G +Y + + I G T LT+ + W
Sbjct: 244 GALYTYGW-SKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTSDG-KLYGW 301
Query: 305 G 305
G
Sbjct: 302 G 302
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-17
Identities = 39/241 (16%), Positives = 69/241 (28%), Gaps = 46/241 (19%)
Query: 71 PNISFSSISAGQSFFCGIRSGGYSLLCWDTNF-------SYNSNFVPKRIYYNDTVLLSS 123
I ++AG + G L W VP+R+ +S
Sbjct: 171 EGIRIKMVAAGAEHTAAVTEDG-DLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSM 229
Query: 124 VSVGNNHVCATTVQGQINCW---------RGDVNISKNAPS-----GELQFESLTSGIDF 169
V+ G H + + G + + GD P ++ G
Sbjct: 230 VACGWRHTISVSYSGALYTYGWSKYGQLGHGD-LEDHLIPHKLEALSNSFISQISGGWRH 288
Query: 170 SCGILTNNKTVRCWGIN--------SISNQIQ----TSFANRSMFSITAGGNHVCGIDSN 217
+ LT++ + WG N + +Q ++ + ++ G H +
Sbjct: 289 TM-ALTSDGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVTER 347
Query: 218 GFVICYGDNKSGQL--------KFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQG 269
V +G +GQL FP A + G + + S W S
Sbjct: 348 NNVFAWGRGTNGQLGIGESVDRNFPKIIEALS-VDGASGQHIESSN-IDPSSGKSWVSPA 405
Query: 270 E 270
E
Sbjct: 406 E 406
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAF-DSELAFLSRL 551
+F +G GSF V + +E AIK E K +E + + E +SRL
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILE--KRHIIKENKVPYVTRERDVMSRL 87
Query: 552 HHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
H V+L + + DE+L Y KNG L ++ + ++ R +EYL
Sbjct: 88 DHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H IIHRD+K NILL+ +++DFG + + + R GT Y+ PE
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE- 202
Query: 663 YGLNVLTAK-----SDVYGLGVVLLELLTGK 688
+LT K SD++ LG ++ +L+ G
Sbjct: 203 ----LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-24
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 498 LENKIGAGSFGVVYKGKLPD---GQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRLH 552
L +G G V+ + D ++VA+K R + A+ F + F E + L+
Sbjct: 16 LGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLR---FRREAQNAAALN 70
Query: 553 HKHLVRLVGYCEEKDERL----LVYDYMKNGALYDHLHDRN--------NVEKNAARGIE 600
H +V + E + +V +Y+ L D +H V +A + +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA----GTVG 656
+ H IIHRD+K +NI++ A +V DFG++ +S + GT
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVIGTAQ 184
Query: 657 YIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703
Y+ PE + + A+SDVY LG VL E+LTG+ F +G +PVS
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-F----TGDSPVS 226
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++F + IG GSFG V + D +++ A+K K + E + F EL + L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF-KELQIMQGLE 73
Query: 553 HKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
H LV L Y + +E + +V D + G L HL + ++ + ++YL
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
N IIHRD+K NILLD ++DF ++ M P + AGT Y+ PE
Sbjct: 133 NQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPE-- 184
Query: 664 GLNVLTAKS--------DVYGLGVVLLELLTGKR 689
+ +++ D + LGV ELL G+R
Sbjct: 185 ---MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 50/227 (22%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS-ELAFLSRL 551
++ IG GSFGVV++ KL + EVAIK K Q+K F + EL + +
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK-------KVLQDKR--FKNRELQIMRIV 89
Query: 552 HHKHLVRLVGY----CEEKDERL--LVYDYMKNGALYDHLHDRNNVEKN----------- 594
H ++V L + ++KDE LV +Y+ +Y +++
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMY 148
Query: 595 -AARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAA 652
R + Y+H+ I HRDIK N+LLD ++ DFG + + +
Sbjct: 149 QLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA-------KILIAGEP- 197
Query: 653 GTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
V YI YY G T D++ G V+ EL+ G+ +F
Sbjct: 198 -NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PLF 242
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 58/238 (24%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HH 553
F L +G G++G VYKG+ + GQ AIK ++E E+ L + HH
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK-----VMDVTGDEEEEIKQEINMLKKYSHH 80
Query: 554 KHLVR-----LVGYCEEKDERL-LVYDYMKNGALYDHLHDRNN----------VEKNAAR 597
+++ + D++L LV ++ G++ D + + + + R
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 598 GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERD-FRPMKAAGT 654
G+ +LH + V IHRDIK N+LL ++ DFG+S + R+ F GT
Sbjct: 141 GLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-----IGT 192
Query: 655 VGYIDPE----------YYGLNVLTAKSDVYGLGVVLLELLTGK---------RAIFK 693
++ PE Y KSD++ LG+ +E+ G RA+F
Sbjct: 193 PYWMAPEVIACDENPDATYD-----FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL 245
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 3e-23
Identities = 31/306 (10%), Positives = 80/306 (26%), Gaps = 75/306 (24%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIK----------------RGETAKTKKFQEKESA---- 540
+G + G+ + + E + + + ++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 541 ----FDSELAFLSRLHHKHLVRLVGYCEEKD--ERLLVYDYMKN------GALYDHLHDR 588
F + K ++R+ + R +Y M++ L H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 589 NNVEKNAARGI--------EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640
++ +A + LH+Y ++H ++ +I+LD + ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261
Query: 641 ESERDFRPMKAAGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
+ + + ++T D + LG+ + + DD
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP-NTDD 320
Query: 696 ESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP 755
+ G I P+ L+ + ++R
Sbjct: 321 AALGG----------------SEWIFRSCKNIPQ----PVRALL----EGFLRYPKEDRL 356
Query: 756 TMADIV 761
+
Sbjct: 357 LPLQAM 362
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 35/253 (13%)
Query: 456 IRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAAT-NNFSLENKIGAGSFGVVYKGK 514
+ R L++ S + +R ++ E T N F +G G FG V +
Sbjct: 145 LTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQ 204
Query: 515 LPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL-LV 572
+ ++ A K+ E + KK + + A +E L +++ + +V L Y E + L LV
Sbjct: 205 VRATGKMYACKKLEKKRIKKRKGEAMAL-NEKQILEKVNSRFVVSLA-YAYETKDALCLV 262
Query: 573 YDYMKNGALYDHLH--DRNNVEKNAAR--------GIEYLHNYAVPPIIHRDIKSSNILL 622
M G L H++ + + A G+E LH I++RD+K NILL
Sbjct: 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILL 319
Query: 623 DAQWTARVSDFGLS--MMGPESERDFRPMKAAGTVGYIDPE-----YYGLNVLTAKSDVY 675
D R+SD GL+ + ++ + GTVGY+ PE Y + D +
Sbjct: 320 DDHGHIRISDLGLAVHVPEGQTIKGR-----VGTVGYMAPEVVKNERYTFSP-----DWW 369
Query: 676 GLGVVLLELLTGK 688
LG +L E++ G+
Sbjct: 370 ALGCLLYEMIAGQ 382
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 47/209 (22%), Positives = 80/209 (38%), Gaps = 30/209 (14%)
Query: 498 LENKIGAGSFGVVYKGKLPD---GQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRLH 552
L +G G G VY+ + D + VA+K + F+ + E RL
Sbjct: 38 LRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTR---MQREARTAGRLQ 92
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHN 604
H+V + + E + + + L L + + + ++ H
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA----GTVGYIDP 660
HRD+K NIL+ A A + DFG++ + + GT+ Y+ P
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE-----KLTQLGNTVGTLYYMAP 204
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGKR 689
E + + T ++D+Y L VL E LTG
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 47/213 (22%), Positives = 88/213 (41%), Gaps = 45/213 (21%)
Query: 499 ENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHL 556
+ +G G G V + GQ+ A+K + K ++ E+ + H+
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKL--LYDSPKARQ-------EVDHHWQASGGPHI 84
Query: 557 VRLVGYCEEKDER----LLVYDYMKNGALYDHLHDRNNV---EKNAAR-------GIEYL 602
V ++ E L++ + M+ G L+ + +R + E+ AA I++L
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 603 HNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYID 659
H++ I HRD+K N+L + +++DFG + ++ T Y+
Sbjct: 145 HSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVA 197
Query: 660 PEYYGLNVLTAKS-----DVYGLGVVLLELLTG 687
PE VL + D++ LGV++ LL G
Sbjct: 198 PE-----VLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 70/241 (29%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAFL 548
+ + KIG G+FG V+K + GQ+VA+K K EKE F E+ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEG-FPITALREIKIL 70
Query: 549 SRLHHKHLVRLVGYCEEKDERL--------LVYDYMKNGALYDH----LHDRNNVEKNAA 596
L H+++V L+ C K LV+D+ +H L V+ +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLS 124
Query: 597 ----------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
G+ Y+H I+HRD+K++N+L+ +++DFGL+ R F
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA-------RAF 174
Query: 647 -RPMKAAG--------TVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691
+ T+ Y PE YG + D++G G ++ E+ T I
Sbjct: 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPI-----DLWGAGCIMAEMWTRS-PI 228
Query: 692 F 692
Sbjct: 229 M 229
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 57/308 (18%), Positives = 99/308 (32%), Gaps = 56/308 (18%)
Query: 440 NGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNFS-- 497
+ G + P + Q + + + L N
Sbjct: 3 SNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 498 ---LENKIGAGSFGVVYKG-KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-H 552
+G G G V + ++ A+K + K + E+ R
Sbjct: 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARR-------EVELHWRASQ 113
Query: 553 HKHLVRLVGYCEEKDER----LLVYDYMKNGALYDHLHDRNNV---EKNAAR-------G 598
H+VR+V E L+V + + G L+ + DR + E+ A+
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 599 IEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMK-AAGT 654
I+YLH+ I HRD+K N+L +++DFG + + T
Sbjct: 174 IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYT 226
Query: 655 VGYIDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
Y+ PE VL + D++ LGV++ LL G F + +
Sbjct: 227 PYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKT--- 277
Query: 710 PAIMAGEL 717
I G+
Sbjct: 278 -RIRMGQY 284
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 8e-23
Identities = 44/245 (17%), Positives = 84/245 (34%), Gaps = 38/245 (15%)
Query: 498 LENKIGAGSFGVVYKGK---LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
++ I G G +Y + +G+ V +K + + Q +E FL+ + H
Sbjct: 84 VKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQA---MAMAERQFLAEVVHP 139
Query: 555 HLVRLVGYCEEKDERL-----LVYDYMKNGALYDHLHDRNNVEK------NAARGIEYLH 603
+V++ + E D +V +Y+ +L + V + + YLH
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLH 199
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA----GTVGYID 659
+ +++ D+K NI+L + ++ D G + + GT G+
Sbjct: 200 S---IGLVYNDLKPENIMLTEE-QLKLIDLGAV----------SRINSFGYLYGTPGFQA 245
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719
PE T +D+Y +G L L G P L +
Sbjct: 246 PEIV-RTGPTVATDIYTVGRTLAALTLDLPT-RNGRYVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 720 ILDRR 724
+D
Sbjct: 304 AIDPD 308
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 9e-23
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLSR 550
++F +++GAG+ GVV+K P G +A K E + Q EL L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-----RELQVLHE 87
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAA-------RGIEYL 602
+ ++V G E + ++M G+L L + E+ +G+ YL
Sbjct: 88 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 147
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD-FRPMKAAGTVGY---- 657
I+HRD+K SNIL++++ ++ DFG+S +S + F GT Y
Sbjct: 148 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-----VGTRSYMSPE 200
Query: 658 -IDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
+ +Y + +SD++ +G+ L+E+ G+
Sbjct: 201 RLQGTHY-----SVQSDIWSMGLSLVEMAVGR 227
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 57/229 (24%), Positives = 86/229 (37%), Gaps = 58/229 (25%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAFL 548
+ KIG GS+GVV+K + GQ VAIK K + ++ E+ L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDP-VIKKIALREIRML 56
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA---------RGI 599
+L H +LV L+ K LV++Y + + L + +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAGTVGYI 658
+ H + IHRD+K NIL+ ++ DFG + R P Y
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFA-------RLLTGPSDY-----YD 160
Query: 659 D---------PE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
D PE YG V DV+ +G V ELL+G ++
Sbjct: 161 DEVATRWYRSPELLVGDTQYGPPV-----DVWAIGCVFAELLSG-VPLW 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 50/230 (21%), Positives = 92/230 (40%), Gaps = 59/230 (25%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAFL 548
+ KIG G++G V+K K + VA+K + + + E S E+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALK-----RVRLDDDDE-GVPSSALREICLL 55
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH----LHDRNNVEKNAA-------- 596
L HK++VRL + LV+++ D D N + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 597 --RGIEYLH-NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKA- 651
+G+ + H ++HRD+K N+L++ ++++FGL+ R F P++
Sbjct: 110 LLKGLGFCHSRN----VLHRDLKPQNLLINRNGELKLANFGLA-------RAFGIPVRCY 158
Query: 652 ---AGTVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
T+ Y P+ Y ++ D++ G + EL R +F
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSI-----DMWSAGCIFAELANAGRPLF 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 59/257 (22%), Positives = 109/257 (42%), Gaps = 67/257 (26%)
Query: 466 MRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKR 525
M +S + + + + K+G G++GVVYK K G+ VA+K
Sbjct: 1 MHHHHHHSSGRENLYFQGLM--------EKYQKLEKVGEGTYGVVYKAKDSQGRIVALK- 51
Query: 526 GETAKTKKFQEKESAFDS----ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGAL 581
+ + E E S E++ L LHH ++V L+ + LV+++M
Sbjct: 52 ----RIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM----- 101
Query: 582 YDH----LHDRNNVEKNAA----------RGIEYLH-NYAVPPIIHRDIKSSNILLDAQW 626
+ + D N + RG+ + H + I+HRD+K N+L+++
Sbjct: 102 -EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR----ILHRDLKPQNLLINSDG 156
Query: 627 TARVSDFGLSMMGPESERDF-RPMKA----AGTVGYIDPE------YYGLNVLTAKSDVY 675
+++DFGL+ R F P+++ T+ Y P+ Y +V D++
Sbjct: 157 ALKLADFGLA-------RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-----DIW 204
Query: 676 GLGVVLLELLTGKRAIF 692
+G + E++TGK +F
Sbjct: 205 SIGCIFAEMITGK-PLF 220
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-22
Identities = 78/287 (27%), Positives = 116/287 (40%), Gaps = 59/287 (20%)
Query: 433 GGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAA 492
G R S + PS +++ + + T + DR +E
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEV-------- 54
Query: 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+++ IG GSFGVVY+ KL G+ VAIK K Q+K EL + +L
Sbjct: 55 --SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-------KVLQDKRFKN-RELQIMRKL 104
Query: 552 HHKHLVRLVGY----CEEKDERLL--VYDYMKNGALYDHLHDRNNVEKN----------- 594
H ++VRL + E+KDE L V DY+ +Y + ++
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 595 -AARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAA 652
R + Y+H++ I HRDIK N+LLD ++ DFG + + +
Sbjct: 164 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA-------KQLVRGEP- 212
Query: 653 GTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
V YI YY G T+ DV+ G VL ELL G + IF
Sbjct: 213 -NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIF 257
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 49/230 (21%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFD--SELAFLS 549
+ F +E G G+FG V GK G VAIK K Q+ + L+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-------KVIQDPRFRNRELQIMQDLA 74
Query: 550 RLHHKHLVRL------VGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKN-------- 594
LHH ++V+L +G + +D L +V +Y+ L+ + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 595 ----AARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFGLSMMGPESERDFRPM 649
R I LH +V + HRDIK N+L++ A T ++ DFG + + P
Sbjct: 134 FLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSA-------KKLSPS 185
Query: 650 KAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
+ V YI YY G T D++ +G + E++ G+ IF
Sbjct: 186 EP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIF 232
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 53/255 (20%), Positives = 98/255 (38%), Gaps = 54/255 (21%)
Query: 469 QRSGTSSKHADRAEEFLLAELAAATN--NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKR 525
GT ++ +AT+ + K+G G++G VYK + VAIK
Sbjct: 7 HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK- 65
Query: 526 GETAKTKKFQEKESAFDS----ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGAL 581
+ + E+E E++ L L H++++ L L+++Y +N L
Sbjct: 66 ----RIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEND-L 119
Query: 582 YDHLHDRNNVEKNAA--------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR---- 629
++ +V G+ + H+ +HRD+K N+LL +
Sbjct: 120 KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVL 176
Query: 630 -VSDFGLSMMGPESERDF-RPMKA----AGTVGYIDPE------YYGLNVLTAKSDVYGL 677
+ DFGL+ R F P++ T+ Y PE +Y +V D++ +
Sbjct: 177 KIGDFGLA-------RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSV-----DIWSI 224
Query: 678 GVVLLELLTGKRAIF 692
+ E+L +F
Sbjct: 225 ACIWAEMLMKT-PLF 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 57/229 (24%), Positives = 93/229 (40%), Gaps = 58/229 (25%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAFL 548
+ +G GS+G+V K + G+ VAIK K + + + E+ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDK-MVKKIAMREIKLL 78
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA---------RGI 599
+L H++LV L+ C++K LV++++ + + D L N GI
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKAAGTVGYI 658
+ H++ IIHRDIK NIL+ ++ DFG + R P + Y
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFA-------RTLAAPGEV-----YD 182
Query: 659 D---------PE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
D PE YG V DV+ +G ++ E+ G +F
Sbjct: 183 DEVATRWYRAPELLVGDVKYGKAV-----DVWAIGCLVTEMFMG-EPLF 225
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 54/228 (23%), Positives = 97/228 (42%), Gaps = 57/228 (25%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAFLS 549
+ KIG G++GVVYK + G+ A+K K + +E E S E++ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALK-----KIRLEKEDE-GIPSTTIREISILK 55
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH----LHDRNNVEKNAA--------- 596
L H ++V+L K +LV++++ D L D +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 597 -RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-RPMKA--- 651
GI Y H+ ++HRD+K N+L++ + +++DFGL+ R F P++
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA-------RAFGIPVRKYTH 159
Query: 652 -AGTVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
T+ Y P+ Y + D++ +G + E++ G +F
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTI-----DIWSVGCIFAEMVNG-TPLF 201
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-21
Identities = 48/291 (16%), Positives = 84/291 (28%), Gaps = 69/291 (23%)
Query: 78 ISAGQSFFCGIRSGGYSLLCWDTNF-------SYNSNFVPKRIYYNDTVLLSSVSVGNNH 130
+ + G ++ W N VP T+ + G
Sbjct: 6 HHSSGRENLYFQGSG-TIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQLIGGEQT 64
Query: 131 VCATTVQGQINCW---------RGDVNISKNAP-------SGELQFESLTSGIDFSCGIL 174
+ A T G++ G S + P ++ ++ SG L
Sbjct: 65 LFAVTADGKLYATGYGAGGRLGIGG-TESVSTPTLLESIQHVFIKKVAVNSGGKHCL-AL 122
Query: 175 TNNKTVRCWGINS--------ISNQIQ----TSFANRSMFSITAGGNHVCGIDSNGFVIC 222
++ V WG S + S + + AGG H + + G +
Sbjct: 123 SSEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVTAAGDLYT 182
Query: 223 YGDNKSGQL--------KFP-----LNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQG 269
+G + G+L P L A G + + + +V WG G
Sbjct: 183 WGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQTLCLTD-DDTVWSWGD-G 240
Query: 270 EY---------------SVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWG 305
+Y ++ + G + GS F+ LT S +V WG
Sbjct: 241 DYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTKSG-AVYTWG 290
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-20
Identities = 48/291 (16%), Positives = 82/291 (28%), Gaps = 74/291 (25%)
Query: 72 NISFSSISAGQSFFCGIRSGGYSLLCWDTNF-------SYNSNFVPKRIYYNDTVLLSSV 124
I ++++G + S G + W + + P+ I + + V
Sbjct: 106 FIKKVAVNSGGKHCLALSSEG-EVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDV 164
Query: 125 SVGNNHVCATTVQGQINCW---------RGDVNISKNAPSGELQFESLTSG--IDFSCG- 172
+ G H T G + W D + P E+L +D +CG
Sbjct: 165 AAGGAHSACVTAAGDLYTWGKGRYGRLGHSDSE-DQLKPK---LVEALQGHRVVDIACGS 220
Query: 173 ------ILTNNKTVRCWGIN--------SISNQIQ----TSFANRSMFSITAGGNHVCGI 214
LT++ TV WG S + + G +
Sbjct: 221 GDAQTLCLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVAL 280
Query: 215 DSNGFVICYGDNKSGQL--------------KFPLNSTAFEYSALSLGFNHSCAIRRLNG 260
+G V +G +L + A++ G H +G
Sbjct: 281 TKSGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKV---IAIATGSLHCVCCTE-DG 336
Query: 261 SVVCWGS-------QGEYS-------VNGIRGKSFESIVSGSNFTCGLTTS 297
V WG G + V ++GK + GS T +TS
Sbjct: 337 EVYTWGDNDEGQLGDGTTNAIQRPRLVAALQGKKVNRVACGSAHTLAWSTS 387
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 38/234 (16%), Positives = 63/234 (26%), Gaps = 55/234 (23%)
Query: 71 PNISFSSISAGQSFFCGIRSGGYSLLCWDTNF-------SYNSNFVPKRIYYNDTVLLSS 123
I ++AG + + + G L W PK + +
Sbjct: 157 RGIEVVDVAAGGAHSACVTAAG-DLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVD 215
Query: 124 VSV--GNNHVCATTVQGQINCW---------RGDVNISKNAPS-----GELQFESLTSGI 167
++ G+ T + W RG + P L + G
Sbjct: 216 IACGSGDAQTLCLTDDDTVWSWGDGDYGKLGRGG-SDGCKVPMKIDSLTGLGVVKVECGS 274
Query: 168 DFSCGILTNNKTVRCWGIN--------SISNQIQ----TSFANRSMFSITAGGNHVCGID 215
FS LT + V WG S + + + + +I G H
Sbjct: 275 QFSV-ALTKSGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCT 333
Query: 216 SNGFVICYGDNKSGQL--------------KFPLNSTAFEYSALSLGFNHSCAI 255
+G V +GDN GQL + ++ G H+ A
Sbjct: 334 EDGEVYTWGDNDEGQLGDGTTNAIQRPRLVAALQGKKV---NRVACGSAHTLAW 384
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 9e-21
Identities = 69/247 (27%), Positives = 106/247 (42%), Gaps = 38/247 (15%)
Query: 465 TMRRQRSGTSSKHADRAEEFL--LAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEV- 521
+RR+++ ++ + A+ F + ++ +F + IG G+FG V KL + +V
Sbjct: 45 PLRREKN--ILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVF 102
Query: 522 AIKRGETAKTKKFQEKESA-FDSELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNG 579
A+K K + + E+A F E L K + L Y + D L LV DY G
Sbjct: 103 AMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGG 159
Query: 580 ALYDHLH-DRNNVEKNAAR--------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630
L L + + + AR I+ +H +HRDIK NIL+D R+
Sbjct: 160 DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRL 216
Query: 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDV---YG-------LGVV 680
+DFG + E + + A GT YI PE +L A YG LGV
Sbjct: 217 ADFGSCLKLME-DGTVQSSVAVGTPDYISPE-----ILQAMEGGKGRYGPECDWWSLGVC 270
Query: 681 LLELLTG 687
+ E+L G
Sbjct: 271 MYEMLYG 277
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 64/237 (27%)
Query: 491 AATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----EL 545
++++ F K+G G++ VYKG G VA+K + K + E S E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK-----EVK--LDSEEGTPSTAIREI 54
Query: 546 AFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH-----LHDRNNVEKNAA---- 596
+ + L H+++VRL +++ LV+++M D+ + R
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELN 108
Query: 597 ----------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
+G+ + H I+HRD+K N+L++ + ++ DFGL+ R F
Sbjct: 109 LVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA-------RAF 158
Query: 647 -RPMKA----AGTVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
P+ T+ Y P+ Y ++ D++ G +L E++TGK +F
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI-----DIWSCGCILAEMITGK-PLF 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 57/230 (24%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAFL 548
+ + +G G F VYK + Q VAIK+ K E + + E+ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKK---IKLGHRSEAKDGINRTALREIKLL 66
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH----LHDRNNVEKNAA-------- 596
L H +++ L+ K LV+D+M + + N++ +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFM------ETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 597 --RGIEYLH-NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKA- 651
+G+EYLH ++ I+HRD+K +N+LLD +++DFGL+ + F P +A
Sbjct: 121 TLQGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGLA-------KSFGSPNRAY 169
Query: 652 ---AGTVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
T Y PE YG+ V D++ +G +L ELL
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGV-----DMWAVGCILAELLLRV-PFL 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-20
Identities = 59/250 (23%), Positives = 93/250 (37%), Gaps = 42/250 (16%)
Query: 465 TMRRQRSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEV-AI 523
+ + + L E+ ++F + IG G+F V K+ +V A+
Sbjct: 32 ELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAM 91
Query: 524 KRGETAKTKKF---QEKESA-FDSELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKN 578
K K+ + E + F E L + + +L + + + L LV +Y
Sbjct: 92 K-----IMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVG 145
Query: 579 GALYDHL-HDRNNVEKNAAR--------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR 629
G L L + AR I+ +H +HRDIK NILLD R
Sbjct: 146 GDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR 202
Query: 630 VSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDV-----YG-------L 677
++DFG + ++ R + A GT Y+ PE +L A YG L
Sbjct: 203 LADFGSCLKL-RADGTVRSLVAVGTPDYLSPE-----ILQAVGGGPGTGSYGPECDWWAL 256
Query: 678 GVVLLELLTG 687
GV E+ G
Sbjct: 257 GVFAYEMFYG 266
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 5e-20
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESA-FDSELAFLSRL 551
++ + IG G+FG V + ++V A+K +K + + +SA F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL--LSKFEMIKRSDSAFFWEERDIMAFA 126
Query: 552 HHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
+ +V+L Y + D L +V +YM G L + + +V + AR ++ +
Sbjct: 127 NSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAI 184
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H+ IHRD+K N+LLD +++DFG M + R A GT YI PE
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPE- 239
Query: 663 YGLNVLTAK--SDVYG-------LGVVLLELLTG 687
VL ++ YG +GV L E+L G
Sbjct: 240 ----VLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-20
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 63/236 (26%)
Query: 501 KIGAGSFGVVYKGK---LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
K+G G++G VYK K D ++ A+K + + SA E+A L L H +++
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISMSAC-REIALLRELKHPNVI 81
Query: 558 RLVGYCEEKDERL--LVYDYMKN--GALYDHLHDRNNVEKNAA--------------RGI 599
L +R L++DY ++ + +K GI
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 600 EYLH-NYAVPPIIHRDIKSSNILLDAQWTAR----VSDFGLSMMGPESERDF----RPMK 650
YLH N+ ++HRD+K +NIL+ + R ++D G + R F +P+
Sbjct: 142 HYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFA-------RLFNSPLKPLA 190
Query: 651 AAG----TVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
T Y PE +Y + D++ +G + ELLT IF +
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAI-----DIWAIGCIFAELLT-SEPIFHCRQ 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 39/219 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKR----GETAKTKKFQEKESAFDSELAF- 547
++ ++G G++GVV K + +P GQ +A+KR + + K+ +L
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL-------MDLDIS 59
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNG--ALYDHLHDRNNV--EKNAA------- 596
+ + V G + + + + M Y + D+ E
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGT 654
+ +E+LH+ +IHRD+K SN+L++A ++ DFG+S ++ ++ AG
Sbjct: 120 KALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-----AGC 172
Query: 655 VGY-----IDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
Y I+PE + KSD++ LG+ ++EL +
Sbjct: 173 KPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILR 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 49/214 (22%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLSR 550
N+ ++G+G+ G V+K + G +A+K R K + + +L + +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRIL-----MDLDVVLK 79
Query: 551 LH-HKHLVRLVGYCEEKDERLLVYDYMKNG--ALYDHLHDR------NNVEKNAARGIEY 601
H ++V+ G + + + M L + + + + Y
Sbjct: 80 SHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYY 139
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGTVGY-- 657
L +IHRD+K SNILLD + ++ DFG+S ++ +++ AG Y
Sbjct: 140 LKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-----AGCAAYMA 192
Query: 658 ---IDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
IDP ++DV+ LG+ L+EL TG+
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 42/221 (19%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKR----GETAKTKKFQEKESAFDSELAFL 548
+ +IG G++G V K P GQ +A+KR + + K+ +L +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL-------MDLDVV 74
Query: 549 SRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV------EKNAA----- 596
R ++V+ G + + + + M + + +V E+
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 597 --RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAA 652
+ + +L IIHRDIK SNILLD ++ DFG+S ++ ++ A
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-----A 186
Query: 653 GTVGY-----IDPEYYGLNVLTAKSDVYGLGVVLLELLTGK 688
G Y IDP +SDV+ LG+ L EL TG+
Sbjct: 187 GCRPYMAPERIDPSASRQG-YDVRSDVWSLGITLYELATGR 226
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 54/229 (23%), Positives = 91/229 (39%), Gaps = 59/229 (25%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDS----ELAFL 548
+ +K+G G++ VYKGK VA+K + + E E E++ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALK-----EIR--LEHEEGAPCTAIREVSLL 54
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDH----LHDRNNVEKNAA-------- 596
L H ++V L + LV++Y+ D D N
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 597 --RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR-PMKA-- 651
RG+ Y H ++HRD+K N+L++ + +++DFGL+ R P K
Sbjct: 109 LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA-------RAKSIPTKTYD 158
Query: 652 --AGTVGYIDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
T+ Y P+ Y + D++G+G + E+ TG R +F
Sbjct: 159 NEVVTLWYRPPDILLGSTDYSTQI-----DMWGVGCIFYEMATG-RPLF 201
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 58/236 (24%)
Query: 492 ATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFD-------- 542
AT+ + +IG G++G VYK + G VA+K +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK-----SVRVPNGGGGGGGLPISTVRE 61
Query: 543 -SELAFLSRLHHKHLVRL----VGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAA 596
+ L L H ++VRL +++ ++ LV++++ L +L A
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAE 120
Query: 597 ----------RGIEYLH-NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645
RG+++LH N I+HRD+K NIL+ + T +++DFGL+ R
Sbjct: 121 TIKDLMRQFLRGLDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLA-------RI 169
Query: 646 F-RPMKAAGTVG---YIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
+ M V Y PE Y V D++ +G + E+ K +F
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPV-----DMWSVGCIFAEMFRRK-PLF 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 50/230 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
N F +G G+FG V K A+K + E A T +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL----------T 197
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
E L H L L Y + +RL V +Y G L+ HL ++ AR
Sbjct: 198 ENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
++YLH+ +++RD+K N++LD +++DFGL + + + F
Sbjct: 257 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF----- 309
Query: 652 AGTVGYIDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGKRAIFKDDE 696
GT Y+ PE VL D +GLGVV+ E++ G+ + D
Sbjct: 310 CGTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 59/222 (26%), Positives = 90/222 (40%), Gaps = 51/222 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
N+F +G G+FG V + A+K + E A T +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----------T 54
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
E L H L L Y + +RL V +Y G L+ HL + AR
Sbjct: 55 ESRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 113
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
+EYLH+ +++RDIK N++LD +++DFGL + + + F
Sbjct: 114 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF----- 165
Query: 652 AGTVGYIDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGK 688
GT Y+ PE VL D +GLGVV+ E++ G+
Sbjct: 166 CGTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 53/208 (25%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ F +G GSFG V K + A+K + K K ++ E +E L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQAVN 99
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
LV+L ++ +V +Y+ G ++ HL + AR EYLH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY-- 662
+I+RD+K N+L+D Q +V+DFG + GT + PE
Sbjct: 160 LD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-----CGTPEALAPEIIL 211
Query: 663 ---YGLNVLTAKSDVYGLGVVLLELLTG 687
Y V D + LGV++ E+ G
Sbjct: 212 SKGYNKAV-----DWWALGVLIYEMAAG 234
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 37/216 (17%)
Query: 494 NNFSLENKIGAGSFGVVY---KGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLS 549
+ F L +G GSFG V+ K D +++ A+K + A K + E L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK--MERDILV 81
Query: 550 RLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIE 600
++H +V+L Y + + +L L+ D+++ G L+ L + + ++
Sbjct: 82 EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKAAGTVGY 657
+LH+ II+RD+K NILLD + +++DFGLS + + F GTV Y
Sbjct: 141 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-----CGTVEY 192
Query: 658 IDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGK 688
+ PE V+ + D + GV++ E+LTG
Sbjct: 193 MAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 51/273 (18%), Positives = 83/273 (30%), Gaps = 79/273 (28%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQ-----EVAIKRGETAKTK--------------- 532
+F +G G FGVV++ K D + + E A+ K
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 533 ----------------------------------KFQEKESAFDSELAFLSRLHHKHLVR 558
A ++ + K+ V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 559 LVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV---EKNAAR--------GIEYLHNYAV 607
+ K + + L D ++ R ++ E +E+LH+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAA---------GTVGY 657
++HRD+K SNI +V DFGL M + E GT Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRA 690
+ PE N + K D++ LG++L ELL
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 52/238 (21%), Positives = 95/238 (39%), Gaps = 68/238 (28%)
Query: 494 NNFSLENKIGAGSFGVVYKGK--LPDGQEVAIKRGETAKTKKFQEKESAFDS----ELAF 547
+ +IG G++G V+K + G+ VA+K + + +E E+A
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALK-----RVRVQTGEE-GMPLSTIREVAV 64
Query: 548 LSRLH---HKHLVRL----VGYCEEKDERL-LVYDYMKNGALYDH-----LHDRNNVEKN 594
L L H ++VRL +++ +L LV++++ D L
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVP 118
Query: 595 AA----------RGIEYLH-NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643
RG+++LH + ++HRD+K NIL+ + +++DFGL+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHR----VVHRDLKPQNILVTSSGQIKLADFGLA------- 167
Query: 644 RDF-RPMK---AAGTVGYIDPEY-----YGLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
R + M T+ Y PE Y V D++ +G + E+ K +F
Sbjct: 168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV-----DLWSVGCIFAEMFRRK-PLF 219
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 55/226 (24%)
Query: 494 NNFSLENKIGAGSFGVVY---KGKLPDGQEV-AIK----------RGETAKTKKFQEKES 539
F L +G G +G V+ K + ++ A+K +TA TK
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK------- 69
Query: 540 AFDSELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR- 597
+E L + H +V L+ Y + +L L+ +Y+ G L+ L ++ A
Sbjct: 70 ---AERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF 125
Query: 598 -------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFR 647
+ +LH II+RD+K NI+L+ Q +++DFGL + F
Sbjct: 126 YLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF- 181
Query: 648 PMKAAGTVGYIDPEYYGLNVLTAKS-----DVYGLGVVLLELLTGK 688
GT+ Y+ PE +L D + LG ++ ++LTG
Sbjct: 182 ----CGTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-18
Identities = 47/311 (15%), Positives = 89/311 (28%), Gaps = 84/311 (27%)
Query: 65 TIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSY----------NSNFVPKRIY 114
VE +SAG S + G + W + + VP ++
Sbjct: 103 VPGKVELQEKVVQVSAGDSHTAALTDDG-RVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQ 161
Query: 115 YNDTVLLSSVSVGNNHVCATTVQGQINCW---------RGD------------------- 146
+ V V+ GN+H+ T G + R
Sbjct: 162 LDVPV--VKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPK 219
Query: 147 -VNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINS-----ISNQIQTS----- 195
V + G ++F+ G F+ +++ V +G+++
Sbjct: 220 CVMLKSRGSRGHVRFQDAFCGAYFTF-AISHEGHVYGFGLSNYHQLGTPGTESCFIPQNL 278
Query: 196 ----FANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEY--------- 242
+ +S + G +H +DS G G + G+L +
Sbjct: 279 TSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPA 338
Query: 243 -SALSLGFNHSCAIRRLNGSVVCWGSQGEY----------------SVNGIRGKSFESIV 285
S+++ G + A+ + +G V WG Y + + S+
Sbjct: 339 VSSVACGASVGYAVTK-DGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVS 397
Query: 286 SGSNFTCGLTT 296
SG T L
Sbjct: 398 SGGQHTVLLVK 408
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 33/259 (12%), Positives = 68/259 (26%), Gaps = 81/259 (31%)
Query: 119 VLLSSVSVGNNHVCATTVQGQINCW---------RGDVNISKNAPSGELQFESLTSGIDF 169
+ S V +H +T G + G+ + + P+ +
Sbjct: 8 AIPKSKKVKVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPA---LVSIPEDVVQA 64
Query: 170 SCG-----ILTNNKTVRCWGINS------------ISNQIQTSFANRSMFSITAGGNHVC 212
G L+ + V +G N + ++AG +H
Sbjct: 65 EAGGMHTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTA 124
Query: 213 GIDSNGFVICYGD--NKSGQL-------------KFPLNSTAFEYSALSLGFNHSCAIRR 257
+ +G V +G + +G + + L+ ++ G +H +
Sbjct: 125 ALTDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPV---VKVASGNDHLVMLTA 181
Query: 258 LNGSVVCWGSQGEY-------------------------------SVNGIRGKSFESIVS 286
+G + G GE S F+
Sbjct: 182 -DGDLYTLGC-GEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFC 239
Query: 287 GSNFTCGLTTSNFSVICWG 305
G+ FT ++ V +G
Sbjct: 240 GAYFTFAISHEG-HVYGFG 257
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 35/199 (17%), Positives = 55/199 (27%), Gaps = 50/199 (25%)
Query: 151 KNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINS-----------ISNQIQTSFANR 199
+ +P + +S + T V G +
Sbjct: 1 RRSPPADAIPKSKKVKVSHRS-HSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPE 59
Query: 200 SMFSITAGGNHVCGIDSNGFVICYGDNKSGQL--------------KFPLNSTAFEYSAL 245
+ AGG H + +G V +G N G L K L +
Sbjct: 60 DVVQAEAGGMHTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKV---VQV 116
Query: 246 SLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIRG-----------------KSFESIVSGS 288
S G +H+ A+ +G V WGS NG+ G + SG+
Sbjct: 117 SAGDSHTAALTD-DGRVFLWGSF--RDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGN 173
Query: 289 NFTCGLTTSNFSVICWGPG 307
+ LT + G G
Sbjct: 174 DHLVMLTADG-DLYTLGCG 191
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 32/184 (17%), Positives = 61/184 (33%), Gaps = 43/184 (23%)
Query: 73 ISFSSISAGQSFFCGIRSGGYSLLCW-DTNF------SYNSNFVPKRI--YYNDTVLLSS 123
+ F G F I G + + +N+ S F+P+ + + N T
Sbjct: 232 VRFQDAFCGAYFTFAISHEG-HVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVG 290
Query: 124 VSVGNNHVCATTVQGQINCW---------RGDVNISKNAPSGELQFESLTSGIDFSCG-- 172
S G +H +G+ G+ K+ P+ L + +CG
Sbjct: 291 FSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPT---LISRLPAVSSVACGAS 347
Query: 173 ---ILTNNKTVRCWGINSISNQ---------------IQTSFANRSMFSITAGGNHVCGI 214
+T + V WG+ + + Q + NR + S+++GG H +
Sbjct: 348 VGYAVTKDGRVFAWGMGT-NYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLL 406
Query: 215 DSNG 218
+
Sbjct: 407 VKDK 410
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 50/222 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
+F L IG GS+ V +L + A+K + + EK
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT--EKH----- 61
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
F +H LV L C + + RL V +Y+ G L H+ + + + AR
Sbjct: 62 --VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 118
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
+ YLH II+RD+K N+LLD++ +++D+G+ + ++ F
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----- 170
Query: 652 AGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGK 688
GT YI PE YG +V D + LGV++ E++ G+
Sbjct: 171 CGTPNYIAPEILRGEDYGFSV-----DWWALGVLMFEMMAGR 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 60/222 (27%), Positives = 88/222 (39%), Gaps = 50/222 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
++F IG GSFG V + + A+K + E E+
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM--SERN----- 90
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
L + H LV L + + ++L V DY+ G L+ HL + AR
Sbjct: 91 --VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAE 147
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
+ YLH+ I++RD+K NILLD+Q ++DFGL + + F
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF----- 199
Query: 652 AGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGK 688
GT Y+ PE Y V D + LG VL E+L G
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTV-----DWWCLGAVLYEMLYGL 236
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 56/230 (24%), Positives = 93/230 (40%), Gaps = 50/230 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
+F+ +G GSFG V + E+ A+K + T EK
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM--VEKR----- 72
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
L +L C + +RL V +Y+ G L H+ ++ A
Sbjct: 73 --VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
G+ +L + II+RD+K N++LD++ +++DFG+ + + + F
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF----- 181
Query: 652 AGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
GT YI PE YG +V D + GV+L E+L G+ +DE
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSV-----DWWAFGVLLYEMLAGQAPFEGEDE 226
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 50/230 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
+F L +G GSFG V+ + + AIK + T EK
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM--VEKR----- 69
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
H L + + E L V +Y+ G L H+ + + + A
Sbjct: 70 --VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 126
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
G+++LH+ I++RD+K NILLD +++DFG+ M+G F
Sbjct: 127 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF----- 178
Query: 652 AGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
GT YI PE Y +V D + GV+L E+L G+ DE
Sbjct: 179 CGTPDYIAPEILLGQKYNHSV-----DWWSFGVLLYEMLIGQSPFHGQDE 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 49/231 (21%), Positives = 81/231 (35%), Gaps = 46/231 (19%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDS--------- 543
+ ++++ I +GS+G V G +G VAIKR T +
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKR--VFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 544 ELAFLSRLHHKHLVRLV-----GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA--- 595
E+ L+ HH +++ L + LV + M+ L +HD+ V
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQ 137
Query: 596 ------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
G+ LH V +HRD+ NILL + DF L+
Sbjct: 138 YFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLAREDTADA----NK 190
Query: 650 KAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
Y+ +Y T D++ G V+ E+ K A+F+
Sbjct: 191 T-----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFR 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F + +G GSFG V+ + A+K + + ++ E E LS +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN-DERLMLSIVT 64
Query: 553 HKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
H ++R+ + +++ ++ DY++ G L+ L A+ +EYLH
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY- 662
+ II+RD+K NILLD +++DFG + P+ GT YI PE
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL-----CGTPDYIAPEVV 175
Query: 663 ----YGLNVLTAKSDVYGLGVVLLELLTG 687
Y ++ D + G+++ E+L G
Sbjct: 176 STKPYNKSI-----DWWSFGILIYEMLAG 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 49/239 (20%), Positives = 83/239 (34%), Gaps = 60/239 (25%)
Query: 498 LENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKH 555
+G G G V + ++ A+K + K + E+ R H
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARR-------EVELHWRASQCPH 72
Query: 556 LVRLVGYCEEKDER----LLVYDYMKNGALYDHLHDRNNV---EKNAAR-------GIEY 601
+VR+V E L+V + + G L+ + DR + E+ A+ I+Y
Sbjct: 73 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 602 LHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
LH+ I HRD+K N+L +++DFG + E
Sbjct: 133 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA---KE----------------T 170
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
E Y + D++ LGV++ LL G F + + I G+
Sbjct: 171 TGEKYDKSC-----DMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKT----RIRMGQY 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 50/222 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
+F L IG GS+ V +L + A++ + + EK
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT--EKH----- 104
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
F +H LV L C + + RL V +Y+ G L H+ + + + AR
Sbjct: 105 --VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 161
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
+ YLH II+RD+K N+LLD++ +++D+G+ + ++ F
Sbjct: 162 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----- 213
Query: 652 AGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGK 688
GT YI PE YG +V D + LGV++ E++ G+
Sbjct: 214 CGTPNYIAPEILRGEDYGFSV-----DWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 50/222 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTKKFQEKESAFDS 543
+NF +G GSFG V ++ + ++ A+K + T EK
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM--TEKR----- 75
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR----- 597
+H L +L C + +RL V +++ G L H+ ++ AR
Sbjct: 76 --ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132
Query: 598 ---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGPESERDFRPMKA 651
+ +LH+ II+RD+K N+LLD + +++DFG+ + + F
Sbjct: 133 IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF----- 184
Query: 652 AGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGK 688
GT YI PE YG V D + +GV+L E+L G
Sbjct: 185 CGTPDYIAPEILQEMLYGPAV-----DWWAMGVLLYEMLCGH 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 7e-17
Identities = 69/421 (16%), Positives = 132/421 (31%), Gaps = 64/421 (15%)
Query: 310 NVSNDSVSLVPFQQEILPGPCDNSSCSECGLYPQSDRLCFGNGNICKSCQNVVPTPSAPP 369
+ + + + + + P + + ++ +
Sbjct: 157 TERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTI 216
Query: 370 PSVEPPRSSSSPSRELTRGLLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKVHNSVQPT 429
S P + + +L + + + + G S
Sbjct: 217 KSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDF-------MGSLSFGISELQK 269
Query: 430 ITRGGSRAGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAEL 489
G + G + P R + G +K + +++
Sbjct: 270 AGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKF 329
Query: 490 AAATN-------NFSLENKIGAGSFGVVYKGKLPDGQEV-AIK---------RGETAKTK 532
N +F+ +G GSFG V + E+ A+K + T
Sbjct: 330 DNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM 389
Query: 533 KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNV 591
EK L +L C + +RL V +Y+ G L H+
Sbjct: 390 --VEKR-------VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 439
Query: 592 EKNAAR--------GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS---MMGP 640
++ A G+ +L + II+RD+K N++LD++ +++DFG+ +
Sbjct: 440 KEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 641 ESERDFRPMKAAGTVGYIDPE-----YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
+ + F GT YI PE YG +V D + GV+L E+L G+ +D
Sbjct: 497 VTTKTF-----CGTPDYIAPEIIAYQPYGKSV-----DWWAFGVLLYEMLAGQAPFEGED 546
Query: 696 E 696
E
Sbjct: 547 E 547
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 9e-17
Identities = 51/259 (19%), Positives = 96/259 (37%), Gaps = 81/259 (31%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ +SL +G GSFG+V + + G+ A+K K Q+ EL + L
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK-------KVLQDPRYKN-RELDIMKVL 57
Query: 552 HHKHLVRL--VGYCEEKDERL------------------------------------LVY 573
H ++++L Y +E ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 574 DYMKNGALYDHLHDRNNVEKN------------AARGIEYLHNYAVPPIIHRDIKSSNIL 621
+Y+ + L+ L ++ R + ++H+ + HRDIK N+L
Sbjct: 118 EYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI---CHRDIKPQNLL 173
Query: 622 LDAQ-WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY-------GLNVLTAKSD 673
++++ T ++ DFG + + P + +V YI +Y G T D
Sbjct: 174 VNSKDNTLKLCDFGSA-------KKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSID 224
Query: 674 VYGLGVVLLELLTGKRAIF 692
++ +G V EL+ GK +F
Sbjct: 225 LWSIGCVFGELILGK-PLF 242
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 36/308 (11%), Positives = 76/308 (24%), Gaps = 81/308 (26%)
Query: 65 TIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYN---------SNFVPKRIYY 115
++ ISAG S + G + W + + + P +
Sbjct: 119 KPDLIDLPGKALCISAGDSHSACLLEDG-RVFAWGSFRDSHGNMGLTIDGNKRTPIDLME 177
Query: 116 NDTVLLSSVSVGNNHVCATTVQGQINCW---------RGDVNISKNAPSGELQFESLT-- 164
S++ G +H+ T G++ R S + + + L
Sbjct: 178 GTVC--CSIASGADHLVILTTAGKVFTVGCAEQGQLGRLS-ERSISGEGRRGKRDLLRPT 234
Query: 165 --------------SGIDFSCGILTNNKTVRCWGINS-----------ISNQIQTSFANR 199
+ + + + + G+N+ +
Sbjct: 235 QLIITRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELK 294
Query: 200 SMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYS-------------ALS 246
+ I G +H + ++ G + G+L L ++
Sbjct: 295 DIRHIAGGQHHTVILTTDLKCSVVGRPEYGRL--GLGDVKDVVEKPTIVKKLTEKIVSVG 352
Query: 247 LGFNHSCAIRRLNGSVVCWGSQGEY----------------SVNGIRGKSFESIVSGSNF 290
G S A+ +G + WGS +GK G
Sbjct: 353 CGEVCSYAVTI-DGKLYSWGSGVNNQLGVGDGDDELEPIVVVSKNTQGKHMLLASGGGQH 411
Query: 291 TCGLTTSN 298
L ++
Sbjct: 412 AIFLVKAD 419
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 33/247 (13%), Positives = 67/247 (27%), Gaps = 68/247 (27%)
Query: 122 SSVSVGNNHVCATTVQGQINCW---------RGDVNISKNAPSGELQFESLTSGIDFSCG 172
+ ++ TV G + G+ + + S + +D S G
Sbjct: 27 ARIAFHLELPKRRTVLGNVLVCGNGDVGQLGLGEDILERKRLS---PVAGIPDAVDISAG 83
Query: 173 -----ILTNNKTVRCWGINS------------ISNQIQTSFANRSMFSITAGGNHVCGID 215
+LT + + +G N ++ I+AG +H +
Sbjct: 84 GMHNLVLTKSGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLL 143
Query: 216 SNGFVICYGDNKSGQLKFPLNSTAFEYS-----------ALSLGFNHSCAIRRLNGSVVC 264
+G V +G + L + + +++ G +H + G V
Sbjct: 144 EDGRVFAWGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVILTT-AGKVFT 202
Query: 265 WGSQGEY--------------------------SVNGIRGKSFESIVSGSNFTCGLTTSN 298
G E + R K FE+I + + T +
Sbjct: 203 VGC-AEQGQLGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNYCTFMRESQT 261
Query: 299 FSVICWG 305
+ G
Sbjct: 262 QVIWATG 268
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-13
Identities = 34/183 (18%), Positives = 55/183 (30%), Gaps = 41/183 (22%)
Query: 162 SLTSGIDFSCGILTNNKTVRCWGINS-----------ISNQIQTSFANRSMFSITAGGNH 210
+ ++ T V G ++ I+AGG H
Sbjct: 28 RIAFHLELPK-RRTVLGNVLVCGNGDVGQLGLGEDILERKRLSPVAGIPDAVDISAGGMH 86
Query: 211 VCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYS-----------ALSLGFNHSCAIRRLN 259
+ +G + +G N G L + E +S G +HS + +
Sbjct: 87 NLVLTKSGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLLE-D 145
Query: 260 GSVVCWGSQGEYS---------------VNGIRGKSFESIVSGSNFTCGLTTSNFSVICW 304
G V WGS S ++ + G SI SG++ LTT+ V
Sbjct: 146 GRVFAWGS-FRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVILTTAG-KVFTV 203
Query: 305 GPG 307
G
Sbjct: 204 GCA 206
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 23/152 (15%), Positives = 42/152 (27%), Gaps = 32/152 (21%)
Query: 184 GINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQL------------ 231
N+ + + + I G V+ G+ GQL
Sbjct: 9 TNNNNAGEAEQQPPKAKRARIAFHLELPKRRTVLGNVLVCGNGDVGQLGLGEDILERKRL 68
Query: 232 -KFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWG--SQG----EYSVNGIR------- 277
A +S G H+ + + +G + +G +G + S +G
Sbjct: 69 SPVAGIPDA---VDISAGGMHNLVLTK-SGDIYSFGCNDEGALGRDTSEDGSESKPDLID 124
Query: 278 -GKSFESIVSGSNFTCGLTTSNFSVICWGPGW 308
I +G + + L V WG
Sbjct: 125 LPGKALCISAGDSHSACLLEDG-RVFAWGSFR 155
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 66/252 (26%), Positives = 104/252 (41%), Gaps = 50/252 (19%)
Query: 494 NNFSLENKIGAGSFGVVY---KGKLPDGQEV-AIKRGETAKTKKFQEKESAFDSELA--- 546
NF L +G G++G V+ K D ++ A+K K +K +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK---VLKKATIVQKAKTTEHTRTERQ 110
Query: 547 -FLSRLHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVEKNAAR------- 597
LV L Y + + +L L+ DY+ G L+ HL R ++ +
Sbjct: 111 VLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 169
Query: 598 -GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESER--DFRPMKAA 652
+E+LH II+RDIK NILLD+ ++DFGLS + E+ER DF
Sbjct: 170 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-----C 221
Query: 653 GTVGYIDPEYYGLNVLTAKSDVYG-------LGVVLLELLTGKRAIFKDDESGGTPVSLV 705
GT+ Y+ P+ ++ + LGV++ ELLTG + F D + +
Sbjct: 222 GTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTG-ASPFTVDGEKNSQAEIS 275
Query: 706 DFAVPAIMAGEL 717
I+ E
Sbjct: 276 R----RILKSEP 283
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 60/238 (25%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS-------- 543
+++F L++ +G G++GVV P G+ VAIK K FD
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------------KIEPFDKPLFALRTL 57
Query: 544 -ELAFLSRLHHKHLVRLV-----GYCEEKDERLLVYDYMKNGALYDHLHD--RNNVEKNA 595
E+ L H++++ + E +E ++ + M+ D LH + +
Sbjct: 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TD-LHRVISTQMLSDD 112
Query: 596 ---------ARGIEYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESE 643
R ++ LH N +IHRD+K SN+L+++ +V DFGL+ ++ +
Sbjct: 113 HIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 644 RDFRPMKAAGTV-GYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
+ P + ++ +Y + DV+ G +L EL + IF
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFP 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 30/282 (10%), Positives = 78/282 (27%), Gaps = 63/282 (22%)
Query: 498 LENKIGAGSFGVVYKGKLPD---GQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRLH 552
L G ++ D ++VA+ + + S LSR+
Sbjct: 35 LLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQ---ETLSRTLRLSRID 89
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA------ARGIEYLHNYA 606
+ R++ + L+V ++++ G+L + + A + H
Sbjct: 90 KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRA- 148
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN 666
+ S + + ++ M + +
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPA--TMPDANPQ---------------------- 182
Query: 667 VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726
D+ G+G L LL + + + + ++ + +
Sbjct: 183 -----DDIRGIGASLYALLVNRWPL--PEAGVRSGLAPA------------ERDTAGQPI 223
Query: 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
P + + ++ A V +G R ++ +++A
Sbjct: 224 EPADIDRDIPFQISAVAARSVQGDGGIRSAST-LLNLMQQAT 264
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 39/232 (16%), Positives = 88/232 (37%), Gaps = 45/232 (19%)
Query: 494 NNFSLENKIGAGSFGVVYKGK---------LPDGQEVAIKRGETAKTKKFQE----KESA 540
+ L++ + G++Y+ P Q+ ++K + + F E + +A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-DAKDGRLFNEQNFFQRAA 100
Query: 541 FDSELAFLSRLHHKHLV---RLVGY-CEEKDERLLVYDYMKNGALYDHLHDRNN------ 590
++ +L+ L+ +G+ + R LV + G D +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSE 158
Query: 591 --VEKNAAR---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSM--MGPE 641
V + A R +E+LH +H ++ + NI +D + ++V + +G +
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 642 SERDFRPMKAAGTVGYIDPEYYGLNV-----LTAKSDVYGLGVVLLELLTGK 688
+ + G D E+ +++ + +SD+ LG +L+ L G
Sbjct: 216 KHVAYVEGSRSPHEG--DLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-16
Identities = 39/312 (12%), Positives = 85/312 (27%), Gaps = 84/312 (26%)
Query: 62 QGGTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCW-----------DTNFSYNSNFVP 110
+ + ++A + C + S G + W P
Sbjct: 137 PRESFPPLAEGHKVVQLAATDNMSCALFSNG-EVYAWGTFRCNEGILGFYQDKIKIQKTP 195
Query: 111 KRIYYNDTVLLSSVSVGNNHVCATTVQGQINCW---------RGDVNISKNAPSGELQFE 161
++ + ++ G +H+ +G + W R + + + +
Sbjct: 196 WKVPTFSKYNIVQLAPGKDHILFLDEEGMVFAWGNGQQNQLGRKVME-RFRLKTLDPRPF 254
Query: 162 SLTSGIDFSCG-----ILTNNKTVRCWGINS-----ISNQIQ-----------TSFANRS 200
L + G LT + + WG+N +S ++ N
Sbjct: 255 GLRHVKYIASGENHCFALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVV 314
Query: 201 MFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEY------------------ 242
+ SI AG +H + +G + G ++ P ++
Sbjct: 315 IRSIAAGEHHSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLN 374
Query: 243 -----SALSLGFNHSCAIRRLNGSVVCWGSQGEY-----------------SVNGIRGKS 280
+++ G +HS A+ + NG WG Y + +
Sbjct: 375 NVPKFKSVAAGSHHSVAVAQ-NGIAYSWGFGETYAVGLGPFEDDTEVPTRIKNTATQDHN 433
Query: 281 FESIVSGSNFTC 292
+ G F+
Sbjct: 434 IILVGCGGQFSV 445
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 46/330 (13%), Positives = 87/330 (26%), Gaps = 106/330 (32%)
Query: 77 SISAGQSFFCGIRSGGYSLLCW----------DTNFSYNSNFVPKRIYY--NDTVLLSSV 124
+ + CW P+ + D + S
Sbjct: 14 NAQEDYKHMYLSVQPL-DIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISF 72
Query: 125 SVGNNHVCATTVQGQINCW-------------------------------RGDVNISKNA 153
+VG H A + + W GD+N ++
Sbjct: 73 AVGGMHTLALDEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELEST 132
Query: 154 PS--GELQFESLTSGIDF---SCG-----ILTNNKTVRCWGINSISNQIQ---------- 193
P+ F L G + L +N V WG N+
Sbjct: 133 PAKIPRESFPPLAEGHKVVQLAATDNMSCALFSNGEVYAWGTFR-CNEGILGFYQDKIKI 191
Query: 194 -------TSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQL---------KFPLNS 237
+F+ ++ + G +H+ +D G V +G+ + QL L+
Sbjct: 192 QKTPWKVPTFSKYNIVQLAPGKDHILFLDEEGMVFAWGNGQQNQLGRKVMERFRLKTLDP 251
Query: 238 TAFEYS---ALSLGFNHSCAIRRLNGSVVCWGSQGEY-------------------SVNG 275
F ++ G NH A+ + + +V WG ++ +
Sbjct: 252 RPFGLRHVKYIASGENHCFALTK-DNKLVSWGL-NQFGQCGVSEDVEDGALVTKPKRLAL 309
Query: 276 IRGKSFESIVSGSNFTCGLTTSNFSVICWG 305
SI +G + + L+ + G
Sbjct: 310 PDNVVIRSIAAGEHHSLILSQDG-DLYSCG 338
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 36/225 (16%), Positives = 66/225 (29%), Gaps = 49/225 (21%)
Query: 77 SISAGQSFFCGIRSGGYSLLCW-----------DTNFSYNSNFVPKRIYYNDTVLLSSVS 125
I++G++ + L+ W + PKR+ D V++ S++
Sbjct: 261 YIASGENHCFALTKDN-KLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVVIRSIA 319
Query: 126 VGNNHVCATTVQGQINCW-RGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWG 184
G +H + G + R D E+ GI K V G
Sbjct: 320 AGEHHSLILSQDGDLYSCGRLD--------MFEV-------GIPKDNLPEYTYKDVH--G 362
Query: 185 INSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQL---------KFP- 234
S+ AG +H + NG +G ++ + + P
Sbjct: 363 KARAVPLPTKLNNVPKFKSVAAGSHHSVAVAQNGIAYSWGFGETYAVGLGPFEDDTEVPT 422
Query: 235 -LNSTAFEYS---ALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNG 275
+ +TA + + G S + G V E +
Sbjct: 423 RIKNTATQDHNIILVGCGGQFSVS-----GGVKLSDEDAEKRADE 462
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 46/225 (20%), Positives = 87/225 (38%), Gaps = 48/225 (21%)
Query: 437 AGSNGGAGSNNSPPSRSATIRRQGSRLLTMRRQRSGTSSKHADRAEEFLLAELAAATNNF 496
+ A ++ ++ Q + S ++ ++ + + +
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD------RY 55
Query: 497 SLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS-----ELAFLSR 550
+ + IG GS+G V + + + VAIK K + E D E+A L+R
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIK-------KILRVFEDLIDCKRILREIAILNR 108
Query: 551 LHHKHLVRLV-----GYCEEKDERLLVYDYMKNGALYDHLHD--RNNVEKNAA------- 596
L+H H+V+++ E+ DE +V + D R V
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SD-FKKLFRTPVYLTELHIKTLLY 163
Query: 597 ---RGIEYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636
G++Y+H I+HRD+K +N L++ + +V DFGL+
Sbjct: 164 NLLVGVKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 65/237 (27%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS-------- 543
++ + IG G++G+V + VAIK K S F+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------------KISPFEHQTYCQRTL 73
Query: 544 -ELAFLSRLHHKHLVRLV-----GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA- 596
E+ L R H++++ + E+ + +V D M+ D + K
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--------DLYKLLKTQHL 125
Query: 597 -------------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643
RG++Y+H+ V +HRD+K SN+LL+ ++ DFGL+ +
Sbjct: 126 SNDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 644 RDFRPMKAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
+ Y+ +Y T D++ +G +L E+L+ + IF
Sbjct: 183 DHTGFLT-----EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFP 233
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 49/230 (21%), Positives = 93/230 (40%), Gaps = 56/230 (24%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLS 549
+ +G+G++G V G++VAIK+ ++ FQ + A + EL L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKK----LSRPFQSEIFAKRAYRELLLLK 78
Query: 550 RLHHKHLVRLV------GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA------- 596
+ H++++ L+ + LV +M+ D +
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--------TDLQKIMGLKFSEEKIQY 130
Query: 597 ------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650
+G++Y+H+ V +HRD+K N+ ++ ++ DFGL+ R
Sbjct: 131 LVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLA----------RHAD 177
Query: 651 AAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
A T GY+ +Y D++ +G ++ E+LTGK +FK
Sbjct: 178 AEMT-GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFK 225
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 43/226 (19%), Positives = 90/226 (39%), Gaps = 45/226 (19%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+++ L K+G G + V++ + + ++V +K K ++K+ E+ L L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVK-----ILKPVKKKKIK--REIKILENL 87
Query: 552 -HHKHLVRL---VGYCEEKDERLLVYDYMKN--GALYDHLHDRNNVE---KNAARGIEYL 602
+++ L V + L+ LY L D ++ + ++Y
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD-YDIRFYMYEILKALDYC 146
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTA-RVSDFGLSMMGPESERDFRPMKA----AGTVGY 657
H+ I+HRD+K N+++D + R+ D+GL+ + P + + +
Sbjct: 147 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLA-------EFYHPGQEYNVRVASRYF 196
Query: 658 IDPE------YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK-DDE 696
PE Y ++ D++ LG +L ++ K F D
Sbjct: 197 KGPELLVDYQMYDYSL-----DMWSLGCMLASMIFRKEPFFHGHDN 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 4e-15
Identities = 35/162 (21%), Positives = 61/162 (37%), Gaps = 6/162 (3%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKK---FQEKESAFDSELAFLSR 550
+ L +G G+FG V + + A R K K + A SEL L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 551 L-HHKHLVRLVGYC-EEKDERLLVYDYMKNGALYDHLHD-RNNVEKNAARGIEYLHNYAV 607
+ HH ++V L+G C + +++ ++ K G L +L RN +G +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
I D+K + + ++ S F + E + P
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 29/177 (16%)
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
A+G+E+L A IHRD+ + NILL + ++ DFGL+ + R A +
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
++ PE V T +SDV+ GV+L E+ + G +P P +
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----------LGASP-------YPGVKID 302
Query: 716 -ELVKILDR--RVGPPEINEAEAVELVAYTAM-HCVNLEGKERPTMADIVANLERAL 768
E + L R+ P+ E Y M C + E +RPT +++V +L L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPE-----MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 36/160 (22%), Positives = 64/160 (40%), Gaps = 28/160 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++ + +IG GSFGV+++G L + Q+VAIK E ++ E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA-----PQLRDEYRTYKLLA 63
Query: 553 H-KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN----------VEKNAARGIEY 601
+ + + +E +LV D + G + L D K ++
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTAR-----VSDFGLS 636
+H + +++RDIK N L+ + V DFG+
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 57/231 (24%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLS 549
+ + +G+G++G V G VA+K+ FQ A + EL L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP----FQSIIHAKRTYRELRLLK 83
Query: 550 RLHHKHLVRLV------GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA------- 596
+ H++++ L+ EE ++ LV M D NN+ K
Sbjct: 84 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG--------ADLNNIVKCQKLTDDHVQ 135
Query: 597 -------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
RG++Y+H+ + IHRD+K SN+ ++ ++ DFGL+ R
Sbjct: 136 FLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLA----------RHT 182
Query: 650 KAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
T GY+ +Y D++ +G ++ ELLTG+ +F
Sbjct: 183 ADEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFP 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 43/158 (27%), Positives = 65/158 (41%), Gaps = 26/158 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
N + L KIG+GSFG +Y G + G+EVAIK E KTK Q E +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQ-----LHIESKIYKMMQ 62
Query: 553 H-KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE----------KNAARGIEY 601
+ + E D ++V + + G + L + + + IEY
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 120
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTA---RVSDFGLS 636
+H+ IHRD+K N L+ + DFGL+
Sbjct: 121 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 28/160 (17%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
NF + KIG G+FG + GK L + VAIK E K++ Q E F +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL-EPMKSRAPQLHL-----EYRFYKQLG 62
Query: 553 H-KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN----------VEKNAARGIEY 601
+ ++ + +V + + G + L D + + +EY
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVS-----DFGLS 636
+H+ +I+RD+K N L+ DF L+
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 49/231 (21%), Positives = 93/231 (40%), Gaps = 57/231 (24%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLS 549
+ +G+G++G V G +VAIK+ + FQ + A + EL L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKK----LYRPFQSELFAKRAYRELRLLK 79
Query: 550 RLHHKHLVRLV------GYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAA------- 596
+ H++++ L+ ++ + LV +M D + K+
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG--------TDLGKLMKHEKLGEDRIQ 131
Query: 597 -------RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
+G+ Y+H + IHRD+K N+ ++ ++ DFGL+ R
Sbjct: 132 FLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLA----------RQA 178
Query: 650 KAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
+ T GY+ +Y T D++ +G ++ E++TGK +FK
Sbjct: 179 DSEMT-GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFK 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 46/236 (19%), Positives = 85/236 (36%), Gaps = 53/236 (22%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + IG G FG +Y + + V K + +EL F R
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEP--SDNGPLFTELKFYQRAAK 92
Query: 554 KHLV---------------RLVGY----CEEKDERLLVYDYMKNGALYDHLHDRNN---- 590
+ + G K R ++ D G+ +++ N
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFS 150
Query: 591 ---VEKNAAR---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSMM---- 638
V + + R +EY+H + +H DIK+SN+LL+ + +V D+GL+
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207
Query: 639 GPESERDFRPMKA-AGTVGYIDPEYYGLNV-----LTAKSDVYGLGVVLLELLTGK 688
G P + GT+ E+ ++ + + D+ LG +++ LTG
Sbjct: 208 GVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 51/228 (22%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLS 549
+ IG+G+ G+V + VAIK+ FQ + A + EL +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP----FQNQTHAKRAYRELVLMK 79
Query: 550 RLHHKHLVRLV------GYCEEKDERLLVYDYMKNGALYDHLHD--RNNVEKNAA----- 596
++HK+++ L+ EE + +V + M + L + ++
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA----N-LCQVIQMELDHERMSYLLY 134
Query: 597 ---RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE--------RD 645
GI++LH+ + IHRD+K SNI++ + T ++ DFGL+ S R
Sbjct: 135 QMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
+R PE D++ +G ++ E++ G +F
Sbjct: 192 YRA-----------PEVILGMGYKENVDIWSVGCIMGEMIKGG-VLFP 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 3e-14
Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 51/228 (22%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLS 549
+ IG+G+ G+V + VAIK+ ++ FQ + A + EL +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK----LSRPFQNQTHAKRAYRELVLMK 116
Query: 550 RLHHKHLVRLV------GYCEEKDERLLVYDYMKNGALYDHLHD--RNNVEKNAA----- 596
++HK+++ L+ EE + LV + M + L + ++
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQVIQMELDHERMSYLLY 171
Query: 597 ---RGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE--------RD 645
GI++LH+ + IHRD+K SNI++ + T ++ DFGL+ S R
Sbjct: 172 QMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFK 693
+R PE D++ +G ++ E++ K +F
Sbjct: 229 YRA-----------PEVILGMGYKENVDIWSVGCIMGEMVRHK-ILFP 264
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 48/250 (19%), Positives = 89/250 (35%), Gaps = 82/250 (32%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS-------- 543
+ + +G G G+V+ + VAIK+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK-------------IVLTDPQSVKHAL 56
Query: 544 -ELAFLSRLHHKHLVRL--------------VGYCEEKDERLLVYDYM--------KNGA 580
E+ + RL H ++V++ VG E + +V +YM + G
Sbjct: 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116
Query: 581 L---------YDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARV 630
L Y L RG++Y+H+ V +HRD+K +N+ ++ + ++
Sbjct: 117 LLEEHARLFMYQLL-----------RGLKYIHSANV---LHRDLKPANLFINTEDLVLKI 162
Query: 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLE 683
DFGL+ + + + ++Y N T D++ G + E
Sbjct: 163 GDFGLARIMDPHYSHKGHLS-----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 217
Query: 684 LLTGKRAIFK 693
+LTGK +F
Sbjct: 218 MLTGK-TLFA 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 42/199 (21%), Positives = 71/199 (35%), Gaps = 36/199 (18%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS--ELAFLS 549
+N+ +++ IG GS+G VY + VAIK+ F++ E+ L+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM----FEDLIDCKRILREITILN 80
Query: 550 RLHHKHLVRLV-----GYCEEKDERLLVYDYMKNGALYDHLHD--RNNVEKNAA------ 596
RL +++RL + DE +V + D L + +
Sbjct: 81 RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLTEEHIKTIL 135
Query: 597 ----RGIEYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMK 650
G ++H IIHRD+K +N LL+ + +V DFGL+ +
Sbjct: 136 YNLLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 651 AAGTVGYIDPEYYGLNVLT 669
LT
Sbjct: 191 LEENEEPGPHNKNLKKQLT 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 66/247 (26%), Positives = 104/247 (42%), Gaps = 68/247 (27%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDS-------- 543
+ L K+G G++G+V+K G+ VA+K K F AF +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK-------KIFD----AFQNSTDAQRTF 56
Query: 544 -ELAFLSRLH-HKHLVRL--VGYCEEKDERLLVYDYMKNGALYDHLHD--RNNVEKNA-- 595
E+ L+ L H+++V L V + + LV+DYM+ D LH R N+ +
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME----TD-LHAVIRANILEPVHK 111
Query: 596 -------ARGIEYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646
+ I+YLH ++HRD+K SNILL+A+ +V+DFGLS R
Sbjct: 112 QYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 647 RPMKAAGTVGYIDPE-------------YY-------GLNVLTAKSDVYGLGVVLLELLT 686
+ + + + +Y G T D++ LG +L E+L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 687 GKRAIFK 693
GK IF
Sbjct: 227 GK-PIFP 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 55/236 (23%), Positives = 90/236 (38%), Gaps = 56/236 (23%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
N + L KIG+G FG++Y ++ A + + SEL F R+
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP-----LFSELKFYQRVA 91
Query: 553 HKHLV---------------RLVGY----CEEKDERLLVYDYMKNGALYDHLHDRNN--- 590
K + G + + R +V + + G + +N
Sbjct: 92 KKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFK 149
Query: 591 ---VEKNAAR---GIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSMM---- 638
V + R +EY+H +H DIK++N+LL + +V +D+GLS
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 639 GPESERDFRPMKA-AGTVGYIDPEYYGLNV-----LTAKSDVYGLGVVLLELLTGK 688
G + P K GT+ E+ L+ L+ +SDV LG +L L GK
Sbjct: 207 GNHKQYQENPRKGHNGTI-----EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 58/220 (26%), Positives = 88/220 (40%), Gaps = 41/220 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
N F L KIG+GSFG +Y G + +EVAIK E KTK Q E L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQ-----LLYESKIYRILQ 60
Query: 553 -HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN----------VEKNAARGIEY 601
+ + + E D +LV D + G + L + + + +E+
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTAR---VSDFGLSM--MGPESER--DFRPMKA-AG 653
+H+ + +HRDIK N L+ A + DFGL+ + + +R K G
Sbjct: 119 VHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 654 TVGYIDPEYYGLNV-----LTAKSDVYGLGVVLLELLTGK 688
T Y +N + + D+ LG VL+ L G
Sbjct: 176 T-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 3e-10
Identities = 30/195 (15%), Positives = 49/195 (25%), Gaps = 53/195 (27%)
Query: 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIK----RGETAKTKKFQEKESAFDSELAF 547
T KIG G FG V++ D VAIK G Q+ E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 548 LSRLH---------HKHLVRLVG------------------YCEEK------------DE 568
L + + L Y K D+
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 569 RLLVYDYMKNGALYDHLHDRNNVEKNA-------ARGIEYLHNYAVPPIIHRDIKSSNIL 621
+V ++ G + + + + A + HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVL 194
Query: 622 LDAQWTARVSDFGLS 636
L ++
Sbjct: 195 LKKTSLKKLHYTLNG 209
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 46/230 (20%), Positives = 88/230 (38%), Gaps = 65/230 (28%)
Query: 501 KIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRLH----- 552
K+G G F V+ K + + VA+K RG+ K + E A + E+ L R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTE---AAEDEIKLLQRVNDADNT 78
Query: 553 ------HKHLVRLVGYCEEKDERL----LVYDYM-KNGALYDHLHDRNNVE------KNA 595
H+++L+ + K +V++ + +N L + + K
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKKYEHRGIPLIYVKQI 136
Query: 596 AR----GIEYLHNYAVPPIIHRDIKSSNILLD------AQWTARVSDFGLSMMGPESERD 645
++ G++Y+H IIH DIK N+L++ +++D G + E +
Sbjct: 137 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 194
Query: 646 FRPMKAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGK 688
I Y G +D++ ++ EL+TG
Sbjct: 195 -----------SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 53/220 (24%), Positives = 84/220 (38%), Gaps = 54/220 (24%)
Query: 502 IGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLSRLHHK---- 554
IG GSFG V K Q VA+K R K+F E+ L L +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHR---QAAEEIRILEHLRKQDKDN 157
Query: 555 --HLVRLVGYCEEKDERLLVYDYM-KNGALYDHLHDRNNV----------EKNAARGIEY 601
+++ ++ ++ + ++ + N LY+ + + + ++
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMN--LYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTA--RVSDFGLSMMGPESERDFRPMKAAGTVGYID 659
LH IIH D+K NILL Q + +V DFG S E +R + YI
Sbjct: 216 LHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYT---------YIQ 261
Query: 660 PEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
+Y G D++ LG +L ELLTG +
Sbjct: 262 SRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGY-PLL 299
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 48/227 (21%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLS 549
+ + +++ IG GSFG V K + + VAIK + K F E+ L
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLN---QAQIEVRLLE 105
Query: 550 RL------HHKHLVRLVGYCEEKDERLLV--------YDYMK-NGALYDHLHDRNNVEKN 594
+ ++V L + ++ LV YD ++ L+ +
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 595 AARGIEYLHNYAVPPIIHRDIKSSNILL--DAQWTARVSDFGLSMMGPESERDFRPMKAA 652
+ +L + IIH D+K NILL + ++ DFG S +R ++
Sbjct: 166 MCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQ----- 217
Query: 653 GTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692
YI +Y G+ D++ LG +L+E+ TG+ +F
Sbjct: 218 ----YIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE-PLF 258
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 50/244 (20%), Positives = 87/244 (35%), Gaps = 62/244 (25%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLS 549
N F + K+G G+FG V + + + + A+K R KK+ + E L
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTR---SAKIEADILK 86
Query: 550 RL-----HHKHLVRLVGYCEEKD------ERLL--VYDYMK-NGALYDHLHDRNNVEKNA 595
++ ++ ++V+ G D E L +Y+ + N H+ D
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 596 ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTV 655
+ + YL + + H D+K NILLD + + + + + +R +
Sbjct: 147 LKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 656 GYID----------------------PEYYGLNVL-----TAKSDVYGLGVVLLELLTGK 688
ID PE V+ SD++ G VL EL TG
Sbjct: 204 --IDFGCATFKSDYHGSIINTRQYRAPE-----VILNLGWDVSSDMWSFGCVLAELYTGS 256
Query: 689 RAIF 692
+F
Sbjct: 257 -LLF 259
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 2e-04
Identities = 34/201 (16%), Positives = 66/201 (32%), Gaps = 46/201 (22%)
Query: 451 SRSATIRRQGSRLLTM---RRQRSGTSSK-----HADRAEEFLLAELAAATNNFSLENKI 502
S T +RQ S + M +R R ++ + R + +L +L A +
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL--KLRQALLELRPAKNV 153
Query: 503 GA-GSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVG 561
G G GK VA+ + + K Q K D ++ +L+ +
Sbjct: 154 LIDGVLGS---GK----TWVAL---DVCLSYKVQCK---MDFKIFWLN----------LK 190
Query: 562 YCEEKDERL-----LVYDYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIK 616
C + L L+Y N + ++ + L + + +
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ--AELRRL----LKSKPYE 244
Query: 617 SSNILLDAQWTARVSD-FGLS 636
+ ++L A+ + F LS
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLS 265
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 74/533 (13%), Positives = 136/533 (25%), Gaps = 204/533 (38%)
Query: 343 QSDRLCFGNGNICKSCQNVVPTPSAPPPSVEPPRSSSSPSRELTRGLL-----AFAIVGS 397
Q DRL N N +V R P +L + LL ++
Sbjct: 115 QRDRLY--NDN-----------QVFAKYNV--SRLQ--PYLKLRQALLELRPAKNVLIDG 157
Query: 398 VGGF------AGIC---TV-------IYCVWTGACFGKKKVHNSVQPTITRGGSRAGSNG 441
V G +C V I+ W +V + + + N
Sbjct: 158 VLGSGKTWVALDVCLSYKVQCKMDFKIF--WLN--LKNCNSPETVLEMLQKLLYQIDPNW 213
Query: 442 GAGSNNS--PPSRSATIRRQGSRLLTMR-------------------------------R 468
+ S++S R +I+ + RLL + R
Sbjct: 214 TSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTR 273
Query: 469 QRS------GTSSKH-----------ADRAEEFL----------LAELAAATNNFSLENK 501
+ ++ H D + L L TN L +
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL-SI 332
Query: 502 IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH------ 555
I + DG + + K + + +S L L ++
Sbjct: 333 IAE---------SIRDG----LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS 379
Query: 556 ------------LVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGIEYLH 603
L + + D ++V + LH + VEK +
Sbjct: 380 VFPPSAHIPTILLSLIWFDVIKSDVMVVV----------NKLHKYSLVEKQPKESTISIP 429
Query: 604 NYAVPPIIHRDIKSS--------NILLDAQWTARVSD----------------FGLSMMG 639
+ I+ ++K ++D + D G +
Sbjct: 430 S------IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 640 PE-SERD--FRPMKAAGTVGYIDPEYYGLNVLTAK--------SDVYGLGVVLLELLTGK 688
E ER FR + ++D L K + + L +L K
Sbjct: 484 IEHPERMTLFRMV-------FLD-----FRFLEQKIRHDSTAWNASGSILNTLQQLKFYK 531
Query: 689 RAIFKDDESGGTPV-SLVDF---AVPAIMAGELVKILDRRVGPPE---INEAE 734
I +D V +++DF ++ + +L + + EA
Sbjct: 532 PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAH 584
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 44/245 (17%), Positives = 77/245 (31%), Gaps = 68/245 (27%)
Query: 493 TNNFSLENKIGAGSFGVVYKG--KLPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFL 548
+ + +G G+FG V + +VA+K R K++E A E+ L
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYRE---AARLEINVL 70
Query: 549 SRLHHK------HLVRLVGYCEEKD------ERLL--VYDYMK-NGALYDHLHDRNNVEK 593
++ K V + + E L ++++K N L ++
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 594 NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA-------------------RVSDFG 634
+ +LH + H D+K NIL RV+DFG
Sbjct: 131 QLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 635 LSMMGPESERDFRPMKAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLLELLTG 687
+ + E + +Y L DV+ +G +L E G
Sbjct: 188 SATF--DHEHHTT---------IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRG 235
Query: 688 KRAIF 692
+F
Sbjct: 236 F-TLF 239
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 48/250 (19%), Positives = 85/250 (34%), Gaps = 78/250 (31%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK--LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFL 548
+ + + + +G G+FG V + G+ VA+K + ++ E A SE+ L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCE---AARSEIQVL 65
Query: 549 SRLHHK------HLVRLVGY----------CEEKDERLL---VYDYMK-NGALYDHLHDR 588
L+ V+++ + E LL YD++K NG L L
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFRLDHI 120
Query: 589 NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTA-------------------R 629
+ + + +LH+ + H D+K NIL +
Sbjct: 121 RKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIK 177
Query: 630 VSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY-------GLNVLTAKSDVYGLGVVLL 682
V DFG + + E + +Y L DV+ +G +L+
Sbjct: 178 VVDFGSATY--DDEHHST---------LVSTRHYRAPEVILALGWSQP-CDVWSIGCILI 225
Query: 683 ELLTGKRAIF 692
E G +F
Sbjct: 226 EYYLGF-TVF 234
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 789 | |||
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3qhy_B | 282 | Beta-lactamase inhibitory protein II; enyzme-inhib | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3mvd_K | 423 | Regulator of chromosome condensation; protein-DNA | 100.0 | |
| 1a12_A | 413 | RCC1, regulator of chromosome condensation 1; guan | 100.0 | |
| 3kci_A | 389 | Probable E3 ubiquitin-protein ligase HERC2; WD40, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3of7_A | 473 | Regulator of chromosome condensation; beta-propell | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4d9s_A | 406 | UVB-resistance protein UVR8; UV resistance, UV-B p | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.61 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.79 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.68 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.31 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.19 | |
| 1p22_A | 435 | F-BOX/WD-repeat protein 1A; ubiquitination, degrad | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.03 | |
| 2ovr_B | 445 | FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.89 | |
| 4fao_E | 124 | Activin receptor type-2B; TGF-beta, CTK, cystine k | 96.61 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.38 | |
| 1gxr_A | 337 | ESG1, transducin-like enhancer protein 1; transcri | 96.34 | |
| 1p22_A | 435 | F-BOX/WD-repeat protein 1A; ubiquitination, degrad | 96.31 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.25 | |
| 2ovr_B | 445 | FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 | 96.25 | |
| 3odt_A | 313 | Protein DOA1; ubiquitin, nuclear protein; HET: MSE | 95.94 | |
| 3vgz_A | 353 | Uncharacterized protein YNCE; beta-propeller, prot | 95.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.69 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 94.92 | |
| 4gbf_A | 400 | Phikz131; 7-bladed beta-propeller, possibly partic | 94.91 | |
| 4aez_A | 401 | CDC20, WD repeat-containing protein SLP1; cell cyc | 94.8 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.76 | |
| 1yfq_A | 342 | Cell cycle arrest protein BUB3; WD repeat WD40 rep | 94.68 | |
| 1bte_A | 97 | Protein (activin receptor type II); serine kinase, | 94.33 | |
| 3v7d_B | 464 | Cell division control protein 4; WD 40 domain, pho | 93.97 | |
| 3odt_A | 313 | Protein DOA1; ubiquitin, nuclear protein; HET: MSE | 93.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.63 | |
| 2hlr_A | 100 | Bone morphogenetic protein receptor type-2; three- | 93.44 | |
| 3v7d_B | 464 | Cell division control protein 4; WD 40 domain, pho | 93.44 | |
| 1k3i_A | 656 | Galactose oxidase precursor; blade beta propeller, | 93.29 | |
| 1pgu_A | 615 | Actin interacting protein 1; WD repeat, seven-blad | 93.0 | |
| 2zwa_A | 695 | Leucine carboxyl methyltransferase 2; HET: SAH CIT | 92.66 | |
| 2zwa_A | 695 | Leucine carboxyl methyltransferase 2; HET: SAH CIT | 91.99 | |
| 3sfz_A | 1249 | APAF-1, apoptotic peptidase activating factor 1; a | 91.6 | |
| 2h62_D | 98 | ACVR2B protein; TGF-beta superfamily, ligand-recep | 91.45 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.99 | |
| 1gxr_A | 337 | ESG1, transducin-like enhancer protein 1; transcri | 90.84 | |
| 1pgu_A | 615 | Actin interacting protein 1; WD repeat, seven-blad | 90.78 | |
| 3vl1_A | 420 | 26S proteasome regulatory subunit RPN14; beta-prop | 90.5 | |
| 3k26_A | 366 | Polycomb protein EED; WD40, structural genomics, N | 90.04 | |
| 3i2n_A | 357 | WD repeat-containing protein 92; WD40 repeats, str | 89.9 | |
| 2z2n_A | 299 | Virginiamycin B lyase; seven-bladed beta-propeller | 89.83 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.67 | |
| 4aez_A | 401 | CDC20, WD repeat-containing protein SLP1; cell cyc | 89.55 | |
| 2iwa_A | 266 | Glutamine cyclotransferase; pyroglutamate, acyltra | 89.43 | |
| 3sfz_A | 1249 | APAF-1, apoptotic peptidase activating factor 1; a | 89.32 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.28 | |
| 2ymu_A | 577 | WD-40 repeat protein; unknown function, two domain | 89.01 | |
| 3mkq_A | 814 | Coatomer beta'-subunit; beta-propeller, alpha-sole | 88.83 | |
| 3mmy_A | 368 | MRNA export factor; mRNA export, nuclear protein; | 88.41 | |
| 1sq9_A | 397 | Antiviral protein SKI8; WD repeat, beta-transducin | 88.31 | |
| 1k3i_A | 656 | Galactose oxidase precursor; blade beta propeller, | 88.24 | |
| 1q7f_A | 286 | NHL, brain tumor CG10719-PA; BRAT, NHL domain, NHL | 88.18 | |
| 2qc5_A | 300 | Streptogramin B lactonase; beta propeller, lyase; | 88.12 | |
| 1r5m_A | 425 | SIR4-interacting protein SIF2; transcription corep | 87.39 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 86.9 | |
| 4g56_B | 357 | MGC81050 protein; protein arginine methyltransfera | 86.8 | |
| 3mkq_A | 814 | Coatomer beta'-subunit; beta-propeller, alpha-sole | 86.72 | |
| 2aq5_A | 402 | Coronin-1A; WD40 repeat, 7-bladed beta-propeller, | 86.68 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 86.5 | |
| 1r5m_A | 425 | SIR4-interacting protein SIF2; transcription corep | 86.06 | |
| 1sq9_A | 397 | Antiviral protein SKI8; WD repeat, beta-transducin | 85.2 | |
| 2uvk_A | 357 | YJHT; unknown function, hypothetical protein, sial | 84.5 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.13 | |
| 3vgz_A | 353 | Uncharacterized protein YNCE; beta-propeller, prot | 83.91 | |
| 4g56_B | 357 | MGC81050 protein; protein arginine methyltransfera | 83.59 | |
| 3zwl_B | 369 | Eukaryotic translation initiation factor 3 subuni; | 83.35 | |
| 4a11_B | 408 | DNA excision repair protein ERCC-8; DNA binding pr | 83.05 | |
| 1q7f_A | 286 | NHL, brain tumor CG10719-PA; BRAT, NHL domain, NHL | 82.78 | |
| 3jro_A | 753 | Fusion protein of protein transport protein SEC13 | 82.27 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 81.96 | |
| 1yfq_A | 342 | Cell cycle arrest protein BUB3; WD repeat WD40 rep | 81.62 | |
| 1k8k_C | 372 | P40, ARP2/3 complex 41 kDa subunit, P41-ARC; beta- | 81.34 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.59 | |
| 3bws_A | 433 | Protein LP49; two-domain, immunoglobulin-like, 7-b | 80.23 | |
| 3vu4_A | 355 | KMHSV2; beta-propeller fold, protein transport; 2. | 80.11 |
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=465.62 Aligned_cols=276 Identities=18% Similarity=0.258 Sum_probs=238.5
Q ss_pred cceeEEEEecCceeeeeeeecCCCcEEEeeC--------------Cccccc--CCCCcEEEEEecCceEEEEEeC-CceE
Q 045256 33 SGSTLAVSYGSATVCAVVAAQPTQRLLCYQG--------------GTIRAV--EPNISFSSISAGQSFFCGIRSG-GYSL 95 (789)
Q Consensus 33 ~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~--------------~~~~~~--~~~~~v~~i~~G~~~~~~l~~~-G~~v 95 (789)
..+|++|+||..|++ ||++||+||+||. +.|.++ ....+|++|+||..|+++|+++ | +|
T Consensus 15 ~~~v~~ia~G~~hs~---al~~~g~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~i~~va~G~~ht~al~~~gg-~v 90 (406)
T 4d9s_A 15 PRKVLIISAGASHSV---ALLSGDIVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQIVSVTCGADHTVAYSQSGM-EV 90 (406)
T ss_dssp CCCEEEEEECSSEEE---EEETTTEEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEETTTT-EE
T ss_pred ccceEEEecCCCeEE---EEEeCCEEEEEeCCCCCCCCCCCcccCcCCEEecccCCCCEEEEEeCcceEEEEECCCC-EE
Confidence 568999999999999 9999999999998 233333 3456899999999999999986 6 99
Q ss_pred EEccCCCCCCCC-------CcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCC------------
Q 045256 96 LCWDTNFSYNSN-------FVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSG------------ 156 (789)
Q Consensus 96 ~~wG~n~~~~~~-------~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~------------ 156 (789)
|+||.|..++.. ..|.++..+.+.+|++|+||..|++||++||+||+||.|..+|++....
T Consensus 91 ~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~alt~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~ 170 (406)
T 4d9s_A 91 YSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLAVTMEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAF 170 (406)
T ss_dssp EEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSCCCEEEEEECGGG
T ss_pred EEEcCCCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEEEcCCCcEEEeCCCCCccCCCCCCCCcccceEeccc
Confidence 999999865532 4688888788888999999999999999999999999999999865422
Q ss_pred -CccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC------------CceeEEEeeCCceeEEEccCCcEEEE
Q 045256 157 -ELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA------------NRSMFSITAGGNHVCGIDSNGFVICY 223 (789)
Q Consensus 157 -~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~------------~~~v~~i~~G~~h~~al~~dG~v~~w 223 (789)
..+|++|+||.+|++| ++++|+||+||.|.+||||.+... ..+|++|+||.+|+++|++||+||+|
T Consensus 171 ~~~~i~~va~G~~hs~a-lt~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~i~~va~G~~ht~~l~~~G~v~~w 249 (406)
T 4d9s_A 171 EGIRIKMVAAGAEHTAA-VTEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSYSGALYTY 249 (406)
T ss_dssp TTCCEEEEEECSSEEEE-EETTSCEEEEECCTTSTTCSSSSCCEEEEEECCCSTTCCEEEEEECSSEEEEEETTCCEEEE
T ss_pred CCCcEEEEecCCCeEEE-EeCCCCEEEeeCCCCCCCCCCCCCCcCccEEecccCCceEEEEEECCCcEEEEcCCCCEEEe
Confidence 1369999999999999 577779999999999999976542 24689999999999999999999999
Q ss_pred EcCCCCCCCcCCCC-----------CccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCC--------------CC
Q 045256 224 GDNKSGQLKFPLNS-----------TAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGI--------------RG 278 (789)
Q Consensus 224 G~n~~Gql~~~~~~-----------~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~--------------~~ 278 (789)
|+|.+|||+..... ....|++|+||.+|++||++ ||+||+||+|.+|||+.. ..
T Consensus 250 G~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~alt~-~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~ 328 (406)
T 4d9s_A 250 GWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALTS-DGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDD 328 (406)
T ss_dssp ECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEET-TSCEEEEECCTTSTTCSSSSSCEEEEEEECCGGG
T ss_pred eCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEEcC-CCeEEEeeCCCCCCCCCCCCCCCccCEEEeccCC
Confidence 99999999765421 23459999999999999999 999999999999997643 24
Q ss_pred CcEEEEEecCceEEEEeecCCeEEEecCCCCCCCCCc
Q 045256 279 KSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDS 315 (789)
Q Consensus 279 ~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~~~~~~ 315 (789)
.+|++|+||.+|++||++|| +||+||+|..+|+|..
T Consensus 329 ~~v~~va~G~~hs~alt~~G-~v~~wG~n~~GqLG~g 364 (406)
T 4d9s_A 329 QKVVQVSCGWRHTLAVTERN-NVFAWGRGTNGQLGIG 364 (406)
T ss_dssp CCEEEEEECSSEEEEEETTS-CEEEEECCTTSTTCSS
T ss_pred CcEEEEEeCCCeEEEEeCCC-CEEEecCCCCCccCCC
Confidence 57999999999999999998 9999999999998763
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=450.98 Aligned_cols=275 Identities=15% Similarity=0.095 Sum_probs=229.6
Q ss_pred cccceeEEEEecCceeeeeeeecCCCcEEEeeC---------------CcccccCCCCcEEEEEecCceEEEEEeCCceE
Q 045256 31 LGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQG---------------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSL 95 (789)
Q Consensus 31 ~~~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~---------------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v 95 (789)
+....+.+|++|..|++ ++++||+||+||. ..|.++....+|++|+||..|+++|++|| +|
T Consensus 21 ~~~~~~~~ia~g~~~~~---~l~~~G~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~v~~va~G~~h~~~l~~~G-~v 96 (423)
T 3mvd_K 21 PPKAKRARIAFHLELPK---RRTVLGNVLVCGNGDVGQLGLGEDILERKRLSPVAGIPDAVDISAGGMHNLVLTKSG-DI 96 (423)
T ss_dssp --------CCCCCCCCC---CCCCCEEEEEEEECTTSTTCSCSSCCEEEEEEECCSCSSEEEEEECSSEEEEEETTS-CE
T ss_pred CccceeeEEecCCccce---eecCCCcEEEEeCCCCCCCCCCCCCccCcCCeEccCCCCceEEeeCCCeEEEEeCCC-eE
Confidence 33556788999999999 9999999999998 24556666678999999999999999999 99
Q ss_pred EEccCCCCCCC---------CCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCC--CCCCCCCCCC---------
Q 045256 96 LCWDTNFSYNS---------NFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRG--DVNISKNAPS--------- 155 (789)
Q Consensus 96 ~~wG~n~~~~~---------~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~--~~~~~~~~~~--------- 155 (789)
|+||.|..+|. ...|.+|.... +|++|+||..|++||++||+||+||. |..+|++...
T Consensus 97 ~~wG~n~~GqLG~~~~~~~~~~~P~~v~~~~--~i~~va~G~~hs~al~~~G~v~~wG~~~n~~GqlG~~~~~~~~~p~~ 174 (423)
T 3mvd_K 97 YSFGCNDEGALGRDTSEDGSESKPDLIDLPG--KALCISAGDSHSACLLEDGRVFAWGSFRDSHGNMGLTIDGNKRTPID 174 (423)
T ss_dssp EEEECCSSSTTCSCCCSTTSSSSCEECCCSS--CEEEEEECSSEEEEEETTSCEEEEECEECSSSEEESBTTBCEEEEEE
T ss_pred EEeECCCCcCCCCCCcCCccccCCeEEcCCC--CEEEEEcCcCeEEEEeCCCeEEEEeCCCCCCCCcCcCCCCCCceeeE
Confidence 99999996652 35677776443 57799999999999999999999998 8888875432
Q ss_pred --CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC-----------------------CCceeEEEeeCCce
Q 045256 156 --GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF-----------------------ANRSMFSITAGGNH 210 (789)
Q Consensus 156 --~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~-----------------------~~~~v~~i~~G~~h 210 (789)
...+|++|+||.+|++| ++++|+||+||.|.+||||.+.. ....|++|+||.+|
T Consensus 175 ~~~~~~i~~va~G~~hs~a-lt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~p~~v~~~~~~~v~~i~~g~~~ 253 (423)
T 3mvd_K 175 LMEGTVCCSIASGADHLVI-LTTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNYC 253 (423)
T ss_dssp SSTTCCEEEEEECSSEEEE-EETTSCEEEEECCTTSTTSSCCTTTTTSCSTTTTTTTSSCEEECCTTCCCEEEEEEETTE
T ss_pred ecCCCcEEEEecCCCeEEE-EecCCeEEEeeCCcCCccCCCcccccccccccccccccCCeEEeecCCccEEEEEECCcE
Confidence 23469999999999999 57777999999999999998542 12458999999999
Q ss_pred eEEE-ccCCcEEEEEcCCCCCCCcCCC----------CCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC--
Q 045256 211 VCGI-DSNGFVICYGDNKSGQLKFPLN----------STAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR-- 277 (789)
Q Consensus 211 ~~al-~~dG~v~~wG~n~~Gql~~~~~----------~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~-- 277 (789)
++++ ++||+||+||.|.+|||+.... ....+|++|+||.+|+++|++ ||+||+||+|.+|||+...
T Consensus 254 ~~~~~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G~~ht~alt~-~G~v~~wG~n~~GqLG~g~~~ 332 (423)
T 3mvd_K 254 TFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVILTT-DLKCSVVGRPEYGRLGLGDVK 332 (423)
T ss_dssp EEEEETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEECSSEEEEEET-TCCEEEEECCGGGTTCSSSCC
T ss_pred EEEEECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcccCeEEEEeC-CCcEEEEECCCCCCCCCCCcc
Confidence 9999 7999999999999999987321 124579999999999999999 9999999999999976432
Q ss_pred ------------CCcEEEEEecCceEEEEeecCCeEEEecCCCCCCCCC
Q 045256 278 ------------GKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSND 314 (789)
Q Consensus 278 ------------~~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~~~~~ 314 (789)
..+|++|+||.+|++||++|| +||+||.|..+|+|.
T Consensus 333 ~~~~~p~~v~~l~~~v~~ia~G~~hs~alt~~G-~v~~wG~n~~GqLG~ 380 (423)
T 3mvd_K 333 DVVEKPTIVKKLTEKIVSVGCGEVCSYAVTIDG-KLYSWGSGVNNQLGV 380 (423)
T ss_dssp SCEEEEEECTTCCSCEEEEEEETTEEEEEETTS-CEEEEECCTTSCSSS
T ss_pred ccccCceEeccCCCCEEEEEcCCCeEEEEcCCC-CEEEECCCCCCCCCC
Confidence 126999999999999999888 999999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=438.97 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=196.2
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++|.+.++||+|+||+||+|+++ +++.||||+++... ....+.|.+|+++|++++|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~----~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC----HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 56888899999999999999864 47889999986543 223456999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh-----------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-----------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA 624 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-----------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 624 (789)
..||||||+++|+|.++|+.. ..++.|+++||+|||+.+ |+||||||+||||++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECC
Confidence 999999999999999998642 368999999999999998 999999999999999
Q ss_pred CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccc
Q 045256 625 QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVS 703 (789)
Q Consensus 625 ~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~ 703 (789)
++.+||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||..... .
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-----~- 267 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----T- 267 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-----H-
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-----H-
Confidence 99999999999987554443333345679999999999999999999999999999999999 8999864321 0
Q ss_pred cccchhhhhhhhhhHHhhc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 704 LVDFAVPAIMAGELVKILD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
+.+..+.. .++..+... +..+.+|+.+||+.||++||||+||+++|+.+.+..
T Consensus 268 -----------~~~~~i~~g~~~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 268 -----------EAIDCITQGRELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp -----------HHHHHHHHTCCCCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred -----------HHHHHHHcCCCCCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 00111111 123333333 345677888999999999999999999999987653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=430.87 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=195.8
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.++||+|+||+||+|++++ .||||+++..... .+..+.|.+|+++|++++|||||++++++.+ +.++|
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPT--PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 44688899999999999999998753 6999998654322 2345679999999999999999999998754 67899
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++|+|.++|+.. ..++.|+++||+|||+++ |+||||||+||||++++.+||+|||+|+.....
T Consensus 109 VmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999999643 368999999999999998 999999999999999999999999999875544
Q ss_pred CCCCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
..........||+.|||||++. ...|+.++|||||||+||||+||+.||...+.. ..+..
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-----------------~~~~~ 248 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-----------------DQIIF 248 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----------------HHHHH
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-----------------HHHHH
Confidence 3333334568999999999985 346899999999999999999999999643320 01111
Q ss_pred hhcccCCC--CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 720 ILDRRVGP--PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 720 ~~d~~~~~--~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+...... .......++..+.+|+.+||+.||++||||.||+++|+.+...
T Consensus 249 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 249 MVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp HHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred HHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 11111111 1111223445677889999999999999999999999987543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=436.78 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=199.7
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
+++++.+.||+|+||+||+|.+. +++.||||+++..... ...++|.+|+.+|++++|||||+++|+|.+.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~---~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG---PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh---HHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 45778899999999999999862 4678999998654322 23456999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD 623 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~ 623 (789)
..+|||||+++|+|.++|+.+ .+++.|+|+||+|||+++ |+||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 999999999999999999542 358999999999999998 99999999999999
Q ss_pred CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 045256 624 AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPV 702 (789)
Q Consensus 624 ~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~ 702 (789)
+++++||+|||+++...............||+.|||||++....++.++|||||||+||||+| |+.||.....
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------ 253 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 253 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence 999999999999986544433333345679999999999999999999999999999999999 8999854321
Q ss_pred ccccchhhhhhhhhhHHhh-cc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 703 SLVDFAVPAIMAGELVKIL-DR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~-d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
.++.+.+ +. +++.+.. ++..+.+|+.+||+.||++||||+||+++|+..
T Consensus 254 ------------~~~~~~i~~~~~~~~p~~----~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 ------------QDVVEMIRNRQVLPCPDD----CPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ------------HHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ------------HHHHHHHHcCCCCCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 0111111 11 2222332 344567788899999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=435.42 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=200.6
Q ss_pred CCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++|.+.+.||+|+||+||+|++. +++.||||+++.... ...++|.+|+++|++++|||||+++++|.+++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD----NARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH----HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh----HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 57889999999999999999863 477899999865432 23456999999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh---------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR---------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~---------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 626 (789)
..||||||+++|+|.++|+.. .+++.|+++||+|||+++ |+||||||+||||++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCC
Confidence 999999999999999999642 358999999999999998 99999999999999999
Q ss_pred cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccc
Q 045256 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 627 ~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 705 (789)
.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||..... .
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-----~--- 237 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-----N--- 237 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----H---
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H---
Confidence 999999999976443332222334568999999999999999999999999999999999 8999864321 0
Q ss_pred cchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 706 DFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+-+..+... ++..+.. ++..+.+|+.+||+.||++|||++||++.|+++.+.
T Consensus 238 ---------~~~~~i~~~~~~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 238 ---------EVIECITQGRVLQRPRT----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ---------HHHHHHHHTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------HHHHHHHcCCCCCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 011112222 2223332 334567788899999999999999999999987654
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=442.61 Aligned_cols=268 Identities=16% Similarity=0.172 Sum_probs=226.4
Q ss_pred EEEecCceeeeeeeecCCCcEEEeeC---------------CcccccCCCCcEEEEEecCceEEEEEeCCceEEEccCCC
Q 045256 38 AVSYGSATVCAVVAAQPTQRLLCYQG---------------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNF 102 (789)
Q Consensus 38 ~i~~G~~h~~~~~~l~~~g~v~~wG~---------------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~ 102 (789)
..+.+..|++ +|+++|+||+||. ..|..+....+|++|+||..|+++|++|| +||+||.|.
T Consensus 12 ~~~~~~~h~~---~l~~~g~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~va~G~~hs~~l~~~G-~v~~wG~n~ 87 (413)
T 1a12_A 12 SKKVKVSHRS---HSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSG-QVYSFGCND 87 (413)
T ss_dssp -CCCCCCCTT---CCCCCBEEEEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEEETTS-CEEEEECCT
T ss_pred hhhhccccce---eecCCCcEEEEECCCCCcCCCCCCccccccceEccCCCCeEEEEeCCCeEEEEcCCC-CEEEEECCC
Confidence 5666789999 9999999999998 24555556678999999999999999999 999999998
Q ss_pred CCCC---------CCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCC--CCCCCCCCCC------------CCcc
Q 045256 103 SYNS---------NFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRG--DVNISKNAPS------------GELQ 159 (789)
Q Consensus 103 ~~~~---------~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~--~~~~~~~~~~------------~~~~ 159 (789)
.+|. ...|.+|... .+|++|+||..|++||++||+||+||. |..+|++... ...+
T Consensus 88 ~GqLG~~~~~~~~~~~P~~v~l~--~~i~~va~G~~hs~alt~~G~v~~wG~~~n~~GqlG~~~~~~~~~~P~~v~~~~~ 165 (413)
T 1a12_A 88 EGALGRDTSVEGSEMVPGKVELQ--EKVVQVSAGDSHTAALTDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVP 165 (413)
T ss_dssp TSTTCSCCCSTTGGGSCEECCCC--SCEEEEEECSSEEEEEETTSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSSC
T ss_pred CCCCCCCCCCCccccCCeEecCC--CcEEEEecCCCeEEEEcCCCcEEEeeCCcCCCCccCcCCccccccCCEEecCCCC
Confidence 6553 2467777432 268899999999999999999999998 7777764321 1246
Q ss_pred EEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC----------------------------CCceeEEEeeCCcee
Q 045256 160 FESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF----------------------------ANRSMFSITAGGNHV 211 (789)
Q Consensus 160 v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~----------------------------~~~~v~~i~~G~~h~ 211 (789)
|++|+||.+|+++ ++++|+||+||.|.+||||.+.. ....|++|+||.+|+
T Consensus 166 i~~ia~G~~hs~a-lt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~P~~v~~~~~g~~~~~~i~~ia~G~~hs 244 (413)
T 1a12_A 166 VVKVASGNDHLVM-LTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFT 244 (413)
T ss_dssp EEEEEECSSEEEE-EETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEE
T ss_pred EEEEEecCceEEE-EcCCCCEEEeeCCCCCccCCCccccccccccccccccccCceEeeccccccCCccEEEEEeCCCEE
Confidence 9999999999999 57777999999999999986421 235699999999999
Q ss_pred EEEccCCcEEEEEcCCCCCCCcCCCC---------C--c--cceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC-
Q 045256 212 CGIDSNGFVICYGDNKSGQLKFPLNS---------T--A--FEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR- 277 (789)
Q Consensus 212 ~al~~dG~v~~wG~n~~Gql~~~~~~---------~--~--~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~- 277 (789)
+||++||+||+||.|.+|||+..... . . .+|++|+||.+|+++|++ ||+||+||+|.+|||+...
T Consensus 245 ~alt~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~~~v~~ia~G~~hs~al~~-~G~v~~wG~n~~GqLG~g~~ 323 (413)
T 1a12_A 245 FAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDS-EGKAYSLGRAEYGRLGLGEG 323 (413)
T ss_dssp EEEETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEET-TSCEEEEECCGGGTTCSCTT
T ss_pred EEEeCCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCCceEEEEecccceEEEEeC-CCCEEEeeCCCCCccCCCCC
Confidence 99999999999999999999765321 1 1 349999999999999999 9999999999999986541
Q ss_pred ------------CCcEEEEEecCceEEEEeecCCeEEEecCCCCCCCCC
Q 045256 278 ------------GKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSND 314 (789)
Q Consensus 278 ------------~~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~~~~~ 314 (789)
..+|++|+||..|++||++|| +||+||.|..+|++.
T Consensus 324 ~~~~~~P~~v~~l~~v~~v~~G~~hs~alt~~G-~v~~wG~n~~gqLG~ 371 (413)
T 1a12_A 324 AEEKSIPTLISRLPAVSSVACGASVGYAVTKDG-RVFAWGMGTNYQLGT 371 (413)
T ss_dssp CCCEEEEEECCSSSSEEEEEECSSEEEEEETTS-CEEEEECCTTSTTCS
T ss_pred CccccCCEEecccCceeEEEECcceEEEEeCCC-CEEEecCCCCCCCCC
Confidence 237999999999999999998 999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=428.33 Aligned_cols=243 Identities=23% Similarity=0.363 Sum_probs=199.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|++.+.||+|+||+||+|+.+ +|+.||||++....... .+.+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 57999999999999999999865 68999999986543322 33588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|||+++|+|.+++... ..++.|++.||+|||+++ |+||||||+||||+.++++||+|||+|+.......
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 9999999999998643 368899999999999999 99999999999999999999999999986544322
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
.....+||+.|||||++.+..|+.++|||||||+||||++|++||...+. . ++.+.+....
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~-------------~~~~~i~~~~ 286 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----L-------------KAMKMIRDNL 286 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H-------------HHHHHHHHSS
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----H-------------HHHHHHHcCC
Confidence 22356899999999999999999999999999999999999999965432 0 0111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+...........+.+|+.+||+.||++|||+.|++++
T Consensus 287 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 287 PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11122223344567788999999999999999999875
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=447.50 Aligned_cols=275 Identities=15% Similarity=0.219 Sum_probs=227.8
Q ss_pred cceeEEEEecCceeeeeeeecCCCcEEEeeC-----------------Cccccc--C--CCCcEEEEEecCceEEEEEeC
Q 045256 33 SGSTLAVSYGSATVCAVVAAQPTQRLLCYQG-----------------GTIRAV--E--PNISFSSISAGQSFFCGIRSG 91 (789)
Q Consensus 33 ~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~-----------------~~~~~~--~--~~~~v~~i~~G~~~~~~l~~~ 91 (789)
+..+....++-.|++ +++.+|+||+||. .+|..+ . ...+|++|+||..|+++|++|
T Consensus 9 ~~~~~~~~~~~~h~~---~~~~~g~v~~wG~n~~GqLG~G~~~~~~~~~~P~~~~~~~~~~~~i~~va~G~~Ht~alt~~ 85 (473)
T 3of7_A 9 MSHIINAQEDYKHMY---LSVQPLDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFAVGGMHTLALDEE 85 (473)
T ss_dssp CTTCCCCGGGGHHHH---CCSSCCEEEEEEECTTSTTCSCSCGGGGEEEEEEECTTSCTTTTCEEEEEECSSEEEEEETT
T ss_pred hhhhhhhcccccccc---cCCCCccEEEEcCCCCCccCCCCCcccccccCcccccccccCCCCEEEEEeCCCeEEEEecC
Confidence 334566677889999 9999999999998 112222 2 346899999999999999999
Q ss_pred CceEEEccCCCCCCCC------------------------------Ccceeeee--C----CcceEEEEEecCCeEEEEe
Q 045256 92 GYSLLCWDTNFSYNSN------------------------------FVPKRIYY--N----DTVLLSSVSVGNNHVCATT 135 (789)
Q Consensus 92 G~~v~~wG~n~~~~~~------------------------------~~p~~v~~--~----~~~~i~~v~~G~~h~~al~ 135 (789)
| +||+||.|..+|.. .+|.+|.. + .+.+|++|+||..|++||+
T Consensus 86 G-~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l~~~~~~~~i~~va~G~~hs~alt 164 (473)
T 3of7_A 86 S-NVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESFPPLAEGHKVVQLAATDNMSCALF 164 (473)
T ss_dssp C-CEEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGCHHHHTTCCEEEEEECSSEEEEEE
T ss_pred C-eEEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccCCcccCCCcEEEEEccCCEEEEEe
Confidence 9 99999999966533 35777764 3 3567999999999999999
Q ss_pred eCCeEEEcCC--CCCCCCCCCC---------------CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC-
Q 045256 136 VQGQINCWRG--DVNISKNAPS---------------GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA- 197 (789)
Q Consensus 136 ~~G~v~~wG~--~~~~~~~~~~---------------~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~- 197 (789)
+||+||+||. +..+|++... ...+|++|+||.+|++| ++++|+||+||.|.+||||.+...
T Consensus 165 ~~G~vy~wG~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs~a-lt~~G~v~~wG~n~~GqLG~~~~~~ 243 (473)
T 3of7_A 165 SNGEVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILF-LDEEGMVFAWGNGQQNQLGRKVMER 243 (473)
T ss_dssp TTSCEEEEECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEEEE-EETTSCEEEEECCTTSTTSSCCCGG
T ss_pred CCCeEEEeeCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeEEE-EeCCCeEEEEeCCCCCCCCCCcccc
Confidence 9999999997 4455554311 12359999999999999 577779999999999999986432
Q ss_pred ------------CceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCC---------------CccceEEeccCcc
Q 045256 198 ------------NRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNS---------------TAFEYSALSLGFN 250 (789)
Q Consensus 198 ------------~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~---------------~~~~v~~i~~G~~ 250 (789)
...|++|+||.+|++||+++|+||+||.|.+|||+..... ...+|++|+||.+
T Consensus 244 ~~~~~~~p~~~~~~~v~~Ia~G~~hs~alt~~G~v~~wG~n~~GqlG~~~~~~~~~~~~~P~~v~~~~~~~i~~ia~G~~ 323 (473)
T 3of7_A 244 FRLKTLDPRPFGLRHVKYIASGENHCFALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDNVVIRSIAAGEH 323 (473)
T ss_dssp GTTTTCSCEECSCCSEEEEEECSSEEEEEETTSCEEEEEECTTSTTCCCSCCCTTCEEEEEEECCCCTTCCEEEEEECSS
T ss_pred ccccccCceecCCcceEEEecCCCeEEEEecCCCEEEeCCCCCCCcCCCCcccCCceeeccccccccCCccEEEEEeCCC
Confidence 1469999999999999999999999999999999765421 1247999999999
Q ss_pred eEEEEEeeCCeEEEeeeCCCCcccCCC--------------------------CCcEEEEEecCceEEEEeecCCeEEEe
Q 045256 251 HSCAIRRLNGSVVCWGSQGEYSVNGIR--------------------------GKSFESIVSGSNFTCGLTTSNFSVICW 304 (789)
Q Consensus 251 h~~al~~~dG~v~~WG~n~~gq~~~~~--------------------------~~~v~~i~~G~~h~~al~~~g~~v~~W 304 (789)
|+++|++ ||+||+||+|.+|||+... ..+|++|+||..|++||+++| +||+|
T Consensus 324 hs~~lt~-~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~~v~~Ia~G~~hs~al~~~G-~vy~w 401 (473)
T 3of7_A 324 HSLILSQ-DGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNNVPKFKSVAAGSHHSVAVAQNG-IAYSW 401 (473)
T ss_dssp EEEEEET-TSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEECCSSCCEEEEEECSSEEEEEETTS-CEEEE
T ss_pred eEEEEeC-CCeEEEEECCCCCccCCCccccccccccccCCceeeeccCcccCCCCceEEEEeCCCeEEEEeCCC-cEEEe
Confidence 9999999 9999999999999987431 127999999999999999888 99999
Q ss_pred cCCCCCCCCC
Q 045256 305 GPGWPNVSND 314 (789)
Q Consensus 305 G~n~~~~~~~ 314 (789)
|.|..+|+|.
T Consensus 402 G~n~~GqLG~ 411 (473)
T 3of7_A 402 GFGETYAVGL 411 (473)
T ss_dssp ECCTTCTTCC
T ss_pred eCCCCCCCCC
Confidence 9999998765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=426.36 Aligned_cols=249 Identities=22% Similarity=0.251 Sum_probs=197.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|++.++||+|+||+||+|+++ +|+.||||+++.... ..+|+.+|++++|||||++++++.+.+.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 56888999999999999999864 689999999864322 24699999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~~~~~ 643 (789)
|||+++|+|.++|++.. .++.|+++||+|||+++ |+||||||+||||+.++ ++||+|||+|+......
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999997543 58899999999999999 99999999999999987 69999999998754432
Q ss_pred CC---CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 644 RD---FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 644 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. ......+||+.|||||++.+..|+.++|||||||+||||+||++||....... + +..+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~------------~~~i 268 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----L------------CLKI 268 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----C------------HHHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----H------------HHHH
Confidence 21 11224579999999999999999999999999999999999999996543311 0 0011
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
.....+. ...+......+.+++.+||+.||++|||+.|++++|+++++...
T Consensus 269 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 269 ASEPPPI-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp HHSCCGG-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred HcCCCCc-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 1111100 00111234456778889999999999999999999999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=431.54 Aligned_cols=243 Identities=26% Similarity=0.368 Sum_probs=193.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++++.||+|+||+||+++.. +|+.||||++....... ...+.+.+|+++|++|+|||||++++++++++.+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH--HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 68999999999999999999864 68999999987544322 3355799999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++|+|.++|..+ ..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999999643 247899999999999999 999999999999999999999999999864322
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...+. .+.+..++.
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------------~~~~~~i~~ 239 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----------------KNLVLKIIS 239 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHHHHHH
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------------HHHHHHHHc
Confidence 1 112245799999999999999999999999999999999999999965431 111222233
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...++.. ......+.+|+.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 240 GSFPPVS---LHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp TCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCCC---ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3222111 1233456788899999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=422.16 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=201.8
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||+++. .+++.||||++.+..... ....+.+.+|+++|++++|||||++++++++++..|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4699999999999999999986 468999999987543322 23345689999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.++|.+.. .++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+.......
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999997543 58899999999999999 99999999999999999999999999987655444
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||...+. .+....++...
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----------------~~~~~~i~~~~ 250 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------------GLIFAKIIKLE 250 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHTC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence 4444567899999999999999999999999999999999999999965432 01112233333
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
...+... ...+++|+.+||+.||++|||++|++.
T Consensus 251 ~~~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 251 YDFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp CCCCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCCccc----CHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 3333322 334677888999999999999998643
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=435.91 Aligned_cols=264 Identities=16% Similarity=0.206 Sum_probs=215.5
Q ss_pred ceeeeeeeecCCCcEEEeeC----------------CcccccCCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCC-
Q 045256 44 ATVCAVVAAQPTQRLLCYQG----------------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNS- 106 (789)
Q Consensus 44 ~h~~~~~~l~~~g~v~~wG~----------------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~- 106 (789)
.+.+ +|++||+||+||. |+|+......++++|+||..|+++|++|| +||+||.|..+|.
T Consensus 11 ~~~~---~l~~~G~v~~wG~n~~GqLG~~~~~~~~~p~~v~~~~~~~i~~i~~G~~~~~~l~~~G-~v~~wG~n~~GqLG 86 (389)
T 3kci_A 11 RENL---YFQGSGTIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQLIGGEQTLFAVTADG-KLYATGYGAGGRLG 86 (389)
T ss_dssp -------------CEEEEEECTTSTTSSCSCSEEEEEEECHHHHHTCEEEEEEETTEEEEEETTS-CEEEEECCGGGTTS
T ss_pred ccce---eECCCCeEEEeeCCCCccCCCCcCccccCCEecccccCCceEEEEeCCCeEEEEcCCC-cEEEEECCCCCCCC
Confidence 4556 8999999999998 33333444568999999999999999999 9999999996553
Q ss_pred ------CCcceeeeeCCcc--eEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCC-------------CccEEEEee
Q 045256 107 ------NFVPKRIYYNDTV--LLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSG-------------ELQFESLTS 165 (789)
Q Consensus 107 ------~~~p~~v~~~~~~--~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~-------------~~~v~~va~ 165 (789)
...|.++..+.++ ++++|+||..|++||++||+||+||.|..+|++.... ..+|++|+|
T Consensus 87 ~g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~va~ 166 (389)
T 3kci_A 87 IGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALSSEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAA 166 (389)
T ss_dssp SSSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEEETTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEE
T ss_pred CCCcCCccCCEEcccccCCceeEEEECcCCCeEEEEcCCCCEEEEeCCCCCcCCCCCCccCcCCeEecccCCCeEEEEEe
Confidence 2467777766554 4578999999999999999999999999998865322 136999999
Q ss_pred eCceeEEEEeCCCeEEEeecCCCCCcccCCCC------------CceeEEEeeCC--ceeEEEccCCcEEEEEcCCCCCC
Q 045256 166 GIDFSCGILTNNKTVRCWGINSISNQIQTSFA------------NRSMFSITAGG--NHVCGIDSNGFVICYGDNKSGQL 231 (789)
Q Consensus 166 G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~------------~~~v~~i~~G~--~h~~al~~dG~v~~wG~n~~Gql 231 (789)
|..|++| ++++|+||+||.|.+||||.+... ..+|++|+||. .|+++|++||+||+||+|.+|||
T Consensus 167 G~~hs~a-lt~~G~v~~wG~n~~GqLG~~~~~~~~~p~~v~~~~~~~v~~ia~G~g~~~t~~l~~~G~v~~wG~n~~GqL 245 (389)
T 3kci_A 167 GGAHSAC-VTAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQTLCLTDDDTVWSWGDGDYGKL 245 (389)
T ss_dssp CSSEEEE-EETTSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECCSSCEEEEEETTTEEEEEECCGGGTT
T ss_pred CcCeEEE-EeCCCeEEEeCCCCCCCcCCCCCcccccceEecccCCCeEEEEEEcCCCcEEEEEccCCEEEEEeCCCCCCC
Confidence 9999999 577779999999999999976542 34589999995 89999999999999999999999
Q ss_pred CcCCC-----------CCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCC--------------CCCcEEEEEe
Q 045256 232 KFPLN-----------STAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGI--------------RGKSFESIVS 286 (789)
Q Consensus 232 ~~~~~-----------~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~--------------~~~~v~~i~~ 286 (789)
+.... ....+|++|+||.+|++||++ ||+||+||+|.+|||+.. .+.+|++|+|
T Consensus 246 G~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~alt~-~G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~v~~ia~ 324 (389)
T 3kci_A 246 GRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTK-SGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIAT 324 (389)
T ss_dssp SSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEEET-TSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEE
T ss_pred CCCCCCCccccEEecccCCCcEEEEeCCCCEEEEEeC-CCeEEEEeCCCCCCCCCCCCccccCCeEeccCCCCCEEEEEe
Confidence 75432 123369999999999999999 999999999999997543 2457999999
Q ss_pred cCceEEEEeecCCeEEEecCCCCCCCCC
Q 045256 287 GSNFTCGLTTSNFSVICWGPGWPNVSND 314 (789)
Q Consensus 287 G~~h~~al~~~g~~v~~WG~n~~~~~~~ 314 (789)
|.+|++||++|| +||+||+|..+|+|.
T Consensus 325 G~~h~~al~~~G-~v~~wG~n~~GqLG~ 351 (389)
T 3kci_A 325 GSLHCVCCTEDG-EVYTWGDNDEGQLGD 351 (389)
T ss_dssp CSSEEEEEETTC-CEEEEECCTTSTTCS
T ss_pred ccCeEEEECCCC-CEEEeeCCCCCcCCC
Confidence 999999999998 999999999999876
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=407.07 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=214.7
Q ss_pred ccceeEEEEecCceeeeeeeecCCCcEEEeeC------CcccccCCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCC
Q 045256 32 GSGSTLAVSYGSATVCAVVAAQPTQRLLCYQG------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYN 105 (789)
Q Consensus 32 ~~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~ 105 (789)
...+|++|++|..|++ +|+ ||+||+||. ..|... ..+|++|+||..|+++|+ || +||+||.|..+|
T Consensus 22 ~~~~i~~ia~G~~h~~---~l~-~G~v~~wG~n~~Gqlg~p~~~--~~~i~~ia~G~~hs~~l~-~G-~v~~wG~n~~Gq 93 (282)
T 3qhy_B 22 AQSGVDAIAGGYFHGL---ALK-GGKVLGWGANLNGQLTMPAAT--QSGVDAIAAGNYHSLALK-DG-EVIAWGGNEDGQ 93 (282)
T ss_dssp GSSSCCEEEECSSEEE---EEE-TTEEEEEECCSSSTTSCCGGG--GSCCCEEEECSSEEEEEE-TT-EEEEEECCTTST
T ss_pred ccCCCcEEEeCCCeEE---EEE-CCEEEEEeCCCCCCCCCCccC--CCCEEEEEeCCCEEEEEE-CC-EEEEeeCCCCCC
Confidence 3457999999999999 888 999999998 233332 348999999999999996 99 999999999888
Q ss_pred CCCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCC-CccEEEEeeeCceeEEEEeCCCeEEEee
Q 045256 106 SNFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSG-ELQFESLTSGIDFSCGILTNNKTVRCWG 184 (789)
Q Consensus 106 ~~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~-~~~v~~va~G~~hs~al~~~~g~v~~wG 184 (789)
.. .|.++. .+|++|+||..|++||+ ||+||+||.|..+|++.+.. ..+|++|+||..|++++ + +|+||+||
T Consensus 94 lg-~P~~~~----~~v~~ia~G~~hs~al~-~G~v~~wG~n~~gqlg~~~~~~~~i~~i~~G~~~~~~l-~-~G~v~~wG 165 (282)
T 3qhy_B 94 TT-VPAEAR----SGVDAIAAGAWASYALK-DGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAV-K-NGGVIAWG 165 (282)
T ss_dssp TC-CCGGGS----SSEEEEEEETTEEEEEE-TTEEEEEECCTTSTTSCCGGGGSSEEEEEECSSEEEEE-E-TTEEEEEE
T ss_pred CC-CCcccC----CCeEEEECcCCEEEEEe-CCeEEEecCCCCCcCCCCccCCCCeEEEEcccCEEEEE-E-CCEEEEec
Confidence 65 566663 25789999999999999 99999999999999976643 34699999999999994 6 47999999
Q ss_pred cCCCCCcccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEE
Q 045256 185 INSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVC 264 (789)
Q Consensus 185 ~n~~gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~ 264 (789)
.|.+||++.+.....+|++|+||.+|+++| +||+||+||+|.+|||+.|.. ...+|++|+||.+|+++|+ ||+||+
T Consensus 166 ~n~~gqlg~p~~~~~~v~~i~~G~~hs~al-~~G~v~~wG~n~~gqlg~p~~-~~~~v~~i~~G~~h~~al~--~g~v~~ 241 (282)
T 3qhy_B 166 DNYFGQTTVPAEAQSGVDDVAGGIFHSLAL-KDGKVIAWGDNRYKQTTVPTE-ALSGVSAIASGEWYSLALK--NGKVIA 241 (282)
T ss_dssp CCTTSTTSCCGGGGSSEEEEEECSSEEEEE-ETTEEEEEECCTTSTTCCCGG-GGSSCCEEEECSSCEEEEE--TTEEEE
T ss_pred CCCCCCCCCceecCCCeEEEEecCCEEEEE-ECCeEEEEECCCCCCCCCCcc-cCCCceEEEcCCCEEEEEE--CCEEEE
Confidence 999999998777777899999999999999 899999999999999987753 4567999999999999998 899999
Q ss_pred eeeCCCCcccCCCCCcEEEEEecCceEEEEeecC
Q 045256 265 WGSQGEYSVNGIRGKSFESIVSGSNFTCGLTTSN 298 (789)
Q Consensus 265 WG~n~~gq~~~~~~~~v~~i~~G~~h~~al~~~g 298 (789)
||+|.+||++.+ .+|++|+||..|++||++++
T Consensus 242 wG~n~~gq~~v~--~~v~~iaaG~~h~~al~~~~ 273 (282)
T 3qhy_B 242 WGSSRTAPSSVQ--SGVSSIEAGPNAAYALKGGS 273 (282)
T ss_dssp ESTTCCCCGGGS--SCEEEEEECSSCEEEEEC--
T ss_pred ecCCCCccccCC--CCcEEEEECcCeEEEEecCC
Confidence 999999999886 58999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-49 Score=412.44 Aligned_cols=242 Identities=27% Similarity=0.442 Sum_probs=189.0
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----CCeEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----KDERL 570 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 570 (789)
|++.++||+|+||+||+|.+. +++.||+|++....... ...+.|.+|+++|++|+|||||+++++|.+ .+.+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 367788999999999999864 68899999986543322 334579999999999999999999999976 34579
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGls~~~~~ 641 (789)
|||||+++|+|.++|++. ..++.|+++||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999999753 258899999999999987 56999999999999984 78999999999976432
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ..+.+.+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----------------~~~~~~i 242 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----------------AQIYRRV 242 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----------------HHHHHHH
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----------------HHHHHHH
Confidence 2 2235689999999999865 6999999999999999999999999543220 0111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....++ ..+......+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 243 TSGVKPA-SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTTCCCG-GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HcCCCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111110 0111122346778899999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=430.00 Aligned_cols=244 Identities=23% Similarity=0.342 Sum_probs=198.4
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.+.|++.+.||+|+||.||+|+.. +|+.||||++....... .+.+.+|+++|++++|||||+++++|.+.+.+||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i 225 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV 225 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence 357999999999999999999864 68999999986543322 2358899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||||++|+|.++++.. ..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+|+.......
T Consensus 226 VmEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999999998643 368899999999999999 99999999999999999999999999986544322
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+. .. ....+.+.....
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~---------~~~~i~~~~~~~ 366 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LK---------AMKMIRDNLPPR 366 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HH---------HHHHHHHSCCCC
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HH---------HHHHHHcCCCCC
Confidence 22356899999999999999999999999999999999999999965432 00 001111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.. .......+.+|+.+||..||++|||+.|++++
T Consensus 367 ~~~----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LKN----LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CSC----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred Ccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 211 12234456778889999999999999999875
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=404.70 Aligned_cols=240 Identities=22% Similarity=0.399 Sum_probs=209.7
Q ss_pred cEEEeeC-----CcccccCCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEecCCeE
Q 045256 57 RLLCYQG-----GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHV 131 (789)
Q Consensus 57 ~v~~wG~-----~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~G~~h~ 131 (789)
+||+||. ..+.+++...+|++|+||..|+++|+ || +||+||.|..+|.. .|... .. +|++|+||..|+
T Consensus 3 ~v~~WG~n~~~~~~~~p~~~~~~i~~ia~G~~h~~~l~-~G-~v~~wG~n~~Gqlg-~p~~~--~~--~i~~ia~G~~hs 75 (282)
T 3qhy_B 3 SVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALK-GG-KVLGWGANLNGQLT-MPAAT--QS--GVDAIAAGNYHS 75 (282)
T ss_dssp EEEEECSCCTTSTTCCCGGGSSSCCEEEECSSEEEEEE-TT-EEEEEECCSSSTTS-CCGGG--GS--CCCEEEECSSEE
T ss_pred EEEEeCCCCCcCcccCCccccCCCcEEEeCCCeEEEEE-CC-EEEEEeCCCCCCCC-CCccC--CC--CEEEEEeCCCEE
Confidence 5999997 23344444558999999999999998 99 99999999988865 34432 22 466999999999
Q ss_pred EEEeeCCeEEEcCCCCCCCCCCCCC-CccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEeeCCce
Q 045256 132 CATTVQGQINCWRGDVNISKNAPSG-ELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITAGGNH 210 (789)
Q Consensus 132 ~al~~~G~v~~wG~~~~~~~~~~~~-~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~G~~h 210 (789)
++|+ ||+||+||.|..+|++.|.. ..+|++|+||.+|+++| + +|+||+||.|.+|||+.......+|++|+||..|
T Consensus 76 ~~l~-~G~v~~wG~n~~Gqlg~P~~~~~~v~~ia~G~~hs~al-~-~G~v~~wG~n~~gqlg~~~~~~~~i~~i~~G~~~ 152 (282)
T 3qhy_B 76 LALK-DGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYAL-K-DGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYT 152 (282)
T ss_dssp EEEE-TTEEEEEECCTTSTTCCCGGGSSSEEEEEEETTEEEEE-E-TTEEEEEECCTTSTTSCCGGGGSSEEEEEECSSE
T ss_pred EEEE-CCEEEEeeCCCCCCCCCCcccCCCeEEEECcCCEEEEE-e-CCeEEEecCCCCCcCCCCccCCCCeEEEEcccCE
Confidence 9996 99999999999999987643 23799999999999995 5 6799999999999999887778889999999999
Q ss_pred eEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC--CCcEEEEEecC
Q 045256 211 VCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR--GKSFESIVSGS 288 (789)
Q Consensus 211 ~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~--~~~v~~i~~G~ 288 (789)
+++|+ ||+||+||.|.+|||+.|... ..+|++|+||.+|+++| + ||+||+||+|.+||++.+. ..+|++|+||.
T Consensus 153 ~~~l~-~G~v~~wG~n~~gqlg~p~~~-~~~v~~i~~G~~hs~al-~-~G~v~~wG~n~~gqlg~p~~~~~~v~~i~~G~ 228 (282)
T 3qhy_B 153 ALAVK-NGGVIAWGDNYFGQTTVPAEA-QSGVDDVAGGIFHSLAL-K-DGKVIAWGDNRYKQTTVPTEALSGVSAIASGE 228 (282)
T ss_dssp EEEEE-TTEEEEEECCTTSTTSCCGGG-GSSEEEEEECSSEEEEE-E-TTEEEEEECCTTSTTCCCGGGGSSCCEEEECS
T ss_pred EEEEE-CCEEEEecCCCCCCCCCceec-CCCeEEEEecCCEEEEE-E-CCeEEEEECCCCCCCCCCcccCCCceEEEcCC
Confidence 99999 899999999999999876543 46899999999999999 8 9999999999999987653 56899999999
Q ss_pred ceEEEEeecCCeEEEecCCCCCCC
Q 045256 289 NFTCGLTTSNFSVICWGPGWPNVS 312 (789)
Q Consensus 289 ~h~~al~~~g~~v~~WG~n~~~~~ 312 (789)
.|++||+ || +||+||.|..+|.
T Consensus 229 ~h~~al~-~g-~v~~wG~n~~gq~ 250 (282)
T 3qhy_B 229 WYSLALK-NG-KVIAWGSSRTAPS 250 (282)
T ss_dssp SCEEEEE-TT-EEEEESTTCCCCG
T ss_pred CEEEEEE-CC-EEEEecCCCCccc
Confidence 9999999 88 9999999977764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=427.58 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=205.8
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEeCC------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-CcceEEE
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-KHLVRLV 560 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~ 560 (789)
+++...++|++.+.||+|+||+||+|.+.. ++.||||++...... ...+.|.+|+++|.+++| ||||+++
T Consensus 58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~---~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh---HHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 455667899999999999999999998532 367999997654322 234569999999999965 9999999
Q ss_pred EEEEeC-CeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccC
Q 045256 561 GYCEEK-DERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDI 615 (789)
Q Consensus 561 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dl 615 (789)
++|.+. +.++||||||++|+|.++|+.. ..++.|+|+||+|||+++ |+||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999765 5689999999999999999642 247889999999999999 999999
Q ss_pred CCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 045256 616 KSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKD 694 (789)
Q Consensus 616 kp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~ 694 (789)
||+||||++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987655444334445678999999999999999999999999999999998 89998643
Q ss_pred CCCCCcccccccchhhhhhhhhhHHhhc--ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 695 DESGGTPVSLVDFAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
... ..+.+.+. .++..+.... ..+.+++.+||+.||++|||+.||+++|+++++.
T Consensus 292 ~~~-----------------~~~~~~i~~g~~~~~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 292 KID-----------------EEFCRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCS-----------------HHHHHHHHHTCCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHH-----------------HHHHHHHHcCCCCCCCccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 320 01111111 1233333333 3466778899999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-49 Score=417.33 Aligned_cols=268 Identities=25% Similarity=0.395 Sum_probs=197.3
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----eE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD----ER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 569 (789)
++|.+.+.||+|+||+||+|++ +|+.||||++..... ....++.|+..+.+++|||||++++++.+.+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688899999999999999998 689999999764321 1222446777778899999999999998764 57
Q ss_pred EEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcC-----CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 570 LLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYA-----VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
||||||+++|+|.++|+.. .+++.|+++||+|||+.. .++|+||||||+||||+.++++||+|||+++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999999999753 378999999999999872 2459999999999999999999999999997
Q ss_pred CCCCCCCC--CcccccccCcCccCccccCCC------CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchh
Q 045256 638 MGPESERD--FRPMKAAGTVGYIDPEYYGLN------VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709 (789)
Q Consensus 638 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 709 (789)
........ .......||+.|||||++.+. .++.++|||||||+||||+||++||....... .+. .+...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~-~p~--~~~~~ 233 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-LPY--YDLVP 233 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC-CTT--TTTSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc-ccc--hhccc
Confidence 64433221 122345799999999998654 46789999999999999999998875443321 111 01000
Q ss_pred hhhhhhhhHH-hhcccCCCC--C-CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 710 PAIMAGELVK-ILDRRVGPP--E-INEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 710 ~~~~~~~~~~-~~d~~~~~~--~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.......+.+ +.+..+.+. . ....+....+.+|+.+||+.||++||||.||++.|+++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0001111222 222222211 1 11235667788999999999999999999999999998653
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=426.13 Aligned_cols=260 Identities=15% Similarity=0.152 Sum_probs=220.4
Q ss_pred ceeEEEEecCceeeeeeeecCCCcEEEeeC----------------CcccccCCCCcEEEEEecCceEEEEEeCCceEEE
Q 045256 34 GSTLAVSYGSATVCAVVAAQPTQRLLCYQG----------------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLC 97 (789)
Q Consensus 34 ~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~----------------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~ 97 (789)
..|++|+||..|++ +|++||+||+||. ..|..+....+|++|+||..|+++|++|| +||+
T Consensus 75 ~~v~~va~G~~h~~---~l~~~G~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~~~~~i~~va~G~~hs~al~~~G-~v~~ 150 (423)
T 3mvd_K 75 PDAVDISAGGMHNL---VLTKSGDIYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLLEDG-RVFA 150 (423)
T ss_dssp SSEEEEEECSSEEE---EEETTSCEEEEECCSSSTTCSCCCSTTSSSSCEECCCSSCEEEEEECSSEEEEEETTS-CEEE
T ss_pred CCceEEeeCCCeEE---EEeCCCeEEEeECCCCcCCCCCCcCCccccCCeEEcCCCCEEEEEcCcCeEEEEeCCC-eEEE
Confidence 46899999999999 9999999999997 24555555568999999999999999999 9999
Q ss_pred ccC--CCCCCC-----CCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCC--------------
Q 045256 98 WDT--NFSYNS-----NFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSG-------------- 156 (789)
Q Consensus 98 wG~--n~~~~~-----~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~-------------- 156 (789)
||. |..++. ...|.++..+....|++|+||..|++||++||+||+||.|..+|++....
T Consensus 151 wG~~~n~~GqlG~~~~~~~~~p~~~~~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~ 230 (423)
T 3mvd_K 151 WGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVILTTAGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDL 230 (423)
T ss_dssp EECEECSSSEEESBTTBCEEEEEESSTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTSSCCTTTTTSCSTTTTTTT
T ss_pred EeCCCCCCCCcCcCCCCCCceeeEecCCCcEEEEecCCCeEEEEecCCeEEEeeCCcCCccCCCcccccccccccccccc
Confidence 998 775542 22344444466678999999999999999999999999999999865321
Q ss_pred ----------CccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC-----------CCceeEEEeeCCceeEEEc
Q 045256 157 ----------ELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF-----------ANRSMFSITAGGNHVCGID 215 (789)
Q Consensus 157 ----------~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~-----------~~~~v~~i~~G~~h~~al~ 215 (789)
...|++|+||..|++++++++|+||+||.|.+||||.+.. ...+|++|+||.+|++||+
T Consensus 231 ~~p~~v~~~~~~~v~~i~~g~~~~~~~~~~~g~v~~wG~n~~gqlg~~~~~~~~~~~p~~~~~~~v~~ia~G~~ht~alt 310 (423)
T 3mvd_K 231 LRPTQLIITRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVILT 310 (423)
T ss_dssp SSCEEECCTTCCCEEEEEEETTEEEEEETTTCCEEEEEECTTCTTSSCCTTCSEEEEEEEECCCSEEEEEECSSEEEEEE
T ss_pred cCCeEEeecCCccEEEEEECCcEEEEEECCCCeEEEEeCCCCCcCCCCCCCCceeeeeEEcCCCCeEEEEcccCeEEEEe
Confidence 1358999999999999777888999999999999998432 1346999999999999999
Q ss_pred cCCcEEEEEcCCCCCCCcCCCCC-----------ccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCC--------
Q 045256 216 SNGFVICYGDNKSGQLKFPLNST-----------AFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGI-------- 276 (789)
Q Consensus 216 ~dG~v~~wG~n~~Gql~~~~~~~-----------~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~-------- 276 (789)
+||+||+||+|.+|||+...... ..+|++|+||.+|++||++ ||+||+||+|.+|||+..
T Consensus 311 ~~G~v~~wG~n~~GqLG~g~~~~~~~~p~~v~~l~~~v~~ia~G~~hs~alt~-~G~v~~wG~n~~GqLG~g~~~~~~~P 389 (423)
T 3mvd_K 311 TDLKCSVVGRPEYGRLGLGDVKDVVEKPTIVKKLTEKIVSVGCGEVCSYAVTI-DGKLYSWGSGVNNQLGVGDGDDELEP 389 (423)
T ss_dssp TTCCEEEEECCGGGTTCSSSCCSCEEEEEECTTCCSCEEEEEEETTEEEEEET-TSCEEEEECCTTSCSSSSSSCCEEEE
T ss_pred CCCcEEEEECCCCCCCCCCCccccccCceEeccCCCCEEEEEcCCCeEEEEcC-CCCEEEECCCCCCCCCCCCCCCcccC
Confidence 99999999999999997654311 1169999999999999998 999999999999997542
Q ss_pred --------CCCcEEEEEecCceEEEEeecC
Q 045256 277 --------RGKSFESIVSGSNFTCGLTTSN 298 (789)
Q Consensus 277 --------~~~~v~~i~~G~~h~~al~~~g 298 (789)
.+.+|.+|+||..|+++|++++
T Consensus 390 ~~v~~~~~~~~~v~~va~G~~ht~~l~~~~ 419 (423)
T 3mvd_K 390 IVVVSKNTQGKHMLLASGGGQHAIFLVKAD 419 (423)
T ss_dssp EECCSTTTTTCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCcccCCCEEEEEEECCCcEEEEEccc
Confidence 2356999999999999999886
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=426.17 Aligned_cols=258 Identities=19% Similarity=0.305 Sum_probs=217.7
Q ss_pred cceeEEEEecCceeeeeeeecCCCcEEEeeCC----------------cccccCCCCcEEEEEecCceEEEEEeCCceEE
Q 045256 33 SGSTLAVSYGSATVCAVVAAQPTQRLLCYQGG----------------TIRAVEPNISFSSISAGQSFFCGIRSGGYSLL 96 (789)
Q Consensus 33 ~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~~----------------~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~ 96 (789)
...|++|+||..|++ +|++||+||+||.. .|..+....+|++|+||..|+++|++|| +||
T Consensus 58 ~~~i~~va~G~~hs~---~l~~~G~v~~wG~n~~GqLG~~~~~~~~~~~P~~v~l~~~i~~va~G~~hs~alt~~G-~v~ 133 (413)
T 1a12_A 58 PEDVVQAEAGGMHTV---CLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDG-RVF 133 (413)
T ss_dssp SSCEEEEEECSSEEE---EEETTSCEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEETTS-CEE
T ss_pred CCCeEEEEeCCCeEE---EEcCCCCEEEEECCCCCCCCCCCCCCccccCCeEecCCCcEEEEecCCCeEEEEcCCC-cEE
Confidence 467999999999999 99999999999971 2334433458999999999999999999 999
Q ss_pred EccC--CCCCCC--------CCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCC-----------
Q 045256 97 CWDT--NFSYNS--------NFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPS----------- 155 (789)
Q Consensus 97 ~wG~--n~~~~~--------~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~----------- 155 (789)
+||. |..++. ...|.+| +....|++|+||..|++||++||+||+||.|..+|++...
T Consensus 134 ~wG~~~n~~GqlG~~~~~~~~~~P~~v--~~~~~i~~ia~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~ 211 (413)
T 1a12_A 134 LWGSFRDNNGVIGLLEPMKKSMVPVQV--QLDVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQG 211 (413)
T ss_dssp EEECEEETTEEEESSBBTBCEEEEEEE--CCSSCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSCGGGTSSSCGGGG
T ss_pred EeeCCcCCCCccCcCCccccccCCEEe--cCCCCEEEEEecCceEEEEcCCCCEEEeeCCCCCccCCCcccccccccccc
Confidence 9998 664432 1247777 4456788999999999999999999999999999886421
Q ss_pred ------------------CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC------------C--ceeEE
Q 045256 156 ------------------GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA------------N--RSMFS 203 (789)
Q Consensus 156 ------------------~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~------------~--~~v~~ 203 (789)
...+|++|+||.+|++| ++++|+||+||.|.+||||.+... . ..|++
T Consensus 212 ~~~~~~P~~v~~~~~g~~~~~~i~~ia~G~~hs~a-lt~~G~v~~wG~n~~gqLG~~~~~~~~~P~~v~~l~~~~~~v~~ 290 (413)
T 1a12_A 212 LERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFA-ISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVG 290 (413)
T ss_dssp HHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEE-EETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEE
T ss_pred ccccccCceEeeccccccCCccEEEEEeCCCEEEE-EeCCCCEEEEeCCCCcCCCCCCCCcccccEEchhccCCCceEEE
Confidence 22469999999999999 567779999999999999976531 1 34999
Q ss_pred EeeCCceeEEEccCCcEEEEEcCCCCCCCcCCC----------CCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcc
Q 045256 204 ITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLN----------STAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSV 273 (789)
Q Consensus 204 i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~----------~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~ 273 (789)
|+||.+|++||++||+||+||+|.+|||+.+.. ....+|++|+||.+|++||++ ||+||+||+|.+|||
T Consensus 291 ia~G~~hs~al~~~G~v~~wG~n~~GqLG~g~~~~~~~~P~~v~~l~~v~~v~~G~~hs~alt~-~G~v~~wG~n~~gqL 369 (413)
T 1a12_A 291 FSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQL 369 (413)
T ss_dssp EEECSSEEEEEETTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEET-TSCEEEEECCTTSTT
T ss_pred EecccceEEEEeCCCCEEEeeCCCCCccCCCCCCccccCCEEecccCceeEEEECcceEEEEeC-CCCEEEecCCCCCCC
Confidence 999999999999999999999999999976521 123389999999999999999 999999999999997
Q ss_pred cCCC----------------CCcEEEEEecCceEEEEeecC
Q 045256 274 NGIR----------------GKSFESIVSGSNFTCGLTTSN 298 (789)
Q Consensus 274 ~~~~----------------~~~v~~i~~G~~h~~al~~~g 298 (789)
+... +.+|++|+||..|+++|++||
T Consensus 370 G~g~~~~~~~P~~v~~~~~~~~~v~~v~~G~~ht~~l~~~g 410 (413)
T 1a12_A 370 GTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKDK 410 (413)
T ss_dssp CSSSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEEEEEC
T ss_pred CCCCCCCcccCeEccccccCCCeEEEEeeCCCcEEEEEecC
Confidence 6432 346999999999999999887
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=426.07 Aligned_cols=264 Identities=18% Similarity=0.258 Sum_probs=220.6
Q ss_pred cccccceeEEEEecCceeeeeeeecCCCcEEEeeC--------------CcccccC--CC--CcEEEEEecCceEEEEEe
Q 045256 29 HALGSGSTLAVSYGSATVCAVVAAQPTQRLLCYQG--------------GTIRAVE--PN--ISFSSISAGQSFFCGIRS 90 (789)
Q Consensus 29 ~~~~~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~--------------~~~~~~~--~~--~~v~~i~~G~~~~~~l~~ 90 (789)
..+....+++|++|..|++ +|++||+||+||. ..|..+. .. .++++|+||..|++||++
T Consensus 48 ~~~~~~~i~~i~~G~~~~~---~l~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~~~~v~i~~G~~h~~al~~ 124 (389)
T 3kci_A 48 EALATLRPVQLIGGEQTLF---AVTADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKHCLALSS 124 (389)
T ss_dssp HHHHHTCEEEEEEETTEEE---EEETTSCEEEEECCGGGTTSSSSSCCEEEEEECGGGTTSCEEEEEECTTCSEEEEEET
T ss_pred ccccCCceEEEEeCCCeEE---EEcCCCcEEEEECCCCCCCCCCCcCCccCCEEcccccCCceeEEEECcCCCeEEEEcC
Confidence 3344557999999999999 9999999999997 1233332 22 356899999999999999
Q ss_pred CCceEEEccCCCCCCC-------CCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCC-------
Q 045256 91 GGYSLLCWDTNFSYNS-------NFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSG------- 156 (789)
Q Consensus 91 ~G~~v~~wG~n~~~~~-------~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~------- 156 (789)
|| +||+||.|..+|. ...|.+|..+.+.+|++|+||..|++||++||+||+||.|..+|++....
T Consensus 125 ~G-~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqLG~~~~~~~~~p~ 203 (389)
T 3kci_A 125 EG-EVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVTAAGDLYTWGKGRYGRLGHSDSEDQLKPK 203 (389)
T ss_dssp TS-CEEEEECCGGGTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEETTSCEEEEECCGGGTTCSSSCCCEEEEE
T ss_pred CC-CEEEEeCCCCCcCCCCCCccCcCCeEecccCCCeEEEEEeCcCeEEEEeCCCeEEEeCCCCCCCcCCCCCcccccce
Confidence 99 9999999985553 34688888888888999999999999999999999999999999865422
Q ss_pred ------CccEEEEeeeC--ceeEEEEeCCCeEEEeecCCCCCcccCCC------------CCceeEEEeeCCceeEEEcc
Q 045256 157 ------ELQFESLTSGI--DFSCGILTNNKTVRCWGINSISNQIQTSF------------ANRSMFSITAGGNHVCGIDS 216 (789)
Q Consensus 157 ------~~~v~~va~G~--~hs~al~~~~g~v~~wG~n~~gqlg~~~~------------~~~~v~~i~~G~~h~~al~~ 216 (789)
..+|++|+||. .|+++ ++++|+||+||.|.+||||.+.. ....|++|+||.+|++||++
T Consensus 204 ~v~~~~~~~v~~ia~G~g~~~t~~-l~~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~v~~G~~hs~alt~ 282 (389)
T 3kci_A 204 LVEALQGHRVVDIACGSGDAQTLC-LTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTK 282 (389)
T ss_dssp ECGGGTTSCEEEEEECCSSCEEEE-EETTTEEEEEECCGGGTTSSSSCCCEEEEEECGGGTTSCEEEEEEETTEEEEEET
T ss_pred EecccCCCeEEEEEEcCCCcEEEE-EccCCEEEEEeCCCCCCCCCCCCCCccccEEecccCCCcEEEEeCCCCEEEEEeC
Confidence 23699999995 89999 57777999999999999997653 22358999999999999999
Q ss_pred CCcEEEEEcCCCCCCCcCCCC-----------CccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC--------
Q 045256 217 NGFVICYGDNKSGQLKFPLNS-----------TAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR-------- 277 (789)
Q Consensus 217 dG~v~~wG~n~~Gql~~~~~~-----------~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~-------- 277 (789)
||+||+||+|.+|||+..... ...+|++|+||.+|++||++ ||+||+||+|.+|||+...
T Consensus 283 ~G~v~~wG~n~~GqLG~g~~~~~~~P~~v~~l~~~~v~~ia~G~~h~~al~~-~G~v~~wG~n~~GqLG~g~~~~~~~P~ 361 (389)
T 3kci_A 283 SGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCTE-DGEVYTWGDNDEGQLGDGTTNAIQRPR 361 (389)
T ss_dssp TSCEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEET-TCCEEEEECCTTSTTCSSSCCCEEEEE
T ss_pred CCeEEEEeCCCCCCCCCCCCccccCCeEeccCCCCCEEEEEeccCeEEEECC-CCCEEEeeCCCCCcCCCCCCCCccCcE
Confidence 999999999999999765321 23469999999999999999 9999999999999975432
Q ss_pred ------CCcEEEEEecCceEEEEeecC
Q 045256 278 ------GKSFESIVSGSNFTCGLTTSN 298 (789)
Q Consensus 278 ------~~~v~~i~~G~~h~~al~~~g 298 (789)
+.+|.+|+||..||+||++++
T Consensus 362 ~v~~~~~~~v~~va~G~~ht~al~~~~ 388 (389)
T 3kci_A 362 LVAALQGKKVNRVACGSAHTLAWSTSK 388 (389)
T ss_dssp ECGGGTTSCCCEEEEETTEEEEECC--
T ss_pred EecccCCCCEEEEEecCCcEEEEecCC
Confidence 457999999999999998653
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=402.39 Aligned_cols=241 Identities=24% Similarity=0.408 Sum_probs=182.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.||||++.+..... ......+.+|+++|++++|||||++++++.+++..|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 58999999999999999999864 68999999987543322 23345689999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+ +|+|.+++.++. .++.|++.||+|||+++ |+||||||+|||++.++++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999 679999987543 68899999999999999 9999999999999999999999999997644332
Q ss_pred CCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.....+||+.|||||++.+..+ +.++|||||||+||||+||+.||...+. ......+...
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----------------~~~~~~i~~~ 227 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----------------PVLFKNISNG 227 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHT
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHHcC
Confidence 2235689999999999988776 5799999999999999999999954321 0011122222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+.. ....+.+|+.+||+.||++|||++|++++
T Consensus 228 ~~~~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 VYTLPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCCCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCCC----CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 2222222 23446678889999999999999999875
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=426.10 Aligned_cols=258 Identities=17% Similarity=0.266 Sum_probs=218.5
Q ss_pred cceeEEEEecCceeeeeeeecCCCcEEEeeCC-------------------------------------cccccC-----
Q 045256 33 SGSTLAVSYGSATVCAVVAAQPTQRLLCYQGG-------------------------------------TIRAVE----- 70 (789)
Q Consensus 33 ~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~~-------------------------------------~~~~~~----- 70 (789)
...|++|+||..|++ ||++||+||+||.. .|..++
T Consensus 66 ~~~i~~va~G~~Ht~---alt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~l~ 142 (473)
T 3of7_A 66 EAKIISFAVGGMHTL---ALDEESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLNELESTPAKIPRESFP 142 (473)
T ss_dssp TTCEEEEEECSSEEE---EEETTCCEEEEECCTTSTTCSCCC---------------------CCHHHHSCEECCGGGCH
T ss_pred CCCEEEEEeCCCeEE---EEecCCeEEEeECCCCCCCCCCCcccccccccccccccCccccccccccccCceecccccCC
Confidence 458999999999999 99999999999980 233333
Q ss_pred ---CCCcEEEEEecCceEEEEEeCCceEEEccCC--CCC---------CCCCcceeeeeCCcceEEEEEecCCeEEEEee
Q 045256 71 ---PNISFSSISAGQSFFCGIRSGGYSLLCWDTN--FSY---------NSNFVPKRIYYNDTVLLSSVSVGNNHVCATTV 136 (789)
Q Consensus 71 ---~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n--~~~---------~~~~~p~~v~~~~~~~i~~v~~G~~h~~al~~ 136 (789)
...+|++|+||..|++||++|| +||+||.| ..+ ....+|.+|..+.+.+|++|+||..|++||++
T Consensus 143 ~~~~~~~i~~va~G~~hs~alt~~G-~vy~wG~n~~~~GqLG~~~~~~~~~~~P~~v~~l~~~~i~~va~G~~hs~alt~ 221 (473)
T 3of7_A 143 PLAEGHKVVQLAATDNMSCALFSNG-EVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLDE 221 (473)
T ss_dssp HHHTTCCEEEEEECSSEEEEEETTS-CEEEEECEEETTEEEESBTTTBSCEEEEEECCCCCSSCEEEEEECSSEEEEEET
T ss_pred cccCCCcEEEEEccCCEEEEEeCCC-eEEEeeCCcCCCCccCCCCCCCccccCcEEccccCCCCEEEEEecCCeEEEEeC
Confidence 2468999999999999999999 99999984 222 13357888888888789999999999999999
Q ss_pred CCeEEEcCCCCCCCCCCCCCC--------------ccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC-----
Q 045256 137 QGQINCWRGDVNISKNAPSGE--------------LQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA----- 197 (789)
Q Consensus 137 ~G~v~~wG~~~~~~~~~~~~~--------------~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~----- 197 (789)
+|+||+||.|..+|++..... .+|++|+||.+|++| ++++|+||+||.|.+||||.+...
T Consensus 222 ~G~v~~wG~n~~GqLG~~~~~~~~~~~~~p~~~~~~~v~~Ia~G~~hs~a-lt~~G~v~~wG~n~~GqlG~~~~~~~~~~ 300 (473)
T 3of7_A 222 EGMVFAWGNGQQNQLGRKVMERFRLKTLDPRPFGLRHVKYIASGENHCFA-LTKDNKLVSWGLNQFGQCGVSEDVEDGAL 300 (473)
T ss_dssp TSCEEEEECCTTSTTSSCCCGGGTTTTCSCEECSCCSEEEEEECSSEEEE-EETTSCEEEEEECTTSTTCCCSCCCTTCE
T ss_pred CCeEEEEeCCCCCCCCCCccccccccccCceecCCcceEEEecCCCeEEE-EecCCCEEEeCCCCCCCcCCCCcccCCce
Confidence 999999999999998654211 369999999999999 567779999999999999976532
Q ss_pred -----------CceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCC-----------------------CCccceE
Q 045256 198 -----------NRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLN-----------------------STAFEYS 243 (789)
Q Consensus 198 -----------~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~-----------------------~~~~~v~ 243 (789)
..+|++|+||.+|+++|++||+||+||+|.+|||+.+.. ....+|+
T Consensus 301 ~~~P~~v~~~~~~~i~~ia~G~~hs~~lt~~G~v~~wG~n~~GqLG~~~~~~~~~~~~~~~~~~~~~~~P~~v~~~~~v~ 380 (473)
T 3of7_A 301 VTKPKRLALPDNVVIRSIAAGEHHSLILSQDGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLPTKLNNVPKFK 380 (473)
T ss_dssp EEEEEECCCCTTCCEEEEEECSSEEEEEETTSCEEEEEECTTCTTCCCGGGCCTTCEECTTSCEEEEEEEEECCSSCCEE
T ss_pred eeccccccccCCccEEEEEeCCCeEEEEeCCCeEEEEECCCCCccCCCccccccccccccCCceeeeccCcccCCCCceE
Confidence 245999999999999999999999999999999985431 1122799
Q ss_pred EeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC-----------------CCcEEEEEecCceEEEEee
Q 045256 244 ALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR-----------------GKSFESIVSGSNFTCGLTT 296 (789)
Q Consensus 244 ~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~-----------------~~~v~~i~~G~~h~~al~~ 296 (789)
+|+||.+|++||++ ||+||+||+|.+|||+... ..+|+.|+||..||+++..
T Consensus 381 ~Ia~G~~hs~al~~-~G~vy~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~~~~~v~~v~cG~~~s~~~~~ 449 (473)
T 3of7_A 381 SVAAGSHHSVAVAQ-NGIAYSWGFGETYAVGLGPFEDDTEVPTRIKNTATQDHNIILVGCGGQFSVSGGV 449 (473)
T ss_dssp EEEECSSEEEEEET-TSCEEEEECCTTCTTCCCSCCSCEEEEEECCCTTTTTEEEEEEEECSSEEEEEEE
T ss_pred EEEeCCCeEEEEeC-CCcEEEeeCCCCCCCCCCCCCccccCCeEecccccCCCeEEEEeeCCCeEEEEEe
Confidence 99999999999998 9999999999999976543 2359999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=410.10 Aligned_cols=241 Identities=27% Similarity=0.373 Sum_probs=188.7
Q ss_pred CCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||+||+++.. +++.||||++++...... ....+.+|+++|++++|||||++++++++++..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 101 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL 101 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 57999999999999999999752 467899999865433221 122478899999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||||+++|+|.++|.+.. .++.|++.||+|||+++ |+||||||+|||++.++++||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999997543 58899999999999999 99999999999999999999999999986433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||...+. .+.+..+.
T Consensus 179 ~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----------------~~~~~~i~ 239 (304)
T 3ubd_A 179 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----------------KETMTMIL 239 (304)
T ss_dssp --C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred CCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----------------HHHHHHHH
Confidence 322 22356899999999999999999999999999999999999999965432 11122233
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVA 762 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~ 762 (789)
...+..+... ...+.+|+.+||+.||++||| ++|+++
T Consensus 240 ~~~~~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 240 KAKLGMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp HCCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred cCCCCCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 3333333332 344667888999999999998 466665
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=409.32 Aligned_cols=249 Identities=18% Similarity=0.258 Sum_probs=212.3
Q ss_pred cccccccccceeEEEEecCceeeeeeeecCCC-cEEEeeC----------------CcccccCCCCcEEEEEecCceEEE
Q 045256 25 PSPAHALGSGSTLAVSYGSATVCAVVAAQPTQ-RLLCYQG----------------GTIRAVEPNISFSSISAGQSFFCG 87 (789)
Q Consensus 25 ~~~~~~~~~~~~~~i~~G~~h~~~~~~l~~~g-~v~~wG~----------------~~~~~~~~~~~v~~i~~G~~~~~~ 87 (789)
|.....+....|++|+||..|++ ||+++| +||+||. |.|+......+|++|+||..|+++
T Consensus 59 P~~v~~l~~~~i~~va~G~~ht~---al~~~gg~v~~wG~n~~GqLG~g~~~~~~~p~~v~~l~~~~i~~ia~G~~h~~a 135 (406)
T 4d9s_A 59 PTQLSALDGHQIVSVTCGADHTV---AYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSHCLA 135 (406)
T ss_dssp EEECGGGTTSCEEEEEECSSEEE---EEETTTTEEEEEECCGGGTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEE
T ss_pred CEEecccCCCCEEEEEeCcceEE---EEECCCCEEEEEcCCCCcCCCCCCCCccccceEecccCCCCEEEEEEChhheEE
Confidence 33444455568999999999999 888875 9999997 344445556689999999999999
Q ss_pred EEeCCceEEEccCCCCCCCC-------CcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCC----
Q 045256 88 IRSGGYSLLCWDTNFSYNSN-------FVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSG---- 156 (789)
Q Consensus 88 l~~~G~~v~~wG~n~~~~~~-------~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~---- 156 (789)
|++|| +||+||.|..+|.. ..|.++..+.+.+|++|+||..|++||++||+||+||.|..+|++....
T Consensus 136 lt~~G-~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~i~~va~G~~hs~alt~~G~v~~wG~n~~GqlG~g~~~~~~ 214 (406)
T 4d9s_A 136 VTMEG-EVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGAEHTAAVTEDGDLYGWGWGRYGNLGLGDRTDRL 214 (406)
T ss_dssp EETTS-CEEEEECCTTSTTCSSSCCCEEEEEECGGGTTCCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSSSSCCEE
T ss_pred EcCCC-cEEEeCCCCCccCCCCCCCCcccceEecccCCCcEEEEecCCCeEEEEeCCCCEEEeeCCCCCCCCCCCCCCcC
Confidence 99999 99999999966643 4688888888888999999999999999999999999999999854321
Q ss_pred ---------CccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC------------CCceeEEEeeCCceeEEEc
Q 045256 157 ---------ELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF------------ANRSMFSITAGGNHVCGID 215 (789)
Q Consensus 157 ---------~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~------------~~~~v~~i~~G~~h~~al~ 215 (789)
..+|++|+||.+|+++ ++++|+||+||.|.+||||.+.. ....|++|+||.+|++||+
T Consensus 215 ~p~~v~~~~~~~i~~va~G~~ht~~-l~~~G~v~~wG~n~~GqlG~g~~~~~~~p~~v~~~~~~~v~~i~~G~~hs~alt 293 (406)
T 4d9s_A 215 VPERVTSTGGEKMSMVACGWRHTIS-VSYSGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMALT 293 (406)
T ss_dssp EEEECCCSTTCCEEEEEECSSEEEE-EETTCCEEEEECCTTSTTCSSSCCCEEEEEECGGGTTSCEEEEEECSSEEEEEE
T ss_pred ccEEecccCCceEEEEEECCCcEEE-EcCCCCEEEeeCCCCCCCCCCCCcCccccEEecccCCCCEEEEEecCCEEEEEc
Confidence 2469999999999999 57777999999999999998654 2345999999999999999
Q ss_pred cCCcEEEEEcCCCCCCCcCCCC-----------CccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCCCC
Q 045256 216 SNGFVICYGDNKSGQLKFPLNS-----------TAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIRGK 279 (789)
Q Consensus 216 ~dG~v~~wG~n~~Gql~~~~~~-----------~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~~~ 279 (789)
+||+||+||+|.+|||+..... ...+|++|+||.+|++||++ ||+||+||+|.+|||+.....
T Consensus 294 ~~G~v~~wG~n~~GqLG~g~~~~~~~p~~v~~~~~~~v~~va~G~~hs~alt~-~G~v~~wG~n~~GqLG~g~~~ 367 (406)
T 4d9s_A 294 SDGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVTE-RNNVFAWGRGTNGQLGIGESV 367 (406)
T ss_dssp TTSCEEEEECCTTSTTCSSSSSCEEEEEEECCGGGCCEEEEEECSSEEEEEET-TSCEEEEECCTTSTTCSSSCC
T ss_pred CCCeEEEeeCCCCCCCCCCCCCCCccCEEEeccCCCcEEEEEeCCCeEEEEeC-CCCEEEecCCCCCccCCCCCC
Confidence 9999999999999999765431 23479999999999999999 999999999999999877543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=400.42 Aligned_cols=242 Identities=26% Similarity=0.384 Sum_probs=180.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe----
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE---- 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 568 (789)
++|++.+.||+|+||+||+|+.+ +++.||||+++.... ....+.+.+|+++|++|+|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR---ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 46999999999999999999864 689999999865432 2234568899999999999999999999976543
Q ss_pred --------EEEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEE
Q 045256 569 --------RLLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR 629 (789)
Q Consensus 569 --------~~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 629 (789)
.|+||||+++|+|.+++..+ ..++.|+++||+|||+++ |+||||||+||||+.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEE
Confidence 68999999999999998743 247889999999999999 99999999999999999999
Q ss_pred EEeeccCcCCCCCCCCC----------cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 630 VSDFGLSMMGPESERDF----------RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 630 l~DfGls~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
|+|||+|+......... .....+||+.|||||++.+..|+.++|||||||+||||++ ||....+
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--- 232 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--- 232 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---
Confidence 99999998654432211 1223579999999999999999999999999999999997 6632110
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+..+.+... +. ...+......+|+.+||+.||++|||+.|++++
T Consensus 233 -------------~~~~~~~~~~~~~--p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 -------------RVRTLTDVRNLKF--PP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -------------HHHHHHHHHTTCC--CH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------------HHHHHHHHhcCCC--CC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011111111111 11 122333445678999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=395.45 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=192.0
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||+||+|++. +|+.||||+++..... ....+.+.+|+++|++++|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV--VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc--hHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 368999999999999999999864 6899999998654322 22344688999999999999999999998643
Q ss_pred -CeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 567 -DERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
+.+||||||++ |+|.+++... ..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 56899999996 6899998653 368999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCC--CCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc------cch
Q 045256 638 MGPESER--DFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV------DFA 708 (789)
Q Consensus 638 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~------~~~ 708 (789)
....... .......+||+.|||||++.+. .++.++||||+||++|||++|++||...+.......... ...
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 6543321 2223456899999999998764 579999999999999999999999975442110000000 000
Q ss_pred hhhhhhhhhHHhhcccCCCCCCCHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 VPAIMAGELVKILDRRVGPPEINEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
............+............ .....+.+|+.+||..||++|||+.|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000001111111111111111111 113445678899999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=389.60 Aligned_cols=202 Identities=24% Similarity=0.419 Sum_probs=167.9
Q ss_pred HHHHHHHhcCCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEE
Q 045256 485 LLAELAAATNNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRL 559 (789)
Q Consensus 485 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 559 (789)
.+..+....++|++.+.||+|+||+||+|+.+ .++.||||++..... ...+.+|+++|+++ +||||+++
T Consensus 12 l~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l 85 (361)
T 4f9c_A 12 LYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGV 85 (361)
T ss_dssp HHHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCC
T ss_pred HHHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceE
Confidence 34455667789999999999999999999753 467899998754322 22477899999998 69999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhHHHhh-----hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEee
Q 045256 560 VGYCEEKDERLLVYDYMKNGALYDHLHD-----RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDF 633 (789)
Q Consensus 560 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~-----~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 633 (789)
++++.+.+..||||||+++++|.++++. ...++.|++.||+|||+++ |+||||||+|||++.+ +.+||+||
T Consensus 86 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 86 KYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp SEEEEETTEEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEECCEEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcC
Confidence 9999999999999999999999999853 3468999999999999999 9999999999999877 79999999
Q ss_pred ccCcCCCCCCCC--------------------------CcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHc
Q 045256 634 GLSMMGPESERD--------------------------FRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLT 686 (789)
Q Consensus 634 Gls~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~ellt 686 (789)
|+|+........ ......+||+.|||||++.+. .|+.++||||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 999754332110 011235799999999998765 58999999999999999999
Q ss_pred CCCCCCCCC
Q 045256 687 GKRAIFKDD 695 (789)
Q Consensus 687 G~~pf~~~~ 695 (789)
|+.||+...
T Consensus 243 G~~Pf~~~~ 251 (361)
T 4f9c_A 243 GRYPFYKAS 251 (361)
T ss_dssp TCSSSSCCS
T ss_pred CCCCCCCCC
Confidence 999997654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=407.45 Aligned_cols=243 Identities=20% Similarity=0.327 Sum_probs=197.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++..+ +|+.||+|++...... ..+.+.+|+++|++|+|||||+++++|.+.+.+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~----~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES----DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH----HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh----hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 68999999999999999999864 6899999997654322 234688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC--CcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ--WTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGls~~~~~ 641 (789)
|||+++|+|.++|.++ ..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|||+++....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999999998543 258899999999999999 9999999999999854 8999999999987544
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|++||...+. .+.+..+.
T Consensus 310 ~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-----------------~~~~~~i~ 369 (573)
T 3uto_A 310 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------------DETLRNVK 369 (573)
T ss_dssp TS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------------HHHHHHHH
T ss_pred CC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----------------HHHHHHHH
Confidence 32 22346899999999999999999999999999999999999999965432 01111222
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 370 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222221122334556788899999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=406.35 Aligned_cols=245 Identities=24% Similarity=0.316 Sum_probs=192.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHH--HHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQ--EKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
++|++.++||+|+||.||+++.+ +|+.||||++.+....... ........++.+++.++|||||+++++|++.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 68999999999999999999865 6899999998754432211 11122334567777889999999999999999999
Q ss_pred EEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||||+++|+|.++|.+.. .++.||+.||+|||+++ |+||||||+||||+.++++||+|||+|+.....
T Consensus 269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999997543 57899999999999999 999999999999999999999999999865433
Q ss_pred CCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
. ....+||+.|||||++.. ..|+.++|||||||+||||++|++||........ ......+.
T Consensus 346 ~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--------------~~i~~~i~ 407 (689)
T 3v5w_A 346 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEIDRMTL 407 (689)
T ss_dssp C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--------------HHHHHHHH
T ss_pred C----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--------------HHHHHhhc
Confidence 2 235689999999999964 5799999999999999999999999965432110 00111222
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
...+..+... ...+.+|+.+||..||++|++ ++||++|
T Consensus 408 ~~~~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 408 TMAVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HCCCCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCCCCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 2233333322 344567888999999999998 6787764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=376.23 Aligned_cols=274 Identities=42% Similarity=0.700 Sum_probs=218.7
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
++....++|++.+.||+|+||.||++.+++++.||||++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS----QGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS----SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh----HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44556789999999999999999999988899999998765432 22446889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeecc
Q 045256 568 ERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 635 (789)
..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 999999999999999988532 358899999999999998 99999999999999999999999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
+................||+.|+|||.+....++.++||||||+++|||++|+.||........ .....+.......+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM--VNLAEWAVESHNNG 263 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC--CCHHHHTHHHHTTT
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH--HHHHHHhhhccccc
Confidence 9764433332233345689999999999888899999999999999999999999976543221 11222222222222
Q ss_pred hhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 716 ELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 716 ~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
.+...++..+. .....+....+.+++.+||+.||++|||+.|++++|+.+++..+
T Consensus 264 ~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 264 QLEQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CCCSSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred cHHHhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 22333333222 22345677888899999999999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=373.55 Aligned_cols=279 Identities=39% Similarity=0.636 Sum_probs=217.6
Q ss_pred HHHHHHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEE
Q 045256 483 EFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGY 562 (789)
Q Consensus 483 ~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 562 (789)
.+...++....++|++.+.||+|+||.||+++..+++.||||++....... ....+.+|++++++++||||++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch---HHHHHHHHHHHHHhccCCCccceEEE
Confidence 455678888999999999999999999999998889999999986543222 12248899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEE
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 630 (789)
+.+.+..++||||+++++|.+++..+ ..++.|+++||+|||+...++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 99999999999999999999998643 358899999999999993233999999999999999999999
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
+|||++......... ......||+.|+|||.+....++.++||||||+++|||++|+.||..............++...
T Consensus 176 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999765433221 2234568999999999988889999999999999999999999995322111111222222222
Q ss_pred hhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
......+..+++..+.. ....+....+.+++.+||+.||++|||+.|++++|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 22223333333333322 22456677788899999999999999999999999864
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.37 Aligned_cols=253 Identities=26% Similarity=0.442 Sum_probs=203.0
Q ss_pred cCCccccceEeecccEEEEEEEeC--------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 563 (789)
.++|++.+.||+|+||.||+++.. ++..||||+++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB---HHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC---HHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 368999999999999999999752 345799999865432 23345689999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhhc------------------------hHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDRN------------------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
.+.+..|+||||+++|+|.+++.... .++.|+++||+|||+.+ |+||||||+|
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~N 233 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 233 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhh
Confidence 99999999999999999999987532 47889999999999998 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESG 698 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~ 698 (789)
||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-- 311 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 311 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--
T ss_pred EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 9999999999999999986544433333334567889999999998899999999999999999999 9999854321
Q ss_pred CcccccccchhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
.++.+.+.. ....+. .....+.+++.+||+.||++||++.|+++.|+++++...+
T Consensus 312 ----------------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 312 ----------------EELFKLLKEGHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp ----------------GGHHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----------------HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 011111111 111122 2334567788899999999999999999999999886554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=363.57 Aligned_cols=266 Identities=23% Similarity=0.330 Sum_probs=201.5
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----eE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD----ER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 569 (789)
++|++.++||+|+||+||+++.. ++.||||++..... ....+..|+.++++++||||+++++++.+.. ..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 57999999999999999999875 78999999754322 2234567999999999999999999998754 36
Q ss_pred EEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhc----------CCCCeEeccCCCCCEEECCCCcEEEEe
Q 045256 570 LLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNY----------AVPPIIHRDIKSSNILLDAQWTARVSD 632 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~----------~~~~ivH~Dlkp~NIll~~~~~~kl~D 632 (789)
++||||+++++|.++++.. ..++.|+++||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 98 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999998653 36899999999999998 7 99999999999999999999999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF 707 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 707 (789)
||+++...............||+.|+|||++.+ ..++.++||||||+++|||+||+.||....+....+......
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999976544433333334678999999999976 355678999999999999999999997654432222110000
Q ss_pred hhhhhhhhhhHHhhcccCCCCCC----CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 708 AVPAIMAGELVKILDRRVGPPEI----NEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 708 ~~~~~~~~~~~~~~d~~~~~~~~----~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+ ....+.+.+......+.. ........+.+|+.+||+.||++|||+.|+++.|+++.+.
T Consensus 255 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHP--SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSC--CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC--chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 000 011112222111111111 1124456688899999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.94 Aligned_cols=244 Identities=23% Similarity=0.412 Sum_probs=197.0
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||+||++.. .+++.||||++....... .+.+.+|+.++++++||||+++++++...+..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK----KELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC----HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH----HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 46899999999999999999985 578999999876443222 3458899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||||+++++|.+++.+. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999999999998653 368899999999999998 99999999999999999999999999876543322
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. .....+....
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------------~~~~~~~~~~ 232 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----------------RALYLIATNG 232 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----------------HHHHHHHHHC
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHhCC
Confidence 223457999999999999999999999999999999999999999543210 0000111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. ............+.+++.+||+.||++|||+.|++++
T Consensus 233 ~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 233 T-PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp S-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred C-CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1 1111123344567788999999999999999999875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.70 Aligned_cols=256 Identities=31% Similarity=0.495 Sum_probs=195.5
Q ss_pred HHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
....++|++.+.||+|+||+||+++. +++.||||++...... .+..+.+.+|++++++++||||+++++++.+.+..
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH--AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCS--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 34457899999999999999999987 6789999997654332 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 570 LLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
++||||+++++|.+++... ..++.|+++||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999998643 257889999999999987 4599999999999999999999999999975
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... . .. ...+
T Consensus 189 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~--------~~-~~~~- 251 (309)
T 3p86_A 189 KASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----A--------QV-VAAV- 251 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----H--------HH-HHHH-
T ss_pred ccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H--------HH-HHHH-
Confidence 43322 122345789999999999999999999999999999999999999854321 0 00 0000
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.........+. .....+.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 252 ~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 252 GFKCKRLEIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHSCCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HhcCCCCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00111122222 2234567788899999999999999999999998764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=361.15 Aligned_cols=258 Identities=24% Similarity=0.444 Sum_probs=199.7
Q ss_pred cCCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
.++|++.+.||+|+||.||++.+. .+..||||+++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT---ERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence 367999999999999999999874 345699999765322 2334568999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||+++++|.++++.. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999998643 358899999999999999 999999999999999999999999999765
Q ss_pred CCCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 640 PESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 640 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------------~~~~ 264 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----------------RDVI 264 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----------------HHHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----------------HHHH
Confidence 4432211 1223346778999999988889999999999999999999 9999854321 0011
Q ss_pred HHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcccCCCC
Q 045256 718 VKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHGS 777 (789)
Q Consensus 718 ~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~~ 777 (789)
..+... ....+. .....+.+++.+||+.||++|||+.|+++.|+++++..+....+
T Consensus 265 ~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~ 321 (325)
T 3kul_A 265 SSVEEGYRLPAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT 321 (325)
T ss_dssp HHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred HHHHcCCCCCCCC----CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence 111111 112222 23345677888999999999999999999999998876654443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=350.58 Aligned_cols=275 Identities=35% Similarity=0.572 Sum_probs=214.8
Q ss_pred HHHHHHHHHhcCCcccc------ceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc
Q 045256 483 EFLLAELAAATNNFSLE------NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL 556 (789)
Q Consensus 483 ~~~~~~l~~~~~~~~~~------~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI 556 (789)
.|...++..++++|... +.||+|+||.||++.. +++.||+|++.........+..+.+.+|++++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 35566777888888766 8999999999999987 6789999997654333333445678999999999999999
Q ss_pred eEEEEEEEeCCeEEEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 557 VRLVGYCEEKDERLLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 557 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
+++++++.+.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCC
Confidence 99999999999999999999999999998632 257899999999999998 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~ 705 (789)
+.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... .+.
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~ 244 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ----LLL 244 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS----BTT
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH----HHH
Confidence 9999999999976544333322334578999999998875 47899999999999999999999996544311 111
Q ss_pred cchhhh-hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 706 DFAVPA-IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 706 ~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.+.... .....+.+.++..+.. ........+.+++.+||+.||++|||+.|++++|+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111100 0111233344443322 235566778889999999999999999999999998743
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.50 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=199.5
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++....... .+..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREK-EETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcccc-HHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 468999999999999999999864 68899999875443322 3345568999999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 99999999999998653 358899999999999999 9999999999999999999999999997654332
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ....+.+..
T Consensus 166 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----------------~~~~~~~~~ 227 (294)
T 4eqm_A 166 L-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-----------------SIAIKHIQD 227 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-----------------HHHHHHHSS
T ss_pred c-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----------------HHHHHHhhc
Confidence 1 1223456899999999999989999999999999999999999999543210 001111111
Q ss_pred cCCCC-CCCHHHHHHHHHHHHHhhcCcCCCCCC-CHHHHHHHHHHHhhhcc
Q 045256 724 RVGPP-EINEAEAVELVAYTAMHCVNLEGKERP-TMADIVANLERALDICD 772 (789)
Q Consensus 724 ~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~~~ 772 (789)
..... .......+..+.+++.+||+.||++|| +++++.+.|++++...+
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~ 278 (294)
T 4eqm_A 228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR 278 (294)
T ss_dssp CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence 11100 000112345677888999999999998 99999999998766544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=360.71 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=197.9
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhH--HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKF--QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
..++|++.+.||+|+||.||++... +++.||+|++........ ....+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3468999999999999999999865 689999999876443221 1123468899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC----cEEEEeeccC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW----TARVSDFGLS 636 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGls 636 (789)
.++||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999998643 368899999999999998 99999999999998876 7999999999
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........ .....||+.|+|||++....++.++||||||+++|||++|+.||..... .+.
T Consensus 167 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-----------------~~~ 226 (361)
T 2yab_A 167 HEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------------QET 226 (361)
T ss_dssp EECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------------HHH
T ss_pred eEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----------------HHH
Confidence 76544321 2245799999999999998999999999999999999999999965432 011
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+..+.......+..........+.+|+.+||..||++|||+.|++++
T Consensus 227 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 227 LANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11121111111111111234557788999999999999999999863
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=353.66 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=196.3
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++.+ .+++.||||++...... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN--PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 46899999999999999999986 57899999998654332 2334568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 99999999999998653 368899999999999998 9999999999999999999999999997543322
Q ss_pred CCCcccccccCcCccCccccCCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLT-AKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
......||+.|+|||++.+..+. .++||||||+++|||++|+.||...+. ......+..
T Consensus 169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------------~~~~~~i~~ 228 (328)
T 3fe3_A 169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----------------KELRERVLR 228 (328)
T ss_dssp ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHH
T ss_pred ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHh
Confidence 22345799999999999877765 799999999999999999999954321 011122222
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+... ...+.+|+.+||..||++|||++|++++
T Consensus 229 ~~~~~p~~~----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 229 GKYRIPFYM----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CCCCCCTTS----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 223223222 2345677888999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.39 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=200.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD----EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 57999999999999999999864 68899999875432 23345689999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 9999999999998752 258899999999999999 9999999999999999999999999997643332
Q ss_pred CCC------------cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 644 RDF------------RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 644 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
... ......||+.|+|||++.+..++.++||||||+++|||++|..||..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---------- 232 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---------- 232 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----------
Confidence 211 1114578999999999999999999999999999999999999985433211110
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
........+...+. .....+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 233 --~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 --GLNVRGFLDRYCPP------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp --SBCHHHHHHHTCCT------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --hhhhhccccccCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00111112221111 112245678889999999999999999999999876544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.25 Aligned_cols=249 Identities=25% Similarity=0.445 Sum_probs=199.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|.+.+.||+|+||.||+|.+. +++.||||+++.... .+..+.|.+|+++|++++||||+++++++.+.+..++
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC---HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC---HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 467899999999999999999976 789999999764322 2234468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.++++... .++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999986532 57889999999999999 999999999999999999999999999754332
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
..........+++.|+|||.+....++.++||||||+++|||++ |+.||..... ....+.+
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------------------~~~~~~~ 328 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------------------QQTREFV 328 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------------------HHHHHHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHH
Confidence 21111112235678999999988889999999999999999998 8888854321 1111122
Q ss_pred cc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 722 d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.. ++..+.. .+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus 329 ~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 329 EKGGRLPCPEL----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp HTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 21 2222222 23456678889999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=364.88 Aligned_cols=257 Identities=26% Similarity=0.419 Sum_probs=203.2
Q ss_pred HHHHHhcCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEE
Q 045256 487 AELAAATNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRL 559 (789)
Q Consensus 487 ~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l 559 (789)
.+++...++|++.+.||+|+||.||++.+ .+++.||||++..... ....+.+.+|++++.++ +||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC---HHHHHHHHHHHHHHHhhcCCcceeee
Confidence 34455678999999999999999999973 3467899999865332 22345689999999999 79999999
Q ss_pred EEEEEeCCe-EEEEEEecCCCchhHHHhhhc-------------------------------------------------
Q 045256 560 VGYCEEKDE-RLLVYDYMKNGALYDHLHDRN------------------------------------------------- 589 (789)
Q Consensus 560 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~------------------------------------------------- 589 (789)
++++.+.+. .++||||+++|+|.++++...
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988655 899999999999999986532
Q ss_pred -------------------------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 590 -------------------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 590 -------------------------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 37889999999999998 99999999999999999999999999986544433
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
........+|+.|+|||++.+..++.++||||||+++|||+| |+.||...... ..+...+..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----------------~~~~~~~~~ 311 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----------------EEFCRRLKE 311 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----------------HHHHHHHHH
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-----------------HHHHHHHHc
Confidence 333345568899999999988899999999999999999998 99998543321 001111111
Q ss_pred --cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 724 --RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 724 --~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
....+.. ....+.+++.+||+.||++|||+.|++++|+++++.
T Consensus 312 ~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 312 GTRMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 1112222 223466778899999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=362.89 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=204.5
Q ss_pred cCCccccceEeecccEEEEEEEeC--------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 563 (789)
.++|.+.+.||+|+||.||++... +++.||||++..... ......+.+|+++++++ +||||+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC---HHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 367999999999999999999852 235799999765432 23345688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
.+.+..++||||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 9999999999999999999998653 258899999999999998 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESG 698 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~ 698 (789)
||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-- 299 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-- 299 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999986554433333334567889999999999999999999999999999999 9999853321
Q ss_pred CcccccccchhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcccCCC
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDHSHG 776 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~~~~ 776 (789)
..+.+.+.. ....+. .....+.+|+.+||+.||++|||++|++++|++++........
T Consensus 300 ----------------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 300 ----------------EELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp ----------------HHHHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred ----------------HHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 111111111 111122 2234567788899999999999999999999999877654443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.92 Aligned_cols=243 Identities=24% Similarity=0.345 Sum_probs=196.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.+ +++.||+|++++..... ......+.+|++++++++||||+++++++.+.+..|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-hhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 57999999999999999999865 68999999986543221 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999999998643 257889999999999998 99999999999999999999999999975332221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......+....
T Consensus 161 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------------~~~~~~i~~~~ 221 (337)
T 1o6l_A 161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------------ERLFELILMEE 221 (337)
T ss_dssp --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHCC
T ss_pred --cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence 22356799999999999999999999999999999999999999964321 00111222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
+..+.. ....+.+++.+||+.||++|| +++|++++
T Consensus 222 ~~~p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 IRFPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 222222 234466778899999999999 89999876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=351.71 Aligned_cols=241 Identities=23% Similarity=0.392 Sum_probs=193.9
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYD 574 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e 574 (789)
|+..+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ----RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC----SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh----HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 677789999999999999876 7999999997654322 23458899999999999999999999999999999999
Q ss_pred ecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 575 YMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 575 ~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
|+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 197 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 197 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence 99999999998642 368899999999999998 99999999999999999999999999876543322 1
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 727 (789)
.....||+.|+|||++....++.++||||||+++|||++|+.||..... . .....+.+. ..+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~------------~~~~~~~~~-~~~ 259 (321)
T 2c30_A 198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----V------------QAMKRLRDS-PPP 259 (321)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H------------HHHHHHHHS-SCC
T ss_pred cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H------------HHHHHHhcC-CCC
Confidence 2345789999999999999999999999999999999999999964321 0 001111111 111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 728 ~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...........+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111122234457788889999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=346.26 Aligned_cols=251 Identities=30% Similarity=0.482 Sum_probs=188.0
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++.+ .++.||||++............+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46899999999999999999997 47899999987654443334456789999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC--------CCcEEEEeeccCc
Q 045256 573 YDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA--------QWTARVSDFGLSM 637 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~DfGls~ 637 (789)
|||+++++|.+++... ..++.|+++||+|||+.+..+|+||||||+|||++. ++.+||+|||++.
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 9999999999998542 368899999999999998666899999999999986 6789999999997
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ...
T Consensus 165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------------~~~ 223 (271)
T 3dtc_A 165 EWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----------------AVA 223 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----------------HHH
T ss_pred ccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHH
Confidence 5433222 2356899999999998888999999999999999999999999543210 001
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
..........+ ........+.+++.+||+.||++|||+.|++++|+++
T Consensus 224 ~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 224 YGVAMNKLALP--IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HhhhcCCCCCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111111110 0112234567788899999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=353.62 Aligned_cols=281 Identities=25% Similarity=0.365 Sum_probs=196.9
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-----CC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-----KD 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~~ 567 (789)
.++|++.+.||+|+||.||+++. +++.||||++....... .....|+..+..++||||+++++.+.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-----~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN-----FINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH-----HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh-----HHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 36899999999999999999987 68999999975432211 112244444556899999999986653 22
Q ss_pred eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhc---------CCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNY---------AVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~---------~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
..++||||+++++|.+++... ..++.|+++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEe
Confidence 568999999999999998643 36889999999999998 6 9999999999999999999999
Q ss_pred eeccCcCCCCCCC------CCcccccccCcCccCccccCC-------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 045256 632 DFGLSMMGPESER------DFRPMKAAGTVGYIDPEYYGL-------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG 698 (789)
Q Consensus 632 DfGls~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~ 698 (789)
|||++........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||+......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999976443211 111224569999999999976 456778999999999999999998886654432
Q ss_pred CcccccccchhhhhhhhhhHHhhcc-----cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDR-----RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~-----~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
.....+............+...+.. .++............+.+|+.+||+.||++|||++|+++.|++++...+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 2211111000000001111111111 11111112234566788899999999999999999999999999988766
Q ss_pred CCCCccccc
Q 045256 774 SHGSISSSG 782 (789)
Q Consensus 774 ~~~~~~~~~ 782 (789)
-...+.++.
T Consensus 323 ~~~~~~~~~ 331 (336)
T 3g2f_A 323 NKSVSPTAH 331 (336)
T ss_dssp ---------
T ss_pred cccCCCccc
Confidence 555555443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=365.96 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=196.4
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||.||++.. .+++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA--RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH--HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 346799999999999999999975 478999999976544322 23456889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC---CCCcEEEEeeccCcCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD---AQWTARVSDFGLSMMG 639 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGls~~~ 639 (789)
+||||+++|+|.+.+..+ ..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||++...
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999988653 368899999999999999 99999999999998 4678999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
..... ......||+.|+|||++....++.++||||||+++|||++|++||...+. ......
T Consensus 164 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----------------~~~~~~ 224 (444)
T 3soa_A 164 EGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----------------HRLYQQ 224 (444)
T ss_dssp CTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHHH
T ss_pred cCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----------------HHHHHH
Confidence 44322 12345799999999999998999999999999999999999999965332 011111
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 225 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 225 IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22222221111112334556788899999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=351.69 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=202.3
Q ss_pred hcCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE 565 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 565 (789)
..++|.+.+.||+|+||.||++.. .+++.||+|++..... ....+.+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS---PSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC---HHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 346899999999999999999975 2457899999864332 2334568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh--------------------------------chHHHHHHHHHHHHHhcCCCCeEec
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR--------------------------------NNVEKNAARGIEYLHNYAVPPIIHR 613 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------------~~i~~~ia~~l~~LH~~~~~~ivH~ 613 (789)
.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~ 174 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHR 174 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccc
Confidence 99999999999999999998652 247889999999999998 9999
Q ss_pred cCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 045256 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIF 692 (789)
Q Consensus 614 Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~ 692 (789)
||||+|||++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999976544433223334467889999999988889999999999999999999 999985
Q ss_pred CCCCCCCcccccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 693 KDDESGGTPVSLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.... ..+.+.+... ...+. .....+.+++.+||+.||++||++.|++++|++++..
T Consensus 255 ~~~~------------------~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPP------------------ERLFNLLKTGHRMERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCG------------------GGHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCH------------------HHHHHHhhcCCcCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 4321 0111111111 11111 2234567788899999999999999999999998764
Q ss_pred c
Q 045256 771 C 771 (789)
Q Consensus 771 ~ 771 (789)
.
T Consensus 313 ~ 313 (314)
T 2ivs_A 313 R 313 (314)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=359.14 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=196.6
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 467999999999999999999864 6899999998654332 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC---CcEEEEeeccCcCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGLSMMGP 640 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGls~~~~ 640 (789)
||||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++.+ +.+||+|||++....
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999988643 368899999999999998 9999999999999865 459999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......+
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----------------~~~~~~i 242 (362)
T 2bdw_A 183 DSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------------HRLYAQI 242 (362)
T ss_dssp TCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHH
T ss_pred CCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHH
Confidence 3322 2245799999999999998999999999999999999999999965331 0011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+..........+.+|+.+||+.||++||++.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1222221211122334557788999999999999999998875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=354.35 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=193.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc---chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 478999999999999999999865 7899999997644322 223468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 99999999999998643 368899999999999999 9999999999999999999999999997654333
Q ss_pred CCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ .......
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----------------~~~~~~~ 223 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----------------EYSDWKE 223 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH----------------HHHHHHT
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH----------------HHHHHhc
Confidence 2222335679999999999977665 7789999999999999999999965433110 0011111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...... ........+.+|+.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 224 KKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TCTTST--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111100 012233455678889999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=363.03 Aligned_cols=250 Identities=27% Similarity=0.519 Sum_probs=189.4
Q ss_pred CCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||.||+|++. ++..||||+++.... ....+.|.+|++++++++||||+++++++.+.+..
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT---EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 57999999999999999999864 567899999865432 23345699999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.++++.. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999998653 258899999999999998 9999999999999999999999999997654
Q ss_pred CCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... .......+++.|+|||++....++.++||||||+++|||++ |+.||..... ..+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------------------~~~~ 260 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------------------QDVI 260 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------------------HHHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHH
Confidence 33221 11122345778999999988899999999999999999998 9999854321 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
+.+.. +...+. .....+.+++.+||+.||++||++.|+++.|+++++..
T Consensus 261 ~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 261 KAVDEGYRLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHHHTTEECCCCT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHHHcCCCCCCCc----cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 11111 122222 22345677888999999999999999999999997654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=345.29 Aligned_cols=247 Identities=26% Similarity=0.457 Sum_probs=198.9
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 3679999999999999999999888899999997654322 23588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999998643 257899999999999999 9999999999999999999999999997543321
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. .......+++.|+|||.+....++.++||||||+++|||++ |+.||..... ......+..
T Consensus 161 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-----------------~~~~~~~~~ 222 (269)
T 4hcu_A 161 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDIST 222 (269)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHT
T ss_pred c-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-----------------HHHHHHHhc
Confidence 1 11223456788999999988899999999999999999999 8988854321 001111111
Q ss_pred c-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 723 R-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 723 ~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
. ....+.. ....+.+++.+||+.||++||+++|++++|+++.+
T Consensus 223 ~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 223 GFRLYKPRL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCCCCCc----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1 1111221 23446778889999999999999999999999865
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=357.84 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=194.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhH-HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKF-QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||++... +++.||||++........ ....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56999999999999999999864 689999999765332211 1124568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc---EEEEeeccC
Q 045256 572 VYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT---ARVSDFGLS 636 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGls 636 (789)
||||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998877542 247889999999999998 999999999999987654 999999999
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........ ......||+.|+|||++....++.++||||||+++|||++|+.||....+ ..
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------------------~~ 240 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------------------RL 240 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------------------HH
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------------------HH
Confidence 76544322 22345799999999999998999999999999999999999999964211 01
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+..................+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11112221111110011234567788999999999999999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=352.87 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=195.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHH--HHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQ--EKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
++|++.+.||+|+||.||++... +++.||+|++......... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46899999999999999999875 6899999998654332211 12456889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC----cEEEEeeccCcC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW----TARVSDFGLSMM 638 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGls~~ 638 (789)
+||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 999999999999998643 368899999999999998 99999999999998887 899999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... .....||+.|+|||++....++.++||||||+++|||++|+.||...... ..+.
T Consensus 168 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------------~~~~ 227 (326)
T 2y0a_A 168 IDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----------------ETLA 227 (326)
T ss_dssp CCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----------------HHHH
T ss_pred CCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----------------HHHH
Confidence 543321 22457899999999999889999999999999999999999999643210 0111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 228 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111110011223456788999999999999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=353.47 Aligned_cols=244 Identities=16% Similarity=0.275 Sum_probs=196.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|.+.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 478999999999999999999865 57899999876432 223458899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC--CCcEEEEeeccCcCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA--QWTARVSDFGLSMMGP 640 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGls~~~~ 640 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 99999999999998643 258899999999999998 999999999999987 7899999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||..... ...+..+
T Consensus 156 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------------~~~~~~i 215 (321)
T 1tki_A 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------------QQIIENI 215 (321)
T ss_dssp TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHH
T ss_pred CCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----------------HHHHHHH
Confidence 332 12245689999999999988899999999999999999999999965332 0111222
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.......+..........+.+++.+||..||++|||+.|++++-
T Consensus 216 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 216 MNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred HcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 22222211111112345677889999999999999999999853
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.23 Aligned_cols=265 Identities=24% Similarity=0.410 Sum_probs=195.9
Q ss_pred cCCccccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~- 566 (789)
.++|++.+.||+|+||+||++++ .+++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 36899999999999999999984 368899999976543 23345688999999999999999999998654
Q ss_pred -CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 567 -DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
...++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4589999999999999998653 257899999999999998 999999999999999999999999999
Q ss_pred cCCCCCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 637 MMGPESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 637 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
.......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+....... ...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--MRMIGNDKQGQMIVF 239 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--HHHHCTTCCTHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH--HhhhcCccccchhHH
Confidence 8654432211 1223456788999999988899999999999999999999998874321100 000000000000111
Q ss_pred hhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 716 ELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 716 ~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+.+.+.. +...+. .....+.+++.+||+.||++|||++|+++.|+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhccCcCCCCc----CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 12222222 122222 2334567788899999999999999999999998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=344.46 Aligned_cols=265 Identities=20% Similarity=0.296 Sum_probs=201.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC--eE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD--ER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~ 569 (789)
.++|++.+.||+|+||+||++... +++.||||++....... ..+.+.+|++++++++||||+++++++.... ..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR---PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS---CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc---hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 357999999999999999999875 48999999976543222 2345789999999999999999999998765 67
Q ss_pred EEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----CCCCcEEEEeec
Q 045256 570 LLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSDFG 634 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG 634 (789)
++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999998653 257899999999999999 9999999999999 888899999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccC--------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYG--------LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||............+..
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred CceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 9976544332 22456899999999885 577899999999999999999999999643321110000000
Q ss_pred chhhhhhhhh---hHH------hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 707 FAVPAIMAGE---LVK------ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 707 ~~~~~~~~~~---~~~------~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
... ...... +.. .....++............+..++.+||+.||++|||++|++++..+.
T Consensus 239 ~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 239 IIT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHH-HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred Hhc-CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 000 000000 000 001122223334567788889999999999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=352.72 Aligned_cols=243 Identities=23% Similarity=0.366 Sum_probs=193.4
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|.+.+.||+|+||.||++.+ .+++.||+|++....... .+....+.+|+++++.++||||+++++++.+.+..++
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 36899999999999999999986 578999999976433221 1223468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+ +|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 99999 67999988643 368899999999999999 9999999999999999999999999997654332
Q ss_pred CCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ..+..
T Consensus 163 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------~~i~~ 222 (336)
T 3h4j_B 163 F---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------KKVNS 222 (336)
T ss_dssp T---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------CCCCS
T ss_pred c---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------HHHHc
Confidence 2 224579999999999988776 78999999999999999999999654321100 00001
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.....+.. ....+.+|+.+||+.||++|||++|++++-
T Consensus 223 ~~~~~p~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 CVYVMPDF----LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SCCCCCTT----SCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CCCCCccc----CCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 11111111 233466788899999999999999998753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.70 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=190.2
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhh--cCCCcceEEEEEEEeC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR--LHHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~---- 566 (789)
.++|++.+.||+|+||+||+++. +++.||||++.... ...+..|.+++.. ++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD-------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG-------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc-------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 46899999999999999999988 68999999975432 1234556666665 7999999999997653
Q ss_pred CeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHH--------hcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 567 DERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLH--------NYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
...++||||+++++|.++++.. ..++.|+++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred ceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 4578999999999999998643 368999999999999 767 9999999999999999999999
Q ss_pred eeccCcCCCCCCCCC--cccccccCcCccCccccCCC------CCCchhHHHHHHHHHHHHHcC----------CCCCCC
Q 045256 632 DFGLSMMGPESERDF--RPMKAAGTVGYIDPEYYGLN------VLTAKSDVYGLGVVLLELLTG----------KRAIFK 693 (789)
Q Consensus 632 DfGls~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvil~elltG----------~~pf~~ 693 (789)
|||+++......... ......||+.|+|||++... .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999986543322211 12234789999999999776 455799999999999999999 666654
Q ss_pred CCCCCCcccccccchhhhhhhhhhHHhhccc---CCCC-CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 694 DDESGGTPVSLVDFAVPAIMAGELVKILDRR---VGPP-EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~---~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
....... ...+.+.+... ...+ ..........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPS-------------FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCC-------------HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcc-------------hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 3221110 01111111111 1111 111234667788999999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=354.85 Aligned_cols=248 Identities=25% Similarity=0.448 Sum_probs=189.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcE----EEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||+||+|.+. +++. ||+|.+..... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 57999999999999999999854 4443 57777653221 223456899999999999999999999998754
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++|+||+++|+|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 78999999999999998653 358899999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------------~~~~ 229 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEIS 229 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------------GGHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH------------------HHHH
Confidence 44433333334557889999999999999999999999999999999 9999854321 1111
Q ss_pred Hhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+.+... ...+.. ....+..++.+||+.||++||++.|++++|+++...
T Consensus 230 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 230 SILEKGERLPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHHTTCCCCCCTT----BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHHcCCCCCCCcc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 222221 122222 233466788899999999999999999999998653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.68 Aligned_cols=255 Identities=26% Similarity=0.367 Sum_probs=202.9
Q ss_pred cCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 565 (789)
.++|++.+.||+|+||.||++.. .+++.||+|++..... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh---HHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 46799999999999999999974 3567899999765432 22345689999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh--------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR--------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence 99999999999999999998643 247889999999999998 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESG 698 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~ 698 (789)
||++.++.+||+|||++................+|+.|+|||.+....++.++||||||+++|||+| |+.||......
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~- 254 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD- 254 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-
Confidence 9999999999999999987554433222334457889999999988899999999999999999999 99998543320
Q ss_pred CcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
....+.+........ .......+.+++.+||+.||++|||+.|++++|+++++...
T Consensus 255 ----------------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 255 ----------------SKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp ----------------HHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ----------------hHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 011111111111100 11223456778889999999999999999999999987543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=353.89 Aligned_cols=244 Identities=24% Similarity=0.335 Sum_probs=192.8
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 570 (789)
.++|++.+.||+|+||.||+++.+ +++.||||++++..... ....+.+.+|..+++++ +||||+++++++.+.+..|
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-HTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc-hhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 378999999999999999999865 58999999986543222 23345678899999988 7999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999998653 258899999999999998 999999999999999999999999999753322
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+. .+....+..
T Consensus 178 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------------~~~~~~i~~ 238 (353)
T 3txo_A 178 G--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----------------DDLFEAILN 238 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHH
T ss_pred C--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHc
Confidence 2 222356799999999999888899999999999999999999999965432 111223333
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH------HHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTM------ADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~ 763 (789)
.....+... ...+.+++.+||+.||++||++ .|++++
T Consensus 239 ~~~~~p~~~----~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 239 DEVVYPTWL----HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CCCCCCTTS----CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCCCCCCC----CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 333333322 2345677889999999999998 777653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.78 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=198.7
Q ss_pred cCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
.++|++.+.||+|+||.||++... +++.||||+++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccC---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 367999999999999999999843 467899999864322 22334588999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhhc---------------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC---cE
Q 045256 567 DERLLVYDYMKNGALYDHLHDRN---------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW---TA 628 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~~---------------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~ 628 (789)
...++||||+++++|.+++.... .++.|+++||+|||+.+ |+||||||+|||++.++ .+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999987532 58899999999999999 99999999999999554 59
Q ss_pred EEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccc
Q 045256 629 RVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDF 707 (789)
Q Consensus 629 kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~ 707 (789)
||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----------- 292 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------- 292 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----------
Confidence 9999999864322222222234567899999999988899999999999999999998 9899854321
Q ss_pred hhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 708 AVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 708 ~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
..+.+.+.. ....+.. ....+.+|+.+||+.||++||++.|++++|+.+.+..+
T Consensus 293 -------~~~~~~i~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 293 -------QEVLEFVTSGGRMDPPKN----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp -------HHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -------HHHHHHHHcCCCCCCCcc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 111111111 1122222 23446778889999999999999999999999876544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=355.07 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=198.7
Q ss_pred hcCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
..++|++.+.||+|+||.||++.. .+++.||+|++..... ....+.+.+|+.+++++ +||||+++++++.
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 447899999999999999999985 2456899999764322 22335688999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh-------------------------------chHHHHHHHHHHHHHhcCCCCeEec
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR-------------------------------NNVEKNAARGIEYLHNYAVPPIIHR 613 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------~~i~~~ia~~l~~LH~~~~~~ivH~ 613 (789)
+.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999998653 247889999999999998 9999
Q ss_pred cCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 045256 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIF 692 (789)
Q Consensus 614 Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~ 692 (789)
||||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999976543332222334567889999999988889999999999999999998 999985
Q ss_pred CCCCCCCcccccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 693 KDDESGGTPVSLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..... ....+.+... ...+. .....+..++.+||+.||++|||+.|++++|+.+++.
T Consensus 277 ~~~~~-----------------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVD-----------------ANFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCS-----------------HHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcH-----------------HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 44320 0111111111 11112 1234567788899999999999999999999998776
Q ss_pred cc
Q 045256 771 CD 772 (789)
Q Consensus 771 ~~ 772 (789)
.+
T Consensus 336 ~~ 337 (344)
T 1rjb_A 336 AE 337 (344)
T ss_dssp --
T ss_pred HH
Confidence 54
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=357.02 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=202.2
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEE
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVG 561 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 561 (789)
.+....++|++.+.||+|+||.||+++.. +++.||||+++.... ....+.+.+|++++++++||||+++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 34455689999999999999999999864 347899999865432 233456899999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhHHHhhh--------------------------------chHHHHHHHHHHHHHhcCCCC
Q 045256 562 YCEEKDERLLVYDYMKNGALYDHLHDR--------------------------------NNVEKNAARGIEYLHNYAVPP 609 (789)
Q Consensus 562 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------------------------~~i~~~ia~~l~~LH~~~~~~ 609 (789)
++.+.+..++||||+++++|.+++... ..++.|+++||+|||+.+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--- 194 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--- 194 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 999999999999999999999998652 248899999999999998
Q ss_pred eEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CC
Q 045256 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GK 688 (789)
Q Consensus 610 ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~ 688 (789)
|+||||||+|||++.++.+||+|||++................+|+.|+|||.+....++.++||||||+++|||++ |+
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999865433222222234567899999999988889999999999999999999 99
Q ss_pred CCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 689 RAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 689 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
.||..... .+....+.+... ..+. .....+.+++.+||+.||++||++.|+++.|+++
T Consensus 275 ~p~~~~~~-----------------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 275 QPYYGMAH-----------------EEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp CTTTTSCH-----------------HHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CcCCCCCh-----------------HHHHHHHhCCCcCCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 99854321 001111112211 1122 2234567788899999999999999999999998
Q ss_pred hhhcc
Q 045256 768 LDICD 772 (789)
Q Consensus 768 ~~~~~ 772 (789)
.+...
T Consensus 334 ~~~~~ 338 (343)
T 1luf_A 334 CERAE 338 (343)
T ss_dssp TC---
T ss_pred Hhhhh
Confidence 66443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=345.94 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=191.9
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.+.||+|+||+||+++..+++.||+|++...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED--EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc--chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34789999999999999999999988999999997653321 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999985 888877543 257899999999999998 999999999999999999999999999765432
Q ss_pred CCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc--cchhhhh--hhhhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV--DFAVPAI--MAGEL 717 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~ 717 (789)
... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.+.. ....+
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 221 223568999999999865 5689999999999999999999999965543221100000 0000000 00000
Q ss_pred HHhhcccCCCCC-CCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPE-INE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~-~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+....... ... ......+.+|+.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000011100000 000 0122456678899999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=353.05 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=194.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 570 (789)
.++|++.++||+|+||.||+++.+ +++.||+|++++..... ....+.+.+|..++.++ +||||+++++++.+.+..|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~-~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 367999999999999999999875 57889999987543322 22234577899999887 8999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+||||+.++++||+|||+++.....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 999999999999998653 257889999999999999 999999999999999999999999999753322
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. ......+||+.|+|||++.+..++.++||||||+++|||++|+.||............. .......+..
T Consensus 207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~--------~~~~~~~i~~ 276 (396)
T 4dc2_A 207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--------EDYLFQVILE 276 (396)
T ss_dssp T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC--------HHHHHHHHHH
T ss_pred C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh--------HHHHHHHHhc
Confidence 2 12335689999999999999999999999999999999999999996433211100000 0011122233
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH------HHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTM------ADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~ 763 (789)
..+..+... ...+.+|+.+||+.||++||++ .|++++
T Consensus 277 ~~~~~p~~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 277 KQIRIPRSL----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCCCCTTS----CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred cccCCCCcC----CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 333333322 3345677889999999999985 566553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=346.80 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=186.6
Q ss_pred CCccccceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||.||+++. .+++.||+|+++.............+.+|++++++++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 6799999999999999999986 478999999987654333233345678999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
|+||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999998653 257889999999999998 99999999999999999999999999875332
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......||+.|+|||++....++.++||||||+++|||++|+.||..... ...+..++
T Consensus 174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----------------~~~~~~i~ 234 (327)
T 3a62_A 174 DGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----------------KKTIDKIL 234 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHHHHH
T ss_pred CCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHH
Confidence 221 12245789999999999988999999999999999999999999964321 01122223
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
......+.. ....+.+++.+||+.||++|| ++.|++++
T Consensus 235 ~~~~~~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 235 KCKLNLPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HTCCCCCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred hCCCCCCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 333332222 234566788899999999999 77888764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=349.14 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=186.2
Q ss_pred HHhcCCccccceEeecccEEEEEEEeCCC----cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLPDG----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE 565 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 565 (789)
....++|++.+.||+|+||.||++.+... ..||||++....... ...+.+.+|++++++++||||+++++++..
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS--SDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C--HHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH--HHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34457899999999999999999986543 279999976543222 234568999999999999999999999988
Q ss_pred CCeE------EEEEEecCCCchhHHHhhh--------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 566 KDER------LLVYDYMKNGALYDHLHDR--------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 566 ~~~~------~lv~e~~~~gsL~~~l~~~--------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
.+.. ++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7665 9999999999999998532 258899999999999998 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~ 704 (789)
+.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------- 246 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------- 246 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-------
Confidence 9999999999976544333222233456789999999988899999999999999999999 88888543320
Q ss_pred ccchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 705 VDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
.....+... ....+. .....+.+++.+||+.||++|||+.|+++.|+++++...
T Consensus 247 ----------~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 247 ----------EIYNYLIGGNRLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ----------GHHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ----------HHHHHHhcCCCCCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 011111111 111222 223456788899999999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=351.18 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=195.3
Q ss_pred HhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhh-HHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKK-FQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
...++|++.+.||+|+||.||++.. .+++.||+|++....... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 3446799999999999999999986 467899999976543221 12334578999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhh------------------------------------------------hchHHHHHHHHHH
Q 045256 569 RLLVYDYMKNGALYDHLHD------------------------------------------------RNNVEKNAARGIE 600 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~------------------------------------------------~~~i~~~ia~~l~ 600 (789)
.++||||+++++|.+++.. ...++.|+++||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999999999998841 1247889999999
Q ss_pred HHHhcCCCCeEeccCCCCCEEECCCC--cEEEEeeccCcCCCCCCC--CCcccccccCcCccCccccCC--CCCCchhHH
Q 045256 601 YLHNYAVPPIIHRDIKSSNILLDAQW--TARVSDFGLSMMGPESER--DFRPMKAAGTVGYIDPEYYGL--NVLTAKSDV 674 (789)
Q Consensus 601 ~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfGls~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv 674 (789)
|||+.+ |+||||||+|||++.++ .+||+|||++........ ........||+.|+|||.+.. ..++.++||
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999998 99999999999998776 899999999975432211 112234578999999999865 678999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCC
Q 045256 675 YGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKER 754 (789)
Q Consensus 675 ~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R 754 (789)
||||+++|||++|+.||..... .+....++......+..........+.+|+.+||+.||++|
T Consensus 260 wslG~il~el~~g~~pf~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVND-----------------ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHCCCCCCCCCh-----------------HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 9999999999999999954332 11122233333222222222344567788999999999999
Q ss_pred CCHHHHHHH
Q 045256 755 PTMADIVAN 763 (789)
Q Consensus 755 Pt~~evl~~ 763 (789)
|++.|++++
T Consensus 323 ps~~~~l~h 331 (345)
T 3hko_A 323 FDAMRALQH 331 (345)
T ss_dssp CCHHHHHHS
T ss_pred CCHHHHhcC
Confidence 999999885
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=337.11 Aligned_cols=248 Identities=25% Similarity=0.429 Sum_probs=199.2
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++..+++..||+|++...... .+.+.+|++++++++||||+++++++.+....++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence 4689999999999999999999988889999997654322 23588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999998653 258899999999999998 9999999999999999999999999997644332
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+..
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~~~~ 220 (268)
T 3sxs_A 159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----------------SEVVLKVSQ 220 (268)
T ss_dssp EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHT
T ss_pred hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----------------HHHHHHHHc
Confidence 21 1223456778999999988889999999999999999999 9999854321 001111111
Q ss_pred c-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 723 R-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 723 ~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
. ....+.. ....+.+++.+||+.||++|||+.|++++|+++.+.
T Consensus 221 ~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 221 GHRLYRPHL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TCCCCCCTT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCCCc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1 1111222 223567788899999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=344.94 Aligned_cols=240 Identities=24% Similarity=0.406 Sum_probs=196.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 57999999999999999999875 68999999976543222 12345678999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 9999999999998653 257889999999999998 999999999999999999999999999764332
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......++...
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------------~~~~~~i~~~~ 219 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------------MKTYEKILNAE 219 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHHCC
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhCC
Confidence 2245799999999999999999999999999999999999999965321 11122233333
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
+..+... ...+.+++.+||..||++|| +++|++++
T Consensus 220 ~~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 LRFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp CCCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 3333322 23456778889999999999 88888864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=343.82 Aligned_cols=248 Identities=28% Similarity=0.450 Sum_probs=196.5
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence 3679999999999999999999988889999997654322 23588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999998652 258899999999999998 9999999999999999999999999997543321
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. .......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... ......+..
T Consensus 175 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----------------~~~~~~~~~ 236 (283)
T 3gen_A 175 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----------------SETAEHIAQ 236 (283)
T ss_dssp H-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----------------HHHHHHHHT
T ss_pred c-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----------------hHHHHHHhc
Confidence 1 11123456788999999988889999999999999999998 9999854321 001111111
Q ss_pred c-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 723 R-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 723 ~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
. ....+... ...+.+++.+||+.||++|||++|++++|+++++.
T Consensus 237 ~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 237 GLRLYRPHLA----SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TCCCCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCCCCCcC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1 11111211 24567788899999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.27 Aligned_cols=242 Identities=25% Similarity=0.364 Sum_probs=189.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe----
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE---- 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~---- 568 (789)
++|++.+.||+|+||.||++++. +++.||||++...... ...+.+.+|++++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE---LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT---THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch---hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 57999999999999999999876 7899999998654322 234568999999999999999999999876542
Q ss_pred -----------------------------------------------------EEEEEEecCCCchhHHHhhh-------
Q 045256 569 -----------------------------------------------------RLLVYDYMKNGALYDHLHDR------- 588 (789)
Q Consensus 569 -----------------------------------------------------~~lv~e~~~~gsL~~~l~~~------- 588 (789)
.++||||+++++|.+++..+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 79999999999999998752
Q ss_pred ----chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC----------CcccccccC
Q 045256 589 ----NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD----------FRPMKAAGT 654 (789)
Q Consensus 589 ----~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~----------~~~~~~~gt 654 (789)
..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 358899999999999998 999999999999999999999999999765443211 112235699
Q ss_pred cCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHH
Q 045256 655 VGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAE 734 (789)
Q Consensus 655 ~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 734 (789)
+.|+|||++.+..++.++||||||+++|||++|..|+... ............ ......
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------------------~~~~~~~~~~~~---~~~~~~ 297 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------------------VRIITDVRNLKF---PLLFTQ 297 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------------------HHHHHHHHTTCC---CHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------------------HHHHHHhhccCC---Cccccc
Confidence 9999999999889999999999999999999987664210 001111111111 111233
Q ss_pred HHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 735 AVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 735 ~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+.+++.+||+.||++|||+.|++++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 44556788999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=363.67 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=198.8
Q ss_pred HHHHHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE
Q 045256 486 LAELAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564 (789)
Q Consensus 486 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 564 (789)
+.++....++|++.++||+|+||.||+++.+ +++.||+|++.+..... ....+.+.+|+.+++.++||||+++++++.
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4455566789999999999999999999875 58899999976532221 112334789999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
+.+..|+||||+++|+|.++++.. ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999998653 357889999999999999 9999999999999999999999999997
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNV----LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
....... .......||+.|+|||++.... ++.++||||||++||||++|+.||...+.
T Consensus 217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----------------- 278 (410)
T 3v8s_A 217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----------------- 278 (410)
T ss_dssp ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------
T ss_pred eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-----------------
Confidence 6543321 1223567999999999997654 78999999999999999999999965432
Q ss_pred hhhhHHhhcc----cCCCCCCCHHHHHHHHHHHHHhhcCcCCCC--CCCHHHHHHH
Q 045256 714 AGELVKILDR----RVGPPEINEAEAVELVAYTAMHCVNLEGKE--RPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~----~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 763 (789)
.....+++.. ..+.... ....+.+|+.+||..+|++ ||+++||+++
T Consensus 279 ~~~~~~i~~~~~~~~~p~~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 279 VGTYSKIMNHKNSLTFPDDND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHHHHHTHHHHCCCCTTCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred hhHHHHHHhccccccCCCccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0111111111 1121111 2344567788899999988 9999999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=351.56 Aligned_cols=244 Identities=23% Similarity=0.351 Sum_probs=181.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||.||+++.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 3467999999999999999999876 57899999976432 2235789999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEeeccCcCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDFGLSMMG 639 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGls~~~ 639 (789)
+||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999999999999998643 368899999999999998 999999999999975 889999999999764
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......
T Consensus 202 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------------~~~~~~ 262 (349)
T 2w4o_A 202 EHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD----------------QFMFRR 262 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH----------------HHHHHH
T ss_pred Cccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc----------------HHHHHH
Confidence 3322 122457899999999999989999999999999999999999999654320 001112
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.............+....+.+|+.+||+.||++|||+.|++++
T Consensus 263 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 263 ILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22222211111112334556788999999999999999999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=349.17 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=201.1
Q ss_pred cCCccccceEeecccEEEEEEEeC--------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 563 (789)
.++|++.+.||+|+||.||++... +++.||+|++..... ....+.+.+|+++++++ +||||+++++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc---HHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 468999999999999999999863 467899999865432 23345688999999999 899999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
.+.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 9999999999999999999998643 247889999999999998 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESG 698 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~ 698 (789)
||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 265 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-- 265 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence 9999999999999999976544332222334457889999999988889999999999999999999 9999854321
Q ss_pred CcccccccchhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 699 GTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
.++.+.+.. ....+. .....+.+++.+||+.||++||++.|+++.|++++.....
T Consensus 266 ----------------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 266 ----------------EELFKLLKEGHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp ----------------HHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----------------HHHHHHHhcCCCCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 011111111 111111 2234567788899999999999999999999999886544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.79 Aligned_cols=266 Identities=17% Similarity=0.195 Sum_probs=199.2
Q ss_pred cCCccccceEeecccEEEEEEEeCC------CcEEEEEEcccchhhhHHHH-------HHHHHHHHHHHhhcCCCcceEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEK-------ESAFDSELAFLSRLHHKHLVRL 559 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~-------~~~~~~E~~~l~~l~HpnIv~l 559 (789)
.++|++.+.||+|+||.||++.+.+ ++.||||++.........+. ...+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998754 47899999765432211111 1234457777888899999999
Q ss_pred EEEEEeC----CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC--C
Q 045256 560 VGYCEEK----DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD--A 624 (789)
Q Consensus 560 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~--~ 624 (789)
++++... ...+|||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++ .
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCC
Confidence 9999775 4479999999 99999998653 268999999999999998 99999999999998 8
Q ss_pred CCcEEEEeeccCcCCCCCCCCC-----cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 625 QWTARVSDFGLSMMGPESERDF-----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 625 ~~~~kl~DfGls~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||++||||+||+.||......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-- 267 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-- 267 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--
Confidence 8999999999997643322111 112345999999999999999999999999999999999999999753321
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
...... ........+.++++..+.... .+..+.+++..||+.||++||++.++++.|++++....
T Consensus 268 --~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 --PKYVRD-SKIRYRENIASLMDKCFPAAN-----APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp --HHHHHH-HHHHHHHCHHHHHHHHSCTTC-----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HHHHHH-HHHHhhhhHHHHHHHhccccc-----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 011110 111112233444444432221 12456778889999999999999999999999987543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.10 Aligned_cols=252 Identities=28% Similarity=0.527 Sum_probs=187.8
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||+||++... ..||+|+++..... ....+.+.+|++++++++||||+++++++ .....++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT--PQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCC--HHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 468999999999999999999864 36999987654322 23345689999999999999999999965 55678999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999998532 368899999999999998 9999999999999999999999999997544322
Q ss_pred CCCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.........||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ..+.+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----------------~~~~~~ 237 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----------------DQIIEM 237 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-----------------HHHHHH
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-----------------HHHHHH
Confidence 222233457899999999986 667889999999999999999999999653320 011111
Q ss_pred hcc-cCC-CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 721 LDR-RVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 721 ~d~-~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
+.. ... ............+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp HHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111 111 1111112334567788899999999999999999999999754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=349.72 Aligned_cols=248 Identities=27% Similarity=0.459 Sum_probs=192.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcE----EEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||.||++.+. +++. |++|.+...... .....+.+|+.++++++||||+++++++. .+.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 88 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSS 88 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC---SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSS
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH---HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCc
Confidence 57999999999999999999864 4554 777765432211 11234778999999999999999999886 466
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 89999999999999998653 257899999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............++..|+|||.+....++.++||||||+++|||++ |+.||...... .+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------------~~~ 227 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------------------EVP 227 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------------------HHH
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------------------HHH
Confidence 55544433445567889999999988889999999999999999999 99998653320 011
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+.+.. ....+.. ....+..++.+||+.||++||++.|++++|+++...
T Consensus 228 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 228 DLLEKGERLAQPQI----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp HHHHTTCBCCCCTT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HHHHcCCCCCCCCc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111 1111111 122356678899999999999999999999998653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=361.61 Aligned_cols=245 Identities=27% Similarity=0.439 Sum_probs=196.8
Q ss_pred HHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-e
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD-E 568 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~-~ 568 (789)
....++|++.+.||+|+||.||++... ++.||||+++... ..+.|.+|+++|++++||||+++++++.+.+ .
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 344578999999999999999999884 7899999986543 2335889999999999999999999988765 6
Q ss_pred EEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 569 RLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
.++||||+++|+|.++++.. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 89999999999999999753 247889999999999998 99999999999999999999999999975
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
..... ....+++.|+|||.+....++.++||||||++||||+| |+.||....... ..
T Consensus 339 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----------------~~ 396 (450)
T 1k9a_A 339 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VV 396 (450)
T ss_dssp CC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-----------------HH
T ss_pred ccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------------HH
Confidence 33221 12356889999999999999999999999999999998 999986433210 00
Q ss_pred HHhhc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 718 VKILD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 718 ~~~~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+.. .++..+.. +...+.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 397 ~~i~~~~~~~~p~~----~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 397 PRVEKGYKMDAPDG----CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHcCCCCCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 11111 12222222 234567788899999999999999999999998653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=367.12 Aligned_cols=247 Identities=28% Similarity=0.472 Sum_probs=198.5
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||+|.+++++.||||+++.... ..+.|.+|+++|++++||||+++++++. .+..++|
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 467899999999999999999998889999999865332 2346899999999999999999999986 5678999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++|+|.++++.. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999998743 257899999999999998 999999999999999999999999999764332
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......++..|+|||.+....++.++||||||++||||+| |+.||..... .++.+.+
T Consensus 338 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------------------~~~~~~i 398 (454)
T 1qcf_A 338 EYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------------------PEVIRAL 398 (454)
T ss_dssp HHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------------------HHHHHHH
T ss_pred cee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHH
Confidence 111 1122346788999999988889999999999999999999 9999854321 0111111
Q ss_pred cc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 722 d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
.. +++.+.. .+..+.+|+.+||+.||++|||++++++.|+++....
T Consensus 399 ~~~~~~~~~~~----~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 399 ERGYRMPRPEN----CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp HHTCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred HcCCCCCCCCC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11 2222222 3345677888999999999999999999999986543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=347.32 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=196.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++.. +++.||+|++....... ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 68999999999999999999875 68999999976543222 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999998753 257899999999999999 999999999999999999999999999764332
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......+....
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------------~~~~~~i~~~~ 254 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------------IQIYEKIVSGK 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHCC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence 2245799999999999999999999999999999999999999964321 01112222333
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
+..+.. ....+.+++.+||+.||++||+ ++|++++
T Consensus 255 ~~~p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 VRFPSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 332322 2344667888999999999998 8888764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=353.24 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=194.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+++|++++||||+++++++.+....++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP----LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch----hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEE
Confidence 367999999999999999999865 688999998765432 123458899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC--CCcEEEEeeccCcCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA--QWTARVSDFGLSMMGP 640 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfGls~~~~ 640 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++....
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 99999999999998643 258899999999999998 999999999999974 4789999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .....||+.|+|||++....++.++||||||+++|||++|+.||...+. ...+..+
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----------------~~~~~~i 262 (387)
T 1kob_A 203 PDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------------LETLQNV 262 (387)
T ss_dssp TTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------------HHHHHHH
T ss_pred CCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----------------HHHHHHH
Confidence 3321 2234789999999999999999999999999999999999999965331 0011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 263 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp HHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111111111112234556788999999999999999999875
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=352.98 Aligned_cols=239 Identities=25% Similarity=0.369 Sum_probs=186.9
Q ss_pred ccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 498 LENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
..+.||+|+||.||++.. .+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..+|||||+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM----KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 367899999999999986 4689999999765432 22346889999999999999999999999999999999999
Q ss_pred CCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE--CCCCcEEEEeeccCcCCCCCCCC
Q 045256 577 KNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL--DAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 577 ~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 999999988542 257889999999999999 9999999999999 6778999999999986544322
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
.....||+.|+|||++....++.++||||||+++|||++|+.||..... ...+.+++....
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----------------~~~~~~i~~~~~ 305 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-----------------AETLNNILACRW 305 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHHTCC
T ss_pred --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHHhccC
Confidence 1234689999999999988999999999999999999999999965432 011222222222
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+..........+.+|+.+||+.||++|||+.|++++
T Consensus 306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 22211112334567788999999999999999999984
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.57 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=186.8
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhH----------------------HHHHHHHHHHHHHHh
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKF----------------------QEKESAFDSELAFLS 549 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~----------------------~~~~~~~~~E~~~l~ 549 (789)
.++|++.+.||+|+||.||++... +++.||||++........ ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999864 688999999765432111 112345889999999
Q ss_pred hcCCCcceEEEEEEEe--CCeEEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 045256 550 RLHHKHLVRLVGYCEE--KDERLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNI 620 (789)
Q Consensus 550 ~l~HpnIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NI 620 (789)
+++||||+++++++.+ .+..++||||+++++|.+++.. ...++.|+++||+|||+.+ |+||||||+||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni 168 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL 168 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence 9999999999999987 5678999999999999887542 3468899999999999998 99999999999
Q ss_pred EECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 045256 621 LLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV---LTAKSDVYGLGVVLLELLTGKRAIFKDDES 697 (789)
Q Consensus 621 ll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvil~elltG~~pf~~~~~~ 697 (789)
|++.++.+||+|||++........ ......||+.|+|||.+.... ++.++||||||+++|||++|+.||.....
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 245 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence 999999999999999976543322 122457899999999997654 47889999999999999999999954321
Q ss_pred CCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 698 GGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. . ....+.......+. .......+.+++.+||+.||++|||+.|++++
T Consensus 246 ----~--------~----~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 246 ----M--------C----LHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp ----H--------H----HHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ----H--------H----HHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 0 0 00111111111111 11223456778889999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.13 Aligned_cols=267 Identities=26% Similarity=0.387 Sum_probs=203.2
Q ss_pred ccccceEeecccEEEEEEEeC-----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--Ce
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DE 568 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~ 568 (789)
|++.+.||+|+||+||++.+. +++.||||++..... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG---PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC---hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 488999999999999988642 678999999865432 23345689999999999999999999999884 56
Q ss_pred EEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
.++||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 89999999999999998653 368899999999999999 99999999999999999999999999986544
Q ss_pred CCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ......+.........+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK---FLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh---hhhhhcccccchhHHHHHHH
Confidence 33211 122345788899999998888999999999999999999999998543210 00001111111122223333
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
+......+. .......+.+|+.+||+.||++|||+.|+++.|+++.+....
T Consensus 264 ~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 264 LERGERLPR--PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HhcccCCCC--CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 333222111 122334567788899999999999999999999999877654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.75 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=195.9
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||.||++... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC--HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 3578999999999999999999864 5889999997654332 233456889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc---EEEEeeccCcCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT---ARVSDFGLSMMG 639 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGls~~~ 639 (789)
+||||+++++|.+.+..+ ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 999999999999887653 358899999999999999 999999999999987655 999999999764
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----------------~~~~~~ 218 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----------------HRLYAQ 218 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHH
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----------------hHHHHH
Confidence 43322 1235689999999999999999999999999999999999999954321 000111
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 219 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111111112233456778889999999999999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=343.16 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=193.0
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++....... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD-PVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC-HHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 378999999999999999999865 68899999986543322 2334568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 99999999999998653 368899999999999998 9999999999999999999999999987644322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. .......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..+...+..
T Consensus 189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------------~~~~~~~~~ 249 (309)
T 2h34_A 189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------------------SVMGAHINQ 249 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------------------HHHHHHHHS
T ss_pred c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------------------HHHHHHhcc
Confidence 1 112245689999999999988999999999999999999999999854321 011111111
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-CHHHHHHHHHHHhhhccc
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERP-TMADIVANLERALDICDH 773 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~~~~~ 773 (789)
....+..........+.+++.+||+.||++|| +++++++.|+++++..+.
T Consensus 250 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 250 AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 11111111122334567788999999999999 999999999998776543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=347.55 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=189.0
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe---
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE--- 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 568 (789)
.++|++.+.||+|+||.||++.. .+++.||||++....... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS-HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC-HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 46899999999999999999986 578999999986543322 3344568999999999999999999999876543
Q ss_pred -EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 -RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 -~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.|+||||+++++|.++++.. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999998653 368899999999999998 999999999999999999999999999765
Q ss_pred CCCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-----------------~~~~ 229 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----------------SVAY 229 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------------HHHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-----------------HHHH
Confidence 433222 1222356899999999999889999999999999999999999999543320 0011
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHH-HHHHHHHHhh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMAD-IVANLERALD 769 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e-vl~~L~~~~~ 769 (789)
..+.....++..........+.+++.+||+.||++||+..+ +...|.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 230 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 11111111110000113345778889999999999996555 4455655543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=354.26 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=193.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||+|++....... ......+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 67999999999999999999865 57899999976543222 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 9999999999998754 357889999999999999 9999999999999999999999999997654332
Q ss_pred CCcccccccCcCccCccccCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 645 DFRPMKAAGTVGYIDPEYYGL---NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
......||+.|+|||++.. ..++.++||||||+++|||++|+.||....... .......+.
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------------~~~~~~~~~ 233 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--------------SKEIVHTFE 233 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--------------HHHHHHHHH
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--------------HHHHHHHHh
Confidence 2235679999999999863 458999999999999999999999996543210 001111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-HHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-MADIVA 762 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-~~evl~ 762 (789)
......+.. ....+..|+.+||+.||++||+ +.++++
T Consensus 234 ~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TTVVTYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HCCCCCCTT----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hcccCCCCc----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 222222222 2345667888999999999998 666654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=348.06 Aligned_cols=254 Identities=20% Similarity=0.190 Sum_probs=198.1
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 570 (789)
.++|++.+.||+|+||.||++.. .+++.||||++..... .+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 46899999999999999999985 5789999998754322 12478999999999 9999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc-----EEEEeeccC
Q 045256 571 LVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT-----ARVSDFGLS 636 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGls 636 (789)
+||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999999 89999998742 368899999999999998 999999999999999887 999999999
Q ss_pred cCCCCCCCCC-----cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 637 MMGPESERDF-----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 637 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
+......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~---~------ 226 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--L---K------ 226 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--H---H------
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--H---H------
Confidence 7643332211 1235679999999999999999999999999999999999999996543210 0 0
Q ss_pred hhhhhhHHhhcccCCCCCCC-HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 712 IMAGELVKILDRRVGPPEIN-EAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~-~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
.....+.+.....+... ....+ .+..++..||+.||++||++.++++.|+++++..
T Consensus 227 ---~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 227 ---ERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp ---HHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ---HHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 00011111000000000 00112 5677888999999999999999999999887643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.35 Aligned_cols=269 Identities=23% Similarity=0.352 Sum_probs=192.5
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhh--cCCCcceEEEEEEEeC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR--LHHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~---- 566 (789)
.++|++.+.||+|+||.||+++.. ++.||||++..... ..+..|.+++.. ++||||+++++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH-------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc-------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 368999999999999999999885 89999998753321 123445555544 4899999999999887
Q ss_pred CeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcC-----CCCeEeccCCCCCEEECCCCcEEEEeec
Q 045256 567 DERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYA-----VPPIIHRDIKSSNILLDAQWTARVSDFG 634 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfG 634 (789)
...++||||+++++|.++++.. ..++.|++.||+|||+.. .++|+||||||+|||++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 6789999999999999998643 368899999999999881 1239999999999999999999999999
Q ss_pred cCcCCCCCCCCC--cccccccCcCccCccccCCCCCCch------hHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 635 LSMMGPESERDF--RPMKAAGTVGYIDPEYYGLNVLTAK------SDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 635 ls~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
++.......... ......||+.|+|||++.......+ +||||||+++|||+||..|+....... .+.. .
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~-~p~~--~ 264 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ-LPYH--D 264 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC-CTTT--T
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc-ccHh--h
Confidence 996543332221 1224578999999999987766554 999999999999999955543221100 0000 0
Q ss_pred chhhhhhhhhhHHhhcc-cCCCCC---CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 707 FAVPAIMAGELVKILDR-RVGPPE---INEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~-~~~~~~---~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
............+.+.. .+.+.. ....+....+.+++.+||+.||++|||+.|++++|+++.+..+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 00000001111122211 111111 1123667788899999999999999999999999999877543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=347.94 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=194.2
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCe
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 568 (789)
...++|++.+.||+|+||.||+++.+ +++.||||+++...... ....+.+..|..++.++ +||||+++++++.+.+.
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34579999999999999999999875 68899999986543221 22344577899999887 89999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.|+||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 99999999999999998653 357899999999999998 9999999999999999999999999997543
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......+
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------------~~~~~~i 230 (345)
T 1xjd_A 170 LGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----------------EELFHSI 230 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHH
T ss_pred cCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----------------HHHHHHH
Confidence 2221 23356899999999999999999999999999999999999999964331 0011112
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHH-HHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMA-DIVA 762 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~ 762 (789)
.......+.. ....+.+++.+||..||++||++. |+++
T Consensus 231 ~~~~~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 231 RMDNPFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHCCCCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HhCCCCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 2222222222 234566788899999999999997 6653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=343.81 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=195.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||+++.+ +++.||+|++.+..... ....+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 57999999999999999999875 58899999987543322 23345688999999988 89999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999998653 357889999999999998 9999999999999999999999999997533222
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ........+...
T Consensus 165 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~--------~~~~~~~~i~~~ 234 (345)
T 3a8x_A 165 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------TEDYLFQVILEK 234 (345)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHHHHHHHC
T ss_pred C--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc--------cHHHHHHHHHcC
Confidence 1 223567999999999999999999999999999999999999999643221100000 000111122223
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH------HHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTM------ADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~------~evl~~ 763 (789)
.+..+.. ....+.+++.+||+.||++||++ .|++++
T Consensus 235 ~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 235 QIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCCCTT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCCCC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 3332322 23446677889999999999995 566654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=338.07 Aligned_cols=249 Identities=30% Similarity=0.461 Sum_probs=192.5
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHH---HHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEK---ESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||.||++.+ .+++.||+|++........... .+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6899999999999999999986 4789999999865433322221 256889999999999999999999986554
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc-----EEEEeecc
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT-----ARVSDFGL 635 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGl 635 (789)
++||||+++++|.+++.+. ..++.|+++||+|||+.+ ++|+||||||+|||++.++. +||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 7999999999999988543 358899999999999987 45999999999999988776 99999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCcccc--CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYY--GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
+...... .....+|+.|+|||.+ ....++.++||||||+++|||++|+.||.......
T Consensus 176 ~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------------- 235 (287)
T 4f0f_A 176 SQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--------------- 235 (287)
T ss_dssp CBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---------------
T ss_pred ccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---------------
Confidence 9753322 2245789999999998 45567899999999999999999999995433210
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
............... ........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 236 IKFINMIREEGLRPT--IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHHHHHhccCCCCC--CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 000111111111110 1112334567888899999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=339.69 Aligned_cols=258 Identities=20% Similarity=0.231 Sum_probs=200.7
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
..++|++.+.||+|+||.||++.. .+++.||+|++..... ...+.+|+.+++++ +|+|++++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 346899999999999999999985 5789999998754322 12478899999999 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc-----EEEEeecc
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT-----ARVSDFGL 635 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfGl 635 (789)
++||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 9999999 89999998742 258899999999999998 999999999999987776 99999999
Q ss_pred CcCCCCCCCC-----CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh
Q 045256 636 SMMGPESERD-----FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 636 s~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
+......... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---------- 227 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK---------- 227 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH----------
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH----------
Confidence 9765433221 1123457999999999999999999999999999999999999999664321100
Q ss_pred hhhhhhhHHhhcccCCCC-CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 711 AIMAGELVKILDRRVGPP-EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~~~~-~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
..+..+.......+ ..........+.+++.+||+.||++||+++++++.|+++++....
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 228 ----QKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp ----HHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ----HHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 00000000000000 000011234577888999999999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=349.23 Aligned_cols=247 Identities=25% Similarity=0.450 Sum_probs=187.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcE----EEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~----vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||.||++.+. +++. |++|.+..... ......+.+|+.++++++||||+++++++.+..
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS---CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 68999999999999999999854 4554 46666543222 123446889999999999999999999998754
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++|+||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 78999999999999998653 358899999999999998 999999999999999999999999999875
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------------------~~~~ 229 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEIS 229 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG------------------GGHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH------------------HHHH
Confidence 44443333334557889999999998899999999999999999999 9999854322 1111
Q ss_pred Hhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 719 KILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 719 ~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
+.+... ...+.. ....+..++.+||+.||++||++.|+++.|+++..
T Consensus 230 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 230 SILEKGERLPQPPI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHHHTTCCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHHHcCCCCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 122221 122222 23346678889999999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=345.13 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=195.8
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~ 570 (789)
.++|++.+.||+|+||.||+++.+ +++.||+|++....... ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 478999999999999999999876 47889999976543222 22345678899999988 7999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999998753 257899999999999998 999999999999999999999999999753322
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...+. ......++.
T Consensus 175 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------------~~~~~~i~~ 235 (353)
T 2i0e_A 175 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------------DELFQSIME 235 (353)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHH
T ss_pred C--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHHh
Confidence 2 122356799999999999999999999999999999999999999964321 111222333
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
..+..+.. ....+.+|+.+||..||++||+ ++|++++
T Consensus 236 ~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 236 HNVAYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCCCCCTT----SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 33332322 2345667888999999999995 5777664
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.25 Aligned_cols=262 Identities=19% Similarity=0.273 Sum_probs=190.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.||+|++...... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc--CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 57999999999999999999875 6889999998654322 22334688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++ +|.+.+.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 999986 66665543 2368899999999999998 9999999999999999999999999997654332
Q ss_pred CCCcccccccCcCccCccccCCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch-hh-hhhhhhhHHh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNV-LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA-VP-AIMAGELVKI 720 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~ 720 (789)
. ......+|+.|+|||++.+.. ++.++||||||+++|||++|+.||+...........+.... .+ ........+.
T Consensus 156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 2 222457899999999997665 79999999999999999999998765432110000000000 00 0000000000
Q ss_pred hccc-------CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRR-------VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~-------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.. ..............+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000000111233456778899999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=362.29 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=199.7
Q ss_pred HHHHHHHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEE
Q 045256 484 FLLAELAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGY 562 (789)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 562 (789)
+.+.++....++|++.++||+|+||+||+++++ +++.||+|++.+..... ......+.+|..++.+++||||++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 345566677889999999999999999999876 47889999976533221 1223348899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
|.+.+..||||||+++|+|.+++.+. ..++.|++.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999999752 247889999999999999 999999999999999999999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 708 (789)
|+++....... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...+..
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~----------- 287 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV----------- 287 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----------
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----------
Confidence 99976443322 1223457999999999986 567899999999999999999999999654320
Q ss_pred hhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCC--CCCHHHHHHH
Q 045256 709 VPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKE--RPTMADIVAN 763 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~--RPt~~evl~~ 763 (789)
+...+++.. .+..+.. .......+.+|+.+||..+|++ ||+++|++++
T Consensus 288 ------~~~~~i~~~~~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 288 ------ETYGKIMNHKERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ------HHHHHHHTHHHHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ------HHHHhhhhccccccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 011111111 1111111 0112334567788899888888 9999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.54 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=188.4
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC--CCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH--HKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||++...+++.||||++...... ....+.+.+|+++|++++ ||||+++++++...+..|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc--HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 469999999999999999999888999999997654322 234456899999999996 5999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||| +.+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||++.......
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 5678999998643 368899999999999998 99999999999996 5799999999998754443
Q ss_pred CCCcccccccCcCccCccccCC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-----------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 712 (789)
.........||+.|+|||++.. ..++.++|||||||+||||++|+.||....+
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---------------- 272 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN---------------- 272 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----------------
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----------------
Confidence 3223335679999999999854 4688999999999999999999999954321
Q ss_pred hhhhhHHhhcccC--CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGELVKILDRRV--GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~~~~~~d~~~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+..+++... ..+... ...+.+|+.+||+.||++||++.|++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 273 QISKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHHHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhCccccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 0112223333221 112222 2346678889999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=349.00 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=187.5
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--CcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--KHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~ 570 (789)
.++|++.+.||+|+||.||++...+++.||||++...... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc--hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 4679999999999999999999888999999997654322 2334568999999999976 99999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
+||| +.+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||++......
T Consensus 86 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 86 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999 4578999998653 368899999999999998 99999999999997 578999999999876544
Q ss_pred CCCCcccccccCcCccCccccCC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL-----------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
..........||+.|+|||++.. ..++.++||||||+++|||++|+.||.....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------------- 225 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--------------- 225 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS---------------
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh---------------
Confidence 33333335679999999999854 6789999999999999999999999954221
Q ss_pred hhhhhhHHhhcccC--CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRV--GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+...++... ..+... ...+.+|+.+||+.||++|||+.|++++
T Consensus 226 -~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 226 -QISKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -HHHHHHHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHhcCCcccCCcccC----CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 0111222232221 112222 2345678889999999999999999876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=357.06 Aligned_cols=256 Identities=24% Similarity=0.313 Sum_probs=199.2
Q ss_pred HHHHHHHHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEE
Q 045256 484 FLLAELAAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGY 562 (789)
Q Consensus 484 ~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 562 (789)
+.+.+.....++|++.+.||+|+||.||+++.+ +++.||||++.+..... ....+.+.+|..++.+++||||++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK-RGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-HGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-HHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 445566667789999999999999999999875 68999999986533222 2223458899999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
+.+.+..||||||+++|+|.+++.+. ..++.|++.||+|||+.+ |+||||||+|||++.++++||+||
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999999753 247889999999999999 999999999999999999999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccC-------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYG-------LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
|+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------- 276 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--------- 276 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---------
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---------
Confidence 99976543322 1223457999999999986 457899999999999999999999999654320
Q ss_pred chhhhhhhhhhHHhhc--ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCC---CCHHHHHHH
Q 045256 707 FAVPAIMAGELVKILD--RRVGPPEINEAEAVELVAYTAMHCVNLEGKER---PTMADIVAN 763 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d--~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R---Pt~~evl~~ 763 (789)
+...+++. ..+..+. ........+.+|+.+||. +|++| |+++|++++
T Consensus 277 --------~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 277 --------ETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --------HHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --------HHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 01111111 1111111 011233456778889998 99998 689998775
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=340.16 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=188.0
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.+.||+|+||+||+++..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc--cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 579999999999999999999888999999997654322 122345789999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 99986 998887642 358899999999999998 99999999999999999999999999865432211
Q ss_pred CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc-hhh-hhhhhhhHHh-
Q 045256 645 DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF-AVP-AIMAGELVKI- 720 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~- 720 (789)
......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... ..... ..+ ........+.
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM-RIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCCTTTSTTGGGST
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHHCCCChhhchhhhccc
Confidence 1123468999999999865 458999999999999999999999996543210000 00000 000 0000000000
Q ss_pred -hcccCCCC-----CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 -LDRRVGPP-----EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 -~d~~~~~~-----~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+...... ..........+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 00001123456678889999999999999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=337.65 Aligned_cols=249 Identities=23% Similarity=0.387 Sum_probs=186.5
Q ss_pred cCCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
.++|++.+.||+|+||.||++.... +..||+|++..... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 4689999999999999999998643 45699998764322 233456889999999999999999999984 567
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 89999999999999998643 257889999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... .......+++.|+|||.+....++.++||||||+++|||++ |+.||...... +...
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-----------------~~~~ 228 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----------------DVIG 228 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------------GHHH
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-----------------HHHH
Confidence 43321 12223456789999999988889999999999999999997 88898543220 0011
Q ss_pred Hhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+... ....+. .....+.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 229 ~i~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 229 RIENGERLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111 111112 2234567788899999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=344.04 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=202.2
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEE
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLV 560 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~ 560 (789)
++....++|++.+.||+|+||.||++.. .+++.||||++..... ......+.+|+++++++ +||||++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT---HSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC---cHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3344567899999999999999999974 3568899999765432 22344688999999999 799999999
Q ss_pred EEEEeCCe-EEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccC
Q 045256 561 GYCEEKDE-RLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDI 615 (789)
Q Consensus 561 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dl 615 (789)
+++...+. .++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 99987654 89999999999999998643 247889999999999998 999999
Q ss_pred CCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 045256 616 KSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKD 694 (789)
Q Consensus 616 kp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~ 694 (789)
||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||+| |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544433333334567889999999988889999999999999999998 99998543
Q ss_pred CCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 695 DESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
.... .....+... .....+.. ....+.+++.+||+.||++|||+.|++++|+++++..
T Consensus 255 ~~~~-------------~~~~~~~~~--~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDE-------------EFCRRLKEG--TRMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSH-------------HHHHHHHHT--CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhH-------------HHHHHhccC--ccCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 2200 000011110 11111222 2234667888999999999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=350.62 Aligned_cols=264 Identities=19% Similarity=0.276 Sum_probs=194.1
Q ss_pred CCccccceEeec--ccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 494 NNFSLENKIGAG--SFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
++|++.+.||+| +||.||+++.. +++.||||++...... .+..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 579999999999 99999999875 6899999998654322 234556889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999998653 258899999999999999 9999999999999999999999999875432
Q ss_pred CCCC-----CCcccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh-
Q 045256 641 ESER-----DFRPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI- 712 (789)
Q Consensus 641 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~- 712 (789)
.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||............+.. ..+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 258 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLL 258 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC-CCCccc
Confidence 1111 111223478999999999987 67899999999999999999999999654332110000000 00000
Q ss_pred -----hhh-------------hhHHhhcccC-------CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 -----MAG-------------ELVKILDRRV-------GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 -----~~~-------------~~~~~~d~~~-------~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
... .+.+.+.... .............+.+|+.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000 0000000000 00000112234567788999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=348.34 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=200.4
Q ss_pred hcCCccccceEeecccEEEEEEEeCC------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
..++|++.+.||+|+||.||++.... .+.||+|.+..... ....+.+.+|+++++++ +||||+++++++.
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH---ADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC---hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34789999999999999999998642 24799998765432 22345688999999999 8999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh----------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR----------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL 622 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~----------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll 622 (789)
+.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 999999999999999999998643 247789999999999998 9999999999999
Q ss_pred CCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 045256 623 DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTP 701 (789)
Q Consensus 623 ~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~ 701 (789)
+.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---- 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN---- 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS----
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh----
Confidence 9999999999999976433332222234457889999999988889999999999999999999 88888543220
Q ss_pred cccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 702 VSLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
....+.+... ...+... ...+..++.+||+.||++|||+.|+++.|+++....+
T Consensus 274 -------------~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 274 -------------SKFYKLVKDGYQMAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp -------------HHHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -------------HHHHHHHhcCCCCCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 0111111111 1111112 3456778889999999999999999999999876543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.20 Aligned_cols=244 Identities=25% Similarity=0.407 Sum_probs=191.7
Q ss_pred cCCccccceEeecccEEEEEEEeCC-C-------cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD-G-------QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 564 (789)
.++|++.+.||+|+||.||++.... + +.||+|++..... ...+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR----NYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG----GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH----HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 3679999999999999999997543 3 4699998754332 23446889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc--------
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT-------- 627 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------- 627 (789)
+.+..++||||+++++|.+++.... .++.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccce
Confidence 9999999999999999999987532 57899999999999999 999999999999998887
Q ss_pred EEEEeeccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 628 ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 628 ~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
+||+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|++.....
T Consensus 160 ~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--------- 224 (289)
T 4fvq_A 160 IKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--------- 224 (289)
T ss_dssp EEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------
T ss_pred eeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---------
Confidence 999999998653221 23457899999999977 77899999999999999999976665433220
Q ss_pred chhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.............+... ...+.+++.+||+.||++|||+.|++++|++++.-
T Consensus 225 --------~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 225 --------QRKLQFYEDRHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp --------HHHHHHHHTTCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred --------HHHHHHhhccCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 00111111111111111 22356788899999999999999999999998653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=342.88 Aligned_cols=263 Identities=21% Similarity=0.342 Sum_probs=196.4
Q ss_pred CCccccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK-- 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 566 (789)
++|++.+.||+|+||.||++++ .+++.||+|++..... ....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence 4588999999999999999983 4688999999765432 22345688999999999999999999999876
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
...++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 5689999999999999998543 258899999999999998 9999999999999999999999999997
Q ss_pred CCCCCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 638 MGPESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 638 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+...... ................
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTHGQMTVTR 251 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCCGGGHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcccccCHHH
Confidence 65443321 1222456788899999998888999999999999999999999886322100 0000000000001111
Q ss_pred hHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 717 LVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 717 ~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
+...+... ...+. .....+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 252 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPP----NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp HHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHhccCCCCCCC----CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 22222221 11122 233456778889999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.16 Aligned_cols=247 Identities=28% Similarity=0.453 Sum_probs=188.4
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.+.||+|+||.||+++. .++.||+|++.... ..+.|.+|++++++++||||+++++++. +..++||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES------ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT------HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh------HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence 5789999999999999999987 47899999975422 2346889999999999999999999876 4579999
Q ss_pred EecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc-EEEEeeccCcCCCC
Q 045256 574 DYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT-ARVSDFGLSMMGPE 641 (789)
Q Consensus 574 e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfGls~~~~~ 641 (789)
||+++++|.+++... ..++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 999999999998643 256789999999999943223999999999999988876 79999999875432
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. ....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . .. ......
T Consensus 159 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~--------~~----~~~~~~ 218 (307)
T 2eva_A 159 HM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP---A--------FR----IMWAVH 218 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS---H--------HH----HHHHHH
T ss_pred cc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc---H--------HH----HHHHHh
Confidence 21 2346899999999999999999999999999999999999998543220 0 00 000011
Q ss_pred cc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 722 DR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 722 d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
.. ..... ......+.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus 219 ~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 219 NGTRPPLI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp TTCCCCCB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred cCCCCCcc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11 11111 12234567788999999999999999999999998776543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=347.26 Aligned_cols=267 Identities=22% Similarity=0.363 Sum_probs=198.7
Q ss_pred CCccccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--C
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--K 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~ 566 (789)
++|++.+.||+|+||.||++++ .+++.||||++..... ...+.+.+|++++++++||||+++++++.. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP----DQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH----HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH----HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 5799999999999999999983 4678999999765432 234468899999999999999999999874 4
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
...++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 5689999999999999998652 257889999999999998 9999999999999999999999999997
Q ss_pred CCCCCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 638 MGPESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 638 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.||....... ...............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCERDVPALSR 252 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC----CCHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhcccccccccHHH
Confidence 65433321 12223467888999999988889999999999999999999999985432100 000000000000111
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
+.+.+......+. .......+.+++.+||+.||++|||+.|++++|++++....
T Consensus 253 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 253 LLELLEEGQRLPA--PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHHhhcccCCCC--CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 2222222221111 12234456778889999999999999999999999876443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=335.06 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=194.0
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--CeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK--DERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--~~~~l 571 (789)
++|++.+.||+|+||.||++.++ ++.||+|++...... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS--TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC--HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 57999999999999999999984 889999997654322 23345689999999999999999999999887 67899
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ ++|+||||||+|||++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999999753 257899999999999976 5599999999999999999999999998754221
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCc---hhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTA---KSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||..... .....
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------------~~~~~ 221 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----------------MEIGM 221 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----------------HHHHH
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----------------HHHHH
Confidence 2346799999999997655444 89999999999999999999854321 00011
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.......... .+......+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 222 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 222 KVALEGLRPT--IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp HHHHSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred HHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111111110 011223456778889999999999999999999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.96 Aligned_cols=247 Identities=22% Similarity=0.362 Sum_probs=195.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhH--HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKF--QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
++|++.+.||+|+||.||++... +++.||+|++........ ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 56999999999999999999865 689999999765433221 112456889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC----cEEEEeeccCcC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW----TARVSDFGLSMM 638 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGls~~ 638 (789)
+||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 999999999999998643 368899999999999998 99999999999999887 799999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... .....||+.|+|||.+....++.++||||||+++|||++|+.||..... ...+.
T Consensus 169 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------------~~~~~ 228 (321)
T 2a2a_A 169 IEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------------QETLA 228 (321)
T ss_dssp CCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----------------HHHHH
T ss_pred cCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHH
Confidence 543321 2245689999999999989999999999999999999999999954321 00111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 229 NITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111111110011223457788999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=335.19 Aligned_cols=247 Identities=26% Similarity=0.447 Sum_probs=198.4
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 3679999999999999999999888899999997654322 23588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999998653 257889999999999999 9999999999999999999999999987543221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||..... ......+..
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~~i~~ 220 (267)
T 3t9t_A 159 Y-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----------------SEVVEDIST 220 (267)
T ss_dssp H-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHHHHHT
T ss_pred c-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----------------HHHHHHHhc
Confidence 1 11123456788999999988889999999999999999999 8888854321 000111111
Q ss_pred c-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 723 R-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 723 ~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
. ....+.. ....+.+++.+||+.||++||++.|++++|+++.+
T Consensus 221 ~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 221 GFRLYKPRL----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TCCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCCCcc----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 1111121 23456778889999999999999999999999865
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=361.25 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=194.5
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||+|.++++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..++|
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 357889999999999999999998888899999865432 12458999999999999999999999876 678999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++|+|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 9999999999998642 257899999999999998 999999999999999999999999999765432
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......++..|+|||.+....++.++||||||++||||++ |+.||..... .++.+.+
T Consensus 334 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------------------~~~~~~i 394 (452)
T 1fmk_A 334 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------------REVLDQV 394 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------------HHHHHHH
T ss_pred cee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHH
Confidence 211 1123356789999999988899999999999999999999 8999854321 0111111
Q ss_pred cc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 722 d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
.. +++.+. .....+.+++.+||+.||++|||++++++.|+++....+
T Consensus 395 ~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 395 ERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp HTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred HcCCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11 222222 234456778889999999999999999999999876543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.97 Aligned_cols=254 Identities=29% Similarity=0.501 Sum_probs=194.4
Q ss_pred cCCccccceEeecccEEEEEEEeCC-----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD-----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
.++|++.+.||+|+||.||+|.... +..||+|++..... ......+.+|++++++++||||+++++++.+.+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT---EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 3678889999999999999997642 23599999765332 223446889999999999999999999999999
Q ss_pred eEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999998643 258899999999999998 99999999999999999999999999976
Q ss_pred CCCCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 639 GPESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 639 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
....... .......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... .+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----------------~~~ 259 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----------------HEV 259 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----------------HHH
Confidence 5433221 11222346788999999988899999999999999999999 9999854321 001
Q ss_pred hHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 717 LVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 717 ~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
...+.+. +...+. .....+.+++.+||+.||++||++.|+++.|+++++..+.
T Consensus 260 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 260 MKAINDGFRLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp HHHHHTTCCCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HHHHHCCCcCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 1111111 122222 2334567788899999999999999999999999876544
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=367.26 Aligned_cols=245 Identities=27% Similarity=0.451 Sum_probs=198.1
Q ss_pred CCccccceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+|.+.. ++.||||+++.... ..+.|.+|+++|++++||||+++++++.+.+..++|
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 568899999999999999998764 78999999865432 234589999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++|+|.++|+.. ..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999642 257889999999999998 999999999999999999999999999865433
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. .......++..|+|||.+....++.++||||||++||||++ |+.||...+. ..+.+.+
T Consensus 372 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------------------~~~~~~~ 432 (495)
T 1opk_A 372 TY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------------SQVYELL 432 (495)
T ss_dssp CE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------------------GGHHHHH
T ss_pred ce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHH
Confidence 21 11223346789999999988889999999999999999999 8888854321 0111112
Q ss_pred cc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 722 d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.. ++..+.. ....+.+|+.+||+.||++|||+.|+++.|+.+++
T Consensus 433 ~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 433 EKDYRMERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp HTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HcCCCCCCCCC----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 22 1222222 23456778889999999999999999999998754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.89 Aligned_cols=245 Identities=23% Similarity=0.349 Sum_probs=184.1
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||+++.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 368999999999999999999875 7889999997653322 2347799999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc--EEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT--ARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfGls~~~~~ 641 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999999998643 368899999999999999 999999999999987765 99999999874322
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAK-SDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||........ ....+..+
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------------~~~~~~~~ 234 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-------------YRKTIQRI 234 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-------------HHHHHHHH
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-------------HHHHHHHH
Confidence 21 1224578999999999987777655 8999999999999999999965433111 01111222
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+.. ......+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 235 LSVKYSIPDD--IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp HTTCCCCCTT--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hcCCCCCCCc--CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 2222211111 1122445678889999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=346.88 Aligned_cols=252 Identities=24% Similarity=0.429 Sum_probs=199.0
Q ss_pred HhcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 564 (789)
...++|++.+.||+|+||.||+|... +++.||+|++..... ......+.+|++++++++||||+++++++.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC---HHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC---HHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 34578999999999999999999754 367899999764332 223446889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 626 (789)
+.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 999999999999999999998642 247889999999999998 99999999999999999
Q ss_pred cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccc
Q 045256 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 627 ~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~ 705 (789)
.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------- 246 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------- 246 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---------
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---------
Confidence 999999999875433222222223456889999999988889999999999999999999 7888754321
Q ss_pred cchhhhhhhhhhHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 706 DFAVPAIMAGELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
......+..... ..+. .....+.+++.+||+.||++|||+.|++++|+++++
T Consensus 247 --------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 --------EQVLRFVMEGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp --------HHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred --------HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 001111111111 1112 223456778889999999999999999999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=333.00 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=193.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 357999999999999999999865 4678999987654332 23458899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---CCCCcEEEEeeccCcCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGls~~~~ 640 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999988643 368899999999999999 9999999999999 788999999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .....+|+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ......+
T Consensus 161 ~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------------~~~~~~~ 219 (277)
T 3f3z_A 161 PGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-----------------SEVMLKI 219 (277)
T ss_dssp TTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHH
T ss_pred Cccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHH
Confidence 3322 2245689999999998754 89999999999999999999999854321 0111112
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 220 REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2222221111111234567788999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.06 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=174.2
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++.. .+++.||+|++....... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh-hhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 35799999999999999999986 478999999976432211 2224568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999998753 258899999999999998 999999999999999999999999998764432
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
... .....+|+.|+|||.+....++.++||||||+++|||++|+.||........ +.....
T Consensus 166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~~ 226 (278)
T 3cok_A 166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------LNKVVL 226 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCS
T ss_pred CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------HHHHhh
Confidence 211 1235689999999999988899999999999999999999999965432110 001111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 227 ADYEMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SCCCCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccCCccc----cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11111111 22346678889999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=350.95 Aligned_cols=268 Identities=21% Similarity=0.291 Sum_probs=203.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC--eE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD--ER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~--~~ 569 (789)
.++|++.++||+|+||+||++.+. +++.||||++...... ...+.+.+|++++++++||||+++++++.+.. ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL---RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG---SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc---chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 357999999999999999999875 4899999998653322 22345789999999999999999999998765 67
Q ss_pred EEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----CCCCcEEEEeec
Q 045256 570 LLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL----DAQWTARVSDFG 634 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG 634 (789)
++||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999998653 257899999999999999 9999999999999 788889999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccCC--------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGL--------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
+++....... .....||+.|+|||++.. ..++.++||||||+++|||++|+.||............+..
T Consensus 162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 162 AARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp GCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred CceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 9976543322 224568999999999854 56788999999999999999999999654321111100000
Q ss_pred chhhhhhhhh---hHH------hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 707 FAVPAIMAGE---LVK------ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 707 ~~~~~~~~~~---~~~------~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
... ...... +.+ .....++............+..++.+||+.||++||++.|+++.++++++.
T Consensus 239 ~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 239 IIT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred Hhc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 000 000000 000 001122223333467788889999999999999999999999999998763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=345.03 Aligned_cols=242 Identities=20% Similarity=0.328 Sum_probs=170.8
Q ss_pred ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEEEEecC
Q 045256 500 NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
+.||+|+||.||++... +++.||||++.... ...+.+|+.+++++. ||||+++++++.+....|+||||++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh-------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 78999999999999875 68999999975421 234778999999997 9999999999999999999999999
Q ss_pred CCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC---cEEEEeeccCcCCCCCCCCC
Q 045256 578 NGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 578 ~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfGls~~~~~~~~~~ 646 (789)
+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||++........
T Consensus 90 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-- 164 (325)
T 3kn6_A 90 GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-- 164 (325)
T ss_dssp SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence 99999998753 368899999999999998 99999999999997665 899999999976443322
Q ss_pred cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCC
Q 045256 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 726 (789)
......+|+.|+|||++....++.++||||||+++|||++|+.||.......... . ..+.+..+......
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~------~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT----S------AVEIMKKIKKGDFS 234 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC----C------HHHHHHHHTTTCCC
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc----c------HHHHHHHHHcCCCC
Confidence 1224568999999999999999999999999999999999999996543311000 0 01111222222222
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+..........+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 2221123345667888999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=350.42 Aligned_cols=242 Identities=23% Similarity=0.377 Sum_probs=182.4
Q ss_pred CCcccc-ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhh-cCCCcceEEEEEEEe----C
Q 045256 494 NNFSLE-NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR-LHHKHLVRLVGYCEE----K 566 (789)
Q Consensus 494 ~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~-l~HpnIv~l~~~~~~----~ 566 (789)
++|.+. ++||+|+||+||++... +++.||||++... ..+.+|++++.+ .+||||+++++++.. .
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 467666 78999999999999865 6889999997532 135678887754 489999999999876 5
Q ss_pred CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEee
Q 045256 567 DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDF 633 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 633 (789)
...||||||+++|+|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence 6689999999999999998653 258899999999999998 999999999999987 789999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
|+++...... ......||+.|+|||++....++.++|||||||+||||++|+.||..........
T Consensus 209 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------------ 273 (400)
T 1nxk_A 209 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------------ 273 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC------------
T ss_pred ccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH------------
Confidence 9997643322 1224578999999999999999999999999999999999999997654321110
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+.......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 274 -~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 274 -GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -SHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011111111111111112234556788999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.86 Aligned_cols=241 Identities=27% Similarity=0.334 Sum_probs=184.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHH-HhhcCCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAF-LSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~-l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||+++.+ +++.||||++.+...... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 57999999999999999999875 578899999876543222 223346667766 577899999999999999999999
Q ss_pred EEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++|+|.+++.... .++.|++.||+|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 999999999999986532 47889999999999999 9999999999999999999999999997532221
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
......+||+.|+|||++.+..++.++||||||+++|||++|+.||...+. .+....++..
T Consensus 194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----------------~~~~~~i~~~ 254 (373)
T 2r5t_A 194 --STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----------------AEMYDNILNK 254 (373)
T ss_dssp --CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----------------HHHHHHHHHS
T ss_pred --CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHHhc
Confidence 122356899999999999999999999999999999999999999965321 1112223333
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl 761 (789)
.+..+... ...+.+|+.+||+.||++||++.+.+
T Consensus 255 ~~~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 255 PLQLKPNI----TNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp CCCCCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred ccCCCCCC----CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 33322222 33466778899999999999985433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.91 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=186.8
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||||++....... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-hHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 367999999999999999999864 68999999976532211 2233457889999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.+++... ..++.|+++||+|||+ .+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 99999999999998643 3578899999999998 77 999999999999999999999999999754332
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. ......||+.|+|||++.+..++.++||||||++||||++|+.||...+. ......+..
T Consensus 303 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------------~~~~~~i~~ 363 (446)
T 4ejn_A 303 GA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------------EKLFELILM 363 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHH
T ss_pred Cc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----------------HHHHHHHHh
Confidence 22 22346799999999999999999999999999999999999999964321 011112222
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.....+... ...+.+|+.+||+.||++|| +++|++++
T Consensus 364 ~~~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 EEIRFPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CCCCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 222222222 24466788899999999999 99999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.01 Aligned_cols=256 Identities=28% Similarity=0.386 Sum_probs=188.7
Q ss_pred HhcCCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
...++|.+.+.||+|+||.||++... +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS--QREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc--hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 34578999999999999999999753 3457999997654322 23345688999999999999999999999876
Q ss_pred Ce-----EEEEEEecCCCchhHHHhh--------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc
Q 045256 567 DE-----RLLVYDYMKNGALYDHLHD--------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT 627 (789)
Q Consensus 567 ~~-----~~lv~e~~~~gsL~~~l~~--------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 627 (789)
+. .++||||+++++|.+++.. ...++.|+++||.|||+.+ |+||||||+|||++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 53 4999999999999999832 2368899999999999998 999999999999999999
Q ss_pred EEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccccc
Q 045256 628 ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 628 ~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~ 706 (789)
+||+|||++................+++.|+|||.+....++.++||||||+++|||++ |+.||......
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------- 256 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------- 256 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---------
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---------
Confidence 99999999976544332222233457889999999998899999999999999999999 88887543210
Q ss_pred chhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 707 FAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
.....+... ....+. .....+.+++.+||+.||++||++.|++++|+++++...
T Consensus 257 --------~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 257 --------EMYDYLLHGHRLKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp --------GHHHHHHTTCCCCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred --------HHHHHHHcCCCCCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 001111111 111111 233456778889999999999999999999999987543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=354.72 Aligned_cols=242 Identities=27% Similarity=0.452 Sum_probs=196.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||+|... +|+.||||++....... .+....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH-TTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 67999999999999999999875 78999999976543221 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++.+. ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 9999999999998643 368899999999999998 99999999999999999999999999976543321
Q ss_pred CCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ......+.+.
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----------------~~~~~~i~~~ 231 (476)
T 2y94_A 172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----------------PTLFKKICDG 231 (476)
T ss_dssp ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----------------HHHHHHHHTT
T ss_pred ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----------------HHHHHHHhcC
Confidence 224579999999999987765 6899999999999999999999964321 0111222233
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+.... ..+.+|+.+||+.||++|||+.|++++
T Consensus 232 ~~~~p~~~s----~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 IFYTPQYLN----PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CCCCCTTCC----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CcCCCccCC----HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 232222222 345678889999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.50 Aligned_cols=250 Identities=23% Similarity=0.411 Sum_probs=197.8
Q ss_pred CCccccc-eEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLEN-KIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|.+.+ .||+|+||.||++.+. +++.||+|+++.... ....+.+.+|++++++++||||+++++++ +.+..
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 84 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL 84 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc---hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence 5676666 9999999999999753 577899999875432 23345688999999999999999999999 55678
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999998532 368899999999999998 9999999999999999999999999997654
Q ss_pred CCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... ......+|+.|+|||.+....++.++||||||+++|||++ |+.||..... ..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------------------~~~~ 223 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------------PEVM 223 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------------------HHHH
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------------------HHHH
Confidence 332211 1223456889999999988889999999999999999999 9999854332 0011
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
+.+.. ....+. .....+.+++.+||+.||++||++.|++++|++++....
T Consensus 224 ~~i~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 224 AFIEQGKRMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCcCCCCC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11111 111112 233456778889999999999999999999999987654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.04 Aligned_cols=241 Identities=27% Similarity=0.394 Sum_probs=190.7
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|++.+.||+|+||.||+++. .+++.||||++....... .+..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 4588999999999999999986 578999999976543222 33445688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||++ |+|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99997 5888887532 358899999999999998 999999999999999999999999999764322
Q ss_pred CCCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
....||+.|+|||++. ...++.++||||||+++|||++|+.||..... ...+..+
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----------------~~~~~~~ 265 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------------MSALYHI 265 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------------HHHHHHH
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----------------HHHHHHH
Confidence 2357899999999983 56789999999999999999999999864321 0011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
........ ........+.+++.+||+.||++|||+.|++++.
T Consensus 266 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 266 AQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp HHSCCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred HhcCCCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11111110 0112234567788899999999999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.13 Aligned_cols=247 Identities=22% Similarity=0.368 Sum_probs=192.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhH--HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKF--QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
++|++.+.||+|+||.||++... +++.||+|++........ ....+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56999999999999999999876 689999998765433221 112456889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC----cEEEEeeccCcC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW----TARVSDFGLSMM 638 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGls~~ 638 (789)
+||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999999998643 368899999999999998 99999999999998877 899999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... .....+++.|+|||.+....++.++||||||+++|||++|+.||..... ...+.
T Consensus 162 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~ 221 (283)
T 3bhy_A 162 IEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----------------QETLT 221 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHH
T ss_pred ccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----------------HHHHH
Confidence 443321 1234689999999999988999999999999999999999999854321 00111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.......+..........+.+++.+||+.||++||++.|++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 222 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 111111111110011223457788999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=332.63 Aligned_cols=250 Identities=26% Similarity=0.446 Sum_probs=198.2
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++. .+..++
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 4468999999999999999999988888999998765332 1345889999999999999999999986 456899
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 99999999999998643 257899999999999999 99999999999999999999999999976543
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... . .....+
T Consensus 162 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------------~----~~~~~~ 223 (279)
T 1qpc_A 162 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------------P----EVIQNL 223 (279)
T ss_dssp SCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------H----HHHHHH
T ss_pred cccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------------H----HHHHHH
Confidence 3211 1123456789999999988889999999999999999999 8888854321 0 001111
Q ss_pred hcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 721 LDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 721 ~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
... ....+. .....+.+++.+||+.||++|||+.++++.|++++....
T Consensus 224 ~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 224 ERGYRMVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred hcccCCCCcc----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111 111111 223456778889999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.49 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=195.6
Q ss_pred CccccceEeecccEEEEEEEeC-CC---cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE-
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DG---QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER- 569 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~- 569 (789)
.|.+.++||+|+||+||++.+. ++ ..||+|++..... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE---MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 4666799999999999999753 22 3699998764332 23345688999999999999999999999877665
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+.+++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999998652 257889999999999998 9999999999999999999999999997643
Q ss_pred CCCC--CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESER--DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.... ........+++.|+|||.+.+..++.++||||||+++|||++|+.|++..... ..+.
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-----------------~~~~ 238 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----------------FDLT 238 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----------------GGHH
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-----------------HHHH
Confidence 3221 11222346789999999999999999999999999999999977776543220 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
+.+.. ....+.. ....+.+++.+||+.||++|||++|+++.|++++....
T Consensus 239 ~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 239 HFLAQGRRLPQPEY----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred HHhhcCCCCCCCcc----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 11111 1111221 23456778889999999999999999999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=335.80 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=190.4
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++.. .+++.||+|++....... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD-AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 5799999999999999999986 478999999976532222 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 573 YDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
|||+++++|.+++... ..++.++++||.|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999988641 258899999999999998 9999999999999999999999999987643
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... ......+++.|+|||.+....++.++||||||+++|||++|+.||...... .. .....+
T Consensus 188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~---------~~~~~~ 250 (310)
T 2wqm_A 188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LY---------SLCKKI 250 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HH---------HHHHHH
T ss_pred CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HH---------HHHHHh
Confidence 3221 122346899999999999989999999999999999999999998643210 00 000111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
........ ........+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 251 ~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 251 EQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp HTTCSCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hcccCCCC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11111110 011223456778889999999999999999999999876544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.38 Aligned_cols=243 Identities=26% Similarity=0.423 Sum_probs=192.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++....... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-HTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch-hhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 367999999999999999999865 57789999876533222 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999998643 368899999999999998 9999999999999999999999999986533322
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+...
T Consensus 164 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~~~~~~~ 222 (279)
T 3fdn_A 164 ----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------------QETYKRISRV 222 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHHT
T ss_pred ----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----------------HHHHHHHHhC
Confidence 1245789999999999999999999999999999999999999854321 0011111112
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
....+.. ....+.+|+.+||+.||++|||++|++++-
T Consensus 223 ~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 EFTFPDF----VTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CCCCCTT----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCCCCCc----CCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 2222222 234466788899999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.56 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=193.3
Q ss_pred cCCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-CC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-KD 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~ 567 (789)
..+|++.+.||+|+||.||+|...+ ...+|+|.+..... ....+.+.+|+.++++++||||+++++++.+ .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC---HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 3578899999999999999998643 23589998764322 2334568899999999999999999998654 55
Q ss_pred eEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 789999999999999998642 257889999999999998 99999999999999999999999999976
Q ss_pred CCCCCCC--CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 639 GPESERD--FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 639 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
....... .......+|+.|+|||.+.+..++.++||||||+++|||++|..|++....... .
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----------------~ 241 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----------------I 241 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT----------------H
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH----------------H
Confidence 5433211 112234577899999999888999999999999999999996555433322110 0
Q ss_pred hHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 717 LVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 717 ~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
...+... ....+.. ....+.+++.+||+.||++|||++|+++.|+++++...
T Consensus 242 ~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 242 TVYLLQGRRLLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHhcCCCCCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0111111 1111222 22356778889999999999999999999999987644
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.72 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=197.9
Q ss_pred HHHhcCCccccc-eEeecccEEEEEEEe---CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE
Q 045256 489 LAAATNNFSLEN-KIGAGSFGVVYKGKL---PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE 564 (789)
Q Consensus 489 l~~~~~~~~~~~-~LG~G~~g~Vy~~~~---~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 564 (789)
+....++|.+.+ .||+|+||.||++.+ .+++.||||++...... ....+.+.+|++++++++||||+++++++
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 334456788888 999999999999954 34678999997654322 23345689999999999999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
+.+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 567789999999999999998653 268899999999999998 999999999999999999999999999
Q ss_pred cCCCCCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 637 MMGPESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 637 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
.......... ......+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------------ 226 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------------ 226 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------------
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------------------
Confidence 7654433211 1122346788999999988889999999999999999999 9999854321
Q ss_pred hhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 715 GELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 715 ~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
..+.+.+.. ....+. .....+.+++.+||+.||++||++.|+++.|++++....
T Consensus 227 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 227 SEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp HHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011111111 111111 233457778889999999999999999999999987544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=341.33 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=195.8
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhh--cCCCcceEEEEEEEeCC--
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR--LHHKHLVRLVGYCEEKD-- 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~--l~HpnIv~l~~~~~~~~-- 567 (789)
..++|++.+.||+|+||.||+++. +++.||||++.... ...+.+|.+++.. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 346799999999999999999998 58999999975422 2346778888887 78999999999998876
Q ss_pred --eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHH--------hcCCCCeEeccCCCCCEEECCCCcEEE
Q 045256 568 --ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLH--------NYAVPPIIHRDIKSSNILLDAQWTARV 630 (789)
Q Consensus 568 --~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl 630 (789)
..++||||+++++|.+++... ..++.|+++||+||| +.+ |+||||||+|||++.++.+||
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEE
Confidence 789999999999999998653 368899999999999 666 999999999999999999999
Q ss_pred EeeccCcCCCCCCCCC--cccccccCcCccCccccCCC------CCCchhHHHHHHHHHHHHHcC----------CCCCC
Q 045256 631 SDFGLSMMGPESERDF--RPMKAAGTVGYIDPEYYGLN------VLTAKSDVYGLGVVLLELLTG----------KRAIF 692 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~SlGvil~elltG----------~~pf~ 692 (789)
+|||++.......... ......||+.|+|||++... .++.++||||||+++|||+|| +.||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 9999997543332111 12345789999999999765 234689999999999999999 45554
Q ss_pred CCCCCCCcccccccchhhhhhhhhhHHh-hcccCCCCCC---CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 693 KDDESGGTPVSLVDFAVPAIMAGELVKI-LDRRVGPPEI---NEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d~~~~~~~~---~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
....... ....+.+. ....+.+... ...+....+.+|+.+||+.||++|||+.|++++|+++.
T Consensus 269 ~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 269 DLVPSDP-------------SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTSCSSC-------------CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCcCcc-------------cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 3322110 01111111 1222211111 12356778889999999999999999999999999986
Q ss_pred hh
Q 045256 769 DI 770 (789)
Q Consensus 769 ~~ 770 (789)
+.
T Consensus 336 ~~ 337 (342)
T 1b6c_B 336 QQ 337 (342)
T ss_dssp HT
T ss_pred HH
Confidence 54
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=344.41 Aligned_cols=250 Identities=25% Similarity=0.400 Sum_probs=195.7
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchh----hhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKT----KKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
...++|++.+.||+|+||.||++.+. +|+.||||++..... ....+..+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34467999999999999999999875 799999998765331 12233355688999999999 7999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
.....++||||+++++|.+++... ..++.|+++||.|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcc
Confidence 999999999999999999998643 368899999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCCCcccccccCcCccCccccC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYG------LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
........ .....||+.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 248 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------------- 310 (365)
T 2y7j_A 248 CHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------------- 310 (365)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred cccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH--------------
Confidence 76543322 22457899999999885 33588899999999999999999999954321
Q ss_pred hhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+..+..................+.+++.+||+.||++|||+.|++++
T Consensus 311 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 ---ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp ---HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011111111111100001223456788999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.01 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=194.3
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT---THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch---hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 357999999999999999999875 6899999997644322 234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999998643 368899999999999998 9999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.........+++.|+|||.+....+ +.++||||||+++|||++|+.||........ .......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~~~~ 223 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----------------EYSDWKE 223 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH----------------HHHHHHT
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH----------------HHHHhhh
Confidence 2222234578999999999987665 7799999999999999999999965432110 0011111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...... ........+.+++.+||+.||++|||+.|++++
T Consensus 224 ~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 224 KKTYLN--PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TCTTST--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccccC--chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 111000 011233456778899999999999999998874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=333.18 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=194.3
Q ss_pred cCCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
.++|++.+.||+|+||.||++...+ +..||+|++..... ....+.+.+|++++++++||||+++++++.+ +.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT---LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSC---HHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccC---chHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence 4679999999999999999998542 23599999765432 2234568999999999999999999999865 45
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 78999999999999998643 257889999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... .......+++.|+|||.+....++.++||||||+++|||++ |+.||...... .. ...+.
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-----~~---------~~~~~ 228 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-----DV---------IGVLE 228 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-----GH---------HHHHH
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-----HH---------HHHHh
Confidence 43322 11223456789999999988889999999999999999998 99998643220 00 00010
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
. ......+.. ....+.+++.+||+.||++||++.|++++|+++++..+
T Consensus 229 ~--~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 229 K--GDRLPKPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp H--TCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred c--CCCCCCCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 0 011122222 23456778889999999999999999999999987543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.10 Aligned_cols=250 Identities=28% Similarity=0.364 Sum_probs=193.2
Q ss_pred CCccccceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||.||+++. .+++.||||+++...........+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999986 478999999986543211112223467899999999 69999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.++||||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999998753 257889999999999998 9999999999999999999999999997643
Q ss_pred CCCCCCcccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||......... .....
T Consensus 211 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-------------~~~~~ 276 (355)
T 1vzo_A 211 ADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------------AEISR 276 (355)
T ss_dssp GGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------------HHHHH
T ss_pred cCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-------------HHHHH
Confidence 3221 12234579999999999975 35789999999999999999999999654331110 00111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVANL 764 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~L 764 (789)
.+.......+. +....+.+|+.+||..||++|| +++|++++.
T Consensus 277 ~~~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 RILKSEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp HHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred HHhccCCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 12222222222 2334567788999999999999 999998865
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=364.07 Aligned_cols=247 Identities=26% Similarity=0.349 Sum_probs=197.2
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.++||+|+||.||+++.. +++.||+|++....... ......+.+|+++|++++||||+++++++.+.+..|
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3468999999999999999999875 68999999986543322 223456889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+||||+.++++||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999988643 257889999999999998 9999999999999999999999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+.+.
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--------------~~~i~~~ 400 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--------------REEVERL 400 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--------------HHHHHHH
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--------------HHHHHHH
Confidence 3321 2245799999999999998999999999999999999999999975433110 0111111
Q ss_pred hc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 721 LD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 721 ~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
+. .....+. .....+.+|+.+||+.||++|| +++|++++
T Consensus 401 i~~~~~~~p~----~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 401 VKEVPEEYSE----RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred hhcccccCCc----cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11 1111111 2234567788899999999999 78888865
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=338.33 Aligned_cols=238 Identities=21% Similarity=0.261 Sum_probs=182.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.++||+|+||+||+|.+. +++.||||++....... .....+..|+..+.++ +||||+++++++.+.+..++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP--KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh--HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 46999999999999999999876 78999999865433222 1222344555555555 89999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+ +++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 99999 66998887643 358899999999999998 999999999999999999999999998764433
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. .....||+.|+|||++.+ .++.++||||||+++|||++|..||+.... ...+..
T Consensus 211 ~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------------------~~~~~~ 266 (311)
T 3p1a_A 211 GA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------------------WQQLRQ 266 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------------------HHHHTT
T ss_pred CC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------------------HHHHhc
Confidence 22 224568999999999876 689999999999999999999877643211 011111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... ..........+.+++.+||+.||++|||+.|++++
T Consensus 267 ~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 267 GYLP--PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TCCC--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCC--cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1110 00011223557788899999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.92 Aligned_cols=256 Identities=20% Similarity=0.309 Sum_probs=177.1
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|+++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE---GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT---CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc---ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 367999999999999999999864 6899999997654322 122357889999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 572 VYDYMKNGALYDHLHDR--------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
||||++ ++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999998 5999988643 246789999999999998 9999999999999999999999999997
Q ss_pred CCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--------ccch
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--------VDFA 708 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--------~~~~ 708 (789)
........ .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||............. ..|.
T Consensus 157 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 157 AFGIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp ETTSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCG
T ss_pred ecCCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhh
Confidence 65432221 224578999999999976 468999999999999999999999996543210000000 0000
Q ss_pred hhhh-----------hhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 VPAI-----------MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 ~~~~-----------~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.... ....+.+.+..... ......+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTK------EPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCS------SCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhccccc------ccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 00000001110000 0122456788899999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=339.03 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=189.4
Q ss_pred cCCcccc-ceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 493 TNNFSLE-NKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 493 ~~~~~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
.++|++. +.||+|+||.||++.. .+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 3578875 7899999999999985 4789999999765432 2234588999999985 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc---EEEEeeccCcC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT---ARVSDFGLSMM 638 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGls~~ 638 (789)
++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999999998653 258899999999999998 999999999999988776 99999999875
Q ss_pred CCCCCC-----CCcccccccCcCccCccccCC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch
Q 045256 639 GPESER-----DFRPMKAAGTVGYIDPEYYGL-----NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 639 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 708 (789)
...... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||...............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-- 241 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA-- 241 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C--
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc--
Confidence 432211 111123468999999999864 56789999999999999999999999765432211100000
Q ss_pred hhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 VPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.........+.......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000011111222222221111011234567788999999999999999999885
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.30 Aligned_cols=245 Identities=24% Similarity=0.355 Sum_probs=190.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
..++|++.+.||+|+||.||++..+ +++.||+|++..... .+.+|++++.++ +||||+++++++.+.+..
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 3467999999999999999999875 688999999765432 144688888888 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC----CcEEEEeeccCc
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ----WTARVSDFGLSM 637 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGls~ 637 (789)
|+||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||+..+ +.+||+|||++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~ 168 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence 9999999999999998643 258899999999999999 9999999999998443 359999999997
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||...... .. .+.+
T Consensus 169 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~------------~~~~ 232 (342)
T 2qr7_A 169 QLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TP------------EEIL 232 (342)
T ss_dssp ECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CH------------HHHH
T ss_pred cCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CH------------HHHH
Confidence 6543322 223457899999999998878899999999999999999999999653221 00 0111
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.......+..........+.+|+.+||..||++||++.|++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122222222211122334556788899999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.75 Aligned_cols=192 Identities=23% Similarity=0.326 Sum_probs=165.2
Q ss_pred HHHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-----CCcceEEEEE
Q 045256 489 LAAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-----HKHLVRLVGY 562 (789)
Q Consensus 489 l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----HpnIv~l~~~ 562 (789)
.....++|++.+.||+|+||.||+++. .+++.||||++.... .....+..|+.++++++ ||||++++++
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-----KYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-----hhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 344568999999999999999999987 468899999976422 22334678999999986 9999999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC--------
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-------- 624 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-------- 624 (789)
+...+..++||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccccc
Confidence 99999999999999 88999998643 257899999999999999 999999999999975
Q ss_pred -----------------CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcC
Q 045256 625 -----------------QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687 (789)
Q Consensus 625 -----------------~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG 687 (789)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 7899999999997643322 245789999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 045256 688 KRAIFKD 694 (789)
Q Consensus 688 ~~pf~~~ 694 (789)
+.||...
T Consensus 256 ~~pf~~~ 262 (360)
T 3llt_A 256 SLLFRTH 262 (360)
T ss_dssp SCSCCCS
T ss_pred CCCCCCC
Confidence 9999654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=333.14 Aligned_cols=242 Identities=22% Similarity=0.372 Sum_probs=184.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||++... +++.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc---hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 46899999999999999999864 6889999987654322 2234688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---CCCCcEEEEeeccCc
Q 045256 573 YDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSM 637 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGls~ 637 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 9999999999988532 258899999999999998 9999999999999 456889999999997
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
....... .....+|+.|+|||.+. ..++.++||||||+++|||++|+.||..... ..... ..
T Consensus 176 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------------~~~~~-~~ 237 (285)
T 3is5_A 176 LFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------------EEVQQ-KA 237 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHH-HH
T ss_pred ecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------------HHHHh-hh
Confidence 6443322 22456899999999986 4688999999999999999999999954321 00000 00
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......... .......+.+++.+||+.||++|||+.|++++
T Consensus 238 -~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 238 -TYKEPNYAVE---CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -HHCCCCCCC-----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -ccCCcccccc---cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001111100 01122345678889999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=345.68 Aligned_cols=244 Identities=16% Similarity=0.202 Sum_probs=193.4
Q ss_pred cCCccccceEeecccEEEEEEE------eCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC---CCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGK------LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH---HKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~ 563 (789)
.++|++.+.||+|+||+||+|. ..+++.||||++..... ..+..|++++++++ |+||+++++++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-------WEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH-------HHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh-------hHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 4679999999999999999993 45688999999765322 23667777777776 99999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhh-------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC------
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHD-------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA------ 624 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~-------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~------ 624 (789)
...+..++||||+++|+|.+++.. ...++.|+++||+|||+.+ |+||||||+||||+.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 999999999999999999999963 2358899999999999998 999999999999998
Q ss_pred -----CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 625 -----QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 625 -----~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+||+.||........
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 293 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence 899999999999654322222233356799999999999999999999999999999999999999864432100
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCC-CCHHHHHHHHHHHhhhc
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKER-PTMADIVANLERALDIC 771 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~R-Pt~~evl~~L~~~~~~~ 771 (789)
. +...+... . . .+.+.+++..|++.+|.+| |+++++.+.|++.+...
T Consensus 294 ----------------~----~~~~~~~~-~-~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 ----------------K----PEGLFRRL-P-H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ----------------E----ECSCCTTC-S-S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----------------e----echhcccc-C-c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0 01111111 1 1 2345567788999999998 68999999999887653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=352.71 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=183.3
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhh----HHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKK----FQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~----~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
..++|.+.+.||+|+||.||+|... +++.||||++....... .......+.+|+++|++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 3578999999999999999999864 57899999976543211 1122235889999999999999999999975 4
Q ss_pred CeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC---CcEEEEeecc
Q 045256 567 DERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGL 635 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGl 635 (789)
+..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeeccc
Confidence 5689999999999999988543 358899999999999998 9999999999999654 4599999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 712 (789)
++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.........
T Consensus 289 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~------------ 353 (419)
T 3i6u_A 289 SKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------------ 353 (419)
T ss_dssp TTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH------------
T ss_pred ceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH------------
Confidence 98754332 122457899999999985 357788999999999999999999999654321110
Q ss_pred hhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+..................+.+|+.+||+.||++|||+.|++++
T Consensus 354 ----~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 354 ----KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----HHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00011111111110011234557788999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=335.28 Aligned_cols=243 Identities=25% Similarity=0.407 Sum_probs=192.4
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|.+.+.||+|+||.||+++.. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 357999999999999999999875 6899999997653321 23458899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---CCCCcEEEEeeccCcCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGls~~~~ 640 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999999988643 258899999999999998 9999999999999 788999999999987533
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------------~~~~~~i 219 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----------------SKLFEKI 219 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----------------HHHHHHH
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHH
Confidence 22 12234689999999999999999999999999999999999999854321 0011111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+..........+.+++.+||+.||++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 220 KEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111111112234557788899999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=360.37 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=196.0
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|.+.++||+|+||.||+++.+ +++.||+|++.+..... ......+.+|++++++++||||+++++++.+.+..|+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 368999999999999999999875 68999999986543322 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 572 VYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
||||+++|+|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++++||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999988642 246889999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.... ......
T Consensus 340 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-------------~~~~~~ 404 (543)
T 3c4z_A 340 KAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-------------KELKQR 404 (543)
T ss_dssp CTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-------------HHHHHH
T ss_pred cCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-------------HHHHHH
Confidence 43322 123458999999999999999999999999999999999999999754321100 011112
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH-----HHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTM-----ADIVA 762 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~ 762 (789)
++......+.. ....+.+|+.+||+.||++||++ .|+++
T Consensus 405 i~~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 405 VLEQAVTYPDK----FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp HHHCCCCCCTT----SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred HhhcccCCCcc----cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 22222222222 23456678889999999999975 56654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.11 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=186.6
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhH-HHHHHHHHHHHHHHhhcC---CCcceEEEEEEEeC
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKF-QEKESAFDSELAFLSRLH---HKHLVRLVGYCEEK 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~ 566 (789)
..++|++.+.||+|+||+||+++. .+++.||||++........ ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999986 4689999999764332111 111123556777776664 99999999999876
Q ss_pred C-----eEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 567 D-----ERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 567 ~-----~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
. ..++||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 4789999997 5999988653 358899999999999999 9999999999999999999999
Q ss_pred eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 632 DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 632 DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
|||++....... ......+|+.|+|||++.+..++.++||||||+++|||++|+.||....+... .......
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-----~~~i~~~ 234 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-----LGKIFDL 234 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-----HHHHHHH
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHHH
Confidence 999997654322 22345789999999999888999999999999999999999999965432100 0000000
Q ss_pred hh---hhhh---HHhhcccCCCC-CCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IM---AGEL---VKILDRRVGPP-EINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~---~~~~---~~~~d~~~~~~-~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ...+ ........... .... .+....+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 0000 00000000000 0000 1223456778899999999999999999874
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=355.43 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=188.4
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||.||++... +++.||||++..... .......+.+|+.+|++++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc--ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 468999999999999999999864 688999999865422 223345688999999999999999999999654
Q ss_pred -CeEEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 567 -DERLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
...|+||||+++ +|.+.+.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CCeEEEEEeCCCC-CHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 357999999976 57666543 3368999999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhh---h
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIM---A 714 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~---~ 714 (789)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+........+ ...+.+... .
T Consensus 215 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 215 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp --CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred CCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 4322 2234678999999999999999999999999999999999999996543210000000 000000000 0
Q ss_pred hhhHHhhcccCC----------------CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVG----------------PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~----------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+..... ............+.+|+.+||..||++|||++|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011111111110 0011112225567889999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=364.90 Aligned_cols=251 Identities=23% Similarity=0.409 Sum_probs=193.2
Q ss_pred CCccccc-eEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLEN-KIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~-~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
+++.+.+ .||+|+||.||+|.+. ++..||||+++..... ...+.|.+|+++|++++||||+++++++.+ +..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK---ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS---TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 3455555 8999999999999763 4567999998754322 234568999999999999999999999976 568
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++|+|.+++... ..++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 9999999999999998532 358899999999999998 9999999999999999999999999998754
Q ss_pred CCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... ......+++.|+|||++....++.++||||||++||||++ |+.||..... .++.
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------------~~~~ 549 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------------PEVM 549 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------------------HHHH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------------------HHHH
Confidence 332211 1112345689999999988899999999999999999998 9999865332 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
+.+.. ++..+. .+...+.+|+.+||+.||++||++.++++.|+.+......
T Consensus 550 ~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 550 AFIEQGKRMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp HHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred HHHHcCCCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11111 222222 2334567788899999999999999999999998766543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.43 Aligned_cols=248 Identities=26% Similarity=0.438 Sum_probs=200.0
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||.||++.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 3467999999999999999999875 478899999764322 2345889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+||||+++++|.+++... ..++.++++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999998642 257889999999999999 9999999999999999999999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
.... .......+++.|+|||.+....++.++||||||+++|||++ |+.||...+. ..+.+
T Consensus 163 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------------------~~~~~ 223 (288)
T 3kfa_A 163 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------------SQVYE 223 (288)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------------------GGHHH
T ss_pred CCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHH
Confidence 3322 12223456789999999988889999999999999999999 8888854321 01111
Q ss_pred hhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 720 ILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 720 ~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+... ...+. .....+.+++.+||+.||++|||+.|+++.|++++..
T Consensus 224 ~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 224 LLEKDYRMERPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCC----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 11112 2234567788899999999999999999999998764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=364.72 Aligned_cols=247 Identities=30% Similarity=0.450 Sum_probs=197.9
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||.||++.++++..||||+++.... ..+.|.+|+++|++++||||+++++++.+ +..+||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 357889999999999999999998888899999865432 12358999999999999999999999876 678999
Q ss_pred EEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++|+|.++|+.. ..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 9999999999999642 257899999999999998 999999999999999999999999999765432
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. .......++..|+|||.+....++.++||||||++||||++ |+.||..... .++.+.+
T Consensus 417 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------------------~~~~~~i 477 (535)
T 2h8h_A 417 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------------REVLDQV 477 (535)
T ss_dssp HH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------------------HHHHHHH
T ss_pred ce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHH
Confidence 11 11122346788999999988899999999999999999999 8988854321 0111111
Q ss_pred cc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 722 d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
.. ++..+. .+...+.+|+.+||+.||++|||+++|++.|++++...
T Consensus 478 ~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 478 ERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11 222222 23345677888999999999999999999999986543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.15 Aligned_cols=255 Identities=18% Similarity=0.209 Sum_probs=195.4
Q ss_pred CCccccceEeecccEEEEEEEeCC---------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceE------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD---------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVR------ 558 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~------ 558 (789)
++|++.+.||+|+||.||++.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 689999999999999999998753 789999987543 24778999999999999987
Q ss_pred ---------EEEEEEe-CCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 045256 559 ---------LVGYCEE-KDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSS 618 (789)
Q Consensus 559 ---------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 618 (789)
+++++.. ....++||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 6778776 67889999999 99999999754 258899999999999998 999999999
Q ss_pred CEEECCCC--cEEEEeeccCcCCCCCCCCC-----cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 045256 619 NILLDAQW--TARVSDFGLSMMGPESERDF-----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 619 NIll~~~~--~~kl~DfGls~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf 691 (789)
|||++.++ .+||+|||+++......... ......||+.|+|||++.+..++.++||||||++||||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 99999999997654332211 112347899999999999989999999999999999999999999
Q ss_pred CCCCCCCCcccccccchhhhhhhhhhHHhhcccC--CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 692 FKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV--GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
....... . . ............. .............+.+++.+||+.||++||++.|+++.|+++++
T Consensus 269 ~~~~~~~---~--------~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 269 TNCLPNT---E--------D-IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp GGGTTCH---H--------H-HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCcCH---H--------H-HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 6543210 0 0 0000111111110 00000001123456778889999999999999999999999987
Q ss_pred hccc
Q 045256 770 ICDH 773 (789)
Q Consensus 770 ~~~~ 773 (789)
....
T Consensus 337 ~~~~ 340 (352)
T 2jii_A 337 DLRV 340 (352)
T ss_dssp HTTC
T ss_pred hcCC
Confidence 6543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=348.45 Aligned_cols=198 Identities=30% Similarity=0.419 Sum_probs=154.8
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCC--
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKD-- 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~-- 567 (789)
..++|++.+.||+|+||.||++.+ .+++.||||++...... ......+.+|+.+++++. ||||+++++++...+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN--STDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC--HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC--hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 347899999999999999999986 46899999987543222 233445778999999997 999999999998654
Q ss_pred eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
..|+||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 6899999998 5999888643 358889999999999999 9999999999999999999999999997543
Q ss_pred CCCC-------------------CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 641 ESER-------------------DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 641 ~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2111 111223579999999999876 678999999999999999999999996543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=330.13 Aligned_cols=242 Identities=26% Similarity=0.446 Sum_probs=188.1
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-CeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK-DERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~l 571 (789)
.++|++.+.||+|+||.||+++. +++.||+|+++... ..+.+.+|++++++++||||+++++++.+. +..++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence 46799999999999999999987 57899999976432 234588999999999999999999997654 46899
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999998653 257889999999999998 99999999999999999999999999875433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. ....+++.|+|||.+....++.++||||||+++|||++ |+.||...... .....+
T Consensus 170 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----------------~~~~~~ 227 (278)
T 1byg_A 170 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------------DVVPRV 227 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----------------GHHHHH
T ss_pred cc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHH
Confidence 21 12356889999999988889999999999999999998 99998543210 000111
Q ss_pred hcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 721 LDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 721 ~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
... ....+. .....+.+++.+||+.||++||++.|+++.|+++...
T Consensus 228 ~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 228 EKGYKMDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCCCcc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 111 111111 2234567788899999999999999999999998653
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=356.44 Aligned_cols=244 Identities=26% Similarity=0.384 Sum_probs=192.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.||||++....... .....+.+|++++++++||||+++++++.+....++|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN--KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc--hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 57999999999999999999875 68999999976433221 2244688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC---CCCcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD---AQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGls~~~~~ 641 (789)
|||+++++|.+++... ..++.|+++||.|||+.+ |+||||||+|||++ .++.+||+|||++.....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 9999999999988643 368899999999999999 99999999999995 456899999999976443
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... .....||+.|+|||++.+ .++.++||||||+++|||++|++||..... .+.+..+.
T Consensus 177 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------------~~~~~~i~ 235 (486)
T 3mwu_A 177 NTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----------------YDILKRVE 235 (486)
T ss_dssp C-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred CCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHH
Confidence 322 224578999999999976 589999999999999999999999965432 01111122
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp HTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred hCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222211111122334557788999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=343.53 Aligned_cols=262 Identities=20% Similarity=0.218 Sum_probs=189.5
Q ss_pred CCccccceEeecccEEEEEEEeC----CCcEEEEEEcccchhhhHHH-------HHHHHHHHHHHHhhcCCCcceEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQE-------KESAFDSELAFLSRLHHKHLVRLVGY 562 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~-------~~~~~~~E~~~l~~l~HpnIv~l~~~ 562 (789)
++|++.+.||+|+||.||++... ++..+|+|++.........+ ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 67999999999999999999875 57789999876543221111 12246788999999999999999999
Q ss_pred EEe----CCeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC--cE
Q 045256 563 CEE----KDERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW--TA 628 (789)
Q Consensus 563 ~~~----~~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~ 628 (789)
+.+ ....++||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence 988 67789999999 89999998653 368899999999999998 99999999999998887 99
Q ss_pred EEEeeccCcCCCCCCCC-----CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc
Q 045256 629 RVSDFGLSMMGPESERD-----FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS 703 (789)
Q Consensus 629 kl~DfGls~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~ 703 (789)
||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~ 269 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD---PVA 269 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC---HHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc---cHH
Confidence 99999999764332211 1113457899999999999889999999999999999999999999543211 000
Q ss_pred cccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 704 LVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
. .... ......+...+...... ......+.+++.+||+.||++||++.++++.|+++.-
T Consensus 270 ~-~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 V-QTAK-TNLLDELPQSVLKWAPS-----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp H-HHHH-HHHHHTTTHHHHHHSCT-----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred H-HHHH-HhhcccccHHHHhhccc-----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0 0000 00000000111111100 0223457778889999999999999999999988643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=338.64 Aligned_cols=249 Identities=30% Similarity=0.497 Sum_probs=193.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcE--EEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQE--VAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~--vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||.||+++.. +++. +++|++..... ....+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc---hHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 57899999999999999999864 4554 48998764322 22334588999999999 899999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 570 LLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCC
Confidence 9999999999999998653 257899999999999998 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~ 704 (789)
+.+||+|||++....... ......+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 179 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------- 247 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------- 247 (327)
T ss_dssp GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------
T ss_pred CeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------
Confidence 999999999986432211 1123456789999999988889999999999999999998 9999854321
Q ss_pred ccchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 705 VDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
......+... ....+. .....+.+++.+||+.||++|||+.|++++|+++++...
T Consensus 248 ---------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 248 ---------AELYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp ---------HHHHHHGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred ---------HHHHHHhhcCCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0001111111 111111 223456778889999999999999999999999987543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=342.93 Aligned_cols=252 Identities=27% Similarity=0.445 Sum_probs=185.5
Q ss_pred CccccceEeecccEEEEEEEeC--CC--cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-CCeE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP--DG--QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-KDER 569 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 569 (789)
.|++.+.||+|+||.||+|... ++ ..||+|.++.... ....+.|.+|+.++++++||||+++++++.+ .+..
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC---SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 5778899999999999999853 22 3689998764322 2334568999999999999999999998754 4578
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999998643 257889999999999998 9999999999999999999999999997643
Q ss_pred CCCCCC--cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 641 ESERDF--RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 641 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
...... ......+++.|+|||.+....++.++||||||+++|||+| |.+||...... . ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~----------------~~ 306 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-D----------------IT 306 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-C----------------HH
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-H----------------HH
Confidence 322111 1123456789999999988899999999999999999999 55565433220 0 00
Q ss_pred HHhhc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 718 VKILD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 718 ~~~~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
..+.. .....+.. ....+.+++.+||+.||++||++.|+++.|++++.....
T Consensus 307 ~~~~~~~~~~~p~~----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 307 VYLLQGRRLLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp HHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred HHHHcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 01111 11222222 234567788899999999999999999999999876543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.94 Aligned_cols=241 Identities=24% Similarity=0.406 Sum_probs=192.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE------- 565 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------- 565 (789)
++|++.+.||+|+||.||++... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 57999999999999999999875 78999999976532 136789999999999999999999865
Q ss_pred ---------CCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC
Q 045256 566 ---------KDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW 626 (789)
Q Consensus 566 ---------~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~ 626 (789)
....++||||+++++|.+++..+ ..++.|+++||.|||+.+ |+|+||||+|||++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 34579999999999999998643 258889999999999998 99999999999999999
Q ss_pred cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 627 TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 627 ~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+....
T Consensus 160 ~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----------- 225 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS----------- 225 (284)
T ss_dssp EEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----------
T ss_pred CEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----------
Confidence 999999999876544322 224568999999999998889999999999999999999998863211
Q ss_pred chhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
.....+.+..+. .. ....+.+++.+||+.||++|||+.|++++|+.+....+.
T Consensus 226 --------~~~~~~~~~~~~--~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 226 --------KFFTDLRDGIIS--DI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp --------HHHHHHHTTCCC--TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred --------HHHHHhhccccc--cc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 001111111111 11 123456788899999999999999999999998665443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.50 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=188.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 68999999999999999999875 5899999987654322 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence 9999999998887542 368889999999999998 99999999999999999999999999976543322
Q ss_pred CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc---hhhhhhh-hhhHH
Q 045256 645 DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF---AVPAIMA-GELVK 719 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~ 719 (789)
. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ..... ..+.... -....
T Consensus 158 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 158 Y--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHHHHTCG
T ss_pred c--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhccccccccccccccc
Confidence 1 124568999999999865 678999999999999999999999996543210000 00000 0000000 00000
Q ss_pred hh-cccCCCCCCC-H-----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 IL-DRRVGPPEIN-E-----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~-d~~~~~~~~~-~-----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ...++.+... . ......+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00 0011111100 0 1223446778999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.34 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=196.7
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchh-----hhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKT-----KKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~ 564 (789)
..++|++.+.||+|+||.||++... +++.||||++..... .......+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3478999999999999999999875 688999999765321 122333556889999999995 999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
+....++||||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 171 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccch
Confidence 999999999999999999998753 358899999999999998 999999999999999999999999998
Q ss_pred cCCCCCCCCCcccccccCcCccCccccC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYG------LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
........ .....+++.|+|||++. ...++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------------- 234 (298)
T 1phk_A 172 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------------- 234 (298)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred hhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------------
Confidence 76543322 22456899999999884 45688999999999999999999999854321
Q ss_pred hhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 235 ---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 235 ---MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp ---HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ---HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 00111122222221111122344567788999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=355.76 Aligned_cols=244 Identities=25% Similarity=0.384 Sum_probs=188.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||+++.. +++.||+|++....... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46999999999999999999875 68899999976543222 1234588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGls~~~~~ 641 (789)
|||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999988643 358899999999999998 999999999999976 45599999999976543
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... .....||+.|+|||++. ..++.++||||||+++|||++|++||..... .+.+..+.
T Consensus 192 ~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------------~~~~~~i~ 250 (494)
T 3lij_A 192 QKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----------------QEILRKVE 250 (494)
T ss_dssp TBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred Ccc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHH
Confidence 322 22457999999999986 4689999999999999999999999964321 01111122
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp HTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 222211111112234556788899999999999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.08 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=192.9
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEE-EeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYC-EEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~ 569 (789)
..++|++.+.||+|+||.||++.. .+++.||||++...... ..+.+|++++++++|++++..+..+ .+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 457899999999999999999986 57889999985443221 2478899999999988877666655 567778
Q ss_pred EEEEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---CCCCcEEEEeeccCc
Q 045256 570 LLVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSM 637 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGls~ 637 (789)
++||||+ +++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999999 8899999863 2368899999999999999 9999999999999 788999999999997
Q ss_pred CCCCCCCC-----CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh
Q 045256 638 MGPESERD-----FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712 (789)
Q Consensus 638 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 712 (789)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------- 225 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----------- 225 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----------
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-----------
Confidence 65433221 11224578999999999999999999999999999999999999997543311110
Q ss_pred hhhhhHHhhcccCCCCC-CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 713 MAGELVKILDRRVGPPE-INEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~-~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
.+..+....+..+. .........+.+++.+||+.||++|||+.|+++.|++++....
T Consensus 226 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 226 ---KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp ---HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ---hhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 00000000000000 0000113457788899999999999999999999999987544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=326.01 Aligned_cols=259 Identities=20% Similarity=0.252 Sum_probs=196.4
Q ss_pred hcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEE-EeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYC-EEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~~~~~ 569 (789)
..++|++.+.||+|+||.||+++. .+++.||||++...... ..+.+|+.++++++|++++..+.++ .+.+..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC------CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch------hHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence 347899999999999999999986 57899999987543322 2478999999999988876666555 566778
Q ss_pred EEEEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---CCCCcEEEEeeccCc
Q 045256 570 LLVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSM 637 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGls~ 637 (789)
++||||+ +++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 9999999 8899999863 2368899999999999998 9999999999999 488899999999997
Q ss_pred CCCCCCCCC-----cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh
Q 045256 638 MGPESERDF-----RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI 712 (789)
Q Consensus 638 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~ 712 (789)
......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~----~~~~ 230 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ--K----YERI 230 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS--H----HHHH
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh--h----hhhh
Confidence 654432211 1234578999999999999999999999999999999999999997543211110 0 0000
Q ss_pred hhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 713 MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
.......... .+. ......+.+++.+||+.||++|||+.|+++.|++++.....
T Consensus 231 ~~~~~~~~~~-~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 231 SEKKMSTPIE-VLC------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHSCHH-HHT------TTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cccccCCchH-HHH------hhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000000000 000 11224567788999999999999999999999999776543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.24 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=188.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----CCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----KDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~ 568 (789)
..|++.+.||+|+||.||++... ++..||+|++...... ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 45788899999999999999864 6788999987654332 2335568999999999999999999999876 345
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGls~~~ 639 (789)
.++||||+++++|.+++... ..++.++++||+|||+.+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 89999999999999998753 257899999999999986 4599999999999997 7899999999999754
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
.... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||...... ..+.+
T Consensus 183 ~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------------~~~~~ 240 (290)
T 1t4h_A 183 RASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----------------AQIYR 240 (290)
T ss_dssp CTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----------------HHHHH
T ss_pred cccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----------------HHHHH
Confidence 3322 224568999999998874 5899999999999999999999999543220 00011
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.....+ ..........+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 RVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhccCCc-cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11111100 00011112346788899999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.18 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=191.7
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhH---------HHHHHHHHHHHHHHhhcCCCcceEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKF---------QEKESAFDSELAFLSRLHHKHLVRLVG 561 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---------~~~~~~~~~E~~~l~~l~HpnIv~l~~ 561 (789)
..++|++.+.||+|+||+||++... +++.||+|++........ ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3468999999999999999999875 578999999865432211 123456889999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC---cEEE
Q 045256 562 YCEEKDERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW---TARV 630 (789)
Q Consensus 562 ~~~~~~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 630 (789)
++.+....++||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEE
Confidence 999999999999999999999988643 368899999999999998 99999999999998775 6999
Q ss_pred EeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh
Q 045256 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP 710 (789)
Q Consensus 631 ~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~ 710 (789)
+|||++....... ......||+.|+|||++.. .++.++||||||+++|||++|+.||.....
T Consensus 191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------- 252 (504)
T 3q5i_A 191 VDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-------------- 252 (504)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------------
T ss_pred EECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------------
Confidence 9999997654332 2224579999999999874 689999999999999999999999965332
Q ss_pred hhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 711 AIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 711 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+..+.......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 253 ---~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 ---QDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 01111111221111111111234557788999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=326.44 Aligned_cols=241 Identities=22% Similarity=0.396 Sum_probs=194.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||+|++....... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK-EGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch-HHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 67999999999999999999875 57889999876533221 22245688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999999998653 358899999999999998 9999999999999999999999999986543322
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+....
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~ 228 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-----------------TETHRRIVNVD 228 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHTTC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-----------------hHHHHHHhccc
Confidence 2245689999999999998999999999999999999999999854321 00111222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+.. ....+.+++.+||+.||++||++.|++++
T Consensus 229 ~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKFPPF----LSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCCCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 222222 23456778889999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=340.07 Aligned_cols=252 Identities=27% Similarity=0.444 Sum_probs=193.5
Q ss_pred cCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~ 566 (789)
.++|++.+.||+|+||.||+++. .+++.||||++..... ......+.+|+.++++++||||+++++++.+.
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS---EQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccc---hhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 36799999999999999999984 3567899999864322 22344688999999999999999999999999
Q ss_pred CeEEEEEEecCCCchhHHHhhh---------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcE
Q 045256 567 DERLLVYDYMKNGALYDHLHDR---------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTA 628 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~---------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~ 628 (789)
+..++||||+++++|.+++... ..++.|+++||.|||+.+ |+||||||+|||++. +..+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999998753 247889999999999998 999999999999984 4569
Q ss_pred EEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccc
Q 045256 629 RVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDF 707 (789)
Q Consensus 629 kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~ 707 (789)
||+|||++................+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----------- 251 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----------- 251 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----------
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----------
Confidence 9999999864332222222234567899999999988889999999999999999998 8888854321
Q ss_pred hhhhhhhhhhHHhh-cc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 708 AVPAIMAGELVKIL-DR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 708 ~~~~~~~~~~~~~~-d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
..+.+.+ .. ....+. .....+.+++.+||+.||++||++.|++++|+.+....+
T Consensus 252 -------~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 252 -------QEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp -------HHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -------HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 0111111 11 111122 223456778889999999999999999999999876443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=343.54 Aligned_cols=248 Identities=11% Similarity=0.034 Sum_probs=175.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc--CCCcceEEE-------EEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL--HHKHLVRLV-------GYC 563 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l--~HpnIv~l~-------~~~ 563 (789)
.+|++.+.||+|+||.||++.+. +++.||||++....... ....+.+.+|+.+++.| +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS-RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTH-HHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccccc-ccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45889999999999999999864 78999999987654322 23345677885555544 699988865 455
Q ss_pred EeC-----------------CeEEEEEEecCCCchhHHHhhh---------------chHHHHHHHHHHHHHhcCCCCeE
Q 045256 564 EEK-----------------DERLLVYDYMKNGALYDHLHDR---------------NNVEKNAARGIEYLHNYAVPPII 611 (789)
Q Consensus 564 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~---------------~~i~~~ia~~l~~LH~~~~~~iv 611 (789)
... ...++||||++ ++|.+++... ..++.|+++||+|||+++ |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 433 33799999999 7999999753 345689999999999999 99
Q ss_pred eccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCC
Q 045256 612 HRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKR 689 (789)
Q Consensus 612 H~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~ 689 (789)
||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++||||||++||||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999997643211 13456799999999987 789999999999999999999999
Q ss_pred CCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 690 AIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 690 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
||............ .. ............+. .......+.+|+.+||+.||++|||+.|++++
T Consensus 292 Pf~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 292 PFGLVTPGIKGSWK--RP--------SLRVPGTDSLAFGS--CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp STTBCCTTCTTCCC--BC--------CTTSCCCCSCCCTT--SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCcCcccccchh--hh--------hhhhccccccchhh--ccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99765332111000 00 00000011111110 01223456778889999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=337.04 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=191.6
Q ss_pred cCCcccc-ceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 493 TNNFSLE-NKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 493 ~~~~~~~-~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
.++|.+. +.||+|+||.||++... +++.||+|++....... .....+.+|+.+++++ +||||+++++++.+.+..
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE--ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 4567777 89999999999999865 68999999976543322 2244688999999999 569999999999999999
Q ss_pred EEEEEecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEeeccC
Q 045256 570 LLVYDYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDFGLS 636 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGls 636 (789)
++||||+++++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999998743 2368899999999999998 999999999999988 789999999999
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
........ .....||+.|+|||++....++.++||||||+++|||++|+.||..... ...
T Consensus 182 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------------~~~ 241 (327)
T 3lm5_A 182 RKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----------------QET 241 (327)
T ss_dssp EEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHH
T ss_pred cccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------------hHH
Confidence 76543321 1245789999999999999999999999999999999999999954332 001
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+.......+..........+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 242 YLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11111111111111122334557788899999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=339.96 Aligned_cols=238 Identities=23% Similarity=0.366 Sum_probs=192.4
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhH----HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKF----QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
.++|++.+.||+|+||.||++.. .+++.||||++........ ......+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999985 4688999999865432111 012234778999999999999999999999999
Q ss_pred eEEEEEEecCCC-chhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 ERLLVYDYMKNG-ALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 ~~~lv~e~~~~g-sL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..++||||+..| +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999777 999988653 258899999999999998 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....+
T Consensus 180 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------------- 235 (335)
T 3dls_A 180 LERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------------- 235 (335)
T ss_dssp CCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------------
T ss_pred CCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------------
Confidence 543322 224578999999999987776 8899999999999999999999854221
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+... ...+.+|+.+||+.||++|||+.|++++
T Consensus 236 --~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 --TVEAAIHPPYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp --GTTTCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred --HHhhccCCCccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112222222 2346678889999999999999999987
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=326.22 Aligned_cols=244 Identities=21% Similarity=0.343 Sum_probs=195.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||++... +++.||+|++....... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 57999999999999999999875 57889999876543222 23345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999988643 358899999999999998 99999999999999999999999999976433221
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......+|+.|+|||.+....++.++||||||+++|||++|+.||..... .+....+....
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------------~~~~~~~~~~~ 231 (294)
T 2rku_A 171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------------KETYLRIKKNE 231 (294)
T ss_dssp --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHTTC
T ss_pred --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHhhcc
Confidence 12235689999999999988899999999999999999999999854321 00111122222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
...+.. ....+.+++.+||+.||++|||+.|++++-
T Consensus 232 ~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 232 YSIPKH----INPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CCCccc----cCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 222222 223466788899999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.80 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=185.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHH-HHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQ-EKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
..++|++.+.||+|+||.||++... +++.||||++......... .....+.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3478999999999999999999875 5899999998654322211 1123578999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999986 888887643 358899999999999999 9999999999999999999999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh---hhh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM---AGE 716 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~ 716 (789)
.... ......+|+.|+|||++.+ ..++.++||||||+++|||++|++||....... .+... ..... ...
T Consensus 164 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i-~~~~~~~~~~~ 236 (346)
T 1ua2_A 164 SPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRI-FETLGTPTEEQ 236 (346)
T ss_dssp SCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH-HHHHCCCCTTT
T ss_pred CCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHH-HHHcCCCChhh
Confidence 3322 2224578999999999865 458999999999999999999999886543200 00000 00000 000
Q ss_pred h---HHhhccc-C-CCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 L---VKILDRR-V-GPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~---~~~~d~~-~-~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
. ....+.. . ..+.... ......+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000000 0 0000000 1223567788999999999999999999885
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=354.03 Aligned_cols=189 Identities=26% Similarity=0.381 Sum_probs=145.9
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||.||++.+. +++.||||++...... ....+.+.+|+++|++++||||+++++++...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED--LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC--HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 468999999999999999999864 6899999987653222 23345688999999999999999999999543
Q ss_pred CeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...|+||||+. ++|.+++... ..++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 130 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred ceEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 56899999985 6999988653 358899999999999999 99999999999999999999999999986
Q ss_pred CCCCCCC-------------------------CcccccccCcCccCcccc-CCCCCCchhHHHHHHHHHHHHHcC
Q 045256 639 GPESERD-------------------------FRPMKAAGTVGYIDPEYY-GLNVLTAKSDVYGLGVVLLELLTG 687 (789)
Q Consensus 639 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvil~elltG 687 (789)
....... .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 5432211 012235789999999976 566799999999999999999994
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=322.71 Aligned_cols=243 Identities=27% Similarity=0.450 Sum_probs=186.8
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++....... .+..+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS-LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc-hhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 468999999999999999999875 78999999976533211 2234568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999998643 358899999999999999 9999999999999999999999999997654332
Q ss_pred CCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. .....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||..... . .....+..
T Consensus 166 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------------~----~~~~~~~~ 225 (276)
T 2h6d_A 166 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------------P----TLFKKIRG 225 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------H----HHHHHHHH
T ss_pred c---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------------H----HHHHHhhc
Confidence 1 123468999999999987765 6899999999999999999999854221 0 00111111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 226 ~~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 226 GVFYIPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CCCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CcccCchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11112221 22446678889999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=339.57 Aligned_cols=264 Identities=23% Similarity=0.409 Sum_probs=198.1
Q ss_pred CCccccceEeecccEEEEEEEe-----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC-
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD- 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~- 567 (789)
++|++.+.||+|+||.||+++. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE----EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS----HHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH----HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 5789999999999999999983 3688999999765322 23456899999999999999999999987654
Q ss_pred -eEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 568 -ERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 568 -~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
..++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 679999999999999998653 257889999999999998 9999999999999999999999999997
Q ss_pred CCCCCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 638 MGPESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 638 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
......... ......++..|+|||.+.+..++.++||||||+++|||+||+.|+...... .................
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--HHHHHCTTCCTHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--HHHhhccccchhhhHHH
Confidence 654432211 112345678899999998888999999999999999999999887432100 00000000000001112
Q ss_pred hHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 717 LVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 717 ~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+.+.+... +..+. .....+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 272 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22223221 22222 2334567788899999999999999999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=332.67 Aligned_cols=253 Identities=17% Similarity=0.294 Sum_probs=191.2
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEe--CCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEE--KDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~--~~~~ 569 (789)
++|++.+.||+|+||.||++.. .+++.||||++.... .+.+.+|++++++++ ||||+++++++.+ ....
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 6799999999999999999975 578999999976432 234889999999997 9999999999998 5678
Q ss_pred EEEEEecCCCchhHHHhh-----hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCCCCCC
Q 045256 570 LLVYDYMKNGALYDHLHD-----RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPESE 643 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~-----~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~~~~~ 643 (789)
++||||+++++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++ .+||+|||++.......
T Consensus 109 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999999999999998754 3468899999999999999 99999999999999776 89999999997654332
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
. .....++..|+|||.+.. ..++.++||||||+++|||++|+.||........ .+... ........+.+.++
T Consensus 186 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~---~l~~~-~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 186 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVRI-AKVLGTEDLYDYID 258 (330)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH---HHHHH-HHHHCHHHHHHHHH
T ss_pred c---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH---HHHHH-HHhcCCchhhhHHH
Confidence 2 224568999999999876 6789999999999999999999999965432100 00000 00000011111111
Q ss_pred ccC-C--------------------CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRV-G--------------------PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~-~--------------------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
... . ............+.+|+.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 100 0 0000111234567788999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=358.33 Aligned_cols=245 Identities=27% Similarity=0.373 Sum_probs=194.9
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||||++....... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 57999999999999999999875 78999999976543221 12244688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---CCCCcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGls~~~~~ 641 (789)
|||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999988643 358899999999999998 9999999999999 5678999999999876433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|++||..... ...+..+.
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----------------~~~~~~i~ 240 (484)
T 3nyv_A 182 SK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-----------------YDILKKVE 240 (484)
T ss_dssp CC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred cc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHH
Confidence 32 1224578999999999866 689999999999999999999999965332 01111222
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 222221111122344567788999999999999999999975
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=338.53 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=183.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||++... +++.||+|++....... ....+.+|++++++++||||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG---APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc---cchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 57999999999999999999875 68899999876433211 112355799999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 999974 998887643 257889999999999999 9999999999999999999999999987543322
Q ss_pred CCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccc----hhhhhhh-h
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDF----AVPAIMA-G 715 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~----~~~~~~~-~ 715 (789)
.. .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||............ .... ..+.... .
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 KT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 21 223468999999999876 56899999999999999999999999654321000000 0000 0000000 0
Q ss_pred hhHHhhcccCCCCCC--CHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 716 ELVKILDRRVGPPEI--NEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 716 ~~~~~~d~~~~~~~~--~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
............... ........+.+|+.+||+.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000000 001123456788999999999999999999884
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.81 Aligned_cols=243 Identities=21% Similarity=0.348 Sum_probs=195.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|.+.+.||+|+||.||++... +++.||+|++....... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 57999999999999999999875 57889999876543222 23445688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999999999988643 358899999999999998 99999999999999999999999999976543222
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
......+|+.|+|||++....++.++||||||+++|||++|+.||..... .+....+....
T Consensus 197 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------------~~~~~~~~~~~ 257 (335)
T 2owb_A 197 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----------------KETYLRIKKNE 257 (335)
T ss_dssp --CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHHTC
T ss_pred --cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----------------HHHHHHHhcCC
Confidence 12245689999999999888899999999999999999999999854321 00111111122
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+.. ....+.+++.+||+.||++||++.|++++
T Consensus 258 ~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 YSIPKH----INPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222 22346678889999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=338.61 Aligned_cols=262 Identities=17% Similarity=0.235 Sum_probs=181.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||+||++... +++.||||++...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE--EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc--cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 367999999999999999999854 7889999998654322 2234457799999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE-----CCCCcEEEEeeccCcC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL-----DAQWTARVSDFGLSMM 638 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DfGls~~ 638 (789)
||||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 9999985 999998653 368899999999999998 9999999999999 4556699999999875
Q ss_pred CCCCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc--cchhhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV--DFAVPAIMAG 715 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 715 (789)
...... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||.............. ..+..... .
T Consensus 187 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~ 263 (329)
T 3gbz_A 187 FGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW-P 263 (329)
T ss_dssp HC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS-T
T ss_pred cCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh-h
Confidence 432221 12234679999999999764 589999999999999999999999965432100000000 00000000 0
Q ss_pred hhHHhh--cccCCC-CCCCHH-----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 716 ELVKIL--DRRVGP-PEINEA-----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 716 ~~~~~~--d~~~~~-~~~~~~-----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...... ...... ...... .....+.+|+.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000 000000 000000 123456788999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=341.62 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=194.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC---HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 368999999999999999999875 688999999765422 2334568899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.+++... ..++.++++||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999998753 26889999999999985 7 999999999999999999999999998543211
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCc--------------c-------
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT--------------P------- 701 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~--------------~------- 701 (789)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... +
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 112357899999999999999999999999999999999999999643210000 0
Q ss_pred cccccchhhhh----hhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 702 VSLVDFAVPAI----MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 702 ~~~~~~~~~~~----~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
..+..+..... ....+..+...... ..........+.+|+.+||+.||++|||++|++++-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 326 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence 00000000000 00011111111111 111122334577888999999999999999999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.99 Aligned_cols=248 Identities=24% Similarity=0.370 Sum_probs=177.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEe------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEE------ 565 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~------ 565 (789)
.+|++.++||+|+||.||++... +++.||+|++.... ......+.+|+.+++++. ||||+++++++..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE----EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS----HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc----hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 57999999999999999999864 68999999875432 233446889999999996 9999999999953
Q ss_pred --CCeEEEEEEecCCCchhHHHhh-----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEe
Q 045256 566 --KDERLLVYDYMKNGALYDHLHD-----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSD 632 (789)
Q Consensus 566 --~~~~~lv~e~~~~gsL~~~l~~-----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 632 (789)
....++||||++ |+|.+++.. ...++.|+++||+|||+.+ ++|+||||||+|||++.++.+||+|
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 334789999996 699998854 2358899999999999986 4599999999999999999999999
Q ss_pred eccCcCCCCCCCCC----------cccccccCcCccCcccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 633 FGLSMMGPESERDF----------RPMKAAGTVGYIDPEYY---GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 633 fGls~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
||++.......... ......+|+.|+|||++ ....++.++||||||+++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99997654332211 11134589999999998 56678999999999999999999999985432210
Q ss_pred cccccccchhhhhhhhhhHHhhccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
++... ...... ....+..|+.+||+.||++||++.|++++|+++.....
T Consensus 261 --------------------~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 --------------------IVNGKYSIPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------------------CCCCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred --------------------hhcCcccCCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 01111 111111 11235678889999999999999999999999876543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=326.31 Aligned_cols=246 Identities=23% Similarity=0.282 Sum_probs=189.9
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE--eCCeE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE--EKDER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~ 569 (789)
.++|++.+.||+|+||.||++... +++.||+|++..............+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999864 688999999876543332344567999999999999999999999985 34578
Q ss_pred EEEEEecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 570 LLVYDYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
++||||++++ |.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999875 6666643 2358899999999999998 999999999999999999999999999765
Q ss_pred CCCCCCCcccccccCcCccCccccCCCC--CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNV--LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
.............+|+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~ 222 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----------------YKLF 222 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHH
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----------------HHHH
Confidence 4433333333456899999999987643 47899999999999999999999854321 0011
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.......+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~i~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 223 ENIGKGSYAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHHHCCCCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHhcCCCCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111222222222 23446678889999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=363.54 Aligned_cols=245 Identities=22% Similarity=0.299 Sum_probs=197.0
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
..++|++.++||+|+||.||+++.. +++.||||++++..... ....+.+..|..++..+ +||||+++++++++.+.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3478999999999999999999865 57889999987543222 22344577899999988 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||||+++|+|.++++.. ..++.|++.||+|||+.+ |+||||||+||||+.++++||+|||+++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 9999999999999998753 357899999999999998 99999999999999999999999999975332
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......||+.|+|||++.+..++.++||||||++||||++|+.||...+. .+....++
T Consensus 495 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----------------~~~~~~i~ 555 (674)
T 3pfq_A 495 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----------------DELFQSIM 555 (674)
T ss_dssp TTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred CCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----------------HHHHHHHH
Confidence 222 23356899999999999999999999999999999999999999965432 11223333
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCH-----HHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTM-----ADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~-----~evl~~ 763 (789)
...+..+.. ....+.+|+.+||+.||++||++ +||+++
T Consensus 556 ~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 556 EHNVAYPKS----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp SSCCCCCTT----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred hCCCCCCcc----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 333333332 33456678889999999999997 666653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=328.07 Aligned_cols=244 Identities=22% Similarity=0.324 Sum_probs=178.8
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++.. .+++.||+|++...... ....+.+.++...++.++||||+++++++.+.+..++
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l 83 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI 83 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc--HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence 46899999999999999999986 47899999997654322 2233345566666888899999999999999999999
Q ss_pred EEEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 572 VYDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
||||+++ +|.+++.. ...++.|+++||+|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999975 88887653 125889999999999997 8 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCcccc----CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYY----GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
...... .....+|+.|+|||.+ ....++.++||||||+++|||++|+.||..... ..
T Consensus 160 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----------------~~ 220 (290)
T 3fme_A 160 LVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT----------------PF 220 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC----------------HH
T ss_pred cccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc----------------hH
Confidence 443322 1234689999999996 566789999999999999999999999854221 01
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+...+........ .......+.+++.+||+.||++|||+.|++++
T Consensus 221 ~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 221 QQLKQVVEEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhccCCCCcc--cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 111222222111111 11233456778889999999999999999884
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=331.50 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=185.9
Q ss_pred CCccccceEeecccEEEEEEEeC--CCc--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP--DGQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||+||++.+. +++ .||+|+++...... .+..+.+.+|++++++++||||+++++++.+.. .
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 57999999999999999999853 333 68999876543221 234456899999999999999999999998754 8
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++....
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999998653 257889999999999998 9999999999999999999999999997654
Q ss_pred CCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... ......++..|+|||.+....++.++||||||+++|||++ |+.||..... ...+.
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----------------~~~~~ 235 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------------SQILH 235 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHH
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----------------HHHHH
Confidence 433211 1223457788999999988888999999999999999999 9999854321 00111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+... ....+. .....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 236 ~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 236 KIDKEGERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp HHHTSCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHHccCCCCCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11111 111111 2334567788899999999999999999999987543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=349.05 Aligned_cols=235 Identities=14% Similarity=0.198 Sum_probs=180.4
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHH---HHHhhcCCCcceEEE-------E
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSEL---AFLSRLHHKHLVRLV-------G 561 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~---~~l~~l~HpnIv~l~-------~ 561 (789)
.++|++.+.||+|+||+||+|.. .+++.||||++....... ....+.+.+|+ +++++++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CC-TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccc-hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 36789999999999999999986 468999999986432222 22345688999 455566899999998 7
Q ss_pred EEEeCCe-----------------EEEEEEecCCCchhHHHhhh---------------chHHHHHHHHHHHHHhcCCCC
Q 045256 562 YCEEKDE-----------------RLLVYDYMKNGALYDHLHDR---------------NNVEKNAARGIEYLHNYAVPP 609 (789)
Q Consensus 562 ~~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~---------------~~i~~~ia~~l~~LH~~~~~~ 609 (789)
++.+.+. .|+||||+ +|+|.+++... ..++.|+++||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 7765532 78999999 57999998642 247899999999999999
Q ss_pred eEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC-----------CCCchhHHHHHH
Q 045256 610 IIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-----------VLTAKSDVYGLG 678 (789)
Q Consensus 610 ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~SlG 678 (789)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++... .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999975322 1224467 999999999877 899999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHH
Q 045256 679 VVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMA 758 (789)
Q Consensus 679 vil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ 758 (789)
++||||++|+.||......... ..+... .... ...+.+|+.+||+.||++|||+.
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~-----------------~~~~~~----~~~~----~~~~~~li~~~L~~dp~~Rpt~~ 355 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGS-----------------EWIFRS----CKNI----PQPVRALLEGFLRYPKEDRLLPL 355 (377)
T ss_dssp HHHHHHHHSSCCC------CCS-----------------GGGGSS----CCCC----CHHHHHHHHHHTCSSGGGCCCHH
T ss_pred HHHHHHHHCCCCCcccccccch-----------------hhhhhh----ccCC----CHHHHHHHHHHcCCCchhCCCHH
Confidence 9999999999999654331110 001110 0111 23466788899999999999999
Q ss_pred HHHHH
Q 045256 759 DIVAN 763 (789)
Q Consensus 759 evl~~ 763 (789)
|++++
T Consensus 356 e~l~h 360 (377)
T 3byv_A 356 QAMET 360 (377)
T ss_dssp HHHTS
T ss_pred HHhhC
Confidence 99873
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.23 Aligned_cols=236 Identities=23% Similarity=0.345 Sum_probs=187.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||++... +++.||+|++....... .....+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS--VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS--HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 57999999999999999999875 78999999976543322 2234578899999999 99999999999999999999
Q ss_pred EEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---------------
Q 045256 572 VYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA--------------- 624 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~--------------- 624 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999998653 258899999999999998 999999999999984
Q ss_pred ----CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 625 ----QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 625 ----~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
...+||+|||++....... ...+|+.|+|||.+.+. .++.++||||||+++|||++|++++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence 4479999999987644322 23589999999999765 566899999999999999999877632210
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..++......... ......+.+++.+||+.||++|||+.|++++
T Consensus 237 -----------------~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -----------------WHEIRQGRLPRIP---QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -----------------HHHHHTTCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----------------HHHHHcCCCCCCC---cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111111111111 1123456778889999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=362.98 Aligned_cols=243 Identities=25% Similarity=0.418 Sum_probs=188.8
Q ss_pred ceEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 500 NKIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
+.||+|+||.||+|.+. .++.||||+++..... ....+.+.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC--GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 47999999999999642 4678999998654322 2334569999999999999999999999964 5688999999
Q ss_pred CCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC-c
Q 045256 577 KNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-R 647 (789)
Q Consensus 577 ~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~-~ 647 (789)
++++|.+++... ..++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++......... .
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999998653 368899999999999998 9999999999999999999999999997654433211 1
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc--c
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--R 724 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~--~ 724 (789)
.....+|+.|+|||++....++.++||||||++||||++ |+.||..... .++.+.+.. +
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------------------~~~~~~i~~~~~ 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------------SEVTAMLEKGER 590 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------------HHHHHHHHTTCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------------------HHHHHHHHcCCC
Confidence 223456789999999988899999999999999999998 9999854322 111122221 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
+..+. .....+.+|+.+||+.||++||++.++++.|+++...
T Consensus 591 ~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 591 MGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 22222 2334567788899999999999999999999988653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.97 Aligned_cols=251 Identities=22% Similarity=0.343 Sum_probs=190.1
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----CCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----KDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~ 568 (789)
++|++.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE----QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS----HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC----HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 5799999999999999999986 578999999875432 2334568899999999999999999999873 346
Q ss_pred EEEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 569 RLLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
.++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 88999999999999988652 258899999999999998 999999999999999999999999988
Q ss_pred cCCCCCCCCC-------cccccccCcCccCccccCCCC---CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 637 MMGPESERDF-------RPMKAAGTVGYIDPEYYGLNV---LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 637 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
.......... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||.......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------- 253 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-------- 253 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--------
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--------
Confidence 6532211110 001234689999999987554 6889999999999999999999984321100
Q ss_pred chhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 707 FAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 707 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
..+...+......+. .......+.+++.+||+.||++||++.|++++|+++..
T Consensus 254 --------~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 --------DSVALAVQNQLSIPQ--SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --------SCHHHHHHCC--CCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --------chhhHHhhccCCCCc--cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 001111111111111 11223456778889999999999999999999998743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.92 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=185.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhh----hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTK----KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
.++|++.+.||+|+||.||++... +++.||||++...... ........+.+|++++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357999999999999999999864 5789999997654321 11122345889999999999999999999987654
Q ss_pred eEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc---EEEEeeccC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT---ARVSDFGLS 636 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfGls 636 (789)
.++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 89999999999999988643 357889999999999998 999999999999987654 999999999
Q ss_pred cCCCCCCCCCcccccccCcCccCcccc---CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYY---GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
....... ......||+.|+|||++ ....++.++||||||+++|||++|+.||......... .
T Consensus 165 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~-------- 229 (322)
T 2ycf_A 165 KILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL----K-------- 229 (322)
T ss_dssp EECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH----H--------
T ss_pred eeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH----H--------
Confidence 7643321 11234689999999997 3567899999999999999999999999654321110 0
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
..+..................+.+++.+||+.||++||++.|+++
T Consensus 230 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 230 ----DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ----HHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 000011111100001123455678899999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=344.24 Aligned_cols=194 Identities=25% Similarity=0.350 Sum_probs=158.9
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||.||++... +++.||||++...... ......+.+|+++|++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED--LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC--hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 468999999999999999999864 5789999998653222 23345688999999999999999999999876
Q ss_pred CeEEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...|+||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 56899999997 5999998753 368899999999999999 99999999999999999999999999976
Q ss_pred CCCCCCC--------------------CcccccccCcCccCcccc-CCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 045256 639 GPESERD--------------------FRPMKAAGTVGYIDPEYY-GLNVLTAKSDVYGLGVVLLELLTGKRAIF 692 (789)
Q Consensus 639 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~SlGvil~elltG~~pf~ 692 (789)
....... .......||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 5433211 112356789999999986 56679999999999999999998766554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=328.39 Aligned_cols=243 Identities=23% Similarity=0.370 Sum_probs=188.5
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||.||++... +++.||+|++..... .+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 4578999999999999999999875 589999998764321 235889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+||||+++++|.+++... ..++.++++||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 999999999999998632 368899999999999999 99999999999999999999999999976433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... ......+++.|+|||.+....++.++||||||+++|||++|+.||..... . ..... +
T Consensus 178 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~------------~~~~~-~ 237 (314)
T 3com_A 178 TMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----M------------RAIFM-I 237 (314)
T ss_dssp TBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----H------------HHHHH-H
T ss_pred hcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----H------------HHHHH-H
Confidence 221 12245689999999999988999999999999999999999999854321 0 00000 1
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.................+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 238 PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111111111122234557788999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=339.87 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=185.0
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|++.+.||+|+||.||++.. .+++.||||++...... ....+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC--HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 46899999999999999999986 46899999997553221 233456889999999999999999999997653
Q ss_pred --eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 --ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 --~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..|+||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 77999988642 358899999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccch----hhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFA----VPA 711 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~----~~~ 711 (789)
.... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...+......... ...+ ...
T Consensus 178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 4332 124578999999999866 679999999999999999999999996543210000000 0000 000
Q ss_pred hhhhhhHHhhcccCC--CCC--CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVG--PPE--INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~--~~~--~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+........+..... ... .........+.+|+.+||..||++|||+.|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000011111111000 000 0001223456678889999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=335.49 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=186.5
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|++.+.||+|+||.||++... +++.||||++...... ......+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC--hHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 368999999999999999999864 6889999997653221 233456889999999999999999999997665
Q ss_pred --eEEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 568 --ERLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 568 --~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
..++||||+++ +|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ccceEEEEEcCCC-CHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 68999999975 88887753 2368899999999999998 999999999999999999999999999764
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhhh---h
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAIM---A 714 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~~---~ 714 (789)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...+......... ...+.+... .
T Consensus 178 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 178 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 3321 1224578999999999999899999999999999999999999996543210000000 000000000 0
Q ss_pred hhhHHhhccc---------------C-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 715 GELVKILDRR---------------V-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 715 ~~~~~~~d~~---------------~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
......+... . +............+.+|+.+||..||++|||++|++++-
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0001111110 0 111111223356778899999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=326.88 Aligned_cols=243 Identities=24% Similarity=0.377 Sum_probs=194.4
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|++.+.||+|+||.||++.. .+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+....++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 5689999999999999999986 46889999997654322 2344688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 573 YDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|||+++++|.+++.. ...++.|+++||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 99 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 99 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp EECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 999999999999864 2368899999999999998 99999999999999999999999999976443321
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
......+++.|+|||.+....++.++||||||+++|||++|+.||..... . .....+.....
T Consensus 175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~------------~~~~~~~~~~~ 236 (303)
T 3a7i_A 175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----M------------KVLFLIPKNNP 236 (303)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H------------HHHHHHHHSCC
T ss_pred -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----H------------HHHHHhhcCCC
Confidence 22345789999999999999999999999999999999999999854321 0 00001111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.. ........+..++.+||+.||++|||+.|++++.
T Consensus 237 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 PT---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CC---CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CC---CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 10 0111234467788899999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.75 Aligned_cols=263 Identities=23% Similarity=0.331 Sum_probs=189.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc--hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 57999999999999999999875 5899999987554322 23344578999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 999999888887642 2368899999999999998 99999999999999999999999999976433222
Q ss_pred CCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhhh----hhhh-
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPAI----MAGE- 716 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~~----~~~~- 716 (789)
......+|+.|+|||.+.+. .++.++||||||+++|||++|+.||............. .....+.. ....
T Consensus 180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 12245689999999999765 78999999999999999999999996543210000000 00000000 0000
Q ss_pred hHHhhcccCCCCCCCH---HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~---~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+....... ......+.+|+.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000000 1234567788999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.56 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=189.2
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK------ 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 566 (789)
++|++.+.||+|+||.||+++. .+++.||+|++....... .....+.+|++++++++||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 5799999999999999999987 578999999876543222 2233577899999999999999999999874
Q ss_pred --CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeecc
Q 045256 567 --DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635 (789)
Q Consensus 567 --~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 635 (789)
+..++||||+++ +|.+.+... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999985 777776542 368999999999999999 99999999999999999999999999
Q ss_pred CcCCCCCCC--CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc-------
Q 045256 636 SMMGPESER--DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV------- 705 (789)
Q Consensus 636 s~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~------- 705 (789)
+........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....+..... .+.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~i~~~~~~~~ 249 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA-LISQLCGSIT 249 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHHHCCCC
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCC
Confidence 976543221 112234578999999998865 568999999999999999999999986543210000 000
Q ss_pred cchhhhhhhhhhHHhhcccCCCCCCCHHHH------HHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 706 DFAVPAIMAGELVKILDRRVGPPEINEAEA------VELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~------~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+........+.+... ........+. ...+.+|+.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELV-KGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCC-SSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccc-cccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 0000000000000000000 0000111111 2346788999999999999999999885
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.50 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=191.1
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--CCeE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--KDER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~ 569 (789)
.++|++.+.||+|+||.||++... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+ ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC--HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 468999999999999999999875 6899999997654322 2334568999999999999999999998864 5678
Q ss_pred EEEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcC--CCCeEeccCCCCCEEECCCCcEEEEeecc
Q 045256 570 LLVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYA--VPPIIHRDIKSSNILLDAQWTARVSDFGL 635 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfGl 635 (789)
++||||+++++|.+++... ..++.|+++||+|||+.+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999998642 257899999999999976 23489999999999999999999999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
+........ ......+++.|+|||.+....++.++||||||+++|||++|+.||..... . .
T Consensus 163 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------~----~ 223 (279)
T 2w5a_A 163 ARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------K----E 223 (279)
T ss_dssp HHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------H----H
T ss_pred heeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------------H----H
Confidence 876433211 11234689999999999888899999999999999999999999854321 0 0
Q ss_pred hhHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 716 ELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 716 ~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
....+..... ..+. .....+.+++.+||+.||++||++.|+++++.
T Consensus 224 ~~~~i~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 224 LAGKIREGKFRRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHHHHHTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHhhcccccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 0111111111 1111 22345677888999999999999999998764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.57 Aligned_cols=274 Identities=20% Similarity=0.252 Sum_probs=194.6
Q ss_pred HHHHHHHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhh-------hHHHHHHHHHHHHHHHhhcCCC
Q 045256 482 EEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK-------KFQEKESAFDSELAFLSRLHHK 554 (789)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~Hp 554 (789)
......++....++|++.+.||+|+||.||++...+++.||||++...... ......+.+.+|++++++++||
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 89 (362)
T 3pg1_A 10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89 (362)
T ss_dssp HHHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred HHHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence 345677888999999999999999999999999888999999987543221 1122345689999999999999
Q ss_pred cceEEEEEEEeC-----CeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCE
Q 045256 555 HLVRLVGYCEEK-----DERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNI 620 (789)
Q Consensus 555 nIv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NI 620 (789)
||+++++++... ...++||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+||
T Consensus 90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 999999998653 35799999998 5888887643 358899999999999998 99999999999
Q ss_pred EECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 621 LLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 621 ll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
|++.++.+||+|||++........ .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999975333221 224568999999999876 6789999999999999999999999965431000
Q ss_pred cccccccc---h----hhhhhhhhhHHhhcccCCC-CCCCHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 700 TPVSLVDF---A----VPAIMAGELVKILDRRVGP-PEINEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 700 ~~~~~~~~---~----~~~~~~~~~~~~~d~~~~~-~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. .+... + ..........+.+...+.. +..... .....+.+|+.+||+.||++|||+.|++++
T Consensus 243 ~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LN-KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HH-HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH-HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 00000 0 0000001111112111111 111111 123456788999999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=325.01 Aligned_cols=244 Identities=26% Similarity=0.395 Sum_probs=182.7
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe------
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE------ 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 565 (789)
.++|++.+.||+|+||.||++... +++.||||++.... ...+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 357999999999999999999864 78999999975422 234568899999999999999999999865
Q ss_pred -------CCeEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEE
Q 045256 566 -------KDERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR 629 (789)
Q Consensus 566 -------~~~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 629 (789)
....++||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 34679999999999999998642 257889999999999998 99999999999999999999
Q ss_pred EEeeccCcCCCCCCC------------CCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 045256 630 VSDFGLSMMGPESER------------DFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696 (789)
Q Consensus 630 l~DfGls~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~ 696 (789)
|+|||++........ ........+++.|+|||.+.+. .++.++||||||+++|||++ ||....+
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 999999976543211 1112245689999999999754 78999999999999999998 4421110
Q ss_pred CCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 697 SGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 234 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 ----------------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ----------------HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----------------HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 001111111111222222223334556788999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=340.93 Aligned_cols=256 Identities=21% Similarity=0.233 Sum_probs=195.5
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-CcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-KHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~ 570 (789)
.++|++.++||+|+||.||++.+ .+++.||||++...... ..+.+|+++++.++| ++|..+..++.+.+..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 47899999999999999999986 56899999986543321 237789999999976 56666667777888899
Q ss_pred EEEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE---CCCCcEEEEeeccCcC
Q 045256 571 LVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL---DAQWTARVSDFGLSMM 638 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfGls~~ 638 (789)
|||||+ +++|.+++.. ...++.|++.||+|||+.+ |+||||||+|||| +.++.+||+|||+++.
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999999 8899999863 2368899999999999998 9999999999999 6889999999999976
Q ss_pred CCCCCCC-----CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 639 GPESERD-----FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 639 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
....... .......||+.|+|||++.+..++.++||||||++||||++|+.||........ .. ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~----~~~~i~ 229 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQ----KYEKIS 229 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HH----HHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HH----HHHHHh
Confidence 5443221 112245799999999999999999999999999999999999999965432110 00 000000
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
...+...+... .......+.+|+..||+.||++||++.+|++.|++++...
T Consensus 230 ~~~~~~~~~~l-------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 230 EKKVATSIEAL-------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHSCHHHH-------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccccccHHHH-------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 11110000000 0112345678889999999999999999999999987643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=327.78 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=187.7
Q ss_pred HhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC--CCcceEEEEEEEeCCe
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH--HKHLVRLVGYCEEKDE 568 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~~ 568 (789)
...++|++.+.||+|+||.||++...+++.||+|++...... ....+.+.+|++++++++ ||||+++++++.+.+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD--NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc--ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 344679999999999999999999888999999997653322 233456899999999997 5999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.++||| +.+++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|||++....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 999999 5678999998653 358899999999999998 999999999999965 899999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCC-----------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGL-----------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 709 (789)
............|++.|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------- 244 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------------- 244 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------------
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-------------
Confidence 4333222234578999999999865 4688899999999999999999999854321
Q ss_pred hhhhhhhhHHhhcccC--CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 710 PAIMAGELVKILDRRV--GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 710 ~~~~~~~~~~~~d~~~--~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
....+...++... ..+... ...+.+++.+||+.||++||++.|++++-
T Consensus 245 ---~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 245 ---QISKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ---HHHHHHHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---HHHHHHHHHhcccccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 0011222222211 111211 23466788899999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=322.78 Aligned_cols=245 Identities=26% Similarity=0.388 Sum_probs=191.6
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 368999999999999999999875 6899999997653322 1234468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC---CcEEEEeeccCcCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ---WTARVSDFGLSMMGP 640 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfGls~~~~ 640 (789)
||||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999987543 368899999999999998 9999999999999764 479999999987644
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .....+++.|+|||.+.+. ++.++||||||+++|||++|+.||..... . ..+..+
T Consensus 176 ~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~------------~~~~~~ 234 (287)
T 2wei_A 176 QNTK---MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE-----Y------------DILKRV 234 (287)
T ss_dssp CCSS---CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H------------HHHHHH
T ss_pred CCCc---cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH-----H------------HHHHHH
Confidence 3321 1234588999999998764 89999999999999999999999864321 0 001111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 1111111111112233456778899999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=332.29 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=185.9
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE 565 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 565 (789)
++....++|++.+.||+|+||.||++.. .+++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 3444568899999999999999999986 4789999999764322 123588999999999 79999999999987
Q ss_pred ------CCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEE
Q 045256 566 ------KDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTAR 629 (789)
Q Consensus 566 ------~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 629 (789)
.+..++||||+++++|.+++... ..++.|++.||+|||+.+ |+|+||||+|||++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 45789999999999999998652 257889999999999998 99999999999999999999
Q ss_pred EEeeccCcCCCCCCCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc
Q 045256 630 VSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL 704 (789)
Q Consensus 630 l~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~ 704 (789)
|+|||++........ ......+++.|+|||++. ...++.++||||||+++|||++|+.||..... .
T Consensus 170 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~-- 240 (326)
T 2x7f_A 170 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----M-- 240 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----H--
T ss_pred EeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----H--
Confidence 999999876433221 122346899999999986 56788999999999999999999999854321 0
Q ss_pred ccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 705 VDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 705 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+..+...... ..........+.+++.+||..||++||++.|++++
T Consensus 241 ----------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 ----------RALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ----------HHHHHHHHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----------HHHHHhhcCccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000111111111 00011123456778889999999999999999884
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-37 Score=323.57 Aligned_cols=242 Identities=24% Similarity=0.414 Sum_probs=185.4
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
+|....+||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 98 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFM 98 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEE
Confidence 444556999999999999986 4688999998765432 22345889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-CCcEEEEeeccCcCCCC
Q 045256 574 DYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-QWTARVSDFGLSMMGPE 641 (789)
Q Consensus 574 e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfGls~~~~~ 641 (789)
||+++++|.+++... ..++.|+++||+|||+.+ |+|+||||+|||++. ++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999998643 236789999999999998 999999999999987 89999999999976443
Q ss_pred CCCCCcccccccCcCccCccccCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
... ......+++.|+|||.+... .++.++||||||+++|||++|+.||...... ..... ...
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~~~~~---~~~ 239 (295)
T 2clq_A 176 INP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-----------QAAMF---KVG 239 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-----------HHHHH---HHH
T ss_pred CCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-----------hHHHH---hhc
Confidence 221 12245689999999998654 3789999999999999999999998543220 00000 000
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+. .....+.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 240 MFKVHPEIPE----SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHCCCCCCCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111111 223456678889999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.41 Aligned_cols=189 Identities=25% Similarity=0.339 Sum_probs=161.0
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc------CCCcceEEEEEEEe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL------HHKHLVRLVGYCEE 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l------~HpnIv~l~~~~~~ 565 (789)
..+|++.+.||+|+||+||++... +++.||||++.... .....+.+|+++++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 367999999999999999999764 58899999976532 2233466788887777 57799999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc--EEEEee
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT--ARVSDF 633 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~Df 633 (789)
....++||||+. ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeec
Confidence 999999999996 5999988643 258899999999999998 999999999999999887 999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
|++...... .....+|+.|+|||++.+..++.++|||||||+||||++|++||...+
T Consensus 247 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 247 GSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 999753322 224578999999999998899999999999999999999999996543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.04 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=186.6
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH----HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 468999999999999999999875 588999998764322 224468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++++|.+++... ..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999987642 358899999999999998 999999999999999999999999987431110
Q ss_pred CCCCcccccccCcCccCcccc-----CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYY-----GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
. .......+++.|+|||++ ....++.++||||||+++|||++|+.||..... ....
T Consensus 171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------------~~~~ 231 (302)
T 2j7t_A 171 L--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------------MRVL 231 (302)
T ss_dssp H--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------------HHHH
T ss_pred c--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----------------HHHH
Confidence 0 011234689999999998 467789999999999999999999999854321 0001
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+..... +...........+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 232 LKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred HHHhccCC-cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11111111 1111122334557788899999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=339.05 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=182.1
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|.+.++||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 4566678999999999987777789999999875422 22467899999887 899999999999999999999
Q ss_pred EEecCCCchhHHHhhhc---------------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC------------
Q 045256 573 YDYMKNGALYDHLHDRN---------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ------------ 625 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~---------------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~------------ 625 (789)
|||++ ++|.+++.... .++.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~ 163 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAE 163 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCC
Confidence 99996 59999986431 38899999999999998 9999999999999653
Q ss_pred -CcEEEEeeccCcCCCCCCCCC--cccccccCcCccCccccCC-------CCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 045256 626 -WTARVSDFGLSMMGPESERDF--RPMKAAGTVGYIDPEYYGL-------NVLTAKSDVYGLGVVLLELLT-GKRAIFKD 694 (789)
Q Consensus 626 -~~~kl~DfGls~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~SlGvil~ellt-G~~pf~~~ 694 (789)
+.+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...
T Consensus 164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 589999999998654433221 1224579999999999965 678999999999999999999 89998532
Q ss_pred CCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 695 DESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
... . ...+...... ..............+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~---~------------~~i~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 244 YSR---E------------SNIIRGIFSL-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TTH---H------------HHHHHTCCCC-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhh---H------------HHHhcCCCCc-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 210 0 0000111110 01111223456677888999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.09 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=183.1
Q ss_pred HHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC--
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK-- 566 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-- 566 (789)
....++|++.+.||+|+||.||++.. .+++.||||++...... ..+|++++++++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecCc
Confidence 44568999999999999999999986 57899999987543221 34799999999999999999998543
Q ss_pred ------------------------------------CeEEEEEEecCCCchhHHHhh------------hchHHHHHHHH
Q 045256 567 ------------------------------------DERLLVYDYMKNGALYDHLHD------------RNNVEKNAARG 598 (789)
Q Consensus 567 ------------------------------------~~~~lv~e~~~~gsL~~~l~~------------~~~i~~~ia~~ 598 (789)
...++||||+++ +|.+.+.. ...++.|+++|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 337899999985 88877753 13578999999
Q ss_pred HHHHHhcCCCCeEeccCCCCCEEEC-CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC-CCCchhHHHH
Q 045256 599 IEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYG 676 (789)
Q Consensus 599 l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S 676 (789)
|+|||+.+ |+||||||+|||++ .++.+||+|||+++........ ....+|+.|+|||.+.+. .++.++||||
T Consensus 154 L~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 154 VGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 99999998 99999999999997 6889999999999765433322 245689999999998764 5899999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhh---hhhhhHHhhc----ccCCCCC-CC-----HHHHHHHHHHHH
Q 045256 677 LGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAI---MAGELVKILD----RRVGPPE-IN-----EAEAVELVAYTA 743 (789)
Q Consensus 677 lGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~d----~~~~~~~-~~-----~~~~~~~l~~l~ 743 (789)
||+++|||++|+.||........ +.... ... ..+.+..+-. ...+... .. +......+.+|+
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~----~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQ----LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHH----HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHH----HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence 99999999999999965432100 00000 000 0000000000 0000000 00 011234467888
Q ss_pred HhhcCcCCCCCCCHHHHHHH
Q 045256 744 MHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 744 ~~cl~~dp~~RPt~~evl~~ 763 (789)
.+||+.||++|||+.|++++
T Consensus 303 ~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=340.23 Aligned_cols=251 Identities=26% Similarity=0.315 Sum_probs=181.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC----C-
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----D- 567 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----~- 567 (789)
.+|++.+.||+|+||.||++++. +++.||||++..... .+.+|+++|++++||||+++++++... +
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 46899999999999999999875 589999998754321 134799999999999999999998642 2
Q ss_pred -eEEEEEEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEee
Q 045256 568 -ERLLVYDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDF 633 (789)
Q Consensus 568 -~~~lv~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~Df 633 (789)
..++||||+++ +|.+.+.. ...++.|+++||+|||+.+ |+||||||+||||+.+ +.+||+||
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DF 201 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 201 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccc
Confidence 25799999986 67666542 2357899999999999998 9999999999999965 67899999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh-
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA- 711 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~- 711 (789)
|+++....... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+.......
T Consensus 202 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~----~l~~i~~~lg 274 (420)
T 1j1b_A 202 GSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD----QLVEIIKVLG 274 (420)
T ss_dssp TTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHC
T ss_pred hhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhC
Confidence 99986543322 1245789999999998654 78999999999999999999999996543210 000000000
Q ss_pred -hhhhhhHHhhcc----cCCCCC-CCH-----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 -IMAGELVKILDR----RVGPPE-INE-----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 -~~~~~~~~~~d~----~~~~~~-~~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
-..+.+.++... .++... ... ......+.+|+.+||..||++||++.|++++
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000111111000 000000 000 1123456788899999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=334.22 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=192.6
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHH-------------HHHHHHHHHHHHHhhcCCCcceEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQ-------------EKESAFDSELAFLSRLHHKHLVRL 559 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~-------------~~~~~~~~E~~~l~~l~HpnIv~l 559 (789)
.++|++.+.||+|+||.||++.. +++.||+|++......... ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999998 8999999997653322110 011568999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhHH------Hhh----------hchHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEE
Q 045256 560 VGYCEEKDERLLVYDYMKNGALYDH------LHD----------RNNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILL 622 (789)
Q Consensus 560 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~----------~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll 622 (789)
++++.+.+..++||||+++++|.++ +.. ...++.|+++||+|||+ .+ |+||||||+|||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 543 23588999999999999 88 9999999999999
Q ss_pred CCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC-CCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 045256 623 DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-VLTA-KSDVYGLGVVLLELLTGKRAIFKDDESGGT 700 (789)
Q Consensus 623 ~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~SlGvil~elltG~~pf~~~~~~~~~ 700 (789)
+.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 259 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV-- 259 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--
Confidence 99999999999999764332 22245789999999999877 6666 9999999999999999999996543210
Q ss_pred ccccccchhhhhhhhhhHHhhcccCCCC---------------CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 701 PVSLVDFAVPAIMAGELVKILDRRVGPP---------------EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~---------------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+.......+ ..........+.+|+.+||+.||++|||+.|++++
T Consensus 260 --------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 --------------ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp --------------HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --------------HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00001111111100 00012234556788899999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=327.38 Aligned_cols=251 Identities=25% Similarity=0.363 Sum_probs=175.0
Q ss_pred HHhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
....++|++.+.||+|+||.||++... +++.||||++..... ....+.+.+|++++++++||||+++++++...+.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 344679999999999999999999854 688999998764332 2234468899999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhh----------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEe
Q 045256 569 RLLVYDYMKNGALYDHLHD----------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSD 632 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~----------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 632 (789)
.++||||+++++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 164 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIAD 164 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEe
Confidence 9999999999999999863 1258889999999999998 99999999999999999999999
Q ss_pred eccCcCCCCCCC---CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccch
Q 045256 633 FGLSMMGPESER---DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFA 708 (789)
Q Consensus 633 fGls~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~ 708 (789)
||++........ ........+|+.|+|||.+.. ..++.++||||||+++|||++|+.||....... .
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~---- 235 (303)
T 2vwi_A 165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK-----V---- 235 (303)
T ss_dssp CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-----H----
T ss_pred ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-----H----
Confidence 999865433211 111223568999999999865 568999999999999999999999986533210 0
Q ss_pred hhhhhhhhhHHhhcccCCCC------CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 VPAIMAGELVKILDRRVGPP------EINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 ~~~~~~~~~~~~~d~~~~~~------~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+....... ..........+.+++.+||+.||++||++.|++++
T Consensus 236 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 236 --------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp --------HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --------HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000000000 00001122456778889999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=334.09 Aligned_cols=257 Identities=19% Similarity=0.259 Sum_probs=188.7
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC--------CCcceEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH--------HKHLVRLVGYC 563 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------HpnIv~l~~~~ 563 (789)
.++|++.+.||+|+||+||+++. .+++.||||++.... ...+.+.+|++++++++ ||||+++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 36899999999999999999985 468899999976432 23345789999999985 78899999999
Q ss_pred E----eCCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCC--
Q 045256 564 E----EKDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQW-- 626 (789)
Q Consensus 564 ~----~~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~-- 626 (789)
. +....++||||+ +++|.+.+... ..++.|+++||+|||+. + |+||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchh
Confidence 8 455789999999 55776666432 35889999999999998 8 99999999999999775
Q ss_pred -----------------------------------------------cEEEEeeccCcCCCCCCCCCcccccccCcCccC
Q 045256 627 -----------------------------------------------TARVSDFGLSMMGPESERDFRPMKAAGTVGYID 659 (789)
Q Consensus 627 -----------------------------------------------~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~a 659 (789)
.+||+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999764332 123578999999
Q ss_pred ccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc-cccccc--------hhhhhhhhhh-HHhhccc-----
Q 045256 660 PEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP-VSLVDF--------AVPAIMAGEL-VKILDRR----- 724 (789)
Q Consensus 660 PE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~-~~~~~~--------~~~~~~~~~~-~~~~d~~----- 724 (789)
||++.+..++.++||||||++||||++|+.||.......... ...... +......... .+.+...
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999998899999999999999999999999996544321100 000000 0000000000 0000000
Q ss_pred CC---C---------CCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VG---P---------PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~---~---------~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+. + ......+....+.+|+.+||+.||++|||++|++++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00 0 001134556778899999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.13 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=190.8
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||.||++... +++.||||++..... ....+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH---QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC---HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC---cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 368999999999999999999864 678899999764322 23345688999999999999999999999765
Q ss_pred CeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
...++||||+++ +|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 368999999975 999988643 368899999999999999 999999999999999999999999999765
Q ss_pred CCCCCCC-cccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhhh----
Q 045256 640 PESERDF-RPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVPA---- 711 (789)
Q Consensus 640 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~~---- 711 (789)
....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||............. ...+...
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 4332211 123457899999999864 4558999999999999999999999996543211000000 0000000
Q ss_pred hhhhhhHHhhcccCCCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..................... ......+.+|+.+||+.||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000011111110111101 1123456788999999999999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=336.19 Aligned_cols=251 Identities=22% Similarity=0.295 Sum_probs=182.0
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe-----
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE----- 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~----- 568 (789)
.+|++.+.||+|+||.||+++..++..||+|++...... ..+|++++++++||||+++++++.....
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 479999999999999999999877777999987543221 2369999999999999999999976543
Q ss_pred -EEEEEEecCCCchhHHHhh------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEEEEeec
Q 045256 569 -RLLVYDYMKNGALYDHLHD------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFG 634 (789)
Q Consensus 569 -~~lv~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG 634 (789)
.++||||+++ ++.+.+.. ...++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999987 44443321 2357889999999999998 99999999999998 79999999999
Q ss_pred cCcCCCCCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh--
Q 045256 635 LSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA-- 711 (789)
Q Consensus 635 ls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~-- 711 (789)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.......
T Consensus 188 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----l~~i~~~~g~ 260 (394)
T 4e7w_A 188 SAKILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ----LVEIIKVLGT 260 (394)
T ss_dssp TCEECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHHHCC
T ss_pred CcccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhCC
Confidence 99765433222 245689999999998654 589999999999999999999999965432100 00000000
Q ss_pred hhhhhhHH----hhcccCCCCC-CCH-----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVK----ILDRRVGPPE-INE-----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~----~~d~~~~~~~-~~~-----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+.. .....++... ... ......+.+|+.+||+.||++|||+.|++++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000 0001111000 000 1123456788899999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=339.29 Aligned_cols=192 Identities=25% Similarity=0.385 Sum_probs=147.4
Q ss_pred CCccc-cceEeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--CC
Q 045256 494 NNFSL-ENKIGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--KD 567 (789)
Q Consensus 494 ~~~~~-~~~LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~ 567 (789)
+.|++ .++||+|+||+||+++.+ +++.||||++...... ..+.+|+++|++++||||+++++++.. ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~------~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS------MSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC------HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC------HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 45665 458999999999999865 5789999998653322 247789999999999999999999965 66
Q ss_pred eEEEEEEecCCCchhHHHhh-----------------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE----CCCC
Q 045256 568 ERLLVYDYMKNGALYDHLHD-----------------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL----DAQW 626 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~-----------------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll----~~~~ 626 (789)
..++||||+++ +|.+++.. ...++.|++.||+|||+.+ |+||||||+|||| +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCC
Confidence 78999999975 88887752 2357889999999999999 9999999999999 7788
Q ss_pred cEEEEeeccCcCCCCCCCC-CcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 627 TARVSDFGLSMMGPESERD-FRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 627 ~~kl~DfGls~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||+||||++|++||....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999865432211 12234578999999999976 458999999999999999999999996554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=338.23 Aligned_cols=240 Identities=20% Similarity=0.303 Sum_probs=179.3
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 572 (789)
.+|++.++||+|+||+||.....+++.||||++...... .+.+|+++|+++ +||||+++++++.+....|+|
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence 468899999999999976665668899999997543222 256799999999 799999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-----CCcEEEEeeccCcC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-----QWTARVSDFGLSMM 638 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGls~~ 638 (789)
|||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99997 5999998643 368999999999999999 999999999999943 34688999999976
Q ss_pred CCCCCCC-CcccccccCcCccCccccC---CCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhh
Q 045256 639 GPESERD-FRPMKAAGTVGYIDPEYYG---LNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 639 ~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~----------------- 235 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----------------- 235 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----------------
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----------------
Confidence 5433221 1223457999999999997 4567889999999999999999 8888743221
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
........................+.+|+.+||+.||++|||+.|+++
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 236 -RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -HHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000111111111111111233445678899999999999999999995
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.97 Aligned_cols=256 Identities=19% Similarity=0.311 Sum_probs=190.6
Q ss_pred cCCccccceEeecccEEEEEEEe--CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCC------cceEEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL--PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK------HLVRLVGYCE 564 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp------nIv~l~~~~~ 564 (789)
.++|++.+.||+|+||.||++.. .+++.||||+++... ...+.+.+|++++++++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 46899999999999999999986 368899999976432 2234578899999988765 4999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC----------
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---------- 624 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---------- 624 (789)
+.+..++||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence 999999999999 78999998653 258899999999999998 999999999999987
Q ss_pred ---------CCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 625 ---------QWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 625 ---------~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6689999999997643321 24578999999999999899999999999999999999999996543
Q ss_pred CCCCc----------cccc--------------ccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCC
Q 045256 696 ESGGT----------PVSL--------------VDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEG 751 (789)
Q Consensus 696 ~~~~~----------~~~~--------------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp 751 (789)
..... +..+ ..|...........+.. ..+.............+.+|+.+||+.||
T Consensus 239 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 239 SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 21000 0000 00000000000000000 00000011122345667889999999999
Q ss_pred CCCCCHHHHHHH
Q 045256 752 KERPTMADIVAN 763 (789)
Q Consensus 752 ~~RPt~~evl~~ 763 (789)
++|||+.|++++
T Consensus 318 ~~Rpt~~ell~h 329 (339)
T 1z57_A 318 AKRITLREALKH 329 (339)
T ss_dssp TTSCCHHHHTTS
T ss_pred ccccCHHHHhcC
Confidence 999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.56 Aligned_cols=261 Identities=19% Similarity=0.290 Sum_probs=182.8
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEE-------
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCE------- 564 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------- 564 (789)
.++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS----HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC----hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 468999999999999999999876 48999999876432 223456889999999999999999999874
Q ss_pred -------eCCeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEE
Q 045256 565 -------EKDERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTAR 629 (789)
Q Consensus 565 -------~~~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 629 (789)
+....++||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++ .++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 5999988642 368899999999999998 99999999999997 567999
Q ss_pred EEeeccCcCCCCCCC-CCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccc
Q 045256 630 VSDFGLSMMGPESER-DFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDF 707 (789)
Q Consensus 630 l~DfGls~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~ 707 (789)
|+|||++........ ........++..|+|||.+.. ..++.++||||||+++|||++|+.||...............
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~- 240 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES- 240 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH-
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-
Confidence 999999976533211 111223467899999998754 67899999999999999999999999654321000000000
Q ss_pred hhhhhhhhhhHHh-------hcccCCCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 708 AVPAIMAGELVKI-------LDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 708 ~~~~~~~~~~~~~-------~d~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+........++ +......+.... ......+.+++.+||+.||++|||+.|++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 -IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp -SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000000000 011111111111 1124567788999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=327.78 Aligned_cols=244 Identities=22% Similarity=0.342 Sum_probs=162.8
Q ss_pred cCCccccc-eEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----C
Q 045256 493 TNNFSLEN-KIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----K 566 (789)
Q Consensus 493 ~~~~~~~~-~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~ 566 (789)
.++|.+.+ +||+|+||.||++... +++.||||++..... . ..+....++.++||||+++++++.. .
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----A---RQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-----H---HHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-----H---HHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 36788855 6999999999999875 689999999754221 1 1222334566799999999999976 4
Q ss_pred CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEee
Q 045256 567 DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDF 633 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 633 (789)
...++||||+++++|.+++..+ ..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Df 175 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDF 175 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecc
Confidence 4589999999999999998653 258899999999999998 999999999999976 456999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
|++....... .....+|+.|+|||++....++.++||||||+++|||++|+.||..........
T Consensus 176 g~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------------ 239 (336)
T 3fhr_A 176 GFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP------------ 239 (336)
T ss_dssp TTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------
T ss_pred ccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh------------
Confidence 9997543322 124567999999999988889999999999999999999999996543311100
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANL 764 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L 764 (789)
.....+.......+..........+.+|+.+||+.||++|||+.|++++-
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 240 -GMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred -hHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 00000111111111111122344567788899999999999999999853
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=354.68 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=194.2
Q ss_pred hcCCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
..++|++.+.||+|+||.||+|.+.. +..||+|++..... ....+.+.+|+.++++++||||+++++++. .+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34679999999999999999998642 45799998764322 233456899999999999999999999984 46
Q ss_pred eEEEEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 ERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..++||||+++++|.+++..+. .++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 6899999999999999987432 57889999999999998 99999999999999999999999999987
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
...... .......+++.|+|||.+....++.++||||||+++|||++ |+.||..... . +.+
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~------------~~~ 602 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----N------------DVI 602 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H------------HHH
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----H------------HHH
Confidence 543322 12223456789999999988899999999999999999997 8889854321 0 011
Q ss_pred HHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 718 VKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 718 ~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+... ....+. .....+.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 603 ~~i~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 603 GRIENGERLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111111 122222 2234567788899999999999999999999998764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.46 Aligned_cols=260 Identities=21% Similarity=0.328 Sum_probs=187.6
Q ss_pred hcCCccccceEeecccEEEEEEEe--CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc---CCCcceEEEEEEE--
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKL--PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL---HHKHLVRLVGYCE-- 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~-- 564 (789)
..++|++.+.||+|+||.||++.. .+++.||+|++....... .....+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 447899999999999999999987 467899999876543221 1112355677777666 8999999999987
Q ss_pred ---eCCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEE
Q 045256 565 ---EKDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVS 631 (789)
Q Consensus 565 ---~~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 631 (789)
.....++||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4566899999998 5999988643 258899999999999998 9999999999999999999999
Q ss_pred eeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--------
Q 045256 632 DFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS-------- 703 (789)
Q Consensus 632 DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~-------- 703 (789)
|||++....... ......+|+.|+|||.+....++.++||||||+++|||++|+.||............
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 999997643221 222456899999999999889999999999999999999999999654321000000
Q ss_pred cccchhhhhhhhhhHHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 704 LVDFAVPAIMAGELVKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...|...... ....+.. ...............+.+|+.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 240 EEDWPRDVAL---PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGGSCTTCSS---CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccCcccccc---chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 0000000 0000000011233456778899999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=334.61 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=175.3
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||.||++.. .+++.||||++...... ......+.+|++++++++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 47899999999999999999985 46889999997653221 22344688999999999999999999998754
Q ss_pred -CeEEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 -DERLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...|+|+||+ +++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 5579999999 6799888764 2368899999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cccchh----hh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LVDFAV----PA 711 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~~~~~----~~ 711 (789)
.... .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.||...+........ ....+. ..
T Consensus 182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~ 256 (367)
T 2fst_X 182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 4322 124578999999999876 67899999999999999999999999654321000000 000000 00
Q ss_pred hhhhhhHHhhcccCCCCCCCHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+......+.+......+..... .....+.+|+.+||..||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0011111121111111111111 123456788899999999999999999886
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.70 Aligned_cols=260 Identities=19% Similarity=0.269 Sum_probs=188.6
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE--
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER-- 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~-- 569 (789)
.++|.+.+.||+|+||.||++... +++.||||++...... ......+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc--hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 468999999999999999999864 6899999997653322 23345688999999999999999999999877654
Q ss_pred ----EEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 570 ----LLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 570 ----~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
++||||++ ++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred ceeEEEEEcccc-ccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 588887753 3468899999999999998 999999999999999999999999999754
Q ss_pred CCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc--ccchhh----hh
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL--VDFAVP----AI 712 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~--~~~~~~----~~ 712 (789)
... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+........+ ...+.. ..
T Consensus 195 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 195 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred ccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 322 123568999999999876 688999999999999999999999996543110000000 000000 00
Q ss_pred hhhhhHHhhcccCCCCCCCHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGELVKILDRRVGPPEINEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+......+..... .....+.+|+.+||+.||++|||+.|++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000011111111111111111 124567788999999999999999999886
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.77 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=189.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC----
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK---- 566 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~---- 566 (789)
..++|++.+.||+|+||.||++... +++.||||++..... ......+.+|++++++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK---PLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS---HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc---chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 3478999999999999999999875 688999999864322 22344578999999999999999999998764
Q ss_pred -CeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 567 -DERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 567 -~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
...++||||++ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999997 5999887642 368899999999999998 99999999999999999999999999976
Q ss_pred CCCCCCCC--------cccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cc--
Q 045256 639 GPESERDF--------RPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LV-- 705 (789)
Q Consensus 639 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~-- 705 (789)
........ ......||+.|+|||++. ...++.++||||||+++|||++|+.||...+........ ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 54322111 112346899999999875 467899999999999999999999999654310000000 00
Q ss_pred ---cchhhhhhhhhhHHhhcccCCCCCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 706 ---DFAVPAIMAGELVKILDRRVGPPEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 706 ---~~~~~~~~~~~~~~~~d~~~~~~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+............+.+......+.... ......+.+|+.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000111111111111011000 1223456788899999999999999999885
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.93 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=174.6
Q ss_pred HhcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe-
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE- 568 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~- 568 (789)
...++|++.+.||+|+||.||++... +++.||||++....... ..+.+|++.+..++||||+++++++.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-----NRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-----HHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 34578999999999999999999874 68999999875432211 235678888899999999999999976544
Q ss_pred ------EEEEEEecCCCchhHHHhh------------hchHHHHHHHHHHHHH--hcCCCCeEeccCCCCCEEECC-CCc
Q 045256 569 ------RLLVYDYMKNGALYDHLHD------------RNNVEKNAARGIEYLH--NYAVPPIIHRDIKSSNILLDA-QWT 627 (789)
Q Consensus 569 ------~~lv~e~~~~gsL~~~l~~------------~~~i~~~ia~~l~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~ 627 (789)
.++||||+++ +|.+.+.. ...++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999987 55554432 1257889999999999 877 999999999999996 899
Q ss_pred EEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc
Q 045256 628 ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD 706 (789)
Q Consensus 628 ~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~ 706 (789)
+||+|||++......... ....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .+..
T Consensus 171 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~ 243 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----QLHE 243 (360)
T ss_dssp EEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred EEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH----HHHH
Confidence 999999999865443322 245689999999998654 48999999999999999999999996543210 0000
Q ss_pred chhhh-hhhhhhHHhhcccC------CCCCCC--------HHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 707 FAVPA-IMAGELVKILDRRV------GPPEIN--------EAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 707 ~~~~~-~~~~~~~~~~d~~~------~~~~~~--------~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... ....+....++... ...... .......+.+|+.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000000000000 000000 01134567788999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.39 Aligned_cols=255 Identities=23% Similarity=0.385 Sum_probs=188.9
Q ss_pred HhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 491 AATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 491 ~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
...++|++.+.||+|+||.||++...+ .+++|++....... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE--DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA 105 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC--CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH--HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence 345789999999999999999998753 59999876543211 12234778999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+||||+++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 999999999999998653 258899999999999998 99999999999998 67999999999865432
Q ss_pred CCC---CCcccccccCcCccCccccCC---------CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchh
Q 045256 642 SER---DFRPMKAAGTVGYIDPEYYGL---------NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709 (789)
Q Consensus 642 ~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 709 (789)
... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------- 248 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------------- 248 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------------
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------------
Confidence 111 112223468999999999864 4578899999999999999999999854321
Q ss_pred hhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 710 PAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 710 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
... ...+.......+.. ......+.+++.+||..||++|||+.|+++.|+++.....
T Consensus 249 ~~~-~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 249 EAI-IWQMGTGMKPNLSQ-----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp HHH-HHHHHTTCCCCCCC-----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred HHH-HHHhccCCCCCCCc-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000 00011111111111 1122346678889999999999999999999999866543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=323.32 Aligned_cols=244 Identities=23% Similarity=0.326 Sum_probs=166.8
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHH-HHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELA-FLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||.||++... +++.||||++....... ....+..|+. +++.++||||+++++++.+.+..++
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH---HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch---HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 68999999999999999999874 68999999986543221 2223445555 7778899999999999999999999
Q ss_pred EEEecCCCchhHHHhh-------------hchHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 572 VYDYMKNGALYDHLHD-------------RNNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~-------------~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
||||+++ +|.+++.. ...++.++++||.|||+. + |+||||||+|||++.++.+||+|||++.
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999986 88777652 126889999999999998 8 9999999999999999999999999997
Q ss_pred CCCCCCCCCcccccccCcCccCcccc----CCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYY----GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
....... .....||+.|+|||.+ ....++.++||||||+++|||++|+.||.........
T Consensus 175 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------------- 238 (327)
T 3aln_A 175 QLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------------- 238 (327)
T ss_dssp C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------
T ss_pred ecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------------
Confidence 6543321 1234689999999998 4567899999999999999999999999653321100
Q ss_pred hhhhHHhhcccCC-CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRRVG-PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~~~-~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+..+...... .+..........+.+|+.+||+.||++||++.|++++
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 239 ---LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ----CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0001111000 0000011223456778889999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=326.25 Aligned_cols=259 Identities=19% Similarity=0.252 Sum_probs=187.6
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe---
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE--- 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 568 (789)
.++|.+.+.||+|+||.||++... +++.||||++...... ......+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS--EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc--hHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 468999999999999999999864 6899999997653321 2334568899999999999999999999987654
Q ss_pred ---EEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 ---RLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ---~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||++ ++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred ceeEEEEecccc-CCHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999997 588887653 3468899999999999998 999999999999999999999999999764
Q ss_pred CCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc---cchhhh----
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV---DFAVPA---- 711 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~---~~~~~~---- 711 (789)
... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...+...... ... ..+...
T Consensus 177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT-QILKVTGVPGTEFVQK 250 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH-HHHHHHCBCCHHHHTT
T ss_pred CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHHHHHH
Confidence 322 123468999999999876 678999999999999999999999996543210000 000 000000
Q ss_pred hhhhhhHHhhcc---c-CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDR---R-VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~---~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.........+.. . ..............+.+|+.+||+.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000011110 0 000000112234556788899999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=319.42 Aligned_cols=244 Identities=21% Similarity=0.326 Sum_probs=169.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||||++....... ...+.+.++..+++.++||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH--HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch--HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 57899999999999999999875 68999999976543222 2233455666678888999999999999999999999
Q ss_pred EEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+ ++.+..++.. ...++.++++||+|||+. + |+|+||||+|||++.++.+||+|||++......
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 9999 4445444432 126889999999999995 8 999999999999999999999999998654332
Q ss_pred CCCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
.. .....+++.|+|||++. ...++.++||||||+++|||++|+.||...... ...+
T Consensus 179 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------------~~~~ 239 (318)
T 2dyl_A 179 KA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD----------------FEVL 239 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH----------------HHHH
T ss_pred cc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc----------------HHHH
Confidence 21 12346899999999984 456889999999999999999999998543210 0111
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..++........ ........+.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 240 TKVLQEEPPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHHSCCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHhccCCCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112221111100 001123446678889999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=322.80 Aligned_cols=192 Identities=25% Similarity=0.318 Sum_probs=159.7
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CC-----cceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HK-----HLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----nIv~l~~~~~ 564 (789)
..++|++.+.||+|+||+||++... +++.||||+++... .....+..|+.+++.++ |+ +|+++++++.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 3578999999999999999999865 67899999976432 22345677888888885 55 4999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC--CCCcEEEEe
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD--AQWTARVSD 632 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~D 632 (789)
..+..++||||+++ +|.+++... ..++.|++.||.|||+.. .+|+||||||+|||++ .++.+||+|
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 99999999999965 999998653 268899999999999521 2399999999999994 578899999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
||++....... ....+|+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 205 FG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 205 FGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99997653321 24578999999999999999999999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.63 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=186.7
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-----------CCcceEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-----------HKHLVRLVG 561 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~ 561 (789)
++|++.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++++++ ||||+++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 5899999999999999999986 478899999976432 22345778999998886 899999999
Q ss_pred EEEeCC----eEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhc-CCCCeEeccCCCCCEEEC---
Q 045256 562 YCEEKD----ERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNY-AVPPIIHRDIKSSNILLD--- 623 (789)
Q Consensus 562 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~-~~~~ivH~Dlkp~NIll~--- 623 (789)
++...+ ..++||||+ +++|.+++... ..++.|++.||+|||+. + |+||||||+|||++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccC
Confidence 998654 689999999 88999998642 25889999999999998 8 99999999999994
Q ss_pred ---CCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCc
Q 045256 624 ---AQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700 (789)
Q Consensus 624 ---~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~ 700 (789)
.++.+||+|||++...... .....+|+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999764332 12347899999999999889999999999999999999999999754321100
Q ss_pred c--ccccc-------chhhhhhhh-h---------------------hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCc
Q 045256 701 P--VSLVD-------FAVPAIMAG-E---------------------LVKILDRRVGPPEINEAEAVELVAYTAMHCVNL 749 (789)
Q Consensus 701 ~--~~~~~-------~~~~~~~~~-~---------------------~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~ 749 (789)
. ..+.. .+....... . +.+.+.... .........+.+|+.+||+.
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY----KFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT----CCCHHHHHHHHHHHGGGGCS
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc----cCCcchHHHHHHHHHHHhcc
Confidence 0 00000 000000000 0 000011111 12245667788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 045256 750 EGKERPTMADIVAN 763 (789)
Q Consensus 750 dp~~RPt~~evl~~ 763 (789)
||++|||++|++++
T Consensus 321 dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 321 DPRKRADAGGLVNH 334 (373)
T ss_dssp STTTCBCHHHHHTC
T ss_pred CccccCCHHHHhhC
Confidence 99999999999885
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.87 Aligned_cols=231 Identities=13% Similarity=0.131 Sum_probs=179.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||++... +++.||||++....... .+..+.+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 67999999999999999999875 48999999987543322 23445688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF 646 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~ 646 (789)
|||+++++|.+++... .+++.|+++||+|||+.+ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred EEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999999998642 368899999999999999 9999999999999999999997443
Q ss_pred cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCC
Q 045256 647 RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVG 726 (789)
Q Consensus 647 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 726 (789)
|++| ++.++||||||+++|||+||+.||............... +.....
T Consensus 175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~--------------~~~~~~ 223 (286)
T 3uqc_A 175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD--------------TAGQPI 223 (286)
T ss_dssp ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC--------------TTSCBC
T ss_pred ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH--------------hccCCC
Confidence 3433 688999999999999999999999765432211000000 000000
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 727 PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 727 ~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
.+..........+.+++.+||+.||++| |+.|+++.|+++....+
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000001223457788999999999999 99999999999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.18 Aligned_cols=240 Identities=24% Similarity=0.414 Sum_probs=181.4
Q ss_pred HHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHH--HHHHHHHHHHHHHhhc----CCCcceEEEEE
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQ--EKESAFDSELAFLSRL----HHKHLVRLVGY 562 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l----~HpnIv~l~~~ 562 (789)
....++|++.+.||+|+||.||++.. .+++.||||++......... .....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999986 46889999998654332211 1223466799999998 89999999999
Q ss_pred EEeCCeEEEEEEe-cCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEEEEe
Q 045256 563 CEEKDERLLVYDY-MKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSD 632 (789)
Q Consensus 563 ~~~~~~~~lv~e~-~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 632 (789)
+.+.+..++|||| +++++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 7889999998753 258899999999999998 99999999999999 889999999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
||++....... .....++..|+|||++....+ +.++||||||+++|||++|+.||....
T Consensus 184 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------------- 243 (312)
T 2iwi_A 184 FGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------------- 243 (312)
T ss_dssp CSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------
T ss_pred cchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------------
Confidence 99987654332 224568999999999876665 458999999999999999999984321
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+........+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 244 -------~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 -------EILEAELHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------HHHHTCCCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------HHhhhccCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111211121 22346678889999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.39 Aligned_cols=255 Identities=17% Similarity=0.261 Sum_probs=187.4
Q ss_pred cCCccccceEeecccEEEEEEEeC-CC-cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc------ceEEEEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DG-QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH------LVRLVGYCE 564 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn------Iv~l~~~~~ 564 (789)
.++|++.+.||+|+||.||++... ++ +.||+|+++... ...+.+.+|++++++++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 368999999999999999999864 34 689999976432 22345788999999997766 999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEE------------
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILL------------ 622 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll------------ 622 (789)
..+..++||||+ +++|.+++... ..++.|+++||+|||+.+ |+||||||+|||+
T Consensus 93 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 93 FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC
T ss_pred eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccc
Confidence 999999999999 56777776543 258899999999999998 9999999999999
Q ss_pred -------CCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 045256 623 -------DAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695 (789)
Q Consensus 623 -------~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~ 695 (789)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999997633222 24578999999999999999999999999999999999999996543
Q ss_pred CCCCcccccc----cchhhhh---------------------hhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcC
Q 045256 696 ESGGTPVSLV----DFAVPAI---------------------MAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLE 750 (789)
Q Consensus 696 ~~~~~~~~~~----~~~~~~~---------------------~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~d 750 (789)
...... .+. ..+.... ......+... .+.............+.+|+.+||+.|
T Consensus 244 ~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~d 321 (355)
T 2eu9_A 244 NREHLV-MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLFDLMRRMLEFD 321 (355)
T ss_dssp HHHHHH-HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred HHHHHH-HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHHHHHHHHhcCC
Confidence 210000 000 0000000 0000000000 000000111233456778999999999
Q ss_pred CCCCCCHHHHHHH
Q 045256 751 GKERPTMADIVAN 763 (789)
Q Consensus 751 p~~RPt~~evl~~ 763 (789)
|++|||+.|++++
T Consensus 322 P~~Rpt~~e~l~h 334 (355)
T 2eu9_A 322 PAQRITLAEALLH 334 (355)
T ss_dssp TTTSCCHHHHTTS
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=321.14 Aligned_cols=242 Identities=24% Similarity=0.413 Sum_probs=189.4
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHH--HHHHHHHHHHHHHhhcC--CCcceEEEEE
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQ--EKESAFDSELAFLSRLH--HKHLVRLVGY 562 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~l~~~ 562 (789)
+.....++|++.+.||+|+||.||++.. .+++.||||++......... ...+.+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3345568899999999999999999985 46889999997654322110 11234678999999996 5999999999
Q ss_pred EEeCCeEEEEEEecCC-CchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEEEEe
Q 045256 563 CEEKDERLLVYDYMKN-GALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSD 632 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~-gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D 632 (789)
+.+.+..++||||+.+ ++|.+++... ..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEee
Confidence 9999999999999986 8999998653 258889999999999998 99999999999999 789999999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
||++....... .....||+.|+|||++....+ +.++||||||+++|||++|+.||....+
T Consensus 194 fg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------------- 254 (320)
T 3a99_A 194 FGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------- 254 (320)
T ss_dssp CTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------------
T ss_pred Ccccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------------
Confidence 99997654322 224568999999999876655 6789999999999999999999843210
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
........+.. ....+.+++.+||+.||++|||+.|++++
T Consensus 255 --------~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 255 --------IIRGQVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --------HHHCCCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------hhccccccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111111 22346678889999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=339.57 Aligned_cols=264 Identities=21% Similarity=0.337 Sum_probs=195.0
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe------C
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE------K 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~ 566 (789)
++|++.+.||+|+||.||++.+ .+++.||||++..... ....+.+.+|++++++++||||+++++++.. .
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~---~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS---PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC---HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC---HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 6899999999999999999986 4689999998765322 2334568899999999999999999998765 6
Q ss_pred CeEEEEEEecCCCchhHHHhhh-----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCc---EEEEe
Q 045256 567 DERLLVYDYMKNGALYDHLHDR-----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT---ARVSD 632 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~-----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 632 (789)
+..++||||+++++|.+++... ..++.+++.||+|||+.+ |+||||||+|||++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence 6789999999999999998752 258899999999999998 999999999999987654 99999
Q ss_pred eccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchh---
Q 045256 633 FGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV--- 709 (789)
Q Consensus 633 fGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~--- 709 (789)
||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... +..+.....
T Consensus 168 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~ 240 (676)
T 3qa8_A 168 LGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKS 240 (676)
T ss_dssp CCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC---
T ss_pred cccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhccc
Confidence 999986543322 2245789999999999999999999999999999999999999964311 000000000
Q ss_pred -hh-hhhhhhHH--hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHH-----HHHHHHHHhhh
Q 045256 710 -PA-IMAGELVK--ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMAD-----IVANLERALDI 770 (789)
Q Consensus 710 -~~-~~~~~~~~--~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~e-----vl~~L~~~~~~ 770 (789)
.. ........ .+...++.+..........+.+++.+||..||++|||+.| +.+.++.+++.
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 00 00000000 0111222233334456677888999999999999999988 66777777653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=341.03 Aligned_cols=235 Identities=19% Similarity=0.275 Sum_probs=186.0
Q ss_pred CCccccceEeecccEEEEEEEeC--CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe---
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP--DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE--- 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 568 (789)
++|++.+.||+|+||.||++.+. +++.||||++..... .+....+.+|++++++++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD---AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC---HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC---HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 68999999999999999999875 589999998764322 2334568899999999999999999999988765
Q ss_pred --EEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 --RLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 --~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.||||||+++++|.+++.. ...++.|+++||+|||+.+ |+||||||+|||++.+ .+||+|||+++...
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred ceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 7999999999999988753 3468899999999999999 9999999999999986 99999999997644
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. ....||+.|+|||++.... +.++||||||++||||++|.+||.......
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------- 283 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------- 283 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------------
T ss_pred cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------------
Confidence 32 2456899999999986654 889999999999999999988875321100
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-CHHHHHHHHHHHhh
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-TMADIVANLERALD 769 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~~ 769 (789)
+. ...........+.+++.+||+.||++|| +++++...|..++.
T Consensus 284 ----~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 284 ----LP-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----CC-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----cc-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00 0001122335577889999999999999 56777777776653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=302.85 Aligned_cols=221 Identities=22% Similarity=0.363 Sum_probs=166.8
Q ss_pred CCcccc-ceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHH-hhcCCCcceEEEEEEEe----C
Q 045256 494 NNFSLE-NKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFL-SRLHHKHLVRLVGYCEE----K 566 (789)
Q Consensus 494 ~~~~~~-~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l-~~l~HpnIv~l~~~~~~----~ 566 (789)
++|.+. +.||+|+||.||++.. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. .
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 567776 7899999999999986 46889999997532 1356788887 55589999999999987 6
Q ss_pred CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEee
Q 045256 567 DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDF 633 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 633 (789)
...++||||+++++|.+++... ..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 6789999999999999998753 258899999999999999 999999999999998 789999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
|++.... ...++.++||||||+++|||++|+.||.............
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--------- 211 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------- 211 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---------
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---------
Confidence 9885421 1346789999999999999999999996543211100000
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.......+..........+.+++.+||+.||++|||+.|++++
T Consensus 212 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 ----TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ----CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000000000001234567788899999999999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.94 Aligned_cols=233 Identities=15% Similarity=0.166 Sum_probs=168.0
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-Ccc---------------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-KHL--------------- 556 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnI--------------- 556 (789)
..|.+.++||+|+||.||++.+ .+++.||||++....... ....+.|.+|+.+++.++| +|.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4577889999999999999985 468999999876433322 1224468899999999977 211
Q ss_pred ------eEEEEEEEe-----CCeEEEEEEecCCCchhHHHh---------------hhchHHHHHHHHHHHHHhcCCCCe
Q 045256 557 ------VRLVGYCEE-----KDERLLVYDYMKNGALYDHLH---------------DRNNVEKNAARGIEYLHNYAVPPI 610 (789)
Q Consensus 557 ------v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~---------------~~~~i~~~ia~~l~~LH~~~~~~i 610 (789)
..+..++.. ....+++|+++ +++|.+++. .+..++.|+++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 111122222 12356777765 579998884 12357789999999999999 9
Q ss_pred EeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCcccc----------CCCCCCchhHHHHHHHH
Q 045256 611 IHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY----------GLNVLTAKSDVYGLGVV 680 (789)
Q Consensus 611 vH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~SlGvi 680 (789)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998753322 224567 999999999 66678899999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHH
Q 045256 681 LLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760 (789)
Q Consensus 681 l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~ev 760 (789)
+|||++|+.||........ ...++.... . .+..+.+|+.+||+.||++||++.|+
T Consensus 307 l~elltg~~Pf~~~~~~~~-----------------~~~~~~~~~----~----~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG-----------------SEWIFRSCK----N----IPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC-----------------SGGGGSSCC----C----CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHCCCCCCCcchhhh-----------------HHHHHhhcc----c----CCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999999999965432110 011111111 1 12456778889999999999998777
Q ss_pred HH
Q 045256 761 VA 762 (789)
Q Consensus 761 l~ 762 (789)
++
T Consensus 362 l~ 363 (413)
T 3dzo_A 362 ME 363 (413)
T ss_dssp TT
T ss_pred Hh
Confidence 54
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.24 Aligned_cols=235 Identities=15% Similarity=0.157 Sum_probs=176.7
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhh----hHHHHHHHHHHHHHHHhhcC---------CCcceEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK----KFQEKESAFDSELAFLSRLH---------HKHLVRLV 560 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~---------HpnIv~l~ 560 (789)
++|++.+.||+|+||+||+++. +++.||||++...... ......+.+.+|+.++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5688899999999999999998 7899999998764321 11122345778888888885 88888888
Q ss_pred EEEE------------------------------eCCeEEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHH
Q 045256 561 GYCE------------------------------EKDERLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLH 603 (789)
Q Consensus 561 ~~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH 603 (789)
+.+. +.+..|+||||+++|++.+.+.+ ...++.|++.||+|||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH 178 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHH
Confidence 8753 26789999999999977766633 2368999999999999
Q ss_pred -hcCCCCeEeccCCCCCEEECCCC--------------------cEEEEeeccCcCCCCCCCCCcccccccCcCccCccc
Q 045256 604 -NYAVPPIIHRDIKSSNILLDAQW--------------------TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662 (789)
Q Consensus 604 -~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~ 662 (789)
+.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||+
T Consensus 179 ~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 179 ASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGG
T ss_pred HhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChhh
Confidence 898 99999999999999887 9999999999764321 3479999999999
Q ss_pred cCCCCCCchhHHHHHHHH-HHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc---cCCCCCCCHHHHHHH
Q 045256 663 YGLNVLTAKSDVYGLGVV-LLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR---RVGPPEINEAEAVEL 738 (789)
Q Consensus 663 ~~~~~~~~~sDv~SlGvi-l~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---~~~~~~~~~~~~~~~ 738 (789)
+.+.. +.++|||||+++ .+++++|..||... .|. ......++.. ...............
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----------LWL-----HYLTDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----------HHH-----HHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCcch-----------hhh-----hHHHHhhhhhhccCcccchhhhhhcCHH
Confidence 98766 889999998766 78888898887321 000 0011112211 111112223467788
Q ss_pred HHHHHHhhcCcCCCCCCCHHHHH
Q 045256 739 VAYTAMHCVNLEGKERPTMADIV 761 (789)
Q Consensus 739 l~~l~~~cl~~dp~~RPt~~evl 761 (789)
+.+|+.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 899999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-29 Score=286.87 Aligned_cols=185 Identities=17% Similarity=0.140 Sum_probs=130.1
Q ss_pred eEeecccEEEEEEE-eCCCcEEEEEEcccch------hhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeEEEE
Q 045256 501 KIGAGSFGVVYKGK-LPDGQEVAIKRGETAK------TKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 501 ~LG~G~~g~Vy~~~-~~~g~~vavK~~~~~~------~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~~lv 572 (789)
.+..|.+|.+..++ .--|+.|++|++.+.. ..+.+...++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34556666665553 2357899999976532 122233456799999999999 799999999999999999999
Q ss_pred EEecCCCchhHHHhhhc-----hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 573 YDYMKNGALYDHLHDRN-----NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~-----~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
|||++|++|.++|.+.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+++....... .
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--W 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---C--C
T ss_pred EecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--c
Confidence 99999999999997543 69999999999999999 99999999999999999999999999986544322 2
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf 691 (789)
....+||+.|||||++.+. +..++|+||+|+++++|.++..++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 3356799999999999764 567899999999999887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-26 Score=262.60 Aligned_cols=188 Identities=16% Similarity=0.182 Sum_probs=147.6
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcccchhh----hHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK----KFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
..++||+|+||.||++.. .++.+++|+....... ......+.+.+|++++++++||||+++..++...+..||||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999954 5788999975442221 11222456899999999999999996666666788889999
Q ss_pred EecCCCchhHHHhhhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC-----cc
Q 045256 574 DYMKNGALYDHLHDRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-----RP 648 (789)
Q Consensus 574 e~~~~gsL~~~l~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~-----~~ 648 (789)
||+++++|.+++.+...++.|++++|+|||+++ |+||||||+|||++. .+||+|||+++......... ..
T Consensus 419 E~~~ggsL~~~l~~~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~ 493 (540)
T 3en9_A 419 SYINGKLAKDVIEDNLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFK 493 (540)
T ss_dssp ECCCSEEHHHHSTTCTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHH
T ss_pred ECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhh
Confidence 999999999999988899999999999999999 999999999999998 99999999998754432111 11
Q ss_pred cccccCcCccCccccCC--CCCCchhHHHHHHHHHHHHHcCCCCC
Q 045256 649 MKAAGTVGYIDPEYYGL--NVLTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 649 ~~~~gt~~y~aPE~~~~--~~~~~~sDv~SlGvil~elltG~~pf 691 (789)
....||+.|||||++.. ..|+..+|+|+..+-.++.+..+.++
T Consensus 494 ~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 494 KAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred hhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 24579999999999976 56788899999999988888777654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.5e-22 Score=210.90 Aligned_cols=159 Identities=14% Similarity=0.129 Sum_probs=124.9
Q ss_pred HHHHHHHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhH-----H---------HHHHHHHHHHHH
Q 045256 482 EEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKF-----Q---------EKESAFDSELAF 547 (789)
Q Consensus 482 ~~~~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~-----~---------~~~~~~~~E~~~ 547 (789)
....+..+......|.+.+.||+|+||.||++...+++.||+|.++....... . .....+.+|+++
T Consensus 78 ~~~~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~ 157 (282)
T 1zar_A 78 SLYSLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 157 (282)
T ss_dssp HHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence 34455666667778888999999999999999987799999999764322110 0 134568899999
Q ss_pred HhhcCCCcceEEEEEEEeCCeEEEEEEecCCCchhHHHh--hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH--DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 548 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
+++++|+++ .+++.. +..++||||+++++|.+ +. +...++.|+++||+|||+.+ |+||||||+|||++ +
T Consensus 158 l~~l~~~~v---~~~~~~-~~~~lvmE~~~g~~L~~-l~~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 158 LQKLQGLAV---PKVYAW-EGNAVLMELIDAKELYR-VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp HHHTTTSSS---CCEEEE-ETTEEEEECCCCEEGGG-CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred HHhccCCCc---CeEEec-cceEEEEEecCCCcHHH-cchhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 999985444 444433 45699999999999998 53 23478999999999999999 99999999999999 9
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccC
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 664 (789)
+.+||+|||+++. +..|+|||++.
T Consensus 229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 EGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999999999853 34578999873
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=6.5e-18 Score=174.96 Aligned_cols=144 Identities=16% Similarity=0.200 Sum_probs=108.6
Q ss_pred HHHHHHhcCCccccceEeecccEEEEEEEe-CCCcE--EEEEEcccchhhh--------------------HHHHHHHHH
Q 045256 486 LAELAAATNNFSLENKIGAGSFGVVYKGKL-PDGQE--VAIKRGETAKTKK--------------------FQEKESAFD 542 (789)
Q Consensus 486 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~~--------------------~~~~~~~~~ 542 (789)
+..+.....-|++.+.||+|+||.||++.. .+|+. ||||+++...... .......+.
T Consensus 39 l~~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 118 (258)
T 1zth_A 39 LYKLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE 118 (258)
T ss_dssp HHHHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred HHHHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence 344444444577889999999999999987 68888 9999865432110 011223578
Q ss_pred HHHHHHhhcCCCcc--eEEEEEEEeCCeEEEEEEecCC-C----chhHHHhh-----hchHHHHHHHHHHHHH-hcCCCC
Q 045256 543 SELAFLSRLHHKHL--VRLVGYCEEKDERLLVYDYMKN-G----ALYDHLHD-----RNNVEKNAARGIEYLH-NYAVPP 609 (789)
Q Consensus 543 ~E~~~l~~l~HpnI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~-----~~~i~~~ia~~l~~LH-~~~~~~ 609 (789)
+|+.+|.+++|+++ ..++.+ +..+|||||+.+ | +|.++... ...++.|++++|.||| +.+
T Consensus 119 ~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~g--- 191 (258)
T 1zth_A 119 KEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAE--- 191 (258)
T ss_dssp HHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSC---
T ss_pred HHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999988764 344432 356899999942 4 67766543 3478999999999999 888
Q ss_pred eEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 610 IIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 610 ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
|+||||||+|||++. .++|+|||++..
T Consensus 192 ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 192 LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999998 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.2e-15 Score=162.17 Aligned_cols=149 Identities=17% Similarity=0.168 Sum_probs=107.9
Q ss_pred HHHHHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhh--------------h---H-HHHHHHHHHHHH
Q 045256 485 LLAELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK--------------K---F-QEKESAFDSELA 546 (789)
Q Consensus 485 ~~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------~---~-~~~~~~~~~E~~ 546 (789)
.+..+..-..-|++.+.||+|+||.||+|...+|+.||||+++..... . . .........|..
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 344555555569999999999999999999999999999986532110 0 0 000112346788
Q ss_pred HHhhcCCCcceEEEEEEEeCCeEEEEEEecCCCchhHHHh--hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC
Q 045256 547 FLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH--DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA 624 (789)
Q Consensus 547 ~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~--~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~ 624 (789)
.|.++.+.++....-+... ..+|||||+++.+|.++.. ....+..|++.+|.|||+.+ ||||||||.|||+++
T Consensus 166 nL~rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp HHHHHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred HHHHHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 8888865554322111112 2379999999988877653 23468899999999999998 999999999999987
Q ss_pred CC----------cEEEEeeccCcC
Q 045256 625 QW----------TARVSDFGLSMM 638 (789)
Q Consensus 625 ~~----------~~kl~DfGls~~ 638 (789)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999997653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3.3e-11 Score=124.62 Aligned_cols=140 Identities=14% Similarity=0.109 Sum_probs=110.6
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~l 571 (789)
...|++...++.|+.+.||++... ++.+++|+........ ...+.+|+++++.+. +..+.++++++.+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 356888888898999999999864 6899999865422111 124888999999984 6778899999998889999
Q ss_pred EEEecCCCchhHHH---hhhchHHHHHHHHHHHHHhcC------------------------------------------
Q 045256 572 VYDYMKNGALYDHL---HDRNNVEKNAARGIEYLHNYA------------------------------------------ 606 (789)
Q Consensus 572 v~e~~~~gsL~~~l---~~~~~i~~~ia~~l~~LH~~~------------------------------------------ 606 (789)
||||+++.+|.+.+ .+...+..+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 88 LMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EEECCSSEEHHHHCCTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EEEecCCeehhhccCCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99999999998763 334468899999999999821
Q ss_pred --------------CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 607 --------------VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 607 --------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876556799998653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=6.8e-11 Score=121.85 Aligned_cols=134 Identities=15% Similarity=0.104 Sum_probs=100.2
Q ss_pred CccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc--ceEEEEEEEeCCeEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH--LVRLVGYCEEKDERLLV 572 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lv 572 (789)
.|.+..+.+.|..+.||++...+|+.+++|+..... ...+.+|+++++.+.+.+ +.+++++....+..++|
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v 93 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 93 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence 444433334566799999988778889999865431 123778999999986545 45588888887788999
Q ss_pred EEecCCCchhHHHh--hhchHHHHHHHHHHHHHhcC--------------------------------------------
Q 045256 573 YDYMKNGALYDHLH--DRNNVEKNAARGIEYLHNYA-------------------------------------------- 606 (789)
Q Consensus 573 ~e~~~~gsL~~~l~--~~~~i~~~ia~~l~~LH~~~-------------------------------------------- 606 (789)
|||+++.+|. .. ....+..++++.|..||+..
T Consensus 94 ~e~i~G~~l~--~~~~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 94 LGEVPGQDLL--SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp EECCSSEETT--TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred EEecCCcccC--cCcCCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 9999998884 22 22367888888999998753
Q ss_pred -----------CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 607 -----------VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 607 -----------~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877666799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.83 E-value=5.6e-09 Score=113.17 Aligned_cols=137 Identities=18% Similarity=0.358 Sum_probs=100.0
Q ss_pred ccceEeecccEEEEEEEeCCCcEEEEEEcc--cchhhhHHHHHHHHHHHHHHHhhcC--CCcceEEEEEEEeC---CeEE
Q 045256 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGE--TAKTKKFQEKESAFDSELAFLSRLH--HKHLVRLVGYCEEK---DERL 570 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~---~~~~ 570 (789)
..+.|+.|.+..||+....+ ..+++|+.. ..... .....+.+|+++++.|. +..+.+++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~---~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLL---PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCC---CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 46789999999999998754 678888755 32211 12235788999999997 45678888888766 3479
Q ss_pred EEEEecCCCchhHH-H-----hhhchHHHHHHHHHHHHHhcC--------------------------------------
Q 045256 571 LVYDYMKNGALYDH-L-----HDRNNVEKNAARGIEYLHNYA-------------------------------------- 606 (789)
Q Consensus 571 lv~e~~~~gsL~~~-l-----~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 606 (789)
+||||+++..+.+. + .++..+..++++.|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EEEECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEEEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99999999877432 1 124467889999999999731
Q ss_pred -----------------CCCeEeccCCCCCEEECCCCc--EEEEeeccCcC
Q 045256 607 -----------------VPPIIHRDIKSSNILLDAQWT--ARVSDFGLSMM 638 (789)
Q Consensus 607 -----------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfGls~~ 638 (789)
.+.++|+|++|.|||++.++. +.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997753 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=5.7e-09 Score=110.28 Aligned_cols=180 Identities=19% Similarity=0.250 Sum_probs=114.0
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCc--ceEEEEEEEeCC---eEEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKH--LVRLVGYCEEKD---ERLLV 572 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lv 572 (789)
.+.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+. +.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4679999999999863 56888974322 22345889999998883 333 334444433332 24789
Q ss_pred EEecCCCchhHHHh------hhchHHHHHHHHHHHHHhcC----------------------------------------
Q 045256 573 YDYMKNGALYDHLH------DRNNVEKNAARGIEYLHNYA---------------------------------------- 606 (789)
Q Consensus 573 ~e~~~~gsL~~~l~------~~~~i~~~ia~~l~~LH~~~---------------------------------------- 606 (789)
||++++.+|.+... ++..+..++++.|+.||+..
T Consensus 95 m~~i~G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp EECCCCEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred EcccCCeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 99999988875322 23467788888888888621
Q ss_pred ---------------CCCeEeccCCCCCEEECC--CCcEEEEeeccCcCCCCCCCCCccc-cc---c---------cCcC
Q 045256 607 ---------------VPPIIHRDIKSSNILLDA--QWTARVSDFGLSMMGPESERDFRPM-KA---A---------GTVG 656 (789)
Q Consensus 607 ---------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfGls~~~~~~~~~~~~~-~~---~---------gt~~ 656 (789)
.+.++|+|++|.||++++ +..+.|+||+.+....... +.... .. . ....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHcC
Confidence 134899999999999988 4567899999875422110 00000 00 0 0001
Q ss_pred ccC-ccccCCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 045256 657 YID-PEYYGLNVLTAKSDVYGLGVVLLELLTGKRAI 691 (789)
Q Consensus 657 y~a-PE~~~~~~~~~~sDv~SlGvil~elltG~~pf 691 (789)
+.. |+... ......+.|+++.++|++.+|+.+|
T Consensus 254 ~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 22211 0112368999999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3.4e-06 Score=87.08 Aligned_cols=131 Identities=18% Similarity=0.235 Sum_probs=93.6
Q ss_pred ceEeecccE-EEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeEEEEEEec
Q 045256 500 NKIGAGSFG-VVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 500 ~~LG~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
+.+..|..+ .||+.... ++..+++|+.... ....+.+|..+|+.+. +--+.+++.++.+.+..++|||++
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 455556555 68988754 4678999974432 1234778999998884 333667888889999999999999
Q ss_pred CCCchhHHHh----hhchHHHHHHHHHHHHHhcC----------------------------------------------
Q 045256 577 KNGALYDHLH----DRNNVEKNAARGIEYLHNYA---------------------------------------------- 606 (789)
Q Consensus 577 ~~gsL~~~l~----~~~~i~~~ia~~l~~LH~~~---------------------------------------------- 606 (789)
++.++.+... ....+..++++.|+-||...
T Consensus 103 ~G~~~~~~~~~~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 103 PGKTAFQVLEEYPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp CSEEHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred CCccccccccCCHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 9988776543 22345566666666666421
Q ss_pred ---------CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 607 ---------VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 607 ---------~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.+.++|+|+.+.|||++.+..+-|+||+.+.
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0227999999999999987767799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=8.4e-06 Score=85.85 Aligned_cols=130 Identities=15% Similarity=0.216 Sum_probs=89.5
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCC---cceEEEEEEE-eCCeEEEEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK---HLVRLVGYCE-EKDERLLVYD 574 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lv~e 574 (789)
.+.++.|....||+. ++.+++|+.... .....+.+|.++|+.|.+. .+.+++.+.. ..+..++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKSQ------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESSH------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCCc------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 467889999999988 567888874221 2234588999999999652 2556666664 3445789999
Q ss_pred ecCCCchhHHHh------hhchHHHHHHHHHHHHHhc-------------------------------------------
Q 045256 575 YMKNGALYDHLH------DRNNVEKNAARGIEYLHNY------------------------------------------- 605 (789)
Q Consensus 575 ~~~~gsL~~~l~------~~~~i~~~ia~~l~~LH~~------------------------------------------- 605 (789)
|+++..|.+... ++..+..++++.|+.||+.
T Consensus 94 ~i~G~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 94 KVQGQILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CCCSEECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ccCCeECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 999988866321 1234455555555555542
Q ss_pred --------------CCCCeEeccCCCCCEEECC---CCc-EEEEeeccCcC
Q 045256 606 --------------AVPPIIHRDIKSSNILLDA---QWT-ARVSDFGLSMM 638 (789)
Q Consensus 606 --------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DfGls~~ 638 (789)
..+.++|+|++|.|||++. ++. ..|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999987653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=1.4e-05 Score=86.18 Aligned_cols=83 Identities=10% Similarity=0.043 Sum_probs=54.6
Q ss_pred cceE-eecccEEEEEEEeC-------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-C--CcceEEEEEEEeC-
Q 045256 499 ENKI-GAGSFGVVYKGKLP-------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-H--KHLVRLVGYCEEK- 566 (789)
Q Consensus 499 ~~~L-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~- 566 (789)
.+.| +.|....+|+.... +++.+++|+.......... ....+.+|+.+++.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~-~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVF-PTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSS-SCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccC-chhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 4677 88889999998764 2678999985442200000 0123678888888884 3 3466777776654
Q ss_pred --CeEEEEEEecCCCchh
Q 045256 567 --DERLLVYDYMKNGALY 582 (789)
Q Consensus 567 --~~~~lv~e~~~~gsL~ 582 (789)
+..++||||+++..+.
T Consensus 104 ~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 104 VLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTSSCEEEEECCCCBCCC
T ss_pred ccCCceEEEEecCCCChh
Confidence 3468999999986654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.84 E-value=7.6e-05 Score=78.41 Aligned_cols=77 Identities=17% Similarity=0.204 Sum_probs=59.8
Q ss_pred cccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC---CCcceEEEEEEEeCCeEEEEE
Q 045256 497 SLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH---HKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 497 ~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~---HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.-.+.|+.|.+..+|+... +++.+++|+.... ....+..|.+.|+.|. ...+.+++.+....+..++||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3456799999999999986 5678889975432 1335788999998884 356788888888888899999
Q ss_pred EecCCCch
Q 045256 574 DYMKNGAL 581 (789)
Q Consensus 574 e~~~~gsL 581 (789)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=7.6e-05 Score=77.67 Aligned_cols=80 Identities=16% Similarity=0.253 Sum_probs=56.3
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--C-cceEEEEEEEeCCeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--K-HLVRLVGYCEEKDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--p-nIv~l~~~~~~~~~~~ 570 (789)
....-.+.+|.|....||+.++.||+.|++|+....... ....|..|.+.|+.|.- + -+.+++++ + ..+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~----~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA----LDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC----CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc----hhhHHHHHHHHHHHHHhhCCCCcceEEec--c--Cce
Confidence 456667889999999999999999999999985432211 12247889999988842 1 23444443 2 347
Q ss_pred EEEEecCCCch
Q 045256 571 LVYDYMKNGAL 581 (789)
Q Consensus 571 lv~e~~~~gsL 581 (789)
+||||++.+..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 89999987653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=3.8e-05 Score=83.98 Aligned_cols=79 Identities=18% Similarity=0.136 Sum_probs=49.2
Q ss_pred cceEeecccEEEEEEEeC-CCcEEEEEEcccchh-hhH--HHHHHHHHHHHHHHhhcCC--Ccce-EEEEEEEeCCeEEE
Q 045256 499 ENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKT-KKF--QEKESAFDSELAFLSRLHH--KHLV-RLVGYCEEKDERLL 571 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~--~~~~~~~~~E~~~l~~l~H--pnIv-~l~~~~~~~~~~~l 571 (789)
.+.||.|.++.||++... +++.+++|....... ... ....+.+..|.++++.+.. |..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 568999999999999754 468899997543211 000 0112246678888888742 4443 45543 4556789
Q ss_pred EEEecCCC
Q 045256 572 VYDYMKNG 579 (789)
Q Consensus 572 v~e~~~~g 579 (789)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.68 E-value=7.7e-05 Score=79.49 Aligned_cols=30 Identities=27% Similarity=0.343 Sum_probs=26.6
Q ss_pred CCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
+.++|+|+++.|||++.+..+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 459999999999999888899999998653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00025 Score=78.07 Aligned_cols=79 Identities=14% Similarity=0.170 Sum_probs=48.3
Q ss_pred CCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCC---CCCchhHHHHHHHHHHHH
Q 045256 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLN---VLTAKSDVYGLGVVLLEL 684 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~SlGvil~el 684 (789)
+.++|+|++|.|||++.+. ++|+||+.+....... +....-..-...|.+|+..... ......++..+...+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4599999999999998876 9999999876422110 0000000001346666655321 122345667888888888
Q ss_pred HcCC
Q 045256 685 LTGK 688 (789)
Q Consensus 685 ltG~ 688 (789)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00034 Score=73.23 Aligned_cols=127 Identities=13% Similarity=0.146 Sum_probs=80.2
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeEEEEEEec-
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDERLLVYDYM- 576 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e~~- 576 (789)
.+.|..|....+|+. +.+++|+........ ....+|+.+++.+....+ .+++.+ +.+.-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 678999999999998 568888754321110 113457777777743223 345443 444457899999
Q ss_pred CCCchhHH-HhhhchHHHHHHHHHHHHHhcC-------------------------------------------------
Q 045256 577 KNGALYDH-LHDRNNVEKNAARGIEYLHNYA------------------------------------------------- 606 (789)
Q Consensus 577 ~~gsL~~~-l~~~~~i~~~ia~~l~~LH~~~------------------------------------------------- 606 (789)
++.+|... +..+..+..++++.|+-||+..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66555432 1111345556666666666432
Q ss_pred -CCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 607 -VPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 607 -~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
.+.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 122799999999999 5566789999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00092 Score=70.94 Aligned_cols=131 Identities=11% Similarity=0.123 Sum_probs=70.8
Q ss_pred cceEeecccEE-EEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--CcceEEEEEEEeCCeEEEEEEe
Q 045256 499 ENKIGAGSFGV-VYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--KHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 499 ~~~LG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~e~ 575 (789)
.+.|..|.... +|+....+++.+++|....... ..+..|+.+++.+.. -.+.+++.+..+ .-+++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-------GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIED 93 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT-------CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-------ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEee
Confidence 34565554444 6677654477888886443211 124456777776642 234556655322 23789999
Q ss_pred cCCCchhHHHhhhc----hHHHHHHHH--------------------------------------------------HHH
Q 045256 576 MKNGALYDHLHDRN----NVEKNAARG--------------------------------------------------IEY 601 (789)
Q Consensus 576 ~~~gsL~~~l~~~~----~i~~~ia~~--------------------------------------------------l~~ 601 (789)
+.+..+.+.+.... ....++.+. ++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 97766654432110 111111111 122
Q ss_pred HHh---cCCCCeEeccCCCCCEEECCC----CcEEEEeeccCcC
Q 045256 602 LHN---YAVPPIIHRDIKSSNILLDAQ----WTARVSDFGLSMM 638 (789)
Q Consensus 602 LH~---~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfGls~~ 638 (789)
|.+ ...+.++|+|+.+.|||++.+ ..+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 211 112458999999999999875 6899999998754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00072 Score=71.32 Aligned_cols=132 Identities=14% Similarity=0.142 Sum_probs=75.1
Q ss_pred cceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-----CcceEEE-E--EEEeCCeEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-----KHLVRLV-G--YCEEKDERL 570 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-----pnIv~l~-~--~~~~~~~~~ 570 (789)
.+.|+.|....+|+....++ .+++|+...... .+.+..|+.+++.|.. |.++... + +....+..+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~------~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE------KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCCC------HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 34567788899999987665 688898654211 1125567777776632 3333210 0 112345678
Q ss_pred EEEEecCCCchhH----H----------Hhhh-----------c---h------------------HHHHHHHHHHHHHh
Q 045256 571 LVYDYMKNGALYD----H----------LHDR-----------N---N------------------VEKNAARGIEYLHN 604 (789)
Q Consensus 571 lv~e~~~~gsL~~----~----------l~~~-----------~---~------------------i~~~ia~~l~~LH~ 604 (789)
++|||+++..+.. . +|.. . . +...+.+.+++|++
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 9999998854311 0 1110 0 0 01113345556654
Q ss_pred cC----CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 605 YA----VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 605 ~~----~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.. .+.++|+|+++.|||++.+..+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 21 2348999999999999887556899998653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00058 Score=73.66 Aligned_cols=74 Identities=15% Similarity=0.198 Sum_probs=43.9
Q ss_pred cceEeecccEEEEEEEeC--------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeE
Q 045256 499 ENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDER 569 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 569 (789)
.+.|..|-...+|+.... +++.+++|+..... .....+.+|.++++.|. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~-- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-----QGVDSLVLESVMFAILAERSLGPQLYGVFP--E-- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-----chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--
Confidence 356777888889999864 24789999853211 11234568999998884 322355665543 2
Q ss_pred EEEEEecCCCch
Q 045256 570 LLVYDYMKNGAL 581 (789)
Q Consensus 570 ~lv~e~~~~gsL 581 (789)
-+||||+++..|
T Consensus 126 g~v~e~i~G~~l 137 (379)
T 3feg_A 126 GRLEQYIPSRPL 137 (379)
T ss_dssp EEEEECCSEEEC
T ss_pred ccEEEEecCccC
Confidence 289999998655
|
| >1p22_A F-BOX/WD-repeat protein 1A; ubiquitination, degradation, signaling protein; HET: SEP; 2.95A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.096 Score=57.11 Aligned_cols=222 Identities=8% Similarity=0.105 Sum_probs=129.1
Q ss_pred ceeEEEEecCceeeeeeeecCCCcEEEeeCC--ccccc--CCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCc
Q 045256 34 GSTLAVSYGSATVCAVVAAQPTQRLLCYQGG--TIRAV--EPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFV 109 (789)
Q Consensus 34 ~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~~--~~~~~--~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~ 109 (789)
..|..++..+.+.+ ....||+|..|-.. ..... .....|..++-.+..-+.-..|| +|..|-.... .
T Consensus 134 ~~v~~~~~d~~~l~---~g~~dg~i~iwd~~~~~~~~~~~~h~~~v~~l~~~~~~l~sg~~dg-~i~vwd~~~~-----~ 204 (435)
T 1p22_A 134 KGVYCLQYDDQKIV---SGLRDNTIKIWDKNTLECKRILTGHTGSVLCLQYDERVIITGSSDS-TVRVWDVNTG-----E 204 (435)
T ss_dssp CCEEEEECCSSEEE---EEESSSCEEEEESSSCCEEEEECCCSSCEEEEECCSSEEEEEETTS-CEEEEESSSC-----C
T ss_pred CcEEEEEECCCEEE---EEeCCCeEEEEeCCCCeEEEEEcCCCCcEEEEEECCCEEEEEcCCC-eEEEEECCCC-----c
Confidence 34677777666666 66789999999652 22222 12346888887555555667789 9999965431 1
Q ss_pred ceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCC----CCCCCCccEEEEeeeCceeEEEEeCCCeEEEeec
Q 045256 110 PKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISK----NAPSGELQFESLTSGIDFSCGILTNNKTVRCWGI 185 (789)
Q Consensus 110 p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~----~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~ 185 (789)
+..........|..++......++-..||.|..|--...... ........|..++....+.+. -..+|+|..|-.
T Consensus 205 ~~~~~~~h~~~v~~l~~~~~~l~s~s~dg~i~vwd~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~s-~~~dg~i~vwd~ 283 (435)
T 1p22_A 205 MLNTLIHHCEAVLHLRFNNGMMVTCSKDRSIAVWDMASPTDITLRRVLVGHRAAVNVVDFDDKYIVS-ASGDRTIKVWNT 283 (435)
T ss_dssp EEEEECCCCSCEEEEECCTTEEEEEETTSCEEEEECSSSSCCEEEEEECCCSSCEEEEEEETTEEEE-EETTSEEEEEET
T ss_pred EEEEEcCCCCcEEEEEEcCCEEEEeeCCCcEEEEeCCCCCCceeeeEecCCCCcEEEEEeCCCEEEE-EeCCCeEEEEEC
Confidence 111111122346677776777777889999999954322211 011112246666664444433 567779999965
Q ss_pred CCCCCcccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEe
Q 045256 186 NSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCW 265 (789)
Q Consensus 186 n~~gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~W 265 (789)
.....+..-......+..++......++-..||.|..|--.. |++-.........|..++....+-+.-.. ||.|..|
T Consensus 284 ~~~~~~~~~~~~~~~v~~~~~~~~~l~~g~~dg~i~iwd~~~-~~~~~~~~~h~~~v~~~~~~~~~l~sg~~-dg~i~vw 361 (435)
T 1p22_A 284 STCEFVRTLNGHKRGIACLQYRDRLVVSGSSDNTIRLWDIEC-GACLRVLEGHEELVRCIRFDNKRIVSGAY-DGKIKVW 361 (435)
T ss_dssp TTCCEEEEEECCSSCEEEEEEETTEEEEEETTSCEEEEETTT-CCEEEEECCCSSCEEEEECCSSEEEEEET-TSCEEEE
T ss_pred CcCcEEEEEcCCCCcEEEEEeCCCEEEEEeCCCeEEEEECCC-CCEEEEEeCCcCcEEEEEecCCEEEEEeC-CCcEEEE
Confidence 432222111112334666666666667778899999996543 33311111122346677765555555555 9999999
Q ss_pred ee
Q 045256 266 GS 267 (789)
Q Consensus 266 G~ 267 (789)
=.
T Consensus 362 d~ 363 (435)
T 1p22_A 362 DL 363 (435)
T ss_dssp EH
T ss_pred EC
Confidence 64
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.00056 Score=75.40 Aligned_cols=73 Identities=21% Similarity=0.313 Sum_probs=48.0
Q ss_pred cceEeecccEEEEEEEeCC--------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeE
Q 045256 499 ENKIGAGSFGVVYKGKLPD--------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDER 569 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~ 569 (789)
.+.|+.|-...+|++...+ ++.+++|+...... ...+.+|..+++.|...++ .++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~------~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET------ESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC------HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc------HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 4678888889999998753 57899998632111 0124578888888853333 56666543 2
Q ss_pred EEEEEecCCCch
Q 045256 570 LLVYDYMKNGAL 581 (789)
Q Consensus 570 ~lv~e~~~~gsL 581 (789)
.+|+||+++.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999986443
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0014 Score=69.32 Aligned_cols=131 Identities=15% Similarity=0.126 Sum_probs=76.8
Q ss_pred ceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc--ceEEEEE-----EEeCCeEEEE
Q 045256 500 NKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH--LVRLVGY-----CEEKDERLLV 572 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn--Iv~l~~~-----~~~~~~~~lv 572 (789)
+.|+ |....||+....+|+.+++|+...... ....+..|..+++.|.... +.+++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 888899999877788899998653211 1123556777777774211 3333332 1234566889
Q ss_pred EEecCCCchh----HH----------Hhhh---------c--h----------HH---------------HHHHHHHHHH
Q 045256 573 YDYMKNGALY----DH----------LHDR---------N--N----------VE---------------KNAARGIEYL 602 (789)
Q Consensus 573 ~e~~~~gsL~----~~----------l~~~---------~--~----------i~---------------~~ia~~l~~L 602 (789)
|||+++..+. +. +|.. . . +. ..+.+.++.+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875432 11 1110 0 0 00 0011123333
Q ss_pred Hhc----CCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 603 HNY----AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 603 H~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
.+. ..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 321 223478999999999999 5 899999987653
|
| >2ovr_B FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 domains, double phosphorylation, transcription-C complex; HET: TPO; 2.50A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 PDB: 2ovp_B* 2ovq_B* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.24 Score=53.91 Aligned_cols=258 Identities=10% Similarity=0.112 Sum_probs=143.3
Q ss_pred EEEEecCceeeeeeeecCCCcEEEeeC--CcccccC--CCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCccee
Q 045256 37 LAVSYGSATVCAVVAAQPTQRLLCYQG--GTIRAVE--PNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKR 112 (789)
Q Consensus 37 ~~i~~G~~h~~~~~~l~~~g~v~~wG~--~~~~~~~--~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~ 112 (789)
..++.-+...+ .-..||+|..|-. ....... ....|..++.-....+.-..|| +|..|-.... .+..
T Consensus 123 ~~~~~~g~~l~---sg~~dg~i~vwd~~~~~~~~~~~~h~~~v~~~~~~~~~l~s~~~dg-~i~vwd~~~~-----~~~~ 193 (445)
T 2ovr_B 123 TCLQFCGNRIV---SGSDDNTLKVWSAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDR-TLKVWNAETG-----ECIH 193 (445)
T ss_dssp EEEEEETTEEE---EEETTSCEEEEETTTCCEEEECCCCSSCEEEEEEETTEEEEEETTS-CEEEEETTTT-----EEEE
T ss_pred EEEEEcCCEEE---EEECCCcEEEEECCCCcEEEEEcCCCCCEEEEEecCCEEEEEeCCC-eEEEEECCcC-----cEEE
Confidence 34444444444 5578999998875 2222221 2335666766666666667889 9999954321 1111
Q ss_pred eeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCc
Q 045256 113 IYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQ 191 (789)
Q Consensus 113 v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gql 191 (789)
......-.|..++......++-..||+|..|--........ ......+..++..... ++.-..+|.|..|-......+
T Consensus 194 ~~~~h~~~v~~~~~~~~~l~s~s~dg~i~~wd~~~~~~~~~~~~~~~~v~~~~~~~~~-l~~~~~dg~i~iwd~~~~~~~ 272 (445)
T 2ovr_B 194 TLYGHTSTVRCMHLHEKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRR-VVSGAYDFMVKVWDPETETCL 272 (445)
T ss_dssp EECCCSSCEEEEEEETTEEEEEETTSEEEEEESSSCCEEEEEECCSSCEEEEEECSSC-EEEEETTSCEEEEEGGGTEEE
T ss_pred EECCCCCcEEEEEecCCEEEEEeCCCEEEEEECCCCcEEEEEcCCcccEEEEEECCCE-EEEEcCCCEEEEEECCCCcEe
Confidence 11112223556766667777788899999995432221110 0111245566553333 444567779999964432222
Q ss_pred ccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCC
Q 045256 192 IQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEY 271 (789)
Q Consensus 192 g~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~g 271 (789)
..-......+..++....+.+.-..||.|..|=-.. +++-.........+..++.....-+.-.. ||.|..|=....-
T Consensus 273 ~~~~~~~~~v~~~~~~~~~l~~~~~d~~i~i~d~~~-~~~~~~~~~~~~~v~~~~~~~~~l~~~~~-dg~i~vwd~~~~~ 350 (445)
T 2ovr_B 273 HTLQGHTNRVYSLQFDGIHVVSGSLDTSIRVWDVET-GNCIHTLTGHQSLTSGMELKDNILVSGNA-DSTVKIWDIKTGQ 350 (445)
T ss_dssp EEECCCSSCEEEEEECSSEEEEEETTSCEEEEETTT-CCEEEEECCCCSCEEEEEEETTEEEEEET-TSCEEEEETTTCC
T ss_pred EEecCCCCceEEEEECCCEEEEEeCCCeEEEEECCC-CCEEEEEcCCcccEEEEEEeCCEEEEEeC-CCeEEEEECCCCc
Confidence 111112234667776666767778899999996543 33211111112234555554555555555 9999999754322
Q ss_pred cccC-----CCCCcEEEEEecCceEEEEeecCCeEEEecCC
Q 045256 272 SVNG-----IRGKSFESIVSGSNFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 272 q~~~-----~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~n 307 (789)
.+.. .....|..++-...+.+.-..|| .|..|--.
T Consensus 351 ~~~~~~~~~~~~~~v~~~~~~~~~l~s~~~dg-~v~iwd~~ 390 (445)
T 2ovr_B 351 CLQTLQGPNKHQSAVTCLQFNKNFVITSSDDG-TVKLWDLK 390 (445)
T ss_dssp EEEEECSTTSCSSCEEEEEECSSEEEEEETTS-EEEEEETT
T ss_pred EEEEEccCCCCCCCEEEEEECCCEEEEEeCCC-eEEEEECC
Confidence 2211 12355777777666655555666 99999643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0023 Score=70.86 Aligned_cols=74 Identities=15% Similarity=0.094 Sum_probs=46.8
Q ss_pred cceEeecccEEEEEEEeCC-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeEEEEEEec
Q 045256 499 ENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~lv~e~~ 576 (789)
.+.|..|-...+|+....+ ++.+++|+........ . .-.+|..+++.|...++ .++++++ .+ .+||||+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-i----dR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-I----NREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-S----CHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-c----CHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEee
Confidence 4678888889999998765 4788898753321110 0 12478888988865445 4566665 22 3599999
Q ss_pred CCCch
Q 045256 577 KNGAL 581 (789)
Q Consensus 577 ~~gsL 581 (789)
++.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00089 Score=72.21 Aligned_cols=74 Identities=11% Similarity=0.075 Sum_probs=43.4
Q ss_pred cceEeecccEEEEEEEeCC---------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCc-ceEEEEEEEeCCe
Q 045256 499 ENKIGAGSFGVVYKGKLPD---------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKH-LVRLVGYCEEKDE 568 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~l~~~~~~~~~ 568 (789)
.+.|+.|-.-.+|+....+ ++.+++|+........ .....|.++++.|...+ ..++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-----~~~~~E~~~l~~L~~~g~~P~~~~~~--~-- 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-----YNTISEFEVYKTMSKYKIAPQLLNTF--N-- 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-----SCHHHHHHHHHHHHHTTSSCCEEEEE--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-----ecHHHHHHHHHHHHhcCCCCceEEec--C--
Confidence 4567778888999998654 2688888754321111 11356888888774333 34565443 2
Q ss_pred EEEEEEecCCCch
Q 045256 569 RLLVYDYMKNGAL 581 (789)
Q Consensus 569 ~~lv~e~~~~gsL 581 (789)
-++||||+++..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 3689999987543
|
| >4fao_E Activin receptor type-2B; TGF-beta, CTK, cystine knot, extracellular domain, signaling protein-signaling protein complex; HET: NAG; 3.36A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.00028 Score=61.42 Aligned_cols=57 Identities=19% Similarity=0.318 Sum_probs=41.6
Q ss_pred CCCcccccccCCCcccCCCCC-CCCCCCCCccCCCcccccCCccccCCCCCCCCCCCCC
Q 045256 312 SNDSVSLVPFQQEILPGPCDN-SSCSECGLYPQSDRLCFGNGNICKSCQNVVPTPSAPP 369 (789)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~C~~-~~c~~~~~~p~~~~~C~~~~~~C~~c~~~~p~~~~~~ 369 (789)
..+.+.+++++||..+..|.+ ++|.+.... ....||||++++|+......|++..|+
T Consensus 50 ~~g~~~i~~qGCw~d~~~C~~~~eCv~t~~~-~~~~fCCC~gdlCN~nfs~~p~~~~~~ 107 (124)
T 4fao_E 50 SSGTIELVKKGCWLDDFNCYDRQECVATEEN-PQVYFCCCEGNFCNERFTHLPEAGGPE 107 (124)
T ss_dssp ETTEEEEEEEEEEECCGGGTTCCSEEECCSS-CSEEEEEECSTTTTSSEEECC------
T ss_pred CCCCEEEEEecccCCCCCCCCCCeeeccCCC-CCcEEEecCCCccCCceeecCCCCCCc
Confidence 345688999999999999977 899865443 348999999999998777777655443
|
| >1gxr_A ESG1, transducin-like enhancer protein 1; transcriptional CO-repressor, WD40, transcription repressor, WD repeat; 1.65A {Homo sapiens} SCOP: b.69.4.1 PDB: 2ce8_A 2ce9_A | Back alignment and structure |
|---|
Probab=96.34 E-value=1.1 Score=45.73 Aligned_cols=215 Identities=11% Similarity=0.068 Sum_probs=97.3
Q ss_pred EEEEeCCceEEEccCCCCCCCCCcceeeee-CCcceEEEEEe--cCCeEEEEeeCCeEEEcCCCCCCC--C-CCCCCCcc
Q 045256 86 CGIRSGGYSLLCWDTNFSYNSNFVPKRIYY-NDTVLLSSVSV--GNNHVCATTVQGQINCWRGDVNIS--K-NAPSGELQ 159 (789)
Q Consensus 86 ~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~-~~~~~i~~v~~--G~~h~~al~~~G~v~~wG~~~~~~--~-~~~~~~~~ 159 (789)
++...|| +|..|-.......... ..+.. .....|..++. .....+.-..||+|+.|--..... . ........
T Consensus 66 l~~~~dg-~i~iw~~~~~~~~~~~-~~~~~~~~~~~v~~~~~~~~~~~l~~~~~d~~i~~~d~~~~~~~~~~~~~~~~~~ 143 (337)
T 1gxr_A 66 VYTGGKG-CVKVWDISHPGNKSPV-SQLDCLNRDNYIRSCKLLPDGCTLIVGGEASTLSIWDLAAPTPRIKAELTSSAPA 143 (337)
T ss_dssp EEEECBS-EEEEEETTSTTCCSCS-EEEECSCTTSBEEEEEECTTSSEEEEEESSSEEEEEECCCC--EEEEEEECSSSC
T ss_pred EEEcCCC-eEEEEECCCCCceeee-ecccccCCCCcEEEEEEcCCCCEEEEEcCCCcEEEEECCCCCcceeeecccCCCc
Confidence 3344477 7888855432211111 11110 12222334443 344555567789999995432211 0 00111123
Q ss_pred EEEEeee-CceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEee--CCceeEEEccCCcEEEEEcCCCCCCCcCCC
Q 045256 160 FESLTSG-IDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITA--GGNHVCGIDSNGFVICYGDNKSGQLKFPLN 236 (789)
Q Consensus 160 v~~va~G-~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~n~~Gql~~~~~ 236 (789)
+..++.- ....++....+|.|+.|-......+..-......+..++. .....+....||.|+.|--...-.+....
T Consensus 144 i~~~~~~~~~~~l~~~~~dg~v~~~d~~~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~~dg~i~~~d~~~~~~~~~~~- 222 (337)
T 1gxr_A 144 CYALAISPDSKVCFSCCSDGNIAVWDLHNQTLVRQFQGHTDGASCIDISNDGTKLWTGGLDNTVRSWDLREGRQLQQHD- 222 (337)
T ss_dssp EEEEEECTTSSEEEEEETTSCEEEEETTTTEEEEEECCCSSCEEEEEECTTSSEEEEEETTSEEEEEETTTTEEEEEEE-
T ss_pred eEEEEECCCCCEEEEEeCCCcEEEEeCCCCceeeeeecccCceEEEEECCCCCEEEEEecCCcEEEEECCCCceEeeec-
Confidence 4454432 2233444566779999965432222111112233555544 33344555678999999643322211111
Q ss_pred CCccceEEec--cCcceEEEEEeeCCeEEEeeeCCCCcccC-CCCCcEEEEEec--CceEEEEeecCCeEEEecC
Q 045256 237 STAFEYSALS--LGFNHSCAIRRLNGSVVCWGSQGEYSVNG-IRGKSFESIVSG--SNFTCGLTTSNFSVICWGP 306 (789)
Q Consensus 237 ~~~~~v~~i~--~G~~h~~al~~~dG~v~~WG~n~~gq~~~-~~~~~v~~i~~G--~~h~~al~~~g~~v~~WG~ 306 (789)
....+..++ -....-++-.. ||.|+.|=......... .....+..++.- +.+.+....|| .|..|-.
T Consensus 223 -~~~~v~~~~~s~~~~~l~~~~~-~~~i~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~dg-~i~~~~~ 294 (337)
T 1gxr_A 223 -FTSQIFSLGYCPTGEWLAVGME-SSNVEVLHVNKPDKYQLHLHESCVLSLKFAYCGKWFVSTGKDN-LLNAWRT 294 (337)
T ss_dssp -CSSCEEEEEECTTSSEEEEEET-TSCEEEEETTSSCEEEECCCSSCEEEEEECTTSSEEEEEETTS-EEEEEET
T ss_pred -CCCceEEEEECCCCCEEEEEcC-CCcEEEEECCCCCeEEEcCCccceeEEEECCCCCEEEEecCCC-cEEEEEC
Confidence 111233333 22333333344 88888886544322211 123345555543 23333334455 8888864
|
| >1p22_A F-BOX/WD-repeat protein 1A; ubiquitination, degradation, signaling protein; HET: SEP; 2.95A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 | Back alignment and structure |
|---|
Probab=96.31 E-value=0.82 Score=49.53 Aligned_cols=223 Identities=8% Similarity=0.070 Sum_probs=126.0
Q ss_pred cEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCC
Q 045256 74 SFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNA 153 (789)
Q Consensus 74 ~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~ 153 (789)
.|..++-.+.+-+.-..|| +|..|-... . .+........-.|..++......+.-..||+|..|--........
T Consensus 135 ~v~~~~~d~~~l~~g~~dg-~i~iwd~~~----~-~~~~~~~~h~~~v~~l~~~~~~l~sg~~dg~i~vwd~~~~~~~~~ 208 (435)
T 1p22_A 135 GVYCLQYDDQKIVSGLRDN-TIKIWDKNT----L-ECKRILTGHTGSVLCLQYDERVIITGSSDSTVRVWDVNTGEMLNT 208 (435)
T ss_dssp CEEEEECCSSEEEEEESSS-CEEEEESSS----C-CEEEEECCCSSCEEEEECCSSEEEEEETTSCEEEEESSSCCEEEE
T ss_pred cEEEEEECCCEEEEEeCCC-eEEEEeCCC----C-eEEEEEcCCCCcEEEEEECCCEEEEEcCCCeEEEEECCCCcEEEE
Confidence 4777777666666677899 999995432 1 112221122334667777666666678899999995432211110
Q ss_pred -CCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcc---cCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCC
Q 045256 154 -PSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQI---QTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSG 229 (789)
Q Consensus 154 -~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg---~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~G 229 (789)
......|..++.-... ++.-..+|+|..|-........ ........|..++....+.++-..||.|..|=-.. +
T Consensus 209 ~~~h~~~v~~l~~~~~~-l~s~s~dg~i~vwd~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~s~~~dg~i~vwd~~~-~ 286 (435)
T 1p22_A 209 LIHHCEAVLHLRFNNGM-MVTCSKDRSIAVWDMASPTDITLRRVLVGHRAAVNVVDFDDKYIVSASGDRTIKVWNTST-C 286 (435)
T ss_dssp ECCCCSCEEEEECCTTE-EEEEETTSCEEEEECSSSSCCEEEEEECCCSSCEEEEEEETTEEEEEETTSEEEEEETTT-C
T ss_pred EcCCCCcEEEEEEcCCE-EEEeeCCCcEEEEeCCCCCCceeeeEecCCCCcEEEEEeCCCEEEEEeCCCeEEEEECCc-C
Confidence 1111246666665444 3435677899999654332221 11112234666666666767778899999996443 3
Q ss_pred CCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccC--CCCCcEEEEEecCceEEEEeecCCeEEEecC
Q 045256 230 QLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNG--IRGKSFESIVSGSNFTCGLTTSNFSVICWGP 306 (789)
Q Consensus 230 ql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~--~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~ 306 (789)
++-.........+..++.....-++-.. ||.|..|=....-.+.. .....|..++..+.+.+.-..|| .|..|--
T Consensus 287 ~~~~~~~~~~~~v~~~~~~~~~l~~g~~-dg~i~iwd~~~~~~~~~~~~h~~~v~~~~~~~~~l~sg~~dg-~i~vwd~ 363 (435)
T 1p22_A 287 EFVRTLNGHKRGIACLQYRDRLVVSGSS-DNTIRLWDIECGACLRVLEGHEELVRCIRFDNKRIVSGAYDG-KIKVWDL 363 (435)
T ss_dssp CEEEEEECCSSCEEEEEEETTEEEEEET-TSCEEEEETTTCCEEEEECCCSSCEEEEECCSSEEEEEETTS-CEEEEEH
T ss_pred cEEEEEcCCCCcEEEEEeCCCEEEEEeC-CCeEEEEECCCCCEEEEEeCCcCcEEEEEecCCEEEEEeCCC-cEEEEEC
Confidence 3311111122345556555555555555 99999997654222221 12345777777555555555566 8888853
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0064 Score=64.58 Aligned_cols=31 Identities=23% Similarity=0.395 Sum_probs=26.8
Q ss_pred CCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
+.++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4489999999999999888899999986643
|
| >2ovr_B FBW7, F-BOX/WD repeat protein 7, F-box PROT; WD40 domains, double phosphorylation, transcription-C complex; HET: TPO; 2.50A {Homo sapiens} SCOP: a.158.1.1 b.69.4.1 PDB: 2ovp_B* 2ovq_B* | Back alignment and structure |
|---|
Probab=96.25 E-value=1.7 Score=46.97 Aligned_cols=222 Identities=10% Similarity=0.108 Sum_probs=123.5
Q ss_pred eEEEEecCceeeeeeeecCCCcEEEeeC--Cccccc--CCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcce
Q 045256 36 TLAVSYGSATVCAVVAAQPTQRLLCYQG--GTIRAV--EPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPK 111 (789)
Q Consensus 36 ~~~i~~G~~h~~~~~~l~~~g~v~~wG~--~~~~~~--~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~ 111 (789)
|..++.-+...+ ....||+|..|-. ...... .....|..++-....-+.-..|| +|..|-.... .+.
T Consensus 162 v~~~~~~~~~l~---s~~~dg~i~vwd~~~~~~~~~~~~h~~~v~~~~~~~~~l~s~s~dg-~i~~wd~~~~-----~~~ 232 (445)
T 2ovr_B 162 VWSSQMRDNIII---SGSTDRTLKVWNAETGECIHTLYGHTSTVRCMHLHEKRVVSGSRDA-TLRVWDIETG-----QCL 232 (445)
T ss_dssp EEEEEEETTEEE---EEETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTEEEEEETTS-EEEEEESSSC-----CEE
T ss_pred EEEEEecCCEEE---EEeCCCeEEEEECCcCcEEEEECCCCCcEEEEEecCCEEEEEeCCC-EEEEEECCCC-----cEE
Confidence 444444344444 5567888888865 222221 12345777777666766777899 9999954421 122
Q ss_pred eeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCC
Q 045256 112 RIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISN 190 (789)
Q Consensus 112 ~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gq 190 (789)
.........+..++....+.++-..||.|..|--........ ......+..++....+ ++.-..+|+|..|-......
T Consensus 233 ~~~~~~~~~v~~~~~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~v~~~~~~~~~-l~~~~~d~~i~i~d~~~~~~ 311 (445)
T 2ovr_B 233 HVLMGHVAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIH-VVSGSLDTSIRVWDVETGNC 311 (445)
T ss_dssp EEEECCSSCEEEEEECSSCEEEEETTSCEEEEEGGGTEEEEEECCCSSCEEEEEECSSE-EEEEETTSCEEEEETTTCCE
T ss_pred EEEcCCcccEEEEEECCCEEEEEcCCCEEEEEECCCCcEeEEecCCCCceEEEEECCCE-EEEEeCCCeEEEEECCCCCE
Confidence 221222334556776666777778899999995322111100 1111246666664444 44356677999996543222
Q ss_pred cccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCC-CcCC--CCCccceEEeccCcceEEEEEeeCCeEEEeee
Q 045256 191 QIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQL-KFPL--NSTAFEYSALSLGFNHSCAIRRLNGSVVCWGS 267 (789)
Q Consensus 191 lg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql-~~~~--~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~ 267 (789)
+..-......+..++......++-..||.|..|--.. |+. ..-. ......|..++-...+-++-.. ||.|..|-.
T Consensus 312 ~~~~~~~~~~v~~~~~~~~~l~~~~~dg~i~vwd~~~-~~~~~~~~~~~~~~~~v~~~~~~~~~l~s~~~-dg~v~iwd~ 389 (445)
T 2ovr_B 312 IHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKT-GQCLQTLQGPNKHQSAVTCLQFNKNFVITSSD-DGTVKLWDL 389 (445)
T ss_dssp EEEECCCCSCEEEEEEETTEEEEEETTSCEEEEETTT-CCEEEEECSTTSCSSCEEEEEECSSEEEEEET-TSEEEEEET
T ss_pred EEEEcCCcccEEEEEEeCCEEEEEeCCCeEEEEECCC-CcEEEEEccCCCCCCCEEEEEECCCEEEEEeC-CCeEEEEEC
Confidence 2111112233556665566666667899999996533 332 1111 1123346666665555555555 999999975
Q ss_pred CC
Q 045256 268 QG 269 (789)
Q Consensus 268 n~ 269 (789)
..
T Consensus 390 ~~ 391 (445)
T 2ovr_B 390 KT 391 (445)
T ss_dssp TT
T ss_pred CC
Confidence 43
|
| >3odt_A Protein DOA1; ubiquitin, nuclear protein; HET: MSE MES; 1.35A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=95.94 E-value=1.1 Score=45.21 Aligned_cols=166 Identities=9% Similarity=-0.044 Sum_probs=84.5
Q ss_pred eecCCCcEEEeeCC-----ccccc--CCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEE
Q 045256 51 AAQPTQRLLCYQGG-----TIRAV--EPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSS 123 (789)
Q Consensus 51 ~l~~~g~v~~wG~~-----~~~~~--~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~ 123 (789)
....||.+..|=-. .+... .....|..++--....+.-..|| +|..|-. ..+........-.+..
T Consensus 76 ~~~~dg~i~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~d~-~i~~~d~-------~~~~~~~~~~~~~v~~ 147 (313)
T 3odt_A 76 FGGKDTMINGVPLFATSGEDPLYTLIGHQGNVCSLSFQDGVVISGSWDK-TAKVWKE-------GSLVYNLQAHNASVWD 147 (313)
T ss_dssp EEETTSCEEEEETTCCTTSCC-CEECCCSSCEEEEEEETTEEEEEETTS-EEEEEET-------TEEEEEEECCSSCEEE
T ss_pred EecCCCeEEEEEeeecCCCCcccchhhcccCEEEEEecCCEEEEEeCCC-CEEEEcC-------CcEEEecccCCCceeE
Confidence 34556666655431 11111 12345777777666667777899 9999941 1122221112222333
Q ss_pred EEe---cCCeEEEEeeCCeEEEcCCCCCCCCCCCCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCce
Q 045256 124 VSV---GNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRS 200 (789)
Q Consensus 124 v~~---G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~ 200 (789)
++. ...+.+.-..||.|..|-...............+..++.-.+..++....+|.|+.|-......+..-......
T Consensus 148 ~~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~dg~i~i~d~~~~~~~~~~~~~~~~ 227 (313)
T 3odt_A 148 AKVVSFSENKFLTASADKTIKLWQNDKVIKTFSGIHNDVVRHLAVVDDGHFISCSNDGLIKLVDMHTGDVLRTYEGHESF 227 (313)
T ss_dssp EEEEETTTTEEEEEETTSCEEEEETTEEEEEECSSCSSCEEEEEEEETTEEEEEETTSEEEEEETTTCCEEEEEECCSSC
T ss_pred EEEccCCCCEEEEEECCCCEEEEecCceEEEEeccCcccEEEEEEcCCCeEEEccCCCeEEEEECCchhhhhhhhcCCce
Confidence 332 55666677889999999522111111111122344444432222555677889999975433222111112233
Q ss_pred eEEEeeCCc-eeEEEccCCcEEEEE
Q 045256 201 MFSITAGGN-HVCGIDSNGFVICYG 224 (789)
Q Consensus 201 v~~i~~G~~-h~~al~~dG~v~~wG 224 (789)
+..++.-.. ..++-..||.|+.|-
T Consensus 228 i~~~~~~~~~~l~~~~~dg~v~iwd 252 (313)
T 3odt_A 228 VYCIKLLPNGDIVSCGEDRTVRIWS 252 (313)
T ss_dssp EEEEEECTTSCEEEEETTSEEEEEC
T ss_pred EEEEEEecCCCEEEEecCCEEEEEE
Confidence 555543322 445556788888885
|
| >3vgz_A Uncharacterized protein YNCE; beta-propeller, protein binding; 1.70A {Escherichia coli} PDB: 3vh0_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=1.3 Score=45.90 Aligned_cols=63 Identities=6% Similarity=-0.066 Sum_probs=32.5
Q ss_pred eEEeccCcceEEEEEeeCCe-EEEeeeCCCCccc---CCCCCcEEEEEecC-ceEEEEeecCCeEEEecC
Q 045256 242 YSALSLGFNHSCAIRRLNGS-VVCWGSQGEYSVN---GIRGKSFESIVSGS-NFTCGLTTSNFSVICWGP 306 (789)
Q Consensus 242 v~~i~~G~~h~~al~~~dG~-v~~WG~n~~gq~~---~~~~~~v~~i~~G~-~h~~al~~~g~~v~~WG~ 306 (789)
+..+..+....+++.. ||+ +|+-..+ .+.+. ......+..+..+. -+.+++..||..+|.=..
T Consensus 266 ~~~~~~~~~~~~~~s~-dg~~l~v~~~~-~~~v~~~d~~~~~~~~~~~~~~~~~~~~~s~dg~~l~v~~~ 333 (353)
T 3vgz_A 266 LAKVAAPESLAVLFNP-ARNEAYVTHRQ-AGKVSVIDAKSYKVVKTFDTPTHPNSLALSADGKTLYVSVK 333 (353)
T ss_dssp EEEEECSSCCCEEEET-TTTEEEEEETT-TTEEEEEETTTTEEEEEEECCSEEEEEEECTTSCEEEEEEE
T ss_pred EEEEEcCCCceEEECC-CCCEEEEEECC-CCeEEEEECCCCeEEEEEecCCCCCeEEEcCCCCEEEEEEc
Confidence 4444555556677776 766 5554432 23322 12233344455443 356777777744766443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.017 Score=63.13 Aligned_cols=74 Identities=9% Similarity=0.051 Sum_probs=46.7
Q ss_pred cceEeecccEEEEEEEeCC--------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeCCeE
Q 045256 499 ENKIGAGSFGVVYKGKLPD--------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEKDER 569 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~~~~ 569 (789)
.+.|..|-.-.+|+....+ ++.+++|+........ ..-.+|..+++.|. +.-..++++.+ . -
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-----idR~~E~~~l~~L~~~gi~P~l~~~~--~--~ 145 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-----YDSKVELDVFRYLSNINIAPNIIADF--P--E 145 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-----CCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-----cCHHHHHHHHHHHHhcCCCCCEEEEc--C--C
Confidence 4567778888999998753 5789999854322111 11346888888774 32234555432 2 3
Q ss_pred EEEEEecCCCch
Q 045256 570 LLVYDYMKNGAL 581 (789)
Q Consensus 570 ~lv~e~~~~gsL 581 (789)
++||||+++..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998654
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=94.92 E-value=0.029 Score=54.41 Aligned_cols=63 Identities=22% Similarity=0.448 Sum_probs=35.7
Q ss_pred eEEeccCcceEEEEEeeCCeEEEeeeCCCCc--ccCCCCCcEEEEEecCceEEEEeecCCeEEEecCC
Q 045256 242 YSALSLGFNHSCAIRRLNGSVVCWGSQGEYS--VNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 242 v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq--~~~~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~n 307 (789)
+.+|+.-+.|+..+-- |++++.+|++++|| ++.-. ..+.++.||..+|+-+..-+ .|--||+.
T Consensus 311 i~~VsG~y~H~vvi~g-d~el~sFG~~sNGQ~~ip~ta-gPfla~~AG~~fTVTVn~~n-yv~FWGDS 375 (400)
T 4gbf_A 311 IGGVSGLYTHYTVMYG-DGQIAFFGNNDNGQCDVDDHA-GPYIQLAAGHNFTVTVNTLN-QVMFWGDS 375 (400)
T ss_dssp CCCCBCSSSEEEC-CT-TTCCCEEECCTTSTTCCCGGG-CCEEEEEECSSEEEEEETTC-CEEEEECC
T ss_pred cccccccccceEEEec-CceeEEeccCCCCceecCCCc-chHHhHhccCCeEEEEecee-eEEEecCC
Confidence 4455555666666555 66666666666666 23321 13556666666666666555 56666665
|
| >4gbf_A Phikz131; 7-bladed beta-propeller, possibly participates in binding of phage to the HOST cell, viral protein; 1.95A {Pseudomonas phage phikz} | Back alignment and structure |
|---|
Probab=94.91 E-value=0.031 Score=54.27 Aligned_cols=104 Identities=8% Similarity=0.041 Sum_probs=63.9
Q ss_pred CCceeEE-EeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccC
Q 045256 197 ANRSMFS-ITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNG 275 (789)
Q Consensus 197 ~~~~v~~-i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~ 275 (789)
.+.+|.+ +.-|..|.+.-.-|--+ .=+ .-........|.+|--|.+-|+.--. +.+|.-|....-.+..
T Consensus 237 ~l~~V~D~~rIg~n~iv~~~~~~iv-~t~-------~~Ta~~~kv~V~~In~ggniTltdV~--~t~~v~nh~tg~~~~a 306 (400)
T 4gbf_A 237 PLNHVIDSMSIGCTHIIMHSIDPLV-APE-------DYTSESSKVHVMEIIRNGNDTSFMVI--SPLWFDGRGNDVTANV 306 (400)
T ss_dssp GGTCEEEEEEECSSEEEEEEECTTS-CGG-------GCCTTTEEEEEEEEEEETTEEEEEEE--CCCCBCTTSCBCHHHH
T ss_pred ccceeeeeEEecccEEEEeccccee-ccC-------CCcceeeEEEEEEEecCCceEEEEee--ceeEEecCCCCeEEEe
Confidence 3445666 89999987752211000 000 00011123357777777777665543 6777777654333333
Q ss_pred CCCCcEEEEEecCceEEEEeecCCeEEEecCCCCCCC
Q 045256 276 IRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVS 312 (789)
Q Consensus 276 ~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~~~ 312 (789)
.. ..+.+|+.-..|+..+--|+ +++.+|+|..||.
T Consensus 307 ns-n~i~~VsG~y~H~vvi~gd~-el~sFG~~sNGQ~ 341 (400)
T 4gbf_A 307 NS-NPIGGVSGLYTHYTVMYGDG-QIAFFGNNDNGQC 341 (400)
T ss_dssp HT-SCCCCCBCSSSEEEC-CTTT-CCCEEECCTTSTT
T ss_pred cC-CccccccccccceEEEecCc-eeEEeccCCCCce
Confidence 22 56778888899999999999 9999999988874
|
| >4aez_A CDC20, WD repeat-containing protein SLP1; cell cycle, KEN-BOX, D-BOX, APC/C; 2.30A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=94.80 E-value=5 Score=42.56 Aligned_cols=219 Identities=9% Similarity=0.110 Sum_probs=107.7
Q ss_pred EEecCceeeeeeeecCCCcEEEeeCC--ccc---ccCCCCcEEEEEe--cCceEEEEEeCCceEEEccCCCCCCCCCcce
Q 045256 39 VSYGSATVCAVVAAQPTQRLLCYQGG--TIR---AVEPNISFSSISA--GQSFFCGIRSGGYSLLCWDTNFSYNSNFVPK 111 (789)
Q Consensus 39 i~~G~~h~~~~~~l~~~g~v~~wG~~--~~~---~~~~~~~v~~i~~--G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~ 111 (789)
++-.+.+.+ +...||+|+-|-.. ... .......|..|+- .+.+-++-..|| .|..|-.... ....
T Consensus 99 ~~~s~~~l~---~~~~d~~v~lw~~~~~~~~~~~~~~~~~~v~~v~~s~~~~~l~~~~~dg-~i~iwd~~~~----~~~~ 170 (401)
T 4aez_A 99 LDWSNLNVV---AVALERNVYVWNADSGSVSALAETDESTYVASVKWSHDGSFLSVGLGNG-LVDIYDVESQ----TKLR 170 (401)
T ss_dssp EEECTTSEE---EEEETTEEEEEETTTCCEEEEEECCTTCCEEEEEECTTSSEEEEEETTS-CEEEEETTTC----CEEE
T ss_pred EeecCCCEE---EEECCCeEEEeeCCCCcEeEeeecCCCCCEEEEEECCCCCEEEEECCCC-eEEEEECcCC----eEEE
Confidence 554555666 66789999999651 111 1112334555553 333444455688 8888854321 1111
Q ss_pred eeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCC--CCCCCccEEEEeee-CceeEEEEeCCCeEEEeecCCC
Q 045256 112 RIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKN--APSGELQFESLTSG-IDFSCGILTNNKTVRCWGINSI 188 (789)
Q Consensus 112 ~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~--~~~~~~~v~~va~G-~~hs~al~~~~g~v~~wG~n~~ 188 (789)
.+ ......|..++......+.-..||.|+.|--....... .......|..++.- ....++.-..+|.|+.|-....
T Consensus 171 ~~-~~~~~~v~~~~~~~~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~s~~~d~~v~iwd~~~~ 249 (401)
T 4aez_A 171 TM-AGHQARVGCLSWNRHVLSSGSRSGAIHHHDVRIANHQIGTLQGHSSEVCGLAWRSDGLQLASGGNDNVVQIWDARSS 249 (401)
T ss_dssp EE-CCCSSCEEEEEEETTEEEEEETTSEEEEEETTSSSCEEEEEECCSSCEEEEEECTTSSEEEEEETTSCEEEEETTCS
T ss_pred Ee-cCCCCceEEEEECCCEEEEEcCCCCEEEEecccCcceeeEEcCCCCCeeEEEEcCCCCEEEEEeCCCeEEEccCCCC
Confidence 12 12233466777766666777889999999643222110 00111235555432 2233444566779999975432
Q ss_pred CCcccCCCCCceeEEEeeC--CceeEEEc---cCCcEEEEEcCCCCCCCcCCCCCccceEEeccC--cceEEEEE--eeC
Q 045256 189 SNQIQTSFANRSMFSITAG--GNHVCGID---SNGFVICYGDNKSGQLKFPLNSTAFEYSALSLG--FNHSCAIR--RLN 259 (789)
Q Consensus 189 gqlg~~~~~~~~v~~i~~G--~~h~~al~---~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G--~~h~~al~--~~d 259 (789)
...-.-......|..++-- ..+.++.. .||.|+.|-... |++-... .....+..++-- ...-++.. + |
T Consensus 250 ~~~~~~~~~~~~v~~~~~~p~~~~ll~~~~gs~d~~i~i~d~~~-~~~~~~~-~~~~~v~~~~~s~~~~~l~~~~g~~-d 326 (401)
T 4aez_A 250 IPKFTKTNHNAAVKAVAWCPWQSNLLATGGGTMDKQIHFWNAAT-GARVNTV-DAGSQVTSLIWSPHSKEIMSTHGFP-D 326 (401)
T ss_dssp SEEEEECCCSSCCCEEEECTTSTTEEEEECCTTTCEEEEEETTT-CCEEEEE-ECSSCEEEEEECSSSSEEEEEECTT-T
T ss_pred CccEEecCCcceEEEEEECCCCCCEEEEecCCCCCEEEEEECCC-CCEEEEE-eCCCcEEEEEECCCCCeEEEEeecC-C
Confidence 2111111112223344332 23344433 589999996433 3321100 112234444432 22222222 4 8
Q ss_pred CeEEEeeeCC
Q 045256 260 GSVVCWGSQG 269 (789)
Q Consensus 260 G~v~~WG~n~ 269 (789)
|.|+.|=...
T Consensus 327 g~i~v~~~~~ 336 (401)
T 4aez_A 327 NNLSIWSYSS 336 (401)
T ss_dssp CEEEEEEEET
T ss_pred CcEEEEecCC
Confidence 9999997654
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.76 E-value=0.015 Score=39.36 Aligned_cols=31 Identities=29% Similarity=0.252 Sum_probs=23.4
Q ss_pred CcccccchhhhHHHHHHHHHHHHHhhheeee
Q 045256 382 SRELTRGLLAFAIVGSVGGFAGICTVIYCVW 412 (789)
Q Consensus 382 ~~~~~~~~i~~iiv~~v~~~~~l~~l~~~~~ 412 (789)
++.++.+.++.|++++++++++++.+++++|
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~ 35 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRS 35 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHe
Confidence 3446678899999999888887777766554
|
| >1yfq_A Cell cycle arrest protein BUB3; WD repeat WD40 repeat beta transducin repeat all beta, signaling protein; 1.10A {Saccharomyces cerevisiae} SCOP: b.69.4.2 PDB: 1u4c_A 2i3s_A 2i3t_A | Back alignment and structure |
|---|
Probab=94.68 E-value=4.4 Score=41.39 Aligned_cols=184 Identities=10% Similarity=0.017 Sum_probs=93.1
Q ss_pred EEEEEeCCceEEEccCCCCCCCCCcceeeee-CCcceEEEEEecCC-eEEEEeeCCeEEEcCC-CCCCCCCCCC--CCcc
Q 045256 85 FCGIRSGGYSLLCWDTNFSYNSNFVPKRIYY-NDTVLLSSVSVGNN-HVCATTVQGQINCWRG-DVNISKNAPS--GELQ 159 (789)
Q Consensus 85 ~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~-~~~~~i~~v~~G~~-h~~al~~~G~v~~wG~-~~~~~~~~~~--~~~~ 159 (789)
-++-..|| +|+.|-...... ...+..+.. ...+.-..++.... +.++-..||.|+.|-- .......... ....
T Consensus 26 l~~~~~d~-~v~iw~~~~~~~-~~~~~~~~~~~~~v~~~~~~~~~~~~l~~~~~dg~i~~wd~~~~~~~~~~~~~~~~~~ 103 (342)
T 1yfq_A 26 LLITSWDG-SLTVYKFDIQAK-NVDLLQSLRYKHPLLCCNFIDNTDLQIYVGTVQGEILKVDLIGSPSFQALTNNEANLG 103 (342)
T ss_dssp EEEEETTS-EEEEEEEETTTT-EEEEEEEEECSSCEEEEEEEESSSEEEEEEETTSCEEEECSSSSSSEEECBSCCCCSC
T ss_pred EEEEcCCC-eEEEEEeCCCCc-cccceeeeecCCceEEEEECCCCCcEEEEEcCCCeEEEEEeccCCceEeccccCCCCc
Confidence 33445678 888885443110 011222221 12223223344455 6666778999999964 3222111111 2224
Q ss_pred EEEEeeeCceeEEEEeCCCeEEEeecCCC--------CCcccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCC
Q 045256 160 FESLTSGIDFSCGILTNNKTVRCWGINSI--------SNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQL 231 (789)
Q Consensus 160 v~~va~G~~hs~al~~~~g~v~~wG~n~~--------gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql 231 (789)
|..++.-....++....+|.|+.|-...+ ++.-........+..++......++-..||.|+.|-....++.
T Consensus 104 v~~l~~~~~~~l~s~~~d~~i~iwd~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~ 183 (342)
T 1yfq_A 104 ICRICKYGDDKLIAASWDGLIEVIDPRNYGDGVIAVKNLNSNNTKVKNKIFTMDTNSSRLIVGMNNSQVQWFRLPLCEDD 183 (342)
T ss_dssp EEEEEEETTTEEEEEETTSEEEEECHHHHTTBCEEEEESCSSSSSSCCCEEEEEECSSEEEEEESTTEEEEEESSCCTTC
T ss_pred eEEEEeCCCCEEEEEcCCCeEEEEcccccccccccccCCeeeEEeeCCceEEEEecCCcEEEEeCCCeEEEEECCccccc
Confidence 55554432333444567779999954321 2211111133456777766666666688999999986552221
Q ss_pred C--cCCCCCccceEEeccCc--ceEEEEEeeCCeEEEeeeCCC
Q 045256 232 K--FPLNSTAFEYSALSLGF--NHSCAIRRLNGSVVCWGSQGE 270 (789)
Q Consensus 232 ~--~~~~~~~~~v~~i~~G~--~h~~al~~~dG~v~~WG~n~~ 270 (789)
. .........+..|+.-. ...++....||.+..|=....
T Consensus 184 ~~~~~~~~~~~~i~~i~~~~~~~~~l~~~~~dg~i~i~~~~~~ 226 (342)
T 1yfq_A 184 NGTIEESGLKYQIRDVALLPKEQEGYACSSIDGRVAVEFFDDQ 226 (342)
T ss_dssp CCEEEECSCSSCEEEEEECSGGGCEEEEEETTSEEEEEECCTT
T ss_pred cceeeecCCCCceeEEEECCCCCCEEEEEecCCcEEEEEEcCC
Confidence 1 11111122355544432 234444444999999877655
|
| >1bte_A Protein (activin receptor type II); serine kinase, ligand binding domain, three-finger transferase; HET: NAG; 1.50A {Mus musculus} SCOP: g.7.1.3 PDB: 2goo_C* 1lx5_B* | Back alignment and structure |
|---|
Probab=94.33 E-value=0.01 Score=49.52 Aligned_cols=49 Identities=22% Similarity=0.365 Sum_probs=38.8
Q ss_pred CcccccccCCCcccCCC-CCCCCCCCCCccCCCcccccCCccccCCCCCCC
Q 045256 314 DSVSLVPFQQEILPGPC-DNSSCSECGLYPQSDRLCFGNGNICKSCQNVVP 363 (789)
Q Consensus 314 ~~~~~~~~~~~~~~~~C-~~~~c~~~~~~p~~~~~C~~~~~~C~~c~~~~p 363 (789)
+.+.++++|||..+..| .+++|.+.. .+....|||+.+++|+......|
T Consensus 45 g~~~i~~qGCw~d~~~C~d~~eCv~t~-~~~~~~fCCC~gd~CN~nft~~p 94 (97)
T 1bte_A 45 GSIEIVKQGCWLDDINCYDRTDCIEKK-DSPEVYFCCCEGNMCNEKFSYFP 94 (97)
T ss_dssp TEEEEEEEEEECSCCCCSCSSSEEECS-SSCSSEEEEECSTTGGGSEEECC
T ss_pred CCEEEEEecccCCCCCCCCcceeecCC-CCCCEEEEECCCCccccCcccCC
Confidence 45788999999999999 468998765 34468899999999987655433
|
| >3v7d_B Cell division control protein 4; WD 40 domain, phospho-peptide complex, E3 ubiquitin ligase, cell cycle, phospho binding protein, phosphorylation; HET: SEP; 2.31A {Saccharomyces cerevisiae} PDB: 1nex_B* 3mks_B* | Back alignment and structure |
|---|
Probab=93.97 E-value=8.1 Score=41.63 Aligned_cols=252 Identities=8% Similarity=0.005 Sum_probs=130.3
Q ss_pred eecCCCcEEEeeC--CcccccC--CCCcEEEEEec----CceEEEEEeCCceEEEccCCCCCCCCC------cc------
Q 045256 51 AAQPTQRLLCYQG--GTIRAVE--PNISFSSISAG----QSFFCGIRSGGYSLLCWDTNFSYNSNF------VP------ 110 (789)
Q Consensus 51 ~l~~~g~v~~wG~--~~~~~~~--~~~~v~~i~~G----~~~~~~l~~~G~~v~~wG~n~~~~~~~------~p------ 110 (789)
....||+|.-|-. ....... ....|..++.- ..+.+.-..|| +|..|-......... .|
T Consensus 178 s~s~dg~i~vwd~~~~~~~~~~~~h~~~v~~l~~~~~~~~~~l~s~s~d~-~i~vwd~~~~~~~~~~~~~~~~~~~~~~~ 256 (464)
T 3v7d_B 178 SGSTDRTVRVWDIKKGCCTHVFEGHNSTVRCLDIVEYKNIKYIVTGSRDN-TLHVWKLPKESSVPDHGEEHDYPLVFHTP 256 (464)
T ss_dssp EEETTSCEEEEETTTTEEEEEECCCSSCEEEEEEEESSSCEEEEEEETTS-CEEEEECCCCCCC------CCSSEEESCG
T ss_pred EEeCCCCEEEEECCCCcEEEEECCCCCccEEEEEecCCCCCEEEEEcCCC-cEEEeeCCCCcccccccccCCcceEeecc
Confidence 4456777777754 2222221 23345555432 23445556788 999996554211100 00
Q ss_pred ------eeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeeeCc-eeEEEEeCCCeEEE
Q 045256 111 ------KRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSGID-FSCGILTNNKTVRC 182 (789)
Q Consensus 111 ------~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G~~-hs~al~~~~g~v~~ 182 (789)
..........+..++....+.+.-..||.|..|--........ ......|..++.-.+ ..++.-..+|+|+.
T Consensus 257 ~~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~d~~i~vwd~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~sg~~dg~i~v 336 (464)
T 3v7d_B 257 EENPYFVGVLRGHMASVRTVSGHGNIVVSGSYDNTLIVWDVAQMKCLYILSGHTDRIYSTIYDHERKRCISASMDTTIRI 336 (464)
T ss_dssp GGCTTEEEEECCCSSCEEEEEEETTEEEEEETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTTTEEEEEETTSCEEE
T ss_pred CCCeEEEEEccCccceEEEEcCCCCEEEEEeCCCeEEEEECCCCcEEEEecCCCCCEEEEEEcCCCCEEEEEeCCCcEEE
Confidence 1111122234557777777777788899999995432211110 111123555554322 23343567779999
Q ss_pred eecCCCCCcccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeE
Q 045256 183 WGINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSV 262 (789)
Q Consensus 183 wG~n~~gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v 262 (789)
|-......+..-......|..++....+.+.-..||.|..|=-+...+...........+..++... ..++... ||.|
T Consensus 337 wd~~~~~~~~~~~~h~~~v~~~~~~~~~l~s~s~dg~v~vwd~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~-dg~i 414 (464)
T 3v7d_B 337 WDLENGELMYTLQGHTALVGLLRLSDKFLVSAAADGSIRGWDANDYSRKFSYHHTNLSAITTFYVSD-NILVSGS-ENQF 414 (464)
T ss_dssp EETTTTEEEEEECCCSSCEEEEEECSSEEEEEETTSEEEEEETTTCCEEEEEECTTCCCEEEEEECS-SEEEEEE-TTEE
T ss_pred EECCCCcEEEEEeCCCCcEEEEEEcCCEEEEEeCCCcEEEEECCCCceeeeecCCCCccEEEEEeCC-CEEEEec-CCeE
Confidence 9653322221111123346667766677777789999999976553332211111222344444433 3455555 8999
Q ss_pred EEeeeCCCCccc---CCCCCcEEEEEecCceEEEEeecCCeEEEec
Q 045256 263 VCWGSQGEYSVN---GIRGKSFESIVSGSNFTCGLTTSNFSVICWG 305 (789)
Q Consensus 263 ~~WG~n~~gq~~---~~~~~~v~~i~~G~~h~~al~~~g~~v~~WG 305 (789)
..|=....-.+. ......|..|+--+...++...+++.++.|-
T Consensus 415 ~iwd~~~g~~~~~~~~~~~~~v~~v~~~~~~l~~~~~~~g~~~i~~ 460 (464)
T 3v7d_B 415 NIYNLRSGKLVHANILKDADQIWSVNFKGKTLVAAVEKDGQSFLEI 460 (464)
T ss_dssp EEEETTTCCEEESCTTTTCSEEEEEEEETTEEEEEEEETTEEEEEE
T ss_pred EEEECCCCcEEehhhccCCCcEEEEEecCCEEEEEEEeCCeEEEEE
Confidence 999654322222 2234567777665555444433333776664
|
| >3odt_A Protein DOA1; ubiquitin, nuclear protein; HET: MSE MES; 1.35A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=93.86 E-value=5.9 Score=39.65 Aligned_cols=248 Identities=10% Similarity=0.046 Sum_probs=115.3
Q ss_pred eecCCCcEEEeeCCcc--ccc--CCCCcEEEEE--ecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEE
Q 045256 51 AAQPTQRLLCYQGGTI--RAV--EPNISFSSIS--AGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSV 124 (789)
Q Consensus 51 ~l~~~g~v~~wG~~~~--~~~--~~~~~v~~i~--~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v 124 (789)
....||.|.-|-.... ... .....|..++ ..+.+-+.-..|| .+..|-...... ..+..........|..+
T Consensus 34 s~~~dg~v~vw~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~dg-~i~~~~~~~~~~--~~~~~~~~~~~~~i~~~ 110 (313)
T 3odt_A 34 SVSRDGTVRLWSKDDQWLGTVVYTGQGFLNSVCYDSEKELLLFGGKDT-MINGVPLFATSG--EDPLYTLIGHQGNVCSL 110 (313)
T ss_dssp EEETTSEEEEEEESSSEEEEEEEECSSCEEEEEEETTTTEEEEEETTS-CEEEEETTCCTT--SCC-CEECCCSSCEEEE
T ss_pred EEEcCCcEEEEECCCCEEEEEeecCCccEEEEEECCCCCEEEEecCCC-eEEEEEeeecCC--CCcccchhhcccCEEEE
Confidence 4578899988865211 111 1122333333 2333444445667 777664433111 11111112223345677
Q ss_pred EecCCeEEEEeeCCeEEEcCCCCCCCCCCCCCCccEEEEeee--CceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeE
Q 045256 125 SVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSG--IDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMF 202 (789)
Q Consensus 125 ~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~~~v~~va~G--~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~ 202 (789)
+.-..+.+.-..||.|..|-...... ........+..+..- ....++....+|.|..|-....-+.- .......+.
T Consensus 111 ~~~~~~l~~~~~d~~i~~~d~~~~~~-~~~~~~~~v~~~~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~~-~~~~~~~i~ 188 (313)
T 3odt_A 111 SFQDGVVISGSWDKTAKVWKEGSLVY-NLQAHNASVWDAKVVSFSENKFLTASADKTIKLWQNDKVIKTF-SGIHNDVVR 188 (313)
T ss_dssp EEETTEEEEEETTSEEEEEETTEEEE-EEECCSSCEEEEEEEETTTTEEEEEETTSCEEEEETTEEEEEE-CSSCSSCEE
T ss_pred EecCCEEEEEeCCCCEEEEcCCcEEE-ecccCCCceeEEEEccCCCCEEEEEECCCCEEEEecCceEEEE-eccCcccEE
Confidence 77667777788899999995111100 000111234444331 23334445677799999521110000 110122233
Q ss_pred EE--eeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcc-eEEEEEeeCCeEEEeeeCCCCcccC--CC
Q 045256 203 SI--TAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFN-HSCAIRRLNGSVVCWGSQGEYSVNG--IR 277 (789)
Q Consensus 203 ~i--~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~-h~~al~~~dG~v~~WG~n~~gq~~~--~~ 277 (789)
.+ +.... .++-..||.|+.|--.. +++-.........+..++.-.. .-++... ||.|+.|=....-.+.. ..
T Consensus 189 ~~~~~~~~~-~~~~~~dg~i~i~d~~~-~~~~~~~~~~~~~i~~~~~~~~~~l~~~~~-dg~v~iwd~~~~~~~~~~~~~ 265 (313)
T 3odt_A 189 HLAVVDDGH-FISCSNDGLIKLVDMHT-GDVLRTYEGHESFVYCIKLLPNGDIVSCGE-DRTVRIWSKENGSLKQVITLP 265 (313)
T ss_dssp EEEEEETTE-EEEEETTSEEEEEETTT-CCEEEEEECCSSCEEEEEECTTSCEEEEET-TSEEEEECTTTCCEEEEEECS
T ss_pred EEEEcCCCe-EEEccCCCeEEEEECCc-hhhhhhhhcCCceEEEEEEecCCCEEEEec-CCEEEEEECCCCceeEEEecc
Confidence 33 33333 55567889999996543 3321111111223444443322 3344444 99999996543222111 11
Q ss_pred CCcEEEEEecCc-eEEEEeecCCeEEEecCC
Q 045256 278 GKSFESIVSGSN-FTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 278 ~~~v~~i~~G~~-h~~al~~~g~~v~~WG~n 307 (789)
...|..++.-.. ..++...|| .|..|=-+
T Consensus 266 ~~~i~~~~~~~~~~~~~~~~dg-~i~iw~~~ 295 (313)
T 3odt_A 266 AISIWSVDCMSNGDIIVGSSDN-LVRIFSQE 295 (313)
T ss_dssp SSCEEEEEECTTSCEEEEETTS-CEEEEESC
T ss_pred CceEEEEEEccCCCEEEEeCCC-cEEEEeCC
Confidence 234555554322 233444455 78888643
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.63 E-value=0.25 Score=53.44 Aligned_cols=28 Identities=32% Similarity=0.429 Sum_probs=23.6
Q ss_pred eEeccCCCCCEEE------CCCCcEEEEeeccCc
Q 045256 610 IIHRDIKSSNILL------DAQWTARVSDFGLSM 637 (789)
Q Consensus 610 ivH~Dlkp~NIll------~~~~~~kl~DfGls~ 637 (789)
++|+|+.+.|||+ +++..++++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999998764
|
| >2hlr_A Bone morphogenetic protein receptor type-2; three-finger toxin, BMP receptor, TGF-beta, transferase; 1.20A {Ovis aries} PDB: 2hlq_A | Back alignment and structure |
|---|
Probab=93.44 E-value=0.023 Score=47.32 Aligned_cols=45 Identities=20% Similarity=0.384 Sum_probs=31.6
Q ss_pred CcccccccCCCc---ccCCCCCCCCCCCCCcc---C-CCcccccCCccccCC
Q 045256 314 DSVSLVPFQQEI---LPGPCDNSSCSECGLYP---Q-SDRLCFGNGNICKSC 358 (789)
Q Consensus 314 ~~~~~~~~~~~~---~~~~C~~~~c~~~~~~p---~-~~~~C~~~~~~C~~c 358 (789)
+.+..+++|||. .+.+|.+++|.+..+.| . ...||||++++|+..
T Consensus 44 g~~~v~~qGCW~~~~d~~~C~~~eCv~t~~~~~~~n~~~~FCCC~gd~CN~n 95 (100)
T 2hlr_A 44 GDINLVKQGCWSHIGDPQECHYEECVVTTTPPSIQNGTYRFCCCSTDLCNVN 95 (100)
T ss_dssp ---CCCEEEEECCCSCTTTSBSSSCBCC----------CCEEEESSTTGGGS
T ss_pred CcEEEEEecCcCcCCCCCCCCCCcccccCCCcccCCCCEEEEECCCCccccc
Confidence 457889999999 78899989998776543 2 257999999999753
|
| >3v7d_B Cell division control protein 4; WD 40 domain, phospho-peptide complex, E3 ubiquitin ligase, cell cycle, phospho binding protein, phosphorylation; HET: SEP; 2.31A {Saccharomyces cerevisiae} PDB: 1nex_B* 3mks_B* | Back alignment and structure |
|---|
Probab=93.44 E-value=10 Score=40.91 Aligned_cols=257 Identities=8% Similarity=0.106 Sum_probs=130.5
Q ss_pred eEEEEecCceeeeeeeecCCCcEEEeeC--CcccccC--CCCcEEEEEecCc-eEEEEEeCCceEEEccCCCCCCCCCcc
Q 045256 36 TLAVSYGSATVCAVVAAQPTQRLLCYQG--GTIRAVE--PNISFSSISAGQS-FFCGIRSGGYSLLCWDTNFSYNSNFVP 110 (789)
Q Consensus 36 ~~~i~~G~~h~~~~~~l~~~g~v~~wG~--~~~~~~~--~~~~v~~i~~G~~-~~~~l~~~G~~v~~wG~n~~~~~~~~p 110 (789)
+..++..+...+ .-..||+|..|-. ..+.... ....|..++--.. .-+.-..|| +|..|-... . .+
T Consensus 125 ~~~~~~~~~~l~---sgs~dg~i~vwd~~~~~~~~~~~~h~~~V~~l~~~~~~~l~s~s~dg-~i~vwd~~~----~-~~ 195 (464)
T 3v7d_B 125 ITCLQFEDNYVI---TGADDKMIRVYDSINKKFLLQLSGHDGGVWALKYAHGGILVSGSTDR-TVRVWDIKK----G-CC 195 (464)
T ss_dssp EEEEEEETTEEE---EEETTSCEEEEETTTTEEEEEECCCSSCEEEEEECSTTEEEEEETTS-CEEEEETTT----T-EE
T ss_pred EEEEEECCCEEE---EEcCCCcEEEEECCCCcEEEEEeCCCcCEEEEEEcCCCEEEEEeCCC-CEEEEECCC----C-cE
Confidence 344555455555 5578999999975 2222221 2335666664332 444556788 999995442 1 11
Q ss_pred eeeeeCCcceEEEEEe----cCCeEEEEeeCCeEEEcCCCCCCCCCC------------------------CCCCccEEE
Q 045256 111 KRIYYNDTVLLSSVSV----GNNHVCATTVQGQINCWRGDVNISKNA------------------------PSGELQFES 162 (789)
Q Consensus 111 ~~v~~~~~~~i~~v~~----G~~h~~al~~~G~v~~wG~~~~~~~~~------------------------~~~~~~v~~ 162 (789)
........-.|..++. ...+.+.-..||+|..|--........ ......+..
T Consensus 196 ~~~~~~h~~~v~~l~~~~~~~~~~l~s~s~d~~i~vwd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~ 275 (464)
T 3v7d_B 196 THVFEGHNSTVRCLDIVEYKNIKYIVTGSRDNTLHVWKLPKESSVPDHGEEHDYPLVFHTPEENPYFVGVLRGHMASVRT 275 (464)
T ss_dssp EEEECCCSSCEEEEEEEESSSCEEEEEEETTSCEEEEECCCCCCC------CCSSEEESCGGGCTTEEEEECCCSSCEEE
T ss_pred EEEECCCCCccEEEEEecCCCCCEEEEEcCCCcEEEeeCCCCcccccccccCCcceEeeccCCCeEEEEEccCccceEEE
Confidence 1111111222333332 234556667899999995432221100 001123555
Q ss_pred EeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEee--CCceeEEEccCCcEEEEEcCCCCCCCcCCCCCcc
Q 045256 163 LTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITA--GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAF 240 (789)
Q Consensus 163 va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~ 240 (789)
++.-... ++.-..+|+|..|-......+..-......|..++. .....++-..||.|..|--.. |++-........
T Consensus 276 ~~~~~~~-l~~~~~d~~i~vwd~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~sg~~dg~i~vwd~~~-~~~~~~~~~h~~ 353 (464)
T 3v7d_B 276 VSGHGNI-VVSGSYDNTLIVWDVAQMKCLYILSGHTDRIYSTIYDHERKRCISASMDTTIRIWDLEN-GELMYTLQGHTA 353 (464)
T ss_dssp EEEETTE-EEEEETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTTTEEEEEETTSCEEEEETTT-TEEEEEECCCSS
T ss_pred EcCCCCE-EEEEeCCCeEEEEECCCCcEEEEecCCCCCEEEEEEcCCCCEEEEEeCCCcEEEEECCC-CcEEEEEeCCCC
Confidence 5444444 333566779999965432222111112223444443 233555557889999995433 333111111223
Q ss_pred ceEEeccCcceEEEEEeeCCeEEEeeeCCCCccc---CCCCCcEEEEEecCceEEEEeecCCeEEEecC
Q 045256 241 EYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVN---GIRGKSFESIVSGSNFTCGLTTSNFSVICWGP 306 (789)
Q Consensus 241 ~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~---~~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~ 306 (789)
.|..++....+-+.-.. ||+|..|=.....+.. ......+..++..+.. ++...|| .|..|=-
T Consensus 354 ~v~~~~~~~~~l~s~s~-dg~v~vwd~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~dg-~i~iwd~ 419 (464)
T 3v7d_B 354 LVGLLRLSDKFLVSAAA-DGSIRGWDANDYSRKFSYHHTNLSAITTFYVSDNI-LVSGSEN-QFNIYNL 419 (464)
T ss_dssp CEEEEEECSSEEEEEET-TSEEEEEETTTCCEEEEEECTTCCCEEEEEECSSE-EEEEETT-EEEEEET
T ss_pred cEEEEEEcCCEEEEEeC-CCcEEEEECCCCceeeeecCCCCccEEEEEeCCCE-EEEecCC-eEEEEEC
Confidence 45666655566666666 9999999766543321 1222344455554443 3333466 8888853
|
| >1k3i_A Galactose oxidase precursor; blade beta propeller, prosequence form, precursor of copper enzyme., oxidoreductase; 1.40A {Fusarium SP} SCOP: b.1.18.2 b.18.1.1 b.69.1.1 PDB: 1gof_A 1gog_A 1goh_A 2eie_A 2jkx_A 2vz1_A 2vz3_A 2eic_A 2eib_A 1t2x_A 2eid_A 2wq8_A | Back alignment and structure |
|---|
Probab=93.29 E-value=1.3 Score=51.13 Aligned_cols=58 Identities=14% Similarity=0.113 Sum_probs=35.0
Q ss_pred ceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEE---ec-CCeEEEEeeCCeEEEcCCC
Q 045256 83 SFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVS---VG-NNHVCATTVQGQINCWRGD 146 (789)
Q Consensus 83 ~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~---~G-~~h~~al~~~G~v~~wG~~ 146 (789)
.|+.++..|| ++|.+|-..... ..+.....-....+. .. ..|++++..||++|++|+.
T Consensus 245 ~~~~~~~~~g-~lyv~GG~~~~~-----v~~yd~~t~~W~~~~~~~~~R~~~s~~~~~dg~iyv~GG~ 306 (656)
T 1k3i_A 245 CPGISMDGNG-QIVVTGGNDAKK-----TSLYDSSSDSWIPGPDMQVARGYQSSATMSDGRVFTIGGS 306 (656)
T ss_dssp SCEEEECTTS-CEEEECSSSTTC-----EEEEEGGGTEEEECCCCSSCCSSCEEEECTTSCEEEECCC
T ss_pred cccccCCCCC-CEEEeCCCCCCc-----eEEecCcCCceeECCCCCccccccceEEecCCeEEEEeCc
Confidence 3456777899 999999754221 222222222233332 12 3588888779999999973
|
| >1pgu_A Actin interacting protein 1; WD repeat, seven-bladed beta-propeller, protein binding; 2.30A {Saccharomyces cerevisiae} SCOP: b.69.4.1 b.69.4.1 PDB: 1pi6_A | Back alignment and structure |
|---|
Probab=93.00 E-value=9.5 Score=42.62 Aligned_cols=242 Identities=11% Similarity=0.063 Sum_probs=115.4
Q ss_pred eecCCCcEEEeeCC--cccccC-C-----CCcEEEEEe-cCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceE
Q 045256 51 AAQPTQRLLCYQGG--TIRAVE-P-----NISFSSISA-GQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLL 121 (789)
Q Consensus 51 ~l~~~g~v~~wG~~--~~~~~~-~-----~~~v~~i~~-G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i 121 (789)
....||+|..|-.. ...... . ...+..+.. .+.+.++-..|| .|+.|-... ..+........-.|
T Consensus 269 ~~~~d~~i~~wd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~g-~i~~~d~~~-----~~~~~~~~~~~~~v 342 (615)
T 1pgu_A 269 TVGADATIRVWDVTTSKCVQKWTLDKQQLGNQQVGVVATGNGRIISLSLDG-TLNFYELGH-----DEVLKTISGHNKGI 342 (615)
T ss_dssp EEETTSEEEEEETTTTEEEEEEECCTTCGGGCEEEEEEEETTEEEEEETTS-CEEEEETTE-----EEEEEEECCCSSCE
T ss_pred EEcCCCcEEEEECCCCcEEEEEcCCCCcccCceeEEEeCCCCeEEEEECCC-CEEEEECCC-----CcEEEEEeCCCCCE
Confidence 44567888777542 111110 0 112333222 445556667788 888885432 11222212223346
Q ss_pred EEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCCCccEEEEeeeCceeEEEEeCCCeEEEeecCC--------------
Q 045256 122 SSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINS-------------- 187 (789)
Q Consensus 122 ~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~-------------- 187 (789)
..++. .. .+.-..||.|..|--. .+. ......|..++.-....++....+|.|..|-...
T Consensus 343 ~~~~~-~~-l~~~~~dg~i~~w~~~---~~~-~~~~~~v~~~~~~~~~~l~~~~~d~~i~~~~~~~~~~~~~~~~~~~s~ 416 (615)
T 1pgu_A 343 TALTV-NP-LISGSYDGRIMEWSSS---SMH-QDHSNLIVSLDNSKAQEYSSISWDDTLKVNGITKHEFGSQPKVASANN 416 (615)
T ss_dssp EEEET-TT-TEEEETTSCEEETTTT---EEE-CCCCSCEEEEECCSTTCCEEEETTTEEEETTEEEEECSSCEEEEEECS
T ss_pred EEEEe-cC-cEEECCCCeEEEEEch---hhc-CcccCceEEEEECCCcEEEEEeCCCCEEEEEcccCcccCCceEEEEcC
Confidence 67777 55 5556788999999644 111 1112245555553233333345555777764221
Q ss_pred -------------------CCCcccCCCCCceeEEEeeCCceeEEEcc-CCcEEEEEcCCCCCCC-cCCCCCccceEEec
Q 045256 188 -------------------ISNQIQTSFANRSMFSITAGGNHVCGIDS-NGFVICYGDNKSGQLK-FPLNSTAFEYSALS 246 (789)
Q Consensus 188 -------------------~gqlg~~~~~~~~v~~i~~G~~h~~al~~-dG~v~~wG~n~~Gql~-~~~~~~~~~v~~i~ 246 (789)
.++.-........+..++....+.+.-.. ||.|+.|-... +++. .........|..++
T Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~d~~i~~~~~~~-~~~~~~~~~~~~~~v~~~~ 495 (615)
T 1pgu_A 417 DGFTAVLTNDDDLLILQSFTGDIIKSVRLNSPGSAVSLSQNYVAVGLEEGNTIQVFKLSD-LEVSFDLKTPLRAKPSYIS 495 (615)
T ss_dssp SSEEEEEETTSEEEEEETTTCCEEEEEECSSCEEEEEECSSEEEEEETTTSCEEEEETTE-EEEEEECSSCCSSCEEEEE
T ss_pred CCCEEEEeCCCceEEEeccCCceeeecccCCCceEEEEcCCEEEEeecCCCeEEEEECCC-ccccccccCCccCceEEEE
Confidence 11110000011223334333334444455 88888886543 2221 01111122354444
Q ss_pred c--CcceEEEEEeeCCeEEEeeeCCCCcccCC---CCCcEEEEEec------------CceEEEEeecCCeEEEecCC
Q 045256 247 L--GFNHSCAIRRLNGSVVCWGSQGEYSVNGI---RGKSFESIVSG------------SNFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 247 ~--G~~h~~al~~~dG~v~~WG~n~~gq~~~~---~~~~v~~i~~G------------~~h~~al~~~g~~v~~WG~n 307 (789)
- ...+-+.-.. ||.|+.|-......+... ....|..++-- +.+-+.-..|| .|+.|--.
T Consensus 496 ~s~~g~~l~~~~~-dg~i~iw~~~~~~~~~~~~~~h~~~v~~~~~sp~~~~~~~~~~~~~~l~~~~~dg-~i~iw~~~ 571 (615)
T 1pgu_A 496 ISPSETYIAAGDV-MGKILLYDLQSREVKTSRWAFRTSKINAISWKPAEKGANEEEIEEDLVATGSLDT-NIFIYSVK 571 (615)
T ss_dssp ECTTSSEEEEEET-TSCEEEEETTTTEEEECCSCCCSSCEEEEEECCCC------CCSCCEEEEEETTS-CEEEEESS
T ss_pred ECCCCCEEEEcCC-CCeEEEeeCCCCcceeEeecCCCCceeEEEEcCccccccccccCCCEEEEEcCCC-cEEEEECC
Confidence 3 3444444445 899999976543333222 33557666653 23333334455 89888753
|
| >2zwa_A Leucine carboxyl methyltransferase 2; HET: SAH CIT; 1.70A {Saccharomyces cerevisiae} PDB: 2zw9_A* 2zzk_A* | Back alignment and structure |
|---|
Probab=92.66 E-value=1.9 Score=50.25 Aligned_cols=171 Identities=10% Similarity=-0.022 Sum_probs=89.6
Q ss_pred CCCcEEEeeCCccccc-------CCCCcEEEEE-e---------cCceEEEEEe-CCceEEEccCCCCCCCCCcceeeee
Q 045256 54 PTQRLLCYQGGTIRAV-------EPNISFSSIS-A---------GQSFFCGIRS-GGYSLLCWDTNFSYNSNFVPKRIYY 115 (789)
Q Consensus 54 ~~g~v~~wG~~~~~~~-------~~~~~v~~i~-~---------G~~~~~~l~~-~G~~v~~wG~n~~~~~~~~p~~v~~ 115 (789)
.++.||.+|....... +....+..+. . =..|++++.. +| ++|..|-.........-..+..
T Consensus 396 ~~~~iyv~GG~~~~~~~~v~~yd~~~~~W~~~~~~~p~~~~p~~R~~hs~~~~~~~~-~lyv~GG~~~~~~~~~dv~~yd 474 (695)
T 2zwa_A 396 AGNDVFYMGGSNPYRVNEILQLSIHYDKIDMKNIEVSSSEVPVARMCHTFTTISRNN-QLLLIGGRKAPHQGLSDNWIFD 474 (695)
T ss_dssp CSSCEEEECCBSSSBCCCEEEEEECSSCEEEEECCCCCSCCCCCCBSCEEEEETTTT-EEEEECCBSSTTCBCCCCEEEE
T ss_pred ECCEEEEECCCCCCCcCcEEEEECCCCeEEEeccCCCCCCCCccccceEEEEEccCC-EEEEEcCCCCCCCccccEEEEe
Confidence 5788999987221110 1123466665 2 1358888876 89 9999986542221111112222
Q ss_pred CCcceEEEEE----ecCCeEEEEeeCCeEEEcCCCCCCC-C-CCCCCCccEEEEee-------eCceeEEEEeCC-CeEE
Q 045256 116 NDTVLLSSVS----VGNNHVCATTVQGQINCWRGDVNIS-K-NAPSGELQFESLTS-------GIDFSCGILTNN-KTVR 181 (789)
Q Consensus 116 ~~~~~i~~v~----~G~~h~~al~~~G~v~~wG~~~~~~-~-~~~~~~~~v~~va~-------G~~hs~al~~~~-g~v~ 181 (789)
...-..+.++ .=..|++++-.+|.+|.+|+..... . ...+....+..+.. -..|++++...+ +.+|
T Consensus 475 ~~t~~W~~~~~~p~~R~~h~~~~~~~~~iyv~GG~~~~~~v~~yd~~t~~W~~~~~~g~~p~~r~~~~a~v~~~~~~~iy 554 (695)
T 2zwa_A 475 MKTREWSMIKSLSHTRFRHSACSLPDGNVLILGGVTEGPAMLLYNVTEEIFKDVTPKDEFFQNSLVSAGLEFDPVSKQGI 554 (695)
T ss_dssp TTTTEEEECCCCSBCCBSCEEEECTTSCEEEECCBCSSCSEEEEETTTTEEEECCCSSGGGGSCCBSCEEEEETTTTEEE
T ss_pred CCCCcEEECCCCCCCcccceEEEEcCCEEEEECCCCCCCCEEEEECCCCceEEccCCCCCCCcccceeEEEEeCCCCEEE
Confidence 2222233332 2245887775699999999743322 0 00011224555543 345665544543 6999
Q ss_pred EeecCCCCC---ccc---CCCCCce------eEEEee-----CCceeEEEccCCcEEEEEc
Q 045256 182 CWGINSISN---QIQ---TSFANRS------MFSITA-----GGNHVCGIDSNGFVICYGD 225 (789)
Q Consensus 182 ~wG~n~~gq---lg~---~~~~~~~------v~~i~~-----G~~h~~al~~dG~v~~wG~ 225 (789)
++|...... +.. -+..... +..+.. -..|++++..+|++|..|.
T Consensus 555 v~GG~~~~~~~~~~~v~~yd~~~~~w~~~~~W~~~~~~p~~~R~~~~~~~~~~~~iyv~GG 615 (695)
T 2zwa_A 555 ILGGGFMDQTTVSDKAIIFKYDAENATEPITVIKKLQHPLFQRYGSQIKYITPRKLLIVGG 615 (695)
T ss_dssp EECCBCTTSSCBCCEEEEEEECTTCSSCCEEEEEEEECGGGCCBSCEEEEEETTEEEEECC
T ss_pred EECCcCCCCCeeeCcEEEEEccCCccccceEEEEcCCCCCCCcccceEEEeCCCEEEEECC
Confidence 999532211 100 0001112 445433 3568888877799999985
|
| >2zwa_A Leucine carboxyl methyltransferase 2; HET: SAH CIT; 1.70A {Saccharomyces cerevisiae} PDB: 2zw9_A* 2zzk_A* | Back alignment and structure |
|---|
Probab=91.99 E-value=3 Score=48.54 Aligned_cols=212 Identities=10% Similarity=-0.010 Sum_probs=104.8
Q ss_pred eCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEE-e---------cCCeEEEEee-CCeEEEcCCCCCCC--CCC---
Q 045256 90 SGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVS-V---------GNNHVCATTV-QGQINCWRGDVNIS--KNA--- 153 (789)
Q Consensus 90 ~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~-~---------G~~h~~al~~-~G~v~~wG~~~~~~--~~~--- 153 (789)
.++ .||.+|-... . ...-..+.....-....+. . =..|++++.. +|++|..|+..... +..
T Consensus 396 ~~~-~iyv~GG~~~-~-~~~~v~~yd~~~~~W~~~~~~~p~~~~p~~R~~hs~~~~~~~~~lyv~GG~~~~~~~~~dv~~ 472 (695)
T 2zwa_A 396 AGN-DVFYMGGSNP-Y-RVNEILQLSIHYDKIDMKNIEVSSSEVPVARMCHTFTTISRNNQLLLIGGRKAPHQGLSDNWI 472 (695)
T ss_dssp CSS-CEEEECCBSS-S-BCCCEEEEEECSSCEEEEECCCCCSCCCCCCBSCEEEEETTTTEEEEECCBSSTTCBCCCCEE
T ss_pred ECC-EEEEECCCCC-C-CcCcEEEEECCCCeEEEeccCCCCCCCCccccceEEEEEccCCEEEEEcCCCCCCCccccEEE
Confidence 778 8999997543 1 1111222222222344555 2 1358888776 99999999743322 100
Q ss_pred -CCCCccEEEEe----eeCceeEEEEeCCCeEEEeecCCCCC-cccCCCCCceeEEEee-------CCcee-EEEccC-C
Q 045256 154 -PSGELQFESLT----SGIDFSCGILTNNKTVRCWGINSISN-QIQTSFANRSMFSITA-------GGNHV-CGIDSN-G 218 (789)
Q Consensus 154 -~~~~~~v~~va----~G~~hs~al~~~~g~v~~wG~n~~gq-lg~~~~~~~~v~~i~~-------G~~h~-~al~~d-G 218 (789)
.+....+..++ .-..|+++++. +|.||++|...... +-.-+.....+..+.. -..|+ +++..+ |
T Consensus 473 yd~~t~~W~~~~~~p~~R~~h~~~~~~-~~~iyv~GG~~~~~~v~~yd~~t~~W~~~~~~g~~p~~r~~~~a~v~~~~~~ 551 (695)
T 2zwa_A 473 FDMKTREWSMIKSLSHTRFRHSACSLP-DGNVLILGGVTEGPAMLLYNVTEEIFKDVTPKDEFFQNSLVSAGLEFDPVSK 551 (695)
T ss_dssp EETTTTEEEECCCCSBCCBSCEEEECT-TSCEEEECCBCSSCSEEEEETTTTEEEECCCSSGGGGSCCBSCEEEEETTTT
T ss_pred EeCCCCcEEECCCCCCCcccceEEEEc-CCEEEEECCCCCCCCEEEEECCCCceEEccCCCCCCCcccceeEEEEeCCCC
Confidence 01111244432 23567777323 55999998532221 0001112334555553 23566 444555 8
Q ss_pred cEEEEEcCC-CC-C-CCcCC--CCCccc------eEEe-----ccCcceEEEEEeeCCeEEEeeeCCC-Cc------cc-
Q 045256 219 FVICYGDNK-SG-Q-LKFPL--NSTAFE------YSAL-----SLGFNHSCAIRRLNGSVVCWGSQGE-YS------VN- 274 (789)
Q Consensus 219 ~v~~wG~n~-~G-q-l~~~~--~~~~~~------v~~i-----~~G~~h~~al~~~dG~v~~WG~n~~-gq------~~- 274 (789)
++|.+|... .| . +..-. .+.... +..+ ..-..|++++.. +|++|..|-... +. +-
T Consensus 552 ~iyv~GG~~~~~~~~~~~v~~yd~~~~~w~~~~~W~~~~~~p~~~R~~~~~~~~~-~~~iyv~GG~~~~~~~~~~~~v~~ 630 (695)
T 2zwa_A 552 QGIILGGGFMDQTTVSDKAIIFKYDAENATEPITVIKKLQHPLFQRYGSQIKYIT-PRKLLIVGGTSPSGLFDRTNSIIS 630 (695)
T ss_dssp EEEEECCBCTTSSCBCCEEEEEEECTTCSSCCEEEEEEEECGGGCCBSCEEEEEE-TTEEEEECCBCSSCCCCTTTSEEE
T ss_pred EEEEECCcCCCCCeeeCcEEEEEccCCccccceEEEEcCCCCCCCcccceEEEeC-CCEEEEECCccCCCCCCCCCeEEE
Confidence 999998532 22 1 10000 001111 3333 334678888876 799999985321 11 00
Q ss_pred -CCCCCcEEEEEe-----------cCceEEEEeecCCeEEEecCC
Q 045256 275 -GIRGKSFESIVS-----------GSNFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 275 -~~~~~~v~~i~~-----------G~~h~~al~~~g~~v~~WG~n 307 (789)
.+.......+.. -..|++++..+| +||..|.+
T Consensus 631 yd~~t~~W~~~~~p~~~~~~~~p~~~gh~~~~~~~g-~i~v~GGg 674 (695)
T 2zwa_A 631 LDPLSETLTSIPISRRIWEDHSLMLAGFSLVSTSMG-TIHIIGGG 674 (695)
T ss_dssp EETTTTEEEECCCCHHHHHHSCCCCSSCEEECC----CEEEECCE
T ss_pred EECCCCeEEEeeccccccCCCCccceeeeEEEeCCC-EEEEEeCC
Confidence 011222332211 124887777676 89999965
|
| >3sfz_A APAF-1, apoptotic peptidase activating factor 1; apoptosis, caspase activation, cytochrome C, procaspase-9, A nucleotide, cytosol; HET: ADP; 3.00A {Mus musculus} PDB: 3shf_A* 3iyt_A* 3iza_A* | Back alignment and structure |
|---|
Probab=91.60 E-value=8.7 Score=47.68 Aligned_cols=146 Identities=8% Similarity=0.052 Sum_probs=71.0
Q ss_pred EEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeE
Q 045256 123 SVSVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMF 202 (789)
Q Consensus 123 ~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~ 202 (789)
.++....+.+.-..||.|..|--..............+..++.-.+..++....+|+|+.|-.........-......|.
T Consensus 1010 ~~s~dg~~l~s~~~dg~i~vwd~~~~~~~~~~~~~~~v~~~~~~~~~~l~~~~~dg~v~vwd~~~~~~~~~~~~~~~~v~ 1089 (1249)
T 3sfz_A 1010 QFTADGKTLISSSEDSVIQVWNWQTGDYVFLQAHQETVKDFRLLQDSRLLSWSFDGTVKVWNVITGRIERDFTCHQGTVL 1089 (1249)
T ss_dssp EECSSSSCEEEECSSSBEEEEETTTTEEECCBCCSSCEEEEEECSSSEEEEEESSSEEEEEETTTTCCCEEEECCSSCCC
T ss_pred EECCCCCEEEEEcCCCEEEEEECCCCceEEEecCCCcEEEEEEcCCCcEEEEECCCcEEEEECCCCceeEEEcccCCcEE
Confidence 33444455566678899999954322211111222346665554444455456777999997543222211111111122
Q ss_pred --EEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccC-cceEEEEEeeCCeEEEeeeCC
Q 045256 203 --SITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLG-FNHSCAIRRLNGSVVCWGSQG 269 (789)
Q Consensus 203 --~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G-~~h~~al~~~dG~v~~WG~n~ 269 (789)
.++......+.-..||+|+.|-......+..-. .....|..++-- ....++....||+|+.|-...
T Consensus 1090 ~~~~s~d~~~l~s~s~d~~v~iwd~~~~~~~~~l~-~h~~~v~~~~~s~dg~~lat~~~dg~i~vwd~~~ 1158 (1249)
T 3sfz_A 1090 SCAISSDATKFSSTSADKTAKIWSFDLLSPLHELK-GHNGCVRCSAFSLDGILLATGDDNGEIRIWNVSD 1158 (1249)
T ss_dssp CEEECSSSSSCEEECCSSCCCEECSSSSSCSBCCC-CCSSCEEEEEECSSSSEEEEEETTSCCCEEESSS
T ss_pred EEEECCCCCEEEEEcCCCcEEEEECCCcceeeeec-cCCCcEEEEEECCCCCEEEEEeCCCEEEEEECCC
Confidence 333333344555678888888544332221111 112234444332 223344444489999996543
|
| >2h62_D ACVR2B protein; TGF-beta superfamily, ligand-receptor complex, hormone/growth factor complex; 1.85A {Homo sapiens} SCOP: g.7.1.3 PDB: 1nys_A 1nyu_A 2h64_C 1s4y_A | Back alignment and structure |
|---|
Probab=91.45 E-value=0.042 Score=45.80 Aligned_cols=43 Identities=19% Similarity=0.300 Sum_probs=35.1
Q ss_pred CcccccccCCCcccCCCC-CCCCCCCCCccCCCcccccCCccccC
Q 045256 314 DSVSLVPFQQEILPGPCD-NSSCSECGLYPQSDRLCFGNGNICKS 357 (789)
Q Consensus 314 ~~~~~~~~~~~~~~~~C~-~~~c~~~~~~p~~~~~C~~~~~~C~~ 357 (789)
+.+..+++|||..+.+|. +++|.+.. .+....|||+.+++|+.
T Consensus 50 g~~~v~~qGCw~d~~~C~d~~eCv~t~-~~~~~~fCCC~gd~CN~ 93 (98)
T 2h62_D 50 GTIELVKKGCWLDDFNCYDRQECVATE-ENPQVYFCCCEGNFCNE 93 (98)
T ss_dssp TEEEEEEEEEEECCGGGTTCSSEECCC-SSCSSEEEEESSTTTTS
T ss_pred CcEEEEEEcccCCCCCCCCcceeeccC-CCCCEEEEECCCCcccc
Confidence 456788999999999994 68998765 34457899999999975
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.99 E-value=0.95 Score=43.91 Aligned_cols=93 Identities=14% Similarity=0.045 Sum_probs=51.5
Q ss_pred CchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCccc
Q 045256 579 GALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649 (789)
Q Consensus 579 gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~ 649 (789)
-+|.++|..+. .+..|.++.|.-+-....+ ..+=+-|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence 37888887554 2344444444333111111 1223456899999999988764 1110
Q ss_pred ccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCC
Q 045256 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKR 689 (789)
Q Consensus 650 ~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~ 689 (789)
.....+.|||... ...+.+.=|||||++||.-+--..
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1123567888764 345788999999999999986443
|
| >1gxr_A ESG1, transducin-like enhancer protein 1; transcriptional CO-repressor, WD40, transcription repressor, WD repeat; 1.65A {Homo sapiens} SCOP: b.69.4.1 PDB: 2ce8_A 2ce9_A | Back alignment and structure |
|---|
Probab=90.84 E-value=15 Score=37.04 Aligned_cols=190 Identities=11% Similarity=0.015 Sum_probs=88.1
Q ss_pred CcEEEEEec--CceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEE--ecCCeEEEEeeCCeEEEcCCCCC
Q 045256 73 ISFSSISAG--QSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVS--VGNNHVCATTVQGQINCWRGDVN 148 (789)
Q Consensus 73 ~~v~~i~~G--~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~--~G~~h~~al~~~G~v~~wG~~~~ 148 (789)
..|..++-- +..-+.-..|| +|..|-..... ..+..........+..++ ....+.+.-..||.|+.|--...
T Consensus 98 ~~v~~~~~~~~~~~l~~~~~d~-~i~~~d~~~~~---~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~~dg~v~~~d~~~~ 173 (337)
T 1gxr_A 98 NYIRSCKLLPDGCTLIVGGEAS-TLSIWDLAAPT---PRIKAELTSSAPACYALAISPDSKVCFSCCSDGNIAVWDLHNQ 173 (337)
T ss_dssp SBEEEEEECTTSSEEEEEESSS-EEEEEECCCC-----EEEEEEECSSSCEEEEEECTTSSEEEEEETTSCEEEEETTTT
T ss_pred CcEEEEEEcCCCCEEEEEcCCC-cEEEEECCCCC---cceeeecccCCCceEEEEECCCCCEEEEEeCCCcEEEEeCCCC
Confidence 345555543 23344445678 89888544211 111111111222233444 34455666678899999954322
Q ss_pred CCCCC-CCCCccEEEEeee-CceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEee--CCceeEEEccCCcEEEEE
Q 045256 149 ISKNA-PSGELQFESLTSG-IDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITA--GGNHVCGIDSNGFVICYG 224 (789)
Q Consensus 149 ~~~~~-~~~~~~v~~va~G-~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG 224 (789)
..... ......+..++.- ....++....+|.|+.|-......+.. ......+..++. .....++-..||.|+.|-
T Consensus 174 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~~dg~i~~~d~~~~~~~~~-~~~~~~v~~~~~s~~~~~l~~~~~~~~i~~~~ 252 (337)
T 1gxr_A 174 TLVRQFQGHTDGASCIDISNDGTKLWTGGLDNTVRSWDLREGRQLQQ-HDFTSQIFSLGYCPTGEWLAVGMESSNVEVLH 252 (337)
T ss_dssp EEEEEECCCSSCEEEEEECTTSSEEEEEETTSEEEEEETTTTEEEEE-EECSSCEEEEEECTTSSEEEEEETTSCEEEEE
T ss_pred ceeeeeecccCceEEEEECCCCCEEEEEecCCcEEEEECCCCceEee-ecCCCceEEEEECCCCCEEEEEcCCCcEEEEE
Confidence 11111 1111245555543 223344456777999996443221111 111222333332 233444445677777775
Q ss_pred cCCCCCCCcCCCCCccceEEeccC--cceEEEEEeeCCeEEEeeeCCC
Q 045256 225 DNKSGQLKFPLNSTAFEYSALSLG--FNHSCAIRRLNGSVVCWGSQGE 270 (789)
Q Consensus 225 ~n~~Gql~~~~~~~~~~v~~i~~G--~~h~~al~~~dG~v~~WG~n~~ 270 (789)
.......... .....+..++-- ..+-+.... ||.|..|-....
T Consensus 253 ~~~~~~~~~~--~~~~~v~~~~~~~~~~~l~~~~~-dg~i~~~~~~~~ 297 (337)
T 1gxr_A 253 VNKPDKYQLH--LHESCVLSLKFAYCGKWFVSTGK-DNLLNAWRTPYG 297 (337)
T ss_dssp TTSSCEEEEC--CCSSCEEEEEECTTSSEEEEEET-TSEEEEEETTTC
T ss_pred CCCCCeEEEc--CCccceeEEEECCCCCEEEEecC-CCcEEEEECCCC
Confidence 4332211111 112234444332 334444444 899999976543
|
| >1pgu_A Actin interacting protein 1; WD repeat, seven-bladed beta-propeller, protein binding; 2.30A {Saccharomyces cerevisiae} SCOP: b.69.4.1 b.69.4.1 PDB: 1pi6_A | Back alignment and structure |
|---|
Probab=90.78 E-value=24 Score=39.29 Aligned_cols=239 Identities=8% Similarity=0.080 Sum_probs=114.9
Q ss_pred eecCCCcEEEeeCCc--cccc--CCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEe
Q 045256 51 AAQPTQRLLCYQGGT--IRAV--EPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSV 126 (789)
Q Consensus 51 ~l~~~g~v~~wG~~~--~~~~--~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~ 126 (789)
+...||++..|-... +... .....|..++. .. .+.-..|| +|..|-.. +.. ....-.|..++.
T Consensus 314 ~~~~~g~i~~~d~~~~~~~~~~~~~~~~v~~~~~-~~-l~~~~~dg-~i~~w~~~--------~~~--~~~~~~v~~~~~ 380 (615)
T 1pgu_A 314 SLSLDGTLNFYELGHDEVLKTISGHNKGITALTV-NP-LISGSYDG-RIMEWSSS--------SMH--QDHSNLIVSLDN 380 (615)
T ss_dssp EEETTSCEEEEETTEEEEEEEECCCSSCEEEEET-TT-TEEEETTS-CEEETTTT--------EEE--CCCCSCEEEEEC
T ss_pred EEECCCCEEEEECCCCcEEEEEeCCCCCEEEEEe-cC-cEEECCCC-eEEEEEch--------hhc--CcccCceEEEEE
Confidence 556788888886522 2211 22346777777 55 55556788 99999543 111 111223444444
Q ss_pred c-CCeEEEEeeCCeEEEcCCCCC---------------------------------CCC-CCCCCCccEEEEeeeCceeE
Q 045256 127 G-NNHVCATTVQGQINCWRGDVN---------------------------------ISK-NAPSGELQFESLTSGIDFSC 171 (789)
Q Consensus 127 G-~~h~~al~~~G~v~~wG~~~~---------------------------------~~~-~~~~~~~~v~~va~G~~hs~ 171 (789)
- ..+.+....||.+..|--... ++. ........+..++.. ...+
T Consensus 381 ~~~~~l~~~~~d~~i~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l 459 (615)
T 1pgu_A 381 SKAQEYSSISWDDTLKVNGITKHEFGSQPKVASANNDGFTAVLTNDDDLLILQSFTGDIIKSVRLNSPGSAVSLS-QNYV 459 (615)
T ss_dssp CSTTCCEEEETTTEEEETTEEEEECSSCEEEEEECSSSEEEEEETTSEEEEEETTTCCEEEEEECSSCEEEEEEC-SSEE
T ss_pred CCCcEEEEEeCCCCEEEEEcccCcccCCceEEEEcCCCCEEEEeCCCceEEEeccCCceeeecccCCCceEEEEc-CCEE
Confidence 2 234444566677777742110 000 000011123344333 2233
Q ss_pred EEEeC-CCeEEEeecCCCCCc--ccCCCCCceeEEEee--CCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEec
Q 045256 172 GILTN-NKTVRCWGINSISNQ--IQTSFANRSMFSITA--GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALS 246 (789)
Q Consensus 172 al~~~-~g~v~~wG~n~~gql--g~~~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~ 246 (789)
+.... +|.|+.|-.... ++ .........|..++. ...+.+.-..||.|+.|--...-.+..........|..++
T Consensus 460 ~~~~~~d~~i~~~~~~~~-~~~~~~~~~~~~~v~~~~~s~~g~~l~~~~~dg~i~iw~~~~~~~~~~~~~~h~~~v~~~~ 538 (615)
T 1pgu_A 460 AVGLEEGNTIQVFKLSDL-EVSFDLKTPLRAKPSYISISPSETYIAAGDVMGKILLYDLQSREVKTSRWAFRTSKINAIS 538 (615)
T ss_dssp EEEETTTSCEEEEETTEE-EEEEECSSCCSSCEEEEEECTTSSEEEEEETTSCEEEEETTTTEEEECCSCCCSSCEEEEE
T ss_pred EEeecCCCeEEEEECCCc-cccccccCCccCceEEEEECCCCCEEEEcCCCCeEEEeeCCCCcceeEeecCCCCceeEEE
Confidence 43455 779999965431 11 111112233555544 4445555678899999965442222111110223455554
Q ss_pred cC-----------cceEEEEEeeCCeEEEeeeCCCCc-ccCC--CCCcEEEEEecCceEEEE-eecCCeEEEec
Q 045256 247 LG-----------FNHSCAIRRLNGSVVCWGSQGEYS-VNGI--RGKSFESIVSGSNFTCGL-TTSNFSVICWG 305 (789)
Q Consensus 247 ~G-----------~~h~~al~~~dG~v~~WG~n~~gq-~~~~--~~~~v~~i~~G~~h~~al-~~~g~~v~~WG 305 (789)
-- ....++....||.|+.|=....++ +... ....|..++--....++. ..|| .|..|=
T Consensus 539 ~sp~~~~~~~~~~~~~~l~~~~~dg~i~iw~~~~~~~~~~~~~~h~~~v~~l~~s~~~~l~s~~~d~-~v~iw~ 611 (615)
T 1pgu_A 539 WKPAEKGANEEEIEEDLVATGSLDTNIFIYSVKRPMKIIKALNAHKDGVNNLLWETPSTLVSSGADA-CIKRWN 611 (615)
T ss_dssp ECCCC------CCSCCEEEEEETTSCEEEEESSCTTCCEEETTSSTTCEEEEEEEETTEEEEEETTS-CEEEEE
T ss_pred EcCccccccccccCCCEEEEEcCCCcEEEEECCCCceechhhhcCccceEEEEEcCCCCeEEecCCc-eEEEEe
Confidence 42 233444444499999998766533 2111 133455543222111333 3344 777774
|
| >3vl1_A 26S proteasome regulatory subunit RPN14; beta-propeller, chaperone, RPT6; 1.60A {Saccharomyces cerevisiae} PDB: 3acp_A | Back alignment and structure |
|---|
Probab=90.50 E-value=19 Score=37.81 Aligned_cols=260 Identities=10% Similarity=0.027 Sum_probs=120.6
Q ss_pred EEEecCceeeeeeeecCCCcEEEeeCCc--ccccCCCCcEEEEEe---cCceEEEEEeCCceEEEccCCCCCCCCCccee
Q 045256 38 AVSYGSATVCAVVAAQPTQRLLCYQGGT--IRAVEPNISFSSISA---GQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKR 112 (789)
Q Consensus 38 ~i~~G~~h~~~~~~l~~~g~v~~wG~~~--~~~~~~~~~v~~i~~---G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~ 112 (789)
+.+--+.+.+ ....||+++-|-... .........+..+.+ .+..-+.-..|| .|..|-... ..+..
T Consensus 63 ~~s~~g~~l~---~~~~d~~v~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~dg-~i~iwd~~~-----~~~~~ 133 (420)
T 3vl1_A 63 TFEKVGSHLY---KARLDGHDFLFNTIIRDGSKMLKRADYTAVDTAKLQMRRFILGTTEG-DIKVLDSNF-----NLQRE 133 (420)
T ss_dssp EEEEEETTEE---EEEETTEEEEEECCSEETTTTSCSCCEEEEEEECSSSCEEEEEETTS-CEEEECTTS-----CEEEE
T ss_pred eeeecCCeEE---EEEcCCcEEEEEecccceeeEEecCCceEEEEEecCCCEEEEEECCC-CEEEEeCCC-----cceee
Confidence 3344444444 445688888886622 222222234444332 333444446788 899995332 11222
Q ss_pred eeeCCcceEEEEEe--cCCeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeeeCc-eeEEEEeCCCeEEEeecCCC
Q 045256 113 IYYNDTVLLSSVSV--GNNHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSGID-FSCGILTNNKTVRCWGINSI 188 (789)
Q Consensus 113 v~~~~~~~i~~v~~--G~~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G~~-hs~al~~~~g~v~~wG~n~~ 188 (789)
......-.|..++. ...+.+.-..||+|..|--........ ..-...|..++.-.+ ..++....+|+|..|-....
T Consensus 134 ~~~~h~~~v~~~~~~~~~~~l~s~s~d~~i~iwd~~~~~~~~~~~~h~~~v~~~~~~~~~~~l~s~~~d~~v~iwd~~~~ 213 (420)
T 3vl1_A 134 IDQAHVSEITKLKFFPSGEALISSSQDMQLKIWSVKDGSNPRTLIGHRATVTDIAIIDRGRNVLSASLDGTIRLWECGTG 213 (420)
T ss_dssp ETTSSSSCEEEEEECTTSSEEEEEETTSEEEEEETTTCCCCEEEECCSSCEEEEEEETTTTEEEEEETTSCEEEEETTTT
T ss_pred ecccccCccEEEEECCCCCEEEEEeCCCeEEEEeCCCCcCceEEcCCCCcEEEEEEcCCCCEEEEEcCCCcEEEeECCCC
Confidence 21112223445543 344566667899999995432222111 111123555544322 22333456779999964322
Q ss_pred CCcccCC---CCCceeEEEee-----------------------CCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccce
Q 045256 189 SNQIQTS---FANRSMFSITA-----------------------GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEY 242 (789)
Q Consensus 189 gqlg~~~---~~~~~v~~i~~-----------------------G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v 242 (789)
..+..-. .....+..++. -..+.++-..||.|..|=-....++..........+
T Consensus 214 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~v~~~~~s~~~~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~~v 293 (420)
T 3vl1_A 214 TTIHTFNRKENPHDGVNSIALFVGTDRQLHEISTSKKNNLEFGTYGKYVIAGHVSGVITVHNVFSKEQTIQLPSKFTCSC 293 (420)
T ss_dssp EEEEEECBTTBTTCCEEEEEEEECCCSSCGGGCCCCCCTTCSSCTTEEEEEEETTSCEEEEETTTCCEEEEECCTTSSCE
T ss_pred ceeEEeecCCCCCCCccEEEEecCCcceeeecccCcccceEEcCCCCEEEEEcCCCeEEEEECCCCceeEEcccccCCCc
Confidence 1111000 01112222221 122344446778888885433222211111112235
Q ss_pred EEeccC--cc-eEEEEEeeCCeEEEeeeCCCCc----ccCCCCCcEEEEEecCceEEEEeecCCeEEEecCC
Q 045256 243 SALSLG--FN-HSCAIRRLNGSVVCWGSQGEYS----VNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 243 ~~i~~G--~~-h~~al~~~dG~v~~WG~n~~gq----~~~~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~n 307 (789)
..++.- .. .-++-.. ||.|+.|=.....+ +.......+..+.......++.....++|..|=-.
T Consensus 294 ~~~~~~~~~~~~l~~g~~-dg~i~vwd~~~~~~~~~~~~~~~~~~v~~~~~~~~~~l~s~~~d~~v~iw~~~ 364 (420)
T 3vl1_A 294 NSLTVDGNNANYIYAGYE-NGMLAQWDLRSPECPVGEFLINEGTPINNVYFAAGALFVSSGFDTSIKLDIIS 364 (420)
T ss_dssp EEEEECSSCTTEEEEEET-TSEEEEEETTCTTSCSEEEEESTTSCEEEEEEETTEEEEEETTTEEEEEEEEC
T ss_pred eeEEEeCCCCCEEEEEeC-CCeEEEEEcCCCcCchhhhhccCCCCceEEEeCCCCEEEEecCCccEEEEecc
Confidence 554433 22 3344444 89999996554333 22123345665655544444444333388888643
|
| >3k26_A Polycomb protein EED; WD40, structural genomics, NPPSFA, national project on prote structural and functional analysis, structural genomics CON SGC; HET: M3L; 1.58A {Homo sapiens} PDB: 3jzn_A* 3k27_A* 3jpx_A* 3jzg_A* 3jzh_A* 3iiw_A* 3ijc_A* 3iiy_A* 3ij0_A* 3ij1_A* 2qxv_A | Back alignment and structure |
|---|
Probab=90.04 E-value=18 Score=36.84 Aligned_cols=215 Identities=10% Similarity=0.106 Sum_probs=102.5
Q ss_pred eEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEe---cCCeEEEEeeCCeEEEcCCCCCCCCCC----CCC
Q 045256 84 FFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSV---GNNHVCATTVQGQINCWRGDVNISKNA----PSG 156 (789)
Q Consensus 84 ~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~---G~~h~~al~~~G~v~~wG~~~~~~~~~----~~~ 156 (789)
.-+.-..|| +|..|-... ......+. ...-.|..++. .....+.-..||.|+.|--........ ...
T Consensus 87 ~l~~~~~dg-~i~v~d~~~----~~~~~~~~-~~~~~i~~~~~~~~~~~~l~s~~~dg~i~iwd~~~~~~~~~~~~~~~~ 160 (366)
T 3k26_A 87 LLAVAGSRG-IIRIINPIT----MQCIKHYV-GHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGH 160 (366)
T ss_dssp EEEEEETTC-EEEEECTTT----CCEEEEEE-SCCSCEEEEEECSSCTTEEEEEETTSCEEEEETTTTEEEEEECSTTSC
T ss_pred EEEEecCCC-EEEEEEchh----ceEeeeec-CCCCcEEEEEECCCCCCEEEEEeCCCeEEEEEeecCeEEEEecccccc
Confidence 344446788 888885442 11111222 12223445554 445566667899999996432221111 112
Q ss_pred CccEEEEeeeC-ceeEEEEeCCCeEEEeecCCCCCcccC----------------------------CCCCceeEEEeeC
Q 045256 157 ELQFESLTSGI-DFSCGILTNNKTVRCWGINSISNQIQT----------------------------SFANRSMFSITAG 207 (789)
Q Consensus 157 ~~~v~~va~G~-~hs~al~~~~g~v~~wG~n~~gqlg~~----------------------------~~~~~~v~~i~~G 207 (789)
...|..++.-. ...++....+|.|+.|-......+... ......|..++--
T Consensus 161 ~~~v~~~~~~~~~~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~ 240 (366)
T 3k26_A 161 RDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWL 240 (366)
T ss_dssp SSCEEEEEECTTSSEEEEEETTSCEEEEESCSHHHHHHHHHHHTCCGGGCSSCCCCEEECCCSEEECSSCSSCCCEEEEE
T ss_pred cCceeEEEECCCCCEEEEecCCCCEEEEECCCCccccccceeEEecCCCCcccccceeeccCccccccCCcceEEEEEEc
Confidence 23466665432 223443556779999964321111000 0011223344333
Q ss_pred CceeEEEccCCcEEEEEcCCCCCCCcCCCCC-------------ccceEEeccCc---ceEEEEEeeCCeEEEeeeCCCC
Q 045256 208 GNHVCGIDSNGFVICYGDNKSGQLKFPLNST-------------AFEYSALSLGF---NHSCAIRRLNGSVVCWGSQGEY 271 (789)
Q Consensus 208 ~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~-------------~~~v~~i~~G~---~h~~al~~~dG~v~~WG~n~~g 271 (789)
....+.-..||.|..|--....+........ ...|..++... ...++....||.|+.|-.....
T Consensus 241 ~~~l~~~~~d~~i~~wd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~s~~~~~~~l~~~~~dg~i~vwd~~~~~ 320 (366)
T 3k26_A 241 GDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVED 320 (366)
T ss_dssp TTEEEEECSSSEEEEEEESSTTCCGGGCCTTCCCEEEEEEEECSSCCSSCCCCEECTTSSEEEEECTTSCEEEEECCSSS
T ss_pred CCEEEEEecCCEEEEEeCCCccccccccccCCcchheeccccccCCcEEEEEEcCCCCCcEEEEEecCCcEEEEECCCCC
Confidence 4566666789999999765443311000000 00122222211 2233333338999999765432
Q ss_pred cc-------cCCC-CCcEEEEEec--CceEEEEeecCCeEEEec
Q 045256 272 SV-------NGIR-GKSFESIVSG--SNFTCGLTTSNFSVICWG 305 (789)
Q Consensus 272 q~-------~~~~-~~~v~~i~~G--~~h~~al~~~g~~v~~WG 305 (789)
.. .... ...|..++-- +.+-+.-..|| .|+.|=
T Consensus 321 ~~~~~~~~~~~~~~~~~v~~~~~s~~~~~l~s~~~dg-~i~iwd 363 (366)
T 3k26_A 321 PHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDA-SIWRWD 363 (366)
T ss_dssp GGGCEEEEECCTTCCSCEEEEEECTTSSEEEEEETTS-EEEEEE
T ss_pred CccccceEEcccccCCceEEEEeCCCCCeEEEEeCCC-EEEEEE
Confidence 21 1111 3456666543 33344444455 888884
|
| >3i2n_A WD repeat-containing protein 92; WD40 repeats, structural genomics, structural genomic consortium, SGC, apoptosis, transcription; 1.95A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.90 E-value=18 Score=36.69 Aligned_cols=172 Identities=9% Similarity=-0.031 Sum_probs=83.7
Q ss_pred ecCCCcEEEeeCC--c-ccccC--CCCcEEEEE--------ecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCC-
Q 045256 52 AQPTQRLLCYQGG--T-IRAVE--PNISFSSIS--------AGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYND- 117 (789)
Q Consensus 52 l~~~g~v~~wG~~--~-~~~~~--~~~~v~~i~--------~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~- 117 (789)
-..||+|..|-.. . +.... ....|..+. ..+.+-+.-..|| +|..|-...... ....+....
T Consensus 86 ~~~dg~i~iwd~~~~~~~~~~~~~~~~~v~~~~~~~~~~~s~~~~~l~~~~~d~-~i~vwd~~~~~~---~~~~~~~~~~ 161 (357)
T 3i2n_A 86 GDFGGNLHIWNLEAPEMPVYSVKGHKEIINAIDGIGGLGIGEGAPEIVTGSRDG-TVKVWDPRQKDD---PVANMEPVQG 161 (357)
T ss_dssp EETTSCEEEECTTSCSSCSEEECCCSSCEEEEEEESGGGCC-CCCEEEEEETTS-CEEEECTTSCSS---CSEEECCCTT
T ss_pred ecCCCeEEEEeCCCCCccEEEEEecccceEEEeeccccccCCCccEEEEEeCCC-eEEEEeCCCCCC---cceeccccCC
Confidence 3557777777542 2 22221 233466663 2333555556788 999995543211 111111111
Q ss_pred --cceEEEEE------ecCCeEEEEeeCCeEEEcCCCCCCCCCCCCCCccEEEEeee----CceeEEEEeCCCeEEEeec
Q 045256 118 --TVLLSSVS------VGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSG----IDFSCGILTNNKTVRCWGI 185 (789)
Q Consensus 118 --~~~i~~v~------~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~~~v~~va~G----~~hs~al~~~~g~v~~wG~ 185 (789)
...+..++ ....+.++-..||.|+.|--..............+..++.- ....++.-..+|.|+.|-.
T Consensus 162 ~~~~~v~~~~~~~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~l~~~~~dg~i~i~d~ 241 (357)
T 3i2n_A 162 ENKRDCWTVAFGNAYNQEERVVCAGYDNGDIKLFDLRNMALRWETNIKNGVCSLEFDRKDISMNKLVATSLEGKFHVFDM 241 (357)
T ss_dssp SCCCCEEEEEEECCCC-CCCEEEEEETTSEEEEEETTTTEEEEEEECSSCEEEEEESCSSSSCCEEEEEESTTEEEEEEE
T ss_pred CCCCceEEEEEEeccCCCCCEEEEEccCCeEEEEECccCceeeecCCCCceEEEEcCCCCCCCCEEEEECCCCeEEEEeC
Confidence 11344555 34455556677899999954322211111111245555543 2333444567779999965
Q ss_pred CCCCCcccCC-----CCCceeEEEeeCCc---eeEEEccCCcEEEEEcCC
Q 045256 186 NSISNQIQTS-----FANRSMFSITAGGN---HVCGIDSNGFVICYGDNK 227 (789)
Q Consensus 186 n~~gqlg~~~-----~~~~~v~~i~~G~~---h~~al~~dG~v~~wG~n~ 227 (789)
.....+.... .....|..++.-.. ..+.-..||.|..|=-..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~l~~~~~dg~i~iwd~~~ 291 (357)
T 3i2n_A 242 RTQHPTKGFASVSEKAHKSTVWQVRHLPQNRELFLTAGGAGGLHLWKYEY 291 (357)
T ss_dssp EEEETTTEEEEEEEECCSSCEEEEEEETTEEEEEEEEETTSEEEEEEEEC
T ss_pred cCCCcccceeeeccCCCcCCEEEEEECCCCCcEEEEEeCCCcEEEeecCC
Confidence 4322211100 12233555544332 344456789999996543
|
| >2z2n_A Virginiamycin B lyase; seven-bladed beta-propeller, antibiotic resistance, E mechanism, virginiamycin B hydrolase streptogramin; HET: MSE; 1.65A {Staphylococcus aureus} PDB: 2z2o_A 2z2p_A* | Back alignment and structure |
|---|
Probab=89.83 E-value=16 Score=36.03 Aligned_cols=89 Identities=3% Similarity=-0.128 Sum_probs=42.6
Q ss_pred eeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEe--cc--CcceEEEEEeeCCeEEEeeeCCCCcccCC-CCCcEEEE
Q 045256 210 HVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSAL--SL--GFNHSCAIRRLNGSVVCWGSQGEYSVNGI-RGKSFESI 284 (789)
Q Consensus 210 h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i--~~--G~~h~~al~~~dG~v~~WG~n~~gq~~~~-~~~~v~~i 284 (789)
+.++++.+|.+|.-... .+++..-.. ...+..+ .. ..-+.+++.. +|.+|.-..+ .+.+... ....+..+
T Consensus 186 ~~i~~~~~g~l~v~~~~-~~~i~~~~~--~g~~~~~~~~~~~~~~~~i~~~~-~g~l~v~~~~-~~~i~~~d~~g~~~~~ 260 (299)
T 2z2n_A 186 VGITKGNDDALWFVEII-GNKIGRITT--SGEITEFKIPTPNARPHAITAGA-GIDLWFTEWG-ANKIGRLTSNNIIEEY 260 (299)
T ss_dssp EEEEECTTSSEEEEETT-TTEEEEECT--TCCEEEEECSSTTCCEEEEEECS-TTCEEEEETT-TTEEEEEETTTEEEEE
T ss_pred eeEEECCCCCEEEEccC-CceEEEECC--CCcEEEEECCCCCCCceeEEECC-CCCEEEeccC-CceEEEECCCCceEEE
Confidence 45777888888765432 233311111 1112222 11 2345667766 8888865433 2332111 12344444
Q ss_pred E--e--cCceEEEEeecCCeEEEec
Q 045256 285 V--S--GSNFTCGLTTSNFSVICWG 305 (789)
Q Consensus 285 ~--~--G~~h~~al~~~g~~v~~WG 305 (789)
. . ..-+.+++ .+| ++|.=.
T Consensus 261 ~~~~~~~~~~~i~~-~~g-~l~v~~ 283 (299)
T 2z2n_A 261 PIQIKSAEPHGICF-DGE-TIWFAM 283 (299)
T ss_dssp ECSSSSCCEEEEEE-CSS-CEEEEE
T ss_pred eCCCCCCccceEEe-cCC-CEEEEe
Confidence 3 2 22355666 666 888744
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.67 E-value=0.13 Score=35.85 Aligned_cols=23 Identities=17% Similarity=0.047 Sum_probs=10.0
Q ss_pred hhhhHHHHHHHHHHHHHhhheee
Q 045256 389 LLAFAIVGSVGGFAGICTVIYCV 411 (789)
Q Consensus 389 ~i~~iiv~~v~~~~~l~~l~~~~ 411 (789)
.++..+++.++++++++++++++
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~ 34 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLF 34 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHH
T ss_pred eEEeehhHHHHHHHHHHHHHHHH
Confidence 34444554444444444333333
|
| >4aez_A CDC20, WD repeat-containing protein SLP1; cell cycle, KEN-BOX, D-BOX, APC/C; 2.30A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=89.55 E-value=23 Score=37.26 Aligned_cols=184 Identities=8% Similarity=0.110 Sum_probs=92.9
Q ss_pred EEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEE--ecCCeEEEEeeCCeEEEcCCCCCCCCCC-C
Q 045256 78 ISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVS--VGNNHVCATTVQGQINCWRGDVNISKNA-P 154 (789)
Q Consensus 78 i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~--~G~~h~~al~~~G~v~~wG~~~~~~~~~-~ 154 (789)
++-...+.++...|| +|+.|-... ......+.......|..++ ....+.++-..||.|..|--........ .
T Consensus 99 ~~~s~~~l~~~~~d~-~v~lw~~~~----~~~~~~~~~~~~~~v~~v~~s~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~ 173 (401)
T 4aez_A 99 LDWSNLNVVAVALER-NVYVWNADS----GSVSALAETDESTYVASVKWSHDGSFLSVGLGNGLVDIYDVESQTKLRTMA 173 (401)
T ss_dssp EEECTTSEEEEEETT-EEEEEETTT----CCEEEEEECCTTCCEEEEEECTTSSEEEEEETTSCEEEEETTTCCEEEEEC
T ss_pred EeecCCCEEEEECCC-eEEEeeCCC----CcEeEeeecCCCCCEEEEEECCCCCEEEEECCCCeEEEEECcCCeEEEEec
Confidence 554556778888999 999996543 1122222221222344444 3445666667799999995432222111 1
Q ss_pred CCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcc-cCCCCCceeEEEee--CCceeEEEccCCcEEEEEcCCCCCC
Q 045256 155 SGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQI-QTSFANRSMFSITA--GGNHVCGIDSNGFVICYGDNKSGQL 231 (789)
Q Consensus 155 ~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg-~~~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~n~~Gql 231 (789)
.....|..++... +.++.-..+|.|+.|-....+... ........|..++. ...+.+.-..||.|..|-... ++.
T Consensus 174 ~~~~~v~~~~~~~-~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~s~~~d~~v~iwd~~~-~~~ 251 (401)
T 4aez_A 174 GHQARVGCLSWNR-HVLSSGSRSGAIHHHDVRIANHQIGTLQGHSSEVCGLAWRSDGLQLASGGNDNVVQIWDARS-SIP 251 (401)
T ss_dssp CCSSCEEEEEEET-TEEEEEETTSEEEEEETTSSSCEEEEEECCSSCEEEEEECTTSSEEEEEETTSCEEEEETTC-SSE
T ss_pred CCCCceEEEEECC-CEEEEEcCCCCEEEEecccCcceeeEEcCCCCCeeEEEEcCCCCEEEEEeCCCeEEEccCCC-CCc
Confidence 1123466676643 445546778899999755322221 11112223444443 233444456789999996543 222
Q ss_pred CcCCCCCccceEEecc--CcceEEEEEe--eCCeEEEeeeC
Q 045256 232 KFPLNSTAFEYSALSL--GFNHSCAIRR--LNGSVVCWGSQ 268 (789)
Q Consensus 232 ~~~~~~~~~~v~~i~~--G~~h~~al~~--~dG~v~~WG~n 268 (789)
..........|..++- ...+-++... .||.|..|=..
T Consensus 252 ~~~~~~~~~~v~~~~~~p~~~~ll~~~~gs~d~~i~i~d~~ 292 (401)
T 4aez_A 252 KFTKTNHNAAVKAVAWCPWQSNLLATGGGTMDKQIHFWNAA 292 (401)
T ss_dssp EEEECCCSSCCCEEEECTTSTTEEEEECCTTTCEEEEEETT
T ss_pred cEEecCCcceEEEEEECCCCCCEEEEecCCCCCEEEEEECC
Confidence 1100111122333332 2233333321 28999999654
|
| >2iwa_A Glutamine cyclotransferase; pyroglutamate, acyltransferase, glutaminyl CYCL N-terminal cyclisation; HET: NAG; 1.6A {Carica papaya} PDB: 2faw_A* | Back alignment and structure |
|---|
Probab=89.43 E-value=5.7 Score=39.95 Aligned_cols=185 Identities=12% Similarity=0.031 Sum_probs=97.1
Q ss_pred EEEEEecCC---eEEEEeeCCeEEEcCCC-CCCCC---CCCCCCccEEEEeeeC-ceeEEEEeCCCeEEEeecCCCCCcc
Q 045256 121 LSSVSVGNN---HVCATTVQGQINCWRGD-VNISK---NAPSGELQFESLTSGI-DFSCGILTNNKTVRCWGINSISNQI 192 (789)
Q Consensus 121 i~~v~~G~~---h~~al~~~G~v~~wG~~-~~~~~---~~~~~~~~v~~va~G~-~hs~al~~~~g~v~~wG~n~~gqlg 192 (789)
+..+..|.. |-+++..||.||.--+. ....+ ..... .-+..+..+. .|..++.-+++++|.-.... +..-
T Consensus 12 v~~~p~~~~~f~~Gl~~~~dg~Lyvstg~~~~s~v~~iD~~tg-~v~~~i~l~~~~fgeGi~~~g~~lyv~t~~~-~~v~ 89 (266)
T 2iwa_A 12 LNEFPHDPYAFTQGLVYAENDTLFESTGLYGRSSVRQVALQTG-KVENIHKMDDSYFGEGLTLLNEKLYQVVWLK-NIGF 89 (266)
T ss_dssp EEEEECCTTCCEEEEEECSTTEEEEEECSTTTCEEEEEETTTC-CEEEEEECCTTCCEEEEEEETTEEEEEETTC-SEEE
T ss_pred EEEEECCCCCCcccEEEeCCCeEEEECCCCCCCEEEEEECCCC-CEEEEEecCCCcceEEEEEeCCEEEEEEecC-CEEE
Confidence 457777754 78899888999985321 11122 11111 1233444333 23333333445787754321 1221
Q ss_pred c-CCCCCceeEEEeeCCceeEEEccCC-cEEEEEcCCCCCCCcCCCCCccceEEeccCcc-------eEEEEEeeCCeEE
Q 045256 193 Q-TSFANRSMFSITAGGNHVCGIDSNG-FVICYGDNKSGQLKFPLNSTAFEYSALSLGFN-------HSCAIRRLNGSVV 263 (789)
Q Consensus 193 ~-~~~~~~~v~~i~~G~~h~~al~~dG-~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~-------h~~al~~~dG~v~ 263 (789)
. .....+.+..|..|..+-.+|+.|| ++|.- |..+++..-......-+..|..|.+ .-+.. . ||++|
T Consensus 90 viD~~t~~v~~~i~~g~~~g~glt~Dg~~l~vs--~gs~~l~viD~~t~~v~~~I~Vg~~~~p~~~~nele~-~-dg~ly 165 (266)
T 2iwa_A 90 IYDRRTLSNIKNFTHQMKDGWGLATDGKILYGS--DGTSILYEIDPHTFKLIKKHNVKYNGHRVIRLNELEY-I-NGEVW 165 (266)
T ss_dssp EEETTTTEEEEEEECCSSSCCEEEECSSSEEEE--CSSSEEEEECTTTCCEEEEEECEETTEECCCEEEEEE-E-TTEEE
T ss_pred EEECCCCcEEEEEECCCCCeEEEEECCCEEEEE--CCCCeEEEEECCCCcEEEEEEECCCCcccccceeEEE-E-CCEEE
Confidence 1 1123344667777623346677665 57753 4455653322223344566666642 12233 3 78887
Q ss_pred E--eeeCCCCcccCCCCCcEEEEEecC---------------ceEEEEeecCCeEEEecCCCCCC
Q 045256 264 C--WGSQGEYSVNGIRGKSFESIVSGS---------------NFTCGLTTSNFSVICWGPGWPNV 311 (789)
Q Consensus 264 ~--WG~n~~gq~~~~~~~~v~~i~~G~---------------~h~~al~~~g~~v~~WG~n~~~~ 311 (789)
+ |..|.--.+....+.-+..|..++ -+.+|++.++.++|+=|.+|...
T Consensus 166 vn~~~~~~V~vID~~tg~V~~~I~~~g~~~~~~~~~~~~~~v~nGIa~~~~~~~lfVTgk~~~~v 230 (266)
T 2iwa_A 166 ANIWQTDCIARISAKDGTLLGWILLPNLRKKLIDEGFRDIDVLNGIAWDQENKRIFVTGKLWPKL 230 (266)
T ss_dssp EEETTSSEEEEEETTTCCEEEEEECHHHHHHHHHTTCTTCCCEEEEEEETTTTEEEEEETTCSEE
T ss_pred EecCCCCeEEEEECCCCcEEEEEECCCcccccccccccccCceEEEEEcCCCCEEEEECCCCCeE
Confidence 3 332222224444555567777652 27889988877999999887653
|
| >3sfz_A APAF-1, apoptotic peptidase activating factor 1; apoptosis, caspase activation, cytochrome C, procaspase-9, A nucleotide, cytosol; HET: ADP; 3.00A {Mus musculus} PDB: 3shf_A* 3iyt_A* 3iza_A* | Back alignment and structure |
|---|
Probab=89.32 E-value=26 Score=43.25 Aligned_cols=213 Identities=9% Similarity=0.078 Sum_probs=94.9
Q ss_pred ceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEe-cCCeEEEEeeCCeEEEcCCCCCCCCCCC-CCCccE
Q 045256 83 SFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSV-GNNHVCATTVQGQINCWRGDVNISKNAP-SGELQF 160 (789)
Q Consensus 83 ~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~-G~~h~~al~~~G~v~~wG~~~~~~~~~~-~~~~~v 160 (789)
.+-+.-..|| +|..|-.... + ...+.. ....+..++. .....++...||+|+.|--......... .....|
T Consensus 1016 ~~l~s~~~dg-~i~vwd~~~~-~----~~~~~~-~~~~v~~~~~~~~~~l~~~~~dg~v~vwd~~~~~~~~~~~~~~~~v 1088 (1249)
T 3sfz_A 1016 KTLISSSEDS-VIQVWNWQTG-D----YVFLQA-HQETVKDFRLLQDSRLLSWSFDGTVKVWNVITGRIERDFTCHQGTV 1088 (1249)
T ss_dssp SCEEEECSSS-BEEEEETTTT-E----EECCBC-CSSCEEEEEECSSSEEEEEESSSEEEEEETTTTCCCEEEECCSSCC
T ss_pred CEEEEEcCCC-EEEEEECCCC-c----eEEEec-CCCcEEEEEEcCCCcEEEEECCCcEEEEECCCCceeEEEcccCCcE
Confidence 3444445678 8888854431 1 111111 1112334433 2345566778999999954322111000 000122
Q ss_pred EEE--eeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEee--CCceeEEEccCCcEEEEEcCCCCCCCcC--
Q 045256 161 ESL--TSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITA--GGNHVCGIDSNGFVICYGDNKSGQLKFP-- 234 (789)
Q Consensus 161 ~~v--a~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~n~~Gql~~~-- 234 (789)
..+ +.-... ++....+|+|+.|-......+..-......|..++. .....+.-..||+|+.|--.....+...
T Consensus 1089 ~~~~~s~d~~~-l~s~s~d~~v~iwd~~~~~~~~~l~~h~~~v~~~~~s~dg~~lat~~~dg~i~vwd~~~~~~~~~~~~ 1167 (1249)
T 3sfz_A 1089 LSCAISSDATK-FSSTSADKTAKIWSFDLLSPLHELKGHNGCVRCSAFSLDGILLATGDDNGEIRIWNVSDGQLLHSCAP 1167 (1249)
T ss_dssp CCEEECSSSSS-CEEECCSSCCCEECSSSSSCSBCCCCCSSCEEEEEECSSSSEEEEEETTSCCCEEESSSSCCCCCCCC
T ss_pred EEEEECCCCCE-EEEEcCCCcEEEEECCCcceeeeeccCCCcEEEEEECCCCCEEEEEeCCCEEEEEECCCCceEEEecc
Confidence 222 222222 333456679999965433332222212233544443 2333344467888888864432222111
Q ss_pred -C-----CCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCC--CCCcEE--EEEecCceEEEEeecCCeEEEe
Q 045256 235 -L-----NSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGI--RGKSFE--SIVSGSNFTCGLTTSNFSVICW 304 (789)
Q Consensus 235 -~-----~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~--~~~~v~--~i~~G~~h~~al~~~g~~v~~W 304 (789)
. ......|..++--......++. +|.|..|--.....+... ....|. .++..+.+-+....|| .|+.|
T Consensus 1168 ~~~~~~~~~~~~~v~~l~fs~dg~~l~s~-~g~v~vwd~~~g~~~~~~~~~~~~i~~~~~s~dg~~l~~~~~dg-~v~vw 1245 (1249)
T 3sfz_A 1168 ISVEEGTATHGGWVTDVCFSPDSKTLVSA-GGYLKWWNVATGDSSQTFYTNGTNLKKIHVSPDFRTYVTVDNLG-ILYIL 1245 (1249)
T ss_dssp CC-------CCSCCCEEEECTTSSCEEEE-SSSEEEBCSSSCBCCCCCCCSSCCCCCCEECSSSCCEEEECTTC-CEEEE
T ss_pred ccccccccccCceEEEEEECCCCCEEEEC-CCeEEEEECCCCceeeeeeccCCcccEEEECCCCCEEEEecCCc-EEEEE
Confidence 0 0112234444443333344455 688888865433322221 112232 2333334444444555 78877
Q ss_pred c
Q 045256 305 G 305 (789)
Q Consensus 305 G 305 (789)
=
T Consensus 1246 ~ 1246 (1249)
T 3sfz_A 1246 Q 1246 (1249)
T ss_dssp C
T ss_pred e
Confidence 4
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.28 E-value=0.14 Score=35.56 Aligned_cols=22 Identities=9% Similarity=0.060 Sum_probs=8.5
Q ss_pred hhhHHHHHHHHHHHHHhhheee
Q 045256 390 LAFAIVGSVGGFAGICTVIYCV 411 (789)
Q Consensus 390 i~~iiv~~v~~~~~l~~l~~~~ 411 (789)
++..+++.++++++++++.+++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~ 33 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVY 33 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeehHHHHHHHHHHHHHHHH
Confidence 4444444333333333333333
|
| >2ymu_A WD-40 repeat protein; unknown function, two domains; 1.79A {Nostoc punctiforme} | Back alignment and structure |
|---|
Probab=89.01 E-value=31 Score=38.07 Aligned_cols=200 Identities=11% Similarity=0.164 Sum_probs=92.0
Q ss_pred cCCCcEEEeeCC-cc-cccC-CCCcEEEEEe--cCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEE--
Q 045256 53 QPTQRLLCYQGG-TI-RAVE-PNISFSSISA--GQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVS-- 125 (789)
Q Consensus 53 ~~~g~v~~wG~~-~~-~~~~-~~~~v~~i~~--G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~-- 125 (789)
..||+|.-|-.. .. ..+. ....+..++- .+.+-+.-..|| +|..|-.+. + ....+.. ..-.|..++
T Consensus 322 ~~d~~i~~w~~~~~~~~~~~~~~~~v~~~~~s~~g~~l~~~~~dg-~v~~~~~~~--~---~~~~~~~-~~~~v~~~~~s 394 (577)
T 2ymu_A 322 SDDKTVKLWNRNGQHLQTLTGHSSSVWGVAFSPDGQTIASASDDK-TVKLWNRNG--Q---LLQTLTG-HSSSVRGVAFS 394 (577)
T ss_dssp ETTSCEEEEETTSCEEEEECCCSSCEEEEEECTTSSEEEEEETTS-EEEEEETTC--C---EEEEEEC-CSSCEEEEEEC
T ss_pred eCCCeEEEEeCCCCeeEEEeCCCCCEEEEEECCCCCEEEEEeCCC-EEEEEcCCC--C---EEEEecC-CCCCeEEEEEC
Confidence 456666666431 11 1111 1234544443 333444456677 888884321 1 1111211 122243444
Q ss_pred ecCCeEEEEeeCCeEEEcCCCCCCCCC--CCCCCccEEEEeee-CceeEEEEeCCCeEEEeecCCCCCcccC-CCCCcee
Q 045256 126 VGNNHVCATTVQGQINCWRGDVNISKN--APSGELQFESLTSG-IDFSCGILTNNKTVRCWGINSISNQIQT-SFANRSM 201 (789)
Q Consensus 126 ~G~~h~~al~~~G~v~~wG~~~~~~~~--~~~~~~~v~~va~G-~~hs~al~~~~g~v~~wG~n~~gqlg~~-~~~~~~v 201 (789)
....+.+.-..||.|..|-.+ ++.. .......|..++.- ....++....+|+|..|-. .+++-.. ......|
T Consensus 395 ~dg~~l~~~~~d~~v~~~~~~--~~~~~~~~~~~~~v~~~~~s~d~~~l~~~~~d~~v~~w~~--~~~~~~~~~~~~~~v 470 (577)
T 2ymu_A 395 PDGQTIASASDDKTVKLWNRN--GQLLQTLTGHSSSVWGVAFSPDDQTIASASDDKTVKLWNR--NGQLLQTLTGHSSSV 470 (577)
T ss_dssp TTSSCEEEEETTSEEEEECTT--CCEEEEEECCSSCEEEEEECTTSSEEEEEETTSEEEEEET--TSCEEEEEECCSSCE
T ss_pred CCCCEEEEEeCCCEEEEEeCC--CCEEEEecCCCCCeEEEEECCCCCEEEEEcCCCEEEEEEC--CCCEEEEEcCCCCCE
Confidence 334455556788999999532 2220 01111235555432 2233444567779999953 2332111 1112234
Q ss_pred EEEeeC--CceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEecc--CcceEEEEEeeCCeEEEee
Q 045256 202 FSITAG--GNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSL--GFNHSCAIRRLNGSVVCWG 266 (789)
Q Consensus 202 ~~i~~G--~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~--G~~h~~al~~~dG~v~~WG 266 (789)
..++.. ....+.-..||.|.-|- ..|++-.........|..|+- -..+-+.-.+ ||.|..|=
T Consensus 471 ~~~~~spd~~~las~~~d~~i~iw~--~~~~~~~~~~~h~~~v~~l~~s~dg~~l~s~~~-dg~v~lwd 536 (577)
T 2ymu_A 471 RGVAFSPDGQTIASASDDKTVKLWN--RNGQLLQTLTGHSSSVRGVAFSPDGQTIASASD-DKTVKLWN 536 (577)
T ss_dssp EEEEECTTSCEEEEEETTSEEEEEE--TTSCEEEEEECCSSCEEEEEECTTSSCEEEEET-TSEEEEEC
T ss_pred EEEEEcCCCCEEEEEeCCCEEEEEc--CCCCEEEEEeCCCCCEEEEEEcCCCCEEEEEEC-cCEEEEEe
Confidence 444432 22333336788898885 345542211111234555543 2333333344 89999994
|
| >3mkq_A Coatomer beta'-subunit; beta-propeller, alpha-solenoid, transport protein; 2.50A {Saccharomyces cerevisiae} PDB: 2ynp_A | Back alignment and structure |
|---|
Probab=88.83 E-value=40 Score=39.11 Aligned_cols=246 Identities=8% Similarity=-0.020 Sum_probs=114.7
Q ss_pred eecCCCcEEEeeCC--cccccC--CCCcEEEEE--ecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEE
Q 045256 51 AAQPTQRLLCYQGG--TIRAVE--PNISFSSIS--AGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSV 124 (789)
Q Consensus 51 ~l~~~g~v~~wG~~--~~~~~~--~~~~v~~i~--~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v 124 (789)
....||+|.-|-.. ...... ....|..++ ..+..-+.-..|| +|..|-.+. ......+.. ..-.|..+
T Consensus 30 ~~~~~g~v~iwd~~~~~~~~~~~~~~~~v~~~~~s~~~~~l~~~~~dg-~i~vw~~~~----~~~~~~~~~-~~~~v~~~ 103 (814)
T 3mkq_A 30 TTLYSGRVEIWNYETQVEVRSIQVTETPVRAGKFIARKNWIIVGSDDF-RIRVFNYNT----GEKVVDFEA-HPDYIRSI 103 (814)
T ss_dssp EEETTSEEEEEETTTTEEEEEEECCSSCEEEEEEEGGGTEEEEEETTS-EEEEEETTT----CCEEEEEEC-CSSCEEEE
T ss_pred EEeCCCEEEEEECCCCceEEEEecCCCcEEEEEEeCCCCEEEEEeCCC-eEEEEECCC----CcEEEEEec-CCCCEEEE
Confidence 33567888777542 121111 122344433 3334444556688 888885442 111122221 11223344
Q ss_pred E--ecCCeEEEEeeCCeEEEcCCCCCCCC--CCCCCCccEEEEeee--CceeEEEEeCCCeEEEeecCCCCCcccCCC-C
Q 045256 125 S--VGNNHVCATTVQGQINCWRGDVNISK--NAPSGELQFESLTSG--IDFSCGILTNNKTVRCWGINSISNQIQTSF-A 197 (789)
Q Consensus 125 ~--~G~~h~~al~~~G~v~~wG~~~~~~~--~~~~~~~~v~~va~G--~~hs~al~~~~g~v~~wG~n~~gqlg~~~~-~ 197 (789)
+ ....+.+.-..||.|..|--...... ........+..++.- ....++....+|+|+.|-............ .
T Consensus 104 ~~s~~~~~l~~~~~dg~i~vw~~~~~~~~~~~~~~~~~~v~~~~~~p~~~~~l~~~~~dg~v~vwd~~~~~~~~~~~~~~ 183 (814)
T 3mkq_A 104 AVHPTKPYVLSGSDDLTVKLWNWENNWALEQTFEGHEHFVMCVAFNPKDPSTFASGCLDRTVKVWSLGQSTPNFTLTTGQ 183 (814)
T ss_dssp EECSSSSEEEEEETTSEEEEEEGGGTSEEEEEEECCSSCEEEEEEETTEEEEEEEEETTSEEEEEETTCSSCSEEEECCC
T ss_pred EEeCCCCEEEEEcCCCEEEEEECCCCceEEEEEcCCCCcEEEEEEEcCCCCEEEEEeCCCeEEEEECCCCcceeEEecCC
Confidence 4 34445555677899988853222111 001111235555543 233445456778999996533222111110 1
Q ss_pred CceeE--EEee--CCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEecc--CcceEEEEEeeCCeEEEeeeCCCC
Q 045256 198 NRSMF--SITA--GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSL--GFNHSCAIRRLNGSVVCWGSQGEY 271 (789)
Q Consensus 198 ~~~v~--~i~~--G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~--G~~h~~al~~~dG~v~~WG~n~~g 271 (789)
...+. ..+. .....+.-..||+|..|-... ++...........|..++. ....-+.-.. ||.|+.|-.....
T Consensus 184 ~~~v~~~~~~~~~~~~~l~~~~~dg~i~~~d~~~-~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~-dg~v~vwd~~~~~ 261 (814)
T 3mkq_A 184 ERGVNYVDYYPLPDKPYMITASDDLTIKIWDYQT-KSCVATLEGHMSNVSFAVFHPTLPIIISGSE-DGTLKIWNSSTYK 261 (814)
T ss_dssp TTCCCEEEECCSTTCCEEEEECTTSEEEEEETTT-TEEEEEEECCSSCEEEEEECSSSSEEEEEET-TSCEEEEETTTCS
T ss_pred CCCEEEEEEEECCCCCEEEEEeCCCEEEEEECCC-CcEEEEEcCCCCCEEEEEEcCCCCEEEEEeC-CCeEEEEECCCCc
Confidence 12233 3333 344555557889999995433 3221100111223444432 2333444444 8999999655432
Q ss_pred cccC--CCCCcEEEEEecCce---EEEEeecCCeEEEec
Q 045256 272 SVNG--IRGKSFESIVSGSNF---TCGLTTSNFSVICWG 305 (789)
Q Consensus 272 q~~~--~~~~~v~~i~~G~~h---~~al~~~g~~v~~WG 305 (789)
.+.. .....+..++..... .++...++ .+..|-
T Consensus 262 ~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~-~~~~~~ 299 (814)
T 3mkq_A 262 VEKTLNVGLERSWCIATHPTGRKNYIASGFDN-GFTVLS 299 (814)
T ss_dssp EEEEECCSSSSEEEEEECTTCGGGEEEEEETT-EEEEEE
T ss_pred EEEEeecCCCcEEEEEEccCCCceEEEEEeCC-CEEEEE
Confidence 2211 123456666543322 35665666 566654
|
| >3mmy_A MRNA export factor; mRNA export, nuclear protein; HET: MES; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.41 E-value=24 Score=35.94 Aligned_cols=194 Identities=12% Similarity=0.065 Sum_probs=97.6
Q ss_pred CCcEEEEEecCc-----eEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEe--cCCeEEEEeeCCeEEEcC
Q 045256 72 NISFSSISAGQS-----FFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSV--GNNHVCATTVQGQINCWR 144 (789)
Q Consensus 72 ~~~v~~i~~G~~-----~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~--G~~h~~al~~~G~v~~wG 144 (789)
...|..|+--.. .-+.-..|| +|..|-....+. .....+.. ..-.|..++. ...+.+.-..||.|..|-
T Consensus 39 ~~~v~~~~~~~~~~~g~~l~~~~~dg-~i~iw~~~~~~~--~~~~~~~~-h~~~v~~~~~~~~~~~l~s~~~dg~v~iwd 114 (368)
T 3mmy_A 39 DDSIGCLSFSPPTLPGNFLIAGSWAN-DVRCWEVQDSGQ--TIPKAQQM-HTGPVLDVCWSDDGSKVFTASCDKTAKMWD 114 (368)
T ss_dssp SSCEEEEEECCTTSSSEEEEEEETTS-EEEEEEECTTSC--EEEEEEEE-CSSCEEEEEECTTSSEEEEEETTSEEEEEE
T ss_pred CCceEEEEEcCCCCCceEEEEECCCC-cEEEEEcCCCCc--eeEEEecc-ccCCEEEEEECcCCCEEEEEcCCCcEEEEE
Confidence 345777765543 333345688 999996543121 11122221 2223444443 445666677899999995
Q ss_pred CCCCCCCCCCCCCccEEEEee---eCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEeeCCceeEEEccCCcEE
Q 045256 145 GDVNISKNAPSGELQFESLTS---GIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVI 221 (789)
Q Consensus 145 ~~~~~~~~~~~~~~~v~~va~---G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~ 221 (789)
-..............|..++. .....++....+|.|+.|=......+ ........+..+..-....++...+|.+.
T Consensus 115 ~~~~~~~~~~~~~~~v~~~~~~~~~~~~~l~~~~~dg~i~vwd~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 193 (368)
T 3mmy_A 115 LSSNQAIQIAQHDAPVKTIHWIKAPNYSCVMTGSWDKTLKFWDTRSSNPM-MVLQLPERCYCADVIYPMAVVATAERGLI 193 (368)
T ss_dssp TTTTEEEEEEECSSCEEEEEEEECSSCEEEEEEETTSEEEEECSSCSSCS-EEEECSSCEEEEEEETTEEEEEEGGGCEE
T ss_pred cCCCCceeeccccCceEEEEEEeCCCCCEEEEccCCCcEEEEECCCCcEE-EEEecCCCceEEEecCCeeEEEeCCCcEE
Confidence 432222111111224666653 34444554567789999964332222 11112223445554455667778889999
Q ss_pred EEEcCCCCCCCc---CCCCCccceEEeccCcce---EEEEEeeCCeEEEeeeCCC
Q 045256 222 CYGDNKSGQLKF---PLNSTAFEYSALSLGFNH---SCAIRRLNGSVVCWGSQGE 270 (789)
Q Consensus 222 ~wG~n~~Gql~~---~~~~~~~~v~~i~~G~~h---~~al~~~dG~v~~WG~n~~ 270 (789)
.|-.....+... ...........+...... .++....||.|..|=....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dg~i~i~~~~~~ 248 (368)
T 3mmy_A 194 VYQLENQPSEFRRIESPLKHQHRCVAIFKDKQNKPTGFALGSIEGRVAIHYINPP 248 (368)
T ss_dssp EEECSSSCEEEEECCCSCSSCEEEEEEEECTTSCEEEEEEEETTSEEEEEESSCS
T ss_pred EEEeccccchhhhccccccCCCceEEEcccCCCCCCeEEEecCCCcEEEEecCCC
Confidence 997554332210 001111223333322221 1444444999999977654
|
| >1sq9_A Antiviral protein SKI8; WD repeat, beta-transducin repeat, WD40 repeat, beta propeller, recombination; 1.90A {Saccharomyces cerevisiae} SCOP: b.69.4.1 PDB: 1s4u_X | Back alignment and structure |
|---|
Probab=88.31 E-value=26 Score=36.34 Aligned_cols=231 Identities=13% Similarity=0.103 Sum_probs=107.2
Q ss_pred ceeEEEEecCceeeeeeeecCCCcEEEeeCCcc--------c-ccC-CCCcEEEEEec------C---ceEEEEEeCCce
Q 045256 34 GSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTI--------R-AVE-PNISFSSISAG------Q---SFFCGIRSGGYS 94 (789)
Q Consensus 34 ~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~~~~--------~-~~~-~~~~v~~i~~G------~---~~~~~l~~~G~~ 94 (789)
..|.+++.-....+ .-..||+|..|-.... . .+. ....|..++-- + .+-+.-..|| +
T Consensus 17 ~~i~~~~~~~~~l~---s~~~dg~i~iw~~~~~~~~~~~~~~~~~~~h~~~v~~~~~~~~~~~~g~~~~~l~s~~~dg-~ 92 (397)
T 1sq9_A 17 ADIFSVSACNSFTV---SCSGDGYLKVWDNKLLDNENPKDKSYSHFVHKSGLHHVDVLQAIERDAFELCLVATTSFSG-D 92 (397)
T ss_dssp SCEEEEEECSSEEE---EEETTSEEEEEESBCCTTCCGGGGEEEEECCTTCEEEEEEEEEEETTTEEEEEEEEEETTS-C
T ss_pred cCeEEEEecCCeEE---EEcCCCEEEEEECCCcccccCCCcceEEecCCCcEEEEEEecccccCCccccEEEEEcCCC-C
Confidence 35666666554444 5578999999976211 1 111 22345555432 3 3444446688 8
Q ss_pred EEEccCCCCCCCCCc-ceeeeeCC----cceEEEEEe------cCCe-EEEEeeCCeEEEcCCCC------CCCCC----
Q 045256 95 LLCWDTNFSYNSNFV-PKRIYYND----TVLLSSVSV------GNNH-VCATTVQGQINCWRGDV------NISKN---- 152 (789)
Q Consensus 95 v~~wG~n~~~~~~~~-p~~v~~~~----~~~i~~v~~------G~~h-~~al~~~G~v~~wG~~~------~~~~~---- 152 (789)
|+.|-.......... ...+.... ...|..++. ...+ .++-..||.|+.|--.. .....
T Consensus 93 i~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~~~ 172 (397)
T 1sq9_A 93 LLFYRITREDETKKVIFEKLDLLDSDMKKHSFWALKWGASNDRLLSHRLVATDVKGTTYIWKFHPFADESNSLTLNWSPT 172 (397)
T ss_dssp EEEEEEEECTTTCCEEEEEECCSCTTGGGSCEEEEEEECCC----CEEEEEEETTSCEEEEEEESSSSHHHHTTTCCCCE
T ss_pred EEEEEccCCcccccccceeecccccccCCCcEEEEEEeeccCCCCceEEEEEeCCCcEEEEeCCccccccccceeeccCc
Confidence 888854432110000 12222221 123434443 3555 55667899999995332 11111
Q ss_pred -C--------CCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC---C---CceeEEEee--CCceeEEEc
Q 045256 153 -A--------PSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF---A---NRSMFSITA--GGNHVCGID 215 (789)
Q Consensus 153 -~--------~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~---~---~~~v~~i~~--G~~h~~al~ 215 (789)
. ......+..++.-.+..++....+|.|+.|-......+..-.. . ...+..++. ...+.++-.
T Consensus 173 ~~~~~~~~~~~~~~~~i~~~~~~~~~~l~~~~~dg~i~i~d~~~~~~~~~~~~~~~h~~~~~~i~~i~~~~~~~~l~~~~ 252 (397)
T 1sq9_A 173 LELQGTVESPMTPSQFATSVDISERGLIATGFNNGTVQISELSTLRPLYNFESQHSMINNSNSIRSVKFSPQGSLLAIAH 252 (397)
T ss_dssp EEEEEEECCSSSSCCCCCEEEECTTSEEEEECTTSEEEEEETTTTEEEEEEECCC---CCCCCEEEEEECSSTTEEEEEE
T ss_pred ceeeeeeccccCCCCCceEEEECCCceEEEEeCCCcEEEEECCCCceeEEEeccccccccCCccceEEECCCCCEEEEEe
Confidence 0 0011234444433222444456778999996543211111111 1 233444443 333444445
Q ss_pred cC---CcEEEEEcCCCCCCCcCCCC------------CccceEEeccC--cceEEEEEeeCCeEEEeeeCC
Q 045256 216 SN---GFVICYGDNKSGQLKFPLNS------------TAFEYSALSLG--FNHSCAIRRLNGSVVCWGSQG 269 (789)
Q Consensus 216 ~d---G~v~~wG~n~~Gql~~~~~~------------~~~~v~~i~~G--~~h~~al~~~dG~v~~WG~n~ 269 (789)
.| |.|..|-....-.+..-..+ ....|..++-- ...-+.-.. ||.|+.|=...
T Consensus 253 ~d~~~g~i~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~-dg~i~iwd~~~ 322 (397)
T 1sq9_A 253 DSNSFGCITLYETEFGERIGSLSVPTHSSQASLGEFAHSSWVMSLSFNDSGETLCSAGW-DGKLRFWDVKT 322 (397)
T ss_dssp EETTEEEEEEEETTTCCEEEEECBC--------CCBSBSSCEEEEEECSSSSEEEEEET-TSEEEEEETTT
T ss_pred cCCCCceEEEEECCCCcccceeccCcccccccccccccCCcEEEEEECCCCCEEEEEeC-CCeEEEEEcCC
Confidence 66 88888864432211110000 12234444432 333334444 89999996543
|
| >1k3i_A Galactose oxidase precursor; blade beta propeller, prosequence form, precursor of copper enzyme., oxidoreductase; 1.40A {Fusarium SP} SCOP: b.1.18.2 b.18.1.1 b.69.1.1 PDB: 1gof_A 1gog_A 1goh_A 2eie_A 2jkx_A 2vz1_A 2vz3_A 2eic_A 2eib_A 1t2x_A 2eid_A 2wq8_A | Back alignment and structure |
|---|
Probab=88.24 E-value=15 Score=41.97 Aligned_cols=50 Identities=8% Similarity=0.031 Sum_probs=30.3
Q ss_pred eecCCCcEEEeeCCc--ccccCC--CCcEEEEEe---c-CceEEEEEeCCceEEEccCC
Q 045256 51 AAQPTQRLLCYQGGT--IRAVEP--NISFSSISA---G-QSFFCGIRSGGYSLLCWDTN 101 (789)
Q Consensus 51 ~l~~~g~v~~wG~~~--~~~~~~--~~~v~~i~~---G-~~~~~~l~~~G~~v~~wG~n 101 (789)
++..+|+||.+|... .+.+.. ...+..+.. . ..|++++..|| ++|++|-.
T Consensus 249 ~~~~~g~lyv~GG~~~~~v~~yd~~t~~W~~~~~~~~~R~~~s~~~~~dg-~iyv~GG~ 306 (656)
T 1k3i_A 249 SMDGNGQIVVTGGNDAKKTSLYDSSSDSWIPGPDMQVARGYQSSATMSDG-RVFTIGGS 306 (656)
T ss_dssp EECTTSCEEEECSSSTTCEEEEEGGGTEEEECCCCSSCCSSCEEEECTTS-CEEEECCC
T ss_pred cCCCCCCEEEeCCCCCCceEEecCcCCceeECCCCCccccccceEEecCC-eEEEEeCc
Confidence 556789999998721 111111 113443321 2 35888877799 99999973
|
| >1q7f_A NHL, brain tumor CG10719-PA; BRAT, NHL domain, NHL repeat, beta-propeller, translation; 1.95A {Drosophila melanogaster} SCOP: b.68.9.1 | Back alignment and structure |
|---|
Probab=88.18 E-value=18 Score=35.82 Aligned_cols=15 Identities=7% Similarity=0.191 Sum_probs=7.1
Q ss_pred eEEEEE-eCCceEEEcc
Q 045256 84 FFCGIR-SGGYSLLCWD 99 (789)
Q Consensus 84 ~~~~l~-~~G~~v~~wG 99 (789)
+.+++. .+| ++|.-+
T Consensus 80 ~~i~~~~~~g-~l~v~~ 95 (286)
T 1q7f_A 80 NRVAVVRNSG-DIIVTE 95 (286)
T ss_dssp EEEEEETTTT-EEEEEE
T ss_pred eEEEEEcCCC-eEEEEc
Confidence 344442 455 555544
|
| >2qc5_A Streptogramin B lactonase; beta propeller, lyase; 1.80A {Staphylococcus cohnii} | Back alignment and structure |
|---|
Probab=88.12 E-value=22 Score=35.16 Aligned_cols=90 Identities=8% Similarity=-0.062 Sum_probs=42.4
Q ss_pred eeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEE--eccC--cceEEEEEeeCCeEEEeeeCCCCcccC-CCCCcEEEE
Q 045256 210 HVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSA--LSLG--FNHSCAIRRLNGSVVCWGSQGEYSVNG-IRGKSFESI 284 (789)
Q Consensus 210 h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~--i~~G--~~h~~al~~~dG~v~~WG~n~~gq~~~-~~~~~v~~i 284 (789)
+.++++.+|.+|.-..+ .+.+..-.. ...+.. +..+ .-+.+++.. +|.+|.-..+. +.+.. .....+..+
T Consensus 191 ~~i~~d~~g~l~v~~~~-~~~i~~~~~--~g~~~~~~~~~~~~~~~~i~~d~-~g~l~v~~~~~-~~i~~~~~~g~~~~~ 265 (300)
T 2qc5_A 191 VGITSGNDGALWFVEIM-GNKIGRITT--TGEISEYDIPTPNARPHAITAGK-NSEIWFTEWGA-NQIGRITNDNTIQEY 265 (300)
T ss_dssp EEEEECTTSSEEEEETT-TTEEEEECT--TCCEEEEECSSTTCCEEEEEECS-TTCEEEEETTT-TEEEEECTTSCEEEE
T ss_pred ceEEECCCCCEEEEccC-CCEEEEEcC--CCcEEEEECCCCCCCceEEEECC-CCCEEEeccCC-CeEEEECCCCcEEEE
Confidence 45677778888864432 222311111 111222 2222 235666766 88988755332 23211 112334444
Q ss_pred Ee----cCceEEEEeecCCeEEEec
Q 045256 285 VS----GSNFTCGLTTSNFSVICWG 305 (789)
Q Consensus 285 ~~----G~~h~~al~~~g~~v~~WG 305 (789)
.. ..-+.+++..+| .+|.=.
T Consensus 266 ~~~~~~~~~~~i~~~~~g-~l~v~~ 289 (300)
T 2qc5_A 266 QLQTENAEPHGITFGKDG-SVWFAL 289 (300)
T ss_dssp ECCSTTCCCCCEEECTTS-CEEEEC
T ss_pred ECCccCCccceeEeCCCC-CEEEEc
Confidence 22 234567776666 888733
|
| >1r5m_A SIR4-interacting protein SIF2; transcription corepressor, WD40 repeat, beta propeller; 1.55A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=87.39 E-value=30 Score=36.00 Aligned_cols=223 Identities=9% Similarity=0.010 Sum_probs=99.6
Q ss_pred cEEEEEec--CceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEe--cCCeEEEEeeCCeEEEcCCCCCC
Q 045256 74 SFSSISAG--QSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSV--GNNHVCATTVQGQINCWRGDVNI 149 (789)
Q Consensus 74 ~v~~i~~G--~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~--G~~h~~al~~~G~v~~wG~~~~~ 149 (789)
.|..++-- +..-+.-..|| +|..|-.+ ......+. .....|..++. ...+.++...||.|..|--....
T Consensus 110 ~v~~~~~s~~~~~l~~~~~dg-~i~i~~~~-----~~~~~~~~-~~~~~v~~~~~~~~~~~l~~~~~d~~i~iwd~~~~~ 182 (425)
T 1r5m_A 110 QVTCLAWSHDGNSIVTGVENG-ELRLWNKT-----GALLNVLN-FHRAPIVSVKWNKDGTHIISMDVENVTILWNVISGT 182 (425)
T ss_dssp CEEEEEECTTSSEEEEEETTS-CEEEEETT-----SCEEEEEC-CCCSCEEEEEECTTSSEEEEEETTCCEEEEETTTTE
T ss_pred ceEEEEEcCCCCEEEEEeCCC-eEEEEeCC-----CCeeeecc-CCCccEEEEEECCCCCEEEEEecCCeEEEEECCCCc
Confidence 45555543 23344445678 88888411 11112221 12223444543 44556667788999999532211
Q ss_pred CC---CCCCCC-------------ccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEe--eCCcee
Q 045256 150 SK---NAPSGE-------------LQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSIT--AGGNHV 211 (789)
Q Consensus 150 ~~---~~~~~~-------------~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~--~G~~h~ 211 (789)
.. ...... ..+..++.-....++....+|.|+.|-......+.........|..++ ......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~i~~~d~~~~~~~~~~~~~~~~i~~~~~~~~~~~l 262 (425)
T 1r5m_A 183 VMQHFELKETGGSSINAENHSGDGSLGVDVEWVDDDKFVIPGPKGAIFVYQITEKTPTGKLIGHHGPISVLEFNDTNKLL 262 (425)
T ss_dssp EEEEECCC---------------CCCBSCCEEEETTEEEEECGGGCEEEEETTCSSCSEEECCCSSCEEEEEEETTTTEE
T ss_pred EEEEeeccccCccceeeccccCCcceeeEEEEcCCCEEEEEcCCCeEEEEEcCCCceeeeeccCCCceEEEEECCCCCEE
Confidence 11 000000 002222222223344456777999997554322211111222344443 333445
Q ss_pred EEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcc-eEEEEEeeCCeEEEeeeCCCCcccC--CCCCcEEEEEec-
Q 045256 212 CGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFN-HSCAIRRLNGSVVCWGSQGEYSVNG--IRGKSFESIVSG- 287 (789)
Q Consensus 212 ~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~-h~~al~~~dG~v~~WG~n~~gq~~~--~~~~~v~~i~~G- 287 (789)
+.-..||.|+.|-... ++...........+..++.-.. .-++... ||.|+.|=....-.+.. .....+..++.-
T Consensus 263 ~~~~~d~~i~i~d~~~-~~~~~~~~~~~~~i~~~~~~~~~~l~~~~~-d~~i~i~d~~~~~~~~~~~~~~~~i~~~~~s~ 340 (425)
T 1r5m_A 263 LSASDDGTLRIWHGGN-GNSQNCFYGHSQSIVSASWVGDDKVISCSM-DGSVRLWSLKQNTLLALSIVDGVPIFAGRISQ 340 (425)
T ss_dssp EEEETTSCEEEECSSS-BSCSEEECCCSSCEEEEEEETTTEEEEEET-TSEEEEEETTTTEEEEEEECTTCCEEEEEECT
T ss_pred EEEcCCCEEEEEECCC-CccceEecCCCccEEEEEECCCCEEEEEeC-CCcEEEEECCCCcEeEecccCCccEEEEEEcC
Confidence 5556788999985433 2221111111223444433222 4444444 89999996543222211 112345444433
Q ss_pred -CceEEEEeecCCeEEEecC
Q 045256 288 -SNFTCGLTTSNFSVICWGP 306 (789)
Q Consensus 288 -~~h~~al~~~g~~v~~WG~ 306 (789)
+.+.++-..|| .|..|--
T Consensus 341 ~~~~l~~~~~dg-~i~i~~~ 359 (425)
T 1r5m_A 341 DGQKYAVAFMDG-QVNVYDL 359 (425)
T ss_dssp TSSEEEEEETTS-CEEEEEC
T ss_pred CCCEEEEEECCC-eEEEEEC
Confidence 22222233344 6777653
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.90 E-value=0.22 Score=34.60 Aligned_cols=34 Identities=15% Similarity=0.008 Sum_probs=26.0
Q ss_pred hhhhHHHHHHHHHHHHHhhheeeeeeeecccccc
Q 045256 389 LLAFAIVGSVGGFAGICTVIYCVWTGACFGKKKV 422 (789)
Q Consensus 389 ~i~~iiv~~v~~~~~l~~l~~~~~~~~~~~~~~~ 422 (789)
....|+++++++++++++++...|...+++++++
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~~ 41 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIKK 41 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSSC
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhhhh
Confidence 4688888888889999999988887666555443
|
| >4g56_B MGC81050 protein; protein arginine methyltransferase, protein complexes, histo methylation, transferase; HET: SAH; 2.95A {Xenopus laevis} | Back alignment and structure |
|---|
Probab=86.80 E-value=31 Score=35.65 Aligned_cols=228 Identities=9% Similarity=0.035 Sum_probs=103.7
Q ss_pred cEEEEEe-cCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEE--ecCCeEEEEeeCCeEEEcCCCCCCC
Q 045256 74 SFSSISA-GQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVS--VGNNHVCATTVQGQINCWRGDVNIS 150 (789)
Q Consensus 74 ~v~~i~~-G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~--~G~~h~~al~~~G~v~~wG~~~~~~ 150 (789)
.|.+|+- .....++-..|| +|..|=... ++.............-.|..|+ ....+.+.-..||+|..|-......
T Consensus 96 ~V~~~~~s~d~~~l~~s~dg-~v~lWd~~~-~~~~~~~~~~~~~h~~~V~~v~~spdg~~l~sgs~dg~v~iwd~~~~~~ 173 (357)
T 4g56_B 96 GVTDVAWVSEKGILVASDSG-AVELWEILE-KESLLVNKFAKYEHDDIVKTLSVFSDGTQAVSGGKDFSVKVWDLSQKAV 173 (357)
T ss_dssp CEEEEEEETTTEEEEEETTS-CEEEC---------CCCCEEECCCSSCEEEEEECSSSSEEEEEETTSCEEEEETTTTEE
T ss_pred CEEEEEEcCCCCEEEEECCC-EEEEeeccc-cceeEEEeeccCCCCCCEEEEEECCCCCEEEEEeCCCeEEEEECCCCcE
Confidence 3555552 233444456678 888884322 1111111111111111233444 3444555567899999995432211
Q ss_pred CCC-CCCCccEEEEeee--CceeEEEEeCCCeEEEeecCCCCCcccC--CCCCceeEEEeeC--CceeEEE-ccCCcEEE
Q 045256 151 KNA-PSGELQFESLTSG--IDFSCGILTNNKTVRCWGINSISNQIQT--SFANRSMFSITAG--GNHVCGI-DSNGFVIC 222 (789)
Q Consensus 151 ~~~-~~~~~~v~~va~G--~~hs~al~~~~g~v~~wG~n~~gqlg~~--~~~~~~v~~i~~G--~~h~~al-~~dG~v~~ 222 (789)
... ..-...|..|+.- ....++....+|+|..|=.......... ......+..|+.- ..+.++. ..||.|+.
T Consensus 174 ~~~~~~h~~~v~~v~~s~~~~~~~~s~~~dg~v~~wd~~~~~~~~~~~~~~~~~~v~~v~~sp~~~~~la~g~~d~~i~~ 253 (357)
T 4g56_B 174 LKSYNAHSSEVNCVAACPGKDTIFLSCGEDGRILLWDTRKPKPATRIDFCASDTIPTSVTWHPEKDDTFACGDETGNVSL 253 (357)
T ss_dssp EEEECCCSSCEEEEEECTTCSSCEEEEETTSCEEECCTTSSSCBCBCCCTTCCSCEEEEEECTTSTTEEEEEESSSCEEE
T ss_pred EEEEcCCCCCEEEEEEccCCCceeeeeccCCceEEEECCCCceeeeeeeccccccccchhhhhcccceEEEeecccceeE
Confidence 111 1111245566542 2233343456779999954322111111 1122335566542 2333443 67899999
Q ss_pred EEcCCCCCCCcCCCCCccceEEecc---CcceEEEEEeeCCeEEEeeeCCCCcccC--CCCCcEEEEEe---cCceEEEE
Q 045256 223 YGDNKSGQLKFPLNSTAFEYSALSL---GFNHSCAIRRLNGSVVCWGSQGEYSVNG--IRGKSFESIVS---GSNFTCGL 294 (789)
Q Consensus 223 wG~n~~Gql~~~~~~~~~~v~~i~~---G~~h~~al~~~dG~v~~WG~n~~gq~~~--~~~~~v~~i~~---G~~h~~al 294 (789)
|--.. +++..........|..|+- |...-+.-.. ||+|+.|=.. .+++-. .-...|..|+- .+...+.-
T Consensus 254 wd~~~-~~~~~~~~~~~~~v~~l~~sp~~~~~lasgs~-D~~i~iwd~~-~~~~~~~~~H~~~V~~vafsP~d~~~l~s~ 330 (357)
T 4g56_B 254 VNIKN-PDSAQTSAVHSQNITGLAYSYHSSPFLASISE-DCTVAVLDAD-FSEVFRDLSHRDFVTGVAWSPLDHSKFTTV 330 (357)
T ss_dssp EESSC-GGGCEEECCCSSCEEEEEECSSSSCCEEEEET-TSCEEEECTT-SCEEEEECCCSSCEEEEEECSSSTTEEEEE
T ss_pred EECCC-CcEeEEEeccceeEEEEEEcCCCCCEEEEEeC-CCEEEEEECC-CCcEeEECCCCCCEEEEEEeCCCCCEEEEE
Confidence 95432 2221111112234555543 2233333344 8999999433 344211 11345666663 23333333
Q ss_pred eecCCeEEEecCC
Q 045256 295 TTSNFSVICWGPG 307 (789)
Q Consensus 295 ~~~g~~v~~WG~n 307 (789)
..|| +|..|=-.
T Consensus 331 s~Dg-~v~iW~~~ 342 (357)
T 4g56_B 331 GWDH-KVLHHHLP 342 (357)
T ss_dssp ETTS-CEEEEECC
T ss_pred cCCC-eEEEEECC
Confidence 4566 88888643
|
| >3mkq_A Coatomer beta'-subunit; beta-propeller, alpha-solenoid, transport protein; 2.50A {Saccharomyces cerevisiae} PDB: 2ynp_A | Back alignment and structure |
|---|
Probab=86.72 E-value=30 Score=40.28 Aligned_cols=213 Identities=9% Similarity=0.001 Sum_probs=99.9
Q ss_pred EeCCceEEEccCCCCCCCCCcceeeee-CCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeee
Q 045256 89 RSGGYSLLCWDTNFSYNSNFVPKRIYY-NDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSG 166 (789)
Q Consensus 89 ~~~G~~v~~wG~n~~~~~~~~p~~v~~-~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G 166 (789)
..|| +|..|-... ......+.. ...+.-...+......+.-..||.|..|--........ ......|..++.-
T Consensus 32 ~~~g-~v~iwd~~~----~~~~~~~~~~~~~v~~~~~s~~~~~l~~~~~dg~i~vw~~~~~~~~~~~~~~~~~v~~~~~s 106 (814)
T 3mkq_A 32 LYSG-RVEIWNYET----QVEVRSIQVTETPVRAGKFIARKNWIIVGSDDFRIRVFNYNTGEKVVDFEAHPDYIRSIAVH 106 (814)
T ss_dssp ETTS-EEEEEETTT----TEEEEEEECCSSCEEEEEEEGGGTEEEEEETTSEEEEEETTTCCEEEEEECCSSCEEEEEEC
T ss_pred eCCC-EEEEEECCC----CceEEEEecCCCcEEEEEEeCCCCEEEEEeCCCeEEEEECCCCcEEEEEecCCCCEEEEEEe
Confidence 4578 888884332 111122221 12233334445555666667899999996433222111 1111235555443
Q ss_pred Cce-eEEEEeCCCeEEEeecCCCCCcccC-CCCCceeEEEee---CCceeEEEccCCcEEEEEcCCCCCCCcCCCC--Cc
Q 045256 167 IDF-SCGILTNNKTVRCWGINSISNQIQT-SFANRSMFSITA---GGNHVCGIDSNGFVICYGDNKSGQLKFPLNS--TA 239 (789)
Q Consensus 167 ~~h-s~al~~~~g~v~~wG~n~~gqlg~~-~~~~~~v~~i~~---G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~--~~ 239 (789)
.+. .++...++|+|..|-......+... ......|..++- .....+.-..||+|+.|--............ ..
T Consensus 107 ~~~~~l~~~~~dg~i~vw~~~~~~~~~~~~~~~~~~v~~~~~~p~~~~~l~~~~~dg~v~vwd~~~~~~~~~~~~~~~~~ 186 (814)
T 3mkq_A 107 PTKPYVLSGSDDLTVKLWNWENNWALEQTFEGHEHFVMCVAFNPKDPSTFASGCLDRTVKVWSLGQSTPNFTLTTGQERG 186 (814)
T ss_dssp SSSSEEEEEETTSEEEEEEGGGTSEEEEEEECCSSCEEEEEEETTEEEEEEEEETTSEEEEEETTCSSCSEEEECCCTTC
T ss_pred CCCCEEEEEcCCCEEEEEECCCCceEEEEEcCCCCcEEEEEEEcCCCCEEEEEeCCCeEEEEECCCCcceeEEecCCCCC
Confidence 222 2444567789999965432222111 111223555543 2334455578899999965432222111111 11
Q ss_pred cceEEecc-CcceEEEEEeeCCeEEEeeeCCCCcccC--CCCCcEEEEEecC--ceEEEEeecCCeEEEecCC
Q 045256 240 FEYSALSL-GFNHSCAIRRLNGSVVCWGSQGEYSVNG--IRGKSFESIVSGS--NFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 240 ~~v~~i~~-G~~h~~al~~~dG~v~~WG~n~~gq~~~--~~~~~v~~i~~G~--~h~~al~~~g~~v~~WG~n 307 (789)
......+. +....++....||+|..|=......+.. .....|..++... ...+.-..|| .|..|-..
T Consensus 187 v~~~~~~~~~~~~~l~~~~~dg~i~~~d~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~dg-~v~vwd~~ 258 (814)
T 3mkq_A 187 VNYVDYYPLPDKPYMITASDDLTIKIWDYQTKSCVATLEGHMSNVSFAVFHPTLPIIISGSEDG-TLKIWNSS 258 (814)
T ss_dssp CCEEEECCSTTCCEEEEECTTSEEEEEETTTTEEEEEEECCSSCEEEEEECSSSSEEEEEETTS-CEEEEETT
T ss_pred EEEEEEEECCCCCEEEEEeCCCEEEEEECCCCcEEEEEcCCCCCEEEEEEcCCCCEEEEEeCCC-eEEEEECC
Confidence 22223332 1233344444489999996543222211 1223455554333 3333334456 89998644
|
| >2aq5_A Coronin-1A; WD40 repeat, 7-bladed beta-propeller, structural protein; HET: CME; 1.75A {Mus musculus} PDB: 2b4e_A | Back alignment and structure |
|---|
Probab=86.68 E-value=34 Score=35.84 Aligned_cols=136 Identities=8% Similarity=0.065 Sum_probs=67.0
Q ss_pred EeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEe---cCCeEEEEeeCCeEEEcCCCCCCCCC---C-----CCCC
Q 045256 89 RSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSV---GNNHVCATTVQGQINCWRGDVNISKN---A-----PSGE 157 (789)
Q Consensus 89 ~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~---G~~h~~al~~~G~v~~wG~~~~~~~~---~-----~~~~ 157 (789)
..|| .|..|-.+..+........+. ...-.|..++. .....+.-..||+|..|--....... . ..-.
T Consensus 54 ~~~g-~i~v~~~~~~~~~~~~~~~~~-~h~~~V~~~~~~p~~~~~l~s~s~dg~v~vw~~~~~~~~~~~~~~~~~~~~h~ 131 (402)
T 2aq5_A 54 SGGG-AFLVLPLGKTGRVDKNVPLVC-GHTAPVLDIAWCPHNDNVIASGSEDCTVMVWEIPDGGLVLPLREPVITLEGHT 131 (402)
T ss_dssp SSSC-CEEEEETTCCEECCTTCCCBC-CCSSCEEEEEECTTCTTEEEEEETTSEEEEEECCTTCCSSCBCSCSEEEECCS
T ss_pred cCCC-EEEEEECccCCCCCCCCceEe-cCCCCEEEEEeCCCCCCEEEEEeCCCeEEEEEccCCCCccccCCceEEecCCC
Confidence 3478 899996554332111111111 11223445554 44555556789999999643321110 0 0111
Q ss_pred ccEEEEeeeCc--eeEEEEeCCCeEEEeecCCCCCcccC--CCCCceeEEEee--CCceeEEEccCCcEEEEEcC
Q 045256 158 LQFESLTSGID--FSCGILTNNKTVRCWGINSISNQIQT--SFANRSMFSITA--GGNHVCGIDSNGFVICYGDN 226 (789)
Q Consensus 158 ~~v~~va~G~~--hs~al~~~~g~v~~wG~n~~gqlg~~--~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~n 226 (789)
..|..|+.-.+ +.++.-..+|+|+.|-......+..- ......|..++- .....+.-..||.|..|--.
T Consensus 132 ~~v~~~~~~p~~~~~l~s~~~dg~i~iwd~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~d~~i~iwd~~ 206 (402)
T 2aq5_A 132 KRVGIVAWHPTAQNVLLSAGCDNVILVWDVGTGAAVLTLGPDVHPDTIYSVDWSRDGALICTSCRDKRVRVIEPR 206 (402)
T ss_dssp SCEEEEEECSSBTTEEEEEETTSCEEEEETTTTEEEEEECTTTCCSCEEEEEECTTSSCEEEEETTSEEEEEETT
T ss_pred CeEEEEEECcCCCCEEEEEcCCCEEEEEECCCCCccEEEecCCCCCceEEEEECCCCCEEEEEecCCcEEEEeCC
Confidence 24555554333 33444567779999975432222111 112233555543 23344445678889998643
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=86.50 E-value=25 Score=35.10 Aligned_cols=72 Identities=14% Similarity=-0.009 Sum_probs=33.5
Q ss_pred cEEEEEec-CceEEEEEeCCceEEEccCCCCCCCC-CcceeeeeCCcceEEEEEecCCeEEEEeeCCe-EEEcCC
Q 045256 74 SFSSISAG-QSFFCGIRSGGYSLLCWDTNFSYNSN-FVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQ-INCWRG 145 (789)
Q Consensus 74 ~v~~i~~G-~~~~~~l~~~G~~v~~wG~n~~~~~~-~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~-v~~wG~ 145 (789)
++.-..++ .....+++.+|+.+|.|+........ ..|..+....+-.+.-...+.....+++.+|+ +|.++.
T Consensus 89 ~~lv~~~~~~~~v~~vd~~Gk~l~~~~~~~~~~~~~~~~~~v~~~~~G~~lv~~~~~~~v~~~d~~G~~~w~~~~ 163 (276)
T 3no2_A 89 NALVAWCGHPSTILEVNMKGEVLSKTEFETGIERPHAQFRQINKNKKGNYLVPLFATSEVREIAPNGQLLNSVKL 163 (276)
T ss_dssp CEEEEEESTTEEEEEECTTSCEEEEEEECCSCSSGGGSCSCCEECTTSCEEEEETTTTEEEEECTTSCEEEEEEC
T ss_pred CEEEEecCCCCEEEEEeCCCCEEEEEeccCCCCcccccccCceECCCCCEEEEecCCCEEEEECCCCCEEEEEEC
Confidence 44433444 44555667788667777653211101 11222222222222222233445566776676 666654
|
| >1r5m_A SIR4-interacting protein SIF2; transcription corepressor, WD40 repeat, beta propeller; 1.55A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=86.06 E-value=35 Score=35.46 Aligned_cols=139 Identities=12% Similarity=0.011 Sum_probs=67.2
Q ss_pred CeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeeeCc-eeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEee
Q 045256 129 NHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSGID-FSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITA 206 (789)
Q Consensus 129 ~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G~~-hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~ 206 (789)
...++...||.|+.|--........ ......|..++.-.+ ..++....+|.|+.|-.......-.-......+..++.
T Consensus 218 ~~~~~~~~~g~i~~~d~~~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~~~~~~~~~~i~~~~~ 297 (425)
T 1r5m_A 218 DKFVIPGPKGAIFVYQITEKTPTGKLIGHHGPISVLEFNDTNKLLLSASDDGTLRIWHGGNGNSQNCFYGHSQSIVSASW 297 (425)
T ss_dssp TEEEEECGGGCEEEEETTCSSCSEEECCCSSCEEEEEEETTTTEEEEEETTSCEEEECSSSBSCSEEECCCSSCEEEEEE
T ss_pred CEEEEEcCCCeEEEEEcCCCceeeeeccCCCceEEEEECCCCCEEEEEcCCCEEEEEECCCCccceEecCCCccEEEEEE
Confidence 4455667889999996433222111 111123555544222 23343566779999965432222111112233444443
Q ss_pred CCc-eeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccC--cceEEEEEeeCCeEEEeeeCC
Q 045256 207 GGN-HVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLG--FNHSCAIRRLNGSVVCWGSQG 269 (789)
Q Consensus 207 G~~-h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G--~~h~~al~~~dG~v~~WG~n~ 269 (789)
... ..++...||.|+.|=... +++-.........+..++.- ...-++-.. ||.|+.|=...
T Consensus 298 ~~~~~l~~~~~d~~i~i~d~~~-~~~~~~~~~~~~~i~~~~~s~~~~~l~~~~~-dg~i~i~~~~~ 361 (425)
T 1r5m_A 298 VGDDKVISCSMDGSVRLWSLKQ-NTLLALSIVDGVPIFAGRISQDGQKYAVAFM-DGQVNVYDLKK 361 (425)
T ss_dssp ETTTEEEEEETTSEEEEEETTT-TEEEEEEECTTCCEEEEEECTTSSEEEEEET-TSCEEEEECHH
T ss_pred CCCCEEEEEeCCCcEEEEECCC-CcEeEecccCCccEEEEEEcCCCCEEEEEEC-CCeEEEEECCC
Confidence 222 556667889999996433 22211111112234444332 333334444 89999996543
|
| >1sq9_A Antiviral protein SKI8; WD repeat, beta-transducin repeat, WD40 repeat, beta propeller, recombination; 1.90A {Saccharomyces cerevisiae} SCOP: b.69.4.1 PDB: 1s4u_X | Back alignment and structure |
|---|
Probab=85.20 E-value=38 Score=35.05 Aligned_cols=192 Identities=15% Similarity=0.100 Sum_probs=89.6
Q ss_pred cEEEEEecCceEEEEEeCCceEEEccCCCCCCCC-Cc-ceeeeeCCcceEEEEE--ec----C---CeEEEEeeCCeEEE
Q 045256 74 SFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSN-FV-PKRIYYNDTVLLSSVS--VG----N---NHVCATTVQGQINC 142 (789)
Q Consensus 74 ~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~-~~-p~~v~~~~~~~i~~v~--~G----~---~h~~al~~~G~v~~ 142 (789)
.|..|+--...-+.-..|| +|..|-........ .. ...+. .....|..++ .. . .+.+....||.|+.
T Consensus 18 ~i~~~~~~~~~l~s~~~dg-~i~iw~~~~~~~~~~~~~~~~~~-~h~~~v~~~~~~~~~~~~g~~~~~l~s~~~dg~i~i 95 (397)
T 1sq9_A 18 DIFSVSACNSFTVSCSGDG-YLKVWDNKLLDNENPKDKSYSHF-VHKSGLHHVDVLQAIERDAFELCLVATTSFSGDLLF 95 (397)
T ss_dssp CEEEEEECSSEEEEEETTS-EEEEEESBCCTTCCGGGGEEEEE-CCTTCEEEEEEEEEEETTTEEEEEEEEEETTSCEEE
T ss_pred CeEEEEecCCeEEEEcCCC-EEEEEECCCcccccCCCcceEEe-cCCCcEEEEEEecccccCCccccEEEEEcCCCCEEE
Confidence 4555555444555556789 99999765422111 11 12222 1222233443 33 3 45555677899999
Q ss_pred cCCCCCCC-----C---CCCCC---CccEEEEeee------CceeEEEEeCCCeEEEeecCC------CCCcc-----cC
Q 045256 143 WRGDVNIS-----K---NAPSG---ELQFESLTSG------IDFSCGILTNNKTVRCWGINS------ISNQI-----QT 194 (789)
Q Consensus 143 wG~~~~~~-----~---~~~~~---~~~v~~va~G------~~hs~al~~~~g~v~~wG~n~------~gqlg-----~~ 194 (789)
|--..... . ..... ...|..++.- ..+-++....+|.|+.|-... ...+- .-
T Consensus 96 w~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~~~~~~ 175 (397)
T 1sq9_A 96 YRITREDETKKVIFEKLDLLDSDMKKHSFWALKWGASNDRLLSHRLVATDVKGTTYIWKFHPFADESNSLTLNWSPTLEL 175 (397)
T ss_dssp EEEEECTTTCCEEEEEECCSCTTGGGSCEEEEEEECCC----CEEEEEEETTSCEEEEEEESSSSHHHHTTTCCCCEEEE
T ss_pred EEccCCcccccccceeecccccccCCCcEEEEEEeeccCCCCceEEEEEeCCCcEEEEeCCccccccccceeeccCccee
Confidence 94222111 1 11110 1345555544 222144456778999996544 12211 00
Q ss_pred -------CCCCceeEEEeeCCc-eeEEEccCCcEEEEEcCCCCCCCcCCCC---C---ccceEEecc--CcceEEEEEee
Q 045256 195 -------SFANRSMFSITAGGN-HVCGIDSNGFVICYGDNKSGQLKFPLNS---T---AFEYSALSL--GFNHSCAIRRL 258 (789)
Q Consensus 195 -------~~~~~~v~~i~~G~~-h~~al~~dG~v~~wG~n~~Gql~~~~~~---~---~~~v~~i~~--G~~h~~al~~~ 258 (789)
......+..++.-.. ..+.-..||.|+.|=-.. ++.-..... . ...+..++- ...+-++-..
T Consensus 176 ~~~~~~~~~~~~~i~~~~~~~~~~l~~~~~dg~i~i~d~~~-~~~~~~~~~~~~h~~~~~~i~~i~~~~~~~~l~~~~~- 253 (397)
T 1sq9_A 176 QGTVESPMTPSQFATSVDISERGLIATGFNNGTVQISELST-LRPLYNFESQHSMINNSNSIRSVKFSPQGSLLAIAHD- 253 (397)
T ss_dssp EEEECCSSSSCCCCCEEEECTTSEEEEECTTSEEEEEETTT-TEEEEEEECCC---CCCCCEEEEEECSSTTEEEEEEE-
T ss_pred eeeeccccCCCCCceEEEECCCceEEEEeCCCcEEEEECCC-CceeEEEeccccccccCCccceEEECCCCCEEEEEec-
Confidence 011222333433221 444446788888886443 222100000 1 223444443 2334344444
Q ss_pred C---CeEEEeeeCC
Q 045256 259 N---GSVVCWGSQG 269 (789)
Q Consensus 259 d---G~v~~WG~n~ 269 (789)
| |.|..|=...
T Consensus 254 d~~~g~i~i~d~~~ 267 (397)
T 1sq9_A 254 SNSFGCITLYETEF 267 (397)
T ss_dssp ETTEEEEEEEETTT
T ss_pred CCCCceEEEEECCC
Confidence 7 8999997553
|
| >2uvk_A YJHT; unknown function, hypothetical protein, sialic acid metabolism, kelch repeat, beta-propeller; HET: MSE; 1.50A {Escherichia coli} | Back alignment and structure |
|---|
Probab=84.50 E-value=19 Score=37.30 Aligned_cols=61 Identities=15% Similarity=0.028 Sum_probs=31.7
Q ss_pred ceEEEEEeCCceEEEccCC-C--CCC-CCCcceeeeeCCcceEEEEEe-----cCCeEEEEeeCCeEEEcCCC
Q 045256 83 SFFCGIRSGGYSLLCWDTN-F--SYN-SNFVPKRIYYNDTVLLSSVSV-----GNNHVCATTVQGQINCWRGD 146 (789)
Q Consensus 83 ~~~~~l~~~G~~v~~wG~n-~--~~~-~~~~p~~v~~~~~~~i~~v~~-----G~~h~~al~~~G~v~~wG~~ 146 (789)
.|++++ -+| +||..|-. . .+. ....-..+.....-..+.++. -..|++++ .+|++|.+|+.
T Consensus 58 ~~~~~~-~~~-~lyv~GG~~~~~~~~~~~~~~v~~yd~~~~~W~~~~~~~p~~r~~~~~~~-~~~~iyv~GG~ 127 (357)
T 2uvk_A 58 QATSAF-IDG-NLYVFGGIGKNSEGLTQVFNDVHKYNPKTNSWVKLMSHAPMGMAGHVTFV-HNGKAYVTGGV 127 (357)
T ss_dssp SCEEEE-ETT-EEEEECCEEECTTSCEEECCCEEEEETTTTEEEECSCCCSSCCSSEEEEE-ETTEEEEEECC
T ss_pred cceEEE-ECC-EEEEEcCCCCCCCccceeeccEEEEeCCCCcEEECCCCCCcccccceEEE-ECCEEEEEeCc
Confidence 466655 478 89999865 1 110 001111122222222333321 23577666 79999999974
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.13 E-value=0.19 Score=35.01 Aligned_cols=33 Identities=12% Similarity=-0.069 Sum_probs=26.0
Q ss_pred hhhhHHHHHHHHHHHHHhhheeeeeeeeccccc
Q 045256 389 LLAFAIVGSVGGFAGICTVIYCVWTGACFGKKK 421 (789)
Q Consensus 389 ~i~~iiv~~v~~~~~l~~l~~~~~~~~~~~~~~ 421 (789)
....|++++++++++++++++..|...++++.+
T Consensus 9 ~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 9 KIPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp CSSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 588888899989999999898887766555443
|
| >3vgz_A Uncharacterized protein YNCE; beta-propeller, protein binding; 1.70A {Escherichia coli} PDB: 3vh0_A* | Back alignment and structure |
|---|
Probab=83.91 E-value=39 Score=34.17 Aligned_cols=17 Identities=24% Similarity=0.239 Sum_probs=8.9
Q ss_pred eEEEEEeeCCe-EEEeeeC
Q 045256 251 HSCAIRRLNGS-VVCWGSQ 268 (789)
Q Consensus 251 h~~al~~~dG~-v~~WG~n 268 (789)
+.+++.. ||+ +|.=..+
T Consensus 317 ~~~~~s~-dg~~l~v~~~~ 334 (353)
T 3vgz_A 317 NSLALSA-DGKTLYVSVKQ 334 (353)
T ss_dssp EEEEECT-TSCEEEEEEEC
T ss_pred CeEEEcC-CCCEEEEEEcc
Confidence 4555655 665 5554443
|
| >4g56_B MGC81050 protein; protein arginine methyltransferase, protein complexes, histo methylation, transferase; HET: SAH; 2.95A {Xenopus laevis} | Back alignment and structure |
|---|
Probab=83.59 E-value=44 Score=34.51 Aligned_cols=183 Identities=9% Similarity=0.084 Sum_probs=85.5
Q ss_pred EEEEEe-cCCeEEEEeeCCeEEEcCCCCCCCCCCC-----CCCccEEEEeeeCc-eeEEEEeCCCeEEEeecCCCCCccc
Q 045256 121 LSSVSV-GNNHVCATTVQGQINCWRGDVNISKNAP-----SGELQFESLTSGID-FSCGILTNNKTVRCWGINSISNQIQ 193 (789)
Q Consensus 121 i~~v~~-G~~h~~al~~~G~v~~wG~~~~~~~~~~-----~~~~~v~~va~G~~-hs~al~~~~g~v~~wG~n~~gqlg~ 193 (789)
|..++- .....++-..||+|..|--......... .-...|..|+.-.+ ..++.-..+|+|..|-.+....+..
T Consensus 97 V~~~~~s~d~~~l~~s~dg~v~lWd~~~~~~~~~~~~~~~~h~~~V~~v~~spdg~~l~sgs~dg~v~iwd~~~~~~~~~ 176 (357)
T 4g56_B 97 VTDVAWVSEKGILVASDSGAVELWEILEKESLLVNKFAKYEHDDIVKTLSVFSDGTQAVSGGKDFSVKVWDLSQKAVLKS 176 (357)
T ss_dssp EEEEEEETTTEEEEEETTSCEEEC--------CCCCEEECCCSSCEEEEEECSSSSEEEEEETTSCEEEEETTTTEEEEE
T ss_pred EEEEEEcCCCCEEEEECCCEEEEeeccccceeEEEeeccCCCCCCEEEEEECCCCCEEEEEeCCCeEEEEECCCCcEEEE
Confidence 445542 2345556677899999942211111110 11123555544322 2233345677999996443222211
Q ss_pred CCCCCceeEEEee---CCceeEEEccCCcEEEEEcCCCCCCCc-CC-CCCccceEEeccC--cceEEEEEeeCCeEEEee
Q 045256 194 TSFANRSMFSITA---GGNHVCGIDSNGFVICYGDNKSGQLKF-PL-NSTAFEYSALSLG--FNHSCAIRRLNGSVVCWG 266 (789)
Q Consensus 194 ~~~~~~~v~~i~~---G~~h~~al~~dG~v~~wG~n~~Gql~~-~~-~~~~~~v~~i~~G--~~h~~al~~~dG~v~~WG 266 (789)
-......|..|+. |....+.-..||+|..|=-. .++... .. ......+..|+.- ..+.++....||.|..|=
T Consensus 177 ~~~h~~~v~~v~~s~~~~~~~~s~~~dg~v~~wd~~-~~~~~~~~~~~~~~~~v~~v~~sp~~~~~la~g~~d~~i~~wd 255 (357)
T 4g56_B 177 YNAHSSEVNCVAACPGKDTIFLSCGEDGRILLWDTR-KPKPATRIDFCASDTIPTSVTWHPEKDDTFACGDETGNVSLVN 255 (357)
T ss_dssp ECCCSSCEEEEEECTTCSSCEEEEETTSCEEECCTT-SSSCBCBCCCTTCCSCEEEEEECTTSTTEEEEEESSSCEEEEE
T ss_pred EcCCCCCEEEEEEccCCCceeeeeccCCceEEEECC-CCceeeeeeeccccccccchhhhhcccceEEEeecccceeEEE
Confidence 1112233555554 22334455788999999432 222211 11 1112235555532 234455543489999996
Q ss_pred eCCCCcccC--CCCCcEEEEEe---cCceEEEEeecCCeEEEec
Q 045256 267 SQGEYSVNG--IRGKSFESIVS---GSNFTCGLTTSNFSVICWG 305 (789)
Q Consensus 267 ~n~~gq~~~--~~~~~v~~i~~---G~~h~~al~~~g~~v~~WG 305 (789)
....-.+.. .....|..++- |...-+.-..|+ +|..|=
T Consensus 256 ~~~~~~~~~~~~~~~~v~~l~~sp~~~~~lasgs~D~-~i~iwd 298 (357)
T 4g56_B 256 IKNPDSAQTSAVHSQNITGLAYSYHSSPFLASISEDC-TVAVLD 298 (357)
T ss_dssp SSCGGGCEEECCCSSCEEEEEECSSSSCCEEEEETTS-CEEEEC
T ss_pred CCCCcEeEEEeccceeEEEEEEcCCCCCEEEEEeCCC-EEEEEE
Confidence 443222211 22345666654 222222334566 899984
|
| >3zwl_B Eukaryotic translation initiation factor 3 subuni; 2.20A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=83.35 E-value=41 Score=34.03 Aligned_cols=170 Identities=9% Similarity=-0.022 Sum_probs=79.5
Q ss_pred eecCCCcEEEeeC--CcccccC--CCCcEEEEEec--CceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEE
Q 045256 51 AAQPTQRLLCYQG--GTIRAVE--PNISFSSISAG--QSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSV 124 (789)
Q Consensus 51 ~l~~~g~v~~wG~--~~~~~~~--~~~~v~~i~~G--~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v 124 (789)
.-..||.|.-|-. ..+.... ....|..++-- +.+-+....|| +|..|-.... ..-..+.....+.-...
T Consensus 49 ~~~~dg~i~vwd~~~~~~~~~~~~h~~~v~~~~~~~~~~~l~s~~~dg-~i~iwd~~~~----~~~~~~~~~~~v~~~~~ 123 (369)
T 3zwl_B 49 SCSKDSSASVWYSLNGERLGTLDGHTGTIWSIDVDCFTKYCVTGSADY-SIKLWDVSNG----QCVATWKSPVPVKRVEF 123 (369)
T ss_dssp EEESSSCEEEEETTTCCEEEEECCCSSCEEEEEECTTSSEEEEEETTT-EEEEEETTTC----CEEEEEECSSCEEEEEE
T ss_pred EEeCCCEEEEEeCCCchhhhhhhhcCCcEEEEEEcCCCCEEEEEeCCC-eEEEEECCCC----cEEEEeecCCCeEEEEE
Confidence 3356788888854 2222221 23345555543 34455556788 9999954321 11111222222222233
Q ss_pred EecCCeEEEEeeC-----CeEEEcCCCCCCCCC--------------CCCCCccEEEEeeeC-ceeEEEEeCCCeEEEee
Q 045256 125 SVGNNHVCATTVQ-----GQINCWRGDVNISKN--------------APSGELQFESLTSGI-DFSCGILTNNKTVRCWG 184 (789)
Q Consensus 125 ~~G~~h~~al~~~-----G~v~~wG~~~~~~~~--------------~~~~~~~v~~va~G~-~hs~al~~~~g~v~~wG 184 (789)
+....+.++...+ |.++.|--....... .......+..++.-. ...++....+|.|+.|-
T Consensus 124 ~~~~~~l~~~~~~~~~~~g~i~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~dg~i~i~d 203 (369)
T 3zwl_B 124 SPCGNYFLAILDNVMKNPGSINIYEIERDSATHELTKVSEEPIHKIITHEGLDAATVAGWSTKGKYIIAGHKDGKISKYD 203 (369)
T ss_dssp CTTSSEEEEEECCBTTBCCEEEEEEEEECTTTCCEEEECSSCSEEEECCTTCCCEEEEEECGGGCEEEEEETTSEEEEEE
T ss_pred ccCCCEEEEecCCccCCCCEEEEEEecCCccceeecccccceeeeccCCcCccceeEEEEcCCCCEEEEEcCCCEEEEEE
Confidence 3444555556666 899999532211110 000000233333221 12233356777999997
Q ss_pred cCCCCCccc-CCCCCceeEEEee--CCceeEEEccCCcEEEEEc
Q 045256 185 INSISNQIQ-TSFANRSMFSITA--GGNHVCGIDSNGFVICYGD 225 (789)
Q Consensus 185 ~n~~gqlg~-~~~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~ 225 (789)
....++.-. .......|..++. .....++-..||.|+.|=.
T Consensus 204 ~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~d~~i~v~d~ 247 (369)
T 3zwl_B 204 VSNNYEYVDSIDLHEKSISDMQFSPDLTYFITSSRDTNSFLVDV 247 (369)
T ss_dssp TTTTTEEEEEEECCSSCEEEEEECTTSSEEEEEETTSEEEEEET
T ss_pred CCCCcEeEEEEecCCCceeEEEECCCCCEEEEecCCceEEEEEC
Confidence 544222211 1112223444443 3334444567888888854
|
| >4a11_B DNA excision repair protein ERCC-8; DNA binding protein, DNA damage repair; HET: DNA; 3.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.05 E-value=46 Score=34.33 Aligned_cols=231 Identities=9% Similarity=0.060 Sum_probs=107.4
Q ss_pred cEEEEEec---CceEEEEEeCCceEEEccCCCCCCCCCcc-eeee-------eCCcceEEEEEe---cCCeEEEEeeCCe
Q 045256 74 SFSSISAG---QSFFCGIRSGGYSLLCWDTNFSYNSNFVP-KRIY-------YNDTVLLSSVSV---GNNHVCATTVQGQ 139 (789)
Q Consensus 74 ~v~~i~~G---~~~~~~l~~~G~~v~~wG~n~~~~~~~~p-~~v~-------~~~~~~i~~v~~---G~~h~~al~~~G~ 139 (789)
.|..++-- +..-+.-..|| +|..|-........... ..+. ....-.|..++. +....+.-..||.
T Consensus 45 ~v~~~~~s~~~~~~l~~~~~dg-~i~iw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~l~s~~~d~~ 123 (408)
T 4a11_B 45 GINTLDIEPVEGRYMLSGGSDG-VIVLYDLENSSRQSYYTCKAVCSIGRDHPDVHRYSVETVQWYPHDTGMFTSSSFDKT 123 (408)
T ss_dssp CEEEEEECTTTCCEEEEEETTS-CEEEEECCCCSSSSCEEECEEEEECTTCTTCCSSCEEEEEECTTCTTCEEEEETTSE
T ss_pred cEEEEEEecCCCCEEEEEcCCC-eEEEEECCCCcccceEeccccccccccccccCCCcEEEEEEccCCCcEEEEEeCCCe
Confidence 45555542 23333445688 89999655422111110 0000 012223445554 4556666778999
Q ss_pred EEEcCCCCCCCCCCCCCCccEEEEeeeCc----eeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEeeCC--ce-eE
Q 045256 140 INCWRGDVNISKNAPSGELQFESLTSGID----FSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITAGG--NH-VC 212 (789)
Q Consensus 140 v~~wG~~~~~~~~~~~~~~~v~~va~G~~----hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~G~--~h-~~ 212 (789)
|..|--..............+..+..-.. ..++.-..+|.|+.|-......+..-......|..++.-. .+ .+
T Consensus 124 i~iwd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~d~~~~~~~~~~~~~~~~v~~~~~~~~~~~ll~ 203 (408)
T 4a11_B 124 LKVWDTNTLQTADVFNFEETVYSHHMSPVSTKHCLVAVGTRGPKVQLCDLKSGSCSHILQGHRQEILAVSWSPRYDYILA 203 (408)
T ss_dssp EEEEETTTTEEEEEEECSSCEEEEEECSSCSSCCEEEEEESSSSEEEEESSSSCCCEEECCCCSCEEEEEECSSCTTEEE
T ss_pred EEEeeCCCCccceeccCCCceeeeEeecCCCCCcEEEEEcCCCeEEEEeCCCcceeeeecCCCCcEEEEEECCCCCcEEE
Confidence 99995432211111111112333333221 1344456777999997543333222222233455555432 33 34
Q ss_pred EEccCCcEEEEEcCCCCCC-Cc--------------CCCCCccceEEecc--CcceEEEEEeeCCeEEEeeeCCCCcccC
Q 045256 213 GIDSNGFVICYGDNKSGQL-KF--------------PLNSTAFEYSALSL--GFNHSCAIRRLNGSVVCWGSQGEYSVNG 275 (789)
Q Consensus 213 al~~dG~v~~wG~n~~Gql-~~--------------~~~~~~~~v~~i~~--G~~h~~al~~~dG~v~~WG~n~~gq~~~ 275 (789)
.-..||.|..|--....+. .. ........|..++. ...+-+.... ||.|..|=.........
T Consensus 204 ~~~~dg~i~i~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~-dg~i~vwd~~~~~~~~~ 282 (408)
T 4a11_B 204 TASADSRVKLWDVRRASGCLITLDQHNGKKSQAVESANTAHNGKVNGLCFTSDGLHLLTVGT-DNRMRLWNSSNGENTLV 282 (408)
T ss_dssp EEETTSCEEEEETTCSSCCSEECCTTTTCSCCCTTTSSCSCSSCEEEEEECTTSSEEEEEET-TSCEEEEETTTCCBCCC
T ss_pred EEcCCCcEEEEECCCCCcccccccccccccceeeccccccccCceeEEEEcCCCCEEEEecC-CCeEEEEECCCCcccee
Confidence 4578899999975433211 00 00111223554443 3334444555 99999997654332111
Q ss_pred ---------CCCCcEEEEEecCceEEEEeecCCeEEEecCC
Q 045256 276 ---------IRGKSFESIVSGSNFTCGLTTSNFSVICWGPG 307 (789)
Q Consensus 276 ---------~~~~~v~~i~~G~~h~~al~~~g~~v~~WG~n 307 (789)
.....+..........++...++ .|..|=..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~v~d~~ 322 (408)
T 4a11_B 283 NYGKVCNNSKKGLKFTVSCGCSSEFVFVPYGS-TIAVYTVY 322 (408)
T ss_dssp CCCCCCCCCSSCCCCEECCSSSSCEEEEEETT-EEEEEETT
T ss_pred ccccccccccccceeEEecCCCceEEEEecCC-EEEEEECc
Confidence 01112222222233344444555 89998743
|
| >1q7f_A NHL, brain tumor CG10719-PA; BRAT, NHL domain, NHL repeat, beta-propeller, translation; 1.95A {Drosophila melanogaster} SCOP: b.68.9.1 | Back alignment and structure |
|---|
Probab=82.78 E-value=33 Score=33.81 Aligned_cols=54 Identities=17% Similarity=0.276 Sum_probs=30.6
Q ss_pred ceEEEEEeeCCeEEEeeeCCCCccc--CCCCCcEEEEEecC----ceEEEEeecCCeEEEec
Q 045256 250 NHSCAIRRLNGSVVCWGSQGEYSVN--GIRGKSFESIVSGS----NFTCGLTTSNFSVICWG 305 (789)
Q Consensus 250 ~h~~al~~~dG~v~~WG~n~~gq~~--~~~~~~v~~i~~G~----~h~~al~~~g~~v~~WG 305 (789)
-..+++.. ||.+|.=.....+.+. ...+..+..+..+. -+.+++..|| ++|+-.
T Consensus 209 p~~i~~d~-~G~l~v~~~~~~~~i~~~~~~g~~~~~~~~~~~~~~~~~i~~~~~g-~l~vs~ 268 (286)
T 1q7f_A 209 PIGVGINS-NGEILIADNHNNFNLTIFTQDGQLISALESKVKHAQCFDVALMDDG-SVVLAS 268 (286)
T ss_dssp EEEEEECT-TCCEEEEECSSSCEEEEECTTSCEEEEEEESSCCSCEEEEEEETTT-EEEEEE
T ss_pred CcEEEECC-CCCEEEEeCCCCEEEEEECCCCCEEEEEcccCCCCcceeEEECCCC-cEEEEC
Confidence 35566665 7888876654432322 13334455555543 2367777777 888753
|
| >3jro_A Fusion protein of protein transport protein SEC13 nucleoporin NUP145; protein complex, cytoplasmic vesicle, endoplasmic reticulum, transport, membrane, mRNA transport; 4.00A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=82.27 E-value=55 Score=37.98 Aligned_cols=216 Identities=9% Similarity=0.046 Sum_probs=105.1
Q ss_pred eecCCCcEEEeeCC----cccccC--CCCcEEEEEec----CceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcce
Q 045256 51 AAQPTQRLLCYQGG----TIRAVE--PNISFSSISAG----QSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVL 120 (789)
Q Consensus 51 ~l~~~g~v~~wG~~----~~~~~~--~~~~v~~i~~G----~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~ 120 (789)
.-..||+|.-|-.. .+.... ....|..++-- +..-+.-..|| +|..|-.... ...+........-.
T Consensus 26 tg~~dg~I~vwd~~~~~~~~~~~l~~h~~~V~~l~~s~~~~~~~l~s~s~Dg-~I~vwd~~~~---~~~~~~~~~~h~~~ 101 (753)
T 3jro_A 26 TCSSDKTIKIFEVEGETHKLIDTLTGHEGPVWRVDWAHPKFGTILASCSYDG-KVLIWKEENG---RWSQIAVHAVHSAS 101 (753)
T ss_dssp EEETTTEEEEEEEETTEEEEEEEECCCSSCEEEEEECCTTSCSEEEEEETTS-CEEEEEEETT---EEEEEEEECCCSSC
T ss_pred EEECCCcEEEEecCCCCCccceeccCCcCceEEEEecCCCCCCEEEEEeCCC-eEEEEECCCC---cccccccccCCCCC
Confidence 33568888777431 222211 23357777643 34455556789 9999954321 10111111112223
Q ss_pred EEEEEec----CCeEEEEeeCCeEEEcCCCCCCCC---CCCCCCccEEEEeeeC--------------ceeEEEEeCCCe
Q 045256 121 LSSVSVG----NNHVCATTVQGQINCWRGDVNISK---NAPSGELQFESLTSGI--------------DFSCGILTNNKT 179 (789)
Q Consensus 121 i~~v~~G----~~h~~al~~~G~v~~wG~~~~~~~---~~~~~~~~v~~va~G~--------------~hs~al~~~~g~ 179 (789)
|..++.- ....+.-..||+|..|--...... ........|..++.-. ...++.-..+|+
T Consensus 102 V~~v~~sp~~~~~~l~sgs~dg~I~vwdl~~~~~~~~~~~~~~~~~v~~l~~~p~~~~~~~~~~~~~d~~~l~sgs~dg~ 181 (753)
T 3jro_A 102 VNSVQWAPHEYGPLLLVASSDGKVSVVEFKENGTTSPIIIDAHAIGVNSASWAPATIEEDGEHNGTKESRKFVTGGADNL 181 (753)
T ss_dssp EEEEEECCGGGCSEEEEEETTSEEEEEECCSSSCCCCEEEECCSSCEEEEEECCCC---------CGGGCCEEEEETTSC
T ss_pred eEEEEECCCCCCCEEEEEeCCCcEEEEEeecCCCcceeEeecCCCceEEEEecCcccccccccccCCCCCEEEEEECCCe
Confidence 4455543 456666788999999954322111 0011112355554322 333444567789
Q ss_pred EEEeecCCCCCccc----CCCCCceeEEEeeC-----CceeEEEccCCcEEEEEcCCCCC-----CCcCCCCCccceEEe
Q 045256 180 VRCWGINSISNQIQ----TSFANRSMFSITAG-----GNHVCGIDSNGFVICYGDNKSGQ-----LKFPLNSTAFEYSAL 245 (789)
Q Consensus 180 v~~wG~n~~gqlg~----~~~~~~~v~~i~~G-----~~h~~al~~dG~v~~wG~n~~Gq-----l~~~~~~~~~~v~~i 245 (789)
|..|-.....+... .......|..++-. ....+.-..||.|..|=-..... +... ......|..+
T Consensus 182 I~iwd~~~~~~~~~~~~~~~~h~~~V~~l~~sp~~~~~~~l~s~s~Dg~I~iwd~~~~~~~~~~~~~~~-~~~~~~v~~l 260 (753)
T 3jro_A 182 VKIWKYNSDAQTYVLESTLEGHSDWVRDVAWSPTVLLRSYLASVSQDRTCIIWTQDNEQGPWKKTLLKE-EKFPDVLWRA 260 (753)
T ss_dssp EEEEEEETTTTEEEEEEEECCCSSCEEEEEECCCCSSSEEEEEEESSSCEEEEEESSSSSCCBCCBSSS-SCCSSCCCCE
T ss_pred EEEEeccCCcccceeeeeecCCCCcEEEEEeccCCCCCCEEEEEecCCEEEEecCCCCCCcceeEEecc-CCCCCceEEE
Confidence 99995433221110 01112335555543 34455557889999996544321 1100 0011123222
Q ss_pred --ccCcceEEEEEeeCCeEEEeeeCCCCc
Q 045256 246 --SLGFNHSCAIRRLNGSVVCWGSQGEYS 272 (789)
Q Consensus 246 --~~G~~h~~al~~~dG~v~~WG~n~~gq 272 (789)
+..+.+-+.-.. ||.|+.|=.+..+.
T Consensus 261 ~~spdg~~l~s~s~-Dg~I~vwd~~~~~~ 288 (753)
T 3jro_A 261 SWSLSGNVLALSGG-DNKVTLWKENLEGK 288 (753)
T ss_dssp EECTTTCCEEEECS-SSCEECCBCCSSSC
T ss_pred EEcCCCCEEEEEcC-CCEEEEEecCCCCC
Confidence 223333333344 89999997665444
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.96 E-value=0.53 Score=34.14 Aligned_cols=30 Identities=13% Similarity=0.369 Sum_probs=20.2
Q ss_pred hHHHHHHHHHHHHHhhheeeeeeeeccccc
Q 045256 392 FAIVGSVGGFAGICTVIYCVWTGACFGKKK 421 (789)
Q Consensus 392 ~iiv~~v~~~~~l~~l~~~~~~~~~~~~~~ 421 (789)
+|++++++++++++++++++|+.-.++|++
T Consensus 11 iIi~svl~GLLLL~Lii~~LwK~GFFKR~~ 40 (54)
T 2l8s_A 11 VILLSAFAGLLLLMLLILALWKIGFFKRPL 40 (54)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTSCC
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCcccCCC
Confidence 455667777777777777777655555554
|
| >1yfq_A Cell cycle arrest protein BUB3; WD repeat WD40 repeat beta transducin repeat all beta, signaling protein; 1.10A {Saccharomyces cerevisiae} SCOP: b.69.4.2 PDB: 1u4c_A 2i3s_A 2i3t_A | Back alignment and structure |
|---|
Probab=81.62 E-value=46 Score=33.40 Aligned_cols=171 Identities=10% Similarity=-0.007 Sum_probs=89.2
Q ss_pred eecCCCcEEEeeC--Cc----ccc-cCCCCcEEEEEe--cCc-eEEEEEeCCceEEEccC-CCCCCCCCcceeeeeC-Cc
Q 045256 51 AAQPTQRLLCYQG--GT----IRA-VEPNISFSSISA--GQS-FFCGIRSGGYSLLCWDT-NFSYNSNFVPKRIYYN-DT 118 (789)
Q Consensus 51 ~l~~~g~v~~wG~--~~----~~~-~~~~~~v~~i~~--G~~-~~~~l~~~G~~v~~wG~-n~~~~~~~~p~~v~~~-~~ 118 (789)
+...||+|.-|-. .. +.. ......|..++- .+. +-+.-..|| +|+.|-. .. + ....+... ..
T Consensus 28 ~~~~d~~v~iw~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~l~~~~~dg-~i~~wd~~~~-~----~~~~~~~~~~~ 101 (342)
T 1yfq_A 28 ITSWDGSLTVYKFDIQAKNVDLLQSLRYKHPLLCCNFIDNTDLQIYVGTVQG-EILKVDLIGS-P----SFQALTNNEAN 101 (342)
T ss_dssp EEETTSEEEEEEEETTTTEEEEEEEEECSSCEEEEEEEESSSEEEEEEETTS-CEEEECSSSS-S----SEEECBSCCCC
T ss_pred EEcCCCeEEEEEeCCCCccccceeeeecCCceEEEEECCCCCcEEEEEcCCC-eEEEEEeccC-C----ceEeccccCCC
Confidence 4467888888754 22 111 112234544443 333 455556688 8888854 32 1 11222210 11
Q ss_pred ceEEEEEec-CCeEEEEeeCCeEEEcCCCC---------CCCCCCCCCCccEEEEeeeCceeEEEEeCCCeEEEeecCC-
Q 045256 119 VLLSSVSVG-NNHVCATTVQGQINCWRGDV---------NISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINS- 187 (789)
Q Consensus 119 ~~i~~v~~G-~~h~~al~~~G~v~~wG~~~---------~~~~~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~- 187 (789)
-.|..++.- ....+.-..||.|..|--.. ............+..++.-.+. +++...+|.|+.|-...
T Consensus 102 ~~v~~l~~~~~~~l~s~~~d~~i~iwd~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~-l~~~~~d~~i~i~d~~~~ 180 (342)
T 1yfq_A 102 LGICRICKYGDDKLIAASWDGLIEVIDPRNYGDGVIAVKNLNSNNTKVKNKIFTMDTNSSR-LIVGMNNSQVQWFRLPLC 180 (342)
T ss_dssp SCEEEEEEETTTEEEEEETTSEEEEECHHHHTTBCEEEEESCSSSSSSCCCEEEEEECSSE-EEEEESTTEEEEEESSCC
T ss_pred CceEEEEeCCCCEEEEEcCCCeEEEEcccccccccccccCCeeeEEeeCCceEEEEecCCc-EEEEeCCCeEEEEECCcc
Confidence 223343322 56666778899999995322 1111111122357777776666 55567788999998654
Q ss_pred CCCcc--cCCCCCceeEEEeeC---CceeEEEccCCcEEEEEcCCC
Q 045256 188 ISNQI--QTSFANRSMFSITAG---GNHVCGIDSNGFVICYGDNKS 228 (789)
Q Consensus 188 ~gqlg--~~~~~~~~v~~i~~G---~~h~~al~~dG~v~~wG~n~~ 228 (789)
..... ........+..|+.- ....++-..||.|..|=.+..
T Consensus 181 ~~~~~~~~~~~~~~~i~~i~~~~~~~~~l~~~~~dg~i~i~~~~~~ 226 (342)
T 1yfq_A 181 EDDNGTIEESGLKYQIRDVALLPKEQEGYACSSIDGRVAVEFFDDQ 226 (342)
T ss_dssp TTCCCEEEECSCSSCEEEEEECSGGGCEEEEEETTSEEEEEECCTT
T ss_pred ccccceeeecCCCCceeEEEECCCCCCEEEEEecCCcEEEEEEcCC
Confidence 22211 111122235555443 344555578899999876555
|
| >1k8k_C P40, ARP2/3 complex 41 kDa subunit, P41-ARC; beta-propeller, structural protein; 2.00A {Bos taurus} SCOP: b.69.4.1 PDB: 1tyq_C* 1u2v_C* 2p9i_C* 2p9k_C* 2p9l_C 2p9n_C* 2p9p_C* 2p9s_C* 2p9u_C* 3rse_C 3dxm_C* 3dxk_C | Back alignment and structure |
|---|
Probab=81.34 E-value=50 Score=33.59 Aligned_cols=212 Identities=8% Similarity=-0.015 Sum_probs=94.2
Q ss_pred ecCCCcEEEeeC--Cc--ccccC--CCCcEEEEEec--CceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEE
Q 045256 52 AQPTQRLLCYQG--GT--IRAVE--PNISFSSISAG--QSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSS 123 (789)
Q Consensus 52 l~~~g~v~~wG~--~~--~~~~~--~~~~v~~i~~G--~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~ 123 (789)
...||+|+-|-. .. +.... ....|..++-- +..-+.-..|| +|..|-... + ...+........-.|..
T Consensus 26 ~~~d~~v~i~~~~~~~~~~~~~~~~h~~~v~~~~~~~~~~~l~~~~~dg-~i~vwd~~~-~--~~~~~~~~~~~~~~v~~ 101 (372)
T 1k8k_C 26 CPNNHEVHIYEKSGNKWVQVHELKEHNGQVTGVDWAPDSNRIVTCGTDR-NAYVWTLKG-R--TWKPTLVILRINRAARC 101 (372)
T ss_dssp ECSSSEEEEEEEETTEEEEEEEEECCSSCEEEEEEETTTTEEEEEETTS-CEEEEEEET-T--EEEEEEECCCCSSCEEE
T ss_pred EeCCCEEEEEeCCCCcEEeeeeecCCCCcccEEEEeCCCCEEEEEcCCC-eEEEEECCC-C--eeeeeEEeecCCCceeE
Confidence 346788877754 21 22111 22345555432 33344445677 787774321 1 01111111111122334
Q ss_pred EEe--cCCeEEEEeeCCeEEEcCCCCCCC-----CCCCCCCccEEEEeeeC-ceeEEEEeCCCeEEEeecCC--------
Q 045256 124 VSV--GNNHVCATTVQGQINCWRGDVNIS-----KNAPSGELQFESLTSGI-DFSCGILTNNKTVRCWGINS-------- 187 (789)
Q Consensus 124 v~~--G~~h~~al~~~G~v~~wG~~~~~~-----~~~~~~~~~v~~va~G~-~hs~al~~~~g~v~~wG~n~-------- 187 (789)
++. ...+.+.-..||.|+.|--..... .........|..++.-. ...++.-..+|.|+.|-...
T Consensus 102 ~~~~~~~~~l~~~~~d~~v~i~d~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~~dg~i~~~d~~~~~~~~~~~ 181 (372)
T 1k8k_C 102 VRWAPNEKKFAVGSGSRVISICYFEQENDWWVCKHIKKPIRSTVLSLDWHPNSVLLAAGSCDFKCRIFSAYIKEVEERPA 181 (372)
T ss_dssp EEECTTSSEEEEEETTSSEEEEEEETTTTEEEEEEECTTCCSCEEEEEECTTSSEEEEEETTSCEEEEECCCTTTSCCCC
T ss_pred EEECCCCCEEEEEeCCCEEEEEEecCCCcceeeeeeecccCCCeeEEEEcCCCCEEEEEcCCCCEEEEEccccccccccc
Confidence 443 344555567789998884322211 00011122455555432 22344356677999996321
Q ss_pred ---------CCCcccCC-CCCceeEEEee--CCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccC-cceEEE
Q 045256 188 ---------ISNQIQTS-FANRSMFSITA--GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLG-FNHSCA 254 (789)
Q Consensus 188 ---------~gqlg~~~-~~~~~v~~i~~--G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G-~~h~~a 254 (789)
.++.-... .....+..++. ...+.+....||.|..|-......+..- ......+..++-- ....++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~l~~~~~d~~i~i~d~~~~~~~~~~-~~~~~~v~~~~~~~~~~~l~ 260 (372)
T 1k8k_C 182 PTPWGSKMPFGELMFESSSSCGWVHGVCFSANGSRVAWVSHDSTVCLADADKKMAVATL-ASETLPLLAVTFITESSLVA 260 (372)
T ss_dssp CBTTBSCCCTTCEEEECCCCSSCEEEEEECSSSSEEEEEETTTEEEEEEGGGTTEEEEE-ECSSCCEEEEEEEETTEEEE
T ss_pred ccccccccchhhheEecCCCCCeEEEEEECCCCCEEEEEeCCCEEEEEECCCCceeEEE-ccCCCCeEEEEEecCCCEEE
Confidence 11111100 11222444443 3335555567888888865432221110 0111233333322 223444
Q ss_pred EEeeCCeEEEeeeCC
Q 045256 255 IRRLNGSVVCWGSQG 269 (789)
Q Consensus 255 l~~~dG~v~~WG~n~ 269 (789)
... ||.++.|-...
T Consensus 261 ~~~-d~~i~i~~~~~ 274 (372)
T 1k8k_C 261 AGH-DCFPVLFTYDS 274 (372)
T ss_dssp EET-TSSCEEEEEET
T ss_pred EEe-CCeEEEEEccC
Confidence 445 88888887654
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.59 E-value=0.7 Score=32.08 Aligned_cols=8 Identities=38% Similarity=0.526 Sum_probs=4.3
Q ss_pred hhhhHHHH
Q 045256 389 LLAFAIVG 396 (789)
Q Consensus 389 ~i~~iiv~ 396 (789)
.++.+++|
T Consensus 13 ~Ia~~vVG 20 (44)
T 2jwa_A 13 SIISAVVG 20 (44)
T ss_dssp HHHHHHHH
T ss_pred chHHHHHH
Confidence 35555555
|
| >3bws_A Protein LP49; two-domain, immunoglobulin-like, 7-bladed beta propeller, unknown function; 1.99A {Leptospira interrogans} | Back alignment and structure |
|---|
Probab=80.23 E-value=44 Score=35.09 Aligned_cols=11 Identities=0% Similarity=0.199 Sum_probs=6.9
Q ss_pred eCCCeEEEeec
Q 045256 175 TNNKTVRCWGI 185 (789)
Q Consensus 175 ~~~g~v~~wG~ 185 (789)
..+|+|+.|-.
T Consensus 322 ~~~~~v~v~d~ 332 (433)
T 3bws_A 322 MCCSKIEVYDL 332 (433)
T ss_dssp TTTTEEEEEET
T ss_pred cCCCEEEEEEC
Confidence 45567777753
|
| >3vu4_A KMHSV2; beta-propeller fold, protein transport; 2.60A {Kluyveromyces marxianus} PDB: 4av9_A 4av8_A 4exv_A | Back alignment and structure |
|---|
Probab=80.11 E-value=57 Score=33.52 Aligned_cols=164 Identities=7% Similarity=0.020 Sum_probs=76.1
Q ss_pred eCCeEEEcCCCCCCCCCCCCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCC-CCcccCCCCCceeEEEeeCCceeEEE
Q 045256 136 VQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGINSI-SNQIQTSFANRSMFSITAGGNHVCGI 214 (789)
Q Consensus 136 ~~G~v~~wG~~~~~~~~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~-gqlg~~~~~~~~v~~i~~G~~h~~al 214 (789)
.|++|..|-...............|..|+.-.+..++ ..++ +|+.|-.... ..+..-. ....+..++. ..+|+
T Consensus 79 ~d~~v~iWd~~~~~~~~~~~~~~~v~~v~~~~~~~~~-~~~~-~i~i~d~~~~~~~~~~~~-~~~~~~~~s~---~~la~ 152 (355)
T 3vu4_A 79 VKEVVHIWDDVKKQDVSRIKVDAPVKDLFLSREFIVV-SYGD-VISVFKFGNPWKRITDDI-RFGGVCEFSN---GLLVY 152 (355)
T ss_dssp STTEEEEEETTTTEEEEEEECSSCEEEEEECSSEEEE-EETT-EEEEEESSTTCCBSSCCE-EEEEEEEEET---TEEEE
T ss_pred CccEEEEEECCCCcEEEEEECCCceEEEEEcCCEEEE-EEcC-EEEEEECCCCceeeEEec-cCCceEEEEc---cEEEE
Confidence 4568888853322111111111246677666555444 4454 9999976544 2221111 1223444443 33343
Q ss_pred ---ccCCcEEEEEcCCCCCCC------------c--CC-CCCccceEEeccCcc-eEEEEEeeCCe-EEEeeeCCCCccc
Q 045256 215 ---DSNGFVICYGDNKSGQLK------------F--PL-NSTAFEYSALSLGFN-HSCAIRRLNGS-VVCWGSQGEYSVN 274 (789)
Q Consensus 215 ---~~dG~v~~wG~n~~Gql~------------~--~~-~~~~~~v~~i~~G~~-h~~al~~~dG~-v~~WG~n~~gq~~ 274 (789)
..||.|..|--+...+.. + .. ..-...|..++--.. ..+|-...||+ |..|-....-.+.
T Consensus 153 ~sg~~~g~v~iwd~~~~~~~~~~~~~~~~~~~~p~~~~~~~h~~~v~~~~~s~~g~~l~s~s~d~~~v~iwd~~~~~~~~ 232 (355)
T 3vu4_A 153 SNEFNLGQIHITKLQSSGSATTQDQGVQQKAILGKGVLIKAHTNPIKMVRLNRKSDMVATCSQDGTIIRVFKTEDGVLVR 232 (355)
T ss_dssp EESSCTTCEEEEECCC------------------CCEEECCCSSCEEEEEECTTSSEEEEEETTCSEEEEEETTTCCEEE
T ss_pred eCCCcCcEEEEEECCCCCccccccccccccccCcccEEEEccCCceEEEEECCCCCEEEEEeCCCCEEEEEECCCCcEEE
Confidence 578999999765433110 0 00 001123444443222 22333333898 9999765432221
Q ss_pred CC----CCCcEEEEEec--CceEEEEeecCCeEEEecC
Q 045256 275 GI----RGKSFESIVSG--SNFTCGLTTSNFSVICWGP 306 (789)
Q Consensus 275 ~~----~~~~v~~i~~G--~~h~~al~~~g~~v~~WG~ 306 (789)
.. ....|..++-- +.+-+.-..|+ +|..|--
T Consensus 233 ~~~~g~h~~~v~~~~~s~~~~~l~s~s~d~-~v~iw~~ 269 (355)
T 3vu4_A 233 EFRRGLDRADVVDMKWSTDGSKLAVVSDKW-TLHVFEI 269 (355)
T ss_dssp EEECTTCCSCEEEEEECTTSCEEEEEETTC-EEEEEES
T ss_pred EEEcCCCCCcEEEEEECCCCCEEEEEECCC-EEEEEEc
Confidence 11 23445555443 23333334455 8888864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 789 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-65 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-55 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-54 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-53 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-52 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-45 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 9e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-23 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 4e-10 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 4e-06 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 1e-05 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 2e-04 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 0.002 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 3e-06 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 1e-05 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 2e-04 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 0.002 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-65
Identities = 72/287 (25%), Positives = 134/287 (46%), Gaps = 39/287 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
++ +IG+GSFG VYKGK +VA+K T ++ AF +E+ L + H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKM--LNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHN 604
+++ +GY + +V + + +LY HLH ++ + A+G++YLH
Sbjct: 64 VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY- 663
IIHRD+KS+NI L T ++ DFGL+ + + + +G++ ++ PE
Sbjct: 123 ---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 664 --GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
N + +SDVY G+VL EL+TG+ + +++ ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----------------RDQIIFMV 222
Query: 722 DRRVGPPEINE--AEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
R P++++ + + + C+ + ERP I+A++E
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 1e-61
Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 33/295 (11%)
Query: 498 LENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLV 557
L+ IG G FG V++GK G+EVA+K +E+ ++E+ L H++++
Sbjct: 7 LQESIGKGRFGEVWRGKW-RGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENIL 60
Query: 558 RLVGYCEEKD----ERLLVYDYMKNGALYDHLHDRNNVEKNA-------ARGIEYLHNYA 606
+ + + + LV DY ++G+L+D+L+ + A G+ +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 607 V-----PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER--DFRPMKAAGTVGYID 659
V P I HRD+KS NIL+ T ++D GL++ + D P GT Y+
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 660 PEYYGLNV------LTAKSDVYGLGVVLLELLTGKR--AIFKDDESGGTPVSLVDFAVPA 711
PE ++ ++D+Y +G+V E+ I +D + + D +V
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
+ + L + P EA+ ++A C G R T I L +
Sbjct: 241 MRKVVCEQKLRPNI-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-60
Identities = 69/284 (24%), Positives = 126/284 (44%), Gaps = 43/284 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
L ++GAG FG V+ G +VA+K K+ AF +E + +L H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVK-----SLKQGSMSPDAFLAEANLMKQLQH 67
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE----------KNAARGIEYLH 603
+ LVRL + + ++ +YM+NG+L D L + ++ A G+ ++
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
IHRD++++NIL+ + +++DFGL+ + ++E R A + + PE
Sbjct: 127 E---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAI 182
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
T KSDV+ G++L E++T R + + E+++ L+R
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----------------PEVIQNLER 225
Query: 724 --RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
R+ P+ E +L+ C ++RPT + + LE
Sbjct: 226 GYRMVRPDNCPEELYQLM----RLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 1e-59
Identities = 62/282 (21%), Positives = 123/282 (43%), Gaps = 31/282 (10%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + +IG+G FG+V+ G + +VAIK ++ E F E + +L H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT-----IREGAMSEEDFIEEAEVMMKLSH 59
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV-EKNAARGI-----EYLHNYAV 607
LV+L G C E+ LV+++M++G L D+L + + G+ E +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
+IHRD+ + N L+ +VSDFG++ + + V + PE + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSR 178
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727
++KSDV+ GV++ E+ + + +++ + +V+ I G R+
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENR----SNSEVVE----DISTGF-------RLYK 223
Query: 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769
P + +++ HC ++RP + ++ L +
Sbjct: 224 PRLASTHVYQIM----NHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 8e-59
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 40/286 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + ++G G FGVV GK +VAIK K+ E F E + L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM-----IKEGSMSEDEFIEEAKVMMNLSH 58
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH---------DRNNVEKNAARGIEYLHN 604
+ LV+L G C ++ ++ +YM NG L ++L + K+ +EYL +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
+HRD+ + N L++ Q +VSDFGLS + E + + V + PE
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLM 174
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724
+ ++KSD++ GV++ E+ + + ++ T + I G R
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERF----TNSETAE----HIAQGL-------R 219
Query: 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770
+ P + + + C + + ERPT +++N+ LD+
Sbjct: 220 LYRPHLASEKVYTI----MYSCWHEKADERPTFKILLSNI---LDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 2e-58
Identities = 62/305 (20%), Positives = 113/305 (37%), Gaps = 49/305 (16%)
Query: 492 ATNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
++F +++GAG+ GVV+K P G +A K + + EL L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ---IIRELQVLHE 60
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE--------KNAARGIEYL 602
+ ++V G E + ++M G+L L + +G+ YL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
I+HRD+K SNIL++++ ++ DFG+S +S GT Y+ PE
Sbjct: 121 REKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPER 174
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD---------------------ESGGTP 701
+ +SD++ +G+ L+E+ G+ I D
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 702 VSLVDFAVPAIMAGELVKILDRRVG------PPEINEAEAVELVAYTAMHCVNLEGKERP 755
L + + + + ++LD V P + E + V C+ ER
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV----NKCLIKNPAERA 290
Query: 756 TMADI 760
+ +
Sbjct: 291 DLKQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 2e-57
Identities = 69/310 (22%), Positives = 126/310 (40%), Gaps = 50/310 (16%)
Query: 484 FLLAELAAATNNFS---------LENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAK 530
F + A F+ +E IGAG FG V G L VAIK ++
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 531 TKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN 590
T+K + F SE + + + H +++ L G + +++ ++M+NG+L L +
Sbjct: 67 TEKQRRD---FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG 123
Query: 591 VE---------KNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641
+ A G++YL + +HRD+ + NIL+++ +VSDFGLS +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 642 SERD---FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG 698
D + + + PE T+ SDV+ G+V+ E+++ + D
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--- 237
Query: 699 GTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMA 758
T +++ I PP ++ A+ + + C + RP
Sbjct: 238 -TNQDVIN------------AIEQDYRLPPPMDCPSALHQL---MLDCWQKDRNHRPKFG 281
Query: 759 DIVANLERAL 768
IV L++ +
Sbjct: 282 QIVNTLDKMI 291
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 195 bits (496), Expect = 4e-57
Identities = 66/322 (20%), Positives = 118/322 (36%), Gaps = 63/322 (19%)
Query: 486 LAELAAATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKES 539
L L NN IG G+FG V++ + P VA+K K + + ++
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM---LKEEASADMQA 61
Query: 540 AFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------- 589
F E A ++ + ++V+L+G C L+++YM G L + L +
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 590 ----------------------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWT 627
+ + A G+ YL +HRD+ + N L+
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMV 178
Query: 628 ARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687
+++DFGLS ++ A + ++ PE N T +SDV+ GVVL E+ +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 688 KRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCV 747
+ ++ + G ++ PE E L+ C
Sbjct: 239 GLQPYYGM----AHEEVIY----YVRDGNILAC-------PENCPLELYNLM----RLCW 279
Query: 748 NLEGKERPTMADIVANLERALD 769
+ +RP+ I L+R +
Sbjct: 280 SKLPADRPSFCSIHRILQRMCE 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 4e-57
Identities = 76/282 (26%), Positives = 116/282 (41%), Gaps = 39/282 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ LE K+G G FG V+ G VAIK K AF E + +L H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK-----TLKPGTMSPEAFLQEAQVMKKLRH 71
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN----------AARGIEYLH 603
+ LV+L ++ +V +YM G+L D L A G+ Y+
Sbjct: 72 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
+HRD++++NIL+ +V+DFGL+ + ++E R A + + PE
Sbjct: 131 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAA 186
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
T KSDV+ G++L EL T R + G ++D + G +
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLD----QVERGYRMPC--- 235
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
PPE E +L+ C E +ERPT + A LE
Sbjct: 236 ---PPECPE-SLHDLM----CQCWRKEPEERPTFEYLQAFLE 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-56
Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 45/284 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
L IG G FG V G G +VA+K + T + AF +E + +++L H
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ------AFLAEASVMTQLRH 59
Query: 554 KHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNN----------VEKNAARGIEYL 602
+LV+L+G E+ L +V +YM G+L D+L R + +EYL
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
+HRD+ + N+L+ A+VSDFGL+ ++ + V + PE
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEA 171
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
+ KSDV+ G++L E+ + R + + VP + G +
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDA-- 221
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
P E++ +C +L+ RP+ + LE
Sbjct: 222 ----PDGCPP-AVYEVM----KNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 64/292 (21%), Positives = 119/292 (40%), Gaps = 40/292 (13%)
Query: 488 ELAAATNNFSLEN-KIGAGSFGVVYKGKL---PDGQEVAIKRGETAKTKKFQEKESAFDS 543
+L +N + + ++G G+FG V +G +VAIK K +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMR 58
Query: 544 ELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNA------ 595
E + +L + ++VRL+G C+ + +LV + G L+ L + N
Sbjct: 59 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 596 -ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAG 653
+ G++YL +HRD+ + N+LL + A++SDFGLS +G +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
+ + PE +++SDV+ GV + E L+ + +K ++ F I
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM----KGPEVMAF----IE 226
Query: 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
G+ ++ PPE E L+ C + ++RP + +
Sbjct: 227 QGKRMEC------PPECPP-ELYALM----SDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-55
Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 56/304 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDG---QEVAIKRGETAKTKKFQEKESAFDSELAFLSR 550
N+ ++ IG G+FG V K ++ + AIKR K ++ F EL L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCK 66
Query: 551 L-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN--------------- 594
L HH +++ L+G CE + L +Y +G L D L +E +
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 595 ---------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645
ARG++YL IHRD+ + NIL+ + A+++DFGLS +
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183
Query: 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV 705
V ++ E +V T SDV+ GV+L E+++ + T L
Sbjct: 184 ---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM----TCAELY 236
Query: 706 DFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765
+ + G ++ P ++ E +L+ C + ERP+ A I+ +L
Sbjct: 237 E----KLPQGYRLEK------PLNCDD-EVYDLM----RQCWREKPYERPSFAQILVSLN 281
Query: 766 RALD 769
R L+
Sbjct: 282 RMLE 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 188 bits (479), Expect = 6e-55
Identities = 64/288 (22%), Positives = 115/288 (39%), Gaps = 43/288 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ ++++K+G G +G VY+G VA+K K+ + F E A + +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIK 71
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE----------KNAARGIEYL 602
H +LV+L+G C + ++ ++M G L D+L + N E + +EYL
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
IHRD+ + N L+ +V+DFGLS + A + + PE
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPES 187
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
N + KSDV+ GV+L E+ T + + + ++ ++L+
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYELLE 230
Query: 723 RRVGPPEINE--AEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
+ + EL+ C +RP+ A+I E
Sbjct: 231 KDYRMERPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-55
Identities = 66/296 (22%), Positives = 121/296 (40%), Gaps = 39/296 (13%)
Query: 494 NNFSLENK-IGAGSFGVVYKGKLPD---GQEVAIKRGETAKTKKFQEKESAFDSELAFLS 549
+LE+K +G+G+FG V KG + VA+K + + E +E +
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE--LLAEANVMQ 63
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE--------KNAARGIEY 601
+L + ++VR++G CE + +LV + + G L +L +V+ + G++Y
Sbjct: 64 QLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYIDP 660
L +HRD+ + N+LL Q A++SDFGLS + + V + P
Sbjct: 123 LEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
E ++KSDV+ GV++ E + + ++ + + GE +
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM----KGSEVTA----MLEKGERMGC 231
Query: 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA-LDICDHSH 775
P E +L+ C + + RP A + L D+ + H
Sbjct: 232 ------PAGCPR-EMYDLM----NLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-54
Identities = 67/308 (21%), Positives = 123/308 (39%), Gaps = 35/308 (11%)
Query: 474 SSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETA 529
S+ + + + + ++ IG G FG VY G L D A+K
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---L 63
Query: 530 KTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER-LLVYDYMKNGALYDHLHDR 588
+ S F +E + H +++ L+G C + L+V YMK+G L + + +
Sbjct: 64 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 589 NNVEKN------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGP 640
+ + + + A +HRD+ + N +LD ++T +V+DFGL+ M
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700
E + A V ++ E T KSDV+ GV+L EL+T + D
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----N 239
Query: 701 PVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+ ++ G RR+ PE E+ + C + + + RP+ +++
Sbjct: 240 TFDITV----YLLQG-------RRLLQPEYCPDPLYEV----MLKCWHPKAEMRPSFSEL 284
Query: 761 VANLERAL 768
V+ +
Sbjct: 285 VSRISAIF 292
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 7e-54
Identities = 58/312 (18%), Positives = 109/312 (34%), Gaps = 66/312 (21%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD------GQEVAIKRGETAKTKKFQEKESAFDSELAF 547
N +G+G+FG V +VA+K K K + A SEL
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM---LKEKADSSEREALMSELKM 93
Query: 548 LSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN------------ 594
+++L H+++V L+G C L+++Y G L ++L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 595 -------------------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGL 635
A+G+E+L +HRD+ + N+L+ ++ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDD 695
+ A V ++ PE + T KSDV+ G++L E+ + +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 696 ESGGTPVSLVDFAVPAIMAGELVKILDRRVGP--PEINEAEAVELVAYTAMHCVNLEGKE 753
+ K++ P E ++ C + ++
Sbjct: 271 P----------------VDANFYKLIQNGFKMDQPFYATEEIYIIM----QSCWAFDSRK 310
Query: 754 RPTMADIVANLE 765
RP+ ++ + L
Sbjct: 311 RPSFPNLTSFLG 322
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 9e-54
Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
++ L +G G++G V + VA+K K+ + E+ L+
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKMLN 61
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
H+++V+ G+ E + + L +Y G L+D + + + A+ G+ YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY- 663
I HRDIK N+LLD + ++SDFGL+ + + R+ K GT+ Y+ PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
DV+ G+VL +L G+ + +S + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------------CQEYSDWKEKKTY 225
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+I+ + L+ + R T+ DI
Sbjct: 226 LNPWKKIDS-APLALL----HKILVENPSARITIPDI 257
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 38/277 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F + +G G FG VY + +A+K A+ +K E E+ S L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLR 64
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
H +++RL GY + L+ +Y G +Y L + ++ + Y H+
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
+IHRDIK N+LL + +++DFG S+ P S R GT+ Y+ PE
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIE 177
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724
+ K D++ LGV+ E L GK T +I
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYK------------RISRVE 220
Query: 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
P+ A +L+ + +RP + +++
Sbjct: 221 FTFPDFVTEGARDLI----SRLLKHNPSQRPMLREVL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-53
Identities = 72/294 (24%), Positives = 128/294 (43%), Gaps = 40/294 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQE-----VAIKRGETAKTKKFQEKESAFDSELAFL 548
+ + + IGAG FG VYKG L VAIK K +++ F E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGEAGIM 63
Query: 549 SRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGI 599
+ H +++RL G + +++ +YM+NGAL L +++ + + A G+
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYI 658
+YL N +HRD+ + NIL+++ +VSDFGLS ++ + E + + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718
PE T+ SDV+ G+V+ E++T + + + E++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----------------HEVM 223
Query: 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772
K ++ P + + M C E RP ADIV+ L++ + D
Sbjct: 224 KAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (467), Expect = 6e-53
Identities = 64/278 (23%), Positives = 107/278 (38%), Gaps = 41/278 (14%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
FS +IG GSFG VY + + + + VAIK+ + + EK E+ FL +L H
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHP 75
Query: 555 HLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE--------KNAARGIEYLHNYA 606
+ ++ G + LV +Y A + ++ A +G+ YLH+
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-- 133
Query: 607 VPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY--- 663
+IHRD+K+ NILL ++ DFG + + + GT ++ PE
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAM 186
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
K DV+ LG+ +EL K +F +S + I E +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSALY----HIAQNESPALQSG 237
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
V C+ ++RPT ++
Sbjct: 238 HWSE------YFRNFV----DSCLQKIPQDRPTSEVLL 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 2e-52
Identities = 69/310 (22%), Positives = 115/310 (37%), Gaps = 61/310 (19%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAF 547
N S +GAG+FG V + VA+K K + A SEL
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM---LKPSAHLTEREALMSELKV 79
Query: 548 LSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA----------- 595
LS L +H ++V L+G C L++ +Y G L + L + + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 596 ---------------ARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640
A+G+ +L + IHRD+ + NILL ++ DFGL+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700
A V ++ PE V T +SDV+ G+ L EL + + +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 252
Query: 701 PVSLVDFAVPAIMAGELVKILDRRVGP--PEINEAEAVELVAYTAMHCVNLEGKERPTMA 758
+ + K++ PE AE +++ C + + +RPT
Sbjct: 253 ------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIM----KTCWDADPLKRPTFK 296
Query: 759 DIVANLERAL 768
IV +E+ +
Sbjct: 297 QIVQLIEKQI 306
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 3e-52
Identities = 67/283 (23%), Positives = 110/283 (38%), Gaps = 46/283 (16%)
Query: 496 FSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHK 554
+ +IG GSF VYKG + EVA K + + F E L L H
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCE--LQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 555 HLVRLVGYCEE----KDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYL 602
++VR E K +LV + M +G L +L ++ R G+++L
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 603 HNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
H PPIIHRD+K NI + + ++ D GL+ + S GT ++ PE
Sbjct: 129 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPE 183
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
Y DVY G+ +LE+ T + + A ++ + +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-----------------NAAQIYRRV 225
Query: 722 DRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADIV 761
V P ++ E E++ C+ ER ++ D++
Sbjct: 226 TSGVKPASFDKVAIPEVKEII----EGCIRQNKDERYSIKDLL 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-52
Identities = 65/285 (22%), Positives = 106/285 (37%), Gaps = 32/285 (11%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+F +G GSF V + L +E AIK E K + K E +SRL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDH 67
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGI-----EYLHNYAVP 608
V+L ++ ++ Y KNG L ++ + ++ R L
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL 668
IIHRD+K NILL+ +++DFG + + + R GT Y+ PE
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 669 TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPP 728
SD++ LG ++ +L+ G +E KI+ P
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNE-----------------YLIFQKIIKLEYDFP 230
Query: 729 EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773
E +A +LV + L+ +R ++ E + H
Sbjct: 231 EKFFPKARDLV----EKLLVLDATKRLGCEEM----EGYGPLKAH 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-51
Identities = 58/284 (20%), Positives = 109/284 (38%), Gaps = 41/284 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
++ + IG GS+G K + DG+ + K + ++ SE+ L L H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKE--LDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 554 KHLVRLVGYCEEKDERLL--VYDYMKNGALYDHLHDRNNVEKN------------AARGI 599
++VR ++ L V +Y + G L + + +
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 600 EYLH--NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGY 657
+ H + ++HRD+K +N+ LD + ++ DFGL+ + + GT Y
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV--GTPYY 180
Query: 658 IDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
+ PE KSD++ LG +L EL + + L I G+
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAG----KIREGKF 231
Query: 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
+I P ++ E E++ +NL+ RP++ +I+
Sbjct: 232 RRI------PYRYSD-ELNEII----TRMLNLKDYHRPSVEEIL 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-51
Identities = 62/287 (21%), Positives = 124/287 (43%), Gaps = 44/287 (15%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQE----VAIKRGETAKTKKFQEKESAFDSELAFLSR 550
F +G+G+FG VYKG +P+G++ VAIK A + K ++ E ++
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMAS 67
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE---------KNAARGIEY 601
+ + H+ RL+G C +L + M G L D++ + + A+G+ Y
Sbjct: 68 VDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
L + ++HRD+ + N+L+ +++DFGL+ + E+++ + ++ E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
+ T +SDV+ GV + EL+T + A E+ IL
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----------------ASEISSIL 226
Query: 722 DR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766
++ R+ P I + ++ + C ++ RP +++ +
Sbjct: 227 EKGERLPQPPICTIDVYMIM----VKCWMIDADSRPKFRELIIEFSK 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 8e-51
Identities = 59/279 (21%), Positives = 114/279 (40%), Gaps = 41/279 (14%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
++ KIG G+ G VY + GQEVAI++ + Q K+ +E+ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ----MNLQQQPKKELIINEILVMREN 74
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNA-------ARGIEYLHN 604
+ ++V + DE +V +Y+ G+L D + + E + +E+LH+
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
+IHRDIKS NILL + +++DFG + M GT ++ PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVT 189
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724
K D++ LG++ +E++ G+ ++ L I
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------------LRALYLIATNG 232
Query: 725 VGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADI 760
+ E A + + C++++ ++R + ++
Sbjct: 233 TPELQNPEKLSAIFRDFL----NRCLDMDVEKRGSAKEL 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-49
Identities = 54/283 (19%), Positives = 110/283 (38%), Gaps = 42/283 (14%)
Query: 493 TNNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ + + ++G G+FG VYK + + A K + K +E+ + E+ L+
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID----TKSEEELEDYMVEIDILASC 66
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIEYL 602
H ++V+L+ ++ ++ ++ GA+ + + V K + YL
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
H+ IIHRD+K+ NIL +++DFG+S + + GT ++ PE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF--IGTPYWMAPEV 181
Query: 663 YGLNVL-----TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717
K+DV+ LG+ L+E+ + + P+ ++ I E
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHEL----NPMRVLL----KIAKSEP 232
Query: 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+ P + + + C+ R T + +
Sbjct: 233 PTLAQ----PSRWSS-NFKDFL----KKCLEKNVDARWTTSQL 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 4e-49
Identities = 64/300 (21%), Positives = 118/300 (39%), Gaps = 49/300 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAF 547
++ ++G GSFG+VY+G VAIK + F +E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASV 76
Query: 548 LSRLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN------------- 594
+ + H+VRL+G + L++ + M G L +L N
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 595 -----AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPM 649
A G+ YL+ +HRD+ + N ++ +T ++ DFG++ E++ +
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193
Query: 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
K V ++ PE V T SDV+ GVVL E+ T ++ + + +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVL 245
Query: 710 PAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769
+M G L+ P + EL C K RP+ +I+++++ ++
Sbjct: 246 RFVMEGGLLDK------PDNCPD-MLFEL----MRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 5e-49
Identities = 63/289 (21%), Positives = 107/289 (37%), Gaps = 40/289 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLS 549
L IG G FG V++G VAIK + + +EK F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK---FLQEALTMR 63
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLH---------DRNNVEKNAARGIE 600
+ H H+V+L+G E + ++ + G L L + +
Sbjct: 64 QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDP 660
YL + +HRDI + N+L+ + ++ DFGLS +S ++ K + ++ P
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAP 178
Query: 661 EYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
E T+ SDV+ GV + E+L F+ ++ I GE + +
Sbjct: 179 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV----KNNDVIG----RIENGERLPM 230
Query: 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769
PP L+ C + RP ++ A L L+
Sbjct: 231 ------PPNCPP-TLYSLM----TKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 2e-48
Identities = 59/288 (20%), Positives = 105/288 (36%), Gaps = 37/288 (12%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLP----DGQEVAIKRGETAKTKKFQEKESAFDSELAFLS 549
+ L K+G GSFGVV +G+ VA+K + + + + F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD-FIREVNAMH 66
Query: 550 RLHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN---------VEKNAARGIE 600
L H++L+RL G ++ V + G+L D L A G+
Sbjct: 67 SLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYID 659
YL + IHRD+ + N+LL + ++ DFGL + + +
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719
PE + SD + GV L E+ T + + ++ +
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQIL----------HKID 228
Query: 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767
R+ PE + ++ + C + ++RPT + L A
Sbjct: 229 KEGERLPRPEDCPQDIYNVM----VQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-47
Identities = 62/308 (20%), Positives = 116/308 (37%), Gaps = 58/308 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLP--------DGQEVAIKRGETAKTKKFQEKESAFDSEL 545
+ L +G G+FG V + +VA+K K+ ++ S SE+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM---LKSDATEKDLSDLISEM 69
Query: 546 AFLSRL-HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKN---------- 594
+ + HK+++ L+G C + ++ +Y G L ++L R
Sbjct: 70 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 595 --------------AARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640
ARG+EYL + IHRD+ + N+L+ +++DFGL+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT 700
+ + V ++ PE + T +SDV+ GV+L E+ T + +
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 242
Query: 701 PVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
V+ + G + P E ++ C + +RPT +
Sbjct: 243 ----VEELFKLLKEGHRMDK------PSNCTN-ELYMMM----RDCWHAVPSQRPTFKQL 287
Query: 761 VANLERAL 768
V +L+R +
Sbjct: 288 VEDLDRIV 295
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 167 bits (425), Expect = 2e-46
Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 42/292 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFD--SELAFLSR 550
N+FS+ IG G FG VY + D G+ A+K + + K Q + A + L+ +S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE--------KNAARGIEYL 602
+V + D+ + D M G L+ HL G+E++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 603 HNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
HN +++RD+K +NILLD R+SD GL+ + +P + GT GY+ PE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEV 176
Query: 663 Y-GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
+ +D + LG +L +LL G + L
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK--------------TKDKHEIDRMTL 222
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773
V P+ E L+ + + R A ++ +
Sbjct: 223 TMAVELPDSFSPELRSLL----EGLLQRDVNRRLGCLGRGAQ-----EVKES 265
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 164 bits (417), Expect = 2e-46
Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 34/291 (11%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLS 549
++ + L +G G V+ + L ++VA+K R + A+ F + F E +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR---FRREAQNAA 62
Query: 550 RLHHKHLVRLVGYCEEKDERL----LVYDYMKNGALYDHLHDRNNVEKNAARGI-----E 600
L+H +V + E + +V +Y+ L D +H + A + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKA-AGTVGYID 659
L+ IIHRD+K +NI++ A +V DFG++ +S A GT Y+
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 660 PEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719
PE + + A+SDVY LG VL E+LTG+ F D +PVS+ + + +
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP-FTGD----SPVSVAY----QHVREDPIP 233
Query: 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-TMADIVANLERALD 769
R G + +V + + + R T A++ A+L R +
Sbjct: 234 PSARHEGLSA----DLDAVV----LKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (422), Expect = 3e-46
Identities = 55/279 (19%), Positives = 117/279 (41%), Gaps = 39/279 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ + + ++G+G+FGVV++ G+ K + + +E++ +++LH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKF----INTPYPLDKYTVKNEISIMNQLH 84
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLH 603
H L+ L E+K E +L+ +++ G L+D + + N + A G++++H
Sbjct: 85 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
I+H DIK NI+ + + + V DFGL+ + D T + PE
Sbjct: 145 E---HSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPE 198
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
+ +D++ +GV+ LL+G +G + + + +
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPF-----AGEDDLETLQ----NVKRCDWEFDE 249
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
D ++ EA + + + + E ++R T+ D
Sbjct: 250 DA---FSSVSP-EAKDFI----KNLLQKEPRKRLTVHDA 280
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (421), Expect = 4e-46
Identities = 52/279 (18%), Positives = 107/279 (38%), Gaps = 39/279 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+++ + ++G G+FGVV++ G A K + + E+ +S L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKF----VMTPHESDKETVRKEIQTMSVLR 81
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNV--EKNA-------ARGIEYLH 603
H LV L E+ +E +++Y++M G L++ + D +N E A +G+ ++H
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 141
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
+H D+K NI+ + + + DFGL+ + GT + PE
Sbjct: 142 E---NNYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPE 195
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
+ +D++ +GV+ LL+G G + + + +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPF-----GGENDDETLR----NVKSCDWNMDD 246
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
I+E + + + + + R T+
Sbjct: 247 SA---FSGISE-DGKDFI----RKLLLADPNTRMTIHQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (414), Expect = 1e-45
Identities = 57/286 (19%), Positives = 108/286 (37%), Gaps = 38/286 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F + +G GSFG V+ + +G+ A+K + + ++ E + E LS +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEH-TNDERLMLSIVT 62
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGI-----EYLHNYAV 607
H ++R+ G ++ + ++ DY++ G L+ L A+ L
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
II+RD+K NILLD +++DFG + P+ GT YI PE
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKP 177
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727
D + G+++ E+L G + + KIL+ +
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------------MKTYEKILNAELRF 220
Query: 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773
P + +L++ + + +R D+ +H
Sbjct: 221 PPFFNEDVKDLLS----RLITRDLSQRLGNLQNGTE-----DVKNH 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-45
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 56/307 (18%)
Query: 494 NNFSLENKIGAGSFGVVYKG------KLPDGQEVAIKRGETAKTKKFQEKESAFDSELAF 547
+ L +G G+FG V + K + VA+K K + A SEL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM---LKEGATHSEHRALMSELKI 69
Query: 548 LSR-LHHKHLVRLVGYCEEKDERL-LVYDYMKNGALYDHLHDRNNVE------------- 592
L HH ++V L+G C + L ++ ++ K G L +L + N
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 593 -----------KNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641
A+G+E+L + IHRD+ + NILL + ++ DFGL+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP 701
R A + ++ PE V T +SDV+ GV+L E+ + + +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------ 240
Query: 702 VSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIV 761
+ + + G ++ P+ E + + + C + E +RPT +++V
Sbjct: 241 -KIDEEFCRRLKEGTRMRA-------PDYTTPEMYQTM----LDCWHGEPSQRPTFSELV 288
Query: 762 ANLERAL 768
+L L
Sbjct: 289 EHLGNLL 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 5e-45
Identities = 56/277 (20%), Positives = 103/277 (37%), Gaps = 32/277 (11%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ + + +G G+F V + + VAIK K + KE + ++E+A L ++
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC---IAKKALEGKEGSMENEIAVLHKI 64
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
H ++V L E L+ + G L+D + ++ + A ++YLH
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 604 NYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
+ + + LD +SDFGLS M + A GT GY+ PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 181
Query: 664 GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723
+ D + +GV+ LL G + L + I+ E
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFY-----DENDAKLFE----QILKAEYEFDSPY 232
Query: 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+I++ A + + H + + ++R T
Sbjct: 233 ---WDDISD-SAKDFI----RHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 2e-44
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 48/289 (16%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKR-----GETAKTKKFQEKESAFDSELAFL 548
N+ + +G G VV + P +E A+K G + ++ QE A E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 549 SRLH-HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GI 599
++ H ++++L E LV+D MK G L+D+L ++ + + R I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYID 659
LH I+HRD+K NILLD +++DFG S E+ GT Y+
Sbjct: 124 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC---GTPSYLA 177
Query: 660 PEYY------GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
PE + D++ GV++ LL G F + ++ IM
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHR----KQMLMLR----MIM 228
Query: 714 AGELVKILDRRVGPPEINE--AEAVELVAYTAMHCVNLEGKERPTMADI 760
+G + G PE ++ +LV + ++ ++R T +
Sbjct: 229 SGNY------QFGSPEWDDYSDTVKDLV----SRFLVVQPQKRYTAEEA 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-44
Identities = 47/278 (16%), Positives = 111/278 (39%), Gaps = 40/278 (14%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ + +G G FG+V++ + K K + E++ L+ H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-----FVKVKGTDQVLVKKEISILNIARH 60
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHN 604
++++ L E +E +++++++ +++ ++ + +++LH+
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARV--SDFGLSMMGPESERDFRPMKAAGTVGYIDPEY 662
I H DI+ NI+ + ++ + +FG + + + Y PE
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEV 174
Query: 663 YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722
+ +V++ +D++ LG ++ LL+G F + T +++ IM E +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGIN-PFLAE----TNQQIIE----NIMNAEYTFDEE 225
Query: 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
EI+ EA++ V + E K R T ++
Sbjct: 226 A---FKEISI-EAMDFV----DRLLVKERKSRMTASEA 255
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 51/279 (18%), Positives = 107/279 (38%), Gaps = 32/279 (11%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIK--RGETAKTKKFQEKESAFDSELAFLSR 550
+ + ++G+G F VV K + G + A K + K+ + + E++ L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 551 LHHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGI-----EYLHNY 605
+ H +++ L E K + +L+ + + G L+D L ++ ++ + A ++
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 606 AVPPIIHRDIKSSNILLDAQWTAR----VSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
I H D+K NI+L + + + DFGL+ GT ++ PE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTPEFVAPE 186
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721
L ++D++ +GV+ LL+G D + + + A
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---------TLANVSAVNYEFED 237
Query: 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+ + A + + + + K+R T+ D
Sbjct: 238 EY---FSNTSA-LAKDFI----RRLLVKDPKKRMTIQDS 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-42
Identities = 59/276 (21%), Positives = 94/276 (34%), Gaps = 29/276 (10%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+F L +G GSFG V+ + Q AIK + + E +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGI-----EYLHNYAV 607
H L + + K+ V +Y+ G L H+ + + + A L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
I++RD+K NILLD +++DFG+ D + GT YI PE
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--MLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727
D + GV+L E+L G+ F L I
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQS-PFHGQ----DEEELFHS------------IRMDNPFY 222
Query: 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763
P E EA +L+ + E ++R + +
Sbjct: 223 PRWLEKEAKDLL----VKLFVREPEKRLGVRGDIRQ 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (378), Expect = 5e-41
Identities = 50/284 (17%), Positives = 105/284 (36%), Gaps = 24/284 (8%)
Query: 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+ KIG G++GVVYK + G+ A+K+ K+ + S E++ L L H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKK--IRLEKEDEGIPSTTIREISILKELKH 59
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVE-----KNAARGIEYLHNYAVP 608
++V+L K +LV++++ +E + + +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 609 PIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVL 668
++HRD+K N+L++ + +++DFGL+ R + + G
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDVLMGSKKY 178
Query: 669 TAKSDVYGLGVVLLELLTGKRAIFKDDESG---------GTPVSLVDFAVPAIMAGELVK 719
+ D++ +G + E++ G E+ GTP S V + +
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 720 ILDRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADI 760
+ + + ++L+ + L+ +R T
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLL----SKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 53/281 (18%), Positives = 100/281 (35%), Gaps = 27/281 (9%)
Query: 500 NKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEK-ESAFDSELAFLSRLHHKHLV 557
+ +G G F VYK + Q VAIK+ + + ++ E+ L L H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 558 RLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGI-----EYLHNYAVPPIIH 612
L+ K LV+D+M+ + + + + + L I+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 613 RDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY-GLNVLTAK 671
RD+K +N+LLD +++DFGL+ R + T Y PE G +
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVTRWYRAPELLFGARMYGVG 181
Query: 672 SDVYGLGVVLLELLTGK------------RAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719
D++ +G +L ELL IF+ + ++P + +
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241
Query: 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+ + + ++L+ R T
Sbjct: 242 GIPLHHIFSAAGD-DLLDLI----QGLFLFNPCARITATQA 277
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 3e-40
Identities = 52/296 (17%), Positives = 113/296 (38%), Gaps = 38/296 (12%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
++ + IG G++G+V + VAIK+ + + + ++ E+ L R
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR---TLREIKILLRF 63
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYM----KNGALYDHLHDRNNVEKNA-------ARGIE 600
H++++ + + Y+ LY L ++ + RG++
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLK 123
Query: 601 YLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS-MMGPESERDFRPMKAAGTVGYID 659
Y+H+ ++HRD+K SN+LL+ ++ DFGL+ + P+ + + T Y
Sbjct: 124 YIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 660 PEY-YGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDES---------GGTPVSLVDFAV 709
PE T D++ +G +L E+L+ + G+P +
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 710 PAIMAGELVKILDRRVGPPEIN-----EAEAVELVAYTAMHCVNLEGKERPTMADI 760
+ A + L + P +++A++L+ + +R +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL----DKMLTFNPHKRIEVEQA 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 148 bits (373), Expect = 3e-40
Identities = 48/295 (16%), Positives = 88/295 (29%), Gaps = 42/295 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL- 551
++ + +IG GSFGV+++G L + Q+VAIK + + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLA 58
Query: 552 HHKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLH 603
+ + + +E +LV D + ++ +H
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 604 NYAVPPIIHRDIKSSNILLDAQWT-----ARVSDFGLSMMGPESE-----RDFRPMKAAG 653
+++RDIK N L+ + V DFG+ + +G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 654 TVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713
T Y+ + + + D+ LG V + L G
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA------------ATNKQ 223
Query: 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
E + + E+ E Y + NL P + + L
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKY-MHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-40
Identities = 47/286 (16%), Positives = 100/286 (34%), Gaps = 26/286 (9%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ KIG G++G V+K K + VA+KR + E+ L L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS--ALREICLLKELK 59
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNN-----VEKNAARGIEYLHNYAV 607
HK++VRL + LV+++ + V+ + ++ L
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
++HRD+K N+L++ ++++FGL+ R + + +G +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS-AEVVTLWYRPPDVLFGAKL 178
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDD----------ESGGTPVSLVDFAVPAIMAGEL 717
+ D++ G + EL R +F + GTP ++ + +
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 718 VKILDRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADI 760
+ + A +L+ + + +R + +
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLL----QNLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-39
Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 44/280 (15%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESA--FDSELAFLSR 550
+ + + +G+G FG VY G + D VAIK E + + E + E+ L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 551 LHHKH--LVRLVGYCEEKDERLLVYDYMKNGA-LYDHLHDRNNVEKNAARGI-----EYL 602
+ ++RL+ + E D +L+ + + L+D + +R +++ AR E +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 603 HNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
+ ++HRDIK NIL+D ++ DFG + ++ GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPE 179
Query: 662 YY-GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720
+ + V+ LG++L +++ G D+E I+ G++
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------------IIRGQVFF- 223
Query: 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
++ E L+ C+ L +RPT +I
Sbjct: 224 ------RQRVSS-ECQHLI----RWCLALRPSDRPTFEEI 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-39
Identities = 62/286 (21%), Positives = 101/286 (35%), Gaps = 35/286 (12%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
N+F +G G+FG V + G+ A+K +++ + +E L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTR 63
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAARGI-----EYLHNYAV 607
H L L + D V +Y G L+ HL + AR L
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV 667
+++RDIK N++LD +++DFGL G GT Y+ PE N
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDND 181
Query: 668 LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGP 727
D +GLGVV+ E++ G+ + L + IL +
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFY-----NQDHERLFE------------LILMEEIRF 224
Query: 728 PEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773
P EA L+ + + K+R A ++ +H
Sbjct: 225 PRTLSPEAKSLL----AGLLKKDPKQRLGGGPSDAK-----EVMEH 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (368), Expect = 2e-39
Identities = 54/293 (18%), Positives = 89/293 (30%), Gaps = 40/293 (13%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
N + L KIG+GSFG +Y G + G+EVAIK + + K E +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQ 60
Query: 553 HKHLVRLVGYC-EEKDERLLVYDYMKNGALYDHLHDRNNVE--------KNAARGIEYLH 603
+ + +C E D ++V + + IEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 604 NYAVPPIIHRDIKSSNIL---LDAQWTARVSDFGLSMMGPESE-----RDFRPMKAAGTV 655
+ IHRD+K N L + DFGL+ ++ GT
Sbjct: 121 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 656 GYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAG 715
Y + + + D+ LG VL+ G A
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGS------------LPWQGLKAATKRQKY 225
Query: 716 ELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768
E + + + E Y C +L ++P + +
Sbjct: 226 ERISEKKMSTPIEVLCKGYPSEFATY-LNFCRSLRFDDKPDYSYLRQLFRNLF 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 58/282 (20%), Positives = 100/282 (35%), Gaps = 47/282 (16%)
Query: 498 LENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKH 555
+G G G V + ++ A+K + E+ R H
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKM---------LQDCPKARREVELHWRASQCPH 66
Query: 556 LVRLVGYCE----EKDERLLVYDYMKNGALYDHLHDRNNVE----------KNAARGIEY 601
+VR+V E + L+V + + G L+ + DR + K+ I+Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQW---TARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
LH+ I HRD+K N+L ++ +++DFG + P T Y+
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYV 180
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718
PE G D++ LGV++ LL G + + AI G
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------------AISPGMKT 227
Query: 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
+I + P +E E V + + E +R T+ +
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 4e-39
Identities = 56/299 (18%), Positives = 115/299 (38%), Gaps = 38/299 (12%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ + KIG G+FG V+K + GQ+VA+K+ + + E+ L L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKK--VLMENEKEGFPITALREIKILQLLK 67
Query: 553 HKHLVRLVGYCEEKDER--------LLVYDYMKNGALYDHLHDRNNVEKNAARGI----- 599
H+++V L+ C K LV+D+ ++ + + + +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS--MMGPESERDFRPMKAAGTVGY 657
L+ I+HRD+K++N+L+ +++DFGL+ ++ + R T+ Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 658 IDPEYY-GLNVLTAKSDVYGLGVVLLELLTGK---------RAIFKDDESGGTPVSLVDF 707
PE G D++G G ++ E+ T + + G+ V
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 708 AVPAIMAGELVKILD------RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
V E ++++ + + + A++L+ + L+ +R D
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI----DKLLVLDPAQRIDSDDA 302
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 4e-39
Identities = 55/286 (19%), Positives = 117/286 (40%), Gaps = 28/286 (9%)
Query: 495 NFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
NF KIG G++GVVYK + G+ VA+K+ + + S E++ L L+H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKK--IRLDTETEGVPSTAIREISLLKELNH 60
Query: 554 KHLVRLVGYCEEKDERLLVYDYMKNGAL-YDHLHDRNNVEKNAARGI-----EYLHNYAV 607
++V+L+ +++ LV++++ + + + + L
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE-YYGLN 666
++HRD+K N+L++ + +++DFGL+ R + T+ Y PE G
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILLGCK 178
Query: 667 VLTAKSDVYGLGVVLLELLTGKR---------AIFKDDESGGTPVSLVDFAVPAIMAGEL 717
+ D++ LG + E++T + +F+ + GTP +V V ++ +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 718 VKILDRRVGPPEINE---AEAVELVAYTAMHCVNLEGKERPTMADI 760
R ++ + L+ ++ + +R +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLL----SQMLHYDPNKRISAKAA 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 5e-39
Identities = 56/300 (18%), Positives = 111/300 (37%), Gaps = 45/300 (15%)
Query: 492 ATNNFSLENKIGAGSFGVVYKGK--LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLS 549
A + +IG G++G V+K + G+ VA+KR + + E+A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR--VRVQTGEEGMPLSTIREVAVLR 62
Query: 550 RL---HHKHLVRLVGYC-----EEKDERLLVYDYMKNGALYDHLHDRN---------NVE 592
L H ++VRL C + + + LV++++ ++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 593 KNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAA 652
RG+++LH++ ++HRD+K NIL+ + +++DFGL+ + +
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--- 176
Query: 653 GTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKR------------AIFKDDESGGT 700
T+ Y PE + D++ +G + E+ K I G
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 701 PVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADI 760
D A+P + +I+E +L+ + C+ +R +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKF-VTDIDE-LGKDLL----LKCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 77/304 (25%), Positives = 113/304 (37%), Gaps = 62/304 (20%)
Query: 495 NFSLENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH 553
+++ IG GSFGVVY+ KL D G+ VAIK K + + + EL + +L H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK--------KVLQDKRFKNRELQIMRKLDH 72
Query: 554 KHLVRLVGYCEEKDER------LLVYDYMKNGALYDHLHDRNNVE-----------KNAA 596
++VRL + E+ LV DY+ H +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 597 RGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAAGTV 655
R + Y+H+ I HRDIK N+LLD ++ DFG + E + + +
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC---SR 186
Query: 656 GYIDP-EYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG---------GTPV--- 702
Y P +G T+ DV+ G VL ELL G+ D GTP
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 703 ------SLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT 756
+ +F P I A K+ R P EA+ L + R T
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPP------EAIALC----SRLLEYTPTARLT 296
Query: 757 MADI 760
+
Sbjct: 297 PLEA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 73/324 (22%), Positives = 121/324 (37%), Gaps = 44/324 (13%)
Query: 462 RLLTMRRQ-RSGTSSKHADRAEEFLLAELAAATNNFSLENKIGAGSFGVVYKGKL----P 516
+LLT++ + R+ + HA++ NF L +G G++G V+ +
Sbjct: 1 QLLTVKHELRTANLTGHAEKV----------GIENFELLKVLGTGAYGKVFLVRKISGHD 50
Query: 517 DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDERLLVYDY 575
G+ A+K + A + + +E L + LV L + + + L+ DY
Sbjct: 51 TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110
Query: 576 MKNGALYDHLHDRNN-----VEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARV 630
+ G L+ HL R V+ + L + II+RDIK NILLD+ +
Sbjct: 111 INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 170
Query: 631 SDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNV-LTAKSDVYGLGVVLLELLTGKR 689
+DFGLS E + G + D + LGV++ ELLTG
Sbjct: 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
Query: 690 AIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNL 749
D E A +IL P+ A A +L+ +
Sbjct: 231 PFTVDGE-------------KNSQAEISRRILKSEPPYPQEMSALAKDLI----QRLLMK 273
Query: 750 EGKERPTMADIVANLERALDICDH 773
+ K+R A+ +I +H
Sbjct: 274 DPKKRLGCGPRDAD-----EIKEH 292
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 8e-36
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 18/212 (8%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ F +G GSFG V K G A+K + K K ++ E +E L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-TLNEKRILQAVN 99
Query: 553 HKHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEKNAAR--------GIEYLHN 604
LV+L ++ +V +Y+ G ++ HL + AR EYLH+
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 605 YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYG 664
+I+RD+K N+L+D Q +V+DFG + R GT + PE
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALAPEIIL 211
Query: 665 LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
D + LGV++ E+ G F D
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (331), Expect = 3e-34
Identities = 49/299 (16%), Positives = 111/299 (37%), Gaps = 49/299 (16%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL- 551
+++ L K+G G + V++ + + ++V +K + K KK + E+ L L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-------EIKILENLR 87
Query: 552 HHKHLVRLVGYCEEKDERL--LVYDYMKNGALYDHLHDRNNVE-----KNAARGIEYLHN 604
+++ L ++ R LV++++ N + + + ++Y H+
Sbjct: 88 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 605 YAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYY 663
I+HRD+K N+++D + R+ D+GL+ + + + + PE
Sbjct: 148 M---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPELL 201
Query: 664 -GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV----------------- 705
+ D++ LG +L ++ K F ++ V +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 706 --DFAVPAIMAGELVKILDRRVGPPEINEA--EAVELVAYTAMHCVNLEGKERPTMADI 760
D I+ K +R V + EA++ + + + + R T +
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL----DKLLRYDHQSRLTAREA 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 9e-32
Identities = 54/296 (18%), Positives = 101/296 (34%), Gaps = 44/296 (14%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ +G+G++G V G +VAIK+ + K EL L +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR--AYRELRLLKHMR 75
Query: 553 HKHLVRLVGYCEEKD------ERLLVYDYMKNGALYDHLHDRNNVE--------KNAARG 598
H++++ L+ + + LV +M G L + +G
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKG 133
Query: 599 IEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYI 658
+ Y+H IIHRD+K N+ ++ ++ DFGL+ +
Sbjct: 134 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT----RWYRA 186
Query: 659 DPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESG---------GTPVSLVDFAV 709
T D++ +G ++ E++TGK D GTP + +
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 710 PAIMAGELVKILDRRVGPPEIN-----EAEAVELVAYTAMHCVNLEGKERPTMADI 760
+ A +K L + AV L+ + L+ ++R T +
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL----EKMLVLDAEQRVTAGEA 298
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-31
Identities = 57/296 (19%), Positives = 109/296 (36%), Gaps = 42/296 (14%)
Query: 493 TNNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL 551
+ + +G+G++G V G VA+K+ K EL L +
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR--TYRELRLLKHM 74
Query: 552 HHKHLVRLVGYCEEKD-----ERLLVYDYMKNGALYDHLHDRNNVEKNA-------ARGI 599
H++++ L+ + + ++ L + + + + + RG+
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 600 EYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYID 659
+Y+H+ IIHRD+K SN+ ++ ++ DFGL+ D T Y
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRA 186
Query: 660 PEYY-GLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDES---------GGTPVSLVDFAV 709
PE D++ +G ++ ELLTG+ D GTP + + +
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 710 PAIMAGELVKILDRRVGPPEINE-----AEAVELVAYTAMHCVNLEGKERPTMADI 760
+ A ++ L + N AV+L+ + L+ +R T A
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL----EKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-30
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 20/215 (9%)
Query: 494 NNFSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH 552
+ IG+G+ G+V + VAIK+ ++ + Q EL + ++
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKK--LSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 553 HKHLVRLVGYC------EEKDERLLVYDYMKNGALYDHLHDRNNVE-----KNAARGIEY 601
HK+++ L+ EE + LV + M + ++ GI++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKH 134
Query: 602 LHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPE 661
LH+ IIHRD+K SNI++ + T ++ DFGL+ S + T Y PE
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV---VTRYYRAPE 188
Query: 662 YYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDE 696
D++ +G ++ E++ K D
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (287), Expect = 3e-28
Identities = 50/255 (19%), Positives = 90/255 (35%), Gaps = 34/255 (13%)
Query: 496 FSLENKIGAGSFGVVYKGK-LPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH- 553
+ L K+G G F V+ K + + VA+K + + A + E+ L R++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDA 69
Query: 554 ----------KHLVRLVGYCEEKDERLLVYDYMKNGALYDHLHDRNNVEK---------- 593
H+++L+ + K + + + L E
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 594 ---NAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSMMGPESERDFRPM 649
G++Y+H IIH DIK N+L++ + ++ +G D
Sbjct: 130 ISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 650 KAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709
+ T Y PE +D++ ++ EL+TG +F+ DE A
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF-LFEPDEGHSYTKDDDHIAQ 246
Query: 710 PAIMAGELVKILDRR 724
+ GEL L R
Sbjct: 247 IIELLGELPSYLLRN 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 8e-23
Identities = 23/152 (15%), Positives = 52/152 (34%), Gaps = 15/152 (9%)
Query: 497 SLENKIGAGSFGVVYKGKLPDGQEVAIK--RGETAKTKKFQ----EKESAFDSELAFLSR 550
++ +G G V+ E +K + KK + + F +R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 551 LHHKHLVRLVGYCEEK----DERLLVYDYMKNGAL-YDHLHDRNNVEKNAARGIEYLHNY 605
+ L +L G K + ++ + + L + + + V + ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637
I+H D+ N+L+ + + DF S+
Sbjct: 122 --RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 59.0 bits (141), Expect = 4e-10
Identities = 46/268 (17%), Positives = 84/268 (31%), Gaps = 48/268 (17%)
Query: 63 GGTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLS 122
G E +I+ G ++ G +L W N +P
Sbjct: 16 GEATVPAEAQSGVDAIAGGYFHGLALKGG--KVLGWGAN-LNGQLTMPAATQSGVD---- 68
Query: 123 SVSVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRC 182
+++ GN H A I + + +++ +G S +
Sbjct: 69 AIAAGNYHSLALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYALKDGKVIAWG 128
Query: 183 --------------WGINSISNQIQTSFANRSM----------------------FSITA 206
G+ ++ + T+ A ++ A
Sbjct: 129 DDSDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDDVA 188
Query: 207 GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWG 266
GG +G VI +GDN+ Q P + + SA++ G +S A++ NG V+ WG
Sbjct: 189 GGIFHSLALKDGKVIAWGDNRYKQTTVPTEALS-GVSAIASGEWYSLALK--NGKVIAWG 245
Query: 267 SQGEYSVNGIRGKSFESIVSGSNFTCGL 294
S + + + SI +G N L
Sbjct: 246 S-SRTAPSSV-QSGVSSIEAGPNAAYAL 271
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 22/133 (16%), Positives = 44/133 (33%), Gaps = 7/133 (5%)
Query: 124 VSVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCW 183
G + G + W + P+ +G F L + V W
Sbjct: 147 ALDGGVYTALAVKNGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSLALKDG-KVIAW 205
Query: 184 GINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYS 243
G N + A + +I +G + + NG VI +G +++ +
Sbjct: 206 GDNRYKQTTVPTEALSGVSAIASGEWYSLALK-NGKVIAWGSSRTAPSSVQSGVS----- 259
Query: 244 ALSLGFNHSCAIR 256
++ G N + A++
Sbjct: 260 SIEAGPNAAYALK 272
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 22/148 (14%), Positives = 47/148 (31%), Gaps = 6/148 (4%)
Query: 216 SNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWG--SQGEYSV 273
+ V+ +G N A++ G+ H A++ G V+ WG G+ ++
Sbjct: 2 AATSVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALK--GGKVLGWGANLNGQLTM 59
Query: 274 NGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDSVSLVPFQQEILPGPCDNS 333
++I +G+ + + VI WG + I G +
Sbjct: 60 PAATQSGVDAIAAGNYHSL--ALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASY 117
Query: 334 SCSECGLYPQSDRLCFGNGNICKSCQNV 361
+ + + D ++ V
Sbjct: 118 ALKDGKVIAWGDDSDGQTTVPAEAQSGV 145
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 21/76 (27%), Positives = 33/76 (43%), Gaps = 3/76 (3%)
Query: 179 TVRCWGINSISNQIQTSFANRSMF-SITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNS 237
+V WG N+ + +S +I G H + G V+ +G N +GQL P +
Sbjct: 5 SVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALK-GGKVLGWGANLNGQLTMP-AA 62
Query: 238 TAFEYSALSLGFNHSC 253
T A++ G HS
Sbjct: 63 TQSGVDAIAAGNYHSL 78
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 39.0 bits (89), Expect = 0.002
Identities = 34/186 (18%), Positives = 60/186 (32%), Gaps = 17/186 (9%)
Query: 131 VCATTVQGQINCW-----RGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKTVRCWGI 185
V AT+V W G+ + A SG +++ G + V WG
Sbjct: 1 VAATSVV----AWGGNNDWGEATVPAEAQSG---VDAIAGGYFHGLAL--KGGKVLGWGA 51
Query: 186 NSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSAL 245
N + + +I AG H +G VI +G N+ GQ P + + + +
Sbjct: 52 NLNGQLTMPAATQSGVDAIAAGNYHSL-ALKDGEVIAWGGNEDGQTTVPAEARSGVDA-I 109
Query: 246 SLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNFTCGLT-TSNFSVICW 304
+ G S A++ S G+ +V ++ G + +
Sbjct: 110 AAGAWASYALKDGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDN 169
Query: 305 GPGWPN 310
G
Sbjct: 170 YFGQTT 175
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 23/194 (11%), Positives = 41/194 (21%), Gaps = 38/194 (19%)
Query: 100 TNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQ 159
+ K V G A + +G + + P E
Sbjct: 201 ERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESC 260
Query: 160 FESLT--------------SGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMF--- 202
F SG + + G A
Sbjct: 261 FIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTL 320
Query: 203 --------SITAGGNHVCGIDSNGFVICYGDNKSGQL----------KFPLNSTAFEY-- 242
S+ G + + +G V +G + QL + E
Sbjct: 321 ISRLPAVSSVACGASVGYAVTKDGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRV 380
Query: 243 -SALSLGFNHSCAI 255
++S G H+ +
Sbjct: 381 VLSVSSGGQHTVLL 394
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (108), Expect = 1e-05
Identities = 19/153 (12%), Positives = 36/153 (23%), Gaps = 17/153 (11%)
Query: 209 NHVCGIDSNGFVICYGDNKSGQL-------------KFPLNSTAFEYSALSLGFNHSCAI 255
+H G V+ G GQL + G H+ +
Sbjct: 6 SHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDV---VQAEAGGMHTVCL 62
Query: 256 RRLNGSVVCWGSQGEYSVNGIRGKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSNDS 315
+ +G V +G E ++ +V G + +
Sbjct: 63 SK-SGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDGRVF 121
Query: 316 VSLVPFQQEILPGPCDNSSCSECGLYPQSDRLC 348
+ + G + S + Q D
Sbjct: 122 LWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPV 154
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 15/70 (21%), Positives = 20/70 (28%), Gaps = 13/70 (18%)
Query: 174 LTNNKTVRCWGINSISNQ--IQTSFANRSMF----------SITAGGNHVCGIDSNGFVI 221
T V G Q + + R AGG H + +G V
Sbjct: 11 STEPGLVLTLGQGD-VGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSGQVY 69
Query: 222 CYGDNKSGQL 231
+G N G L
Sbjct: 70 SFGCNDEGAL 79
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 0.002
Identities = 39/273 (14%), Positives = 65/273 (23%), Gaps = 38/273 (13%)
Query: 60 CYQGGTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTV 119
+ V+ + S +A G + + V
Sbjct: 93 GKVELQEKVVQVSAGDSHTAALTDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDV 152
Query: 120 LLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESLTSGIDFSCGILTNNKT 179
+ V+ GN+H+ T G + G+L L
Sbjct: 153 PVVKVASGNDHLVMLTADGDLYTLG-------CGEQGQLGRVPELFANRGGRQGLERLLV 205
Query: 180 VRCWGINSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTA 239
+C + S ++ F G I G V +G + QL P +
Sbjct: 206 PKCVMLKSRGSRGHVRFQ-----DAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESC 260
Query: 240 FEYSALS------------LGFNHSCAIRRLNGSVVCWGSQGEYSVNGI----------- 276
F L+ G H G G +
Sbjct: 261 FIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTL 320
Query: 277 --RGKSFESIVSGSNFTCGLTTSNFSVICWGPG 307
R + S+ G++ +T V WG G
Sbjct: 321 ISRLPAVSSVACGASVGYAVTKDG-RVFAWGMG 352
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 0.002
Identities = 28/188 (14%), Positives = 50/188 (26%), Gaps = 39/188 (20%)
Query: 67 RAVEPNISFSSISAGQSFFCGIRSGG--------YSLLCWDTNFSYNSNFVPKRIYYNDT 118
R ++ F G F I G + N T
Sbjct: 214 RGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNST 273
Query: 119 VLLSSVSVGNNHVCATTVQGQINCW---------RGDVNISKNAPSGELQFESLTSGIDF 169
S G +H +G+ G+ K+ P+ L +
Sbjct: 274 KSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPT---LISRLPAVSSV 330
Query: 170 SCG-----ILTNNKTVRCWGIN-------------SISNQIQ-TSFANRSMFSITAGGNH 210
+CG +T + V WG+ ++ NR + S+++GG H
Sbjct: 331 ACGASVGYAVTKDGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQH 390
Query: 211 VCGIDSNG 218
+ +
Sbjct: 391 TVLLVKDK 398
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 789 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.22 | |
| d1k3ia3 | 387 | Galactose oxidase, central domain {Fungi (Fusarium | 97.44 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.33 | |
| d1k3ia3 | 387 | Galactose oxidase, central domain {Fungi (Fusarium | 97.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.65 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.51 | |
| d1p22a2 | 293 | F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Hom | 95.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.41 | |
| d2ovrb2 | 342 | F-box/WD repeat-containing protein 7, FBXW7 {Human | 95.22 | |
| d1btea_ | 96 | Type II activin receptor {Mouse (Mus musculus) [Ta | 94.2 | |
| d1p22a2 | 293 | F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Hom | 94.09 | |
| d2h62d1 | 91 | Type II activin receptor {Mouse (Mus musculus), is | 92.13 | |
| d2ovrb2 | 342 | F-box/WD repeat-containing protein 7, FBXW7 {Human | 92.13 | |
| d1l0qa2 | 301 | Surface layer protein {Archaeon Methanosarcina maz | 91.31 | |
| d1rwia_ | 260 | Serine/threonine-protein kinase PknD {Mycobacteriu | 89.76 | |
| d1nexb2 | 355 | Cdc4 propeller domain {Baker's yeast (Saccharomyce | 89.12 | |
| d2bbkh_ | 355 | Methylamine dehydrogenase, H-chain {Paracoccus den | 88.25 | |
| d1nexb2 | 355 | Cdc4 propeller domain {Baker's yeast (Saccharomyce | 87.88 | |
| d1qksa2 | 432 | C-terminal (heme d1) domain of cytochrome cd1-nitr | 87.78 | |
| d1rwia_ | 260 | Serine/threonine-protein kinase PknD {Mycobacteriu | 81.88 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=411.97 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=194.8
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.+.||+|+||+||+|+++ ..||||+++...... ...+.|.+|+++|++++|||||++++++. .+..++
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP--QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT--THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH--HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 3578999999999999999999864 369999986543222 33457999999999999999999999875 456899
Q ss_pred EEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
||||+++|+|.++|+.. ..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999998642 368899999999999998 999999999999999999999999999876544
Q ss_pred CCCCcccccccCcCccCccccCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGL---NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
..........||+.|||||++.. ..++.++|||||||+||||+||+.||...... ..+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-----------------~~~~~ 220 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----------------DQIIF 220 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----------------HHHHH
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-----------------HHHHH
Confidence 43333445679999999999854 35899999999999999999999999643320 01111
Q ss_pred hhcccCCCC--CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 720 ILDRRVGPP--EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 720 ~~d~~~~~~--~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+......+ .......++.+.+|+.+||+.||++|||++|++++|+.+.+.
T Consensus 221 ~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 221 MVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp HHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111111111 111122345677889999999999999999999999998654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=406.52 Aligned_cols=247 Identities=26% Similarity=0.470 Sum_probs=191.4
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||+||+|.+.+++.||||+++..... .++|.+|++++++++||||++++++|.+++..++|
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 3689999999999999999999988899999998653322 24589999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++|+|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999999998642 358899999999999998 9999999999999999999999999997654433
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
.. ......||+.|+|||++....++.++|||||||+||||+|+..|++.... . .++.+.+..
T Consensus 156 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~----~-------------~~~~~~i~~ 217 (263)
T d1sm2a_ 156 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----N-------------SEVVEDIST 217 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC----H-------------HHHHHHHHH
T ss_pred ce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC----H-------------HHHHHHHHh
Confidence 22 22245689999999999999999999999999999999996655543221 0 011111111
Q ss_pred --cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 724 --RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 724 --~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
++..+... ...+.+|+.+||+.||++||||+|++++|+++++
T Consensus 218 ~~~~~~p~~~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 218 GFRLYKPRLA----STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TCCCCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcccc----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 12222222 3456778889999999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=407.90 Aligned_cols=247 Identities=23% Similarity=0.349 Sum_probs=195.3
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
.++|++.+.||+|+||+||+|+.+ +++.||||++...... +..+.+.+|+++|++++||||+++++++.+++..||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 468999999999999999999874 6899999998654322 233468899999999999999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++|+|.++|..+ ..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999999998643 268999999999999999 9999999999999999999999999998754443
Q ss_pred CCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.........||+.|||||++.+..+ +.++|||||||+||||+||+.||....+... .......
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~----------------~~~~~~~ 221 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ----------------EYSDWKE 221 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH----------------HHHHHHT
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH----------------HHHHHhc
Confidence 3333345689999999999987766 5789999999999999999999965433110 0011111
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..... .........+.+|+.+||+.||++|||++|++++
T Consensus 222 ~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 222 KKTYL--NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TCTTS--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 1112233455678889999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=405.68 Aligned_cols=241 Identities=26% Similarity=0.433 Sum_probs=198.1
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+..... ....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK-AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999875 68899999976543322 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.+++.... .++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 99999999999987532 58899999999999999 9999999999999999999999999997654332
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+. ...+..+....
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------------~~~~~~i~~~~ 220 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----------------QETYKRISRVE 220 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHTTC
T ss_pred ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----------------HHHHHHHHcCC
Confidence 2346799999999999999999999999999999999999999954321 01112222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+.. ..+.+.+|+.+||+.||++|||++|++++
T Consensus 221 ~~~p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 FTFPDF----VTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 222222 23456778889999999999999999874
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=404.25 Aligned_cols=243 Identities=23% Similarity=0.404 Sum_probs=197.9
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh----HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 5799999999999999999986 46899999997654322 234588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
|||+++|+|.+++.+. ..++.|++.||+|||+++ |+||||||+|||++.++++||+|||+++.......
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 9999999999987643 368999999999999999 99999999999999999999999999986543322
Q ss_pred CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC
Q 045256 646 FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV 725 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 725 (789)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...+. ...+..+.....
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------------~~~~~~~~~~~~ 233 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----------------LRALYLIATNGT 233 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------------HHHHHHHHHHCS
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----------------HHHHHHHHhCCC
Confidence 22356799999999999999999999999999999999999999954321 001111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 726 GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 726 ~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ...+......+++|+.+||+.||++|||+.|++++
T Consensus 234 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 234 PE-LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CC-CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CC-CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11123344567788999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-48 Score=407.00 Aligned_cols=252 Identities=26% Similarity=0.497 Sum_probs=191.3
Q ss_pred cCCccccceEeecccEEEEEEEeCC-Cc---EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPD-GQ---EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~-g~---~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
.++|++.++||+|+||+||+|.++. ++ .||||++...... ...+.|.+|+++|++++|||||++++++.+.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE---KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 3678899999999999999998642 32 5889987643332 234569999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||+++|+|.+++... ..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999987642 368899999999999998 999999999999999999999999999875
Q ss_pred CCCCCCCc---ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhh
Q 045256 640 PESERDFR---PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAG 715 (789)
Q Consensus 640 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 715 (789)
........ .....+|+.|||||.+....++.++|||||||+||||+| |++||..... .
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------------------~ 240 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------------------Q 240 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------------H
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------------------H
Confidence 44332211 122457899999999999999999999999999999998 8999854321 0
Q ss_pred hhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 716 ELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 716 ~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
++.+.+.. +++.+. +.+..+.+|+.+||+.||++|||+.|+++.|+++++..+
T Consensus 241 ~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 241 DVINAIEQDYRLPPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp HHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HHHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 11111111 222222 234556788899999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=402.46 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=198.3
Q ss_pred hcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~l 571 (789)
..++|++.+.||+|+||+||+|.+++++.||||+++.... ..+.|.+|+++|++++|||||++++++.+ +..++
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3468999999999999999999998889999999865332 23458999999999999999999998754 56799
Q ss_pred EEEecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||+++|+|.+++.. ..+++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++....
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccC
Confidence 9999999999997753 2368999999999999998 99999999999999999999999999987544
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
... .......||+.|||||++....++.++|||||||+||||+||+.|++..... .+.+..+.
T Consensus 162 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------------~~~~~~i~ 224 (272)
T d1qpca_ 162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------------PEVIQNLE 224 (272)
T ss_dssp SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----------------HHHHHHHH
T ss_pred Ccc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----------------HHHHHHHH
Confidence 322 1223457899999999998889999999999999999999977766443220 00111111
Q ss_pred cc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 722 DR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 722 d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.. ++..+.. .++.+.+|+.+||+.||++||||+|+++.|++...
T Consensus 225 ~~~~~~~p~~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 225 RGYRMVRPDN----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCccc----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 11 1222222 23456778899999999999999999999998754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=399.43 Aligned_cols=253 Identities=28% Similarity=0.489 Sum_probs=195.2
Q ss_pred CCccccceEeecccEEEEEEEeCCC-----cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDG-----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
+.|++.++||+|+||+||+|.+++. ..||||++...... .....|.+|++++++++|||||++++++.+.+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh---HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 5688999999999999999986532 36999997643322 234468999999999999999999999999999
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++||||++++++.+++.+. .+++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999887542 368999999999999998 999999999999999999999999999875
Q ss_pred CCCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... .......||+.|||||++....++.++|||||||+||||++++.|++.... ..++.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----------------~~~~~ 223 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----------------NHEVM 223 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----------------HHHHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----------------HHHHH
Confidence 443222 222335689999999999999999999999999999999998777644321 01111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhccc
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICDH 773 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~~ 773 (789)
+.+.. +++.+. ..+..+.+|+.+||+.||++||||.||++.|+++++..+.
T Consensus 224 ~~i~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 224 KAINDGFRLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp HHHHTTCCCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred HHHhccCCCCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence 22222 122222 2345577889999999999999999999999999876553
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=406.03 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=196.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||+|+.. +++.||||++....... ....+.+.+|+++|++++||||+++++++.+++..|+|
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC-HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 57999999999999999999874 68999999986543322 22345689999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.+++.... .++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999987543 57899999999999999 99999999999999999999999999987654444
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
........||+.|||||++.+..++.++|||||||+||||++|+.||...+. ......+....
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------------~~~~~~i~~~~ 226 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----------------YLIFQKIIKLE 226 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHTTC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----------------HHHHHHHHcCC
Confidence 3334456799999999999999999999999999999999999999964321 01112222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+.. ....+.+|+.+||+.||++|||++|+++.
T Consensus 227 ~~~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 227 YDFPEK----FFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCCCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCCCcc----CCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 322222 23456788899999999999999997553
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=398.95 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=184.3
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe--CCeEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE--KDERL 570 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~~ 570 (789)
++|++.+.||+|+||+||+++.+ +|+.||||++...... ....+.+.+|+++|++++||||+++++++.+ .+.+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT--EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC--HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC--HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 57999999999999999999864 6899999998765432 2334568999999999999999999999965 44589
Q ss_pred EEEEecCCCchhHHHhhh------------chHHHHHHHHHHHHHhcCC--CCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 571 LVYDYMKNGALYDHLHDR------------NNVEKNAARGIEYLHNYAV--PPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~------------~~i~~~ia~~l~~LH~~~~--~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
+||||+++|+|.+++.+. ..++.|++.||+|||+.+. .+|+||||||+||||+.++.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999998532 2588999999999998652 34999999999999999999999999999
Q ss_pred cCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 637 MMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 637 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
+....... ......||+.|||||++.+..++.++|||||||++|||+||+.||...+. . +.
T Consensus 162 ~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~------------~~ 222 (269)
T d2java1 162 RILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----K------------EL 222 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----H------------HH
T ss_pred eecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----H------------HH
Confidence 87543322 22346799999999999999999999999999999999999999954321 0 01
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+........+ ....+.+.+|+.+||+.||++|||+.|++++
T Consensus 223 ~~~i~~~~~~~~~---~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 223 AGKIREGKFRRIP---YRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp HHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCCCCC---cccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1112222221111 1223456778889999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=393.31 Aligned_cols=242 Identities=29% Similarity=0.464 Sum_probs=199.7
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.++||+|+||+||+|++++++.||||+++..... .++|.+|++++++++||||++++++|.+++..++||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 689999999999999999999988889999998754322 235899999999999999999999999999999999
Q ss_pred EecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++|+|.+++.. ..+++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999998653 2368899999999999998 99999999999999999999999999976544332
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHH-hhc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK-ILD 722 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d 722 (789)
. ......+|+.|+|||.+....++.++||||||+++|||+| |+.||..... .++.. +..
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------------------~~~~~~i~~ 216 (258)
T d1k2pa_ 156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------------------SETAEHIAQ 216 (258)
T ss_dssp C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------------------HHHHHHHHT
T ss_pred e-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------------------HHHHHHHHh
Confidence 2 2334578999999999999999999999999999999998 7888854321 01111 111
Q ss_pred -ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 723 -RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 723 -~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
.++..+... ...+.+|+.+||+.||++|||++|++++|.+
T Consensus 217 ~~~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 217 GLRLYRPHLA----SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCCCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCcccc----cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 122333322 3456788899999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-48 Score=403.35 Aligned_cols=248 Identities=25% Similarity=0.432 Sum_probs=201.4
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||+||+|.++ +++.||||+++.... ..+.|.+|+++|++++|||||+++++|.+.+..+
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 3467999999999999999999875 588999999765332 2345899999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 571 LVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+||||+++|+|.+++.+. ..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999998642 357899999999999998 9999999999999999999999999998754
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.... .......|++.|+|||++.+..++.++|||||||++|||++|+.||+...+ ...+.+.
T Consensus 167 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----------------~~~~~~~ 228 (287)
T d1opja_ 167 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYEL 228 (287)
T ss_dssp SSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----------------HHHHHHH
T ss_pred CCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----------------HHHHHHH
Confidence 4322 122234578999999999999999999999999999999998887754332 0112222
Q ss_pred hccc--CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 721 LDRR--VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 721 ~d~~--~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
+... +..+.. .+..+.+|+.+||+.||++|||++|+++.|+.+++
T Consensus 229 i~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 229 LEKDYRMERPEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HhcCCCCCCCcc----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2222 222222 33456788899999999999999999999988754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=399.35 Aligned_cols=243 Identities=22% Similarity=0.309 Sum_probs=193.5
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
+.|++.+.||+|+||+||+|++. +++.||||++...... ..+.+.+|+++|++++|||||++++++.+.+..++|
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE----ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG----GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH----HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence 56899999999999999999864 6889999998654322 234588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
|||+++|+|.+++.+. ..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 9999999999987542 258899999999999999 9999999999999999999999999986532211
Q ss_pred CCCcccccccCcCccCccccC-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 644 RDFRPMKAAGTVGYIDPEYYG-----LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.......||+.|||||++. ...++.++|||||||+||||+||+.||...... +.+.
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-----------------~~~~ 225 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-----------------RVLL 225 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----------------GHHH
T ss_pred --ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-----------------HHHH
Confidence 1122457999999999983 456899999999999999999999999653320 0111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.....+ ...........+.+|+.+||+.||++|||++|++++
T Consensus 226 ~i~~~~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 226 KIAKSEPP-TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp HHHHSCCC-CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHcCCCC-CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12221111 111122344567788899999999999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=391.62 Aligned_cols=242 Identities=27% Similarity=0.440 Sum_probs=188.1
Q ss_pred ccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe----CCeEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE----KDERL 570 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----~~~~~ 570 (789)
|++.++||+|+||+||+|.+. +++.||+|++...... ....+.|.+|+++|++++|||||++++++.+ ...+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 367788999999999999865 6889999987654332 2334569999999999999999999999876 34579
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC-CCCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD-AQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfGls~~~~~ 641 (789)
+||||+++|+|.+++.+. ..++.|+++||+|||+++ ++|+||||||+|||++ +++.+||+|||+++....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999998653 358899999999999986 5699999999999996 578999999999976433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
. ......||+.|||||++.+ .++.++|||||||+||||++|+.||...... ..+.+.+
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----------------~~~~~~i 225 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----------------AQIYRRV 225 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----------------HHHHHHH
T ss_pred C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----------------HHHHHHH
Confidence 2 2235689999999999865 5999999999999999999999999543220 0111111
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.....+. .........+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 TSGVKPA-SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTTCCCG-GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HcCCCCc-ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1111111 0111123346778999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=407.30 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=197.2
Q ss_pred hcCCccccceEeecccEEEEEEEeCC-C-----cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD-G-----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCE 564 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~ 564 (789)
..++|++.++||+|+||+||+|+... + ..||+|.+..... ......+.+|+.+|.++ +|||||++++++.
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD---SSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC---HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34689999999999999999998642 2 3689998754322 22334688999999998 8999999999999
Q ss_pred eCCeEEEEEEecCCCchhHHHhhh-------------------------------chHHHHHHHHHHHHHhcCCCCeEec
Q 045256 565 EKDERLLVYDYMKNGALYDHLHDR-------------------------------NNVEKNAARGIEYLHNYAVPPIIHR 613 (789)
Q Consensus 565 ~~~~~~lv~e~~~~gsL~~~l~~~-------------------------------~~i~~~ia~~l~~LH~~~~~~ivH~ 613 (789)
+.+..++||||+++|+|.++|+.+ ..++.|+++||+|||+++ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 999999999999999999998643 247889999999999998 9999
Q ss_pred cCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCC
Q 045256 614 DIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIF 692 (789)
Q Consensus 614 Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~ 692 (789)
||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986544443333335568999999999999999999999999999999998 899985
Q ss_pred CCCCCCCcccccccchhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHH
Q 045256 693 KDDESGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLER 766 (789)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~ 766 (789)
..... ..+.+++.. ++..+.. .+..+.+|+.+||+.||++|||++||+++|..
T Consensus 269 ~~~~~-----------------~~~~~~~~~~~~~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPVD-----------------ANFYKLIQNGFKMDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCS-----------------HHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHH-----------------HHHHHHHhcCCCCCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 43320 111222222 2222222 23456788899999999999999999999963
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-47 Score=401.25 Aligned_cols=246 Identities=23% Similarity=0.374 Sum_probs=184.0
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..+.|++.+.||+|+||+||+|+.+ +++.||||++....... ....+.+|+++|++++||||+++++++.+.+..|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 83 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLY 83 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3467999999999999999999875 68999999986543322 2345889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC---CCCcEEEEeeccCcCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD---AQWTARVSDFGLSMMG 639 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfGls~~~ 639 (789)
|||||+++|+|.++|.++ ..++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 999999999999999654 258999999999999999 99999999999994 5789999999999864
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
..... .....||+.|||||++.+..++.++|||||||+||||++|+.||..... ......
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------------~~~~~~ 220 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----------------AKLFEQ 220 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHHH
T ss_pred cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----------------HHHHHH
Confidence 43322 2246799999999999999999999999999999999999999964321 011122
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.......+..........+.+|+.+||+.||++|||++|++++
T Consensus 221 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 22222222222222344557788999999999999999999885
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=393.12 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=196.9
Q ss_pred CCccccce-EeecccEEEEEEEeC---CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENK-IGAGSFGVVYKGKLP---DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~-LG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|.+.+. ||+|+||+||+|.++ ++..||||+++.... ....+.|.+|+++|++++|||||++++++.+ +..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 83 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 83 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC---HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC---HHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence 56777774 999999999999754 345799999865432 2334569999999999999999999999865 568
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
||||||+++|+|.+++... ..++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999999987532 368999999999999998 9999999999999999999999999998755
Q ss_pred CCCCC-CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERD-FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... .......||+.|+|||++....++.++|||||||++|||+| |+.||..... .++.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~------------------~~~~ 222 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------------------PEVM 222 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------------------HHHH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH------------------HHHH
Confidence 43322 22234568999999999988899999999999999999998 8999854322 0111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+.. ++..+.. .+..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 223 ~~i~~~~~~~~p~~----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 223 AFIEQGKRMECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCCCCCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCc----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11111 2222222 334567788999999999999999999999887543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=407.75 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=195.8
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||+||+|+.. +++.||+|+++..... ...+.+.+|+++|++++|||||+++++|.+++..|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP---AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT---THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3578999999999999999999864 6899999998654322 23446889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 571 LVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
+||||+++|+|.+++.+. ..++.|+++||.|||+ ++ |+||||||+||||+.++++||+|||+|+....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999998753 3588999999999997 47 99999999999999999999999999975322
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccc-------c------cch
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSL-------V------DFA 708 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~-------~------~~~ 708 (789)
. ......||+.|||||++.+..|+.++|||||||++|||++|+.||...+......... . ...
T Consensus 158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 1224689999999999999999999999999999999999999997644311000000 0 000
Q ss_pred -----------hhhhh-hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 709 -----------VPAIM-AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 709 -----------~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+... .+......... ++..........+.+|+.+||..||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000 00011111111 0111111123456778889999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-47 Score=399.93 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=203.7
Q ss_pred HHHHHHhcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEE
Q 045256 486 LAELAAATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRL 559 (789)
Q Consensus 486 ~~~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l 559 (789)
+.+++..+++|++.+.||+|+||+||+|+.+ +++.||||++..... .+..+.|.+|+++|++++||||+++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS---ADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC---HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC---hHHHHHHHHHHHHHHhcCCCCcccc
Confidence 3445666789999999999999999999853 457899999865332 2334569999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCchhHHHhh--------------------------------hchHHHHHHHHHHHHHhcCC
Q 045256 560 VGYCEEKDERLLVYDYMKNGALYDHLHD--------------------------------RNNVEKNAARGIEYLHNYAV 607 (789)
Q Consensus 560 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~--------------------------------~~~i~~~ia~~l~~LH~~~~ 607 (789)
+++|.+.+..+++|||+++|+|.++|+. ...++.|++.||+|||+++
T Consensus 82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~- 160 (301)
T d1lufa_ 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK- 160 (301)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-
Confidence 9999999999999999999999999853 2357899999999999998
Q ss_pred CCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcC
Q 045256 608 PPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTG 687 (789)
Q Consensus 608 ~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG 687 (789)
|+||||||+|||||.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||+||||++|
T Consensus 161 --ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 161 --FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHcc
Confidence 999999999999999999999999999765444333334456789999999999999999999999999999999999
Q ss_pred CC-CCCCCCCCCCcccccccchhhhhhhhhhHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHH
Q 045256 688 KR-AIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLE 765 (789)
Q Consensus 688 ~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~ 765 (789)
.. ||..... .+.+..+.+... ..+.. ++..+.+|+.+||+.||++||||.||+++|+
T Consensus 239 ~~~p~~~~~~-----------------~e~~~~v~~~~~~~~p~~----~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 239 GLQPYYGMAH-----------------EEVIYYVRDGNILACPEN----CPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp TCCTTTTSCH-----------------HHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCCH-----------------HHHHHHHHcCCCCCCCcc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 75 5533221 011112222222 12222 2345677889999999999999999999999
Q ss_pred HHh
Q 045256 766 RAL 768 (789)
Q Consensus 766 ~~~ 768 (789)
++.
T Consensus 298 ~i~ 300 (301)
T d1lufa_ 298 RMC 300 (301)
T ss_dssp HTT
T ss_pred Hhc
Confidence 974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=394.49 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=198.3
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhH--HHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKF--QEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
.++|++.+.||+|+||+||+|+. .+|+.||||++.+...... ....+.+.+|+++|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999987 4689999999865433221 12345689999999999999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC----cEEEEeeccCc
Q 045256 570 LLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW----TARVSDFGLSM 637 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfGls~ 637 (789)
||||||+++|+|.+++.+.. .++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||++.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhh
Confidence 99999999999999987543 58899999999999999 99999999999998776 59999999997
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
....... .....+|+.|+|||++.+..++.++|||||||+||||++|+.||...+. .+.+
T Consensus 166 ~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------------~~~~ 225 (293)
T d1jksa_ 166 KIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----------------QETL 225 (293)
T ss_dssp ECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHH
T ss_pred hcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-----------------HHHH
Confidence 6543322 2345789999999999999999999999999999999999999965432 0011
Q ss_pred HHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 718 VKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 718 ~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
..+.......+..........+.+|+.+||+.||++|||++|++++
T Consensus 226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111111112234556788999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=390.02 Aligned_cols=241 Identities=25% Similarity=0.426 Sum_probs=188.7
Q ss_pred ceEeecccEEEEEEEeCC---CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEec
Q 045256 500 NKIGAGSFGVVYKGKLPD---GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDYM 576 (789)
Q Consensus 500 ~~LG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~~ 576 (789)
++||+|+||+||+|.+++ ++.||||+++..... ....+.|.+|+++|++++|||||+++++|.+ +..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND--PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC--HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence 479999999999997643 468999998653322 2334579999999999999999999999865 5678999999
Q ss_pred CCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCC-c
Q 045256 577 KNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDF-R 647 (789)
Q Consensus 577 ~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~-~ 647 (789)
++|+|.+++++. ..++.|+++||+|||+.+ |+||||||+||||+.++.+||+|||+++......... .
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999998753 368899999999999998 9999999999999999999999999998654433221 2
Q ss_pred ccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc--c
Q 045256 648 PMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR--R 724 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~--~ 724 (789)
.....||+.|||||.+....++.++|||||||++|||+| |+.||..... .++.+.+.. +
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------------------~~~~~~i~~~~~ 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------------------SEVTAMLEKGER 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------------HHHHHHHHTTCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------------------HHHHHHHHcCCC
Confidence 224568999999999998899999999999999999998 8999854321 111122221 2
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHh
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERAL 768 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~ 768 (789)
+..+.. .+..+.+|+.+||+.||++|||++||++.|+...
T Consensus 229 ~~~p~~----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 MGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCcc----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 222222 3345677889999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-46 Score=396.29 Aligned_cols=239 Identities=27% Similarity=0.375 Sum_probs=192.4
Q ss_pred CccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 495 NFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
.|++.+.||+|+||+||+|+. .+++.||||++....... .+..+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 489999999999999999986 468899999986544322 334556899999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
||+++|+|..++..+ ..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||++......
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 999999987765432 368999999999999999 999999999999999999999999999764322
Q ss_pred CcccccccCcCccCccccCC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 646 FRPMKAAGTVGYIDPEYYGL---NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... ...+..+..
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----------------~~~~~~i~~ 228 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------------MSALYHIAQ 228 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----------------HHHHHHHHH
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----------------HHHHHHHHh
Confidence 24579999999999853 4689999999999999999999999964321 011122222
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHH
Q 045256 723 RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVA 762 (789)
Q Consensus 723 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~ 762 (789)
...+... .......+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCCCCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC--CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2221111 1123345778889999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-46 Score=400.89 Aligned_cols=243 Identities=20% Similarity=0.324 Sum_probs=197.2
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE----SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH----HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch----hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 57999999999999999999864 689999999865432 2234688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC--CCCcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD--AQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGls~~~~~ 641 (789)
|||+++|+|.+++.+. ..++.|++.||+|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 9999999999998532 258899999999999999 99999999999995 467899999999986543
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. ......||+.|||||++.+..++.++|||||||++|||++|+.||...+. .+.+..+.
T Consensus 179 ~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----------------~~~~~~i~ 238 (350)
T d1koaa2 179 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----------------DETLRNVK 238 (350)
T ss_dssp TS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHH
T ss_pred cc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----------------HHHHHHHH
Confidence 32 22346799999999999999999999999999999999999999964321 01112222
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+........+.+.+|+.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222222222334567788999999999999999999885
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=388.90 Aligned_cols=247 Identities=29% Similarity=0.450 Sum_probs=194.1
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
.++|++.+.||+|+||+||+|++++++.||||+++..... .+.|.+|+.++++++|||||++++++. .++.++|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~-----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC-----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC-----HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEE
Confidence 3679999999999999999999988889999998654321 245899999999999999999999985 4668999
Q ss_pred EEecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+++|+|.+++.. ...++.|+++||+|||+++ |+||||||+|||||.++++||+|||+++.....
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999988753 2368999999999999998 999999999999999999999999999865433
Q ss_pred CCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
... ......+|+.|+|||++....++.++||||||++||||++|+.|++.... ..++...+.
T Consensus 167 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----------------~~~~~~~i~ 228 (285)
T d1fmka3 167 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----------------NREVLDQVE 228 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----------------HHHHHHHHH
T ss_pred Cce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----------------HHHHHHHHH
Confidence 322 22345689999999999999999999999999999999998777654332 011111122
Q ss_pred c--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 723 R--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 723 ~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
. +.+.+. ...+.+.+|+.+||+.||++||++++|++.|++....
T Consensus 229 ~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 RGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred hcCCCCCCc----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 1 112222 3345677889999999999999999999999987654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.8e-46 Score=398.68 Aligned_cols=243 Identities=22% Similarity=0.345 Sum_probs=197.5
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+++|++++|||||++++++.+++..|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL----DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH----HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh----HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5799999999999999999986 47899999997654322 234588999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEEC--CCCcEEEEeeccCcCCCC
Q 045256 573 YDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLD--AQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfGls~~~~~ 641 (789)
|||+++|+|.+++... ..++.|+++||+|||+++ |+||||||+||||+ .++.+||+|||++.....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCC
Confidence 9999999999887542 258999999999999999 99999999999997 578999999999987544
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKIL 721 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (789)
.. ......||+.|+|||++.+..++.++|||||||+||||+||+.||..... ...+..+.
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------------~~~~~~i~ 241 (352)
T d1koba_ 182 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----------------LETLQNVK 241 (352)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----------------HHHHHHHH
T ss_pred CC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHH
Confidence 32 22346789999999999999999999999999999999999999964332 01112222
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 222222222222334556788999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-45 Score=386.51 Aligned_cols=255 Identities=24% Similarity=0.344 Sum_probs=195.5
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe---
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE--- 568 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~--- 568 (789)
.++|++.+.||+|+||+||+|.. .+++.||||+++...... .+....|.+|++++++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD-PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 46899999999999999999986 478999999987644332 3345579999999999999999999999987543
Q ss_pred -EEEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 -RLLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 -~~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.||||||+++++|.+++... ..++.|++.||+|||+++ |+||||||+|||++.++..+|+|||++...
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 78999999999999988653 368999999999999999 999999999999999999999999998654
Q ss_pred CCCCC-CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESER-DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... ........||+.|||||++.+..++.++|||||||++|||+||++||..... .+...
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----------------~~~~~ 224 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----------------VSVAY 224 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----------------HHHHH
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----------------HHHHH
Confidence 33222 2223356799999999999999999999999999999999999999964321 00111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-CHHHHHHHHHHHh
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-TMADIVANLERAL 768 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-t~~evl~~L~~~~ 768 (789)
..+.....++.......+..+.+++.+||+.||++|| |++|+++.|.+++
T Consensus 225 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1222211111111122345677888999999999999 8999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-46 Score=391.51 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=191.4
Q ss_pred HHhcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEE
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGY 562 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 562 (789)
+...++|++.+.||+|+||.||+|... +++.||||+++..... ...+.+.+|..++.++ +||||+.++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc---HHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344578999999999999999999853 3468999997643322 2334577788888777 68999999999
Q ss_pred EEeCC-eEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 045256 563 CEEKD-ERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKS 617 (789)
Q Consensus 563 ~~~~~-~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp 617 (789)
+.+.+ ..++||||+++|+|.++|+.+ ..++.|+++||+|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87654 589999999999999998642 257889999999999998 99999999
Q ss_pred CCEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCC-CCCCCCC
Q 045256 618 SNILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKR-AIFKDDE 696 (789)
Q Consensus 618 ~NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~-pf~~~~~ 696 (789)
+||||+.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+|+.. ||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987655544444445679999999999999999999999999999999999765 5533221
Q ss_pred CCCcccccccchhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 697 SGGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
. ..+...+.. ++..+.. ....+.+++.+||+.||++|||++|++++|+++++.
T Consensus 243 ~-----------------~~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 D-----------------EEFCRRLKEGTRMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp S-----------------HHHHHHHHHTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H-----------------HHHHHHHhcCCCCCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 0 011111111 1222222 233467788899999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-45 Score=388.71 Aligned_cols=243 Identities=24% Similarity=0.344 Sum_probs=199.1
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||.||+++. .+++.||||++++..... ....+.+.+|+.+|++++||||+++++++++.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 5799999999999999999986 478999999987543322 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|.+++.... .++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999987543 57889999999999999 99999999999999999999999999986543322
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||...+. ......+....
T Consensus 161 --~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----------------~~~~~~i~~~~ 221 (337)
T d1o6la_ 161 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----------------ERLFELILMEE 221 (337)
T ss_dssp --CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHCC
T ss_pred --ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----------------HHHHHHHhcCC
Confidence 22356899999999999999999999999999999999999999965432 01112222333
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
+..+.... ..+.+|+.+||+.||++||+ ++|++++
T Consensus 222 ~~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 IRFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 33333333 34567888999999999995 8888874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.8e-45 Score=379.41 Aligned_cols=248 Identities=25% Similarity=0.351 Sum_probs=199.2
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhh-----hHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTK-----KFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEE 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~ 565 (789)
.++|++.+.||+|+||+||+++. .+++.||||++...... ......+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999986 47899999998654321 22334456889999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 566 KDERLLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
++..||||||+++|+|.++|+.+. .++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999997543 68899999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCCCcccccccCcCccCccccC------CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYG------LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
....... .....||+.|+|||++. ...++.++||||+||+||||++|+.||.....
T Consensus 159 ~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------------- 220 (277)
T d1phka_ 159 QLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------------- 220 (277)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---------------
T ss_pred EccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---------------
Confidence 7544322 23467999999999884 34578899999999999999999999965431
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......++......+..........+.+|+.+||+.||++|||++|++++
T Consensus 221 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 221 --MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 01112222222222222223345567788999999999999999998765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=380.81 Aligned_cols=241 Identities=27% Similarity=0.450 Sum_probs=186.7
Q ss_pred cCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-CCeEEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE-KDERLL 571 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~~l 571 (789)
.++|++.+.||+|+||.||+|++ .|+.||||+++... ..+.|.+|++++++++||||+++++++.+ ++.+++
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 35789999999999999999998 57889999986532 22458899999999999999999999865 456899
Q ss_pred EEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 572 VYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
||||+++|+|.++|.++ .+++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 99999999999998653 258999999999999998 99999999999999999999999999976433
Q ss_pred CCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. ....++..|+|||++.+..++.++||||||+++|||+| |++||..... ..+ ...+
T Consensus 156 ~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~------------~~~i 213 (262)
T d1byga_ 156 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDV------------VPRV 213 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGH------------HHHH
T ss_pred CC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHH------------HHHH
Confidence 22 23467899999999988899999999999999999999 5666643221 000 1111
Q ss_pred hc-ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 721 LD-RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 721 ~d-~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
.. .+...+.. ....+.+|+.+||+.||++|||+.|++++|+++..
T Consensus 214 ~~~~~~~~~~~----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 214 EKGYKMDAPDG----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcc----CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 11 12222222 23456778899999999999999999999998753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=391.10 Aligned_cols=247 Identities=25% Similarity=0.460 Sum_probs=190.7
Q ss_pred CCccccceEeecccEEEEEEEeC-CCc----EEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQ----EVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~ 568 (789)
++|++.++||+|+||+||+|.+. +|+ .||+|+++.... ....+.|.+|++++++++|||||+++++|.++ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 47999999999999999999864 444 588887654322 22345689999999999999999999999864 5
Q ss_pred EEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 569 RLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
.++++||+.+++|.+++... .+++.|+++||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 67889999999999987643 368899999999999998 999999999999999999999999999876
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
.............||+.|+|||++.++.++.++|||||||+||||+| |++||..... .++.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~------------------~~~~ 223 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------------SEIS 223 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG------------------GGHH
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH------------------HHHH
Confidence 55444433344568999999999999999999999999999999999 6777643221 1111
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
+.+.. ++..+.. ....+.+|+.+||+.||++|||+.|++++|+++..
T Consensus 224 ~~i~~~~~~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 224 SILEKGERLPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHHHHTCCCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCcc----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 22221 2222222 23456778889999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=385.46 Aligned_cols=250 Identities=23% Similarity=0.382 Sum_probs=187.9
Q ss_pred hcCCccccceEeecccEEEEEEEeCC----CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD----GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD 567 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~ 567 (789)
..++|++.+.||+|+||.||+|.+.. +..||||.++.... ....+.|.+|+++|++++||||+++++++. .+
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS---DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 34689999999999999999998643 34688888754332 233456999999999999999999999985 46
Q ss_pred eEEEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
..|+||||+++|+|.+++... ..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 789999999999999986532 357899999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhh
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGEL 717 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (789)
...... .......||+.|+|||.+....++.++|||||||+||||+| |++||..... .. -.
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~------------~~ 219 (273)
T d1mp8a_ 158 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----ND------------VI 219 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG------------HH
T ss_pred ccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HH------------HH
Confidence 543322 22234568999999999999999999999999999999998 7888754332 00 01
Q ss_pred HHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 718 VKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 718 ~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+... +++.+. ..+..+.+|+.+||+.||++|||+.||+++|+++++.
T Consensus 220 ~~i~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 220 GRIENGERLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111111 122222 2334577888999999999999999999999998765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6e-45 Score=386.77 Aligned_cols=240 Identities=24% Similarity=0.410 Sum_probs=197.4
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||+|+. .+|+.||||++++..... ....+.+.+|+.+|++++||||+++++++.+.+..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 5799999999999999999986 468999999986543222 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+++|+|..++... ..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 9999999999988643 257889999999999999 9999999999999999999999999998754332
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
....||+.|||||++.+..++.++|||||||+||||+||+.||...+. .+....+....
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----------------~~~~~~i~~~~ 217 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----------------MKTYEKILNAE 217 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHHHHHCC
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----------------HHHHHHHHcCC
Confidence 246899999999999999999999999999999999999999965331 11122233333
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
...+.... ..+.+++.+||..||++|| |++|++++
T Consensus 218 ~~~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 33333222 3456778889999999996 89999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=388.55 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=203.9
Q ss_pred cCCccccceEeecccEEEEEEEe------CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL------PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~ 565 (789)
.++|++.++||+|+||.||+|++ .+++.||||+++.... ......|.+|+.+++++ +|||||++++++.+
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH---LTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC---HHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 46899999999999999999975 3467899999865433 23344688999999999 69999999999999
Q ss_pred CCeEEEEEEecCCCchhHHHhhh--------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCC
Q 045256 566 KDERLLVYDYMKNGALYDHLHDR--------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSN 619 (789)
Q Consensus 566 ~~~~~lv~e~~~~gsL~~~l~~~--------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~N 619 (789)
.+..++||||+++|+|.++|+.. ..++.|+++||+|||+++ |+||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence 99999999999999999998642 258899999999999999 9999999999
Q ss_pred EEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 045256 620 ILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGG 699 (789)
Q Consensus 620 Ill~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~ 699 (789)
||++.++.+||+|||+++...............||+.|+|||.+....++.++||||||+++|||+|++.|++.....
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~-- 253 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999998766554444444567899999999999999999999999999999999965555433221
Q ss_pred cccccccchhhhhhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 700 TPVSLVDFAVPAIMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.+.+.++++....... +...+..+.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 254 --------------~~~~~~~i~~~~~~~~--~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 254 --------------DSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp --------------SHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------HHHHHHHHhcCCCCCC--cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 1112223332221111 112334577888999999999999999999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=383.25 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=186.4
Q ss_pred CCccccceEeecccEEEEEEEeC--CC--cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP--DG--QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.+.||+|+||+||+|++. ++ ..||||++....... .+..+.|.+|+++|++++||||+++++++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 57999999999999999999753 22 368999876544322 2344579999999999999999999999965 567
Q ss_pred EEEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
++||||+++++|.+++..+ .+++.|+++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 8999999999999887543 368999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCC-cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDF-RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
...... ......++..|+|||.+....++.++||||||+++|||+| |+.||...+. .+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----------------~~~~~ 225 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----------------SQILH 225 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----------------HHHHH
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----------------HHHHH
Confidence 443322 2223467889999999999999999999999999999998 8999854321 01112
Q ss_pred Hhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHH
Q 045256 719 KILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERA 767 (789)
Q Consensus 719 ~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~ 767 (789)
.+... +++.+. ..+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 226 ~i~~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 KIDKEGERLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHTSCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22222 122222 2334577889999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-44 Score=391.72 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=190.6
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHH---HHHHHHHhhcCCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAF---DSELAFLSRLHHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~---~~E~~~l~~l~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.++||+|+||.||+|+.. +|+.||||++.+...... .....+ .+|+++++.++||||+++++++.+.+..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~-~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH-TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh-hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 68999999999999999999865 689999999765433221 112223 3457777888999999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCC
Q 045256 570 LLVYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPE 641 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~ 641 (789)
|+||||+++|+|.++|.+. ..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999998653 257889999999999999 99999999999999999999999999986543
Q ss_pred CCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHh
Q 045256 642 SERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKI 720 (789)
Q Consensus 642 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (789)
.. .....||+.|+|||++.. ..++.++|||||||+||||+||+.||........ .......
T Consensus 160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--------------~~~~~~~ 221 (364)
T d1omwa3 160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--------------HEIDRMT 221 (364)
T ss_dssp SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--------------HHHHHHS
T ss_pred Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--------------HHHHHhc
Confidence 32 234579999999999864 5689999999999999999999999965432100 0001111
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCC-----HHHHHHH
Q 045256 721 LDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPT-----MADIVAN 763 (789)
Q Consensus 721 ~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt-----~~evl~~ 763 (789)
.......+.. ....+.+|+.+||+.||++||| ++|++++
T Consensus 222 ~~~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 222 LTMAVELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SSCCCCCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ccCCCCCCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1112222222 2344677888999999999999 6888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=381.86 Aligned_cols=268 Identities=25% Similarity=0.378 Sum_probs=196.4
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----eE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD----ER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~----~~ 569 (789)
++|.+.+.||+|+||+||+|++ +|+.||||++..... .....+.|+..+.+++||||+++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5688899999999999999997 689999998754321 1122345666667889999999999998764 57
Q ss_pred EEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcC-----CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 570 LLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYA-----VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
++||||+++|+|.++|++. .+++.++++||+|||+.. .++|+||||||+||||+.++.+||+|||+++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 8999999999999999753 368999999999999752 2459999999999999999999999999997
Q ss_pred CCCCCCCC--CcccccccCcCccCccccCCCC------CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchh
Q 045256 638 MGPESERD--FRPMKAAGTVGYIDPEYYGLNV------LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV 709 (789)
Q Consensus 638 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~ 709 (789)
........ .......||+.|+|||++.... ++.++|||||||+||||+||..||.................
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~- 235 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD- 235 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS-
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc-
Confidence 65433221 2233567999999999986542 57789999999999999999988754433211111110000
Q ss_pred hhhhhhhhH-HhhcccCCCC---CCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 710 PAIMAGELV-KILDRRVGPP---EINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 710 ~~~~~~~~~-~~~d~~~~~~---~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.....+. ...+..+.+. .....+....+.+|+.+||+.||++|||+.||+++|+++.+.
T Consensus 236 --~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 236 --PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp --CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0111111 2222222211 111345667788999999999999999999999999988643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-45 Score=385.79 Aligned_cols=249 Identities=30% Similarity=0.502 Sum_probs=194.0
Q ss_pred CCccccceEeecccEEEEEEEeCC-Cc--EEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEeCCeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPD-GQ--EVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEEKDER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~~~~~ 569 (789)
++|++.++||+|+||+||+|.+++ +. .||||++...... +..+.|.+|+++|+++ +||||++++++|.+++..
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh---HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 578999999999999999998653 44 4778876433222 2344689999999999 799999999999999999
Q ss_pred EEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 570 LLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
++||||+++|+|.++|+.+ .+++.|+++||.|||+.+ |+||||||+|||++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCC
Confidence 9999999999999998643 257899999999999998 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~ 705 (789)
+.+||+|||+++....... .....+|..|+|||.+....++.++||||||+++|||++|..|++....
T Consensus 164 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------- 231 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------- 231 (309)
T ss_dssp GCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---------
T ss_pred CceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC---------
Confidence 9999999999975433222 1234689999999999999999999999999999999998765433221
Q ss_pred cchhhhhhhhhh-HHhhcc-cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhcc
Q 045256 706 DFAVPAIMAGEL-VKILDR-RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDICD 772 (789)
Q Consensus 706 ~~~~~~~~~~~~-~~~~d~-~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~~ 772 (789)
..++ ..+... ++..+. .....+.+|+.+||+.||++||||+||+++|+++++...
T Consensus 232 --------~~~~~~~i~~~~~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 232 --------CAELYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp --------HHHHHHHGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --------HHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 0111 111111 222222 233457788899999999999999999999999986443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=387.70 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=202.7
Q ss_pred HHhcCCccccceEeecccEEEEEEEeC------CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEE
Q 045256 490 AAATNNFSLENKIGAGSFGVVYKGKLP------DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYC 563 (789)
Q Consensus 490 ~~~~~~~~~~~~LG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 563 (789)
+...++|++.+.||+|+||+||+|.+. +++.||||+++.... ......|.+|++++++++||||+++++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC---HHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccC---hHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 334578999999999999999999753 357899999864332 22345689999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCchhHHHhhh------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC
Q 045256 564 EEKDERLLVYDYMKNGALYDHLHDR------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ 625 (789)
Q Consensus 564 ~~~~~~~lv~e~~~~gsL~~~l~~~------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~ 625 (789)
...+..++||||+++|+|.+++... .+++.++++||.|||+++ |+||||||+|||++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCC
Confidence 9999999999999999999988632 358899999999999998 9999999999999999
Q ss_pred CcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc
Q 045256 626 WTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV 705 (789)
Q Consensus 626 ~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~ 705 (789)
+++||+|||+++...............+|+.|+|||.+.+..++.++||||||++||||+||+.|++....
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------- 240 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------- 240 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---------
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC---------
Confidence 99999999999865444433334455789999999999999999999999999999999999644332211
Q ss_pred cchhhhhhhhhhHHhhccc-CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 706 DFAVPAIMAGELVKILDRR-VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
..+.+..+.+.. +..+.. .+..+.+++.+||+.||++||||+||+++|++.++
T Consensus 241 -------~~~~~~~i~~~~~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 241 -------NEQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -------HHHHHHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------HHHHHHHHHhCCCCCCccc----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 011112222322 222222 23457788899999999999999999999988755
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.5e-44 Score=385.23 Aligned_cols=240 Identities=24% Similarity=0.322 Sum_probs=196.9
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++++.||+|+||.||+|+++ +|+.||||++.+..... ....+.+.+|+++|++++||||+++++++.+....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC-HHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 57999999999999999999874 68999999976543322 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
|||+.+|+|.+++.+. ..++.|+++||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 9999999999998653 258899999999999999 9999999999999999999999999998654322
Q ss_pred CCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhccc
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDRR 724 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 724 (789)
....||+.|||||++.+..++.++|||||||+||||+||+.||...+. ...+..+....
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----------------~~~~~~i~~~~ 254 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----------------IQIYEKIVSGK 254 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------------HHHHHHHHHCC
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----------------HHHHHHHhcCC
Confidence 246799999999999999999999999999999999999999964321 01112223333
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 725 VGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 725 ~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
...+... ...+.+++.+||+.||++|+ |++|++++
T Consensus 255 ~~~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 VRFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 3333322 33456778899999999994 89999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=382.28 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=196.4
Q ss_pred hcCCccccceEeecccEEEEEEEeCC--------CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLPD--------GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGY 562 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~ 562 (789)
..++|.+.+.||+|+||.||+|+... +..||||+++..... ....++.+|...+.++ +|||||+++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH---HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh---HHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 34689999999999999999997532 247999998654332 2344688899999888 89999999999
Q ss_pred EEeCCeEEEEEEecCCCchhHHHhhh------------------------chHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 045256 563 CEEKDERLLVYDYMKNGALYDHLHDR------------------------NNVEKNAARGIEYLHNYAVPPIIHRDIKSS 618 (789)
Q Consensus 563 ~~~~~~~~lv~e~~~~gsL~~~l~~~------------------------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~ 618 (789)
|.+++..++||||+++|+|.++|..+ ..++.|++.||+|||+.+ |+||||||+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 99999999999999999999998633 258899999999999999 999999999
Q ss_pred CEEECCCCcEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 045256 619 NILLDAQWTARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLT-GKRAIFKDDES 697 (789)
Q Consensus 619 NIll~~~~~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~ellt-G~~pf~~~~~~ 697 (789)
|||++.++.+||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |++||.....
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~- 243 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 243 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence 99999999999999999987655444444445678999999999999999999999999999999998 5666632211
Q ss_pred CCcccccccchhhhhhhhhhHHhhcc--cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 698 GGTPVSLVDFAVPAIMAGELVKILDR--RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
..+.+.+.. ++..+.. .+..+.+|+.+||+.||++|||+.||++.|+++++.
T Consensus 244 -----------------~~~~~~i~~~~~~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 244 -----------------EELFKLLKEGHRMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp -----------------HHHHHHHHTTCCCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------------HHHHHHHHcCCCCCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 011112222 2222222 234567889999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=384.50 Aligned_cols=244 Identities=17% Similarity=0.284 Sum_probs=196.7
Q ss_pred hcCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEE
Q 045256 492 ATNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERL 570 (789)
Q Consensus 492 ~~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~ 570 (789)
..++|++.+.||+|+||+||+|... +++.||||+++.... ....+.+|+++|++++||||+++++++.+.+..|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-----DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 3478999999999999999999865 688999999865432 2235889999999999999999999999999999
Q ss_pred EEEEecCCCchhHHHhhhc---------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC--CcEEEEeeccCcCC
Q 045256 571 LVYDYMKNGALYDHLHDRN---------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ--WTARVSDFGLSMMG 639 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~~---------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfGls~~~ 639 (789)
|||||+++|+|.+++.+.. .++.|+++||+|||+++ |+||||||+|||++.+ ..+||+|||+++..
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999999996532 57899999999999999 9999999999999854 58999999999764
Q ss_pred CCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHH
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVK 719 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (789)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...+..
T Consensus 155 ~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-----------------~~~~~~ 214 (321)
T d1tkia_ 155 KPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----------------QQIIEN 214 (321)
T ss_dssp CTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----------------HHHHHH
T ss_pred ccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-----------------HHHHHH
Confidence 3332 22345789999999999999999999999999999999999999965432 011122
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 720 ILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 720 ~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.......+..........+.+|+.+||..||++|||+.|++++
T Consensus 215 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22222222211111234556788999999999999999999884
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=383.45 Aligned_cols=242 Identities=23% Similarity=0.364 Sum_probs=189.6
Q ss_pred CCccccc-eEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc-CCCcceEEEEEEEe----C
Q 045256 494 NNFSLEN-KIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL-HHKHLVRLVGYCEE----K 566 (789)
Q Consensus 494 ~~~~~~~-~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~----~ 566 (789)
++|.+.. .||+|+||+||+|+. .+++.||||+++.. ..+.+|++++.++ +||||++++++|++ .
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 5788775 699999999999986 56899999997542 1366899887665 89999999999976 3
Q ss_pred CeEEEEEEecCCCchhHHHhhh----------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEee
Q 045256 567 DERLLVYDYMKNGALYDHLHDR----------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDF 633 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~----------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~Df 633 (789)
..+|+||||+++|+|.++|.++ ..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence 5689999999999999999753 258899999999999999 999999999999975 567999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhh
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIM 713 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~ 713 (789)
|+++....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||...+.......
T Consensus 159 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~----------- 224 (335)
T d2ozaa1 159 GFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------- 224 (335)
T ss_dssp TTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------
T ss_pred ceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH-----------
Confidence 99986544332 2346799999999999999999999999999999999999999976543211100
Q ss_pred hhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 714 AGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 714 ~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
....+.......+..........+.+|+.+||+.||++|||+.|++++
T Consensus 225 --~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 225 --MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000111111112222233455677889999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=377.00 Aligned_cols=246 Identities=28% Similarity=0.460 Sum_probs=193.5
Q ss_pred cceEeecccEEEEEEEeCCC----cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-CeEEEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPDG----QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK-DERLLVY 573 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~-~~~~lv~ 573 (789)
.++||+|+||+||+|++.++ ..||||+++.... ....+.|.+|+++|++++||||+++++++.+. ...++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccC---HHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 57899999999999986542 2589998764322 23345699999999999999999999998764 5789999
Q ss_pred EecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 574 e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
||+++++|.++++.+ ..++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999999988643 368999999999999998 99999999999999999999999999987544332
Q ss_pred CC--cccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhc
Q 045256 645 DF--RPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILD 722 (789)
Q Consensus 645 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 722 (789)
.. ......||+.|+|||.+....++.++||||||++||||+||+.||....... .+ ...+..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~------------~~~i~~ 249 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DI------------TVYLLQ 249 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------C------------HHHHHT
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HH------------HHHHHc
Confidence 21 2223568999999999999999999999999999999999988876433210 00 011111
Q ss_pred -ccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhh
Q 045256 723 -RRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDI 770 (789)
Q Consensus 723 -~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~ 770 (789)
.++..+... .+.+.+|+.+||+.||++||+|.||+++|++++..
T Consensus 250 g~~~~~p~~~----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 250 GRRLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcccC----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 122222222 34567788899999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-44 Score=378.81 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=192.4
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHh-hcCCCcceEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLS-RLHHKHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||+||+|+.. +++.||||++++...... +..+.+..|..++. .++||||+++++++.+++..|+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh-HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 57999999999999999999875 689999999865433222 22334556666654 6899999999999999999999
Q ss_pred EEEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCC
Q 045256 572 VYDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESE 643 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~ 643 (789)
||||+++|+|.+++... ..++.|++.||+|||+++ |+||||||+|||++.++++||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999998753 358899999999999999 9999999999999999999999999997644332
Q ss_pred CCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhHHhhcc
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELVKILDR 723 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 723 (789)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. . .-...+...
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~------------~~~~~i~~~ 218 (320)
T d1xjda_ 158 A--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----E------------ELFHSIRMD 218 (320)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H------------HHHHHHHHC
T ss_pred c--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----H------------HHHHHHHcC
Confidence 2 22346799999999999999999999999999999999999999964332 0 011112222
Q ss_pred cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHH-HHHH
Q 045256 724 RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMA-DIVA 762 (789)
Q Consensus 724 ~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~-evl~ 762 (789)
....+... ...+.+|+.+||+.||++||++. |+++
T Consensus 219 ~~~~p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NPFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCCccC----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 22222222 34467788899999999999996 6754
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-42 Score=383.32 Aligned_cols=264 Identities=15% Similarity=0.125 Sum_probs=219.4
Q ss_pred ceeeeeeeecCCCcEEEeeC---------------CcccccCCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCC-
Q 045256 44 ATVCAVVAAQPTQRLLCYQG---------------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSN- 107 (789)
Q Consensus 44 ~h~~~~~~l~~~g~v~~wG~---------------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~- 107 (789)
.|++ ++++||+||+||. +.|..+....+|++|+||..|++||++|| +||+||.|..+|..
T Consensus 6 ~h~~---~~~~~G~vy~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~ia~G~~h~~al~~~G-~vy~wG~n~~GQLG~ 81 (401)
T d1a12a_ 6 SHRS---HSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSG-QVYSFGCNDEGALGR 81 (401)
T ss_dssp CCTT---CCCCCBEEEEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEEETTS-CEEEEECCTTSTTCS
T ss_pred eEEE---EECCCCEEEEEeCCCCCCCCCCCCCceeccCEEeCCCCCeEEEEeCCCEEEEEeCCC-EEEEEeCCCCCCCCc
Confidence 6999 9999999999998 34555555668999999999999999999 99999999976632
Q ss_pred ------CcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCC--------------CCCccEEEEeeeC
Q 045256 108 ------FVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAP--------------SGELQFESLTSGI 167 (789)
Q Consensus 108 ------~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~--------------~~~~~v~~va~G~ 167 (789)
..|.+.......+|++|+||..|++++++||+||+||.+...+.... .....+++|++|.
T Consensus 82 g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~~~g~v~~wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~g~ 161 (401)
T d1a12a_ 82 DTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGN 161 (401)
T ss_dssp CCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEETTSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECS
T ss_pred ccccccccccccccccccceeeecccccceeeccccccceeccccccccccccccCCccccceeeeeccCCceeEEEecc
Confidence 23444444455678899999999999999999999997654432111 1124689999999
Q ss_pred ceeEEEEeCCCeEEEeecCCCCCcccCCC----------------------------CCceeEEEeeCCceeEEEccCCc
Q 045256 168 DFSCGILTNNKTVRCWGINSISNQIQTSF----------------------------ANRSMFSITAGGNHVCGIDSNGF 219 (789)
Q Consensus 168 ~hs~al~~~~g~v~~wG~n~~gqlg~~~~----------------------------~~~~v~~i~~G~~h~~al~~dG~ 219 (789)
.|+++ ++++|++|+||.|.+||+|.... ....|.+|+||..|+++|+++|+
T Consensus 162 ~~~~~-~~~~g~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~~l~~~g~ 240 (401)
T d1a12a_ 162 DHLVM-LTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGH 240 (401)
T ss_dssp SEEEE-EETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEEETTCC
T ss_pred cceee-eecCCcccccccCCccccCCCCccccccCCccccccccccceeeccccCCCCCceEEEEEecCCeEEEEecCCe
Confidence 99999 57777999999999999976432 12358899999999999999999
Q ss_pred EEEEEcCCCCCCCcCCCC-------------CccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC---------
Q 045256 220 VICYGDNKSGQLKFPLNS-------------TAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR--------- 277 (789)
Q Consensus 220 v~~wG~n~~Gql~~~~~~-------------~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~--------- 277 (789)
||+||.|.+||++..... ....++.+++|..|++++++ +|+||+||.|.+||++...
T Consensus 241 v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~g~~~~~~l~~-~g~v~~wG~n~~gqlG~g~~~~~~~~P~ 319 (401)
T d1a12a_ 241 VYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDS-EGKAYSLGRAEYGRLGLGEGAEEKSIPT 319 (401)
T ss_dssp EEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEEET-TSCEEEEECCGGGTTCSCTTCCCEEEEE
T ss_pred EeeecccceecccccccccceeccccccccccceeEEEEeeeccceeeecc-CCCEEEecccccCccCCCcccccccCCE
Confidence 999999999999654321 13468999999999999999 9999999999999975432
Q ss_pred ----CCcEEEEEecCceEEEEeecCCeEEEecCCCCCCCCC
Q 045256 278 ----GKSFESIVSGSNFTCGLTTSNFSVICWGPGWPNVSND 314 (789)
Q Consensus 278 ----~~~v~~i~~G~~h~~al~~~g~~v~~WG~n~~~~~~~ 314 (789)
..+|++|+||.+|++||++|| +||+||.|.++|+|.
T Consensus 320 ~i~~~~~i~~Is~G~~hs~alt~dG-~v~~WG~n~~GQLG~ 359 (401)
T d1a12a_ 320 LISRLPAVSSVACGASVGYAVTKDG-RVFAWGMGTNYQLGT 359 (401)
T ss_dssp ECCSSSSEEEEEECSSEEEEEETTS-CEEEEECCTTSTTCS
T ss_pred EcCCCCCeEEEEeeCCEEEEEeCCC-eEEEEecCCCCCCCC
Confidence 357999999999999999998 999999999999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=373.63 Aligned_cols=260 Identities=22% Similarity=0.225 Sum_probs=184.0
Q ss_pred ccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHH-HHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEEEe
Q 045256 498 LENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQ-EKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVYDY 575 (789)
Q Consensus 498 ~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~e~ 575 (789)
.+++||+|+||+||+|+++ +|+.||||+++........ ...+.+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3689999999999999864 6899999998654432221 1234588999999999999999999999999999999999
Q ss_pred cCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCCCc
Q 045256 576 MKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERDFR 647 (789)
Q Consensus 576 ~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~~~ 647 (789)
++++++..++... ..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-- 156 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-- 156 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc--
Confidence 9987777665422 368899999999999999 999999999999999999999999999765443322
Q ss_pred ccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccccccc---chhhhhhhhhhHHhhcc
Q 045256 648 PMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVD---FAVPAIMAGELVKILDR 723 (789)
Q Consensus 648 ~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~d~ 723 (789)
.....||+.|+|||++.. ..++.++|||||||++|||+||++||....+..... .+.. .+...............
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~-~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT-RIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH-HHHHhcCCCChhhccchhccchhh
Confidence 224578999999998864 467999999999999999999999986543210000 0000 00000000000000000
Q ss_pred cC-CCCCCCHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 724 RV-GPPEINEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 724 ~~-~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.. ..+..... ...+.+.+|+.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 00000011 123456788999999999999999999874
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=371.64 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=217.7
Q ss_pred cceeEEEEecCceeeeeeeecCCCcEEEeeC----------------CcccccCCCCcEEEEEecCceEEEEEeCCceEE
Q 045256 33 SGSTLAVSYGSATVCAVVAAQPTQRLLCYQG----------------GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLL 96 (789)
Q Consensus 33 ~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~----------------~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~ 96 (789)
...|++|+||..|++ ||++||+||+||. +.|..+....+|++|+||..|++++++|| +||
T Consensus 46 ~~~i~~ia~G~~h~~---al~~~G~vy~wG~n~~GQLG~g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~~~g-~v~ 121 (401)
T d1a12a_ 46 PEDVVQAEAGGMHTV---CLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDG-RVF 121 (401)
T ss_dssp SSCEEEEEECSSEEE---EEETTSCEEEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEEETTS-CEE
T ss_pred CCCeEEEEeCCCEEE---EEeCCCEEEEEeCCCCCCCCcccccccccccccccccccceeeecccccceeeccccc-cce
Confidence 356999999999999 9999999999997 34455566778999999999999999999 999
Q ss_pred EccCCCCCC--------CCCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCC-------------
Q 045256 97 CWDTNFSYN--------SNFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPS------------- 155 (789)
Q Consensus 97 ~wG~n~~~~--------~~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~------------- 155 (789)
+||.+.+.+ ....+..+....+..+++|++|..|+++++++|++|+||.+..+|++...
T Consensus 122 ~wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~~~~g~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~ 201 (401)
T d1a12a_ 122 LWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLE 201 (401)
T ss_dssp EEECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEEETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHH
T ss_pred eccccccccccccccCCccccceeeeeccCCceeEEEecccceeeeecCCcccccccCCccccCCCCccccccCCccccc
Confidence 999876322 12233444445566788999999999999999999999999888774321
Q ss_pred ----------------CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCC--------------CceeEEEe
Q 045256 156 ----------------GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFA--------------NRSMFSIT 205 (789)
Q Consensus 156 ----------------~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~--------------~~~v~~i~ 205 (789)
...+|++|+||..|+++ ++++|+||+||.|.+++++..... ...+++++
T Consensus 202 ~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~~-l~~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~ 280 (401)
T d1a12a_ 202 RLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFA-ISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFS 280 (401)
T ss_dssp HHHSCEECCCBCSSCCSBCCEEEEEEETTEEEE-EETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEE
T ss_pred cccccceeeccccCCCCCceEEEEEecCCeEEE-EecCCeEeeecccceecccccccccceeccccccccccceeEEEEe
Confidence 11358999999999999 566679999999999999876542 24488999
Q ss_pred eCCceeEEEccCCcEEEEEcCCCCCCCcCCC----------CCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccC
Q 045256 206 AGGNHVCGIDSNGFVICYGDNKSGQLKFPLN----------STAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNG 275 (789)
Q Consensus 206 ~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~----------~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~ 275 (789)
+|..|+++++++|+||+||.|.+|||+.... ....+|++|+||.+|++||++ ||+||+||+|.+|||+.
T Consensus 281 ~g~~~~~~l~~~g~v~~wG~n~~gqlG~g~~~~~~~~P~~i~~~~~i~~Is~G~~hs~alt~-dG~v~~WG~n~~GQLG~ 359 (401)
T d1a12a_ 281 GGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQLGT 359 (401)
T ss_dssp ECSSEEEEEETTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEEET-TSCEEEEECCTTSTTCS
T ss_pred eeccceeeeccCCCEEEecccccCccCCCcccccccCCEEcCCCCCeEEEEeeCCEEEEEeC-CCeEEEEecCCCCCCCC
Confidence 9999999999999999999999999965432 234579999999999999999 99999999999999755
Q ss_pred CC----------------CCcEEEEEecCceEEEEeecC
Q 045256 276 IR----------------GKSFESIVSGSNFTCGLTTSN 298 (789)
Q Consensus 276 ~~----------------~~~v~~i~~G~~h~~al~~~g 298 (789)
.. +.+|.+|+||..|+++|++||
T Consensus 360 G~~~~~~~P~~v~~~~~~~~~v~~v~~G~~hs~~l~~d~ 398 (401)
T d1a12a_ 360 GQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKDK 398 (401)
T ss_dssp SSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEEEEEC
T ss_pred CCCCCEecCEEeeccCCCCCEEEEEEEccceEEEEEECC
Confidence 32 346999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=365.66 Aligned_cols=237 Identities=24% Similarity=0.415 Sum_probs=187.2
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHH--HHHHHHHHHHHHHhhcC--CCcceEEEEEEEeCC
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQ--EKESAFDSELAFLSRLH--HKHLVRLVGYCEEKD 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~--~~~~~~~~E~~~l~~l~--HpnIv~l~~~~~~~~ 567 (789)
.++|++.++||+|+||+||+|+. .+++.||||++......... .....+.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999986 47899999998654322211 11123668999999996 899999999999999
Q ss_pred eEEEEEEecCC-CchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCC-CcEEEEeeccCc
Q 045256 568 ERLLVYDYMKN-GALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQ-WTARVSDFGLSM 637 (789)
Q Consensus 568 ~~~lv~e~~~~-gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfGls~ 637 (789)
..++||||+.+ +++.+++..+ ..++.|+++||+|||+++ |+||||||+|||++.+ +.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 5777777543 358899999999999999 9999999999999854 799999999997
Q ss_pred CCCCCCCCCcccccccCcCccCccccCCCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhh
Q 045256 638 MGPESERDFRPMKAAGTVGYIDPEYYGLNVL-TAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGE 716 (789)
Q Consensus 638 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (789)
...... .....||+.|+|||++.+..+ +.++|||||||+||||+||+.||...++
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------------- 215 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------------- 215 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------------
T ss_pred eccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------------
Confidence 643322 224679999999999976655 5779999999999999999999853210
Q ss_pred hHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+.......+... +..+.+|+.+||+.||++|||++|++++
T Consensus 216 ---i~~~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 ---IIRGQVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---HHHCCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---HhhcccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111111112222 2346778889999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.6e-43 Score=369.21 Aligned_cols=262 Identities=20% Similarity=0.247 Sum_probs=189.7
Q ss_pred CCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLVY 573 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 573 (789)
++|++.++||+|+||+||+|++++++.||||++...... ....+.+.+|+.+|++++||||+++++++.+.+..+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED--EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG--GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 689999999999999999999999999999998654332 223456889999999999999999999999999999999
Q ss_pred EecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCCC
Q 045256 574 DYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESERD 645 (789)
Q Consensus 574 e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~~ 645 (789)
||+.++.+..+.... ..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 999887766665432 368999999999999998 99999999999999999999999999876433322
Q ss_pred CcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--------ccccchhhhhhhhh
Q 045256 646 FRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--------SLVDFAVPAIMAGE 716 (789)
Q Consensus 646 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--------~~~~~~~~~~~~~~ 716 (789)
......+++.|+|||.+.. ..++.++|||||||++|||++|+.||...++...... ....+....... .
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~ 233 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP-K 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST-T
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh-h
Confidence 2224468999999999865 4568999999999999999999999964432100000 000000000000 0
Q ss_pred hHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 717 LVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 717 ~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
......... .+...........+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00000011223456788999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=365.74 Aligned_cols=262 Identities=20% Similarity=0.308 Sum_probs=187.5
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++.+.||+|+||+||+|.+ .+++.||||+++..... ....+.+.+|+++|++++||||+++++++.+.+..|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC--hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 5899999999999999999986 57899999998654322 22345688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhh----------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCC
Q 045256 573 YDYMKNGALYDHLHD----------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPES 642 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~----------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~ 642 (789)
|||+.+ ++.+++.. ...++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 999976 55554432 2368999999999999999 999999999999999999999999999764433
Q ss_pred CCCCcccccccCcCccCccccCCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchh-hhhhhhhhHHh
Q 045256 643 ERDFRPMKAAGTVGYIDPEYYGLNV-LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAV-PAIMAGELVKI 720 (789)
Q Consensus 643 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 720 (789)
.. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+.............. ...........
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 22 222457999999999876654 588999999999999999999999654321000000000000 00000000000
Q ss_pred hcccCC--C-CCCCH----HHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 721 LDRRVG--P-PEINE----AEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 721 ~d~~~~--~-~~~~~----~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.+.... . ..... ......+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000 0 00000 0122456778899999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=366.33 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=184.6
Q ss_pred cCCccccceEeecccEEEEEEEeC-C-CcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhc---CCCcceEEEEEEEe--
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-D-GQEVAIKRGETAKTKKFQEKESAFDSELAFLSRL---HHKHLVRLVGYCEE-- 565 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l---~HpnIv~l~~~~~~-- 565 (789)
.++|++++.||+|+||+||+|++. + ++.||||+++....... ....+.+|+++|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS--CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch--HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 468999999999999999999863 4 56799999865432211 112355677777666 79999999999864
Q ss_pred ---CCeEEEEEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEee
Q 045256 566 ---KDERLLVYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDF 633 (789)
Q Consensus 566 ---~~~~~lv~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 633 (789)
....+++|||++++++...... ...++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2357899999998766544321 2368999999999999999 999999999999999999999999
Q ss_pred ccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCccc--------ccc
Q 045256 634 GLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPV--------SLV 705 (789)
Q Consensus 634 Gls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~--------~~~ 705 (789)
|++....... ......||+.|+|||++.+..++.++|||||||++|||++|++||...++...... ...
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9987543322 23356799999999999999999999999999999999999999965432100000 000
Q ss_pred cchhhhhhhhhhHHhhcccC-CCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 706 DFAVPAIMAGELVKILDRRV-GPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 706 ~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
.|...... ......... .+.........+.+.+|+.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVAL---PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSS---CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccc---hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 000000000 00000011223456678889999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=356.20 Aligned_cols=264 Identities=23% Similarity=0.307 Sum_probs=183.9
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEe-------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEE------- 565 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------- 565 (789)
++|++.+.||+|+||+||+|++ .+|+.||||++....... .....+.+|+++|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 6899999999999999999986 478999999976543322 223457899999999999999999999865
Q ss_pred -CCeEEEEEEecCCCchhHHHhh--------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccC
Q 045256 566 -KDERLLVYDYMKNGALYDHLHD--------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLS 636 (789)
Q Consensus 566 -~~~~~lv~e~~~~gsL~~~l~~--------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls 636 (789)
....++||||++++.+...... ...++.|+++||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 3457999999988666554332 2368999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCC--CcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccc--cc-cc---
Q 045256 637 MMGPESERD--FRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVS--LV-DF--- 707 (789)
Q Consensus 637 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~--~~-~~--- 707 (789)
......... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||....+....... .. ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 765433221 122345799999999998654 6899999999999999999999999643210000000 00 00
Q ss_pred hhhhhhhhhhHHhhcccCCCCCCCHHH------HHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 708 AVPAIMAGELVKILDRRVGPPEINEAE------AVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 708 ~~~~~~~~~~~~~~d~~~~~~~~~~~~------~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...........+.+..... ......+ ....+.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSS-CCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhccccc-ccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000000000000000 0111111 12345678999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=362.78 Aligned_cols=249 Identities=28% Similarity=0.369 Sum_probs=192.9
Q ss_pred CCccccceEeecccEEEEEEEe----CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-CcceEEEEEEEeCCe
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL----PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-KHLVRLVGYCEEKDE 568 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~ 568 (789)
++|++.+.||+|+||+||+|.. .+|+.||||+++...........+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5799999999999999999974 24789999998654332222223457899999999976 899999999999999
Q ss_pred EEEEEEecCCCchhHHHhhhc--------hHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 569 RLLVYDYMKNGALYDHLHDRN--------NVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 569 ~~lv~e~~~~gsL~~~l~~~~--------~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
.+++|||+.+++|.+++.... .++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999986543 57889999999999999 9999999999999999999999999997654
Q ss_pred CCCCCCcccccccCcCccCccccCCC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhhhhhH
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLN--VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMAGELV 718 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (789)
..... ......|++.|+|||.+... .++.++|||||||+||||++|+.||......... ..-..
T Consensus 181 ~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-------------~~i~~ 246 (322)
T d1vzoa_ 181 ADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-------------AEISR 246 (322)
T ss_dssp GGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-------------HHHHH
T ss_pred ccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-------------HHHHH
Confidence 33222 23346789999999998654 4688999999999999999999999765432111 00111
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCC-----CHHHHHHH
Q 045256 719 KILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERP-----TMADIVAN 763 (789)
Q Consensus 719 ~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RP-----t~~evl~~ 763 (789)
.........+. .....+.+|+.+||+.||++|| |++|++++
T Consensus 247 ~~~~~~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 247 RILKSEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred hcccCCCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11122222222 2334566778899999999999 47888874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=351.27 Aligned_cols=263 Identities=18% Similarity=0.233 Sum_probs=193.5
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCCeEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKDERLLV 572 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~~lv 572 (789)
++|++++.||+|+||+||+|++ .+++.||||+++..... ......+.+|+.+|++++||||+++++++.+.+..+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD--EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS--TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC--hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 5899999999999999999986 47889999998654322 23455688999999999999999999999999999999
Q ss_pred EEecCCCchhHHHhhh--------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCCCCCC
Q 045256 573 YDYMKNGALYDHLHDR--------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGPESER 644 (789)
Q Consensus 573 ~e~~~~gsL~~~l~~~--------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~~~~~ 644 (789)
+|++.+++|..++... ..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.++.......
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 9999998888876543 368899999999999998 99999999999999999999999999986544332
Q ss_pred CCcccccccCcCccCccccCCCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh--hhhhhhhHHhh
Q 045256 645 DFRPMKAAGTVGYIDPEYYGLNV-LTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP--AIMAGELVKIL 721 (789)
Q Consensus 645 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 721 (789)
. .....+++.|+|||.+.... ++.++|||||||++|||++|+.||+...........+...... ........+..
T Consensus 157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred c--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2 22345778999999987654 6899999999999999999999986543211000000000000 00000000000
Q ss_pred cc-------cCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 722 DR-------RVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 722 d~-------~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
+. ...............+.+|+.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000011112223456678889999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.2e-40 Score=347.29 Aligned_cols=256 Identities=20% Similarity=0.221 Sum_probs=195.2
Q ss_pred cCCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-CcceEEEEEEEeCCeEE
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-KHLVRLVGYCEEKDERL 570 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~~~~~~~ 570 (789)
.++|++.+.||+|+||+||+|++. +++.||||++...... ..+.+|+++++.|+| +|++.+++++.+....+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 77 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 77 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence 468999999999999999999864 6889999986543221 237789999999965 89999999999999999
Q ss_pred EEEEecCCCchhHHHhhh---------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC-----CCcEEEEeeccC
Q 045256 571 LVYDYMKNGALYDHLHDR---------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA-----QWTARVSDFGLS 636 (789)
Q Consensus 571 lv~e~~~~gsL~~~l~~~---------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfGls 636 (789)
+||||+ +++|.+++... ..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a 153 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 153 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccccee
Confidence 999999 67999988643 258999999999999999 999999999999964 578999999999
Q ss_pred cCCCCCCCC-----CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhh
Q 045256 637 MMGPESERD-----FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPA 711 (789)
Q Consensus 637 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~ 711 (789)
+........ .......||+.|||||++.+..++.++||||||+++|||+||+.||.......... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~------~~~~ 227 (293)
T d1csna_ 154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ------KYER 227 (293)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH------HHHH
T ss_pred EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH------HHHH
Confidence 765433211 12234579999999999999999999999999999999999999996543311100 0000
Q ss_pred hhhhhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhhhc
Q 045256 712 IMAGELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALDIC 771 (789)
Q Consensus 712 ~~~~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~~~ 771 (789)
+......... +.+. ..+++.+..++..|+..+|++||+++.+.+.|+++++..
T Consensus 228 i~~~~~~~~~-~~l~------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 228 IGEKKQSTPL-RELC------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHHSCH-HHHT------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhccCCCCh-HHhc------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 0000000000 0000 012244677788899999999999999999999887643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=360.15 Aligned_cols=264 Identities=21% Similarity=0.270 Sum_probs=185.6
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|++.+.||+|+||+||+|.+ .+|+.||||+++..... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS--ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS--HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC--hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 47899999999999999999986 46899999998753322 233456889999999999999999999998654
Q ss_pred --eEEEEEEecCCCchhHHHhh-------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 568 --ERLLVYDYMKNGALYDHLHD-------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 568 --~~~lv~e~~~~gsL~~~l~~-------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
.+|+||||+ +.+|..+++. ...++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 469999999 4577776643 2368999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCc----------ccccccc
Q 045256 639 GPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGT----------PVSLVDF 707 (789)
Q Consensus 639 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~----------~~~~~~~ 707 (789)
..... ....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... +......
T Consensus 171 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 171 ADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp CCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 43322 24578999999998865 56789999999999999999999999654321100 0000000
Q ss_pred hhhhhhhhhhHHhhccc-CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHHh
Q 045256 708 AVPAIMAGELVKILDRR-VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN--LERAL 768 (789)
Q Consensus 708 ~~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~~ 768 (789)
....... .....+... ..............+.+|+.+||..||++|||++|++++ ++.+.
T Consensus 246 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 246 LQSDEAK-NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CSCHHHH-HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hcchhhh-hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000 000000000 000000001122345678889999999999999999987 55543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-41 Score=360.61 Aligned_cols=269 Identities=19% Similarity=0.242 Sum_probs=189.3
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD---- 567 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~---- 567 (789)
.++|++++.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+++|++++||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH---QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC---HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC---hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 46799999999999999999975 5799999999865432 233446889999999999999999999997653
Q ss_pred eEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 568 ERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
..+++++|+.+++|.+++..+ ..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 235556677799999998643 368999999999999999 9999999999999999999999999997644
Q ss_pred CCCCC-CcccccccCcCccCccccC-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh--h----h
Q 045256 641 ESERD-FRPMKAAGTVGYIDPEYYG-LNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP--A----I 712 (789)
Q Consensus 641 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~--~----~ 712 (789)
..... .......||+.|+|||++. ...++.++||||+||++|||++|+.||...+..............+ . .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 33221 2233567999999999984 4567899999999999999999999996543210000000000000 0 0
Q ss_pred hhhhhHHhhcccCCCCCCCHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHH
Q 045256 713 MAGELVKILDRRVGPPEINEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN--LERA 767 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 767 (789)
..................... .....+.+|+.+||+.||++|||+.|++++ |++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000001010000000011 112346678999999999999999999986 5543
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=5.8e-39 Score=334.46 Aligned_cols=240 Identities=22% Similarity=0.379 Sum_probs=197.8
Q ss_pred CcEEEeeC-----CcccccCCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEecCCe
Q 045256 56 QRLLCYQG-----GTIRAVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNH 130 (789)
Q Consensus 56 g~v~~wG~-----~~~~~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~G~~h 130 (789)
-+|++||. ..|+++....+|++|+||..|+|+|+ || +||+||.|.++|... |... ...|++|+||..|
T Consensus 4 ~sv~~WG~~~~~~~~~~~~~~~~~i~~va~G~~h~~al~-dG-~v~~wG~N~~GQlG~-~~~~----~~~v~~v~~G~~~ 76 (273)
T d1jtdb_ 4 TSVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALK-GG-KVLGWGANLNGQLTM-PAAT----QSGVDAIAAGNYH 76 (273)
T ss_dssp SEEEEESSCCSSSTTCCCGGGSSSEEEEEECSSEEEEEE-TT-EEEEEECCTTSTTSC-CGGG----GSCCCEEEECSSE
T ss_pred CEEEEECCCCCCCceeccccCCCCcEEEEccCCEEEEEE-CC-EEEEEeCCCCCceee-eecc----cccceEEecCCCc
Confidence 46999997 33344444458999999999999998 89 999999999988653 2222 2246699999999
Q ss_pred EEEEeeCCeEEEcCCCCCCCCCCCCCC-ccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEeeCCc
Q 045256 131 VCATTVQGQINCWRGDVNISKNAPSGE-LQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITAGGN 209 (789)
Q Consensus 131 ~~al~~~G~v~~wG~~~~~~~~~~~~~-~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~G~~ 209 (789)
+++|+ ||+||+||.+..+|+..+... ..++.|++|..|+++ +++ |+||+||.+..++..........|+.++++.+
T Consensus 77 ~~al~-dg~v~~wG~~~~gq~~~~~~~~~~~~~i~~~~~~~~~-~~d-g~v~~~g~~~~~~~~~~~~~~~~v~~~~~~~~ 153 (273)
T d1jtdb_ 77 SLALK-DGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYA-LKD-GKVIAWGDDSDGQTTVPAEAQSGVTALDGGVY 153 (273)
T ss_dssp EEEEE-TTEEEEEECCTTSTTCCCGGGGSSCCEEEEETTEEEE-EET-TEEEEEECCTTSTTSCCGGGGSSEEEEEECSS
T ss_pred eeeee-eeeeeccCCCcceeeccccccccceeEEeeecccccc-ccc-ccceecccCCCCceeeeccCCceEEEEeccce
Confidence 99997 899999999999998765432 348899999999998 465 59999999999998877666677877777665
Q ss_pred eeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccCCC--CCcEEEEEec
Q 045256 210 HVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNGIR--GKSFESIVSG 287 (789)
Q Consensus 210 h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~~~--~~~v~~i~~G 287 (789)
| +++.++|.+|+||.|.+||+..+.. ...+|++|+||.+|+++|+ ||+||+||.|.+||++.+. ..+|++|+||
T Consensus 154 ~-~~~~~~g~~~~~G~~~~g~~~~~~~-~~~~v~~Is~G~~h~~~l~--dG~v~~WG~n~~Gql~~~~~~~~~v~~I~~G 229 (273)
T d1jtdb_ 154 T-ALAVKNGGVIAWGDNYFGQTTVPAE-AQSGVDDVAGGIFHSLALK--DGKVIAWGDNRYKQTTVPTEALSGVSAIASG 229 (273)
T ss_dssp E-EEEEETTEEEEEECCTTSTTSCCGG-GSSSEEEEEECSSEEEEEE--TTEEEEEECCTTSTTCCCGGGGSSCCEEEEC
T ss_pred e-eeeecccceeEeecccCCccccccc-ccCCccceeccceeeEEEe--cCcEEEcCCCCCCccCCCccCCCCcEEEEeC
Confidence 5 5555689999999999999976554 3468999999999999985 7999999999999988753 4779999999
Q ss_pred CceEEEEeecCCeEEEecCCCCCC
Q 045256 288 SNFTCGLTTSNFSVICWGPGWPNV 311 (789)
Q Consensus 288 ~~h~~al~~~g~~v~~WG~n~~~~ 311 (789)
..|+++|+ || +||+||+|..++
T Consensus 230 ~~~~~~l~-~g-~v~~WG~~~~~~ 251 (273)
T d1jtdb_ 230 EWYSLALK-NG-KVIAWGSSRTAP 251 (273)
T ss_dssp SSCEEEEE-TT-EEEEESTTCCCC
T ss_pred cceEEEEE-CC-EEEEECCCCCCC
Confidence 99999995 87 999999997665
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.3e-40 Score=354.83 Aligned_cols=257 Identities=17% Similarity=0.273 Sum_probs=187.9
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeC--CeE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEK--DER 569 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~--~~~ 569 (789)
++|++.++||+|+||+||+|+. .+++.||||+++... .+.+.+|+++|++++ ||||+++++++... ...
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 5799999999999999999986 468999999976532 234788999999995 99999999999854 458
Q ss_pred EEEEEecCCCchhHHHhh-----hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeeccCcCCCCCC
Q 045256 570 LLVYDYMKNGALYDHLHD-----RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGLSMMGPESE 643 (789)
Q Consensus 570 ~lv~e~~~~gsL~~~l~~-----~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGls~~~~~~~ 643 (789)
++||||+++++|..+.+. ...++.|+++||+|||+++ |+||||||+|||++.++ .+||+|||++.......
T Consensus 108 ~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999999999887542 3468999999999999999 99999999999998654 69999999997654432
Q ss_pred CCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh--------
Q 045256 644 RDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA-------- 714 (789)
Q Consensus 644 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 714 (789)
. .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.||............+..........
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 2345789999999998664 579999999999999999999999975543111000000000000000
Q ss_pred ---hhhHHhhcccCC------CCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 715 ---GELVKILDRRVG------PPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 715 ---~~~~~~~d~~~~------~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
............ ............+.+|+.+||..||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000 0011112233456778899999999999999999864
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=1.1e-38 Score=332.43 Aligned_cols=244 Identities=21% Similarity=0.306 Sum_probs=200.8
Q ss_pred ccceeEEEEecCceeeeeeeecCCCcEEEeeCCcccc----cCCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCC
Q 045256 32 GSGSTLAVSYGSATVCAVVAAQPTQRLLCYQGGTIRA----VEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSN 107 (789)
Q Consensus 32 ~~~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~~~~~~----~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~ 107 (789)
....|++|++|..|+| +|+ ||+||+||...--+ .....+|++|+||..|+++|+ || +||+||.|.+++..
T Consensus 24 ~~~~i~~va~G~~h~~---al~-dG~v~~wG~N~~GQlG~~~~~~~~v~~v~~G~~~~~al~-dg-~v~~wG~~~~gq~~ 97 (273)
T d1jtdb_ 24 AQSGVDAIAGGYFHGL---ALK-GGKVLGWGANLNGQLTMPAATQSGVDAIAAGNYHSLALK-DG-EVIAWGGNEDGQTT 97 (273)
T ss_dssp GSSSEEEEEECSSEEE---EEE-TTEEEEEECCTTSTTSCCGGGGSCCCEEEECSSEEEEEE-TT-EEEEEECCTTSTTC
T ss_pred CCCCcEEEEccCCEEE---EEE-CCEEEEEeCCCCCceeeeecccccceEEecCCCceeeee-ee-eeeccCCCcceeec
Confidence 3457999999999999 887 89999999932221 122447899999999999996 89 99999999988743
Q ss_pred CcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCCCCCc-cEEEEeeeCceeEEEEeCCCeEEEeecC
Q 045256 108 FVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAPSGEL-QFESLTSGIDFSCGILTNNKTVRCWGIN 186 (789)
Q Consensus 108 ~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~~-~v~~va~G~~hs~al~~~~g~v~~wG~n 186 (789)
+|.++. .. ++.|++|..|+++++ ||++|+||.+..++...+.... .|+.+++ ..|+++++++ |.+|+||.|
T Consensus 98 -~~~~~~--~~--~~~i~~~~~~~~~~~-dg~v~~~g~~~~~~~~~~~~~~~~v~~~~~-~~~~~~~~~~-g~~~~~G~~ 169 (273)
T d1jtdb_ 98 -VPAEAR--SG--VDAIAAGAWASYALK-DGKVIAWGDDSDGQTTVPAEAQSGVTALDG-GVYTALAVKN-GGVIAWGDN 169 (273)
T ss_dssp -CCGGGG--SS--CCEEEEETTEEEEEE-TTEEEEEECCTTSTTSCCGGGGSSEEEEEE-CSSEEEEEET-TEEEEEECC
T ss_pred -cccccc--cc--eeEEeeecccccccc-cccceecccCCCCceeeeccCCceEEEEec-cceeeeeecc-cceeEeecc
Confidence 344432 22 448999999999886 8999999988887766554432 3555555 4555564665 599999999
Q ss_pred CCCCcccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEee
Q 045256 187 SISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWG 266 (789)
Q Consensus 187 ~~gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG 266 (789)
.++|+........+|++|+||.+|+++|+ ||+||+||.|.+|||+.+.. ...+|++|+||..|+++| + ||+||+||
T Consensus 170 ~~g~~~~~~~~~~~v~~Is~G~~h~~~l~-dG~v~~WG~n~~Gql~~~~~-~~~~v~~I~~G~~~~~~l-~-~g~v~~WG 245 (273)
T d1jtdb_ 170 YFGQTTVPAEAQSGVDDVAGGIFHSLALK-DGKVIAWGDNRYKQTTVPTE-ALSGVSAIASGEWYSLAL-K-NGKVIAWG 245 (273)
T ss_dssp TTSTTSCCGGGSSSEEEEEECSSEEEEEE-TTEEEEEECCTTSTTCCCGG-GGSSCCEEEECSSCEEEE-E-TTEEEEES
T ss_pred cCCcccccccccCCccceeccceeeEEEe-cCcEEEcCCCCCCccCCCcc-CCCCcEEEEeCcceEEEE-E-CCEEEEEC
Confidence 99999888878888999999999999997 89999999999999987754 346799999999999998 5 89999999
Q ss_pred eCCCCcccCCCCCcEEEEEecCceEEEEe
Q 045256 267 SQGEYSVNGIRGKSFESIVSGSNFTCGLT 295 (789)
Q Consensus 267 ~n~~gq~~~~~~~~v~~i~~G~~h~~al~ 295 (789)
+|.++|.+.+ .++.+|.+|..|.+||+
T Consensus 246 ~~~~~~~~~~--~~~~~i~~~~~~~~al~ 272 (273)
T d1jtdb_ 246 SSRTAPSSVQ--SGVSSIEAGPNAAYALK 272 (273)
T ss_dssp TTCCCCGGGS--SCEEEEEECSSCEEEEE
T ss_pred CCCCCCCCCC--CCceeEEeCcceEEEec
Confidence 9999998766 67999999999999996
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.3e-40 Score=348.75 Aligned_cols=253 Identities=21% Similarity=0.225 Sum_probs=186.3
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDERLL 571 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~~l 571 (789)
++|++.+.||+|+||+||+|++ .+++.||||++...... ..+..|++++++++|+|+ +.+..++.+.+..++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 5799999999999999999986 46899999986543221 247789999999987665 455566677888899
Q ss_pred EEEecCCCchhHHHhh---------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECC---CCcEEEEeeccCcCC
Q 045256 572 VYDYMKNGALYDHLHD---------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDA---QWTARVSDFGLSMMG 639 (789)
Q Consensus 572 v~e~~~~gsL~~~l~~---------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfGls~~~ 639 (789)
||||+. ++|.+.+.. ...++.|+++||+|||+++ |+||||||+|||++. +..+||+|||+|+..
T Consensus 81 vme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999995 577666542 2368899999999999999 999999999999854 557999999999865
Q ss_pred CCCCCC-----CcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhhhhhh
Q 045256 640 PESERD-----FRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVPAIMA 714 (789)
Q Consensus 640 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~~~~~ 714 (789)
...... .......||+.|||||.+.+..++.++|||||||++|||+||+.||.......... .... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~-~~~~-----~~~ 230 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYER-----ISE 230 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHH-----HHH
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHH-HHHH-----hhc
Confidence 443221 12234579999999999999999999999999999999999999996543311110 0000 000
Q ss_pred hhhHHhhcccCCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHHHHHHhh
Q 045256 715 GELVKILDRRVGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVANLERALD 769 (789)
Q Consensus 715 ~~~~~~~d~~~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~L~~~~~ 769 (789)
....... ..+ ....+..+.+++.+||+.||++||++.++.+.|+.++.
T Consensus 231 ~~~~~~~-~~~------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 231 KKMSTPI-EVL------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHHHSCH-HHH------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccCCCCh-hHh------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000000 000 01123456778889999999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-40 Score=357.37 Aligned_cols=255 Identities=25% Similarity=0.309 Sum_probs=181.7
Q ss_pred CccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeCC------
Q 045256 495 NFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEKD------ 567 (789)
Q Consensus 495 ~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~------ 567 (789)
+|+..++||+|+||+||+|++. +++.||||++..... .+.+|+++|++++||||++++++|....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 5888999999999999999875 689999999865432 1347999999999999999999986532
Q ss_pred eEEEEEEecCCCchhHHHh-----------hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCC-cEEEEeecc
Q 045256 568 ERLLVYDYMKNGALYDHLH-----------DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQW-TARVSDFGL 635 (789)
Q Consensus 568 ~~~lv~e~~~~gsL~~~l~-----------~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfGl 635 (789)
..+|||||++++.+..+.+ ....++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence 4689999998754333322 12358999999999999998 99999999999999775 899999999
Q ss_pred CcCCCCCCCCCcccccccCcCccCccccCC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccccchhh--hh
Q 045256 636 SMMGPESERDFRPMKAAGTVGYIDPEYYGL-NVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLVDFAVP--AI 712 (789)
Q Consensus 636 s~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~~~~~~--~~ 712 (789)
+........ .....||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+.... +...... ..
T Consensus 170 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~----l~~i~~~~g~~ 242 (350)
T d1q5ka_ 170 AKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ----LVEIIKVLGTP 242 (350)
T ss_dssp CEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH----HHHHHHHHCCC
T ss_pred hhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH----HHHHHHHhCCC
Confidence 976544332 224578999999998764 5789999999999999999999999965432100 0000000 00
Q ss_pred hhhhhHHh----hcccCCCCC------CCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH--HHHH
Q 045256 713 MAGELVKI----LDRRVGPPE------INEAEAVELVAYTAMHCVNLEGKERPTMADIVAN--LERA 767 (789)
Q Consensus 713 ~~~~~~~~----~d~~~~~~~------~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~--L~~~ 767 (789)
..+.+.+. .+....... .........+.+|+.+||..||++|||+.|++++ ++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00000010 000110000 0011123345678889999999999999999975 4444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=351.44 Aligned_cols=261 Identities=20% Similarity=0.235 Sum_probs=184.0
Q ss_pred CCccccceEeecccEEEEEEEeC-CCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC------
Q 045256 494 NNFSLENKIGAGSFGVVYKGKLP-DGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK------ 566 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~------ 566 (789)
++|++.++||+|+||+||+|.+. +|+.||||++...... ......+.+|+.+|++++||||++++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~--~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC--HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 68999999999999999999865 6899999998654332 23345688999999999999999999999643
Q ss_pred CeEEEEEEecCCCchhHHHhh------hchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 567 DERLLVYDYMKNGALYDHLHD------RNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~------~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
...|+||||+.+ ++.+.+.. ...++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+++...
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred ceeEEEEeccch-HHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence 578999999976 55555443 2368999999999999999 9999999999999999999999999987644
Q ss_pred CCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc--cchhhhh---hhh
Q 045256 641 ESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV--DFAVPAI---MAG 715 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~~---~~~ 715 (789)
... ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||...+.......... ....+.. ...
T Consensus 171 ~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 171 TSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 332 22345789999999999999999999999999999999999999965432100000000 0000000 001
Q ss_pred hhHHhhccc----------------CCCCCCCHHHHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 716 ELVKILDRR----------------VGPPEINEAEAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 716 ~~~~~~d~~----------------~~~~~~~~~~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...+..... ..............+.+|+.+||..||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111111111 111111123445667889999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-39 Score=351.35 Aligned_cols=261 Identities=21% Similarity=0.273 Sum_probs=186.2
Q ss_pred cCCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcceEEEEEEEeC-----
Q 045256 493 TNNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHLVRLVGYCEEK----- 566 (789)
Q Consensus 493 ~~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~----- 566 (789)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|+++|++++||||+++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS--IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS--HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 46899999999999999999985 57999999998754322 22344688999999999999999999998643
Q ss_pred CeEEEEEEecCCCchhHHHhhh-------chHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCC
Q 045256 567 DERLLVYDYMKNGALYDHLHDR-------NNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMG 639 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~~-------~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~ 639 (789)
...++++||+.+++|.+++..+ ..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++...
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 3346777888899999998643 368999999999999999 999999999999999999999999998753
Q ss_pred CCCCCCCcccccccCcCccCccccCCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcccccc--cchhhh----h
Q 045256 640 PESERDFRPMKAAGTVGYIDPEYYGLN-VLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTPVSLV--DFAVPA----I 712 (789)
Q Consensus 640 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~~~~~--~~~~~~----~ 712 (789)
... .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.......... ...... .
T Consensus 172 ~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 246 (348)
T d2gfsa1 172 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246 (348)
T ss_dssp TGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred Ccc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence 322 2345789999999987654 568899999999999999999999965432100000000 000000 0
Q ss_pred hhhhhHHhhcccCCCCCCCHH----HHHHHHHHHHHhhcCcCCCCCCCHHHHHHH
Q 045256 713 MAGELVKILDRRVGPPEINEA----EAVELVAYTAMHCVNLEGKERPTMADIVAN 763 (789)
Q Consensus 713 ~~~~~~~~~d~~~~~~~~~~~----~~~~~l~~l~~~cl~~dp~~RPt~~evl~~ 763 (789)
...............+..... .....+.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000011111111111111111 123446678899999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-34 Score=314.45 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=179.0
Q ss_pred CCccccceEeecccEEEEEEEe-CCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-----------CCcceEEEE
Q 045256 494 NNFSLENKIGAGSFGVVYKGKL-PDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-----------HKHLVRLVG 561 (789)
Q Consensus 494 ~~~~~~~~LG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------HpnIv~l~~ 561 (789)
.+|++.++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++ |+||+++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3699999999999999999986 4789999999865432 2234678888888775 578999998
Q ss_pred EEEe--CCeEEEEEEecCCCchhHHHh-----------hhchHHHHHHHHHHHHHh-cCCCCeEeccCCCCCEEECCCC-
Q 045256 562 YCEE--KDERLLVYDYMKNGALYDHLH-----------DRNNVEKNAARGIEYLHN-YAVPPIIHRDIKSSNILLDAQW- 626 (789)
Q Consensus 562 ~~~~--~~~~~lv~e~~~~gsL~~~l~-----------~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlkp~NIll~~~~- 626 (789)
++.. ....+++++++.......... ....++.|+++||+|||+ .+ |+||||||+||||+.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCc
Confidence 8864 355677888776655433322 123589999999999998 66 99999999999997654
Q ss_pred -----cEEEEeeccCcCCCCCCCCCcccccccCcCccCccccCCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCcc
Q 045256 627 -----TARVSDFGLSMMGPESERDFRPMKAAGTVGYIDPEYYGLNVLTAKSDVYGLGVVLLELLTGKRAIFKDDESGGTP 701 (789)
Q Consensus 627 -----~~kl~DfGls~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~SlGvil~elltG~~pf~~~~~~~~~~ 701 (789)
.++++|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||...+......
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 49999999987543222 24579999999999999999999999999999999999999996544321110
Q ss_pred cc--cccc-------hhhhhhh-hhhHHhhcc-----cCCC------------CCCCHHHHHHHHHHHHHhhcCcCCCCC
Q 045256 702 VS--LVDF-------AVPAIMA-GELVKILDR-----RVGP------------PEINEAEAVELVAYTAMHCVNLEGKER 754 (789)
Q Consensus 702 ~~--~~~~-------~~~~~~~-~~~~~~~d~-----~~~~------------~~~~~~~~~~~l~~l~~~cl~~dp~~R 754 (789)
.. +... +...... .......+. .+.. ...........+.+|+.+||..||++|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 00 0000 0000000 000011110 0000 011224556678889999999999999
Q ss_pred CCHHHHHHH
Q 045256 755 PTMADIVAN 763 (789)
Q Consensus 755 Pt~~evl~~ 763 (789)
||++|++++
T Consensus 320 pta~e~L~H 328 (362)
T d1q8ya_ 320 ADAGGLVNH 328 (362)
T ss_dssp BCHHHHHTC
T ss_pred cCHHHHhcC
Confidence 999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=2.3e-22 Score=196.21 Aligned_cols=167 Identities=14% Similarity=0.164 Sum_probs=120.8
Q ss_pred ccccceEeecccEEEEEEEeCCCcEEEEEEcccchhh--------------hHHHHHHHHHHHHHHHhhcCCCcceEEEE
Q 045256 496 FSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTK--------------KFQEKESAFDSELAFLSRLHHKHLVRLVG 561 (789)
Q Consensus 496 ~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~ 561 (789)
+.+.++||+|+||+||+|.+.+|+.||||+++..... ........+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3467899999999999999889999999986532110 01112234567899999999999998876
Q ss_pred EEEeCCeEEEEEEecCCCchhHHHh-hhchHHHHHHHHHHHHHhcCCCCeEeccCCCCCEEECCCCcEEEEeeccCcCCC
Q 045256 562 YCEEKDERLLVYDYMKNGALYDHLH-DRNNVEKNAARGIEYLHNYAVPPIIHRDIKSSNILLDAQWTARVSDFGLSMMGP 640 (789)
Q Consensus 562 ~~~~~~~~~lv~e~~~~gsL~~~l~-~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~~~ 640 (789)
+. ..+++|||+++..+.++.. ....++.|++++|+|||+++ |+||||||+|||++++ .++|+|||++....
T Consensus 82 ~~----~~~lvme~~~~~~~~~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp EE----TTEEEEECCCCEEGGGCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred ec----CCEEEEEeeccccccchhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 53 2379999999876655432 23478999999999999999 9999999999999865 58999999986543
Q ss_pred CCCCCCcccccccCcCccC------ccccCCCCCCchhHHHHHHHHH
Q 045256 641 ESERDFRPMKAAGTVGYID------PEYYGLNVLTAKSDVYGLGVVL 681 (789)
Q Consensus 641 ~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDv~SlGvil 681 (789)
.+... .|.. .|.+ .+.|+.++|+||..--+
T Consensus 154 ~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 154 EEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp STTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 22110 1111 1112 35678889999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.38 E-value=8.8e-07 Score=88.52 Aligned_cols=145 Identities=15% Similarity=0.134 Sum_probs=97.4
Q ss_pred HHHHhcCCccccceEeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcC-CCcceEEEEEEEeC
Q 045256 488 ELAAATNNFSLENKIGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLH-HKHLVRLVGYCEEK 566 (789)
Q Consensus 488 ~l~~~~~~~~~~~~LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~~ 566 (789)
++....+.|+..+..+-++...||+... +++.+++|+........ ...+.+|...+..+. +--+.+++.+..+.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~ 82 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence 3444446677666555455678999875 55677888755433222 113667888887774 33356777888888
Q ss_pred CeEEEEEEecCCCchhHHHhh---hchHHHHHHHHHHHHHhcC-------------------------------------
Q 045256 567 DERLLVYDYMKNGALYDHLHD---RNNVEKNAARGIEYLHNYA------------------------------------- 606 (789)
Q Consensus 567 ~~~~lv~e~~~~gsL~~~l~~---~~~i~~~ia~~l~~LH~~~------------------------------------- 606 (789)
+..++||+++++.++.+.... ...+..++++.++.||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred CceEEEEEecccccccccccccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence 889999999999887655432 2235555666666666421
Q ss_pred -------------------CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 607 -------------------VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 607 -------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
.+.++|+|+.|.|||++++...-|+||+.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0227899999999999987666799998664
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.22 E-value=1.2e-06 Score=87.05 Aligned_cols=130 Identities=15% Similarity=0.076 Sum_probs=84.8
Q ss_pred eEeeccc-EEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC--CcceEEEEEEEeCCeEEEEEEecC
Q 045256 501 KIGAGSF-GVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH--KHLVRLVGYCEEKDERLLVYDYMK 577 (789)
Q Consensus 501 ~LG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H--pnIv~l~~~~~~~~~~~lv~e~~~ 577 (789)
.+..|.. ..||+...+++..+++|........ .+..|...++.+.. --+.+++.+..+.+..++||||++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4445543 6899999888888999985443221 36678888887743 235667888888888999999999
Q ss_pred CCchhHHHhhhchHHHHHHH---------------------------------------------------HHHHHHhcC
Q 045256 578 NGALYDHLHDRNNVEKNAAR---------------------------------------------------GIEYLHNYA 606 (789)
Q Consensus 578 ~gsL~~~l~~~~~i~~~ia~---------------------------------------------------~l~~LH~~~ 606 (789)
+.++.+..........++.+ .+..+....
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 86654321111111222222 233333322
Q ss_pred C----CCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 607 V----PPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 607 ~----~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
. +.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 227999999999999987667899998653
|
| >d1k3ia3 b.69.1.1 (A:151-537) Galactose oxidase, central domain {Fungi (Fusarium sp.) [TaxId: 29916]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: Galactose oxidase, central domain family: Galactose oxidase, central domain domain: Galactose oxidase, central domain species: Fungi (Fusarium sp.) [TaxId: 29916]
Probab=97.44 E-value=0.0016 Score=67.52 Aligned_cols=258 Identities=13% Similarity=0.008 Sum_probs=129.2
Q ss_pred cCceeeeeeeecCCCcEEEeeCCcccc------------cCC--CCcEEEE---EecC---ceEEEEEeCCceEEEccCC
Q 045256 42 GSATVCAVVAAQPTQRLLCYQGGTIRA------------VEP--NISFSSI---SAGQ---SFFCGIRSGGYSLLCWDTN 101 (789)
Q Consensus 42 G~~h~~~~~~l~~~g~v~~wG~~~~~~------------~~~--~~~v~~i---~~G~---~~~~~l~~~G~~v~~wG~n 101 (789)
-..|.. ++..||+||.+|...+.. +-. ...+.++ .... .|+.++..|| ++|..|..
T Consensus 20 ~~~~~a---~~~~~gkv~v~GG~~~~~~~~~~~~~~~~~~yd~~t~~w~~~~~~~~~~~~~~~~~~~~~~g-~i~v~Gg~ 95 (387)
T d1k3ia3 20 VPAAAA---IEPTSGRVLMWSSYRNDAFGGSPGGITLTSSWDPSTGIVSDRTVTVTKHDMFCPGISMDGNG-QIVVTGGN 95 (387)
T ss_dssp CCSEEE---EETTTTEEEEEEECCCTTTCSCCCSEEEEEEECTTTCCBCCCEEEECSCCCSSCEEEECTTS-CEEEECSS
T ss_pred cccEEE---EEeeCCEEEEEEeecCcccCCCCCceeEEEEEECCCCcEeecCCCCCCcccceeEEEEecCC-cEEEeecC
Confidence 345777 788999999998822211 110 0112222 1222 3567888999 99999865
Q ss_pred CCCCCCCcceeeeeCCcceEEEEE----ecCCeEEEEeeCCeEEEcCCCCCCCCCCC------CCCccEEEEe-------
Q 045256 102 FSYNSNFVPKRIYYNDTVLLSSVS----VGNNHVCATTVQGQINCWRGDVNISKNAP------SGELQFESLT------- 164 (789)
Q Consensus 102 ~~~~~~~~p~~v~~~~~~~i~~v~----~G~~h~~al~~~G~v~~wG~~~~~~~~~~------~~~~~v~~va------- 164 (789)
.... ..+........+.+. ..+.|++++..||+||.+|+......... +....+..+.
T Consensus 96 ~~~~-----~~~yd~~~~~w~~~~~~~~~r~~~~~~~~~dG~v~v~GG~~~~~~~~~~v~~yd~~~~~W~~~~~~~~~~~ 170 (387)
T d1k3ia3 96 DAKK-----TSLYDSSSDSWIPGPDMQVARGYQSSATMSDGRVFTIGGSWSGGVFEKNGEVYSPSSKTWTSLPNAKVNPM 170 (387)
T ss_dssp STTC-----EEEEEGGGTEEEECCCCSSCCSSCEEEECTTSCEEEECCCCCSSSCCCCEEEEETTTTEEEEETTSCSGGG
T ss_pred CCcc-----eeEecCccCcccccccccccccccceeeecCCceeeeccccccccccceeeeecCCCCceeecCCCccccc
Confidence 4211 122222222222222 24579999999999999987433221110 0111122211
Q ss_pred ---------eeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeE------------EEeeCCceeEEEccCCcEEEE
Q 045256 165 ---------SGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMF------------SITAGGNHVCGIDSNGFVICY 223 (789)
Q Consensus 165 ---------~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~------------~i~~G~~h~~al~~dG~v~~w 223 (789)
....+..++.-.+|+++.+|.+..... ........+. ..+....|++....+|+||.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~G~~~~~g~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~v~v~ 249 (387)
T d1k3ia3 171 LTADKQGLYRSDNHAWLFGWKKGSVFQAGPSTAMNW-YYTSGSGDVKSAGKRQSNRGVAPDAMCGNAVMYDAVKGKILTF 249 (387)
T ss_dssp CCCCTTGGGTTTCSCCEEECGGGCEEECCSSSEEEE-EECSTTCEEEEEEECEETTEECCCCBTCEEEEEETTTTEEEEE
T ss_pred ccccccceeeccceeEEEEeCCCCEEEecCcCCcEE-ecCcccCcEeeccccccCcccCcccccccEEEeeccCCceEEE
Confidence 111222222334568888875422111 1111111111 112233344444678999999
Q ss_pred EcCCCCCCCcCCC-----------CCccceEEec----cCcceEEEEEeeCCeEEEeeeCCCCccc------------CC
Q 045256 224 GDNKSGQLKFPLN-----------STAFEYSALS----LGFNHSCAIRRLNGSVVCWGSQGEYSVN------------GI 276 (789)
Q Consensus 224 G~n~~Gql~~~~~-----------~~~~~v~~i~----~G~~h~~al~~~dG~v~~WG~n~~gq~~------------~~ 276 (789)
|-...++...... ........+. ....|+.++.. ||+||+.|-...+... .+
T Consensus 250 GG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~r~~~~~~~~~-dg~i~v~GG~~~~~~~~~~~~~~~ve~Ydp 328 (387)
T d1k3ia3 250 GGSPDYQDSDATTNAHIITLGEPGTSPNTVFASNGLYFARTFHTSVVLP-DGSTFITGGQRRGIPFEDSTPVFTPEIYVP 328 (387)
T ss_dssp CCBSSSSSSBCCCCEEEEECCSTTSCCEEEECTTCCSSCCBSCEEEECT-TSCEEEECCBSBCCTTCCCSBCCCCEEEEG
T ss_pred EeccCCCCCcccceeecccccccccCCCceeeccccccccccceeeecc-CCeEEEECCcccCccCCCCcEeceEEEEEC
Confidence 9655444321110 0001122221 23567788877 9999999865443311 11
Q ss_pred CCCcEEEEE----ecCceEEE-EeecCCeEEEecCCCCCC
Q 045256 277 RGKSFESIV----SGSNFTCG-LTTSNFSVICWGPGWPNV 311 (789)
Q Consensus 277 ~~~~v~~i~----~G~~h~~a-l~~~g~~v~~WG~n~~~~ 311 (789)
.....+.++ .-..|+.+ |..|| +||..|.+..+.
T Consensus 329 ~~~~W~~~~~~~~~R~~Hs~a~l~~dG-~v~v~GG~~~~~ 367 (387)
T d1k3ia3 329 EQDTFYKQNPNSIVRVYHSISLLLPDG-RVFNGGGGLCGD 367 (387)
T ss_dssp GGTEEEECCCCSSCCCTTEEEEECTTS-CEEEEECCCCTT
T ss_pred CCCeEEECCCCCCcccceEEEEECCCC-EEEEEeCCCcCC
Confidence 223344443 23468765 45677 999999875543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.33 E-value=0.00019 Score=75.49 Aligned_cols=81 Identities=15% Similarity=0.153 Sum_probs=48.3
Q ss_pred cceEeecccEEEEEEEeCC-CcEEEEEEcccchhh---hHHHHHHHHHHHHHHHhhcC-C--CcceEEEEEEEeCCeEEE
Q 045256 499 ENKIGAGSFGVVYKGKLPD-GQEVAIKRGETAKTK---KFQEKESAFDSELAFLSRLH-H--KHLVRLVGYCEEKDERLL 571 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~~~~~E~~~l~~l~-H--pnIv~l~~~~~~~~~~~l 571 (789)
.+.||.|..-.||+....+ ++.+++|........ .+....+....|.+.|+.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999998654 678999964321110 01111122445777777663 2 334555543 5566789
Q ss_pred EEEecCCCch
Q 045256 572 VYDYMKNGAL 581 (789)
Q Consensus 572 v~e~~~~gsL 581 (789)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1k3ia3 b.69.1.1 (A:151-537) Galactose oxidase, central domain {Fungi (Fusarium sp.) [TaxId: 29916]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: Galactose oxidase, central domain family: Galactose oxidase, central domain domain: Galactose oxidase, central domain species: Fungi (Fusarium sp.) [TaxId: 29916]
Probab=97.19 E-value=0.005 Score=63.58 Aligned_cols=220 Identities=11% Similarity=0.014 Sum_probs=110.4
Q ss_pred eecCCCcEEEeeCCc--ccccCC--CCcEEEEE----ecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEE
Q 045256 51 AAQPTQRLLCYQGGT--IRAVEP--NISFSSIS----AGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLS 122 (789)
Q Consensus 51 ~l~~~g~v~~wG~~~--~~~~~~--~~~v~~i~----~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~ 122 (789)
++..||+++..|... .+.+.. ...++.+. ....|++++..|| +||.+|..........-..+.....-...
T Consensus 82 ~~~~~g~i~v~Gg~~~~~~~~yd~~~~~w~~~~~~~~~r~~~~~~~~~dG-~v~v~GG~~~~~~~~~~v~~yd~~~~~W~ 160 (387)
T d1k3ia3 82 SMDGNGQIVVTGGNDAKKTSLYDSSSDSWIPGPDMQVARGYQSSATMSDG-RVFTIGGSWSGGVFEKNGEVYSPSSKTWT 160 (387)
T ss_dssp EECTTSCEEEECSSSTTCEEEEEGGGTEEEECCCCSSCCSSCEEEECTTS-CEEEECCCCCSSSCCCCEEEEETTTTEEE
T ss_pred EEecCCcEEEeecCCCcceeEecCccCcccccccccccccccceeeecCC-ceeeeccccccccccceeeeecCCCCcee
Confidence 678899999988611 111110 11122211 2357999999999 99999975422211111111111111111
Q ss_pred EE-----------------EecCCeEEEEeeCCeEEEcCCCCCCCCCCCCCCccEEEE-----------eeeCceeEEEE
Q 045256 123 SV-----------------SVGNNHVCATTVQGQINCWRGDVNISKNAPSGELQFESL-----------TSGIDFSCGIL 174 (789)
Q Consensus 123 ~v-----------------~~G~~h~~al~~~G~v~~wG~~~~~~~~~~~~~~~v~~v-----------a~G~~hs~al~ 174 (789)
.+ ..+....+....+|+++.+|...............+..+ ..-..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (387)
T d1k3ia3 161 SLPNAKVNPMLTADKQGLYRSDNHAWLFGWKKGSVFQAGPSTAMNWYYTSGSGDVKSAGKRQSNRGVAPDAMCGNAVMYD 240 (387)
T ss_dssp EETTSCSGGGCCCCTTGGGTTTCSCCEEECGGGCEEECCSSSEEEEEECSTTCEEEEEEECEETTEECCCCBTCEEEEEE
T ss_pred ecCCCcccccccccccceeeccceeEEEEeCCCCEEEecCcCCcEEecCcccCcEeeccccccCcccCcccccccEEEee
Confidence 11 123333455667899999886433211111111111111 11122333434
Q ss_pred eCCCeEEEeecCCCCCcccCCC------------CCceeEEE----eeCCceeEEEccCCcEEEEEcCCCCCCCcCC---
Q 045256 175 TNNKTVRCWGINSISNQIQTSF------------ANRSMFSI----TAGGNHVCGIDSNGFVICYGDNKSGQLKFPL--- 235 (789)
Q Consensus 175 ~~~g~v~~wG~n~~gqlg~~~~------------~~~~v~~i----~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~--- 235 (789)
..+|+||.+|....++...... .......+ ..-..|+.++..||+||..|-+..+......
T Consensus 241 ~~~g~v~v~GG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~r~~~~~~~~~dg~i~v~GG~~~~~~~~~~~~~ 320 (387)
T d1k3ia3 241 AVKGKILTFGGSPDYQDSDATTNAHIITLGEPGTSPNTVFASNGLYFARTFHTSVVLPDGSTFITGGQRRGIPFEDSTPV 320 (387)
T ss_dssp TTTTEEEEECCBSSSSSSBCCCCEEEEECCSTTSCCEEEECTTCCSSCCBSCEEEECTTSCEEEECCBSBCCTTCCCSBC
T ss_pred ccCCceEEEEeccCCCCCcccceeecccccccccCCCceeeccccccccccceeeeccCCeEEEECCcccCccCCCCcEe
Confidence 5567999999654443322111 00011111 1234678888889999999977655442211
Q ss_pred ------CCCccceEEec----cCcceEEEE-EeeCCeEEEeeeCCCCc
Q 045256 236 ------NSTAFEYSALS----LGFNHSCAI-RRLNGSVVCWGSQGEYS 272 (789)
Q Consensus 236 ------~~~~~~v~~i~----~G~~h~~al-~~~dG~v~~WG~n~~gq 272 (789)
++....++.++ .-..|+.++ .. ||+||+.|-+..+.
T Consensus 321 ~~ve~Ydp~~~~W~~~~~~~~~R~~Hs~a~l~~-dG~v~v~GG~~~~~ 367 (387)
T d1k3ia3 321 FTPEIYVPEQDTFYKQNPNSIVRVYHSISLLLP-DGRVFNGGGGLCGD 367 (387)
T ss_dssp CCCEEEEGGGTEEEECCCCSSCCCTTEEEEECT-TSCEEEEECCCCTT
T ss_pred ceEEEEECCCCeEEECCCCCCcccceEEEEECC-CCEEEEEeCCCcCC
Confidence 11222444443 234577664 55 99999999876554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.65 E-value=0.00074 Score=68.92 Aligned_cols=125 Identities=16% Similarity=0.117 Sum_probs=73.2
Q ss_pred cEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc--eEEE-----EEEEeCCeEEEEEEecCCC
Q 045256 507 FGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL--VRLV-----GYCEEKDERLLVYDYMKNG 579 (789)
Q Consensus 507 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI--v~l~-----~~~~~~~~~~lv~e~~~~g 579 (789)
-=.||+++.++|+.|++|+.+.... ..+++..|++.+..|....+ +..+ ..+...+..+.+++++++.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 3589999999999999998654322 12346678888877742222 1111 1223456678899999864
Q ss_pred chh----HH----------Hhh---------hc---------------------------hHHHHHHHHHHHHHhc----
Q 045256 580 ALY----DH----------LHD---------RN---------------------------NVEKNAARGIEYLHNY---- 605 (789)
Q Consensus 580 sL~----~~----------l~~---------~~---------------------------~i~~~ia~~l~~LH~~---- 605 (789)
.+. +. +|. +. .+...+.+.++.+...
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 321 11 110 00 0111123334444332
Q ss_pred CCCCeEeccCCCCCEEECCCCcEEEEeeccCcC
Q 045256 606 AVPPIIHRDIKSSNILLDAQWTARVSDFGLSMM 638 (789)
Q Consensus 606 ~~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~~ 638 (789)
....++|+|+.+.|||++++ ..++||+-+..
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 12348999999999999754 45889987653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.51 E-value=0.0028 Score=66.36 Aligned_cols=74 Identities=18% Similarity=0.244 Sum_probs=47.4
Q ss_pred cceEeecccEEEEEEEeCCC--------cEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCCCcc-eEEEEEEEeCCeE
Q 045256 499 ENKIGAGSFGVVYKGKLPDG--------QEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHHKHL-VRLVGYCEEKDER 569 (789)
Q Consensus 499 ~~~LG~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-v~l~~~~~~~~~~ 569 (789)
.+.|..|-.=.+|++...++ +.|++++.-... .. ....+|..+++.+.-.++ .++++++.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~----idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TE----SHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CH----HHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hh----hHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 46788788889999986543 457776643211 11 124578888888853344 467776532
Q ss_pred EEEEEecCCCchh
Q 045256 570 LLVYDYMKNGALY 582 (789)
Q Consensus 570 ~lv~e~~~~gsL~ 582 (789)
.+|+||+++..|.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred ceEEEEeccccCC
Confidence 6899999875543
|
| >d1p22a2 b.69.4.1 (A:253-545) F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD-repeat protein 1 (beta-TRCP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.71 E-value=0.84 Score=42.62 Aligned_cols=222 Identities=8% Similarity=0.098 Sum_probs=116.4
Q ss_pred ceeEEEEecCceeeeeeeecCCCcEEEeeC--CcccccCC--CCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCc
Q 045256 34 GSTLAVSYGSATVCAVVAAQPTQRLLCYQG--GTIRAVEP--NISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFV 109 (789)
Q Consensus 34 ~~~~~i~~G~~h~~~~~~l~~~g~v~~wG~--~~~~~~~~--~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~ 109 (789)
..|..++.-+.+.+ .-..||+|.-|=. .+++.... ...|..|+-....-+.-..|| ++..|=......
T Consensus 16 ~~V~c~~~d~~~l~---sgs~Dg~i~vWd~~~~~~~~~l~~H~~~V~~v~~~~~~l~s~s~D~-~i~~~~~~~~~~---- 87 (293)
T d1p22a2 16 KGVYCLQYDDQKIV---SGLRDNTIKIWDKNTLECKRILTGHTGSVLCLQYDERVIITGSSDS-TVRVWDVNTGEM---- 87 (293)
T ss_dssp CCEEEEECCSSEEE---EEESSSCEEEEESSSCCEEEEECCCSSCEEEEECCSSEEEEEETTS-CEEEEESSSCCE----
T ss_pred CCEEEEEEcCCEEE---EEeCCCeEEEEECCCCcEEEEEecCCCCEeeeecccceeecccccc-cccccccccccc----
Confidence 34556666554444 4467898888843 33333332 345777776555545556788 888885443111
Q ss_pred ceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCC----CCCCCCccEEEEeeeCceeEEEEeCCCeEEEeec
Q 045256 110 PKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISK----NAPSGELQFESLTSGIDFSCGILTNNKTVRCWGI 185 (789)
Q Consensus 110 p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~----~~~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~ 185 (789)
.... ............-....+....++.+..|-....... ........+..+.......+. ...+|.|..|-.
T Consensus 88 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~-~s~d~~i~~~d~ 165 (293)
T d1p22a2 88 LNTL-IHHCEAVLHLRFNNGMMVTCSKDRSIAVWDMASPTDITLRRVLVGHRAAVNVVDFDDKYIVS-ASGDRTIKVWNT 165 (293)
T ss_dssp EEEE-CCCCSCEEEEECCTTEEEEEETTSCEEEEECSSSSCCEEEEEECCCSSCEEEEEEETTEEEE-EETTSEEEEEET
T ss_pred cccc-cccccccccccccccceeecccccceeEeeccccccccccccccccccccccceeccccccc-ccCCCceeeecC
Confidence 1111 1111122233444445566677888888853322211 001111234445555555444 456779999976
Q ss_pred CCCCCcccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEe
Q 045256 186 NSISNQIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCW 265 (789)
Q Consensus 186 n~~gqlg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~W 265 (789)
.....+..-......+..++....+.++-..||.|.-|-....-.+.... .....+..++.....-++-.. ||+|..|
T Consensus 166 ~~~~~~~~~~~~~~~v~~~~~~~~~l~~~~~dg~i~i~d~~~~~~~~~~~-~~~~~v~~~~~~~~~l~sg~~-dg~i~iw 243 (293)
T d1p22a2 166 STCEFVRTLNGHKRGIACLQYRDRLVVSGSSDNTIRLWDIECGACLRVLE-GHEELVRCIRFDNKRIVSGAY-DGKIKVW 243 (293)
T ss_dssp TTCCEEEEEECCSSCEEEEEEETTEEEEEETTSCEEEEETTTCCEEEEEC-CCSSCEEEEECCSSEEEEEET-TSCEEEE
T ss_pred CCCcEEEEEcccccccccccCCCCeEEEecCCCEEEEEecccceeeeeec-ccceeeeeccccceEEEEEcC-CCEEEEE
Confidence 54333322222233455666666777777899999999654433221111 112234444444444444444 9999999
Q ss_pred ee
Q 045256 266 GS 267 (789)
Q Consensus 266 G~ 267 (789)
-.
T Consensus 244 d~ 245 (293)
T d1p22a2 244 DL 245 (293)
T ss_dssp EH
T ss_pred EC
Confidence 53
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.41 E-value=0.027 Score=56.41 Aligned_cols=144 Identities=14% Similarity=0.143 Sum_probs=76.8
Q ss_pred HHHHHhcCCccccce-----EeecccEEEEEEEeCCCcEEEEEEcccchhhhHHHHHHHHHHHHHHHhhcCC-----Ccc
Q 045256 487 AELAAATNNFSLENK-----IGAGSFGVVYKGKLPDGQEVAIKRGETAKTKKFQEKESAFDSELAFLSRLHH-----KHL 556 (789)
Q Consensus 487 ~~l~~~~~~~~~~~~-----LG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~H-----pnI 556 (789)
+++.....+|.+.+. |..|---+.|+....+| .+++|+....... .++..|++++..|.. |..
T Consensus 6 ~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~------~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 6 DELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK------NDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp HHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C------CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred HHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH------HHHHHHHHHHHhhhhcccccccc
Confidence 445555567766443 34566678899988665 5889986543211 124556667776642 222
Q ss_pred eEEEE---EEEeCCeEEEEEEecCCCchhHH--------------Hhh--------------------------------
Q 045256 557 VRLVG---YCEEKDERLLVYDYMKNGALYDH--------------LHD-------------------------------- 587 (789)
Q Consensus 557 v~l~~---~~~~~~~~~lv~e~~~~gsL~~~--------------l~~-------------------------------- 587 (789)
+...+ +.........++.++.+...... ++.
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 21100 11224456677777765332110 000
Q ss_pred hchHHHHHHHHHHHHHhcC----CCCeEeccCCCCCEEECCCCcEEEEeeccCc
Q 045256 588 RNNVEKNAARGIEYLHNYA----VPPIIHRDIKSSNILLDAQWTARVSDFGLSM 637 (789)
Q Consensus 588 ~~~i~~~ia~~l~~LH~~~----~~~ivH~Dlkp~NIll~~~~~~kl~DfGls~ 637 (789)
...+...+....+.+-... .-+++|+|+.++||+++.+...-|.||+.+.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0011222223333333221 1238999999999999988777899999764
|
| >d2ovrb2 b.69.4.1 (B:2365-2706) F-box/WD repeat-containing protein 7, FBXW7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD repeat-containing protein 7, FBXW7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.22 E-value=1.4 Score=42.09 Aligned_cols=245 Identities=10% Similarity=0.104 Sum_probs=126.4
Q ss_pred ecCCCcEEEeeC--CcccccCC--CCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEec
Q 045256 52 AQPTQRLLCYQG--GTIRAVEP--NISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVG 127 (789)
Q Consensus 52 l~~~g~v~~wG~--~~~~~~~~--~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~G 127 (789)
-..||+|.-|=. .+++.... ...|.+++--....+.-..|| ++..|-...... ..........+......
T Consensus 33 gs~Dg~i~vWd~~~~~~~~~~~~h~~~V~~v~~~~~~l~s~s~D~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 106 (342)
T d2ovrb2 33 GSDDNTLKVWSAVTGKCLRTLVGHTGGVWSSQMRDNIIISGSTDR-TLKVWNAETGEC-----IHTLYGHTSTVRCMHLH 106 (342)
T ss_dssp EETTSCEEEEETTTCCEEEECCCCSSCEEEEEEETTEEEEEETTS-CEEEEETTTTEE-----EEEECCCSSCEEEEEEE
T ss_pred EeCCCeEEEEECCCCCEEEEEeCCCCCEEEEEeCCCccccceecc-cccccccccccc-----eecccccceeEeeeecc
Confidence 356888888844 33333222 335667766555555556788 888886554111 11111122234455555
Q ss_pred CCeEEEEeeCCeEEEcCCCCCCCCCCC-CCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEEEee
Q 045256 128 NNHVCATTVQGQINCWRGDVNISKNAP-SGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFSITA 206 (789)
Q Consensus 128 ~~h~~al~~~G~v~~wG~~~~~~~~~~-~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~i~~ 206 (789)
.........|+.+..|-.......... ............... ++....+|.|..|-......+.........+..++.
T Consensus 107 ~~~~~~~~~d~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~i~~~d~~~~~~~~~~~~~~~~~~~~~~ 185 (342)
T d2ovrb2 107 EKRVVSGSRDATLRVWDIETGQCLHVLMGHVAAVRCVQYDGRR-VVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQF 185 (342)
T ss_dssp TTEEEEEETTSEEEEEESSSCCEEEEEECCSSCEEEEEECSSC-EEEEETTSCEEEEEGGGTEEEEEECCCSSCEEEEEE
T ss_pred cccccccccceeEEEeecccccceeeeecccccceeeccccce-eeeecCCCeEEEeecccceeeEEEcCcccccccccC
Confidence 666667778899888854322111000 000111222222222 233456678999875433222211112223445555
Q ss_pred CCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCccc---C--CCCCcE
Q 045256 207 GGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVN---G--IRGKSF 281 (789)
Q Consensus 207 G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~---~--~~~~~v 281 (789)
...+.+.-..||.|..|-....-.+... ......+..++.-...-+.-.. ||+++.|=........ . .....+
T Consensus 186 ~~~~l~s~~~dg~i~~~d~~~~~~~~~~-~~~~~~v~~~~~~~~~l~s~s~-d~~i~iwd~~~~~~~~~~~~~~~~~~~~ 263 (342)
T d2ovrb2 186 DGIHVVSGSLDTSIRVWDVETGNCIHTL-TGHQSLTSGMELKDNILVSGNA-DSTVKIWDIKTGQCLQTLQGPNKHQSAV 263 (342)
T ss_dssp CSSEEEEEETTSCEEEEETTTCCEEEEE-CCCCSCEEEEEEETTEEEEEET-TSCEEEEETTTCCEEEEECSTTSCSSCE
T ss_pred CCCEEEEEeCCCeEEEeecccceeeeEe-cccccceeEEecCCCEEEEEcC-CCEEEEEecccccccccccccceeeece
Confidence 5566666688999999965443222111 1112235555555554444455 9999999655433311 1 113445
Q ss_pred EEEEecCceEEEEeecCCeEEEecC
Q 045256 282 ESIVSGSNFTCGLTTSNFSVICWGP 306 (789)
Q Consensus 282 ~~i~~G~~h~~al~~~g~~v~~WG~ 306 (789)
..++....+.+.-..|| +|..|=-
T Consensus 264 ~~~~~~~~~~~s~s~Dg-~i~iwd~ 287 (342)
T d2ovrb2 264 TCLQFNKNFVITSSDDG-TVKLWDL 287 (342)
T ss_dssp EEEEECSSEEEEEETTS-EEEEEET
T ss_pred eecccCCCeeEEEcCCC-EEEEEEC
Confidence 66666555555555566 9999953
|
| >d1btea_ g.7.1.3 (A:) Type II activin receptor {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Snake toxin-like superfamily: Snake toxin-like family: Extracellular domain of cell surface receptors domain: Type II activin receptor species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.20 E-value=0.0048 Score=49.10 Aligned_cols=48 Identities=21% Similarity=0.304 Sum_probs=38.3
Q ss_pred CCcccccccCCCcccCCCC-CCCCCCCCCccCCCcccccCCccccCCCCC
Q 045256 313 NDSVSLVPFQQEILPGPCD-NSSCSECGLYPQSDRLCFGNGNICKSCQNV 361 (789)
Q Consensus 313 ~~~~~~~~~~~~~~~~~C~-~~~c~~~~~~p~~~~~C~~~~~~C~~c~~~ 361 (789)
.+.+.++++|||..+.+|- +++|.+..+.| .+.|||+.+++|+.....
T Consensus 43 ~g~~~i~~qGCw~d~~~cc~~~~Cv~~~~~~-~~~FCCC~gd~CN~nfs~ 91 (96)
T d1btea_ 43 SGSIEIVKQGCWLDDINCYDRTDCIEKKDSP-EVYFCCCEGNMCNEKFSY 91 (96)
T ss_dssp TTEEEEEEEEEECSCCCCSCSSSEEECSSSC-SSEEEEECSTTGGGSEEE
T ss_pred CCCEEEEEecCcCCCCCcccccccccCCCCC-ceEEEeCCCCcccccccc
Confidence 4568999999999988984 57898765544 589999999999875544
|
| >d1p22a2 b.69.4.1 (A:253-545) F-box/WD-repeat protein 1 (beta-TRCP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD-repeat protein 1 (beta-TRCP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.09 E-value=2.2 Score=39.37 Aligned_cols=221 Identities=8% Similarity=0.078 Sum_probs=112.1
Q ss_pred EEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcceeeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCCC
Q 045256 75 FSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPKRIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNAP 154 (789)
Q Consensus 75 v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~~ 154 (789)
|..++.-+.+-+.=..|| +|..|=.+. ..+........-.|..|+....+.+.-..||.+..|--.........
T Consensus 18 V~c~~~d~~~l~sgs~Dg-~i~vWd~~~-----~~~~~~l~~H~~~V~~v~~~~~~l~s~s~D~~i~~~~~~~~~~~~~~ 91 (293)
T d1p22a2 18 VYCLQYDDQKIVSGLRDN-TIKIWDKNT-----LECKRILTGHTGSVLCLQYDERVIITGSSDSTVRVWDVNTGEMLNTL 91 (293)
T ss_dssp EEEEECCSSEEEEEESSS-CEEEEESSS-----CCEEEEECCCSSCEEEEECCSSEEEEEETTSCEEEEESSSCCEEEEE
T ss_pred EEEEEEcCCEEEEEeCCC-eEEEEECCC-----CcEEEEEecCCCCEeeeecccceeecccccccccccccccccccccc
Confidence 444444333333335688 898984331 12222222223346678876666666678999999953322222111
Q ss_pred C-CCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCccc---CCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCC
Q 045256 155 S-GELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQ---TSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQ 230 (789)
Q Consensus 155 ~-~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~---~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gq 230 (789)
. ..........-... ++....++.+..|-......... .......+..+.......+....||.|..|-... ++
T Consensus 92 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~~~~~~~~s~d~~i~~~d~~~-~~ 169 (293)
T d1p22a2 92 IHHCEAVLHLRFNNGM-MVTCSKDRSIAVWDMASPTDITLRRVLVGHRAAVNVVDFDDKYIVSASGDRTIKVWNTST-CE 169 (293)
T ss_dssp CCCCSCEEEEECCTTE-EEEEETTSCEEEEECSSSSCCEEEEEECCCSSCEEEEEEETTEEEEEETTSEEEEEETTT-CC
T ss_pred cccccccccccccccc-eeecccccceeEeeccccccccccccccccccccccceecccccccccCCCceeeecCCC-Cc
Confidence 1 11112222222222 23345666888886543322211 0111223445555566667778899999996544 33
Q ss_pred CCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCcccC--CCCCcEEEEEecCceEEEEeecCCeEEEec
Q 045256 231 LKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVNG--IRGKSFESIVSGSNFTCGLTTSNFSVICWG 305 (789)
Q Consensus 231 l~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~~--~~~~~v~~i~~G~~h~~al~~~g~~v~~WG 305 (789)
+-.........+..++....+.++-.. ||++..|-....-.+.. .....+..++......++-..|| +|..|-
T Consensus 170 ~~~~~~~~~~~v~~~~~~~~~l~~~~~-dg~i~i~d~~~~~~~~~~~~~~~~v~~~~~~~~~l~sg~~dg-~i~iwd 244 (293)
T d1p22a2 170 FVRTLNGHKRGIACLQYRDRLVVSGSS-DNTIRLWDIECGACLRVLEGHEELVRCIRFDNKRIVSGAYDG-KIKVWD 244 (293)
T ss_dssp EEEEEECCSSCEEEEEEETTEEEEEET-TSCEEEEETTTCCEEEEECCCSSCEEEEECCSSEEEEEETTS-CEEEEE
T ss_pred EEEEEcccccccccccCCCCeEEEecC-CCEEEEEecccceeeeeecccceeeeeccccceEEEEEcCCC-EEEEEE
Confidence 211111112235555555566666666 99999996554333222 12233455555544444444566 888884
|
| >d2h62d1 g.7.1.3 (D:8-98) Type II activin receptor {Mouse (Mus musculus), isoform IIB [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Snake toxin-like superfamily: Snake toxin-like family: Extracellular domain of cell surface receptors domain: Type II activin receptor species: Mouse (Mus musculus), isoform IIB [TaxId: 10090]
Probab=92.13 E-value=0.014 Score=45.62 Aligned_cols=44 Identities=18% Similarity=0.314 Sum_probs=35.4
Q ss_pred CCcccccccCCCcccCCCCC-CCCCCCCCccCCCcccccCCccccC
Q 045256 313 NDSVSLVPFQQEILPGPCDN-SSCSECGLYPQSDRLCFGNGNICKS 357 (789)
Q Consensus 313 ~~~~~~~~~~~~~~~~~C~~-~~c~~~~~~p~~~~~C~~~~~~C~~ 357 (789)
.+.+.++++|||..+.+|-+ ++|.+... |....|||+.+++|+.
T Consensus 42 ~~~i~i~~qGCw~d~~~c~~~~eCv~~~~-~~~~~FCCC~gd~CN~ 86 (91)
T d2h62d1 42 SGTIELVKKGCWLDDFNCYDRQECVATEE-NPQVYFCCCEGNFCNE 86 (91)
T ss_dssp TTEEEEEEEEEEECCGGGTTCSSEECCCS-SCSSEEEEESSTTTTS
T ss_pred CCCEEEEEecccCCCCCcccccccCccCC-CCceEEEeCCCCcccc
Confidence 35688999999999888854 78986544 4458999999999964
|
| >d2ovrb2 b.69.4.1 (B:2365-2706) F-box/WD repeat-containing protein 7, FBXW7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: F-box/WD repeat-containing protein 7, FBXW7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.13 E-value=4.9 Score=37.83 Aligned_cols=222 Identities=9% Similarity=0.081 Sum_probs=113.2
Q ss_pred eEEEEecCceeeeeeeecCCCcEEEeeCCccc----ccCCCCcEEEEEecCceEEEEEeCCceEEEccCCCCCCCCCcce
Q 045256 36 TLAVSYGSATVCAVVAAQPTQRLLCYQGGTIR----AVEPNISFSSISAGQSFFCGIRSGGYSLLCWDTNFSYNSNFVPK 111 (789)
Q Consensus 36 ~~~i~~G~~h~~~~~~l~~~g~v~~wG~~~~~----~~~~~~~v~~i~~G~~~~~~l~~~G~~v~~wG~n~~~~~~~~p~ 111 (789)
|.+++--....+ ....|+++..|-..... .......+...............|+ ++..|-.... ....
T Consensus 60 V~~v~~~~~~l~---s~s~D~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~i~~~~~~~~----~~~~ 131 (342)
T d2ovrb2 60 VWSSQMRDNIII---SGSTDRTLKVWNAETGECIHTLYGHTSTVRCMHLHEKRVVSGSRDA-TLRVWDIETG----QCLH 131 (342)
T ss_dssp EEEEEEETTEEE---EEETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTEEEEEETTS-EEEEEESSSC----CEEE
T ss_pred EEEEEeCCCccc---cceecccccccccccccceecccccceeEeeeecccccccccccce-eEEEeecccc----ccee
Confidence 444444333333 44567777777662111 1122334555666666667777888 8888854431 1111
Q ss_pred eeeeCCcceEEEEEecCCeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCC
Q 045256 112 RIYYNDTVLLSSVSVGNNHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISN 190 (789)
Q Consensus 112 ~v~~~~~~~i~~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gq 190 (789)
.+.. ...............+.-..||.+..|.......... ......+..++....+ ++.-..+|+|+.|-......
T Consensus 132 ~~~~-~~~~~~~~~~~~~~~~~~~~d~~i~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~-l~s~~~dg~i~~~d~~~~~~ 209 (342)
T d2ovrb2 132 VLMG-HVAAVRCVQYDGRRVVSGAYDFMVKVWDPETETCLHTLQGHTNRVYSLQFDGIH-VVSGSLDTSIRVWDVETGNC 209 (342)
T ss_dssp EEEC-CSSCEEEEEECSSCEEEEETTSCEEEEEGGGTEEEEEECCCSSCEEEEEECSSE-EEEEETTSCEEEEETTTCCE
T ss_pred eeec-ccccceeeccccceeeeecCCCeEEEeecccceeeEEEcCcccccccccCCCCE-EEEEeCCCeEEEeeccccee
Confidence 1111 1112223444455566667789988885322211100 0011134444443333 33346677999997544333
Q ss_pred cccCCCCCceeEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcC--CCCCccceEEeccCcceEEEEEeeCCeEEEeeeC
Q 045256 191 QIQTSFANRSMFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFP--LNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQ 268 (789)
Q Consensus 191 lg~~~~~~~~v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~--~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n 268 (789)
+-........+..++.-....++-..||.++.|=.......... .......+..++....+-+.-.+ ||+|..|=-.
T Consensus 210 ~~~~~~~~~~v~~~~~~~~~l~s~s~d~~i~iwd~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~s~-Dg~i~iwd~~ 288 (342)
T d2ovrb2 210 IHTLTGHQSLTSGMELKDNILVSGNADSTVKIWDIKTGQCLQTLQGPNKHQSAVTCLQFNKNFVITSSD-DGTVKLWDLK 288 (342)
T ss_dssp EEEECCCCSCEEEEEEETTEEEEEETTSCEEEEETTTCCEEEEECSTTSCSSCEEEEEECSSEEEEEET-TSEEEEEETT
T ss_pred eeEecccccceeEEecCCCEEEEEcCCCEEEEEecccccccccccccceeeeceeecccCCCeeEEEcC-CCEEEEEECC
Confidence 32222223345566666666666688999999965443322111 11112345555555555445555 9999999644
|
| >d1l0qa2 b.69.2.3 (A:1-301) Surface layer protein {Archaeon Methanosarcina mazei [TaxId: 2209]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: YVTN repeat-like/Quinoprotein amine dehydrogenase family: YVTN repeat domain: Surface layer protein species: Archaeon Methanosarcina mazei [TaxId: 2209]
Probab=91.31 E-value=5.7 Score=36.89 Aligned_cols=46 Identities=13% Similarity=0.174 Sum_probs=26.0
Q ss_pred eeecCCCcEEEeeCCcccccCCCCcEEEEEecCc-eEEEEEeCCceEEEccCC
Q 045256 50 VAAQPTQRLLCYQGGTIRAVEPNISFSSISAGQS-FFCGIRSGGYSLLCWDTN 101 (789)
Q Consensus 50 ~~l~~~g~v~~wG~~~~~~~~~~~~v~~i~~G~~-~~~~l~~~G~~v~~wG~n 101 (789)
++-..|++|.-|=. ....-+..|..|.. |.+++..||+.+|+-+..
T Consensus 6 V~~~~~~~v~v~D~------~t~~~~~~i~~g~~p~~va~spdG~~l~v~~~~ 52 (301)
T d1l0qa2 6 IANSESDNISVIDV------TSNKVTATIPVGSNPMGAVISPDGTKVYVANAH 52 (301)
T ss_dssp EEETTTTEEEEEET------TTTEEEEEEECSSSEEEEEECTTSSEEEEEEGG
T ss_pred EEECCCCEEEEEEC------CCCeEEEEEECCCCceEEEEeCCCCEEEEEECC
Confidence 34556677766632 11223444555543 778888888557765543
|
| >d1rwia_ b.68.9.1 (A:) Serine/threonine-protein kinase PknD {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 6-bladed beta-propeller superfamily: NHL repeat family: NHL repeat domain: Serine/threonine-protein kinase PknD species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=89.76 E-value=1 Score=42.61 Aligned_cols=54 Identities=11% Similarity=0.097 Sum_probs=27.7
Q ss_pred CcceEEEEEeeCCeEEEeeeCCCCccc-C-CCCCcEEEEE-ec--CceEEEEeecCCeEEEe
Q 045256 248 GFNHSCAIRRLNGSVVCWGSQGEYSVN-G-IRGKSFESIV-SG--SNFTCGLTTSNFSVICW 304 (789)
Q Consensus 248 G~~h~~al~~~dG~v~~WG~n~~gq~~-~-~~~~~v~~i~-~G--~~h~~al~~~g~~v~~W 304 (789)
+.-+.+++.. +|.+|.=-+. .+++- . +.......+. .+ .-+.+++..+| .||.=
T Consensus 182 ~~p~gi~~d~-~g~l~vsd~~-~~~i~~~~~~~~~~~~~~~~~~~~P~~i~~d~~g-~l~va 240 (260)
T d1rwia_ 182 TAPWGIAVDE-AGTVYVTEHN-TNQVVKLLAGSTTSTVLPFTGLNTPLAVAVDSDR-TVYVA 240 (260)
T ss_dssp CSEEEEEECT-TCCEEEEETT-TTEEEEECTTCSCCEECCCCSCCCEEEEEECTTC-CEEEE
T ss_pred CCCccceeee-eeeeeeeecC-CCEEEEEeCCCCeEEEEccCCCCCeEEEEEeCCC-CEEEE
Confidence 3456777876 8998854433 23321 1 1111122221 12 23578888777 78763
|
| >d1nexb2 b.69.4.1 (B:370-744) Cdc4 propeller domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Cdc4 propeller domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=89.12 E-value=9.2 Score=35.94 Aligned_cols=141 Identities=12% Similarity=0.098 Sum_probs=70.9
Q ss_pred EEEecCCeEEEEeeCCeEEEcCCCCCCCCCC-CCCCccEEEEeeeCceeEEEEeCCCeEEEeecCCCCCcccCCC-CCce
Q 045256 123 SVSVGNNHVCATTVQGQINCWRGDVNISKNA-PSGELQFESLTSGIDFSCGILTNNKTVRCWGINSISNQIQTSF-ANRS 200 (789)
Q Consensus 123 ~v~~G~~h~~al~~~G~v~~wG~~~~~~~~~-~~~~~~v~~va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~-~~~~ 200 (789)
..+....+.+.-..||++..|-......... ..-...|..++.-..+ ++.-..+|+|..|-.+...+.-.... ....
T Consensus 208 ~~~~~~~~~~~~~~d~~i~i~d~~~~~~~~~~~~h~~~v~~~~~~~~~-l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~~ 286 (355)
T d1nexb2 208 IYDHERKRCISASMDTTIRIWDLENGELMYTLQGHTALVGLLRLSDKF-LVSAAADGSIRGWDANDYSRKFSYHHTNLSA 286 (355)
T ss_dssp EEETTTTEEEEEETTSCEEEEETTTCCEEEEECCCSSCCCEEEECSSE-EEEECTTSEEEEEETTTCCEEEEEECTTCCC
T ss_pred cccccceeeecccccceEEeeeccccccccccccccccccccccccce-eeeeecccccccccccccceecccccCCceE
Confidence 3444566677778899999985432221111 0011134455544444 34356778999996654433211111 1111
Q ss_pred eEEEeeCCceeEEEccCCcEEEEEcCCCCCCCcC-CCCCccceEEeccCcceEE-EEEeeCCeEEEeee
Q 045256 201 MFSITAGGNHVCGIDSNGFVICYGDNKSGQLKFP-LNSTAFEYSALSLGFNHSC-AIRRLNGSVVCWGS 267 (789)
Q Consensus 201 v~~i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~-~~~~~~~v~~i~~G~~h~~-al~~~dG~v~~WG~ 267 (789)
+.....+.. .++-..||+|.-|=- ..|++-.. .......|..++--..+-+ +... ||+++.|=+
T Consensus 287 ~~~~~~~~~-~l~~g~d~~i~vwd~-~tg~~~~~~~~~~~~~V~~v~~~~~~~~~~~s~-dg~~~l~~~ 352 (355)
T d1nexb2 287 ITTFYVSDN-ILVSGSENQFNIYNL-RSGKLVHANILKDADQIWSVNFKGKTLVAAVEK-DGQSFLEIL 352 (355)
T ss_dssp CCEEEECSS-EEEEEETTEEEEEET-TTCCBCCSCTTTTCSEEEEEEEETTEEEEEEES-SSCEEEEEE
T ss_pred EEEEcCCCC-EEEEEeCCEEEEEEC-CCCCEEEEEecCCCCCEEEEEEcCCeEEEEEEC-CCcEEEEEE
Confidence 223343443 344467899999953 34665321 1112234555543333333 3444 898777743
|
| >d2bbkh_ b.69.2.1 (H:) Methylamine dehydrogenase, H-chain {Paracoccus denitrificans [TaxId: 266]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: YVTN repeat-like/Quinoprotein amine dehydrogenase family: Methylamine dehydrogenase, H-chain domain: Methylamine dehydrogenase, H-chain species: Paracoccus denitrificans [TaxId: 266]
Probab=88.25 E-value=7.5 Score=37.19 Aligned_cols=23 Identities=4% Similarity=-0.088 Sum_probs=16.0
Q ss_pred eeCCceeEEEccCCcEEEEEcCC
Q 045256 205 TAGGNHVCGIDSNGFVICYGDNK 227 (789)
Q Consensus 205 ~~G~~h~~al~~dG~v~~wG~n~ 227 (789)
.....+.+....+|++|.|..+.
T Consensus 203 ~~~~~~~~~~~~~~~~~v~~~~~ 225 (355)
T d2bbkh_ 203 SQKAGRLVWPTYTGKIHQIDLSS 225 (355)
T ss_dssp ETTTTEEEEEBTTSEEEEEECTT
T ss_pred cCCCCeEEEecCCCeEEEEecCC
Confidence 33444556667889999998665
|
| >d1nexb2 b.69.4.1 (B:370-744) Cdc4 propeller domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: WD40 repeat-like family: WD40-repeat domain: Cdc4 propeller domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=87.88 E-value=11 Score=35.33 Aligned_cols=174 Identities=6% Similarity=-0.041 Sum_probs=84.7
Q ss_pred cCCeEEEEeeCCeEEEcCCCCCCCCCCC-CCCccEEE--EeeeCceeEEEEeCCCeEEEeecCCCCCcccCCCCCceeEE
Q 045256 127 GNNHVCATTVQGQINCWRGDVNISKNAP-SGELQFES--LTSGIDFSCGILTNNKTVRCWGINSISNQIQTSFANRSMFS 203 (789)
Q Consensus 127 G~~h~~al~~~G~v~~wG~~~~~~~~~~-~~~~~v~~--va~G~~hs~al~~~~g~v~~wG~n~~gqlg~~~~~~~~v~~ 203 (789)
.....+.-..|+.+..|--......... .....+.. ......+. +....+|+|+.|-......+..-......|..
T Consensus 170 ~~~~~~~~~~d~~i~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~i~i~d~~~~~~~~~~~~h~~~v~~ 248 (355)
T d1nexb2 170 HGNIVVSGSYDNTLIVWDVAQMKCLYILSGHTDRIYSTIYDHERKRC-ISASMDTTIRIWDLENGELMYTLQGHTALVGL 248 (355)
T ss_dssp ETTEEEEEETTSCEEEEETTTTEEEEEECCCSSCEEEEEEETTTTEE-EEEETTSCEEEEETTTCCEEEEECCCSSCCCE
T ss_pred ccceeeeecccceeeeeecccccceeeeeccccccccccccccceee-ecccccceEEeeeccccccccccccccccccc
Confidence 3444555566777887753222111100 01112222 22222333 33456678998865433222221112233556
Q ss_pred EeeCCceeEEEccCCcEEEEEcCCCCCCCcCCCCCccceEEeccCcceEEEEEeeCCeEEEeeeCCCCccc-C---CCCC
Q 045256 204 ITAGGNHVCGIDSNGFVICYGDNKSGQLKFPLNSTAFEYSALSLGFNHSCAIRRLNGSVVCWGSQGEYSVN-G---IRGK 279 (789)
Q Consensus 204 i~~G~~h~~al~~dG~v~~wG~n~~Gql~~~~~~~~~~v~~i~~G~~h~~al~~~dG~v~~WG~n~~gq~~-~---~~~~ 279 (789)
++....+.+.-..||.|..|=.+..-+.-.........+.....+.. -++-.. ||+|..|=-. .|++- . ....
T Consensus 249 ~~~~~~~l~~~~~dg~i~iwd~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~g~-d~~i~vwd~~-tg~~~~~~~~~~~~ 325 (355)
T d1nexb2 249 LRLSDKFLVSAAADGSIRGWDANDYSRKFSYHHTNLSAITTFYVSDN-ILVSGS-ENQFNIYNLR-SGKLVHANILKDAD 325 (355)
T ss_dssp EEECSSEEEEECTTSEEEEEETTTCCEEEEEECTTCCCCCEEEECSS-EEEEEE-TTEEEEEETT-TCCBCCSCTTTTCS
T ss_pred cccccceeeeeecccccccccccccceecccccCCceEEEEEcCCCC-EEEEEe-CCEEEEEECC-CCCEEEEEecCCCC
Confidence 66666666666889999999665543321111111122333333333 344445 9999999543 35532 1 1234
Q ss_pred cEEEEEecCceEE-EEeecCCeEEEec
Q 045256 280 SFESIVSGSNFTC-GLTTSNFSVICWG 305 (789)
Q Consensus 280 ~v~~i~~G~~h~~-al~~~g~~v~~WG 305 (789)
.|..++--..+.+ +...|| +++.|=
T Consensus 326 ~V~~v~~~~~~~~~~~s~dg-~~~l~~ 351 (355)
T d1nexb2 326 QIWSVNFKGKTLVAAVEKDG-QSFLEI 351 (355)
T ss_dssp EEEEEEEETTEEEEEEESSS-CEEEEE
T ss_pred CEEEEEEcCCeEEEEEECCC-cEEEEE
Confidence 5777765445443 344566 877664
|
| >d1qksa2 b.70.2.1 (A:136-567) C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase {Paracoccus denitrificans [TaxId: 266]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase family: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase domain: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase species: Paracoccus denitrificans [TaxId: 266]
Probab=87.78 E-value=15 Score=36.82 Aligned_cols=44 Identities=9% Similarity=0.160 Sum_probs=26.9
Q ss_pred eecCCCcEEEeeCCcccccCCCCcEEEEEecCc-eEEEEEeCCceEEEccC
Q 045256 51 AAQPTQRLLCYQGGTIRAVEPNISFSSISAGQS-FFCGIRSGGYSLLCWDT 100 (789)
Q Consensus 51 ~l~~~g~v~~wG~~~~~~~~~~~~v~~i~~G~~-~~~~l~~~G~~v~~wG~ 100 (789)
....+|+|.-|=- ....-+..+..|.. |.++...||+++|+-+.
T Consensus 37 ~~~d~g~v~v~D~------~t~~v~~~~~~g~~~~~v~fSpDG~~l~~~s~ 81 (432)
T d1qksa2 37 TLRDAGQIALIDG------STYEIKTVLDTGYAVHISRLSASGRYLFVIGR 81 (432)
T ss_dssp EETTTTEEEEEET------TTCCEEEEEECSSCEEEEEECTTSCEEEEEET
T ss_pred EEcCCCEEEEEEC------CCCcEEEEEeCCCCeeEEEECCCCCEEEEEcC
Confidence 5678888887732 12223445555643 77777888866766543
|
| >d1rwia_ b.68.9.1 (A:) Serine/threonine-protein kinase PknD {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 6-bladed beta-propeller superfamily: NHL repeat family: NHL repeat domain: Serine/threonine-protein kinase PknD species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=81.88 E-value=2.3 Score=39.95 Aligned_cols=93 Identities=11% Similarity=0.018 Sum_probs=43.8
Q ss_pred eEEEEeeCCeEEEcCCCCCCCCCCCCCCcc-EEEEeee---CceeEEEEeCCCeEEEeecCCCCCccc-CCCC-CceeEE
Q 045256 130 HVCATTVQGQINCWRGDVNISKNAPSGELQ-FESLTSG---IDFSCGILTNNKTVRCWGINSISNQIQ-TSFA-NRSMFS 203 (789)
Q Consensus 130 h~~al~~~G~v~~wG~~~~~~~~~~~~~~~-v~~va~G---~~hs~al~~~~g~v~~wG~n~~gqlg~-~~~~-~~~v~~ 203 (789)
|.+|+..||.+|.......++......... ......+ .-+.++ ...+|.+|+-... ++... .... ...+..
T Consensus 17 ~~vavd~dG~i~v~~~~~~~~i~~~~~~~~~~~~~~~~~~~~p~gva-v~~~g~i~v~d~~--~~~i~~~~~~~~~~~~~ 93 (260)
T d1rwia_ 17 SGVAVDSAGNVYVTSEGMYGRVVKLATGSTGTTVLPFNGLYQPQGLA-VDGAGTVYVTDFN--NRVVTLAAGSNNQTVLP 93 (260)
T ss_dssp EEEEECTTCCEEEEECSSSCEEEEEC----CEEECCCCSCCSCCCEE-ECTTCCEEEEETT--TEEEEECTTCSCCEECC
T ss_pred CEEEEcCCCCEEEEEcCCCCEEEEEcCCCceEEEeccCCccCceEEE-EcCCCCEEEeeee--eceeeeeeeccceeeee
Confidence 677899999999875544443311111111 1111111 224566 3556688764422 11111 1111 111111
Q ss_pred Ee-eCCceeEEEccCCcEEEEEc
Q 045256 204 IT-AGGNHVCGIDSNGFVICYGD 225 (789)
Q Consensus 204 i~-~G~~h~~al~~dG~v~~wG~ 225 (789)
.. ...-+.++++.+|.+|..-.
T Consensus 94 ~~~~~~p~~iavd~~g~i~v~d~ 116 (260)
T d1rwia_ 94 FDGLNYPEGLAVDTQGAVYVADR 116 (260)
T ss_dssp CCSCCSEEEEEECTTCCEEEEEG
T ss_pred eeeeeecccccccccceeEeecc
Confidence 11 12336788899999997643
|